PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, L; Liu, WQ; Lei, JH; Guan, F; Li, MJ; Song, WJ; Li, YL; Wang, T				Chen, Lin; Liu, Wen-qi; Lei, Jia-hui; Guan, Fei; Li, Man-jun; Song, Wen-jian; Li, Yong-long; Wang, Ting			Chronic Schistosoma japonicum Infection Reduces Immune Response to Vaccine against Hepatitis B in Mice	PLOS ONE			English	Article							PROTECTIVE EFFICACY; MANSONI INFECTION; IMMUNOGENICITY; METAANALYSIS; ACTIVATION; ANTIBODIES; CHILDREN; INFANTS	Background: Hepatitis B and schistosomiasis are most prevalent in Africa and Asia, and co-infections of both are frequent in these areas. The immunomodulation reported to be induced by schistosome infections might restrict immune control of hepatitis B virus (HBV) leading to more severe viral infection. Vaccination is the most effective measure to control and prevent HBV infection, but there is evidence for a reduced immune response to the vaccine in patients with chronic schistosomiasis japonica. Methodology/Principal Findings: In this paper, we demonstrate in a mouse model that a chronic Schistosoma japonicum infection can inhibit the immune response to hepatitis B vaccine (HBV vaccine) and lead to lower production of anti-HBs antibodies, interferon-gamma (IFN-gamma) and interleukin-2 (IL-2). After deworming with Praziquantel (PZQ), the level of anti-HBs antibodies gradually increased and the Th2-biased profile slowly tapered. At 16 weeks after deworming, the levels of anti-HBs antibodies and Th1/Th2 cytokines returned to the normal levels. Conclusions/Significance: The results suggest that the preexisting Th2-dominated immune profile in the host infected with the parasite may down-regulate levels of anti-HBs antibodies and Th1 cytokines. To improve the efficacy of HBV vaccination in schistosome infected humans it may be valuable to treat them with praziquantel (PZQ) some time prior to HBV vaccination. Citation: Chen L, Liu W-q, Lei J-h, Guan F, Li M-j, et al. (2012) Chronic Schistosoma japonicum Infection Reduces Immune Response to Vaccine against Hepatitis B in Mice. PLoS ONE 7(12): e51512. doi:10.1371/journal.pone.0051512	[Chen, Lin; Liu, Wen-qi; Lei, Jia-hui; Guan, Fei; Li, Man-jun; Li, Yong-long; Wang, Ting] Huazhong Univ Sci & Technol, Dept Parasitol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, Lin] Jianghan Univ, Wuhan Inst Biomed Sci, Wuhan, Peoples R China; [Song, Wen-jian] Jianghan Univ, Dept Parasitol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Jianghan University; Jianghan University	Wang, T (corresponding author), Huazhong Univ Sci & Technol, Dept Parasitol, Tongji Med Coll, Wuhan 430074, Peoples R China.	wangting139@mail.hust.edu.cn	Lei, Jiahui/HGV-0100-2022	LI, MANJUN/0000-0002-5296-7614	National Nature and Science Foundation of China [81000738]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Nature and Science Foundation of China (project grant 81000738). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Bocher WO, 2000, HEPATOLOGY, V31, P480, DOI 10.1002/hep.510310231; Borkow G, 2006, PARASITE IMMUNOL, V28, P605, DOI 10.1111/j.1365-3024.2006.00918.x; Borkow G, 2002, CLIN DIAGN LAB IMMUN, V9, P505, DOI 10.1128/CDLI.9.3.505-507.2002; Borkow G, 2000, J CLIN INVEST, V106, P1053, DOI 10.1172/JCI10182; Bundy D, 2000, PARASITOL TODAY, V16, P273, DOI 10.1016/S0169-4758(00)01689-6; Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Eren R, 1998, IMMUNOLOGY, V93, P154; GHAFFAR YA, 1989, LANCET, V2, P272; GHAFFAR YA, 1990, AM J TROP MED HYG, V43, P516, DOI 10.4269/ajtmh.1990.43.516; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guan you-gen, 2008, CHINESE J CHILD HLTH, V16, P494; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Lanata CF, 1996, J INFECT DIS, V174, P268, DOI 10.1093/infdis/174.2.268; McClary H, 2000, J EXP MED, V192, P289, DOI 10.1084/jem.192.2.289; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; Muniz-Junqueira M I, 1996, Rev Soc Bras Med Trop, V29, P441, DOI 10.1590/S0037-86821996000500006; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; SAMUEL D, 1993, NEW ENGL J MED, V329, P1842, DOI 10.1056/NEJM199312163292503; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Sjogren MH, 2005, AM J MED, V118, P34, DOI 10.1016/j.amjmed.2005.07.012; Song Wen-Jian, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P163; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; SUTTER RW, 1991, LANCET, V338, P715, DOI 10.1016/0140-6736(91)91442-W; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; WAINWRIGHT RB, 1989, JAMA-J AM MED ASSOC, V261, P2362, DOI 10.1001/jama.261.16.2362; Wu G.L., 2005, HUMAN PARASITOLOGY, V3rd ed.; Zai XJ, 2002, RAILWAY MED J, V30, P63; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	36	27	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51512	10.1371/journal.pone.0051512	http://dx.doi.org/10.1371/journal.pone.0051512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272112	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800050
J	Chen, LF; Chen, HP; Huang, YS; Huang, KY; Chou, P; Lee, CC				Chen, Li-Fu; Chen, Hsin-Pai; Huang, Yung-Sung; Huang, Kuang-Yung; Chou, Pesus; Lee, Ching-Chih			Pneumococcal Pneumonia and the Risk of Stroke: A Population-Based Follow-Up Study	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; MYOCARDIAL-INFARCTION; DISEASE; ATHEROSCLEROSIS; VACCINATION	Background: To investigate the risk of developing stroke in patients hospitalized following a diagnosis of pneumococcal pneumonia. Methods: The study cohorts comprised of patients hospitalized with a principal diagnosis of pneumococcal pneumonia (n = 745), with a random sampling of control individuals in 2004 (n = 1490). The Cox proportional hazard model was used to compare the stroke-free survival rate between the cohorts after adjusting for possible confounding and risk factors for a two-year follow up. Instrumental variable analysis (IVA) was used to address potential biases associated with measured and unmeasured confounding variables. Results: Of the 153 patients with stroke, 80 (10.7%) were from the pneumococcal pneumonia cohort, and 73 (4.9%) were from the control group. The risk of stroke was 3.65 times higher (95% confidence interval, 2.25-5.90; P<0.001) in patients with pneumococcal pneumonia after adjusting for patient characteristics, co-morbidities, geographic region, urbanization level of residence, and socioeconomic status during the first year. IVA showed an additional 14% risk of stroke for pneumococcal pneumonia patients (odds ratio = 1.14; 95% CI, 1.02-1.26, P = 0.032). Conclusions: Patients with pneumococcal pneumonia carry an increased risk for stroke than the general population. Further studies are warranted for developing better diagnostic and follow-up strategies for patients with increased risk.	[Chen, Li-Fu] Natl Yang Ming Univ Hosp, Dept Emergency Med, Ilan, Taiwan; [Chen, Hsin-Pai] Natl Yang Ming Univ Hosp, Dept Internal Med, Ilan, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Clin Epidemiol & Biostat, Chiayi, Taiwan; [Huang, Kuang-Yung; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, CC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan.	hematcd@hotmail.com	Lei, Jiahui/HGV-0100-2022	LI, MANJUN/0000-0002-5296-7614				Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Elkind MSV, 2010, STROKE, V41, pE117, DOI 10.1161/STROKEAHA.109.571299; Gross PL, 2000, SEMIN THROMB HEMOST, V26, P463, DOI 10.1055/s-2000-13202; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Lamontagne F, 2008, CAN MED ASSOC J, V179, P773, DOI 10.1503/cmaj.070221; Libby P, 1997, CIRCULATION, V96, P4095; Mendall MA, 1997, HEART, V78, P273, DOI 10.1136/hrt.78.3.273; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smieja M, 2003, CIRCULATION, V107, P251, DOI 10.1161/01.CIR.0000044940.65226.1F; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Zysk G, 2001, INFECT IMMUN, V69, P845, DOI 10.1128/IAI.69.2.845-852.2001	15	27	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51452	10.1371/journal.pone.0051452	http://dx.doi.org/10.1371/journal.pone.0051452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23272112	gold, Green Submitted, Green Published			2022-12-27	WOS:000313236200111
J	Barakat, KH; Jordheim, LP; Perez-Pineiro, R; Wishart, D; Dumontet, C; Tuszynski, JA				Barakat, Khaled H.; Jordheim, Lars P.; Perez-Pineiro, Rolando; Wishart, David; Dumontet, Charles; Tuszynski, Jack A.			Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; ACCOMMODATING RECEPTOR FLEXIBILITY; COMPLEMENTATION GROUP-A; DRUG-LIKE INHIBITORS; MOLECULAR-DYNAMICS; DNA-REPAIR; CISPLATIN; ERCC1; XPA; EXPRESSION	Background: Nucleotide excision repair (NER) removes many types of DNA lesions including those induced by UV radiation and platinum-based therapy. Resistance to platinum-based therapy correlates with high expression of ERCC1, a major element of the NER machinery. The interaction between ERCC1 and XPA is essential for a successful NER function. Therefore, one way to regulate NER is by inhibiting the activity of ERCC1 and XPA. Methodology/Principal Findings: Here we continued our earlier efforts aimed at the identification and characterization of novel inhibitors of the ERCC1-XPA interaction. We used a refined virtual screening approach combined with a biochemical and biological evaluation of the compounds for their ability to interact with ERCC1 and to sensitize cells to UV radiation. Our findings reveal a new validated ERCC1-XPA inhibitor that significantly sensitized colon cancer cells to UV radiation indicating a strong inhibition of the ERCC1-XPA interaction. Conclusions: NER is a major factor in acquiring resistance to platinum-based therapy. Regulating the NER pathway has the potential of improving the efficacy of platinum treatments. One approach that we followed is to inhibit the essential interaction between the two NER elements, ERCC1 and XPA. Here, we performed virtual screening against the ERCC1-XPA interaction and identified novel inhibitors that block the XPA-ERCC1 binding. The identified inhibitors significantly sensitized colon cancer cells to UV radiation indicating a strong inhibition of the ERCC1-XPA interaction. Citation: Barakat KH, Jordheim LP, Perez-Pineiro R, Wishart D, Dumontet C, et al. (2012) Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction. PLoS ONE 7(12): e51329. doi:10.1371/journal.pone.0051329	[Barakat, Khaled H.; Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Barakat, Khaled H.] Fayoum Univ, Dept Engn Math & Phys, Al Fayyum, Egypt; [Jordheim, Lars P.; Dumontet, Charles] Univ Lyon, Lyon, France; [Jordheim, Lars P.; Dumontet, Charles] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France; [Jordheim, Lars P.; Dumontet, Charles] Ctr Rech Cancerol Lyon, CNRS, UMR 5286, Lyon, France; [Tuszynski, Jack A.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Perez-Pineiro, Rolando; Wishart, David] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wishart, David] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada	University of Alberta; Egyptian Knowledge Bank (EKB); Fayoum University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; University of Alberta; University of Alberta; University of Alberta	Tuszynski, JA (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.	jackt@ualberta.ca	Wishart, David Scott/ABI-3181-2020; Tuszynski, Jack/AAA-2073-2020; Jordheim, Lars Petter/X-7228-2019; Pineiro, Rolando Perez/O-7117-2018	Tuszynski, Jack/0000-0001-9976-0429; Jordheim, Lars Petter/0000-0003-3948-7090; Pineiro, Rolando Perez/0000-0001-6107-1898; Dumontet, Charles/0000-0003-1875-134X; Wishart, David S/0000-0002-3207-2434; Barakat, Khaled/0000-0002-3567-7279	Allard Foundation	Allard Foundation	The only source of funding for this project was the Allard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 2001, CURR OPIN CHEM BIOL, V5, P375, DOI 10.1016/S1367-5931(00)00217-9; Amaro RE, 2008, P NATL ACAD SCI USA, V105, P17278, DOI 10.1073/pnas.0805820105; Babakhani A, 2009, COMPUT BIOL CHEM, V33, P160, DOI 10.1016/j.compbiolchem.2008.12.002; Barakat K., 2010, 17 CAN S THEOR CHEM; Barakat K, 2011, DNA REPAIR PATHWAYS; Barakat K.H., 2011, HDB RES COMPUTATIONA; Barakat K, 2010, J MOL GRAPH MODEL, V28, P555, DOI 10.1016/j.jmgm.2009.12.003; Barakat KH, 2009, J MOL GRAPH MODEL, V28, P113, DOI 10.1016/j.jmgm.2009.04.009; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Bellmunt J, 2007, ANN ONCOL, V18, P522, DOI 10.1093/annonc/mdl435; Bennett MJ, 2010, CHEM BIOL, V17, P725, DOI 10.1016/j.chembiol.2010.05.019; Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cummings M, 2006, BIOCHEM PHARMACOL, V72, P166, DOI 10.1016/j.bcp.2006.04.025; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Durrant JD, 2010, J MED CHEM, V53, P5025, DOI 10.1021/jm100456a; Durrant JD, 2010, COMPUT BIOL CHEM, V34, P97, DOI 10.1016/j.compbiolchem.2010.03.005; Handra-Luca A, 2007, CLIN CANCER RES, V13, P3855, DOI 10.1158/1078-0432.CCR-07-0252; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jiang H, 1999, CANCER RES, V59, P4529; Jordheim LP, 2005, MOL CANCER THER, V4, P1268, DOI 10.1158/1535-7163.MCT-05-0121; Jun HJ, 2008, BRIT J CANCER, V99, P167, DOI 10.1038/sj.bjc.6604464; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lin JH, 2003, BIOPOLYMERS, V68, P47, DOI 10.1002/bip.10218; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; MARKOWITZ M, 2006, 16 INT AIDS C TOR CA; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagao A, 2008, BIOCHEM BIOPH RES CO, V370, P301, DOI 10.1016/j.bbrc.2008.03.078; Ni HH, 2001, J MED CHEM, V44, P3043, DOI 10.1021/jm010205y; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Philippopoulos M, 1999, PROTEINS, V36, P87, DOI 10.1002/(SICI)1097-0134(19990701)36:1<87::AID-PROT8>3.0.CO;2-R; Rosenberg E, 2001, CANCER RES, V61, P764; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Routier S, 2005, J MED CHEM, V48, P1401, DOI 10.1021/jm049213f; Routier S, 2001, TETRAHEDRON LETT, V42, P7025, DOI 10.1016/S0040-4039(01)01308-9; Sarasin A, 1999, MUTAT RES-FUND MOL M, V428, P5, DOI 10.1016/S1383-5742(99)00025-3; Schames JR, 2004, J MED CHEM, V47, P1879, DOI 10.1021/jm0341913; Schneider G, 2002, DRUG DISCOV TODAY, V7, P64, DOI 10.1016/S1359-6446(01)02091-8; Shahzad MMK, 2009, DRUG RESIST UPDATE, V12, P148, DOI 10.1016/j.drup.2009.09.001; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; SHOICHET BK, 1993, SCIENCE, V259, P1445, DOI 10.1126/science.8451640; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; WELCOMME N, 1978, ANN PHARM FR, V36, P135; Welsh C, 2004, INT J CANCER, V110, P352, DOI 10.1002/ijc.20134; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q	54	52	52	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51329	10.1371/journal.pone.0051329	http://dx.doi.org/10.1371/journal.pone.0051329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272099	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800042
J	Buehler, E; Chen, YC; Martin, S				Buehler, Eugen; Chen, Yu-Chi; Martin, Scott			C911: A Bench-Level Control for Sequence Specific siRNA Off-Target Effects	PLOS ONE			English	Article								Small interfering RNAs (siRNAs) have become a ubiquitous experimental tool for down-regulating mRNAs. Unfortunately, off-target effects are a significant source of false positives in siRNA experiments and an effective control for them has not previously been identified. We introduce two methods of mismatched siRNA design for negative controls based on changing bases in the middle of the siRNA to their complement bases. To test these controls, a test set of 20 highly active siRNAs (10 true positives and 10 false positives) was identified from a genome-wide screen performed in a cell-line expressing a simple, constitutively expressed luciferase reporter. Three controls were then synthesized for each of these 20 siRNAs, the first two using the proposed mismatch design methods and the third being a simple random permutation of the sequence (scrambled siRNA). When tested in the original assay, the scrambled siRNAs showed significantly reduced activity in comparison to the original siRNAs, regardless of whether they had been identified as true or false positives, indicating that they have little utility as experimental controls. In contrast, one of the proposed mismatch design methods, dubbed C911 because bases 9 through 11 of the siRNA are replaced with their complement, was able to completely distinguish between the two groups. False positives due to off-target effects maintained most of their activity when the C911 mismatch control was tested, whereas true positives whose phenotype was due to on-target effects lost most or all of their activity when the C911 mismatch was tested. The ability of control siRNAs to distinguish between true and false positives, if widely adopted, could reduce erroneous results being reported in the literature and save research dollars spent on expensive follow-up experiments.	[Buehler, Eugen; Chen, Yu-Chi; Martin, Scott] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Buehler, E (corresponding author), NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	eugen.buehler@nih.gov		Buehler, Eugen/0000-0001-7167-676X	Intramural Research Program of the National Institutes of Health, National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Team RDC, 2019, R LANG ENV STAT COMP; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	14	81	82	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51942	10.1371/journal.pone.0051942	http://dx.doi.org/10.1371/journal.pone.0051942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251657	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800112
J	Davies, WIL; Tay, BH; Zheng, L; Danks, JA; Brenner, S; Foster, RG; Collin, SP; Hankins, MW; Venkatesh, B; Hunt, DM				Davies, Wayne I. L.; Tay, Boon-Hui; Zheng, Lei; Danks, Janine A.; Brenner, Sydney; Foster, Russell G.; Collin, Shaun P.; Hankins, Mark W.; Venkatesh, Byrappa; Hunt, David M.			Evolution and Functional Characterisation of Melanopsins in a Deep-Sea Chimaera (Elephant Shark, Callorhinchus milii)	PLOS ONE			English	Article							GANGLION-CELLS; DIFFERENTIAL EXPRESSION; LIGHT RESPONSE; VA-OPSIN; RHODOPSIN; RETINA; LOCALIZATION; GENES; BIOLUMINESCENCE; PHOTORECEPTORS	Non-visual photoreception in mammals is primarily mediated by two splice variants that derive from a single melanopsin (OPN4M) gene, whose expression is restricted to a subset of retinal ganglion cells. Physiologically, this sensory system regulates the photoentrainment of many biological rhythms, such as sleep via the melatonin endocrine system and pupil constriction. By contrast, melanopsin exists as two distinct lineages in non-mammals, opn4m and opn4x, and is broadly expressed in a wide range of tissue types, including the eye, brain, pineal gland and skin. Despite these findings, the evolution and function of melanopsin in early vertebrates are largely unknown. We, therefore, investigated the complement of opn4 classes present in the genome of a model deep-sea cartilaginous species, the elephant shark (Callorhinchus milii), as a representative vertebrate that resides at the base of the gnathostome (jawed vertebrate) lineage. We reveal that three melanopsin genes, opn4m1, opn4m2 and opn4x, are expressed in multiple tissues of the elephant shark. The two opn4m genes are likely to have arisen as a result of a lineage-specific duplication, whereas "long'' and "short'' splice variants are generated from a single opn4x gene. By using a heterologous expression system, we suggest that these genes encode functional photopigments that exhibit both "invertebrate-like'' bistable and classical "vertebrate-like'' monostable biochemical characteristics. We discuss the evolution and function of these melanopsin pigments within the context of the diverse photic and ecological environments inhabited by this chimaerid holocephalan, as well as the origin of non-visual sensory systems in early vertebrates.	[Davies, Wayne I. L.; Collin, Shaun P.; Hunt, David M.] Univ Western Australia, Sch Anim Biol, Oceans Inst, Perth, WA 6009, Australia; [Davies, Wayne I. L.; Collin, Shaun P.; Hunt, David M.] Univ Western Australia, Lions Eye Inst, Perth, WA 6009, Australia; [Davies, Wayne I. L.; Zheng, Lei; Foster, Russell G.; Hankins, Mark W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [Tay, Boon-Hui; Brenner, Sydney; Venkatesh, Byrappa] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Comparat Genom Lab, Biopolis, Singapore; [Danks, Janine A.] RMIT Univ, Hlth Innovat Res Inst, Sch Med Sci, Comparat Endocrinol & Biochem Lab, Melbourne, Vic, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia; University of Oxford; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Royal Melbourne Institute of Technology (RMIT)	Hunt, DM (corresponding author), Univ Western Australia, Sch Anim Biol, Oceans Inst, Perth, WA 6009, Australia.	mark.hankins@eye.ox.ac.uk; mcbbv@imcb.a-star.edu.sg; david.hunt@uwa.edu.au	Zheng, Lei/AAF-6159-2019; Hunt, David M/K-6024-2012; Collin, Shaun/K-8827-2012; Davies, Wayne/I-1547-2014	Hunt, David M/0000-0002-9264-3948; Collin, Shaun/0000-0001-6236-0771; Davies, Wayne/0000-0003-0232-1812; Venkatesh, Byrappa/0000-0003-3620-0277; FOSTER, RUSSELL/0000-0001-6055-2067	Australian Research Council (ARC); United Kingdom Biotechnology and Biological Sciences Research Council (UK BBSRC); Biomedical Research Council (BRC) of the Agency for Science, Technology, and Research (A*STAR) in Singapore	Australian Research Council (ARC)(Australian Research Council); United Kingdom Biotechnology and Biological Sciences Research Council (UK BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biomedical Research Council (BRC) of the Agency for Science, Technology, and Research (A*STAR) in Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants awarded by the Australian Research Council (ARC) to DMH and SPC, and as part of a Future Fellowship to WILD; the United Kingdom Biotechnology and Biological Sciences Research Council (UK BBSRC) separately to DMH and MWH; and the Biomedical Research Council (BRC) of the Agency for Science, Technology, and Research (A*STAR) in Singapore to BV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; Bailey MJ, 2005, MOL BRAIN RES, V134, P345, DOI 10.1016/j.molbrainres.2004.11.003; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Cheng N, 2009, NATURE, V460, P899, DOI 10.1038/nature08175; Collin SP, 2009, PHILOS T R SOC B, V364, P2925, DOI 10.1098/rstb.2009.0099; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davies WIL, 2012, MOL ECOL, V21, P3121, DOI 10.1111/j.1365-294X.2012.05617.x; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Davies WL, 2007, FASEB J, V21, P2713, DOI 10.1096/fj.06-8057com; Davies WL, 2012, EXP EYE RES, V97, P161, DOI 10.1016/j.exer.2010.07.020; Davies WL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1444, DOI 10.1039/c0pp00203h; Davies WL, 2009, MOL BIOL EVOL, V26, P1803, DOI 10.1093/molbev/msp089; Davies WL, 2009, GENOME RES, V19, P415, DOI 10.1101/gr.084509.108; Davies WL, 2011, ADAPTIVE GENE LOSS V; DENTON EJ, 1990, LIGHT AND LIFE IN THE SEA, P127; Drivenes O, 2003, J COMP NEUROL, V456, P84, DOI 10.1002/cne.10523; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Grone BP, 2007, J BIOL RHYTHM, V22, P558, DOI 10.1177/0748730407308285; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Hope AJ, 1997, P ROY SOC B-BIOL SCI, V264, P155, DOI 10.1098/rspb.1997.0023; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt DM, 2001, J EXP BIOL, V204, P3333; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Jerlov N. G., 1976, MARINE OPTICS; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Last PR, 1994, SHARKS RAYS AUSTR, P513; Marshall N. B., 1979, DEV DEEP SEA BIOL; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Muller LPD, 2010, J COMP NEUROL, V518, P4813, DOI 10.1002/cne.22490; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; POTTER I C, 1979, Environmental Biology of Fishes, V4, P65, DOI 10.1007/BF00005929; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Provencio I, 2011, SCI AM, V304, P54, DOI 10.1038/scientificamerican0511-54; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Rollag MD, 2003, J BIOL RHYTHM, V18, P227, DOI [10.1177/0748730403018003005, 10.1177/0748730403253382]; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sansom IJ, 1996, NATURE, V379, P628, DOI 10.1038/379628a0; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tomonari S, 2007, GENE EXPR PATTERNS, V7, P746, DOI 10.1016/j.modgep.2007.06.001; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; TUDGE C, 2000, VARIETY LIFE; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Zhao ZM, 1998, J MOL EVOL, V46, P494, DOI 10.1007/PL00013147	70	16	16	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51276	10.1371/journal.pone.0051276	http://dx.doi.org/10.1371/journal.pone.0051276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251480	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800038
J	Dean, D; Turingan, RS; Thomann, HU; Zolotova, A; Rothschild, J; Joseph, SJ; Read, TD; Tan, E; Selden, RF				Dean, Deborah; Turingan, Rosemary S.; Thomann, Hans-Ulrich; Zolotova, Anna; Rothschild, James; Joseph, Sandeep J.; Read, Timothy D.; Tan, Eugene; Selden, Richard F.			A Multiplexed Microfluidic PCR Assay for Sensitive and Specific Point-of-Care Detection of Chlamydia trachomatis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ACID AMPLIFICATION TESTS; CHAIN-REACTION ASSAY; AMPLICOR-PCR; SEX WORKERS; SCREENING-TESTS; HIGH PREVALENCE; CELL-CULTURE; PERFORMANCE; DIAGNOSIS	Background: Chlamydia trachomatis (Ct) is the most common cause of bacterial sexually transmitted diseases (STD) worldwide. While commercial nucleic acid amplification tests (NAAT) are available for Ct, none are rapid or inexpensive enough to be used at the point-of-care (POC). Towards the first Ct POC NAAT, we developed a microfluidic assay that simultaneously interrogates nine Ct loci in 20 minutes. Methodology and Principal Findings: Endocervical samples were selected from 263 women at high risk for Ct STDs (similar to 35% prevalence). A head-to-head comparison was performed with the Roche-Amplicor NAAT. 129 (49.0%) and 88 (33.5%) samples were positive by multiplex and Amplicor assays, respectively. Sequencing resolved 71 discrepant samples, confirming 53 of 53 positive multiplex samples and 12 of 18 positive Amplicor samples. The sensitivity and specificity were 91.5% and 100%, and 62.4% and 95.9%, respectively, for multiplex and Amplicor assays. Positive and negative predictive values were 100% and 91%, and 94.1% and 68.6%, respectively. Conclusions: This is the first rapid multiplex approach to Ct detection, and the assay was also found to be superior to a commercial NAAT. In effect, nine simultaneous reactions significantly increased sensitivity and specificity. Our assay can potentially increase Ct detection in globally diverse clinical settings at the POC. Citation: Dean D, Turingan RS, Thomann H-U, Zolotova A, Rothschild J, et al. (2012) A Multiplexed Microfluidic PCR Assay for Sensitive and Specific Point-of-Care Detection of Chlamydia trachomatis. PLoS ONE 7(12): e51685. doi: 10.1371/journal.pone.0051685	[Turingan, Rosemary S.; Thomann, Hans-Ulrich; Zolotova, Anna; Tan, Eugene; Selden, Richard F.] NetBio, Waltham, MA USA; [Dean, Deborah; Rothschild, James] Childrens Hosp, Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Dean, Deborah; Rothschild, James] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Dean, Deborah; Rothschild, James] Univ Calif San Francisco, Joint Grad Program Bioengn, Berkeley, CA USA; [Joseph, Sandeep J.; Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Joseph, Sandeep J.; Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Emory University; Emory University	Selden, RF (corresponding author), NetBio, Waltham, MA USA.	richard.selden@netbio.com		Joseph, Sandeep/0000-0003-0697-2487; Read, Timothy/0000-0001-8966-9680	Small Business Innovation Research Program Award from the National Institute of Allergy and Infectious Diseases [R43AI084206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098843, R43AI084206] Funding Source: NIH RePORTER	Small Business Innovation Research Program Award from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by a Small Business Innovation Research Program Award to NetBio (R43AI084206 to DD, TDR and RFS) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TRENDS REP SEX TRANS; Bandea CI, 2009, J CLIN MICROBIOL, V47, P215, DOI 10.1128/JCM.01338-08; BASS CA, 1993, J CLIN MICROBIOL, V31, P2648, DOI 10.1128/JCM.31.10.2648-2653.1993; BAUWENS JE, 1993, J CLIN MICROBIOL, V31, P3023, DOI 10.1128/JCM.31.11.3023-3027.1993; BIANCHI A, 1994, SEX TRANSM DIS, V21, P196, DOI 10.1097/00007435-199407000-00003; CATRY MA, 1995, GENITOURIN MED, V71, P247; Centers for Disease Control and Prevention, 2009, EXP CONS M SUMM REP; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Desai VK, 2003, SEX TRANSM INFECT, V79, P111, DOI 10.1136/sti.79.2.111; Dukers-Muijrers NHTM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034108; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gaydos CA, 2010, J CLIN MICROBIOL, V48, P3236, DOI 10.1128/JCM.01019-10; Gaydos CA, 2005, INFECT DIS CLIN N AM, V19, P367, DOI 10.1016/j.idc.2005.03.006; Gaydos CA, 2004, J CLIN MICROBIOL, V42, P3041, DOI 10.1128/JCM.42.7.3041-3045.2004; Giese H, 2009, J FORENSIC SCI, V54, P1287, DOI 10.1111/j.1556-4029.2009.01200.x; Gill P, 2001, CROAT MED J, V42, P229; Joseph SJ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-28; Kim AA, 2005, SEX TRANSM DIS, V32, P745, DOI 10.1097/01.olq.0000175384.44106.be; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mahilum-Tapay L, 2007, BMJ-BRIT MED J, V335, P1190, DOI 10.1136/bmj.39402.463854.AE; MAHONY JB, 1994, J CLIN MICROBIOL, V32, P2490, DOI 10.1128/JCM.32.10.2490-2493.1994; McClelland RS, 2005, J INFECT DIS, V191, P333, DOI 10.1086/427262; Moller JK, 2010, J CLIN MICROBIOL, V48, P440, DOI 10.1128/JCM.01446-09; Mulcahy GM, 1998, CLIN CHEM, V44, P1575; Nessa K, 2005, SEX TRANSM DIS, V32, P13, DOI 10.1097/01.olq.0000148298.26228.74; Parra-Sanchez M, 2012, DIAGNOSTIC MICROBIOL; Pasternack R, 1996, J CLIN MICROBIOL, V34, P995, DOI 10.1128/JCM.34.4.995-998.1996; Peeling RW, 2006, SEX TRANSM INFECT, V82, P425, DOI 10.1136/sti.2005.017251; Peterson EM, 1997, J CLIN MICROBIOL, V35, P957, DOI 10.1128/JCM.35.4.957-959.1997; Read TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010595; Sabido M, 2009, J CLIN MICROBIOL, V47, P475, DOI 10.1128/JCM.01975-08; Saison F, 2007, J CLIN MICROBIOL, V45, P4011, DOI 10.1128/JCM.01343-07; Satterwhite C. L., 2011, Morbidity and Mortality Weekly Report, V60, P370; Schachter J, 2008, SEX TRANSM DIS, V35, P637, DOI 10.1097/OLQ.0b013e31817bdd7e; Schwebke JR, 1997, SEX TRANSM DIS, V24, P181, DOI 10.1097/00007435-199704000-00001; SKULNICK M, 1991, J CLIN MICROBIOL, V29, P2086, DOI 10.1128/JCM.29.9.2086-2088.1991; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Toye B, 1996, J CLIN MICROBIOL, V34, P1396, DOI 10.1128/JCM.34.6.1396-1400.1996; Unemo M, 2007, Euro Surveill, V12, pE5; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Watson EJ, 2002, J MED MICROBIOL, V51, P1021, DOI 10.1099/0022-1317-51-12-1021; Yin YP, 2006, SEX TRANSM INFECT, V82, pV33, DOI 10.1136/sti.2006.022475	42	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51685	10.1371/journal.pone.0051685	http://dx.doi.org/10.1371/journal.pone.0051685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272140	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800064
J	Jimenez, DJ; Andreote, FD; Chaves, D; Montana, JS; Osorio-Forero, C; Junca, H; Zambrano, MM; Baena, S				Javier Jimenez, Diego; Andreote, Fernando Dini; Chaves, Diego; Salvador Montana, Jose; Osorio-Forero, Cesar; Junca, Howard; Mercedes Zambrano, Maria; Baena, Sandra			Structural and Functional Insights from the Metagenome of an Acidic Hot Spring Microbial Planktonic Community in the Colombian Andes	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; BACTERIAL COMMUNITIES; GEOTHERMAL SPRINGS; SULFIDE MINE; DIVERSITY; DNA; SEQUENCES; MATS; METABOLISM; GENERATION	A taxonomic and annotated functional description of microbial life was deduced from 53 Mb of metagenomic sequence retrieved from a planktonic fraction of the Neotropical high Andean (3,973 meters above sea level) acidic hot spring El Coquito (EC). A classification of unassembled metagenomic reads using different databases showed a high proportion of Gammaproteobacteria and Alphaproteobacteria (in total read affiliation), and through taxonomic affiliation of 16S rRNA gene fragments we observed the presence of Proteobacteria, micro-algae chloroplast and Firmicutes. Reads mapped against the genomes Acidiphilium cryptum JF-5, Legionella pneumophila str. Corby and Acidithiobacillus caldus revealed the presence of transposase-like sequences, potentially involved in horizontal gene transfer. Functional annotation and hierarchical comparison with different datasets obtained by pyrosequencing in different ecosystems showed that the microbial community also contained extensive DNA repair systems, possibly to cope with ultraviolet radiation at such high altitudes. Analysis of genes involved in the nitrogen cycle indicated the presence of dissimilatory nitrate reduction to N2 (narGHI, nirS, norBCDQ and nosZ), associated with Proteobacteria-like sequences. Genes involved in the sulfur cycle (cysDN, cysNC and aprA) indicated adenylsulfate and sulfite production that were affiliated to several bacterial species. In summary, metagenomic sequence data provided insight regarding the structure and possible functions of this hot spring microbial community, describing some groups potentially involved in the nitrogen and sulfur cycling in this environment. Citation: Jimenez DJ, Andreote FD, Chaves D, Montana JS, Osorio-Forero C, et al. (2012) Structural and Functional Insights from the Metagenome of an Acidic Hot Spring Microbial Planktonic Community in the Colombian Andes. PLoS ONE 7(12): e52069. doi:10.1371/journal.pone.0052069	[Javier Jimenez, Diego; Chaves, Diego; Salvador Montana, Jose; Osorio-Forero, Cesar; Junca, Howard; Mercedes Zambrano, Maria; Baena, Sandra] Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Colombia; [Salvador Montana, Jose; Baena, Sandra] Pontificia Univ Javeriana, Unidad Saneamiento & Biotecnol Ambiental, Dept Biol, Bogota, Colombia; [Andreote, Fernando Dini] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Soil Sci, Piracicaba, Brazil; [Osorio-Forero, Cesar; Junca, Howard; Mercedes Zambrano, Maria] Corp CorpoGen, Mol Genet Res Grp, Bogota, Colombia; [Osorio-Forero, Cesar; Junca, Howard; Mercedes Zambrano, Maria] Corp CorpoGen, Microbial Ecol Res Grp, Bogota, Colombia; [Javier Jimenez, Diego] Univ Groningen, Dept Microbial Ecol, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	Pontificia Universidad Javeriana; Universidade de Sao Paulo; University of Groningen	Jimenez, DJ (corresponding author), Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Colombia.	djimenez1909@gmail.com	Zambrano, Maria Mercedes/AAD-2805-2019; Jimenez, Diego/GNW-3973-2022; Baena, Sandra/AAF-8165-2019; Andreote, Fernando Dini/B-8499-2012; Junca, Howard/K-5525-2014; Montaña-Lara, Jose Salvador/AAE-7239-2019	Zambrano, Maria Mercedes/0000-0002-0796-4473; Andreote, Fernando Dini/0000-0002-9883-9968; Junca, Howard/0000-0003-4546-6229; Baena, Sandra/0000-0001-5377-9079; Montana-Lara, Jose Salvador/0000-0002-1970-8637; Jimenez Avella, Diego Javier/0000-0002-9339-6520	COLCIENCIAS - SENA [6570-392-19990]; MAVDT [15]	COLCIENCIAS - SENA(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); MAVDT	This research was supported by COLCIENCIAS - SENA (project number 6570-392-19990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank G. Lopez, L. Bohorquez and L. Delgado for help with sampling and J.R. Bustos for technical assistance. This research was done under permits from MAVDT (contract number 15, 2008) for access to genetic resources) and UAESPNN (research permit code DTNO-N-20/2007).	Aguilera A, 2010, INT MICROBIOL, V13, P21, DOI 10.2436/20.1501.01.108; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral-Zettler LA, 2011, ISME J, V5, P42, DOI 10.1038/ismej.2010.101; Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600; Belnap CP, 2011, ISME J, V5, P1152, DOI 10.1038/ismej.2010.200; Bohnebeck U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-459; Bohorquez LC, 2012, MICROB ECOL, V63, P103, DOI 10.1007/s00248-011-9943-3; Brazelton WJ, 2009, ISME J, V3, P1420, DOI 10.1038/ismej.2009.79; Burton NP, 2000, EXTREMOPHILES, V4, P315, DOI 10.1007/s007920070019; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Dini-Andreote Francisco, 2012, Microb Ecol, V64, P1, DOI 10.1007/s00248-012-0017-y; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; Edwards Robert A, 2006, BMC Genomics, V7, P57; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Fan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039948; Furuhata K, 2010, J INFECT CHEMOTHER, V16, P367, DOI 10.1007/s10156-010-0062-8; Gerlach W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-430; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; GILBERT JR, 2008, NATL GEOGR, V213, P8; Gomes J, 2004, FOOD TECHNOL BIOTECH, V42, P223; Gori F, 2011, BIOINFORMATICS, V27, P196, DOI 10.1093/bioinformatics/btq649; Hamamura N, 2005, APPL ENVIRON MICROB, V71, P5943, DOI 10.1128/AEM.71.10.5943-5950.2005; Hao CB, 2010, EXTREMOPHILES, V14, P465, DOI 10.1007/s00792-010-0324-5; Hiraishi A, 2005, BERGEYS MANUAL SYSTE, V2, P54; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Huang Y, 2009, HDB MOL MICROBIAL EC, P784; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; IDEAM, 2005, ATL RAD SOL COL MAP; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Jimenez DJ, 2012, WORLD J MICROB BIOT, V28, P361, DOI 10.1007/s11274-011-0828-x; Johnson DB, 2009, ADV MICROB PHYSIOL, V54, P201, DOI 10.1016/S0065-2911(08)00003-9; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Ju X, 2008, ENVIRON MICROBIOL, V9, P1078; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kato S, 2011, FEMS MICROBIOL LETT, V319, P34, DOI 10.1111/j.1574-6968.2011.02267.x; Klatt CG, 2011, ISME J, V5, P1262, DOI 10.1038/ismej.2011.73; Kozubal MA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00109; Kurosawa H, 2010, JPN J INFECT DIS, V63, P78; Lau MCY, 2009, EXTREMOPHILES, V13, P139, DOI 10.1007/s00792-008-0205-3; LAWRENCE ME, 1986, J HISTOCHEM CYTOCHEM, V34, P761, DOI 10.1177/34.6.2422253; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Liu ZF, 2011, ISME J, V5, P1279, DOI 10.1038/ismej.2011.37; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lokendra Kumar, 2011, Biotechnology, V10, P121; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathur J, 2007, APPL ENVIRON MICROB, V73, P2612, DOI 10.1128/AEM.02567-06; McCready Shirley, 2005, Saline Syst, V1, P3, DOI 10.1186/1746-1448-1-3; Meyer B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001514; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mirete S, 2011, FEMS MICROBIOL ECOL, V77, P165, DOI 10.1111/j.1574-6941.2011.01095.x; Mitra S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S17; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Norris PR, 2001, ENCY LIFE SCI, P1, DOI [10.1038/npg.els.0000336, DOI 10.1038/NPG.ELS.0000336]; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rowe OF, 2007, ENVIRON MICROBIOL, V9, P1761, DOI 10.1111/j.1462-2920.2007.01294.x; Rzhepishevska OI, 2007, APPL ENVIRON MICROB, V73, P7367, DOI 10.1128/AEM.01497-07; Rzonca B, 2003, J HYDROL, V280, P272, DOI 10.1016/S0022-1694(03)00231-2; Montana JS, 2012, ANTON LEEUW INT J G, V101, P205, DOI 10.1007/s10482-011-9624-8; Schrenk MO, 1998, SCIENCE, V279, P1519, DOI 10.1126/science.279.5356.1519; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Siering PL, 2006, GEOMICROBIOL J, V23, P129, DOI 10.1080/01490450500533916; Silander Kaisa, 2008, V439, P1, DOI 10.1007/978-1-59745-188-8_1; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Snyder TM, 2008, J AM CHEM SOC, V130, P1392, DOI 10.1021/ja076780u; Steele HL, 2009, J MOL MICROB BIOTECH, V16, P25, DOI 10.1159/000142892; Stout LM, 2009, FEMS MICROBIOL ECOL, V70, P402, DOI 10.1111/j.1574-6941.2009.00780.x; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tekere M, 2011, AFR J BIOTECHNOL, V10, P18005, DOI 10.5897/AJB11.899; Tirawongsaroj P, 2008, J BIOTECHNOL, V133, P42, DOI 10.1016/j.jbiotec.2007.08.046; Tomova I, 2010, WORLD J MICROB BIOT, V26, P2019, DOI 10.1007/s11274-010-0386-7; Vos M, 2009, TRENDS MICROBIOL, V17, P226, DOI 10.1016/j.tim.2009.03.001; Weingart U, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-390; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	82	51	54	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52069	10.1371/journal.pone.0052069	http://dx.doi.org/10.1371/journal.pone.0052069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251687	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800139
J	Lescai, F; Bonfiglio, S; Bacchelli, C; Chanudet, E; Waters, A; Sisodiya, SM; Kasperaviciute, D; Williams, J; Harold, D; Hardy, J; Kleta, R; Cirak, S; Williams, R; Achermann, JC; Anderson, J; Kelsell, D; Vulliamy, T; Houlden, H; Wood, N; Sheerin, U; Tonini, GP; Mackay, D; Hussain, K; Sowden, J; Kinsler, V; Osinska, J; Brooks, T; Hubank, M; Beales, P; Stupka, E				Lescai, Francesco; Bonfiglio, Silvia; Bacchelli, Chiara; Chanudet, Estelle; Waters, Aoife; Sisodiya, Sanjay M.; Kasperaviciute, Dalia; Williams, Julie; Harold, Denise; Hardy, John; Kleta, Robert; Cirak, Sebahattin; Williams, Richard; Achermann, John C.; Anderson, John; Kelsell, David; Vulliamy, Tom; Houlden, Henry; Wood, Nicholas; Sheerin, Una; Tonini, Gian Paolo; Mackay, Donna; Hussain, Khalid; Sowden, Jane; Kinsler, Veronica; Osinska, Justyna; Brooks, Tony; Hubank, Mike; Beales, Philip; Stupka, Elia			Characterisation and Validation of Insertions and Deletions in 173 Patient Exomes	PLOS ONE			English	Article							OF-FUNCTION VARIANTS; GENE	Recent advances in genomics technologies have spurred unprecedented efforts in genome and exome re-sequencing aiming to unravel the genetic component of rare and complex disorders. While in rare disorders this allowed the identification of novel causal genes, the missing heritability paradox in complex diseases remains so far elusive. Despite rapid advances of next-generation sequencing, both the technology and the analysis of the data it produces are in its infancy. At present there is abundant knowledge pertaining to the role of rare single nucleotide variants (SNVs) in rare disorders and of common SNVs in common disorders. Although the 1,000 genome project has clearly highlighted the prevalence of rare variants and more complex variants (e.g. insertions, deletions), their role in disease is as yet far from elucidated. We set out to analyse the properties of sequence variants identified in a comprehensive collection of exome re-sequencing studies performed on samples from patients affected by a broad range of complex and rare diseases (N = 173). Given the known potential for Loss of Function (LoF) variants to be false positive, we performed an extensive validation of the common, rare and private LoF variants identified, which indicated that most of the private and rare variants identified were indeed true, while common novel variants had a significantly higher false positive rate. Our results indicated a strong enrichment of very low-frequency insertion/deletion variants, so far under-investigated, which might be difficult to capture with low coverage and imputation approaches and for which most of study designs would be under-powered. These insertions and deletions might play a significant role in disease genetics, contributing specifically to the underlining rare and private variation predicted to be discovered through next generation sequencing.	[Lescai, Francesco; Osinska, Justyna; Brooks, Tony; Hubank, Mike; Stupka, Elia] UCL, UCL Genom, London, England; [Lescai, Francesco] UCL, Div Res Strategy, London, England; [Lescai, Francesco; Bacchelli, Chiara; Chanudet, Estelle; Beales, Philip] UCL, UCL Inst Child Hlth, GOSgene, London, England; [Bonfiglio, Silvia; Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Sisodiya, Sanjay M.; Kasperaviciute, Dalia; Hardy, John; Houlden, Henry; Wood, Nicholas; Sheerin, Una] UCL, UCL Inst Neurol, London, England; [Williams, Julie; Harold, Denise] Cardiff Univ, Dept Psychol Med, Cardiff, S Glam, Wales; [Kelsell, David; Vulliamy, Tom] Barts & London, Blizard Inst Cell & Mol Sci, London, England; [Tonini, Gian Paolo] Natl Canc Res Inst IST, Genoa, Italy; [Mackay, Donna] UCL, Inst Ophthalmol, London, England; [Stupka, Elia] UCL, Inst Canc, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; University College London; Cardiff University; University of London; Queen Mary University London; University of London; University College London; University of London; University College London	Lescai, F (corresponding author), UCL, UCL Genom, London, England.	f.lescai@ucl.ac.uk; stupka.elia@hsr.it	Cirak, Sebahattin/AAZ-6829-2020; e, Chanudet/N-4064-2015; Achermann, John/C-5476-2008; Cirak, Sebahattin/AAX-9593-2020; Beales, Philip L/C-7367-2009; Houlden, Henry J/C-1532-2008; Hubank, Michael JF/C-1837-2008; Kinsler, Veronica A./AAO-8195-2021; Achermann, John/N-2906-2019; Bonfiglio, Silvia/AAC-1988-2019; Kelsell, David P/F-8767-2011; Hardy, John/C-2451-2009; Wood, Nicholas/C-2505-2009	Achermann, John/0000-0001-8787-6272; Houlden, Henry J/0000-0002-2866-7777; Hubank, Michael JF/0000-0002-2901-0742; Achermann, John/0000-0001-8787-6272; Hardy, John/0000-0002-3122-0423; Mackay, Donna/0000-0002-2499-1203; Lescai, Francesco/0000-0002-6399-9101; Williams, Julie/0000-0002-4069-0259; Harold, Denise/0000-0001-5195-0143; Wood, Nicholas/0000-0002-9500-3348; Bonfiglio, Silvia/0000-0002-4422-1580; Sowden, Jane/0000-0003-0937-2479; Anderson, William/0000-0001-7509-3203; Kelsell, David/0000-0002-9910-7144; Stupka, Elia/0000-0003-3154-4011	Great Ormond Street Hospital (GOSH) Biomedical Research Centre (BRC) of the National Institute for Health Research (NIHR); European Community [223026, 241665]; Wellcome Trust [084730]; Tuberous Sclerosis Association; United Kingdom Medical Research Council [G0400126]; UCLH CRDC [F136]; National Institute for Health Research (NIHR) [08-08-SCC]; Epilepsy Society; Department of Health's NIHR Biomedical Research Centres of the Italian Neuroblastoma Foundation; Medical Research Council Translational Research Award [G0802528]; MRC [G0802760, G0802138, G0902227, G0400126, G1001253, MC_G1000735, G108/638] Funding Source: UKRI; Medical Research Council [G108/638, G0802760, G0801418B, G0902227, G0802138, G1001253, MC_G1000735, G0400126] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10376] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1257] Funding Source: researchfish	Great Ormond Street Hospital (GOSH) Biomedical Research Centre (BRC) of the National Institute for Health Research (NIHR); European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Tuberous Sclerosis Association; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCLH CRDC; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Epilepsy Society; Department of Health's NIHR Biomedical Research Centres of the Italian Neuroblastoma Foundation; Medical Research Council Translational Research Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity	GOSgene funding at the University College London (UCL) Institute of Child Health is supported by the Great Ormond Street Hospital (GOSH) Biomedical Research Centre (BRC) of the National Institute for Health Research (NIHR). Sebahattin Cirak has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreements number 223026 (NMD-Chip) and 241665 (BIO-NMD). This work was also supported by grants from The Wellcome Trust (084730), Tuberous Sclerosis Association, United Kingdom Medical Research Council (G0400126), UCLH CRDC (F136), The National Institute for Health Research (NIHR) (08-08-SCC) and the Epilepsy Society. This work was partly undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme Gian Paolo Tonini for technical support as fellowship of the Italian Neuroblastoma Foundation. Francesco Lescai received support from the Medical Research Council Translational Research Award (G0802528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Biesecker LG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-128; Hu J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r9; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Ku C-S, 2011, ANN NEUROL; Li Y, 2010, NANO LETT, P1; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Maxmen A, 2011, CELL, V144, P635, DOI 10.1016/j.cell.2011.02.033; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Ramagopalan SV, 2011, ANN NEUROL, V70, P881, DOI 10.1002/ana.22678; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158	21	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51292	10.1371/journal.pone.0051292	http://dx.doi.org/10.1371/journal.pone.0051292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251486	Green Published, gold			2022-12-27	WOS:000312386800040
J	Pazmandi, K; Kumar, BV; Szabo, K; Boldogh, I; Szoor, A; Vereb, G; Veres, A; Lanyi, A; Rajnavolgyi, E; Bacsi, A				Pazmandi, Kitti; Kumar, Brahma V.; Szabo, Krisztina; Boldogh, Istvan; Szoor, Arpad; Vereb, Gyorgy; Veres, Agota; Lanyi, Arpad; Rajnavolgyi, Eva; Bacsi, Attila			Ragweed Subpollen Particles of Respirable Size Activate Human Dendritic Cells	PLOS ONE			English	Article							POLLEN STARCH GRANULES; HOUSE-DUST MITE; BET V 1; OXIDATIVE STRESS; AIRWAY INFLAMMATION; ELECTRON-MICROSCOPY; NADPH OXIDASE; LYMPH-NODES; HUMAN LUNG; T-CELLS	Ragweed (Ambrosia artemisiifolia) pollen grains, which are generally considered too large to reach the lower respiratory tract, release subpollen particles (SPPs) of respirable size upon hydration. These SPPs contain allergenic proteins and functional NAD(P)H oxidases. In this study, we examined whether exposure to SPPs initiates the activation of human monocyte-derived dendritic cells (moDCs). We found that treatment with freshly isolated ragweed SPPs increased the intracellular levels of reactive oxygen species (ROS) in moDCs. Phagocytosis of SPPs by moDCs, as demonstrated by confocal laser-scanning microscopy, led to an up-regulation of the cell surface expression of CD40, CD80, CD86, and HLA-DQ and an increase in the production of IL-6, TNF-alpha, IL-8, and IL-10. Furthermore, SPP-treated moDCs had an increased capacity to stimulate the proliferation of naive T cells. Co-culture of SPP-treated moDCs with allogeneic CD3(+) pan-T cells resulted in increased secretion of IFN-gamma and IL-17 by T cells of both allergic and non-allergic subjects, but induced the production of IL-4 exclusively from the T cells of allergic individuals. Addition of exogenous NADPH further increased, while heat-inactivation or pre-treatment with diphenyleneiodonium (DPI), an inhibitor of NADPH oxidases, strongly diminished, the ability of SPPs to induce phenotypic and functional changes in moDCs, indicating that these processes were mediated, at least partly, by the intrinsic NAD(P)H oxidase activity of SPPs. Collectively, our data suggest that inhaled ragweed SPPs are fully capable of activating dendritic cells (DCs) in the airways and SPPs' NAD(P)H oxidase activity is involved in initiation of adaptive immune responses against innocuous pollen proteins. Citation: Pazmandi K, Kumar BV, Szabo K, Boldogh I, Szoor A, et al. (2012) Ragweed Subpollen Particles of Respirable Size Activate Human Dendritic Cells. PLoS ONE 7(12): e52085. doi:10.1371/journal.pone.0052085	[Pazmandi, Kitti; Kumar, Brahma V.; Szabo, Krisztina; Veres, Agota; Lanyi, Arpad; Rajnavolgyi, Eva; Bacsi, Attila] Univ Debrecen, Med & Hlth Sci Ctr, Dept Immunol, Debrecen, Hungary; [Boldogh, Istvan] Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX USA; [Szoor, Arpad; Vereb, Gyorgy] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, Debrecen, Hungary	University of Debrecen; University of Texas System; University of Texas Medical Branch Galveston; University of Debrecen	Bacsi, A (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Immunol, Debrecen, Hungary.	bacsi.attila@gmail.com	Szabó, Krisztina/AAK-3483-2021; Vereb, György/A-4241-2008; Rajnavölgyi, Éva/D-4384-2013	Vereb, György/0000-0003-2157-3265; Bacsi, Attila/0000-0002-2311-2975; Szabo, Krisztina/0000-0002-0079-3659; Pazmandi, Kitti Linda/0000-0001-7709-6707	Hungarian Scientific Research Fund [K-73347, NK-101538]; National Institutes of Environmental Health and Sciences [RO1-ES018948]; National Institute of Allergic and Infectious Diseases [AI062885-01]; European Union; European Social Fund; Janos Bolyai Fellowship from the Hungarian Academy of Sciences; Faculty of Medicine Research Fund from the University of Debrecen (Bridging Fund);  [TAMOP 4.2.1/B-09/1/KONV-2010-0007];  [TAMOP 4.2.2/B-10/1-2010-0024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021830] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Institutes of Environmental Health and Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Allergic and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union(European Commission); European Social Fund(European Social Fund (ESF)); Janos Bolyai Fellowship from the Hungarian Academy of Sciences; Faculty of Medicine Research Fund from the University of Debrecen (Bridging Fund); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Hungarian Scientific Research Fund (K-73347 to A.B. and NK-101538 to E.R.), National Institutes of Environmental Health and Sciences (RO1-ES018948 to I.B.), National Institute of Allergic and Infectious Diseases (AI062885-01 to I.B.) and the TAMOP 4.2.1/B-09/1/KONV-2010-0007 and TAMOP 4.2.2/B-10/1-2010-0024 projects (to A.B., E.R. and K.P.). The project is co-financed by the European Union and the European Social Fund. A.B. was also supported by the Janos Bolyai Fellowship from the Hungarian Academy of Sciences and by the Faculty of Medicine Research Fund from the University of Debrecen (Bridging Fund 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Chakra O, 2011, INT ARCH ALLERGY IMM, V154, P128, DOI 10.1159/000320227; Abou Chakra OR, 2011, WORLD ALLERGY ORGAN, V4, P4, DOI 10.1097/WOX.0b013e318205ab44; Allakhverdi Z, 2005, ALLERGY, V60, P1157, DOI 10.1111/j.1398-9995.2005.00861.x; Bacsi A, 2005, J ALLERGY CLIN IMMUN, V116, P836, DOI 10.1016/j.jaci.2005.06.002; Bacsi A, 2006, J ALLERGY CLIN IMMUN, V118, P844, DOI 10.1016/j.jaci.2006.07.006; BAER H, 1980, J ALLERGY CLIN IMMUN, V66, P281, DOI 10.1016/0091-6749(80)90022-6; Barnes C, 2000, ANN ALLERG ASTHMA IM, V84, P47, DOI 10.1016/S1081-1206(10)62740-8; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Bullens DMA, 2005, CLIN EXP ALLERGY, V35, P1535, DOI 10.1111/j.1365-2222.2005.02352.x; Buters JTM, 2010, ALLERGY, V65, P850, DOI 10.1111/j.1398-9995.2009.02286.x; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Csillag A, 2010, J IMMUNOL, V184, P2377, DOI 10.4049/jimmunol.0803938; Currie AJ, 2000, J IMMUNOL, V164, P3878, DOI 10.4049/jimmunol.164.7.3878; de Heer HJ, 2001, J EXP MED, V193, P51; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Demedts IK, 2006, AM J RESP CELL MOL, V35, P387, DOI 10.1165/rcmb.2005-0382OC; DRIESSEN MNBM, 1991, EUR RESPIR J, V4, P359; Erpenbeck VJ, 2005, AM J PHYSIOL-LUNG C, V288, pL692, DOI 10.1152/ajplung.00362.2004; Gilles S, 2011, J ALLERGY CLIN IMMUN, V127, P454, DOI 10.1016/j.jaci.2010.12.1082; Grote M, 2001, J ALLERGY CLIN IMMUN, V108, P109, DOI 10.1067/mai.2001.116431; Grote M, 2000, J ALLERGY CLIN IMMUN, V105, P1140, DOI 10.1067/mai.2000.107044; Hammad H, 2006, J ALLERGY CLIN IMMUN, V118, P331, DOI 10.1016/j.jaci.2006.03.041; Hashimoto T, 2005, INT ARCH ALLERGY IMM, V137, P51, DOI 10.1159/000085432; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kimura M, 2002, INT ARCH ALLERGY IMM, V127, P191, DOI 10.1159/000053863; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Maemura K, 2005, IMMUNOL CELL BIOL, V83, P336, DOI 10.1111/j.1440-1711.2005.01323.x; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Masten BJ, 2006, J IMMUNOL, V177, P7784, DOI 10.4049/jimmunol.177.11.7784; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Okano M, 2001, AM J RESP CRIT CARE, V164, P1501, DOI 10.1164/ajrccm.164.8.2011072; Oswalt Matthew L, 2008, Allergy Asthma Clin Immunol, V4, P130, DOI 10.1186/1710-1492-4-3-130; Pazmandi K, 2012, FREE RADICAL BIO MED, V52, P635, DOI 10.1016/j.freeradbiomed.2011.11.022; RAFNAR T, 1991, J BIOL CHEM, V266, P1229; Rangasamy T, 2010, AM J RESP CELL MOL, V43, P276, DOI 10.1165/rcmb.2008-0438OC; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; ROSENBERG GL, 1983, J ALLERGY CLIN IMMUN, V71, P302, DOI 10.1016/0091-6749(83)90084-2; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schappi GF, 1999, ALLERGY, V54, P478, DOI 10.1034/j.1398-9995.1999.00838.x; Schleh C, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-8; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Taramarcaz P, 2005, SWISS MED WKLY, V135, P538; Taylor PE, 2004, CLIN EXP ALLERGY, V34, P1591, DOI 10.1111/j.1365-2222.2004.02078.x; Taylor PE, 2002, J ALLERGY CLIN IMMUN, V109, P51, DOI 10.1067/mai.2002.120759; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Verhasselt V, 1998, EUR J IMMUNOL, V28, P3886; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wark PAB, 2002, CLIN EXP ALLERGY, V32, P1750, DOI 10.1046/j.1365-2222.2002.01556.x; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1; Winkler C, 2010, EXP LUNG RES, V36, P522, DOI 10.3109/01902141003790148; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108	55	20	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52085	10.1371/journal.pone.0052085	http://dx.doi.org/10.1371/journal.pone.0052085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251688	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000312386800140
J	Prorok, P; Saint-Pierre, C; Gasparutto, D; Fedorova, OS; Ishchenko, AA; Leh, H; Buckle, M; Tudek, B; Saparbaev, M				Prorok, Paulina; Saint-Pierre, Christine; Gasparutto, Didier; Fedorova, Olga S.; Ishchenko, Alexander A.; Leh, Herve; Buckle, Malcolm; Tudek, Barbara; Saparbaev, Murat			Highly Mutagenic Exocyclic DNA Adducts Are Substrates for the Human Nucleotide Incision Repair Pathway	PLOS ONE			English	Article							BASE EXCISION-REPAIR; COLI ENDONUCLEASE-III; HUMAN AP ENDONUCLEASE; ESCHERICHIA-COLI; IONIZING-RADIATION; LIPID-PEROXIDATION; TARGETED DELETION; BIOLOGICAL RESPONSES; OXIDATIVE DAMAGE; N-GLYCOSYLASE	Background: Oxygen free radicals induce lipid peroxidation (LPO) that damages and breaks polyunsaturated fatty acids in cell membranes. LPO-derived aldehydes and hydroxyalkenals react with DNA leading to the formation of etheno(e)-bases including 1, N-6-ethenoadenine (epsilon A) and 3,N-4-ethenocytosine (epsilon C). The epsilon A and epsilon C residues are highly mutagenic in mammalian cells and eliminated in the base excision repair (BER) pathway and/or by AlkB family proteins in the direct damage reversal process. BER initiated by DNA glycosylases is thought to be the major pathway for the removal of non-bulky endogenous base damage. Alternatively, in the nucleotide incision repair (NIR) pathway, the apurinic/apyrimidinic (AP) endonucleases can directly incise DNA duplex 59 to a damaged base in a DNA glycosylase-independent manner. Methodology/Principal Findings: Here we have characterized the substrate specificity of human major AP endonuclease 1, APE1, towards epsilon A, epsilon C, thymine glycol (Tg) and7,8-dihydro-8-oxoguanine (8oxoG) residues when present in duplex DNA. APE1 cleaves oligonucleotide duplexes containing epsilon A, epsilon C and Tg, but not those containing 8oxoG. Activity depends strongly on sequence context. The apparent kinetic parameters of the reactions suggest that APE1 has a high affinity for DNA containing e-bases but cleaves DNA duplexes at an extremely slow rate. Consistent with this observation, oligonucleotide duplexes containing an e-base strongly inhibit AP site nicking activity of APE1 with IC50 values in the range of 5- 10 nM. MALDI-TOF MS analysis of the reaction products demonstrated that APE1-catalyzed cleavage of epsilon A.T and epsilon C.G duplexes generates, as expected, DNA fragments containing 5'-terminal epsilon-base residue. Conclusions/Significance: The fact that epsilon-bases and Tg in duplex DNA are recognized and cleaved by APE1 in vitro, suggests that NIR may act as a backup pathway to BER to remove a large variety of genotoxic base lesions in human cells. Citation: Prorok P, Saint-Pierre C, Gasparutto D, Fedorova OS, Ishchenko AA, et al. (2012) Highly Mutagenic Exocyclic DNA Adducts Are Substrates for the Human Nucleotide Incision Repair Pathway. PLoS ONE 7(12): e51776. doi:10.1371/journal.pone.0051776	[Prorok, Paulina; Ishchenko, Alexander A.; Tudek, Barbara; Saparbaev, Murat] Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS UMR8200, Grp Reparat ADN, Villejuif, France; [Prorok, Paulina] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Saint-Pierre, Christine; Gasparutto, Didier] CEA, INAC, SCIB UMR CEA UJF E3, Lab Les Acides Nucl, Grenoble, France; [Fedorova, Olga S.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Leh, Herve; Buckle, Malcolm] CNRS, ENS Cachan, LBPA, Cachan, France; [Tudek, Barbara] Univ Warsaw, Inst Genet & Biotechnol, Warsaw, Poland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Warsaw	Tudek, B (corresponding author), Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS UMR8200, Grp Reparat ADN, Villejuif, France.	tudek@ibb.waw.pl; smurat@igr.fr	Ishchenko, Alexander/D-4133-2013; Fedorova, Olga/ABE-6637-2020; Fedorova, Olga S./E-1291-2013; Saparbaev, Murat K/N-3225-2015; Saparbaev, Murat/AAC-5478-2020	Ishchenko, Alexander/0000-0002-0488-8858; Fedorova, Olga/0000-0002-4001-7187; Fedorova, Olga S./0000-0002-4001-7187; Saparbaev, Murat K/0000-0002-4630-1074; Saparbaev, Murat/0000-0002-4630-1074; Prorok, Paulina/0000-0002-1427-1528	Polish-French collaborative [346/N-INCA/2008/0, 303 819540]; Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique [PICS N5479-Russie]; CNRS-INCA-MSHE Franco-Pologne [3037987]; Electricite de France; Contrat Radioprotection; Fondation de France [2012 00029161]; Russian Ministry of Education and Science; International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''; European Union - Regional Development Fund; Electricite de France, EDF (Scientific Commission - Council of Radiation Protection)	Polish-French collaborative; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); CNRS-INCA-MSHE Franco-Pologne; Electricite de France; Contrat Radioprotection; Fondation de France(Fondation de France); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''; European Union - Regional Development Fund; Electricite de France, EDF (Scientific Commission - Council of Radiation Protection)	This work was supported by Polish-French collaborative grants No346/N-INCA/2008/0 and No303 819540 [to BT] and grants from Fondation pour la Recherche Medicale (http://www.frm.org) [EQUIPES FRM 2007 to MS]; Centre National de la Recherche Scientifique (http://www.cnrs.fr) [PICS N5479-Russie, and CNRS-INCA-MSHE Franco-Pologne #3037987 to MS]; Electricite de France (http://www.edf.fr) Contrat Radioprotection [RB 2011 to MS and DG]; Fondation de France (http://www.fondationdefrance.org) [#2012 00029161 to AAI]. Russian Ministry of Education and Science (http://mon.gov.ru) [to OSF and AAI]. PP was supported by the fellowship from International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''. The project is co-financed by European Union - Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Electricite de France, EDF (Scientific Commission - Council of Radiation Protection). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; This research was funded by Electricite de France, EDF (Scientific Commission - Council of Radiation Protection). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akasaka S, 1999, CHEM RES TOXICOL, V12, P501, DOI 10.1021/tx980259j; Asaeda A, 2000, BIOCHEMISTRY-US, V39, P1959, DOI 10.1021/bi9917075; Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; Barbin A, 2003, CANCER RES, V63, P7699; Bartsch H, 2000, TOXICOLOGY, V153, P105, DOI 10.1016/S0300-483X(00)00307-3; BASU AK, 1993, BIOCHEMISTRY-US, V32, P12793, DOI 10.1021/bi00210a031; BASU AK, 1987, BIOCHEMISTRY-US, V26, P5626, DOI 10.1021/bi00392a007; BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; BOLT HM, 1988, CRIT REV TOXICOL, V18, P299, DOI 10.3109/10408448809037469; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Chan MK, 2009, DNA REPAIR, V8, P786, DOI 10.1016/j.dnarep.2009.03.001; CHEN DS, 1994, ANN NY ACAD SCI, V726, P306, DOI 10.1111/j.1749-6632.1994.tb52834.x; Chou KM, 2003, J BIOL CHEM, V278, P18289, DOI 10.1074/jbc.M212143200; Christov PP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/850234; D'Ham C, 1999, BIOCHEMISTRY-US, V38, P3335, DOI 10.1021/bi981982b; Daviet S, 2007, DNA REPAIR, V6, P8, DOI 10.1016/j.dnarep.2006.08.001; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Friedberg EC, 2006, DNA REPAIR, V5, P189, DOI 10.1016/j.dnarep.2005.09.009; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Fu D, 2012, DNA REPAIR, V11, P46, DOI 10.1016/j.dnarep.2011.10.004; Gelin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012241; Gros L, 2004, J BIOL CHEM, V279, P17723, DOI 10.1074/jbc.M314010200; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Guengerich F P, 1994, IARC Sci Publ, P57; Gunther T, 2006, MAGNESIUM RES, V19, P225; Guliaev AB, 2004, NUCLEIC ACIDS RES, V32, P2844, DOI 10.1093/nar/gkh594; Hang B, 1998, P NATL ACAD SCI USA, V95, P13561, DOI 10.1073/pnas.95.23.13561; Hang B, 1997, P NATL ACAD SCI USA, V94, P12869, DOI 10.1073/pnas.94.24.12869; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Huamani J, 2004, MOL CELL BIOL, V24, P8145, DOI 10.1128/MCB.24.18.8145-8153.2004; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2006, P NATL ACAD SCI USA, V103, P2564, DOI 10.1073/pnas.0508582103; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Levine RL, 2000, CANCER RES, V60, P4098; Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; MORIYA M, 1994, P NATL ACAD SCI USA, V91, P11899, DOI 10.1073/pnas.91.25.11899; NAIR J, 1995, CARCINOGENESIS, V16, P613, DOI 10.1093/carcin/16.3.613; Nogues C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044287; Ocampo MTA, 2002, MOL CELL BIOL, V22, P6111, DOI 10.1128/MCB.22.17.6111-6121.2002; Pandya GA, 1996, BIOCHEMISTRY-US, V35, P11487, DOI 10.1021/bi960170h; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; Redrejo-Rodriguez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021039; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; SINGER B, 1992, P NATL ACAD SCI USA, V89, P9386, DOI 10.1073/pnas.89.20.9386; Speina E, 2001, J BIOL CHEM, V276, P21821, DOI 10.1074/jbc.M100998200; Takao M, 2002, J BIOL CHEM, V277, P42205, DOI 10.1074/jbc.M206884200; Tell G, 2010, MOL CELL BIOL, V30, P366, DOI 10.1128/MCB.01174-09; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; Wang D, 2004, MOL CANCER THER, V3, P679; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Winczura A, 2012, FREE RADICAL RES, V46, P442, DOI 10.3109/10715762.2012.658516; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	67	22	22	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51776	10.1371/journal.pone.0051776	http://dx.doi.org/10.1371/journal.pone.0051776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251620	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800083
J	Wang, S; Diao, N; Lu, CY; Wu, J; Gao, Y; Chen, JZ; Zhou, ZM; Huang, HQ; Shao, LY; Jin, JL; Weng, XH; Zhang, Y; Zhang, WH				Wang, Sen; Diao, Ni; Lu, Chanyi; Wu, Jing; Gao, Yan; Chen, Jiazhen; Zhou, Zumo; Huang, Heqing; Shao, Lingyun; Jin, Jialin; Weng, Xinhua; Zhang, Ying; Zhang, Wenhong			Evaluation of the Diagnostic Potential of IP-10 and IL-2 as Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated Population	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; WHOLE-BLOOD; IFN-GAMMA; RELEASE ASSAYS; T-CELLS; INFECTION; RESPONSES; CHILDREN	Background: The Mycobacterium tuberculosis (Mtb)-specific T-cell interferon gamma release assays (IGRAs) are useful in detecting Mtb infection but perform poorly at distinguishing active tuberculosis disease (ATB) and latent tuberculosis infection (LTBI). This study is aimed at evaluating additional cytokines as biomarkers besides interferon-gamma (IFN-gamma) to improve the identification of ATB and LTBI. Methodology/Principal Findings: Sixty-six patients with ATB, 73 household contacts (HHC) of ATB patients and 76 healthy controls (HC) were recruited to undergo QuantiFERON TB GOLD in-tube assay (QFT) and the enzyme-linked immunosorbent assay (ELISA) where the release of IFN-gamma, IFN-gamma inducible protein 10 (IP-10), Interleukin 2 (IL-2) and Tumor Necrosis Factor-alpha (TNF-alpha) was determined in the whole blood with or without antigen-stimulation. The positive rates of the QFT, IP-10 and IL-2 tests were 86.4%, 89.4% and 86.4% for the ATB group with no difference between them (p > 0.05). However, QFT in combination with IP-10 and IL-2 significantly increased the detection rate to 95.5% in the ATB group (p = 0.03) and the indeterminate rate of all samples decreased from 2.3% (5/215) to 0.4% (1/215). The un-stimulated level of IP-10 was significantly higher in the HHC than the ATB and HC groups. The IP-10 responses were strongly associated with extended Mtb exposure time and the degree of smear-positivity of the index cases. The IL-2/IFN-gamma ratio in the antigen-stimulated plasma could discriminate LTBI from ATB with a sensitivity of 77.2% and a specificity of 87.2%. Conclusion: The increased Mtb-specific antigen-stimulated expression of IP-10 and IL-2 may be useful for detecting both ATB and LTBI. Combining the QFT with IP-10 and IL-2 could increase the detection accuracy of active TB over the QFT alone. Citation: Wang S, Diao N, Lu C, Wu J, Gao Y, et al. (2012) Evaluation of the Diagnostic Potential of IP-10 and IL-2 as Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated Population. PLoS ONE 7(12): e51338. doi:10.1371/journal.pone.0051338	[Wang, Sen; Diao, Ni; Lu, Chanyi; Wu, Jing; Gao, Yan; Chen, Jiazhen; Shao, Lingyun; Jin, Jialin; Weng, Xinhua; Zhang, Ying; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Zhou, Zumo; Huang, Heqing] Peoples Hosp Zhuji, Zhuji, Zhejiang, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Zhang, Ying; Zhang, Wenhong] Fudan Univ, Shanghai Med Coll, MOE Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Zhang, Ying; Zhang, Wenhong] Fudan Univ, Shanghai Med Coll, MOH, Shanghai 200433, Peoples R China; [Zhang, Wenhong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fudan University; Fudan University; Fudan University	Zhang, WH (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	yzhang@jhsph.edu; zhangwenhong@fudan.edu.cn	Wu, Jing/GQI-1843-2022	Wu, Jing/0000-0002-1224-0912	Key Technologies Research and Development Program for Infectious Diseases of China [2013ZX10003001-002]; Shanghai Science and Technology Development Funds [10XD1400900, 10QA1401100]; National Natural Science Foundation of China [30901277]; Key Project of Science and Technology of Shanghai [10411955000]	Key Technologies Research and Development Program for Infectious Diseases of China; Shanghai Science and Technology Development Funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai	This work was supported by research grants from the Key Technologies Research and Development Program for Infectious Diseases of China (2013ZX10003001-002), Shanghai Science and Technology Development Funds (10XD1400900, 10QA1401100), National Natural Science Foundation of China (30901277) and the Key Project of Science and Technology of Shanghai (10411955000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039228; Alessandri AL, 2006, INFLAMM RES, V55, P528, DOI 10.1007/s00011-006-5136-9; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Bibova I, 2012, DIAGN MICR INFEC DIS, V72, P68, DOI 10.1016/j.diagmicrobio.2011.09.024; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chakera A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-143; Chen DY, 2011, INT J TUBERC LUNG D, V15, P192; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Kasprowicz VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020606; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Lighter-Fisher J, 2010, INT J TUBERC LUNG D, V14, P1548; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC; Matulis G, 2008, ANN RHEUM DIS, V67, P84, DOI 10.1136/ard.2007.070789; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pedersen P A, 1990, Ugeskr Laeger, V152, P828; Petrucci R, 2008, PEDIATR INFECT DIS J, V27, P1073, DOI 10.1097/INF.0b013e31817d05a3; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Suter-Riniker F, 2011, CLIN VACCINE IMMUNOL; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	45	56	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51338	10.1371/journal.pone.0051338	http://dx.doi.org/10.1371/journal.pone.0051338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272100	Green Submitted, gold, Green Published			2022-12-27	WOS:000312386800043
J	Wei, RC; Yang, CF; Zeng, M; Terry, F; Zhu, K; Yang, CH; Altmeyer, R; Martin, W; De Groot, AS; Leng, QB				Wei, Ruicheng; Yang, Chunfu; Zeng, Mei; Terry, Frances; Zhu, Kai; Yang, Chunhui; Altmeyer, Ralf; Martin, William; De Groot, Anne S.; Leng, Qibin			A Dominant EV71-Specific CD4+T Cell Epitope Is Highly Conserved among Human Enteroviruses	PLOS ONE			English	Article							VP1 CAPSID PROTEIN; MEMORY T-CELLS; MOUTH-DISEASE; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; HUMORAL IMMUNITY; 71 INFECTION; HAND; FOOT; IDENTIFICATION	CD4+ T cell-mediated immunity plays a central role in determining the immunopathogenesis of viral infections. However, the role of CD4+ T cells in EV71 infection, which causes hand, foot and mouth disease (HFMD), has yet to be elucidated. We applied a sophisticated method to identify promiscuous CD4+ T cell epitopes contained within the sequence of the EV71 polyprotein. Fifteen epitopes were identified, and three of them are dominant ones. The most dominant epitope is highly conserved among enterovirus species, including HFMD-related coxsackieviruses, HFMD-unrelated echoviruses and polioviruses. Furthermore, the CD4+ T cells specific to the epitope indeed cross-reacted with the homolog of poliovirus 3 Sabin. Our findings imply that CD4+ T cell responses to poliovirus following vaccination, or to other enteroviruses to which individuals may be exposed in early childhood, may have a modulating effect on subsequent CD4+ T cell response to EV71 infection or vaccine.	[Wei, Ruicheng; Yang, Chunfu; Zhu, Kai; Yang, Chunhui; Altmeyer, Ralf; Leng, Qibin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Terry, Frances; Martin, William; De Groot, Anne S.] EpiVax Inc, Providence, RI USA; [Zeng, Mei] Fudan Univ, Childrens Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [De Groot, Anne S.] Univ Rhode Isl, Inst Immunol & Informat, Providence, RI 02908 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Fudan University; University of Rhode Island	Leng, QB (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	qbleng@sibs.ac.cn	Yang, Chunfu/S-3051-2019; De Groot, Annie/B-6221-2013	De Groot, Annie/0000-0001-5911-1459	National Basic Research Program of China [973 Program] [2011CB504903]; National Natural Science Foundation of China [81172807, 31270951, 30972726]; Li Ka Shing Foundation; 100-Talent Program of CAS; SA-SIBS Scholarship Program	National Basic Research Program of China [973 Program](National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Foundation; 100-Talent Program of CAS(Chinese Academy of Sciences); SA-SIBS Scholarship Program	This work was supported by the National Basic Research Program of China [973 Program, grant number 2011CB504903], the National Natural Science Foundation of China [grant numbers 81172807, 31270951 and 30972726], the Li Ka Shing Foundation and the 100-Talent Program of CAS. QL is supported by the SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P213; Bond KB, 2001, AIDS RES HUM RETROV, V17, P703, DOI 10.1089/088922201750236988; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cello J, 1996, J GEN VIROL, V77, P2097, DOI 10.1099/0022-1317-77-9-2097; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chang LY, 2008, PEDIATRICS, V122, P1271, DOI 10.1542/peds.2007-3735; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; De Groot A, 2011, IMMUNOME RES, V7, P3; De Groot AS, 2009, CLIN IMMUNOL, V131, P189, DOI 10.1016/j.clim.2009.01.009; De Groot AS, 2011, IMMUNOME RES, V7, P7; Deng CY, 2011, CLIN VACCINE IMMUNOL, V18, P1589, DOI 10.1128/CVI.05132-11; Dong YZ, 2004, INFECT IMMUN, V72, P2412, DOI 10.1128/IAI.72.4.2412-2415.2004; Foo DGW, 2008, VIRAL IMMUNOL, V21, P215, DOI 10.1089/vim.2007.0089; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Hu XM, 2012, J CLIN MICROBIOL, V50, P288, DOI 10.1128/JCM.05828-11; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; KUTUBUDDIN M, 1992, J VIROL, V66, P3042, DOI 10.1128/JVI.66.5.3042-3047.1992; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; LECLERC C, 1991, J VIROL, V65, P711, DOI 10.1128/JVI.65.2.711-718.1991; Lin YW, 2009, J VIROL, V83, P6477, DOI 10.1128/JVI.00434-09; MAHON BP, 1995, J EXP MED, V181, P1285, DOI 10.1084/jem.181.4.1285; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMurry JA, 2007, VACCINE, V25, P3179, DOI 10.1016/j.vaccine.2007.01.039; MEISTER GE, 1995, VACCINE, V13, P581, DOI 10.1016/0264-410X(94)00014-E; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Moss SF, 2011, VACCINE, V29, P2085, DOI 10.1016/j.vaccine.2010.12.130; Otero M, 2006, VACCINE, V24, P4461, DOI 10.1016/j.vaccine.2005.08.010; Park SH, 2011, CLIN LAB, V57, P959; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Schanen BC, 2011, VACCINE, V29, P3299, DOI 10.1016/j.vaccine.2011.02.019; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yang CF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-306; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	40	11	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51957	10.1371/journal.pone.0051957	http://dx.doi.org/10.1371/journal.pone.0051957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251663	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800118
J	Winther, SO; Thiesson, HC; Poulsen, LN; Chehri, M; Agerskov, H; Tepel, M				Winther, Stine O.; Thiesson, Helle C.; Poulsen, Lene N.; Chehri, Mahtab; Agerskov, Hanne; Tepel, Martin			The Renal Arterial Resistive Index and Stage of Chronic Kidney Disease in Patients with Renal Allograft	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; VASCULAR-RESISTANCE; ULTRASOUND; SURVIVAL; EQUATION	Objective: The study investigated the optimal threshold value of renal arterial resistive index as assessed by Doppler ultrasonography determining chronic kidney disease stage 4 or higher in patients with renal allograft. Methods: In a cross-sectional study the renal arterial resistive index were obtained in interlobar arteries by Doppler ultrasonography in 78 patients with renal allograft. The stage of chronic kidney disease was determined by the estimated glomerular filtration rate equation. Results: The median renal arterial resistive index was 0.61 (interquartile range, 0.56 to 0.66). We observed a significant association between renal arterial resistive index above the upper quartile and chronic kidney disease stage 4 or higher (relative risk, 4.64; 95% confidence interval, 1.71 to 12.55; p = 0.003 by Fisher's exact test). Multivariate logistic regression analysis showed that renal arterial resistive indices (p = 0.02) and time since transplantation (p = 0.04), but not age, gender, or blood pressure were significantly associated with chronic kidney disease stage 4 or higher. Conclusion: A renal arterial resistive index higher than 0.66 may determine the threshold value of chronic kidney disease stage 4 or higher in patients with renal allograft. Citation: Winther SO, Thiesson HC, Poulsen LN, Chehri M, Agerskov H, et al. (2012) The Renal Arterial Resistive Index and Stage of Chronic Kidney Disease in Patients with Renal Allograft. PLoS ONE 7(12): e51772. doi:10.1371/journal.pone.0051772	[Winther, Stine O.; Thiesson, Helle C.; Poulsen, Lene N.; Chehri, Mahtab; Agerskov, Hanne; Tepel, Martin] Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark; [Tepel, Martin] Univ So Denmark, Inst Mol Med Cardiovasc & Renal Res, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Tepel, M (corresponding author), Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark.	mtepel@health.sdu.dk	Tepel, Martin/GRS-9581-2022	Tepel, Martin/0000-0002-0086-0997; Agerskov, Hanne/0000-0002-3271-0686	European Union (Interreg 4A) [62-1.2-10]	European Union (Interreg 4A)	This study was supported by European Union (Interreg 4A, number 62-1.2-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlouli A, 2009, UROL J, V6, P194; de Vries APJ, 2006, AM J TRANSPLANT, V6, P364, DOI 10.1111/j.1600-6143.2005.01192.x; Doi Y, 2012, HYPERTENSION, V60, P770, DOI 10.1161/HYPERTENSIONAHA.112.196717; Gaston RS, 2011, CURR OPIN ORGAN TRAN, V16, P594, DOI 10.1097/MOT.0b013e32834c23a7; Gerhart MK, 2010, NEPHROL DIAL TRANSPL, V25, P1294, DOI 10.1093/ndt/gfp631; Ikee R, 2005, AM J KIDNEY DIS, V46, P603, DOI 10.1053/j.ajkd.2005.06.006; Krol R, 2011, TRANSPL P, V43, P2926, DOI 10.1016/j.transproceed.2011.08.019; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin ZY, 2002, ABDOM IMAGING, V28, P230, DOI 10.1007/s00261-002-0024-4; Loock MT, 2010, CLIN J AM SOC NEPHRO, V5, P1867, DOI 10.2215/CJN.01210210; Marcantoni C, 2007, J NEPHROL, V20, P518; McArthur C, 2011, RADIOLOGY, V259, P278, DOI 10.1148/radiol.10101329; MOSTBECK GH, 1991, J ULTRAS MED, V10, P189, DOI 10.7863/jum.1991.10.4.189; Radermacher J, 2003, NEW ENGL J MED, V349, P115, DOI 10.1056/NEJMoa022602; Schnell D, 2012, INTENS CARE MED, V38, P1751, DOI 10.1007/s00134-012-2692-z; Tublin ME, 1999, RADIOLOGY, V213, P258, DOI 10.1148/radiology.213.1.r99oc19258; White CA, 2010, CLIN CHEM, V56, P474, DOI 10.1373/clinchem.2009.135111	17	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51772	10.1371/journal.pone.0051772	http://dx.doi.org/10.1371/journal.pone.0051772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272164	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800080
J	Woodman, ME; Worth, RG; Wooten, RM				Woodman, Michael E.; Worth, Randall G.; Wooten, R. Mark			Capsule Influences the Deposition of Critical Complement C3 Levels Required for the Killing of Burkholderia pseudomallei via NADPH-Oxidase Induction by Human Neutrophils	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INTRACELLULAR LIFE-CYCLE; FEBRILE NEUTROPENIA; SERUM RESISTANCE; SECRETION SYSTEM; MURINE MODEL; MELIOIDOSIS; INFECTION; THAILANDENSIS; PHAGOCYTOSIS	Burkholderia pseudomallei is the causative agent of melioidosis and is a major mediator of sepsis in its endemic areas. Because of the low LD50 via aerosols and resistance to multiple antibiotics, it is considered a Tier 1 select agent by the CDC and APHIS. B. pseudomallei is an encapsulated bacterium that can infect, multiply, and persist within a variety of host cell types. In vivo studies suggest that macrophages and neutrophils are important for controlling B. pseudomallei infections, however few details are known regarding how neutrophils respond to these bacteria. Our goal is to describe the capacity of human neutrophils to control highly virulent B. pseudomallei compared to the relatively avirulent, acapsular B. thailandensis using in vitro analyses. B. thailandensis was more readily phagocytosed than B. pseudomallei, but both displayed similar rates of persistence within neutrophils, indicating they possess similar inherent abilities to escape neutrophil clearance. Serum opsonization studies showed that both were resistant to direct killing by complement, although B. thailandensis acquired significantly more C3 on its surface than B. pseudomallei, whose polysaccharide capsule significantly decreased the levels of complement deposition on the bacterial surface. Both Burkholderia species showed significantly enhanced uptake and killing by neutrophils after critical levels of C3 were deposited. Serum-opsonized Burkholderia induced a significant respiratory burst by neutrophils compared to unopsonized bacteria, and neutrophil killing was prevented by inhibiting NADPH-oxidase. In summary, neutrophils can efficiently kill B. pseudomallei and B. thailandensis that possess a critical threshold of complement deposition, and the relative differences in their ability to resist surface opsonization may contribute to the distinct virulence phenotypes observed in vivo.	[Woodman, Michael E.; Worth, Randall G.; Wooten, R. Mark] Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Wooten, RM (corresponding author), Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	R.Mark.Wooten@utoledo.edu	Wooten, Ronald Mark/AAO-4263-2020	Worth, Randall/0000-0002-2626-7964	American Heart Association Postdoctoral Fellowship [11POST7320010]; Public Health Service from National Institute of Allergy and Infectious Disease [R01-AI073452, U01-AI077764]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073452, U01AI077764] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Fellowship(American Heart Association); Public Health Service from National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by American Heart Association Postdoctoral Fellowship 11POST7320010 (MEW), Public Health Service grant R01-AI073452 (RMW) from the National Institute of Allergy and Infectious Disease, and Public Health Service grant U01-AI077764 (RMW) from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; Brett PJ, 1997, EPIDEMIOL INFECT, V118, P137, DOI 10.1017/S095026889600739X; Brett PJ, 2003, FEMS MICROBIOL LETT, V218, P323, DOI 10.1111/j.1574-6968.2003.tb11536.x; Brett PJ, 2000, ACTA TROP, V74, P201, DOI 10.1016/S0001-706X(99)00071-6; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Charoensap J, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-20; Cheng AC, 2004, EUR J CLIN MICROBIOL, V23, P205, DOI 10.1007/s10096-003-1088-y; Cheng AC, 2004, CLIN INFECT DIS, V38, P32, DOI 10.1086/380456; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2007, CLIN INFECT DIS, V45, P308, DOI 10.1086/519261; Christenson Bernard, 2003, Bol Asoc Med P R, V95, P17; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Corbett D, 2009, F1000 BIOL REP, V1, P1; Corral DM, 2008, CAN RESPIR J, V15, P237, DOI 10.1155/2008/290412; Costantini C, 2011, J LEUKOCYTE BIOL, V89, P221, DOI 10.1189/jlb.0510250; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Dance DAB, 2005, EMERG INF DIS 21ST C, P99; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Dorman SE, 1998, CLIN INFECT DIS, V26, P889, DOI 10.1086/513928; DREVETS DA, 1994, INFECT IMMUN, V62, P2222, DOI 10.1128/IAI.62.6.2222-2228.1994; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Egan AM, 1996, INFECT IMMUN, V64, P4952, DOI 10.1128/IAI.64.12.4952-4959.1996; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; FESAP, 2011, REC SEL AG PROGR; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Harley VS, 1998, MICROBIOS, V94, P35; Healey T, 2001, INTERN MED J, V31, P406, DOI 10.1046/j.1445-5994.2001.00095.x; Heiss C, 2012, CARBOHYD RES, V349, P90, DOI 10.1016/j.carres.2011.12.011; Inglis TJJ, 2006, AM J TROP MED HYG, V75, P947, DOI 10.4269/ajtmh.2006.75.947; ISMAIL G, 1988, MICROBIOL IMMUNOL, V32, P645, DOI 10.1111/j.1348-0421.1988.tb01426.x; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kanthawong S, 2012, INT J ANTIMICROB AG, V39, P39, DOI 10.1016/j.ijantimicag.2011.09.010; Kanthawong S, 2009, INT J ANTIMICROB AG, V34, P309, DOI 10.1016/j.ijantimicag.2009.05.012; Kespichayawattana W, 2004, MICROB PATHOGENESIS, V36, P287, DOI 10.1016/j.micpath.2004.01.001; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Laws TR, 2011, MICROB PATHOGENESIS, V51, P471, DOI 10.1016/j.micpath.2011.07.002; Leelarasamee A, 2000, ACTA TROP, V74, P129, DOI 10.1016/S0001-706X(99)00061-3; Mandell GL, 2005, PHARMACOTHERAPY, V25, p130S, DOI 10.1592/phco.2005.25.12part2.130S; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Merino S, 2010, ENCY LIFE SCI, P1; Miralles Iracema Sampaio, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P51, DOI 10.1590/S0036-46652004000100011; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Mukhopadhyay C, 2010, TROP DOCT, V40, P165, DOI 10.1258/td.2010.090461; NAGHIBI M, 1987, DIABETES RES CLIN PR, V4, P27, DOI 10.1016/S0168-8227(87)80030-X; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Ngugi SA, 2010, VACCINE, V28, P7551, DOI 10.1016/j.vaccine.2010.08.058; PARRY MF, 1981, ANN INTERN MED, V95, P293, DOI 10.7326/0003-4819-95-3-293; Perez JM, 1997, CLIN INFECT DIS, V25, P164, DOI 10.1086/516896; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Powell K, 2003, FEMS MICROBIOL LETT, V224, P315, DOI 10.1016/S0378-1097(03)00473-7; PROKESCH RC, 1982, ANTIMICROB AGENTS CH, V21, P373, DOI 10.1128/AAC.21.3.373; RAZAK N, 1982, J GEN APPL MICROBIOL, V28, P509, DOI 10.2323/jgam.28.509; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; Riyapa D, 2012, INFECT IMMU IN PRESS; ROBERTS IS, 1989, BIOCHEM SOC T, V17, P462, DOI 10.1042/bst0170462; Rolim DB, 2005, EMERG INFECT DIS, V11, P1458, DOI 10.3201/eid1109.050493; SCHLESINGER LS, 1994, INFECT IMMUN, V62, P280, DOI 10.1128/IAI.62.1.280-289.1994; Sim SH, 2011, INT J ANTIMICROB AG, V38, P270, DOI 10.1016/j.ijantimicag.2011.06.002; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Stephens DP, 2002, INTERN MED J, V32, P143, DOI 10.1046/j.1445-5994.2002.00195.x; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; Taylor Clare M., 2005, V12, P55, DOI 10.1159/000081689; Titball RW, 2008, T R SOC TROP MED HYG, V102; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VANDENBROEK PJ, 1989, REV INFECT DIS, V11, P213; Vietri N. J., 2007, MED ASPECTS BIOL WAR, P147; Warawa J, 2005, FEMS MICROBIOL LETT, V242, P101, DOI 10.1016/j.femsle.2004.10.045; Warawa JM, 2009, INFECT IMMUN, V77, P5252, DOI 10.1128/IAI.00824-09; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120	100	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52276	10.1371/journal.pone.0052276	http://dx.doi.org/10.1371/journal.pone.0052276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251706	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800158
J	Xue, WY; Ruprecht, C; Street, N; Hematy, K; Chang, C; Frommer, WB; Persson, S; Niittyla, T				Xue, Weiya; Ruprecht, Colin; Street, Nathaniel; Hematy, Kian; Chang, Christine; Frommer, Wolf B.; Persson, Staffan; Niittyla, Totte			Paramutation-Like Interaction of T-DNA Loci in Arabidopsis	PLOS ONE			English	Article							ORIENTED CELL EXPANSION; METHYLATION PATTERNS; EPIGENETIC INHERITANCE; CYTOSINE METHYLATION; DEFENSE RESPONSES; ANCHORED PROTEIN; RNA-POLYMERASE; R1 LOCUS; ZEA-MAYS; MAIZE	In paramutation, epigenetic information is transferred from one allele to another to create a gene expression state which is stably inherited over generations. Typically, paramutation describes a phenomenon where one allele of a gene down-regulates the expression of another allele. Paramutation has been described in several eukaryotes and is best understood in plants. Here we describe an unexpected paramutation-like trans SALK T-DNA interaction in Arabidopsis. Unlike most of the previously described paramutations, which led to gene silencing, the trans SALK T-DNA interaction caused an increase in the transcript levels of the endogenous gene (COBRA) where the T-DNA was inserted. This increased COBRA expression state was stably inherited for several generations and led to the partial suppression of the cobra phenotype. DNA methylation was implicated in this trans SALK T-DNA interaction since mutation of the DNA methyltransferase 1 in the suppressed cobra caused a reversal of the suppression. In addition, null mutants of the DNA demethylase ROS1 caused a similar COBRA transcript increase in the cobra SALK T-DNA mutant as the trans T-DNA interaction. Our results provide a new example of a paramutation-like trans T-DNA interaction in Arabidopsis, and establish a convenient hypocotyl elongation assay to study this phenomenon. The results also alert to the possibility of unexpected endogenous transcript increase when two T-DNAs are combined in the same genetic background. Citation: Xue W, Ruprecht C, Street N, Hematy K, Chang C, et al. (2012) Paramutation-Like Interaction of T-DNA Loci in Arabidopsis. PLoS ONE 7(12): e51651. doi:10.1371/journal.pone.0051651	[Xue, Weiya; Niittyla, Totte] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Ruprecht, Colin; Persson, Staffan] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Street, Nathaniel] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Hematy, Kian] INRA AgroParisTech, Inst Jean Pierre Bourgin, Versailles, France; [Chang, Christine; Frommer, Wolf B.; Niittyla, Totte] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA	Swedish University of Agricultural Sciences; Umea University; Max Planck Society; Umea University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Carnegie Institution for Science	Niittyla, T (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden.	totte.niittyla@slu.se	xue, weiya/L-5834-2015; Hématy, Kian/AAD-8989-2021; Frommer, Wolf B/K-5042-2017; Persson, Staffan/S-8399-2016; Street, Nathaniel Robert/B-3920-2008; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Persson, Staffan/0000-0002-6377-5132; Street, Nathaniel Robert/0000-0001-6031-005X; Frommer, Wolf B/0000-0001-6465-0115; Niittyla, Totte/0000-0001-8029-1503; Ruprecht, Colin/0000-0003-4362-2208; Hematy, Kian/0000-0002-3933-3852	Swedish research agency FORMAS; Human Frontier Science Program and Bio4Energy; Swedish Programme for renewable energy	Swedish research agency FORMAS; Human Frontier Science Program and Bio4Energy; Swedish Programme for renewable energy	This work was supported by grants from the Swedish research agency FORMAS, the Human Frontier Science Program and Bio4Energy, the Swedish Programme for renewable energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Baubec T, 2009, PLANT J, V57, P542, DOI 10.1111/j.1365-313X.2008.03699.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; COE EH, 1966, GENETICS, V53, P1035; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Dische Z, 1962, METHODS CARBOHYDRATE, P478; Erhard KF, 2011, CURR OPIN PLANT BIOL, V14, P210, DOI 10.1016/j.pbi.2011.02.005; Erhard KF, 2009, SCIENCE, V323, P1201, DOI 10.1126/science.1164508; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Gao YB, 2013, MOL PLANT, V6, P539, DOI 10.1093/mp/sss093; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Haring M, 2010, PLANT J, V63, P366, DOI 10.1111/j.1365-313X.2010.04245.x; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hong SM, 2010, PLANT CELL PHYSL, V51, P1964; Kankel MW, 2003, GENETICS, V163, P1109; Ko JH, 2006, J EXP BOT, V57, P2923, DOI 10.1093/jxb/erl052; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; PATTERSON GI, 1995, GENETICS, V140, P1389; Penterman J, 2007, PLANT PHYSIOL, V145, P1549, DOI 10.1104/pp.107.107730; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Sidorenko L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000725; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Urdvardi MK, 2008, PLANT CELL, V20, P1736; Walker EL, 1998, GENETICS, V148, P1973; Walker EL, 2001, GENETICS, V159, P1201; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	44	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51651	10.1371/journal.pone.0051651	http://dx.doi.org/10.1371/journal.pone.0051651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272131	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800059
J	Qin, B; Chen, TT; Cao, AZ; Wang, HY; Xing, LP; Ling, HQ; Wang, DW; Yu, CM; Xiao, J; Ji, JH; Chen, XL; Chen, PD; Liu, DJ; Wang, XE				Qin, Bi; Chen, Tingting; Cao, Aizhong; Wang, Haiyan; Xing, Liping; Ling, Hongqing; Wang, Daowen; Yu, Chunmei; Xiao, Jin; Ji, Jianhui; Chen, Xueluan; Chen, Peidu; Liu, Dajun; Wang, Xiue			Cloning of a Conserved Receptor-Like Protein Kinase Gene and Its Use as a Functional Marker for Homoeologous Group-2 Chromosomes of the Triticeae Species	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; DISEASE RESISTANCE; DIFFERENTIAL EXPRESSION; HEXAPLOID WHEAT; RICE; ARABIDOPSIS; FAMILY; EVOLUTION; GENOMES; CANCER	Receptor-like kinases (RLKs) play broad biological roles in plants. We report on a conserved receptor-like protein kinase (RPK) gene from wheat and other Triticeae species. The TaRPK1 was isolated from the Triticum aestivum cv. Prins - Triticum timopheevii introgression line IGVI-465 carrying the powdery mildew resistance gene Pm6. The TaRPK1 was mapped to homoeologous chromosomes 2A (TaRPK1-2A), 2D (TaRPK1-2D) and the Pm6-carrier chromosome 2G (TaRPK1-2G) of IGVI-465. Under the tested conditions, only the TaRPK1-2G allele was actively transcribed, producing two distinct transcripts via alternative splicing. The predicted 424-amino acid protein of TaRPK1-2G contained a signal peptide, a transmembrane domain and an intracellular serine/threonine kinase domain, but lacked a typical extracellular domain. The expression of TaRPK1-2G gene was up-regulated upon the infection by Blumeria graminis f.sp. tritici (Bgt) and treatment with methyl jasmonate (MeJA), but down-regulated in response to treatments of SA and ABA. Over-expression of TaRPK1-2G in the powdery mildew susceptible wheat variety Prins by a transient expression assay showed that it slightly reduced the haustorium index of the infected Bgt. These data indicated that TaRPK1-2G participated in the defense response to Bgt infection and in the JA signaling pathway. Phylogenetic analysis indicated that TaRPK1-2G was highly conserved among plant species, and the amino acid sequence similarity of TaRPK1-2G among grass species was more than 86%. Based on its conservation, the RPK gene-based STS primers were designed, and used to amplify the RPK orthologs from the homoeologous group-2 chromosomes of all the tested Triticeae species, such as chromosome 2G of T. timopheevii, 2R of Secale cereale, 2H of Hordeum vulgare, 2S of Aegilops speltoides, 2S(l) of Ae. longissima, 2M(g) of Ae. geniculata, 2S(p) and 2U(p) of Ae. peregrina. The developed STS markers serve as conserved functional markers for the identification of homoeologous group-2 chromosomes of the Triticeae species. Citation: Qin B, Chen T, Cao A, Wang H, Xing L, et al. (2012) Cloning of a Conserved Receptor-Like Protein Kinase Gene and Its Use as a Functional Marker for Homoeologous Group-2 Chromosomes of the Triticeae Species. PLoS ONE 7(12): e49718. doi:10.1371/journal.pone.0049718	[Qin, Bi; Chen, Tingting; Cao, Aizhong; Wang, Haiyan; Xing, Liping; Xiao, Jin; Ji, Jianhui; Chen, Xueluan; Chen, Peidu; Liu, Dajun; Wang, Xiue] Nanjing Agr Univ, Cytogenet Inst, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Ling, Hongqing; Wang, Daowen; Yu, Chunmei] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Qin, Bi] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Biol & Genet Resources Rubber Tree, Danzhou, Hainan, Peoples R China	Nanjing Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Wang, XE (corresponding author), Nanjing Agr Univ, Cytogenet Inst, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	xiuew@njau.edu.cn	Ling, Hong-Qing/ABC-9451-2020	wang, dao wen/0000-0002-6230-8735	Chinese High Tech Program of China [2011AA1001]; Natural Science Foundation of Jiangsu Province [BK2006720]; Important National Science and Technology Specific Projects of Transgenic Research [2011ZX08002-001]; Program of Introducing Talents of Discipline [B08025]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Ministry of Science and Technology of China [2011BAD07B02-2]	Chinese High Tech Program of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Important National Science and Technology Specific Projects of Transgenic Research; Program of Introducing Talents of Discipline; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by grants from the Chinese High Tech Program of China (No. 2011AA1001), the Natural Science Foundation of Jiangsu Province (No. BK2006720), Important National Science and Technology Specific Projects of Transgenic Research (No. 2011ZX08002-001), the Program of Introducing Talents of Discipline to Universities (No. B08025) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). Research in Daowen Wang's group is supported in part by a grant (2011BAD07B02-2) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, HUM MOL GENET, V15, P777, DOI 10.1093/hmg/ddi492; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Dong LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013548; Egawa C, 2006, GENES GENET SYST, V81, P77, DOI 10.1266/ggs.81.77; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Feuillet C, 1998, PLANT MOL BIOL, V37, P943, DOI 10.1023/A:1006062016593; Feuillet C, 1997, PLANT J, V11, P45, DOI 10.1046/j.1365-313X.1997.11010045.x; Feuillet C, 2001, PLANT PHYSIOL, V125, P1304, DOI 10.1104/pp.125.3.1304; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; [郭志爱 GUO Zhi-Ai], 2009, [作物学报, Acta Agronomica Sinica], V35, P1764; Ji JH, 2008, EUPHYTICA, V163, P159, DOI 10.1007/s10681-007-9578-0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li Qiang, 2005, Yichuan, V27, P808; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Park YJ, 2004, MOL CELLS, V17, P492; Qin B, 2011, THEOR APPL GENET, V123, P207, DOI 10.1007/s00122-011-1577-9; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Shirasu K, 1999, PLANT J, V17, P293, DOI 10.1046/j.1365-313X.1999.00376.x; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Soleymanlou N, 2005, CELL DEATH DIFFER, V12, P441, DOI 10.1038/sj.cdd.4401593; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Song YZ, 1995, NATURE, V373, P536; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tan EK, 2005, NEUROGENETICS, V6, P179, DOI 10.1007/s10048-005-0001-5; Tao W, 2000, THEOR APPL GENET, V100, P564, DOI 10.1007/s001220050074; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Torii KU, 2000, ADV BOT RES, V32, P225, DOI 10.1016/S0065-2296(00)32026-2; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; WALKER JC, 1993, PLANT J, V3, P451, DOI 10.1046/j.1365-313X.1993.t01-23-00999.x; WALKER JC, 1994, PLANT MOL BIOL, V26, P1599, DOI 10.1007/BF00016492; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474; Zhang XC, 2007, PLANT PHYSIOL, V145, P1577, DOI 10.1104/pp.107.108720; Zhou HB, 2007, PLANT J, V52, P420, DOI 10.1111/j.1365-313X.2007.03246.x	43	4	4	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e49718	10.1371/journal.pone.0049718	http://dx.doi.org/10.1371/journal.pone.0049718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272050	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600004
J	Tristan, A; Rasigade, JP; Ruizendaal, E; Laurent, F; Bes, M; Meugnier, H; Lina, G; Etienne, J; Celard, M; Tattevin, P; Monecke, S; Le Moing, V; Vandenesch, F				Tristan, Anne; Rasigade, Jean-Philippe; Ruizendaal, Esmee; Laurent, Frederic; Bes, Michele; Meugnier, Helene; Lina, Gerard; Etienne, Jerome; Celard, Marie; Tattevin, Pierre; Monecke, Stefan; Le Moing, Vincent; Vandenesch, Francois		French AEPEI Study Grp Infective E	Rise of CC398 Lineage of Staphylococcus aureus among Infective Endocarditis Isolates Revealed by Two Consecutive Population-Based Studies in France	PLOS ONE			English	Article							METHICILLIN-RESISTANT; MORTALITY; GENOTYPE; CRITERIA; CLFA	Staphylococcus aureus isolates from two prospective studies on infective endocarditis (IE) conducted in 1999 and 2008 and isolated from non-IE bacteremia collected in 2006 were spa-typed and their virulence factors were analyzed with a microarray. Both populations were genetically diverse, with no virulence factors or genotypes significantly more associated with the IE isolates compared with the non-IE isolates. The population structure of the IE isolates did not change much between 1999 and 2008, with the exception of the appearance of CC398 methicillin-susceptible Staphylococcus aureus (MSSA) isolates responsible for 5.6% of all cases in 2008. In 1999, this lineage was responsible for no cases. The increasing prevalence of S. aureus in IE is apparently not the result of a major change in staphylococcal population structure over time, with the exception of the emerging CC398 MSSA lineage. Citation: Tristan A, Rasigade J-P, Ruizendaal E, Laurent F, Bes M, et al. (2012) Rise of CC398 Lineage of Staphylococcus aureus among Infective Endocarditis Isolates Revealed by Two Consecutive Population-Based Studies in France. PLoS ONE 7(12): e51172. doi:10.1371/journal.pone.0051172	[Tristan, Anne; Rasigade, Jean-Philippe; Ruizendaal, Esmee; Laurent, Frederic; Bes, Michele; Meugnier, Helene; Lina, Gerard; Etienne, Jerome; Celard, Marie; Vandenesch, Francois] Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Bron, France; [Tristan, Anne; Rasigade, Jean-Philippe; Laurent, Frederic; Bes, Michele; Lina, Gerard; Etienne, Jerome; Vandenesch, Francois] Univ Lyon, Domaine Buire, Lyon, France; [Tristan, Anne; Rasigade, Jean-Philippe; Laurent, Frederic; Bes, Michele; Lina, Gerard; Etienne, Jerome; Vandenesch, Francois] INSERM, U851, Bacterial Pathogenesis & Innate Immun Lab, F-69008 Lyon, France; [Tattevin, Pierre] Pontchaillou Univ Hosp, Infect Dis & Intens Care Unit, Rennes, France; [Monecke, Stefan] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Le Moing, Vincent] Hop Gui de Chauliac, Dept Malad Infect & Trop, Montpellier, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Technische Universitat Dresden; Universite de Montpellier; CHU de Montpellier	Tristan, A (corresponding author), Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Bron, France.	anne.tristan@univ-lyon1.fr	Laurent, Frederic/M-4719-2014; Rasigade, Jean-Philippe/L-9320-2014; Lina, Gerard J/L-9352-2014; TRISTAN, Anne/GSN-8306-2022; ETIENNE, Jerome/C-5471-2014; Ruizendaal, Esmée/AAG-6157-2020; Tristan, Anne/L-9464-2014; Vandenesch, Francois/C-7209-2014; Rasigade, Jean-Philippe/AAE-1667-2021; LAURENT, Frederic/AGM-0706-2022	Rasigade, Jean-Philippe/0000-0002-8264-0452; TRISTAN, Anne/0000-0001-9471-2655; ETIENNE, Jerome/0000-0002-3348-3315; Vandenesch, Francois/0000-0001-9412-7106; Lina, Gerard/0000-0002-9236-7998; Le Moing, Vincent/0000-0002-9529-2792; laurent, frederic/0000-0003-0609-9091	Programme Hospitalier de Recherche Clinique (clinical research program); French Ministry of Health	Programme Hospitalier de Recherche Clinique (clinical research program); French Ministry of Health	The study was supported by a Programme Hospitalier de Recherche Clinique (clinical research program) funded by the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Entenza JM, 2005, INFECT IMMUN, V73, P990, DOI 10.1128/IAI.73.2.990-998.2005; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hienz SA, 1996, J INFECT DIS, V174, P83, DOI 10.1093/infdis/174.1.83; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Kaasch AJ, 2011, CLIN INFECT DIS, V53, P1, DOI 10.1093/cid/cir320; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rijnders MIA, 2009, J CLIN MICROBIOL, V47, P4090, DOI 10.1128/JCM.00820-09; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Thuny F, 2010, EUR HEART J, V31, P1826, DOI 10.1093/eurheartj/ehq154; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09	31	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51172	10.1371/journal.pone.0051172	http://dx.doi.org/10.1371/journal.pone.0051172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272091	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600019
J	Wang, N; Zhou, Y; Jiang, L; Li, DH; Yang, JW; Zhang, CY; Zen, K				Wang, Nan; Zhou, Yang; Jiang, Lei; Li, Donghai; Yang, Junwei; Zhang, Chen-Yu; Zen, Ke			Urinary MicroRNA-10a and MicroRNA-30d Serve as Novel, Sensitive and Specific Biomarkers for Kidney Injury	PLOS ONE			English	Article							CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; IDENTIFICATION; EXPRESSION; DIAGNOSIS; DISEASE; TARGETS; CANCER; SERUM	The steadily increasing incidence of kidney injury is a significant threat to human health. The current tools available for the early detection of kidney injury, however, have limited sensitivity or specificity. Thus, the development of novel biomarkers to detect early kidney injury is of high importance. Employing mouse renal ischemia-reperfusion and streptozotocin (STZ)-induced renal injury as acute and chronic kidney injury model, respectively, we assessed the alteration of microRNA (miRNA) in mouse urine, serum and kidney tissue by TaqMan probe-based qRT-PCR assay. Our results demonstrated that kidney-enriched microRNA-10a (miR-10a) and microRNA-30d (miR-30d) were readily detected in mouse urine and the levels of urinary miR-10a and miR-30d were positively correlated with the degree of kidney injury induced by renal ischemia-reperfusion or STZ diabetes. In contrast, no such alteration of miR-10a and miR-30d levels was observed in mouse serum after kidney injury. Compared with the blood urea nitrogen (BUN) assay, the test for urinary miR-10a and miR-30d levels was more sensitive for the detection of acute kidney injury. Furthermore, the substantial elevation of the urinary miR-10a and miR-30d levels was also observed in focal segmental glomerulosclerosis (FSGS) patients compared to healthy donors. In conclusion, the present study collectively demonstrates that urinary miR-10a and miR-30d represent a novel noninvasive, sensitive, specific and potentially high-throughput method for detecting renal injury. Citation: Wang N, Zhou Y, Jiang L, Li D, Yang J, et al. (2012) Urinary MicroRNA-10a and MicroRNA-30d Serve as Novel, Sensitive and Specific Biomarkers for Kidney Injury. PLoS ONE 7(12): e51140. doi:10.1371/journal.pone.0051140	[Wang, Nan; Li, Donghai; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zhou, Yang; Jiang, Lei; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Res Ctr Nephrol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn; cyzhang@nju.edu.cn; kzen@nju.edu.cn			National Basic Research Program of China (973 Program) [2012CB517603, 2011CB504803]; National Natural Science Foundation of China [30988003, 30890044, 30800946, 30871019, 30890032, 31071232, 31000323, 90608010, 90813035]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (No. 2012CB517603, 2011CB504803), the grants from the National Natural Science Foundation of China (Nos. 30988003, 30890044, 30800946, 30871019, 30890032, 31071232, 31000323, 90608010 and 90813035), and the Natural Science Foundation of Jiangsu Province (BK2011013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Contu R, 2010, CIRC RES, V107, P573, DOI 10.1161/CIRCRESAHA.110.227983; Dieterle F, 2008, CURR OPIN DRUG DISC, V11, P60; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Hewitt SM, 2004, J AM SOC NEPHROL, V15, P1677, DOI 10.1097/01.ASN.0000129114.92265.32; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Ho J, 2011, J AM SOC NEPHROL, V22, P1053, DOI 10.1681/ASN.2010080841; Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Kumar S, 2009, J AM SOC NEPHROL, V20, P2412, DOI 10.1681/ASN.2008080868; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li N, 2012, CANCER RES, V72, P154, DOI 10.1158/0008-5472.CAN-11-2484; Lorenzen JM, 2011, AM J TRANSPLANT, V11, P2221, DOI 10.1111/j.1600-6143.2011.03679.x; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wang G, 2012, LUPUS, V21, P1190; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Westhuyzen J, 2003, NEPHROL DIAL TRANSPL, V18, P543, DOI 10.1093/ndt/18.3.543; Xue XC, 2011, J IMMUNOL, V187, P5879, DOI 10.4049/jimmunol.1100535; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215	35	61	78	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51140	10.1371/journal.pone.0051140	http://dx.doi.org/10.1371/journal.pone.0051140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272089	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386600018
J	Marques-Vidal, P; Schmid, R; Bochud, M; Bastardot, F; von Kanel, R; Paccaud, F; Glaus, J; Preisig, M; Waeber, G; Vollenweider, P				Marques-Vidal, Pedro; Schmid, Remy; Bochud, Murielle; Bastardot, Francois; von Kaenel, Roland; Paccaud, Fred; Glaus, Jennifer; Preisig, Martin; Waeber, Gerard; Vollenweider, Peter			Adipocytokines, Hepatic and Inflammatory Biomarkers and Incidence of Type 2 Diabetes. The CoLaus Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MIDDLE-AGED MEN; GAMMA-GLUTAMYL-TRANSFERASE; RISK PREDICTION; INCREMENTAL VALUE; CLINICAL UTILITY; POPULATION; ADIPONECTIN; MELLITUS; MARKERS	Context: There is contradictory information regarding the prognostic importance of adipocytokines, hepatic and inflammatory biomarkers on the incidence of type 2 diabetes. The objective was to assess the prognostic relevance of adipocytokine and inflammatory markers (C-reactive protein - CRP; interleukin-1beta - IL-1 beta; interleukin-6- IL-6; tumour necrosis factor-alpha - TNF-alpha; leptin and adiponectin) and gamma-glutamyl transpeptidase (gamma GT) on the incidence of type 2 diabetes. Methods: Prospective, population-based study including 3,842 non-diabetic participants (43.3% men, age range 35 to 75 years), followed for an average of 5.5 years (2003-2008). The endpoint was the occurrence of type 2 diabetes. Results: 208 participants (5.4%, 66 women) developed type 2 diabetes during follow-up. On univariate analysis, participants who developed type 2 diabetes had significantly higher baseline levels of IL-6, CRP, leptin and gamma GT, and lower levels of adiponectin than participants who remained free of type 2 diabetes. After adjusting for a validated type 2 diabetes risk score, only the associations with adiponectin: Odds Ratio and (95% confidence interval): 0.97 (0.64-1.47), 0.84 (0.55-1.30) and 0.64 (0.40-1.03) for the second, third and forth gender-specific quartiles respectively, remained significant (P-value for trend = 0.05). Adding each marker to a validated type 2 diabetes risk score (including age, family history of type 2 diabetes, height, waist circumference, resting heart rate, presence of hypertension, HDL cholesterol, triglycerides, fasting glucose and serum uric acid) did not improve the area under the ROC or the net reclassification index; similar findings were obtained when the markers were combined, when the markers were used as continuous (log-transformed) variables or when gender-specific quartiles were used. Conclusion: Decreased adiponectin levels are associated with an increased risk for incident type 2 diabetes, but they seem to add little information regarding the risk of developing type 2 diabetes to a validated risk score.	[Marques-Vidal, Pedro; Schmid, Remy; Bochud, Murielle; Paccaud, Fred] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Bastardot, Francois; Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Bastardot, Francois; Waeber, Gerard; Vollenweider, Peter] Fac Biol & Med, Lausanne, Switzerland; [von Kaenel, Roland] Univ Bern, Inselspital, Univ Hosp Bern, Div Psychosomat Med, CH-3010 Bern, Switzerland; [von Kaenel, Roland] Univ Bern, Bern, Switzerland; [Glaus, Jennifer; Preisig, Martin] CHU Vaudois, Dept Psychiat, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Marques-Vidal, P (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Pedro-Manuel.Marques-Vidal@chuv.ch	Marques-Vidal, Pedro M/C-9449-2009; Glaus, Jennifer/C-7887-2017; Colaus, PsyColaus/K-6607-2013; paccaud, fred/M-7516-2019; Bastardot, Francois/J-4013-2017; Bastardot, François/P-7809-2019; von Känel, Roland/B-1811-2019; Bochud, Murielle/A-3981-2010	Marques-Vidal, Pedro M/0000-0002-4548-8500; Glaus, Jennifer/0000-0001-8883-9473; Bastardot, Francois/0000-0003-4060-0353; Bastardot, François/0000-0003-4060-0353; von Känel, Roland/0000-0002-8929-5129; Bochud, Murielle/0000-0002-5727-0218; Waeber, Gerard/0000-0003-4193-788X; Preisig, Martin/0000-0001-5689-4259	Swiss National Science Foundation [33CSCO-122661]; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	The CoLaus study was supported by research grants from the Swiss National Science Foundation (grant no: 33CSCO-122661) from GlaxoSmithKline and the Faculty of Biology and Medicine of Lausanne, Switzerland. Murielle Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Aromaa, 2008, REV HLTH EXAMINATION; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Choi KM, 2004, DIABETES RES CLIN PR, V64, P99, DOI 10.1016/j.diabres.2003.10.007; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cook NR, 2012, AM J EPIDEMIOL, V176, P488, DOI 10.1093/aje/kws208; deGoma EM, 2012, ATHEROSCLEROSIS, V224, P274, DOI 10.1016/j.atherosclerosis.2012.07.017; Doi Y, 2007, OBESITY, V15, P1841, DOI 10.1038/oby.2007.218; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Finkelstein MM, 2001, AIHAJ, V62, P195, DOI 10.1080/15298660108984622; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Gautier A, 2010, DIABETOLOGIA, V53, P247, DOI 10.1007/s00125-009-1602-6; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hsiao JY, 2007, PANCREAS, V35, P343, DOI 10.1097/mpa.0b013e31811f44fd; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Kanaya AM, 2006, ARCH INTERN MED, V166, P350, DOI 10.1001/archinte.166.3.350; Kerr KF, 2011, AM J EPIDEMIOL, V174, P364, DOI 10.1093/aje/kwr086; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Lee DH, 2004, J CLIN ENDOCR METAB, V89, P5410, DOI 10.1210/jc.2004-0505; Lee DH, 2003, DIABETOLOGIA, V46, P359, DOI 10.1007/s00125-003-1036-5; Lee SA, 2007, CANCER EPIDEM BIOMAR, V16, P2464, DOI 10.1158/1055-9965.EPI-07-0374; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Loomba R, 2012, HEPATOLOGY; Marques-Vidal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021002; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Mihaescu R, 2010, AM J EPIDEMIOL, V172, P353, DOI 10.1093/aje/kwq122; Montonen J, 2011, EUR J EPIDEMIOL, V26, P29, DOI 10.1007/s10654-010-9539-0; Moons KGM, 2010, CLIN CHEM, V56, P537, DOI 10.1373/clinchem.2009.134155; Ong KL, 2011, DIABETOLOGIA, V54, P2552, DOI 10.1007/s00125-011-2227-0; Oriol-Zerbe Christina, 2007, Eur J Gen Pract, V13, P27, DOI 10.1080/13814780601050541; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Schmid R, 2012, ARCH INTERN MED, V172, P188, DOI 10.1001/archinte.172.2.188; Schmid R, 2011, DIABETES CARE, V34, P1863, DOI 10.2337/dc11-0206; Schmidt MI, 2006, DIABETOLOGIA, V49, P2086, DOI 10.1007/s00125-006-0351-z; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Skeppholm M, 2008, CLIN CHEM LAB MED, V46, P1175, DOI 10.1515/CCLM.2008.219; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Sun Q, 2010, DIABETES, V59, P611, DOI 10.2337/db09-1343; Tabak AG, 2009, HORM METAB RES, V41, P626, DOI 10.1055/s-0029-1216359; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; von Kanel R, 2010, NEUROIMMUNOMODULAT, V17, P39, DOI 10.1159/000243084; Wacholder S, 2012, AM J EPIDEMIOL, V176, P495, DOI 10.1093/aje/kws255; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	54	50	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51768	10.1371/journal.pone.0051768	http://dx.doi.org/10.1371/journal.pone.0051768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251619	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200164
J	Nakamura, S; Grigoriev, I; Nogi, T; Hamaji, T; Cassimeris, L; Mimori-Kiyosue, Y				Nakamura, Satoko; Grigoriev, Ilya; Nogi, Taisaku; Hamaji, Tomoko; Cassimeris, Lynne; Mimori-Kiyosue, Yuko			Dissecting the Nanoscale Distributions and Functions of Microtubule-End-Binding Proteins EB1 and ch-TOG in Interphase HeLa Cells	PLOS ONE			English	Article							STRUCTURED ILLUMINATION MICROSCOPY; XENOPUS EGG EXTRACTS; PLUS-END; IN-VITRO; TRACKING PROTEINS; MINI SPINDLES; DYNAMICS; XMAP215; APC; DROSOPHILA	Recently, the EB1 and XMAP215/TOG families of microtubule binding proteins have been demonstrated to bind autonomously to the growing plus ends of microtubules and regulate their behaviour in in vitro systems. However, their functional redundancy or difference in cells remains obscure. Here, we compared the nanoscale distributions of EB1 and ch-TOG along microtubules using high-resolution microscopy techniques, and also their roles in microtubule organisation in interphase HeLa cells. The ch-TOG accumulation sites protruded similar to 100 nm from the EB1 comets. Overexpression experiments showed that ch-TOG and EB1 did not interfere with each other's localisation, confirming that they recognise distinct regions at the ends of microtubules. While both EB1 and ch-TOG showed similar effects on microtubule plus end dynamics and additively increased microtubule dynamicity, only EB1 exhibited microtubule-cell cortex attachment activity. These observations indicate that EB1 and ch-TOG regulate microtubule organisation differently via distinct regions in the plus ends of microtubules.	[Nakamura, Satoko; Nogi, Taisaku; Hamaji, Tomoko; Mimori-Kiyosue, Yuko] RIKEN, Ctr Dev Biol, Opt Image Anal Unit, Kobe, Hyogo, Japan; [Grigoriev, Ilya] Univ Utrecht, Div Cell Biol, Fac Sci, Utrecht, Netherlands; [Cassimeris, Lynne] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	RIKEN; Utrecht University; Lehigh University	Mimori-Kiyosue, Y (corresponding author), RIKEN, Ctr Dev Biol, Opt Image Anal Unit, Kobe, Hyogo, Japan.	y-kiyosue@cdb.riken.jp	Nogi, Taisaku/F-4675-2017	Cassimeris, Lynne/0000-0003-1058-0734	Takeda Science Foundation; Kurata Memorial Hitachi Science and Technology Foundation; JSPS Funding Program for Next Generation World-Leading Researchers (NEXT program); Uehara Memorial Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurata Memorial Hitachi Science and Technology Foundation; JSPS Funding Program for Next Generation World-Leading Researchers (NEXT program); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants from the Takeda Science Foundation, the Kurata Memorial Hitachi Science and Technology Foundation, the JSPS Funding Program for Next Generation World-Leading Researchers (NEXT program), and Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Behrens J, 2012, J BIOL CHEM; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bonfils C, 2007, J BIOL CHEM, V282, P5570, DOI 10.1074/jbc.M605641200; Brittle AL, 2005, EMBO J, V24, P1387, DOI 10.1038/sj.emboj.7600629; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cassimeris L, 2001, J CELL SCI, V114, P3025; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; Charrasse S, 1998, J CELL SCI, V111, P1371; CHARRASSE S, 1995, EUR J BIOCHEM, V234, P406, DOI 10.1111/j.1432-1033.1995.406_b.x; Currie JD, 2011, MOL BIOL CELL, V22, P4343, DOI 10.1091/mbc.E11-06-0520; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Gierke S, 2012, CURR BIOL, V22, P753, DOI 10.1016/j.cub.2012.02.069; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Grigoriev I, 2010, METHOD CELL BIOL, V97, P91, DOI 10.1016/S0091-679X(10)97006-4; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hotta A, 2010, J CELL BIOL, V189, P901, DOI 10.1083/jcb.200910095; Jiang K, 2012, CURR BIOL; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Mimori-Kiyosue Y, 2007, GENES CELLS, V12, P219, DOI 10.1111/j.1365-2443.2007.01045.x; Mimori-Kiyosue Y, 2011, CYTOSKELETON, V68, P603, DOI 10.1002/cm.20540; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schaefer LH, 2004, J MICROSC-OXFORD, V216, P165, DOI 10.1111/j.0022-2720.2004.01411.x; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmidt N, 2012, J CELL BIOL, V198, P421, DOI 10.1083/jcb.201111130; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; SU LK, 1995, CANCER RES, V55, P2972; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108	56	38	38	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51442	10.1371/journal.pone.0051442	http://dx.doi.org/10.1371/journal.pone.0051442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251535	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200110
J	Sadarangani, M; Hoe, JC; Callaghan, MJ; Jones, C; Chan, H; Makepeace, K; Daniels-Treffandier, H; Deadman, ME; Bayliss, C; Feavers, I; van der Ley, P; Pollard, AJ				Sadarangani, Manish; Hoe, J. Claire; Callaghan, Martin J.; Jones, Claire; Chan, Hannah; Makepeace, Katherine; Daniels-Treffandier, Helene; Deadman, Mary E.; Bayliss, Christopher; Feavers, Ian; van der Ley, Peter; Pollard, Andrew J.			Construction of Opa-Positive and Opa-Negative Strains of Neisseria meningitidis to Evaluate a Novel Meningococcal Vaccine	PLOS ONE			English	Article							MEMBRANE VESICLE VACCINE; SEROGROUP-B; GENETIC-TRANSFORMATION; MONOCLONAL-ANTIBODIES; CRITICAL DETERMINANTS; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; OPACITY PROTEINS; EPITHELIAL-CELLS; IMMUNE-RESPONSE	Neisseria meningitidis is a major global pathogen causing invasive disease with a mortality of 5-10%. Most disease in developed countries is caused by serogroup B infection, against which there is no universal vaccine. Opacity-associated adhesin (Opa) proteins are major meningococcal outer membrane proteins, which have shown recent promise as a potential novel vaccine. Immunisation of mice with different Opa variants elicited high levels of meningococcal-specific bactericidal antibodies, demonstrating proof in principle for this approach. Opa proteins are critical in meningococcal pathogenesis, mediating bacterial adherence to host cells, and modulating human cellular immunity via interactions with T cells and neutrophils, although there are conflicting data regarding their effects on CD4(+) T cells. We constructed Opa-positive and Opa-negative meningococcal strains to allow further evaluation of Opa as a vaccine component. All four opa genes from N. meningitidis strain H44/76 were sequentially disrupted to construct all possible combinations of N. meningitidis strains deficient in one, two, three, or all four opa genes. The transformations demonstrated that homologous recombination of exogenous DNA into the meningococcal chromosome can occur with as little as 80 bp, and that minor sequence differences are permissible. Anti-Opa bactericidal antibody responses following immunisation of mice with recombinant Opa were specific to the Opa variant used in immunisation. No immunomodulatory effects were observed when Opa was contained within meningococcal outer membrane vesicles (OMVs), compared to Opa-negative OMVs. These observations support the incorporation of Opa in meningococcal vaccines.	[Sadarangani, Manish; Hoe, J. Claire; Callaghan, Martin J.; Jones, Claire; Makepeace, Katherine; Daniels-Treffandier, Helene; Deadman, Mary E.; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford, England; [Sadarangani, Manish; Hoe, J. Claire; Callaghan, Martin J.; Jones, Claire; Makepeace, Katherine; Daniels-Treffandier, Helene; Deadman, Mary E.; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Sadarangani, Manish] Univ British Columbia, Dept Pediat, Div Infect Dis, Vancouver, BC V6T 1W5, Canada; [Sadarangani, Manish] BC Childrens Hosp, Vancouver, BC, Canada; [Chan, Hannah; Feavers, Ian] Natl Inst Biol Stand & Controls, Div Bacteriol, Potters Bar, Herts, England; [Bayliss, Christopher] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [van der Ley, Peter] Natl Inst Publ Hlth & Environm RIVM, Dept Vaccinol, Bilthoven, Netherlands	University of Oxford; University of Oxford; University of British Columbia; BC Childrens Hospital; University of British Columbia; National Institute for Biological Standards & Control; University of Leicester; Netherlands National Institute for Public Health & the Environment	Sadarangani, M (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.	manish.sadarangani@paediatrics.ox.ac.uk	DANIELS-TREFFANDIER, Hélène/AAN-8475-2021; Sadarangani, Manish/V-5609-2019; Daniels-Treffandier, Hélène Sophie/Y-7461-2019	Bayliss, Christopher/0000-0002-5564-2145; Sadarangani, Manish/0000-0002-9985-6452; Daniels, Helene/0000-0001-7426-2423; Deadman, Mary/0000-0002-6074-017X	Action Medical Research through a Research Training Fellowship [RTF1263]; Meningitis UK; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centres funding scheme; Novartis; GlaxoSmithKline; Pfizer; Sanofi Pasteur	Action Medical Research through a Research Training Fellowship; Meningitis UK; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Sanofi Pasteur	This study was funded by Action Medical Research, through a Research Training Fellowship awarded to MS (RTF1263), and Meningitis UK and supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AJP and IF are named inventors on Opa related patents (0428381.8, dated 24/12/2004 and WO2006/067469 A2, dated 22/12/2005). AJP is an advisor to the UK Department of Health's Joint Committee on Vaccines and Immunisation on meningococcal vaccines. AJP conducts clinical trials of meningococcal vaccines on behalf of the University of Oxford and his department has received unrestricted educational grants from vaccine manufacturers (Novartis, GlaxoSmithKline, Pfizer and Sanofi Pasteur) for organisation of educational activities, but he receives no personal payments from them. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baethgen LF, 2008, TROP MED INT HEALTH, V13, P31, DOI 10.1111/j.1365-3156.2007.01970.x; Baker M G, 2001, J Paediatr Child Health, V37, pS13, DOI 10.1046/j.1440-1754.2001.00722.x; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Bonvehi P, 2010, CLIN VACCINE IMMUNOL, V17, P1460, DOI 10.1128/CVI.00129-10; Borrow R, 2001, METH MOLEC MED, V66, P289, DOI 10.1385/1-59259-148-5:289; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Bradley CJ, 2005, CELL MICROBIOL, V7, P1490, DOI 10.1111/j.1462-5822.2005.00572.x; Callaghan MJ, 2011, INFECT IMMUN, V79, P2810, DOI 10.1128/IAI.01338-10; Callaghan MJ, 2008, J CLIN MICROBIOL, V46, P3033, DOI 10.1128/JCM.00005-08; Callaghan MJ, 2006, INFECT IMMUN, V74, P5085, DOI 10.1128/IAI.00293-06; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; CATLIN BW, 1960, J BACTERIOL, V79, P579, DOI 10.1128/JB.79.4.579-590.1960; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; DANNER DB, 1982, GENE, V18, P101, DOI 10.1016/0378-1119(82)90062-2; de Jonge MI, 2004, VACCINE, V22, P4021, DOI 10.1016/j.vaccine.2004.03.047; de Jonge MI, 2003, INFECT IMMUN, V71, P2331, DOI 10.1128/IAI.71.5.2331-2340.2003; de Jonge MI, 2002, EUR J BIOCHEM, V269, P5215, DOI 10.1046/j.1432-1033.2002.03228.x; DEMORAES JC, 1992, LANCET, V340, P1074; FINNE J, 1983, LANCET, V2, P355; Fisseha M, 2005, INFECT IMMUN, V73, P4070, DOI 10.1128/IAI.73.7.4070-4080.2005; GomezDuarte OG, 1997, INFECT IMMUN, V65, P3857; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Gray-Owen SD, 2003, SCAND J INFECT DIS, V35, P614, DOI 10.1080/00365540310016042; Gunn JS, 1996, MOL GEN GENET, V251, P509, DOI 10.1007/BF02173639; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; Hobbs MM, 1998, MICROBIOL-UK, V144, P157, DOI 10.1099/00221287-144-1-157; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Keiser PB, 2010, VACCINE, V28, P6970, DOI 10.1016/j.vaccine.2010.08.048; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HSW, 2007, INFECT IMMUN, V75, P4449, DOI 10.1128/IAI.00222-07; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; MANDRELL RE, 1989, INFECT IMMUN, V57, P1590, DOI 10.1128/IAI.57.5.1590-1598.1989; Martin DR, 2006, CLIN VACCINE IMMUNOL, V13, P486, DOI 10.1128/CVI.13.4.486-491.2006; Milagres LG, 1998, INFECT IMMUN, V66, P4755, DOI 10.1128/IAI.66.10.4755-4761.1998; Moore J, 2005, J BIOL CHEM, V280, P31489, DOI 10.1074/jbc.M506354200; Morelli G, 1997, MOL MICROBIOL, V25, P1047, DOI 10.1046/j.1365-2958.1997.5211882.x; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Norheim G, 2004, VACCINE, V22, P2171, DOI 10.1016/j.vaccine.2003.11.047; NORONHA CP, 1995, INT J EPIDEMIOL, V24, P1050, DOI 10.1093/ije/24.5.1050; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; POOLMAN JT, 1995, CLIN DIAGN LAB IMMUN, V2, P69, DOI 10.1128/CDLI.2.1.69-72.1995; Ramsay M, 2006, EU IBIS NETWORK INVA; Rosenqvist E, 1999, INFECT IMMUN, V67, P1267, DOI 10.1128/IAI.67.3.1267-1276.1999; ROSENQVIST E, 1995, INFECT IMMUN, V63, P4642, DOI 10.1128/IAI.63.12.4642-4652.1995; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rowe HA, 2007, CELL MICROBIOL, V9, P154, DOI 10.1111/j.1462-5822.2006.00775.x; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sierra G. V., 1991, NIPH ANN, V14, P208; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; SJURSEN H, 1990, APMIS, V98, P1061, DOI 10.1111/j.1699-0463.1990.tb05035.x; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; STEIN DC, 1989, CLIN MICROBIOL REV, V2, pS146, DOI 10.1128/CMR.2.Suppl.S146-S149.1989; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; VANDERLEY P, 1992, INFECT IMMUN, V60, P3156, DOI 10.1128/IAI.60.8.3156-3161.1992; VANDERLEY P, 1995, VACCINE, V13, P401, DOI 10.1016/0264-410X(95)98264-B; VanDerVoort ER, 1996, INFECT IMMUN, V64, P2745, DOI 10.1128/IAI.64.7.2745-2751.1996; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Warren MJ, 2004, FEMS IMMUNOL MED MIC, V41, P43, DOI 10.1016/j.femsim.2004.01.002; Weber MVR, 2006, INT J MED MICROBIOL, V296, P475, DOI 10.1016/j.ijmm.2006.05.004; Wedege E, 2001, METH MOLEC MED, V66, P275, DOI 10.1385/1-59259-148-5:275; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; WHO, 1998, CONTR EP MEN DIS WHO, V2nd ed.; Wiertz EJHJ, 1996, INFECT IMMUN, V64, P298, DOI 10.1128/IAI.64.1.298-304.1996; WIERTZ EJHJ, 1991, J IMMUNOL, V147, P2012; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514; Youssef AR, 2009, INFECT IMMUN, V77, P5170, DOI 10.1128/IAI.00355-09	77	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51045	10.1371/journal.pone.0051045	http://dx.doi.org/10.1371/journal.pone.0051045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251421	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200056
J	Miljkovic, D; Stare, T; Mozetic, I; Podpecan, V; Petek, M; Witek, K; Dermastia, M; Lavrac, N; Gruden, K				Miljkovic, Dragana; Stare, Tjasa; Mozetic, Igor; Podpecan, Vid; Petek, Marko; Witek, Kamil; Dermastia, Marina; Lavrac, Nada; Gruden, Kristina			Signalling Network Construction for Modelling Plant Defence Response	PLOS ONE			English	Article							SALICYLIC-ACID; TRANSCRIPTION FACTORS; SYSTEMS BIOLOGY; CROSS-TALK; JASMONATE; INFORMATION; PATHWAY; NONEXPRESSOR; ACTIVATION; EXTRACTION	Plant defence signalling response against various pathogens, including viruses, is a complex phenomenon. In resistant interaction a plant cell perceives the pathogen signal, transduces it within the cell and performs a reprogramming of the cell metabolism leading to the pathogen replication arrest. This work focuses on signalling pathways crucial for the plant defence response, i.e., the salicylic acid, jasmonic acid and ethylene signal transduction pathways, in the Arabidopsis thaliana model plant. The initial signalling network topology was constructed manually by defining the representation formalism, encoding the information from public databases and literature, and composing a pathway diagram. The manually constructed network structure consists of 175 components and 387 reactions. In order to complement the network topology with possibly missing relations, a new approach to automated information extraction from biological literature was developed. This approach, named Bio3graph, allows for automated extraction of biological relations from the literature, resulting in a set of (component1, reaction, component2) triplets and composing a graph structure which can be visualised, compared to the manually constructed topology and examined by the experts. Using a plant defence response vocabulary of components and reaction types, Bio3graph was applied to a set of 9,586 relevant full text articles, resulting in 137 newly detected reactions between the components. Finally, the manually constructed topology and the new reactions were merged to form a network structure consisting of 175 components and 524 reactions. The resulting pathway diagram of plant defence signalling represents a valuable source for further computational modelling and interpretation of omics data. The developed Bio3graph approach, implemented as an executable language processing and graph visualisation workflow, is publically available at http://ropot.ijs.si/bio3graph/and can be utilised for modelling other biological systems, given that an adequate vocabulary is provided.	[Miljkovic, Dragana; Mozetic, Igor; Podpecan, Vid; Lavrac, Nada] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia; [Miljkovic, Dragana; Podpecan, Vid] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia; [Lavrac, Nada] Univ Nova Gorica, Sch Engn & Management, Nova Gorica, Slovenia; [Stare, Tjasa; Petek, Marko; Dermastia, Marina; Gruden, Kristina] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Witek, Kamil] Sainsbury Lab, Norwich, Norfolk, England; [Witek, Kamil] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Nova Gorica; National Institute of Biology - Slovenia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Miljkovic, D (corresponding author), Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia.	dragana.miljkovic@ijs.si	Gruden, kristina/AAI-6439-2020; Petek, Marko/L-6692-2019	Petek, Marko/0000-0003-3644-7827; Mozetic, Igor/0000-0002-5466-0608; gruden, kristina/0000-0001-5906-8569	Slovenian Research Agency [P4 0165, J4-2228, J4-4165, P2-0103]; AD Futura Scholarship	Slovenian Research Agency(Slovenian Research Agency - Slovenia); AD Futura Scholarship	This work was supported by the Slovenian Research Agency grants P4 0165, J4-2228, J4-4165 and P2-0103 and AD Futura Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiadou S, 2010, TRENDS BIOTECHNOL, V28, P381, DOI 10.1016/j.tibtech.2010.04.005; BARNES J, 1986, NATURE, V324, P446, DOI 10.1038/324446a0; Bird S., 2009, NATURAL LANGUAGE PRO; Blaschke C, 2001, Genome Inform, V12, P123; Blaschke C, 2002, IEEE INTELL SYST, V17, P14, DOI 10.1109/MIS.2002.999215; Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Chandra-Shekara AC, 2004, PLANT J, V40, P647, DOI 10.1111/j.1365-313X.2004.02241.x; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen HM, 2009, PLANT CELL, V21, P2527, DOI 10.1105/tpc.108.065193; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Cohen KB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040020; Corney DPA, 2004, BIOINFORMATICS, V20, P3206, DOI 10.1093/bioinformatics/bth386; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Devoto A, 2005, PHYSIOL PLANTARUM, V123, P161, DOI 10.1111/j.1399-3054.2004.00418.x; Eronen L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-119; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Genoud T, 2001, PLANT PHYSIOL, V126, P1430, DOI 10.1104/pp.126.4.1430; Gfeller A, 2010, SCI SIGNAL, V3; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Ibdah M, 2009, PLANT PHYSIOL, V150, P416, DOI 10.1104/pp.109.135848; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Kestler HA, 2008, BIOESSAYS, V30, P1110, DOI 10.1002/bies.20834; Kiss T, 2006, COMPUT LINGUIST, V32, P485, DOI 10.1162/coli.2006.32.4.485; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Krallinger M, 2009, NUCLEIC ACIDS RES, V37, pW160, DOI 10.1093/nar/gkp484; Krummenacker M, 2005, BIOINFORMATICS, V21, P3454, DOI 10.1093/bioinformatics/bti546; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Leon-Reyes A, 2010, MOL PLANT MICROBE IN, V23, P187, DOI 10.1094/MPMI-23-2-0187; Leon-Reyes A, 2009, PLANT PHYSIOL, V149, P1797, DOI 10.1104/pp.108.133926; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Maier F, 2011, MOL PLANT PATHOL, V12, P73, DOI 10.1111/j.1364-3703.2010.00653.x; Moore JW, 2011, PLANT CELL, V23, P2809, DOI 10.1105/tpc.111.087346; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; Pieterse CMJ, 2001, AGBIOTECHNET, V3, P1; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Podpecan V, 2012, COMPUT J, V55, P82, DOI 10.1093/comjnl/bxr077; Raza S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-36; Raza S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-63; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Rhee SY, 2006, BIOTECH AGR FOREST, V57, P141; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Sato M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001011; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Sevon P, 2006, LECT NOTES COMPUT SC, V4075, P35; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Somssich IE, 1998, TRENDS PLANT SCI, V3, P86, DOI 10.1016/S1360-1385(98)01199-6; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stepanova Anna N, 2005, Sci STKE, V2005, pcm4, DOI 10.1126/stke.2762005cm4; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tsesmetzis N, 2008, PLANT CELL, V20, P1426, DOI 10.1105/tpc.108.057976; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Tsuruoka Y, 2005, P C HUMAN LANGUAGE T, P467, DOI DOI 10.3115/1220575.1220634; van Wees SCM, 2000, P NATL ACAD SCI USA, V97, P8711, DOI 10.1073/pnas.130425197; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042	71	17	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51822	10.1371/journal.pone.0051822	http://dx.doi.org/10.1371/journal.pone.0051822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272172	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300032
J	Ando, T; Sato, S; Toyooka, T; Kobayashi, H; Nawashiro, H; Ashida, H; Obara, M				Ando, Takahiro; Sato, Shunichi; Toyooka, Terushige; Kobayashi, Hiroaki; Nawashiro, Hiroshi; Ashida, Hiroshi; Obara, Minoru			Photomechanical Wave-Driven Delivery of siRNAs Targeting Intermediate Filament Proteins Promotes Functional Recovery after Spinal Cord Injury in Rats	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; SMALL INTERFERING RNA; INDUCED STRESS WAVES; IMPROVES NEURONAL SURVIVAL; ADENOVIRAL GENE-TRANSFER; GROWTH IN-VITRO; REACTIVE ASTROCYTES; NEURITE GROWTH; AXONAL GROWTH; GLIAL SCAR	The formation of glial scars after spinal cord injury (SCI) is one of the factors inhibiting axonal regeneration. Glial scars are mainly composed of reactive astrocytes overexpressing intermediate filament (IF) proteins such as glial fibrillary acidic protein (GFAP) and vimentin. In the current study, we delivered small interfering RNAs (siRNAs) targeting these IF proteins to SCI model rats using photomechanical waves (PMWs), and examined the restoration of motor function in the rats. PMWs are generated by irradiating a light-absorbing material with 532-nm nanosecond laser pulses from a Q-switched Nd:YAG laser. PMWs can site-selectively increase the permeability of the cell membrane for molecular delivery. Rat spinal cord was injured using a weight-drop device and the siRNA(s) solutions were intrathecally injected into the vicinity of the exposed SCI, to which PMWs were applied. We first confirmed the substantial uptake of fluorescence-labeled siRNA by deep glial cells; then we delivered siRNAs targeting GFAP and vimentin into the lesion. The treatment led to a significant improvement in locomotive function from five days post-injury in rats that underwent PMW-mediated siRNA delivery. This was attributable to the moderate silencing of the IF proteins and the subsequent decrease in the cavity area in the injured spinal tissue. Citation: Ando T, Sato S, Toyooka T, Kobayashi H, Nawashiro H, et al. (2012) Photomechanical Wave-Driven Delivery of siRNAs Targeting Intermediate Filament Proteins Promotes Functional Recovery after Spinal Cord Injury in Rats. PLoS ONE 7(12): e51744. doi:10.1371/journal.pone.0051744	[Sato, Shunichi; Ashida, Hiroshi] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan; [Ando, Takahiro; Obara, Minoru] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 223, Japan; [Toyooka, Terushige; Kobayashi, Hiroaki; Nawashiro, Hiroshi] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; Keio University; National Defense Medical College - Japan	Sato, S (corresponding author), Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan.	shunsato@ndmc.ac.jp	Ando, Takahiro/H-5209-2019; Ando, Takahiro/R-8374-2019		National Defense Medical College; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [10J04881] Funding Source: KAKEN	National Defense Medical College; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for the Special Research Program of the National Defense Medical College and a Grant-in-Aid for Research Fellows of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif AA, 2006, J NEUROSCI RES, V84, P553, DOI 10.1002/jnr.20968; Aizawa K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253325; Ando T, 2012, APPL PHYS A IN PRESS; Ando T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3642014; Ando T, 2012, ULTRASOUND MED BIOL, V38, P75, DOI 10.1016/j.ultrasmedbio.2011.10.020; Ando T, 2009, APPL SURF SCI, V255, P9898, DOI 10.1016/j.apsusc.2009.04.115; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; Desclaux M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006227; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Doukas AG, 2004, ADV DRUG DELIVER REV, V56, P559, DOI 10.1016/j.addr.2003.10.031; Duck F.A., 1990, MED PHYS, V18; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; FABBRO R, 1990, J APPL PHYS, V68, P775, DOI 10.1063/1.346783; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Hyun JK, 2009, J NEUROTRAUM, V26, P1773, DOI [10.1089/neu.2007.0485, 10.1089/neu.2007-0485]; Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Kondoh T, 2000, NEUROL MED-CHIR, V40, P618, DOI 10.2176/nmc.40.618; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Koshiyama K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.018105; Kurita A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3628313; Lauer U, 1997, GENE THER, V4, P710, DOI 10.1038/sj.gt.3300462; Lee S, 1996, ULTRASOUND MED BIOL, V22, P1285, DOI 10.1016/S0301-5629(96)00149-4; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Li SD, 2007, J CONTROL RELEASE, V123, P181, DOI 10.1016/j.jconrel.2007.09.004; Mannes AJ, 1998, BRAIN RES, V793, P1, DOI 10.1016/S0006-8993(97)01422-4; Menet V, 2000, GLIA, V31, P267, DOI 10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Menet V, 2001, J NEUROSCI, V21, P6147; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Nakajima H, 2005, NEUROSCI LETT, V385, P30, DOI 10.1016/j.neulet.2005.05.012; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Ogura M, 2004, LASER SURG MED, V34, P242, DOI 10.1002/lsm.20024; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pettigrew DB, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-8; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Romero MI, 1998, GENE THER, V5, P1612, DOI 10.1038/sj.gt.3300774; Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005; Sato S, 2011, OPT LETT, V36, P4545, DOI 10.1364/OL.36.004545; Satoh Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2128432; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Shimamura M, 2005, J GENE MED, V7, P1468, DOI 10.1002/jgm.793; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Takahashi M, 2007, J CONTROL RELEASE, V117, P267, DOI 10.1016/j.jconrel.2006.10.026; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Takeshita F, 2006, CANCER SCI, V97, P689, DOI 10.1111/j.1349-7006.2006.00234.x; Tang W, 2006, PLANT SCI, V171, P375, DOI 10.1016/j.plantsci.2006.04.005; Teng Q, 2005, GENE THER, V12, P108, DOI 10.1038/sj.gt.3302400; Terakawa M, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2160407; Terakawa M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2745313; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; Toyooka T, 2011, J NEUROTRAUM, V28, P607, DOI 10.1089/neu.2010.1520; von Meyenburg J, 1998, EXP NEUROL, V154, P583, DOI 10.1006/exnr.1998.6912; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005; Yao CP, 2008, IEEE T NANOBIOSCI, V7, P111, DOI 10.1109/TNB.2008.2000742; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; You SW, 2003, RESTOR NEUROL NEUROS, V21, P39	78	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51744	10.1371/journal.pone.0051744	http://dx.doi.org/10.1371/journal.pone.0051744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272155	Green Submitted, gold, Green Published			2022-12-27	WOS:000312386800076
J	Carmona, SJ; Sartor, PA; Leguizamon, MS; Campetella, OE; Aguero, F				Carmona, Santiago J.; Sartor, Paula A.; Leguizamon, Maria S.; Campetella, Oscar E.; Agueero, Fernan			Diagnostic Peptide Discovery: Prioritization of Pathogen Diagnostic Markers Using Multiple Features	PLOS ONE			English	Article							B-CELL EPITOPES; TRYPANOSOMA-CRUZI; TANDEM REPEATS; ANTIGENIC DETERMINANTS; ENHANCE IMMUNOGENICITY; PROTEIN; PREDICTION; INFECTION; SELECTION; IMMUNODOMINANT	The availability of complete pathogen genomes has renewed interest in the development of diagnostics for infectious diseases. Synthetic peptide microarrays provide a rapid, high-throughput platform for immunological testing of potential B-cell epitopes. However, their current capacity prevent the experimental screening of complete "peptidomes". Therefore, computational approaches for prediction and/or prioritization of diagnostically relevant peptides are required. In this work we describe a computational method to assess a defined set of molecular properties for each potential diagnostic target in a reference genome. Properties such as sub-cellular localization or expression level were evaluated for the whole protein. At a higher resolution (short peptides), we assessed a set of local properties, such as repetitive motifs, disorder (structured vs natively unstructured regions), trans-membrane spans, genetic polymorphisms (conserved vs. divergent regions), predicted B-cell epitopes, and sequence similarity against human proteins and other potential cross-reacting species (e.g. other pathogens endemic in overlapping geographical locations). A scoring function based on these different features was developed, and used to rank all peptides from a large eukaryotic pathogen proteome. We applied this method to the identification of candidate diagnostic peptides in the protozoan Trypanosoma cruzi, the causative agent of Chagas disease. We measured the performance of the method by analyzing the enrichment of validated antigens in the high-scoring top of the ranking. Based on this measure, our integrative method outperformed alternative prioritizations based on individual properties (such as B-cell epitope predictors alone). Using this method we ranked similar to 10 million 12-mer overlapping peptides derived from the complete T. cruzi proteome. Experimental screening of 190 high-scoring peptides allowed the identification of 37 novel epitopes with diagnostic potential, while none of the low scoring peptides showed significant reactivity. Many of the metrics employed are dependent on standard bioinformatic tools and data, so the method can be easily extended to other pathogen genomes. Citation: Carmona SJ, Sartor PA, Leguizamon MS, Campetella OE, Aguero F (2012) Diagnostic Peptide Discovery: Prioritization of Pathogen Diagnostic Markers Using Multiple Features. PLoS ONE 7(12): e50748. doi:10.1371/journal.pone.0050748	[Carmona, Santiago J.; Leguizamon, Maria S.; Campetella, Oscar E.; Agueero, Fernan] Univ Nacl San Martin, Inst Tecnol Chascomus IIB INTECH, Inst Invest Biotecnol, Consejo Invest Cientif & Tecn UNSAM CONICET, San Martin, Buenos Aires, Argentina; [Sartor, Paula A.; Leguizamon, Maria S.] Univ Buenos Aires, Fac Med, Inst Microbiol & Parasitol Med, Buenos Aires, DF, Argentina	University of Buenos Aires	Aguero, F (corresponding author), Univ Nacl San Martin, Inst Tecnol Chascomus IIB INTECH, Inst Invest Biotecnol, Consejo Invest Cientif & Tecn UNSAM CONICET, San Martin, Buenos Aires, Argentina.	fernan@unsam.edu.ar	Carmona, Santiago J/E-9356-2015; Aguero, Fernan/F-5606-2013	Carmona, Santiago J/0000-0002-2495-0671; Aguero, Fernan/0000-0003-1331-5741; Campetella, Oscar/0000-0002-7018-375X	University of San Martin [PROG07F/1]; Special Programme for Research and Training in Tropical Diseases (WHO/World Bank/UNDP/UNICEF)	University of San Martin; Special Programme for Research and Training in Tropical Diseases (WHO/World Bank/UNDP/UNICEF)	This work was supported by grants from the University of San Martin (PROG07F/1) to Dr. Campetella and Dr. Aguero, and the Special Programme for Research and Training in Tropical Diseases (WHO/World Bank/UNDP/UNICEF) to Dr. Aguero. Dr. Carmona and Dr. Sartor are fellows of the National Research Council of Argentina (CONICET). Dr. Leguizamon, Dr. Campetella, and Dr. Aguero are members of the Research Career of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AA, 2009, NUCLEIC ACIDS RES, V37, pD544, DOI 10.1093/nar/gkn874; AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1; Alvarez P, 2001, INFECT IMMUN, V69, P7946, DOI 10.1128/IAI.69.12.7946-7949.2001; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Andresen Heiko, 2009, V509, P123, DOI 10.1007/978-1-59745-372-1_8; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; BURNS JM, 1992, P NATL ACAD SCI USA, V89, P1239, DOI 10.1073/pnas.89.4.1239; BUSCHIAZZO A, 1992, MOL BIOCHEM PARASIT, V54, P125, DOI 10.1016/0166-6851(92)90105-S; CAZZULO JJ, 1992, FASEB J, V6, P3259, DOI 10.1096/fasebj.6.14.1426764; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840; Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Horn D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-2; Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kanduc Darja, 2010, Self Nonself, V1, P255, DOI 10.4161/self.1.3.11897; Kjerrulf M, 1997, MOL IMMUNOL, V34, P599, DOI 10.1016/S0161-5890(97)00078-3; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kronegg J, 1999, DETECTION PREDICTION; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liang L, 2011, J PROTEOME RES, V10, P4813, DOI 10.1021/pr200619r; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; List C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000771; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; Ludin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017546; Maksimov P, 2012, CLIN VACCINE IMMUNOL, V19, P865, DOI 10.1128/CVI.00119-12; Mollick Joseph A, 2003, Cancer Immun, V3, P3; Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Peeling RW, 2011, INFECT DIS CLIN N AM, V25, P693, DOI 10.1016/j.idc.2011.06.002; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723; Pereira CM, 1998, FEMS MICROBIOL LETT, V164, P125, DOI 10.1111/j.1574-6968.1998.tb13077.x; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Torres D, 2006, INFECT IMMUN, V74, P4932, DOI 10.1128/IAI.00442-06; Toseland Christopher P, 2005, Immunome Res, V1, P4, DOI 10.1186/1745-7580-1-4; Vanniasinkam T, 2001, J CLIN MICROBIOL, V39, P1633, DOI 10.1128/JCM.39.4.1633-1637.2001; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Yankai Z, 2006, BIOCHEM BIOPH RES CO, V345, P1365, DOI 10.1016/j.bbrc.2006.05.022; ZHENG BJ, 1993, VACCINE, V11, P1191, DOI 10.1016/0264-410X(93)90042-V	63	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50748	10.1371/journal.pone.0050748	http://dx.doi.org/10.1371/journal.pone.0050748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272069	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800015
J	Momma, K; Noguchi, S; Malicdan, MCV; Hayashi, YK; Minami, N; Kamakura, K; Nonaka, I; Nishino, I				Momma, Kazunari; Noguchi, Satoru; Malicdan, May Christine V.; Hayashi, Yukiko K.; Minami, Narihiro; Kamakura, Keiko; Nonaka, Ikuya; Nishino, Ichizo			Rimmed Vacuoles in Becker Muscular Dystrophy Have Similar Features with Inclusion Myopathies	PLOS ONE			English	Article							LINKED DILATED CARDIOMYOPATHY; OXIDATIVE STRESS; DISTAL MYOPATHY; MOLECULAR-BASIS; BODY MYOSITIS; DUCHENNE; DELETION; PATHOGENESIS; AUTOPHAGY; MUTATIONS	Rimmed vacuoles in myofibers are thought to be due to the accumulation of autophagic vacuoles, and can be characteristic in certain myopathies with protein inclusions in myofibers. In this study, we performed a detailed clinical, molecular, and pathological characterization of Becker muscular dystrophy patients who have rimmed vacuoles in muscles. Among 65 Becker muscular dystrophy patients, we identified 12 patients who have rimmed vacuoles and 11 patients who have deletions in exons 45-48 in DMD gene. All patients having rimmed vacuoles showed milder clinical features compared to those without rimmed vacuoles. Interestingly, the rimmed vacuoles in Becker muscular dystrophy muscles seem to represent autophagic vacuoles and are also associated with polyubiquitinated protein aggregates. These findings support the notion that rimmed vacuoles can appear in Becker muscular dystrophy, and may be related to the chronic changes in muscle pathology induced by certain mutations in the DMD gene. Citation: Momma K, Noguchi S, Malicdan MCV, Hayashi YK, Minami N, et al. (2012) Rimmed Vacuoles in Becker Muscular Dystrophy Have Similar Features with Inclusion Myopathies. PLoS ONE 7(12): e52002. doi: 10.1371/journal.pone.0052002	[Momma, Kazunari; Noguchi, Satoru; Malicdan, May Christine V.; Hayashi, Yukiko K.; Minami, Narihiro; Nonaka, Ikuya; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Momma, Kazunari; Kamakura, Keiko] Natl Def Med Coll, Dept Neurol, Saitama, Japan	National Center for Neurology & Psychiatry - Japan; National Defense Medical College - Japan	Noguchi, S (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan.	noguchi@ncnp.go.jp	Malicdan, May Christine/F-2806-2013; Nishino, Ichizo/G-2676-2010; Malicdan, May Christine/AAK-7422-2021	Nishino, Ichizo/0000-0001-9452-112X; 	Japan Society for the Promotion of Science KAKENHI Grant [23390236]; Welfare and Comprehensive Research on Disability Health and Welfare; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry [22-5]; Research on rare and intractable diseases from the Ministry of Health and Labour; US National Institute of Child Health and Human Development (NICHD)	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Welfare and Comprehensive Research on Disability Health and Welfare; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry; Research on rare and intractable diseases from the Ministry of Health and Labour; US National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 23390236 and by Welfare and Comprehensive Research on Disability Health and Welfare and by Intramural Research Grant (22-5) for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry, Research on rare and intractable diseases from the Ministry of Health and Labour. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the attending physicians, patients, and their families for their participation in this study. The authors also thank Ms. Kazu Iwasawa, Ms. Kaoru Tatezawa, Ms. Megumu, Ogawa, Dr. Nobuhiro Morone, and Ms. Kanako Goto (National Institute of Neuroscience, NCNP) for their technical assistance. The monoclonal antibody (H4A3) developed by J. T. August and James E.K. Hildreth was obtained from the Development Studies Hybridoma Bank (DSHB) developed under the auspices of the US National Institute of Child Health and Human Development (NICHD) and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242, USA.	Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x; Broccolini A, 2009, MUSCLE NERVE, V40, P340, DOI 10.1002/mus.21385; Dalakas MC, 2006, NAT CLIN PRACT NEURO, V2, P437, DOI 10.1038/ncpneuro0261; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; DenDunnen JT, 2006, CURR PROTOC HUM GENE; DEVISSER M, 1990, ANN NEUROL, V27, P578, DOI 10.1002/ana.410270521; Ferlini A, 1999, NEUROMUSCULAR DISORD, V9, P339, DOI 10.1016/S0960-8966(99)00015-2; Henderson DM, 2011, HUM MOL GENET, V20, P2955, DOI 10.1093/hmg/ddr199; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; KOENIG M, 1989, AM J HUM GENET, V45, P498; Lawler JM, 2011, J PHYSIOL-LONDON, V589, P2161, DOI 10.1113/jphysiol.2011.207456; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Malicdan MCV, 2008, CURR OPIN NEUROL, V21, P596, DOI 10.1097/WCO.0b013e32830dd595; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2007, AUTOPHAGY, V3, P396, DOI 10.4161/auto.4270; Malicdan MCV, 2009, METHOD ENZYMOL, V453, P379, DOI 10.1016/S0076-6879(08)04019-6; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nakamura A, 2008, J CLIN NEUROSCI, V15, P757, DOI 10.1016/j.jocn.2006.12.012; Nishino Ichizo, 2006, Semin Pediatr Neurol, V13, P90, DOI 10.1016/j.spen.2006.06.004; Raben N, 2007, AUTOPHAGY, V3, P546, DOI 10.4161/auto.4591; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; Sugie K, 2005, J NEUROPATH EXP NEUR, V64, P513, DOI 10.1093/jnen/64.6.513; TAKEMITSU M, 1993, ACTA NEUROPATHOL, V85, P256; Tasaki N, 2001, INTERNAL MED, V40, P1215, DOI 10.2169/internalmedicine.40.1215; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; Yazaki M, 1999, EUR NEUROL, V42, P145, DOI 10.1159/000008089	28	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52002	10.1371/journal.pone.0052002	http://dx.doi.org/10.1371/journal.pone.0052002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251671	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800126
J	Pinamonti, G; Marro, J; Torres, JJ				Pinamonti, Giovanni; Marro, J.; Torres, Joaquin J.			Stochastic Resonance Crossovers in Complex Networks	PLOS ONE			English	Article							NOISE; INFORMATION; MODELS; FREQUENCY; SYSTEMS	Here we numerically study the emergence of stochastic resonance as a mild phenomenon and how this transforms into an amazing enhancement of the signal-to-noise ratio at several levels of a disturbing ambient noise. The setting is a cooperative, interacting complex system modelled as an Ising-Hopfield network in which the intensity of mutual interactions or "synapses" varies with time in such a way that it accounts for, e.g., a kind of fatigue reported to occur in the cortex. This induces nonequilibrium phase transitions whose rising comes associated to various mechanisms producing two types of resonance. The model thus clarifies the details of the signal transmission and the causes of correlation among noise and signal. We also describe short-time persistent memory states, and conclude on the limited relevance of the network wiring topology. Our results, in qualitative agreement with the observation of excellent transmission of weak signals in the brain when competing with both intrinsic and external noise, are expected to be of wide validity and may have technological application. We also present here a first contact between the model behavior and psychotechnical data. Citation: Pinamonti G, Marro J, Torres JJ (2012) Stochastic Resonance Crossovers in Complex Networks. PLoS ONE 7(12): e51170. doi:10.1371/journal.pone.0051170	[Torres, Joaquin J.] Univ Granada, Inst Carlos Theoret & Computat Phys 1, Granada, Spain; Univ Granada, Dept Electromagnetism & Matter Phys, Granada, Spain	University of Granada; University of Granada	Torres, JJ (corresponding author), Univ Granada, Inst Carlos Theoret & Computat Phys 1, Granada, Spain.	jtorres@onsager.ugr.es	Torres, Joaquín J./C-1385-2012; Torres, Joaquín J./AAE-6228-2019	Torres, Joaquín J./0000-0001-6175-9676; 	Andalusian Regional Government "Junta de Andalucia" [FQM-01505]; Spanish Science and Innovation Ministry MICINN-FEDER [FIS2009-08451]; Spanish Science and Innovation Ministry MICINN-GREIB [GREIB.PT_2011_19]	Andalusian Regional Government "Junta de Andalucia"(Junta de Andalucia); Spanish Science and Innovation Ministry MICINN-FEDER; Spanish Science and Innovation Ministry MICINN-GREIB	The work was supported by the following: Andalusian Regional Government "Junta de Andalucia," project number FQM-01505; Spanish Science and Innovation Ministry MICINN-FEDER, project number FIS2009-08451; and Spanish Science and Innovation Ministry MICINN-GREIB, project number GREIB.PT_2011_19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; [Anonymous], 2009, EUR PHYS J B, V69, P1; Barbi M, 2005, BIOSYSTEMS, V79, P61, DOI 10.1016/j.biosystems.2004.09.003; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Brey JJ, 1996, PHYS LETT A, V216, P240, DOI 10.1016/0375-9601(96)00291-5; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Cortes JM, 2006, NEURAL COMPUT, V18, P614, DOI 10.1162/089976606775623342; de Franciscis S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041105; de Franciscis S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036114; Dimov II, 2012, QUANT FINANC, V12, P567, DOI 10.1080/14697688.2012.664931; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Fulinski A, 2000, J STAT PHYS, V101, P483, DOI 10.1023/A:1026463523619; GAMMAITONI L, 1989, PHYS REV LETT, V62, P349, DOI 10.1103/PhysRevLett.62.349; Ghosh PK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.020601; Golyandina N., 2001, ANAL TIME SERIES STR, DOI DOI 10.1201/9781420035841; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hong H, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021102; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izus GG, 1998, PHYS REV E, V58, P93, DOI 10.1103/PhysRevE.58.93; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Johnson S, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46006; JUNG P, 1995, PHYS REV LETT, V74, P2130, DOI 10.1103/PhysRevLett.74.2130; Kim BJ, 2001, EUROPHYS LETT, V56, P333, DOI 10.1209/epl/i2001-00524-7; Krawiecki A, 2008, ACTA PHYS POL B, V39, P1103; Krawiecki A, 2003, PHYSICA A, V317, P597, DOI 10.1016/S0378-4371(02)01375-4; Krawiecki A, 2009, EUR PHYS J B, V69, P81, DOI 10.1140/epjb/e2009-00082-x; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lugo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002860; Marro J, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02017; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; McDonnell M.D., 2008, STOCH RES SUPR, DOI DOI 10.1017/CBO9780511535239; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; Mejias JF, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48008; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Munakata T, 2005, J PHYS SOC JPN, V74, P2094, DOI 10.1143/JPSJ.74.2094; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Radicchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029910; Sagues F, 2007, PHYS TODAY, V79, P829; Sato AH, 2006, PHYSICA A, V369, P753, DOI 10.1016/j.physa.2006.02.009; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Snieder R, 2010, PHYS TODAY, V63, P44, DOI 10.1063/1.3490500; Tessone CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.194101; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Torres JJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053014; Torres JJ, 2008, NEURAL NETWORKS, V21, P1272, DOI 10.1016/j.neunet.2008.07.002; Torres JJ, 2004, NEUROCOMPUTING, V58, P229, DOI 10.1016/j.neucom.2004.01.048; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tuckwell HC, 2012, ARXIV1202249; Vilar JMG, 1997, PHYS REV LETT, V78, P2882, DOI 10.1103/PhysRevLett.78.2882; Weaver RL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.134301; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Yasuda H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118103; Zhang JQ, 2008, SCI CHINA SER G, V51, P492, DOI 10.1007/s11433-008-0061-2	60	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51170	10.1371/journal.pone.0051170	http://dx.doi.org/10.1371/journal.pone.0051170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272090	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800028
J	Podgorski, K; Terpetschnig, E; Klochko, OP; Obukhova, OM; Haas, K				Podgorski, Kaspar; Terpetschnig, Ewald; Klochko, Oleksii P.; Obukhova, Olena M.; Haas, Kurt			Ultra-Bright and -Stable Red and Near-Infrared Squaraine Fluorophores for In Vivo Two-Photon Imaging	PLOS ONE			English	Article							SINGLE-CELL ELECTROPORATION; QUANTUM DOTS; MOLECULES; DYES	Fluorescent dyes that are bright, stable, small, and biocompatible are needed for high-sensitivity two-photon imaging, but the combination of these traits has been elusive. We identified a class of squaraine derivatives with large two-photon action cross-sections (up to 10,000 GM) at near-infrared wavelengths critical for in vivo imaging. We demonstrate the biocompatibility and stability of a red-emitting squaraine-rotaxane (SeTau-647) by imaging dye-filled neurons in vivo over 5 days, and utility for sensitive subcellular imaging by synthesizing a specific peptide-conjugate label for the synaptic protein PSD-95.	[Podgorski, Kaspar; Haas, Kurt] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Podgorski, Kaspar; Haas, Kurt] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Terpetschnig, Ewald] SETA BioMed, Urbana, IL USA; [Klochko, Oleksii P.; Obukhova, Olena M.] Natl Acad Sci Ukraine, State Sci Inst, Inst Single Crystals, Kharkov, Ukraine	University of British Columbia; University of British Columbia; National Academy of Sciences Ukraine; Institute for Scintillation Materials of the National Academy of Sciences of Ukraine	Haas, K (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	kurt.haas@ubc.ca	Haas, Kurt/B-3812-2009	Haas, Kurt/0000-0003-4754-1560; Obukhova, Olena/0000-0002-5961-3202	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkaya EU, 1997, TETRAHEDRON LETT, V38, P4513, DOI 10.1016/S0040-4039(97)00917-9; Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; Arunkumar E, 2005, J AM CHEM SOC, V127, P3288, DOI 10.1021/ja042404n; Bakalova R, 2011, INT J NANOMED, V6, P1719, DOI 10.2147/IJN.S17995; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Chung SJ, 2006, J AM CHEM SOC, V128, P14444, DOI 10.1021/ja065556m; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DICK B, 1982, J CHEM PHYS, V76, P5755, DOI 10.1063/1.442971; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; LAW KY, 1993, CHEM REV, V93, P449, DOI 10.1021/cr00017a020; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Patsenker LD, 2011, BIOANAL REV, V3, P115, DOI DOI 10.1007/S12566-011-0025-2; Patsenker LD, 2010, SPRINGER SER FLUORES, V09, P159, DOI 10.1007/978-3-642-04701-5_5; Podgorski K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001236; Povrozin YA, 2009, ANAL BIOCHEM, V390, P136, DOI 10.1016/j.ab.2009.03.047; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sharma SC, 2009, BIOPOLYMERS, V92, P183, DOI 10.1002/bip.21172; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; Sreejith S, 2008, J MATER CHEM, V18, P264, DOI 10.1039/b707734c; TERPETSCHNIG E, 1994, ANAL BIOCHEM, V217, P197, DOI 10.1006/abio.1994.1109; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wei GD, 2011, NANO LETT, V11, P4261, DOI 10.1021/nl2022515; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	30	34	34	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51980	10.1371/journal.pone.0051980	http://dx.doi.org/10.1371/journal.pone.0051980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251670	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800125
J	Sarzynski, MA; Jacobson, P; Rankinen, T; Carlsson, B; Sjostrom, L; Bouchard, C; Carlsson, LMS				Sarzynski, Mark A.; Jacobson, Peter; Rankinen, Tuomo; Carlsson, Bjorn; Sjostrom, Lars; Bouchard, Claude; Carlsson, Lena M. S.			Changes in Uric Acid Levels following Bariatric Surgery Are Not Associated with SLC2A9 Variants in the Swedish Obese Subjects Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SERUM URATE; METABOLIC SYNDROME; BLOOD-PRESSURE; WEIGHT CHANGE; RISK-FACTORS; EXCRETION; FAMILY; GOUT; DETERMINANT	Context and Objective: Obesity and SLC2A9 genotype are strong determinants of uric acid levels. However, data on SLC2A9 variants and weight loss induced changes in uric acid levels are missing. We examined whether the changes in uric acid levels two- and ten-years after weight loss induced by bariatric surgery were associated with SLC2A9 single nucleotide polymorphisms (SNPs) in the Swedish Obese Subjects study. Methods: SNPs (N = 14) identified by genome-wide association studies and exonic SNPs in the SLC2A9 gene locus were genotyped. Cross-sectional associations were tested before (N = 1806), two (N = 1664) and ten years (N = 1201) after bariatric surgery. Changes in uric acid were compared between baseline and Year 2 (N = 1660) and years 2 and 10 (N = 1172). A multiple testing corrected threshold of P = 0.007 was used for statistical significance. Results: Overall, 11 of the 14 tested SLC2A9 SNPs were significantly associated with cross-sectional uric acid levels at all three time points, with rs13113918 showing the strongest association at each time point (R-2 = 3.725.2%, 3.9 x 10-(22)<= p <= 7.7 x 10(-11)). One SNP (rs737267) showed a significant association (R-2 = 0.60%, P = 0.002) with change in uric acid levels from baseline to Year 2, as common allele homozygotes (C/C, N = 957) showed a larger decrease in uric acid (-61.4 mu mol/L) compared to minor allele carriers (A/X: -51.7 mu mol/L, N = 702). No SNPs were associated with changes in uric acid from years 2 to 10. Conclusions: SNPs in the SLC2A9 locus contribute significantly to uric acid levels in obese individuals, and the associations persist even after considerable weight loss due to bariatric surgery. However, we found little evidence for an interaction between genotype and weight change on the response of uric acid to bariatric surgery over ten years. Thus, the fluctuations in uric acid levels among the surgery group appear to be driven by the weight losses and gains, independent of SLC2A9 genotypes. Citation: Sarzynski MA, Jacobson P, Rankinen T, Carlsson B, Sjostrom L, et al. (2012) Changes in Uric Acid Levels following Bariatric Surgery Are Not Associated with SLC2A9 Variants in the Swedish Obese Subjects Study. PLoS ONE 7(12): e51658. doi: 10.1371/journal.pone.0051658	[Jacobson, Peter; Carlsson, Bjorn; Sjostrom, Lars; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Sarzynski, Mark A.; Rankinen, Tuomo; Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA USA	University of Gothenburg; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Carlsson, LMS (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden.	lena.carlsson@medic.gu.se	Bouchard, Claude/AAE-2035-2019; Bouchard, Claude/A-7637-2009; Sarzynski, Mark/A-9798-2014; Rankinen, Tuomo/N-1984-2017; Carlsson, Lena/F-7570-2018	Bouchard, Claude/0000-0002-0048-491X; Carlsson, Lena/0000-0003-4145-6242; Jacobson, Peter/0000-0002-1769-1827	Coypu Foundation; Swedish Research Council [K2010-55X-11285-13]; Swedish foundation for Strategic Research; Swedish Diabetes Foundation; Swedish federal government under the LUA/ALF agreement; John W. Barton Sr. Chair in Genetics and Nutrition; Hoffmann LaRoche; sanofi-aventis; Johnson Johnson; AstraZeneca; Biovitrum; Bristol-Myers Squibb; GlaxoSmithKline; Lenimen; Merck; Novo Nordisk; Servier	Coypu Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Diabetes Foundation; Swedish federal government under the LUA/ALF agreement; John W. Barton Sr. Chair in Genetics and Nutrition; Hoffmann LaRoche(Hoffmann-La Roche); sanofi-aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); AstraZeneca(AstraZeneca); Biovitrum; Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Lenimen; Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Servier(Servier)	This work was supported by grants from the Coypu Foundation to the Human Genomics Laboratory at Pennington Biomedical Research Center, the Swedish Research Council (K2010-55X-11285-13), the Swedish foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research, the Swedish Diabetes Foundation, and the Swedish federal government under the LUA/ALF agreement. C. Bouchard is partially supported by the John W. Barton Sr. Chair in Genetics and Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: P. Jacobson reported receiving research grants from Hoffmann LaRoche. B. Carlsson reported being employed by and holding stocks in AstraZeneca. L. Sjostrom reported obtaining unrestricted Swedish Obese Subjects grants from sanofi-aventis and Johnson & Johnson since 2007; receiving lecture and consulting fees from AstraZeneca, Biovitrum, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Lenimen, Merck, Novo Nordisk, Hoffmann LaRoche, sanofi-aventis, and Servier; and holding stocks in Lenimen and being chairman of its board. C. Bouchard reported receiving consulting fees from the Weight Watchers Scientific Advisory Board and is a member of the Scientific Advisory Board of Pathway Genomics. L. Carlsson reported serving as a consultant for AstraZeneca and holding stocks in Sahltech. The other authors have nothing to disclose. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Charles BA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-17; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; HEYDEN S, 1985, J CHRON DIS, V38, P281, DOI 10.1016/0021-9681(85)90073-6; Ishizaka N, 2010, J RHEUMATOL, V37, P410, DOI 10.3899/jrheum.090736; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Luyckx FH, 1998, DIABETES METAB, V24, P355; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; RAO DC, 1982, HUM GENET, V60, P257, DOI 10.1007/BF00303013; Rathmann W, 2007, EUR J EPIDEMIOL, V22, P439, DOI 10.1007/s10654-007-9132-3; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Neto AS, 2011, ARQ BRAS ENDOCRINOL, V55, P38, DOI 10.1590/S0004-27302011000100005; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Takahashi S, 1997, METABOLISM, V46, P1162, DOI 10.1016/S0026-0495(97)90210-9; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; WHITFIELD JB, 1983, ACTA GENET MED GEMEL, V32, P117, DOI 10.1017/S0001566000006401; Wilk JB, 2000, HUM GENET, V106, P355, DOI 10.1007/s004390051050; YAMASHITA S, 1986, INT J OBESITY, V10, P255	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51658	10.1371/journal.pone.0051658	http://dx.doi.org/10.1371/journal.pone.0051658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272134	Green Submitted, gold, Green Published			2022-12-27	WOS:000312386800061
J	Wu, B; Liu, HL; Zhang, S; Dong, XR; Wu, G				Wu, Bian; Liu, Hong-Li; Zhang, Sheng; Dong, Xiao-Rong; Wu, Gang			Lack of an Association between Two BER Gene Polymorphisms and Breast Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							EXCISION-REPAIR GENES; IONIZING-RADIATION SENSITIVITY; POLY(ADP-RIBOSE) POLYMERASE-1; DNA-DAMAGE; XRCC1; ADPRT; APE1; VARIANTS; POPULATION; VAL762ALA	Background: The base excision repair (BER) pathway removes DNA damage caused by ionizing radiation, reactive oxidative species and methylating agents. ADPRT and APE1 are two important genes in the BER pathway. Several studies have evaluated the association between polymorphisms in the two BER genes (ADPRT Val762Ala and APE1 Asp148Glu) and breast cancer risk. However, the results are inconsistent. Methodology/Principal Findings: In this study, we conducted a meta-analysis to derive a more precise estimation. A total of 8 studies were included in the meta-analysis (6 studies with 2,521 cases and 2,652 controls for ADPRT Val762Ala polymorphism and 5 studies with 2,539 cases and 2,572 controls for APE1 Asp148Glu polymorphism). For ADPRT Val762Ala polymorphism, no obvious associations were found for all genetic models (Val/Ala vs. Val/Val: OR = 0.960, 95% CI = 0.845-1.090; Ala/Ala vs. Val/Val: OR = 0.897, 95% CI = 0.683-1.178; dominant model: OR = 0.953, 95% CI = 0.843-1.077; and recessive model: OR = 1.084, 95% CI = 0.838-1.403). For APE1 Asp148Glu polymorphism, also no obvious associations were found for all genetic models (Asp/Glu vs. Asp/Asp: OR = 0.947, 95% CI = 0.829-1.082; Glu/Glu vs. Asp/Asp: OR = 0.958, 95% CI = 0.813-1.129; dominant model: OR = 0.946, 95% CI = 0.835-1.072; and recessive model: OR = 1.004, 95% CI = 0.873-1.155). In the subgroup analysis by ethnicity or study design, still no obvious associations were found. Conclusions/Significance: This meta-analysis indicates that ADPRT Val762Ala and APE1 Asp148Glu polymorphisms are not associated with increased breast cancer risk. Citation: Wu B, Liu H-L, Zhang S, Dong X-R, Wu G (2012) Lack of an Association between Two BER Gene Polymorphisms and Breast Cancer Risk: A Meta-Analysis. PLoS ONE 7(12): e50857. doi:10.1371/journal.pone.0050857	[Wu, Bian; Liu, Hong-Li; Zhang, Sheng; Dong, Xiao-Rong; Wu, Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Wu, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan 430074, Peoples R China.	wg1893@hotmail.com						BARZILAY G, 1995, BIOESSAYS, V17, P713, DOI 10.1002/bies.950170808; Bieche I, 1996, CLIN CANCER RES, V2, P1163; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Cao WH, 2007, MUTAT RES-GEN TOX EN, V632, P20, DOI 10.1016/j.mrgentox.2007.04.011; Cottet F, 2000, J MOL MED, V78, P431, DOI 10.1007/s001090050488; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Durocher F, 2007, J HUM GENET, V52, P963, DOI 10.1007/s10038-007-0203-9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Ghabreau L, 2004, INT J CANCER, V109, P317, DOI 10.1002/ijc.11731; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Gu DY, 2009, MUTAGENESIS, V24, P507, DOI 10.1093/mutage/gep036; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu JJ, 2001, CARCINOGENESIS, V22, P917, DOI 10.1093/carcin/22.6.917; Hu JJ, 2002, ENVIRON MOL MUTAGEN, V39, P208, DOI 10.1002/em.10058; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Ji YN, 2011, MOL BIOL REP, V38, P4537, DOI 10.1007/s11033-010-0584-2; Jin XM, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-38; Johnson-Thompson MC, 2000, CANCER, V88, P1224, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1224::AID-CNCR8>3.0.CO;2-H; Li CY, 2007, CANCER-AM CANCER SOC, V110, P867, DOI 10.1002/cncr.22861; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mohrenweiser HW, 2003, MUTAT RES-FUND MOL M, V526, P93, DOI 10.1016/S0027-5107(03)00049-6; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Sangrajrang S, 2008, BREAST CANCER RES TR, V111, P279, DOI 10.1007/s10549-007-9773-7; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Zhai XJ, 2006, ONCOL REP, V15, P247; Zhang XM, 2005, CANCER RES, V65, P722; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50857	10.1371/journal.pone.0050857	http://dx.doi.org/10.1371/journal.pone.0050857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272074	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800018
J	Acevedo, P; Melo-Ferreira, J; Real, R; Alves, PC				Acevedo, Pelayo; Melo-Ferreira, Jose; Real, Raimundo; Celio Alves, Paulo			Past, Present and Future Distributions of an Iberian Endemic, Lepus granatensis: Ecological and Evolutionary Clues from Species Distribution Models	PLOS ONE			English	Article							CLIMATE-CHANGE; ENVIRONMENTAL SUITABILITY; REPRODUCTIVE-BIOLOGY; HABITAT SUITABILITY; MITOCHONDRIAL-DNA; NICHE OVERLAP; HARE; POPULATION; TIMIDUS; INTROGRESSION	The application of species distribution models (SDMs) in ecology and conservation biology is increasing and assuming an important role, mainly because they can be used to hindcast past and predict current and future species distributions. However, the accuracy of SDMs depends on the quality of the data and on appropriate theoretical frameworks. In this study, comprehensive data on the current distribution of the Iberian hare (Lepus granatensis) were used to i) determine the species' ecogeographical constraints, ii) hindcast a climatic model for the last glacial maximum (LGM), relating it to inferences derived from molecular studies, and iii) calibrate a model to assess the species future distribution trends (up to 2080). Our results showed that the climatic factor (in its pure effect and when it is combined with the land-cover factor) is the most important descriptor of the current distribution of the Iberian hare. In addition, the model's output was a reliable index of the local probability of species occurrence, which is a valuable tool to guide species management decisions and conservation planning. Climatic potential obtained for the LGM was combined with molecular data and the results suggest that several glacial refugia may have existed for the species within the major Iberian refugium. Finally, a high probability of occurrence of the Iberian hare in the current species range and a northward expansion were predicted for future. Given its current environmental envelope and evolutionary history, we discuss the macroecology of the Iberian hare and its sensitivity to climate change.	[Acevedo, Pelayo; Real, Raimundo] Univ Malaga, Biogeog Div & Conservat Res Team, E-29071 Malaga, Spain; [Acevedo, Pelayo; Melo-Ferreira, Jose; Celio Alves, Paulo] Univ Porto, InBio Lab Associado, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Acevedo, Pelayo] CSIC UCLM JCCM, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Celio Alves, Paulo] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Celio Alves, Paulo] Univ Montana, Coll Forestry & Conservat, Wildlife Biol Program, Missoula, MT 59812 USA	Universidad de Malaga; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidade do Porto; University of Montana System; University of Montana	Acevedo, P (corresponding author), UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain.	pelayo.acevedo@cresa.uab.cat	Melo-Ferreira, José/E-9784-2010; Acevedo, Pelayo/L-6737-2013; ALVES, Paulo Célio/B-5448-2009; Real, Raimundo/E-6559-2010	Melo-Ferreira, José/0000-0003-4473-1908; Acevedo, Pelayo/0000-0002-3509-7696; ALVES, Paulo Célio/0000-0003-4797-0939; Real, Raimundo/0000-0002-6642-1284	Vicerrectorado de Investigacion of the University of Malaga; Spanish Government [CGL2009-11316/BOS]; "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa'' of the Generalitat de Catalunya; European Community; Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/43264/2008]; European Social Fund; FCT [PTDC/BIA-EVF/111931/2009, PTDC/BIA-EVF/115069/2009]; FEDER	Vicerrectorado de Investigacion of the University of Malaga; Spanish Government(Spanish GovernmentEuropean Commission); "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa'' of the Generalitat de Catalunya(Generalitat de Catalunya); European Community(European Commission); Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission)	P.A. was supported by the Vicerrectorado de Investigacion of the University of Malaga and partially by the project CGL2009-11316/BOS of the Spanish Government and FEDER. Currently, P.A. holds a Beatriu de Pinos fellowship funded by "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa'' of the Generalitat de Catalunya, and the COFUND Programme - Marie Curie Actions under 7th Marc Programme of the European Community. J.M.- F. was funded from the SFRH/BPD/43264/2008 post-doctoral grant by by Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) and the European Social Fund. Financial support was partially obtained from the Research Projects PTDC/BIA-EVF/111931/2009 and PTDC/BIA-EVF/115069/2009, by FCT and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2009, ANN ZOOL FENN, V46, P39, DOI 10.5735/086.046.0105; Acevedo P, 2007, ACTA OECOL, V31, P174, DOI 10.1016/j.actao.2006.09.003; Acevedo P, 2012, GLOBAL CHANGE BIOL, V18, P1509, DOI 10.1111/j.1365-2486.2012.02655.x; Acevedo P, 2011, LANDSCAPE ECOL, V26, P19, DOI 10.1007/s10980-010-9538-2; Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Acevedo P, 2010, DIVERS DISTRIB, V16, P515, DOI 10.1111/j.1472-4642.2010.00662.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almeida J, 2004, QUANT GEO G, V13, P127; Altuna J., 1970, MUNIBE SOC CIENCIAS, V22, P165; Alves PC, 2003, MOL PHYLOGENET EVOL, V27, P70, DOI 10.1016/S1055-7903(02)00417-7; Alves PC, 2002, MAMM BIOL, V67, P358, DOI 10.1078/1616-5047-00051; Alzaga V, 2008, BEHAV ECOL SOCIOBIOL, V62, P769, DOI 10.1007/s00265-007-0502-3; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Barbosa AM, 2010, CONSERV BIOL, V24, P1378, DOI 10.1111/j.1523-1739.2010.01517.x; Barbosa AM, 2009, ECOL MODEL, V220, P747, DOI 10.1016/j.ecolmodel.2008.12.004; Bicheron P., 2008, GLOBCOVER 2005 PRODU; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Brambilla M, 2012, J ANIM ECOL, V81, P781, DOI 10.1111/j.1365-2656.2012.01970.x; Brambilla M, 2010, BIOL CONSERV, V143, P2770, DOI 10.1016/j.biocon.2010.07.025; Brambilla M, 2009, BIOL CONSERV, V142, P2033, DOI 10.1016/j.biocon.2009.03.033; Brunet M, 2007, GENERACION ESCENARIO; Carro F, 2010, LIBEBRE IBERICA; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Delibes-Mateos M, 2007, BIOL CONSERV, V137, P149, DOI 10.1016/j.biocon.2007.01.024; ESRI, 2011, ARCGIS DESKT REL 10; Estrada A, 2011, BIOL CONSERV, V144, P1120, DOI 10.1016/j.biocon.2010.12.031; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farfan MA, 2012, J ZOOL, V286, P258, DOI 10.1111/j.1469-7998.2011.00873.x; Farfan MA, 2004, ACTA THERIOL, V49, P319, DOI 10.1007/BF03192531; Fouquet A, 2010, BIOL CONSERV, V143, P1375, DOI 10.1016/j.biocon.2010.03.012; Franklin J, 2009, MAPPING SPECIES DIST; Gao XJ, 2008, GLOBAL PLANET CHANGE, V62, P195, DOI 10.1016/j.gloplacha.2008.02.002; Gortazar C, 2007, WILDLIFE BIOL, V13, P244, DOI 10.2981/0909-6396(2007)13[244:ALSOBH]2.0.CO;2; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Illan JG, 2010, GLOBAL ECOL BIOGEOGR, V19, P159, DOI 10.1111/j.1466-8238.2009.00507.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Knowles LL, 2010, MOL ECOL, V19, P3727, DOI 10.1111/j.1365-294X.2010.04702.x; LAZO A, 1992, Z SAUGETIERKD, V57, P373; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Marquez AL, 2011, CLIMATIC CHANGE, V1-23; Melo-Ferreira J, 2007, MOL ECOL, V16, P605, DOI 10.1111/j.1365-294X.2006.03166.x; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Melo-Ferreira J, 2012, SYST BIOL, V61, P367, DOI 10.1093/sysbio/syr114; Melo-Ferreira J, 2009, MOL ECOL, V18, P2643, DOI 10.1111/j.1365-294X.2009.04221.x; Melo-Ferreira J, 2011, EVOLUTION, V65, P1956, DOI 10.1111/j.1558-5646.2011.01261.x; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Pauperio J, 2008, EUR J WILDLIFE RES, V54, P571, DOI 10.1007/s10344-008-0181-z; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Real R, 2003, J BIOGEOGR, V30, P939, DOI 10.1046/j.1365-2699.2003.00871.x; Real R, 2009, DIVERS DISTRIB, V15, P390, DOI 10.1111/j.1472-4642.2008.00546.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rivas-Martinez S., 2004, BIOCLIMATIC MAP EURO; Sanchez-Fernandez D, 2011, DIVERS DISTRIB, V17, P163, DOI 10.1111/j.1472-4642.2010.00716.x; Smith AT, 2008, IUCN 2011 IUCN RED L; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Tapia L, 2010, ACTA THERIOL, V55, P73, DOI 10.4098/j.at.0001-7051.018.2009; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Tuanmu MN, 2011, J BIOGEOGR, V38, P1510, DOI 10.1111/j.1365-2699.2011.02479.x; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Vargas JM, 2007, WILDLIFE RES, V34, P498, DOI 10.1071/WR06012; Vaughn CC, 2000, ECOGRAPHY, V23, P11, DOI 10.1034/j.1600-0587.2000.230102.x; Wilson CD, 2011, BIOL CONSERV, V144, P821, DOI 10.1016/j.biocon.2010.11.014; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	86	24	24	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51529	10.1371/journal.pone.0051529	http://dx.doi.org/10.1371/journal.pone.0051529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272115	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386600029
J	Wakao, S; Kitada, M; Kuroda, Y; Ogura, F; Murakami, T; Niwa, A; Dezawa, M				Wakao, Shohei; Kitada, Masaaki; Kuroda, Yasumasa; Ogura, Fumitaka; Murakami, Toru; Niwa, Akira; Dezawa, Mari			Morphologic and Gene Expression Criteria for Identifying Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HUMAN FIBROBLASTS; HUMAN BLASTOCYSTS; DEFINED FACTORS; LINES; DIFFERENTIATION; MOUSE; SOX2; PRECURSORS; INDUCTION	Induced pluripotent stem (iPS) cells can be generated from somatic cells by the forced expression of four factors, Oct3/4, Sox2, Klf4, and c-Myc. While a great variety of colonies grow during induction, only a few of them develop into iPS cells. Researchers currently use visual observation to identify iPS cells and select colonies resembling embryonic stem (ES) cells, and there are no established objective criteria. Therefore, we exhaustively analyzed the morphology and gene expression of all the colonies generated from human fibroblasts after transfection with four retroviral vectors encoding individual factors (192 and 203 colonies in two experiments) and with a single polycistronic retroviral vector encoding all four factors (199 and 192 colonies in two experiments). Here we demonstrate that the morphologic features of emerged colonies can be categorized based on six parameters, and all generated colonies that could be passaged were classified into seven subtypes in colonies transfected with four retroviral vectors and six subtypes with a single polycistronic retroviral vector, both including iPS cell colonies. The essential qualifications for iPS cells were: cells with a single nucleolus; nucleus to nucleolus (N/Nls) ratio similar to 2.19: cell size similar to 43.5 mu m(2) : a nucleus to cytoplasm (N/C) ratio similar to 0.87: cell density in a colony similar to 5900 cells/mm(2) : and number of cell layer single. Most importantly, gene expression analysis revealed for the first time that endogenous Sox2 and Cdx2 were expressed specifically in iPS cells, whereas Oct3/4 and Nanog, popularly used markers for identifying iPS cells, are expressed in colonies other than iPS cells, suggesting that Sox2 and Cdx2 are reliable markers for identifying iPS cells. Our findings indicate that morphologic parameters and the expression of endogenous Sox2 and Cdx2 can be used to accurately identify iPS cells. Citation: Wakao S, Kitada M, Kuroda Y, Ogura F, Murakami T, et al. (2012) Morphologic and Gene Expression Criteria for Identifying Human Induced Pluripotent Stem Cells. PLoS ONE 7(12): e48677. doi:10.1371/journal.pone.0048677	[Wakao, Shohei; Kitada, Masaaki; Ogura, Fumitaka; Murakami, Toru; Dezawa, Mari] Tohoku Univ, Dept Stem Cell Biol & Histol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kuroda, Yasumasa; Dezawa, Mari] Tohoku Univ, Grad Sch Med, Dept Anat & Anthropol, Sendai, Miyagi 980, Japan; [Niwa, Akira] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan	Tohoku University; Tohoku University; Kyoto University	Wakao, S (corresponding author), Tohoku Univ, Dept Stem Cell Biol & Histol, Grad Sch Med, Sendai, Miyagi 980, Japan.	wakao@med.tohoku.ac.jp; mdezawa@med.tohoku.ac.jp	Kitada, Masaaki/I-1591-2017	Kitada, Masaaki/0000-0002-4103-9767	Ministry of Education, Culture Sports, Science, and Technology, Japan [23390060]; Grants-in-Aid for Scientific Research [22790181, 23659145] Funding Source: KAKEN	Ministry of Education, Culture Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (23390060) from the Ministry of Education, Culture Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Khoo MLM, 2005, BIOL REPROD, V73, P1147, DOI 10.1095/biolreprod.104.036673; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Spassky N, 2000, GLIA, V29, P143, DOI 10.1002/(SICI)1098-1136(20000115)29:2<143::AID-GLIA7>3.3.CO;2-4; Spassky N, 1998, J NEUROSCI, V18, P8331; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Ware CB, 2006, STEM CELLS, V24, P2677, DOI 10.1634/stemcells.2005-0452; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zappone MV, 2000, DEVELOPMENT, V127, P2367	26	33	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e48677	10.1371/journal.pone.0048677	http://dx.doi.org/10.1371/journal.pone.0048677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272044	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386600002
J	Barash, U; Arvatz, G; Farfara, R; Naroditsky, I; Doweck, I; Feld, S; Ben-Izhak, O; Ilan, N; Nativ, O; Vlodavsky, I				Barash, Uri; Arvatz, Gil; Farfara, Roy; Naroditsky, Inna; Doweck, Ilana; Feld, Sari; Ben-Izhak, Ofer; Ilan, Neta; Nativ, Ofer; Vlodavsky, Israel			Clinical Significance of Heparanase Splice Variant (T5) in Renal Cell Carcinoma: Evaluation by a Novel T5-Specific Monoclonal Antibody	PLOS ONE			English	Article							MAMMALIAN HEPARANASE; TUMOR PROGRESSION; CANCER METASTASIS; EXPRESSION; LOCALIZATION; CLONING; ACTIVATION; RECEPTOR; HEAD; VEGF	T5 is a novel splice variant of heparanase, an endo-beta-D-glucuronidase capable of cleaving heparan sulfate side chains at a limited number of sites. T5 splice variant is endowed with pro-tumorigenic properties, enhancing cell proliferation, anchorage independent growth and tumor xenograft development despite lack of heparan sulfate-degrading activity typical of heparanase. T5 is over expressed in the majority of human renal cell carcinoma biopsies examined, suggesting that this splice variant is clinically relevant. T5 is thought to assume a distinct three-dimensional conformation compared with the wild type heparanase protein. We sought to exploit this presumed feature by generating monoclonal antibodies that will recognize the unique structure of T5 without, or with minimal recognition of heparanase, thus enabling more accurate assessment of the clinical relevance of T5. We provide evidence that such a monoclonal antibody, 9c9, preferentially recognizes T5 compared with heparanase by ELISA, immunoblotting and immunohistochemistry. In order to uncover the clinical significance of T5, a cohort of renal cell carcinoma specimens was subjected to immunostaining applying the 9c9 antibody. Notably, T5 staining intensity was significantly associated with tumor size (p = 0.004) and tumor grade (p = 0.02). Our results suggest that T5 is a functional, pro-tumorigenic entity.	[Barash, Uri; Arvatz, Gil; Feld, Sari; Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, Haifa, Israel; [Farfara, Roy; Nativ, Ofer] Bnai Zion Med Ctr, Dept Urol, Haifa, Israel; [Naroditsky, Inna; Ben-Izhak, Ofer] Rambam Hlth Care Campus, Dept Pathol, Haifa, Israel; [Doweck, Ilana] Carmel Hosp, Dept Otolaryngol Head & Neck Surg, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center; Rambam Health Care Campus; Clalit Health Services; Carmel Medical Center	Vlodavsky, I (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, Haifa, Israel.	Vlodavsk@cc.huji.ac.il		Barash, Uri/0000-0003-1049-270X; Doweck, Ilana/0000-0002-1065-0299	Israel Science Foundation [593/10]; National Cancer Institute, National Institutes of Health [CA106456]; Israel Cancer Research Fund (ICRF); US-Israel Binational Science Foundation (BSF); Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Cancer Research Fund (ICRF); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (grant 593/10); National Cancer Institute, National Institutes of Health (grant CA106456); the Israel Cancer Research Fund (ICRF); the US-Israel Binational Science Foundation (BSF), and the Rappaport Family Institute Fund to I. Vlodavsky. I. Vlodavsky is a Research Professor of the ICRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvatz G, 2011, CANCER METAST REV, V30, P253, DOI 10.1007/s10555-011-9288-x; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Barash U, 2010, FASEB J, V24, P1239, DOI 10.1096/fj.09-147074; Bertolesi GE, 2011, DEV DYNAM, V240, P2657, DOI 10.1002/dvdy.22770; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dempsey LA, 2000, GLYCOBIOLOGY, V10, P467, DOI 10.1093/glycob/10.5.467; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Edge SB, 2010, AJCC CANC STAGING MA; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2007, FASEB J, V21, P3986, DOI 10.1096/fj.07-8866com; Haimov-Kochman R, 2002, MOL HUM REPROD, V8, P566, DOI 10.1093/molehr/8.6.566; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; Levy-Adam F, 2010, J BIOL CHEM, V285, P28010, DOI 10.1074/jbc.M110.116384; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; Mikami S, 2008, CLIN CANCER RES, V14, P6055, DOI 10.1158/1078-0432.CCR-08-0750; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Nasser NJ, 2007, BIOCHEM BIOPH RES CO, V354, P33, DOI 10.1016/j.bbrc.2006.12.189; Nasser NJ, 2005, P NATL ACAD SCI USA, V102, P15161, DOI 10.1073/pnas.0507279102; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Ren JC, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-158; Sato M, 2008, CELL BIOCHEM FUNCT, V26, P676, DOI 10.1002/cbf.1492; Shafat I, 2006, BIOCHEM BIOPH RES CO, V341, P958, DOI 10.1016/j.bbrc.2006.01.048; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; van Alphen RJ, 2009, BRIT J CANCER, V100, P228, DOI 10.1038/sj.bjc.6604801; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Weidle UH, 2011, CANCER GENOM PROTEOM, V8, P211; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zisman A, 2002, J CLIN ONCOL, V20, P4559, DOI 10.1200/JCO.2002.05.111	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51494	10.1371/journal.pone.0051494	http://dx.doi.org/10.1371/journal.pone.0051494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251556	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200123
J	Naturil-Alfonso, C; Saenz-de-Juano, MD; Penaranda, DS; Vicente, JS; Marco-Jimenez, F				Naturil-Alfonso, Carmen; dels Desamparats Saenz-de-Juano, Maria; Penaranda, David S.; Vicente, Jose S.; Marco-Jimenez, Francisco			Transcriptome Profiling of Rabbit Parthenogenetic Blastocysts Developed under In Vivo Conditions	PLOS ONE			English	Article							VITRO CULTURE-CONDITIONS; GENE-EXPRESSION; BOVINE EMBRYOS; STEM-CELLS; MECHANISMS	Parthenogenetic embryos are one attractive alternative as a source of embryonic stem cells, although many aspects related to the biology of parthenogenetic embryos and parthenogenetically derived cell lines still need to be elucidated. The present work was conducted to investigate the gene expression profile of rabbit parthenote embryos cultured under in vivo conditions using microarray analysis. Transcriptomic profiles indicate 2541 differentially expressed genes between parthenotes and normal in vivo fertilised blastocysts, of which 76 genes were upregulated and 16 genes downregulated in in vivo cultured parthenote blastocyst, using 3 fold-changes as a cut-off. While differentially upregulated expressed genes are related to transport and protein metabolic process, downregulated expressed genes are related to DNA and RNA binding. Using microarray data, 6 imprinted genes were identified as conserved among rabbits, humans and mice: GRB10, ATP10A, ZNF215, NDN, IMPACT and SFMBT2. We also found that 26 putative genes have at least one member of that gene family imprinted in other species. These data strengthen the view that a large fraction of genes is differentially expressed between parthenogenetic and normal embryos cultured under the same conditions and offer a new approach to the identification of imprinted genes in rabbit.	[Naturil-Alfonso, Carmen; dels Desamparats Saenz-de-Juano, Maria; Penaranda, David S.; Vicente, Jose S.; Marco-Jimenez, Francisco] Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46071 Valencia, Spain	Universitat Politecnica de Valencia	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46071 Valencia, Spain.	fmarco@dca.upv.es	Jiménez, Francisco Marco/I-7126-2012; Peñaranda, David Sanchez/L-3003-2014; Vicente, Jose/F-7738-2017	Jiménez, Francisco Marco/0000-0002-5226-4118; Peñaranda, David Sanchez/0000-0002-0861-976X; Saenz-de-Juano, Mara D./0000-0002-2860-2252; Vicente, Jose/0000-0003-0481-3802	Generalitat Valenciana research programme [Prometeo 2009/125]	Generalitat Valenciana research programme(Center for Forestry Research & Experimentation (CIEF))	This work was supported by Generalitat Valenciana research programme (Prometeo 2009/125). Carmen Naturil was supported by Generalitat Valenciana research programme (Prometeo 2009/125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoon AS, 2012, THERIOGENOLOGY, V77, P1240, DOI 10.1016/j.theriogenology.2011.11.004; Besenfelder U, 1998, J VET MED A, V45, P577, DOI 10.1111/j.1439-0442.1998.tb00861.x; BilodeauGoeseels S, 1997, BIOL REPROD, V56, P1323, DOI 10.1095/biolreprod56.5.1323; Bischoff SR, 2009, BIOL REPROD, V81, P906, DOI 10.1095/biolreprod.109.078139; Brevini IAL, 2008, CELL PROLIFERAT, V41, P20, DOI 10.1111/j.1365-2184.2008.00485.x; Chen ZS, 2009, STEM CELLS, V27, P2136, DOI 10.1002/stem.158; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corcoran D, 2006, REPRODUCTION, V131, P651, DOI 10.1530/rep.1.01015; Cruz-Correa M, 2009, EPIGENETICS-US, V4, P114, DOI 10.4161/epi.4.2.7954; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Harness JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014499; Koh CJ, 2009, METHODS, V47, P90, DOI 10.1016/j.ymeth.2008.08.002; Labrecque R, 2011, REPROD FERT DEVELOP, V23, P591, DOI 10.1071/RD10243; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Liu N, 2010, J MOL CELL BIOL, V2, P333, DOI 10.1093/jmcb/mjq029; Llobat L, 2012, REPROD DOMEST ANIM, V47, P629, DOI 10.1111/j.1439-0531.2011.01934.x; Lonergan P, 2003, REPRODUCTION, V126, P337, DOI 10.1530/rep.0.1260337; Lu ZY, 2010, J ASSIST REPROD GEN, V27, P285, DOI 10.1007/s10815-010-9408-5; Mamo S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-67; Marco-Jimenez F, 2010, REPROD DOMEST ANIM, V45, pE118, DOI 10.1111/j.1439-0531.2009.01532.x; Mehaisen GMK, 2006, THERIOGENOLOGY, V65, P1279, DOI 10.1016/j.theriogenology.2005.08.007; Memili E, 2000, ZYGOTE, V8, P87, DOI 10.1017/S0967199400000861; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Naturil-Alfonso C, 2011, ANIM REPROD SCI, V127, P222, DOI 10.1016/j.anireprosci.2011.08.005; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Park CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022216; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; Rizos D, 2008, REPROD DOMEST ANIM, V43, P44, DOI 10.1111/j.1439-0531.2008.01230.x; Santos AN, 2004, REPRODUCTION, V128, P517, DOI 10.1530/rep.1.00204; Sritanaudomchai H, 2010, HUM REPROD, V25, P1927, DOI 10.1093/humrep/deq144; Thurston A, 2008, REPRODUCTION, V135, P29, DOI 10.1530/REP-07-0211; Vrana KE, 2003, P NATL ACAD SCI USA, V100, P11911, DOI 10.1073/pnas.2034195100; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; Weltzien FA, 2005, GEN COMP ENDOCR, V142, P134, DOI 10.1016/j.ygcen.2004.12.019	36	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51271	10.1371/journal.pone.0051271	http://dx.doi.org/10.1371/journal.pone.0051271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251477	Green Published, gold			2022-12-27	WOS:000313236200080
J	Wang, LM; Jia, C; Yu, ZY; Liu, XL; Kang, LP; Cong, Y; Shan, YJ; Zhao, ZH; Ma, BP; Cong, YW				Wang, Limei; Jia, Chao; Yu, Zuyin; Liu, Xiaolan; Kang, Liping; Cong, Yue; Shan, Yajun; Zhao, Zhenhu; Ma, Baiping; Cong, Yuwen			Pennogenin Tetraglycoside Induces Rat Myometrial Contraction and MLC20 Phosphorylation via PLC-IP3 and RhoA/Rho Kinase Signaling Pathways	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; SMOOTH-MUSCLE CONTRACTION; RHO-ASSOCIATED KINASE; UTERINE CONTRACTILITY; STRUCTURAL REQUIREMENT; RECEPTOR ANTAGONIST; ROK-ALPHA; CELLS; ACTIVATION; GLYCOSIDES	Background: Total steroidal saponins extracted from the rhizome of Paris polyphylla Sm. var. yunnanensis (TSSPs) have been widely used in China for the treatment of abnormal uterine bleeding. We previously studied the main active constituents of TSSPs and their structure-activity relationships with respect to rat myometrial contractions. Tg (pennogenin tetraglycoside) was identified as one of the active ingredients in TSSPs able to induce rat myometrial contractions. However, the mechanisms underlying the pharmacological actions on uterine activity have not been described clearly. Methods: Here Tg was screened for effects on contractile activity in isolated uterine strips from estrogen-primed rats and on MLC20 phosphorylation and related signaling pathways in cultured rat myometrial cells as determined by Western blot. Intracellular calcium ([Ca2+](i)) was monitored under a confocal microscope using Fluo-4 AM-loaded myometrial cells. Results: Tg dose-dependently stimulated rat myometrial contractions as well as MLC20 phosphorylation in vitro, which could be completely suppressed by an inhibitor of myosin light chain kinase (MLCK). Use of Ca2+ channel blockers and kinase inhibitors demonstrated that Tg-induced myometrial contractions are mediated by activation of the phospholipase C (PLC)-inositol triphosphate (IP3) signaling pathway, resulting in increased MLC20 phosphorylation. Furthermore, Y27632, a specific inhibitor of Rho kinase (ROK), notably suppressed Tg-stimulated myometrial contractions and decreased MLC20 phosphorylation. Conclusions: These data provide evidence that rat myometrial contractility induced by Tg results from enhanced MLC20 phosphorylation, while both PLC-IP3 and RhoA/ROK signaling pathways mediate the process. These mechanisms may be responsible for the therapeutic effects of TSSPs on abnormal uterine bleeding.	[Wang, Limei; Jia, Chao; Yu, Zuyin; Liu, Xiaolan; Cong, Yue; Shan, Yajun; Zhao, Zhenhu; Cong, Yuwen] Beijing Inst Radiat Med, Dept Pathophysiol, Beijing, Peoples R China; [Kang, Liping; Ma, Baiping] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Cong, YW (corresponding author), Beijing Inst Radiat Med, Dept Pathophysiol, Beijing, Peoples R China.	congyw@nic.bmi.ac.cn			Nature Science Foundation of China [NSFC: 30672640]; NSFC joint Foundation of Yunnan [U1032601]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC joint Foundation of Yunnan	This work was supported, in part, by grants from the Nature Science Foundation of China (NSFC: 30672640) and the NSFC joint Foundation of Yunnan (U1032601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Arner A, 1999, Rev Physiol Biochem Pharmacol, V134, P63; Ascher-Landsberg J, 1999, J SOC GYNECOL INVEST, V6, P240, DOI 10.1016/S1071-5576(99)00031-3; Bae J, 1999, TOXICOL APPL PHARM, V155, P261, DOI 10.1006/taap.1998.8614; Bao JJ, 2002, P NATL ACAD SCI USA, V99, P9556, DOI 10.1073/pnas.142298599; Barata H, 2004, ENDOCRINOLOGY, V145, P881, DOI 10.1210/en.2003-0774; CHEN C, 1983, YUNNAN ZHI WU YAN JI, V0005; Chen CX, 1992, YUNNAN ZHIWU YANJIU, V14, P111; Cong Y, 2012, THROMB RES, V129, pE209, DOI 10.1016/j.thromres.2012.02.001; Eddinger TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC493, DOI 10.1152/ajpcell.00131.2007; Fu YL, 2008, J THROMB HAEMOST, V6, P524, DOI 10.1111/j.1538-7836.2007.02881.x; Gao Y, 2001, IUBMB LIFE, V51, P337; GORECKA A, 1976, BIOCHEM BIOPH RES CO, V71, P325, DOI 10.1016/0006-291X(76)90286-2; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; [康利平 Kang Liping], 2005, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V15, P25; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Lee YH, 2001, EXP PHYSIOL, V86, P283, DOI 10.1113/eph8602184; Leung T, 1996, MOL CELL BIOL, V16, P5313; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Matthew A, 2004, BIOL RES, V37, P617; NOHARA T, 1973, CHEM PHARM BULL, V21, P1240, DOI 10.1248/cpb.21.1240; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Shintani Y, 2000, BRIT J PHARMACOL, V130, P1165, DOI 10.1038/sj.bjp.0703410; Shojo H, 2001, J MOL RECOGNIT, V14, P401, DOI 10.1002/jmr.551; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; Splettstoesser F, 2007, BRIT J PHARMACOL, V151, P1176, DOI 10.1038/sj.bjp.0707335; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Taggart MJ, 1999, EXP CELL RES, V251, P92, DOI 10.1006/excr.1999.4565; TIAN Y, 1986, Journal of Traditional Chinese Medicine, V6, P178; Woodcock NA, 2004, AM J OBSTET GYNECOL, V190, P222, DOI 10.1016/S0002-9378(03)00925-6; Wray S, 2003, J SOC GYNECOL INVEST, V10, P252, DOI 10.1016/S1071-5576(03)00089-3; Yu ZY, 2007, INT J CANCER, V121, P2084, DOI 10.1002/ijc.22945; Yu ZY, 2010, J PHARM PHARMACOL, V62, P521, DOI 10.1211/jpp.62.04.0016; Zhang JY, 1999, CLIN CHIM ACTA, V289, P79, DOI 10.1016/S0009-8981(99)00160-6; Zhao L., 2005, J PRACT TRADIT CHIN, V21, P455	37	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51536	10.1371/journal.pone.0051536	http://dx.doi.org/10.1371/journal.pone.0051536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251567	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200131
J	Zhang, S; Xu, ZW; Gao, Y; Wu, YH; Li, ZH; Liu, HF; Zhang, CG				Zhang, Shuang; Xu, Zhiwei; Gao, Yan; Wu, Yonghong; Li, Zhihui; Liu, Haifeng; Zhang, Chenggang			Bidirectional Crosstalk between Stress-Induced Gastric Ulcer and Depression under Chronic Stress	PLOS ONE			English	Article							CENTRAL HISTAMINERGIC MECHANISM; PITUITARY-ADRENAL AXIS; REPEATED IMMOBILIZATION; RESPONSES; MODEL; RAT; ADAPTATION; INHIBITOR; MELATONIN; DESPAIR	Stress contributes to a variety of diseases and disorders such as depression and peptic ulcer. The present study aimed to investigate the correlation between stress ulcer and depression in pathogenesis and treatment by using chronic stress depression (CSD), chronic psychological stress ulcer (CPSU) and water immersion restrain stress models in rats. Our data showed that the ulcer index of the animals after CSD exposure was significantly higher than that of controls. Depression-like behaviors were observed in rat after CPSU exposure. Fluoxetine hydrochloride significantly reduced the ulcer index of rats exposed to CPSU stress, while ranitidine inhibited depression-like behavior of the animals in CSD group. The ulcer index of rats administered with mifepristone after CPSU stress was markedly reduced compared to CPSU group, although there was no significant difference in the depression-like behavior between mifepristone-treated CSD group and naive controls. We also found that the rats exposed to CPSU or CSD stress displayed a lower level of corticosterone than naive controls, however, the acute stress (AS) group showed an opposite result. Additionally, in order to study the relevance of H-2 receptors and depression, we treated the CSD group with cimetidine and famotidine respectively. The data showed that cimetidine inhibited depression-like behavior in CSD rats, and famotidine had no impact on depression. Overall our data suggested that the hypothalamic-pituitary-adrenal (HPA) axis dysfunction may be the key role in triggering depression and stress ulcer. Acid-suppressing drugs and antidepressants could be used for treatment of depression and stress ulcer respectively. The occurrence of depression might be inhibited by blocking the central H-2 receptors.	[Zhang, Shuang; Xu, Zhiwei; Gao, Yan; Wu, Yonghong; Li, Zhihui; Zhang, Chenggang] Beijing Inst Radiat Med, State Key Lab Prote, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China; [Zhang, Shuang; Liu, Haifeng] Chinese Peoples Armed Police Forces, Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Zhang, Chenggang] Anhui Med Univ, Sch Life Sci, Hefei, Anhui, Peoples R China	Academy of Military Medical Sciences - China; Anhui Medical University	Liu, HF (corresponding author), Chinese Peoples Armed Police Forces, Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China.	haifengliu333@163.com; zhangcg@bmi.ac.cn	Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304	National Basic Research Project (973 program) [2012CB518200]; Natural Science Foundation of China [81100979, 81070741, 30900830]; Special Key Programs for Science and Technology of China [2012ZX09102301-016]	National Basic Research Project (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Key Programs for Science and Technology of China	This work was supported by the National Basic Research Project (973 program) (2012CB518200), the General Program (81100979, 81070741, 30900830) of the Natural Science Foundation of China, and Special Key Programs for Science and Technology of China (2012ZX09102301-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Sater KA, 2012, EUR J PHARMACOL, V688, P42, DOI 10.1016/j.ejphar.2012.04.019; Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; Bielajew C, 2003, STRESS, V6, P269, DOI 10.1080/10253890310001602829; Booij S. H., 2012, PSYCHONEUROENDOCRINO; Brzozowska I, 2009, J PHYSIOL PHARMACOL, V60, P47; Brzozowski T, 2007, J PHYSIOL PHARMACOL, V58, P53; DAQUILA PS, 1994, PHYSIOL BEHAV, V56, P861, DOI 10.1016/0031-9384(94)90316-6; Dickens M, 2009, J NEUROENDOCRINOL, V21, P832, DOI 10.1111/j.1365-2826.2009.01908.x; Fraites MJP, 2009, TOXICOL SCI, V112, P88, DOI 10.1093/toxsci/kfp194; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; GADEKMICHALSKA A, 1991, AGENTS ACTIONS, V32, P203; Gorka Z, 1996, PHARMACOL BIOCHEM BE, V54, P229, DOI 10.1016/0091-3057(95)02173-6; Gourley SL, 2008, BIOL PSYCHIAT, V64, P884, DOI 10.1016/j.biopsych.2008.06.016; Gourley SL, 2008, BIOL PSYCHIAT, V63, P353, DOI 10.1016/j.biopsych.2007.07.016; Harty RF, 2004, DIGEST DIS SCI, V49, P1875, DOI 10.1007/s10620-004-9586-z; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; KANOF PD, 1978, NATURE, V272, P329, DOI 10.1038/272329a0; Kato A, 2010, BIOSCI BIOTECH BIOCH, V74, P812, DOI 10.1271/bbb.90897; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; KENNETT GA, 1985, EUR J PHARMACOL, V119, P143, DOI 10.1016/0014-2999(85)90290-0; KENNETT GA, 1985, BRAIN RES, V330, P253, DOI 10.1016/0006-8993(85)90684-5; Madrigal JLM, 2001, NEUROPSYCHOPHARMACOL, V24, P420, DOI 10.1016/S0893-133X(00)00208-6; McKernan DP, 2009, PROG NEUROBIOL, V88, P246, DOI 10.1016/j.pneurobio.2009.04.006; Mei XT, 2011, PHARMACOL BIOCHEM BE, V99, P66, DOI 10.1016/j.pbb.2011.04.002; Mennigen JA, 2010, AQUAT TOXICOL, V100, P354, DOI 10.1016/j.aquatox.2010.08.016; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Murison R, 2001, INTEGR PHYS BEH SCI, V36, P75, DOI 10.1007/BF02733948; NATH C, 1988, LIFE SCI, V42, P2413, DOI 10.1016/0024-3205(88)90339-6; NATH C, 1982, PSYCHOPHARMACOLOGY, V76, P228, DOI 10.1007/BF00432550; Pardon MC, 2000, PHYSIOL BEHAV, V70, P7, DOI 10.1016/S0031-9384(00)00216-X; Perdrizet GA, 1997, CELL STRESS CHAPERON, V2, P214, DOI 10.1379/1466-1268(1997)002<0214:HSABRT>2.3.CO;2; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Rai D, 2003, J PHARMACOL SCI, V93, P458, DOI 10.1254/jphs.93.458; ROBINS AH, 1984, POSTGRAD MED J, V60, P353, DOI 10.1136/pgmj.60.703.353; Rybakina E G, 2009, Ross Fiziol Zh Im I M Sechenova, V95, P1324; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Saxena B, 2011, PHARMACOL REP, V63, P1413; SELYE H, 1965, Nurs Forum, V4, P28, DOI 10.1111/j.1744-6198.1965.tb01011.x; SELYE H, 1946, J ALLERGY, V17, P231, DOI 10.1016/0021-8707(46)90148-7; SELYE H, 1964, Ind Med Surg, V33, P621; SELYE H, 1954, Int Rec Med Gen Pract Clin, V167, P181; Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230; Suleyman H, 2009, CHEM-BIOL INTERACT, V180, P318, DOI 10.1016/j.cbi.2009.03.002; Suri D, 2012, NEUROSCIENCE; Thornton LM, 2010, HEALTH PSYCHOL, V29, P333, DOI 10.1037/a0018836; Verma P, 2010, PHYSIOL BEHAV, V99, P276, DOI 10.1016/j.physbeh.2009.11.002; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011	50	21	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51148	10.1371/journal.pone.0051148	http://dx.doi.org/10.1371/journal.pone.0051148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251441	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200064
J	Koo, HJ; Gang, DR				Koo, Hyun Jo; Gang, David R.			Suites of Terpene Synthases Explain Differential Terpenoid Production in Ginger and Turmeric Tissues	PLOS ONE			English	Article							ZINGIBER-ZERUMBET SMITH; CURCUMA-LONGA; FUNCTIONAL-CHARACTERIZATION; GLANDULAR TRICHOMES; SESQUITERPENE SYNTHASES; BY-PRODUCT; BIOSYNTHESIS; OFFICINALE; CLONING; OIL	The essential oils of ginger (Zingiber officinale) and turmeric (Curcuma longa) contain a large variety of terpenoids, some of which possess anticancer, antiulcer, and antioxidant properties. Despite their importance, only four terpene synthases have been identified from the Zingiberaceae family: (+)-germacrene D synthase and (S)-beta-bisabolene synthase from ginger rhizome, and alpha-humulene synthase and beta-eudesmol synthase from shampoo ginger (Zingiber zerumbet) rhizome. We report the identification of 25 mono-and 18 sesquiterpene synthases from ginger and turmeric, with 13 and 11, respectively, being functionally characterized. Novel terpene synthases, (-)-caryolan-1-ol synthase and alpha-zingiberene/beta-sesquiphellandrene synthase, which is responsible for formation of the major sesquiterpenoids in ginger and turmeric rhizomes, were also discovered. These suites of enzymes are responsible for formation of the majority of the terpenoids present in these two plants. Structures of several were modeled, and a comparison of sets of paralogs suggests how the terpene synthases in ginger and turmeric evolved. The most abundant and most important sesquiterpenoids in turmeric rhizomes, (+)-alpha-turmerone and (+)-beta-turmerone, are produced from (-)-alpha-zingiberene and (-)-beta-sesquiphellandrene, respectively, via alpha-zingiberene/beta-sesquiphellandrene oxidase and a still unidentified dehydrogenase.	Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; Univ Arizona, Inst Bio5, Tucson, AZ USA	University of Arizona; University of Arizona	Gang, DR (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	gangd@wsu.edu			US National Science Foundation [DBI-0227618]	US National Science Foundation(National Science Foundation (NSF))	This research was funded by a grant from the US National Science Foundation to DRG (grant #DBI-0227618; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 1995, IDENTIFICATION ESSEN; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; de Kraker JW, 1998, PLANT PHYSIOL, V117, P1381, DOI 10.1104/pp.117.4.1381; Ficker CE, 2003, MYCOSES, V46, P29, DOI 10.1046/j.1439-0507.2003.00838.x; Fischer MJC, 2011, BIOTECHNOL BIOENG, V108, P1883, DOI 10.1002/bit.23129; Fujisawa M, 2010, PLANTA, V232, P121, DOI 10.1007/s00425-010-1137-6; Garms S, 2012, PHYTOCHEMISTRY, V75, P6, DOI 10.1016/j.phytochem.2011.12.009; Gennadios HA, 2009, BIOCHEMISTRY-US, V48, P6175, DOI 10.1021/bi900483b; Gopfert JC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-86; Golding BT, 1992, J CHEM SOC P1, V1, P1519; Habib SHM, 2008, CLINICS, V63, P807, DOI 10.1590/S1807-59322008000600017; Hiserodt R, 1996, J CHROMATOGR A, V740, P51, DOI 10.1016/0021-9673(96)00103-3; Hyatt DC, 2007, P NATL ACAD SCI USA, V104, P5360, DOI 10.1073/pnas.0700915104; Jayaprakasha GK, 2002, Z NATURFORSCH C, V57, P828; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; Jiang HL, 2006, PHYTOCHEMISTRY, V67, P1673, DOI 10.1016/j.phytochem.2005.08.001; Jianjun Q, 2008, THORAC CARDIOV SURG, V56, P103, DOI 10.1055/s-2007-965708; Jurenka JS, 2009, ALTERN MED REV, V14, P141; KISO Y, 1983, PHYTOCHEMISTRY, V22, P596, DOI 10.1016/0031-9422(83)83057-X; Kreiser W, 1999, HELV CHIM ACTA, V82, P1427, DOI 10.1002/(SICI)1522-2675(19990908)82:9<1427::AID-HLCA1427>3.0.CO;2-S; Kundu JK, 2009, FORUM NUTR, V61, P182, DOI 10.1159/000212750; Lee HS, 2006, BIORESOURCE TECHNOL, V97, P1372, DOI 10.1016/j.biortech.2005.07.006; Lee Y, 2009, BMB REP, V42, P96, DOI 10.5483/BMBRep.2009.42.2.096; Leong-Skornickova J, 2007, ANN BOT-LONDON, V100, P505, DOI 10.1093/aob/mcm144; Lopez P, 2005, J AGR FOOD CHEM, V53, P6939, DOI 10.1021/jf050709v; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Nakano C, 2011, J BIOL CHEM, P21; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Nigam N, 2009, CANCER CHEMOTH PHARM, V24, P24; Nishiyama T, 2005, J AGR FOOD CHEM, V53, P959, DOI 10.1021/jf0483873; Oswald M, 2007, FEMS YEAST RES, V7, P413, DOI 10.1111/j.1567-1364.2006.00172.x; Picaud S, 2006, ARCH BIOCHEM BIOPHYS, V452, P17, DOI 10.1016/j.abb.2006.06.007; Ponnamperuma K, 1996, ARCH BIOCHEM BIOPHYS, V329, P9, DOI 10.1006/abbi.1996.0185; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Shukla Y, 2007, FOOD CHEM TOXICOL, V45, P683, DOI 10.1016/j.fct.2006.11.002; Wang G, 2005, CELL MOL LIFE SCI, V62, P881, DOI 10.1007/s00018-005-5017-3; Wang GD, 2008, PLANT PHYSIOL, V148, P1254, DOI 10.1104/pp.108.125187; YAMAHARA J, 1992, YAKUGAKU ZASSHI, V112, P645, DOI 10.1248/yakushi1947.112.9_645; YAMAHARA J, 1988, J ETHNOPHARMACOL, V23, P299, DOI 10.1016/0378-8741(88)90009-8; Yu F, 2008, FEBS LETT, V582, P565, DOI 10.1016/j.febslet.2008.01.020; Yu FN, 2008, PLANTA, V227, P1291, DOI 10.1007/s00425-008-0700-x; Zhuang XF, 2012, PLANT J, V69, P70, DOI 10.1111/j.1365-313X.2011.04771.x	44	30	33	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51481	10.1371/journal.pone.0051481	http://dx.doi.org/10.1371/journal.pone.0051481			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272109	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300017
J	Naf, S; Escote, X; Yanez, RE; Ballesteros, M; Simon, I; Gil, P; Megia, A; Vendrell, J				Naef, Silvia; Escote, Xavier; Elena Yanez, Rosa; Ballesteros, Monica; Simon, Inmaculada; Gil, Pilar; Megia, Ana; Vendrell, Joan			Zinc-alpha 2-Glycoprotein Is Unrelated to Gestational Diabetes: Anthropometric and Metabolic Determinants in Pregnant Women and Their Offspring	PLOS ONE			English	Article							LIPID-MOBILIZING FACTOR; SERUM ZINC-ALPHA-2-GLYCOPROTEIN; ADIPONECTIN; ZINC-ALPHA(2)-GLYCOPROTEIN; ADIPOKINE; GLUCOSE; WEIGHT; FAT; ZAG	Context: Zinc-alpha 2-Glycoprotein (ZAG) is an adipokine with lipolytic action and is positively associated with adiponectin in adipose tissue. We hypothesize that ZAG may be related with hydrocarbonate metabolism disturbances observed in gestational diabetes mellitus (GDM). Objective: The aim of this study was to analyze serum ZAG concentration and its relationship with carbohydrate metabolism in pregnant women and its influence on fetal growth. Design: 207 pregnant women (130 with normal glucose tolerance (NGT) and 77 with GDM) recruited in the early third trimester and their offspring were studied. Cord blood was obtained at delivery and neonatal anthropometry was assessed in the first 48 hours. ZAG was determined in maternal serum and cord blood. Results: ZAG concentration was lower in cord blood than in maternal serum, but similar concentration was observed in NGT and GDM pregnant women. Also similar levels were found between offspring of NGT and GDM women. In the bivariate analysis, maternal ZAG (mZAG) was positively correlated with adiponectin and HDL cholesterol, and negatively correlated with insulin and triglyceride concentrations, and HOMA index. On the other hand, cord blood ZAG (cbZAG) was positively correlated with fat-free mass, birth weight and gestational age at delivery. After adjusting for confounding variables, gestational age at delivery and HDL cholesterol emerged as the sole determinants of cord blood ZAG and maternal ZAG concentrations, respectively. Conclusion: mZAG was not associated with glucose metabolism during pregnancy. ZAG concentration was lower in cord blood compared with maternal serum. cbZAG was independently correlated with gestational age at delivery, suggesting a role during the accelerated fetal growth during latter pregnancy.	[Naef, Silvia; Escote, Xavier; Elena Yanez, Rosa; Simon, Inmaculada; Gil, Pilar; Megia, Ana; Vendrell, Joan] Univ Rovira & Virgili, IISPV, Endocrinol & Diabet Unit, Hosp Univ Tarragona Joan 23, Tarragona, Spain; [Naef, Silvia; Escote, Xavier; Elena Yanez, Rosa; Simon, Inmaculada; Gil, Pilar; Megia, Ana; Vendrell, Joan] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Ballesteros, Monica] Univ Rovira & Virgili, Obstet & Gynecol Serv, IISPV, Hosp Univ Tarragona Joan 23, Tarragona, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Naf, S (corresponding author), Univ Rovira & Virgili, IISPV, Endocrinol & Diabet Unit, Hosp Univ Tarragona Joan 23, Tarragona, Spain.	snafco@hotmail.com	Vendrell, Joan j/V-4034-2018; Escote, Xavier/AAC-6335-2019; Escote, Xavier/G-3440-2015; Escoté, Xavier/AAH-2973-2020; Gil, Pilar Rivera/W-6910-2019; Megia, Ana/W-5556-2019	Vendrell, Joan j/0000-0002-6994-6115; Escote, Xavier/0000-0003-1172-3995; Escote, Xavier/0000-0003-1172-3995; Gil, Pilar Rivera/0000-0002-6587-7538; Megia, Ana/0000-0002-5101-9452	Universitat Rovira I Virgili [Exp.2010 FIB01004]; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBERDEM is an initiative of the Instituto de Salud Carlos III [CB07708/0012]	Universitat Rovira I Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBERDEM is an initiative of the Instituto de Salud Carlos III	REY is supported by a fellowship Ajut predoctoral per a la contractacio de personal investigador novell (Exp.2010 FIB01004) from Universitat Rovira I Virgili. AM is grateful to the Institut d'Investigacio Sanitaria Pere Virgili (IISPV) for the 2010 grant: "Programa d'ajuts per el desenvolupament de la recerca". CIBERDEM is an initiative of the Instituto de Salud Carlos III (CB07708/0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Ballesteros M, 2011, DIABETES CARE, V34, P2418, DOI 10.2337/dc11-0788; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Catalano PM, 1999, AM J OBSTET GYNECOL, V180, P903, DOI 10.1016/S0002-9378(99)70662-9; Ceperuelo-Mallafre V, 2009, J CLIN ENDOCR METAB, V94, P5062, DOI 10.1210/jc.2009-0764; DAUNCEY MJ, 1977, ARCH DIS CHILD, V52, P223, DOI 10.1136/adc.52.3.223; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Gong FY, 2009, INT J OBESITY, V33, P1023, DOI 10.1038/ijo.2009.141; HARRIS M, 1979, DIABETES, V28, P1039; Hirai K, 1998, CANCER RES, V58, P2359; Marrades MP, 2008, J PHYSIOL BIOCHEM, V64, P61, DOI 10.1007/BF03168235; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazaki-Tovi S, 2009, J PERINAT MED, V37, P637, DOI 10.1515/JPM.2009.101; Mracek T, 2010, CLIN ENDOCRINOL, V72, P334, DOI 10.1111/j.1365-2265.2009.03658.x; Ortega-Senovilla H, 2011, DIABETES CARE, V34, P2061, DOI 10.2337/dc11-0715; Retnakaran R, 2007, DIABETIC MED, V24, P245, DOI 10.1111/j.1464-5491.2007.02077.x; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj.bjc.6600086; Russell ST, 2010, ENDOCRINOLOGY, V151, P948, DOI 10.1210/en.2009-0827; Selva DM, 2009, J CLIN ENDOCR METAB, V94, P4499, DOI 10.1210/jc.2009-0758; Sociedad espanola de ginecologia y obstetricia, 2006, AV DIABETOL, V22, P73; Stejskal D, 2008, CLIN BIOCHEM, V41, P313, DOI 10.1016/j.clinbiochem.2007.11.010; Stepan H, 2012, J ENDOCRINOL INVEST, V35, P562, DOI 10.3275/7877; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; Tsangaris GT, 2006, IN VIVO, V20, P479; Yeung DCY, 2009, J CLIN ENDOCR METAB, V94, P2531, DOI 10.1210/jc.2009-0058; Yilmaz Y, 2011, CLIN CHEM LAB MED, V49, P93, DOI 10.1515/CCLM.2011.022	28	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e47601	10.1371/journal.pone.0047601	http://dx.doi.org/10.1371/journal.pone.0047601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272038	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300002
J	Yamazaki, S; Maruyama, A; Okada, K; Matsumoto, M; Morita, A; Seya, T				Yamazaki, Sayuri; Maruyama, Akira; Okada, Kohei; Matsumoto, Misako; Morita, Akimichi; Seya, Tsukasa			Dendritic Cells from Oral Cavity Induce Foxp3(+) Regulatory T Cells upon Antigen Stimulation	PLOS ONE			English	Article							RETINOIC-ACID; LANGERHANS CELLS; TGF-BETA; RECEPTOR; DIFFERENTIATION; HOMEOSTASIS; ACTIVATION; MICROBIOTA; TOLERANCE; EXPANSION	Evidence is accumulating that dendritic cells (DCs) from the intestines have the capacity to induce Foxp3(+) CD4(+) regulatory T cells (T-regs) and regulate immunity versus tolerance in the intestines. However, the contribution of DCs to controlling immunity versus tolerance in the oral cavity has not been addressed. Here, we report that DCs from the oral cavity induce Foxp3(+) T-regs as well as DCs from intestine. We found that oral-cavity-draining cervical lymph nodes contained higher frequencies of Foxp3(+) T-regs and ROR-gamma t(+) CD4(+) T cells than other lymph nodes. The high frequency of Foxp3(+) T-regs in the oral-cavity-draining cervical lymph nodes was not dependent on the Toll like receptor (TLR) adaptor molecules, Myd88 and TICAM-1 (TRIF). In contrast, the high frequency of ROR-gamma t(+) CD4(+) T cells relies on Myd88 and TICAM-1. In vitro data showed that CD11c(+) DCs from oral-cavity-draining cervical lymph nodes have the capacity to induce Foxp3(+) T-regs in the presence of antigen. These data suggest that, as well as in the intestinal environment, antigen-presenting DCs may play a vital role in maintaining tolerance by inducing Foxp3(+) T-regs in the oral cavity.	[Yamazaki, Sayuri; Maruyama, Akira; Okada, Kohei; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Yamazaki, Sayuri; Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan	Hokkaido University; Nagoya City University	Yamazaki, S (corresponding author), Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Sapporo, Hokkaido, Japan.	yamazas@med.nagoya-cu.ac.jp; seya-tu@pop.med.hokudai.ac.jp	Seya, Tsukasa/A-4336-2012		Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; MEXT; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Grants-in-Aid for Scientific Research [24659214] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a Grant-in-Aid for challenging Exploratory Research (SY) and a Grant-in-Aid for Scientific Research B (SY) from Japan Society for the Promotion of Science, the Mochida Memorial Foundation for Medical and Pharmaceutical Research (SY) and Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research) and the Ministry of Health, Labor, and Welfare of Japan. Specified financial supports by a MEXT Grant-in-Project 'the Carcinogenic Spiral' and the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) are gratefully acknowledged. These funding bodies had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript.	Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Azukizawa H, 2011, EUR J IMMUNOL, V41, P1420, DOI 10.1002/eji.201040930; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; de Aguero MG, 2012, J CLIN INVEST, V122, P1700, DOI 10.1172/JCI59725; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; Hand T, 2010, CURR OPIN IMMUNOL, V22, P63, DOI 10.1016/j.coi.2010.01.008; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Lieberman SM, 2012, EUR J IMMUNOL, V42, P1429, DOI 10.1002/eji.201142286; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Naik S, 2012, SCIENCE; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Onodera T, 2009, J IMMUNOL, V183, P5608, DOI 10.4049/jimmunol.0804116; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Yamazaki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018833; Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075	48	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51665	10.1371/journal.pone.0051665	http://dx.doi.org/10.1371/journal.pone.0051665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272135	Green Published, gold			2022-12-27	WOS:000312483300021
J	Choi, JS; Baek, HM; Kim, S; Kim, MJ; Youk, JH; Moon, HJ; Kim, EK; Han, KH; Kim, DH; Kim, SI; Koo, JS				Choi, Ji Soo; Baek, Hyeon-Man; Kim, Suhkmann; Kim, Min Jung; Youk, Ji Hyun; Moon, Hee Jung; Kim, Eun-Kyung; Han, Kyung Hwa; Kim, Dong-Hyun; Kim, Seung Il; Koo, Ja Seung			HR-MAS MR Spectroscopy of Breast Cancer Tissue Obtained with Core Needle Biopsy: Correlation with Prognostic Factors	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CHOLINE KINASE-ACTIVITY; NEOADJUVANT CHEMOTHERAPY; NMR-SPECTROSCOPY; LESIONS; METABOLISM; DIAGNOSIS; WOMEN; MAMMOGRAPHY; MARKERS	The purpose of this study was to examine the correlation between high-resolution magic angle spinning (HR-MAS) magnetic resonance (MR) spectroscopy using core needle biopsy (CNB) specimens and histologic prognostic factors currently used in breast cancer patients. After institutional review board approval and informed consent were obtained for this study, CNB specimens were collected from 36 malignant lesions in 34 patients. Concentrations and metabolic ratios of various choline metabolites were estimated by HR-MAS MR spectroscopy using CNB specimens. HR-MAS spectroscopic values were compared according to histopathologic variables [tumor size, lymph node metastasis, histologic grade, status of estrogens receptor (ER), progesterone receptor (PR), HER2 (a receptor for human epidermal growth factor), and Ki-67, and triple negativity]. Multivariate analysis was performed with Orthogonal Projections to Latent Structure-Discriminant Analysis (OPLS-DA). HR-MAS MR spectroscopy quantified and discriminated choline metabolites in all CNB specimens of the 36 breast cancers. Several metabolite markers [free choline (Cho), phosphocholine (PC), creatine (Cr), taurine, myo-inositol, scyllo-inositol, total choline (tCho), glycine, Cho/Cr, tCho/Cr, PC/Cr] on HR-MAS MR spectroscopy were found to correlate with histologic prognostic factors [ER, PR, HER2, histologic grade, triple negativity, Ki-67, poor prognosis]. OPLS-DA multivariate models were generally able to discriminate the status of histologic prognostic factors (ER, PR, HER2, Ki-67) and prognosis groups. Our study suggests that HR-MAS MR spectroscopy using CNB specimens can predict tumor aggressiveness prior to surgery in breast cancer patients. In addition, it may be helpful in the detection of reliable markers for breast cancer characterization.	[Choi, Ji Soo; Kim, Min Jung; Youk, Ji Hyun; Moon, Hee Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea; [Choi, Ji Soo] Natl Canc Ctr, Dept Radiol, Goyang Si, Gyeonggi Do, South Korea; [Baek, Hyeon-Man] Korea Basic Sci Inst, Div Magnet Resonance, Taejon, South Korea; [Kim, Suhkmann] Pusan Natl Univ, Chem Inst Funct Mat, Pusan, South Korea; [Kim, Suhkmann] Pusan Natl Univ, Dept Chem, Pusan, South Korea; [Han, Kyung Hwa] Yonsei Univ, Coll Med, Dept Res Affair, Seoul, South Korea; [Kim, Dong-Hyun] Yonsei Univ, Coll Elect & Elect Engn, Seoul 120749, South Korea; [Kim, Seung Il] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Koo, Ja Seung] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); Korea Basic Science Institute (KBSI); Pusan National University; Pusan National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017; Kim, Dong-Hyun/G-5096-2012	Kim, Eun-Kyung/0000-0002-3368-5013; koo, ja seung/0000-0003-4546-4709; Han, Kyunghwa/0000-0002-5687-7237; Moon, Hee Jung/0000-0002-5643-5885	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [A110700]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (A110700). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; American Cancer Society Inc, 2011, BREAST CANC FACTS FI; Bassett LW, 2007, RADIOL CLIN N AM, V45, P881, DOI 10.1016/j.rcl.2007.06.010; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Beckonert O, 2003, NMR BIOMED, V16, P1, DOI 10.1002/nbm.797; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2007, RADIOL CLIN N AM, V45, P895, DOI 10.1016/j.rcl.2007.06.001; Birdsall T C, 1998, Altern Med Rev, V3, P128; Bolan PJ, 2003, MAGNET RESON MED, V50, P1134, DOI 10.1002/mrm.10654; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Bruening W, 2010, ANN INTERN MED, V152, P238, DOI 10.7326/0003-4819-152-1-201001050-00190; Cao MD, 2012, NMR BIOMED, V25, P369, DOI 10.1002/nbm.1762; Cecil KM, 2001, BREAST CANCER RES TR, V68, P45, DOI 10.1023/A:1017911211090; Chen JH, 2011, NMR BIOMED, V24, P316, DOI 10.1002/nbm.1595; Cheng LL, 1998, CANCER RES, V58, P1825; Cheng LL, 1998, J MAGN RESON, V135, P194, DOI 10.1006/jmre.1998.1578; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Dorrius MD, 2011, RADIOLOGY, V259, P695, DOI 10.1148/radiol.11101855; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Giskeodegard GF, 2010, J PROTEOME RES, V9, P972, DOI 10.1021/pr9008783; Glunde K, 2006, EXPERT REV MOL DIAGN, V6, P821, DOI 10.1586/14737159.6.6.821; GREEN TR, 1991, BIOCHIM BIOPHYS ACTA, V1073, P91, DOI 10.1016/0304-4165(91)90187-L; GRIBBESTAD IS, 1993, ANTICANCER RES, V13, P1973; Gribbestad IS, 1999, ANTICANCER RES, V19, P1737; Gruber S, 2011, RADIOLOGY, V261, P752, DOI 10.1148/radiol.11102096; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Katz-Brull R, 2002, CANCER RES, V62, P1966; Koo JS, 2009, J KOREAN MED SCI, V24, P1150, DOI 10.3346/jkms.2009.24.6.1150; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Le-Petross HT, 2011, CANCER-AM CANCER SOC, V117, P3900, DOI 10.1002/cncr.25971; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025563; Moran J, 2000, PFLUG ARCH EUR J PHY, V439, P271, DOI 10.1007/s004240050940; Mountford CE, 2001, BRIT J SURG, V88, P1234, DOI 10.1046/j.0007-1323.2001.01864.x; Nakagami K, 1999, JPN J CANCER RES, V90, P1212, DOI 10.1111/j.1349-7006.1999.tb00698.x; Natarajan K, 2000, ADV ENZYME REGUL, V40, P271, DOI 10.1016/S0065-2571(99)00026-6; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Roebuck JR, 1998, RADIOLOGY, V209, P269, DOI 10.1148/radiology.209.1.9769842; Sands CJ, 2009, ANAL CHEM, V81, P6458, DOI 10.1021/ac900828p; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shin HJ, 2012, AM J ROENTGENOL, V198, pW488, DOI 10.2214/AJR.11.7292; SINGER S, 1995, CANCER RES, V55, P5140; Sitter B, 2002, NMR BIOMED, V15, P327, DOI 10.1002/nbm.775; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Sitter B, 2010, NMR BIOMED, V23, P424, DOI 10.1002/nbm.1478; Taylor JL, 2003, MAGNET RESON MED, V50, P627, DOI 10.1002/mrm.10562; Tozaki M, 2010, J MAGN RESON IMAGING, V31, P895, DOI 10.1002/jmri.22118; Wen H, 2010, J HEPATOL, V52, P228, DOI 10.1016/j.jhep.2009.11.002	49	31	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51712	10.1371/journal.pone.0051712	http://dx.doi.org/10.1371/journal.pone.0051712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272149	Green Published, gold			2022-12-27	WOS:000312386800070
J	Park, HY; Jun, CD; Jeon, SJ; Choi, SS; Kim, HR; Choi, DB; Kwak, S; Lee, HS; Cheong, JS; So, HS; Lee, YJ; Park, DS				Park, Hyun Young; Jun, Chang-Duk; Jeon, Se-Jeong; Choi, See-Sung; Kim, Hak-Ryul; Choi, Dan-Bee; Kwak, Seongae; Lee, Hak-Seung; Cheong, Jin Sung; So, Hong-Seob; Lee, Young-Jin; Park, Do-Sim			Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EXPRESSION; ATHEROSCLEROSIS; INFLAMMATION; MACROPHAGES; POPULATION; BIOMARKER; DISEASE; INJURY	Background and Purpose: YKL-40 is associated with various neurological disorders. However, circulatory YKL-40 levels early after onset of acute ischemic stroke (AIS) have not been systematically assessed. We aimed to identify the temporal changes and clinical usefulness of measuring serum YKL-40 immediately following AIS. Methods: Serum YKL-40 and C-reactive protein (CRP) levels were monitored over time in AIS patients (n = 105) and compared with those of stroke-free controls (n = 34). Infarct volume and stroke severity (National Institutes of Health Stroke Scale; NIHSS) were measured within 48 hours of symptom onset, and functional outcome (modified Rankin Scale; mRS) was measured 3 months after AIS. Results: Within 12 hours of symptom onset, levels of YKL-40 (251 vs. 41 ng/mL) and CRP (1.50 vs. 0.96 mu g/mL) were elevated in AIS patients compared to controls. The power of YKL-40 for discriminating AIS patients from controls was superior to that of CRP (area under the curve 0.84 vs. 0.64) and YKL-40 (r = 0.26, P<0.001) but not CRP levels were correlated with mRS. On day 2 of admission (D2), YKL-40 levels correlated with infarct volume and NIHSS. High YKL-40 levels predicted poor functional outcome (odds ratio 5.73, P = 0.03). YKL-40 levels peaked on D2 and declined on D3, whereas CRP levels were highest on D3. Conclusions: Our results demonstrate serial changes in serum YKL-40 levels immediately following AIS and provide the first evidence that it is a valid indicator of AIS extent and an early predictor of functional outcome.	[Choi, Dan-Bee; Kwak, Seongae; Lee, Young-Jin; Park, Do-Sim] Wonkwang Univ, Sch Med, Dept Lab Med, Iksan, South Korea; [Park, Hyun Young; Lee, Hak-Seung] Wonkwang Univ, Sch Med, Dept Neurol, Iksan, South Korea; [Jun, Chang-Duk] GIST, Sch Life Sci, Kwangju, South Korea; [Jeon, Se-Jeong; Choi, See-Sung; Cheong, Jin Sung] Wonkwang Univ, Sch Med, Dept Radiol, Iksan, South Korea; [Kim, Hak-Ryul] Wonkwang Univ, Sch Med, Dept Internal Med, Iksan, South Korea; [So, Hong-Seob] Wonkwang Univ, Sch Med, Dept Microbiol, Iksan, South Korea; [So, Hong-Seob; Park, Do-Sim] Wonkwang Univ, Inst Wonkwang Clin Med, Sch Med, Iksan, South Korea; [So, Hong-Seob; Park, Do-Sim] Wonkwang Univ, Inst Wonkwang Med Sci, Ctr Metab Funct Regulat, Iksan, South Korea	Wonkwang University; Wonkwang University; Gwangju Institute of Science & Technology (GIST); Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University	Park, DS (corresponding author), Wonkwang Univ, Sch Med, Dept Lab Med, Iksan, South Korea.	emailds@hanmail.net	Park, Do-Sim/B-6594-2013; Park, Do-Sim/P-1529-2019; Park, Do-Sim/CAF-2588-2022	Park, Do-Sim/0000-0002-6001-4223; Park, Do-Sim/0000-0002-6001-4223; 	National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0030718]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0030718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bonneh-Barkay D, 2012, BRAIN PATHOL, V22, P530, DOI 10.1111/j.1750-3639.2011.00550.x; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Coull BM, 2007, STROKE, V38, P631, DOI 10.1161/01.STR.0000255945.89287.23; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; den Hertog HM, 2009, J NEUROL, V256, P2003, DOI 10.1007/s00415-009-5228-x; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Idicula TT, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-18; Kastrup J, 2012, IMMUNOBIOLOGY, V217, P483, DOI 10.1016/j.imbio.2011.04.007; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Michelsen AE, 2010, ATHEROSCLEROSIS, V211, P589, DOI 10.1016/j.atherosclerosis.2010.02.035; Ormstad H, 2011, J NEUROL, V258, P677, DOI 10.1007/s00415-011-6006-0; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Song IU, 2009, CEREBROVASC DIS, V28, P545, DOI 10.1159/000247597; van Everdingen KJ, 1998, STROKE, V29, P1783, DOI 10.1161/01.STR.29.9.1783; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Waje-Andreassen U, 2005, ACTA NEUROL SCAND, V111, P360, DOI 10.1111/j.1600-0404.2005.00416.x; Winbeck K, 2002, STROKE, V33, P2459, DOI 10.1161/01.STR.0000029828.51413.82; Youn CS, 2012, AM J EMERG MED, V30, P124, DOI 10.1016/j.ajem.2010.11.006	23	11	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51722	10.1371/journal.pone.0051722	http://dx.doi.org/10.1371/journal.pone.0051722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272150	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800071
J	Rogers, EE; Stenger, DC				Rogers, Elizabeth E.; Stenger, Drake C.			A Conjugative 38 kB Plasmid Is Present in Multiple Subspecies of Xylella fastidiosa	PLOS ONE			English	Article							LEAF SCORCH DISEASE; PIERCES-DISEASE; GENOME SEQUENCES; IV SECRETION; STRAINS; RECOMBINATION; DIVERSITY; BACTERIUM; CALIFORNIA; SYSTEMS	A similar to 38kB plasmid (pXF-RIV5) was present in the Riv5 strain of Xylella fastidiosa subsp. multiplex isolated from ornamental plum in southern California. The complete nucleotide sequence of pXF-RIV5 is almost identical to that of pXFAS01 from X. fastidiosa subsp. fastidiosa strain M23; the two plasmids vary at only 6 nucleotide positions. BLAST searches and phylogenetic analyses indicate pXF-RIV5 and pXFAS01 share some similarity to chromosomal and plasmid (pXF51) sequences of X. fastidiosa subsp. pauca strain 9a5c and more distant similarity to plasmids from a wide variety of bacteria. Both pXF-RIV5 and pXFAS01 encode homologues of a complete Type IV secretion system involved in conjugation and DNA transfer among bacteria. Mating pair formation proteins (Trb) from Yersinia pseudotuberculosis IP31758 are the mostly closely related non-X. fastidiosa proteins to most of the Trb proteins encoded by pXF-RIV5 and pXFAS01. Unlike many bacterial conjugative plasmids, pXF-RIV5 and pXFAS01 do not carry homologues of known accessory modules that confer selective advantage on host bacteria. However, both plasmids encode seven hypothetical proteins of unknown function and possess a small transposon-associated region encoding a putative transposase and associated factor. Vegetative replication of pXF-RIV5 and pXFAS01 appears to be under control of RepA protein and both plasmids have an origin of DNA replication (oriV) similar to that of pRP4 and pR751 from Escherichia coli. In contrast, conjugative plasmids commonly encode TrfA and have an oriV similar to those found in IncP-1 incompatibility group plasmids. The presence of nearly identical plasmids in single strains from two distinct subspecies of X. fastidiosa is indicative of recent horizontal transfer, probably subsequent to the introduction of subspecies fastidiosa to the United States in the late 19th century.	[Rogers, Elizabeth E.; Stenger, Drake C.] USDA, ARS, Parlier, CA USA	United States Department of Agriculture (USDA)	Rogers, EE (corresponding author), USDA, ARS, Parlier, CA USA.	elizabeth.rogers@ars.usda.gov	Rogers, Elizabeth/AAB-3643-2021; Rogers, Elizabeth E/D-2087-2009	Rogers, Elizabeth/0000-0002-0545-4744; Rogers, Elizabeth E/0000-0002-0545-4744	United States Department of Agriculture [5302-22000-008-00D]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was supported by United States Department of Agriculture Appropriated Project 5302-22000-008-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2008, APPL ENVIRON MICROB, V74, P3690, DOI 10.1128/AEM.02388-07; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Chen J, 2005, PHYTOPATHOLOGY, V95, P708, DOI 10.1094/PHYTO-95-0708; Chen J, 2010, J BACTERIOL, V192, P4534, DOI 10.1128/JB.00651-10; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Guilhabert MR, 2006, PLASMID, V55, P70, DOI 10.1016/j.plasmid.2005.06.004; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Klockgether J, 2004, J BACTERIOL, V186, P518, DOI 10.1128/JB.186.2.518-534.2004; Kung SH, 2011, APPL ENVIRON MICROB, V77, P5278, DOI 10.1128/AEM.00730-11; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marques MV, 2001, PLASMID, V45, P184, DOI 10.1006/plas.2000.1514; Melanson RA, 2012, PLANT DIS, V96, P1123, DOI 10.1094/PDIS-09-11-0730-RE; Nunney L, 2012, PHYTOPATHOLOGY, V102, P456, DOI 10.1094/PHYTO-10-11-0298; Nunney L, 2011, PHYTOPATHOLOGY, V101, pS130; Nunney L, 2012, APPL ENVIRON MICROB, V78, P4702, DOI 10.1128/AEM.01126-12; Nunney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015488; PANSEGRAU W, 1988, BIOCHIM BIOPHYS ACTA, V951, P365, DOI 10.1016/0167-4781(88)90108-X; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Stenger DC, 2011, APPL ENVIRON MICROB, V77, P2522, DOI 10.1128/AEM.02789-10; Stenger DC, 2010, PHYSIOL MOL PLANT P, V74, P238, DOI 10.1016/j.pmpp.2010.03.003; Van der Auwera GA, 2009, ANTON LEEUW INT J G, V96, P193, DOI 10.1007/s10482-009-9316-9; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601; Zhang S, 2011, J BACTERIOL, V193, P5576, DOI 10.1128/JB.05430-11	29	17	17	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52131	10.1371/journal.pone.0052131	http://dx.doi.org/10.1371/journal.pone.0052131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251694	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800146
J	Sommer, CA; Christodoulou, C; Gianotti-Sommer, A; Shen, SS; Sailaja, BS; Hezroni, H; Spira, A; Meshorer, E; Kotton, DN; Mostoslavsky, G				Sommer, Cesar A.; Christodoulou, Constantina; Gianotti-Sommer, Andreia; Shen, Steven S.; Sailaja, Badi Sri; Hezroni, Hadas; Spira, Avrum; Meshorer, Eran; Kotton, Darrell N.; Mostoslavsky, Gustavo			Residual Expression of Reprogramming Factors Affects the Transcriptional Program and Epigenetic Signatures of Induced Pluripotent Stem Cells	PLOS ONE			English	Article							C-MYC; IPS CELLS; GENERATION; MOUSE; DIFFERENTIATION; ACTIVATION; INDUCTION; COMPLEX; ES	Delivery of the transcription factors Oct4, Klf4, Sox2 and c-Myc via integrating viral vectors has been widely employed to generate induced pluripotent stem cell (iPSC) lines from both normal and disease-specific somatic tissues, providing an invaluable resource for medical research and drug development. Residual reprogramming transgene expression from integrated viruses nevertheless alters the biological properties of iPSCs and has been associated with a reduced developmental competence both in vivo and in vitro. We performed transcriptional profiling of mouse iPSC lines before and after excision of a polycistronic lentiviral reprogramming vector to systematically define the overall impact of persistent transgene expression on the molecular features of iPSCs. We demonstrate that residual expression of the Yamanaka factors prevents iPSCs from acquiring the transcriptional program exhibited by embryonic stem cells (ESCs) and that the expression profiles of iPSCs generated with and without c-Myc are indistinguishable. After vector excision, we find 36% of iPSC clones show normal methylation of the Gtl2 region, an imprinted locus that marks ESC-equivalent iPSC lines. Furthermore, we show that the reprogramming factor Klf4 binds to the promoter region of Gtl2. Regardless of Gtl2 methylation status, we find similar endodermal and hepatocyte differentiation potential comparing syngeneic Gtl2(ON) vs Gtl2(OFF) iPSC clones. Our findings provide new insights into the reprogramming process and emphasize the importance of generating iPSCs free of any residual transgene expression.	[Christodoulou, Constantina; Kotton, Darrell N.] Boston Univ, Ctr Pulm, Boston, MA 02215 USA; [Sommer, Cesar A.; Gianotti-Sommer, Andreia; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Med, Gastroenterol Sect, Boston, MA 02118 USA; [Shen, Steven S.; Spira, Avrum] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02118 USA; [Sailaja, Badi Sri; Hezroni, Hadas; Meshorer, Eran] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Kotton, Darrell N.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Hebrew University of Jerusalem; Boston University	Kotton, DN (corresponding author), Boston Univ, Ctr Pulm, Boston, MA 02215 USA.	dkotton@bu.edu; gmostosl@bu.edu	Sommer, Cesar A/H-9187-2013	Kotton, Darrell/0000-0002-9604-8476; Mostoslavsky, Gustavo/0000-0002-0784-2169; Spira, Avrum/0000-0003-1467-0489; Meshorer, Eran/0000-0003-4777-986X; Sailaja, Badi Sri/0000-0003-4488-738X; Christodoulou, Constantina/0000-0001-5371-2210	NIH [PO1 HL047049-16A1, 1RC2HL101535-01, 1R01 HL095993-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101535, P01HL047049, R01HL095993] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	GM and DNK are supported by NIH PO1 HL047049-16A1, 1RC2HL101535-01, and 1R01 HL095993-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Christodoulou C, 2011, J CLIN INVEST, V121, P2313, DOI 10.1172/JCI43853; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; Hezroni H, 2011, J BIOL CHEM; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Martinez-Fernandez A, 2010, J CARDIOVASC TRANSL, V3, P13, DOI 10.1007/s12265-009-9150-5; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sommer CA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt26; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Unternaehrer JJ, 2011, PHILOS T R SOC B, V366, P2274, DOI 10.1098/rstb.2011.0017; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	52	35	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51711	10.1371/journal.pone.0051711	http://dx.doi.org/10.1371/journal.pone.0051711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272148	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800069
J	Tsuda, K; Yamanaka, K; Kondo, M; Matsubara, K; Sasaki, R; Tomimoto, H; Gabazza, EC; Mizutani, H				Tsuda, Kenshiro; Yamanaka, Keiichi; Kondo, Makoto; Matsubara, Kimiko; Sasaki, Ryogen; Tomimoto, Hidekazu; Gabazza, Esteban C.; Mizutani, Hitoshi			Ustekinumab Improves Psoriasis without Altering T Cell Cytokine Production, Differentiation, and T Cell Receptor Repertoire Diversity	PLOS ONE			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; LONG-TERM EFFICACY; CONTROLLED-TRIAL; DOUBLE-BLIND; PHASE-III; MODERATE; SAFETY; ETANERCEPT; THERAPY; INDUCTION	Ustekinumab is a fully human IgG1 kappa monoclonal antibody targeting interleukin (IL)-12/23 p40 subunit. The role of IL-12/23-mediated pathway in the mechanism of various inflammatory disorders especially psoriasis has been well recognized. Recently the long-term efficacy and safety of ustekinumab in patients with moderate-to-severe psoriasis has been evaluated in phase 2/3 clinical trials, and the results showed no significant risk for serious adverse effects, infections, or malignancies. Ustekinumab inhibits the function of the IL-12/23 p40 subunit, and therefore it is believed that inhibition of IL-12 p40 pathway decreases IFN-gamma production. The major concern for the use of ustekinumab is the possibility of increased immunosuppression due to low IFN-gamma production. However, the effects of ustekinumab on CD4(+) T cell function have not been fully investigated so far. In this study, we explored changes in cytokine production by memory CD4(+) T cells as well as in the differentiation of naive T cells to helper T cell (Th) 1, Th2, or Th17 cells in psoriasis patients treated with ustekinumab. The effect of the treatment on T cell receptor repertoire diversity was also evaluated. The results showed that ustekinumab improves clinical manifestation in patients with psoriasis without affecting cytokine production in memory T cells, T cell maturation, or T cell receptor repertoire diversity. Although the number of patients is limited, the present study suggests that T cell immune response remains unaffected in psoriasis patients treated with ustekinumab. Citation: Tsuda K, Yamanaka K, Kondo M, Matsubara K, Sasaki R, et al. (2012) Ustekinumab Improves Psoriasis without Altering T Cell Cytokine Production, Differentiation, and T Cell Receptor Repertoire Diversity. PLoS ONE 7(12): e51819. doi:10.1371/journal.pone.0051819	[Tsuda, Kenshiro; Yamanaka, Keiichi; Kondo, Makoto; Matsubara, Kimiko; Mizutani, Hitoshi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan; [Sasaki, Ryogen; Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 514, Japan; [Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University	Yamanaka, K (corresponding author), Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan.	yamake@clin.medic.mie-u.ac.jp		Gabazza, Esteban/0000-0001-5748-1499; Kondo, Makoto/0000-0003-1560-6067	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591643, 24591647]; Grants-in-Aid for Scientific Research [23591643] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	K. Yamanaka (23591643) and H. Mizutani (24591647) receive grants for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Other authors do not receive any financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, J RHEUMATOL, V36, P914, DOI 10.3899/jrheum.081041; Alwawi EA, 2009, DERMATOL THER, V22, P431, DOI 10.1111/j.1529-8019.2009.01259.x; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Gordon KB, 2012, J AM ACAD DERMATOL, V66, P742, DOI 10.1016/j.jaad.2011.06.041; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hata H, 2004, INT IMMUNOL, V16, P1733, DOI 10.1093/intimm/dxh174; Igarashi A, 2012, J DERMATOL, V39, P242, DOI 10.1111/j.1346-8138.2011.01347.x; Kimball AB, 2012, BRIT J DERMATOL, V166, P861, DOI [10.1111/j.1365-2133.2011.10901.x, 10.1111/j.1365-2133.2012.10901.x]; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lebwohl M, 2012, J AM ACAD DERMATOL, V66, P731, DOI 10.1016/j.jaad.2011.06.011; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Naldi L, 2005, BRIT J DERMATOL, V152, P597, DOI 10.1111/j.1365-2133.2005.06563.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nijsten T, 2005, J AM ACAD DERMATOL, V52, P434, DOI 10.1016/j.jaad.2004.10.862; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; STERN RS, 1995, J AM ACAD DERMATOL, V33, P44, DOI 10.1016/0190-9622(95)90008-X; Thaci D, 2008, BRIT J DERMATOL, V159, P18, DOI 10.1111/j.1365-2133.2008.08781.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Tsuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031465; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamanaka K, 2010, ARCH DERMATOL RES, V302, P453, DOI 10.1007/s00403-009-1023-x; Yawalkar N, 2003, BLOOD, V102, P4059, DOI 10.1182/blood-2003-04-1044	30	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51819	10.1371/journal.pone.0051819	http://dx.doi.org/10.1371/journal.pone.0051819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251632	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800091
J	Tumbarello, M; Trecarichi, EM; Caira, M; Candoni, A; Pastore, D; Cattaneo, C; Fanci, R; Nosari, A; Spadea, A; Busca, A; Vianelli, N; Spanu, T; Pagano, L				Tumbarello, Mario; Trecarichi, Enrico Maria; Caira, Morena; Candoni, Anna; Pastore, Domenico; Cattaneo, Chiara; Fanci, Rosa; Nosari, Annamaria; Spadea, Antonio; Busca, Alessandro; Vianelli, Nicola; Spanu, Teresa; Pagano, Livio		He MABIS Hematological	Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ACUTE PHYSIOLOGY; ESCHERICHIA-COLI; BONE-MARROW; CARE; TRANSPLANT; OUTCOMES; SEPSIS; TRENDS	Background: The aim of this study was to develop and validate a reliable clinical prediction rule that could be employed to identify patients at higher likelihood of mortality among those with hematological malignancies (HMs) and bacterial bloodstream infections (BBSIs). Methods and Findings: We conducted a retrospective cohort study in nine Italian hematological units. The derivation cohort consisted of adult patients with BBSI and HMs admitted to the Catholic University Hospital (Rome) between January 2002 and December 2008. Survivors and nonsurvivors were compared to identify predictors of 30-day mortality. The validation cohort consisted of patients hospitalized with BBSI and HMs who were admitted in 8 other Italian hematological units between January 2009 and December 2010. The inclusion and exclusion criteria were identical for both cohorts, with type and stage of HMs used as matching criteria. In the derivation set (247 episodes), the multivariate analysis yielded the following significant mortality-related risk factors acute renal failure (Odds Ratio [OR] 6.44, Confidential Interval [CI], 2.36-17.57, P < 0.001); severe neutropenia (absolute neutrophil count <100/mm(3)) (OR 4.38, CI, 2.04-9.43, P < 0.001); nosocomial infection (OR, 3.73, CI, 1.36-10.22, P = 0.01); age >= 65 years (OR, 3.42, CI, 1.49-7.80, P = 0.003); and Charlson Comorbidity Index >= 4 (OR, 3.01, CI 1.36-6.65, P = 0.006). The variables unable to be evaluated at that time (for example, prolonged neutropenia) were not included in the final logistic model. The equal-weight risk score model, which assigned 1 point to each risk factor, yielded good-excellent discrimination in both cohorts, with areas under the receiver operating curve of 0.83 versus 0.93 (derivation versus validation) and good calibration (Hosmer-Lemshow P = 0.16 versus 0.75). Conclusions: The risk index accurately identifies patients with HMs and BBSIs at high risk for mortality; a better initial predictive approach may yield better therapeutic decisions for these patients, with an eventual reduction in mortality. Citation: Tumbarello M, Trecarichi EM, Caira M, Candoni A, Pastore D, et al. (2012) Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality. PLoS ONE 7(12): e51612. doi:10.1371/journal.pone.0051612	[Tumbarello, Mario; Trecarichi, Enrico Maria] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, Rome, Italy; [Caira, Morena; Pagano, Livio] Univ Cattolica Sacro Cuore, Ist Ematol, Rome, Italy; [Candoni, Anna] Univ Udine, Clin Ematol, I-33100 Udine, Italy; [Pastore, Domenico] Univ Bari, Div Ematol, Bari, Italy; [Cattaneo, Chiara] Spedali Civil Brescia, UO Ematol, I-25125 Brescia, Italy; [Fanci, Rosa] Azienda Osped Univ Careggi, Unita Operat Ematol, Florence, Italy; [Nosari, Annamaria] Osped Niguarda Ca Granda, Div Ematol, Milan, Italy; [Nosari, Annamaria] Osped Niguarda Ca Granda, Ctr Trapianti Midollo, Milan, Italy; [Spadea, Antonio] Ist Regina Elena, I-00161 Rome, Italy; [Busca, Alessandro] Osped Molinette, Div Ematol, Turin, Italy; [Vianelli, Nicola] Univ Bologna, Ist Ematol & Oncol Clin Lorenzo & Ariosto Seragno, Bologna, Italy; [Spanu, Teresa] Univ Cattolica Sacro Cuore, Ist Microbiol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Udine; Universita degli Studi di Bari Aldo Moro; Hospital Spedali Civili Brescia; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Bologna; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Tumbarello, M (corresponding author), Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, Rome, Italy.	tumbarello@rm.unicatt.it	Trecarichi, Enrico/AAQ-5600-2020; Candoni, Anna/AAU-6289-2020; Tumbarello, Mario/A-8549-2019; Cattaneo, Chiara/AAB-9276-2019; Candoni, Anna/ABE-1708-2021; Vianelli, Nicola/AAD-1676-2021; Busca, Alessandro/J-5305-2018; pagano, livio/J-3020-2018; pagano, livio/A-2024-2008	Candoni, Anna/0000-0003-4436-1310; Tumbarello, Mario/0000-0002-9519-8552; Busca, Alessandro/0000-0001-5361-5613; pagano, livio/0000-0001-8287-928X; TRECARICHI, ENRICO/0000-0001-9064-7745; Vianelli, Nicola/0000-0001-5886-036X; SPADEA, ANTONIO/0000-0002-3651-2951	Italian Ministry for University and Scientific Research (Fondi Ateneo Linea) [D-1 2011]	Italian Ministry for University and Scientific Research (Fondi Ateneo Linea)	This work was partially supported by grants from the Italian Ministry for University and Scientific Research (Fondi Ateneo Linea D-1 2011). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collin BA, 2001, CLIN INFECT DIS, V33, P947, DOI 10.1086/322604; Dettenkofer M, 2005, CLIN INFECT DIS, V40, P926, DOI 10.1086/428046; Freifeld AG, 2011, CLIN INFECT DIS, V52, P427, DOI 10.1093/cid/ciq147; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gaytan-Martinez J, 2000, ARCH MED RES, V31, P388, DOI 10.1016/S0188-4409(00)00080-1; Hampshire PA, 2009, CRIT CARE, V13, DOI 10.1186/cc8016; Hatamabadi HR, 2012, AM J EMERG MED, V30, P1141, DOI 10.1016/j.ajem.2011.08.005; Hwang SY, 2012, AM J EMERG MED, V30, P749, DOI 10.1016/j.ajem.2011.05.022; Klastersky J, 2007, INT J ANTIMICROB AG, V30, pS51, DOI 10.1016/j.ijantimicag.2007.06.012; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Klastersky Jean, 1998, Current Opinion in Oncology, V10, P284, DOI 10.1097/00001622-199807000-00002; Madani TA, 2000, INFECTION, V28, P367, DOI 10.1007/s150100070007; Paganini HR, 2007, CANCER, V109, P2572, DOI 10.1002/cncr.22704; Pagano L, 2012, ANN HEMATOL, V91, P767, DOI 10.1007/s00277-011-1373-2; Rhee JY, 2009, SHOCK, V31, P146, DOI 10.1097/SHK.0b013e318182f98f; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Safdar A, 2006, EUR J CLIN MICROBIOL, V25, P522, DOI 10.1007/s10096-006-0173-4; Serody JS, 2000, NEW ENGL J MED, V342, P217; Soares M, 2010, INTENS CARE MED, V36, P1188, DOI 10.1007/s00134-010-1807-7; Trecarichi EM, 2009, J INFECTION, V58, P299, DOI 10.1016/j.jinf.2009.02.002; Trecarichi EM, 2011, HAEMATOL-HEMATOL J, V96, pE1, DOI 10.3324/haematol.2010.036640; Tumbarello M, 2008, ANTIMICROB AGENTS CH, V52, P3244, DOI 10.1128/AAC.00063-08; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Tumbarello M, 2011, ANTIMICROB AGENTS CH, V55, P3485, DOI 10.1128/AAC.00009-11; Tumbarello M, 2009, DIAGN MICR INFEC DIS, V64, P320, DOI 10.1016/j.diagmicrobio.2009.02.008; Wisplinghoff H, 2003, INFECT CONT HOSP EP, V24, P905, DOI 10.1086/502158; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339; Worth LJ, 2009, BLOOD REV, V23, P113, DOI 10.1016/j.blre.2008.10.003	30	46	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51612	10.1371/journal.pone.0051612	http://dx.doi.org/10.1371/journal.pone.0051612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272123	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800057
J	Wright, DJ; Holmes, P; Di Russo, F; Loporto, M; Smith, D				Wright, David J.; Holmes, Paul; Di Russo, Francesco; Loporto, Michela; Smith, Dave			Reduced Motor Cortex Activity during Movement Preparation following a Period of Motor Skill Practice	PLOS ONE			English	Article							POTENTIALS; ANATOMY; AREAS	Experts in a skill produce movement-related cortical potentials (MRCPs) of smaller amplitude and later onset than novices. This may indicate that, following long-term training, experts require less effort to plan motor skill performance. However, no longitudinal evidence exists to support this claim. To address this, EEG was used to study the effect of motor skill training on cortical activity related to motor planning. Ten non-musicians took part in a 5-week training study learning to play guitar. At week 1, the MRCP was recorded from motor areas whilst participants played the G Major scale. Following a period of practice of the scale, the MRCP was recorded again at week 5. Results showed that the amplitude of the later pre-movement components were smaller at week 5 compared to week 1. This may indicate that, following training, less activity at motor cortex sites is involved in motor skill preparation. This supports claims for a more efficient motor preparation following motor skill training. Citation: Wright DJ, Holmes P, Di Russo F, Loporto M, Smith D (2012) Reduced Motor Cortex Activity during Movement Preparation following a Period of Motor Skill Practice. PLoS ONE 7(12): e51886. doi:10.1371/journal.pone.0051886	[Wright, David J.; Holmes, Paul; Loporto, Michela; Smith, Dave] Manchester Metropolitan Univ, Inst Performance Res, Manchester M15 6BH, Lancs, England; [Di Russo, Francesco] Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy; [Di Russo, Francesco] IRCCS, Santa Lucia Fdn, Neuropsychol Ctr, Rome, Italy	Manchester Metropolitan University; Foro Italico University of Rome; IRCCS Santa Lucia	Smith, D (corresponding author), Manchester Metropolitan Univ, Inst Performance Res, Manchester M15 6BH, Lancs, England.	d.d.smith@mmu.ac.uk	Di Russo, Francesco/N-6686-2015	Di Russo, Francesco/0000-0002-3127-9433; Wright, David/0000-0001-9568-0237; Holmes, Paul/0000-0003-0821-3580	Manchester Metropolitan University through HEFCE RAE	Manchester Metropolitan University through HEFCE RAE	This research was funded by the Manchester Metropolitan University through HEFCE RAE quality rated research income. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya KN, 2011, J BODYW MOV THER, V15, P528, DOI 10.1016/j.jbmt.2011.01.023; Babiloni C, 2010, BEHAV BRAIN RES, V207, P466, DOI 10.1016/j.bbr.2009.10.034; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Cunnington R, 1996, HUM MOVEMENT SCI, V15, P627, DOI 10.1016/0167-9457(96)00018-8; Del Percio C, 2008, NEUROIMAGE, V42, P1544, DOI 10.1016/j.neuroimage.2008.05.061; Di Russo F, 2005, MED SCI SPORT EXER, V37, P1586, DOI 10.1249/01.mss.0000177458.71676.0d; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Fattapposta F, 1996, ELECTROEN CLIN NEURO, V99, P495, DOI 10.1016/S0013-4694(96)96560-8; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Hatfield B, 2006, PSYCHOBIOLOGY PHYS A, P221; Hatta A, 2009, NEUROSCI LETT, V459, P105, DOI 10.1016/j.neulet.2009.05.005; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Kita Y, 2001, NEUROREPORT, V12, P2221, DOI 10.1097/00001756-200107200-00035; Koeneke S, 2004, NEUROREPORT, V15, P1279, DOI 10.1097/01.wnr.0000127463.10147.e7; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; LANG W, 1992, EXP BRAIN RES, V89, P435; Magill R.A, 2020, MOTOR LEARNING CONTR, V12th; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rockschool, 2008, GUIT GRAD 2; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; TAYLOR MJ, 1978, ELECTROEN CLIN NEURO, V45, P568, DOI 10.1016/0013-4694(78)90157-8; Toma K, 2003, BEREITSCHAFTSPOTENTI, P113; Wright DJ, 2012, HUM MOVEMENT SCI, V31, P567, DOI 10.1016/j.humov.2011.07.001; Wright DJ, 2011, J MOTOR BEHAV, V43, P193, DOI 10.1080/00222895.2011.557751	31	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51886	10.1371/journal.pone.0051886	http://dx.doi.org/10.1371/journal.pone.0051886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251647	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000312386800103
J	Haga, C; Kondo, N; Suzuki, K; Sato, M; Ando, D; Yokomichi, H; Tanaka, T; Yamagata, Z				Haga, Chiyori; Kondo, Naoki; Suzuki, Kohta; Sato, Miri; Ando, Daisuke; Yokomichi, Hiroshi; Tanaka, Taichiro; Yamagata, Zentaro			Developmental Trajectories of Body Mass Index Among Japanese Children and Impact of Maternal Factors during Pregnancy	PLOS ONE			English	Article							CHILDHOOD OBESITY; GENDER-DIFFERENCES; RISK-FACTORS; SMOKING; ASSOCIATION; ADOLESCENTS; OVERWEIGHT; ADULTHOOD; ASTHMA; GROWTH	Background: The aims of this study were to 1) determine the distinct patterns of body mass index (BMI) trajectories in Japanese children, and 2) elucidate the maternal factors during pregnancy, which contribute to the determination of those patterns. Methodology/Principal Findings: All of the children (1,644 individuals) born in Koshu City, Japan, between 1991 and 1998 were followed in a longitudinal study exploring the subjects' BMI. The BMI was calculated 11 times for each child between birth and 12 years of age. Exploratory latent class growth analyses were conducted to identify trajectory patterns of the BMI z-scores. The distribution of BMI trajectories were best characterized by a five-group model for boys and a six-group model for girls. The groups were named "stable thin," "stable average," "stable high average," "progressive overweight," and "progressive obesity" in both sexes; girls were allocated to an additional group called "progressive average." Multinomial logistic regression found that maternal weight, smoking, and skipping breakfast during pregnancy were associated with children included in the progressive obesity pattern rather than the stable average pattern. These associations were stronger for boys than for girls. Conclusions/Significance: Multiple developmental patterns in Japanese boys and girls were identified, some of which have not been identified in Western countries. Maternal BMI and some unfavorable behaviors during early pregnancy may impact a child's pattern of body mass development. Further studies to explain the gender and regional differences that were identified are warranted, as these may be important for early life prevention of weight-associated health problems. Citation: Haga C, Kondo N, Suzuki K, Sato M, Ando D, et al. (2012) Developmental Trajectories of Body Mass Index Among Japanese Children and Impact of Maternal Factors during Pregnancy. PLoS ONE 7(12): e51896. doi: 10.1371/journal.pone.0051896	[Haga, Chiyori; Kondo, Naoki; Suzuki, Kohta; Sato, Miri; Yokomichi, Hiroshi; Yamagata, Zentaro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Yamanashi, Japan; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Dept Hlth Econ & Epidemiol Res, Tokyo, Japan; [Ando, Daisuke] Natl Def Acad, Dept Phys Educ, Kanagawa, Japan; [Tanaka, Taichiro] Toho Univ, Fac Med, Dept Environm & Occupat Hlth, Tokyo, Japan	University of Yamanashi; University of Tokyo; National Defence Academy - Japan; Toho University	Haga, C (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Yamanashi, Japan.	chiyorih@yamanashi.ac.jp; zenymgt@yamanashi.ac.jp	Kondo, Naoki/K-3898-2012; Yokomichi, Hiroshi/B-2816-2013; Kondo, Naoki/ABC-5865-2020	Kondo, Naoki/0000-0002-6425-6844; Yokomichi, Hiroshi/0000-0001-7369-155X; Kondo, Naoki/0000-0002-6425-6844	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [24792544, 22119504, 23390173]; Grants-in-Aid for Scientific Research [24790614, 23390173, 24792544] Funding Source: KAKEN	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) 24792544, 22119504, 23390173 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. (http://www.jsps.go.jp/j-grantsinaid/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alati R, 2006, EPIDEMIOLOGY, V17, P138, DOI 10.1097/01.ede.0000198148.02347.33; Bao Weihang, 1994, Archives of Internal Medicine, V154, P1842, DOI 10.1001/archinte.154.16.1842; Baschat AA, 2011, ULTRASOUND OBST GYN, V37, P501, DOI 10.1002/uog.9008; Costello J, 2007, MEASUREMENT DESIGN L; Dietz WH, 2000, LANCET, V356, P2027, DOI 10.1016/S0140-6736(00)03396-1; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Figueroa-Munoz JI, 2001, THORAX, V56, P133, DOI 10.1136/thorax.56.2.133; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Galloway T, 2007, AM J HUM BIOL, V19, P774, DOI 10.1002/ajhb.20637; Gorog K, 2011, MATERN CHILD HLTH J, V15, P985, DOI 10.1007/s10995-009-0543-5; Hejazi Samar, 2009, Health Rep, V20, P63; Hoekstra T, 2011, LONGITUD LIFE COURSE, V2, P319; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2010, TRAJ GROUP BASED MOD; Kass ER, 1995, J AM STAT ASSOC, V90, P928; Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476; Kirchengast S, 2008, COLLEGIUM ANTROPOL, V32, P1079; Lewy VD, 2001, J PEDIATR-US, V138, P38, DOI 10.1067/mpd.2001.109603; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; Lorson BA, 2009, J AM DIET ASSOC, V109, P474, DOI 10.1016/j.jada.2008.11.022; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; Malina MR, 1991, DEV PHYS; Mizutani T, 2007, OBESITY, V15, P3133, DOI 10.1038/oby.2007.373; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; National Obesity Observatory, 2009, INT COMP OBESITY PRE; Papalia D. E., 2009, HUMAN DEV; Parizkova J., 2005, CHILDHOOD OBESITY PR, V2nd ed., DOI [10.1201/9781420038965, DOI 10.1201/9781420038965]; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; SMOAK CG, 1987, AM J EPIDEMIOL, V125, P364, DOI 10.1093/oxfordjournals.aje.a114543; Suzuki K, 2012, J EPIDEMIOL; Suzuki K, 2010, INT J OBES LOND; Suzuki K, 2009, J EPIDEMIOL, V19, P136, DOI 10.2188/jea.JE20081012; Takayanagi K, 1993, Clin Perform Qual Health Care, V1, P29; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; US Department of Health and Human Services & US Department of Agriculture, 2010, DIET GUID AM 2010; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; WHO, 2006, WHO CHILD GROWTH STA	43	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51896	10.1371/journal.pone.0051896	http://dx.doi.org/10.1371/journal.pone.0051896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272187	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600047
J	Hu, FL; Zhang, L; Zheng, J; Zhao, L; Huang, J; Shao, WW; Liao, QY; Ma, T; Geng, L; Yin, CC; Qiu, XY				Hu, Fanlei; Zhang, Li; Zheng, Jie; Zhao, Ling; Huang, Jing; Shao, Wenwei; Liao, Qinyuan; Ma, Teng; Geng, Li; Yin, C. Cameron; Qiu, Xiaoyan			Spontaneous Production of Immunoglobulin M in Human Epithelial Cancer Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; NF-KAPPA-B; NASOPHARYNGEAL CARCINOMA-CELLS; CHAIN CONSTANT-REGION; ALPHA HEAVY-CHAIN; CPG DNA; MESSENGER-RNA; TUMOR-CELLS; MOLECULAR-PATTERNS; CELLULAR INVASION	It is well known that B-1 B cells are the main cell type that is responsible for the production of natural immunoglobulin M (IgM) and can respond to infection by increasing IgM secretion. However, we unexpectedly found that some epithelial cells also can express rearranged IgM transcript that has natural IgM characteristics, such as germline-encoded and restricted rearrangement patterns. Here we studied IgM expression in human non-B cells and found that IgM was frequently expressed by many human epithelial cancer cells as well as non-cancer epithelial cells. Moreover, CD79A and CD79B, two molecules that are physically linked to membranous IgM on the surface of B cells to form the B cell antigen receptor complex, were also expressed on the cell surface of epithelial cancer cells and co-located with IgM. Like the natural IgM, the epithelial cancer cell-derived IgM recognized a series of microbial antigens, such as single-stranded DNA, double-stranded DNA, lipopolysaccharide, and the HEp-2 cell antigen. More important, stimulation of the toll-like receptor 9 (TLR9), which mimics bacterial infection, substantially increased the secretion of IgM in human epithelial cancer cells. These findings indicate that human epithelial cancer cells as well as non-cancer epithelial cells can spontaneously produce IgM with natural antibody activity.	[Hu, Fanlei] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China; [Hu, Fanlei; Zhang, Li; Zheng, Jie; Huang, Jing; Shao, Wenwei; Liao, Qinyuan; Ma, Teng; Qiu, Xiaoyan] Peking Univ, Sch Basic Med Sci, Dept Immunol, Beijing 100871, Peoples R China; [Zhao, Ling; Geng, Li] Peking Univ, Hosp 3, Dept Gynaecol, Beijing 100871, Peoples R China; [Yin, C. Cameron] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Peking University; Peking University; Peking University; University of Texas System; UTMD Anderson Cancer Center	Qiu, XY (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Immunol, Beijing 100871, Peoples R China.	qiuxy@bjmu.edu.cn	ma, teng/C-3274-2014	ma, teng/0000-0003-2826-721X	National Natural Science Foundation of China [30973389, 30772470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 30973389 and 30772470 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Billstrom MA, 1998, J VIROL, V72, P5535, DOI 10.1128/JVI.72.7.5535-5544.1998; Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Deng Yu-qing, 2006, Zhonghua Zhongliu Zazhi, V28, P88; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-1; FRITZ G, 1990, MUTAT RES, V244, P49, DOI 10.1016/0165-7992(90)90107-U; GOTHGOLDSTEIN R, 1987, CARCINOGENESIS, V8, P1449, DOI 10.1093/carcin/8.10.1449; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Huang J, 2008, INT J BIOCHEM CELL B, V40, P1604, DOI 10.1016/j.biocel.2007.12.004; Huang J, 2009, J HISTOCHEM CYTOCHEM, V57, P339, DOI 10.1369/jhc.2008.951434; Ilvesaro JM, 2008, MOL CANCER RES, V6, P1534, DOI 10.1158/1541-7786.MCR-07-2005; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jego G, 2006, LEUKEMIA, V20, P1130, DOI 10.1038/sj.leu.2404226; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Landers CD, 2005, CLIN IMMUNOL, V116, P236, DOI 10.1016/j.clim.2005.04.013; Latz E, 2004, J ENDOTOXIN RES, V10, P406, DOI 10.1179/096805104225006525; Lee G, 2009, CANCER BIOMARK, V5, P137, DOI 10.3233/CBM-2009-0610; Lee S, 2004, J NEUROIMMUNOL, V153, P50, DOI 10.1016/j.jneuroim.2004.04.013; Li J, 2001, J PROTEIN CHEM, V20, P265, DOI 10.1023/A:1010912311564; Li M, 2004, INT J BIOCHEM CELL B, V36, P2250, DOI 10.1016/j.biocel.2004.03.017; Liang H, 1996, J CLIN INVEST, V98, P1119, DOI 10.1172/JCI118894; Liu HD, 2007, CELL SIGNAL, V19, P419, DOI 10.1016/j.cellsig.2006.07.012; MARTIN NH, 1969, J CLIN PATHOL, V22, P117, DOI 10.1136/jcp.22.2.117; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Pisetsky DS, 1999, BIOCHEM PHARMACOL, V58, P1981, DOI 10.1016/S0006-2952(99)00294-4; Qiu XY, 2003, CANCER RES, V63, P6488; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Ren T, 2007, CANCER BIOL THER, V6, P1704, DOI 10.4161/cbt.6.11.4826; Roberts TL, 2005, J IMMUNOL, V174, P605, DOI 10.4049/jimmunol.174.2.605; Sanada M, 2004, DNA REPAIR, V3, P413, DOI 10.1016/j.dnarep.2003.12.008; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Schroering AG, 2009, CANCER RES, V69, P6307, DOI 10.1158/0008-5472.CAN-09-0899; Shimizu T, 2004, INT IMMUNOL, V16, P675, DOI 10.1093/intimm/dxh069; Stefani D V, 1971, Zh Mikrobiol Epidemiol Immunobiol, V48, P126; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Tsuchimoto D, MUTAT RES, V703, P37; Vollmer J, 2004, IMMUNOLOGY, V113, P212, DOI 10.1111/j.1365-2567.2004.01962.x; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Wang LX, 2007, INT IMMUNOPHARMACOL, V7, P646, DOI 10.1016/j.intimp.2007.01.005; Yi AK, 1999, INT IMMUNOL, V11, P2015, DOI 10.1093/intimm/11.12.2015; Yi AK, 1996, J IMMUNOL, V157, P5394; Zhang QW, 2001, J PHARMACOL EXP THER, V298, P141; Zhang SA, 2010, CELL MOL LIFE SCI, V67, P985, DOI 10.1007/s00018-009-0231-z; Zheng H, 2007, MOL IMMUNOL, V44, P2221, DOI 10.1016/j.molimm.2006.11.010; Zheng H, 2007, CELL BIOL INT, V31, P82, DOI 10.1016/j.cellbi.2006.09.009; Zheng J, 2009, J BIOL CHEM, V284, P13610, DOI 10.1074/jbc.M809524200; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015; Zhu XH, 2008, APPL IMMUNOHISTO M M, V16, P232, DOI 10.1097/PAI.0b013e31814c915a; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	58	23	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51423	10.1371/journal.pone.0051423	http://dx.doi.org/10.1371/journal.pone.0051423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251529	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200104
J	Lee, SA; Winkler-Rhoades, N; Spelke, ES				Lee, Sang Ah; Winkler-Rhoades, Nathan; Spelke, Elizabeth S.			Spontaneous Reorientation Is Guided by Perceived Surface Distance, Not by Image Matching Or Comparison	PLOS ONE			English	Article							HEAD-DIRECTION CELLS; GEOMETRIC MODULE; SPATIAL REORIENTATION; INFANTS SENSITIVITY; EXPERIMENTAL ARENAS; INFORMATION-CONTENT; ENCLOSED SPACES; YOUNG-CHILDREN; COGNITIVE MAPS; NAVIGATION	Humans and animals recover their sense of position and orientation using properties of the surface layout, but the processes underlying this ability are disputed. Although behavioral and neurophysiological experiments on animals long have suggested that reorientation depends on representations of surface distance, recent experiments on young children join experimental studies and computational models of animal navigation to suggest that reorientation depends either on processing of any continuous perceptual variables or on matching of 2D, depthless images of the landscape. We tested the surface distance hypothesis against these alternatives through studies of children, using environments whose 3D shape and 2D image properties were arranged to enhance or cancel impressions of depth. In the absence of training, children reoriented by subtle differences in perceived surface distance under conditions that challenge current models of 2D-image matching or comparison processes. We provide evidence that children's spontaneous navigation depends on representations of 3D layout geometry.	[Lee, Sang Ah] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Lee, Sang Ah; Winkler-Rhoades, Nathan; Spelke, Elizabeth S.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Winkler-Rhoades, Nathan] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Trento; Harvard University; Massachusetts Institute of Technology (MIT)	Lee, SA (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	sangah@gmail.com	Lee, Sang Ah/O-8501-2017	Lee, Sang Ah/0000-0002-7887-6067	National Insitutes of Health [HD 23103]; Center for Mind/Brain Sciences at University of Trento; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023103] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD023103] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Mind/Brain Sciences at University of Trento; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by National Insitutes of Health-grant HD 23103 to ESS and Postdoctoral Research Fellowship to SAL by the Center for Mind/Brain Sciences at University of Trento. (http://grants.nih.gov/grants/oer.htm). (http://www.socialcapitalgateway.org/content/website/university-trento-center-mindbrain-sciences-cimec). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AA, 2007, PSYCHOL SCI, V18, P569, DOI 10.1111/j.1467-9280.2007.01941.x; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; Cheng K., 1984, P409; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cheng K, 2008, TRENDS COGN SCI, V12, P355, DOI 10.1016/j.tics.2008.06.004; Cheung A, 2008, J EXP PSYCHOL ANIM B, V34, P15, DOI 10.1037/0097-7403.34.1.15; Chiandetti C, 2008, ANIM COGN, V11, P139, DOI 10.1007/s10071-007-0099-y; Chiandetti C, 2010, ANIM COGN, V13, P463, DOI 10.1007/s10071-009-0297-x; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Gallistel C. R., 1990, ORG LEARNING; Gibson JJ, 1950, PERCEPTION VISUAL WO; GRANRUD CE, 1985, PERCEPT PSYCHOPHYS, V37, P415, DOI 10.3758/BF03202872; Hartley T, 2004, COGNITION, V94, P39, DOI 10.1016/j.cognition.2003.12.001; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Huttenlocher J, 2007, DEVELOPMENTAL SCI, V10, P741, DOI 10.1111/j.1467-7687.2007.00609.x; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Knight R, 2011, J NEUROSCI, V31, P15681, DOI 10.1523/JNEUROSCI.2257-11.2011; Lee SA, 2012, ANIM COGN, V15, P861, DOI 10.1007/s10071-012-0512-z; Lee SA, 2012, BIOL LETTERS, V8, P492, DOI 10.1098/rsbl.2012.0067; Lee SA, 2012, COGNITION, V123, P144, DOI 10.1016/j.cognition.2011.12.015; Lee SA, 2011, PSYCHON B REV, V18, P192, DOI 10.3758/s13423-010-0035-z; Lee SA, 2010, COGNITIVE PSYCHOL, V61, P152, DOI 10.1016/j.cogpsych.2010.04.002; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Lourenco SF, 2009, J EXP CHILD PSYCHOL, V104, P313, DOI 10.1016/j.jecp.2009.05.007; Nardini M, 2008, COGNITION, V106, P519, DOI 10.1016/j.cognition.2007.02.007; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; Pearce JM, 2001, J EXP PSYCHOL-ANIM B, V27, P329, DOI 10.1037//0097-7403.27.4.329; Pecchia T, 2010, J EXP BIOL, V213, P2987, DOI 10.1242/jeb.043315; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; RESTLE F, 1957, PSYCHOL REV, V64, P217, DOI 10.1037/h0040678; Rock I., 1983, LOGIC PERCEPTION; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; Shusterman A, 2011, COGNITION, V120, P186, DOI 10.1016/j.cognition.2011.04.004; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sturzl W, 2008, J EXP PSYCHOL ANIM B, V34, P1, DOI 10.1037/0097-7403.34.1.1; Sturz BR, 2011, PSYCHON B REV, V18, P848, DOI 10.3758/s13423-011-0111-z; TAUBE JS, 1990, J NEUROSCI, V10, P436; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Twyman A, 2007, DEV PSYCHOL, V43, P1523, DOI 10.1037/0012-1649.43.6.1523; Twyman AD, 2009, J COMP PSYCHOL, V123, P342, DOI 10.1037/a0015400; WALLACH H, 1963, AM J PSYCHOL, V76, P191, DOI 10.2307/1419156; WEHNER R, 1990, ANNU REV NEUROSCI, V13, P403, DOI 10.1146/annurev.ne.13.030190.002155; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wystrach A, 2011, J EXP PSYCHOL-ANIM B, V37, P420, DOI 10.1037/a0023886; Wystrach A, 2009, CURR BIOL, V19, P61, DOI 10.1016/j.cub.2008.11.054; YONAS A, 1985, DEV PSYCHOL, V21, P161, DOI 10.1037/0012-1649.21.1.161	47	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51373	10.1371/journal.pone.0051373	http://dx.doi.org/10.1371/journal.pone.0051373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251511	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200098
J	Qiao, LN; Xie, L; Shi, K; Zhou, TF; Hua, YM; Liu, HM				Qiao, Lina; Xie, Liang; Shi, Kun; Zhou, Tongfu; Hua, Yimin; Liu, Hanmin			Notch Signaling Change in Pulmonary Vascular Remodeling in Rats with Pulmonary Hypertension and Its Implication for Therapeutic Intervention	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL GROWTH-FACTOR; ARTERIAL-HYPERTENSION; IN-VITRO; DEPENDENT PATHWAY; PROGENITOR CELLS; CYCLE ARREST; FACTOR-BETA; ANGIOGENESIS; DIFFERENTIATION	Pulmonary hypertension (PH) is a fatal disease that lacks an effective therapy. Notch signaling pathway plays a crucial role in the angiogenesis and vascular remodeling. However, its roles in vascular remodeling in PH have not been well studied. In the current study, using hypoxia-induced PH model in rat, we examined the expression of Notch and its downstream factors. Then, we used vessel strip culture system and c-secretase inhibitor DAPT, a Notch signaling inhibitor to determine the effect of Notch signaling in vascular remodeling and its potential therapeutic value. Our results indicated that Notch 1-4 were detected in the lung tissue with variable levels in different cell types such as smooth muscle cells and endothelial cells of pulmonary artery, bronchia, and alveoli. In addition, following the PH induction, all of Notch1, Notch3, Notch4 receptor, and downstream factor, HERP1 in pulmonary arteries, mRNA expressions were increased with a peak at 1-2 weeks. Furthermore, the vessel wall thickness from rats with hypoxia treatment increased after cultured for 8 days, which could be decreased approximately 30% by DAPT, accompanied with significant increase of expression level of apoptotic factors (caspase-3 and Bax) and transformation of vascular smooth muscle cell (VSMC) phenotype from synthetic towards contractile. In conclusion, the current study suggested Notch pathway plays an important role in pulmonary vascular remodeling in PH and targeting Notch signaling pathway could be a valuable approach to design new therapy for PH.	[Qiao, Lina; Xie, Liang; Zhou, Tongfu; Hua, Yimin; Liu, Hanmin] Sichuan Univ, W China Univ Hosp 2, Dept Pediat Cardiol, Chengdu 610064, Peoples R China; [Qiao, Lina; Xie, Liang; Zhou, Tongfu; Hua, Yimin; Liu, Hanmin] Sichuan Univ, W China Univ Hosp 2, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Minist Educ, Chengdu 610064, Peoples R China; [Shi, Kun] Chengdu Women & Children Ctr Hosp, Dept Cardiol, Chengdu, Peoples R China	Sichuan University; Sichuan University	Qiao, LN (corresponding author), Sichuan Univ, W China Univ Hosp 2, Dept Pediat Cardiol, Chengdu 610064, Peoples R China.	iaqiao@163.com	Liu, Han/GVT-8296-2022		National Natural Science Foundation of China [30700913]; Program for Changjiang Scholars and Innovative Research Team in University "PCSIRT" [IRT0935]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University "PCSIRT"(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was supported by National Natural Science Foundation of China (30700913) and Program for Changjiang Scholars and Innovative Research Team in University "PCSIRT" (IRT0935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, AM HEART J, V162, P201, DOI 10.1016/j.ahj.2011.05.012; Ahmed Zubair, 2009, V467, P3, DOI 10.1007/978-1-59745-241-0_1; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bordonaro M, 2011, EXP CELL RES, V317, P1368, DOI 10.1016/j.yexcr.2011.03.019; Boucher J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00081; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Cowan KN, 1999, CIRC RES, V84, P1223, DOI 10.1161/01.RES.84.10.1223; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dong X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018481; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hirashima M, 2009, ANAT SCI INT, V84, P95, DOI 10.1007/s12565-009-0026-1; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Kume T, 2010, HISTOL HISTOPATHOL, V25, P637, DOI 10.14670/HH-25.637; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Li JL, 2005, CANCER CELL, V8, P1, DOI 10.1016/j.ccr.2005.06.013; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; McLaughlin VV, 2011, EUR RESPIR REV, V20, P262, DOI 10.1183/09059180.00006411; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miniati D, 2010, AM J PHYSIOL-LUNG C, V298, pL169, DOI 10.1152/ajplung.00188.2009; MONTESANO R, 1985, CELL, V42, P469, DOI 10.1016/0092-8674(85)90104-7; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Morrow D, 2007, AM J PHYSIOL-CELL PH, V292, pC488, DOI 10.1152/ajpcell.00337.2005; Mutoh T, 2012, STEM CELLS, V30, P561, DOI 10.1002/stem.1019; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Noseda M, 2005, CIRC RES, V97, P102, DOI 10.1161/01.RES.0000174380.06673.81; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Qiao Li-na, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P766; [乔莉娜 QIAO LiNa], 2011, [中国当代儿科杂志, Chinese Journal of Contemporary Pediatrics], V13, P503; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Sakata Y, 2004, ARTERIOSCL THROM VAS, V24, P2069, DOI 10.1161/01.ATV.0000143936.77094.a4; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007572; Wang QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037365; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yamamoto M, 1997, HISTOCHEM CELL BIOL, V107, P279, DOI 10.1007/s004180050113; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yidiz P, 2009, CLIN CHIM ACTA, V403, P9, DOI 10.1016/j.cca.2009.01.018; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhang YT, 2010, GLIA, V58, P964, DOI 10.1002/glia.20978; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	76	40	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51514	10.1371/journal.pone.0051514	http://dx.doi.org/10.1371/journal.pone.0051514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251561	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200127
J	Ramachandran, V; Malaisamy, M; Ponnaiah, M; Kaliaperuaml, K; Vadivoo, S; Gupte, MD				Ramachandran, Vidya; Malaisamy, Muniyandi; Ponnaiah, Manickam; Kaliaperuaml, Kanagasabai; Vadivoo, Selvaraj; Gupte, Mohan Digambar			Impact of Chikungunya on Health Related Quality of Life Chennai, South India	PLOS ONE			English	Article							VIRUS-INFECTION; REUNION ISLAND; EPIDEMIC; BURDEN; SF-36; FEVER	Background: Chikungunya Virus (CHIKV) infection affects large populations and leads to prolonged and debilitating pain affecting health related quality of life (HRQoL). We assess the impact of CHIKV on HRQoL of clinical CHIKV (C-CHIKV) patients in a suburban locality of Chennai City, South India. Further, we determined factors associated with clinical recovery among C-CHIKV patients. Methods: We followed-up 403 of 425 adult C-CHIKV cases identified during an outbreak. On the basis of a reassessment of their current clinical status through self-reporting, we categorized them as 'clinically recovered' (n = 308) or 'not recovered' (n = 95). In the absence of base-line information on HRQoL, we included a comparison group of healthy normal's recruited by frequency matching for age and sex from the neighbourhood (n = 308). We conducted a comparative cross-sectional study of these three groups and estimated HRQoL scores using SF-36 questionnaire. We tested the differences in the median scores by Kruksall Wallistest. We identified factors associated with 'recovery' as compared to not-recovery by calculating Adjusted Odds Ratio (AOR) and 95% Confidence Intervals through multiple regression analysis. Results: As compared to 'normals', we observed a 20 and five-fold reductions in HRQoL scores for C-CHIKV patients 'not recovered' and 'recovered' respectively. Differences in HRQoL scores for all the domains were statistically significant between three groups (p<0.001). Younger age, male, absence of rashes, affliction of less than five types of joints and two weeks of joint swelling were significantly associated with recovery. HRQoL scores improved with time among those 'clinically recovered'. Conclusion: This study provides evidence for sharp reductions in quality of life not only during active C-CHIKV associated illness but also for several months after clinical recovery compared to healthy normals. This has implications for developing intervention programmes in countries with high risk of CHIKV outbreaks.	[Ramachandran, Vidya; Ponnaiah, Manickam; Kaliaperuaml, Kanagasabai; Vadivoo, Selvaraj; Gupte, Mohan Digambar] Indian Council Med Res, Natl Inst Epidemiol, Training Div, Chennai, Tamil Nadu, India; [Malaisamy, Muniyandi] Indian Council Med Res, Natl Inst Res TB, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Ramachandran, V (corresponding author), Indian Council Med Res, Natl Inst Epidemiol, Training Div, Chennai, Tamil Nadu, India.	doctorvidya@gmail.com	Ponnaiah, Manickam/ABD-4622-2021	Ponnaiah, Manickam/0000-0002-0797-0822	intramural funds of National Institute of Epidemiology, Chennai	intramural funds of National Institute of Epidemiology, Chennai	This work was funded by intramural funds of National Institute of Epidemiology, Chennai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; de Andrade DC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-31; Indian Medical Association Epidemic Control cell, 2006, FACTS SHEETS CHIK; International Living, 2010, LEARN WE CALC QUAL L; Kaur P, 2008, EMERG INFECT DIS, V14, P1623, DOI 10.3201/eid1410.070569; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; SHAH KV, 1964, INDIAN J MED RES, V52, P676; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1; WHO, 2006, GLOB AL RESP GAR CHI	16	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51519	10.1371/journal.pone.0051519	http://dx.doi.org/10.1371/journal.pone.0051519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251562	Green Published, gold			2022-12-27	WOS:000313236200128
J	Smith, CT; Stocken, DD; Dunn, J; Cox, T; Ghaneh, P; Cunningham, D; Neoptolemos, JP				Smith, Catrin Tudur; Stocken, Deborah D.; Dunn, Janet; Cox, Trevor; Ghaneh, Paula; Cunningham, David; Neoptolemos, John P.			The Value of Source Data Verification in a Cancer Clinical Trial	PLOS ONE			English	Article							DATA QUALITY; CONDUCT	Background: Source data verification (SDV) is a resource intensive method of quality assurance frequently used in clinical trials. There is no empirical evidence to suggest that SDV would impact on comparative treatment effect results from a clinical trial. Methods: Data discrepancies and comparative treatment effects obtained following 100% SDV were compared to those based on data without SDV. Overall survival (OS) and Progression-free survival (PFS) were compared using Kaplan-Meier curves, log-rank tests and Cox models. Tumour response classifications and comparative treatment Odds Ratios (ORs) for the outcome objective response rate, and number of Serious Adverse Events (SAEs) were compared. OS estimates based on SDV data were compared against estimates obtained from centrally monitored data. Findings: Data discrepancies were identified between different monitoring procedures for the majority of variables examined, with some variation in discrepancy rates. There were no systematic patterns to discrepancies and their impact was negligible on OS, the primary outcome of the trial (HR (95% CI): 1.18(0.99 to 1.41), p = 0.064 with 100% SDV; 1.18(0.99 to 1.42), p = 0.068 without SDV; 1.18(0.99 to 1.40), p = 0.073 with central monitoring). Results were similar for PFS. More extreme discrepancies were found for the subjective outcome overall objective response (OR (95% CI): 1.67(1.04 to 2.68), p = 0.03 with 100% SDV; 2.45(1.49 to 4.04), p = 0.0003 without any SDV) which was mostly due to differing CT scans. Interpretation: Quality assurance methods used in clinical trials should be informed by empirical evidence. In this empirical comparison, SDV was expensive and identified random errors that made little impact on results and clinical conclusions of the trial. Central monitoring using an external data source was a more efficient approach for the primary outcome of OS. For the subjective outcome objective response, an independent blinded review committee and tracking system to monitor missing scan data could be more efficient than SDV.	[Smith, Catrin Tudur] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Stocken, Deborah D.] Univ Birmingham, Birmingham Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England; [Dunn, Janet] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Cox, Trevor; Ghaneh, Paula; Neoptolemos, John P.] Univ Liverpool, Canc Res UK Liverpool Canc Trials Unit, Liverpool L69 3BX, Merseyside, England; [Cunningham, David] Royal Marsden Hosp, Dept Med, Sutton, Surrey, England	University of Liverpool; University of Birmingham; University of Warwick; Cancer Research UK; University of Liverpool; Royal Marsden NHS Foundation Trust	Smith, CT (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	cat1@liv.ac.uk	Cox, Trevor F/E-5567-2013; Neoptolemos, John/HGU-7742-2022	Tudur Smith, Catrin/0000-0003-3051-1445; Stocken, Deborah/0000-0001-8031-1738; Dunn, Janet/0000-0001-7313-4446; Neoptolemos, John/0000-0002-6201-7399; Cunningham, David/0000-0001-5158-1069; Cox, Trevor/0000-0003-3045-5594	Medical Research Council [G0800792]; Cancer Research UK; Cancer Research UK [11883, 8968] Funding Source: researchfish; Medical Research Council [UD99999939] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10126] Funding Source: researchfish; MRC [G0800792] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CTS is supported by the Medical Research Council [grant number G0800792]. The cancer clinical trial was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PROSPECTIVE CLUSTER; [Anonymous], 1996, E6R1 INT C HARM TECH; [Anonymous], 2012, OPTIMISATION MONITOR; Baigent C, 2008, CLIN TRIALS, V5, P49, DOI 10.1177/1740774507087554; Bakobaki JM, 2012, CLIN TRIALS, V9, P257, DOI 10.1177/1740774511427325; Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.3.CO;2-F; Clinical Trials Transformation Initiative (CTTI), 2012, EFF EFF MON COMP QUA; Eisenstein EL, 2005, AM HEART J, V149, P482, DOI 10.1016/j.ahj.2004.04.049; Favalli G, 2000, EUR J CANCER, V36, P1125, DOI 10.1016/S0959-8049(00)00090-3; Funning S, 2009, QUAL ASSUR J, V12, P3, DOI DOI 10.1002/QAJ.433; Lane JA, 2011, J CLIN EPIDEMIOL, V64, P628, DOI 10.1016/j.jclinepi.2010.10.003; Lienard JL, 2006, CLIN TRIALS, V3, P486, DOI 10.1177/1740774506070807; Morrison BW, 2011, CLIN TRIALS, V8, P342, DOI 10.1177/1740774511402703; MRC/DH/MHRA Joint Project, 2012, RISK AD APPR MAN CLI; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205	15	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51623	10.1371/journal.pone.0051623	http://dx.doi.org/10.1371/journal.pone.0051623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251597	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200149
J	Yoneya, K; Uefune, M; Takabayashi, J				Yoneya, Kinuyo; Uefune, Masayoshi; Takabayashi, Junji			An Apparent Trade-Off between Direct and Signal-Based Induced Indirect Defence against Herbivores in Willow Trees	PLOS ONE			English	Article							INDUCED PLANT; VOLATILES; RESISTANCE; INDUCTION; RESPONSES; COSTS	Signal-based induced indirect defence refers to herbivore-induced production of plant volatiles that attract carnivorous natural enemies of herbivores. Relationships between direct and indirect defence strategies were studied using tritrophic systems consisting of six sympatric willow species, willow leaf beetles (Plagiodera versicolora), and their natural predators, ladybeetles (Aiolocaria hexaspilota). Relative preferences of ladybeetles for prey-infested willow plant volatiles, indicating levels of signal-based induced indirect defence, were positively correlated with the vulnerability of willow species to leaf beetles, assigned as relative levels of direct defence. This correlation suggested a possible trade-off among the species, in terms of resource limitation between direct defence and signal-based induced indirect defence. However, analyses of volatiles from infested and uninfested plants showed that the specificity of infested volatile blends (an important factor determining the costs of signal-based induced indirect defence) did not affect the attractiveness of infested plant volatiles. Thus, the suggested trade-off in resource limitation was unlikely. Rather, principal coordinates analysis showed that this 'apparent trade-off' between direct and signal-based induced indirect defence was partially explained by differential preferences of ladybeetles to infested plant volatiles of the six willow species. We also showed that relative preferences of ladybeetles for prey-infested willow plant volatiles were positively correlated with oviposition preferences of leaf beetles and with the distributions of leaf beetles in the field. These correlations suggest that ladybeetles use the specificity of infested willow plant volatiles to find suitable prey patches.	[Yoneya, Kinuyo; Uefune, Masayoshi; Takabayashi, Junji] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan	Kyoto University	Takabayashi, J (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	junji@ecology.kyoto-u.ac.jp	Takabayashi, Junji/G-2212-2010	Takabayashi, Junji/0000-0002-3575-9952; Uefune, Masayoshi/0000-0002-9570-8938	Kyoto University; JSPS;  [19101009]	Kyoto University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This research was partly supported by a Grant-in-Aid for Scientific Research (S) (No. 19101009), by the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" of Kyoto University, and by JSPS Core-to-Core project "Studies on ecological interaction networks that promote biodiversity -From gene to ecosystem-. KY was supported by a JSPS Research Fellowship for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1998, OIKOS, V83, P227, DOI 10.2307/3546834; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; DAVIDSON DW, 1993, TRENDS ECOL EVOL, V8, P326, DOI 10.1016/0169-5347(93)90240-P; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dicke M, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P483; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Heil M, 2002, ANN BOT-LONDON, V89, P503, DOI 10.1093/aob/mcf076; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Hilker M, 2002, ENTOMOL EXP APPL, V104, P181, DOI 10.1023/A:1021232319226; Horikoshi M, 1997, J CHEM ECOL, V23, P1505, DOI 10.1023/B:JOEC.0000006418.49537.5d; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Maeda T, 2001, APPL ENTOMOL ZOOL, V36, P47, DOI 10.1303/aez.2001.47; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MOLE S, 1994, OIKOS, V71, P3, DOI 10.2307/3546166; Ness JH, 2003, OECOLOGIA, V134, P210, DOI 10.1007/s00442-002-1110-6; Sabelis M. W., 1992, INSECT CHEM ECOLOGY, P122; Schoonhoven L. M., 2005, Insect-plant biology; Shiojiri K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012161; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; TAKABAYASHI J, 1991, PHYTOCHEMISTRY, V30, P1459, DOI 10.1016/0031-9422(91)84186-V; Turlings Ted C. J., 2002, P148, DOI 10.1017/CBO9780511542190.007; van Ballegooijen WM, 2004, P NATL ACAD SCI USA, V101, P18246, DOI 10.1073/pnas.0405682101; Yoneya K, 2009, PHYSIOL ENTOMOL, V34, P379, DOI 10.1111/j.1365-3032.2009.00701.x	29	10	13	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51505	10.1371/journal.pone.0051505	http://dx.doi.org/10.1371/journal.pone.0051505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251559	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200126
J	Adnan, H; Quach, H; MacIntosh, K; Antenos, M; Kirby, GM				Adnan, Humaira; Quach, Holly; MacIntosh, Kimberley; Antenos, Monica; Kirby, Gordon M.			Low Levels of GSTA1 Expression Are Required for Caco-2 Cell Proliferation	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; COLON-CANCER CELLS; LINE CACO-2; OXIDATIVE STRESS; EPITHELIAL-CELLS; SODIUM-BUTYRATE; PPAR-GAMMA; IN-VITRO; APOPTOSIS; DIFFERENTIATION	The colonic epithelium continuously regenerates with transitions through various cellular phases including proliferation, differentiation and cell death via apoptosis. Human colonic adenocarcinoma (Caco-2) cells in culture undergo spontaneous differentiation into mature enterocytes in association with progressive increases in expression of glutathione S-transferase alpha-1 (GSTA1). We hypothesize that GSTA1 plays a functional role in controlling proliferation, differentiation and apoptosis in Caco-2 cells. We demonstrate increased GSTA1 levels associated with decreased proliferation and increased expression of differentiation markers alkaline phosphatase, villin, dipeptidyl peptidase-4 and E-cadherin in postconfluent Caco-2 cells. Results of MTS assays, BrdU incorporation and flow cytometry indicate that forced expression of GSTA1 significantly reduces cellular proliferation and siRNA-mediated down-regulation of GSTA1 significantly increases cells in S-phase and associated cell proliferation. Sodium butyrate (NaB) at a concentration of 1 mM reduces Caco-2 cell proliferation, increases differentiation and increases GSTA1 activity 4-fold by 72 hours. In contrast, 10 mM NaB causes significant toxicity in preconfluent cells via apoptosis through caspase-3 activation with reduced GSTA1 activity. However, GSTA1 down-regulation by siRNA does not alter NaB-induced differentiation or apoptosis in Caco-2 cells. While 10 mM NaB causes GSTA1-JNK complex dissociation, phosphorylation of JNK is not altered. These findings suggest that GSTA1 levels may play a role in modulating enterocyte proliferation but do not influence differentiation or apoptosis.	[Adnan, Humaira; Quach, Holly; MacIntosh, Kimberley; Antenos, Monica; Kirby, Gordon M.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Kirby, GM (corresponding author), Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	gkirby@uoguelph.ca	Antenos, Monica/J-8985-2017	Antenos, Monica/0000-0001-6350-2911	Canadian Institutes of Health Research [86499]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institutes of Health Research (grant number 86499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; AGARWAL R, 1992, BIOCHEM PHARMACOL, V44, P2047, DOI 10.1016/0006-2952(92)90108-U; Balogh LM, 2008, J BIOL CHEM, V283, P16702, DOI 10.1074/jbc.M801725200; Bull AW, 2003, CARCINOGENESIS, V24, P1717, DOI 10.1093/carcin/bgg131; Burg D, 2006, BIOCHEM PHARMACOL, V71, P268, DOI 10.1016/j.bcp.2005.11.003; Castro-Caldas M, 2009, NEUROSCI LETT, V451, P241, DOI 10.1016/j.neulet.2009.01.017; CHANTRET I, 1994, J CELL SCI, V107, P213; Chopra DP, 2010, STEM CELLS DEV, V19, P131, DOI 10.1089/scd.2009.0109; Dzierzewicz Z, 2002, ACTA BIOCHIM POL, V49, P211; Ebert MN, 2003, CARCINOGENESIS, V24, P1637, DOI 10.1093/carcin/bgg122; Ferruzza S, 2011, TOXICOL IN VITRO; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; Hokaiwado N, 2008, CARCINOGENESIS, V29, P1134, DOI 10.1093/carcin/bgn097; Holley SL, 2007, CARCINOGENESIS, V28, P2268, DOI 10.1093/carcin/bgm135; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Liang FQ, 2005, EXP EYE RES, V80, P113, DOI 10.1016/j.exer.2004.08.017; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Liu XJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-684; Louis M, 2004, INT J ONCOL, V25, P1701; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; Mariadason JM, 2001, GASTROENTEROLOGY, V120, P889, DOI 10.1053/gast.2001.22472; Matthews GM, 2012, CHEMOTHERAPY, V58, P102, DOI 10.1159/000335672; Menard D, 2004, CAN J GASTROENTEROL, V18, P39, DOI 10.1155/2004/640897; Ng L, 2007, MOL PHARMACOL, V71, P201, DOI 10.1124/mol.106.028563; Orchel A, 2005, DIGEST DIS SCI, V50, P490, DOI 10.1007/s10620-005-2463-6; Paumi CM, 2001, J BIOL CHEM, V276, P7952, DOI 10.1074/jbc.M009400200; Pettersson PL, 2001, J BIOL CHEM, V276, P11698, DOI 10.1074/jbc.M009146200; Pshezhetsky AV, 2007, PROTEOMICS, V7, P2201, DOI 10.1002/pmic.200600956; Romero L, 2006, BIOCHEM J, V400, P135, DOI 10.1042/BJ20060110; Ruscoe JE, 2001, J PHARMACOL EXP THER, V298, P339; Scharmach E, 2009, TOXICOLOGY, V265, P122, DOI 10.1016/j.tox.2009.09.017; Schwab M, 2006, APOPTOSIS, V11, P1801, DOI 10.1007/s10495-006-9788-2; Sharma A, 2006, ARCH BIOCHEM BIOPHYS, V452, P165, DOI 10.1016/j.abb.2006.04.006; Simon-Assman P, 2007, CELL BIOL TOXICOL, V23, P241, DOI 10.1007/s10565-006-0175-0; Stokrova J, 2006, INT J ONCOL, V28, P559; Tetlow N, 2004, PHARMACOGENETICS, V14, P657, DOI 10.1097/00008571-200410000-00003; Townsend DM, 2005, METHOD ENZYMOL, V401, P287, DOI 10.1016/S0076-6879(05)01019-0; Turella P, 2005, CANCER RES, V65, P3751, DOI 10.1158/0008-5472.CAN-04-3903; Uchida K, 2000, MECH AGEING DEV, V116, P135, DOI 10.1016/S0047-6374(00)00129-9	42	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51739	10.1371/journal.pone.0051739	http://dx.doi.org/10.1371/journal.pone.0051739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251616	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900117
J	Low, JL; Naidoo, A; Yeo, G; Gehring, AJ; Ho, ZZ; Yau, YH; Shochat, SG; Kranz, DM; Bertoletti, A; Grotenbreg, GM				Low, Jianrong L.; Naidoo, Anneta; Yeo, Gladys; Gehring, Adam J.; Ho, Zi Zong; Yau, Yin Hoe; Shochat, Susana G.; Kranz, David M.; Bertoletti, Antonio; Grotenbreg, Gijsbert M.			Binding of TCR Multimers and a TCR-Like Antibody with Distinct Fine-Specificities Is Dependent on the Surface Density of HLA Complexes	PLOS ONE			English	Article							T-CELL-RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEXES; HEPATITIS-B-VIRUS; CLASS-I COMPLEXES; PEPTIDE-MHC; HIGH-AFFINITY; ANTIGEN PRESENTATION; MONOCLONAL-ANTIBODY; LIGAND RECOGNITION; VIRAL PEPTIDE	Class I Major Histocompatibility Complex (MHC) molecules evolved to sample degraded protein fragments from the interior of the cell, and to display them at the surface for immune surveillance by CD8(+) T cells. The ability of these lymphocytes to identify immunogenic peptide-MHC (pMHC) products on, for example, infected hepatocytes, and to subsequently eliminate those cells, is crucial for the control of hepatitis B virus (HBV). Various protein scaffolds have been designed to recapitulate the specific recognition of presented antigens with the aim to be exploited both diagnostically (e. g. to visualize cells exposed to infectious agents or cellular transformation) and therapeutically (e. g. for the delivery of drugs to compromised cells). In line with this, we report the construction of a soluble tetrameric form of an alpha beta T cell receptor (TCR) specific for the HBV epitope Env(183-191) restricted by HLA-A*02:01, and compare its avidity and fine-specificity with a TCR-like monoclonal antibody generated against the same HLA target. A flow cytometry-based assay with streptavidin-coated beads loaded with Env(183-191)/HLA-A*02: 01 complexes at high surface density, enabled us to probe the specific interaction of these molecules with their cognate pMHC. We demonstrate that the TCR tetramer has similar avidity for the pMHC as the antibody, but they differ in their fine-specificity, with only the TCR tetramer being capable of binding both natural variants of the Env(183-191) epitope found in HBV genotypes A/C/D (187Arg) and genotype B (187Lys). Collectively, the results highlight the promiscuity of our soluble TCR, which could be an advantageous feature when targeting cells infected with a mutation-prone virus, but that binding of the soluble oligomeric TCR relies considerably on the surface density of the presented antigen.	[Yeo, Gladys; Grotenbreg, Gijsbert M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Low, Jianrong L.; Naidoo, Anneta; Gehring, Adam J.; Ho, Zi Zong; Bertoletti, Antonio] ASTAR, Singapore Inst Clin Sci, Agcy Sci Technol & Res, Singapore, Singapore; [Low, Jianrong L.; Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL USA; [Grotenbreg, Gijsbert M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biol Sci, Singapore 117595, Singapore; [Bertoletti, Antonio] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Yeo, Gladys; Grotenbreg, Gijsbert M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Immunol Programme, Singapore 117595, Singapore; [Yau, Yin Hoe; Shochat, Susana G.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Grotenbreg, GM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore.	grotenbreg@nus.edu.sg	Hoe, YAU Yin/A-2817-2011; Bertoletti, Antonio/AAD-4830-2022	Hoe, YAU Yin/0000-0001-8136-2393; Bertoletti, Antonio/0000-0002-2942-0485; Gehring, Adam/0000-0003-1150-5840	Agency for Science Technology and Research (A*Star), Singapore; Singapore National Research Foundation (NRF) Research Fellowship [NRF2007NRF-RF001-226]	Agency for Science Technology and Research (A*Star), Singapore(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation (NRF) Research Fellowship(National Research Foundation, Singapore)	This work was supported by the Agency for Science Technology and Research (A*Star), Singapore and the Singapore National Research Foundation (NRF) Research Fellowship (NRF2007NRF-RF001-226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anikeeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041466; Anikeeva N, 2009, CLIN IMMUNOL, V130, P98, DOI 10.1016/j.clim.2008.08.025; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Bertoletti A, 2000, CURR OPIN IMMUNOL, V12, P403, DOI 10.1016/S0952-7915(00)00108-4; Biddison WE, 2003, J IMMUNOL, V171, P3064, DOI 10.4049/jimmunol.171.6.3064; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Chew SL, 2011, J BIOL CHEM, V286, P28466, DOI 10.1074/jbc.M111.262691; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Fooksman DR, 2006, J IMMUNOL, V176, P6673, DOI 10.4049/jimmunol.176.11.6673; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gehring AJ, 2007, J VIROL, V81, P2940, DOI 10.1128/JVI.02415-06; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Grotenbreg GM, 2008, P NATL ACAD SCI USA, V105, P3831, DOI 10.1073/pnas.0711504105; GUILHOT S, 1992, J VIROL, V66, P2670, DOI 10.1128/JVI.66.5.2670-2678.1992; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Hulsmeyer M, 2005, J BIOL CHEM, V280, P2972, DOI 10.1074/jbc.M411323200; Hwang J, 1998, BIOPHYS J, V74, P2184, DOI 10.1016/S0006-3495(98)77927-5; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; Ji C, 2012, HEPATOLOGY; Laugel B, 2005, J BIOL CHEM, V280, P1882, DOI 10.1074/jbc.M409427200; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; Marrack P, 2008, CURR OPIN IMMUNOL, V20, P203, DOI 10.1016/j.coi.2008.03.008; MATKO J, 1994, J IMMUNOL, V152, P3353; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Messaoudi I, 1999, J IMMUNOL, V163, P3286; MURPHY DB, 1992, J IMMUNOL, V148, P3483; OHerrin SM, 1997, J EXP MED, V186, P1333, DOI 10.1084/jem.186.8.1333; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sastry KSR, 2011, J VIROL, V85, P1935, DOI 10.1128/JVI.01990-10; Schodin BA, 1996, MOL IMMUNOL, V33, P819, DOI 10.1016/0161-5890(96)00038-7; SELLS MA, 1988, J VIROL, V62, P2836, DOI 10.1128/JVI.62.8.2836-2844.1988; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Stone JD, 2011, J IMMUNOL, V187, P6281, DOI 10.4049/jimmunol.1101734; Subbramanian RA, 2004, NAT BIOTECHNOL, V22, P1429, DOI 10.1038/nbt1024; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Zhu X, 2006, J IMMUNOL, V176, P3223, DOI 10.4049/jimmunol.176.5.3223	58	2	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51397	10.1371/journal.pone.0051397	http://dx.doi.org/10.1371/journal.pone.0051397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251518	Green Published, gold			2022-12-27	WOS:000312201900078
J	Baltazar, GC; Guha, S; Lu, WN; Lim, J; Boesze-Battaglia, K; Laties, AM; Tyagi, P; Kompella, UB; Mitchell, CH				Baltazar, Gabriel C.; Guha, Sonia; Lu, Wennan; Lim, Jason; Boesze-Battaglia, Kathleen; Laties, Alan M.; Tyagi, Puneet; Kompella, Uday B.; Mitchell, Claire H.			Acidic Nanoparticles Are Trafficked to Lysosomes and Restore an Acidic Lysosomal pH and Degradative Function to Compromised ARPE-19 Cells	PLOS ONE			English	Article							ROD OUTER SEGMENTS; PIGMENT-EPITHELIUM; GENE DELIVERY; RPE CELLS; ACIDIFICATION; PHAGOCYTOSIS; INHIBITION; PURIFICATION; STIMULATION; BINDING	Lysosomal enzymes function optimally in acidic environments, and elevation of lysosomal pH can impede their ability to degrade material delivered to lysosomes through autophagy or phagocytosis. We hypothesize that abnormal lysosomal pH is a key aspect in diseases of accumulation and that restoring lysosomal pH will improve cell function. The propensity of nanoparticles to end up in the lysosome makes them an ideal method of delivering drugs to lysosomes. This study asked whether acidic nanoparticles could traffic to lysosomes, lower lysosomal pH and enhance lysosomal degradation by the cultured human retinal pigmented epithelial cell line ARPE-19. Acidic nanoparticles composed of poly (DL-lactide-co-glycolide) (PLGA) 502 H, PLGA 503 H and poly (DL-lactide) (PLA) colocalized to lysosomes of ARPE-19 cells within 60 min. PLGA 503 H and PLA lowered lysosomal pH in cells compromised by the alkalinizing agent chloroquine when measured 1 hr. after treatment, with acidification still observed 12 days later. PLA enhanced binding of Bodipy-pepstatin-A to the active site of cathepsin D in compromised cells. PLA also reduced the cellular levels of opsin and the lipofuscin-like autofluorescence associated with photoreceptor outer segments. These observations suggest the acidification produced by the nanoparticles was functionally effective. In summary, acid nanoparticles lead to a rapid and sustained lowering of lysosomal pH and improved degradative activity.	[Baltazar, Gabriel C.; Guha, Sonia; Lu, Wennan; Lim, Jason; Mitchell, Claire H.] Univ Penn, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Boesze-Battaglia, Kathleen] Univ Penn, Dept Biochem, Philadelphia, PA USA; [Laties, Alan M.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Tyagi, Puneet; Kompella, Uday B.] Univ Colorado Denver, Aurora, CO USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Mitchell, CH (corresponding author), Univ Penn, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA.	chm@exchange.upenn.edu		Guha, Sonia/0000-0002-7585-8381	National Institutes of Health [NIH EY013434, EY015537, EY018705, EY017045]; Vision Research Core Grant [EY001583]; Research to Prevent Blindness; Paul and Evanina Bell Mackall Foundation Trust; Beckman Institute for Macular Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY017045, R29EY010420, R01EY013434, R01EY010420, R21EY018705, P30EY001583, R01EY015537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision Research Core Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Paul and Evanina Bell Mackall Foundation Trust; Beckman Institute for Macular Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by National Institutes of Health grants NIH EY013434 and EY015537 (CHM), EY018705 (KBB), EY017045 (AML), Vision Research Core Grant EY001583 (CHM and AML), Research to Prevent Blindness (AML), the Paul and Evanina Bell Mackall Foundation Trust (AML), and the Beckman Institute for Macular Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEIS D, 1994, EUR J BIOCHEM, V219, P905, DOI 10.1111/j.1432-1033.1994.tb18572.x; Baltazar G, 2010, INVEST OPHTH VIS SCI, V51; Baltazar G, 2011, INVEST OPHTH VIS SCI, V52, P3216; Barrett A, 1977, PROTINASES MAMMALIAN, P220; Bejjani R, 2005, MOL VIS, V11, P124; Blanchette CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006056; Bourges JL, 2003, INVEST OPHTH VIS SCI, V44, P3562, DOI 10.1167/iovs.02-1068; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Chen PM, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-10; Chen Y, 1999, J BIOL CHEM, V274, P18364, DOI 10.1074/jbc.274.26.18364; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; DEGUCHI J, 1994, INVEST OPHTH VIS SCI, V35, P568; Diebold Y, 2010, PROG RETIN EYE RES, V29, P596, DOI 10.1016/j.preteyeres.2010.08.002; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Elner Victor M, 2002, Trans Am Ophthalmol Soc, V100, P301; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Guha S, 2012, J NEUROCHEM, V122, P823, DOI 10.1111/j.1471-4159.2012.07804.x; HALL MO, 1987, EXP EYE RES, V45, P907, DOI 10.1016/S0014-4835(87)80105-7; HALL MO, 1993, INVEST OPHTH VIS SCI, V34, P2392; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HAYASAKA S, 1977, EXP EYE RES, V25, P317, DOI 10.1016/0014-4835(77)90099-9; HAYASAKA S, 1975, J BIOCHEM-TOKYO, V78, P1365, DOI 10.1093/oxfordjournals.jbchem.a131034; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Kompella UB, 2007, NANOMED-NANOTECHNOL, V3, P342, DOI 10.1016/j.nano.2007.10.034; KROGSTAD DJ, 1987, AM J TROP MED HYG, V36, P213, DOI 10.4269/ajtmh.1987.36.213; LAVAIL MM, 1976, EXP EYE RES, V23, P277, DOI 10.1016/0014-4835(76)90209-8; Li W, 2011, BIOMATERIALS, V32, P4030, DOI 10.1016/j.biomaterials.2011.02.008; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; Liu J, 2012, AM J PHYSIOL-CELL PH, V303, pC160, DOI 10.1152/ajpcell.00278.2011; Lu W, 2007, J PHARMACOL EXP THER, V323, P157, DOI 10.1124/jpet.107.124545; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Peters S, 2006, OPHTHAL RES, V38, P83, DOI 10.1159/000090268; Prow TW, 2008, NANOMED-NANOTECHNOL, V4, P340, DOI 10.1016/j.nano.2008.06.003; Roizenblatt R, 2006, J NEUROSCI METH, V153, P154, DOI 10.1016/j.jneumeth.2005.10.001; SIAKOTOS AN, 1978, INVEST OPHTH VIS SCI, V17, P618; Singh SR, 2009, GENE THER, V16, P645, DOI 10.1038/gt.2008.185; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021; Zhao Y, 2004, MACROMOL BIOSCI, V4, P901, DOI 10.1002/mabi.200400072	40	88	91	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e49635	10.1371/journal.pone.0049635	http://dx.doi.org/10.1371/journal.pone.0049635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272048	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300007
J	Glombiewski, JA; Nestoriuc, Y; Rief, W; Glaesmer, H; Braehler, E				Glombiewski, Julia A.; Nestoriuc, Yvonne; Rief, Winfried; Glaesmer, Heide; Braehler, Elmar			Medication Adherence in the General Population	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; DRUG-THERAPY; NONADHERENCE; MEDICINES; BELIEFS; PERSISTENCE; PREDICTORS	Background: Adherence to medication is low in specific populations who need chronic medication. However, adherence to medication is also of interest in a more general fashion, independent of specific populations or side effects of particular drugs. If clinicians and researchers expect patients to show close to full adherence, it is relevant to know how likely the achievement of this goal is. Population based rates can provide an estimate of efforts needed to achieve near complete adherence in patient populations. The objective of the study was to collect normative data for medication nonadherence in the general population. Methods and Findings: We assessed 2,512 persons (a representative sample of German population). Adherence was measured by Rief Adherence Index. We also assessed current medication intake and side effects. We found that at least 33% of Germans repeatedly fail to follow their doctor's recommendations regarding pharmacological treatments and only 25% of Germans describe themselves as fully adherent. Nonadherence to medication occurs more often in younger patients with higher socioeconomic status taking short-term medications than in older patients with chronic conditions. Experience with medication side effects was the most prominent predictor of nonadherence. Conclusions: The major strengths of our study are a representative sample and a novel approach to assess adherence. Nonadherece seems to be commonplace in the general population. Therefore adherence cannot be expected per se but needs special efforts on behalf of prescribers and public health initiatives. Nonadherence to medication should not only be considered as a drug-specific behaviour problem, but as a behaviour pattern that is independent of the prescribed medication.	[Glombiewski, Julia A.; Nestoriuc, Yvonne; Rief, Winfried] Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany; [Glaesmer, Heide; Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany; [Nestoriuc, Yvonne] Univ Hamburg, Dept Clin Psychol & Psychotherapy, Hamburg, Germany	Philipps University Marburg; Leipzig University; University of Hamburg	Glombiewski, JA (corresponding author), Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany.	glombiew@staff.uni-marburg.de	Rief, Winfried/ABD-4994-2021; Braehler, Elmar/C-6535-2009	Rief, Winfried/0000-0002-7019-2250; Braehler, Elmar/0000-0002-2648-2728; Nestoriuc, Yvonne/0000-0003-2191-0495				Bardel A, 2007, EUR J CLIN PHARMACOL, V63, P307, DOI 10.1007/s00228-006-0246-4; BARSKY AJ, 1990, J PSYCHIAT RES, V24, P323, DOI 10.1016/0022-3956(90)90004-A; Bates TR, 2009, EXPERT OPIN PHARMACO, V10, P2973, DOI 10.1517/14656560903376186; Briesacher BA, 2008, PHARMACOTHERAPY, V28, P437, DOI 10.1592/phco.28.4.437; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Cooper V, 2009, AIDS CARE, V21, P520, DOI 10.1080/09540120802301824; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Curkendall S, 2005, VALUE HEALTH, V8, P360, DOI 10.1016/S1098-3015(10)62959-2; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Frankenfield DL, 2010, J HEALTH CARE POOR U, V21, P518, DOI 10.1353/hpu.0.0314; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Horne R, 2007, JAIDS-J ACQ IMM DEF, V45, P334; Ingersoll KS, 2008, J BEHAV MED, V31, P213, DOI 10.1007/s10865-007-9147-y; Jackson C, 2006, PATIENT EDUC COUNS, V61, P212, DOI 10.1016/j.pec.2005.03.010; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Nestoriuc Y, 2010, ARTHRIT CARE RES, V62, P791, DOI 10.1002/acr.20160; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Rief W, 2011, PHARMACOEPIDEM DR S, V20, P405, DOI 10.1002/pds.2067; Sandelowski M, 2009, AIDS CARE, V21, P953, DOI 10.1080/09540120802626212; Simoni Jane M, 2008, Curr Infect Dis Rep, V10, P515, DOI 10.1007/s11908-008-0083-y; Steiner JF, 2010, MED CARE, V48, P193, DOI 10.1097/MLR.0b013e3181d51ddf; van Bruggen R, 2009, PHARMACOEPIDEM DR S, V18, P983, DOI 10.1002/pds.1810; World Health Organization, 2003, ADHERENCE LONG TERM; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728; Ziller V, 2009, ANN ONCOL, V20, P431, DOI 10.1093/annonc/mdn646	27	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50537	10.1371/journal.pone.0050537	http://dx.doi.org/10.1371/journal.pone.0050537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272064	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300009
J	Lorgis, L; Gudjoncik, A; Richard, C; Mock, L; Buffet, P; Brunel, P; Janin-Manificat, L; Beer, JC; Brunet, D; Touzery, C; Rochette, L; Cottin, Y; Zeller, M				Lorgis, Luc; Gudjoncik, Aurelie; Richard, Carole; Mock, Laurent; Buffet, Philippe; Brunel, Philippe; Janin-Manificat, Luc; Beer, Jean-Claude; Brunet, Damien; Touzery, Claude; Rochette, Luc; Cottin, Yves; Zeller, Marianne			Pre-Infarction Angina and Outcomes in Non-ST-Segment Elevation Myocardial Infarction: Data from the RICO Survey	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; SUSTAINED VENTRICULAR-ARRHYTHMIAS; PREINFARCTION ANGINA; GLOBAL REGISTRY; HOSPITAL OUTCOMES; ELDERLY-PATIENTS; PROTECTION; PECTORIS; ANGIOPLASTY; THROMBOLYSIS	Background: The presence of pre-infarction angina (PIA) has been shown to confer cardioprotection after ST-segment elevation myocardial infarction (STEMI). However, the clinical impact of PIA in non-ST-segment elevation myocardial infarction (NSTEMI) remains to be determined. Methods and Results: From the obseRvatoire des Infarctus de Cote d'Or (RICO) survey, 1541 consecutive patients admitted in intensive care unit with a first NSTEMI were included. Patients who experienced chest pain <7 days before the episode leading to admission were defined as having PIA and were compared with patients without PIA. Incidence of in-hospital ventricular arrhythmias (VAs), heart failure and 30-day mortality were collected. Among the 1541 patients included in the study, 693 (45%) patients presented PIA. PIA was associated with a lower creatine kinase peak, as a reflection of infarct size (231(109-520) vs. 322(148-844) IU/L, p<0.001) when compared with the group without PIA. Patients with PIA developed fewer VAs, by 3 fold (1.6% vs. 4.0%, p = 0.008) and heart failure (18.0% vs. 22.4%, p = 0.040) during the hospital stay. Overall, there was a decrease in early CV events by 26% in patients with PIA (19.2% vs. 25.9%, p = 0.002). By multivariate analysis, PIA remained independently associated with less VAs. Conclusion: From this large contemporary prospective study, our work showed that PIA is very frequent in patients admitted for a first NSTEMI, and is associated with a better prognosis, including reduced infarct size and in hospital VAs. Accordingly, protecting the myocardium by ischemic or pharmacological conditioning not only in STEMI, but in all type of MI merits further attention.	[Lorgis, Luc; Gudjoncik, Aurelie; Richard, Carole; Rochette, Luc; Cottin, Yves; Zeller, Marianne] SFR Sante Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, INSERM, U866, Dijon, France; [Lorgis, Luc; Gudjoncik, Aurelie; Richard, Carole; Buffet, Philippe; Beer, Jean-Claude; Touzery, Claude; Cottin, Yves] Univ Hosp, Dept Cardiol, Dijon, France; [Mock, Laurent; Brunel, Philippe; Brunet, Damien] Clin Fontaine Les Dijon, Dept Cardiol, Fontaine Les Dijon, France; [Janin-Manificat, Luc] CH Beaune, Dept Cardiol, Beaune, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne	Zeller, M (corresponding author), SFR Sante Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, INSERM, U866, Dijon, France.	marianne.zeller@u-bourgogne.fr	COTTIN, YVES/ABA-4622-2020	Rochette, Luc/0000-0001-9973-8803	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Conseil Regional de Bourgogne; Federation Francaise de Cardiologie; Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM); Agence Regionale de Sante (ARS) de Bourgogne	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Federation Francaise de Cardiologie; Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM); Agence Regionale de Sante (ARS) de Bourgogne(Region Bourgogne-Franche-Comte)	This work was supported by the University Hospital of Dijon, Association de Cardiologie de Bourgogne, Conseil Regional de Bourgogne, Federation Francaise de Cardiologie, and by grants from the Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM), and the Agence Regionale de Sante (ARS) de Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete P, 2003, AM J CLIN NUTR, V78, P796, DOI 10.1093/ajcn/78.4.796; Abete P, 1997, J AM COLL CARDIOL, V30, P947, DOI 10.1016/S0735-1097(97)00256-8; Airaksinen KEJ, 1997, J AM COLL CARDIOL, V29, P1035, DOI 10.1016/S0735-1097(97)00042-9; Al-Khatib SM, 2002, CIRCULATION, V106, P309, DOI 10.1161/01.CIR.0000022692.49934.E3; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Ambrosio G, 2010, EUR HEART J, V31, P430, DOI 10.1093/eurheartj/ehp457; Andreotti F, 1996, NEW ENGL J MED, V334, P7, DOI 10.1056/NEJM199601043340102; Avezum A, 2008, AM J CARDIOL, V102, P1577, DOI 10.1016/j.amjcard.2008.08.009; Bahr RD, 2000, AM HEART J, V140, P126, DOI 10.1067/mhj.2000.106641; Banerjee S, 1999, AM J PHYSIOL-HEART C, V277, pH2488, DOI 10.1152/ajpheart.1999.277.6.H2488; Bjorck L, 2010, ARCH INTERN MED, V170, P1375, DOI 10.1001/archinternmed.2010.203; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Braunwald E, 1996, NEW ENGL J MED, V334, P51, DOI 10.1056/NEJM199601043340113; Brieger D, 2009, HEART, V95, P888, DOI 10.1136/hrt.2008.153387; Cambou JP, 2007, ARCH MAL COEUR VAISS, V100, P524; Colonna P, 2002, AM HEART J, V144, P796, DOI 10.1067/mhj.2002.123835; Edwards RJ, 2002, HEART, V88, P604, DOI 10.1136/heart.88.6.604; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Gheeraert PJ, 2001, J AM COLL CARDIOL, V38, P1369, DOI 10.1016/S0735-1097(01)01561-3; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Iglesias-Garriz I, 2005, REV ESP CARDIOL, V58, P484, DOI 10.1157/13074842; Ishihara M, 2005, AM J CARDIOL, V95, P622, DOI 10.1016/j.amjcard.2004.11.009; Ishihara M, 2001, J AM COLL CARDIOL, V38, P1007, DOI 10.1016/S0735-1097(01)01477-2; Itoh T, 2006, AM J CARDIOL, V97, P1157, DOI 10.1016/j.amjcard.2005.11.032; Jimenez-Navarro M, 2001, REV ESP CARDIOL, V54, P1161, DOI 10.1016/S0300-8932(01)76474-3; Jimenez-Navarro M, 2001, AM J CARDIOL, V87, P11; Kloner RA, 1998, CIRCULATION, V97, P1848, DOI 10.1161/01.CIR.97.18.1848; Kloner RA, 1998, CIRCULATION, V97, P1042, DOI 10.1161/01.CIR.97.11.1042; KLONER RA, 1995, CIRCULATION, V91, P37, DOI 10.1161/01.CIR.91.1.37; Kloner RA, 1998, J THROMB THROMBOLYS, V6, P89, DOI 10.1023/A:1008833101817; Leesar MA, 2001, CIRCULATION, V103, P2935, DOI 10.1161/01.CIR.103.24.2935; LIU GS, 1991, CIRCULATION, V84, P350, DOI 10.1161/01.CIR.84.1.350; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Newby KH, 1998, CIRCULATION, V98, P2567, DOI 10.1161/01.CIR.98.23.2567; Noda T, 1999, J AM COLL CARDIOL, V34, P1966, DOI 10.1016/S0735-1097(99)00462-3; Okishige K, 1996, J AM COLL CARDIOL, V28, P70, DOI 10.1016/0735-1097(96)00119-2; Ovize M, 1995, AM J PHYSIOL, V269, P72; Papadopoulos CE, 2003, INT J CARDIOL, V92, P209, DOI 10.1016/S0167-5273(03)00087-1; Pasceri V, 1996, CIRCULATION, V94, P1850, DOI 10.1161/01.CIR.94.8.1850; Pomerantz BJ, 2000, J SURG RES, V90, P191, DOI 10.1006/jsre.2000.5889; Spencer FA, 2002, AM J CARDIOL, V90, P1056, DOI 10.1016/S0002-9149(02)02769-8; Takahashi T, 2002, AM J CARDIOL, V90, P465, DOI 10.1016/S0002-9149(02)02515-8; Takeuchi T, 2011, CIRC J, V75, P1192, DOI 10.1253/circj.CJ-10-0906; Tomoda H, 1999, AM J CARDIOL, V84, P621, DOI 10.1016/S0002-9149(99)00405-1; VEGH A, 1992, CARDIOVASC RES, V26, P487, DOI 10.1093/cvr/26.5.487; Wu ZK, 2002, CIRCULATION, V106, P3091, DOI 10.1161/01.CIR.0000041430.32233.5B; YELLON DM, 1995, J MOL CELL CARDIOL, V27, P1023, DOI 10.1016/0022-2828(95)90071-3; Zeller M, 2005, ARCH INTERN MED, V165, P1192, DOI 10.1001/archinte.165.10.1192	48	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e48513	10.1371/journal.pone.0048513	http://dx.doi.org/10.1371/journal.pone.0048513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272043	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300005
J	Singh, O; Chan, JY; Lin, K; Heng, CCT; Chowbay, B				Singh, Onkar; Chan, Jason Yongsheng; Lin, Keegan; Heng, Charles Chuah Thuan; Chowbay, Balram			SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemiae	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CHRONIC MYELOGENOUS LEUKEMIA; STANDARD-DOSE IMATINIB; GENETIC POLYMORPHISMS; MOLECULAR RESPONSES; PLASMA-LEVELS; CML PATIENTS; TROUGH CONCENTRATION; CANCER-PATIENTS; ASSOCIATION	Objective: This study aimed to explore the influence of SLC22A1, PXR, ABCG2, ABCB1 and CYP3A5*3 genetic polymorphisms on imatinib mesylate (IM) pharmacokinetics in Asian patients with chronic myeloid leukemia (CML). Patients and Methods: Healthy subjects belonging to three Asian populations (Chinese, Malay, Indian; n = 70 each) and CML patients (n = 38) were enrolled in a prospective pharmacogenetics study. Imatinib trough (C-0h) and clearance (CL) were determined in the patients at steady state. Haplowalk method was applied to infer the haplotypes and generalized linear model (GLM) to estimate haplotypic effects on IM pharmacokinetics. Association of haplotype copy numbers with IM pharmacokinetics was defined by Mann-Whitney U test. Results: Global haplotype score statistics revealed a SLC22A1 sub-haplotypic region encompassing three polymorphisms (rs3798168, rs628031 and IVS7+850C>T), to be significantly associated with IM clearance (p = 0.013). Haplotype-specific GLM estimated that the haplotypes AGT and CGC were both associated with 22% decrease in clearance compared to CAC [CL (*10(-2) L/hr/mg): CAC vs AGT: 4.03 vs 3.16, p = 0.017; CAC vs CGC: 4.03 vs 3.15, p = 0.017]. Patients harboring 2 copies of AGT or CGC haplotypes had 33.4% lower clearance and 50% higher C-0h than patients carrying 0 or 1 copy [CL(*10(-2) L/hr/mg): 2.19 vs 3.29, p = 0.026; C-0h (*10(-6) 1/ml): 4.76 vs 3.17, p = 0.013, respectively]. Further subgroup analysis revealed SLC22A1 and ABCB1 haplotypic combinations to be significantly associated with clearance and C-0h (p = 0.002 and 0.009, respectively). Conclusion: This exploratory study suggests that SLC22A1-ABCB1 haplotypes may influence IM pharmacokinetics in Asian CML patients. Citation: Singh O, Chan JY, Lin K, Heng CCT, Chowbay B (2012) SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia. PLoS ONE 7(12): e51771. doi:10.1371/journal.pone.0051771	[Singh, Onkar; Chan, Jason Yongsheng; Lin, Keegan; Chowbay, Balram] Natl Canc Ctr Singapore, Lab Clin Pharmacol, Div Med Sci, Humphrey Oei Inst Canc Res, Singapore, Singapore; [Heng, Charles Chuah Thuan] Singapore Gen Hosp, Dept Haematol, Singapore 0316, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital	Chowbay, B (corresponding author), Natl Canc Ctr Singapore, Lab Clin Pharmacol, Div Med Sci, Humphrey Oei Inst Canc Res, Singapore, Singapore.	ctebal@nccs.com.sg	Chan, Jason Yongsheng/AAC-4863-2020	Chan, Jason Yongsheng/0000-0002-4801-3703	NMRC Institutional Grant [NMCCE10123, NMPPG11122]; Singhealth Research Fund [SRFIM07103]	NMRC Institutional Grant; Singhealth Research Fund(SingHealth)	This project was supported by funds from the NMRC Institutional Grant (NMCCE10123 and NMPPG11122) and the Singhealth Research Fund (SRFIM07103) [http://www.nmrc.gov.sg/content/nmrc_internet/home.html, http://research.singhealth.com.sg/Pages/home.aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awidi A, 2010, LEUKEMIA RES, V34, P1573, DOI 10.1016/j.leukres.2010.07.014; Balram C, 2003, EUR J CLIN PHARMACOL, V59, P123, DOI 10.1007/s00228-003-0594-2; Bazeos A, 2010, LEUKEMIA, V24, P1243, DOI 10.1038/leu.2010.86; Chen LG, 2010, J PHARMACOL EXP THER, V335, P42, DOI 10.1124/jpet.110.170159; Chowbay B, 2003, PHARMACOGENETICS, V13, P89, DOI 10.1097/00008571-200302000-00005; Cortes JE, 2009, LEUKEMIA, V23, P1537, DOI 10.1038/leu.2009.88; Crossman LC, 2005, BLOOD, V106, P1133, DOI 10.1182/blood-2005-02-0694; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744; Faber E, 2012, ANN HEMATOL, V91, P923, DOI 10.1007/s00277-011-1394-x; Forrest DL, 2009, LEUKEMIA RES, V33, P271, DOI 10.1016/j.leukres.2008.07.015; Gardner ER, 2006, CLIN PHARMACOL THER, V80, P192, DOI 10.1016/j.clpt.2006.05.003; Gurney H, 2007, CLIN PHARMACOL THER, V82, P33, DOI 10.1038/sj.clpt.6100201; Haouala A, 2011, BLOOD, V117, pE75, DOI 10.1182/blood-2010-07-294330; Hu S, 2008, CLIN CANCER RES, V14, P3141, DOI 10.1158/1078-0432.CCR-07-4913; Hughes Timothy, 2006, Hematology Am Soc Hematol Educ Program, P211, DOI 10.1182/asheducation-2006.1.211; Hughes TP, 2010, BLOOD, V116, P3758, DOI 10.1182/blood-2010-03-273979; Jada SR, 2007, CANCER SCI, V98, P1461, DOI 10.1111/j.1349-7006.2007.00541.x; Karami S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007013; Kim DH, 2009, CLIN CANCER RES, V15, P4750, DOI 10.1158/1078-0432.CCR-09-0145; Koren-Michowitz M, 2012, HEMATOL ONCOL; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Li QB, 2010, ACTA PHARMACOL SIN, V31, P999, DOI 10.1038/aps.2010.79; Maffioli M, 2011, LEUKEMIA RES, V35, P1014, DOI 10.1016/j.leukres.2010.12.004; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Nardinelli L, 2012, ACTA HAEMATOL-BASEL, V127, P228, DOI 10.1159/000336610; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Oostendorp RL, 2007, BIOMED CHROMATOGR, V21, P747, DOI 10.1002/bmc.816; Picard S, 2007, BLOOD, V109, P3496, DOI 10.1182/blood-2006-07-036012; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sandanaraj E, 2008, CLIN CANCER RES, V14, P7116, DOI 10.1158/1078-0432.CCR-08-0411; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scherag A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013967; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Sohn SK, 2011, LEUKEMIA LYMPHOMA, V52, P1024, DOI 10.3109/10428194.2011.563885; Takahashi N, 2010, CLIN PHARMACOL THER, V88, P809, DOI 10.1038/clpt.2010.186; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; van Erp NR, 2007, CLIN CANCER RES, V13, P7394, DOI 10.1158/1078-0432.CCR-07-0346; Velpandian T, 2004, J CHROMATOGR B, V804, P431, DOI 10.1016/j.jchromb.2004.01.032; Wang YF, 2008, BRIT J CLIN PHARMACO, V65, P885, DOI 10.1111/j.1365-2125.2008.03150.x; White DL, 2010, LEUKEMIA, V24, P1962, DOI 10.1038/leu.2010.188; White DL, 2007, BLOOD, V110, P4064, DOI 10.1182/blood-2007-06-093617; Yamakawa Y, 2011, THER DRUG MONIT, V33, P244, DOI 10.1097/FTD.0b013e31820beb02; Zhang L, 1998, ANNU REV PHARMACOL, V38, P431, DOI 10.1146/annurev.pharmtox.38.1.431; Zhang WW, 2009, J CLIN ONCOL, V27, P3642, DOI 10.1200/JCO.2008.19.4076; Zhong JS, 2012, ACTA HAEMATOL-BASEL, V127, P221, DOI 10.1159/000336244; Zhou QY, 2005, BRIT J CLIN PHARMACO, V59, P415, DOI 10.1111/j.1365-2125.2004.02330.x	50	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51771	10.1371/journal.pone.0051771	http://dx.doi.org/10.1371/journal.pone.0051771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272163	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300027
J	Jordan, LKB; Lindeman, KC; Spieler, RE				Jordan, Lance K. B.; Lindeman, Kenyon C.; Spieler, Richard E.			Depth-Variable Settlement Patterns and Predation Influence on Newly Settled Reef Fishes (Haemulon spp., Haemulidae)	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ONE-TREE-REEF; CORAL-REEF; HABITAT COMPLEXITY; SEAGRASS BEDS; ARTIFICIAL REEFS; POSTSETTLEMENT SURVIVORSHIP; NEARSHORE HARDBOTTOM; RECRUITMENT PATTERNS; ASSEMBLAGE STRUCTURE	During early demersal ontogeny, many marine fishes display complex habitat-use patterns. Grunts of the speciose genus Haemulon are among the most abundant fishes on western North Atlantic coral reefs, with most species settling to shallow habitats (<= 12 m). To gain understanding into cross-shelf distributional patterns exhibited by newly settled stages of grunts <2 cm total length), we examined: 1) depth-specific distributions of congeners at settlement among sites at 8 m, 12 m, and 21 m, and 2) depth-variable predation pressure on newly settled individuals (species pooled). Of the six species identified from collections of newly settled specimens (n = 2125), Haemulon aurolineatum (tomtate), H. flavolineatum (French grunt), and H. striatum (striped grunt) comprised 98% of the total abundance; with the first two species present at all sites. Prevalence of H. aurolineatum and H. flavolineatum decreased substantially from the 8-m site to the two deeper sites. In contrast, H. striatum was absent from the 8-m site and exhibited its highest frequency at the 21-m site. Comparison of newly settled grunt delta density for all species on caged (predator exclusion) and control artificial reefs at the shallowest site (8-m) revealed no difference, while the 12-m and 21-m sites exhibited significantly greater delta densities on the caged treatment. This result, along with significantly higher abundances of co-occurring piscivorous fishes at the deeper sites, indicated lower predation pressure at the 8-m site. This study suggests habitat-use patterns of newly settled stages of some coral reef fishes that undergo ontogenetic shifts are a function of depth-variable predation pressure while, for at least one deeper-water species, proximity to adult habitat appears to be an important factor affecting settlement distribution. Citation: Jordan LKB, Lindeman KC, Spieler RE (2012) Depth-Variable Settlement Patterns and Predation Influence on Newly Settled Reef Fishes (Haemulon spp., Haemulidae). PLoS ONE 7(12): e50897. doi:10.1371/journal.pone.0050897	[Jordan, Lance K. B.; Spieler, Richard E.] Nova SE Univ, Natl Coral Reef Inst, Oceanog Ctr, Dania, FL 33004 USA; [Lindeman, Kenyon C.] Florida Inst Technol, Dept Educ & Interdisciplinary Studies, Melbourne, FL 32901 USA	Nova Southeastern University; Florida Institute of Technology	Jordan, LKB (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Oceanog Ctr, Dania, FL 33004 USA.	Lance@microwavetelemetry.com		Lindeman, Ken/0000-0003-4098-4158	National Oceanic and Atmospheric Administration Coastal Ocean Program	National Oceanic and Atmospheric Administration Coastal Ocean Program(National Oceanic Atmospheric Admin (NOAA) - USA)	This manuscript is a result of research partially funded by the National Oceanic and Atmospheric Administration Coastal Ocean Program under an award to Nova Southeastern University for the National Coral Reef Institute (NCRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams AJ, 2002, MAR ECOL PROG SER, V228, P213, DOI 10.3354/meps228213; Adams AJ, 2004, B MAR SCI, V75, P93; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Appeldoorn RS, 2009, CARIBB J SCI, V45, P304; Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Banks K. W, 2008, CORAL REEFS US, P125; Baron RM, 2004, ESTUAR COAST SHELF S, V60, P431, DOI 10.1016/j.ecss.2004.02.002; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beets J, 1997, MAR ECOL PROG SER, V148, P11, DOI 10.3354/meps148011; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bohnsack J.A., 1991, P412; BOHNSACK JA, 1989, B MAR SCI, V44, P631; BOHNSACK JA, 1994, B MAR SCI, V55, P796; BROTHERS E B, 1981, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V178, P369; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; Chittaro PM, 2005, ENVIRON BIOL FISH, V72, P175, DOI 10.1007/s10641-004-9077-2; Claro Rodolfo, 2001, P194; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; Connell SD, 1996, MAR BIOL, V126, P347, DOI 10.1007/BF00347459; Connell SD, 1997, J EXP MAR BIOL ECOL, V213, P181, DOI 10.1016/S0022-0981(96)02773-6; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; D'Alessandro E, 2007, MAR ECOL PROG SER, V331, P85, DOI 10.3354/meps331085; Dahlgren CP, 2000, ECOLOGY, V81, P2227; de la Moriniere EC, 2004, MAR BIOL, V144, P139, DOI 10.1007/s00227-003-1167-8; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; Dorenbosch M, 2009, MAR ECOL PROG SER, V379, P181, DOI 10.3354/meps07896; Eklund A.M., 1997, P 8 INT COR REEF S, V2, P1139; Ferro F, 2005, SEFSC532 NOAA NMFS, P73; Fisher RA, 1925, STAT METHODS RES WOR, P318; Fletcher D, 2005, ENVIRON ECOL STAT, V12, P45, DOI 10.1007/s10651-005-6817-1; Gaston K.J., 1994, RARITY, P205; Gilliam DS, 2008, 08 ENV PROT DEP BIOL, P105; Gilliam DS, 1999, THESIS NOVA SE U FT, P111; Grol MGG, 2008, MAR ECOL PROG SER, V366, P137, DOI 10.3354/meps07509; HAMNER WM, 1988, B MAR SCI, V42, P459; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Heck K.L. Jr, 1991, P281; HELFMAN GS, 1982, ANIM BEHAV, V30, P317, DOI 10.1016/S0003-3472(82)80042-0; Hill RL, 2002, THESIS U PUERTO RICO, P152; Hixon M.A., 1991, P475; HIXON MA, 1989, B MAR SCI, V44, P666; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; HIXON MA, 1991, THEOR POPUL BIOL, V39, P178, DOI 10.1016/0040-5809(91)90035-E; Holmes TH, 2011, ANIM BEHAV, V81, P543, DOI 10.1016/j.anbehav.2010.11.019; Horinouchi M, 2009, MAR ECOL PROG SER, V377, P43, DOI 10.3354/meps07869; Huijbers CM, 2008, J EXP MAR BIOL ECOL, V357, P134, DOI 10.1016/j.jembe.2008.01.004; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jordan LKB, 2005, J EXP MAR BIOL ECOL, V326, P170, DOI 10.1016/j.jembe.2005.05.023; Jordan LKB, 2004, PROCEEDINGS OF THE FIFTY-FIFTH ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P322; Kingsford MJ, 2002, B MAR SCI, V70, P309; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; Levin P, 1997, OECOLOGIA, V112, P55, DOI 10.1007/s004420050283; LIMOUZYPARIS C, 1994, B MAR SCI, V54, P857; LINDEMAN KC, 1986, B MAR SCI, V39, P673; Lindeman KC, 1999, FISH B-NOAA, V97, P508; Lindeman KC, 2000, B MAR SCI, V66, P929; Lindeman KC, 2006, GUIDE EARLY STAGES A, P1597; Lindeman Kenneth C., 2001, Proceedings of the Gulf and Caribbean Fisheries Institute, V52, P732; Lindeman Kenyon C., 1998, Proceedings of the Gulf and Caribbean Fisheries Institute, V50, P385; LIVINGSTON RJ, 1982, MAR ECOL PROG SER, V7, P1, DOI 10.3354/meps007001; LO NCH, 1992, CAN J FISH AQUAT SCI, V49, P2515, DOI 10.1139/f92-278; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Marnane MJ, 2002, MAR ECOL PROG SER, V231, P261, DOI 10.3354/meps231261; McFarland W.N., 1980, Proceedings of the Gulf and Caribbean Fisheries Institute, V32, P132; MCFARLAND WN, 1985, FISH B-NOAA, V83, P413; MCIVOR CC, 1988, ECOLOGY, V69, P1341, DOI 10.2307/1941632; Meekan MG, 1996, MAR ECOL PROG SER, V137, P25, DOI 10.3354/meps137025; Milinski M, 1986, BEHAV TELEOST FISHES, P285; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; OGDEN JC, 1977, MAR BIOL, V42, P273, DOI 10.1007/BF00397751; PARRISH JD, 1989, MAR ECOL PROG SER, V58, P143, DOI 10.3354/meps058143; PETRANKA JW, 1983, COPEIA, P624, DOI 10.2307/1444326; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; Power M.E., 1987, P333; Power RM, 2003, P GULF CARIB FISH I, V54, P401; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Rice J., 1995, MATH STAT DATA ANAL, P597; Rocha LA, 2008, MOL PHYLOGENET EVOL, V48, P918, DOI 10.1016/j.ympev.2008.05.024; Seber G., 1982, ESTIMATION ANIMAL AB, P654; Serafy JE, 2007, B MAR SCI, V80, P609; Sherman RL, 2002, ICES J MAR SCI, V59, pS196, DOI 10.1006/jmsc.2001.1163; Sherman RL, 2000, THESIS NOVA SE U FT, P173; SHULMAN MJ, 1983, ECOLOGY, V64, P1508, DOI 10.2307/1937505; SHULMAN MJ, 1987, MAR ECOL PROG SER, V39, P233, DOI 10.3354/meps039233; SHULMAN MJ, 1985, ECOLOGY, V66, P1056, DOI 10.2307/1940565; SHULMAN MJ, 1984, J EXP MAR BIOL ECOL, V74, P85, DOI 10.1016/0022-0981(84)90039-X; SHULMAN MJ, 1985, J EXP MAR BIOL ECOL, V89, P205, DOI 10.1016/0022-0981(85)90127-3; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Spina AP, 2000, ENVIRON BIOL FISH, V57, P393, DOI 10.1023/A:1007682010268; STARCK WALTER A., 1966, ICHTHYOL AQUARIUM J, V38, P313; Theilacker G.H., 1974, P287; Victor B.C., 1991, P231; Vigliola L, 2002, OECOLOGIA, V131, P89, DOI 10.1007/s00442-001-0866-4; Wahl DH, 1995, CAN J FISH AQUAT SCI, V52, P2312, DOI 10.1139/f95-823; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141	104	5	5	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50897	10.1371/journal.pone.0050897	http://dx.doi.org/10.1371/journal.pone.0050897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272077	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800020
J	O'Mahony, DS; Glavan, BJ; Holden, TD; Fong, C; Black, RA; Rona, G; Tejera, P; Christiani, DC; Wurfel, MM				O'Mahony, D. Shane; Glavan, Bradford J.; Holden, Tarah D.; Fong, Christie; Black, R. Anthony; Rona, Gail; Tejera, Paula; Christiani, David C.; Wurfel, Mark M.			Inflammation and Immune-Related Candidate Gene Associations with Acute Lung Injury Susceptibility and Severity: A Validation Study	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; COLONY-ENHANCING FACTOR; IL-6 LEVELS; POLYMORPHISMS; MORTALITY; RISK; ARDS; INTERLEUKIN-10; TRANSCRIPTION; HAPLOTYPE	Introduction: Common variants in genes related to inflammation, innate immunity, epithelial cell function, and angiogenesis have been reported to be associated with risks for Acute Lung Injury (ALI) and related outcomes. We tested whether previously-reported associations can be validated in an independent cohort at risk for ALI. Methods: We identified 37 genetic variants in 27 genes previously associated with ALI and related outcomes. We prepared allelic discrimination assays for 12 SNPs from 11 genes with MAF>0.05 and genotyped these SNPs in Caucasian subjects from a cohort of critically ill patients meeting criteria for the systemic inflammatory response syndrome (SIRS) followed for development of ALI, duration of mechanical ventilation, and in-hospital death. We tested for associations using additive and recessive genetic models. Results: Among Caucasian subjects with SIRS (n = 750), we identified a nominal association between rs2069832 in IL6 and ALI susceptibility (ORadj 1.61; 95% confidence interval [CI], 1.04-2.48, P = 0.03). In a sensitivity analysis limiting ALI cases to those who qualified for the Acute Respiratory Distress Syndrome (ARDS), rs61330082 in NAMPT was nominally associated with risk for ARDS. In terms of ALI outcomes, SNPs in MBL2 (rs1800450) and IL8 (rs4073) were nominally associated with fewer ventilator-free days (VFDs), and SNPs in NFE2L2 (rs6721961) and NAMPT (rs61330082) were nominally associated with 28-day mortality. The directions of effect for these nominal associations were in the same direction as previously reported but none of the associations survived correction for multiple hypothesis testing. Conclusion: Although our primary analyses failed to statistically validate prior associations, our results provide some support for associations between SNPs in IL6 and NAMPT and risk for development of lung injury and for SNPs in IL8, MBL2, NFE2L2 and NAMPT with severity in ALI outcomes. These associations provide further evidence that genetic factors in genes related to immunity and inflammation contribute to ALI pathogenesis. Citation: O'Mahony DS, Glavan BJ, Holden TD, Fong C, Black RA, et al. (2012) Inflammation and Immune-Related Candidate Gene Associations with Acute Lung Injury Susceptibility and Severity: A Validation Study. PLoS ONE 7(12): e51104. doi: 10.1371/journal.pone.0051104	[O'Mahony, D. Shane; Glavan, Bradford J.; Holden, Tarah D.; Fong, Christie; Rona, Gail; Wurfel, Mark M.] Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98104 USA; [Tejera, Paula; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Black, R. Anthony] Univ Washington, Inst Translat Hlth Sci, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle	Wurfel, MM (corresponding author), Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, 325 9Th Ave, Seattle, WA 98104 USA.	mmwurfel@u.washington.edu		Tejera, Paula/0000-0002-0317-890X	National Institutes of Health [5RC2HL101779-02, UL1RR025014]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants 5RC2HL101779-02 and UL1RR025014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MH, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-73; Andia DC, 2012, ARCH ORAL BIOL; Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; Bouros Demosthenes, 2004, BMC Pulm Med, V4, P6, DOI 10.1186/1471-2466-4-6; Cho HY, 2002, AM J RESP CELL MOL, V26, P42, DOI 10.1165/ajrcmb.26.1.4536; Christie JD, 2006, EUR RESPIR J, V27, P669, DOI 10.1183/09031936.06.00017306; Christie JD, 2008, CRIT CARE MED; Edwards BJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-18; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Flores C, 2008, TRANSL RES, V152, P11, DOI 10.1016/j.trsl.2008.05.006; Gao L, 2009, AM J PHYSIOL-LUNG C, V296, pL713, DOI 10.1152/ajplung.90269.2008; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glavan BJ, 2011, AM J RESP CRIT CARE, V183, P356, DOI 10.1164/rccm.201003-0351OC; Gong MN, 2007, CRIT CARE MED, V35, P48, DOI 10.1097/01.CCM.0000251132.10689.F3; Gong MN, 2006, EUR RESPIR J, V27, P674, DOI 10.1183/09031936.06.00046405; Gong MN, 2005, EUR RESPIR J, V26, P382, DOI 10.1183/09031936.05.00000505; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Hildebrand F, 2007, CYTOKINE, V37, P192, DOI 10.1016/j.cyto.2007.03.008; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Marshall RP, 2002, CHEST, V121, p68S, DOI 10.1378/chest.121.3_suppl.68S; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Medford ARL, 2005, THORAX, V60, P244, DOI 10.1136/thx.2004.034785; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Nonas Stephanie A, 2005, Proc Am Thorac Soc, V2, P188, DOI 10.1513/pats.200501-005AC; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Quasney MW, 2004, CRIT CARE MED, V32, P1115, DOI 10.1097/01.CCM.0000124872.55243.5A; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Roupie E, 1999, INTENS CARE MED, V25, P920, DOI 10.1007/s001340050983; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shah CV, 2010, CHEST, V138, P1054, DOI 10.1378/chest.09-2697; Sheu CC, 2009, EUR RESPIR J, V33, P543, DOI 10.1183/09031936.00091308; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stapleton RD, 2011, CRIT CARE MED, V39, P1655, DOI 10.1097/CCM.0b013e318218669d; Su L, 2009, INTENS CARE MED, V35, P1024, DOI 10.1007/s00134-009-1413-8; Sutherland AM, 2005, ARCH INTERN MED, V165, P75, DOI 10.1001/archinte.165.1.75; Wang N, 2012, MOL BIOL REP, V39, P2831, DOI 10.1007/s11033-011-1042-5; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC	39	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51104	10.1371/journal.pone.0051104	http://dx.doi.org/10.1371/journal.pone.0051104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251429	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800026
J	Peng, LM; Yang, CR; Su, JG				Peng, Limin; Yang, Chunrong; Su, Jianguo			Protective Roles of Grass Carp Ctenopharyngodon idella Mx Isoforms against Grass Carp Reovirus	PLOS ONE			English	Article							PANCREATIC NECROSIS VIRUS; SEABREAM SPARUS-AURATA; ANTIVIRAL ACTIVITY; EXPRESSION ANALYSIS; GENE-EXPRESSION; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; ATLANTIC SALMON; INFLUENZA-VIRUS; LEUCINE-ZIPPER	Background: Myxovirus resistance (Mx) proteins are crucial effectors of the innate antiviral response against a wide range of viruses, mediated by the type I interferon (IFN-I) signaling pathway. However, the antiviral activity of Mx proteins is diverse and complicated in different species. Methodology/Principal Findings: In the current study, two novel Mx genes (CiMx1 and CiMx3) were identified in grass carp (Ctenopharyngodon idella). CiMx1 and CiMx3 proteins exhibit high sequence identity (92.1%), and low identity with CiMx2 (49.2% and 49.5%, respectively) from the GenBank database. The predicted three-dimensional (3D) structures are distinct among the three isoforms. mRNA instability motifs also display significant differences in the three genes. The spatial and temporal expression profiles of three C. idella Mx genes and the IFN-I gene were investigated by real-time fluorescence quantitative RT-PCR (qRT-PCR) following infection with grass carp reovirus (GCRV) in vivo and in vitro. The results demonstrated that all the four genes were implicated in the anti-GCRV immune response, that mRNA expression of Mx genes might be independent of IFN-I, and that CIK cells are suitable for antiviral studies. By comparing expression patterns following GCRV challenge or poly(I: C) treatment, it was observed that GCRV blocks mRNA expression of the four genes. To determine the functions of Mx genes, three CiMx cDNAs were cloned into expression vectors and utilized for transfection of CIK cells. The protection conferred by each recombinant CiMx protein against GCRV infection was evaluated. Antiviral activity against GCRV was demonstrated by reduced cytopathic effect, lower virus titer and lower levels of expressed viral transcripts. The transcription of IFN-I gene was also monitored. Conclusions/Significance: The results indicate all three Mx genes can suppress replication of grass carp reovirus and overexpression of Mx genes mediate feedback inhibition of the IFN-I gene.	[Peng, Limin; Su, Jianguo] NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Yang, Chunrong] NW A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Su, JG (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	su.jianguo@gmail.com	Su, Jianguo/G-9277-2012; Su, Jianguo/A-7444-2015	Su, Jianguo/0000-0002-9083-0715; Su, Jianguo/0000-0002-9083-0715; Su, Jianguo/0000-0002-1340-6144	Program for New Century Excellent Talents in University [NCET-08-0466]; Chinese Universities Scientific Fund [QN2009022]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Universities Scientific Fund	The study was supported by the Program for New Century Excellent Talents in University (NCET-08-0466) and the Chinese Universities Scientific Fund (QN2009022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAZZIGHER L, 1993, VIROLOGY, V195, P100, DOI 10.1006/viro.1993.1350; Caipang C, 2004, MAR BIOTECHNOL, V6, P475; Chen YM, 2008, DEV COMP IMMUNOL, V32, P825, DOI 10.1016/j.dci.2007.12.003; De Zoysa M, 2007, FISH SHELLFISH IMMUN, V23, P86, DOI 10.1016/j.fsi.2006.09.007; DeWitte-Orr SJ, 2007, FISH SHELLFISH IMMUN, V23, P670, DOI 10.1016/j.fsi.2007.01.017; DICE JF, 1975, P NATL ACAD SCI USA, V72, P3893, DOI 10.1073/pnas.72.10.3893; Eisenacher K, 2012, EUR J CELL BIOL, V91, P36, DOI 10.1016/j.ejcb.2011.01.011; Ewald SJ, 2011, IMMUNOGENETICS, V63, P363, DOI 10.1007/s00251-010-0509-1; Fernandez-Trujillo MA, 2011, MOL IMMUNOL, V49, P107, DOI 10.1016/j.molimm.2011.07.023; Fernandez-Trujillo MA, 2011, MOL IMMUNOL, V48, P1216, DOI 10.1016/j.molimm.2011.03.008; Fernandez-Trujillo MA, 2008, FISH SHELLFISH IMMUN, V24, P187, DOI 10.1016/j.fsi.2007.10.010; Fernandez-Trujillo MA, 2006, FISH SHELLFISH IMMUN, V21, P577, DOI 10.1016/j.fsi.2006.03.003; Fullaondo A, 2012, DEV COMP IMMUNOL, V36, P262, DOI 10.1016/j.dci.2011.08.007; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 1998, REV SCI TECH OIE, V17, P220, DOI 10.20506/rst.17.1.1084; Haller O., 2008, REV SCI TECH, V28, P219; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; Jensen V, 2000, J INTERF CYTOK RES, V20, P701, DOI 10.1089/10799900050116408; Kileng O, 2007, FISH SHELLFISH IMMUN, V23, P378, DOI 10.1016/j.fsi.2006.11.011; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee JY, 2000, DEV COMP IMMUNOL, V24, P407, DOI 10.1016/S0145-305X(99)00060-9; Li G, 2009, MOL BIOL EVOL, V26, P1619, DOI 10.1093/molbev/msp074; Lockhart K, 2007, FISH SHELLFISH IMMUN, V22, P151, DOI 10.1016/j.fsi.2006.04.002; MEIER E, 1990, J VIROL, V64, P6263, DOI 10.1128/JVI.64.12.6263-6269.1990; MELEN K, 1992, J BIOL CHEM, V267, P25898; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Pletneva LM, 2006, J INTERF CYTOK RES, V26, P914, DOI 10.1089/jir.2006.26.914; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saint-Jean SR, 2007, FISH SHELLFISH IMMUN, V23, P390, DOI 10.1016/j.fsi.2006.11.012; Schusser B, 2011, J VIROL, V85, P8307, DOI 10.1128/JVI.00535-11; Su JG, 2011, FISH SHELLFISH IMMUN, V30, P830, DOI 10.1016/j.fsi.2011.01.006; Su JG, 2009, FISH SHELLFISH IMMUN, V26, P828, DOI 10.1016/j.fsi.2008.12.007; Tafalla C, 2007, FISH SHELLFISH IMMUN, V23, P210, DOI 10.1016/j.fsi.2006.10.009; Tafalla C, 2004, FISH SHELLFISH IMMUN, V16, P11, DOI 10.1016/S1050-4648(03)00010-X; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Trobridge GD, 1997, J VIROL, V71, P5304, DOI 10.1128/JVI.71.7.5304-5311.1997; Wahle E, 1997, PROG NUCLEIC ACID RE, V57, P41, DOI 10.1016/S0079-6603(08)60277-9; Wang L, 2011, MOL IMMUNOL, V49, P359, DOI 10.1016/j.molimm.2011.09.010; Workenhe ST, 2010, MOL IMMUNOL, V47, P2525, DOI 10.1016/j.molimm.2010.06.009; Wu YC, 2007, FISH SHELLFISH IMMUN, V23, P97, DOI 10.1016/j.fsi.2006.09.008; Wu YC, 2010, FISH SHELLFISH IMMUN, V28, P467, DOI 10.1016/j.fsi.2009.12.008; Zenke K, 2009, FISH SHELLFISH IMMUN, V26, P599, DOI 10.1016/j.fsi.2008.09.012; Zhang YB, 2004, IMMUNOGENETICS, V56, P68, DOI 10.1007/s00251-004-0658-1; Zhang YB, 2007, DEV COMP IMMUNOL, V31, P232, DOI 10.1016/j.dci.2006.05.015; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001; Zou J, 2010, CURR PHARM DESIGN, V16, P4185, DOI 10.2174/138161210794519093	55	46	51	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52142	10.1371/journal.pone.0052142	http://dx.doi.org/10.1371/journal.pone.0052142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251697	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800148
J	Silachev, DN; Isaev, NK; Pevzner, IB; Zorova, LD; Stelmashook, EV; Novikova, SV; Plotnikov, EY; Skulachev, VP; Zorov, DB				Silachev, Denis N.; Isaev, Nikolay K.; Pevzner, Irina B.; Zorova, Ljubava D.; Stelmashook, Elena V.; Novikova, Svetlana V.; Plotnikov, Egor Y.; Skulachev, Vladimir P.; Zorov, Dmitry B.			The Mitochondria-Targeted Antioxidants and Remote Kidney Preconditioning Ameliorate Brain Damage through Kidney-to-Brain Cross-Talk	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; GLYCOGEN-SYNTHASE KINASE-3-BETA; N-ACETYL-CYSTEINE; PLASTOQUINONE DERIVATIVES; INTERRUPT EXECUTION; HIF-ALPHA; ERYTHROPOIETIN; ISCHEMIA; REPERFUSION; TOOLS	Background: Many ischemia-induced neurological pathologies including stroke are associated with high oxidative stress. Mitochondria-targeted antioxidants could rescue the ischemic organ by providing specific delivery of antioxidant molecules to the mitochondrion, which potentially suffers from oxidative stress more than non-mitochondrial cellular compartments. Besides direct antioxidative activity, these compounds are believed to activate numerous protective pathways. Endogenous anti-ischemic defense may involve the very powerful neuroprotective agent erythropoietin, which is mainly produced by the kidney in a redox-dependent manner, indicating an important role of the kidney in regulation of brain ischemic damage. The goal of this study is to track the relations between the kidney and the brain in terms of the amplification of defense mechanisms during SkQR1 treatment and remote renal preconditioning and provide evidence that the kidney can generate signals inducing a tolerance to oxidative stress-associated brain pathologies. Methodology/Principal Findings: We used the cationic plastoquinone derivative, SkQR1, as a mitochondria-targeted antioxidant to alleviate the deleterious consequences of stroke. A single injection of SkQR1 before cerebral ischemia in a dose-dependent manner reduces infarction and improves functional recovery. Concomitantly, an increase in the levels of erythropoietin in urine and phosphorylated glycogen synthase kinase-3 beta (GSK-3 beta) in the brain was detected 24 h after SkQR1 injection. However, protective effects of SkQR1 were not observed in rats with bilateral nephrectomy and in those treated with the nephrotoxic antibiotic gentamicin, indicating the protective role of humoral factor(s) which are released from functional kidneys. Renal preconditioning also induced brain protection in rats accompanied by an increased erythropoietin level in urine and kidney tissue and P-GSK-3 beta in brain. Co-cultivation of SkQR1-treated kidney cells with cortical neurons resulted in enchanced phosphorylation of GSK-3 beta in neuronal cells. Conclusion: The results indicate that renal preconditioning and SkQR1-induced brain protection may be mediated through the release of EPO from the kidney.	[Silachev, Denis N.; Isaev, Nikolay K.; Plotnikov, Egor Y.; Skulachev, Vladimir P.; Zorov, Dmitry B.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Silachev, Denis N.; Isaev, Nikolay K.; Pevzner, Irina B.; Zorova, Ljubava D.; Stelmashook, Elena V.; Novikova, Svetlana V.; Plotnikov, Egor Y.; Skulachev, Vladimir P.; Zorov, Dmitry B.] Moscow MV Lomonosov State Univ, Mitoengn Res Inst, Moscow, Russia; [Isaev, Nikolay K.; Stelmashook, Elena V.; Novikova, Svetlana V.] Russian Acad Med Sci, Res Ctr Neurol, Moscow, Russia; [Pevzner, Irina B.; Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Zorova, Ljubava D.] Moscow MV Lomonosov State Univ, Ctr Int Laser, Moscow 119899, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Research Center of Neurology; Russian Academy of Medical Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University	Zorov, DB (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	zorov@genebee.msu.su	Plotnikov, Egor Y/F-8592-2019; Zorova, Ljubava/AAC-7286-2022; Zorov, Dmitry B./AAB-1738-2019; Silachev, Denis/ABE-8515-2020; Stelmashook, Elena V/B-4442-2012; Isaev, Nikolay K/B-4194-2012; Zorova, Ljubava D/J-3554-2017; Silachev, Denis N/C-9464-2012; Pevzner, Irina B/S-6178-2018	Plotnikov, Egor Y/0000-0003-2838-3704; Zorova, Ljubava/0000-0001-9046-712X; Zorov, Dmitry B./0000-0003-0863-8490; Zorova, Ljubava D/0000-0001-9046-712X; Skulachev, Vladimir/0000-0001-5141-7517; Stelmashook, Elena/0000-0003-2533-7673; Silachev, Denis/0000-0003-0581-9755; Isaev, Nickolay/0000-0001-8427-1163	Research Institute of Mitoengineering; RFBR [12-04-00025, 11-04-00771, 11-04-01307]; Russian Federation [MK-729.2012.4]	Research Institute of Mitoengineering; RFBR(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation)	This study was supported by the Research Institute of Mitoengineering; RFBR grants, 12-04-00025, 11-04-00771 and 11-04-01307; Grant of the President of the Russian Federation MK-729.2012.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; Anisimov VN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1329, DOI 10.1134/S0006297908120055; Antonenko YN, 2008, J MEMBRANE BIOL, V222, P141, DOI 10.1007/s00232-008-9108-6; Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018; Bakeeva LE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1288, DOI 10.1134/S000629790812002X; BARONE FC, 1991, BRAIN RES BULL, V26, P285, DOI 10.1016/0361-9230(91)90240-K; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Bergmann MW, 2011, EUR J HEART FAIL, V13, P560, DOI 10.1093/eurjhf/hfr002; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Canbolat O, 1998, RESP PHYSIOL, V114, P175, DOI 10.1016/S0034-5687(98)00080-2; Cocheme HM, 2007, MITOCHONDRION, V7, pS94, DOI 10.1016/j.mito.2007.02.007; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diwan V, 2008, J CARDIOVASC PHARM, V51, P126, DOI 10.1097/FJC.0b013e31815d88c9; Diwan V, 2008, MOL CELL BIOCHEM, V315, P195, DOI 10.1007/s11010-008-9808-3; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Hagen T, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/436981; Hildebrandt W, 2002, BLOOD, V99, P1552, DOI 10.1182/blood.V99.5.1552; Hobbs CE, 2008, PEDIATR INT, V50, P481, DOI 10.1111/j.1442-200X.2008.02705.x; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; HUNTER AJ, 1995, TRENDS PHARMACOL SCI, V16, P123, DOI 10.1016/S0165-6147(00)88999-3; [Исаев Н.К. Isaev N.K.], 2012, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V77, P1201; Ishida T, 1997, SHOCK, V8, P86, DOI 10.1097/00024382-199708000-00003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jelkmann W, 1997, KIDNEY INT, V51, P497, DOI 10.1038/ki.1997.69; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Ludman AJ, 2011, HEART, V97, P1560, DOI 10.1136/hrt.2011.223867; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCCLANAHAN TB, 1993, FASEB J, V7, pA118; Miura T, 2010, CARDIOVASC RES, V88, P7, DOI 10.1093/cvr/cvq206; Momeni M, 2011, EUR J APPL PHYSIOL, V111, P2681, DOI 10.1007/s00421-011-1893-4; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Neroev VV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1317, DOI 10.1134/S0006297908120043; Neumcke I, 1999, ENDOCRINOLOGY, V140, P641, DOI 10.1210/en.140.2.641; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Plotnikov EY, 2007, KIDNEY INT, V72, P1493, DOI 10.1038/sj.ki.5002568; Plotnikov EY, 2011, BBA-MOL BASIS DIS, V1812, P77, DOI 10.1016/j.bbadis.2010.09.008; Plotnikov EY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P145, DOI 10.1134/S0006297910020045; Prunier F, 2012, AM HEART J, V163, P200, DOI 10.1016/j.ahj.2011.11.005; Quiroz JA, 2010, NEUROPSYCHOBIOLOGY, V62, P50, DOI 10.1159/000314310; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Silachev DN, 2009, B EXP BIOL MED+, V147, P269, DOI 10.1007/s10517-009-0489-z; Skulachev MV, 2011, CURR DRUG TARGETS, V12, P800; Skulachev VP, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1385, DOI 10.1134/S0006297907120139; Skulachev VP, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1400, DOI 10.1134/S0006297909120165; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Zembron-Lacny A, 2009, PHYSIOL RES, V58, P855, DOI 10.33549/physiolres.931590	55	37	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51553	10.1371/journal.pone.0051553	http://dx.doi.org/10.1371/journal.pone.0051553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272118	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800053
J	Valero, ML; de Queiroz, FM; Stuhmer, W; Viana, F; Pardo, LA				Valero, Maria Ll.; de Queiroz, Fernanda Mello; Stuehmer, Walter; Viana, Felix; Pardo, Luis A.			TRPM8 Ion Channels Differentially Modulate Proliferation and Cell Cycle Distribution of Normal and Cancer Prostate Cells	PLOS ONE			English	Article							MENTHOL RECEPTOR TRPM8; COLD SENSITIVITY; SENSORY NEURONS; EXPRESSION; TEMPERATURE; ACTIVATION; CARCINOMA; MARKER; RNA; IDENTIFICATION	Overexpression of the cation-permeable channel TRPM8 in prostate cancers might represent a novel opportunity for their treatment. Inhibitors of TRPM8 reduce the growth of prostate cancer cells. We have used two recently described and highly specific blockers, AMTB and JNJ41876666, and RNAi to determine the relevance of TRPM8 expression in the proliferation of non-tumor and tumor cells. Inhibition of the expression or function of the channel reduces proliferation rates and proliferative fraction in all tumor cells tested, but not of non-tumor prostate cells. We observed no consistent acceleration of growth after stimulation of the channel with menthol or icilin, indicating that basal TRPM8 expression is enough to sustain growth of prostate cancer cells. Citation: Valero MLI, Mello de Queiroz F, Stuhmer W, Viana F, Pardo LA (2012) TRPM8 Ion Channels Differentially Modulate Proliferation and Cell Cycle Distribution of Normal and Cancer Prostate Cells. PLoS ONE 7(12): e51825. doi:10.1371/journal.pone.0051825	[Valero, Maria Ll.; de Queiroz, Fernanda Mello; Stuehmer, Walter; Pardo, Luis A.] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Valero, Maria Ll.; Viana, Felix] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain; [Stuehmer, Walter] DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); German Research Foundation (DFG)	Pardo, LA (corresponding author), Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, Hermann Rein Str 3, D-37075 Gottingen, Germany.	pardo@em.mpg.de	Stuehmer, Walter/A-2176-2009; Pardo, Luis/C-5066-2013; Viana, Felix/U-8533-2017	Stuehmer, Walter/0000-0002-0642-7764; Pardo, Luis/0000-0003-1375-4349; Viana, Felix/0000-0003-1439-949X	Max-Planck Society [SAF2010-14990, PROMETEO2010-046]; Spanish Government (F.P.I)	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Spanish Government (F.P.I)(Spanish Government)	Financed by the Max-Planck Society and grants SAF2010-14990 and PROMETEO2010-046 to FV. MV was the recipient of a predoctoral fellowship of the Spanish Government (F.P.I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ J, 1992, J BIOL CHEM, V267, P11789; Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Bai VU, 2010, INT J ONCOL, V36, P443, DOI 10.3892/ijo_00000518; Bantounas I, 2004, J MOL ENDOCRINOL, V33, P545, DOI 10.1677/jme.1.01582; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Chodon D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-212; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Cunha AC, 2006, CANCER LETT, V236, P229, DOI 10.1016/j.canlet.2005.05.021; De Blas GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006095; DEGEORGES A, 1995, INT J CANCER, V62, P724, DOI 10.1002/ijc.2910620613; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Flourakis M, 2009, BBA-MOL CELL RES, V1793, P1105, DOI 10.1016/j.bbamcr.2009.01.009; Fuessel S, 2003, INT J ONCOL, V23, P221; Fuessel S, 2006, PROSTATE, V66, P811, DOI 10.1002/pros.20404; Garcia-Martinez C, 2006, J PAIN, V7, P735, DOI 10.1016/j.jpain.2006.03.008; Gkika D, 2010, ONCOGENE, V29, P4611, DOI 10.1038/onc.2010.210; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jimenez-Lara AM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-15; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kiessling A, 2003, PROSTATE, V56, P270, DOI 10.1002/pros.10265; Kim SH, 2009, BBA-MOL BASIS DIS, V1792, P33, DOI 10.1016/j.bbadis.2008.09.012; Lashinger ESR, 2008, AM J PHYSIOL-RENAL, V295, pF803, DOI 10.1152/ajprenal.90269.2008; Lebedeva IV, 2005, MOL THER, V11, P4, DOI 10.1016/j.ymthe.2004.08.012; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Malkia A, 2011, CURR PHARM BIOTECHNO, V12, P54, DOI 10.2174/138920111793937916; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Montell C, 2006, NAT NEUROSCI, V9, P466, DOI 10.1038/nn0406-466; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Parks DJ, 2011, J MED CHEM, V54, P233, DOI 10.1021/jm101075v; Pavet V, 2011, ONCOGENE, V30, P1, DOI 10.1038/onc.2010.460; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodriguez Luis G., 2004, V294, P23; Sanchez MG, 2005, EUR J PHARMACOL, V515, P20, DOI 10.1016/j.ejphar.2005.04.010; Stein RJ, 2004, J UROLOGY, V172, P1175, DOI 10.1097/01.ju.0000134880.55119.cf; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsavaler L, 2001, CANCER RES, V61, P3760; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Valero M, 2011, PFLUG ARCH EUR J PHY, V461, P99, DOI 10.1007/s00424-010-0895-0; Voets T., 2007, V179, P329; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Weil A, 2005, MOL PHARMACOL, V68, P518, DOI 10.1124/mol.105.012146; Yamamura H, 2008, AM J PHYSIOL-CELL PH, V295, pC296, DOI 10.1152/ajpcell.00499.2007; Yang ZH, 2009, ASIAN J ANDROL, V11, P157, DOI 10.1038/aja.2009.1; Zhang L, 2006, ENDOCR-RELAT CANCER, V13, P27, DOI 10.1677/erc.1.01093; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	56	49	53	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51825	10.1371/journal.pone.0051825	http://dx.doi.org/10.1371/journal.pone.0051825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251635	Green Published, gold			2022-12-27	WOS:000312386800093
J	Wang, Y; Teng, HL; Huang, ZH				Wang, Ying; Teng, Hong-Lin; Huang, Zhi-hui			Intrinsic Migratory Properties of Cultured Schwann Cells Based on Single-Cell Migration Assay	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; OLFACTORY ENSHEATHING CELLS; CONTUSED SPINAL-CORD; NEURONAL MIGRATION; GROWTH-FACTOR; MYOSIN-II; AXON ENSHEATHMENT; GENE-EXPRESSION; EXCHANGE FACTOR; DISTINCT ROLES	The migration of Schwann cells is critical for development of peripheral nervous system and is essential for regeneration and remyelination after nerve injury. Although several factors have been identified to regulate Schwann cell migration, intrinsic migratory properties of Schwann cells remain elusive. In this study, based on time-lapse imaging of single isolated Schwann cells, we examined the intrinsic migratory properties of Schwann cells and the molecular cytoskeletal machinery of soma translocation during migration. We found that cultured Schwann cells displayed three motile phenotypes, which could transform into each other spontaneously during their migration. Local disruption of F-actin polymerization at leading front by a Cytochalasin D or Latrunculin A gradient induced collapse of leading front, and then inhibited soma translocation. Moreover, in migrating Schwann cells, myosin II activity displayed a polarized distribution, with the leading process exhibiting higher expression than the soma and trailing process. Decreasing this front-to-rear difference of myosin II activity by frontal application of a ML-7 or BDM (myosin II inhibitors) gradient induced the collapse of leading front and reversed soma translocation, whereas, increasing this front-to-rear difference of myosin II activity by rear application of a ML-7 or BDM gradient or frontal application of a Caly (myosin II activator) gradient accelerated soma translocation. Taken together, these results suggest that during migration, Schwann cells display malleable motile phenotypes and the extension of leading front dependent on F-actin polymerization pulls soma forward translocation mediated by myosin II activity. Citation: Wang Y, Teng H-L, Huang Z-h (2012) Intrinsic Migratory Properties of Cultured Schwann Cells Based on Single-Cell Migration Assay. PLoS ONE 7(12): e51824. doi:10.1371/journal.pone.0051824	[Wang, Ying; Huang, Zhi-hui] Wenzhou Med Coll, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China; [Wang, Ying] Wenzhou Med Coll, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China; [Wang, Ying; Huang, Zhi-hui] Wenzhou Med Coll, Inst Neurosci, Wenzhou, Zhejiang, Peoples R China; [Teng, Hong-Lin] Wenzhou Med Coll, Affiliated Hosp 1, Dept Spine Surg, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Huang, ZH (corresponding author), Wenzhou Med Coll, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China.	hzhzju021@163.com			Natural Science Foundation of Zhejiang Province [Y2090545, Y2110242, Y2110364]; National Natural Science Foundation [31100779, 81100903]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by Natural Science Foundation of Zhejiang Province (Y2090545, Y2110242, Y2110364), and National Natural Science Foundation (31100779, 81100903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FT, 2010, GLIA, V58, P857, DOI 10.1002/glia.20970; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; BAILEY SB, 1993, J NEUROCYTOL, V22, P176, DOI 10.1007/BF01246356; Ban DX, 2009, BRAIN RES, V1256, P149, DOI 10.1016/j.brainres.2008.11.098; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; BARONVANEVERCOOREN A, 1993, J NEUROSCI RES, V35, P428; Bryan DJ, 1999, J RECONSTR MICROSURG, V15, P591, DOI 10.1055/s-2007-1000143; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; Cao L, 2007, GLIA, V55, P897, DOI 10.1002/glia.20511; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cornejo M, 2010, NEUROCHEM RES, V35, P1643, DOI 10.1007/s11064-010-0225-0; Dubovy P, 2001, GLIA, V33, P36, DOI 10.1002/1098-1136(20010101)33:1<36::AID-GLIA1004>3.0.CO;2-B; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Feltri ML, 2008, GLIA, V56, P1508, DOI 10.1002/glia.20752; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Han IS, 2007, J CELL SCI, V120, P246, DOI 10.1242/jcs.03322; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4; Huang ZH, 2008, CELL RES, V18, P479, DOI 10.1038/cr.2008.38; Huang ZH, 2011, EXP CELL RES, V317, P2823, DOI 10.1016/j.yexcr.2011.09.004; Huang ZH, 2011, J CELL SCI, V124, P186, DOI 10.1242/jcs.071357; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jin FZ, 2011, DEVELOPMENT, V138, P1329, DOI 10.1242/dev.058677; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lavdas AA, 2008, CURR MED CHEM, V15, P151; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liu J, 2006, J CELL SCI, V119, P933, DOI 10.1242/jcs.02796; Lobsiger CS, 2002, BIOL CHEM, V383, P245, DOI 10.1515/BC.2002.026; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Mitchel JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024316; Nodari A, 2007, J CELL BIOL, V177, P1063, DOI 10.1083/jcb.200610014; Novak N, 2011, J CELL BIOL, V192, P243, DOI 10.1083/jcb.201010013; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Perlin JR, 2011, DEVELOPMENT, V138, P4639, DOI 10.1242/dev.068072; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Thomas MG, 2002, NEUROCHEM RES, V27, P1305, DOI 10.1023/A:1021615530960; Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Wang HB, 2008, J CELL BIOL, V182, P1171, DOI 10.1083/jcb.200802091; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yamauchi J, 2011, J NEUROSCI, V31, P12579, DOI 10.1523/JNEUROSCI.2738-11.2011; Yu WM, 2009, J CELL SCI, V122, P929, DOI 10.1242/jcs.033928	59	17	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51824	10.1371/journal.pone.0051824	http://dx.doi.org/10.1371/journal.pone.0051824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251634	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800092
J	Singh, PP; Lucchi, NW; Blackstock, A; Udhayakumar, V; Singh, N				Singh, Puspendra P.; Lucchi, Naomi W.; Blackstock, Anna; Udhayakumar, Venkatachalam; Singh, Neeru			Intervillous Macrophage Migration Inhibitory Factor Is Associated with Adverse Birth Outcomes in a Study Population in Central India	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; RAPID DIAGNOSTIC-TEST; PLACENTAL MALARIA; INFECTED ERYTHROCYTES; PREGNANCY OUTCOMES; UP-REGULATION; FACTOR MIF; BLOOD; EXPRESSION; CYTOKINES	Macrophage migration inhibitory factor (MIF) is a pluripotent factor produced by a variety of cells. It plays an important biological role in the regulation of pregnancy and has been shown to influence malaria pathogenesis. In this study, the levels of MIF in the peripheral, cord and placental intervillous blood (IVB) plasma collected from women residing in a malaria endemic region of Central India was determined and its association with malaria in pregnancy and birth outcomes was investigated. MIF levels were significantly different in IVB, peripheral, and cord plasma, with IVB plasma having the highest MIF levels and peripheral plasma having the lowest. Placental malaria positive women had significantly higher IVB plasma MIF levels than placental malaria negative women, but this relationship was not seen in peripheral or cord plasma MIF levels. In addition, the odds of stillbirth and low birth weight deliveries for the uppermost placental MIF quartile (irrespective of placental malaria status) was significantly higher than that of the lowest placental MIF quartile, supporting the hypothesis that elevated concentrations of placental MIF may be associated with an increased risk of adverse birth outcome. Citation: Singh PP, Lucchi NW, Blackstock A, Udhayakumar V, Singh N (2012) Intervillous Macrophage Migration Inhibitory Factor Is Associated with Adverse Birth Outcomes in a Study Population in Central India. PLoS ONE 7(12): e51678. doi:10.1371/journal.pone.0051678	[Singh, Puspendra P.; Singh, Neeru] Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India; [Singh, Puspendra P.; Singh, Neeru] Natl Inst Malaria Res Field Unit, Jabalpur, Madhya Pradesh, India; [Lucchi, Naomi W.; Blackstock, Anna; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Blackstock, Anna] Atlanta Res & Educ Fdn, VA Med Ctr, Decatur, GA USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Singh, N (corresponding author), Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India.	neeru.singh@gmail.com	Singh, Pushpendra P./P-6421-2018; Singh, Puspendra/R-5135-2019; Singh, Puspendra/P-1772-2017; Singh, Puspendra/F-5751-2012	Singh, Pushpendra P./0000-0003-3813-4322; Singh, Puspendra/0000-0003-2616-9309; Lucchi, Naomi/0000-0001-8789-8041	Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Govt. of India, New Delhi	Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Govt. of India, New Delhi	The study was funded by Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Govt. of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Awandare GA, 2006, CLIN IMMUNOL, V119, P219, DOI 10.1016/j.clim.2005.12.003; Beeson JG, 2002, INFECT IMMUN, V70, P5412, DOI 10.1128/IAI.70.10.5412-5415.2002; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bharti PK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-126; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Cardaropoli S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/639342; Carli C, 2009, ENDOCRINOLOGY, V150, P3128, DOI 10.1210/en.2008-1088; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; Chaisavaneeyakorn S, 2002, J INFECT DIS, V186, P1371, DOI 10.1086/344322; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V18, P405, DOI 10.1080/14767050500361703; Chaiyaroj SC, 2004, ACTA TROP, V89, P319, DOI 10.1016/j.actatropica.2003.10.010; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Diamond-Smith Nadia, 2009, Malar J, V8, P24, DOI 10.1186/1475-2875-8-24; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; Fried M, 1998, J IMMUNOL, V160, P2523; GALBRAITH RM, 1980, T ROY SOC TROP MED H, V74, P61, DOI 10.1016/0035-9203(80)90012-7; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Hamer DH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-210; Kochar Dhanpat K., 1998, Indian Journal of Malariology, V35, P123; Leopardi O, 1996, PATHOL RES PRACT, V192, P892, DOI 10.1016/S0344-0338(96)80068-9; Letta F, 2002, AM J REPROD IMMUNOL, V48, P404, DOI 10.1034/j.1600-0897.2002.01152.x; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Martiney JA, 2000, INFECT IMMUN, V68, P2259, DOI 10.1128/IAI.68.4.2259-2267.2000; McGready R, 2004, AM J TROP MED HYG, V70, P398, DOI 10.4269/ajtmh.2004.70.398; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Moore JM, 1999, J INFECT DIS, V179, P1218, DOI 10.1086/314737; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Nair Latika S., 1993, Indian Journal of Malariology, V30, P207; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Pearce BD, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.066; RANDALL CL, 1987, ALCOHOL CLIN EXP RES, V11, P32, DOI 10.1111/j.1530-0277.1987.tb01256.x; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Sakamoto Y, 2005, J REPROD IMMUNOL, V66, P161, DOI 10.1016/j.jri.2005.04.005; Singh N, 2003, ANN TROP MED PARASIT, V97, P875, DOI 10.1179/000349803225002688; Singh N, 1999, B WORLD HEALTH ORGAN, V77, P567; Singh N, 2000, ANN TROP MED PARASIT, V94, P421, DOI 10.1080/00034983.2000.11813560; Singh Neeru, 1996, Indian Journal of Malariology, V33, P41; Singh Neeru, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P10; Singh Neeru, 1995, Indian Journal of Malariology, V32, P6; Swope MD, 1999, REV PHYSIOL BIOCH P, V139, P1, DOI 10.1007/BFb0033647; Todros T, 2005, EUR J OBSTET GYN R B, V123, P162, DOI 10.1016/j.ejogrb.2005.03.014; URQUHART AD, 1994, CLIN INFECT DIS, V19, P117, DOI 10.1093/clinids/19.1.117; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51678	10.1371/journal.pone.0051678	http://dx.doi.org/10.1371/journal.pone.0051678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272137	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386600035
J	Bockisch, CJ; Khojasteh, E; Straumann, D; Hegemann, SCA				Bockisch, Christopher J.; Khojasteh, Elham; Straumann, Dominik; Hegemann, Stefan C. A.			Development of Eye Position Dependency of Slow Phase Velocity during Caloric Stimulation	PLOS ONE			English	Article							HUMAN VESTIBULOOCULAR REFLEX; ALEXANDERS LAW; NEURAL INTEGRATOR; OCULOMOTOR INTEGRATOR; GUINEA-PIG; MODEL; PLASTICITY; NYSTAGMUS; ASYMMETRY; MOVEMENTS	The nystagmus in patients with vestibular disorders often has an eye position dependency, called Alexander's law, where the slow phase velocity is higher with gaze in the fast phase direction compared with gaze in the slow phase direction. Alexander's law has been hypothesized to arise either due to adaptive changes in the velocity-to-position neural integrator, or as a consequence of processing of the vestibular-ocular reflex. We tested whether Alexander's law arises only as a consequence of non-physiologic vestibular stimulation. We measured the time course of the development of Alexander's law in healthy humans with nystagmus caused by three types of caloric vestibular stimulation: cold (unilateral inhibition), warm (unilateral excitation), and simultaneous bilateral bithermal (one side cold, the other warm) stimulation, mimicking the normal push-pull pattern of vestibular stimulation. Alexander's law, measured as a negative slope of the velocity versus position curve, was observed in all conditions. A reversed pattern of eye position dependency (positive slope) was found <10% of the time. The slope often changed with nystagmus velocity (cross-correlation of nystagmus speed and slope was significant in 50% of cases), and the average lag of the slope with the speed was not significantly different from zero. Our results do not support the hypothesis that Alexander's law can only be observed with non-physiologic vestibular stimulation. Further, the rapid development of Alexander's law, while possible for an adaptive mechanism, is nonetheless quite fast compared to most other ocular motor adaptations. These results suggest that Alexander's law may not be a consequence of a true adaptive mechanism.	[Bockisch, Christopher J.; Khojasteh, Elham; Hegemann, Stefan C. A.] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.; Straumann, Dominik] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.; Straumann, Dominik; Hegemann, Stefan C. A.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Bockisch, CJ (corresponding author), Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland.	chris.bockisch@usz.ch	Hegemann, Stefan/B-4640-2013; Hegemann, Stefan/AAT-4425-2020	Hegemann, Stefan/0000-0002-9464-352X; Hegemann, Stefan/0000-0002-9464-352X; Bockisch, Christopher/0000-0003-1054-2578	Swiss National Science Foundation [320000_122535/1]; Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; FQRNT (Fonds de Rescherch du Quebec) from Quebec, Canada	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; FQRNT (Fonds de Rescherch du Quebec) from Quebec, Canada	This study was supported by the Swiss National Science Foundation grant (number 320000_122535/1) and the Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland. E. Khojasteh receives the FQRNT (Fonds de Rescherch du Quebec) post-doctoral scholarship from Quebec, Canada. None of individuals employed or contracted by the funders (other than the named authors) played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; Alexander G, 1912, HDB KINDERHEILKUNDE, P84; Anagnostou E, 2011, NEUROREPORT, V22, P239, DOI 10.1097/WNR.0b013e3283451769; BECKER W, 1973, VISION RES, V13, P1021, DOI 10.1016/0042-6989(73)90141-7; Bockisch CJ, 2008, J NEUROPHYSIOL, V100, P3105, DOI 10.1152/jn.90381.2008; Chan WWP, 2007, P ANN INT IEEE EMBS, P1156, DOI 10.1109/IEMBS.2007.4352501; Chan WWP, 2005, J NEUROPHYSIOL, V93, P3709, DOI 10.1152/jn.00814.2004; Crane BT, 1998, J NEUROPHYSIOL, V80, P1151, DOI 10.1152/jn.1998.80.3.1151; CRAWFORD JD, 1993, EXP BRAIN RES, V96, P443; DOSLAK MJ, 1982, ANN OTO RHINOL LARYN, V91, P316, DOI 10.1177/000348948209100318; DOSLAK MJ, 1979, BIOL CYBERN, V34, P181, DOI 10.1007/BF00336969; Hegemann S, 2007, JARO-J ASSOC RES OTO, V8, P551, DOI 10.1007/s10162-007-0095-6; Hess K., 1982, NEUROSCI LETT S, V10, P242; Jeffcoat B, 2008, J NEUROPHYSIOL, V100, P154, DOI 10.1152/jn.00055.2008; JONES GM, 1988, EXP BRAIN RES, V69, P531; Khojasteh E, 2012, EUROPEAN J NEUROSCIE; Mensh BD, 2004, VISION RES, V44, P711, DOI 10.1016/j.visres.2003.10.015; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Murofushi T, 1997, ACTA OTO-LARYNGOL, V117, P66, DOI 10.3109/00016489709117994; MUROFUSHI T, 1995, EXP BRAIN RES, V103, P174; OOSTERVELD WJ, 1987, ARCH OTO-RHINO-LARYN, V244, P155, DOI 10.1007/BF00464260; Paige GD, 1998, J NEUROPHYSIOL, V80, P2391, DOI 10.1152/jn.1998.80.5.2391; PAIGE GD, 1985, ACTA OTO-LARYNGOL, V100, P321, DOI 10.3109/00016488509126555; Peterka RJ, 2004, J NEUROPHYSIOL, V92, P2333, DOI 10.1152/jn.00174.2004; Robinson D.A., 1975, BASIC MECH OCULAR MO, P337; ROBINSON DA, 1968, SCIENCE, V161, P1219, DOI 10.1126/science.161.3847.1219; ROBINSON DA, 1984, ANN NEUROL, V16, P714, DOI 10.1002/ana.410160614; SCHERER H, 1986, EXP BRAIN RES, V64, P255; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Zhou W, 2007, J NEUROPHYSIOL, V97, P2780, DOI 10.1152/jn.00812.2006	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51409	10.1371/journal.pone.0051409	http://dx.doi.org/10.1371/journal.pone.0051409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251522	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000313236200102
J	Gotoh, M; Sano-Maeda, K; Murofushi, H; Murakami-Murofushi, K				Gotoh, Mari; Sano-Maeda, Katsura; Murofushi, Hiromu; Murakami-Murofushi, Kimiko			Protection of Neuroblastoma Neuro2A Cells from Hypoxia-Induced Apoptosis by Cyclic Phosphatidic Acid (cPA)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DNA-POLYMERASE-ALPHA; LYSOPHOSPHATIDIC ACID; PC12 CELLS; BIOLOGICAL FUNCTIONS; HUMAN SERUM; AUTOTAXIN; RECEPTOR; INHIBITION; PHYLPA	Cyclic phosphatidic acid (cPA) is a naturally occurring phospholipid mediator with a unique cyclic phosphate ring at the sn-2 and sn-3 positions of its glycerol backbone. We have previously shown that cPA significantly suppresses ischemia-induced delayed neuronal death and the accumulation of glial fibrillary acidic protein in the CA1 region of the rat hippocampus. These results indicated that the systemic administration of cPA can protect hippocampal neurons against ischemia-induced delayed neuronal cell death. In the current study, we investigated the effects of cPA on neuronal cell death caused by hypoxia in vitro and the molecular mechanisms underlying these effects. We used cobalt chloride (CoCl2) to expose cells to hypoxic conditions in vitro. Treating mouse neuroblastoma (Neuro2A) cells with CoCl2 induced nuclear DNA condensation and phosphatidylserine exposure. However, adding cPA led to the suppression of CoCl2-induced apoptosis in a cPA dose-dependent manner and attenuated the increase in the Bax/Bcl-2 ratio caused by CoCl2. Quantitative PCR analysis showed that Neuro2A cells strongly express the LPA(1), LPA(2), and LPA(6), which are G-protein coupled receptors that can be activated by cPA. To date, LPA(1) and LPA(2) have been reported to exhibit antiapoptotic activity. Therefore, to assess the roles of LPA(1) and LPA(2) on cPA-induced neuroprotective functions, Ki16425, a selective LPA(1) and LPA(3) antagonist, was adopted to know the LPA(1) function and siRNA was used to knockdown the expression of LPA(2). On the basis of our results, we propose that cPA-induced protection of Neuro2A cells from CoCl2-induced hypoxia damage is mediated via LPA(2).	[Gotoh, Mari; Sano-Maeda, Katsura; Murofushi, Hiromu; Murakami-Murofushi, Kimiko] Ochanomizu Univ, Div Life Sci, Tokyo 112, Japan	Ochanomizu University	Murakami-Murofushi, K (corresponding author), Ochanomizu Univ, Div Life Sci, Tokyo 112, Japan.	murofushi.kimiko@ocha.ac.jp	GOTOH, Mari/AAX-4457-2020	GOTOH, Mari/0000-0002-8052-4247	Princess Takamatsu Cancer Research Fund; Rational Evolutionary Design of Advanced Biomolecules (REDS3) Project; Central Saitama Area in the Program for Fostering Regional Innovation (City Area Type); Ministry for Education, Culture, Sports, Science and Technology of Japan [22790203]	Princess Takamatsu Cancer Research Fund; Rational Evolutionary Design of Advanced Biomolecules (REDS3) Project; Central Saitama Area in the Program for Fostering Regional Innovation (City Area Type); Ministry for Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Princess Takamatsu Cancer Research Fund, the Rational Evolutionary Design of Advanced Biomolecules (REDS3) Project, Central Saitama Area in the Program for Fostering Regional Innovation (City Area Type), a Grant-in-Aid for Scientific Research (KAKENHI, No. 22790203) from the Ministry for Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fujiwara Y, 2003, J NEUROCHEM, V87, P1272, DOI 10.1046/j.1471-4159.2003.02106.x; Fujiwara Y, 2008, BBA-MOL CELL BIOL L, V1781, P519, DOI 10.1016/j.bbalip.2008.05.002; Gotoh M, 2012, BIOCHEM SOC T, V40, P31, DOI 10.1042/BST20110608; Gotoh M, 2010, EUR J PHARMACOL, V649, P206, DOI 10.1016/j.ejphar.2010.09.052; Gupte R, 2010, BIOORG MED CHEM LETT, V20, P7525, DOI 10.1016/j.bmcl.2010.09.115; Jung JY, 2007, LIFE SCI, V80, P1355, DOI 10.1016/j.lfs.2006.11.033; Kakiuchi Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-33; KOBAYASHI S, 1993, TETRAHEDRON LETT, V34, P4047, DOI 10.1016/S0040-4039(00)60612-3; Kobayashi T, 1999, LIFE SCI, V65, P2185, DOI 10.1016/S0024-3205(99)00483-X; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lu N, 2007, BASIC CLIN PHARMACOL, V101, P41, DOI 10.1111/j.1742-7843.2007.00074.x; Murakami-Murofushi K, 2002, BBA-MOL CELL BIOL L, V1582, P1, DOI 10.1016/S1388-1981(02)00131-2; MURAKAMIMUROFUSHI K, 1992, J BIOL CHEM, V267, P21512; Nozaki E, 2012, BIOORGAN MED CHEM, V20, P3196, DOI 10.1016/j.bmc.2012.03.060; Nozaki E, 2011, CYTOLOGIA, V76, P73, DOI 10.1508/cytologia.76.73; Nozaki E, 2011, BBA-MOL CELL BIOL L, V1811, P271, DOI 10.1016/j.bbalip.2011.01.003; Ohta H, 2006, MOL PHARM, V64, P994; Sarada SKS, 2008, BRAIN RES, V1209, P29, DOI 10.1016/j.brainres.2008.02.041; Shan L, 2008, J CHROMATOGR B, V862, P161, DOI 10.1016/j.jchromb.2007.12.003; TAKAHASHI Y, 1993, CELL STRUCT FUNCT, V18, P135, DOI 10.1247/csf.18.135; Tanaka R, 2011, BIOORG MED CHEM LETT, V21, P4180, DOI 10.1016/j.bmcl.2011.05.083; Uchiyama A, 2007, BBA-MOL CELL BIOL L, V1771, P103, DOI 10.1016/j.bbalip.2006.10.001; Valentine WJ, 2010, CELL SIGNAL, V22, P1543, DOI 10.1016/j.cellsig.2010.05.023; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Zhang SQ, 2011, MOL CELL BIOCHEM, V354, P161, DOI 10.1007/s11010-011-0815-4; Zou WG, 2002, J NEUROSCI RES, V67, P837, DOI 10.1002/jnr.10168; Zou WG, 2001, J NEUROSCI RES, V64, P646, DOI 10.1002/jnr.1118	32	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51093	10.1371/journal.pone.0051093	http://dx.doi.org/10.1371/journal.pone.0051093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251428	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200058
J	Honing, H; Merchant, H; Haden, GP; Prado, L; Bartolo, R				Honing, Henkjan; Merchant, Hugo; Haden, Gabor P.; Prado, Luis; Bartolo, Ramon			Rhesus Monkeys (Macaca mulatta) Detect Rhythmic Groups in Music, but Not the Beat	PLOS ONE			English	Article							CHIMPANZEE PAN-TROGLODYTES; MISMATCH NEGATIVITY; EMERGENT METER; PERCEPTION; INDUCTION	It was recently shown that rhythmic entrainment, long considered a human-specific mechanism, can be demonstrated in a selected group of bird species, and, somewhat surprisingly, not in more closely related species such as nonhuman primates. This observation supports the vocal learning hypothesis that suggests rhythmic entrainment to be a by-product of the vocal learning mechanisms that are shared by several bird and mammal species, including humans, but that are only weakly developed, or missing entirely, in nonhuman primates. To test this hypothesis we measured auditory event-related potentials (ERPs) in two rhesus monkeys (Macaca mulatta), probing a well-documented component in humans, the mismatch negativity (MMN) to study rhythmic expectation. We demonstrate for the first time in rhesus monkeys that, in response to infrequent deviants in pitch that were presented in a continuous sound stream using an oddball paradigm, a comparable ERP component can be detected with negative deflections in early latencies (Experiment 1). Subsequently we tested whether rhesus monkeys can detect gaps (omissions at random positions in the sound stream; Experiment 2) and, using more complex stimuli, also the beat (omissions at the first position of a musical unit, i.e. the 'downbeat'; Experiment 3). In contrast to what has been shown in human adults and newborns (using identical stimuli and experimental paradigm), the results suggest that rhesus monkeys are not able to detect the beat in music. These findings are in support of the hypothesis that beat induction (the cognitive mechanism that supports the perception of a regular pulse from a varying rhythm) is species-specific and absent in nonhuman primates. In addition, the findings support the auditory timing dissociation hypothesis, with rhesus monkeys being sensitive to rhythmic grouping (detecting the start of a rhythmic group), but not to the induced beat (detecting a regularity from a varying rhythm).	[Honing, Henkjan; Haden, Gabor P.] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands; [Merchant, Hugo; Prado, Luis; Bartolo, Ramon] Univ Nacl Autonoma Mexico, Dept Cognit Neurosci, Inst Neurobiol, Queretaro, Mexico	University of Amsterdam; Universidad Nacional Autonoma de Mexico	Honing, H (corresponding author), Univ Amsterdam, Cognit Sci Ctr Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands.	honing@uva.nl	Bartolo, Ramon/AAB-6579-2022; Honing, Henkjan/A-1362-2012; Háden, Gábor Péter/A-2098-2011; Merchant, Hugo/E-8703-2019	Bartolo, Ramon/0000-0003-2165-9747; Honing, Henkjan/0000-0001-7046-7923; Merchant, Hugo/0000-0002-3488-9501	University of Amsterdam; Hendrik Muller chair, Royal Netherlands Academy of Arts and 8 Sciences (KNAW); Consejo Nacional de Ciencia y Tecnologia [151223]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN206508]; Hendrik Muller chair, Royal Netherlands Academy of Arts and Sciences (KNAW)	University of Amsterdam; Hendrik Muller chair, Royal Netherlands Academy of Arts and 8 Sciences (KNAW); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Hendrik Muller chair, Royal Netherlands Academy of Arts and Sciences (KNAW)	The research of HH and GH was supported by the Research Priority Area 'Brain & Cognition' at the University of Amsterdam. The first author (HH) is supported by the Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and 8 Sciences (KNAW). The second author's research (HM) was supported by Consejo Nacional de Ciencia y Tecnologia Grant 151223, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Grant: IN206508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research of H.H. and G.H. is part of the Research Priority Area 'Brain & Cognition' at the University of Amsterdam. The first author (H.H.) is supported by the Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and Sciences (KNAW). We thank Raul Paulin for his technical assistance. We are grateful to Istvan Winkler, Fleur Bouwer and two anonymous reviewers for their comments on an earlier version of this manuscript.	Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Brown S, 2000, ORIGINS OF MUSIC, P3; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Deutsch D, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P183, DOI 10.1016/B978-0-12-381460-9.00006-7; Fitch WT, 2009, CURR BIOL, V19, pR403, DOI 10.1016/j.cub.2009.04.004; Fukushima H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013366; Grahn JA, 2012, TOP COGN SCI, V4, P585, DOI 10.1111/j.1756-8765.2012.01213.x; Grube M, 2010, P NATL ACAD SCI USA, V107, P11597, DOI 10.1073/pnas.0910473107; Harris PG, 2001, ANN NY ACAD SCI, V930, P414, DOI 10.1111/j.1749-6632.2001.tb05756.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hasegawa A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00120; Honing H, 2012, ANN NY ACAD SCI, V1252, P85, DOI 10.1111/j.1749-6632.2011.06402.x; Honing H, 2009, ANN NY ACAD SCI, V1169, P93, DOI 10.1111/j.1749-6632.2009.04761.x; Horvath J, 2010, NEUROREPORT, V21, P537, DOI 10.1097/WNR.0b013e3283398094; Jongsma MLA, 2004, BIOL PSYCHOL, V66, P129, DOI 10.1016/j.biopsycho.2003.10.002; Konoike N, 2012, NEUROSCI RES, V74, P64, DOI 10.1016/j.neures.2012.06.002; Ladinig O, 2011, MUSIC PERCEPT, V28, P444; Ladinig O, 2009, MUSIC PERCEPT, V26, P377, DOI 10.1525/MP.2009.26.4.377; Merchant H, 2011, P NATL ACAD SCI USA, V108, P19784, DOI 10.1073/pnas.1112933108; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2006, MUSIC PERCEPT, V24, P99, DOI 10.1525/mp.2006.24.1.99; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; Teki S, 2011, J NEUROSCI, V31, P3805, DOI 10.1523/JNEUROSCI.5561-10.2011; Ueno A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001442; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Yabe H, 1997, NEUROREPORT, V8, P1971, DOI 10.1097/00001756-199705260-00035; Zarco W, 2009, J NEUROPHYSIOL, V102, P3191, DOI 10.1152/jn.00066.2009	30	87	87	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51369	10.1371/journal.pone.0051369	http://dx.doi.org/10.1371/journal.pone.0051369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251509	Green Published, gold			2022-12-27	WOS:000313236200097
J	Nickerson, KP; McDonald, C				Nickerson, Kourtney P.; McDonald, Christine			Crohn's Disease-Associated Adherent-Invasive Escherichia coli Adhesion Is Enhanced by Exposure to the Ubiquitous Dietary Polysaccharide Maltodextrin	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOME; MUCOSAL FLORA; ILEAL MUCOSA; E. COLI; BIOFILM FORMATION; GROWTH; EPIDEMIOLOGY; DIVERSITY; TRANSPORT	Crohn's disease (CD) is associated with intestinal dysbiosis evidenced by an altered microbiome forming thick biofilms on the epithelium. Additionally, adherent-invasive E. coli (AIEC) strains are frequently isolated from ileal lesions of CD patients indicating a potential role for these strains in disease pathogenesis. The composition and characteristics of the host microbiome are influenced by environmental factors, particularly diet. Polysaccharides added to food as emulsifiers, stabilizers or bulking agents have been linked to bacteria-associated intestinal disorders. The escalating consumption of polysaccharides in Western diets parallels an increased incidence of CD during the latter 20th century. In this study, the effect of a polysaccharide panel on adhesiveness of the CD-associated AIEC strain LF82 was analyzed to determine if these food additives promote disease-associated bacterial phenotypes. Maltodextrin (MDX), a polysaccharide derived from starch hydrolysis, markedly enhanced LF82 specific biofilm formation. Biofilm formation of multiple other E. coli strains was also promoted by MDX. MDX-induced E. coli biofilm formation was independent of polysaccharide chain length indicating a requirement for MDX metabolism. MDX exposure induced type I pili expression, which was required for MDX-enhanced biofilm formation. MDX also increased bacterial adhesion to human intestinal epithelial cell monolayers in a mechanism dependent on type 1 pili and independent of the cellular receptor CEACAM6, suggesting a novel mechanism of epithelial cell adhesion. Analysis of mucosa-associated bacteria from individuals with and without CD showed increased prevalence of malX, a gene essential for MDX metabolism, uniquely in the ileum of CD patients. These findings demonstrate that the ubiquitous dietary component MDX enhances E. coli adhesion and suggests a mechanism by which Western diets rich in specific polysaccharides may promote dysbiosis of gut microbes and contribute to disease susceptibility.	[Nickerson, Kourtney P.; McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA; [Nickerson, Kourtney P.; McDonald, Christine] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	McDonald, C (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA.	mcdonac2@ccf.org		Nickerson, Kourtney/0000-0001-7852-593X; McDonald, Christine/0000-0002-6745-9487	National Institutes of Health [R01DK082437, R01DK050984]; Howard Hughes Medical Institute "Med into Grad" Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050984, R01DK082437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute "Med into Grad" Initiative(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were funded in part by National Institutes of Health grants R01DK082437 and R01DK050984, the Howard Hughes Medical Institute "Med into Grad" Initiative and the generosity of Gerald and Nancy Goldberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Baker Phillip I, 2009, Expert Rev Gastroenterol Hepatol, V3, P535, DOI 10.1586/egh.09.47; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Beal J, 2012, J PEDIAT; BeMiller JN, 2009, J AGR FOOD CHEM, V57, P8125, DOI 10.1021/jf8039236; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Carvalho FA, 2008, INFLAMM BOWEL DIS, V14, P1051, DOI 10.1002/ibd.20423; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Chronakis IS, 1998, CRIT REV FOOD SCI, V38, P599, DOI 10.1080/10408699891274327; Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Cotter PD, 2011, CURR OPIN GASTROEN, V27, P99, DOI 10.1097/MOG.0b013e328341dc67; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hill DR, 2012, J BIOL CHEM; Jensen SR, 2011, J MICROBIOL METH, V86, P111, DOI 10.1016/j.mimet.2011.04.002; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; KEIGHLEY MRB, 1978, GUT, V19, P1099, DOI 10.1136/gut.19.12.1099; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Martinez-Medina M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-202; Martinez-Medina M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/ibd.20860; McDonald DE, 2001, BRIT J NUTR, V86, P487, DOI 10.1079/BJN2001416; Montagne L, 2004, J ANIM SCI, V82, P2364; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; REIDL J, 1991, J BACTERIOL, V173, P4862, DOI 10.1128/jb.173.15.4862-4876.1991; Rolhion N, 2007, MOL MICROBIOL, V63, P1684, DOI 10.1111/j.1365-2958.2007.05638.x; Rowan NJ, 1997, APPL ENVIRON MICROB, V63, P1182, DOI 10.1128/AEM.63.3.1182-1184.1997; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; SCHWAN WR, 1992, J BACTERIOL, V174, P2367, DOI 10.1128/JB.174.7.2367-2375.1992; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sepehri S, 2011, INFLAMM BOWEL DIS, V17, P1451, DOI 10.1002/ibd.21509; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; STOWE SP, 1990, GASTROENTEROLOGY, V98, P104, DOI 10.1016/0016-5085(90)91297-J; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2009, J PHYSIOL PHARMACOL, V60, P61; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 2009, INFLAMM BOWEL DIS, V15, P359, DOI 10.1002/ibd.20763; Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vasquez N, 2007, INFLAMM BOWEL DIS, V13, P684, DOI 10.1002/ibd.20084; Vejborg RM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-316; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	58	93	96	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e52132	10.1371/journal.pone.0052132	http://dx.doi.org/10.1371/journal.pone.0052132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251695	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200175
J	Tito, RY; Knights, D; Metcalf, J; Obregon-Tito, AJ; Cleeland, L; Najar, F; Roe, B; Reinhard, K; Sobolik, K; Belknap, S; Foster, M; Spicer, P; Knight, R; Lewis, CM				Tito, Raul Y.; Knights, Dan; Metcalf, Jessica; Obregon-Tito, Alexandra J.; Cleeland, Lauren; Najar, Fares; Roe, Bruce; Reinhard, Karl; Sobolik, Kristin; Belknap, Samuel; Foster, Morris; Spicer, Paul; Knight, Rob; Lewis, Cecil M., Jr.			Insights from Characterizing Extinct Human Gut Microbiomes	PLOS ONE			English	Article							ENTERS; DIET; DNA	In an effort to better understand the ancestral state of the human distal gut microbiome, we examine feces retrieved from archaeological contexts (coprolites). To accomplish this, we pyrosequenced the 16S rDNA V3 region from duplicate coprolite samples recovered from three archaeological sites, each representing a different depositional environment: Hinds Cave (similar to 8000 years B. P.) in the southern United States, Caserones (1600 years B. P.) in northern Chile, and Rio Zape in northern Mexico (1400 years B. P.). Clustering algorithms grouped samples from the same site. Phyletic representation was more similar within sites than between them. A Bayesian approach to source-tracking was used to compare the coprolite data to published data from known sources that include, soil, compost, human gut from rural African children, human gut, oral and skin from US cosmopolitan adults and non-human primate gut. The data from the Hinds Cave samples largely represented unknown sources. The Caserones samples, retrieved directly from natural mummies, matched compost in high proportion. A substantial and robust proportion of Rio Zape data was predicted to match the gut microbiome found in traditional rural communities, with more minor matches to other sources. One of the Rio Zape samples had taxonomic representation consistent with a child. To provide an idealized scenario for sample preservation, we also applied source tracking to previously published data for Otzi the Iceman and a soldier frozen for 93 years on a glacier. Overall these studies reveal that human microbiome data has been preserved in some coprolites, and these preserved human microbiomes match more closely to those from the rural communities than to those from cosmopolitan communities. These results suggest that the modern cosmopolitan lifestyle resulted in a dramatic change to the human gut microbiome.	[Tito, Raul Y.; Obregon-Tito, Alexandra J.; Cleeland, Lauren; Foster, Morris; Spicer, Paul; Lewis, Cecil M., Jr.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Knights, Dan] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Metcalf, Jessica; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Najar, Fares; Roe, Bruce] Univ Oklahoma, Dept Chem & Biochem, Adv Ctr Genome Technol, Norman, OK 73019 USA; [Reinhard, Karl] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA; [Sobolik, Kristin; Belknap, Samuel] Univ Maine, Climate Change Inst, Orono, ME USA; [Sobolik, Kristin; Belknap, Samuel] Univ Maine, Dept Anthropol, Orono, ME USA	University of Oklahoma System; University of Oklahoma - Norman; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Oklahoma System; University of Oklahoma - Norman; University of Nebraska System; University of Nebraska Lincoln; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Lewis, CM (corresponding author), Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA.	cmlewis@ou.edu	Tito, Raul/CAG-3546-2022; Knight, Rob/D-1299-2010; Reinhard, Karl/AAT-7881-2020	Tito Tadeo, Raul Yhossef/0000-0001-9660-7621; Obregon-Tito, Alexandra/0000-0003-2508-7176; Knight, Rob/0000-0002-0975-9019	National Institutes of Health [R01 HG005172-01, R01 GM089886-01A1]; National Science Foundation (NSF) [0845314]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089886] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [0845314] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Support for this research is from the National Institutes of Health (grants R01 HG005172-01 and R01 GM089886-01A1) and the National Science Foundation (NSF#0845314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baker GC, 2004, BIOCHEM SOC T, V32, P218, DOI 10.1042/BST0320218; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glass EM, 2010, COLD SPRING HARB PRO; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jimenez FA, 2012, J PARASITOL, V98, P304, DOI 10.1645/GE-2915.1; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lord K.J., 1984, ZOOARCHAEOLOGY HINDS; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Neel JV, 1998, PERSPECT BIOL MED, V42, P44; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Rollo Franco, 2006, Med Secoli, V18, P725; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tito RY, 2011, AM J PHYS ANTHROPOL, V145, P653, DOI 10.1002/ajpa.21526; Tito RY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003703; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Watanabe K, 2008, CURR MICROBIOL, V56, P458, DOI 10.1007/s00284-008-9107-y; Wilkinson L, 2011, VISUALIZATION COMPUT, P1; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	36	126	130	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51146	10.1371/journal.pone.0051146	http://dx.doi.org/10.1371/journal.pone.0051146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251439	gold, Green Published			2022-12-27	WOS:000313236200062
J	Zhang, G; Karns, R; Sun, GY; Indugula, SR; Cheng, H; Havas-Augustin, D; Novokmet, N; Durakovic, Z; Missoni, S; Chakraborty, R; Rudan, P; Deka, R				Zhang, Ge; Karns, Rebekah; Sun, Guangyun; Indugula, Subba Rao; Cheng, Hong; Havas-Augustin, Dubravka; Novokmet, Natalija; Durakovic, Zijad; Missoni, Sasa; Chakraborty, Ranajit; Rudan, Pavao; Deka, Ranjan			Finding Missing Heritability in Less Significant Loci and Allelic Heterogeneity: Genetic Variation in Human Height	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ISLAND POPULATION; VARIANTS	Genome-wide association studies (GWAS) have identified many common variants associated with complex traits in human populations. Thus far, most reported variants have relatively small effects and explain only a small proportion of phenotypic variance, leading to the issues of 'missing' heritability and its explanation. Using height as an example, we examined two possible sources of missing heritability: first, variants with smaller effects whose associations with height failed to reach genome-wide significance and second, allelic heterogeneity due to the effects of multiple variants at a single locus. Using a novel analytical approach we examined allelic heterogeneity of height-associated loci selected from SNPs of different significance levels based on the summary data of the GIANT (stage 1) studies. In a sample of 1,304 individuals collected from an island population of the Adriatic coast of Croatia, we assessed the extent of height variance explained by incorporating the effects of less significant height loci and multiple effective SNPs at the same loci. Our results indicate that approximately half of the 118 loci that achieved stringent genome-wide significance (p-value<5 x 10(-8)) showed evidence of allelic heterogeneity. Additionally, including less significant loci (i.e., p-value<5 x 10(-4)) and accounting for effects of allelic heterogeneity substantially improved the variance explained in height.	[Zhang, Ge] Cincinnati Childrens Hosp, Div Human Genet, Cincinnati, OH USA; [Karns, Rebekah; Sun, Guangyun; Indugula, Subba Rao; Cheng, Hong; Deka, Ranjan] Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45221 USA; [Havas-Augustin, Dubravka; Novokmet, Natalija; Durakovic, Zijad; Missoni, Sasa; Rudan, Pavao] Inst Anthropol Res, Zagreb, Croatia; [Chakraborty, Ranajit] Univ N Texas Hlth Sci Ctr, Inst Appl Genet, Ctr Computat Genom, Ft Worth, TX USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Institute for Anthropological Research Zagreb; University of North Texas System; University of North Texas Health Science Center	Deka, R (corresponding author), Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45221 USA.	ranjan.deka@uc.edu	Missoni, Sasa/G-8821-2013; Zhang, Ge/F-1809-2011	Missoni, Sasa/0000-0002-6542-9970	National Institutes of Health, United States of America [R01 DK069845, R01 DK069845-4S, P30 ES006096]; Croatian Ministry of Science, Education and Sports [196-1962766-2751, 196-1962766-2747, 196-0342282-0291]; National Institutes of Environmental Health Sciences, USA [T32 ES010957]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES010957, P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); National Institutes of Environmental Health Sciences, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by grants from the National Institutes of Health, United States of America (R01 DK069845, R01 DK069845-4S and P30 ES006096) and from the Croatian Ministry of Science, Education and Sports (196-1962766-2751, 196-1962766-2747 and 196-0342282-0291). RK was supported by a training grant fellowship from the National Institutes of Environmental Health Sciences, USA (T32 ES010957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Carvalho BS, 2010, BIOINFORMATICS, V26, P242, DOI 10.1093/bioinformatics/btp624; Deka R, 2012, ANN HUM BIOL, V39, P46, DOI 10.3109/03014460.2011.637512; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Karns R, 2012, ANN HUM GENET, V76, P121, DOI 10.1111/j.1469-1809.2011.00698.x; Karns R, 2011, EUR J HUM GENET, V19, P341, DOI 10.1038/ejhg.2010.178; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029475; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375	21	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51211	10.1371/journal.pone.0051211	http://dx.doi.org/10.1371/journal.pone.0051211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251454	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200069
J	Ojima, H; Taira, M; Kubota, M; Horikawa, J				Ojima, Hisayuki; Taira, Masato; Kubota, Michinori; Horikawa, Junsei			Recognition of Non-Harmonic Natural Sounds by Small Mammals Using Competitive Training	PLOS ONE			English	Article							SHORT-TERM-MEMORY; TEMPORAL FINE-STRUCTURE; ULTRASOUND PRODUCTION; AUDITORY OBJECTS; SONG PERCEPTION; RHESUS-MONKEYS; STRUCTURE CUES; COMMUNICATION; SPEECH; DISCRIMINATION	Animals recognize biologically relevant sounds, such as the non-harmonic sounds made by some predators, and respond with adaptive behaviors, such as escaping. To clarify which acoustic parameters are used for identifying non-harmonic, noise-like, broadband sounds, guinea pigs were conditioned to a natural target sound by introducing a novel training procedure in which 2 or 3 guinea pigs in a group competed for food. A set of distinct behavioral reactions was reliably induced almost exclusively to the target sound in a 2-week operant training. When fully conditioned, individual animals were separately tested for recognition of a set of target-like sounds that had been modified from the target sound, with spectral ranges eliminated or with fine or coarse temporal structures altered. The results show that guinea pigs are able to identify the noise-like non-harmonic natural sounds by relying on gross spectral compositions and/or fine temporal structures, just as birds are thought to do in the recognition of harmonic birdsongs. These findings are discussed with regard to similarities and dissimilarities to harmonic sound recognition. The results suggest that similar but not identical processing that requires different time scales might be used to recognize harmonic and non-harmonic sounds, at least in small mammals.	[Ojima, Hisayuki; Taira, Masato] Tokyo Med & Dent Univ, Ctr Brain Integrat Res CBIR & Cognit Neurobiol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Kubota, Michinori] Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan; [Horikawa, Junsei] Toyohashi Univ Technol, Grad Sch Comp Sci & Engn, Toyohashi, Aichi, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Toyohashi University of Technology	Ojima, H (corresponding author), Tokyo Med & Dent Univ, Ctr Brain Integrat Res CBIR & Cognit Neurobiol, Grad Sch Med & Dent Sci, Tokyo, Japan.	yojima.cnb@tmd.ac.jp			Japan Society for the Promotion of Science [22500368]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (C)(General) from Japan Society for the Promotion of Science (no. 22500368 to H.O.). Please see http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIN JT, 1972, ANIM BEHAV, V20, P175, DOI 10.1016/S0003-3472(72)80189-1; BERRYMAN JC, 1976, Z TIERPSYCHOL, V41, P80; Braaten RF, 2006, J COMP PSYCHOL, V120, P79, DOI 10.1037/0735-7036.120.2.79; Comins JA, 2010, COGNITION, V117, P38, DOI 10.1016/j.cognition.2010.06.009; DAMATO MR, 1985, ANIM LEARN BEHAV, V13, P375, DOI 10.3758/BF03208013; Dooling RJ, 2002, J ACOUST SOC AM, V112, P748, DOI 10.1121/1.1494447; DRULLMAN R, 1995, J ACOUST SOC AM, V97, P585, DOI 10.1121/1.413112; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; Fritz J, 2005, P NATL ACAD SCI USA, V102, P9359, DOI 10.1073/pnas.0503998102; Geissler DB, 2002, P NATL ACAD SCI USA, V99, P9021, DOI 10.1073/pnas.122606499; Gentner TQ, 2008, J ACOUST SOC AM, V124, P1350, DOI 10.1121/1.2945705; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Harper LV, 1976, BIOL GUINEA PIG, P31, DOI DOI 10.1016/B978-0-12-730050-4.50010-7; Hopkins K, 2009, J ACOUST SOC AM, V125, P442, DOI 10.1121/1.3037233; Itatani N, 2011, J NEUROPHYSIOL, V105, P188, DOI 10.1152/jn.00496.2010; Knudsen DP, 2010, BRAIN LANG, V115, P59, DOI 10.1016/j.bandl.2009.09.008; KOJIMA S, 1980, J EXP ANAL BEHAV, V33, P359, DOI 10.1901/jeab.1980.33-359; KONISHI M, 1993, SCI AM, V268, P66, DOI 10.1038/scientificamerican0493-66; KRAEMER PJ, 1984, ANIM LEARN BEHAV, V12, P275, DOI 10.3758/BF03199968; Lebrun N, 1998, NEUROIMAGE, V8, P79, DOI 10.1006/nimg.1998.0347; Lesica NA, 2008, J NEUROSCI, V28, P5412, DOI 10.1523/JNEUROSCI.0073-08.2008; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lohr B, 2006, J COMP PSYCHOL, V120, P239, DOI 10.1037/0735-7036.120.3.239; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; MARLER P, 1967, SCIENCE, V157, P769, DOI 10.1126/science.157.3790.769; Nagel KI, 2010, J NEUROPHYSIOL, V104, P1426, DOI 10.1152/jn.00028.2010; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Ojima H, 2010, CEREB CORTEX, V20, P339, DOI 10.1093/cercor/bhp103; Pfingst BE, 2011, HEARING RES, V281, P65, DOI 10.1016/j.heares.2011.05.002; REMEZ RE, 1981, SCIENCE, V212, P947, DOI 10.1126/science.7233191; SCHNIDER A, 1994, BRAIN, V117, P281, DOI 10.1093/brain/117.2.281; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; SIMMONS JA, 1974, SCIENCE, V186, P1130, DOI 10.1126/science.186.4169.1130; Vernaleo BA, 2011, J ACOUST SOC AM, V129, P3373, DOI 10.1121/1.3560121; WALLACE J, 1980, ANIM LEARN BEHAV, V8, P10, DOI 10.3758/BF03209724; Wohr M, 2010, HBK BEHAV NEUROSCI, V19, P159, DOI 10.1016/B978-0-12-374593-4.00016-4	40	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51318	10.1371/journal.pone.0051318	http://dx.doi.org/10.1371/journal.pone.0051318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251497	gold, Green Submitted, Green Published			2022-12-27	WOS:000312201900069
J	Rizzi, C; Bianco, MV; Blanco, FC; Soria, M; Gravisaco, MJ; Montenegro, V; Vagnoni, L; Buddle, B; Garbaccio, S; Delgado, F; Leal, KS; Cataldi, AA; Dellagostin, OA; Bigi, F				Rizzi, Caroline; Veronica Bianco, Maria; Carlos Blanco, Federico; Soria, Marcelo; Jose Gravisaco, Maria; Montenegro, Valeria; Vagnoni, Lucas; Buddle, Bryce; Garbaccio, Sergio; Delgado, Fernando; Leal, Karen Silva; Adrian Cataldi, Angel; Dellagostin, Odir Antonio; Bigi, Fabiana			Vaccination with a BCG Strain Overexpressing Ag85B Protects Cattle against Mycobacterium bovis Challenge	PLOS ONE			English	Article							MAJOR EXTRACELLULAR PROTEINS; TUBERCULOSIS VACCINE; STABLE EXPRESSION; IMMUNE-RESPONSES; INFECTED CATTLE; T-CELLS; ANTIGENS; MEMORY; MACROPHAGES; GENERATION	Mycobacterium bovis is the causative agent of tuberculosis in cattle but also infects other animals, including humans. Previous studies in cattle have demonstrated that the protection induced by BCG is not complete. In order to improve the protection efficacy of BCG, in this study we overexpressed Ag85B in a BCG Pasteur strain, by using an expression system based on the use of an auxotrophic strain for the leucine amino acid, and complementation with leuD. We found that vaccination of cattle with BCG overexpressing Ag85B induced higher production of IL-17 and IL-4 mRNA upon purified protein derivative (PPDB) stimulation of peripheral blood mononuclear cells (PBMCs) than vaccination with BCG. Moreover, the IL-17 mRNA expression after vaccination negatively correlated with disease severity resulting from a subsequent challenge with M. bovis, suggesting that this cytokine is a potential biomarker of cattle protection against bovine tuberculosis. Importantly, vaccination with the recombinant BCG vaccine protected cattle better than the wild-type BCG Pasteur.	[Rizzi, Caroline; Leal, Karen Silva; Dellagostin, Odir Antonio] Univ Fed Pelotas, Nucleo Biotecnol, CDTec, Pelotas, Brazil; [Veronica Bianco, Maria; Carlos Blanco, Federico; Jose Gravisaco, Maria; Montenegro, Valeria; Adrian Cataldi, Angel; Bigi, Fabiana] CICVyA INTA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Soria, Marcelo] Univ Buenos Aires, Fac Agron, INBA CONICET, Buenos Aires, DF, Argentina; [Vagnoni, Lucas; Garbaccio, Sergio; Delgado, Fernando] CICVyA INTA, Inst Patobiol, Buenos Aires, DF, Argentina; [Buddle, Bryce] AgResearch, Hopkirk Res Inst, Palmerston North, New Zealand	Universidade Federal de Pelotas; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); AgResearch - New Zealand	Dellagostin, OA (corresponding author), Univ Fed Pelotas, Nucleo Biotecnol, CDTec, Pelotas, Brazil.	odir@ufpel.edu.br	Dellagostin, Odir/C-2331-2009; Rizzi, Caroline/M-7187-2019; Rizzi, Caroline/H-1014-2014	Dellagostin, Odir/0000-0003-2803-4088; Rizzi, Caroline/0000-0001-5810-9592; Rizzi, Caroline/0000-0001-5810-9592; Buddle, Bryce/0000-0001-6197-6689	SECyT [PICT2324]; MinCyT UE Mercosur grant BiotechSur; INTA [AEBIO243512]; CNPq [482376/2010-4]; NIH [1R01AI083084-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083084] Funding Source: NIH RePORTER	SECyT(Secretaria de Ciencia y Tecnologia (SECYT)); MinCyT UE Mercosur grant BiotechSur; INTA; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present study was supported by SECyT grant PICT2324, MinCyT UE Mercosur grant BiotechSur and INTA grant AEBIO243512, CNPq grant 482376/2010-4 and partially supported by NIH 1R01AI083084-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Badell E, 2009, VACCINE, V27, P28, DOI 10.1016/j.vaccine.2008.10.034; Bange FC, 1996, INFECT IMMUN, V64, P1794, DOI 10.1128/IAI.64.5.1794-1799.1996; Bastos RG, 2009, VACCINE, V27, P6495, DOI 10.1016/j.vaccine.2009.08.044; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Blanco FC, 2009, MICROBIOL IMMUNOL, V53, P460, DOI 10.1111/j.1348-0421.2009.00141.x; Borsuk S, 2007, TUBERCULOSIS, V87, P474, DOI 10.1016/j.tube.2007.07.006; Buddle BM, 2005, VET IMMUNOL IMMUNOP, V108, P45, DOI 10.1016/j.vetimm.2005.08.002; Buddle BM, 2005, VACCINE, V23, P3581, DOI 10.1016/j.vaccine.2005.01.150; Buddle BM, 2011, TUBERCULOSIS, V91, P400, DOI 10.1016/j.tube.2011.07.001; Cataldi A, 2010, ART & SCIENCE OF TUBERCULOSIS VACCINE DEVELOPMENT, P185; Flores-Villalva S, 2012, CLIN VACCINE IMMUNOL, V19, P797, DOI 10.1128/CVI.05668-11; Hope JC, 2011, CLIN VACCINE IMMUNOL, V18, P373, DOI 10.1128/CVI.00543-10; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Horwitz MA, 2006, VACCINE, V24, P1593, DOI 10.1016/j.vaccine.2005.10.002; Horwitz MA, 2005, MICROBES INFECT, V7, P947, DOI 10.1016/j.micinf.2005.04.002; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530; Hu XD, 2009, DNA CELL BIOL, V28, P191, DOI 10.1089/dna.2008.0790; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Lopez-Valencia G, 2010, RES VET SCI, V88, P44, DOI 10.1016/j.rvsc.2009.05.022; Maue AC, 2007, VACCINE, V25, P4735, DOI 10.1016/j.vaccine.2007.03.052; McMurray DN, 2011, EXPERT REV VACCINES, V10, P1675, DOI [10.1586/erv.11.144, 10.1586/ERV.11.144]; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Meikle V, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-37; Nambiar JK, 2012, EUR J IMMUNOL, V42, P385, DOI 10.1002/eji.201141903; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Qie YQ, 2009, SCAND J IMMUNOL, V69, P342, DOI 10.1111/j.1365-3083.2009.02231.x; Seixas FK, 2010, BIOL RES, V43, P13, DOI [10.4067/S0716-97602010000100003, /S0716-97602010000100003]; Skinner MA, 2005, INFECT IMMUN, V73, P4441, DOI 10.1128/IAI.73.7.4441-4444.2005; Thacker TC, 2007, VET IMMUNOL IMMUNOP, V119, P204, DOI 10.1016/j.vetimm.2007.05.009; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier M, 2011, EXPERT REV VACCINES, V10, P1083, DOI [10.1586/erv.11.22, 10.1586/ERV.11.22]; Waters W Ray, 2011, Clin Dev Immunol, V2011, P768542, DOI 10.1155/2011/768542; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Wedlock DN, 2008, CLIN VACCINE IMMUNOL, V15, P765, DOI 10.1128/CVI.00034-08; Wedlock DN, 2005, INFECT IMMUN, V73, P3540, DOI 10.1128/IAI.73.6.3540-3546.2005; Whelan AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029194; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992	42	38	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51396	10.1371/journal.pone.0051396	http://dx.doi.org/10.1371/journal.pone.0051396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251517	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900077
J	Li, X; Stones, DS; Wang, HD; Deng, HL; Liu, XG; Wang, G				Li, Xin; Stones, Douglas S.; Wang, Haidong; Deng, Hualiang; Liu, Xiaoguang; Wang, Gang			NetMODE: Network Motif Detection without Nauty	PLOS ONE			English	Article							ALGORITHM; DISCOVERY; TOOL	A motif in a network is a connected graph that occurs significantly more frequently as an induced subgraph than would be expected in a similar randomized network. By virtue of being atypical, it is thought that motifs might play a more important role than arbitrary subgraphs. Recently, a flurry of advances in the study of network motifs has created demand for faster computational means for identifying motifs in increasingly larger networks. Motif detection is typically performed by enumerating subgraphs in an input network and in an ensemble of comparison networks; this poses a significant computational problem. Classifying the subgraphs encountered, for instance, is typically performed using a graph canonical labeling package, such as Nauty, and will typically be called billions of times. In this article, we describe an implementation of a network motif detection package, which we call NetMODE. NetMODE can only perform motif detection for k-node subgraphs when k <= 6, but does so without the use of Nauty. To avoid using Nauty, NetMODE has an initial pretreatment phase, where k-node graph data is stored in memory (k <= 5). For k=6 we take a novel approach, which relates to the Reconstruction Conjecture for directed graphs. We find that NetMODE can perform up to around 30 times faster than its predecessors when k <= 5 and up to around 20 times faster when k=6 (the exact improvement varies considerably). NetMODE also (a) includes a method for generating comparison graphs uniformly at random, (b) can interface with external packages (e. g. R), and (c) can utilize multi-core architectures. NetMODE is available from netmode.sf.net.	[Stones, Douglas S.] Monash Univ, Clayton Sch Informat Technol, Clayton, Vic 3800, Australia; [Li, Xin; Wang, Haidong; Deng, Hualiang; Wang, Gang] Nankai Univ, Coll Informat Tech Sci, Nankai Baidu Joint Lab, Tianjin 300071, Peoples R China; [Stones, Douglas S.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia; [Liu, Xiaoguang] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China	Monash University; Nankai University; Monash University; Nankai University	Stones, DS (corresponding author), Monash Univ, Clayton Sch Informat Technol, Clayton, Vic 3800, Australia.	the_empty_element@yahoo.com; liuxg74@yahoo.com.cn; wgzwp@163.com	Stones, Rebecca/S-8691-2019		NSFC of China [60903028, 61070014]; Key Projects in the Tianjin Science & Technology Pillar Program [11ZCKFGX01100]; ARC	NSFC of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Tianjin Science & Technology Pillar Program; ARC(Australian Research Council)	This work was supported in part by NSFC of China (60903028, 61070014), Key Projects in the Tianjin Science & Technology Pillar Program (11ZCKFGX01100). Stones was also supported by an ARC grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Artzy-Randrup Y, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056708; Baskerville K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051903; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brand M, 2012, TROUBLE NETWOR UNPUB; Bruno Francesco, 2010, International Journal of Knowledge Discovery in Bioinformatics, V1, P81, DOI 10.4018/jkdb.2010100206; Chen C, 2008, LECT N BIOINFORMAT, V5265, P448, DOI 10.1007/978-3-540-88436-1_38; Ciriello Giovanni, 2008, Briefings in Functional Genomics & Proteomics, V7, P147, DOI 10.1093/bfgp/eln015; Ginoza R, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011921; Hu JL, 2009, FRONT COMPUT SCI CHI, V3, P412, DOI 10.1007/s11704-009-0045-z; Kashani ZRM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-318; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Konagurthu AS, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-73; Koskas M., 2011, BOOK ABSTRACTS JOURN, V2011, P53; Liu YC, 2010, PATTERN RECOGN LETT, V31, P2170, DOI 10.1016/j.patrec.2009.10.009; Maslov S, 2003, HANDBOOK OF GRAPHS AND NETWORKS: FROM THE GENOME TO THE INTERNET, P168; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Milo R., 2003, UNIFORM GENERATION R; Omidi S, 2009, GENES GENET SYST, V84, P385, DOI 10.1266/ggs.84.385; Picard F, 2008, J COMPUT BIOL, V3, P347; Qin Gui-min, 2009, Acta Electronica Sinica, V37, P2258; Ribeiro Pedro, 2010, Proceedings of the 2010 IEEE International Conference on Cluster Computing (CLUSTER 2010), P217, DOI 10.1109/CLUSTER.2010.27; Ribeiro Pedro, 2009, Proceedings of the 2009 5th IEEE International Conference on e-Science (e-Science 2009), P80, DOI 10.1109/e-Science.2009.20; Ribeiro P, 2010, P 2010 ACM S APPL CO, P1559, DOI DOI 10.1145/1774088.1774422; Ribeiro P, 2010, BIONFORMATICS 2010: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON BIOINFORMATICS, P56; Ribeiro P, 2010, LECT N BIOINFORMAT, V6293, P238, DOI 10.1007/978-3-642-15294-8_20; Ribeiro P, 2011, COMM COM INF SC, V127, P380; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Schreiber F., 2004, P INT WORKSH NETW TO, P91; Schreiber F, 2008, ANAL BIOL NETWORKS, P85; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Wan R., 2009, BIOL DATA MINING PRO, P117, DOI [10.4018/978-1-60566-398-2.ch008, DOI 10.4018/978-1-60566-398-2.CH008]; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2005, LECT NOTES COMPUT SC, V3692, P165; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Wong E, 2012, BRIEF BIOINFORM, V13, P202, DOI 10.1093/bib/bbr033; Yu LB, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON PARALLEL AND DISTRIBUTED PROCESSING WITH APPLICATIONS, PROCEEDINGS, P555, DOI 10.1109/ISPA.2009.88	37	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50093	10.1371/journal.pone.0050093	http://dx.doi.org/10.1371/journal.pone.0050093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272055	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300008
J	Albers, DJ; Hripcsak, G; Schmidt, M				Albers, D. J.; Hripcsak, George; Schmidt, Michael			Population Physiology: Leveraging Electronic Health Record Data to Understand Human Endocrine Dynamics	PLOS ONE			English	Article							CONTROL-ORIENTED MODEL; GLUCOSE DYNAMICS; INSULIN; OSCILLATIONS	Studying physiology and pathophysiology over a broad population for long periods of time is difficult primarily because collecting human physiologic data can be intrusive, dangerous, and expensive. One solution is to use data that have been collected for a different purpose. Electronic health record (EHR) data promise to support the development and testing of mechanistic physiologic models on diverse populations and allow correlation with clinical outcomes, but limitations in the data have thus far thwarted such use. For example, using uncontrolled population-scale EHR data to verify the outcome of time dependent behavior of mechanistic, constructive models can be difficult because: (i) aggregation of the population can obscure or generate a signal, (ii) there is often no control population with a well understood health state, and (iii) diversity in how the population is measured can make the data difficult to fit into conventional analysis techniques. This paper shows that it is possible to use EHR data to test a physiological model for a population and over long time scales. Specifically, a methodology is developed and demonstrated for testing a mechanistic, time-dependent, physiological model of serum glucose dynamics with uncontrolled, population-scale, physiological patient data extracted from an EHR repository. It is shown that there is no observable daily variation the normalized mean glucose for any EHR subpopulations. In contrast, a derived value, daily variation in nonlinear correlation quantified by the time-delayed mutual information (TDMI), did reveal the intuitively expected diurnal variation in glucose levels amongst a random population of humans. Moreover, in a population of continuously (tube) fed patients, there was no observable TDMI-based diurnal signal. These TDMI-based signals, via a glucose insulin model, were then connected with human feeding patterns. In particular, a constructive physiological model was shown to correctly predict the difference between the general uncontrolled population and a subpopulation whose feeding was controlled. Citation: Albers DJ, Hripcsak G, Schmidt M (2012) Population Physiology: Leveraging Electronic Health Record Data to Understand Human Endocrine Dynamics. PLoS ONE 7(12): e48058. doi: 10.1371/journal.pone.0048058	[Albers, D. J.; Hripcsak, George] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Schmidt, Michael] Columbia Univ, Dept Neurol, New York, NY USA	Columbia University; Columbia University	Albers, DJ (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.	david.albers@dbmi.columbia.edu			National Library of Medicine - National Institutes of Health grant [RO1 LM06910]; NATIONAL LIBRARY OF MEDICINE [R01LM006910] Funding Source: NIH RePORTER	National Library of Medicine - National Institutes of Health grant; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors would like to acknowledge the financial support provided by National Library of Medicine - National Institutes of Health grant RO1 LM06910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2010, PHILOS T R SOC A, V368, P4893, DOI 10.1098/rsta.2010.0237; Albers DJ, 2012, CHAOS SOLITON FRACT, V45, P853, DOI 10.1016/j.chaos.2012.03.003; Albers DJ, 2012, CHAOS, V22, DOI 10.1063/1.3675621; Albers D. J., 2010, PHYS LETT A; Astrom K. J., 2008, FEEDBACK SYSTEMS INT; Blanco P, 2010, INT J BIOMEDICAL ENG, V1, P1; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Bolander F. F., 2004, MOL ENDOCRINOLOGY; Brunetti P, 2003, ARTIF CELL BLOOD SUB, V31, P127, DOI 10.1081/BIO-120020169; Fabietti PG, 2007, DIABETES TECHNOL THE, V9, P327, DOI 10.1089/dia.2006.0030; Fabietti PG, 2006, MED BIOL ENG COMPUT, V44, P69, DOI 10.1007/s11517-005-0012-2; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; Hirata Y, 2010, CHAOS, V20, DOI DOI 10.1063/1.3526968; Hripcsak G, 2007, COMPUT BIOL MED, V37, P296, DOI 10.1016/j.compbiomed.2006.02.001; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; Inscho EW, 2009, HYPERTENSION, V53, P299, DOI 10.1161/HYPERTENSIONAHA.108.119982; Kacsoh B., 2000, ENDOCRINE PHYSL; Kaldor N., 1961, THEORY CAPITAL, P177, DOI DOI 10.1007/978-1-349-08452-4_10; Kantz H., 2003, NONLINEAR TIME SERIE; Karsh BT, 2010, J AM MED INFORM ASSN, V17, P617, DOI 10.1136/jamia.2010.005637; KATZ J, 1984, J CLIN INVEST, V74, P1901, DOI 10.1172/JCI111610; Keener J., 2008, MATH PHYSL, V1; Keener James, 2008, MATH PHYSL; Keller J, 2002, J APPL PHYSIOL, V93, P592, DOI 10.1152/japplphysiol.00807.2001; Keller J, 2001, AM J PHYSIOL-GASTR L, V93, P592; Kirk D, 1988, OPTIMAL CONTROL THEO; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Levin SA, 2003, B AM MATH SOC, V40, P3; Lorenc A, 1988, Q J ROY METEOR SOC, V112, P1177; Makroglou A, 2006, APPL NUMER MATH, V56, P559, DOI 10.1016/j.apnum.2005.04.023; McQueen D. M., 2000, MECH NEW MILLENNIUM; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Moghissi E, 2009, ENDOCRINE PRACTICE, V15; Moore Gray, 2003, JOINT STAT M; Peschke E, 1998, DIABETOLOGIA, V41, P1085, DOI 10.1007/s001250051034; Sagreiya H, 2010, J BIOMED INFORM, V43, P747, DOI 10.1016/j.jbi.2010.03.014; SCHIFF S. J., 2011, NEURAL CONTROL ENG E; Schmidt J, 2012, CRIT CARE MED; Sedigh-Sarvestan M, 34 ANN INT IN PRESS; Sprott JC, 2003, CHAOS TIME SERIES AN; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; STURIS J, 1991, AM J PHYSIOL, V260, pE801, DOI 10.1152/ajpendo.1991.260.5.E801; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732	45	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e48058	10.1371/journal.pone.0048058	http://dx.doi.org/10.1371/journal.pone.0048058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272040	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800002
J	Desaki, Y; Otomo, I; Kobayashi, D; Jikumaru, Y; Kamiya, Y; Venkatesh, B; Tsuyumu, S; Kaku, H; Shibuya, N				Desaki, Yoshitake; Otomo, Ippei; Kobayashi, Daijiro; Jikumaru, Yusuke; Kamiya, Yuji; Venkatesh, Balakrishnan; Tsuyumu, Shinji; Kaku, Hanae; Shibuya, Naoto			Positive Crosstalk of MAMP Signaling Pathways in Rice Cells	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DEFENSE RESPONSES; GENE-EXPRESSION; DENDRITIC CELLS; INNATE IMMUNITY; BACTERIAL LIPOPOLYSACCHARIDES; PANTOEA-AGGLOMERANS; MOLECULAR-PATTERNS; ELICITORS; ACCUMULATION	Plants have evolved efficient defense mechanisms known as priming and synergy, both of which can mobilize defense responses more extensively against successive pathogen invasion or simultaneous stimulation by different signal molecules. However, the mechanisms underlying these phenomena were largely unknown. In the present study, we used cultured rice cells and combination of purified MAMP molecules as a model system to study the mechanisms of these phenomena. We found that the pretreatment of rice cells with a low concentration of bacterial lipopolysaccharide (LPS) apparently primed the defense responses induced by successive N-acetylchitooctaose (GN8) treatment. On the other hand, simultaneous treatment with GN8 and LPS also resulted in the similar enhancement of defense responses observed for the LPS-induced priming, indicating that the synergistic effects of these MAMPs are basically responsible for such enhancement of defense responses, though the effect could be interpreted as "priming'' under some experimental conditions. These results also indicate that such a positive crosstalk of signaling cascade downstream of MAMP receptors seems to occur very rapidly, probably at early step(s) of signaling pathway. Comprehensive analysis of phytohormones revealed a specific enhancement of the synthesis of jasmonic acid (JA), both in the LPS pretreatment and also simultaneous treatment, indicating a role of JA in the enhancement of downstream responses.	[Desaki, Yoshitake; Otomo, Ippei; Kobayashi, Daijiro; Kaku, Hanae; Shibuya, Naoto] Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa, Japan; [Jikumaru, Yusuke; Kamiya, Yuji] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Venkatesh, Balakrishnan; Tsuyumu, Shinji] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan	Meiji University; RIKEN; Shizuoka University	Shibuya, N (corresponding author), Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa, Japan.	shibuya@isc.meiji.ac.jp	Kamiya, Yuji/F-9420-2010; Desaki, Yoshitake/M-7264-2015	Kamiya, Yuji/0000-0003-4415-520X; Desaki, Yoshitake/0000-0002-0916-9051	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Private Universities Foundation for the Development of Fundamental Research Strategies	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Private Universities Foundation for the Development of Fundamental Research Strategies	This research was supported in part by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN, NS), Private Universities Foundation for the Development of Fundamental Research Strategies (NS) and also a Grant-in-Aid for JSPS fellow (YD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam SN, 2009, MOL PLANT PATHOL, V10, P375, DOI [10.1111/j.1364-3703.2009.00537.x, 10.1111/J.1364-3703.2009.00537.X]; Bakker PAHM, 2007, PHYTOPATHOLOGY, V97, P239, DOI 10.1094/PHYTO-97-2-0239; Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; DAVIS KR, 1986, PLANT MOL BIOL, V6, P23, DOI 10.1007/BF00021303; Desaki Y, 2006, PLANT CELL PHYSIOL, V47, P1530, DOI 10.1093/pcp/pcl019; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Hadley JS, 2005, INFECT IMMUN, V73, P7613, DOI 10.1128/IAI.73.11.7613-7619.2005; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Makela SM, 2011, MOL IMMUNOL, V48, P505, DOI 10.1016/j.molimm.2010.10.005; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Newman MA, 2002, PLANT J, V29, P487, DOI 10.1046/j.0960-7412.2001.00233.x; Nojiri H, 1996, PLANT PHYSIOL, V110, P387, DOI 10.1104/pp.110.2.387; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; Ortmann I, 2006, PLANTA, V224, P963, DOI 10.1007/s00425-006-0271-7; Ortmann I, 2006, FEBS LETT, V580, P4491, DOI 10.1016/j.febslet.2006.07.025; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pieterse CMJ, 1996, PLANT CELL, V8, P1225, DOI 10.1105/tpc.8.8.1225; SCHWACKE R, 1992, PLANTA, V187, P136, DOI 10.1007/BF00201635; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tsukada K, 2002, PHYSIOL PLANTARUM, V116, P373, DOI 10.1034/j.1399-3054.2002.1160313.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Yamaguchi T, 2002, J PLANT PHYSIOL, V159, P1147, DOI 10.1078/0176-1617-00877; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Zhu YJ, 2003, PHYSIOL MOL PLANT P, V63, P237, DOI 10.1016/j.pmpp.2004.03.003	34	13	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51953	10.1371/journal.pone.0051953	http://dx.doi.org/10.1371/journal.pone.0051953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251660	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800115
J	Hu, JCC; Chan, HC; Simmer, SG; Seymen, F; Richardson, AS; Hu, YY; Milkovich, RN; Estrella, NMRP; Yildirim, M; Bayram, M; Chen, CF; Simmer, JP				Hu, Jan C. -C.; Chan, Hui-Chen; Simmer, Stephen G.; Seymen, Figen; Richardson, Amelia S.; Hu, Yuanyuan; Milkovich, Rachel N.; Estrella, Ninna M. R. P.; Yildirim, Mine; Bayram, Merve; Chen, Chiung-Fen; Simmer, James P.			Amelogenesis Imperfecta in Two Families with Defined AMELX Deletions in ARHGAP6	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; ENAMEL DEFECTS; Y-CHROMOSOME; DENTAL ENAMEL; SHORT ARM; GENE; MICE; MUTATION; TRANSCRIPT; PHENOTYPE	Amelogenesis imperfecta (AI) is a group of inherited conditions featuring isolated enamel malformations. About 5% of AI cases show an X-linked pattern of inheritance, which are caused by mutations in AMELX. In humans there are two, non-allelic amelogenin genes: AMELX (Xp22.3) and AMELY (Yp11.2). About 90% of amelogenin expression is from AMELX, which is nested within intron 1 of the gene encoding Rho GTPase activating protein 6 (ARHGAP6). We recruited two AI families and determined that their disease-causing mutations were partial deletions in ARHGAP6 that completely deleted AMELX. Affected males in both families had a distinctive enamel phenotype resembling "snow-capped'' teeth. The 96,240 bp deletion in family 1 was confined to intron 1 of ARHGAP6 (g.302534_398773del96240), but removed alternative ARHGAP6 promoters 1c and 1d. Analyses of developing teeth in mice showed that ARHGAP6 is not expressed from these promoters in ameloblasts. The 52,654 bp deletion in family 2 (g.363924_416577del52654insA) removed ARHGAP6 promoter 1d and exon 2, precluding normal expression of ARHGAP6. The male proband of family 2 had slightly thinner enamel with greater surface roughness, but exhibited the same pattern of enamel malformations characteristic of males in family 1, which themselves showed minor variations in their enamel phenotypes. We conclude that the enamel defects in both families were caused by amelogenin insufficiency, that deletion of AMELX results in males with a characteristic snow-capped enamel phenotype, and failed ARHGAP6 expression did not appreciably alter the severity of enamel defects when AMELX was absent. Citation: Hu JC-C, Chan H-C, Simmer SG, Seymen F, Richardson AS, et al. (2012) Amelogenesis Imperfecta in Two Families with Defined AMELX Deletions in ARHGAP6. PLoS ONE 7(12): e52052. doi:10.1371/journal.pone.0052052	[Hu, Jan C. -C.; Chan, Hui-Chen; Simmer, Stephen G.; Richardson, Amelia S.; Hu, Yuanyuan; Milkovich, Rachel N.; Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Seymen, Figen; Yildirim, Mine; Bayram, Merve] Istanbul Univ, Dept Pedodont, Fac Dent, Istanbul, Turkey; [Estrella, Ninna M. R. P.; Chen, Chiung-Fen] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Istanbul University; University of Michigan System; University of Michigan	Hu, JCC (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	janhu@umich.edu	Hu, Jan C-C./F-5679-2015; Bayram, Merve/B-1230-2018; Koruyucu, M/AAC-6713-2020; Seymen, Figen/AAC-6736-2020	Hu, Jan C-C./0000-0002-9294-0248; Bayram, Merve/0000-0002-8440-367X; Koruyucu, M/0000-0002-2077-5095; Seymen, Figen/0000-0001-7010-2035; Simmer, James/0000-0002-7192-6105	NSF grant [EAR-9911352]; NIDCR/NIH [DE015846, DE019775]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019775, R01DE015846] Funding Source: NIH RePORTER	NSF grant(National Science Foundation (NSF)); NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NSF grant #EAR-9911352 and NIDCR/NIH Grants DE015846 and DE019775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akane A, 1998, Methods Mol Biol, V98, P245; BACKMAN B, 1988, HUM HERED, V38, P189, DOI 10.1159/000153785; BACKMAN B, 1988, SCAND J DENT RES, V96, P505; Barron MJ, 2010, HUM MOL GENET, V19, P1230, DOI 10.1093/hmg/ddq001; BERKMAN M D, 1971, Birth Defects Original Article Series, V7, P204; Chan HC, 2011, EUR J ORAL SCI, V119, P311, DOI 10.1111/j.1600-0722.2011.00857.x; Chang YM, 2003, J FORENSIC SCI, V48, P1309; Crampton N, 2006, EUR J ORAL SCI, V114, P133, DOI 10.1111/j.1600-0722.2006.00274.x; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; GIBSON CW, 1991, BIOCHEM BIOPH RES CO, V174, P1306, DOI 10.1016/0006-291X(91)91564-S; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hobson GM, 2009, AM J MED GENET A, V149A, P1698, DOI 10.1002/ajmg.a.32968; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Oliveira MAHD, 2010, MICROSC RES TECHNIQ, V73, P572, DOI 10.1002/jemt.20796; Iwase M, 2007, CELLS TISSUES ORGANS, V186, P49, DOI 10.1159/000102680; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Kawasaki K, 2008, J DENT RES, V87, P520, DOI 10.1177/154405910808700608; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; LAGERSTROM M, 1990, AM J HUM GENET, V46, P120; LAGERSTROMFERMER M, 1993, GENOMICS, V17, P89, DOI 10.1006/geno.1993.1287; Lattanzi W, 2005, HUM GENET, V116, P395, DOI 10.1007/s00439-004-1238-z; Li Y, 2011, CELLS TISSUES ORGANS, V194, P227, DOI 10.1159/000324559; Meredith RW, 2011, P ROY SOC B-BIOL SCI, V278, P993, DOI 10.1098/rspb.2010.1280; Mitchell RJ, 2006, ANN HUM BIOL, V33, P227, DOI 10.1080/03014460600594620; Ochocka AM, 2008, INT J BIOCHEM CELL B, V40, P2264, DOI 10.1016/j.biocel.2008.03.007; Ou X, 2011, INT J LEGAL MED, V7, P7; Parry DA, AM J HUM GE IN PRESS; Prakash SK, 2005, CALCIFIED TISSUE INT, V77, P23, DOI 10.1007/s00223-004-1213-7; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Ryu OH, 1999, J DENT RES, V78, P743, DOI 10.1177/00220345990780030601; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Simmer JP, 2011, CELLS TISSUES ORGANS, V194, P211, DOI 10.1159/000324260; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; SIMMER JP, 1995, DENT ENAMEL FORMATIO, P59; Simmer JP, 2011, J ORAL SCI; Sire JY, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-246; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; UCHIDA T, 1991, HISTOCHEMISTRY, V96, P129, DOI 10.1007/BF00315983; Witkop CJ, 1976, ORAL FACIAL GENETICS, P151; WITKOP CJ, 1989, J ORAL PATHOL, V17, P547; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; Wright JT, 2011, CELLS TISSUES ORGANS, V194, P279, DOI 10.1159/000324339; Wright JT, 2003, CONNECT TISSUE RES, V44, P72, DOI 10.1080/03008200390152124; Yamakoshi Y, 2011, EUR J ORAL SCI, V119, P206, DOI 10.1111/j.1600-0722.2011.00866.x	53	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52052	10.1371/journal.pone.0052052	http://dx.doi.org/10.1371/journal.pone.0052052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251683	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800136
J	Kawahara, T; Ito, H; Terao, H; Kato, Y; Uemura, H; Kubota, Y; Matsuzaki, J				Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Kato, Yoshitake; Uemura, Hiroji; Kubota, Yoshinobu; Matsuzaki, Junichi			Effectiveness of Ureteroscopy-Assisted Retrograde Nephrostomy (UARN) for Percutaneous Nephrolithotomy (PCNL)	PLOS ONE			English	Article							SUPINE VALDIVIA; COMPLICATIONS; CLASSIFICATION; REMOVAL; LITHOTRIPSY; POSITION; ACCESS	Objective: To determine the impact of ureteroscopy-assisted retrograde nephrostomy (UARN) during percutaneous nephrolithotomy (PCNL). Materials and Methods: From April 2009 to September 2011, a total of 50 patients underwent PCNL for large renal stones (stone burden > 2 cm). We performed UARN in the Galdakao-modified Valdivia position for 27 patients (UARN PCNL) and ultrasonography-assisted percutaneous nephrostomy in the prone position for 23 patients (prone PCNL). Results: UARN PCNL significantly improved the stone-free rate (81.5% vs 52.2%) and the rate of residual stones (< 4 mm, 92.6% vs 65.2%, P < 0.05). The median length of the operation was significantly shorter for UARN PCNL, at 160 min, compared to 299 min for prone PCNL (P < 0.001). There was one intraoperative complication in prone PCNL, namely a hemorrhage that resulted in stopping the initial treatment, but it was cured conservatively. The postoperative complications included a high grade fever that persisted for three days in two UARN PCNL patients (7.4%) and six prone PCNL patients (26.1%). The Clavien grading scores showed significantly lower postoperative complications for UARN PCNL compared to prone PCNL. Conclusion: UARN is associated with a higher stone-free rate, shorter operation time, and fewer complications during PCNL than prone PCNL.	[Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Kato, Yoshitake; Matsuzaki, Junichi] Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Kawahara, Takashi; Ito, Hiroki; Uemura, Hiroji; Kubota, Yoshinobu] Yokohama City Univ, Dept Urol, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Yokohama City University	Matsuzaki, J (corresponding author), Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan.	j_matsuzaki@kamakura-medical.com	KAWAHARA, TAKASHI/A-4944-2013					Al-Otaibi K, 1999, J UROLOGY, V162, P674, DOI 10.1097/00005392-199909010-00009; Andreoni C, 2000, J UROLOGY, V164, P1290, DOI 10.1016/S0022-5347(05)67158-3; CASTANEDAZUNIGA WR, 1982, UROL CLIN N AM, V9, P113; Chu L, 2011, J ENDOUROL, V25, P751, DOI 10.1089/end.2010.0400; Daels F, 2009, J ENDOUROL, V23, P1615, DOI 10.1089/end.2009.1526; de la Rosette J, 2011, J ENDOUROL, V25, P11, DOI 10.1089/end.2010.0424; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; ESUVARANATHAN K, 1991, J UROLOGY, V146, P1213, DOI 10.1016/S0022-5347(17)38048-5; FERNSTROM I, 1976, SCAND J UROL NEPHROL, V10, P257, DOI 10.1080/21681805.1976.11882084; Fischbach F, 2011, CARDIOVASC INTER RAD, V34, P857, DOI 10.1007/s00270-010-0065-y; GOODWIN WE, 1955, JAMA-J AM MED ASSOC, V157, P891, DOI 10.1001/jama.1955.02950280015005; HUNTER PT, 1985, J UROLOGY, V133, P369, DOI 10.1016/S0022-5347(17)48981-6; Ibarluzea G, 2007, BJU INT, V100, P233, DOI 10.1111/j.1464-410X.2007.06960.x; Ibarluzea Gonzalez G, 2001, Arch Esp Urol, V54, P951; Kawahara T, 2011, BJU INT; Kawahara T, 2012, J ENDOUROLOGY B; Kawahara Takashi, 2012, J Med Case Rep, V6, P194, DOI 10.1186/1752-1947-6-194; Labate G, 2011, J ENDOUROL, V25, P1275, DOI 10.1089/end.2011.0067; LAWSON RK, 1983, UROLOGY, V22, P580, DOI 10.1016/0090-4295(83)90299-6; Scoffone CM, 2008, EUR UROL, V54, P1393, DOI 10.1016/j.eururo.2008.07.073; Skolarikos A, 2005, EUR UROL, V47, P22, DOI 10.1016/j.eururo.2004.08.009; Tefekli A, 2008, EUR UROL, V53, P184, DOI 10.1016/j.eururo.2007.06.049; Uria JGV, 1998, J UROLOGY, V160, P1975, DOI 10.1016/S0022-5347(01)62217-1; Valdivia JG, 2011, J ENDOUROL; Valdivia Uria J G, 1987, Arch Esp Urol, V40, P177; Wynberg JB, 2012, J ENDOUROL	26	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52149	10.1371/journal.pone.0052149	http://dx.doi.org/10.1371/journal.pone.0052149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251698	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800149
J	Rice, RH; Bradshaw, KM; Durbin-Johnson, BP; Rocke, DM; Eigenheer, RA; Phinney, BS; Sundberg, JP				Rice, Robert H.; Bradshaw, Katie M.; Durbin-Johnson, Blythe P.; Rocke, David M.; Eigenheer, Richard A.; Phinney, Brett S.; Sundberg, John P.			Differentiating Inbred Mouse Strains from Each Other and Those with Single Gene Mutations Using Hair Proteomics	PLOS ONE			English	Article							STATISTICAL-MODEL; PELAGE HAIR; MICE; FOLLICLE; PROTEINS; SHAFT	Mutant laboratory mice with distinctive hair phenotypes are useful for identifying genes responsible for hair diseases. The work presented here demonstrates that shotgun proteomic profiling can distinguish hair shafts from different inbred mouse strains. For this purpose, analyzing the total hair shaft provided better discrimination than analyzing the isolated solubilized and particulate (cross-linked) fractions. Over 100 proteins exhibited significant differences among the 11 strains and 5 mutant stocks across the wide spectrum of strains surveyed. Effects on the profile of single gene mutations causing hair shaft defects were profound. Since the hair shaft provides a discrete sampling of the species proteome, with constituents serving important functions in epidermal appendages and throughout the body, this work provides a foundation for noninvasive diagnosis of genetic diseases of hair and perhaps other tissues.	[Rice, Robert H.; Bradshaw, Katie M.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Rice, Robert H.; Bradshaw, Katie M.] Univ Calif Davis, Forens Sci Grad Program, Davis, CA 95616 USA; [Durbin-Johnson, Blythe P.; Rocke, David M.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Eigenheer, Richard A.; Phinney, Brett S.] Univ Calif Davis, Prote Core, Davis, CA 95616 USA; [Sundberg, John P.] Jackson Lab, Dept Res, Bar Harbor, ME 04609 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Jackson Laboratory	Rice, RH (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.	rhrice@ucdavis.edu	Rocke, David M/I-7044-2013; Phinney, Brett/S-6404-2016; Rice, Robert/AAP-7813-2021	Rocke, David M/0000-0002-3958-7318; Phinney, Brett/0000-0003-3870-3302; 	NIH [AR047204, AR056635, 2 P42 ES04699]; North American Hair Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047204, R01AR056635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Hair Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by NIH grants AR047204, AR056635 and 2 P42 ES04699 and the North American Hair Research Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy NR, 2012, ANAL BIOCHEM, V421, P43, DOI 10.1016/j.ab.2011.10.011; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Elmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M1111.014555, DOI 10.1074/MCP.M1111.014555]; Fantauzzo KA, 2008, HUM MOL GENET, V17, P3539, DOI 10.1093/hmg/ddn247; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Hopkins CE, 2005, ARCH BIOCHEM BIOPHYS, V443, P1, DOI 10.1016/j.abb.2005.08.020; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lee YJ, 2006, MOL CELL PROTEOMICS, V5, P789, DOI 10.1074/mcp.M500278-MCP200; Mecklenburg L, 2005, EXP DERMATOL, V14, P561, DOI 10.1111/j.0906-6705.2005.00343.x; Mentzer SE, 2008, VET DERMATOL, V19, P358, DOI 10.1111/j.1365-3164.2008.00709.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Pragst F, 2006, CLIN CHIM ACTA, V370, P17, DOI 10.1016/j.cca.2006.02.019; Rehulkova H, 2009, J MASS SPECTROM, V44, P1613, DOI 10.1002/jms.1675; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; Rice RH, 1999, ANAT RECORD, V254, P231; Rice RH, 2011, J INVEST DERMATOL, V131, P1936, DOI 10.1038/jid.2011.133; Rice RH, 2010, J PROTEOME RES, V9, P6752, DOI 10.1021/pr1009349; Rice RH, 2009, J INVEST DERMATOL, V129, P2120, DOI 10.1038/jid.2009.52; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Sperling L., 2003, ATLAS HAIR PATHOLOGY, Vfirst; Srogi K, 2007, REV ENVIRON CONTAM T, V189, P107, DOI 10.1007/978-0-387-35368-5_5; Sundberg, 1994, HDB MOUSE MUTATIONS; Sundberg JP, 2009, JAVMA-J AM VET MED A, V234, P1530, DOI 10.2460/javma.234.12.1530; SUNDBERG JP, 1994, J INVEST DERMATOL, V102, P847, DOI 10.1111/1523-1747.ep12382416; Sundberg JP., 1994, HDB MOUSE MUTATIONS, P57; Sundberg JP, 1994, HDB MOUSE MUTATIONS, P345; Whiting D. A., 1998, COLOR ATLAS DIFFEREN; Whiting DA., 1994, DISORDERS HAIR GROWT, P91; Wu B, 2013, EXP DERMATO IN PRESS; Wu BJ, 2010, J INVEST DERMATOL, V130, P2666, DOI 10.1038/jid.2010.168	32	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51956	10.1371/journal.pone.0051956	http://dx.doi.org/10.1371/journal.pone.0051956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251662	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800117
J	Wisotzkey, RG; Konikoff, CE; Newfeld, SJ				Wisotzkey, Robert G.; Konikoff, Charlotte E.; Newfeld, Stuart J.			Hippo Pathway Phylogenetics Predicts Monoubiquitylation of Salvador and Merlin/Nf2	PLOS ONE			English	Article							TGF-BETA; YAP; UBIQUITINATION; EVOLUTION; FAMILY; DEUBIQUITYLATION; PHOSPHORYLATION; DIVERSIFICATION; IDENTIFICATION; DOMAIN	Recently we employed phylogenetics to predict that the cellular interpretation of TGF-beta signals is modulated by monoubiquitylation cycles affecting the Smad4 signal transducer/tumor suppressor. This prediction was subsequently validated by experiments in flies, frogs and mammalian cells. Here we apply a phylogenetic approach to the Hippo pathway and predict that two of its signal transducers, Salvador and Merlin/Nf2 (also a tumor suppressor) are regulated by monoubiquitylation. This regulatory mechanism does not lead to protein degradation but instead serves as a highly efficient "off/on'' switch when the protein is subsequently deubiquitylated. Overall, our study shows that the creative application of phylogenetics can predict new roles for pathway components and new mechanisms for regulating intercellular signaling pathways.	[Newfeld, Stuart J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA; [Wisotzkey, Robert G.] NextBio, Santa Clara, CA USA; [Konikoff, Charlotte E.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle	Newfeld, SJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA.	newfeld@asu.edu	Konikoff, Charlotte/F-2320-2011		National Science Foundation [DBI-0939454]; National Institutes of Health [HG002516]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002516] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	CEK is supported in part by National Science Foundation DBI-0939454. SJN is supported in part by National Institutes of Health HG002516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; [Anonymous], SMAD SIGNAL TRANSDUC; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; Cai YD, 2012, AMINO ACIDS, V42, P1387, DOI 10.1007/s00726-011-0835-0; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; Dupont S, 2012, FEBS LETT, V586, P1913, DOI 10.1016/j.febslet.2012.03.037; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gray RS, 2009, DEV DYNAM, V238, P2044, DOI 10.1002/dvdy.22028; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hedges S. B., 2009, TIME TREE LIFE; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Jukam D, 2011, DEV CELL, V21, P874, DOI 10.1016/j.devcel.2011.10.004; Konikoff CE, 2008, J MOL EVOL, V67, P323, DOI 10.1007/s00239-008-9159-4; Konikoff CE, 2010, J MOL EVOL, V70, P303, DOI 10.1007/s00239-010-9337-z; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Mrkobrada S, 2006, J MOL BIOL, V362, P430, DOI 10.1016/j.jmb.2006.07.007; Newfeld SJ, 1999, GENETICS, V152, P783; Ponte I, 1998, MOL BIOL EVOL, V15, P702, DOI 10.1093/oxfordjournals.molbev.a025973; Poy F, 2001, NAT STRUCT BIOL, V8, P1053, DOI 10.1038/nsb720; Quijano JC, 2011, GENETICS, V189, P809, DOI 10.1534/genetics.111.133801; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Record CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011905; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sebe-Pedros A, 2012, CELL REP, V1, P13, DOI 10.1016/j.celrep.2011.11.004; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Stinchfield MJ, 2012, DEVELOPMENT, V139, P2721, DOI 10.1242/dev.077206; Takaesu NT, 2006, GENETICS, V174, P1299, DOI 10.1534/genetics.106.064956; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yogesha SD, 2011, PROTEIN SCI, V20, P2113, DOI 10.1002/pro.751; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	43	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51599	10.1371/journal.pone.0051599	http://dx.doi.org/10.1371/journal.pone.0051599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272121	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800055
J	Zakrzewski, P; Medema, MH; Gevorgyan, A; Kierzek, AM; Breitling, R; Takano, E				Zakrzewski, Piotr; Medema, Marnix H.; Gevorgyan, Albert; Kierzek, Andrzej M.; Breitling, Rainer; Takano, Eriko			MultiMetEval: Comparative and Multi-Objective Analysis of Genome-Scale Metabolic Models	PLOS ONE			English	Article							CONSTRAINT-BASED MODELS; STREPTOMYCES-COELICOLOR; IN-SILICO; CLAVULANIC ACID; QUANTITATIVE PREDICTION; HETEROLOGOUS EXPRESSION; CELLULAR-METABOLISM; NETWORK ANALYSIS; COBRA TOOLBOX; GENE-CLUSTER	Comparative metabolic modelling is emerging as a novel field, supported by the development of reliable and standardized approaches for constructing genome-scale metabolic models in high throughput. New software solutions are needed to allow efficient comparative analysis of multiple models in the context of multiple cellular objectives. Here, we present the user-friendly software framework Multi-Metabolic Evaluator (MultiMetEval), built upon SurreyFBA, which allows the user to compose collections of metabolic models that together can be subjected to flux balance analysis. Additionally, MultiMetEval implements functionalities for multi-objective analysis by calculating the Pareto front between two cellular objectives. Using a previously generated dataset of 38 actinobacterial genome-scale metabolic models, we show how these approaches can lead to exciting novel insights. Firstly, after incorporating several pathways for the biosynthesis of natural products into each of these models, comparative flux balance analysis predicted that species like Streptomyces that harbour the highest diversity of secondary metabolite biosynthetic gene clusters in their genomes do not necessarily have the metabolic network topology most suitable for compound overproduction. Secondly, multi-objective analysis of biomass production and natural product biosynthesis in these actinobacteria shows that the well-studied occurrence of discrete metabolic switches during the change of cellular objectives is inherent to their metabolic network architecture. Comparative and multi-objective modelling can lead to insights that could not be obtained by normal flux balance analyses. MultiMetEval provides a powerful platform that makes these analyses straightforward for biologists. Sources and binaries of MultiMetEval are freely available from https://github.com/PiotrZakrzewski/MetEval/downloads. Citation: Zakrzewski P, Medema MH, Gevorgyan A, Kierzek AM, Breitling R, et al. (2012) MultiMetEval: Comparative and Multi-Objective Analysis of Genome-Scale Metabolic Models. PLoS ONE 7(12): e51511. doi:10.1371/journal.pone.0051511	[Zakrzewski, Piotr; Medema, Marnix H.; Breitling, Rainer] Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands; [Zakrzewski, Piotr; Medema, Marnix H.; Takano, Eriko] Univ Groningen, Dept Microbial Physiol, Groningen, Netherlands; [Gevorgyan, Albert; Kierzek, Andrzej M.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Breitling, Rainer] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland	University of Groningen; University of Groningen; University of Surrey; University of Glasgow	Breitling, R (corresponding author), Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands.	rainer.breitling@glasgow.ac.uk; e.takano@rug.nl	Medema, Marnix H./AAR-3138-2021	Medema, Marnix H./0000-0002-2191-2821; Kierzek, Andrzej/0000-0002-2605-9057; Takano, Eriko/0000-0002-6791-3256; Breitling, Rainer/0000-0001-7173-0922	Dutch Technology Foundation (STW), which is the applied science division of the Netherlands Organisation for Scientific Research (NWO); Technology Programme of the Ministry of Economic Affairs [STW 10463]; NWO-Vidi fellowship; Rosalind Franklin Fellowship, University of Groningen	Dutch Technology Foundation (STW), which is the applied science division of the Netherlands Organisation for Scientific Research (NWO); Technology Programme of the Ministry of Economic Affairs; NWO-Vidi fellowship; Rosalind Franklin Fellowship, University of Groningen	This work was supported by the Dutch Technology Foundation (STW), which is the applied science division of the Netherlands Organisation for Scientific Research (NWO), and the Technology Programme of the Ministry of Economic Affairs [STW 10463]. RB is supported by an NWO-Vidi fellowship, and ET by a Rosalind Franklin Fellowship, University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2006, FEMS MICROBIOL REV, V30, P187, DOI 10.1111/j.1574-6976.2005.00009.x; Alam MT, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-202; Alam MT, 2011, FEBS LETT, V585, P2389, DOI 10.1016/j.febslet.2011.06.014; Alexander DC, 2010, APPL ENVIRON MICROB, V76, P6877, DOI 10.1128/AEM.01248-10; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blank LM, 2005, FEMS YEAST RES, V5, P545, DOI 10.1016/j.femsyr.2004.09.008; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Brooks J. Paul, 2012, Advances in Bioinformatics, V2012, P323472, DOI 10.1155/2012/323472; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Freitag A, 2006, METAB ENG, V8, P653, DOI 10.1016/j.ymben.2006.07.003; Gevorgyan A, 2011, BIOINFORMATICS, V27, P433, DOI 10.1093/bioinformatics/btq679; Gonzalez-Lergier J, 2005, J AM CHEM SOC, V127, P9930, DOI 10.1021/ja051586y; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ives PR, 1997, MICROBIOL-UK, V143, P3573, DOI 10.1099/00221287-143-11-3573; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; Latendresse M, 2012, BIOINFORMATICS, V28, P388, DOI 10.1093/bioinformatics/btr681; Lee FC, 2010, METAB ENG, V12, P251, DOI 10.1016/j.ymben.2009.12.003; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Marler RT, 2004, STRUCT MULTIDISCIP O, V26, P369, DOI 10.1007/s00158-003-0368-6; Medema MH, 2012, NAT REV MICROBIOL, V10, P191, DOI 10.1038/nrmicro2717; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Medema MH, 2011, MICROB BIOTECHNOL, V4, P300, DOI 10.1111/j.1751-7915.2010.00226.x; Medema MH, 2011, NAT REV MICROBIOL, V9, P131, DOI 10.1038/nrmicro2478; Mithani A, 2011, MOL BIOL EVOL, V28, P483, DOI 10.1093/molbev/msq213; Nagrath D, 2010, METAB ENG, V12, P429, DOI 10.1016/j.ymben.2010.05.003; Nieselt K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-10; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; Pfeifer BA, 2001, MICROBIOL MOL BIOL R, V65, P106, DOI 10.1128/MMBR.65.1.106-118.2001; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; ROMERO J, 1986, APPL ENVIRON MICROB, V52, P892, DOI 10.1128/AEM.52.4.892-897.1986; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Scherr N, 2009, CURR OPIN MICROBIOL, V12, P699, DOI 10.1016/j.mib.2009.10.003; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Stevens DC, 2010, APPL ENVIRON MICROB, V76, P2681, DOI 10.1128/AEM.02841-09; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Vo TD, 2004, J BIOL CHEM, V279, P39532, DOI 10.1074/jbc.M403782200; Yanai K, 2006, P NATL ACAD SCI USA, V103, P9661, DOI 10.1073/pnas.0603251103; Zhao XQ, 2010, ARCH MICROBIOL, V192, P289, DOI 10.1007/s00203-010-0548-x	54	27	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51511	10.1371/journal.pone.0051511	http://dx.doi.org/10.1371/journal.pone.0051511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272111	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000312386800049
J	Pivato, M; De Franceschi, G; Tosatto, L; Frare, E; Kumar, D; Aioanei, D; Brucale, M; Tessari, I; Bisaglia, M; Samori, B; de Laureto, PP; Bubacco, L				Pivato, Micaela; De Franceschi, Giorgia; Tosatto, Laura; Frare, Erica; Kumar, Dhruv; Aioanei, Daniel; Brucale, Marco; Tessari, Isabella; Bisaglia, Marco; Samori, Bruno; de laureto, Patrizia Polverino; Bubacco, Luigi			Covalent alpha-Synuclein Dimers: Chemico-Physical and Aggregation Properties	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; AMYLOID FIBRIL FORMATION; PARKINSONS-DISEASE; CORE STRUCTURE; ALZHEIMERS-DISEASE; SOLID-STATE; CONFORMATION; SPECTROSCOPY; ABSORPTION; SEQUENCE	The aggregation of alpha-synuclein into amyloid fibrils constitutes a key step in the onset of Parkinson's disease. Amyloid fibrils of alpha-synuclein are the major component of Lewy bodies, histological hallmarks of the disease. Little is known about the mechanism of aggregation of alpha-synuclein. During this process, alpha-synuclein forms transient intermediates that are considered to be toxic species. The dimerization of alpha-synuclein could represent a rate-limiting step in the aggregation of the protein. Here, we analyzed four covalent dimers of alpha-synuclein, obtained by covalent link of the N-terms, C-terms, tandem cloning of two sequences and tandem juxtaposition in one protein of the 1-104 and 29-140 sequences. Their biophysical properties in solution were determined by CD, FT-IR and NMR spectroscopies. SDS-induced folding was also studied. The fibrils formation was analyzed by ThT and polarization fluorescence assays. Their morphology was investigated by TEM and AFM-based quantitative morphometric analysis. All dimers were found to be devoid of ordered secondary structure under physiological conditions and undergo alpha-helical transition upon interaction with SDS. All protein species are able to form amyloid-like fibrils. The reciprocal orientation of the alpha-synuclein monomers in the dimeric constructs affects the kinetics of the aggregation process and a scale of relative amyloidogenic propensity was determined. Structural investigations by FT IR spectroscopy, and proteolytic mapping of the fibril core did not evidence remarkable difference among the species, whereas morphological analyses showed that fibrils formed by dimers display a lower and diversified level of organization in comparison with alpha-synuclein fibrils. This study demonstrates that although alpha-synuclein dimerization does not imply the acquisition of a preferred conformation by the participating monomers, it can strongly affect the aggregation properties of the molecules. The results presented highlight a substantial role of the relative orientation of the individual monomer in the definition of the fibril higher structural levels. Citation: Pivato M, De Franceschi G, Tosatto L, Frare E, Kumar D, et al. (2012) Covalent alpha-Synuclein Dimers: Chemico-Physical and Aggregation Properties. PLoS ONE 7(12): e50027. doi:10.1371/journal.pone.0050027	[Pivato, Micaela; De Franceschi, Giorgia; Frare, Erica; de laureto, Patrizia Polverino] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Tosatto, Laura; Tessari, Isabella; Bisaglia, Marco; Bubacco, Luigi] Univ Padua, Dept Biol, Padua, Italy; [Kumar, Dhruv; Aioanei, Daniel; Samori, Bruno] Univ Bologna, Dept Biochem, I-40126 Bologna, Italy; [Brucale, Marco] CNR, Inst Nanostruct Mat ISMN, Rome, Italy	University of Padua; University of Padua; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR)	de Laureto, PP (corresponding author), Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy.	patrizia.polverinodelaureto@unipd.it; luigi.bubacco@unipd.it	Kumar, Dhruv/AAF-7440-2019; Tessari, Isabella/K-7847-2016; kumar, Dhruv/C-1090-2011; Tosatto, Laura/K-1746-2014; Bubacco, Luigi/B-5602-2012; Brucale, Marco/G-2455-2018	Kumar, Dhruv/0000-0003-2586-9397; Tessari, Isabella/0000-0002-5823-645X; kumar, Dhruv/0000-0003-2586-9397; Tosatto, Laura/0000-0002-5966-8131; Bubacco, Luigi/0000-0001-7927-9208; BRUCALE, MARCO/0000-0001-7244-4389	Progetti di Ricerca di Interesse Nazionale (PRIN) [2008SYP7]	Progetti di Ricerca di Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	IT, MB and LB were supported by Progetti di Ricerca di Interesse Nazionale (PRIN) 2008 (Prot. 2008SYP79). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adochitei A, 2011, REV ROUM CHIM, V56, P783; Aioanei D, 2012, LAZY SHORTEST PATH C; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cookson MR, 2009, MOL NEURODEGENER, V4, P114; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; FABIAN H, 1993, APPL SPECTROSC, V47, P1513, DOI 10.1366/0003702934067469; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferreon ACM, 2007, BIOCHEMISTRY-US, V46, P4499, DOI 10.1021/bi602461y; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Karyagina I, 2011, BIOPHYS J, V101, pL1, DOI 10.1016/j.bpj.2011.05.052; Kloepper KD, 2007, J PHYS CHEM B, V111, P13353, DOI 10.1021/jp077036z; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Luk KC, 2007, BIOCHEMISTRY-US, V46, P12522, DOI 10.1021/bi701128c; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Oberg KA, 2004, EUR J BIOCHEM, V271, P2937, DOI 10.1111/j.1432-1033.2004.04220.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Takahashi T, 2002, BRAIN RES, V938, P73, DOI 10.1016/S0006-8993(02)02498-8; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; van Raaij ME, 2008, BIOPHYS J, V95, P4871, DOI 10.1529/biophysj.107.127464; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang W, 2011, P NATL ACAD SCI USA, V109, P2336; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wellner N, 1996, BIOCHEM J, V319, P741, DOI 10.1042/bj3190741; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang F, 2008, BIOCHEM BIOPH RES CO, V368, P388, DOI 10.1016/j.bbrc.2008.01.091; Zhou WB, 2004, J BIOL CHEM, V279, P10128, DOI 10.1074/jbc.M307563200; Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200	58	29	29	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50027	10.1371/journal.pone.0050027	http://dx.doi.org/10.1371/journal.pone.0050027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272053	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600006
J	Althaus, CL; Heijne, JCM; Herzog, SA; Roellin, A; Low, N				Althaus, Christian L.; Heijne, Janneke C. M.; Herzog, Sereina A.; Roellin, Adrian; Low, Nicola			Individual and Population Level Effects of Partner Notification for Chlamydia trachomatis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CONCURRENT PARTNERSHIPS; TRANSMISSION DYNAMICS; DISEASE TRANSMISSION; SCREENING PROGRAMS; UNITED-STATES; GONORRHEA; IMPACT; MODEL; NETWORKS	Partner notification (PN or contact tracing) is an important aspect of treating bacterial sexually transmitted infections (STIs), such as Chlamydia trachomatis. It facilitates the identification of new infected cases that can be treated through individual case management. PN also acts indirectly by limiting onward transmission in the general population. However, the impact of PN, both at the level of individuals and the population, remains unclear. Since it is difficult to study the effects of PN empirically, mathematical and computational models are useful tools for investigating its potential as a public health intervention. To this end, we developed an individual-based modeling framework called Rstisim. It allows the implementation of different models of STI transmission with various levels of complexity and the reconstruction of the complete dynamic sexual partnership network over any time period. A key feature of this framework is that we can trace an individual's partnership history in detail and investigate the outcome of different PN strategies for C. trachomatis. For individual case management, the results suggest that notifying three or more partners from the preceding 18 months yields substantial numbers of new cases. In contrast, the successful treatment of current partners is most important for preventing re-infection of index cases and reducing further transmission of C. trachomatis at the population level. The findings of this study demonstrate the difference between individual and population level outcomes of public health interventions for STIs.	[Althaus, Christian L.; Heijne, Janneke C. M.; Herzog, Sereina A.; Roellin, Adrian; Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Roellin, Adrian] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore	University of Bern; National University of Singapore	Althaus, CL (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	christian.althaus@alumni.ethz.ch	Low, Nicola/H-4718-2019; Herzog, Sereina A/K-8865-2017; Althaus, Christian L./F-6008-2015; Roellin, Adrian/I-4067-2015	Low, Nicola/0000-0003-4817-8986; Herzog, Sereina A/0000-0002-5373-5866; Althaus, Christian L./0000-0002-5230-6760; Rollin, Adrian/0000-0003-0488-0183	NIHR Health Technology Assessment Programme [07/42/02]; Swiss National Science Foundation [320030-118424, 320030-135654, PDFMP3-124952]; National Institute for Health Research [07/42/02] Funding Source: researchfish	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is part of a project funded by the NIHR Health Technology Assessment Programme (project number 07/42/02). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. JCMH and SAH acknowledge financial support by the Swiss National Science Foundation (project numbers 320030-118424, 320030-135654 and PDFMP3-124952). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CL, 2012, SEX TRANSM DIS, V39, P402, DOI 10.1097/OLQ.0b013e318248a550; Althaus CL, 2012, J R SOC INTERFACE, V9, P136, DOI 10.1098/rsif.2011.0131; Althaus CL, 2010, EPIDEMICS-NETH, V2, P123, DOI 10.1016/j.epidem.2010.04.002; Armbruster B, 2007, HEALTH CARE MANAG SC, V10, P341, DOI 10.1007/s10729-007-9027-6; BASHH Clinical Effectiveness Group, 2006, 2006 UK NAT GUID MAN; Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400; Bauch C, 2000, P ROY SOC B-BIOL SCI, V267, P2019, DOI 10.1098/rspb.2000.1244; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; BUTTS CT, 2008, NETWORK CLASSES RELA; Carre H, 2008, SEX TRANSM INFECT, V84, P239, DOI 10.1136/sti.2007.028068; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; Chow JM, 2012, SEX TRANSM DIS, V39, P89, DOI 10.1097/OLQ.0b013e318245f95c; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; de Blasio BF, 2007, P NATL ACAD SCI USA, V104, P10762, DOI 10.1073/pnas.0611337104; DIETZ K, 1988, J MATH BIOL, V26, P1, DOI 10.1007/BF00280169; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Farewell VT, 1992, AIDS EPIDEMIOLOGY ME, P143; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; Gray RT, 2009, J INFECT DIS, V199, P1680, DOI 10.1086/598983; Handcock Mark S., 2003, STATNET SOFTWARE TOO; Heijne JCM, 2011, J INFECT DIS, V203, P372, DOI 10.1093/infdis/jiq050; Heijne JCM, 2013, SEX TRANSM INFECT, V89, P57, DOI 10.1136/sextrans-2011-050468; Herzog SA, 2011, SEX TRANSM INFECT, V87, P420, DOI 10.1136/sti.2011.049320; House T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000721; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; KATZ BP, 1992, STAT MED, V11, P565, DOI 10.1002/sim.4780110502; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Khan A, 2005, SEX TRANSM DIS, V32, P260, DOI 10.1097/01.olq.0000161089.53411.cb; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; Kretzschmar M, 1996, MATH BIOSCI, V133, P165, DOI 10.1016/0025-5564(95)00093-3; Kretzschmar M, 2012, SEX TRANSM DIS, V39, P325, DOI 10.1097/OLQ.0b013e31824e52c2; Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mercer CH, 2011, AM J PUBLIC HEALTH, V101, P2117, DOI 10.2105/AJPH.2011.300211; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Muller J, 2000, MATH BIOSCI, V164, P39, DOI 10.1016/S0025-5564(99)00061-9; Quinn TC, 1996, JAMA-J AM MED ASSOC, V276, P1737, DOI 10.1001/jama.276.21.1737; R Core Team, 2020, R LANG ENV STAT COMP; Regan DG, 2008, J INFECT DIS, V198, P349, DOI 10.1086/589883; Regan DG, 2008, T ROY SOC TROP MED H, V102, P207, DOI 10.1016/j.trstmh.2007.08.009; Rogers SM, 2007, SEX TRANSM INFECT, V84, P23, DOI 10.1136/sti.2007.027029; Tayal SC, 2010, INT J STD AIDS, V21, P516, DOI 10.1258/ijsa.2010.010011; Trelle S, 2007, BMJ-BRIT MED J, V334, P354, DOI 10.1136/bmj.39079.460741.7C; Tu WZ, 2011, J R STAT SOC A STAT, V174, P975, DOI 10.1111/j.1467-985X.2011.00691.x; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; Wolfram Research Inc, 2008, TITL MATH ED VERS 7; World Health Organisation, 1999, SEX TRANSM DIS POL P; Zimmerman-Rogers H, 1999, SEX TRANSM DIS, V26, P49, DOI 10.1097/00007435-199901000-00008	59	22	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51438	10.1371/journal.pone.0051438	http://dx.doi.org/10.1371/journal.pone.0051438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251534	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200109
J	Khateb, S; Zelinger, L; Ben-Yosef, T; Merin, S; Crystal-Shalit, O; Gross, M; Banin, E; Sharon, D				Khateb, Samer; Zelinger, Lina; Ben-Yosef, Tamar; Merin, Saul; Crystal-Shalit, Ornit; Gross, Menachem; Banin, Eyal; Sharon, Dror			Exome Sequencing Identifies a Founder Frameshift Mutation in an Alternative Exon of USH1C as the Cause of Autosomal Recessive Retinitis Pigmentosa with Late-Onset Hearing Loss	PLOS ONE			English	Article							USH2A GENE; DEAFNESS; HARMONIN; DEFECTS	We used a combined approach of homozygosity mapping and whole exome sequencing (WES) to search for the genetic cause of autosomal recessive retinitis pigmentosa (arRP) in families of Yemenite Jewish origin. Homozygosity mapping of two arRP Yemenite Jewish families revealed a few homozygous regions. A subsequent WES analysis of the two index cases revealed a shared homozygous novel nucleotide deletion (c.1220delG) leading to a frameshift (p.Gly407Glufs*56) in an alternative exon (#15) of USH1C. Screening of additional Yemenite Jewish patients revealed a total of 16 homozygous RP patients (with a carrier frequency of 0.008 in controls). Funduscopic and electroretinography findings were within the spectrum of typical RP. While other USH1C mutations usually cause Usher type I (including RP, vestibular dysfunction and congenital deafness), audiometric screening of 10 patients who are homozygous for c.1220delG revealed that patients under 40 years of age had normal hearing while older patients showed mild to severe high tone sensorineural hearing loss. This is the first report of a mutation in a known USH1 gene that causes late onset rather than congenital sensorineural hearing loss. The c.1220delG mutation of USH1C accounts for 23% of RP among Yemenite Jewish patients in our cohort.	[Khateb, Samer; Zelinger, Lina; Merin, Saul; Banin, Eyal; Sharon, Dror] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel; [Ben-Yosef, Tamar] Technion Israel Inst Technol, Rappaport Fac Med, Dept Genet, Haifa, Israel; [Crystal-Shalit, Ornit] Meir Med Ctr, Dept Ophthalmol, Kefar Sava, Israel; [Gross, Menachem] Hadassah Hebrew Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center	Banin, E (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel.	banine@cc.huji.ac.il; dror.sharon1@gmail.com	Sharon, Dror/P-4539-2015; Zelinger, Lina/L-3272-2019	Sharon, Dror/0000-0002-1789-5811; Zelinger, Lina/0000-0003-3028-7172	Foundation Fighting Blindness USA [BR-GE-0510-0490-HUJ]; Israeli Science Foundation [612/09]; Yedidut 1 research grant	Foundation Fighting Blindness USA; Israeli Science Foundation(Israel Science Foundation); Yedidut 1 research grant	This study was financially supported by the Foundation Fighting Blindness USA (BR-GE-0510-0490-HUJ to DS), by the legacy heritage biomedical program of the Israeli Science Foundation (grant number 612/09 to DS and TBY), and the Yedidut 1 research grant (to EB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Aller E, 2004, EUR J HUM GENET, V12, P407, DOI 10.1038/sj.ejhg.5201138; Auslender N, 2007, INVEST OPHTH VIS SCI, V48, P5431, DOI 10.1167/iovs.07-0736; Beit-Ya'acov A, 2007, INVEST OPHTH VIS SCI, V48, P4308, DOI 10.1167/iovs.07-0244; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; Clark J G, 1981, ASHA, V23, P493; Engdahl B, 2002, INT J AUDIOL, V41, P78, DOI 10.3109/14992020209101315; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Haim Marianne, 2002, Acta Ophthalmol Scand Suppl, P1; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Kaiserman N, 2007, ARCH OPHTHALMOL-CHIC, V125, P219, DOI 10.1001/archopht.125.2.219; Lillo C, 2006, ADV EXP MED BIOL, V572, P341; Ouyang XM, 2002, HUM GENET, V111, P26, DOI 10.1007/s00439-002-0736-0; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Rozen S, 2000, Methods Mol Biol, V132, P365; Saihan Z, 2011, RETINA-J RET VIT DIS, V31, P1708, DOI 10.1097/IAE.0b013e31820d3fd1; Sandberg MA, 2008, INVEST OPHTH VIS SCI, V49, P5532, DOI 10.1167/iovs.08-2009; Scanlan MJ, 1999, BBA-GENE STRUCT EXPR, V1445, P39, DOI 10.1016/S0167-4781(99)00033-0; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Xu WJ, 2011, MOL VIS, V17, P1537	23	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51566	10.1371/journal.pone.0051566	http://dx.doi.org/10.1371/journal.pone.0051566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251578	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200135
J	Wen, HX; Li, YJ; Malek, SN; Kim, YC; Xu, J; Chen, PX; Xiao, FX; Huang, X; Zhou, XZ; Xuan, ZY; Mankala, S; Hou, GH; Rowley, JD; Zhang, MQ; Wang, SM				Wen, Hongxiu; Li, Yongjin; Malek, Sami N.; Kim, Yeong C.; Xu, Jia; Chen, Peixian; Xiao, Fengxia; Huang, Xin; Zhou, Xianzheng; Xuan, Zhenyu; Mankala, Shiva; Hou, Guihua; Rowley, Janet D.; Zhang, Michael Q.; Wang, San Ming			New Fusion Transcripts Identified in Normal Karyotype Acute Myeloid Leukemia	PLOS ONE			English	Article							GENE FUSIONS; RNA; MUTATIONS; CANCER; EXPRESSION; HETEROGENEITY; ADULTS; ALK; AML; RET	Genetic aberrations contribute to acute myeloid leukemia (AML). However, half of AML cases do not contain the well-known aberrations detectable mostly by cytogenetic analysis, and these cases are classified as normal karyotype AML. Different outcomes of normal karyotype AML suggest that this subgroup of AML could be genetically heterogeneous. But lack of genetic markers makes it difficult to further study this subgroup of AML. Using paired-end RNAseq method, we performed a transcriptome analysis in 45 AML cases including 29 normal karyotype AML, 8 abnormal karyotype AML and 8 AML without karyotype informaiton. Our study identified 134 fusion transcripts, all of which were formed between the partner genes adjacent in the same chromosome and distributed at different frequencies in the AML cases. Seven fusions are exclusively present in normal karyotype AML, and the rest fusions are shared between the normal karyotype AML and abnormal karyotype AML. CIITA, a master regulator of MHC class II gene expression and truncated in B-cell lymphoma and Hodgkin disease, is found to fuse with DEXI in 48% of normal karyotype AML cases. The fusion transcripts formed between adjacent genes highlight the possibility that certain such fusions could be involved in oncological process in AML, and provide a new source to identify genetic markers for normal karyotype AML.	[Wen, Hongxiu; Kim, Yeong C.; Xiao, Fengxia; Wang, San Ming] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Li, Yongjin; Xuan, Zhenyu; Mankala, Shiva; Zhang, Michael Q.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA; [Malek, Sami N.] Univ Michigan, Med Ctr, Dept Med, Ann Arbor, MI 48109 USA; [Xu, Jia; Hou, Guihua] Shandong Univ, Sch Med, Inst Expt Nucl Med, Jinan 250100, Peoples R China; [Chen, Peixian] Univ Nebraska Med Ctr, Dept Med, Omaha, NE USA; [Huang, Xin; Zhou, Xianzheng] New York Med Coll, Sch Med, New York, NY USA; [Rowley, Janet D.] Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA; [Wang, San Ming] Univ Nebraska Med Ctr, Eppley Canc Inst, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Texas System; University of Texas Dallas; University of Michigan System; University of Michigan; Shandong University; University of Nebraska System; University of Nebraska Medical Center; New York Medical College; University of Chicago; University of Chicago Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, SM (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA.	sanming.wang@unmc.edu	, san ming wang/ABG-4910-2020; LI, YONGJIN/E-1688-2011	Xuan, Zhenyu/0000-0001-9344-8493	American Recovery and Reinvestment Act [RC1CA145889]; NATIONAL CANCER INSTITUTE [RC1CA145889] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by the American Recovery and Reinvestment Act of 2009, RC1CA145889 (S. M. W., J.D.R., M.Q.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audouard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017109; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429; Grimwade D., 2004, Annals of Hematology, V83, pS45; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Hata K, 2002, AM J PHYSIOL-GASTR L, V282, pG1035, DOI 10.1152/ajpgi.00494.2001; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Luo BQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020364; Marcucci G, 2005, CURR OPIN HEMATOL, V12, P68, DOI 10.1097/01.moh.0000149608.29685.d1; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nimer SD, 2008, BEST PRACT RES CL HA, V21, P43, DOI 10.1016/j.beha.2007.11.010; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; OHANLON TP, 1995, BIOCHEM BIOPH RES CO, V210, P556, DOI 10.1006/bbrc.1995.1696; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Salzman J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001156; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Strunk CJ, 2009, AM J HEMATOL, V84, P308, DOI 10.1002/ajh.21396; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wood CG, 2009, FUTURE ONCOL, V5, P763, DOI 10.2217/FON.09.46; Zhang YM, 2012, CANCER DISCOV, V2, P598, DOI 10.1158/2159-8290.CD-12-0042	37	27	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51203	10.1371/journal.pone.0051203	http://dx.doi.org/10.1371/journal.pone.0051203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251452	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200067
J	Hikima, J; Yi, MK; Ohtani, M; Jung, CY; Kim, YK; Mun, JY; Kim, YR; Takeyama, H; Aoki, T; Jung, TS				Hikima, Jun-ichi; Yi, Mi-Kyong; Ohtani, Maki; Jung, Chan Yong; Kim, Young Kyu; Mun, Ji Young; Kim, Young Rim; Takeyama, Haruko; Aoki, Takashi; Jung, Tae Sung			LGP2 Expression is Enhanced by Interferon Regulatory Factor 3 in Olive Flounder, Paralichthys olivaceus	PLOS ONE			English	Article							I-LIKE-RECEPTORS; DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; RIG-I; JAPANESE FLOUNDER; FUNCTIONAL-CHARACTERIZATION; ANTIVIRAL RESPONSES; ATLANTIC COD; RECOGNITION; ACTIVATION	In innate immunity, LGP2 (laboratory of genetics and physiology 2) plays a very important role in the production of type I interferon (IFN) through recognition of cytosolic viral RNA. Although viral infection or stimulation with double-strand RNA dramatically induces expression of the LGP2 gene, the underlying transcriptional mechanism has never been studied. Here, we cloned and characterized the 5'-upstream region (-1,337 bp) of the LGP2 gene in olive flounder (Paralichthys olivaceus). Numerous canonical motifs for IFN-regulatory factors (IRFs) were found in this region, and reporter assays identified a poly I: C-responsive promoter region (-506 to -398) that regulated LGP2 transcription. Transcriptional activity of the LGP2 promoter was strongly enhanced by IRF3, which bound to IRF3 motif #3 (-480). The LGP2 promoter was also responsive to viral infection in vitro. These results suggest that LGP2 transcriptional control is crucially involved to regulated by IRF3 function after viral infection or stimulation with poly I:C.	[Hikima, Jun-ichi; Yi, Mi-Kyong; Ohtani, Maki; Jung, Chan Yong; Kim, Young Kyu; Mun, Ji Young; Kim, Young Rim; Aoki, Takashi; Jung, Tae Sung] Gyeongsang Natl Univ, Aquat Biotechnol Ctr, Coll Vet Med, Jinju, Gyeongnam, South Korea; [Takeyama, Haruko] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Aoki, Takashi] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care ASMeW, Shinjuku Ku, Tokyo, Japan	Gyeongsang National University; Waseda University; Waseda University	Aoki, T (corresponding author), Gyeongsang Natl Univ, Aquat Biotechnol Ctr, Coll Vet Med, Jinju, Gyeongnam, South Korea.	aokitaka@aoni.waseda.jp; jungts@gmail.com	Hikima, Jun-ichi/AAI-6983-2020; Jung, Tae Sung/G-8245-2017	Hikima, Jun-ichi/0000-0002-4184-7422; Jung, Tae Sung/0000-0001-6028-0946	World Class University Program [R32-10253]; Ministry of Education, Science and Technology, Republic of Korea	World Class University Program; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Our research was supported by a grant from the World Class University Program (R32-10253) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Huang T, 2010, FISH SHELLFISH IMMUN, V29, P349, DOI 10.1016/j.fsi.2010.04.001; Jun Eun g, 2009, Journal of Bacteriology and Virology, V39, P145; Kasai H., 2001, FISH SCI HOKKAIDO U, V52, P67; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Mccoy CE, 2008, J BIOL CHEM, V283, P14277, DOI 10.1074/jbc.M709731200; Ohtani M, 2012, DEV COMP IMMUNOL, V36, P697, DOI 10.1016/j.dci.2011.10.008; Ohtani M, 2010, J IMMUNOL, V185, P7507, DOI 10.4049/jimmunol.1001850; Ooi EL, 2006, FISH SHELLFISH IMMUN, V21, P293, DOI 10.1016/j.fsi.2005.12.004; Rise ML, 2010, PHYSIOL GENOMICS, V42, P266, DOI 10.1152/physiolgenomics.00168.2009; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seppola M, 2009, DEV COMP IMMUNOL, V33, P1205, DOI 10.1016/j.dci.2009.06.013; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Yasuike M, 2011, COMP IMMUNOL MICROB, V34, P83, DOI 10.1016/j.cimid.2010.02.005; Yazawa R, 2006, TRANSGENIC RES, V15, P385, DOI 10.1007/s11248-006-0009-0; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	28	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51522	10.1371/journal.pone.0051522	http://dx.doi.org/10.1371/journal.pone.0051522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251565	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900096
J	Hilker, R; Pilatus, U; Eggers, C; Hagenah, J; Roggendorf, J; Baudrexel, S; Klein, JC; Neumaier, B; Fink, GR; Steinmetz, H; Klein, C; Hattingen, E				Hilker, Rueediger; Pilatus, Ulrich; Eggers, Carsten; Hagenah, Johann; Roggendorf, Julia; Baudrexel, Simon; Klein, Johannes C.; Neumaier, Bernd; Fink, Gereon R.; Steinmetz, Helmuth; Klein, Christine; Hattingen, Elke			The Bioenergetic Status Relates to Dopamine Neuron Loss in Familial PD with PINK1 Mutations	PLOS ONE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; PARKINSONS-DISEASE; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; BRAIN; MYOINOSITOL; RECOMMENDATIONS; METABOLISM; ASTROCYTES; GLUTAMATE	Mutations in the PINK1 gene cause autosomal recessive familial Parkinson's disease (PD). The gene encodes a mitochondrial protein kinase that plays an important role in maintaining mitochondrial function and integrity. However, the pathophysiological link between mutation-related bioenergetic deficits and the degenerative process in dopaminergic neurons remains to be elucidated. We performed phosphorous (P-31) and proton (H-1) 3-T magnetic resonance spectroscopic imaging (MRSI) in 11 members of a German family with hereditary PD due to PINK1 mutations (PARK6) compared to 23 age-matched controls. All family members had prior 18-Fluorodopa (FDOPA) positron emission tomography (PET). The striatal FDOPA uptake was correlated with quantified metabolic brain mapping in MRSI. At group level, the heterozygous PINK1 mutation carriers did not show any MRSI abnormalities relative to controls. In contrast, homozygous individuals with manifest PD had putaminal GPC, PCr, HEP and beta-ATP levels well above the 2SD range of controls. Across all subjects, the FDOPA K-i values correlated positively with MI (r = 0.879, p<0.001) and inversely with beta-ATP (r = -0.784, p = 0.008) and GPC concentrations (r = -0.651, p = 0.030) in the putamen. Our combined imaging data suggest that the dopaminergic deficit in this family with PD due to PINK1 mutations relates to osmolyte dysregulation, while the delivery of high energy phosphates was preserved. Our results corroborate the hypothesis that PINK1 mutations result in reduced neuronal survival, most likely due to impaired cellular stress resistance.	[Hilker, Rueediger; Roggendorf, Julia; Baudrexel, Simon; Klein, Johannes C.; Steinmetz, Helmuth] Goethe Univ Frankfurt, Dept Neurol, Frankfurt, Germany; [Pilatus, Ulrich; Hattingen, Elke] Goethe Univ Frankfurt, Inst Neuroradiol, Frankfurt, Germany; [Eggers, Carsten; Fink, Gereon R.] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Hagenah, Johann; Klein, Christine] Med Univ Lubeck, Sect Clin & Mol Neurogenet, Dept Neurol, D-23538 Lubeck, Germany; [Neumaier, Bernd] Max Planck Inst Neurol Res, D-50931 Cologne, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of Cologne; University of Lubeck; Max Planck Society	Hilker, R (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Frankfurt, Germany.	hilker@med.uni-frankfurt.de	Hattingen, Elke/D-7880-2015; Fink, Gereon R./AFW-9377-2022; Klein, Christine/AGK-8003-2022; Fink, Gereon R./E-1616-2012; Neumaier, Bernd/G-7058-2019	Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Hattingen, Elke/0000-0002-8392-9004; Neumaier, Bernd/0000-0001-5425-3116; Klein, Christine/0000-0003-2102-3431	Medtronic; Cephalon; Deutsche Parkinson Vereinigung (dPV); Bundesministerium fur Bildung und Forschung; Goethe-University of Frankfurt; Bachmann-Strauss Dystonia; Parkinson Foundation; Deutsche Forschungsgemeinschaft; Boehringer Ingelheim; Centogene; Hermann and Lilly Schilling Foundation; Possehl Foundation	Medtronic(Medtronic); Cephalon; Deutsche Parkinson Vereinigung (dPV); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Goethe-University of Frankfurt; Bachmann-Strauss Dystonia; Parkinson Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim(Boehringer Ingelheim); Centogene; Hermann and Lilly Schilling Foundation; Possehl Foundation	Ruediger Hilker has received speaker honoraria from Medtronic, Orion, GlaxoSmithKline, TEVA, Cephalon, Solvay, Desitin and Boehringer Ingelheim as well as travel funding from Medtronic and Cephalon. He serves or has served on a scientific advisory board for Cephalon. He has received research funding from the Deutsche Parkinson Vereinigung (dPV), Bundesministerium fur Bildung und Forschung and the Goethe-University of Frankfurt. Johann Hagenah receives funding from the Bachmann-Strauss Dystonia & Parkinson Foundation. Gereon Fink serves as an editorial board member of Cortex, Zeitschrift fur Neuropsychologie, and Fortschritte der Neurologie Psychiatrie; receives royalties from the publication of the books Funktionelle MRT in Psychiatrie und Neurologie and Neurologische Differentialdiagnose; received honoraria for speaking engagements from TEVA, Desitin, GlaxoSmith-Kline and Boehringer Ingelheim; and receives research support from the Bundesministerium fur Bildung und Forschung and the Deutsche Forschungsgemeinschaft. Helmuth Steinmetz has received speaker honoraria from Boehringer Ingelheim and Sanofi Aventis and has contracts with the publishers Elsevier, Thieme and Springer. Christine Klein is a member of the editorial board of "Neurology" and has served as editor of the "Continuum Issue Neurogenetics 2008" and as faculty at the Annual Meetings of the American Academy of Neurology since 2004. She received consulting fees from Boehringer Ingelheim and Centogene and received honoraria for speaking from Boehringer Ingelheim and Shire. Klein is the recipient of a career development award from the Hermann and Lilly Schilling Foundation. She is funded by the Deutsche Forschungsgemeinschaft, the Possehl Foundation, and received institutional support from the University of Luebeck for genetics research. Ulrich Pilatus, Carsten Eggers, Julia Roggendorf, Simon Baudrexel, Johannes Klein, Bernd Neumaier and Elke Hattingen report no disclosures. None of the above funding was for this specific study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abramov AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025622; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; [Anonymous], 2003, MOV DISORD, V18, P738; Brand A, 1999, J NEUROSCI RES, V58, P576, DOI 10.1002/(SICI)1097-4547(19991115)58:4<576::AID-JNR10>3.0.CO;2-D; Cholet N, 2001, J CEREBR BLOOD F MET, V21, P404, DOI 10.1097/00004647-200104000-00009; Eggers C, 2010, NEUROLOGY, V74, P1798, DOI 10.1212/WNL.0b013e3181e0f79c; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Haussinger D, 2000, J HEPATOL, V32, P1035, DOI 10.1016/S0168-8278(00)80110-5; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Hetherington HP, 1996, MAGNET RESON MED, V36, P21, DOI 10.1002/mrm.1910360106; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Klein C, 2005, EUR J HUM GENET; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Papa S, 2009, J BIOENERG BIOMEMBR, V41, P509, DOI 10.1007/s10863-009-9252-4; PETTEGREW JW, 1995, NEUROBIOL AGING, V16, P973, DOI 10.1016/0197-4580(95)02017-9; PETTEGREW JW, 1988, ARCH NEUROL-CHICAGO, V45, P1093, DOI 10.1001/archneur.1988.00520340047010; Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2; Prebil Mateja, 2011, Archives of Physiology and Biochemistry, V117, P64, DOI 10.3109/13813455.2010.539616; Prestel J, 2008, J NEUROL, V255, P643, DOI 10.1007/s00415-008-0763-4; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Ross BD, 1998, NEUROIMAG CLIN N AM, V8, P809; ROSS BD, 1991, NMR BIOMED, V4, P59, DOI 10.1002/nbm.1940040205; Siger M, 2009, ALZ DIS ASSOC DIS, V23, P57, DOI 10.1097/WAD.0b013e3181875434; Thomas KJ, 2009, INT J BIOCHEM CELL B, V41, P2025, DOI 10.1016/j.biocel.2009.02.018; THURSTON JH, 1989, PEDIATR RES, V26, P482, DOI 10.1203/00006450-198911000-00024; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Valenzuela MJ, 2001, NEUROLOGY, V56, P592, DOI 10.1212/WNL.56.5.592; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zhu XP, 2006, ALZ DIS ASSOC DIS, V20, P77, DOI 10.1097/01.wad.0000213809.12553.fc	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51308	10.1371/journal.pone.0051308	http://dx.doi.org/10.1371/journal.pone.0051308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251494	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900067
J	Isern, N; Fort, J; Vander Linden, M				Isern, Neus; Fort, Joaquim; Vander Linden, Marc			Space Competition and Time Delays in Human Range Expansions. Application to the Neolithic Transition	PLOS ONE			English	Article							POPULATION-SIZE; NEAR-EAST; EUROPE; DIFFUSION; SPREAD; WAVE	Space competition effects are well-known in many microbiological and ecological systems. Here we analyze such an effect in human populations. The Neolithic transition (change from foraging to farming) was mainly the outcome of a demographic process that spread gradually throughout Europe from the Near East. In Northern Europe, archaeological data show a slowdown on the Neolithic rate of spread that can be related to a high indigenous (Mesolithic) population density hindering the advance as a result of the space competition between the two populations. We measure this slowdown from a database of 902 Early Neolithic sites and develop a time-delayed reaction-diffusion model with space competition between Neolithic and Mesolithic populations, to predict the observed speeds. The comparison of the predicted speed with the observations and with a previous non-delayed model show that both effects, the time delay effect due to the generation lag and the space competition between populations, are crucial in order to understand the observations.	[Isern, Neus] Univ Autonoma Barcelona, Dept Prehist, Cerdanyola Del Valles, Spain; [Fort, Joaquim] Univ Girona, Dept Fis, Complex Syst Lab, Girona, Catalonia, Spain; [Vander Linden, Marc] UCL, Inst Archaeol, London, England	Autonomous University of Barcelona; Universitat de Girona; University of London; University College London	Isern, N (corresponding author), Univ Autonoma Barcelona, Dept Prehist, Cerdanyola Del Valles, Spain.	Neus.Isern@uab.cat	Linden, Marc Vander/AFO-2422-2022; Isern, Neus/G-8530-2015	Linden, Marc Vander/0000-0002-0120-7754; Isern, Neus/0000-0001-8386-5373	Ministry of Science [CSD-2010-00034, FIS-2009-13050]; Generalitat de Catalunya [2009-SGR-374]; European Commission [NEST-028192]	Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Generalitat de Catalunya(Generalitat de Catalunya); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the Ministry of Science (grants SimulPast-Consolider-CSD-2010-00034 and FIS-2009-13050) and the Generalitat de Catalunya (Grup Consolidat 2009-SGR-374). The Neolithic database was assembled as part of the project Formation of Europe prehistoric population dynamics and the roots of socio-cultural diversity, funded by the European Commission (NEST-028192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman A.J., 1973, EXPLANATION CULTURE, P343; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Amor DR, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061905; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Barker G., 2006, AGR REVOLUTION PREHI; BIRDSELL JB, 1957, COLD SPRING HARB SYM, V22, P47, DOI 10.1101/SQB.1957.022.01.008; Bocquet-Appel JP, 2012, J ARCHAEOL SCI, V39, P531, DOI 10.1016/j.jas.2011.10.010; Bocquet-Appel JP, 2011, SCIENCE, V333, P560, DOI 10.1126/science.1208880; Bocquet-Appel JP, 2009, J ARCHAEOL SCI, V36, P807, DOI 10.1016/j.jas.2008.11.004; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Collard M, 2010, J ARCHAEOL SCI, V37, P866, DOI 10.1016/j.jas.2009.11.016; Coward F, 2008, J ARCHAEOL SCI, V35, P42, DOI 10.1016/j.jas.2007.02.022; Fedotov S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026107; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Fort J, 1999, PHYS REV LETT, V82, P867, DOI 10.1103/PhysRevLett.82.867; Fort J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031913; Fort J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.178101; Fort J, 2012, AM ANTIQUITY, V77, P203, DOI 10.7183/0002-7316.77.2.203; Fort J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/8/086001; Gamba C, 2012, MOL ECOL, V21, P45, DOI 10.1111/j.1365-294X.2011.05361.x; Gause G. F., 1934, STRUGGLE EXISTENCE; Gkiasta M, 2003, ANTIQUITY, V77, P45, DOI 10.1017/S0003598X00061330; Guerrero E, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P57, DOI 10.1007/978-1-4020-8539-0_4; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Isern N, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/58002; Isern N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123002; Isern N, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10012; Isern N, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.057103; Louwe Kooijmans L.P., 2009, J ARCHAEOLOGY LOW CO, V1, P27; Mendez V, 1999, PHYS REV E, V60, P5231, DOI 10.1103/PhysRevE.60.5231; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; Ortega-Cejas V, 2004, ECOLOGY, V85, P258, DOI 10.1890/02-0606; Patterson MA, 2010, J ARCHAEOL SCI, V37, P2929, DOI 10.1016/j.jas.2010.07.003; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Price T.D., 2003, WIDENING HARVEST NEO, P273; REYNOLDS JC, 1985, J ANIM ECOL, V54, P149, DOI 10.2307/4627; ROBERTS DF, 1968, NATURE, V220, P1084, DOI 10.1038/2201084a0; Shennan S, 2007, J ARCHAEOL SCI, V34, P1339, DOI 10.1016/j.jas.2006.10.031; Sibson R., 1981, INTERPRETING MULTIVA, P21, DOI DOI 10.1007/3-540-26772-7_8; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Stuiver M., 2010, CALIB RADIOCARBON CA; Vander Linden M, EUR J ARCHAEOL UNPUB; Vermeersch PM, 2010, RADIOCARBON PAELOLIT; Viner S., 2011, DYNAMICS NEOLITHISAT, P41; Zvelebil M., 1984, NOR ARCHAEOL REV, V17, P104, DOI [10.1080/00293652.1984.9965402, DOI 10.1080/00293652.1984.9965402]	48	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51106	10.1371/journal.pone.0051106	http://dx.doi.org/10.1371/journal.pone.0051106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	052ML	23251430	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900041
J	Ordinario, E; Han, HJ; Furuta, S; Heiser, LM; Jakkula, LR; Rodier, F; Spellman, PT; Campisi, J; Gray, JW; Bissell, MJ; Kohwi, Y; Kohwi-Shigematsu, T				Ordinario, Ellen; Han, Hye-Jung; Furuta, Saori; Heiser, Laura M.; Jakkula, Lakshmi R.; Rodier, Francis; Spellman, Paul T.; Campisi, Judith; Gray, Joe W.; Bissell, Mina J.; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi			ATM Suppresses SATB1-Induced Malignant Progression in Breast Epithelial Cells	PLOS ONE			English	Article							BINDING-PROTEIN 1; DNA-DAMAGE; MESENCHYMAL TRANSITION; ATAXIA-TELANGIECTASIA; 3-DIMENSIONAL CULTURE; CANCER PATHOGENESIS; TUMOR PROGRESSION; GASTRIC-CANCER; SATB1; EXPRESSION	SATB1 drives metastasis when expressed in breast tumor cells by radically reprogramming gene expression. Here, we show that SATB1 also has an oncogenic activity to transform certain non-malignant breast epithelial cell lines. We studied the non-malignant MCF10A cell line, which is used widely in the literature. We obtained aliquots from two different sources (here we refer to them as MCF10A-1 and MCF10A-2), but found them to be surprisingly dissimilar in their responses to oncogenic activity of SATB1. Ectopic expression of SATB1 in MCF10A-1 induced tumor-like morphology in three-dimensional cultures, led to tumor formation in immunocompromised mice, and when injected into tail veins, led to lung metastasis. The number of metastases correlated positively with the level of SATB1 expression. In contrast, SATB1 expression in MCF10A-2 did not lead to any of these outcomes. Yet DNA copy-number analysis revealed that MCF10A-1 is indistinguishable genetically from MCF10A-2. However, gene expression profiling analysis revealed that these cell lines have significantly divergent signatures for the expression of genes involved in oncogenesis, including cell cycle regulation and signal transduction. Above all, the early DNA damage-response kinase, ATM, was greatly reduced in MCF10A-1 cells compared to MCF10A-2 cells. We found the reason for reduction to be phenotypic drift due to long-term cultivation of MCF10A. ATM knockdown in MCF10A-2 and two other non-malignant breast epithelial cell lines, 184A1 and 184B4, enabled SATB1 to induce malignant phenotypes similar to that observed for MCF10A-1. These data indicate a novel role for ATM as a suppressor of SATB1-induced malignancy in breast epithelial cells, but also raise a cautionary note that phenotypic drift could lead to dramatically different functional outcomes.	[Ordinario, Ellen; Han, Hye-Jung; Furuta, Saori; Heiser, Laura M.; Jakkula, Lakshmi R.; Rodier, Francis; Spellman, Paul T.; Campisi, Judith; Gray, Joe W.; Bissell, Mina J.; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Campisi, Judith] Buck Inst Res Aging, Novato, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	TKohwi-Shigematsu@lbl.gov	Furuta, Saori/P-9677-2018; Gray, Joe/AAX-9549-2020	Furuta, Saori/0000-0003-1121-0487; Rodier, Francis/0000-0003-2523-309X	National Cancer Institute [R37CA039681]; National Institutes of Health, National Cancer Institute [P50 CA 58207, U54 CA 112970]; National Institute on Aging [R37AG009909, P01AG017242]; Low Dose Radiation Research Program, US Department of Energy [DE-AC02-05CH11231]; NRSA [F32CA138109]; NATIONAL CANCER INSTITUTE [U54CA112970, P50CA058207, R37CA039681, F32CA138109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009909, P01AG017242] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Low Dose Radiation Research Program, US Department of Energy(United States Department of Energy (DOE)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Cancer Institute grant R37CA039681 to TK-S; the National Institutes of Health, National Cancer Institute grants P50 CA 58207 and U54 CA 112970 to JG; National Institute on Aging grants R37AG009909 and P01AG017242 to JC and Low Dose Radiation Research Program, US Department of Energy (DE-AC02-05CH11231) to TK-S and JC; and NRSA fellowship (F32CA138109) to EO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Alvarez JD, 2000, GENE DEV, V14, P521; Balamotis MA, 2012, MOL CELL BIOL, V32, P333, DOI 10.1128/MCB.05917-11; Bissell M J, 1981, Int Rev Cytol, V70, P27, DOI 10.1016/S0074-7696(08)61130-4; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Choi E, 2012, DEV CELL, V22, P295, DOI 10.1016/j.devcel.2012.01.009; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hanker LC, 2011, BREAST, V20, P309, DOI 10.1016/j.breast.2010.10.002; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Imbalzano KM, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-7; Iorns E, 2010, JNCI-J NATL CANCER I, V102, P1284, DOI 10.1093/jnci/djq243; Ji HJ, 1997, CANCER RES, V57, P759; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kohwi-Shigematsu T, 2012, SEMIN CANC BIOL; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Li QQ, 2010, CANCER SCI, V101, P80, DOI 10.1111/j.1349-7006.2009.01372.x; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Mandriota SJ, 2010, J BIOL CHEM, V285, P13092, DOI 10.1074/jbc.M109.078360; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; McInnes N, 2012, ONCOGENE, V31, P1045, DOI 10.1038/onc.2011.293; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAINE TM, 1992, INT J CANCER, V50, P463, DOI 10.1002/ijc.2910500323; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; SOULE HD, 1990, CANCER RES, V50, P6075; Stampfer MR, 1997, MOL BIOL CELL, V8, P2391, DOI 10.1091/mbc.8.12.2391; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; TAIT L, 1990, CANCER RES, V50, P6087; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tysnes BB, 2007, BBA-REV CANCER, V1775, P283, DOI 10.1016/j.bbcan.2007.01.001; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; WALEN KH, 1989, CANCER GENET CYTOGEN, V37, P249, DOI 10.1016/0165-4608(89)90056-3; Wang B, 1997, ANTICANCER RES, V17, P4387; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Yamayoshi A, 2011, OLIGONUCLEOTIDES, V21, P115, DOI 10.1089/oli.2010.0277; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Ye CZ, 2007, CANCER-AM CANCER SOC, V109, P1729, DOI 10.1002/cncr.22592	70	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51786	10.1371/journal.pone.0051786	http://dx.doi.org/10.1371/journal.pone.0051786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251624	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900118
J	Pathai, S; Weiss, HA; Lawn, SD; Peto, T; D'Costa, LM; Cook, C; Wong, TY; Gilbert, CE				Pathai, Sophia; Weiss, Helen A.; Lawn, Stephen D.; Peto, Tunde; D'Costa, Leris M.; Cook, Colin; Wong, Tien Y.; Gilbert, Clare E.			Retinal Arterioles Narrow with Increasing Duration of Anti-Retroviral Therapy in HIV Infection: A Novel Estimator of Vascular Risk in HIV?	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; VESSEL DIAMETERS; CARDIOVASCULAR RISK; BLOOD-PRESSURE; ATHEROSCLEROSIS RISK; CALIBER; AGE; INFLAMMATION; ASSOCIATION; MORTALITY	Objectives: HIV infection is associated with an increased risk of age-related morbidity mediated by immune dysfunction, atherosclerosis and inflammation. Changes in retinal vessel calibre may reflect cumulative structural damage arising from these mechanisms. The relationship of retinal vessel calibre with clinical and demographic characteristics was investigated in a population of HIV-infected individuals in South Africa. Methods: Case-control study of 491 adults >= 30 years, composed of 242 HIV-infected adults and 249 age-and gender-matched HIV-negative controls. Retinal vessel calibre was measured using computer-assisted techniques to determine mean arteriolar and venular diameters of each eye. Results: The median age was 40 years (IQR: 35-48 years). Among HIV-infected adults, 87.1% were receiving highly active antiretroviral therapy (HAART) (median duration, 58 months), their median CD4 count was 468 cells/mu L, and 84.3% had undetectable plasma viral load. Unadjusted mean retinal arteriolar diameters were 163.67+/-17.69 mu m in cases and 161.34+/-17.38 mu m in controls (p = 0.15). Unadjusted mean venular diameters were 267.77+/-18.21 mu m in cases and 270.81+/-18.98 mu m in controls (p = 0.07). Age modified the effect of retinal arteriolar and venular diameters in relation to HIV status, with a tendency towards narrower retinal diameters in HIV cases but not in controls. Among cases, retinal arteriolar diameters narrowed with increasing duration of HAART, independently of age (167.83 mu m <3 years of HAART vs. 158.89 mu m >6 years, p-trend = 0.02), and with a HIV viral load >10,000 copies/mu L while on HAART (p = 0.05). HIV-related venular changes were not detected. Conclusions: Narrowing of retinal arteriolar diameters is associated with HAART duration and viral load, and may reflect heightened inflammatory and pro-atherogenic states of the systemic vasculature. Measurement of retinal vascular calibre could be an innovative non-invasive method of estimating vascular risk in HIV-infected individuals.	[Pathai, Sophia; D'Costa, Leris M.; Gilbert, Clare E.] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England; [Pathai, Sophia; Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Weiss, Helen A.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Fac Epidemiol & Populat Hlth, London WC1, England; [Peto, Tunde] UCL Inst Ophthalmol, London, England; [Peto, Tunde] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Cook, Colin] Univ Cape Town, Dept Ophthalmol, Fac Hlth Sci, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cape Town; National University of Singapore; Singapore National Eye Center	Pathai, S (corresponding author), London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England.	sophia.pathai@lshtm.ac.uk; clare.gilbert@lshtm.ac.uk	Peto, Tunde/G-8812-2018; Wong, Tien Yin/AAC-9724-2020; weiss, helen/ABC-7823-2021; Pathai, Sophia/GLU-7811-2022	Peto, Tunde/0000-0001-6265-0381; Wong, Tien Yin/0000-0002-8448-1264; weiss, helen/0000-0003-3547-7936; Pathai, Sophia/0000-0002-2835-4666	Wellcome Trust [090354/Z/09/Z, 088590]; NIHR Biomedical Research Centre at Moorfield's Eye Hospital and Institute of Ophthalmology	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre at Moorfield's Eye Hospital and Institute of Ophthalmology	SP and SDL are funded by the Wellcome Trust (Grants 090354/Z/09/Z to SP and 088590 to SDL) (www.wellcome.ac.uk). TP is funded by NIHR Biomedical Research Centre at Moorfield's Eye Hospital and Institute of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JV, 2009, CURR OPIN HIV AIDS, V4, P176, DOI 10.1097/COH.0b013e328329c62f; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; D'Agostino RB, 2012, J INFECT DIS, V205, pS362, DOI 10.1093/infdis/jis196; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks Steven G, 2009, Top HIV Med, V17, P118; Fisher M, 2012, CURR OPIN INFECT DIS, V25, P1, DOI 10.1097/QCO.0b013e32834f14fa; Gangaputra S, 2012, AM J OPHTHALMOL, V153, P434, DOI 10.1016/j.ajo.2011.08.028; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Ho JE, 2012, AIDS, V26, P1115, DOI 10.1097/QAD.0b013e328352ce54; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, HYPERTENSION, V47, P189, DOI 10.1161/01.HYP.0000199104.61945.33; Ikram MK, 2006, BRAIN, V129, P182, DOI 10.1093/brain/awh688; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Klein R, 2006, ARCH OPHTHALMOL-CHIC, V124, P87, DOI 10.1001/archopht.124.1.87; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Knudtson MD, 2004, BRIT J OPHTHALMOL, V88, P57, DOI 10.1136/bjo.88.1.57; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Liew G, 2006, HYPERTENSION, V48, pE10, DOI 10.1161/01.HYP.0000231652.97173.4c; Lo J, 2012, J INFECT DIS, V205, pS368, DOI 10.1093/infdis/jis201; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Martin J, 2010, ANN INTERN MED, V153, P477, DOI 10.7326/0003-4819-153-7-201010050-00013; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Negin Joel, 2012, AIDS, V26 Suppl 1, pS1; Nguyen TT, 2010, STROKE, V41, P1343, DOI 10.1161/STROKEAHA.110.581017; PARR JC, 1974, AM J OPHTHALMOL, V77, P472, DOI 10.1016/0002-9394(74)90457-7; PARR JC, 1974, AM J OPHTHALMOL, V77, P478, DOI 10.1016/0002-9394(74)90458-9; Rochtchina E, 2008, INVEST OPHTH VIS SCI, V49, P1362, DOI 10.1167/iovs.07-0150; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Saag MS, 2011, CLIN INFECT DIS, V53, P1140, DOI 10.1093/cid/cir629; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Solages A, 2006, CLIN INFECT DIS, V42, P1325, DOI 10.1086/503261; Sun C, 2008, INVEST OPHTH VIS SCI, V49, P1784, DOI 10.1167/iovs.07-1450; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Wong TY, 2006, ARCH INTERN MED, V166, P2388, DOI 10.1001/archinte.166.21.2388; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2005, OPHTHALMOLOGY, V112, P553, DOI 10.1016/j.ophtha.2004.11.026; Wong TY, 2004, AM J OPHTHALMOL, V137, P1050, DOI 10.1016/j.ajo.2004.01.035; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P2528, DOI 10.1001/jama.287.19.2528	48	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51405	10.1371/journal.pone.0051405	http://dx.doi.org/10.1371/journal.pone.0051405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251521	Green Published, Green Accepted, gold			2022-12-27	WOS:000312201900080
J	Yu, R; Broady, R; Huang, YS; Wang, Y; Yu, J; Gao, M; Levings, M; Wei, SC; Zhang, SQ; Xu, A; Su, MW; Dutz, J; Zhang, XJ; Zhou, YW				Yu, Richard; Broady, Raewyn; Huang, Yuanshen; Wang, Yang; Yu, Jie; Gao, Min; Levings, Megan; Wei, Shencai; Zhang, Shengquan; Xu, Aie; Su, Mingwan; Dutz, Jan; Zhang, Xuejun; Zhou, Youwen			Transcriptome Analysis Reveals Markers of Aberrantly Activated Innate Immunity in Vitiligo Lesional and Non-Lesional Skin	PLOS ONE			English	Article							NATURAL-KILLER-CELL; SUSCEPTIBILITY LOCI; GENERALIZED VITILIGO; MULTIPLE-SCLEROSIS; UP-REGULATION; T-CELLS; MELANOCYTES; RECEPTORS; EXPRESSION; LIGANDS	Background: Vitiligo is characterized by the death of melanocytes in the skin. This is associated with the presence of T cell infiltrates in the lesional borders. However, at present, there is no detailed and systematic characterization on whether additional cellular or molecular changes are present inside vitiligo lesions. Further, it is unknown if the normal appearing non-lesional skin of vitiligo patients is in fact normal. The purpose of this study is to systematically characterize the molecular and cellular characteristics of the lesional and non-lesional skin of vitiligo patients. Methods and Materials: Paired lesional and non-lesional skin biopsies from twenty-three vitiligo patients and normal skin biopsies from sixteen healthy volunteers were obtained with informed consent. The following aspects were analyzed: (1) transcriptome changes present in vitiligo skin using DNA microarrays and qRT-PCR; (2) abnormal cellular infiltrates in vitiligo skin explant cultures using flow cytometry; and (3) distribution of the abnormal cellular infiltrates in vitiligo skin using immunofluorescence microscopy. Results: Compared with normal skin, vitiligo lesional skin contained 17 genes (mostly melanocyte-specific genes) whose expression was decreased or absent. In contrast, the relative expression of 13 genes was up-regulated. The up-regulated genes point to aberrant activity of the innate immune system, especially natural killer cells in vitiligo. Strikingly, the markers of heightened innate immune responses were also found to be up-regulated in the non-lesional skin of vitiligo patients. Conclusions and Clinical Implications: As the first systematic transcriptome characterization of the skin in vitiligo patients, this study revealed previously unknown molecular markers that strongly suggest aberrant innate immune activation in the microenvironment of vitiligo skin. Since these changes involve both lesional and non-lesional skin, our results suggest that therapies targeting the entire skin surface may improve treatment outcomes. Finally, this study revealed novel mediators that may facilitate future development of vitiligo therapies.	[Yu, Richard; Huang, Yuanshen; Wang, Yang; Wei, Shencai; Zhang, Shengquan; Su, Mingwan; Dutz, Jan; Zhou, Youwen] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Yu, Richard; Gao, Min; Zhang, Shengquan; Zhang, Xuejun; Zhou, Youwen] Anhui Med Univ, Inst Dermatol, Hefei, Peoples R China; [Broady, Raewyn] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Yu, Jie; Levings, Megan] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Xu, Aie] Third Peoples Hosp, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China; [Dutz, Jan; Zhou, Youwen] British Columbia Canc Agcy, Skin Tumor Grp, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; Anhui Medical University; University of British Columbia; University of British Columbia; British Columbia Cancer Agency	Dutz, J (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	dutz@interchange.ubc.ca; ayzxj@vip.sina.com; ywzhou@interchange.ubc.ca	Chen, Gang/G-2722-2010	, Yang/0000-0001-7805-2861; Levings, Megan/0000-0002-0305-5790	National Natural Sciences Foundation of China [30628021]; Canadian Institutes of Health Research; Canadian Dermatology Foundation; Astellas Pharma Research Competition, Canada	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation; Astellas Pharma Research Competition, Canada	This work was supported by grants from National Natural Sciences Foundation of China (No. 30628021), Canadian Institutes of Health Research, Canadian Dermatology Foundation, and Astellas Pharma Research Competition, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Tahir M, 2010, AUTOIMMUN REV, V9, P516, DOI 10.1016/j.autrev.2010.02.013; Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; ALABADIE MSK, 1995, INT J DERMATOL, V34, P837, DOI 10.1111/j.1365-4362.1995.tb04417.x; Basak PY, 2008, J EUR ACAD DERMATOL, V22, P970, DOI 10.1111/j.1468-3083.2008.02681.x; Boelaert K, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.06.030; Boissy RE, 2009, EXP DERMATOL, V18, P583, DOI 10.1111/j.1600-0625.2008.00826.x; BREATHNACH AS, 1966, J INVEST DERMATOL, V47, P125, DOI 10.1038/jid.1966.117; Broady R, 2010, BLOOD, V116, P5748, DOI 10.1182/blood-2010-07-295436; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Dalbeth N, 2002, ARTHRITIS RHEUM, V46, P1763, DOI 10.1002/art.10410; Darrah E, 2010, CELL DEATH DIFFER, V17, P624, DOI 10.1038/cdd.2009.197; Deretzi G, 2010, MULT SCLER J, V16, P1091, DOI 10.1177/1352458510375708; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; DURHAMPIERRE DG, 1995, J AM ACAD DERMATOL, V33, P26, DOI 10.1016/0190-9622(95)90005-5; French AR, 2004, ARTHRITIS RES THER, V6, P8, DOI 10.1186/ar1034; GHONEUM M, 1987, J AM ACAD DERMATOL, V17, P600, DOI 10.1016/S0190-9622(87)70243-6; Glassman SJ, 2011, CLIN SCI, V120, P99, DOI 10.1042/CS20090603; Goldbach-Mansky R, 2005, ANN RHEUM DIS, V64, P715, DOI 10.1136/ard.2003.007039; Grimes PE, 2005, JAMA-J AM MED ASSOC, V293, P730, DOI 10.1001/jama.293.6.730; Harris JE, 2012, J INVEST DERMATOL; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HH, 2010, ONCOL REP, V24, P1043, DOI 10.3892/or_00000953; Jacob SE, 2008, DERMATOL SURG, V34, P844, DOI 10.1111/j.1524-4725.2008.34158.x; Jin Y, 2007, J INVEST DERMATOL, V127, P2558, DOI 10.1038/sj.jid.5700953; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Jones CD, 1996, PHOTODERMATOL PHOTO, V12, P204, DOI 10.1111/j.1600-0781.1996.tb00201.x; KAMHOLZ J, 1992, J NEUROSCI RES, V31, P231, DOI 10.1002/jnr.490310204; Karlsen TH, 2007, J HEPATOL, V46, P899, DOI 10.1016/j.jhep.2007.01.032; Kemp EH, 2011, EXP DERMATOL, V20, P35, DOI 10.1111/j.1600-0625.2010.01181.x; Kennah E, 2009, BLOOD, V113, P4646, DOI 10.1182/blood-2008-08-174037; Kim DK, 2004, MOL IMMUNOL, V41, P53, DOI 10.1016/j.molimm.2004.01.004; Kingo K, 2008, J DERMATOL SCI, V52, P39, DOI 10.1016/j.jdermsci.2008.03.013; Kingo K, 2007, J DERMATOL SCI, V48, P113, DOI 10.1016/j.jdermsci.2007.06.004; Kitamura R, 2004, J PATHOL, V202, P463, DOI 10.1002/path.1538; Kocer B, 2009, EUR J NEUROL, V16, pE78, DOI 10.1111/j.1468-1331.2009.02563.x; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Le Poole I. Caroline, 2008, V10, P227, DOI 10.1159/000131485; Liang YH, 2007, J INVEST DERMATOL, V127, P2552, DOI 10.1038/sj.jid.5700904; Long EO, 2002, J EXP MED, V196, P1399, DOI 10.1084/jem.20021747; MOZZANICA N, 1992, J AM ACAD DERMATOL, V26, P693, DOI 10.1016/0190-9622(92)70094-V; MOZZANICA N, 1989, J AM ACAD DERMATOL, V20, P591, DOI 10.1016/S0190-9622(89)70069-4; Nonaka D, 2008, AM J SURG PATHOL, V32, P1291, DOI 10.1097/PAS.0b013e3181658c14; Perricone R, 2008, AUTOIMMUN REV, V7, P384, DOI 10.1016/j.autrev.2008.03.002; PORTER JR, 1991, J HEALTH SOC BEHAV, V32, P192, DOI 10.2307/2137152; Pridgeon C, 2003, RHEUMATOLOGY, V42, P870, DOI 10.1093/rheumatology/keg240; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Rashtak Shadi, 2008, V10, P344, DOI 10.1159/000131754; Ren YQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000523; Renedo M, 2000, GENOMICS, V65, P129, DOI 10.1006/geno.2000.6163; Ringrose A, 2006, LEUKEMIA, V20, P1593, DOI 10.1038/sj.leu.2404321; Ronday HK, 2001, RHEUMATOLOGY, V40, P55, DOI 10.1093/rheumatology/40.1.55; Schepis D, 2009, IMMUNOLOGY, V126, P140, DOI 10.1111/j.1365-2567.2008.02887.x; Senel E, 2007, INDIAN J DERMATOL VE, V73, P423, DOI 10.4103/0378-6323.37065; Serrao VV, 2008, EUR J DERMATOL, V18, P342, DOI 10.1684/ejd.2008.0402; SLOMINSKI A, 1989, J ROY SOC MED, V82, P539, DOI 10.1177/014107688908200911; Spritz RA, 2004, AM J HUM GENET, V74, P188, DOI 10.1086/381134; Spritz RA, 2007, PIGM CELL RES, V20, P271, DOI 10.1111/j.1600-0749.2007.00384.x; Spritz Richard A, 2011, J Invest Dermatol, V131, pE18, DOI 10.1038/skinbio.2011.7; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Stromberg S, 2008, PIGM CELL MELANOMA R, V21, P162, DOI 10.1111/j.1755-148X.2007.00429.x; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; Thompson AR, 2002, BRIT J HEALTH PSYCH, V7, P213, DOI 10.1348/135910702169457; Trachtenberg EA, 2009, ANN NEUROL, V65, P626, DOI 10.1002/ana.21747; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Wang X, 2003, J AUTOIMMUN, V21, P149, DOI 10.1016/S0896-8411(03)00087-8; Wang Y, 2011, BLOOD, V117, P3826, DOI 10.1182/blood-2010-07-294819; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Whitton ME, 2008, J AM ACAD DERMATOL, V59, P713, DOI 10.1016/j.jaad.2008.06.023; Xu SX, 2010, ACTA DERM-VENEREOL, V90, P131, DOI 10.2340/00015555-0820; Yamagiwa S, 2009, MED MOL MORPHOL, V42, P1, DOI 10.1007/s00795-008-0434-7; Yuan L, 2010, INT J CARDIOL; Zhang XJ, 2005, J DERMATOL SCI, V39, P137, DOI 10.1016/j.jdermsci.2005.06.004; Zhou Y, 1996, Exp Dermatol, V5, P138, DOI 10.1111/j.1600-0625.1996.tb00108.x; Zhu KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023089	80	60	65	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51040	10.1371/journal.pone.0051040	http://dx.doi.org/10.1371/journal.pone.0051040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251420	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900035
J	Sears, BF; Schlunk, AD; Rohr, JR				Sears, Brittany F.; Schlunk, Andrea D.; Rohr, Jason R.			Do Parasitic Trematode Cercariae Demonstrate a Preference for Susceptible Host Species?	PLOS ONE			English	Article							DISEASE; INFECTION; PATTERNS; DIGENEA; MALFORMATIONS; RECOGNITION; STRATEGIES; RESISTANCE; MIRACIDIA; TADPOLES	Many parasites are motile and exhibit behavioural preferences for certain host species. Because hosts can vary in their susceptibility to infections, parasites might benefit from preferentially detecting and infecting the most susceptible host, but this mechanistic hypothesis for host-choice has rarely been tested. We evaluated whether cercariae (larval trematode parasites) prefer the most susceptible host species by simultaneously presenting cercariae with four species of tadpole hosts. Cercariae consistently preferred hosts in the following order: Anaxyrus (=Bufo) terrestris (southern toad), Hyla squirella (squirrel tree frog), Lithobates (=Rana) sphenocephala (southern leopard frog), and Osteopilus septentrionalis (Cuban tree frog). These host species varied in susceptibility to cercariae in an order similar to their attractiveness with a correlation that approached significance. Host attractiveness to parasites also varied consistently and significantly among individuals within a host species. If heritable, this individual-level host variation would represent the raw material upon which selection could act, which could promote a Red Queen "arms race" between host cues and parasite detection of those cues. If, in general, motile parasites prefer to infect the most susceptible host species, this phenomenon could explain aggregated distributions of parasites among hosts and contribute to parasite transmission rates and the evolution of virulence. Parasite preferences for hosts belie the common assumption of disease models that parasites seek and infect hosts at random.	[Sears, Brittany F.; Schlunk, Andrea D.; Rohr, Jason R.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Sears, BF (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	bsears@mail.usf.edu	Rohr, Jason R./AAJ-5856-2021	Sears, Brittany/0000-0002-8515-8573	University of South Florida	University of South Florida	BFS was supported by a University of South Florida Presidential Fellowship (http://www.grad.usf.edu/presidential-fellowships.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARUS V, 1967, Vestnik Ceskoslovenske Spolecnosti Zoologicke, V31, P1; Burkett-Cadena ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017681; BYRD ELON E., 1938, JOUR PARASITOL, V24, P379, DOI 10.2307/3272115; BYRD ELON E., 1935, TRANS AMER MICROSC SOC, V54, P196, DOI 10.2307/3222133; Campbell RA, 1997, FOLIA PARASIT, V44, P199; Center NPWR, 1997, CHECKL AMPH SPEC ID; COHEN LM, 1980, J PARASITOL, V66, P362, DOI 10.2307/3280843; COMBES C, 1994, PARASITOLOGY, V109, pS3, DOI 10.1017/S0031182000085048; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dybdahl MF, 2004, J EVOLUTION BIOL, V17, P967, DOI 10.1111/j.1420-9101.2004.00759.x; FEILER W, 1988, PARASITOLOGY, V96, P493, DOI 10.1017/S0031182000080136; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; FLIER J, 1980, SCIENCE, V208, P503, DOI 10.1126/science.6245447; Fried B, 1997, PARASITOL RES, V83, P666, DOI 10.1007/s004360050316; Gosner K. L., 1960, Herpetologica, V16, P183; HAAS W, 1995, PARASITOL TODAY, V11, P468, DOI 10.1016/0169-4758(95)80066-2; Haas W, 2003, ZOOLOGY, V106, P349, DOI 10.1078/0944-2006-00125; HAAS W, 1994, J PARASITOL, V80, P345, DOI 10.2307/3283401; Haberl B, 2000, PARASITOLOGY, V120, P479, DOI 10.1017/S0031182099005697; Hanken J., 1981, Functional Photography, V16, P22; Heinicke MP, 2011, BIOL LETTERS, V7, P407, DOI 10.1098/rsbl.2010.1131; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Johnson PTJ, 2009, J ANIM ECOL, V78, P191, DOI 10.1111/j.1365-2656.2008.01455.x; Koehler AV, 2011, PARASITOLOGY, V138, P100, DOI 10.1017/S0031182010001022; Krist AC, 2000, PARASITOLOGY, V121, P395, DOI 10.1017/S0031182099006538; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lannoo Michael, 2005, P349; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Mouritsen KN, 2001, INT J PARASITOL, V31, P1417, DOI 10.1016/S0020-7519(01)00247-8; Olson PD, 2003, INT J PARASITOL, V33, P733, DOI 10.1016/S0020-7519(03)00049-3; Raffel TR, 2011, OECOLOGIA, V165, P1031, DOI 10.1007/s00442-010-1776-0; Raffel TR, 2008, TRENDS ECOL EVOL, V23, P610, DOI 10.1016/j.tree.2008.06.015; Reichard M, 2010, EVOLUTION, V64, P3047, DOI 10.1111/j.1558-5646.2010.01032.x; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rohr JR, 2010, FUNCT ECOL, V24, P1110, DOI 10.1111/j.1365-2435.2010.01709.x; Santoro M, 2011, DIS AQUAT ORGAN, V95, P233, DOI 10.3354/dao02365; Schell SC., 1970, KNOW TREMATODES; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Simpson JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007861; SMITHGILL SJ, 1979, AM NAT, V113, P563, DOI 10.1086/283413; StatSoft, 2009, STATISTICA; TALBOT S. BENTON, 1934, TRANS AMER MICROSC SOC, V53, P40, DOI 10.2307/3222335; TALBOT S. BENTON, 1933, PARASITOLOGY, V25, P518, DOI 10.1017/S0031182000019764; Taylor CN, 2004, CAN J ZOOL, V82, P701, DOI [10.1139/z04-037, 10.1139/Z04-037]; THOMAS J. D., 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P413; Todd BD, 2007, AM NAT, V170, P793, DOI 10.1086/521958; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Venesky MD, 2012, OECOLOGIA, V169, P23, DOI 10.1007/s00442-011-2171-1; Wassersug R.J., 1973, P273; Wilson WD, 2005, J PARASITOL, V91, P1040, DOI 10.1645/GE-465R.1	50	19	19	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51012	10.1371/journal.pone.0051012	http://dx.doi.org/10.1371/journal.pone.0051012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272084	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300015
J	Dawson, K; Wu, CT; Qi, XY; Nattel, S				Dawson, Kristin; Wu, Chia-Tung; Qi, Xiao Yan; Nattel, Stanley			Congestive Heart Failure Effects on Atrial Fibroblast Phenotype: Differences between Freshly-Isolated and Cultured Cells	PLOS ONE			English	Article							CARDIAC FIBROBLASTS; EXPRESSION PROFILES; GROWTH-FACTOR; FIBRILLATION; MATRIX; MYOFIBROBLASTS; RECRUITMENT; INFARCTION; MONOLAYERS; IMPROVES	Introduction: Fibroblasts are important in the atrial fibrillation (AF) substrate resulting from congestive heart failure (CHF). We previously noted changes in in vivo indices of fibroblast function in a CHF dog model, but could not detect changes in isolated cells. This study assessed CHF-induced changes in the phenotype of fibroblasts freshly isolated from control versus CHF dogs, and examined effects of cell culture on these differences. Methods/Results: Left-atrial fibroblasts were isolated from control and CHF dogs (ventricular tachypacing 240 bpmx2 weeks). Freshly-isolated fibroblasts were compared to fibroblasts in primary culture. Extracellular-matrix (ECM) gene-expression was assessed by qPCR, protein by Western blot, fibroblast morphology with immunocytochemistry, and K+-current with patch-clamp. Freshly-isolated CHF fibroblasts had increased expression-levels of collagen-1 (10-fold), collagen-3 (5-fold), and fibronectin-1 (3-fold) vs. control, along with increased cell diameter (13.4 +/- 0.4 mu m vs control 8.4 +/- 0.3 mu m) and cell spreading (shape factor 0.81 +/- 0.02 vs. control 0.87 +/- 0.02), consistent with an activated phenotype. Freshly-isolated control fibroblasts displayed robust tetraethylammonium (TEA)-sensitive K+-currents that were strongly downregulated in CHF. The TEA-sensitive K+-current differences between control and CHF fibroblasts were attenuated after 2-day culture and eliminated after 7 days. Similarly, cell-culture eliminated the ECM protein-expression and shape differences between control and CHF fibroblasts. Conclusions: Freshly-isolated CHF and control atrial fibroblasts display distinct ECM-gene and morphological differences consistent with in vivo pathology. Culture for as little as 48 hours activates fibroblasts and obscures the effects of CHF. These results demonstrate potentially-important atrial-fibroblast phenotype changes in CHF and emphasize the need for caution in relating properties of cultured fibroblasts to in vivo systems. Citation: Dawson K, Wu C-T, Qi XY, Nattel S (2012) Congestive Heart Failure Effects on Atrial Fibroblast Phenotype: Differences between Freshly-Isolated and Cultured Cells. PLoS ONE 7(12): e52032. doi: 10.1371/journal.pone.0052032	[Dawson, Kristin; Wu, Chia-Tung; Qi, Xiao Yan; Nattel, Stanley] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Dawson, Kristin; Nattel, Stanley] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Wu, Chia-Tung; Nattel, Stanley] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Wu, Chia-Tung] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Wu, Chia-Tung] Univ Taoyuan, Tao Yuan, Taiwan; [Wu, Chia-Tung; Nattel, Stanley] Univ Montreal, Montreal, PQ, Canada	Universite de Montreal; McGill University; Universite de Montreal; Chang Gung Memorial Hospital; Universite de Montreal	Nattel, S (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	stanley.nattel@icm-mhi.org		Nattel, Stanley/0000-0002-5565-3311	Quebec Heart and Stroke Foundation, Canadian Institutes of Health Research [MGP6957, MOP44365]; Fondation Leducq (European-North American Atrial Fibrillation Network, ENAFRA)	Quebec Heart and Stroke Foundation, Canadian Institutes of Health Research; Fondation Leducq (European-North American Atrial Fibrillation Network, ENAFRA)	Funding came from Quebec Heart and Stroke Foundation, Canadian Institutes of Health Research (MGP6957, MOP44365), Fondation Leducq (European-North American Atrial Fibrillation Network, ENAFRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agocha A, 1997, CELL TISSUE RES, V288, P87, DOI 10.1007/s004410050795; Ashihara T, 2012, CIRC RES, V110, P275, DOI 10.1161/CIRCRESAHA.111.255026; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Bellucci C, 2007, MOL MED, V13, P542, DOI 10.2119/2007-00034.Bellucci; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Burstein B, 2008, CIRCULATION, V117, P1630, DOI 10.1161/CIRCULATIONAHA.107.748053; Burstein B, 2009, CIRC RES, V105, P1213, DOI 10.1161/CIRCRESAHA.108.183400; Cardin S, 2007, CIRC RES, V100, P425, DOI 10.1161/01.RES.0000258428.09589.1a; Castella LF, 2010, J CELL SCI, V123, P1751, DOI 10.1242/jcs.066795; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Ehrlich JR, 2002, J CARDIOVASC ELECTR, V13, P399, DOI 10.1046/j.1540-8167.2002.00399.x; Fenelon G, 1996, PACE, V19, P95, DOI 10.1111/j.1540-8159.1996.tb04796.x; Flack EC, 2006, J MOL CELL CARDIOL, V40, P474, DOI 10.1016/j.yjmcc.2006.01.019; FRIES KM, 1994, CLIN IMMUNOL IMMUNOP, V72, P283, DOI 10.1006/clin.1994.1144; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Hanna N, 2004, CARDIOVASC RES, V63, P236, DOI 10.1016/j.cardiores.2004.03.026; Hinchcliff M, 2012, CLIN EXP RHEUMATOL, V30, pS86; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Jarvis MD, 2006, AM J PHYSIOL-HEART C, V291, pH1952, DOI 10.1152/ajpheart.00764.2005; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kupfer P, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-23; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; Maleckar MM, 2009, BIOPHYS J, V97, P2179, DOI [10.1016/j.bpj.2009.07.054, 10.1016/j.bpj.2009.07.0.54]; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Rohr S, 2011, J CARDIOVASC PHARM, V57, P389, DOI 10.1097/FJC.0b013e3182137e17; Rohr S, 2009, HEART RHYTHM, V6, P848, DOI 10.1016/j.hrthm.2009.02.038; Roncoroni L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-40; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Thompson SA, 2011, CIRCULATION, V123, P2083, DOI 10.1161/CIRCULATIONAHA.110.015057; Woodiwiss AJ, 2001, CIRCULATION, V103, P155; Xie YF, 2009, HEART RHYTHM, V6, P1641, DOI 10.1016/j.hrthm.2009.08.003; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52; Yperman J, 2004, TISSUE ENG, V10, P1368, DOI 10.1089/ten.2004.10.1368; Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329; ZEYDEL M, 1991, CELL TISSUE RES, V265, P353, DOI 10.1007/BF00398083; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	39	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52032	10.1371/journal.pone.0052032	http://dx.doi.org/10.1371/journal.pone.0052032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251678	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800131
J	Diz, R; Garland, A; Vincent, BG; Johnson, MC; Spidale, N; Wang, B; Tisch, R				Diz, Ramiro; Garland, Alaina; Vincent, Benjamin G.; Johnson, Mark C.; Spidale, Nicholas; Wang, Bo; Tisch, Roland			Autoreactive Effector/Memory CD4(+) and CD8(+) T Cells Infiltrating Grafted and Endogenous Islets in Diabetic NOD Mice Exhibit Similar T Cell Receptor Usage	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; PERIPHERAL-BLOOD; IMMUNE DYSREGULATION; STATISTICAL-ANALYSIS; GENE USAGE; FOLLOW-UP; MOUSE; REPERTOIRE; INSULITIS; MELLITUS	Islet transplantation provides a "cure'' for type 1 diabetes but is limited in part by recurrent autoimmunity mediated by beta cell-specific CD4(+) and CD8(+) T cells. Insight into the T cell receptor (TCR) repertoire of effector T cells driving recurrent autoimmunity would aid the development of immunotherapies to prevent islet graft rejection. Accordingly, we used a multi-parameter flow cytometry strategy to assess the TCR variable beta (V beta) chain repertoires of T cell subsets involved in autoimmune-mediated rejection of islet grafts in diabetic NOD mouse recipients. Naive CD4(+) and CD8(+) T cells exhibited a diverse TCR repertoire, which was similar in all tissues examined in NOD recipients including the pancreas and islet grafts. On the other hand, the effector/memory CD8(+) T cell repertoire in the islet graft was dominated by one to four TCR V beta chains, and specific TCR V beta chain usage varied from recipient to recipient. Similarly, islet graft- infiltrating effector/memory CD4(+) T cells expressed a limited number of prevalent TCR V beta chains, although generally TCR repertoire diversity was increased compared to effector/memory CD8(+) T cells. Strikingly, the majority of NOD recipients showed an increase in TCR V beta 12-bearing effector/memory CD4(+) T cells in the islet graft, most of which were proliferating, indicating clonal expansion. Importantly, TCR V beta usage by effector/memory CD4(+) and CD8(+) T cells infiltrating the islet graft exhibited greater similarity to the repertoire found in the pancreas as opposed to the draining renal lymph node, pancreatic lymph node, or spleen. Together these results demonstrate that effector/memory CD4(+) and CD8(+) T cells mediating autoimmune rejection of islet grafts are characterized by restricted TCR V beta chain usage, and are similar to T cells that drive destruction of the endogenous islets. Citation: Diz R, Garland A, Vincent BG, Johnson MC, Spidale N, et al. (2012) Autoreactive Effector/Memory CD4(+) and CD8(+) T Cells Infiltrating Grafted and Endogenous Islets in Diabetic NOD Mice Exhibit Similar T Cell Receptor Usage. PLoS ONE 7(12): e52054. doi:10.1371/journal.pone.0052054	[Diz, Ramiro; Garland, Alaina; Vincent, Benjamin G.; Johnson, Mark C.; Spidale, Nicholas; Wang, Bo; Tisch, Roland] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Tisch, R (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	rmtisch@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022		National Institutes of Health (NIH) grant [R01AI058014]; NIH training grant [5T32 AI07273]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058014, T32AI007273] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health (NIH) grant (R01AI058014, RT). AG, MCJ and NS were supported by a NIH training grant (5T32 AI07273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Berard M, 2002, IMMUNOLOGY, V106, P127, DOI 10.1046/j.1365-2567.2002.01447.x; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Brooks-Worrell B, 2001, J IMMUNOL, V166, P5265, DOI 10.4049/jimmunol.166.8.5265; BUDD RC, 1987, J IMMUNOL, V138, P3583; CANDEIAS S, 1991, P NATL ACAD SCI USA, V88, P6167, DOI 10.1073/pnas.88.14.6167; Ciupe SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000396; Codina-Busqueta E, 2011, J IMMUNOL, V186, P3787, DOI 10.4049/jimmunol.1002423; Coulombe M, 2004, ADV EXP MED BIOL, V552, P154; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; DREXLER K, 1993, IMMUNOL LETT, V37, P187, DOI 10.1016/0165-2478(93)90030-6; Eisenbarth GS, 2003, J CLIN INVEST, V111, P179, DOI 10.1172/JCI200317621; GALLEY KA, 1995, J IMMUNOL, V154, P2969; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; He M, 2005, BIOINFORMATICS, V21, P3697, DOI 10.1093/bioinformatics/bti600; Jager E, 2000, INT J CANCER, V86, P538; Kaufman DL, 2001, DIABETES, V50, P2459, DOI 10.2337/diabetes.50.11.2459; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kepler TB, 2005, BIOINFORMATICS, V21, P3394, DOI 10.1093/bioinformatics/bti539; Komagata Y, 1996, INT IMMUNOL, V8, P807, DOI 10.1093/intimm/8.6.807; Li J, 2010, BLOOD, V115, P3580, DOI 10.1182/blood-2009-10-246991; Li L, 2008, DIABETES, V57, P2099, DOI 10.2337/db08-0383; Li L, 2009, J IMMUNOL, V183, P7585, DOI 10.4049/jimmunol.0901587; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; Liu CP, 2006, ANN NY ACAD SCI, V1079, P161, DOI 10.1196/annals.1375.025; Liu ZJ, 2012, DIABETES, V61, P1160, DOI 10.2337/db11-0867; Mallone R, 2008, CURR DIABETES REP, V8, P101, DOI 10.1007/s11892-008-0019-9; Morice WG, 2004, AM J CLIN PATHOL, V121, P373, DOI 10.1309/3A32DTVMH640M2QA; NAGATA M, 1992, DIABETES, V41, P998, DOI 10.2337/diabetes.41.8.998; NAKANO N, 1991, J EXP MED, V173, P1091, DOI 10.1084/jem.173.5.1091; Pilch H, 2002, CLIN DIAGN LAB IMMUN, V9, P257, DOI 10.1128/CDLI.9.2.257-266.2002; Plesner A, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/979527; Prasad S, 2012, J AUTOIMMUN; Roep BO, 1999, J AUTOIMMUN, V13, P267, DOI 10.1006/jaut.1999.0312; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; SARUKHAN A, 1995, INT IMMUNOL, V7, P139, DOI 10.1093/intimm/7.1.139; SARUKHAN A, 1994, EUR J IMMUNOL, V24, P1750, DOI 10.1002/eji.1830240805; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; Tian J, 2001, J IMMUNOL, V166, P7144, DOI 10.4049/jimmunol.166.12.7144; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TOYODA H, 1992, IMMUNOL LETT, V32, P241, DOI 10.1016/0165-2478(92)90056-T; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vincent BG, 2010, J IMMUNOL, V184, P4196, DOI 10.4049/jimmunol.0903931; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WATERS SH, 1992, DIABETES, V41, P308, DOI 10.2337/diabetes.41.3.308; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wong CP, 2006, J IMMUNOL, V176, P1637, DOI 10.4049/jimmunol.176.3.1637; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Young EF, 2009, AUTOIMMUNITY, V42, P678, DOI 10.3109/08916930903213993; Zechel MA, 1998, IMMUNOL REV, V164, P111, DOI 10.1111/j.1600-065X.1998.tb01213.x	63	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52054	10.1371/journal.pone.0052054	http://dx.doi.org/10.1371/journal.pone.0052054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251685	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800137
J	Liu, J; Huang, J; Ma, SG				Liu, Jin; Huang, Jian; Ma, Shuangge			Analysis of Genome-Wide Association Studies with Multiple Outcomes Using Penalization	PLOS ONE			English	Article							COORDINATE DESCENT; MODEL SELECTION; COMPLEX TRAITS; REGRESSION; MICE	Genome-wide association studies have been extensively conducted, searching for markers for biologically meaningful outcomes and phenotypes. Penalization methods have been adopted in the analysis of the joint effects of a large number of SNPs (single nucleotide polymorphisms) and marker identification. This study is partly motivated by the analysis of heterogeneous stock mice dataset, in which multiple correlated phenotypes and a large number of SNPs are available. Existing penalization methods designed to analyze a single response variable cannot accommodate the correlation among multiple response variables. With multiple response variables sharing the same set of markers, joint modeling is first employed to accommodate the correlation. The group Lasso approach is adopted to select markers associated with all the outcome variables. An efficient computational algorithm is developed. Simulation study and analysis of the heterogeneous stock mice dataset show that the proposed method can outperform existing penalization methods. Citation: Liu J, Huang J, Ma S (2012) Analysis of Genome-Wide Association Studies with Multiple Outcomes Using Penalization. PLoS ONE 7(12): e51198. doi: 10.1371/journal.pone.0051198	[Liu, Jin; Ma, Shuangge] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Huang, Jian] Univ Iowa, Dept Biostat, Dept Stat & Actuarial Sci, Iowa City, IA USA	Yale University; University of Iowa	Liu, J (corresponding author), Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA.	jin.liu.jl2329@yale.edu; shuangge.ma@yale.edu		HUANG, Jian/0000-0002-5218-9269	NIH [CA165923, CA142774, CA120988]; NSF [DMS1208225]; NATIONAL CANCER INSTITUTE [R01CA142774, R21CA165923, R01CA120988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research of JL and SM has been partly supported by NIH awards CA165923 and CA142774. The research of JH is partially supported by NIH awards CA120988, CA142774 and NSF award DMS1208225. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breheny P, 2011, ANN APPL STAT, V5, P232, DOI 10.1214/10-AOAS388; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Chen K, 2012, J R STAT SOC B, V74, P203, DOI 10.1111/j.1467-9868.2011.01002.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; HUANG J., 2011, STAT SINICA IN PRESS; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Mazumder R, 2011, J AM STAT ASSOC, V106, P1125, DOI 10.1198/jasa.2011.tm09738; Meinshausen N, 2009, J AM STAT ASSOC, V104, P1671, DOI 10.1198/jasa.2009.tm08647; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wang LF, 2007, BIOINFORMATICS, V23, P1486, DOI 10.1093/bioinformatics/btm125; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Yuan M, 2007, J ROY STAT SOC B, V69, P329, DOI 10.1111/j.1467-9868.2007.00591.x	18	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51198	10.1371/journal.pone.0051198	http://dx.doi.org/10.1371/journal.pone.0051198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272092	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800030
J	Ritz, R; Scheidle, C; Noell, S; Roser, F; Schenk, M; Dietz, K; Strauss, WSL				Ritz, Rainer; Scheidle, Christian; Noell, Susan; Roser, Florian; Schenk, Martin; Dietz, Klaus; Strauss, Wolfgang S. L.			In Vitro Comparison of Hypericin and 5-Aminolevulinic Acid-Derived Protoporphyrin IX for Photodynamic Inactivation of Medulloblastoma Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; GLIOMA-CELLS; GLIOBLASTOMA-MULTIFORME; MOLECULAR EFFECTORS; MALIGNANT GLIOMA; SINGLET OXYGEN; FLUORESCENCE; THERAPY; ACCUMULATION; PORPHYRIN	Background: Hypericin (HYP) is a naturally occurring photosensitizer. Cellular uptake and photodynamic inactivation after incubation with this photosensitizer have neither been examined in medulloblastoma cells in vitro, nor compared with 5-aminolevulinic acid-derived protoporphyrin IX (5-ALA-derived PpIX). Methods: In 3 medulloblastoma cell lines (D283 Med, Daoy, and D341 Med) the time-and concentration-dependent intracellular accumulation of HYP and 5-ALA-derived PpIX was analyzed by fluorescence microscopy (FM) and FACS. Photocytotoxicity was measured after illumination at 595 nm (HYP) and 635 nm (5-ALA-derived PpIX) in D283 Med cells and compared to U373 MG glioma cells. Results: All medulloblastoma cell lines exhibited concentration-and time-dependent uptake of HYP. Incubation with HYP up to 10 mu M resulted in a rapid increase in fluorescence intensity, which peaked between 2 and 4 hours. 5-ALA-derived PpIX accumulation increased in D283 Med cells by 22% over baseline after 5-ALA incubation up to 1.2 mM. Photocytotoxicity of 5-ALA-derived PpIX was higher in D283 Med medulloblastoma compared to U373MG glioma. The LD50 [lethal dose (light dose that is required to reduce cell survival to 50% of control)] of 5-ALA-derived PpIX was 3.8 J/cm(2) in D283 Med cells versus 5.7 J/cm(2) in U373MG glioma cells. Photocytotoxicity of HYP in D283 Med cells was determined at 2.5 mu M after an incubation time of 2 h and an illumination wavelength of 595 nm. The LD50 value was 0.47 J/cm(2). Conclusion: By its 5-fold increase in fluorescence over autofluorescence levels HYP has excellent properties for tumor visualization in medulloblastomas. The high photocytotoxicity of HYP, compared to 5-ALA-derived PpIX, is convincingly demonstrated by its 8- to 13-fold lower LD50. Therefore HYP might be a promising molecule for intraoperative visualization and photodynamic treatment of medulloblastomas.	[Ritz, Rainer; Scheidle, Christian; Noell, Susan; Roser, Florian] Univ Tubingen, Dept Neurosurg, Tubingen, Germany; [Schenk, Martin] Univ Tubingen, Dept Gen Visceral & Transplant Surg, Tubingen, Germany; [Dietz, Klaus] Univ Tubingen, Dept Med Biometry, Tubingen, Germany; [Strauss, Wolfgang S. L.] Univ Ulm, Inst Lasertechnol Med & Messtech, Ulm, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ulm University	Ritz, R (corresponding author), Univ Hosp Giessen & Marburg, Dept Neurosurg, Marburg, Germany.	rainer_ritz@hotmail.com	Dietz, Klaus/R-9268-2016	Dietz, Klaus/0000-0001-8503-9737; Roser, Florian/0000-0002-7854-6789				Ali SM, 2002, INT J ONCOL, V21, P531; Amo T, 2009, CELL BIOCHEM FUNCT, V27, P503, DOI 10.1002/cbf.1603; Bhuvaneswari R, 2007, INT J MOL MED, V20, P421; Blank M, 2004, INT J CANCER, V111, P596, DOI 10.1002/ijc.20285; Blank M, 2001, ONCOL RES, V12, P409; Blank M, 2001, PHOTOCHEM PHOTOBIOL, V74, P120, DOI 10.1562/0031-8655(2001)074&lt;0120:ACAOHI&gt;2.0.CO;2; Boiy A, 2011, J PHOTOCH PHOTOBIO B, V102, P123, DOI 10.1016/j.jphotobiol.2010.09.012; Buytaert E, 2008, ONCOGENE, V27, P1916, DOI 10.1038/sj.onc.1210825; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Carre J, 1999, CELL MOL BIOL, V45, P433; Chen B, 2000, CANCER LETT, V150, P111, DOI 10.1016/S0304-3835(99)00381-X; COULDWELL WT, 1991, NEUROSURGERY, V29, P880, DOI 10.1227/00006123-199112000-00013; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; DIWU Z, 1995, PHOTOCHEM PHOTOBIOL, V61, P529, DOI 10.1111/j.1751-1097.1995.tb09903.x; DIWU ZJ, 1993, FREE RADICAL BIO MED, V14, P209, DOI 10.1016/0891-5849(93)90012-J; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Ehrenberg B, 1998, PHOTOCHEM PHOTOBIOL, V68, P135, DOI 10.1111/j.1751-1097.1998.tb02479.x; Eleouet S, 2000, NEUROL RES, V22, P361, DOI 10.1080/01616412.2000.11740685; Eljamel MS, 2008, LASER MED SCI, V23, P361, DOI 10.1007/s10103-007-0494-2; FAUTREL A, 1991, TOXICOL IN VITRO, V5, P543, DOI 10.1016/0887-2333(91)90090-Z; Hadjur C, 1996, PHOTOCHEM PHOTOBIOL, V64, P375, DOI 10.1111/j.1751-1097.1996.tb02474.x; Hendrickx N, 2005, BIOCHEM BIOPH RES CO, V337, P928, DOI 10.1016/j.bbrc.2005.09.135; Huntosova V, 2012, PHOTOCH PHOTOBIO SCI, V11, P1428, DOI 10.1039/c2pp05409d; Jacquez John A., 1985, COMPARTMENTAL ANAL B; Karioti A, 2010, INT J MOL SCI, V11, P562, DOI 10.3390/ijms11020562; Kemmner W, 2008, FASEB J, V22, P500, DOI 10.1096/fj.07-8888com; Kubin A, 2005, CURR PHARM DESIGN, V11, P233, DOI 10.2174/1381612053382287; Luksiene Zivile, 2003, Medicina (Kaunas), V39, P677; Martinez-Poveda B, 2005, EUR J PHARMACOL, V516, P97, DOI 10.1016/j.ejphar.2005.03.047; Moan J, 1997, INT J CANCER, V70, P90, DOI 10.1002/(SICI)1097-0215(19970106)70:1<90::AID-IJC14>3.0.CO;2-H; Olivo M, 2006, CURR CLIN PHARMACOL, V1, P217, DOI 10.2174/157488406778249370; Packer RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1419, DOI 10.1001/archneur.65.11.1419; Riesenberg R, 1996, EUR J CANCER, V32A, P328, DOI 10.1016/0959-8049(95)00548-X; Ritz R, 2005, INT J ONCOL, V27, P1543; Ritz R, 2007, INT J ONCOL, V30, P659; Sailer R, 2007, PHOTOCH PHOTOBIO SCI, V6, P145, DOI 10.1039/b611715e; Sattler S, 1997, J PHARM SCI, V86, P1120, DOI 10.1021/js970004a; SCHNECKENBURGER H, 1988, J PHOTOCH PHOTOBIO B, V2, P355, DOI 10.1016/1011-1344(88)85054-1; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 1998, J PHOTOCH PHOTOBIO B, V45, P160, DOI 10.1016/S1011-1344(98)00176-6; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stylli SS, 2004, J CLIN NEUROSCI, V11, P584, DOI 10.1016/j.jocn.2004.02.001; TAKAHASHI I, 1989, BIOCHEM BIOPH RES CO, V165, P1207, DOI 10.1016/0006-291X(89)92730-7; Theodossiou T, 2004, PHOTOCHEM PHOTOBIOL, V80, P438, DOI 10.1562/2004-06-30-RA-220.1; Theodossiou TA, 2009, MOL PHARMACEUT, V6, P1775, DOI 10.1021/mp900166q; THOMAS C, 1992, PHOTOCHEM PHOTOBIOL, V55, P831, DOI 10.1111/j.1751-1097.1992.tb08531.x; THOMAS C, 1992, PHOTOCHEM PHOTOBIOL, V55, P47, DOI 10.1111/j.1751-1097.1992.tb04208.x; Uberriegler KP, 1995, PHOTOCHEM PHOTOBIOL, V62, P1052; UTSUMI T, 1995, ARCH BIOCHEM BIOPHYS, V316, P493, DOI 10.1006/abbi.1995.1065; Uzdensky AB, 2001, LASER MED SCI, V16, P276, DOI 10.1007/PL00011364; Van de Putte M, 2006, INT J ONCOL, V28, P655; Vandenbogaerde AL, 1998, J PHOTOCH PHOTOBIO B, V45, P87, DOI 10.1016/S1011-1344(98)00163-8; Vandenbogaerde AL, 1997, J PHOTOCH PHOTOBIO B, V38, P136, DOI 10.1016/S1011-1344(96)07446-5; WyssDesserich MT, 1996, BIOCHEM BIOPH RES CO, V224, P819, DOI 10.1006/bbrc.1996.1106	54	27	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51974	10.1371/journal.pone.0051974	http://dx.doi.org/10.1371/journal.pone.0051974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251668	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800123
J	Vetukuri, RR; Asman, AKM; Tellgren-Roth, C; Jahan, SN; Reimegard, J; Fogelqvist, J; Savenkov, E; Soderbom, F; Avrova, AO; Whisson, SC; Dixelius, C				Vetukuri, Ramesh R.; Asman, Anna K. M.; Tellgren-Roth, Christian; Jahan, Sultana N.; Reimegard, Johan; Fogelqvist, Johan; Savenkov, Eugene; Soderbom, Fredrik; Avrova, Anna O.; Whisson, Stephen C.; Dixelius, Christina			Evidence for Small RNAs Homologous to Effector-Encoding Genes and Transposable Elements in the Oomycete Phytophthora infestans	PLOS ONE			English	Article							LATE BLIGHT RESISTANCE; ENDOGENOUS SIRNAS; STRUCTURAL BASIS; INTERFERING RNA; GENOME; PLANT; PATHOGEN; MICRORNAS; DIVERSE; EVOLUTION	Phytophthora infestans is the oomycete pathogen responsible for the devastating late blight disease on potato and tomato. There is presently an intense research focus on the role(s) of effectors in promoting late blight disease development. However, little is known about how they are regulated, or how diversity in their expression may be generated among different isolates. Here we present data from investigation of RNA silencing processes, characterized by non-coding small RNA molecules (sRNA) of 19-40 nt. From deep sequencing of sRNAs we have identified sRNAs matching numerous RxLR and Crinkler (CRN) effector protein genes in two isolates differing in pathogenicity. Effector gene-derived sRNAs were present in both isolates, but exhibited marked differences in abundance, especially for CRN effectors. Small RNAs in P. infestans grouped into three clear size classes of 21, 25/26 and 32 nt. Small RNAs from all size classes mapped to RxLR effector genes, but notably 21 nt sRNAs were the predominant size class mapping to CRN effector genes. Some effector genes, such as PiAvr3a, to which sRNAs were found, also exhibited differences in transcript accumulation between the two isolates. The P. infestans genome is rich in transposable elements, and the majority of sRNAs of all size classes mapped to these sequences, predominantly to long terminal repeat (LTR) retrotransposons. RNA silencing of Dicer and Argonaute genes provided evidence that generation of 21 nt sRNAs is Dicer-dependent, while accumulation of longer sRNAs was impacted by silencing of Argonaute genes. Additionally, we identified six microRNA (miRNA) candidates from our sequencing data, their precursor sequences from the genome sequence, and target mRNAs. These miRNA candidates have features characteristic of both plant and metazoan miRNAs. Citation: Vetukuri RR, Asman AKM, Tellgren-Roth C, Jahan SN, Reimegard J, et al. (2012) Evidence for Small RNAs Homologous to Effector-Encoding Genes and Transposable Elements in the Oomycete Phytophthora infestans. PLoS ONE 7(12): e51399. doi:10.1371/journal.pone.0051399	[Vetukuri, Ramesh R.; Asman, Anna K. M.; Jahan, Sultana N.; Fogelqvist, Johan; Savenkov, Eugene; Dixelius, Christina] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Plant Biol & Forest Genet, Uppsala, Sweden; [Vetukuri, Ramesh R.; Asman, Anna K. M.; Jahan, Sultana N.; Fogelqvist, Johan; Savenkov, Eugene; Dixelius, Christina] Linnean Ctr Plant Biol, Uppsala, Sweden; [Tellgren-Roth, Christian] Uppsala Univ, Rudbeck Lab, SciLifeLab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Reimegard, Johan] KTH, Sch Biotechnol, SciLife Lab, Solna, Sweden; [Soderbom, Fredrik] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [Avrova, Anna O.; Whisson, Stephen C.] James Hutton Inst, Dundee, Scotland	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; SciLifeLab; Uppsala University; Royal Institute of Technology; SciLifeLab; Uppsala University; James Hutton Institute	Vetukuri, RR (corresponding author), Swedish Univ Agr Sci, Uppsala BioCtr, Dept Plant Biol & Forest Genet, Uppsala, Sweden.	Ramesh.Vetukuri@slu.se		Tellgren-Roth, Christian/0000-0003-0502-3693; Savenkov, Eugene/0000-0002-5802-5089	Formas(Forskningsradet for miljo, areella naringar och samhallsbyggande); SJV(sverige jordbruksverket); SLF(Stiftelsen Lantbruksforskning); SLU(Sveriges Lantbruks universitet); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Biotechnology and Biological Sciences Research Council (BBSRC)	Formas(Forskningsradet for miljo, areella naringar och samhallsbyggande); SJV(sverige jordbruksverket); SLF(Stiftelsen Lantbruksforskning); SLU(Sveriges Lantbruks universitet); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Formas(Forskningsradet for miljo, areella naringar och samhallsbyggande), SJV(sverige jordbruksverket), SLF(Stiftelsen Lantbruksforskning) and SLU(Sveriges Lantbruks universitet) supported this work. SCW and AOA were supported by grants from the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD) and the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Avrova AO, 2008, CELL MICROBIOL, V10, P2271, DOI 10.1111/j.1462-5822.2008.01206.x; Avrova AO, 2003, FUNGAL GENET BIOL, V40, P4, DOI 10.1016/S1087-1845(03)00063-X; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bozkurt TO, 2011, P NATL ACAD SCI USA, V108, P20832, DOI 10.1073/pnas.1112708109; Braun L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000920; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Cooke D. E. L., 2007, Proceedings of the Tenth Workshop of an European Network for Development of an Integrated Control Strategy of Potato Late Blight, Bologna, Italy, 2-5 May 2007, P145; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; de Haro JP, 2009, EUKARYOT CELL, V8, P1486, DOI 10.1128/EC.00191-09; Dick MW, 2001, MYCOTA, V7, P39; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Flier WG, 2001, PLANT PATHOL, V50, P292, DOI 10.1046/j.1365-3059.2001.00574.x; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grenville-Briggs LJ, 2005, FUNGAL GENET BIOL, V42, P244, DOI 10.1016/j.fgb.2004.11.009; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Harper JT, 2005, INT J SYST EVOL MICR, V55, P487, DOI 10.1099/ijs.0.63216-0; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Judelson HS, 2007, EUKARYOT CELL, V6, P1200, DOI 10.1128/EC.00311-06; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Kamoun S, 1999, FUNGAL GENET BIOL, V28, P94, DOI 10.1006/fgbi.1999.1166; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Kojima KK, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-12; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kreuze JF, 2005, J VIROL, V79, P7227, DOI 10.1128/JVI.79.11.7227-7238.2005; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li GC, 2011, MOL PLANT MICROBE IN, V24, P1132, DOI 10.1094/MPMI-11-10-0276; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nicolas FE, 2003, EMBO J, V22, P3983, DOI 10.1093/emboj/cdg384; Norden-Krichmar TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022870; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Tang G, 2004, BIOCH DISSECTION RNA, P223; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Tsui CKM, 2009, MOL PHYLOGENET EVOL, V50, P129, DOI 10.1016/j.ympev.2008.09.027; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; van West P, 1999, MOL CELL, V3, P339, DOI 10.1016/S1097-2765(00)80461-X; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vetukuri RR, 2011, FUNGAL BIOL-UK, V115, P1225, DOI 10.1016/j.funbio.2011.08.007; Vetukuri RR, 2011, MOL PLANT PATHOL, V12, P772, DOI [10.1111/J.1364-3703.2011.00710.X, 10.1111/j.1364-3703.2011.00710.x]; Vleeshouwers VGAA, 2011, ANNU REV PHYTOPATHOL, V49, P507, DOI 10.1146/annurev-phyto-072910-095326; Wang H, 2011, PLANT J, V67, P292, DOI 10.1111/j.1365-313X.2011.04594.x; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010; Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI 10.1111/J.1364-3703.2005.00272.X; Whisson SC, 2005, FUNGAL GENET BIOL, V42, P351, DOI 10.1016/j.fgb.2005.01.004; Whisson Stephen, 2012, Mob Genet Elements, V2, P110; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Xie FL, 2010, BIOINFORMATICS, V26, P3002, DOI 10.1093/bioinformatics/btq568; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	100	52	57	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51399	10.1371/journal.pone.0051399	http://dx.doi.org/10.1371/journal.pone.0051399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272103	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800044
J	Fujita-Jimbo, E; Yu, ZL; Li, H; Yamagata, T; Mori, M; Momoi, T; Momoi, MY				Fujita-Jimbo, Eriko; Yu, Zhi-Ling; Li, Hong; Yamagata, Takanori; Mori, Masato; Momoi, Takashi; Momoi, Mariko Y.			Mutation in Parkinson Disease-Associated, G-Protein-Coupled Receptor 37 (GPR37/PaelR) Is Related to Autism Spectrum Disorder	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROPEPTIDE HEAD ACTIVATOR; PEPTIDE RECEPTOR; PAEL RECEPTOR; BRAIN; GPR37; OXYTOCIN; CLONING; GENES; LOCUS	Little is known about the molecular pathogenesis of Autism spectrum disorder (ASD), a neurodevelopmental disorder. Here we identified two mutations in the G-protein-coupled receptor 37 gene (GPR37) localized on chromosome 7q31-33, called the AUTS1 region, of ASD patients; 1585-1587 ttc del (Del312F) in one Japanese patient and G2324A (R558Q) in one Caucasian patient. The Del312F was located in the conserved transmembrane domain, and the R558Q was located in a conserved region just distal to the last transmembrane domain. In addition, a potential ASD-related GPR37 variant, T589M, was found in 7 affected Caucasian men from five different families. Our results suggested that some alleles in GPR37 were related to the deleterious effect of ASD. GPR37 is associated with the dopamine transporter to modulate dopamine uptake, and regulates behavioral responses to dopaminergic drugs. Thus, dopaminergic neurons may be involved in the ASD. However, we also detected the Del321F mutation in the patient's unaffected father and R558Q in not only an affected brother but also an unaffected mother. The identification of unaffected parents that carried the mutated alleles suggested that the manifestation of ASD was also influenced by factors other than these mutations, including endoplasmic reticulum stress of the mutated proteins or gender. Our study will provide the new insight into the molecular pathogenesis of ASD.	[Fujita-Jimbo, Eriko; Yu, Zhi-Ling; Li, Hong; Yamagata, Takanori; Mori, Masato; Momoi, Mariko Y.] Jichi Med Univ, Dept Pediat, Shimotsukeshi, Tochigi, Japan; [Yu, Zhi-Ling] China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Liaoning, Peoples R China; [Li, Hong] Detroit Med Ctr, Dept Pediat, Detroit, MI USA; [Momoi, Takashi] Int Univ Hlth & Welf, Ctr Med Sci, Ohtawara, Tochigi, Japan	Jichi Medical University; China Medical University; Detroit Medical Center; International University of Health & Welfare	Momoi, MY (corresponding author), Jichi Med Univ, Dept Pediat, Shimotsukeshi, Tochigi, Japan.	mymomoi@jichi.ac.jp			National Institute of Mental Health [MH64547]; Ministries of Education, Science and Culture, Japan; Ministry of Health, Labour and Welfare, Japan [KAKENHI 21200011, 22591135, 23390275, 24500386]; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ministries of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank the patients and their families for their participation. And also, we gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium* and the participating AGRE families. The Autism Genetic Resource Exchange is a program of Cure Autism Now and is supported, in part, by grant MH64547 from the National Institute of Mental Health to Daniel H. Geschwind (PI). This work was supported by the grants from the Ministries of Education, Science and Culture, Japan, the Ministry of Health, Labour and Welfare, Japan (KAKENHI 21200011, 22591135, 23390275, 24500386), and Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Asato MR, 2004, J CHILD NEUROL, V19, P241, DOI 10.1177/088307380401900401; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Curatolo Paolo, 2002, Eur J Paediatr Neurol, V6, P15, DOI 10.1053/ejpn.2001.0538; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fujita E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.23; Hutcheson HB, 2003, AM J MED GENET B, V117B, P90, DOI 10.1002/ajmg.b.10033; Imai Y, 2007, NEUROSCI RES, V59, P413, DOI 10.1016/j.neures.2007.08.005; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kawasawa Y, 2003, GENOME RES, V13, P1466, DOI 10.1101/gr.1087603; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kouroku Y, 1998, BIOCHEM BIOPH RES CO, V247, P780, DOI 10.1006/bbrc.1998.8815; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lim MM, 2005, INT J DEV NEUROSCI, V23, P235, DOI 10.1016/j.ijdevneu.2004.05.006; Marazziti D, 2004, P NATL ACAD SCI USA, V101, P10189, DOI 10.1073/pnas.0403661101; Marazziti D, 1998, GENOMICS, V53, P315, DOI 10.1006/geno.1998.5433; Marazziti D, 1997, GENOMICS, V45, P68, DOI 10.1006/geno.1997.4900; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Momoi T, 2010, CELL BIOL INT, V34, P13, DOI 10.1042/CBI20090250; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; ODAKA A, 1995, BIOCHEM BIOPH RES CO, V206, P821, DOI 10.1006/bbrc.1995.1117; Rezgaoui M, 2006, J CELL SCI, V119, P542, DOI 10.1242/jcs.02766; SCHALLER HC, 1989, DEVELOPMENT, V107, P99; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takahashi R, 2003, J NEUROL, V250, P25, DOI 10.1007/s00415-003-1305-8; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107	34	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51155	10.1371/journal.pone.0051155	http://dx.doi.org/10.1371/journal.pone.0051155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251443	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200065
J	Horikoshi, M; Goto, D; Segawa, S; Yoshiga, Y; Iwanami, K; Inoue, A; Tanaka, Y; Matsumoto, I; Sumida, T				Horikoshi, Masanobu; Goto, Daisuke; Segawa, Seiji; Yoshiga, Yohei; Iwanami, Keiichi; Inoue, Asuka; Tanaka, Yuki; Matsumoto, Isao; Sumida, Takayuki			Activation of Invariant NKT Cells with Glycolipid Ligand alpha-Galactosylceramide Ameliorates Glucose-6-Phosphate Isomerase Peptide-Induced Arthritis	PLOS ONE			English	Article							KILLER T-CELLS; COLLAGEN-INDUCED ARTHRITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INDUCED JOINT INFLAMMATION; RHEUMATOID-ARTHRITIS; IFN-GAMMA; MICE; INHIBIT; IMMUNIZATION; PROTECTS	Objective: Invariant natural killer T (iNKT) cells regulate collagen-induced arthritis (CIA) when activated by their potent glycolipid ligand, alpha-galactosylceramide (alpha-GalCer). Glucose-6-phosphate isomerase (GPI)-induced arthritis is a closer model of human rheumatoid arthritis based on its association with CD4+ T cells and cytokines such as TNF-alpha and IL-6 than CIA. Dominant T cell epitope peptide of GPI (GPI325-339) can induce arthritis similar to GPI-induced arthritis. In this study, we investigated the roles of activation of iNKT cells by alpha-GalCer in GPI peptide-induced arthritis. Methods: Arthritis was induced in susceptible DBA1 mice with GPI peptide and its severity was assessed clinically. The arthritic mice were treated with either the vehicle (DMSO) or alpha-GalCer. iNKT cells were detected in draining lymph nodes (dLNs) by flow cytometry, while serum anti-GPI antibody levels were measured by enzyme-linked immunosorbent assay. To evaluate GPI peptide-specific cytokine production from CD4+ T cells, immunized mice were euthanized and dLN CD4+ cells were re-stimulated by GPI-peptide in the presence of antigen-presenting cells. Results: alpha-GalCer induced iNKT cell expansion in dLNs and significantly decreased the severity of GPI peptide-induced arthritis. In alpha-GalCer-treated mice, anti-GPI antibody production (total IgG, IgG1, IgG2b) and IL-17, IFN-gamma, IL-2, and TNF-alpha produced by GPI peptide-specific T cells were significantly suppressed at day 10. Moreover, GPI-reactive T cells from mice immunized with GPI and alpha-GalCer did not generate any cytokines even when these cells were co-cultured with APC from mice immunized with GPI alone. In vitro depletion of iNKT cells did not alter the suppressive effect of alpha-GalCer on CD4+ T cells. Conclusion: alpha-GalCer significantly suppressed GPI peptide-induced arthritis through the suppression of GPI-specific CD4+ T cells.	[Horikoshi, Masanobu; Goto, Daisuke; Segawa, Seiji; Iwanami, Keiichi; Inoue, Asuka; Tanaka, Yuki; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki, Japan; [Yoshiga, Yohei] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of Tsukuba; University of New Mexico	Sumida, T (corresponding author), Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki, Japan.	tsumida@md.tsukuba.ac.jp	ç°ä, ææ/Q-2571-2019	ç°ä, ææ/0000-0001-9822-9804	Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labour and Welfare and from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bruns L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2777; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Chiba A, 2005, ARTHRITIS RHEUM-US, V52, P1941, DOI 10.1002/art.21056; Coppieters K, 2007, J IMMUNOL, V179, P2300, DOI 10.4049/jimmunol.179.4.2300; Diana J, 2011, J EXP MED, V208, P729, DOI 10.1084/jem.20101692; Frey O, 2011, J AUTOIMMUN, V36, P161, DOI 10.1016/j.jaut.2010.12.006; Furlan R, 2003, EUR J IMMUNOL, V33, P1830, DOI 10.1002/eji.200323885; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hua J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027038; Iwanami K, 2008, ARTHRITIS RHEUM-US, V58, P754, DOI 10.1002/art.23222; Iwanami K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2854; Iwanami K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2545; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kaieda S, 2007, ARTHRITIS RHEUM, V56, P1836, DOI 10.1002/art.22714; Kim HY, 2005, J EXP MED, V201, P41, DOI 10.1084/jem.20041400; Kim HY, 2006, J CLIN INVEST, V116, P2484, DOI 10.1172/JCI27219; Mars LT, 2009, P NATL ACAD SCI USA, V106, P6238, DOI 10.1073/pnas.0809317106; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2437; Miellot A, 2005, EUR J IMMUNOL, V35, P3704, DOI 10.1002/eji.200535235; Monteiro M, 2010, J IMMUNOL, V185, P2157, DOI 10.4049/jimmunol.1000359; Oh SJ, 2011, J IMMUNOL, V186, P6815, DOI 10.4049/jimmunol.1003916; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Schubert D, 2004, J IMMUNOL, V172, P4503, DOI 10.4049/jimmunol.172.7.4503; STRUYK L, 1995, ARTHRITIS RHEUM-US, V38, P577, DOI 10.1002/art.1780380502; Tripp CH, 2009, J IMMUNOL, V182, P7644, DOI 10.4049/jimmunol.0900134; Yoshiga Y, 2011, CLIN EXP IMMUNOL, V164, P236, DOI 10.1111/j.1365-2249.2011.04369.x	29	18	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51215	10.1371/journal.pone.0051215	http://dx.doi.org/10.1371/journal.pone.0051215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251456	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200071
J	Saunders, DN; Tindall, EA; Shearer, RF; Roberson, J; Decker, A; Wilson, JA; Hayes, VM				Saunders, Darren N.; Tindall, Elizabeth A.; Shearer, Robert F.; Roberson, Jacquelyn; Decker, Amy; Wilson, Jean Amos; Hayes, Vanessa M.			A Novel SERPINA1 Mutation Causing Serum Alpha(1)-Antitrypsin Deficiency	PLOS ONE			English	Article							DISEASE; SERPINOPATHIES; DIVERSITY; GENE	Mutations in the SERPINA1 gene can cause deficiency in the circulating serine protease inhibitor alpha(1)-Antitrypsin (alpha(1)AT). alpha(1)AT deficiency is the major contributor to pulmonary emphysema and liver disease in persons of European ancestry, with a prevalence of 1 in 2500 in the USA. We present the discovery and characterization of a novel SERPINA1 mutant from an asymptomatic Middle Eastern male with circulating alpha(1)AT deficiency. This 49 base pair deletion mutation (T379 Delta), originally mistyped by IEF, causes a frame-shift replacement of the last sixteen alpha(1)AT residues and adds an extra twenty-four residues. Functional analysis showed that the mutant protein is not secreted and prone to intracellular aggregation.	[Saunders, Darren N.; Tindall, Elizabeth A.; Shearer, Robert F.; Hayes, Vanessa M.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Saunders, Darren N.; Shearer, Robert F.] Kinghorn Canc Ctr, Sydney, NSW, Australia; [Saunders, Darren N.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Roberson, Jacquelyn; Decker, Amy] Henry Ford Hosp, Detroit, MI 48202 USA; [Wilson, Jean Amos] Quest Diagnost Nichols Inst, Valencia, CA USA	Garvan Institute of Medical Research; University of New South Wales Sydney; Henry Ford Health System; Henry Ford Hospital; Nichols Institute	Saunders, DN (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	d.saunders@garvan.org.au	Hayes, Vanessa/W-3728-2019; Hayes, Vanessa M/GPP-2807-2022	Hayes, Vanessa M/0000-0002-4524-7280; Saunders, Darren/0000-0003-0924-0513	Cancer Institute New South Wales; National Health and Medical Research Council of Australia	Cancer Institute New South Wales; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by grants from the Cancer Institute New South Wales as a Career Development Fellowship (DNS and VMH) and a National Health and Medical Research Council of Australia training Fellowship (EAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco I, 2001, CLIN GENET, V60, P431, DOI 10.1034/j.1399-0004.2001.600605.x; Bottomley SP, 2011, EMBO REP, V12, P983, DOI 10.1038/embor.2011.187; de Serres FJ, 2003, ENVIRON HEALTH PERSP, V111, P1851, DOI 10.1289/ehp.6511; Dickens JA, 2011, DRUG DES DEV THER, V5, P391, DOI 10.2147/DDDT.S14018; Ekeowa UI, 2009, CLIN SCI, V116, P837, DOI 10.1042/CS20080484; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Greene Catherine M, 2010, Proc Am Thorac Soc, V7, P346, DOI 10.1513/pats.201002-019AW; Hayes V M, 1999, Nucleic Acids Res, V27, pe29, DOI 10.1093/nar/27.20.e29; Hayes VM, 2003, HUM MUTAT, V22, P59, DOI 10.1002/humu.10231; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lomas DA, 2005, CLIN MED, V5, P249, DOI 10.7861/clinmedicine.5-3-249; Luisetti M, 2004, THORAX, V59, P164, DOI 10.1136/thorax.2003.006494; Rachelefsky G, 2008, J ALLERGY CLIN IMMUN, V121, P833, DOI 10.1016/j.jaci.2007.12.1183; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Tsutsui Y, 2012, P NATL ACAD SCI USA, V109, P4467, DOI 10.1073/pnas.1109125109; Wu Y, 1998, NUCLEIC ACIDS RES, V26, P5432, DOI 10.1093/nar/26.23.5432; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Zaimidou S, 2009, HUM MUTAT, V30, P308, DOI 10.1002/humu.20857	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51762	10.1371/journal.pone.0051762	http://dx.doi.org/10.1371/journal.pone.0051762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251618	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200163
J	Zheng, YM; Zhu, XJ; Zhou, PZ; Lan, X; Xu, HY; Li, M; Gao, ZB				Zheng, Yueming; Zhu, Xuejing; Zhou, Pingzheng; Lan, Xi; Xu, Haiyan; Li, Min; Gao, Zhaobing			Hexachlorophene Is a Potent KCNQ1/KCNE1 Potassium Channel Activator Which Rescues LQTs Mutants	PLOS ONE			English	Article							LONG-QT-SYNDROME; I-KS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; KV7 CHANNELS; MUTATIONS; KVLQT1; ISK; KCNQ1; ARRHYTHMIAS; MECHANISMS	The voltage-gated KCNQ1 potassium channel is expressed in cardiac tissues, and coassembly of KCNQ1 with an auxiliary KCNE1 subunit mediates a slowly activating current that accelerates the repolarization of action potential in cardiomyocytes. Mutations of KCNQ1 genes that result in reduction or loss of channel activity cause prolongation of repolarization during action potential, thereby causing long QT syndrome (LQTs). Small molecule activators of KCNQ1/KCNE1 are useful both for understanding the mechanism of the complex activity and for developing therapeutics for LQTs. In this study we report that hexachlorophene (HCP), the active component of the topical anti-infective prescription drug pHisoHex, is a KCNQ1/KCNE1 activator. HCP potently increases the current amplitude of KCNQ1/KCNE1 expressed by stabilizing the channel in an open state with an EC50 of 4.61 +/- 1.29 mu M. Further studies in cardiomyocytes showed that HCP significantly shortens the action potential duration at 1 mu M. In addition, HCP is capable of rescuing the loss of function of the LQTs mutants caused by either impaired activation gating or phosphatidylinositol-4,5-bisphosphate (PIP2) binding affinity. Our results indicate HCP is a novel KCNQ1/KCNE1 activator and may be a useful tool compound for the development of LQTs therapeutics.	[Zheng, Yueming; Zhu, Xuejing; Zhou, Pingzheng; Lan, Xi; Xu, Haiyan; Li, Min; Gao, Zhaobing] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Shanghai 200031, Peoples R China; [Li, Min] Johns Hopkins Univ, Dept Neurosci, High Throughput Biol Ctr, Baltimore, MD USA; [Li, Min] Johns Hopkins Univ, Sch Med, Johns Hopkins Ion Channel Ctr, Baltimore, MD USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Johns Hopkins University; Johns Hopkins University	Li, M (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Shanghai 200031, Peoples R China.	minli@jhmi.edu; zb.gao@mail.shcnc.ac.cn			National Natural Science Foundation of China (NSFC) [81072579]; NIH [MH084691, GM070959]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Natural Science Foundation of China (NSFC, 81072579) and NIH grants (MH084691, GM070959). NSFC and NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol I, 1999, EMBO J, V18, P4137, DOI 10.1093/emboj/18.15.4137; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bianchi L, 2000, AM J PHYSIOL-HEART C, V279, pH3003, DOI 10.1152/ajpheart.2000.279.6.H3003; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Busch AE, 1997, BRIT J PHARMACOL, V122, P187, DOI 10.1038/sj.bjp.0701434; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Franqueza L, 1999, J BIOL CHEM, V274, P21063, DOI 10.1074/jbc.274.30.21063; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Gribkoff VK, 2008, EXPERT OPIN THER TAR, V12, P565, DOI 10.1517/14728222.12.5.565 ; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Herbert Ernest, 2002, Med Sci Monit, V8, pRA240; Hsu JTA, 2004, FEBS LETT, V574, P116, DOI 10.1016/j.febslet.2004.08.015; Jia CX, 2011, PHARMACOLOGY, V87, P297, DOI 10.1159/000327384; JUNGERMA.E, 1968, J AM OIL CHEM SOC, V45, P345, DOI 10.1007/BF02667108; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Mruk K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004236; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Park S, 2006, MOL PHARMACOL, V70, P960, DOI 10.1124/mol.106.024729; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Salata JJ, 1998, MOL PHARMACOL, V54, P220, DOI 10.1124/mol.54.1.220; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Seebohm G, 2003, CIRC RES, V93, P941, DOI 10.1161/01.RES.0000102866.67863.2B; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Vatta M, 2000, CURR OPIN CARDIOL, V15, P12, DOI 10.1097/00001573-200001000-00003; Wickenden AD, 2009, CURR PHARM DESIGN, V15, P1773, DOI 10.2174/138161209788186326; Wollnik B, 1997, HUM MOL GENET, V6, P1943, DOI 10.1093/hmg/6.11.1943; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Yamashita F, 2001, J MOL CELL CARDIOL, V33, P197, DOI 10.1006/jmcc.2000.1300	34	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51820	10.1371/journal.pone.0051820	http://dx.doi.org/10.1371/journal.pone.0051820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251633	gold, Green Published			2022-12-27	WOS:000313236200168
J	Jakola, AS; Unsgard, G; Myrmel, KS; Kloster, R; Torp, SH; Lindal, S; Solheim, O				Jakola, Asgeir S.; Unsgard, Geirmund; Myrmel, Kristin S.; Kloster, Roar; Torp, Sverre H.; Lindal, Sigurd; Solheim, Ole			Low Grade Gliomas in Eloquent Locations - Implications for Surgical Strategy, Survival and Long Term Quality of Life	PLOS ONE			English	Article							RESECTION; RADIOTHERAPY; VALUATIONS; EUROQOL; IMPACT; SERIES; ADULTS; EXTENT; TUMORS	Background: Surgical management of suspected LGG remains controversial. A key factor when deciding a surgical strategy is often the tumors' perceived relationship to eloquent brain regions Objective: To study the association between tumor location, survival and long-term health related quality of life (HRQL) in patients with supratentorial low-grade gliomas (LGG). Methods: Adults (>= 18 years) operated due to newly diagnosed LGG from 1998 through 2009 included from two Norwegian university hospitals. After review of initial histopathology, 153 adults with supratentorial WHO grade II LGG were included in the study. Tumors' anatomical location and the relationship to eloquent regions were graded. Survival analysis was adjusted for known prognostic factors and the initial surgical procedure (biopsy or resection). In long-term survivors, HRQL was assessed with disease specific questionnaires (EORTC QLQ-C30 and BN20) as well as a generic questionnaire (EuroQol 5D). Results: There was a significant association between eloquence and survival (log-rank, p<0.001). The estimated 5-year survival was 77% in non-eloquent tumors, 71% in intermediate located tumors and 54% in eloquent tumors. In the adjusted analysis the hazard ratio of increasing eloquence was 1.5 (95% CI 1.1-2.0, p = 0.022). There were no differences in HRQL between patients with eloquent and non-eloquent tumors. The most frequent self-reported symptoms were related to fatigue, cognition, and future uncertainty. Conclusion: Eloquently located LGGs are associated with impaired survival compared to non-eloquently located LGG, but in long-term survivors HRQL is similar. Although causal inference from observational data should be done with caution, the findings illuminate the delicate balance in surgical decision making in LGGs, and add support to the probable survival benefits of aggressive surgical strategies, perhaps also in eloquent locations.	[Jakola, Asgeir S.; Unsgard, Geirmund; Solheim, Ole] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Jakola, Asgeir S.; Solheim, Ole] Norwegian Univ Sci & Technol, MI Lab, N-7034 Trondheim, Norway; [Jakola, Asgeir S.; Unsgard, Geirmund] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Unsgard, Geirmund; Solheim, Ole] Natl Ctr Ultrasound Surg 3D, Trondheim, Norway; [Myrmel, Kristin S.; Lindal, Sigurd] Univ Hosp No Norway, Dept Pathol, Tromso, Norway; [Kloster, Roar] Univ Hosp No Norway, Dept Ophthalmol & Neurosurg, Tromso, Norway; [Torp, Sverre H.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU)	Jakola, AS (corresponding author), St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway.	asgeir.s.jakola@ntnu.no	Jakola, Asgeir S/J-1738-2018; Torp, Sverre Helge/AAN-4229-2020	Jakola, Asgeir S/0000-0002-2860-9331; Torp, Sverre Helge/0000-0001-8345-6852; Solheim, Ole/0000-0002-5954-4817				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Aaronson NK, 2011, J CLIN ONCOLOGY; Chang EF, 2011, J NEUROSURG, V114, P566, DOI 10.3171/2010.6.JNS091246; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claus EB, 2005, CANCER-AM CANCER SOC, V103, P1227, DOI 10.1002/cncr.20867; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Duffau H, 2008, J NEUROSURG, V109, P461, DOI 10.3171/JNS/2008/109/9/0461; Jakola AS, 2011, J NEUROSURG, V114, P1622, DOI 10.3171/2011.1.JNS101657; Keles GE, 2001, J NEUROSURG, V95, P735, DOI 10.3171/jns.2001.95.5.0735; Klein M, 2002, LANCET, V360, P1361, DOI 10.1016/S0140-6736(02)11398-5; Klein M, 2001, J CLIN ONCOL, V19, P4037, DOI 10.1200/JCO.2001.19.20.4037; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; Lang FF, 2006, J CLIN ONCOL, V24, P1236, DOI 10.1200/JCO.2005.05.2399; Liu R, 2009, NEURO-ONCOLOGY, V11, P330, DOI 10.1215/15228517-2008-093; NORD E, 1991, HEALTH POLICY, V18, P25, DOI 10.1016/0168-8510(91)90141-J; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Radner H, 2002, PATHOLOGE, V23, P260, DOI 10.1007/s00292-002-0530-8; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Seiz M, 2011, CEN EUR NEUROSURG; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Taphoorn MJB, 2010, EUR J CANCER, V46, P1033, DOI 10.1016/j.ejca.2010.01.012; Wessels PH, 2003, LANCET NEUROL, V2, P395, DOI 10.1016/S1474-4422(03)00434-4; Whittle IR, 2004, J NEUROL NEUROSUR PS, V75, P31, DOI 10.1136/jnnp.2004.040501; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yavas C, 2011, SUPPORT CARE CANCER, P1	26	38	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51450	10.1371/journal.pone.0051450	http://dx.doi.org/10.1371/journal.pone.0051450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251537	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900088
J	Loyau, A; Cornuau, JH; Clobert, J; Danchin, E				Loyau, Adeline; Cornuau, Jeremie H.; Clobert, Jean; Danchin, Etienne			Incestuous Sisters: Mate Preference for Brothers over Unrelated Males in Drosophila melanogaster	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; INBREEDING AVOIDANCE; NO EVIDENCE; KIN RECOGNITION; CHOICE; DEPRESSION; RELATEDNESS; POPULATION; SIMILARITY; LEVEL	The literature is full of examples of inbreeding avoidance, while recent mathematical models predict that inbreeding tolerance or even inbreeding preference should be expected under several realistic conditions like e. g. polygyny. We investigated male and female mate preferences with respect to relatedness in the fruit fly D. melanogaster. Experiments offered the choice between a first order relative (full-sibling or parent) and an unrelated individual with the same age and mating history. We found that females significantly preferred mating with their brothers, thus supporting inbreeding preference. Moreover, females did not avoid mating with their fathers, and males did not avoid mating with their sisters, thus supporting inbreeding tolerance. Our experiments therefore add empirical evidence for inbreeding preference, which strengthens the prediction that inbreeding tolerance and preference can evolve under specific circumstances through the positive effects on inclusive fitness.	[Loyau, Adeline; Cornuau, Jeremie H.; Clobert, Jean] CNRS Moulis, CNRS, Stn Ecol Expt, USR 2936, St Girons, France; [Loyau, Adeline; Danchin, Etienne] Univ Toulouse 3, CNRS, ENFA, Lab Evolut & Diversite Biol EDB,UMR 5174, F-31062 Toulouse, France; [Loyau, Adeline; Danchin, Etienne] Univ Toulouse, UMR 5174, Toulouse, France; [Loyau, Adeline] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Loyau, A (corresponding author), CNRS Moulis, CNRS, Stn Ecol Expt, USR 2936, St Girons, France.	al@adeline-loyau.net	Loyau, Adeline/F-8682-2010; Danchin, Etienne/AAB-2091-2021	Loyau, Adeline/0000-0003-4230-5892; Danchin, Etienne/0000-0002-5013-9612	"Laboratoire d'Excellence (LABEX)" entitled TULIP [ANR-10-LABX-41]; CNRS; Ministry of Research	"Laboratoire d'Excellence (LABEX)" entitled TULIP; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This work was funded by the "Laboratoire d'Excellence (LABEX)" entitled TULIP (ANR-10-LABX-41), a CNRS post-doc to AL, and a fellowship from the Ministry of Research to JHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2008, GENETICS, V179, P503, DOI 10.1534/genetics.107.086363; Ala-Honkola O, 2011, EVOLUTION, V65, P2699, DOI 10.1111/j.1558-5646.2011.01317.x; Avila V, 2010, J EVOLUTION BIOL, V23, P1937, DOI 10.1111/j.1420-9101.2010.02058.x; BARNARD CJ, 1988, ANIM BEHAV, V36, P1078, DOI 10.1016/S0003-3472(88)80067-8; BATESON P, 1982, NATURE, V295, P236, DOI 10.1038/295236a0; Bateson P., 1983, P257; Blomqvist D, 2002, NATURE, V419, P613, DOI 10.1038/nature01104; BLOUIN SF, 1988, TRENDS ECOL EVOL, V3, P230, DOI 10.1016/0169-5347(88)90164-4; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; Daniels SJ, 2000, CONDOR, V102, P482, DOI 10.1650/0010-5422(2000)102[0482:IDAIEO]2.0.CO;2; De Luca PA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1869, DOI 10.1007/s00265-008-0616-2; Edvardsson M, 2008, ANIM BEHAV, V75, P1519, DOI 10.1016/j.anbehav.2007.10.005; Elias J, 2010, MOL ECOL, V19, P2336, DOI 10.1111/j.1365-294X.2010.04645.x; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Freeman-Gallant CR, 2003, MOL ECOL, V12, P3077, DOI 10.1046/j.1365-294X.2003.01968.x; Frere CH, 2010, P ROY SOC B-BIOL SCI, V277, P2667, DOI 10.1098/rspb.2010.0039; Frommen JG, 2006, BIOL LETTERS, V2, P232, DOI 10.1098/rsbl.2005.0432; Gerlach G, 2006, ANIM BEHAV, V71, P1371, DOI 10.1016/j.anbehav.2005.10.010; Guevara-Fiore P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1601, DOI 10.1007/s00265-010-0973-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hansson B, 2007, BEHAV ECOL, V18, P157, DOI 10.1093/beheco/arl062; Hatchwell BJ, 2000, P ROY SOC B-BIOL SCI, V267, P813, DOI 10.1098/rspb.2000.1076; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Holand O, 2007, BIOL LETTERS, V3, P36, DOI 10.1098/rsbl.2006.0575; Jamieson IG, 2009, BEHAV ECOL, V20, P575, DOI 10.1093/beheco/arp034; Jones B, 2003, GENETICS, V163, P1193; KEANE B, 1990, ANIM BEHAV, V39, P264, DOI 10.1016/S0003-3472(05)80870-X; Koenig WD, 1999, ANIM BEHAV, V57, P1287, DOI 10.1006/anbe.1999.1093; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kuo TH, 2012, J EXP BIOL, V215, P814, DOI 10.1242/jeb.064980; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Loyau A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00768; Mack PD, 2002, EVOLUTION, V56, P1789, DOI 10.1111/j.0014-3820.2002.tb00192.x; Mack PD, 2000, GENETICA, V110, P31, DOI 10.1023/A:1017538505627; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Mulard H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-147; Narraway C, 2010, J EVOLUTION BIOL, V23, P2550, DOI 10.1111/j.1420-9101.2010.02113.x; Olsson M, 2003, P ROY SOC B-BIOL SCI, V270, pS254, DOI 10.1098/rsbl.2003.0079; Parker G.A., 1979, P123; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Puurtinen M, 2011, EVOLUTION, V65, P1501, DOI 10.1111/j.1558-5646.2010.01217.x; Reid JM, 2006, AM NAT, V168, P1, DOI 10.1086/504852; Richard M, 2009, P ROY SOC B-BIOL SCI, V276, P2779, DOI 10.1098/rspb.2009.0319; Rioux-Paquette E, 2010, ANIM BEHAV, V80, P865, DOI 10.1016/j.anbehav.2010.08.006; Robinson SP, 2012, J EVOLUTION BIOL, V25, P716, DOI 10.1111/j.1420-9101.2012.02466.x; Robinson SP, 2009, BIOL J LINN SOC, V98, P501, DOI 10.1111/j.1095-8312.2009.01301.x; Ruedi EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006150; Schielzeth H, 2008, ANIM BEHAV, V76, P1927, DOI 10.1016/j.anbehav.2008.08.014; Schjorring S, 2007, EVOLUTION, V61, P423, DOI 10.1111/j.1558-5646.2007.00028.x; SHARP PM, 1984, GENETICS, V106, P601; Swindell WR, 2006, J EVOLUTION BIOL, V19, P1257, DOI 10.1111/j.1420-9101.2005.01074.x; Swindell WR, 2006, EVOLUTION, V60, P762, DOI 10.1111/j.0014-3820.2006.tb01154.x; Szulkin M, 2009, J ANIM ECOL, V78, P778, DOI 10.1111/j.1365-2656.2009.01544.x; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; Thurin N, 2009, J EVOLUTION BIOL, V22, P2481, DOI 10.1111/j.1420-9101.2009.01864.x; Tomaru M, 2000, ANIM BEHAV, V60, P797, DOI 10.1006/anbe.2000.1543; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Wheelwright NT, 2006, ANIM BEHAV, V71, P631, DOI 10.1016/j.anbehav.2005.06.012; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037	63	20	20	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51293	10.1371/journal.pone.0051293	http://dx.doi.org/10.1371/journal.pone.0051293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251487	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900062
J	Xie, P; Jiang, YJ; Zhang, XM; Yang, SB				Xie, Peng; Jiang, Yanjun; Zhang, Xiaoming; Yang, Shengbo			The Study of Intramuscular Nerve Distribution Patterns and Relative Spindle Abundance of the Thenar and Hypothenar Muscles in Human Hand	PLOS ONE			English	Article							ULNAR NERVE; MEDIAN NERVES; DENSITY; BRANCH	Background: The intramuscular nerve distribution and relative spindle abundance of the human hand have not been well defined, although this is important in guiding hand surgery. Methods: Forty human hands were dissected and subjected to modified Sihler's stain and haematoxylin and eosin stain to investigate intramuscular nerve distribution and relative spindle abundance, respectively. Results: The flexor pollicis brevis (FPB), adductor pollicis (AP), and abductor digiti minimi (ADM) contain separate nerve compartments. Neural anastomoses were observed in the thenar and hypothenar muscles, including the Y-like, O-like, H-like, and U-like appearance. We found that U-like neural anastomoses may be the characteristic of the opponens muscles. The relative spindle abundance was the greatest in the opponens muscles which may coordinate fine movements. Conclusion: Except for the two opponens muscles, the rest of the thenar and hypothenar muscles could be used as whole muscle or half-muscle donors for muscle transplant. Our nerve map of the hand offers valuable guidance for hand reconstruction.	[Xie, Peng; Jiang, Yanjun; Yang, Shengbo] Zunyi Med Coll, Dept Anat, Zunyi, Guizhou, Peoples R China; [Zhang, Xiaoming] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Zunyi Medical University; University of Kansas; University of Kansas Medical Center	Yang, SB (corresponding author), Zunyi Med Coll, Dept Anat, Zunyi, Guizhou, Peoples R China.	ShengboYangZY@hotmail.com			Provincial Natural Science Foundation of Guizhou [C-292]; Graduate Foundation of Zunyi Medical College [F-350]	Provincial Natural Science Foundation of Guizhou; Graduate Foundation of Zunyi Medical College	This work was supported by Provincial Natural Science Foundation of Guizhou (C-292) and Graduate Foundation of Zunyi Medical College (F-350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins SE, 2009, J HAND SURG-EUR VOL, V34E, P47, DOI 10.1177/1753193408097489; Banks RW, 2006, J ANAT, V208, P753, DOI 10.1111/j.1469-7580.2006.00558.x; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; BUXTON DF, 1990, J MORPHOL, V203, P345, DOI 10.1002/jmor.1052030309; Cao DY, 2009, J NEUROPHYSIOL, V101, P1722, DOI 10.1152/jn.90976.2008; Gonzalez MC, 2010, CLIN NUTR, V29, P268, DOI 10.1016/j.clnu.2009.08.012; HOMMA T, 1991, ACTA ANAT, V141, P139; HOMMA T, 1992, ACTA ANAT, V145, P44; HUTTON RS, 1992, SPORTS MED, V14, P406, DOI 10.2165/00007256-199214060-00007; Im S, 2008, AM J PHYS MED REHAB, V87, P703, DOI 10.1097/PHM.0b013e31817fa167; Kararizou E, 2005, ANAL QUANT CYTOL, V27, P1; Kulkarni V, 2001, NEUROL INDIA, V49, P355; Loukas M, 2011, CLIN ANAT, V24, P197, DOI 10.1002/ca.21093; Mu L, 2010, BIOTECH HISTOCHEM, V85, P19, DOI 10.3109/10520290903048384; Murata K, 2004, J HAND SURG-AM, V29A, P500, DOI 10.1016/j.jhsa.2004.01.006; Osterlund C, 2011, ANAT REC, V294, P683, DOI 10.1002/ar.21347; Takeuchi Y, 1995, ACTA ANAT NIPPON, V70, P313; Uysal AC, 2005, J HAND SURG-AM, V30A, P172, DOI 10.1016/j.jhsa.2004.06.001; Wang Z, 2012, J NEUROPHYSIOL, V108, P83, DOI 10.1152/jn.00074.2012; Yu DZ, 2010, SURG RADIOL ANAT, V32, P637, DOI 10.1007/s00276-010-0644-2	20	9	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51538	10.1371/journal.pone.0051538	http://dx.doi.org/10.1371/journal.pone.0051538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251569	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900099
J	Kekesi, KA; Juhasz, G; Simor, A; Gulyassy, P; Szego, EM; Hunyadi-Gulyas, E; Darula, Z; Medzihradszky, KF; Palkovits, M; Penke, B; Czurko, A				Kekesi, Katalin Adrienna; Juhasz, Gabor; Simor, Attila; Gulyassy, Peter; Szego, Eva Monika; Hunyadi-Gulyas, Eva; Darula, Zsuzsanna; Medzihradszky, Katalin F.; Palkovits, Miklos; Penke, Botond; Czurko, Andras			Altered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; ANTERIOR CINGULATE CORTEX; CALCIUM-BINDING PROTEINS; GENE-EXPRESSION ANALYSIS; OF-THE-LITERATURE; BIPOLAR DISORDER; GEL-ELECTROPHORESIS; PROTEOMIC ANALYSIS; FRONTAL-CORTEX; HUMAN BRAIN	Probing molecular brain mechanisms related to increased suicide risk is an important issue in biological psychiatry research. Gene expression studies on post mortem brains indicate extensive changes prior to a successful suicide attempt; however, proteomic studies are scarce. Thus, we performed a DIGE proteomic analysis of post mortem tissue samples from the prefrontal cortex and amygdala of suicide victims to identify protein changes and biomarker candidates of suicide. Among our matched spots we found 46 and 16 significant differences in the prefrontal cortex and amygdala, respectively; by using the industry standard t test and 1.3 fold change as cut off for significance. Because of the risk of false discoveries (FDR) in these data, we also made FDR adjustment by calculating the q-values for all the t tests performed and by using 0.06 and 0.4 as alpha thresholds we reduced the number of significant spots to 27 and 9 respectively. From these we identified 59 proteins in the cortex and 11 proteins in the amygdala. These proteins are related to biological functions and structures such as metabolism, the redox system, the cytoskeleton, synaptic function, and proteolysis. Thirteen of these proteins (CBR1, DPYSL2, EFHD2, FKBP4, GFAP, GLUL, HSPA8, NEFL, NEFM, PGAM1, PRDX6, SELENBP1 and VIM,) have already been suggested to be biomarkers of psychiatric disorders at protein or genome level. We also pointed out 9 proteins that changed in both the amygdala and the cortex, and from these, GFAP, INA, NEFL, NEFM and TUBA1 are interacting cytoskeletal proteins that have a functional connection to glutamate, GABA, and serotonin receptors. Moreover, ACTB, CTSD and GFAP displayed opposite changes in the two examined brain structures that might be a suitable characteristic for brain imaging studies. The opposite changes of ACTB, CTSD and GFAP in the two brain structures were validated by western blot analysis. Citation: Kekesi KA, Juhasz G, Simor A, Gulyassy P, Szego EM, et al. (2012) Altered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide. PLoS ONE 7(12): e50532. doi:10.1371/journal.pone.0050532	[Kekesi, Katalin Adrienna; Juhasz, Gabor; Simor, Attila; Gulyassy, Peter; Szego, Eva Monika; Czurko, Andras] Eotvos Lorand Univ, Inst Biol, Lab Prote, Budapest, Hungary; [Kekesi, Katalin Adrienna] Eotvos Lorand Univ, Dept Physiol & Neurobiol, Budapest, Hungary; [Hunyadi-Gulyas, Eva; Darula, Zsuzsanna; Medzihradszky, Katalin F.] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Prote Res Grp, H-6701 Szeged, Hungary; [Medzihradszky, Katalin F.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Palkovits, Miklos] Semmelweis Univ, Hungarian Acad Sci, Neuromorphol Res Grp, H-1085 Budapest, Hungary; [Penke, Botond; Czurko, Andras] Univ Szeged, Dept Med Chem, Szeged, Hungary	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of California System; University of California San Francisco; Hungarian Academy of Sciences; Semmelweis University; Szeged University	Kekesi, KA (corresponding author), Eotvos Lorand Univ, Inst Biol, Lab Prote, Budapest, Hungary.	kakekesi@dec001.geobio.elte.hu	Simor, Attila/R-8071-2018; Palkovits, Miklos/F-2707-2013; Kékesi, Katalin Adrienna A/H-3484-2017; Czurkó, András/H-5500-2019; Juhász, Gábor/I-7781-2017	Palkovits, Miklos/0000-0003-0578-0387; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Juhász, Gábor/0000-0002-0849-6931; Szego, Eva Monika/0000-0002-2629-2131; Hunyadi-Gulyas, Eva/0000-0003-2089-1499; Czurko, Andras/0000-0002-1985-7296	FP-7 Health EC [201 159]; Social Renewal Operational Programme [TAMOP-4.2.2/08/1, TAMOP 4.2.1./B-09/1/KMR-2010-0003]; Economic Competitiveness Operational Programme [GVOP-3.2.1.-2004-04-0309]; NKTH EGISPSYCH grant	FP-7 Health EC; Social Renewal Operational Programme; Economic Competitiveness Operational Programme; NKTH EGISPSYCH grant	This work was supported by the FP-7 Health EC project 201 159 (Memoload), the Social Renewal Operational Programme (TAMOP-4.2.2/08/1) to G. Juhasz, K.F. Medzihradszky and B. Penke; the Economic Competitiveness Operational Programme (GVOP-3.2.1.-2004-04-0309) to G. Juhasz, the Social Renewal Operational Programme (TAMOP 4.2.1./B-09/1/KMR-2010-0003) to G. Juhasz, A. Czurko and K. A. Kekesi and NKTH EGISPSYCH grant to B. Penke, G. Juhasz and A. Czurko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarian S, 2008, BIOL PSYCHIAT, V64, P643, DOI 10.1016/j.biopsych.2008.06.013; Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Altshuler LL, 2010, BIPOLAR DISORD, V12, P541, DOI 10.1111/j.1399-5618.2010.00838.x; Arai R, 2007, PROTEINS, V67, P732, DOI 10.1002/prot.21299; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Arnold SE, 2001, ARCH GEN PSYCHIAT, V58, P829, DOI 10.1001/archpsyc.58.9.829; Banay-Schwartz M, 1998, NEUROCHEM RES, V23, P953, DOI 10.1023/A:1021028304481; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Behan AT, 2009, MOL PSYCHIATR, V14, P601, DOI 10.1038/mp.2008.7; Ben-Efraim YJ, 2012, MOL PSYCHIA IN PRESS; Ben-Shachar D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000817; Bernard R, 2011, MOL PSYCHIATR, V16, P634, DOI 10.1038/mp.2010.44; BERNSTEIN HG, 1992, ACTA HISTOCHEM, P19; Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Brown LA, 2010, DEPRESS ANXIETY, V27, P310, DOI 10.1002/da.20609; Buckland PR, 2004, BBA-MOL BASIS DIS, V1690, P238, DOI 10.1016/j.bbadis.2004.06.023; Burbaeva GS, 2003, WORLD J BIOL PSYCHIA, V4, P177, DOI 10.1080/15622970310029916; Byne W, 2008, SCHIZOPHR RES, V98, P118, DOI 10.1016/j.schres.2007.09.034; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Casini A, 2003, BIOORG MED CHEM LETT, V13, P2765, DOI 10.1016/S0960-894X(03)00507-9; Clark D, 2007, PROTEOM CLIN APPL, V1, P157, DOI 10.1002/prca.200600541; Coryell W, 2007, PSYCHIAT RES, V150, P187, DOI 10.1016/j.psychres.2006.01.021; Crecelius A, 2008, PROTEOMICS, V8, P1276, DOI 10.1002/pmic.200700728; Crow TJ, 2007, AM J PSYCHIAT, V164, P13, DOI 10.1176/appi.ajp.164.1.13; Dong E, 2007, P NATL ACAD SCI USA, V104, P4676, DOI 10.1073/pnas.0700529104; Du LS, 2001, J AFFECT DISORDERS, V65, P37, DOI 10.1016/S0165-0327(00)00274-3; Dwivedi Y, 2009, INT J NEUROPSYCHOPH, V12, P1337, DOI 10.1017/S1461145709990575; Ehlers MD, 1998, J NEUROSCI, V18, P720; English JA, 2009, PROTEOMICS, V9, P3368, DOI 10.1002/pmic.200900015; Ernst C, 2009, PROG NEUROBIOL, V89, P315, DOI 10.1016/j.pneurobio.2009.09.001; Falcone T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011089; Gall D, 2005, PROG BRAIN RES, V148, P321, DOI 10.1016/S0079-6123(04)48025-X; Garbett Krassimira, 2008, Neuropsychopharmacol Hung, V10, P9; Gardner A, 2008, CNS SPECTRUMS, V13, P805, DOI 10.1017/S1092852900013936; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Gollan JK, 2005, DEV PSYCHOPATHOL, V17, P1151, DOI 10.1017/S0954579405050546; Gonda X, 2011, J PSYCHOPHARMACOL, V25, P857, DOI 10.1177/0269881110376693; Grover D, 2009, AM J MED GENET B, V150B, P977, DOI 10.1002/ajmg.b.30927; Gudmundsson P, 2010, PSYCHIAT RES, V176, P174, DOI 10.1016/j.psychres.2008.11.012; Gvion Y, 2011, ARCH SUICIDE RES, V15, P93, DOI 10.1080/13811118.2011.565265; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Heinz A, 2007, BIOL PSYCHIAT, V61, P1011, DOI 10.1016/j.biopsych.2006.08.019; Hercher C, 2009, J PSYCHIATR RES, V43, P947, DOI 10.1016/j.jpsychires.2009.01.006; Huang JTJ, 2008, MOL PSYCHIATR, V13, P1118, DOI 10.1038/sj.mp.4002108; Hunter AM, 2010, ACTA PSYCHIAT SCAND, V122, P461, DOI 10.1111/j.1600-0447.2010.01560.x; Ikeda M, 2008, HUM MOL GENET, V17, P3212, DOI 10.1093/hmg/ddn217; Ji BH, 2009, J PROTEOME RES, V8, P3633, DOI 10.1021/pr800876z; Jia YB, 2004, EUR PSYCHIAT, V19, P377, DOI 10.1016/j.eurpsy.2004.07.006; Jimenez-Trevino L, 2011, ACTAS ESP PSIQUIATRI, V39, P61; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Kanazawa T, 2008, AM J MED GENET B, V147B, P686, DOI 10.1002/ajmg.b.30664; Kanazawa T, 2009, SCHIZOPHR RES, V113, P268, DOI 10.1016/j.schres.2009.06.011; KANEKO M, 1993, NEUROSCI LETT, V157, P195, DOI 10.1016/0304-3940(93)90735-4; Karolewicz B, 2009, INT J NEUROPSYCHOPH, V12, P143, DOI 10.1017/S1461145708008985; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Karp NA, 2007, MOL CELL PROTEOMICS, V6, P1354, DOI 10.1074/mcp.M600274-MCP200; Kasper S, 2010, WORLD J BIOL PSYCHIA, V11, P36, DOI 10.3109/15622970701691503; Kekesi KA, 2006, CELL MOL NEUROBIOL, V26, P833, DOI 10.1007/s10571-006-9103-3; Kim S, 2010, MOL PSYCHIATR, V15, P326, DOI 10.1038/mp.2008.99; Klempan TA, 2009, MOL PSYCHIATR, V14, P175, DOI 10.1038/sj.mp.4002110; Knittel D, 2008, AM J FOREN MED PATH, V29, P238, DOI 10.1097/PAF.0b013e3181834540; Kodydkova J, 2009, CLIN BIOCHEM, V42, P1368, DOI 10.1016/j.clinbiochem.2009.06.006; Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023; Kroes RA, 2006, NEUROSCIENCE, V137, P37, DOI 10.1016/j.neuroscience.2005.08.076; KUGLER P, 1993, INT REV CYTOL, V147, P285, DOI 10.1016/S0074-7696(08)60771-8; Lewis DA, 2002, NEUROPSYCHOPHARMACOL, V26, P143, DOI 10.1016/S0893-133X(01)00393-1; Liu Q, 2009, EUR NEUROPSYCHOPHARM, V19, P796, DOI 10.1016/j.euroneuro.2009.06.010; Lopez JL, 2007, J CHROMATOGR B, V849, P190, DOI 10.1016/j.jchromb.2006.11.049; Magno LAV, 2010, GENES BRAIN BEHAV, V9, P411, DOI 10.1111/j.1601-183X.2010.00571.x; Malkesman O, 2009, TRENDS PHARMACOL SCI, V30, P165, DOI 10.1016/j.tips.2009.01.004; Mann JJ, 2009, BIOL PSYCHIAT, V65, P556, DOI 10.1016/j.biopsych.2008.11.021; Mann JJ, 2001, NEUROPSYCHOPHARMACOL, V24, P467, DOI 10.1016/S0893-133X(00)00228-1; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Martins-de-Souza D, 2010, J PSYCHIATR RES, V44, P1176, DOI 10.1016/j.jpsychires.2010.04.014; Martins-De-Souza D, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-17; Matsuzawa D, 2009, AM J MED GENET B, V150B, P86, DOI 10.1002/ajmg.b.30776; Matthews PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038211; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGuffin P, 2010, EUR PSYCHIAT, V25, P275, DOI 10.1016/j.eurpsy.2009.12.012; McHugh PC, 2010, J PSYCHOPHARMACOL, V24, P1243, DOI 10.1177/0269881109102786; McHugh PC, 2008, J NEUROSCI RES, V86, P306, DOI 10.1002/jnr.21482; Meerwijk EL, 2010, PERSPECT PSYCHIATR C, V46, P65, DOI 10.1111/j.1744-6163.2009.00239.x; Miguel-Hidalgo JJ, 2010, J AFFECT DISORDERS, V127, P230, DOI 10.1016/j.jad.2010.06.003; Monoranu CM, 2009, NEUROPATH APPL NEURO, V35, P329, DOI 10.1111/j.1365-2990.2008.01003a.x; Musazzi L, 2010, J PSYCHIATR RES, V44, P511, DOI 10.1016/j.jpsychires.2009.11.008; Musselman DL, 1996, AM J PSYCHIAT, V153, P1313; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Neves FS, 2010, J AFFECT DISORDERS, V125, P98, DOI 10.1016/j.jad.2009.12.026; Newton SS, 2004, MOL BRAIN RES, V129, P185, DOI 10.1016/j.molbrainres.2004.06.032; Nordentoft M, 2007, DAN MED BULL, V54, P306; Novikova SI, 2006, NEUROBIOL DIS, V23, P61, DOI 10.1016/j.nbd.2006.02.002; Oquendo MA, 2003, ARCH GEN PSYCHIAT, V60, P14, DOI 10.1001/archpsyc.60.1.14; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Paulson L, 2007, J NEURAL TRANSM, V114, P885, DOI 10.1007/s00702-007-0626-7; Paulson L, 2004, PROTEOMICS, V4, P819, DOI 10.1002/pmic.200300622; Pennington K, 2008, MOL PSYCHIATR, V13, P1102, DOI 10.1038/sj.mp.4002098; Pennington K, 2008, PROTEOMICS, V8, P5097, DOI 10.1002/pmic.200800415; Poulter MO, 2008, BIOL PSYCHIAT, V64, P645, DOI 10.1016/j.biopsych.2008.05.028; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rapoport SI, 2009, BRAIN RES REV, V61, P185, DOI 10.1016/j.brainresrev.2009.06.003; Robinson AA, 2009, PROTEOMICS, V9, P4433, DOI 10.1002/pmic.200900287; ROY A, 1989, ARCH GEN PSYCHIAT, V46, P609; SALLANONMOULIN M, 1994, MOL BRAIN RES, V22, P113, DOI 10.1016/0169-328X(94)90038-8; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Scaini G, 2010, BRAIN RES BULL, V82, P224, DOI 10.1016/j.brainresbull.2010.03.006; Schlicht K, 2007, J PSYCHIATR RES, V41, P493, DOI 10.1016/j.jpsychires.2006.04.006; Schmitt A, 2007, J NEURAL TRANSM, V114, P527, DOI 10.1007/s00702-006-0601-8; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sillaber I, 2008, PSYCHOPHARMACOLOGY, V200, P557, DOI 10.1007/s00213-008-1232-6; Sivagnanasundaram S, 2007, PROTEOM CLIN APPL, V1, P1291, DOI 10.1002/prca.200700230; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Smalla KH, 2008, MOL PSYCHIATR, V13, P878, DOI 10.1038/mp.2008.60; Steffek AE, 2008, SCHIZOPHR RES, V103, P71, DOI 10.1016/j.schres.2008.04.032; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki G, 2009, HUM MOL GENET, V18, P1652, DOI 10.1093/hmg/ddp086; Szego EM, 2010, PSYCHONEUROENDOCRINO, V35, P807, DOI 10.1016/j.psyneuen.2009.11.006; Szego EM, 2010, EUR NEUROPSYCHOPHARM, V20, P96, DOI 10.1016/j.euroneuro.2009.11.003; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Takahashi S, 2008, SCHIZOPHR RES, V104, P153, DOI 10.1016/j.schres.2008.05.028; Tatro ET, 2009, BRAIN RES, V1286, P1, DOI 10.1016/j.brainres.2009.06.036; Tatro ET, 2009, J NEUROIMMUNE PHARM, V4, P218, DOI 10.1007/s11481-009-9146-6; Taurines R, 2011, J PSYCHOPHARMACOL, V25, P151, DOI 10.1177/0269881109106931; Taylor K, 2000, SCHIZOPHR RES, V44, P245, DOI 10.1016/S0920-9964(99)00194-2; Taylor PJ, 2011, PSYCHOL BULL, V137, P391, DOI 10.1037/a0022935; Tonge R, 2001, PROTEOMICS, V1, P377; Toyooka K, 1999, AM J MED GENET, V88, P164, DOI 10.1002/(SICI)1096-8628(19990416)88:2<164::AID-AJMG13>3.0.CO;2-3; Vaccarino V, 2008, BIOL PSYCHIAT, V64, P476, DOI 10.1016/j.biopsych.2008.04.023; Vawter MP, 2004, NEUROCHEM RES, V29, P1245, DOI 10.1023/B:NERE.0000023611.99452.47; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Yanagi M, 2005, J HUM GENET, V50, P210, DOI 10.1007/s10038-005-0241-0; Yang CH, 2012, J NEUROSCI, V32, P7550, DOI 10.1523/JNEUROSCI.5902-11.2012; Yuan PX, 2010, J AFFECT DISORDERS, V124, P164, DOI 10.1016/j.jad.2009.10.017	143	46	46	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50532	10.1371/journal.pone.0050532	http://dx.doi.org/10.1371/journal.pone.0050532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23272063	Green Published, gold, Green Accepted			2022-12-27	WOS:000312589700016
J	Ge, HY; Ni, SS; Wang, XA; Xu, N; Liu, Y; Wang, X; Wang, LY; Song, DL; Song, YL; Bai, CX				Ge, Haiyan; Ni, Songshi; Wang, Xingan; Xu, Nuo; Liu, Ying; Wang, Xun; Wang, Lingyan; Song, Dongli; Song, Yuanlin; Bai, Chunxue			Dexamethasone Reduces Sensitivity to Cisplatin by Blunting p53-Dependent Cellular Senescence in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NF-KAPPA-B; DNA-DAMAGE; GROWTH-INHIBITION; INDUCED APOPTOSIS; RESISTANCE; CHEMOTHERAPY; ACTIVATION; THERAPY; P53; GEMCITABINE	Introduction: Dexamethasone (DEX) co-treatment has proved beneficial in NSCLC patients, improving clinical symptoms by the reduction of side effects after chemotherapy. However, recent studies have shown that DEX could render cancer cells more insensitive to cytotoxic drug therapy, but it is not known whether DEX co-treatment could influence therapy-induced senescence (TIS), and unknown whether it is in a p53-dependent or p53-independent manner. Methods: We examined in different human NSCLC cell lines and detected cellular senescence after cisplatin (DDP) treatment in the presence or absence of DEX. The in vivo effect of the combination of DEX and DDP was assessed by tumor growth experiments using human lung cancer cell lines growing as xenograft tumors in nude mice. Results: Co-treatment with DEX during chemotherapy in NSCLC resulted in increased tumor cell viability and inhibition of TIS compared with DDP treated group. DEX co-treatment cells exhibited the decrease of DNA damage signaling pathway proteins, the lower expression of p53 and p21(CIP1), the lower cellular secretory program and down-regulation of NF-kappa B and its signaling cascade. DEX also significantly reduced DDP sensitivity in vivo. Conclusions: Our results underscore that DEX reduces chemotherapy sensitivity by blunting therapy induced cellular senescence after chemotherapy in NSCLC, which may, at least in part, in a p53-dependent manner. These data therefore raise concerns about the widespread combined use of gluocorticoids (GCs) with antineoplastic drugs in the clinical management of cancer patients.	[Ge, Haiyan; Wang, Xingan; Xu, Nuo; Wang, Xun; Wang, Lingyan; Song, Dongli; Song, Yuanlin; Bai, Chunxue] Fudan Univ, Dept Pulm Med, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Ge, Haiyan; Ni, Songshi; Liu, Ying] Nantong Univ, Dept Resp Med, Affiliated Hosp, Nantong, Peoples R China	Fudan University; Nantong University	Bai, CX (corresponding author), Fudan Univ, Dept Pulm Med, Zhongshan Hosp, Shanghai 200433, Peoples R China.	bai.chunxue@zs-hospital.sh.cn		Bai, Chunxue/0000-0001-5798-3130	3rd program of National Project "973''; 3rd program of National Project "985''; National Natural Key Science foundation of China [30930090]; National Natural Science Foundation of China [30971306/H0107]	3rd program of National Project "973''; 3rd program of National Project "985''; National Natural Key Science foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the 3rd program of National Project "973'' (to Chunxue Bai), 3rd program of National Project "985'' (to Chunxue Bai), National Natural Key Science foundation of China (30930090) (to Chunxue Bai), and National Natural Science Foundation of China (30971306/H0107) (to Songshi Ni) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen YX, 2010, ENDOCR-RELAT CANCER, V17, P39, DOI 10.1677/ERC-08-0296; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Ewald JA, 2009, J BIOMOL SCREEN, V14, P853, DOI 10.1177/1087057109340314; Fan WM, 2004, CURR MED CHEM, V11, P403, DOI 10.2174/0929867043455990; Gassler N, 2005, BRIT J CANCER, V92, P1084, DOI 10.1038/sj.bjc.6602453; Helbig L, 2011, J BIOL CHEM, V286, P12991, DOI 10.1074/jbc.M110.190645; Herr I, 2003, CANCER RES, V63, P3112; Hesketh PJ, 2012, SUPPORT CARE CANCER, V20, P653, DOI 10.1007/s00520-011-1312-8; Isbister GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038739; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin X, 2012, MOL CANC RES; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee YK, 2012, ARCH DERMATOL RES, V304, P73, DOI 10.1007/s00403-011-1176-2; Madsen SH, 2011, STEROIDS, V76, P1474, DOI 10.1016/j.steroids.2011.07.018; Meng L, 2011, ONCOGENE, V30, P1716, DOI 10.1038/onc.2010.550; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; O'Prey J, 2010, CELL CYCLE, V9, P947, DOI 10.4161/cc.9.5.10872; Qian YH, 2009, BBA-MOL CELL RES, V1793, P764, DOI 10.1016/j.bbamcr.2009.01.017; Raabe EH, 2011, CLIN CANCER RES, V17, P3590, DOI 10.1158/1078-0432.CCR-10-3349; Rebbaa A, 2006, CELL DEATH DIFFER, V13, P1960, DOI 10.1038/sj.cdd.4401895; Rho JK, 2007, CANCER RES, V67, P1163, DOI 10.1158/0008-5472.CAN-06-2037; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rossetto D, 2010, CLIN CANCER RES, V16, P4543, DOI 10.1158/1078-0432.CCR-10-0513; Rovillain E, 2011, ONCOGENE, V30, P2356, DOI 10.1038/onc.2010.611; Rutz HP, 2002, LANCET, V360, P1969, DOI 10.1016/S0140-6736(02)11922-2; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Schneider G, 2011, BBA-REV CANCER, V1815, P90, DOI 10.1016/j.bbcan.2010.10.003; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Song JH, 2011, CANCER RES, V71, P506, DOI 10.1158/0008-5472.CAN-10-1977; Sui MH, 2006, INT J CANCER, V119, P712, DOI 10.1002/ijc.21743; Sumikawa T, 2008, INT J ONCOL, V32, P683; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Tan XL, 2011, CLIN CANCER RES, V17, P5801, DOI 10.1158/1078-0432.CCR-11-1133; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; Wagenblast J, 2009, ONCOL REP, V22, P171, DOI 10.3892/or_00000421; Wang H, 2004, CLIN CANCER RES, V10, P1633, DOI 10.1158/1078-0432.CCR-0829-3; Wang Q, 2011, INT J CANCER, V128, P1546, DOI 10.1002/ijc.25482; Weichhart T, 2011, BLOOD, V117, P4273, DOI 10.1182/blood-2010-09-310888; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Xu N, 2012, ACTA PHARMACOL SIN, V33, P675, DOI 10.1038/aps.2011.188; Yang N, 2011, HEPATO-GASTROENTEROL, V58, P1730, DOI 10.5754/hge11153; Zhang C, 2006, CANCER BIOL THER, V5, P59, DOI 10.4161/cbt.5.1.2272; Zhang CW, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-61; Zhang Y, 2012, J CELL PHYSIOL, V227, P35, DOI 10.1002/jcp.22722	53	30	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51821	10.1371/journal.pone.0051821	http://dx.doi.org/10.1371/journal.pone.0051821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272171	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300031
J	Goodin, DS				Goodin, Douglas S.			The Genetic and Environmental Bases of Complex Human-Disease: Extending the Utility of Twin-Studies	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; RECURRENCE RISKS; CONCORDANCE; PREVALENCE; SUSCEPTIBILITY; MODEL	Making only the assumption that twins are representative of the population from which they are drawn, we here develop a simple mathematical model (using widely available epidemiological information) that sheds considerable light on the pathogenesis of complex human diseases. Specifically, for the case of multiple sclerosis (MS), we demonstrate that the vast majority of patients (>= 94%), possibly all, require genetic susceptibility in order to get MS. Nevertheless, only a tiny fraction of the population (<= 2.2%) is actually susceptible to getting this disease; a finding which is highly consistent in all of the studied populations across both North America and Europe. Men are more likely to be susceptible than women although susceptible women are more than twice as likely to actually develop MS compared to susceptible men (i.e., they have a greater disease penetrance). This is because women are more responsive to the environmental factors involved in MS pathogenesis than men. These differences account for the current gender-ratio (3:1, favoring women) and also for the increasing incidence of MS in women around the world. By contrast, the most important genetic marker for MS susceptibility (DRB1*1501) influences the likelihood of susceptibility but not the penetrance of the disease. Nevertheless, even for this major susceptibility allele, only a very small fraction of DRB1*1501carriers (<5%) are susceptible to getting MS and for only a minority of MS patients (similar to 41%) does this allele contribute to their susceptibility. Moreover, each copy of this allele seems to make an independent contribution to susceptibility. Finally, at least three environmental events are necessary for MS pathogenesis and, during the course of their lives, the large majority of the population (>= 69%) experiences an environmental exposure, which is sufficient to produce MS in, at least, some susceptible genotypes. Also, susceptible men (compared to susceptible women) have a lower threshold, a greater hazard-rate, or both in response to the environmental factors involved in MS pathogenesis.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu						ALPEROVITCH A, 1992, ANN NEUROL, V32, P724; Bager P, 2006, AM J EPIDEMIOL, V163, P1112, DOI 10.1093/aje/kwj148; BELLAMY N, 1992, ANN RHEUM DIS, V51, P588, DOI 10.1136/ard.51.5.588; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2006, MCALPINES MULTIPLE S, V4th; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Goodin DS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-101; Goodin DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004565; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hohler T, 1999, ANN RHEUM DIS, V58, P435, DOI 10.1136/ard.58.7.435; Islam T, 2006, ANN NEUROL, V60, P56, DOI 10.1002/ana.20871; Kuusisto H, 2008, EUR J NEUROL, V15, P1106, DOI 10.1111/j.1468-1331.2008.02262.x; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Nielsen NM, 2005, AM J EPIDEMIOL, V162, P774, DOI 10.1093/aje/kwi280; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; PAYAMI H, 1994, ANN NEUROL, V36, P659, DOI 10.1002/ana.410360417; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Ristori G, 2006, ANN NEUROL, V59, P27, DOI 10.1002/ana.20683; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sadovnick AD, 1999, CLIN GENET, V56, P118, DOI 10.1034/j.1399-0004.1999.560204.x; Sadovnick AD, 2005, LANCET NEUROL, V4, P611, DOI 10.1016/S1474-4422(05)70170-8; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sundquist K, 2008, RHEUMATOLOGY, V47, P1199, DOI 10.1093/rheumatology/ken184; Sundstrom P, 2003, J NEUROL NEUROSUR PS, V74, P29, DOI 10.1136/jnnp.74.1.29; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Torkildsen NG, 2008, MULT SCLER J, V14, P1191, DOI 10.1177/1352458508093890; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Witte JS, 1999, GENET EPIDEMIOL, V16, P290, DOI 10.1002/(SICI)1098-2272(1999)16:3<290::AID-GEPI5>3.0.CO;2-8	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e47875	10.1371/journal.pone.0047875	http://dx.doi.org/10.1371/journal.pone.0047875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272039	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300003
J	Miranda, JJ; Diez-Canseco, F; Lema, C; Lescano, AG; Lagarde, M; Blaauw, D; Huicho, L				Jaime Miranda, J.; Diez-Canseco, Francisco; Lema, Claudia; Lescano, Andres G.; Lagarde, Mylene; Blaauw, Duane; Huicho, Luis			Stated Preferences of Doctors for Choosing a Job in Rural Areas of Peru: A Discrete Choice Experiment	PLOS ONE			English	Article							HEALTH-WORKERS; POLICY INTERVENTIONS; HUMAN-RESOURCES; RETENTION; ATTRACT; NURSES	Background: Doctors' scarcity in rural areas remains a serious problem in Latin America and Peru. Few studies have explored job preferences of doctors working in underserved areas. We aimed to investigate doctors' stated preferences for rural jobs. Methods and Findings: A labelled discrete choice experiment (DCE) was performed in Ayacucho, an underserved department of Peru. Preferences were assessed for three locations: rural community, Ayacucho city (Ayacucho's capital) and other provincial capital city. Policy simulations were run to assess the effect of job attributes on uptake of a rural post. Multiple conditional logistic regressions were used to assess the relative importance of job attributes and of individual characteristics. A total of 102 doctors participated. They were five times more likely to choose a job post in Ayacucho city over a rural community (OR 4.97, 95% CI 1.2; 20.54). Salary increases and bonus points for specialization acted as incentives to choose a rural area, while increase in the number of years needed to get a permanent post acted as a disincentive. Being male and working in a hospital reduced considerably chances of choosing a rural job, while not living with a partner increased them. Policy simulations showed that a package of 75% salary increase, getting a permanent contract after two years in rural settings, and getting bonus points for further specialisation increased rural job uptake from 21% to 77%. A package of 50% salary increase plus bonus points for further specialisation would also increase the rural uptake from 21% to 52%. Conclusions: Doctors are five times more likely to favour a job in urban areas over rural settings. This strong preference needs to be overcome by future policies aimed at improving the scarcity of rural doctors. Some incentives, alone or combined, seem feasible and sustainable, whilst others may pose a high fiscal burden.	[Jaime Miranda, J.; Diez-Canseco, Francisco; Huicho, Luis] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.; Huicho, Luis] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru; [Lema, Claudia] Salud Sin Limites Peru, Lima, Peru; [Lescano, Andres G.] US Naval Med Res Unit 6 NAMRU 6, Dept Parasitol, Lima, Peru; [Lescano, Andres G.] US Naval Med Res Unit 6 NAMRU 6, Publ Hlth Training Program, Lima, Peru; [Lescano, Andres G.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Lagarde, Mylene] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Fac Publ Hlth & Policy, London WC1, England; [Blaauw, Duane] Univ Witwatersrand, Ctr Hlth Policy, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Huicho, Luis] Univ Nacl Mayor San Marcos, Sch Med, Lima 14, Peru; [Huicho, Luis] Inst Nacl Salud Nino, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; Universidad Nacional Mayor de San Marcos	Huicho, L (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	lhuicho@gmail.com	Lescano, Andres G/B-8479-2008; Huicho, Luis/AAD-7353-2019; Lescano, Andres G./M-9849-2019; Lagarde, Mylene/GVS-9289-2022	Lescano, Andres G/0000-0001-9779-633X; Lescano, Andres G./0000-0001-9779-633X; Huicho, Luis/0000-0002-5272-5885; Miranda, J. Jaime/0000-0002-4738-5468; Diez-Canseco, Francisco/0000-0002-7611-8190	Alliance for Health Policy and Systems Research (AHPSR) [PO200090444]; National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; Fogarty International Center of the National Institutes of Health of the United States of America [2D43 TW000393]; FOGARTY INTERNATIONAL CENTER [D43TW007393] Funding Source: NIH RePORTER	Alliance for Health Policy and Systems Research (AHPSR); National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fogarty International Center of the National Institutes of Health of the United States of America; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Alliance for Health Policy and Systems Research (AHPSR: http://www.who.int/alliance-hpsr/en/) to LH as Principal Investigator from Universidad Peruana Cayetano Heredia (TSA No. PO200090444). JJM, FDC (Investigators) and LH (Member of Consultative Board) are affiliated with CRONICAS Centre of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia, which is funded by the National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract No. HHSN268200900033C. Participation of AGL was funded by the program 2D43 TW000393 "Peruvian Consortium of Training in Infectious Diseases" awarded to NAMRU-6 by the Fogarty International Center of the National Institutes of Health of the United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Taghreed, 2011, Rev Peru Med Exp Salud Publica, V28, P323; Afzal Muhammad, 2011, Rev. perú. med. exp. salud publica, V28, P298, DOI 10.1590/s1726-46342011000200018; Arroyo Juan, 2006, Ciênc. saúde coletiva, V11, P1063, DOI 10.1590/S1413-81232006000400027; Asociacion Atocongo Asociacion Civil Transparencia Grupo RPP Pontificia Universidad Catolica del Peru, 2011, ENC LIM COM VAM 2011; Bhutta Z, 2010, LANCET, V376, P1375; Blaauw D, 2010, B WORLD HEALTH ORGAN, V88, P350, DOI 10.2471/BLT.09.072918; Caballero Patricia, 2010, Rev. perú. med. exp. salud publica, V27, P398, DOI 10.1590/s1726-46342010000300013; Curisinche Maricela, 2011, Rev. perú. med. exp. salud publica, V28, P372; Dayrit Manuel M, 2011, Rev Peru Med Exp Salud Publica, V28, P327; Dieleman Marjolein, 2003, Hum Resour Health, V1, P10, DOI 10.1186/1478-4491-1-10; Dolea C, 2010, B WORLD HEALTH ORGAN, V88, P379, DOI 10.2471/BLT.09.070607; DuBois C-A, 2006, HUMAN RESOURCES HLTH; Dussault Gilles, 2006, Hum Resour Health, V4, P12, DOI 10.1186/1478-4491-4-12; Alcalde-Rabanal JE, 2011, SALUD PUBLICA MEXICO, V53, pS243; Glassman A, 2008, LANCET, V371, P693, DOI 10.1016/S0140-6736(08)60311-6; GRADE, 2006, EST REC HUM SAL PER; Huicho L, 2012, CAD SAUDE PUBLICA, V28, P729, DOI 10.1590/S0102-311X2012000400012; Huicho L, 2010, B WORLD HEALTH ORGAN, V88, P357, DOI 10.2471/BLT.09.070920; *I NAC EST INF, 2000, ENC DEM SAL FAM ENDE; Instituto Nacional de Estadistica e Informatica, 2006, CENS POBL VIV 2005; Instituto Nacional de Estadistica e Informatica, 2007, ENC DEM SAL FAM ENDE; Instituto Nacional de Estadistica e Informatica, 2010, ENC DEM SAL FAM ENDE; Jumpa Manuel, 2007, Hum Resour Health, V5, P5, DOI 10.1186/1478-4491-5-5; Kruijshaar ME, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-31; Kuhfeld W.F., 2010, SAS; Lagarde M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-62; Mangham L, 18 ESAU; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Mayta-Tristan P, 2010, REV PERU MED EXP SAL, V28, P186, DOI DOI 10.1590/S1726-46342011000200004; Mayta-Tristan P, 2008, LANCET, V371, P1577, DOI 10.1016/S0140-6736(08)60685-6; McCaffery James A., 2011, Rev. perú. med. exp. salud publica, V28, P316; *MIN HLTH PER, 2010, QUE SERV RUR URB MAR; Ministy of Health of Peru, 2011, EXP PLAN REC HUM SAL; Mullei K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S1; Pan American Health Organization, 2008, SER REN AT PRIM SAL; Pan American Health Organization, 2007, SAL AM PER; Pardo Karim, 2011, Rev. perú. med. exp. salud publica, V28, P342; Programa de las Naciones Unidas Para el Desarrollo, 2005, MAP IND DES HUM NIV; Rechel B, 2006, HLTH CARE WORKFORCE; Rockers P, 2011, DETERMINING PRIORITY; Sousa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033399; Urcullo G, 2008, HLTH WORKER SALARIES; Webb R, 2005, NEW SOCIAL CONTRACT, P191; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; Yagui Martín, 2011, Rev. perú. med. exp. salud publica, V28, P175, DOI 10.1590/s1726-46342011000200002; Zevallos Leslie, 2011, Rev. perú. med. exp. salud publica, V28, P177, DOI 10.1590/s1726-46342011000200003; Zurn Pascal, 2004, Hum Resour Health, V2, P13, DOI 10.1186/1478-4491-2-13	49	28	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50567	10.1371/journal.pone.0050567	http://dx.doi.org/10.1371/journal.pone.0050567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272065	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000312483300010
J	Kao, YC; Jiang, SJ; Pan, WA; Wang, KC; Chen, PK; Wei, HJ; Chen, WS; Chang, BI; Shi, GY; Wu, HL				Kao, Yuan-Chung; Jiang, Shinn-Jong; Pan, Wen-An; Wang, Kuan-Chieh; Chen, Po-Ku; Wei, Hsi-Ju; Chen, Wei-Sheng; Chang, Bi-Ing; Shi, Guey-Yueh; Wu, Hua-Lin			The Epidermal Growth Factor-like Domain of CD93 Is a Potent Angiogenic Factor	PLOS ONE			English	Article							LECTIN-LIKE RECEPTOR; ENDOTHELIAL-CELLS; C1Q-MEDIATED ENHANCEMENT; AA4 ANTIGEN; IN-VITRO; C1QR(P); PHAGOCYTOSIS; SURFACE; THROMBOMODULIN; EXPRESSION	Human CD93, an epidermal growth factor (EGF)-like domain containing transmembrane protein, is predominantly expressed in the vascular endothelium. Studies have shown that AA4, the homolog of CD93 in mice, may mediate cell migration and angiogenesis in endothelial cells. Soluble CD93 has been detected in the plasma of healthy individuals. However, the role of soluble CD93 in the endothelium remains unclear. Recombinant soluble CD93 proteins with EGF-like domains (rCD93D123, with domains 1, 2, and 3; and rCD93D23, with domains 2 and 3) were generated to determine their functions in angiogenesis. We found that rCD93D23 was more potent than rCD93D123 in stimulating the proliferation and migration of human umbilical vein endothelial cells (HUVECs). Production of matrix-metalloproteinase 2 increased after the HUVECs were treated with rCD93D23. Further, in a tube formation assay, rCD93D23 induced cell differentiation of HUVECs through phosphoinositide 3-kinase/Akt/endothelial nitric oxide synthase and extracellular signal-regulated kinases-1/2 signaling. Moreover, rCD93D23 promoted blood vessel formation in a Matrigel-plug assay and an oxygen-induced retinopathy model in vivo. Our findings suggest that the soluble EGF-like domain containing CD93 protein is a novel angiogenic factor acting on the endothelium.	[Kao, Yuan-Chung; Jiang, Shinn-Jong; Pan, Wen-An; Wang, Kuan-Chieh; Chen, Po-Ku; Wei, Hsi-Ju; Chen, Wei-Sheng; Chang, Bi-Ing; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Kao, Yuan-Chung; Jiang, Shinn-Jong; Pan, Wen-An; Wang, Kuan-Chieh; Chen, Po-Ku; Wei, Hsi-Ju; Chen, Wei-Sheng; Chang, Bi-Ing; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Cardiovasc Res Ctr, Tainan 70101, Taiwan; [Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Shi, GY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	gyshi@mail.ncku.edu.tw; halnwu@mail.ncku.edu.tw			National Science Council [NSC99-2323-B-006-003]; National Cheng Kung University through the Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Cheng Kung University through the Ministry of Education, Taiwan	This work was supported by the National Science Council grant NSC99-2323-B-006-003 and a grant from the "Aim for the Top University Plan" of the National Cheng Kung University through the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlson SS, 2005, J IMMUNOL, V175, P1239, DOI 10.4049/jimmunol.175.2.1239; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chung BH, 2009, PHYTOTHER RES; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Danet GH, 2002, P NATL ACAD SCI USA, V99, P10441, DOI 10.1073/pnas.162104799; Dean YD, 2000, J BIOL CHEM, V275, P34382, DOI 10.1074/jbc.M006229200; Dean YD, 2001, EUR J IMMUNOL, V31, P1370, DOI 10.1002/1521-4141(200105)31:5<1370::AID-IMMU1370>3.0.CO;2-B; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Fonseca MI, 2001, J LEUKOCYTE BIOL, V70, P793; Garg P, 2011, AM J PHYSIOL-LUNG C, V301, pL79, DOI 10.1152/ajplung.00287.2010; Greenlee MC, 2009, INFLAMM RES, V58, P909, DOI 10.1007/s00011-009-0064-0; GUAN E, 1994, J IMMUNOL, V152, P4005; Ikewaki N, 2007, MICROBIOL IMMUNOL, V51, P1189, DOI 10.1111/j.1348-0421.2007.tb04014.x; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kanno Y, 2006, J THROMB HAEMOST, V4, P1602, DOI 10.1111/j.1538-7836.2006.01978.x; Koch AE, 2000, ANN RHEUM DIS, V59, P65, DOI 10.1136/ard.59.suppl_1.i65; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; Kuo CH, 2012, BLOOD, V119, P1302, DOI 10.1182/blood-2011-08-376038; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Lee OH, 2000, BRIT J CANCER, V82, P385; Maharjan S, 2011, EUR J PHARMACOL, V657, P35, DOI 10.1016/j.ejphar.2011.01.040; Malarstig A, 2011, J INTERN MED, V270, P229, DOI 10.1111/j.1365-2796.2011.02364.x; McGreal EP, 2002, J IMMUNOL, V168, P5222, DOI 10.4049/jimmunol.168.10.5222; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; Nepomuceno RR, 1998, J IMMUNOL, V160, P1929; Nepomuceno RR, 1999, J IMMUNOL, V162, P3583; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; Park CC, 2001, J IMMUNOL, V167, P1644, DOI 10.4049/jimmunol.167.3.1644; Park M, 2003, J CELL PHYSIOL, V196, P512, DOI 10.1002/jcp.10332; PASSANITI A, 1992, LAB INVEST, V67, P519; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267; Shi CS, 2005, CIRCULATION, V111, P1627, DOI 10.1161/01.CIR.0000160364.05405.B5; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648	35	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51647	10.1371/journal.pone.0051647	http://dx.doi.org/10.1371/journal.pone.0051647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272129	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300020
J	Ma, L; Makino, Y; Yamaza, H; Akiyama, K; Hoshino, Y; Song, GT; Kukita, T; Nonaka, K; Shi, ST; Yamaza, T				Ma, Lan; Makino, Yusuke; Yamaza, Haruyoshi; Akiyama, Kentaro; Hoshino, Yoshihiro; Song, Guangtai; Kukita, Toshio; Nonaka, Kazuaki; Shi, Songtao; Yamaza, Takayoshi			Cryopreserved Dental Pulp Tissues of Exfoliated Deciduous Teeth Is a Feasible Stem Cell Resource for Regenerative Medicine	PLOS ONE			English	Article							HUMAN BONE-MARROW; SYSTEMIC-LUPUS-ERYTHEMATOSUS; UMBILICAL-CORD BLOOD; STEM/PROGENITOR CELLS; PROGENITOR CELLS; APICAL PAPILLA; STROMAL CELLS; IN-VITRO; RECOVERY; MICE	Human exfoliated deciduous teeth have been considered to be a promising source for regenerative therapy because they contain unique postnatal stem cells from human exfoliated deciduous teeth (SHED) with self-renewal capacity, multipotency and immunomodulatory function. However preservation technique of deciduous teeth has not been developed. This study aimed to evaluate that cryopreserved dental pulp tissues of human exfoliated deciduous teeth is a retrievable and practical SHED source for cell-based therapy. SHED isolated from the cryopreserved deciduous pulp tissues for over 2 years (25-30 months) (SHED-Cryo) owned similar stem cell properties including clonogenicity, self-renew, stem cell marker expression, multipotency, in vivo tissue regenerative capacity and in vitro immunomodulatory function to SHED isolated from the fresh tissues (SHED-Fresh). To examine the therapeutic efficacy of SHED-Cryo on immune diseases, SHED-Cryo were intravenously transplanted into systemic lupus erythematosus (SLE) model MRL/lpr mice. Systemic SHED-Cryo-transplantation improved SLE-like disorders including short lifespan, elevated autoantibody levels and nephritis-like renal dysfunction. SHED-Cryo amended increased interleukin 17-secreting helper T cells in MRL/lpr mice systemically and locally. SHED-Cryo-transplantation was also able to recover osteoporosis bone reduction in long bones of MRL/lpr mice. Furthermore, SHED-Cryo-mediated tissue engineering induced bone regeneration in critical calvarial bone-defect sites of immunocompromised mice. The therapeutic efficacy of SHED-Cryo transplantation on immune and skeletal disorders was similar to that of SHED-Fresh. These data suggest that cryopreservation of dental pulp tissues of deciduous teeth provide a suitable and desirable approach for stem cell-based immune therapy and tissue engineering in regenerative medicine. Citation: Ma L, Makino Y, Yamaza H, Akiyama K, Hoshino Y, et al. (2012) Cryopreserved Dental Pulp Tissues of Exfoliated Deciduous Teeth Is a Feasible Stem Cell Resource for Regenerative Medicine. PLoS ONE 7(12): e51777. doi:10.1371/journal.pone.0051777	[Ma, Lan; Makino, Yusuke; Kukita, Toshio; Yamaza, Takayoshi] Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 812, Japan; [Ma, Lan; Yamaza, Haruyoshi; Hoshino, Yoshihiro; Nonaka, Kazuaki] Kyushu Univ, Grad Sch Dent Sci, Dept Pediat Dent, Fukuoka 812, Japan; [Akiyama, Kentaro; Shi, Songtao] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent USC, Los Angeles, CA 90033 USA; [Song, Guangtai] Wuhan Univ, Sch Stomatol, Dept Pedodont, Wuhan 430072, Peoples R China	Kyushu University; Kyushu University; University of Southern California; Wuhan University	Yamaza, T (corresponding author), Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 812, Japan.	yamazata@dent.kyushu-u.ac.jp	Yamaza, Haruyoshi/AAD-4011-2019	Yamaza, Haruyoshi/0000-0003-1138-3943; Yamaza, Takayoshi/0000-0001-7055-3370	Ministry of Education, Culture, Sports, Science and Technology of Japan for Challenging Exploratory Research Project [24659815, 23659967]; Young Scientists of Japan Society for Promotion of Science [20790260]; National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, USA [R01DE17449, R01DE019156]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019156, R01DE017449] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24592806] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan for Challenging Exploratory Research Project; Young Scientists of Japan Society for Promotion of Science; National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, USA; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grants from Ministry of Education, Culture, Sports, Science and Technology of Japan for Challenging Exploratory Research Project (no. 24659815 to TY and no. 23659967 to KN) and for Young Scientists (B) (no. 20790260 to HY) of Japan Society for Promotion of Science and from National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, USA (R01DE17449 and R01DE019156 to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; AREMAN EM, 1990, BONE MARROW TRANSPL, V6, P203; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; Danjo A, 2007, BIOCHEM BIOPH RES CO, V360, P199, DOI 10.1016/j.bbrc.2007.06.028; Ding G, 2010, J CELL PHYSIOL, V223, P415, DOI 10.1002/jcp.22050; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19; Garvin G, 2007, CLIN ORTHOD RELAT RE, V465, P202; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hubel A, 1997, TRANSFUS MED REV, V11, P224, DOI 10.1053/tmrv.1997.0110224; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Kwan MD, 2008, HUM MOL GENET, V17, pR93, DOI 10.1093/hmg/ddn071; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Lizier NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039885; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Miura Y, 2006, STEM CELLS, V24, P2428, DOI 10.1634/stemcells.2006-0089; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Nourbakhsh N, 2011, INT J DEV BIOL, V55, P189, DOI 10.1387/ijdb.103090nn; Panetta NJ, 2009, PANMINERVA MED, V51, P25; Perry BC, 2008, TISSUE ENG PART C-ME, V14, P149, DOI 10.1089/ten.tec.2008.0031; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Sakai VT, 2010, J DENT RES, V89, P791, DOI 10.1177/0022034510368647; Seo BM, 2008, ORAL DIS, V14, P428, DOI 10.1111/j.1601-0825.2007.01396.x; Seo BM, 2005, J DENT RES, V84, P907, DOI 10.1177/154405910508401007; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; Watt Suzanne M, 2007, Methods Mol Biol, V368, P237; Woods EJ, 2004, CRYOBIOLOGY, V48, P146, DOI 10.1016/j.cryobiol.2004.03.002; Woods EJ, 2007, TRANSFUS MED HEMOTH, V34, P276, DOI 10.1159/000104183; Yamaza T, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt5; Yamaza T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002615; Yamaza T, 2009, BLOOD, V113, P2595, DOI 10.1182/blood-2008-10-182246; Yang J, 2011, RHEUMATOLOGY, V50, P1366, DOI 10.1093/rheumatology/ker116; Zhao ZG, 2008, CANCER INVEST, V26, P391, DOI 10.1080/07357900701788049; Zheng Y, 2012, J DENT RES, V91, P676, DOI 10.1177/0022034512449834; Zheng Y, 2009, J DENT RES, V88, P249, DOI 10.1177/0022034509333804; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	53	94	105	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51777	10.1371/journal.pone.0051777	http://dx.doi.org/10.1371/journal.pone.0051777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251621	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800084
J	McLernon, DJ; Dillon, JF; Sullivan, FM; Roderick, P; Rosenberg, WM; Ryder, SD; Donnan, PT				McLernon, David J.; Dillon, John F.; Sullivan, Frank M.; Roderick, Paul; Rosenberg, William M.; Ryder, Stephen D.; Donnan, Peter T.			The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI)	PLOS ONE			English	Article							RECORD-LINKAGE; DISEASE; MODEL; RISK; SURVIVAL; POPULATION; EPIDEMIOLOGY; VALIDATION; PROGNOSIS; METFORMIN	Background: Although liver function tests (LFTs) are routinely measured in primary care, raised levels in patients with no obvious liver disease may trigger a range of subsequent expensive and unnecessary management plans. The aim of this study was to develop and validate a prediction model to guide decision-making by general practitioners, which estimates risk of one year all-cause mortality in patients with no obvious liver disease. Methods: In this population-based historical cohort study, biochemistry data from patients in Tayside, Scotland, with LFTs performed in primary care were record-linked to secondary care and prescription databases to ascertain baseline characteristics, and to mortality data. Using this derivation cohort a survival model was developed to predict mortality. The model was assessed for calibration, discrimination (using the C-statistic) and performance, and validated using a separate cohort of Scottish primary care practices. Results: From the derivation cohort (n = 95 977), 2.7% died within one year. Predictors of mortality included: age; male gender; social deprivation; history of cancer, renal disease, stroke, ischaemic heart disease or respiratory disease; statin use; and LFTs (albumin, transaminase, alkaline phosphatase, bilirubin, and gamma-glutamyltransferase). The C-statistic for the final model was 0.82 (95% CI 0.80-0.84), and was similar in the validation cohort (n = 11 653) 0.86 (0.79-0.90). As an example of performance, for a 10% predicted probability cut-off, sensitivity = 52.8%, specificity = 94.0%, PPV = 21.0%, NPV = 98.5%. For the model without LFTs the respective values were 43.8%, 92.8%, 15.6%, 98.1%. Conclusions: The Algorithm for Liver Function Investigations (ALFI) is the first model to successfully estimate the probability of all-cause mortality in patients with no apparent liver disease having LFTs in primary care. While LFTs added to the model's discrimination and sensitivity, the clinical utility of ALFI remains to be established since LFTs did not improve an already high NPV for short term mortality and only modestly improved a very low PPV. Citation: McLernon DJ, Dillon JF, Sullivan FM, Roderick P, Rosenberg WM, et al. (2012) The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI). PLoS ONE 7(12): e50965. doi:10.1371/journal.pone.0050965	[McLernon, David J.] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland; [Dillon, John F.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Sullivan, Frank M.; Donnan, Peter T.] Univ Dundee, Med Res Inst, Div Populat Hlth Sci, Dundee, Scotland; [Roderick, Paul] Univ Southampton, Fac Med, Acad Unit Primary Care & Populat Sci, Southampton SO9 5NH, Hants, England; [Rosenberg, William M.] UCL, Div Med, Ctr Hepatol, London, England; [Rosenberg, William M.] UCL, ULCH UCL NIHR Biomed Res Ctr, London, England; [Ryder, Stephen D.] Nottingham Univ Hosp NHS Trust, Dept Gastroenterol, Nottingham, England; [Ryder, Stephen D.] Biomed Res Unit, Nottingham, England	University of Aberdeen; University of Dundee; University of Dundee; University of Southampton; University of London; University College London; University of London; University College London; Nottingham University Hospital NHS Trust	McLernon, DJ (corresponding author), Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland.	d.mclernon@abdn.ac.uk	Rosenberg, William/ABA-1071-2021; McLernon, David/D-5167-2012; Sullivan, Frank/L-8286-2019	Rosenberg, William/0000-0002-2732-2304; McLernon, David/0000-0001-8905-2429; Sullivan, Frank/0000-0002-6623-4964; Donnan, Peter/0000-0001-7828-0610; Ryder, Stephen David/0000-0001-9649-4444; Dillon, John/0000-0002-2164-4476	National Health Service Research & Development Programme Health Technology Assessment Programme [03/38/02]; Backett Weir Russell Career Development Fellowship; UK National Health Service Research & Development Programme Health Technology Assessment Programme; National Institute for Health Research [03/38/02] Funding Source: researchfish	National Health Service Research & Development Programme Health Technology Assessment Programme; Backett Weir Russell Career Development Fellowship; UK National Health Service Research & Development Programme Health Technology Assessment Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Health Service Research & Development Programme Health Technology Assessment Programme (project number 03/38/02) and the Backett Weir Russell Career Development Fellowship. Department of Health Disclaimer: The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: DJM (while employed by the University of Dundee), PTD, JFD, and FMS declare financial support to their institutions for the submitted work from the UK National Health Service Research & Development Programme Health Technology Assessment Programme. DJM declares financial support to his institution for the submitted work from the Backett Weir Russell Career Development Fellowship. SR received reimbursement of travel costs to attend study meetings from the UK National Health Service Research & Development Programme Health Technology Assessment Programme grant. PR and WMR have no competing interests to declare.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Armstrong MJ, 2012, J HEPATOL, V56, P234, DOI 10.1016/j.jhep.2011.03.020; CARSTAIRS V, 1989, COMMUNITY MED, V11, P210, DOI 10.1093/oxfordjournals.pubmed.a042469; Chambless LE, 2011, STAT MED, V30, P22, DOI 10.1002/sim.4026; Clinical Practice Research Datalink, 2012, WELCOME TO THE CLINI; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Donnan PT, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13250; Donnan PT, 2008, ARCH INTERN MED, V168, P1416, DOI 10.1001/archinte.168.13.1416; Donnan PT, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-54; Donnan PT, 2004, BRIT MED J, V328, P1297, DOI 10.1136/bmj.328.7451.1297; Donnan PT, 2009, HEALTH TECHNOL ASSES, V13, pix; Dorans K, 2009, NAT MED, V15, P226, DOI 10.1038/nm0309-226a; Evans JMM, 1999, BRIT J CLIN PHARMACO, V47, P105, DOI 10.1046/j.1365-2125.1999.00853.x; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; McLernon DJ, 2009, FAM PRACT, V26, P251, DOI 10.1093/fampra/cmp025; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524; NHS National Services Scotland, 2012, SMR01 GENERAL ACUTE; NHS National Services Scotland, 2011, GENERAL PRACTICE PRA; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Roderick P, 2004, BMJ-BRIT MED J, V328, P987, DOI 10.1136/bmj.328.7446.987; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Rubin DB, 2004, MULTIPLE IMPUTATION; Schalk BWM, 2006, AM J EPIDEMIOL, V164, P969, DOI 10.1093/aje/kwj312; Sherwood P, 2001, BRIT MED J, V322, P276, DOI 10.1136/bmj.322.7281.276; SORENSEN HT, 1991, DAN MED BULL, V38, P420; Soriano S, 2007, CLIN NEPHROL, V67, P352; Steinke DT, 2002, J BIOMED INFORM, V35, P186, DOI 10.1016/S1532-0464(02)00526-9; Steinke DT, 2002, GUT, V50, P100, DOI 10.1136/gut.50.1.100; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Steyerberg E., 2009, CLIN PREDICTION MODE; Swierczynski J, 2009, OBES SURG, V19, P883, DOI 10.1007/s11695-008-9521-z; Theal RM, 1996, AM FAM PHYSICIAN, V53, P2111; University of Aberdeen, PRIMARY CARE CLINICA; University of Dundee, 2012, HEALTH INFORMATICS C; Zhang ZJ, 2012, J CLIN ENDOCR METAB, V97, P2347, DOI 10.1210/jc.2012-1267; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50965	10.1371/journal.pone.0050965	http://dx.doi.org/10.1371/journal.pone.0050965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272082	Green Accepted, Green Published, gold			2022-12-27	WOS:000312386800023
J	Tu, HF; Liu, CJ; Chang, CL; Wang, PW; Kao, SY; Yang, CC; Yu, EH; Lin, SC; Chang, KW				Tu, Hsi-Feng; Liu, Chung-Ji; Chang, Che-Lun; Wang, Pei-Wen; Kao, Shou-Yen; Yang, Cheng-Chieh; Yu, En-Hao; Lin, Shu-Chun; Chang, Kuo-Wei			The Association between Genetic Polymorphism and the Processing Efficiency of miR-149 Affects the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							GASTRIC-CANCER; MICRORNA; EXPRESSION; RISK; APOPTOSIS; SURVIVAL; LIN28; URIDYLATION; VARIANTS; TONGUE	MicroRNAs (miRNAs) play important roles in modulating the neoplastic process of cancers including head and neck squamous cell carcinoma (HNSCC). A genetic polymorphism (rs2292832, C.T) has been recently identified in the precursor of miR-149; nevertheless its clinicopathological implications remain obscure. In this study, we showed that miR-149 is down-regulated in HNSCC compared to normal mucosa and this is associated with a poorer patient survival. In addition, HNSCC patients with the T/T genotype have more advanced tumors and a worse prognosis. Multivariate analysis indicated that patients carried the T/T genotype have a 2.81-fold (95% CI: 1.58-4.97) increased risk of nodal metastasis and 1.66-fold (95% CI: 1.05-2.60) increased risk of mortality compared to other groups. T/T genotype also predicted the worse prognosis of buccal mucosa carcinoma subset of HNSCC. In vitro analysis indicated that exogenous miR-149 expression reduces the migration of HNSCC cells. Moreover, HNSCC cell subclones carrying the pri-mir-149 sequence containing the T variant show a low processing efficacy when converting the pre-mir-149 to mature miR-149. These findings suggest that miR-149 suppresses tumor cell mobility, and that the pre-mir-149 polymorphism may affect the processing of miR-149, resulting in a change in the abundance of the mature form miRNA, which, in turn, modulates tumor progression and patient survival. Citation: Tu H-F, Liu C-J, Chang C-L, Wang P-W, Kao S-Y, et al. (2012) The Association between Genetic Polymorphism and the Processing Efficiency of miR-149 Affects the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. PLoS ONE 7(12): e51606. doi:10.1371/journal.pone.0051606	[Kao, Shou-Yen; Yang, Cheng-Chieh; Lin, Shu-Chun; Chang, Kuo-Wei] Taipei Vet Gen Hosp, Dept Stomatol, Taipei, Taiwan; [Wang, Pei-Wen; Lin, Shu-Chun] Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan; [Tu, Hsi-Feng; Liu, Chung-Ji; Kao, Shou-Yen; Yang, Cheng-Chieh; Yu, En-Hao; Lin, Shu-Chun; Chang, Kuo-Wei] Natl Yang Ming Univ, Dept Dent, Taipei 112, Taiwan; [Tu, Hsi-Feng; Yu, En-Hao] Natl Yang Ming Univ Hosp, Dept Dent, Ilan, Taiwan; [Liu, Chung-Ji; Chang, Che-Lun] MacKay Mem Hosp, Dept Oral & Maxillofacial Surg, Taipei, Taiwan; [Liu, Chung-Ji] MacKay Med Coll, New Taipei City, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College	Lin, SC (corresponding author), Taipei Vet Gen Hosp, Dept Stomatol, Taipei, Taiwan.	sclin@ym.edu.tw; ckcw@ym.edu.tw			National Yang Ming University Hospital [RD2010-003]; National Science Council in Taiwan [NSC98-2314-B-010-017-MY2, NSC-99-2628-B-195-002-MY3, NSC-99-2628-B-010-012-MY3]	National Yang Ming University Hospital; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from National Yang Ming University Hospital (RD2010-003) and National Science Council (NSC98-2314-B-010-017-MY2; NSC-99-2628-B-195-002-MY3, NSC-99-2628-B-010-012-MY3) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; [Anonymous], 2011, MOL CARCINOG; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030585; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hoffman AE, 2009, CANC RES; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hung PS, 2008, J PERIODONTAL RES, V43, P673, DOI 10.1111/j.1600-0765.2007.01070.x; Hung PS, 2012, ORAL ONCOL, V48, P404, DOI 10.1016/j.oraloncology.2011.11.019; Jeong Chang-hee, 2009, Journal of Periodontal & Implant Science, V39, P253; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Li D, 2011, OMICS, V15, P673, DOI 10.1089/omi.2011.0064; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031615; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu CJ, 2004, J ORAL PATHOL MED, V33, P327, DOI 10.1111/j.1600-0714.2004.00092.x; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lo WL, 2011, J PATHOL, V223, P482, DOI 10.1002/path.2826; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sharan RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042759; Shieh TM, 2007, CLIN CANCER RES, V13, P4378, DOI 10.1158/1078-0432.CCR-06-2685; Vinci S, 2011, CLIN CHEM LAB MED; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x	42	45	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51606	10.1371/journal.pone.0051606	http://dx.doi.org/10.1371/journal.pone.0051606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272122	Green Submitted, gold, Green Published			2022-12-27	WOS:000312386800056
J	Odafe, S; Torpey, K; Khamofu, H; Ogbanufe, O; Oladele, EA; Kuti, O; Adedokun, O; Badru, T; Okechukwu, E; Chabikuli, O				Odafe, Solomon; Torpey, Kwasi; Khamofu, Hadiza; Ogbanufe, Obinna; Oladele, Edward A.; Kuti, Oluwatosin; Adedokun, Oluwasanmi; Badru, Titilope; Okechukwu, Emeka; Chabikuli, Otto			The Pattern of Attrition from an Antiretroviral Treatment Program in Nigeria	PLOS ONE			English	Article							SOUTH-AFRICA; THERAPY; OUTCOMES; MORTALITY; ADULTS; CHALLENGES; TENOFOVIR; CHILDREN; SERVICE; INCOME	Objective: To evaluate the rate and factors associated with attrition of patients receiving ART in tertiary and secondary hospitals in Nigeria. Methods and Findings: We reviewed patient level data collected between 2007 and 2010 from 11 hospitals across Nigeria. Kaplan-Meier product-limit and Cox regression were used to determine probability of retention in care and risk factors for attrition respectively. Of 6,408 patients in the cohort, 3,839 (59.9%) were females, median age of study population was 33years (IQR: 27-40) and 4,415 (69%) were from secondary health facilities. The NRTI backbone was Stavudine (D4T) in 3708 (57.9%) and Zidovudine (ZDV) in 2613 (40.8%) of patients. Patients lost to follow up accounted for 62.7% of all attrition followed by treatment stops (25.3%) and deaths (12.0%). Attrition was 14.1 (N = 624) and 15.1% (N = 300) in secondary and tertiary hospitals respectively (p = 0.169) in the first 12 months on follow up. During the 13 to 24 months follow up period, attrition was 10.7% (N = 407) and 19.6% (N = 332) in secondary and tertiary facilities respectively (p<0.001). Median time to lost to follow up was 11.1 (IQR: 6.1 to 18.5) months in secondary compared with 13.6 (IQR: 9.9 to 17.0) months in tertiary sites (p = 0.002). At 24 months follow up, male gender [AHR 1.18, 95% CI: 1.01-1.37, P = 0.038]; WHO clinical stage III [AHR 1.30, 95%CI: 1.03-1.66, P = 0.03] and clinical stage IV [AHR 1.90, 95%CI: 1.20-3.02, p = 0.007] and care in a tertiary hospital [AHR 2.21, 95% CI: 1.83-2.67, p<0.001], were associated with attrition. Conclusion: Attrition could potentially be reduced by decentralizing patients on ART after the first 12 months on therapy to lower level facilities, earlier initiation on treatment and strengthening adherence counseling amongst males. Citation: Odafe S, Torpey K, Khamofu H, Ogbanufe O, Oladele EA, et al. (2012) The Pattern of Attrition from an Antiretroviral Treatment Program in Nigeria. PLoS ONE 7(12): e51254. doi:10.1371/journal.pone.0051254	[Odafe, Solomon; Torpey, Kwasi; Khamofu, Hadiza; Ogbanufe, Obinna; Oladele, Edward A.; Kuti, Oluwatosin] Prevent Care & Treatment Dept, Abuja, Nigeria; [Adedokun, Oluwasanmi; Badru, Titilope] Monitoring & Evaluat Dept, Abuja, Nigeria; [Okechukwu, Emeka] HIV AIDS TB Unit USAID Nigeria, Abuja, Nigeria; [Chabikuli, Otto] Med Univ Southern Africa, Dept Family Med, Medusa, South Africa	Sefako Makgatho Health Sciences University	Odafe, S (corresponding author), Prevent Care & Treatment Dept, Abuja, Nigeria.	sfodafe@gmail.com	Odafe, Solomon/AAJ-2390-2020; Fazli, Ghazal/AAE-8320-2022; Okechukwu, Emeka Franklin/AAH-1130-2020	Oladele, Edward Adekola/0000-0003-4999-1397; Torpey, Kwasi/0000-0003-1628-2922; Adedokun, Oluwasanmi/0000-0002-4678-9735	FHI360's Global HIV/AIDS Initiative in Nigeria; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) [620-A-00-04-00122-00]	FHI360's Global HIV/AIDS Initiative in Nigeria; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this paper was provided by FHI360's Global HIV/AIDS Initiative in Nigeria with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) Cooperative Agreement No. 620-A-00-04-00122-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Castelnuovo B, 2011, JAIDS-J ACQ IMM DEF, V56, P59, DOI 10.1097/QAI.0b013e3181f5bd03; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Chi BH, 2010, JAIDS-J ACQ IMM DEF, V54, P63, DOI 10.1097/QAI.0b013e3181c6c65c; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Federal Ministry of Health (FMoH), 2007, NAT GUID HIV AIDS TR, P32; Federal Ministry of Health (FMoH), 2004, HLTH PLANN RES STAT; Federal Ministry of Health (FMoH), 2007, NAT GUID PAED HIV AI, p116to120; [Federal Ministry of Health (FMOH) National AIDS/STI Control Programme (NASCP)], 2007, INTRODUCTION, P12; Mateo MG, 2012, EXPERT OPIN DRUG SAF, V11, P473, DOI 10.1517/14740338.2012.676639; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Minga A, 2010, AIDS RES HUM RETROV, V26, P991, DOI 10.1089/aid.2009.0309; National Agency for the Control of AIDS (NACA), 2007, STRAT PLANN RES, P20; National agency for the control of AIDS (NACA), 2010, POL STRAT, P82; O'Brien DP, 2006, AIDS, V20, P1955, DOI 10.1097/01.aids.0000247117.66585.ce; Odafe S, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17424; Ratsela A, 2010, J INFECT DIS, V202, P1529, DOI 10.1086/656718; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rouet F, 2006, AIDS, V20, P2315, DOI 10.1097/QAD.0b013e328010943b; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tayler-Smith K, 2011, TROPICAL MED INT HLT, P16; UNAIDS, 2009, HIV AIDS EST NIG; UNAIDS, 2009, EP FACTSH; Unge C, 2008, AIDS CARE, V20, P146, DOI 10.1080/09540120701513677; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; VERDUGO RM, 2007, FARM HOSP, V31, P200; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; WHO UNAIDS UNICEF, 2010, URB HEARTION, P4; World Health Organization (WHO) HIV/AIDS, 2006, PAT MON GUID HIV CAR, P30	40	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51254	10.1371/journal.pone.0051254	http://dx.doi.org/10.1371/journal.pone.0051254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272094	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600021
J	Xue, FM; Zhang, HP; Hao, HJ; Shi, ZY; Zhou, C; Feng, BS; Yang, PC				Xue, Fu-Min; Zhang, Huan-Ping; Hao, Hui-Jie; Shi, Zhao-Yang; Zhou, Chuan; Feng, Baisui; Yang, Ping-Chang			CD98 Positive Eosinophils Contribute to T Helper 1 Pattern Inflammation	PLOS ONE			English	Article							BOWEL-DISEASE; EPITHELIAL CD98; GALECTIN-3; ACTIVATION; MECHANISMS; ASTHMA; CELLS	Background and Aims: The pathogenesis of inflammatory bowel disease (IBD) has not been fully understood yet. Eosinophils (Eo) are one type of the major proinflammatory cells of the chronic inflammation in the intestine. CD98 is involved in the pathogenesis of a number of inflammations. This study aims to elucidate the role of CD98(+) Eos in the initiation of intestinal inflammation. Methods: The colon biopsies were collected from 60 patients with IBD. The expression of CD98 in the biopsies was examined by immunohistochemistry. The serum levels of the flagellin (FGN) antibody and Eo-derived mediators in the culture supernatants were assessed by enzyme-linked immunosorbent assay. The role of FGN on Eo activation was examined in a cell culture model. The role of FGN in the induction of colitis was observed in a mouse model. Results: Compared to normal controls, the frequency of CD98(+) Eos was markedly increased in the IBD colon mucosa. FGN were detected in the colon biopsies and in the sera of IBD patients. Exposure to FGN induced the expression of galectin 3 (the ligand of CD98) in dendritic cells. The exposure to galectin 3 activated the CD98(+) Eos. After treatment with FGN intrarectally, mice with eosinophilia showed severe inflammation in the colon. Conclusions: The interaction of galectin 3 and CD98 can induce Eos to release chemical mediators that contributes to the initiation of the intestinal inflammation.	[Zhang, Huan-Ping; Yang, Ping-Chang] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Xue, Fu-Min; Hao, Hui-Jie; Shi, Zhao-Yang; Zhou, Chuan; Feng, Baisui] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou, Peoples R China	McMaster University; Zhengzhou University	Yang, PC (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	yangp@mcmaster.ca	Yang, Ping-Chang/K-4669-2019		Natural Science Foundation of China [81070288]; Canadian Institutes of Health Research [191063, 220058, 177843]; Natural Sciences, Engineering Research Council of Canada (NSERC) [371268]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences, Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by grants from the Natural Science Foundation of China (#81070288), the Canadian Institutes of Health Research (#191063, #220058 and #177843), Natural Sciences, Engineering Research Council of Canada (NSERC, #371268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broide DH, 2011, J ALLERGY CLIN IMMUN, V127, P689, DOI 10.1016/j.jaci.2011.01.027; Chiu CG, 2010, AM J PATHOL, V176, P2067, DOI 10.2353/ajpath.2010.090353; Dalton P, 2007, FEBS J, V274, P2715, DOI 10.1111/j.1742-4658.2007.05806.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Hang TTN, 2011, J CLIN INVEST, V121, P1733, DOI 10.1172/JCI44631; Kargili AE, 2004, RHEUMATOL INT, V24, P321, DOI 10.1007/s00296-004-0469-6; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Kucharzik T, 2005, LAB INVEST, V85, P932, DOI 10.1038/labinvest.3700289; Lamouse-Smith Esi S N, 2006, Curr Gastroenterol Rep, V8, P390, DOI 10.1007/s11894-006-0024-6; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Motomura Y, 2010, AM J PHYSIOL-GASTR L, V299, pG1354, DOI 10.1152/ajpgi.00324.2010; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Peterson CGB, 2002, AM J GASTROENTEROL, V97, P1755; Podolsky DK, 2003, J GASTROENTEROL, V38, P63; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Qiu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022004; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Taha Y, 2001, DIGEST DIS SCI, V46, P888, DOI 10.1023/A:1010781224158; van Stijn CMW, 2009, MOL IMMUNOL, V46, P3292, DOI 10.1016/j.molimm.2009.07.026; von Wattenwyl F, 2001, EUR J GASTROEN HEPAT, V13, P721, DOI 10.1097/00042737-200106000-00018; Woodruff SA, 2011, J PEDIATR GASTR NUTR, V52, P650, DOI 10.1097/MPG.0b013e3182128512; Yan YT, 2008, BBA-GEN SUBJECTS, V1780, P1087, DOI 10.1016/j.bbagen.2008.06.007; Yanavitski Marat, 2011, Curr Heart Fail Rep, V8, P206, DOI 10.1007/s11897-011-0065-5	24	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51830	10.1371/journal.pone.0051830	http://dx.doi.org/10.1371/journal.pone.0051830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272174	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600042
J	Giljov, A; Karenina, K; Malashichev, Y				Giljov, Andrey; Karenina, Karina; Malashichev, Yegor			Does Bipedality Predict the Group-Level Manual Laterality in Mammals?	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; ORANGUTANS PONGO-PYGMAEUS; GORILLAS GORILLA-GORILLA; HAND PREFERENCES; CAPTIVE CHIMPANZEES; MOTOR LATERALITY; RIGHT-HANDEDNESS; GREAT APES; EVOLUTION; POSTURE	Background: Factors determining patterns of laterality manifestation in mammals remain unclear. In primates, the upright posture favours the expression of manual laterality across species, but may have little influence within a species. Whether the bipedalism acts the same in non-primate mammals is unknown. Our recent findings in bipedal and quadrupedal marsupials suggested that differences in laterality pattern, as well as emergence of manual specialization in evolution might depend on species-specific body posture. Here, we evaluated the hypothesis that the postural characteristics are the key variable shaping the manual laterality expression across mammalian species. Methodology/Principal Findings: We studied forelimb preferences in a most bipedal marsupial, brush-tailed bettong, Bettongia penicillata in four different types of unimanual behavior. The significant left-forelimb preference at the group level was found in all behaviours studied. In unimanual feeding on non-living food, catching live prey and nest-material collecting, all or most subjects were lateralized, and among lateralized bettongs a significant majority displayed left-forelimb bias. Only in unimanual supporting of the body in the tripedal stance the distribution of lateralized and non-lateralized individuals did not differ from chance. Individual preferences were consistent across all types of behaviour. The direction or the strength of forelimb preferences were not affected by the animals' sex. Conclusions/Significance: Our findings support the hypothesis that the expression of manual laterality depends on the species-typical postural habit. The interspecies comparison illustrates that in marsupials the increase of bipedality corresponds with the increase of the degree of group-level forelimb preference in a species. Thus, bipedalism can predict pronounced manual laterality at both intra-and interspecific levels in mammals. We also conclude that quadrupedal position in biped species can slightly hinder the expression of manual laterality, but the evoked biped position in quadrupedal species does not necessarily lead to the enhanced manifestation of manual laterality.	[Giljov, Andrey; Karenina, Karina; Malashichev, Yegor] St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia; [Malashichev, Yegor] St Petersburg State Univ, Dept Embryol, St Petersburg, Russia	Saint Petersburg State University; Saint Petersburg State University	Malashichev, Y (corresponding author), St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia.	malashichev@gmail.com	Giljov, Andrey/O-4755-2014; Karenina, Karina/B-9781-2012; Malashichev, Yegor/D-3511-2013	Giljov, Andrey/0000-0002-7533-1600; Karenina, Karina/0000-0001-8200-6876; Malashichev, Yegor/0000-0003-3813-5712	Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia" [P2379]	Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia"	This research was supported by the Federal Grant-in-Aid Program "Human Capital for Science and Education in Innovative Russia" (Governmental Contract No. P2379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annett M, 2002, HANDEDNESS BRAIN ASY; Austin NP, 2012, ANIM BEHAV, V83, P239, DOI 10.1016/j.anbehav.2011.10.033; Bisazza A, 1996, NATURE, V379, P408, DOI 10.1038/379408a0; Bisazza A, 2001, PHYSIOL BEHAV, V72, P575, DOI 10.1016/S0031-9384(01)00417-6; Blois-Heulin C, 2007, J COMP PSYCHOL, V121, P205, DOI 10.1037/0735-7036.121.2.205; Blois-Heulin C, 2006, AM J PRIMATOL, V68, P429, DOI 10.1002/ajp.20239; Braccini S, 2010, J HUM EVOL, V58, P234, DOI 10.1016/j.jhevol.2009.11.008; Brown C, 2011, BEHAV ECOL, V22, P1201, DOI 10.1093/beheco/arr114; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Chapelain A, 2006, BEHAV BRAIN RES, V173, P237, DOI 10.1016/j.bbr.2006.06.028; CLAPHAM PJ, 1995, ANIM BEHAV, V50, P73, DOI 10.1006/anbe.1995.0222; CLARK MM, 1993, DEV PSYCHOBIOL, V26, P185, DOI 10.1002/dev.420260402; Corbetta D, 2003, BEHAV BRAIN SCI, V26, P217; COREN S, 1977, SCIENCE, V198, P631, DOI 10.1126/science.335510; DODSON DL, 1992, AM J PRIMATOL, V26, P191, DOI 10.1002/ajp.1350260305; Faurie C, 2005, CURR ANTHROPOL, V46, P142, DOI 10.1086/427101; Fine ML, 1996, PHYSIOL BEHAV, V60, P753; Giljov A, BMC EVOL BI IN PRESS; Giljov AN, 2011, RUSSIAN ORNITHOLOGIC, V20, P1151, DOI 10.1016/j.cub.2015.05.043; Giljov A, 2012, ANIM BEHAV, V83, P525, DOI 10.1016/j.anbehav.2011.11.031; GUIARD Y, 1987, J MOTOR BEHAV, V19, P486; HARRIS LJ, 1989, CAN J PSYCHOL, V43, P369, DOI 10.1037/h0084228; Harrison RM, 2010, PRIMATES, V51, P251, DOI 10.1007/s10329-010-0191-9; Hook Michelle A., 2004, P325; HOPKINS WD, 1993, J COMP PSYCHOL, V107, P403, DOI 10.1037/0735-7036.107.4.403; HOPKINS WD, 1993, J COMP PSYCHOL, V107, P162, DOI 10.1037/0735-7036.107.2.162; Hopkins WD, 2005, INT J PRIMATOL, V26, P259, DOI 10.1007/s10764-005-2924-y; Hopkins WD, 2003, J COMP PSYCHOL, V117, P302, DOI 10.1037/0735-7036.117.3.302; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Hopkins WD, 2008, AM J PHYS ANTHROPOL, V137, P113, DOI 10.1002/ajpa.20834; Hopkins WD, 2006, PSYCHOL BULL, V132, P538, DOI 10.1037/0033-2909.132.4.538; Joly M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038228; Kear Benjamin P., 2008, P25, DOI 10.1007/978-1-4020-6997-0_2; Konerding WS, 2012, J COMP PSYCHOL, V126, P15, DOI 10.1037/a0024638; Malashichev YB, 2006, J COMP PSYCHOL, V120, P401, DOI 10.1037/0735-7036.120.4.401; McGreevy PD, 2007, LATERALITY, V12, P449, DOI 10.1080/13576500701275881; McGreevy PD, 2010, J VET BEHAV, V5, P318, DOI 10.1016/j.jveb.2010.05.001; McGrew W. C., 1994, HDB PSYCHOL ANTHR, P171; Megirian D, 1977, Ann N Y Acad Sci, V299, P197, DOI 10.1111/j.1749-6632.1977.tb41907.x; Milliken GW, 2005, J COMP PSYCHOL, V119, P430, DOI 10.1037/0735-7036.119.4.430; Murphy J, 2005, APPL ANIM BEHAV SCI, V91, P297, DOI 10.1016/j.applanim.2004.11.001; Niemitz C, 2010, NATURWISSENSCHAFTEN, V97, P241, DOI 10.1007/s00114-009-0637-3; OLSON DA, 1990, AM J PRIMATOL, V20, P83, DOI 10.1002/ajp.1350200203; Papademetriou E, 2005, J COMP PSYCHOL, V119, P33, DOI 10.1037/0735-7036.119.1.33; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; Rogers LJ, 2009, PHILOS T R SOC B, V364, P943, DOI 10.1098/rstb.2008.0225; ROGERS LJ, 1993, ANIM BEHAV, V45, P409, DOI 10.1006/anbe.1993.1049; SANFORD C, 1984, BRAIN BEHAV EVOLUT, V25, P217, DOI 10.1159/000118867; Scheumann M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-52; Sieg AE, 2010, BEHAV BRAIN RES, V206, P135, DOI 10.1016/j.bbr.2009.08.023; Skoyles JR, 2006, MED HYPOTHESES, V66, P1060, DOI 10.1016/j.mehy.2006.01.042; Stancher G, 2006, BEHAV BRAIN RES, V173, P315, DOI 10.1016/j.bbr.2006.06.023; STODART ELEANOR, 1966, CSIRO WILDLIFE RES, V11, P91; Szalay F. S., 1994, EVOLUTIONARY HIST MA; TONOOKA R, 1995, INT J PRIMATOL, V16, P17; TUTTLE R. H., 1986, APES WORLD THEIR SOC; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Ward Jeannette P., 1993, P43; Ward JP, 1995, CREATURES OF THE DARK, P293; Webster KN, 2003, J COMP PHYSIOL B, V173, P549, DOI 10.1007/s00360-003-0364-6; Wells DL, 2009, ANIM BEHAV, V78, P537, DOI 10.1016/j.anbehav.2009.06.010; Wells DL, 2003, BEHAV PROCESS, V61, P27, DOI 10.1016/S0376-6357(02)00161-4; Westergaard G C, 1997, Laterality, V2, P65, DOI 10.1080/135765097397657; Westergaard GC, 1998, J COMP PSYCHOL, V112, P55, DOI 10.1037//0735-7036.112.1.55; WINDSOR DE, 1971, J ZOOL, V163, P165, DOI 10.1111/j.1469-7998.1971.tb04530.x	65	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51583	10.1371/journal.pone.0051583	http://dx.doi.org/10.1371/journal.pone.0051583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251583	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200139
J	Mantri, CK; Dash, JP; Mantri, JV; Dash, CCV				Mantri, Chinmay K.; Dash, Jui Pandhare; Mantri, Jyoti Velamarti; Dash, Chandravanu C. V.			Cocaine Enhances HIV-1 Replication in CD4+T Cells by Down-Regulating MiR-125b	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD MONONUCLEAR-CELLS; MICRORNA EXPRESSION; DISEASE PROGRESSION; CRACK-COCAINE; NORMAL DONORS; DRUGS; ABUSE; INFECTION; CHEMOKINE	The main objective of this study was to examine effects of cocaine on HIV-1 replication in primary CD4+ T cells. Cocaine a commonly used drug among HIV-1 positive individuals serves as a cofactor for HIV-1 infection and progression to acquired immunodeficiency syndrome (AIDS). Accumulating evidence suggest that cocaine increases HIV-1 replication in cell cultures, peripheral blood mononuclear cells (PBMCs) and animal models. Intriguingly, there are no studies on cocaine-induced alterations in HIV-1 replication in primary CD4+ T cells that serve as the main targets for HIV-1 replication in vivo. In this report, we demonstrate cocaine-induced enhancement of HIV-1 replication in primary CD4+ T cells isolated from human PBMCs. To decipher a potential mechanism, we examined whether cocaine targets the innate antiviral immunity of CD4+ T cells mediated by cellular microRNAs (miRNAs). This is because recently a network of anti-HIV miRNAs in CD4+ T cells is highlighted to suppress viral replication. Our genome wide miRNA expression analysis indicated downregulation of several anti-HIV miRNAs (miR-28, miR-125b, miR-150, miR-223, and miR-382) in cocaine treated CD4+ T cells. However, our real-time quantitative PCR analysis revealed significant downregulation of miR-125b only. Our results illustrated that miR-125b knockdown enhances HIV-1 replication, whereas overexpression of miR-125b decreases HIV-1 replication in these cells. Therefore, we believe miR-125b is a key player for the cocaine induced enhancement of HIV-1 replication in CD4+ T cells. Since, miR-125b targets the 3' UTR regions of HIV-1 transcripts and inhibits viral protein translation, our data suggest modulation of post entry steps of HIV-1 by cocaine. Given that a plethora of studies suggest that cocaine regulates HIV entry, our results implicate a potentially novel mechanism by which cocaine can increase viral replication in CD4+ T cells.	[Mantri, Chinmay K.; Dash, Jui Pandhare; Mantri, Jyoti Velamarti; Dash, Chandravanu C. V.] Meharry Med Coll, Lab Retrovirol & Epigenet, Ctr AIDS Hlth Dispar Res, Vanderbilt Meharry Ctr AIDS Res,Dept Biochem & Ca, Nashville, TN 37208 USA	Meharry Medical College; Vanderbilt University	Dash, CCV (corresponding author), Meharry Med Coll, Lab Retrovirol & Epigenet, Ctr AIDS Hlth Dispar Res, Vanderbilt Meharry Ctr AIDS Res,Dept Biochem & Ca, Nashville, TN 37208 USA.	cdash@mmc.edu	Mantri, Chinmay Kumar Kumar/AAX-6509-2021; Mantri, Chinmay Kumar/N-2704-2017	Mantri, Chinmay Kumar/0000-0002-9682-368X; Dash, Chandravanu/0000-0003-4466-8355; Pandhare, Jui/0000-0002-0356-064X	National Institute on Drug Abuse/National Institutes of Health [DA024558, DA30896, DA033892]; Vanderbilt CTSA grant from NCRR/NIH [UL1 RR024975-01]; Meharry Translational Research Center (MeTRC) CTSA from NCRR/NIH [U54 RR026140]; Meharry Translational Research Center (MeTRC) CTSA from NIMHD/NIH [U54 MD007593]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978, UL1RR024975, U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033892, R00DA024558, R03DA030896] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	National Institute on Drug Abuse/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Vanderbilt CTSA grant from NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Meharry Translational Research Center (MeTRC) CTSA from NCRR/NIH; Meharry Translational Research Center (MeTRC) CTSA from NIMHD/NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work is partly supported by grants (DA024558, DA30896, DA033892) from National Institute on Drug Abuse/National Institutes of Health, the Vanderbilt CTSA grant UL1 RR024975-01 from NCRR/NIH, and the Meharry Translational Research Center (MeTRC) CTSA grant (U54 RR026140 from NCRR/NIH and U54 MD007593 from NIMHD/NIH to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; ANTHONY JC, 1991, AM J EPIDEMIOL, V134, P1175, DOI 10.1093/oxfordjournals.aje.a116021; BAGASRA O, 1993, J INFECT DIS, V168, P1157, DOI 10.1093/infdis/168.5.1157; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baum MK, 2009, JAIDS-J ACQ IMM DEF, V50, P93, DOI 10.1097/QAI.0b013e3181900129; Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20, DOI 10.1002/jlb.62.1.20; Cabral GA, 2006, J NEUROIMMUNE PHARM, V1, P280, DOI 10.1007/s11481-006-9023-5; CHAISSON RE, 1989, JAMA-J AM MED ASSOC, V261, P561, DOI 10.1001/jama.261.4.561; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chiang K, 2011, FUTURE VIROL, V6, P209, DOI 10.2217/FVL.10.92; CLOUSE KA, 1989, J IMMUNOL, V142, P431; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cook JA, 2008, AIDS, V22, P1355, DOI 10.1097/QAD.0b013e32830507f2; DONAHOE RM, 1988, ADV BIOCHEM PSYCHOPH, V44, P145; Duncan R, 2007, FRONT BIOSCI-LANDMRK, V12, P1488, DOI 10.2741/2162; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Friedman H, 1996, ADV EXP MED BIOL, V402, P225; Friedman H, 2006, FEMS IMMUNOL MED MIC, V47, P330, DOI 10.1111/j.1574-695X.2006.00097.x; GOEDERT JJ, 1984, ANN NY ACAD SCI, V437, P192, DOI 10.1111/j.1749-6632.1984.tb37137.x; Halpern JH, 2003, J CLIN ENDOCR METAB, V88, P1188, DOI 10.1210/jc.2002-020804; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Khalsa JH, 2004, J NEUROIMMUNOL, V147, P6, DOI 10.1016/j.jneuroim.2003.10.007; Kopnisky KL, 2007, BRAIN BEHAV IMMUN, V21, P428, DOI 10.1016/j.bbi.2007.01.011; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nair MPN, 2000, CLIN DIAGN LAB IMMUN, V7, P96, DOI 10.1128/CDLI.7.1.96-100.2000; Nair MPN, 2001, ADV EXP MED BIOL, V493, P235; PETERSON PK, 1991, J IMMUNOL, V146, P81; Reynolds JL, 2009, J CLIN IMMUNOL, V29, P646, DOI 10.1007/s10875-009-9309-5; Rofael HZ, 2003, TOXICOLOGY, V188, P101, DOI 10.1016/S0300-483X(03)00081-7; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Roth MD, 2002, J INFECT DIS, V185, P701, DOI 10.1086/339012; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; SIEGEL L, 1986, Journal of Substance Abuse Treatment, V3, P271, DOI 10.1016/0740-5472(86)90039-5; Stephens BG, 2004, AM J FOREN MED PATH, V25, P1, DOI 10.1097/01.paf.0000118960.58334.a9; Telesnitsky A., 1997, P121; VANDYKE C, 1976, SCIENCE, V191, P859, DOI 10.1126/science.56036; Wang X, 2011, AM J PATHOL, V178, P41, DOI 10.1016/j.ajpath.2010.11.042; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; WATZL B, 1990, LIFE SCI, V46, P1319, DOI 10.1016/0024-3205(90)90331-K; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	44	52	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51387	10.1371/journal.pone.0051387	http://dx.doi.org/10.1371/journal.pone.0051387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251514	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200099
J	Prasad, R; Atul; Soni, A; Puri, SK; Sijwali, PS				Prasad, Rajesh; Atul; Soni, Awakash; Puri, Sunil Kumar; Sijwali, Puran Singh			Expression, Characterization, and Cellular Localization of Knowpains, Papain-Like Cysteine Proteases of the Plasmodium knowlesi Malaria Parasite	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; RECOMBINANT FALCIPAIN-2; OOCYST PRODUCTION; INHIBITION; PROTEINASE; GENE; IDENTIFICATION; HEMOGLOBINASE; SPECIFICITY; INFECTIONS	Papain-like cysteine proteases of malaria parasites degrade haemoglobin in an acidic food vacuole to provide amino acids for intraerythrocytic parasites. These proteases are potential drug targets because their inhibitors block parasite development, and efforts are underway to develop chemotherapeutic inhibitors of these proteases as the treatments for malaria. Plasmodium knowlesi has recently been shown to be an important human pathogen in parts of Asia. We report expression and characterization of three P. knowlesi papain-like proteases, termed knowpains (KP2-4). Recombinant knowpains were produced using a bacterial expression system, and tested for various biochemical properties. Antibodies against recombinant knowpains were generated and used to determine their cellular localization in parasites. Inhibitory effects of the cysteine protease inhibitor E64 were assessed on P. knowlesi culture to validate drug target potential of knowpains. All three knowpains were present in the food vacuole, active in acidic pH, and capable of degrading haemoglobin at the food vacuolar pH (approximate to 5.5), suggesting roles in haemoglobin degradation. The proteases showed absolute (KP2 and KP3) to moderate (KP4) preference for peptide substrates containing leucine at the P2 position; KP4 preferred arginine at the P2 position. While the three knowpains appear to have redundant roles in haemoglobin degradation, KP4 may also have a role in degradation of erythrocyte cytoskeleton during merozoite egress, as it displayed broad substrate specificity and was primarily localized at the parasite periphery. Importantly, E64 blocked erythrocytic development of P. knowlesi, with enlargement of food vacuoles, indicating inhibition of haemoglobin hydrolysis and supporting the potential for inhibition of knowpains as a strategy for the treatment of malaria. Functional expression and characterization of knowpains should enable simultaneous screening of available cysteine protease inhibitor libraries against knowpains for developing broadly effective compounds active against multiple human malaria parasites.	[Prasad, Rajesh; Atul; Sijwali, Puran Singh] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India; [Soni, Awakash; Puri, Sunil Kumar] Cent Drug Res Inst, Div Parasitol, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Sijwali, PS (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India.	psijwali@ccmb.res.in	Prasad, Rajesh/O-4794-2019		Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants from the Department of Biotechnology (DBT) and the Council of Scientific and Industrial Research (CSIR), India. The funders did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Brooks SR, 2000, MOL BIOCHEM PARASIT, V106, P77, DOI 10.1016/S0166-6851(99)00201-7; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; Dhawan S, 2003, J BIOL CHEM, V278, P30180, DOI 10.1074/jbc.M305132200; DLUZEWSKI AR, 1986, EXP PARASITOL, V62, P416, DOI 10.1016/0014-4894(86)90050-0; Dua M, 2001, MOL BIOCHEM PARASIT, V116, P95, DOI 10.1016/S0166-6851(01)00306-1; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Eksi S, 2007, ANTIMICROB AGENTS CH, V51, P1064, DOI 10.1128/AAC.01012-06; Eksi S, 2004, MOL MICROBIOL, V53, P243, DOI 10.1111/j.1365-2958.2004.04108.x; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Ettari R, 2010, MED RES REV, V30, P136, DOI 10.1002/med.20163; Gelb MH, 2007, CURR OPIN CHEM BIOL, V11, P440, DOI 10.1016/j.cbpa.2007.05.038; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; HADLEY T, 1983, EXP PARASITOL, V55, P306, DOI 10.1016/0014-4894(83)90027-9; Hogg T, 2006, J BIOL CHEM, V281, P25425, DOI 10.1074/jbc.M603776200; Jeong JJ, 2006, BLOOD CELL MOL DIS, V36, P429, DOI 10.1016/j.bcmd.2006.02.003; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Kocken CHM, 2002, INFECT IMMUN, V70, P655, DOI 10.1128/IAI.70.2.655-660.2002; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; Marco M, 2012, CURR TOP MED CHEM, V12, P408, DOI 10.2174/156802612799362913; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; Muller IB, 2010, FUTURE MICROBIOL, V5, P1857, DOI 10.2217/FMB.10.136; Na BK, 2004, BIOCHEM J, V378, P529, DOI 10.1042/BJ20031487; Na BK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000849; Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694; Ramjee MK, 2006, BIOCHEM J, V399, P47, DOI 10.1042/BJ20060422; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Rosenthal PJ, 1996, ANTIMICROB AGENTS CH, V40, P1600, DOI 10.1128/AAC.40.7.1600; ROSENTHAL PJ, 1991, J CLIN INVEST, V88, P1467, DOI 10.1172/JCI115456; ROSENTHAL PJ, 1992, MOL BIOCHEM PARASIT, V51, P143, DOI 10.1016/0166-6851(92)90209-3; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; ROSENTHAL PJ, 1993, J CLIN INVEST, V91, P1052, DOI 10.1172/JCI116262; Rupp I, 2008, MOL BIOCHEM PARASIT, V158, P208, DOI 10.1016/j.molbiopara.2007.12.009; SALAS F, 1995, INFECT IMMUN, V63, P2120, DOI 10.1128/IAI.63.6.2120-2125.1995; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P8721, DOI 10.1073/pnas.0402738101; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Singh A, 2002, BIOCHEM J, V368, P273, DOI 10.1042/BJ20020753; Singh A, 2007, PROTEIN ENG DES SEL, V20, P171, DOI 10.1093/protein/gzm009; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh N, 2006, EXP PARASITOL, V112, P187, DOI 10.1016/j.exppara.2005.10.007; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Subramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005156; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; WHO, 2011, WORLD MALARIA REPORT 2011, P1	55	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51619	10.1371/journal.pone.0051619	http://dx.doi.org/10.1371/journal.pone.0051619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251596	gold, Green Submitted, Green Published			2022-12-27	WOS:000313236200148
J	Seidl, MF; Wang, RP; Van den Ackerveken, G; Govers, F; Snel, B				Seidl, Michael F.; Wang, Rui-Peng; Van den Ackerveken, Guido; Govers, Francine; Snel, Berend			Bioinformatic Inference of Specific and General Transcription Factor Binding Sites in the Plant Pathogen Phytophthora infestans	PLOS ONE			English	Article							TATA BOX; REGULATORY ELEMENTS; GENOME SEQUENCES; PROMOTER; IDENTIFICATION; INITIATOR; MANNITOL; NETWORK; ARCHITECTURE; RECOGNITION	Plant infection by oomycete pathogens is a complex process. It requires precise expression of a plethora of genes in the pathogen that contribute to a successful interaction with the host. Whereas much effort has been made to uncover the molecular systems underlying this infection process, mechanisms of transcriptional regulation of the genes involved remain largely unknown. We performed the first systematic de-novo DNA motif discovery analysis in Phytophthora. To this end, we utilized the genome sequence of the late blight pathogen Phytophthora infestans and two related Phytophthora species (P. ramorum and P. sojae), as well as genome-wide in planta gene expression data to systematically predict 19 conserved DNA motifs. This catalog describes common eukaryotic promoter elements whose functionality is supported by the presence of orthologs of known general transcription factors. Together with strong functional enrichment of the common promoter elements towards effector genes involved in pathogenicity, we obtained a new and expanded picture of the promoter structure in P. infestans. More intriguingly, we identified specific DNA motifs that are either highly abundant or whose presence is significantly correlated with gene expression levels during infection. Several of these motifs are observed upstream of genes encoding transporters, RXLR effectors, but also transcriptional regulators. Motifs that are observed upstream of known pathogenicity-related genes are potentially important binding sites for transcription factors. Our analyses add substantial knowledge to the as of yet virtually unexplored question regarding general and specific gene regulation in this important class of pathogens. We propose hypotheses on the effects of cis-regulatory motifs on the gene regulation of pathogenicity-related genes and pinpoint motifs that are prime targets for further experimental validation.	[Seidl, Michael F.; Wang, Rui-Peng; Van den Ackerveken, Guido; Snel, Berend] Univ Utrecht, Dept Biol, Utrecht, Netherlands; [Seidl, Michael F.; Van den Ackerveken, Guido; Govers, Francine; Snel, Berend] Ctr BioSyst Genom, Wageningen, Netherlands; [Wang, Rui-Peng] Vrije Univ Amsterdam, Ctr Integrat Bioinformat VU IBIVU, Amsterdam, Netherlands; [Govers, Francine] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands	Utrecht University; Centre for BioSystems Genomics; Vrije Universiteit Amsterdam; Wageningen University & Research	Seidl, MF (corresponding author), Univ Utrecht, Dept Biol, Utrecht, Netherlands.	m.f.seidl@uu.nl	Van den Ackerveken, Guido/B-8568-2011; Snel, Berend/B-8886-2011; Govers, Francine/A-5616-2009; Seidl, Michael F./ABD-6042-2021	Van den Ackerveken, Guido/0000-0002-0183-8978; Snel, Berend/0000-0002-5804-8547; Govers, Francine/0000-0001-5311-929X; Seidl, Michael F/0000-0002-5218-2083	Centre for BioSystems Genomics (CBSG)	Centre for BioSystems Genomics (CBSG)	This project was financed by the Centre for BioSystems Genomics (CBSG) which is part of The Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (http://www.cbsg.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Fong AMV, 2007, EUKARYOT CELL, V6, P2222, DOI 10.1128/EC.00328-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Chaturvedi V, 1996, MICROBIOL-UK, V142, P937, DOI 10.1099/00221287-142-4-937; Chaturvedi V, 1996, J IMMUNOL, V156, P3836; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EIDE D, 1988, MOL CELL BIOL, V8, P737, DOI 10.1128/MCB.8.2.737; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Govers F, 2006, MOL PLANT MICROBE IN, V19, P1295, DOI 10.1094/MPMI-19-1295; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jiang RHY, 2006, MOL BIOL EVOL, V23, P338, DOI 10.1093/molbev/msj039; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Judelson HS, 2007, ADV GENET, V57, P97, DOI 10.1016/S0065-2660(06)57003-8; Judelson HS, 2012, EUKARYOT CELL, V11, P1304, DOI 10.1128/EC.00155-12; JUDELSON HS, 1992, MOL GEN GENET, V234, P138, DOI 10.1007/BF00272355; JUDELSON HS, 1989, GENE, V79, P207, DOI 10.1016/0378-1119(89)90203-5; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; McLeod A, 2004, EUKARYOT CELL, V3, P91, DOI 10.1128/EC.3.1.91-99.2004; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; PIETERSE CMJ, 1994, GENE, V138, P67, DOI 10.1016/0378-1119(94)90784-6; Pritsker M, 2004, GENOME RES, V14, P99; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Rayko E, 2010, NEW PHYTOL, V188, P52, DOI 10.1111/j.1469-8137.2010.03371.x; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Seidl MF, 2012, GENOME BIOL EVOL, V4, P199, DOI 10.1093/gbe/evs003; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; Skalamera D, 2006, AUSTRALAS PLANT PATH, V35, P593, DOI 10.1071/AP06063; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tani S, 2006, EUKARYOT CELL, V5, P745, DOI 10.1128/EC.5.4.745-752.2006; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Dongen Stijn, 2000, INFORM SYSTEMS INS R, V2000; van Noort V, 2006, TRENDS GENET, V22, P73, DOI 10.1016/j.tig.2005.12.002; Vandepoele K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r103; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Voegele RT, 2005, PLANT PHYSIOL, V137, P190, DOI 10.1104/pp.104.051839; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Xiang QJ, 2009, FUNGAL GENET BIOL, V46, P400, DOI 10.1016/j.fgb.2009.02.006; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029	70	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51295	10.1371/journal.pone.0051295	http://dx.doi.org/10.1371/journal.pone.0051295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251489	Green Published, gold			2022-12-27	WOS:000313236200087
J	Han, J; Lynne, AM; David, DE; Tang, HL; Xu, JS; Nayak, R; Kaldhone, P; Logue, CM; Foley, SL				Han, Jing; Lynne, Aaron M.; David, Donna E.; Tang, Hailin; Xu, Joshua; Nayak, Rajesh; Kaldhone, Pravin; Logue, Catherine M.; Foley, Steven L.			DNA Sequence Analysis of Plasmids from Multidrug Resistant Salmonella enterica Serotype Heidelberg Isolates	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; COMPARATIVE GENOMICS; SEROVAR HEIDELBERG; VIRULENCE PLASMID; UNITED-STATES; FOOD ANIMALS; INFECTIONS; PREVALENCE; SYSTEMS	Salmonella enterica serovar Heidelberg is among the most detected serovars in swine and poultry, ranks among the top five serotypes associated with human salmonellosis and is disproportionately associated with invasive infections and mortality in humans. Salmonella are known to carry plasmids associated with antimicrobial resistance and virulence. To identify plasmid-associated genes in multidrug resistant S. enterica serovar Heidelberg, antimicrobial resistance plasmids from five isolates were sequenced using the 454 LifeSciences pyrosequencing technology. Four of the isolates contained incompatibility group (Inc) A/C multidrug resistance plasmids harboring at least eight antimicrobial resistance genes. Each of these strains also carried a second resistance plasmid including two IncFIB, an IncHI2 and a plasmid lacking an identified Inc group. The fifth isolate contained an IncI1 plasmid, encoding resistance to gentamicin, streptomycin and sulfonamides. Some of the IncA/C plasmids lacked the full concert of transfer genes and yet were able to be conjugally transferred, likely due to the transfer genes carried on the companion plasmids in the strains. Several non-IncA/C resistance plasmids also carried putative virulence genes. When the sequences were compared to previously sequenced plasmids, it was found that while all plasmids demonstrated some similarity to other plasmids, they were unique, often due to differences in mobile genetic elements in the plasmids. Our study suggests that Salmonella Heidelberg isolates harbor plasmids that co-select for antimicrobial resistance and virulence, along with genes that can mediate the transfer of plasmids within and among other bacterial isolates. Prevalence of such plasmids can complicate efforts to control the spread of S. enterica serovar Heidelberg in food animal and human populations.	[Han, Jing; Nayak, Rajesh; Foley, Steven L.] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Lynne, Aaron M.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Lynne, Aaron M.; David, Donna E.; Kaldhone, Pravin; Foley, Steven L.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Tang, Hailin; Xu, Joshua] ICF Int Incorporat NCTR FDA, Jefferson, AR USA; [Logue, Catherine M.] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Ames, IA USA	US Food & Drug Administration (FDA); Texas State University System; Sam Houston State University; Marshfield Clinic; Iowa State University	Foley, SL (corresponding author), US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA.	Steven.Foley@fda.hhs.gov	Kaldhone, Pravin/ABG-5075-2021	Foley, Steven/0000-0003-3146-4548; Logue, Catherine/0000-0002-6098-2662	Marshfield Clinic Research Foundation; National Center for Toxicological Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103625] Funding Source: NIH RePORTER	Marshfield Clinic Research Foundation; National Center for Toxicological Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was internally funded by the Marshfield Clinic Research Foundation and the National Center for Toxicological Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buzby JC, 2006, AMBER WAVES, V4, P5; Buzby JC, 1996, BACTERIAL FOODBORNE; Call DR, 2010, ANTIMICROB AGENTS CH, V54, P590, DOI 10.1128/AAC.00055-09; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Centers for Disease Control and Prevention, 2011, SALM SURV ANN SUMM 2; Centers for Disease Control and Prevention, 2008, SALM SURV ANN SUMM 2; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; FDA, 2011, NAT ANT RES MON SYST; Fernandez-Alarcon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023415; Frenzen P. D., 1999, FoodReview, V22, P10; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Garcia-Quintanilla M, 2006, J BACTERIOL, V188, P7963, DOI 10.1128/JB.00995-06; Han J, 2011, SEQUENCING PLASMIDS; Han J, 2011, J CLIN MICROBIOL, V49, P1130, DOI 10.1128/JCM.01931-10; Hennessy TW, 2004, CLIN INFECT DIS, V38, pS237, DOI 10.1086/381593; Johnson TJ, 2006, ANTIMICROB AGENTS CH, V50, P3929, DOI 10.1128/AAC.00569-06; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2011, PLASMID, V66, P144, DOI 10.1016/j.plasmid.2011.07.003; Johnson TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015524; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kaldhone P, 2008, APPL ENVIRON MICROB, V74, P5038, DOI 10.1128/AEM.00409-08; Kennedy M, 2004, CLIN INFECT DIS, V38, pS142, DOI 10.1086/381580; Lynne AM, 2009, FOODBORNE PATHOG DIS, V6, P207, DOI 10.1089/fpd.2008.0172; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Poole TL, 2009, FOODBORNE PATHOG DIS, V6, P1185, DOI 10.1089/fpd.2009.0316; PULLINGER GD, 1992, MOL MICROBIOL, V6, P1631, DOI 10.1111/j.1365-2958.1992.tb00888.x; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sande MA, 2004, SANFORD GUIDE ANTIMI; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Scharff R.L., 2010, PRODUCE SAFETY PROJE; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Vugia DJ, 2004, CLIN INFECT DIS, V38, pS149, DOI 10.1086/381581; WANG ZL, 1994, BIOTECHNIQUES, V16, P460; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Winokur PL, 2000, ANTIMICROB AGENTS CH, V44, P2777, DOI 10.1128/AAC.44.10.2777-2783.2000; Zhao S, 2008, APPL ENVIRON MICROB, V74, P6656, DOI 10.1128/AEM.01249-08; Zhao S, 2006, FOODBORNE PATHOG DIS, V3, P106, DOI 10.1089/fpd.2006.3.106; Zhao S, 2003, J CLIN MICROBIOL, V41, P5366, DOI 10.1128/JCM.41.12.5366-5371.2003	41	66	68	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51160	10.1371/journal.pone.0051160	http://dx.doi.org/10.1371/journal.pone.0051160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251446	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900049
J	Jiang, YS; Zhang, RJ; Zheng, JJ; Liu, PP; Tang, GP; Lv, HC; Zhang, LY; Shang, ZW; Zhan, YB; Lv, WH; Shi, M; Zhang, RM				Jiang, Yongshuai; Zhang, Ruijie; Zheng, Jiajia; Liu, Panpan; Tang, Guoping; Lv, Hongchao; Zhang, Lanying; Shang, Zhenwei; Zhan, Yuanbo; Lv, Wenhua; Shi, Miao; Zhang, Ruimin			Meta-Analysis of 125 Rheumatoid Arthritis-Related Single Nucleotide Polymorphisms Studied in the Past Two Decades	PLOS ONE			English	Article							SUSCEPTIBILITY; ASSOCIATION; GENETICS; HETEROGENEITY; PHOSPHATASE; DISEASE; PADI4; BIAS	Objective: Candidate gene association studies and genome-wide association studies (GWAs) have identified a large number of single nucleotide polymorphisms (SNPs) loci affecting susceptibility to rheumatoid arthritis (RA). However, for the same locus, some studies have yielded inconsistent results. To assess all the available evidence for association, we performed a meta-analysis on previously published case-control studies investigating the association between SNPs and RA. Methods: Two hundred and sixteen studies, involving 125 SNPs, were reviewed. For each SNP, three genetic models were considered: the allele, dominant and recessive effects models. For each model, the effect summary odds ratio (OR) and 95% CIs were calculated. Cochran's Q-statistics were used to assess heterogeneity. If the heterogeneity was high, a random effects model was used for meta-analysis, otherwise a fixed effects model was used. Results: The meta-analysis results showed that: (1) 30, 28 and 26 SNPs were significantly associated with RA (P<0.01) for the allele, dominant, and recessive models, respectively. (2) rs2476601 (PTPN22) showed the strongest association for all the three models: OR = 1.605, 95% CI: 1.540-1.672, P<1.00E215 for the T-allele; OR = 1.638, 95% CI: 1.565-1.714, P<1.00E-15 for the T/T+T/C genotype and OR = 2.544, 95% CI: 2.173-2.978, P<1.00E215 for the T/T genotype. (3) Only 23 (18.4%), 13 (10.4%) and 15 (12.0%) SNPs had high heterogeneity (P<0.01) for the three models, respectively. (4) For some of the SNPs, there was no publication bias according to Funnel plots and Egger's regression tests (P<0.01). For the other SNPs, the associations were tested in only a few studies, and may have been subject to publication bias. More studies on these loci are required. Conclusion: Our meta-analysis provides a comprehensive evaluation of the RA association studies from the past two decades. The detailed meta-analysis results are available at: http://210.46.85.180/DRAP/index.php/Metaanalysis/index.	[Jiang, Yongshuai; Zhang, Ruijie; Zheng, Jiajia; Liu, Panpan; Tang, Guoping; Lv, Hongchao; Zhang, Lanying; Shang, Zhenwei; Lv, Wenhua; Shi, Miao] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Zhan, Yuanbo; Zhang, Ruimin] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Zhang, RJ (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	zhangruijie2009@yahoo.com.cn; zhangrmokok@126.com		Jiang, Yongshuai/0000-0002-7163-6554	National Natural Science Foundation of China [81172842, 31200934]; Natural Science Foundation of Heilongjiang Province [C201206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 81172842, 31200934) and Natural Science Foundation of Heilongjiang Province (Grant No. C201206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bowes J, 2008, RHEUMATOLOGY, V47, P399, DOI 10.1093/rheumatology/ken005; Egger M, 1997, BMJ-BRIT MED J, V315, P1371, DOI 10.1136/bmj.315.7119.1371; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HASSTEDT SJ, 1994, AM J HUM GENET, V55, P738; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Iwamoto T, 2006, RHEUMATOLOGY, V45, P804, DOI 10.1093/rheumatology/kel023; Ji JD, 2010, MOL BIOL REP, V37, P141, DOI 10.1007/s11033-009-9553-z; Ke-Wei R, 2012, ARCH MED RES; Klareskog L, 2006, NAT CLIN PRACT RHEUM, V2, P425, DOI 10.1038/ncprheum0249; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kvien TK, 1997, SCAND J RHEUMATOL, V26, P412, DOI 10.3109/03009749709065712; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee YH, 2007, RHEUMATOL INT, V27, P827, DOI 10.1007/s00296-007-0320-y; Lee YH, 2011, MOL BIOL REP, V38, P3643, DOI 10.1007/s11033-010-0477-4; Lee YH, 2010, RHEUMATOL INT, V30, P661, DOI 10.1007/s00296-009-1051-z; Li YH, 2009, SEMIN IMMUNOL, V21, P318, DOI 10.1016/j.smim.2009.04.002; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Milicic A, 2001, TISSUE ANTIGENS, V58, P50, DOI 10.1034/j.1399-0039.2001.580110.x; Munoz-Valle JF, 2010, CLIN CHIM ACTA, V411, P725, DOI 10.1016/j.cca.2010.02.001; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; Totaro MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024292; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Zintzaras E, 2006, CLIN GENET, V69, P327, DOI 10.1111/j.1399-0004.2006.00605.x	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51571	10.1371/journal.pone.0051571	http://dx.doi.org/10.1371/journal.pone.0051571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251581	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900105
J	Landreau, F; Galeano, P; Caltana, LR; Masciotra, L; Chertcoff, A; Pontoriero, A; Baumeister, E; Amoroso, M; Brusco, HA; Tous, MI; Savy, VL; Arnaiz, MDL; de Erausquin, GA				Landreau, Fernando; Galeano, Pablo; Caltana, Laura R.; Masciotra, Luis; Chertcoff, Agustin; Pontoriero, A.; Baumeister, Elsa; Amoroso, Marcela; Brusco, Herminia A.; Tous, Monica I.; Savy, Vilma L.; del Rosario Lores Arnaiz, Maria; de Erausquin, Gabriel A.			Effects of Two Commonly Found Strains of Influenza A Virus on Developing Dopaminergic Neurons, in Relation to the Pathophysiology of Schizophrenia	PLOS ONE			English	Article							BACTERIAL-ENDOTOXIN EXPOSURE; INFECTION CAUSES ALTERATIONS; PARKINSONS-DISEASE; PRENATAL EXPOSURE; VIRAL-INFECTION; PREFRONTAL CORTEX; EXTRAPYRAMIDAL SYMPTOMS; PHARMACOLOGICAL CHANGES; IMMUNE ACTIVATION; A/WSN/33 VIRUS	Influenza virus (InfV) infection during pregnancy is a known risk factor for neurodevelopment abnormalities in the offspring, including the risk of schizophrenia, and has been shown to result in an abnormal behavioral phenotype in mice. However, previous reports have concentrated on neuroadapted influenza strains, whereas increased schizophrenia risk is associated with common respiratory InfV. In addition, no specific mechanism has been proposed for the actions of maternal infection on the developing brain that could account for schizophrenia risk. We identified two common isolates from the community with antigenic configurations H3N2 and H1N1 and compared their effects on developing brain with a mouse modified-strain A/WSN/33 specifically on the developing of dopaminergic neurons. We found that H1N1 InfV have high affinity for dopaminergic neurons in vitro, leading to nuclear factor kappa B activation and apoptosis. Furthermore, prenatal infection of mothers with the same strains results in loss of dopaminergic neurons in the offspring, and in an abnormal behavioral phenotype. We propose that the well-known contribution of InfV to risk of schizophrenia during development may involve a similar specific mechanism and discuss evidence from the literature in relation to this hypothesis.	[de Erausquin, Gabriel A.] Univ S Florida, Dept Psychiat & Neurosci, Roskamp Lab Brain Dev Modulat & Repair, Tampa, FL 33620 USA; [Landreau, Fernando; Pontoriero, A.; Baumeister, Elsa; Tous, Monica I.; Savy, Vilma L.] ANLIS Dr Carlos G Malbran, Inst Nacl Enfermedades Infecciosas, Dept Virol, Buenos Aires, DF, Argentina; [Galeano, Pablo] Univ Buenos Aires, Fac Med, Lab Citoarquitectura & Plasticidad Neuronal, Inst Invest Prof Dr Alberto C Taquini ININCA, Buenos Aires, DF, Argentina; [Caltana, Laura R.; Masciotra, Luis] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia Profesor E De Ro, Buenos Aires, DF, Argentina; [Chertcoff, Agustin; Brusco, Herminia A.] ANLIS Dr Carlos G Malbran, Inst Nacl Producc Biol, Buenos Aires, DF, Argentina; [del Rosario Lores Arnaiz, Maria] Univ Buenos Aires, Fac Psicol, Buenos Aires, DF, Argentina	State University System of Florida; University of South Florida; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	de Erausquin, GA (corresponding author), Univ S Florida, Dept Psychiat & Neurosci, Roskamp Lab Brain Dev Modulat & Repair, Tampa, FL 33620 USA.	gdeeraus@health.usf.edu	de Erausquin, Gabriel A/G-5840-2010; Pontoriero, Antonio/AAN-4455-2020; de Erausquin, Gabriel A./Z-1952-2019	de Erausquin, Gabriel A/0000-0001-6423-4461; Pontoriero, Antonio/0000-0003-3011-6779; de Erausquin, Gabriel A./0000-0001-6423-4461; Galeano, Pablo/0000-0003-4491-2039				ADAMS W, 1993, BRIT J PSYCHIAT, V163, P522, DOI 10.1192/bjp.163.4.522; Akil M, 1999, AM J PSYCHIAT, V156, P1580, DOI 10.1176/ajp.156.10.1580; Albert KA, 2002, ARCH GEN PSYCHIAT, V59, P705, DOI 10.1001/archpsyc.59.8.705; Anastasia A, 2007, J NEUROCHEM, V103, P1542, DOI 10.1111/j.1471-4159.2007.04856.x; Anastasia A, 2009, J NEUROCHEM, V109, P755, DOI 10.1111/j.1471-4159.2009.06001.x; Aronsson F, 2003, VIRAL IMMUNOL, V16, P415, DOI 10.1089/088282403322396208; Aronsson F, 2002, J NEUROVIROL, V8, P353, DOI 10.1080/13550280290100480; Aronsson F, 2001, J NEUROVIROL, V7, P117; Asp L, 2005, NEUROREPORT, V16, P1111, DOI 10.1097/00001756-200507130-00016; Benes FM, 1997, AID SYN10 3 0 CO, P2; Beraki S, 2005, MOL PSYCHIATR, V10, P299, DOI 10.1038/sj.mp.4001545; BOGERTS B, 1983, BIOL PSYCHIAT, V18, P951; Brask J, 2005, J NEUROVIROL, V11, P395, DOI 10.1080/13550280500186916; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; CALIGIURI MP, 1993, AM J PSYCHIAT, V150, P1343; Carter CJ, 2009, SCHIZOPHRENIA BULL, V35, P1163, DOI 10.1093/schbul/sbn054; CARTER CJ, 1980, BRAIN RES, V192, P163, DOI 10.1016/0006-8993(80)91016-1; Carvey PM, 2003, FRONT BIOSCI-LANDMRK, V8, pS826, DOI 10.2741/1158; CHAKOS MH, 1992, PSYCHOPHARMACOL BULL, V28, P81; CHATTERJEE A, 1995, AM J PSYCHIAT, V152, P1724; Chen LC, 2004, J APPL PHYSIOL, V97, P17, DOI 10.1152/japplphysiol.01355.2003; COTTER D, 1995, SCHIZOPHR RES, V16, P233, DOI 10.1016/0920-9964(94)E0082-I; CROW TJ, 1992, BRIT J PSYCHIAT, V161, P570, DOI 10.1192/S0007125000129915; Dale RC, 2004, BRAIN, V127, P21, DOI 10.1093/brain/awh008; DASSA D, 1995, ACTA PSYCHIAT SCAND, V92, P145, DOI 10.1111/j.1600-0447.1995.tb09558.x; de Erausquin GA, 2003, MOL PHARMACOL, V63, P784, DOI 10.1124/mol.63.4.784; DEERAUSQUIN G, 1992, NEUROSCI LETT, V145, P121, DOI 10.1016/0304-3940(92)90001-N; DEERAUSQUIN G, 1994, MOL BRAIN RES, V21, P303, DOI 10.1016/0169-328X(94)90261-5; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fatemi SH, 1999, MOL PSYCHIATR, V4, P145, DOI 10.1038/sj.mp.4000520; Fatemi SH, 2000, NEUROREPORT, V11, P1493, DOI 10.1097/00001756-200005150-00026; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; Fatemi SH, 1998, AID SYN8 3 0 CO, P2; Fruntes V, 2008, MED SCI MONITOR, V14, pRA71; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; GRILLI M, 1991, J NEUROCHEM, V56, P2108, DOI 10.1111/j.1471-4159.1991.tb03473.x; Holtze M, 2008, J NEUROSCI RES, V86, P3674, DOI 10.1002/jnr.21799; Honer WG, 2005, J PSYCHOPHARMACOL, V19, P277, DOI 10.1177/0269881105051539; Izumoto Y, 1999, BIOL PSYCHIAT, V46, P119, DOI 10.1016/S0006-3223(98)00359-X; Kawashima H, 2004, NEUROCHEM RES, V29, P1537, DOI 10.1023/B:NERE.0000029566.22533.c6; Kimura Y, 2000, Nihon Rinsho, V58, P2211; Kolomeets N S, 1999, Neurosci Behav Physiol, V29, P217; LAING P, 1989, P NATL ACAD SCI USA, V86, P1998, DOI 10.1073/pnas.86.6.1998; Le TQ, 2006, BIOL CHEM, V387, P467, DOI 10.1515/BC.2006.062; Leyva-Grado VH, 2009, J NEUROIMMUNOL, V211, P73, DOI 10.1016/j.jneuroim.2009.03.016; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Ling ZD, 2004, NEUROSCIENCE, V124, P619, DOI 10.1016/j.neuroscience.2003.12.017; Ling ZD, 2002, MOVEMENT DISORD, V17, P116, DOI 10.1002/mds.10078; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Masciotra L., 2005, TRENDS SCHIZOPHRENIA, P27; MEDNICK SA, 1990, ARCH GEN PSYCHIAT, V47, P292; Mino Y, 2000, J PSYCHIAT RES, V34, P133, DOI 10.1016/S0022-3956(00)00003-0; Morgan V, 1997, SCHIZOPHR RES, V26, P25, DOI 10.1016/S0920-9964(97)00033-9; Mori I, 2000, MICROBES INFECT, V2, P1329, DOI 10.1016/S1286-4579(00)01286-7; Mori I, 1999, J NEUROVIROL, V5, P355, DOI 10.3109/13550289909029476; Mori I, 2000, MICROBIOL IMMUNOL, V44, P729, DOI 10.1111/j.1348-0421.2000.tb02556.x; Mori I, 2003, J GEN VIROL, V84, P2401, DOI 10.1099/vir.0.19188-0; Mori I, 2002, VIROLOGY, V303, P287, DOI 10.1006/viro.2002.1601; Mori I, 2002, J GEN VIROL, V83, P2109, DOI 10.1099/0022-1317-83-9-2109; Mori I, 2001, MICROBES INFECT, V3, P475, DOI 10.1016/S1286-4579(01)01403-4; Munk-Jorgensen P, 2001, BRIT J PSYCHIAT, V178, pS30, DOI 10.1192/bjp.178.40.s30; Nakajima K, 1997, Nihon Rinsho, V55, P2693; OCALLAGHAN E, 1991, LANCET, V337, P1248, DOI 10.1016/0140-6736(91)92919-S; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rosa A, 2004, AM J PSYCHIAT, V161, P1110, DOI 10.1176/appi.ajp.161.6.1110; Rubin SA, 2004, J NEUROVIROL, V10, P305, DOI 10.1080/13550280490499579; Selten JP, 1999, SCHIZOPHR RES, V38, P85, DOI 10.1016/S0920-9964(99)00005-5; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Sperner-Unterweger B, 2005, FORTSCHR NEUROL PSYC, V73, pS38, DOI 10.1055/s-2005-915544; Takahashi M, 2001, ADV NEUROL, V86, P91; TAKAHASHI M, 1995, J EXP MED, V181, P2161, DOI 10.1084/jem.181.6.2161; Takahashi M, 1999, JPN J INFECT DIS, V52, P89; Takahashi M, 1997, Parkinsonism Relat Disord, V3, P97, DOI 10.1016/S1353-8020(97)00010-2; TAKEI N, 1995, AM J PSYCHIAT, V152, P150; VALCHAR M, 1995, MOL NEUROBIOL, V11, P111, DOI 10.1007/BF02740689; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wolff AL, 1999, J PSYCHIATR NEUROSCI, V24, P304; Yamada T, 1996, Parkinsonism Relat Disord, V2, P187, DOI 10.1016/S1353-8020(96)00024-7; Yamada T, 1996, Parkinsonism Relat Disord, V2, P113, DOI 10.1016/1353-8020(96)00006-5; Yuede CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011374; Zuckerman L, 2005, J PSYCHIATR RES, V39, P311, DOI 10.1016/j.jpsychires.2004.08.008; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	84	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51068	10.1371/journal.pone.0051068	http://dx.doi.org/10.1371/journal.pone.0051068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251423	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900037
J	Levanic, DL; Horvat, T; Martincic, J; Bauer, N				Levanic, Dunja Leljak; Horvat, Tomislav; Martincic, Jelena; Bauer, Natasa			A Novel Bipartite Nuclear Localization Signal Guides BPM1 Protein to Nucleolus Suggesting Its Cullin3 Independent Function	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; DOMAIN; FAMILY; COMPLEXES; MEMBERS; EMBRYOGENESIS; SEQUENCE; INSIGHTS	BPM1 belongs to the MATH-BTB family of proteins, which act as substrate-binding adaptors for the Cullin3-based E3 ubiquitin ligase. MATH-BTB proteins associate with Cullin3 via the BTB domain and with the substrate protein via the MATH domain. Few BPM1-interacting proteins with different functions are recognized, however, specific roles of BPM1, depending on its cellular localization have not been studied so far. Here, we found a novel bipartite nuclear localization signal at the C-terminus of the BPM1 protein, responsible for its nuclear and nucleolar localization and sufficient to drive the green fluorescent protein and cytoplasmic BPM4 protein into the nucleus. Co-localization analysis in live Nicotiana tabacum BY2 cells indicates a Cullin3 independent function since BPM1 localization is predominantly nucleolar and thus devoid of Cullin3. Treatment of BY2 cells with the proteasome inhibitor MG132 blocks BPM1 and Cullin3 degradation, suggesting turnover of both proteins through the ubiquitin-proteasome pathway. Possible roles of BPM1 in relation to its in vivo localization are discussed.	[Levanic, Dunja Leljak; Horvat, Tomislav; Martincic, Jelena; Bauer, Natasa] Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia	University of Zagreb	Bauer, N (corresponding author), Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia.	natasa.bauer@zg.biol.pmf.hr		Bauer, Natasa/0000-0003-4124-0193	Ministry of Science, Education and Sports of the Republic of Croatia [119-1191196-1225, 119-1191196-1224]; Alexander Von Humboldt Foundation	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Alexander Von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by Ministry of Science, Education and Sports of the Republic of Croatia, Projects 119-1191196-1225, leader Sibila Jelaska (NB, DLL, JM) and 119-1191196-1224, leader Vlatka Zoldos (TH), and Alexander Von Humboldt Foundation (DLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bernhardt A, 2006, PLANT J, V47, P591, DOI 10.1111/j.1365-313X.2006.02810.x; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Choo YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041350; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Gingerich DJ, 2005, J BIOL CHEM, V280, P18810, DOI 10.1074/jbc.M413247200; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Juranic M, 2012, PLANT CELL, DOI [10.1105/tcp.112.107169, DOI 10.1105/TCP.112.107169]; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Launholt D, 2006, PLANT CELL, V18, P2904, DOI 10.1105/tpc.106.047274; Lechner E, 2011, DEV CELL, V21, P1116, DOI 10.1016/j.devcel.2011.10.018; Lee JH, 2011, MOL CELLS, V31, P201, DOI 10.1007/s10059-011-0031-9; Liu JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042621; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Pang SZ, 1996, PLANT PHYSIOL, V112, P893, DOI 10.1104/pp.112.3.893; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Sekimoto T, 2005, NUCL IMPORT EXPORT P; Soll J, 2002, CURR OPIN PLANT BIOL, V5, P529, DOI 10.1016/S1369-5266(02)00296-0; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Takahashi I, 2002, BBA-MOL CELL RES, V1591, P63, DOI 10.1016/S0167-4889(02)00249-5; Thomann A, 2005, PLANT J, V43, P437, DOI 10.1111/j.1365-313X.2005.02467.x; Thomann A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000328; Weber H, 2005, PLANT PHYSIOL, V137, P83, DOI 10.1104/pp.104.052654; Weber H, 2010, CHARAKTERISIERUNG BT; Weber H, 2009, FEBS J, V276, P6624, DOI 10.1111/j.1742-4658.2009.07373.x; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	54	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51184	10.1371/journal.pone.0051184	http://dx.doi.org/10.1371/journal.pone.0051184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251450	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900052
J	Noguchi, K; Ishibashi, K; Miyokawa, K; Hokari, M; Kanno, T; Hirano, T; Yamamoto, N; Takaku, H				Noguchi, Kousei; Ishibashi, Keisuke; Miyokawa, Kaori; Hokari, Manami; Kanno, Tomoyuki; Hirano, Tomoya; Yamamoto, Norio; Takaku, Hiroshi			HIV-1 Suppressive Sequences Are Modulated by Rev Transport of Unspliced RNA and Are Required for Efficient HIV-1 Production	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MICRORNA TARGET SITES; MESSENGER-RNA; GENOMIC RNAS; P-BODIES; INTRACELLULAR TRAFFICKING; RESPONSIVE ELEMENT; CELLULAR MICRORNA; BINDING-PROTEIN; TRANSLATION	The unspliced human immunodeficiency virus type 1 (HIV-1) RNAs are translated as Gag and Gag-Pol polyproteins or packaged as genomes into viral particles. Efficient translation is necessary before the transition to produce infective virions. The viral protein Rev exports all intron-containing viral RNAs; however, it also appears to enhance translation. Cellular microRNAs target cellular and viral mRNAs to silence their translation and enrich them at discrete cytoplasmic loci that overlap with the putative interim site of Gag and the genome. Here, we analyzed how Rev-mediated transport and the splicing status of the mRNA influenced the silencing status imposed by microRNA. Through identification and mutational analysis of the silencing sites in the HIV-1 genome, we elucidated the effect of silencing on virus production. Renilla luciferase mRNA, which contains a let-7 targeting site in its 39 untranslated region, was mediated when it was transported by Rev and not spliced, but it was either not mediated when it was spliced even in a partial way or it was Rev-independent. The silencing sites in the pol and env-nef regions of the HIV-1 genome, which were repressed in T cells and other cell lines, were Drosha-dependent and could also be modulated by Rev in an unspliced state. Mutant viruses that contained genomic mutations that reflect alterations to show more derepressive effects in the 39 untranslated region of the Renilla luciferase gene replicated more slowly than wild-type virus. These findings yield insights into the HIV-1 silencing sites that might allow the genome to avoid translational machinery and that might be utilized in coordinating virus production during initial virus replication. However, the function of Rev to modulate the silencing sites of unspliced RNAs would be advantageous for the efficient translation that is required to support protein production prior to viral packaging and particle production.	[Noguchi, Kousei; Takaku, Hiroshi] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 275, Japan; [Ishibashi, Keisuke; Miyokawa, Kaori; Hokari, Manami; Kanno, Tomoyuki; Hirano, Tomoya; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan; [Yamamoto, Norio] Natl Inst Infect Dis, Influenza Virus Res Ctr, Musashimurayama, Tokyo, Japan	Chiba Institute of Technology; Chiba Institute of Technology; National Institute of Infectious Diseases (NIID)	Noguchi, K (corresponding author), Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 275, Japan.	k3kousei@yahoo.co.jp; hiroshi.takaku@it-chiba.ac.jp			Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); Ministry of Health, Labor; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Science, Sports, and Culture, Japan	Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); Ministry of Health, Labor; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant from the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT), by a Grant-in-Aid for AIDS research from the Ministry of Health, Labor, by a Grant-in-Aid for Science Research from the Japan Society for the Promotion of Science (JSPS), and by a Grant-in-Aid for High Technology Research (HTR) from the Ministry of Education, Science, Sports, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Ajamian L, 2008, RNA, V14, P914, DOI 10.1261/rna.829208; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; BARKSDALE SK, 1995, MOL CELL BIOL, V15, P2962; Basyuk E, 2003, DEV CELL, V5, P161, DOI 10.1016/S1534-5807(03)00188-6; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Black AC, 1996, VIRUS GENES, V12, P275, DOI 10.1007/BF00284648; Blissenbach M, 2010, J VIROL, V84, P6598, DOI 10.1128/JVI.02264-09; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; BOGERD HP, 1991, P NATL ACAD SCI USA, V88, P5704, DOI 10.1073/pnas.88.13.5704; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; BRIGHTY DW, 1994, P NATL ACAD SCI USA, V91, P8314, DOI 10.1073/pnas.91.18.8314; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Carlton JG, 2009, BIOCHEM SOC T, V37, P195, DOI 10.1042/BST0370195; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Chable-Bessia C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-26; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; Charnay N, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-74; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cullen BR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000787; DAGOSTINO DM, 1992, MOL CELL BIOL, V12, P1375, DOI 10.1128/MCB.12.3.1375; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Dorweiler IJ, 2006, J VIROL, V80, P3634, DOI 10.1128/JVI.80.7.3634-3643.2006; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallego J, 2003, J BIOL CHEM, V278, P40385, DOI 10.1074/jbc.M301041200; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gibbings D, 2010, TRENDS CELL BIOL, V20, P491, DOI 10.1016/j.tcb.2010.06.001; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Groom HCT, 2009, J GEN VIROL, V90, P1303, DOI 10.1099/vir.0.011460-0; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hu ZX, 2011, J VIROL, V85, P11309, DOI 10.1128/JVI.05578-11; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Keating CP, 2009, NUCLEIC ACIDS RES, V37, P945, DOI 10.1093/nar/gkn1015; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kemler I, 2010, J VIROL, V84, P6352, DOI 10.1128/JVI.00363-10; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Komano J, 2004, MOL BIOL CELL, V15, P5197, DOI 10.1091/mbc.E04-04-0279; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Li N, 2008, NUCLEIC ACIDS RES, V36, P4277, DOI 10.1093/nar/gkn388; Li ZH, 2009, J VIROL, V83, P12751, DOI 10.1128/JVI.01325-09; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mertz JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-10; Mikaelian I, 1996, J MOL BIOL, V257, P246, DOI 10.1006/jmbi.1996.0160; Molle D, 2009, J BIOL CHEM, V284, P19727, DOI 10.1074/jbc.M109.019844; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Najera I, 1999, J MOL BIOL, V285, P1951, DOI 10.1006/jmbi.1998.2473; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; OREILLY MM, 1995, VIROLOGY, V213, P373, DOI 10.1006/viro.1995.0010; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; Sharma A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002612; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Sugiyama R, 2011, NUCLEIC ACIDS RES, V39, P589, DOI 10.1093/nar/gkq794; Sun GH, 2010, NUCLEIC ACIDS RES, V38, P239, DOI 10.1093/nar/gkp870; Suzuki J, 2002, J VIROL, V76, P3015, DOI 10.1128/JVI.76.6.3015-3022.2002; Swanson CM, 2006, TRAFFIC, V7, P1440, DOI 10.1111/j.1600-0854.2006.00488.x; Swanson CM, 2010, J VIROL, V84, P6748, DOI 10.1128/JVI.02526-09; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Urcuqui-Inchima S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016686; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wolff H, 2003, NUCLEIC ACIDS RES, V31, P2839, DOI 10.1093/nar/gkg390; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003	91	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51393	10.1371/journal.pone.0051393	http://dx.doi.org/10.1371/journal.pone.0051393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251516	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900076
J	Chargui, A; Cesaro, A; Mimouna, S; Fareh, M; Brest, P; Naquet, P; Darfeuille-Michaud, A; Hebuterne, X; Mograbi, B; Vouret-Craviari, V; Hofman, P				Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Fareh, Mohamed; Brest, Patrick; Naquet, Philippe; Darfeuille-Michaud, Arlette; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul			Subversion of Autophagy in Adherent Invasive Escherichia coli-Infected Neutrophils Induces Inflammation and Cell Death	PLOS ONE			English	Article							CROHNS-DISEASE; ILEAL MUCOSA; MACROPHAGES; PATHWAYS; MANIPULATION; IMMUNITY; STRAINS; PLB-985	Invading bacteria are recognized, captured and killed by a specialized form of autophagy, called xenophagy. Recently, defects in xenophagy in Crohn's disease (CD) have been implicated in the pathogenesis of human chronic inflammatory diseases of uncertain etiology of the gastrointestinal tract. We show here that pathogenic adherent-invasive Escherichia coli (AIEC) isolated from CD patients are able to adhere and invade neutrophils, which represent the first line of defense against bacteria. Of particular interest, AIEC infection of neutrophil-like PLB-985 cells blocked autophagy at the autolysosomal step, which allowed intracellular survival of bacteria and exacerbated interleukin-8 (IL-8) production. Interestingly, this block in autophagy correlated with the induction of autophagic cell death. Likewise, stimulation of autophagy by nutrient starvation or rapamycin treatment reduced intracellular AIEC survival and IL-8 production. Finally, treatment with an inhibitor of autophagy decreased cell death of AIEC-infected neutrophil-like PLB-985 cells. In conclusion, excessive autophagy in AIEC infection triggered cell death of neutrophils.	[Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Brest, Patrick; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul] Inst Res Canc & Aging, Nice, France; [Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Brest, Patrick; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul] CNRS, INSERM, U1081, UMR7284,Team 3, F-06034 Nice, France; [Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Fareh, Mohamed; Brest, Patrick; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Brest, Patrick; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul] Equipe Labellisee Fdn Assoc Rech Canc, Villejuif, France; [Fareh, Mohamed] Fac Med Nice, INSERM, U898, F-06034 Nice, France; [Naquet, Philippe] Ctr Imunol Marseille Luminy, UMR 631, Marseille, France; [Darfeuille-Michaud, Arlette] INSERM, U1071, Clermont Ferrand, France; [Darfeuille-Michaud, Arlette] INRA, USC2018, Clermont Ferrand, France; [Hebuterne, Xavier] CHU Nice, Hop Archet, Dept Gastroenterol, Nice, France; [Hofman, Paul] Pasteur Hosp, CHU Nice, Lab Clin & Expt Pathol & Human Biobank, Human Biobank, Nice, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; CHU Nice; CHU Nice	Mograbi, B (corresponding author), Inst Res Canc & Aging, Nice, France.	mograbi@unice.fr; vouret@unice.fr; hofman.p@chu-nice.fr	Hofman, Paul/P-7654-2018; Mograbi, Baharia/N-5531-2018; Cesaro, Annabelle/AAX-3177-2020; brest, patrick/B-7311-2012; Mograbi, Baharia/Q-7953-2019	Hofman, Paul/0000-0003-0431-9353; brest, patrick/0000-0002-1252-4747; Mograbi, Baharia/0000-0002-1025-3429; Fareh, Mohamed/0000-0001-9551-8213	Infectiopole Sud PACA; Association Francois Aupetit; Institut National de la Sante et de la Recherche Medicale; Agence de l'Environnement et de la Maitrise de l'Energie [08 62 C 0044]; Agence regionale sante Provence Alpes Cote d'Azur and Direction regionale de l'Environnement, de l'amenagement et du logement [6.3.3.3]	Infectiopole Sud PACA; Association Francois Aupetit; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence de l'Environnement et de la Maitrise de l'Energie; Agence regionale sante Provence Alpes Cote d'Azur and Direction regionale de l'Environnement, de l'amenagement et du logement	Funding provided by Infectiopole Sud PACA (A. Chargui: postdoctoral fellowship), Association Francois Aupetit, "Institut National de la Sante et de la Recherche Medicale'', "Agence de l'Environnement et de la Maitrise de l'Energie'' (A B and A. Cesaro: convention ADEME no 08 62 C 0044), "Agence regionale sante Provence Alpes Cote d'Azur and Direction regionale de l'Environnement, de l'amenagement et du logement'' (A B: plan regional sante environnement PRSE PACA no6.3.3.3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Cesaro A, 2010, AM J PHYSIOL-GASTR L, V299, pG32, DOI 10.1152/ajpgi.00282.2009; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hausmann M, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/574568; Hofman P, 1996, AM J PHYSIOL-CELL PH, V271, pC312, DOI 10.1152/ajpcell.1996.271.1.C312; Hofman PM, 2010, WORLD J GASTROENTERO, V16, P5790, DOI 10.3748/wjg.v16.i46.5790; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lapaquette P, 2012, CELL MICROBIOL; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Maianski NA, 2003, BLOOD, V101, P1987, DOI 10.1182/blood-2002-02-0522; MALCOLM ID, 1979, ARCH INTERN MED, V139, P675, DOI 10.1001/archinte.139.6.675; Mihalache CC, 2011, J IMMUNOL, V186, P6532, DOI 10.4049/jimmunol.1004055; Mimouna S, 2011, GUT MICROBES, V2, P335, DOI [10.4161/gmic.18771, 10.4161/gmic.2.6.18771]; Mitroulis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029318; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Panyasrivanit M, 2011, VIROLOGY, V418, P74, DOI 10.1016/j.virol.2011.07.010; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Raso T, 2011, CURR MICROBIOL, V63, P131, DOI 10.1007/s00284-011-9947-8; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Semiramoth N, 2009, J LEUKOCYTE BIOL, V85, P310, DOI 10.1189/jlb.0608350; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; TUCKER KA, 1987, BLOOD, V70, P372; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112	43	49	53	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51727	10.1371/journal.pone.0051727	http://dx.doi.org/10.1371/journal.pone.0051727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272151	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800072
J	Marinkovic, T; Sysi-Aho, M; Oresic, M				Marinkovic, Tijana; Sysi-Aho, Marko; Oresic, Matej			Integrated Model of Metabolism and Autoimmune Response in beta-Cell Death and Progression to Type 1 Diabetes	PLOS ONE			English	Article							AUTO-IMMUNE DISEASE; PROTECTIVE AUTOIMMUNITY; NATURAL-HISTORY; ONSET; CHILDREN	Progression to type 1 diabetes is characterized by complex interactions of environmental, metabolic and immune system factors, involving both degenerative pathways leading to loss of pancreatic beta-cells as well as protective pathways. The interplay between the degenerative and protective pathways may hold the key to disease outcomes, but no models have so far captured the two together. Here we propose a mathematical framework, an ordinary differential equation (ODE) model, which integrates metabolism and the immune system in early stages of disease process. We hypothesize that depending on the degree of regulation, autoimmunity may also play a protective role in the initial response to stressors. We assume that beta-cell destruction follows two paths of loss: degenerative and autoimmune-induced loss. The two paths are mutually competing, leading to termination of the degenerative loss and further to elimination of the stress signal and the autoimmune response, and ultimately stopping the beta-cell loss. The model describes well our observations from clinical and non-clinical studies and allows exploration of how the rate of beta-cell loss depends on the amplitude and duration of autoimmune response.	[Marinkovic, Tijana; Sysi-Aho, Marko; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland	VTT Technical Research Center Finland	Oresic, M (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	matej.oresic@vtt.fi	Oresic, Matej/AAV-3978-2020; Oresic, Matej/K-7673-2016	Oresic, Matej/0000-0002-2856-9165	Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) [250114]	Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research)(Academy of Finland)	The study was supported by Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research 2012-2017, Decision No. 250114, http://www.symmys.fi/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2005, DIABETES, V54, pS25, DOI 10.2337/diabetes.54.suppl_2.S25; BURNET M, 1959, BRIT MED J, V2, P720, DOI 10.1136/bmj.2.5154.720; BURNET M, 1959, BMJ-BRIT MED J, V2, P645, DOI 10.1136/bmj.2.5153.645; De Blasio BF, 1999, DIABETES, V48, P1677, DOI 10.2337/diabetes.48.9.1677; Kimpimaki T, 2002, J CLIN ENDOCR METAB, V87, P4572, DOI 10.1210/jc.2002-020018; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Maree AFM, 2006, PHILOS T R SOC A, V364, P1267, DOI 10.1098/rsta.2006.1769; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Mehta D, 2005, AM J PHYSIOL-LUNG C, V289, pL174, DOI 10.1152/ajplung.00165.2005; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NERUP J, 1988, DIABETES CARE, V11, P16; NERUP J, 1994, DIABETOLOGIA, V37, pS82, DOI 10.1007/BF00400830; Nevo U, 2003, TRENDS MOL MED, V9, P88, DOI 10.1016/S1471-4914(03)00024-8; Nevo U, 2004, J THEOR BIOL, V227, P583, DOI 10.1016/j.jtbi.2003.11.031; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; Schwartz M, 2003, TRENDS NEUROSCI, V26, P297, DOI 10.1016/S0166-2236(03)00126-7; Selivanov VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001115; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Topp B, 2000, J THEOR BIOL, V206, P605, DOI 10.1006/jtbi.2000.2150; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001	24	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51909	10.1371/journal.pone.0051909	http://dx.doi.org/10.1371/journal.pone.0051909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251651	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800107
J	Papazi, A; Assimakopoulos, K; Kotzabasis, K				Papazi, Aikaterini; Assimakopoulos, Konstantinos; Kotzabasis, Kiriakos			Bioenergetic Strategy for the Biodegradation of p-Cresol by the Unicellular Green Alga Scenedesmus obliquus	PLOS ONE			English	Article							BACTERIAL-DEGRADATION; ALCALIGENES-EUTROPHUS; PHENOLIC-COMPOUNDS; CLEAVAGE PATHWAY; ADJUST; MICROALGAE; METHANOL; PSEUDOMONAS; CARBON; LIGHT	Cultures from the unicellular green alga Scenedesmus obliquus biodegrade the toxic p-cresol (4-methylphenol) and use it as alternative carbon/energy source. The biodegradation procedure of p-cresol seems to be a two-step process. HPLC analyses indicate that the split of the methyl group (first step) that is possibly converted to methanol (increased methanol concentration in the growth medium), leading, according to our previous work, to changes in the molecular structure and function of the photosynthetic apparatus and therefore to microalgal biomass increase. The second step is the fission of the intermediately produced phenol. A higher p-cresol concentration results in a higher p-cresol biodegradation rate and a lower total p-cresol biodegradability. The first biodegradation step seems to be the most decisive for the effectiveness of the process, because methanol offers energy for the further biodegradation reactions. The absence of LHCII from the Scenedesmus mutant wt-lhc stopped the methanol effect and significantly reduced the p-cresol biodegradation (only 9%). The present contribution deals with an energy distribution between microalgal growth and p-cresol biodegradation, activated by p-cresol concentration. The simultaneous biomass increase with the detoxification of a toxic phenolic compound (p-cresol) could be a significant biotechnological aspect for further applications. Citation: Papazi A, Assimakopoulos K, Kotzabasis K (2012) Bioenergetic Strategy for the Biodegradation of p-Cresol by the Unicellular Green Alga Scenedesmus obliquus. PLoS ONE 7(12): e51852. doi:10.1371/journal.pone.0051852	[Papazi, Aikaterini; Assimakopoulos, Konstantinos; Kotzabasis, Kiriakos] Univ Crete, Dept Biol, Iraklion, Crete, Greece	University of Crete	Kotzabasis, K (corresponding author), Univ Crete, Dept Biol, Iraklion, Crete, Greece.	kotzab@biology.uoc.gr	Kotzabasis, Kiriakos/AAP-1448-2021	Kotzabasis, Kiriakos/0000-0002-1002-6365				Aaronson S., 1980, ALGAE BIOMASS PROD; Ahamad PYA, 1999, WORLD J MICROB BIOT, V15, P321, DOI 10.1023/A:1008821120432; BISCHOFF H, 1963, U TEXAS PUBL, V6318, P1, DOI DOI 10.1016/J.CEJ.2012.11.063; Bishop NL, 1971, PREPARATION PHOTOSYN; BRUCE NC, 1989, BIOCHEM J, V262, P303, DOI 10.1042/bj2620303; BUCKMAN NG, 1984, J CHROMATOGR, V284, P441, DOI 10.1016/S0021-9673(01)87845-6; DAGLEY S, 1957, BIOCHEM J, V66, P227, DOI 10.1042/bj0660227; DELIEU T, 1981, NEW PHYTOL, V89, P165, DOI 10.1111/j.1469-8137.1981.tb07480.x; Dernetriou G, 2007, BBA-BIOENERGETICS, V1767, P272, DOI 10.1016/j.bbabio.2007.02.020; Diaz E, 2004, INT MICROBIOL, V7, P173; Gaffron H, 1939, BIOL ZENTRALBL, V43, P402; HAGGBLOM M, 1990, J BASIC MICROB, V30, P115, DOI 10.1002/jobm.3620300214; Holden M, 1965, CHLOROPHYLL CHEM BIO, P462; HUGHES EJL, 1983, J BACTERIOL, V154, P1363, DOI 10.1128/JB.154.3.1363-1370.1983; James MO, 1977, XENOBIOTIC METABOLIZ, P171; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; JOHNSON BF, 1971, J BACTERIOL, V107, P468, DOI 10.1128/JB.107.2.468-475.1971; Ke L, BIORESOUR TECHNOL, V101, P6961; KNACKMUSS HJ, 1978, ARCH MICROBIOL, V117, P1, DOI 10.1007/BF00689343; KOBAYASHI H, 1982, ENVIRON SCI TECHNOL, V16, pA170, DOI 10.1021/es00097a002; Komossa D, 1995, METABOLIC PROCESSES, P69; Kotzabasis K, 1999, J BIOTECHNOL, V70, P357, DOI 10.1016/S0168-1656(99)00088-7; Kuhl A, 1962, PHYSL SPEICHERUNG KO, P157; Lima SAC, 2004, WATER RES, V38, P97, DOI 10.1016/j.watres.2003.09.005; Lovell CR, 2002, MAR ECOL PROG SER, V229, P11, DOI 10.3354/meps229011; Lutz C, 2005, BBA-BIOENERGETICS, V1710, P24, DOI 10.1016/j.bbabio.2005.09.001; Navakoudis E, 2007, BBA-BIOENERGETICS, V1767, P948, DOI 10.1016/j.bbabio.2007.05.003; Oswald W.J., 1957, T AM SOC CIV ENG, V122, P73, DOI [DOI 10.1061/TACEAT.0007483, 10.1061/TACEAT.0007483]; Papazi A, 2008, J BIOTECHNOL, V135, P366, DOI 10.1016/j.jbiotec.2008.05.009; Papazi A, 2007, J BIOTECHNOL, V129, P706, DOI 10.1016/j.jbiotec.2007.02.021; PIEPER DH, 1985, FEMS MICROBIOL LETT, V29, P63; Pinto G, 2002, BIOTECHNOL LETT, V24, P2047, DOI 10.1023/A:1021367304315; POWLOWSKI JB, 1985, J BACTERIOL, V163, P1126, DOI 10.1128/JB.163.3.1126-1135.1985; ROJO F, 1987, SCIENCE, V238, P1395, DOI 10.1126/science.3479842; Safonova E, 2005, ENG LIFE SCI, V5, P234, DOI 10.1002/elsc.200520077; Semple KT, 1996, APPL ENVIRON MICROB, V62, P1265, DOI 10.1128/AEM.62.4.1265-1273.1996; SENGER H, 1986, PHYSIOL PLANTARUM, V68, P119, DOI 10.1111/j.1399-3054.1986.tb06605.x; Sfichi L, 2004, PHOTOCHEM PHOTOBIOL, V80, P499, DOI 10.1562/0031-8655(2004)080<0499:TPATUS>2.0.CO;2; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; TAEGER K, 1988, APPL MICROBIOL BIOT, V28, P603, DOI 10.1007/BF00250420; Tallur PN, 2006, CURR MICROBIOL, V53, P529, DOI 10.1007/s00284-006-0309-x; Theodoridou A, 2002, BBA-GEN SUBJECTS, V1573, P189, DOI 10.1016/S0304-4165(02)00438-5; Thies F, 1996, PLANT PHYSIOL, V112, P361, DOI 10.1104/pp.112.1.361; WOOD PJ, 1971, ANAL BIOCHEM, V39, P418, DOI 10.1016/0003-2697(71)90432-5; Yan H, 2004, CHEMOSPHERE, V55, P1281, DOI 10.1016/j.chemosphere.2003.12.019	45	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51852	10.1371/journal.pone.0051852	http://dx.doi.org/10.1371/journal.pone.0051852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251641	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800098
J	Taylor, AE; Kuper, H; Varma, RD; Wells, JC; Bell, JD; Radhakrishna, KV; Kulkarni, B; Kinra, S; Timpson, NJ; Ebrahim, S; Smith, GD; Ben-Shlomo, Y				Taylor, Amy E.; Kuper, Hannah; Varma, Ravi D.; Wells, Jonathan C.; Bell, Jimmy D.; Radhakrishna, K. V.; Kulkarni, Bharati; Kinra, Sanjay; Timpson, Nicholas J.; Ebrahim, Shah; Smith, George Davey; Ben-Shlomo, Yoav			Validation of Dual Energy X-Ray Absorptiometry Measures of Abdominal Fat by Comparison with Magnetic Resonance Imaging in an Indian Population	PLOS ONE			English	Article							TOTAL-BODY FAT; ADIPOSE-TISSUE; 4-COMPARTMENT MODEL; COMPUTED-TOMOGRAPHY; INSULIN-RESISTANCE; ASIAN INDIANS; VISCERAL FAT; SOFT-TISSUE; DXA; WOMEN	Objective: Abdominal adiposity is an important risk factor for diabetes and cardiovascular disease in Indians. Dual energy Xray absorptiometry (DXA) can be used to determine abdominal fat depots, being more accessible and less costly than gold standard measures such as magnetic resonance imaging (MRI). DXA has not been fully validated for use in South Asians. Here, we determined the accuracy of DXA for measurement of abdominal fat in an Indian population by comparison with MRI. Design: 146 males and females (age range 18-74, BMI range 15-46 kg/m(2)) from Hyderabad, India underwent whole body DXA scans on a Hologic Discovery A scanner, from which fat mass in two abdominal regions was calculated, from the L1 to L4 vertebrae (L1L4) and from the L2 to L4 vertebrae (L2L4). Abdominal MRI scans (axial T1-weighted spin echo images) were taken, from which adipose tissue volumes were calculated for the same regions. Results: Intra-class correlation coefficients between DXA and MRI measures of abdominal fat were high (0.98 for both regions). Although at the level of the individual, differences between DXA and MRI could be large (95% of DXA measures were between 0.8 and 1.4 times MRI measures), at the sample level, DXA only slightly overestimated MRI measures of abdominal fat mass (mean difference in L1L4 region: 2% (95% CI: 0%, 5%), mean difference in L2L4 region: 4% (95% CI: 1%, 7%)). There was evidence of a proportional bias in the association between DXA and MRI (correlation between difference and mean 20.3), with overestimation by DXA greater in individuals with less abdominal fat (mean bias in leaner half of sample was 6% for L1L4 (95% CI: 2, 11%) and 7% for L2L4 (95% CI: 3,12%). Conclusions: DXA measures of abdominal fat are suitable for use in Indian populations and provide a good indication of abdominal adiposity at the population level. Citation: Taylor AE, Kuper H, Varma RD, Wells JC, Bell JD, et al. (2012) Validation of Dual Energy X-Ray Absorptiometry Measures of Abdominal Fat by Comparison with Magnetic Resonance Imaging in an Indian Population. PLoS ONE 7(12): e51042. doi:10.1371/journal.pone.0051042	[Taylor, Amy E.; Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Kuper, Hannah] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Varma, Ravi D.] Krishna Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Wells, Jonathan C.] Childrens Nutr Res Ctr, Inst Child Hlth, London, England; [Bell, Jimmy D.] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Metab & Mol Imaging Grp, London, England; [Radhakrishna, K. V.; Kulkarni, Bharati] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Kinra, Sanjay; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Ebrahim, Shah] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India	University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Imperial College London; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Taylor, AE (corresponding author), Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England.	amy.taylor@bristol.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Fox, Laura J/C-6249-2016; Kulkarni, Bharati/ABB-3188-2020; Kulkarni, Bharati/C-9036-2011; Wells, Jonathan/A-4604-2009; Attrill, Lauren/V-1688-2018; Timpson, Nicholas John/O-7548-2015; Davey Smith, George/A-7407-2013	Ben-Shlomo, Yoav/0000-0001-6648-3007; Kulkarni, Bharati/0000-0003-0636-318X; Kulkarni, Bharati/0000-0003-0636-318X; Wells, Jonathan/0000-0003-0411-8025; Timpson, Nicholas John/0000-0002-7141-9189; Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Bell, Jimmy/0000-0003-3804-1281; s, hema/0000-0002-3440-9475	Wellcome Trust Grant [WT083707MA]; Wellcome Trust PhD Studentship [WT083431MA]; UK Medical Research Council [G0600705]; MRC; National Institute of Nutrition; Medical Research Council [MC_U120061305, G0600705] Funding Source: researchfish; MRC [G0600705, MC_U120061305] Funding Source: UKRI	Wellcome Trust Grant(Wellcome Trust); Wellcome Trust PhD Studentship(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Nutrition; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Hyderabad DXA Study was funded by a Wellcome Trust Grant (WT083707MA). Amy Taylor is funded by a 4 year Wellcome Trust PhD Studentship (WT083431MA). The MRC Centre for Causal Analyses in Translational Epidemiology (CAiTE) receives funds from the UK Medical Research Council (G0600705). The MRC Clinical Sciences Centre acknowledges funding from the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participants of the Hyderabad DXA Study and the field staff at the National Institute of Nutrition who carried out the data collection for the Hyderabad DXA Study. We are grateful to the National Institute of Nutrition for supporting the running of the Hyderabad DXA Study. We would also like to thank employees at the Krishna Institute of Medical Sciences who performed the MRI scans.	Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7; Anjana M, 2004, DIABETES CARE, V27, P2948, DOI 10.2337/diacare.27.12.2948; Benfield LL, 2009, INT J BODY COMPOSITI, V7, P131; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Browning LM, 2011, OBESITY FACTS, V4, P9, DOI 10.1159/000324546; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Despres JP, 1996, HUMAN BODY COMPOSITI, P149; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; ENTENMAN C, 1958, J APPL PHYSIOL, V13, P129, DOI 10.1152/jappl.1958.13.1.129; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; Goel K, 2008, OBESITY, V16, P451, DOI 10.1038/oby.2007.55; International Atomic Energy Agency, 2012, RAD PROT DXA PREGN; JENSEN MD, 1995, AM J CLIN NUTR, V61, P274, DOI 10.1093/ajcn/61.2.274; Kamel EG, 1999, INT J OBESITY, V23, P686, DOI 10.1038/sj.ijo.0800904; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; LaForgia J, 2009, OBESITY, V17, P821, DOI 10.1038/oby.2008.595; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Litaker MS, 2003, OBES RES, V11, P1545, DOI 10.1038/oby.2003.206; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Nelson TL, 2008, DIABETES-METAB RES, V24, P33, DOI 10.1002/dmrr.747; O'Connor DP, 2011, MED SCI SPORT EXER, V43, P1785, DOI 10.1249/MSS.0b013e318216d90f; Paradisi G, 1999, DIABETES CARE, V22, P1310, DOI 10.2337/diacare.22.8.1310; ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Sakai Y, 2006, J CLIN DENSITOM, V9, P191, DOI 10.1016/j.jocd.2006.03.008; Scherzer R, 2008, AM J CLIN NUTR, V88, P1088, DOI 10.1093/ajcn/88.4.1088; Shen W, 2003, OBES RES, V11, P5, DOI 10.1038/oby.2003.3; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; SOHLSTROM A, 1993, AM J CLIN NUTR, V58, P830, DOI 10.1093/ajcn/58.6.830; Sopher AB, 2004, PEDIATRICS, V113, P1285, DOI 10.1542/peds.113.5.1285; SVENDSEN OL, 1993, INT J OBESITY, V17, P45; Thomas EL, 2003, INT J OBESITY, V27, P211, DOI 10.1038/sj.ijo.802229; Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778; THOMAS LW, 1962, Q J EXP PHYSIOL CMS, V47, P179, DOI 10.1113/expphysiol.1962.sp001589; Thomsen TK, 1998, EUR J SURG, V164, P133; TOTHILL P, 1994, EUR J CLIN NUTR, V48, P781; Tothill P, 2000, ANN NY ACAD SCI, V904, P63; Tothill P, 1998, APPL RADIAT ISOTOPES, V49, P457, DOI 10.1016/S0969-8043(97)00053-5; Van der Ploeg GE, 2003, J APPL PHYSIOL, V94, P499, DOI 10.1152/japplphysiol.00436.2002; VANLOAN MD, 1995, MED SCI SPORT EXER, V27, P587; Williams JE, 2006, AM J CLIN NUTR, V83, P1047, DOI 10.1093/ajcn/83.5.1047	45	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51042	10.1371/journal.pone.0051042	http://dx.doi.org/10.1371/journal.pone.0051042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272086	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000312386800025
J	Kordes, C; Sawitza, I; Gotze, S; Haussinger, D				Kordes, Claus; Sawitza, Iris; Goetze, Silke; Haeussinger, Dieter			Stellate Cells from Rat Pancreas Are Stem Cells and Can Contribute to Liver Regeneration	PLOS ONE			English	Article							FAT-STORING CELLS; PROGENITOR CELLS; IN-VITRO; NESTIN EXPRESSION; EPITHELIAL-CELLS; OVAL CELLS; ADULT-RAT; DIFFERENTIATION; LINEAGE; ISLETS	The identity of pancreatic stem/progenitor cells is still under discussion. They were suggested to derive from the pancreatic ductal epithelium and/or islets. Here we report that rat pancreatic stellate cells (PSC), which are thought to contribute to pancreatic fibrosis, have stem cell characteristics. PSC reside in islets and between acini and display a gene expression pattern similar to umbilical cord blood stem cells and mesenchymal stem cells. Cytokine treatment of isolated PSC induced the expression of typical hepatocyte markers. The PSC-derived hepatocyte-like cells expressed endodermal proteins such as bile salt export pump along with the mesodermal protein vimentin. The transplantation of culture-activated PSC from enhanced green fluorescent protein-expressing rats into wild type rats after partial hepatectomy in the presence of 2-acetylaminofluorene revealed that PSC were able to reconstitute large areas of the host liver through differentiation into hepatocytes and cholangiocytes. This developmental fate of transplanted PSC was confirmed by fluorescence in situ hybridization of chromosome Y after gender-mismatched transplantation of male PSC into female rats. Transplanted PSC displayed long-lasting survival, whereas muscle fibroblasts were unable to integrate into the host liver. The differentiation potential of PSC was further verified by the transplantation of clonally expanded PSC. PSC clones maintained the expression of stellate cell and stem cell markers and preserved their differentiation potential, which indicated self-renewal potential of PSC. These findings demonstrate that PSC have stem cell characteristics and can contribute to the regeneration of injured organs through differentiation across tissue boundaries. Citation: Kordes C, Sawitza I, Gotze S, Haussinger D (2012) Stellate Cells from Rat Pancreas Are Stem Cells and Can Contribute to Liver Regeneration. PLoS ONE 7(12): e51878. doi: 10.1371/journal.pone.0051878	[Kordes, Claus; Sawitza, Iris; Goetze, Silke; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Kordes, Claus/AFM-1775-2022	Kordes, Claus/0000-0003-0782-1998	German Research Foundation through the Collaborative Research Center CRC [974]; Research Commission of the Medical Faculty of the Heinrich Heine University Dusseldorf	German Research Foundation through the Collaborative Research Center CRC; Research Commission of the Medical Faculty of the Heinrich Heine University Dusseldorf	This work was supported by the German Research Foundation through the Collaborative Research Center CRC 974 ("Communication and Systems Relevance during Liver Injury and Regeneration") and the Research Commission of the Medical Faculty of the Heinrich Heine University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; BISGAARD HC, 1991, J CELL PHYSIOL, V147, P333, DOI 10.1002/jcp.1041470220; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; FITZGERALD PJ, 1952, NATURE, V170, P929, DOI 10.1038/170929b0; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GARD AL, 1985, J NEUROIMMUNOL, V8, P359, DOI 10.1016/S0165-5728(85)80073-4; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Higgins GM, 1931, ARCH PATHOL, V12, P186; IKEJIRI N, 1990, Kurume Medical Journal, V37, P67, DOI 10.2739/kurumemedj.37.67; Karanu FN, 2003, LEUKEMIA, V17, P1366, DOI 10.1038/sj.leu.2402973; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Kubitz R, 2004, GASTROENTEROLOGY, V126, P541, DOI 10.1053/j.gastro.2003.11.003; Lange C, 2005, TRANSPL P, V37, P276, DOI 10.1016/j.transproceed.2004.11.087; Lardon J, 2002, HISTOCHEM CELL BIOL, V117, P535, DOI 10.1007/s00418-002-0412-4; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Niki T, 1999, HEPATOLOGY, V29, P520, DOI 10.1002/hep.510290232; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; POUR P, 1978, AM J PATHOL, V90, P295; Ramiya VK, 2000, NAT MED, V6, P278; Rao MS, 1996, GENE EXPRESSION, V6, P15; RAO MS, 1989, AM J PATHOL, V134, P1069; REDDY JK, 1991, DIGEST DIS SCI, V36, P502, DOI 10.1007/BF01298883; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; TATEMATSU M, 1984, AM J PATHOL, V114, P418; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Uyama N, 2006, GUT, V55, P1276, DOI 10.1136/gut.2005.078865; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425; Zhang QH, 2007, DNA CELL BIOL, V26, P497, DOI 10.1089/dna.2006.0562; Zhao LN, 2007, J MOL HISTOL, V38, P53, DOI 10.1007/s10735-007-9078-5; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	39	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51878	10.1371/journal.pone.0051878	http://dx.doi.org/10.1371/journal.pone.0051878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272184	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600046
J	Anandakrishnan, R				Anandakrishnan, Ramu			A Partition Function Approximation Using Elementary Symmetric Functions	PLOS ONE			English	Article							MONTE-CARLO; COMPUTATIONAL-COMPLEXITY; CRYSTAL STATISTICS; PK(A) VALUES; SPIN SYSTEMS; ISING-MODEL; SIMULATIONS; IDENTITIES; RANGE	In statistical mechanics, the canonical partition function Z can be used to compute equilibrium properties of a physical system. Calculating Z however, is in general computationally intractable, since the computation scales exponentially with the number of particles N in the system. A commonly used method for approximating equilibrium properties, is the Monte Carlo (MC) method. For some problems the MC method converges slowly, requiring a very large number of MC steps. For such problems the computational cost of the Monte Carlo method can be prohibitive. Presented here is a deterministic algorithm - the direct interaction algorithm (DIA) - for approximating the canonical partition function Z in similar to N-2 operations. The DIA approximates the partition function as a combinatorial sum of products known as elementary symmetric functions (ESFs), which can be computed in similar to N-2 operations. The DIA was used to compute equilibrium properties for the isotropic 2D Ising model, and the accuracy of the DIA was compared to that of the basic Metropolis Monte Carlo method. Our results show that the DIA may be a practical alternative for some problems where the Monte Carlo method converge slowly, and computational speed is a critical constraint, such as for very large systems or web-based applications.	Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Anandakrishnan, R (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	ramu@vt.edu	Anandakrishnan, Ramu/AAB-9040-2020	Anandakrishnan, Ramu/0000-0003-0422-3984				Anandakrishnan R, 2008, J COMPUT BIOL, V15, P165, DOI 10.1089/cmb.2007.0144; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Baker FB, 1996, APPL PSYCH MEAS, V20, P169, DOI 10.1177/014662169602000206; Bakk A, 2003, PHYSICA A, V323, P504, DOI 10.1016/S0378-4371(03)00018-9; BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; BASHFORD D, 1993, BIOCHEMISTRY-US, V32, P8045, DOI 10.1021/bi00082a027; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Beale PD, 1996, PHYS REV LETT, V76, P78, DOI 10.1103/PhysRevLett.76.78; Binder K, 1997, MONTE CARLO SIMULATI; Blote HWJ, 2002, COMPUT PHYS COMMUN, V147, P58, DOI 10.1016/S0010-4655(02)00204-7; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; CIPRA B. A., 2000, SIAM NEWS, V33, P1; Garliauskas A., 2006, Nonlinear Analysis Modelling and Control, V11, P367; Glazer MA, 2001, STAT MECH SURVIVAL G; Goldberg LA, 2003, RANDOM STRUCT ALGOR, V23, P133, DOI 10.1002/rsa.10090; KAUFMAN B, 1949, PHYS REV, V76, P1232, DOI 10.1103/PhysRev.76.1232; Kilambi KP, 2012, BIOPHYS J, V103, P587, DOI 10.1016/j.bpj.2012.06.044; Kittel C, 1980, THERMAL PHYS; Krauth W, 2006, STAT MECH ALGORITHMS; Landau DP, 2004, AM J PHYS, V72, P1294, DOI 10.1119/1.1707017; MCCOY B. M., 2013, 2 DIMENSIONAL ISING, DOI [10.4159/harvard.9780674180758, DOI 10.4159/HARVARD.9780674180758]; MEAD DG, 1992, AM MATH MON, V99, P749, DOI 10.2307/2324242; Nayfonov A, 1998, ASTROPHYS J, V499, P489, DOI 10.1086/305607; Onsager L, 1944, PHYS REV, V65, P117, DOI 10.1103/PhysRev.65.117; Pathria R. K., 2011, STAT MECH; ROBINSON DW, 1961, AM MATH MON, V68, P367, DOI 10.2307/2311593; Wang FG, 2001, PHYS REV LETT, V86, P2050, DOI 10.1103/PhysRevLett.86.2050; WOLFF U, 1989, PHYS REV LETT, V62, P361, DOI 10.1103/PhysRevLett.62.361; [No title captured]	30	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51352	10.1371/journal.pone.0051352	http://dx.doi.org/10.1371/journal.pone.0051352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251504	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200093
J	Bruno, R; Andrews, A; Garvey, B; Huntoon, K; Mazumder, R; Olson, J; Sanders, D; Weinbaum, I; Gorman, P				Bruno, Richard; Andrews, Allen; Garvey, Brian; Huntoon, Kristin; Mazumder, Rajarshi; Olson, Jaleh; Sanders, David; Weinbaum, Ilana; Gorman, Paul			Videotaped Patient Stories: Impact on Medical Students' Attitudes Regarding Healthcare for the Uninsured and Underinsured	PLOS ONE			English	Article							UNDERSERVED PATIENTS	The attitudes of medical students toward the current United States healthcare system are not well described in the literature. A graded survey was developed to assess awareness and motivation toward the care of the uninsured and underinsured as well as the impact of a video intervention on these attitudes. The survey, which showed good internal consistency (Cronbach's alpha = 0.85), was administered before and after viewing a collection of videotaped patient stories. Although a spectrum of beliefs emerged from the analysis of survey responses, some common attitudes were identified. Eighty-five percent of respondents either agreed or strongly agreed that medical care should be provided to everyone, regardless of their ability to pay. In addition, 66% indicated they would be willing to forgo a portion of their income to provide care to those who do not have access to healthcare services. These values were strongly correlated with increasing respondent age and primary care specialty choice (p < 0.01). The video intervention did not heavily influence student responses, perhaps due to a ceiling effect created by the large number of students who were already sympathetic toward the underserved. Overall, this data reflects that United States medical students recognize a need to provide care to the underserved and are willing to make personal sacrifices to meet that need.	[Bruno, Richard; Andrews, Allen; Garvey, Brian; Mazumder, Rajarshi; Olson, Jaleh; Sanders, David; Weinbaum, Ilana; Gorman, Paul] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA; [Huntoon, Kristin] New York Coll Osteopath Med, Old Westbury, NY USA; [Gorman, Paul] OHSU Dept Med Informat & Clin Epidemiol, Portland, OR USA	Oregon Health & Science University; New York Institute Technology	Bruno, R (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA.	brunor@ohsu.edu		Huntoon, Kristin/0000-0002-7211-8986; Garvey, Brian/0000-0002-1151-5531; Mazumder, Rajarshi/0000-0002-0489-5089; Bruno, Richard/0000-0001-9803-2876	Robert L. Bacon Endowment Fund for Medical Education Enrichment	Robert L. Bacon Endowment Fund for Medical Education Enrichment	This study was funded by the Robert L. Bacon Endowment Fund for Medical Education Enrichment. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMC, 2006, TABL 26 TOT ACT ENR; Cooney N., 2011, CHANGE HEART WHAT PS; CRANDALL SJS, 1993, JAMA-J AM MED ASSOC, V269, P2519; Crandall SJS, 2007, ADV HEALTH SCI EDUC, V12, P71, DOI 10.1007/s10459-005-2297-1; DeNavas-Walt C. PB, 2010, US CENSUS BUREAU CUR, P60; Frank E, 2008, PREV MED, V47, P140, DOI 10.1016/j.ypmed.2007.12.015; Huntoon KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023557; LERNER MJ, 1966, J PERS SOC PSYCHOL, V4, P203, DOI 10.1037/h0023562; Newton BW, 2008, ACAD MED, V83, P244, DOI 10.1097/ACM.0b013e3181637837; Ross PT, 2010, J NATL MED ASSOC, V102, P761, DOI 10.1016/S0027-9684(15)30672-6; Sigerist H. E., 1941, MED HUMAN WELFARE; Wayne S, 2010, J HEALTH CARE POOR U, V21, P438, DOI 10.1353/hpu.0.0317; Wieland ML, 2010, MAYO CLIN PROC, V85, P728, DOI 10.4065/mcp.2009.0703; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; Xul Solar Bell, 2010, BELL	15	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51827	10.1371/journal.pone.0051827	http://dx.doi.org/10.1371/journal.pone.0051827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251636	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200169
J	Hornak, K; Corno, G				Hornak, Karel; Corno, Gianluca			Every Coin Has a Back Side: Invasion by Limnohabitans planktonicus Promotes the Maintenance of Species Diversity in Bacterial Communities	PLOS ONE			English	Article							SPRING PHYTOPLANKTON BLOOM; FRESH-WATER RESERVOIR; ECOSYSTEM ENGINEERS; IN-SITU; AEROMONAS-HYDROPHILA; BIOLOGICAL INVASIONS; PLANT INVASIONS; GROWTH; BACTERIOPLANKTON; PRODUCTIVITY	One of the earliest challenges for ecologists has been to study the impact of invasive species on microbial communities. Although bacteria are fundamental in biological processes, current knowledge on invasion effects by aquatic nonpathogenic bacteria is still limited. Using pure cultures of diverse planktonic bacteria as model organisms at two different carbon concentration levels, we tested the response of an assembled community to the invasion by Limnohabitans planktonicus, an opportunistic bacterium, successful in freshwaters. The invader, introduced at the early stationary growth phase of the resident community, caused a strong decrement of the abundance of the dominant species. This was due to competition for nutrients and a potential allelopathic interaction. Simultaneously, resident species formerly unable to successfully compete within the community, thus potentially exposed to competitive exclusion, increased their abundances. The overall result of the invasion was preservation of species diversity, the higher the lower was the substrate content available. Our study provides new insights into bacterial invasions, offering an alternative interpretation of invasions for community ecology.	[Hornak, Karel] Acad Sci Czech Republic, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic; [Hornak, Karel] Univ Zurich, Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland; [Corno, Gianluca] CNR, Inst Ecosyst Study, Verbania, Italy	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Zurich; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR)	Hornak, K (corresponding author), Acad Sci Czech Republic, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic.	hornak@hbu.cas.cz	Corno, Gianluca/K-1658-2018; CORNO, GIANLUCA/AAB-8889-2019	Corno, Gianluca/0000-0002-7423-8797; CORNO, GIANLUCA/0000-0002-7423-8797	CNR Institute of Ecosystem Study - Short Term mobility project; Czech Science Foundation [GAP504/10/1534]	CNR Institute of Ecosystem Study - Short Term mobility project; Czech Science Foundation(Grant Agency of the Czech Republic)	The study was supported by the CNR Institute of Ecosystem Study - Short Term mobility project 2011 awarded to G. C., and by the Czech Science Foundation under project GAP504/10/1534 awarded to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom JF, 2010, ENVIRON MICROBIOL, V12, P2486, DOI 10.1111/j.1462-2920.2010.02222.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Castilla JC, 2004, MAR ECOL PROG SER, V268, P119, DOI 10.3354/meps268119; Corno G, 2008, ENVIRON MICROBIOL, V10, P2857, DOI 10.1111/j.1462-2920.2008.01713.x; Corno G, 2008, J LIMNOL, V67, P107, DOI 10.4081/jlimnol.2008.107; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Davies KF, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P237; Eckert EM, 2012, ENVIRON MICROBIOL, V14, P794, DOI 10.1111/j.1462-2920.2011.02639.x; Glockner FO, 1998, APPL ENVIRON MICROB, V64, P1895; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P2946, DOI 10.1099/ijs.0.022384-0; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hervas A, 2009, ENVIRON MICROBIOL, V11, P1612, DOI 10.1111/j.1462-2920.2009.01926.x; Hodgson DJ, 2002, P ROY SOC B-BIOL SCI, V269, P2277, DOI 10.1098/rspb.2002.2146; Hornak K, 2006, AQUAT MICROB ECOL, V45, P277, DOI 10.3354/ame045277; Hutchinson G. E., 1967, TREATISE LIMNOLOGY; Jagmann N, 2010, ENVIRON MICROBIOL, V12, P1787, DOI 10.1111/j.1462-2920.2010.02271.x; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jezbera J, 2006, ENVIRON MICROBIOL, V8, P1330, DOI 10.1111/j.1462-2920.2006.01026.x; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jousset A, 2011, ISME J, V5, P1108, DOI 10.1038/ismej.2011.9; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; Kneitel JM, 2003, AM NAT, V162, P165, DOI 10.1086/376585; KRATZ TK, 1987, AM NAT, V129, P830, DOI 10.1086/284678; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lindstrom ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025883; Litchman E, 2010, ECOL LETT, V13, P1560, DOI 10.1111/j.1461-0248.2010.01544.x; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336; RIPPEY SR, 1980, MICROBIAL ECOL, V6, P45, DOI 10.1007/BF02020374; ROLLER C, 1994, MICROBIOL-UK, V140, P2849, DOI 10.1099/00221287-140-10-2849; Sekar R, 2003, APPL ENVIRON MICROB, V69, P2928, DOI 10.1128/AEm.69.5.2928-2935.2003; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Simek K, 2010, APPL ENVIRON MICROB, V76, P1406, DOI 10.1128/AEM.02517-09; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Wonham MJ, 2005, MAR ECOL PROG SER, V289, P109, DOI 10.3354/meps289109; Zeder M, 2009, ENVIRON MICROBIOL, V11, P2676, DOI 10.1111/j.1462-2920.2009.01994.x; Zotina T, 2003, FRESHWATER BIOL, V48, P1859, DOI 10.1046/j.1365-2427.2003.01134.x	49	16	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51576	10.1371/journal.pone.0051576	http://dx.doi.org/10.1371/journal.pone.0051576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251582	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000313236200138
J	Le Tourneau, C; Gan, HK; Razak, ARA; Paoletti, X				Le Tourneau, Christophe; Gan, Hui K.; Razak, Albiruni R. A.; Paoletti, Xavier			Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents	PLOS ONE			English	Article							CANCER CLINICAL-TRIALS; CONTINUAL REASSESSMENT METHOD; TOXICITY; EFFICACY	Background: Statistical simulations have consistently demonstrated that new dose-escalation designs such as accelerated titration design (ATD) and continual reassessment method (CRM)-type designs outperform the standard "3+3" design in phase I cancer clinical trials. Methods: We evaluated the actual efficiency of different dose escalation methods employed in first-in-human phase I clinical trials of targeted agents administered as single agents published over the last decade. Results: Forty-nine per cent of the 84 retrieved trials used the standard "3+3" design. Newer designs used included ATD in 42%, modified CRM [mCRM] in 7%, and pharmacologically guided dose escalation in 1%. The median numbers of dose levels explored in trials using "3+3", ATD and mCRM designs were 6, 8 and 10, respectively. More strikingly, the mean MTD to starting dose ratio appeared to be at least twice as high for trials using mCRM or ATD designs as for trials using a standard "3+3" design. Despite this, the mean number of patients exposed to a dose below the MTD was similar in trials using "3+3", ATD and mCRM designs. Conclusion: Our results support a more extensive implementation of innovative dose escalation designs such as mCRM and ATD in phase I cancer clinical trials of molecularly targeted agents.	[Le Tourneau, Christophe] Inst Curie, Dept Med Oncol, Paris, France; [Gan, Hui K.] Austin Hosp, Joint Austin Ludwig Oncol Unit, Melbourne, Vic 3084, Australia; [Razak, Albiruni R. A.] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M4X 1K9, Canada; [Paoletti, Xavier] Inst Curie, Dept Biostat, Paris, France; [Le Tourneau, Christophe; Paoletti, Xavier] Inst Curie, INSERM, U900, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Florey Institute of Neuroscience & Mental Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Le Tourneau, C (corresponding author), Inst Curie, Dept Med Oncol, Paris, France.	Christophe.LeTourneau@curie.net	Abdul Razak, Albiruni Ryan/C-4608-2015; Gan, Hui/C-5407-2013	Abdul Razak, Albiruni Ryan/0000-0001-7657-9950; Gan, Hui/0000-0001-7319-8546	Institut National du Cancer [2010-1-PL SHS-06-IC-1]	Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by a grant from the Institut National du Cancer (#2010-1-PL SHS-06-IC-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung YK, 2000, BIOMETRICS, V56, P1177, DOI 10.1111/j.0006-341X.2000.01177.x; Eckhardt SG, 1999, P AM SOC CLIN ONCOL; Hunsberger S, 2005, STAT MED, V24, P2171, DOI 10.1002/sim.2102; Iasonos A, 2008, CLIN TRIALS, V5, P465, DOI 10.1177/1740774508096474; Le Tourneau C, 2011, EUR J CANCER, V47, P1468, DOI 10.1016/j.ejca.2011.03.016; Le Tourneau C, 2010, J CLIN ONCOL, V28, P1401, DOI 10.1200/JCO.2009.25.9606; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; O'Quigley J, 2003, BIOMETRICS, V59, P430, DOI 10.1111/1541-0420.00050; Postel-Vinay S, 2011, J CLIN ONCOL, V29, P1728, DOI 10.1200/JCO.2010.31.9236; Rogatko A, 2007, J CLIN ONCOL, V25, P4982, DOI 10.1200/JCO.2007.12.1012; Thall PF, 2004, BIOMETRICS, V60, P684, DOI 10.1111/j.0006-341X.2004.00218.x; Walling J, 1997, P AM SOC CLIN ONCOL; Yin GS, 2006, BIOMETRICS, V62, P777, DOI 10.1111/j.1541-0420.2006.00534.x; Zhang W, 2006, STAT MED, V25, P2365, DOI 10.1002/sim.2325	14	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51039	10.1371/journal.pone.0051039	http://dx.doi.org/10.1371/journal.pone.0051039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251419	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200055
J	Lui, NP; Chen, LW; Yung, WH; Chan, YS; Yung, KKL				Lui, Nga-Ping; Chen, Liang-Wei; Yung, Wing-Ho; Chan, Ying-Shing; Yung, Ken Kin-Lam			Endogenous Repair by the Activation of Cell Survival Signalling Cascades during the Early Stages of Rat Parkinsonism	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ASTROCYTES IN-SITU; NEUROTROPHIC FACTOR; BASAL GANGLIA; NEURODEGENERATIVE DISEASE; DOPAMINERGIC-NEURONS; REACTIVE ASTROCYTES; SPLICE VARIANTS; GENE-EXPRESSION; UP-REGULATION	Here we report a previously unknown self repair mechanism during extremely early stages of rat Parkinsonism. Two important cell survival signaling cascades, Phosphatidylinositol-3 kinases (PI3K)/Akt pathway and extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) pathway, could be responsible for this potential endogenous rescue system. In the 6-hydroxydopamine-lesioned rat, the phosphorylated p44/42 MAPK and its downstream target, the phosphorylated Bad at Ser 112, were up-regulated at post-lesion day 3 and lasted for a couple of weeks. Although the change in the phosphorylated Akt kinase was negligible throughout the studied period, its downstream target, the phosphorylated Bad at 136, was increased from post-lesion day 3 to post-lesion day 14. In the mean time, nestin-positive reactive astrocytes with low levels of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) appeared at post-lesion day 3 in 6-hydroxydopamine-lesioned rat. BDNF was expressed in both striatum and substantia nigra whereas GDNF was displayed in striatum only. At post-lesion day 14, nestin, BDNF and GDNF expressions were diminished. These neurotrophic factors were believed to initiate the above anti-apoptotic signal transduction cascades as we could see that their expression patterns were similar. The data strongly suggest that there is an endogenous repair effort by evoking the cell survival signaling and possibly via the releases of BDNF and GDNF from nestin-immunoreactive reactive astrocytes. ERK/MAPK pathway was proposed to be the key endogenous neuroprotective mechanisms, particularly in early stages of rat Parkinsonism. However, the self repair effort is only functional within an extremely short time window immediately after onset.	[Lui, Nga-Ping; Yung, Ken Kin-Lam] Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China; [Chen, Liang-Wei] Forth Mil Med Univ, Inst Neurosci, Xiangtan, Peoples R China; [Yung, Wing-Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Chan, Ying-Shing] Univ Hong Kong, Dept Physiol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Ying-Shing] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; Air Force Military Medical University; Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong	Yung, KKL (corresponding author), Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China.	kklyung@hkbu.edu.hk	Yung, Ho/R-6161-2018	Yung, Ho/0000-0002-5542-8173; Chan, Ying Shing/0000-0002-6228-1595; Yung, Ken KL/0000-0002-9588-2573	Hong Kong Baptist University [IRMC/12-13/1C-BIOL]; Hong Kong Research Grants Council [HKBU 212607]; National Natural Science Foundation of China [81271455]	Hong Kong Baptist University; Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported by Hong Kong Baptist University (Interdisciplinary Research Scheme IRMC/12-13/1C-BIOL-YUNG KL) Hong Kong Research Grants Council (HKBU 212607) and National Natural Science Foundation of China (81271455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado F, 2002, J NEUROSCI, V22, P9430; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Blum D, 2001, BIOCHEM PHARMACOL, V62, P473, DOI 10.1016/S0006-2952(01)00680-3; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Chen LW, 2005, CURR DRUG TARGETS, V6, P821, DOI 10.2174/138945005774574506; Chen LW, 2004, NEUROSCIENCE, V126, P941, DOI 10.1016/j.neuroscience.2004.04.020; Chen LW, 2002, BRAIN RES, V925, P9, DOI 10.1016/S0006-8993(01)03253-X; Chlocco MJ, 2007, PARKINSONISM RELAT D, V13, pS321, DOI 10.1016/S1353-8020(08)70024-5; Collier TJ, 2005, EXP NEUROL, V191, pS60, DOI 10.1016/j.expneurol.2004.08.018; da Costa CA, 2006, J BIOL CHEM, V281, P9824, DOI 10.1074/jbc.M513903200; Dechant G, 2001, CELL TISSUE RES, V305, P229, DOI 10.1007/s004410100378; Dodel RC, 1999, MOL BRAIN RES, V64, P141, DOI 10.1016/S0169-328X(98)00318-0; Duffy HS, 2000, J NEUROSCI, V20; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; Fernando RI, 2004, MOL BIOL CELL, V15, P3266, DOI 10.1091/mbc.E03-11-0823; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hamner S, 2001, MOL CELL NEUROSCI, V17, P97, DOI 10.1006/mcne.2000.0905; Henning J, 2008, NEUROSCI RES, V62, P246, DOI 10.1016/j.neures.2008.09.001; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Ho R, 2002, CANCER RES, V62, P6462; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Jaboin J, 2002, CANCER RES, V62, P6756; Kamada H, 2007, J CEREBR BLOOD F MET, V27, P521, DOI 10.1038/sj.jcbfm.9600367; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kim YS, 2010, EPILEPSY RES, V92, P30, DOI 10.1016/j.eplepsyres.2010.08.004; Lev N, 2003, PROG NEURO-PSYCHOPH, V27, P245, DOI 10.1016/S0278-5846(03)00019-8; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2004, BRAIN PATHOL, V14, P275; Neff F, 2002, ANN NY ACAD SCI, V973, P70, DOI 10.1111/j.1749-6632.2002.tb04608.x; Nozaki C, 1998, ONCOGENE, V16, P293, DOI 10.1038/sj.onc.1201548; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; Oh-Hashi K, 2006, NEUROSCI LETT, V405, P100, DOI 10.1016/j.neulet.2006.06.027; Oiwa Y, 2003, J NEUROSURG, V98, P136, DOI 10.3171/jns.2003.98.1.0136; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Peterson AL, 2008, NEUROTHERAPEUTICS, V5, P270, DOI 10.1016/j.nurt.2008.02.003; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rodriguez M, 2001, EXP NEUROL, V169, P163, DOI 10.1006/exnr.2000.7624; Saavedra A, 2008, PROG NEUROBIOL, V86, P186, DOI 10.1016/j.pneurobio.2008.09.006; SACHS C, 1975, BIOCHEM PHARMACOL, V24, P1, DOI 10.1016/0006-2952(75)90304-4; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Sgambato V, 2003, J NEUROCHEM, V86, P153, DOI 10.1046/j.1471-4159.2003.01816.x; Shimohama S, 2003, TRENDS MOL MED, V9, P360, DOI 10.1016/S1471-4914(03)00117-5; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Ugarte SD, 2003, J NEUROSCI RES, V73, P105, DOI 10.1002/jnr.10632; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Volterra A, 2004, GLIA, V47, P249, DOI 10.1002/glia.20080; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yacoubian TA, 2009, BBA-MOL BASIS DIS, V1792, P676, DOI 10.1016/j.bbadis.2008.09.009; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004	67	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51294	10.1371/journal.pone.0051294	http://dx.doi.org/10.1371/journal.pone.0051294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251488	Green Published, gold			2022-12-27	WOS:000313236200086
J	Wei, H; Kamat, AM; Aldousari, S; Ye, YQ; Huang, MS; Dinney, CP; Wu, XF				Wei, Hua; Kamat, Ashish M.; Aldousari, Saad; Ye, Yuanqing; Huang, Maosheng; Dinney, Colin P.; Wu, Xifeng			Genetic Variations in the Transforming Growth Factor Beta Pathway as Predictors of Bladder Cancer Risk	PLOS ONE			English	Article							COLORECTAL-CANCER; FACTOR-C; BREAST-CANCER; RECEPTOR; EXPRESSION; APOPTOSIS; VARIANTS; CELLS; TGFBR1-ASTERISK-6A; ASSOCIATION	Bladder cancer is the fifth most common cancer in the United States, and identifying genetic markers that may predict susceptibility in high-risk population is always needed. The purpose of our study is to determine whether genetic variations in the transforming growth factor-beta (TGF-beta) pathway are associated with bladder cancer risk. We identified 356 single-nucleotide polymorphisms (SNPs) in 37 key genes from this pathway and evaluated their association with cancer risk in 801 cases and 801 controls. Forty-one SNPs were significantly associated with cancer risk, and after adjusting for multiple comparisons, 9 remained significant (Q-value <= 0.1). Haplotype analysis further revealed three haplotypes within VEGFC and two haplotypes in EGFR were significantly associated with increased bladder cancer risk compared to the most common haplotype. Classification and regression tree analysis further revealed potential high-order gene-gene interactions, with VEGFC: rs3775194 being the initial split, which suggests that this variant is responsible for the most variation in risk. Individuals carrying the common genotype for VEGFC: rs3775194 and EGFR: rs7799627 and the variant genotype for VEGFR: rs4557213 had a 4.22-fold increase in risk, a much larger effect magnitude than that conferred by common genotype for VEGFR: rs4557213. Our study provides the first epidemiological evidence supporting a connection between TGF-beta pathway variants and bladder cancer risk.	[Wei, Hua; Ye, Yuanqing; Huang, Maosheng; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Kamat, Ashish M.; Aldousari, Saad; Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, XF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org		Dinney, Colin/0000-0002-8969-711X	National Institutes of Health [U01 CA 127615, R01 CA 74880, P50 CA 91846, R01 CA 131335]; NATIONAL CANCER INSTITUTE [P50CA091846, R01CA074880, R01CA131335, U01CA127615] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (U01 CA 127615, R01 CA 74880, P50 CA 91846, and R01 CA 131335) (www.NIH.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando H, 2006, ONCOL REP, V15, P653; Bian Y, 2005, J CLIN ONCOL, V23, P3074, DOI 10.1200/JCO.2005.00.281; Carvajal-Carmona LG, 2010, P NATL ACAD SCI USA, V107, P7858, DOI 10.1073/pnas.1002816107; Castillejo A, 2009, INT J CANCER, V124, P608, DOI 10.1002/ijc.24013; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Fujimoto J, 2004, BRIT J CANCER, V91, P466, DOI 10.1038/sj.bjc.6601963; Hagimoto N, 2002, J IMMUNOL, V168, P6470, DOI 10.4049/jimmunol.168.12.6470; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hou Y, 2011, CELL MOL NEUROBIOL, V31, P7, DOI 10.1007/s10571-010-9530-z; Inman GJ, 2000, J IMMUNOL, V165, P2500, DOI 10.4049/jimmunol.165.5.2500; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Li Y, INT UROL NEPHROL, V42, P315; Lin MB, 2011, CARCINOGENESIS, V32, P1050, DOI 10.1093/carcin/bgr067; Motyl T, 1998, EUR J CELL BIOL, V75, P367, DOI 10.1016/S0171-9335(98)80070-8; Noordhuis MG, 2011, CLIN CANCER RES, V17, P1317, DOI 10.1158/1078-0432.CCR-10-2320; Okamoto M, 1997, CELL GROWTH DIFFER, V8, P921; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Shida Atsuo, 2006, Int J Clin Oncol, V11, P38, DOI 10.1007/s10147-005-0528-3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skoglund J, 2007, CLIN CANCER RES, V13, P3748, DOI 10.1158/1078-0432.CCR-06-2865; Sriplakich S, 1999, BJU INT, V83, P498; TORREAMIONE G, 1990, P NATL ACAD SCI USA, V87, P1486, DOI 10.1073/pnas.87.4.1486; Wu XF, 2008, BJU INT, V102, P1207, DOI 10.1111/j.1464-410X.2008.07961.x; Wu XF, 2007, FRONT BIOSCI-LANDMRK, V12, P192, DOI 10.2741/2058; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Zachos I, 2010, EXPERT OPIN INV DRUG, V19, P875, DOI 10.1517/13543784.2010.496450; Zhang ZZ, 2008, CARCINOGENESIS, V29, P1973, DOI 10.1093/carcin/bgn183; Zu XB, 2006, BJU INT, V98, P1090, DOI 10.1111/j.1464-410X.2006.06446.x	28	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51758	10.1371/journal.pone.0051758	http://dx.doi.org/10.1371/journal.pone.0051758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251617	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200162
J	Li, X; Tian, XB; Zhang, B; Zhang, YQ; Chen, JP				Li, Xi; Tian, Xiaobo; Zhang, Bo; Zhang, Yanqi; Chen, Jieping			Variation in Dicer Gene Is Associated with Increased Survival in T-Cell Lymphoma	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; LUNG-CANCER; PROGNOSIS; DROSHA; IDENTIFICATION; RECURRENCE; BAFF	Dicer, an endonuclease in RNase III family, is essential for the RNA interference (RNAi) pathway. Aberrant expression of Dicer has been shown in various cancers including some subtypes of T cell lymphoma (TCL), which influences patient prognosis. A single-nucleotide polymorphism (SNP) rs3742330A>G has been identified in the Dicer gene, located in the 3' untranslated region (3' UTR) that is important for mRNA transcript stability. We investigated whether rs3742330 is associated with the survival in 163 TCL patients. Significant association between Dicer rs3742330 and TCL survival were found. Patients carrying the GG genotype (n = 12) had a significantly increased overall survival (OS) compared with those carrying the GA and AA genotypes (n = 70 and n = 81, respectively; p = 0.031). Moreover, the significant association was maintained for patients with mature T type (n = 134; p = 0.026). In multivariate Cox-regression analysis, rs3742330 proved to be an independent predictor for OS, together with the commonly used International Prognostic Index (IPI) and BAFF rs9514828, another SNP we have previously reported to be associated with TCL survival, with hazard ratios (HRs) for patient death rate of 8.956 (95% CI, 1.210 to 66.318; p = 0.032) for the GA genotype and 10.145 (95% CI, 1.371 to 75.084; p = 0.023) for the AA genotype. Furthermore, we observed cumulative effects of Dicer rs3742330 and BAFF rs9514828 on TCL survival. Compared with patients carrying zero unfavorable genotype, those carrying one and two unfavorable genotypes had an increased risk of death with a HR of 7.104 (95% CI, 0.969-53.086; p = 0.054) and 14.932 (95% CI, 1.950-114.354; p = 0.009), respectively, with a significant dose-response trend (p(trend) = 0.004). In conclusion, Dicer rs3742330 is associated with TCL survival, suggesting that genetic variation might play a role in predicting prognosis of TCL patients.	[Li, Xi; Tian, Xiaobo; Zhang, Bo; Chen, Jieping] Third Mil Med Univ, Southwest Hosp, Dept Hematol, Chongqing, Peoples R China; [Zhang, Yanqi] Third Mil Med Univ, Dept Hlth Stat, Coll Prevent Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Chen, JP (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Hematol, Chongqing, Peoples R China.	chenjpxn@yahoo.com.cn		Li, Xi/0000-0001-7106-1677	National Natural Science Foundation of China [NSFC 81270605, 30971066]; Chongqing Natural Science Fund Project [2008BA5001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Fund Project	This work was supported by the National Natural Science Foundation of China (NSFC 81270605, 30971066) and the Chongqing Natural Science Fund Project (2008BA5001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Campayo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022509; CARBONE PP, 1971, CANCER RES, V31, P1860; Chan WC, 1997, BLOOD, V89, P3909; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; de Haas EC, 2008, J CLIN ONCOL, V26, P1817, DOI 10.1200/JCO.2007.14.1606; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Faber C, 2011, EUR J CANCER, V47, P1414, DOI 10.1016/j.ejca.2011.01.006; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guo XF, 2012, J CANCER RES CLIN, V138, P49, DOI 10.1007/s00432-011-1058-1; Ibarrola-Villava M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019271; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim JG, 2008, CLIN CANCER RES, V14, P62, DOI 10.1158/1078-0432.CCR-07-1537; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kwong YL, 2009, LANCET ONCOL, V10, P1093, DOI 10.1016/S1470-2045(09)70265-7; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Merkel O, 2010, P NATL ACAD SCI USA, V107, P16228, DOI 10.1073/pnas.1009719107; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Novak AJ, 2006, J CLIN ONCOL, V24, P983, DOI 10.1200/JCO.2005.02.7938; Nuckel H, 2007, BLOOD, V109, P290, DOI 10.1182/blood-2006-03-007567; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Piccaluga PP, 2010, CURR HEMATOL MALIG R, V5, P222, DOI 10.1007/s11899-010-0062-x; Rizvi MA, 2006, BLOOD, V107, P1255, DOI 10.1182/blood-2005-03-1306; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Suzumiya J, 2009, ANN ONCOL, V20, P715, DOI 10.1093/annonc/mdn696; Valencak J, 2011, J DERMATOL SCI, V64, P185, DOI 10.1016/j.jdermsci.2011.08.011; van Kester MS, 2011, MOL ONCOL, V5, P273, DOI 10.1016/j.molonc.2011.02.003; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Yang QP, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-77; Zhai K, 2012, CLIN CANCER RES, V18, P2250, DOI 10.1158/1078-0432.CCR-11-3009; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	45	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51640	10.1371/journal.pone.0051640	http://dx.doi.org/10.1371/journal.pone.0051640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251602	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900111
J	Pacioni, S; Rueger, MA; Nistico, G; Bornstein, SR; Park, DM; McKay, RD; Androutsellis-Theotokis, A				Pacioni, Simone; Rueger, Maria Adele; Nistico, Giuseppe; Bornstein, Stefan R.; Park, Deric M.; McKay, Ron D.; Androutsellis-Theotokis, Andreas			Fast, Potent Pharmacological Expansion of Endogenous Hes3+/Sox2+Cells in the Adult Mouse and Rat Hippocampus	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEUROGENESIS IN-VITRO; SUBVENTRICULAR ZONE; GROWTH-FACTOR; PROGENITOR PROLIFERATION; DENTATE GYRUS; MAMMALIAN FOREBRAIN; HUNTINGTONS-DISEASE; GENE-EXPRESSION	The adult hippocampus is involved in learning and memory. As a consequence, it is a brain region of remarkable plasticity. This plasticity exhibits itself both as cellular changes and neurogenesis. For neurogenesis to occur, a population of local stem cells and progenitor cells is maintained in the adult brain and these are able to proliferate and differentiate into neurons which contribute to the hippocampal circuitry. There is much interest in understanding the role of immature cells in the hippocampus, in relation to learning and memory. Methods and mechanisms that increase the numbers of these cells will be valuable in this research field. We show here that single injections of soluble factors into the lateral ventricle of adult rats and mice induces the rapid (within one week) increase in the number of putative stem cells/progenitor cells in the hippocampus. The established progenitor marker Sox2 together with the more recently established marker Hes3, were used to quantify the manipulation of the Sox2/Hes3 double-positive cell population. We report that in both adult rodent species, Sox2+/Hes3+ cell numbers can be increased within one week. The most prominent increase was observed in the hilus of the dentate gyrus. This study presents a fast, pharmacological method to manipulate the numbers of endogenous putative stem cells/progenitor cells. This method may be easily modified to alter the degree of activation (e. g. by the use of osmotic pumps for delivery, or by repeat injections through implanted cannulas), in order to be best adapted to different paradigms of research (neurodegenerative disease, neuroprotection, learning, memory, plasticity, etc).	[Pacioni, Simone; Nistico, Giuseppe; Androutsellis-Theotokis, Andreas] European Brain Res Inst, Rome, Italy; [Rueger, Maria Adele] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas] Univ Dresden, Dept Med, Dresden, Germany; [Park, Deric M.] Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA; [McKay, Ron D.] Lieber Inst Brain Dev, Baltimore, MD USA; [Androutsellis-Theotokis, Andreas] Ctr Regenerat Therapies Dresden, Dresden, Germany	University of Cologne; Technische Universitat Dresden; University of Virginia; Technische Universitat Dresden	Androutsellis-Theotokis, A (corresponding author), European Brain Res Inst, Rome, Italy.	Andreas.Theotokis@uniklinikum-dresden.de	Park, Deric/C-5675-2013	Androutsellis-Theotokis, Andreas/0000-0002-1985-4589	Else Kroener-Fresenius-Stiftung [060_3636]; Center for Regenerative Therapies Dresden (CRTD) [043_267598]; National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS, NIH); European Brain Research Institute (EBRI-Rome)	Else Kroener-Fresenius-Stiftung; Center for Regenerative Therapies Dresden (CRTD); National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); European Brain Research Institute (EBRI-Rome)	This work was supported by a grant from the Else Kroener-Fresenius-Stiftung (060_3636), and a grant from the Center for Regenerative Therapies Dresden (CRTD, 043_267598) to AAT, as well as the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NINDS, NIH), and the European Brain Research Institute (EBRI-Rome). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010841; Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009414; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Artegiani B, 2011, J EXP MED, V208, P937, DOI 10.1084/jem.20102167; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; Craig CG, 1996, J NEUROSCI, V16, P2649; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kittappa R, 2012, MOL NEUROBIOL; Klein C, 2005, DEVELOPMENT, V132, P4497, DOI 10.1242/dev.02037; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Latini L, 2010, J NEUROSCI RES, V88, P500, DOI 10.1002/jnr.22238; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu JL, 1998, J NEUROSCI, V18, P7768; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580; Pekcec A, 2006, NEUROREPORT, V17, P571, DOI 10.1097/00001756-200604240-00003; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Rajan P, 1998, J NEUROSCI, V18, P3620; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Routsellis-Theotokis Andreas, 2008, V438, P31, DOI 10.1007/978-1-59745-133-8_4; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang YZ, 2011, STEM CELLS, V29, P907, DOI 10.1002/stem.644; Wexler E, 2002, TRENDS NEUROSCI, V25, P225, DOI 10.1016/S0166-2236(02)02153-7; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027	76	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51630	10.1371/journal.pone.0051630	http://dx.doi.org/10.1371/journal.pone.0051630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251599	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900110
J	Heidebrecht, CL; Quach, S; Pereira, JA; Quan, SD; Kolbe, F; Finkelstein, M; Buckeridge, DL; Kwong, JC				Heidebrecht, Christine L.; Quach, Susan; Pereira, Jennifer A.; Quan, Sherman D.; Kolbe, Faron; Finkelstein, Michael; Buckeridge, David L.; Kwong, Jeffrey C.		Public Hlth Agcy Canada	Incorporating Scannable Forms into Immunization Data Collection Processes: A Mixed-Methods Study	PLOS ONE			English	Article							DATA-ENTRY; SURVEILLANCE; CANADA; SYSTEM	Introduction: Individual-level immunization data captured electronically can facilitate evidence-based decision-making and planning. Populating individual-level records through manual data entry is time-consuming. An alternative is to use scannable forms, completed at the point of vaccination and subsequently scanned and exported to a database or registry. To explore the suitability of this approach for collecting immunization data, we conducted a feasibility study in two settings in Ontario, Canada. Methods and Findings: Prior to the 2011-2012 influenza vaccination campaign, we developed a scannable form template and a corresponding database that captured required demographic and clinical data elements. We examined efficiency, data quality, and usability through time observations, record audits, staff interviews, and client surveys. The mean time required to scan and verify forms (62.3 s) was significantly shorter than manual data entry (69.5 s) in one organization, whereas there was no difference (36.6 s vs. 35.4 s) in a second organization. Record audits revealed no differences in data quality between records populated by scanning versus manual data entry. Data processing personnel and immunized clients found the processes involved to be straightforward, while nurses and managers had mixed perceptions regarding the ease and merit of using scannable forms. Printing quality and other factors rendered some forms unscannable, necessitating manual entry. Conclusions: Scannable forms can facilitate efficient data entry, but certain features of the forms, as well as the workflow and infrastructure into which they are incorporated, should be evaluated and adapted if scannable forms are to be a meaningful alternative to manual data entry.	[Heidebrecht, Christine L.; Quach, Susan; Pereira, Jennifer A.; Quan, Sherman D.; Kwong, Jeffrey C.] Publ Hlth Ontario, Infect Dis, Toronto, ON, Canada; [Quan, Sherman D.] Univ Hlth Network, Ctr Innovat Complex Care, Toronto, ON, Canada; [Kolbe, Faron; Finkelstein, Michael] Toronto Publ Hlth, Communicable Dis Control Directorate, Toronto, ON, Canada; [Finkelstein, Michael; Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Buckeridge, David L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Buckeridge, David L.] Agence Sante & Serv Sociaux Montreal, Direct Sante Publ, Montreal, PQ, Canada; [Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; McGill University; University of Toronto; University of Toronto	Kwong, JC (corresponding author), Publ Hlth Ontario, Infect Dis, Toronto, ON, Canada.	jeff.kwong@utoronto.ca			Canadian Institutes of Health Research [4IRR96974]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by an operating grant from the Canadian Institutes of Health Research, grant 4IRR96974 (www.cihr.ca). The Canadian Association for Immunization Research and Evaluation provided networking assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biondich PG, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P56; Heidebrecht CL, 2011, CAN J PUBLIC HEALTH, V102, P349, DOI 10.1007/BF03404175; Heidebrecht CL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-523; Heisey-Grove DM, 2011, PUBLIC HEALTH REP, V126, P13, DOI 10.1177/003335491112600105; Jinks C, 2003, COMPUT BIOL MED, V33, P425, DOI 10.1016/S0010-4825(03)00012-X; Jorgensen CK, 1998, COMPUT BIOL MED, V28, P659, DOI 10.1016/S0010-4825(98)00038-9; Klein Elizabeth W, 2006, Prim Care Companion J Clin Psychiatry, V8, P324; O'Rourke MK, 1999, J EXPO ANAL ENV EPID, V9, P471, DOI 10.1038/sj.jea.7500043; Quach S, 2011, VACCINE, V29, P1997, DOI 10.1016/j.vaccine.2010.09.016; Quan H, 2011, CONTEMP CLIN TRIALS, V32, P173, DOI 10.1016/j.cct.2010.12.004; Saxena S, 2004, TRANSFUSION, V44, P1350, DOI 10.1111/j.1537-2995.2004.03117.x; Secor ER, 2004, J ALTERN COMPLEM MED, V10, P506, DOI 10.1089/1075553041323704; Thompson IM, 1999, J HOSP INFECT, V43, pS275, DOI 10.1016/S0195-6701(99)90099-3; Writing team for the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Vaccine Coverage Theme Group, 2010, CMAJ, V182, P273, DOI 10.1503/cmaj.091515; [No title captured]	15	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e49627	10.1371/journal.pone.0049627	http://dx.doi.org/10.1371/journal.pone.0049627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272047	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300006
J	Irie, A; Harada, K; Araki, N; Nishimura, Y				Irie, Atsushi; Harada, Kumiko; Araki, Norie; Nishimura, Yasuharu			Phosphorylation of SET Protein at Ser171 by Protein Kinase D2 Diminishes Its Inhibitory Effect on Protein Phosphatase 2A	PLOS ONE			English	Article							T-CELL-CLONE; C-MU; ACTIVATION; REGULATOR; APOPTOSIS; PEPTIDE; RAF-1; PROLIFERATION; ASSOCIATION; DETERMINES	We previously reported that protein kinase D2 (PKD2) in T cells is promptly activated after T-cell receptor (TCR) stimulation and involved in the activation of interleukin-2 promoter and T cell death, and that one of its candidate substrate is SET protein, a natural inhibitor for protein phosphatase 2A (PP2A). In this study, we investigated the target amino acid residues of SET phosphorylated by PKD2 and the effects of phosphorylation of SET on PP2A phosphatase activity. In vitro kinase assay using various recombinant SET mutants having Ser/Thr to Ala substitutions revealed that Ser171 of SET is one of the sites phosphorylated by PKD2. Recombinant SET with phosphorylation-mimic Ser171 to Glu substitution reduced its inhibitory effects on PP2A phosphatase activity compared with Ser171 to Ala substituted or wild-type SET. In addition, knockdown of PKD2 in Jurkat cells by RNAi or treatment of human CD4(+) T cell clone with the PKD2 inhibitor Go6976 resulted in reduced PP2A activity after TCR-stimulation judged from phosphorylation status of Tyr307 of the catalytic subunit of PP2A. These results suggest that PKD2 is involved in the regulation of PP2A activity in activated T cells through phosphorylation of Ser171 of SET. Citation: Irie A, Harada K, Araki N, Nishimura Y (2012) Phosphorylation of SET Protein at Ser171 by Protein Kinase D2 Diminishes Its Inhibitory Effect on Protein Phosphatase 2A. PLoS ONE 7(12): e51242. doi:10.1371/journal.pone.0051242	[Irie, Atsushi; Harada, Kumiko; Nishimura, Yasuharu] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Honjo, Kumamoto, Japan; [Araki, Norie] Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Honjo, Kumamoto, Japan	Kumamoto University; Kumamoto University	Nishimura, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Honjo, Kumamoto, Japan.	mxnishim@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [15510165, 17510167, 20510191]; Grants-in-Aid for Scientific Research [23510243] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (C) 15510165, 17510167 and 20510191 from Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen J, 2011, CARCINOGENESIS, V32, P1198, DOI 10.1093/carcin/bgr113; Chen YZ, 1996, J IMMUNOL, V157, P3783; Chetoui N, 2006, MOL IMMUNOL, V43, P1687, DOI 10.1016/j.molimm.2005.09.010; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Estanyol JM, 1999, J BIOL CHEM, V274, P33161, DOI 10.1074/jbc.274.46.33161; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Irie A, 2003, EUR J IMMUNOL, V33, P1497, DOI 10.1002/eji.200323618; Irie A, 2006, INT IMMUNOL, V18, P1737, DOI 10.1093/intimm/dxl108; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Kim JR, 2006, BIOCHEM BIOPH RES CO, V341, P19, DOI 10.1016/j.bbrc.2005.12.143; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Li MF, 1999, J MOL BIOL, V293, P1067, DOI 10.1006/jmbi.1999.3207; Liu P, 2007, FEBS LETT, V581, P1377, DOI 10.1016/j.febslet.2007.02.055; Marklund U, 2003, IMMUNITY, V19, P491, DOI 10.1016/S1074-7613(03)00260-7; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Tsukamoto H, 2006, EUR J IMMUNOL, V36, P1926, DOI 10.1002/eji.200535803; Vera J, 2007, PROTEOMICS, V7, P578, DOI 10.1002/pmic.200600458; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	40	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51242	10.1371/journal.pone.0051242	http://dx.doi.org/10.1371/journal.pone.0051242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251465	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800032
J	Lige, B; Romano, JD; Sampels, V; Sonda, S; Joiner, KA; Coppens, I				Lige, Bao; Romano, Julia D.; Sampels, Vera; Sonda, Sabrina; Joiner, Keith A.; Coppens, Isabelle			Introduction of Caveolae Structural Proteins into the Protozoan Toxoplasma Results in the Formation of Heterologous Caveolae but Not Caveolar Endocytosis	PLOS ONE			English	Article							TRANSCRIPT RELEASE FACTOR; PLASMA-MEMBRANE; POLYMERASE-I; LIPID RAFTS; CHOLESTEROL-BINDING; MAMMALIAN CAVEOLIN; VESICLE FORMATION; DENSE GRANULES; GENE FAMILY; EXPRESSION	Present on the plasma membrane of most metazoans, caveolae are specialized microdomains implicated in several endocytic and trafficking mechanisms. Caveolins and the more recently discovered cavins are the major protein components of caveolae. Previous studies reported that caveolar invaginations can be induced de novo on the surface of caveolae-negative mammalian cells upon heterologous expression of caveolin-1. However, it remains undocumented whether other components in the transfected cells participate in caveolae formation. To address this issue, we have exploited the protozoan Toxoplasma as a heterologous expression system to provide insights into the minimal requirements for caveogenesis and caveolar endocytosis. Upon expression of caveolin-1, Toxoplasma accumulates prototypical exocytic caveolae 'precursors' in the cytoplasm. Toxoplasma expressing caveolin-1 alone, or in conjunction with cavin-1, neither develops surface-located caveolae nor internalizes caveolar ligands. These data suggest that the formation of functional caveolae at the plasma membrane in Toxoplasma and, by inference in all non-mammalian cells, requires effectors other than caveolin-1 and cavin-1. Interestingly, Toxoplasma co-expressing caveolin-1 and cavin-1 displays an impressive spiraled network of membranes containing the two proteins, in the cytoplasm. This suggests a synergistic activity of caveolin-1 and cavin-1 in the morphogenesis and remodeling of membranes, as illustrated for Toxoplasma. Citation: Lige B, Romano JD, Sampels V, Sonda S, Joiner KA, et al. (2012) Introduction of Caveolae Structural Proteins into the Protozoan Toxoplasma Results in the Formation of Heterologous Caveolae but Not Caveolar Endocytosis. PLoS ONE 7(12): e51773. doi:10.1371/journal.pone.0051773	[Lige, Bao; Romano, Julia D.; Sampels, Vera; Coppens, Isabelle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Sonda, Sabrina] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Joiner, Keith A.] Univ Arizona, Coll Med, Arizona Hlth Sci Ctr, Tucson, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Zurich; University of Arizona; University of Arizona Health Sciences	Coppens, I (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	icoppens@jhsph.edu	Joiner, Keith/AAH-1059-2021	Joiner, Keith/0000-0003-3062-823X; Romano, Julia/0000-0001-8956-7377	National Institutes of Health [AI060767]; American Heart Association [0230079N, 0755368U]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this research was provided by the National Institutes of Health (AI060767) and the American Heart Association (0230079N and 0755368U). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Assossou O, 2003, FEMS MICROBIOL LETT, V224, P161, DOI 10.1016/S0378-1097(03)00479-8; Azzouz N, 2002, INT J PARASITOL, V32, P677, DOI 10.1016/S0020-7519(02)00009-7; Bai L, 2011, CELL RES, V21, P1088, DOI 10.1038/cr.2011.56; Chaturvedi S, 1999, J BIOL CHEM, V274, P2424, DOI 10.1074/jbc.274.4.2424; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engelman JA, 1998, FEBS LETT, V429, P330, DOI 10.1016/S0014-5793(98)00619-X; Field MC, 2007, ADV EXP MED BIOL, V607, P84; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; FOUSSARD F, 1991, PARASITOLOGY, V102, P367, DOI 10.1017/S0031182000064313; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Hatanaka M, 1998, BIOCHEM BIOPH RES CO, V253, P382, DOI 10.1006/bbrc.1998.9744; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ikonen E, 2004, BIOCHEM SOC T, V32, P121, DOI 10.1042/BST0320121; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Karsten V, 1998, J CELL BIOL, V141, P1323, DOI 10.1083/jcb.141.6.1323; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kiss AL, 2012, ADV EXP MED BIOL, V729, P14, DOI 10.1007/978-1-4614-1222-9_2; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Li SW, 1996, J BIOL CHEM, V271, P28647, DOI 10.1074/jbc.271.45.28647; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lige B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002410; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nam HW, 2009, KOREAN J PARASITOL, V47, pS29, DOI 10.3347/kjp.2009.47.S.S29; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Parkar NS, 2009, ANTIOXID REDOX SIGN, V11, P1301, DOI 10.1089/ARS.2008.2397; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parussini F, 2010, MOL MICROBIOL, V76, P1340, DOI 10.1111/j.1365-2958.2010.07181.x; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Quittnat F, 2004, MOL BIOCHEM PARASIT, V138, P107, DOI 10.1016/j.molbiopara.2004.08.004; Robibaro B, 2001, INT J PARASITOL, V31, P1343, DOI 10.1016/S0020-7519(01)00252-1; Rodighiero C, 2001, J BIOL CHEM, V276, P36939, DOI 10.1074/jbc.M104245200; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Simionescu M, 2009, CELL TISSUE RES, V335, P27, DOI 10.1007/s00441-008-0688-3; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sonda S, 2005, ANTIMICROB AGENTS CH, V49, P1794, DOI 10.1128/AAC.49.5.1794-1801.2005; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; Uittenbogaard A, 2000, J BIOL CHEM, V275, P25595, DOI 10.1074/jbc.M003401200; Verkade P, 2000, J CELL BIOL, V148, P727, DOI 10.1083/jcb.148.4.727; Verma P, 2010, MOL BIOL CELL, V21, P2226, DOI 10.1091/mbc.E09-05-0417; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305	71	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51773	10.1371/journal.pone.0051773	http://dx.doi.org/10.1371/journal.pone.0051773			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272165	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800081
J	Shah, A; Silverstein, PS; Kumar, S; Singh, DP; Kumar, A				Shah, Ankit; Silverstein, Peter S.; Kumar, Santosh; Singh, Dhirendra P.; Kumar, Anil			Synergistic Cooperation between Methamphetamine and HIV-1 gsp120 through the P13K/Akt Pathway Induces IL-6 but not IL-8 Expression in Astrocytes	PLOS ONE			English	Article							KAPPA-B PATHWAY; TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASE; CEREBROSPINAL-FLUID; NEURONAL APOPTOSIS; FACTOR-ALPHA; CODON USAGE; PROTEIN TAT; P38 MAPK	HIV-1 envelope protein gp120 has been extensively studied for neurotoxic effects that have been attributed to the increased expression of various proinflammatory cytokines in the CNS. Recently we have shown that methamphetamine (MA) also increases expression of proinflammatory cytokines in astrocytes. However, combined effect of gp120 and MA is not known. The present study was undertaken to determine cumulative effect and the mechanism(s)/pathways involved in the functional interaction between gp120 and MA in SVGA astrocytes. Our results clearly suggest that gp120 and MA affect IL-6 but not IL-8 in a synergistic manner and this synergy was mediated by PI3K/Akt and NF-kB pathways. Inhibition of either of these pathways could abrogate the increased expression of IL-6 due to MA or gp120 alone, as well as the increased expression of IL-6 when the astrocytes were treated with both gp120 and MA. These results were confirmed by both, using chemical inhibitors/siRNA as well as western blotting. This study therefore provides novel information regarding the interaction between MA and gp120 in terms of the expression of IL-6 and the mechanisms underlying potential synergy between MA and gp120 in astrocytes. Citation: Shah A, Silverstein PS, Kumar S, Singh DP, Kumar A (2012) Synergistic Cooperation between Methamphetamine and HIV-1 gsp120 through the P13K/Akt Pathway Induces IL-6 but not IL-8 Expression in Astrocytes. PLoS ONE 7(12): e52060. doi:10.1371/journal.pone.0052060	[Shah, Ankit; Silverstein, Peter S.; Kumar, Santosh; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA; [Singh, Dhirendra P.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA	University of Missouri System; University of Missouri Kansas City; University of Nebraska System; University of Nebraska Medical Center	Kumar, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	kumaran@umkc.edu	Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022	SHAH, ANKIT/0000-0002-9771-8777	National Institute on Drug Abuse [DA025528, DA025011]	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institute on Drug Abuse (DA025528 and DA025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2006, NEUROTOXICOLOGY, V27, P217, DOI 10.1016/j.neuro.2005.10.003; Andre S, 1998, J VIROL, V72, P1497; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; BUZY J, 1992, BRAIN RES, V598, P10, DOI 10.1016/0006-8993(92)90161-2; Cass WA, 2003, BRAIN RES, V984, P133, DOI 10.1016/S0006-8993(03)03122-6; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Deshpande M, 2005, NEUROTOX RES, V7, P183, DOI 10.1007/BF03036448; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; Eugenin EA, 2011, J NEUROSCI, V31, P9456, DOI 10.1523/JNEUROSCI.1460-11.2011; Goncalves J, 2008, ANN NY ACAD SCI, V1139, P103, DOI 10.1196/annals.1432.043; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Huang C, 2009, BRAIN RES, V1257, P75, DOI 10.1016/j.brainres.2008.11.088; Kanmogne Georgette D, 2007, J Cereb Blood Flow Metab, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Kao SJ, 2005, IMMUNOLOGY, V115, P366, DOI 10.1111/j.1365-2567.2005.02160.x; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2006, J NEUROIMMUNE PHARM, V1, P138, DOI 10.1007/s11481-006-9011-9; Li JL, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-31; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Lipton SA, 1991, BRAIN PATHOL, V1, P193, DOI 10.1111/j.1750-3639.1991.tb00659.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Medders KE, 2010, J IMMUNOL, V185, P4883, DOI 10.4049/jimmunol.0902535; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nath A, 2001, J NEUROVIROL, V7, P66; Nath A, 2002, JAIDS-J ACQ IMM DEF, V31, pS62, DOI 10.1097/00126334-200210012-00006; Osborne MPH, 2008, ANN NY ACAD SCI, V1139, P206, DOI 10.1196/annals.1432.034; Pu H, 2003, MOL CELL NEUROSCI, V24, P224, DOI 10.1016/S1044-7431(03)00171-4; Ramirez SH, 2009, J CEREBR BLOOD F MET, V29, P1933, DOI 10.1038/jcbfm.2009.112; Reddy PV, 2011, NEUROCHEM INT; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Ribeiro FM, 2011, MOL NEUROBIOL, V43, P1, DOI 10.1007/s12035-010-8153-1; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Shah A, 2011, BIOCHEM BIOPH RES CO, V414, P112, DOI 10.1016/j.bbrc.2011.09.033; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Shah A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-96; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Steinman L, 2008, J CLIN INVEST, V118, P3557, DOI 10.1172/JCI36532; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tata DA, 2008, SYNAPSE, V62, P325, DOI 10.1002/syn.20497; Theodore S, 2006, ANN NY ACAD SCI, V1074, P178, DOI 10.1196/annals.1369.018; Tocharus J, 2010, J PINEAL RES, V48, P347, DOI 10.1111/j.1600-079X.2010.00761.x; Toussi SS, 2009, AIDS RES HUM RETROV, V25, P1117, DOI 10.1089/aid.2008.0282; Turchan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-3; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Viviani B, 2006, J BIOL CHEM, V281, P30212, DOI 10.1074/jbc.M602156200; WAGNER GC, 1980, BRAIN RES, V181, P151, DOI 10.1016/0006-8993(80)91265-2; Wang SF, 2008, TOXICOLOGY, V246, P234, DOI 10.1016/j.tox.2008.01.020; Yang B, 2009, MICROVASC RES, V77, P212, DOI 10.1016/j.mvr.2008.11.003; Yang YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013427; Zou SP, 2011, BRAIN, V134, P3613, DOI 10.1093/brain/awr281	61	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52060	10.1371/journal.pone.0052060	http://dx.doi.org/10.1371/journal.pone.0052060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251686	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800138
J	Wang, G; He, J; Zhao, JY; Yun, WT; Xie, CZ; Taub, JW; Azmi, A; Mohammad, RM; Dong, Y; Kong, W; Guo, YJ; Ge, YB				Wang, Guan; He, Jing; Zhao, Jianyun; Yun, Wenting; Xie, Chengzhi; Taub, Jeffrey W.; Azmi, Asfar; Mohammad, Ramzi M.; Dong, Yan; Kong, Wei; Guo, Yingjie; Ge, Yubin			Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer	PLOS ONE			English	Article							ACUTE MEGAKARYOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; DNA-DAMAGE; (ARYLOXOPROPENYL)PYRROLYL HYDROXYAMIDES; VALPROIC ACID; CELL-DEATH; INHIBITORS; FAMILY; EXPRESSION; GEMCITABINE	Background: Pancreatic cancer is a highly malignant disease with an extremely poor prognosis. Histone deacetylase inhibitors (HDACIs) have shown promising antitumor activities against preclinical models of pancreatic cancer, either alone or in combination with chemotherapeutic agents. In this study, we sought to identify clinically relevant histone deacetylases (HDACs) to guide the selection of HDAC inhibitors (HDACIs) tailored to the treatment of pancreatic cancer. Methodology: HDAC expression in seven pancreatic cancer cell lines and normal human pancreatic ductal epithelial cells was determined by Western blotting. Antitumor interactions between class I-and class II-selective HDACIs were determined by MTT assays and standard isobologram/CompuSyn software analyses. The effects of HDACIs on cell death, apoptosis and cell cycle progression, and histone H4, alpha-tubulin, p21, and gamma H2AX levels were determined by colony formation assays, flow cytometry analysis, and Western blotting, respectively. Results: The majority of classes I and II HDACs were detected in the pancreatic cancer cell lines, albeit at variable levels. Treatments with MGCD0103 (a class I-selective HDACI) resulted in dose-dependent growth arrest, cell death/apoptosis, and cell cycle arrest in G2/M phase, accompanied by induction of p21 and DNA double-strand breaks (DSBs). In contrast, MC1568 (a class IIa-selective HDACI) or Tubastatin A (a HDAC6-selective inhibitor) showed minimal effects. When combined simultaneously, MC1568 significantly enhanced MGCD0103-induced growth arrest, cell death/apoptosis, and G2/M cell cycle arrest, while Tubastatin A only synergistically enhanced MGCD0103-induced growth arrest. Although MC1568 or Tubastatin A alone had no obvious effects on DNA DSBs and p21 expression, their combination with MGCD0103 resulted in cooperative induction of p21 in the cells. Conclusion: Our results suggest that classes I and II HDACs are potential therapeutic targets for treating pancreatic cancer. Accordingly, treating pancreatic cancer with pan-HDACIs may be more beneficial than class-or isoform-selective inhibitors.	[Wang, Guan; He, Jing; Zhao, Jianyun; Yun, Wenting; Xie, Chengzhi; Dong, Yan; Kong, Wei; Guo, Yingjie; Ge, Yubin] Jilin Univ, Coll Life Sci, State Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China; [Taub, Jeffrey W.] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA; [Taub, Jeffrey W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Taub, Jeffrey W.; Ge, Yubin] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA; [Dong, Yan] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Kong, Wei] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China; [Xie, Chengzhi; Azmi, Asfar; Mohammad, Ramzi M.; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA	Jilin University; Children's Hospital of Michigan; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Tulane University; Jilin University; Wayne State University	Guo, YJ (corresponding author), Jilin Univ, Coll Life Sci, State Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China.	guoyinjie@jlu.edu.cn; gey@karmanos.org	xie, chengzhi/F-9615-2012	Ge, Yubin/0000-0002-8748-716X; Dong, Yan/0000-0003-1622-5354; AZMI, ASFAR/0000-0003-1178-9505	Jilin University, Changchun, China; National Natural Science Foundation of China [31071105]; Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit	Jilin University, Changchun, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit	This study was supported by grants from Jilin University, Changchun, China, the National Natural Science Foundation of China (No. 31071105), and in part by a Start-up Fund from the Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chun SG, 2009, CANCER BIOL THER, V8, P1328, DOI 10.4161/cbt.8.14.8633; Conti C, 2010, CANCER RES, V70, P4470, DOI 10.1158/0008-5472.CAN-09-3028; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Edwards H, 2009, BLOOD, V114, P2744, DOI 10.1182/blood-2008-09-179812; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gaymes TJ, 2006, MOL CANCER RES, V4, P563, DOI 10.1158/1541-7786.MCR-06-0111; Ge YB, 2005, JNCI-J NATL CANCER I, V97, P226, DOI 10.1093/jnci/dji026; Giovannetti E, 2006, MOL CANCER THER, V5, P1387, DOI 10.1158/1535-7163.MCT-06-0004; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Karagiannis TC, 2007, LEUKEMIA, V21, P61, DOI 10.1038/sj.leu.2404464; Kauh J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010376; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kullmann F, 2009, BRIT J CANCER, V100, P1032, DOI 10.1038/sj.bjc.6604983; Kumagai T, 2007, INT J CANCER, V121, P656, DOI 10.1002/ijc.22558; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Ledent V, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-24; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mai A, 2003, J MED CHEM, V46, P4826, DOI 10.1021/jm034167p; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Sasaki H, 2004, LUNG CANCER, V46, P171, DOI 10.1016/j.lungcan.2004.03.021; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Strimpakos A, 2008, CANCER METAST REV, V27, P495, DOI 10.1007/s10555-008-9134-y; Sung V, 2011, CANCER SCI, V102, P1201, DOI 10.1111/j.1349-7006.2011.01921.x; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xie CZ, 2012, PEDIATR BLOOD CANCER, V59, P1245, DOI 10.1002/pbc.24152; Xie CZ, 2010, CLIN CANCER RES, V16, P5499, DOI 10.1158/1078-0432.CCR-10-1707; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781	49	26	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52095	10.1371/journal.pone.0052095	http://dx.doi.org/10.1371/journal.pone.0052095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251689	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800141
J	Zheng, SX; Ren, HY; Li, WH; Lan, ZC				Zheng, Shuxia; Ren, Haiyan; Li, Wenhuai; Lan, Zhichun			Scale-Dependent Effects of Grazing on Plant C: N: P Stoichiometry and Linkages to Ecosystem Functioning in the Inner Mongolia Grassland	PLOS ONE			English	Article							TYPICAL STEPPE; SOIL; TERRESTRIAL; VEGETATION; RESPONSES; TRAITS; CARBON; MINERALIZATION; BIODIVERSITY; MANAGEMENT	Background: Livestock grazing is the most prevalent land use of grasslands worldwide. The effects of grazing on plant C, N, P contents and stoichiometry across hierarchical levels, however, have rarely been studied; particularly whether the effects are mediated by resource availability and the underpinning mechanisms remain largely unclear. Methodology/Principal Findings: Using a multi-organization-level approach, we examined the effects of grazing on the C, N, and P contents and stoichiometry in plant tissues (leaves and roots) and linkages to ecosystem functioning across three vegetation types (meadow, meadow steppe, and typical steppe) in the Inner Mongolia grassland, China. Our results showed that the effects of grazing on the C, N, and P contents and stoichiometry in leaves and roots differed substantially among vegetation types and across different hierarchical levels (species, functional group, and vegetation type levels). The magnitude of positive effects of grazing on leaf N and P contents increased progressively along the hierarchy of organizational levels in the meadow, whereas its negative effect on leaf N content decreased considerably along hierarchical levels in both the typical and meadow steppes. Grazing increased N and P allocation to aboveground in the meadow, while greater N and P allocation to belowground was found in the typical and meadow steppes. The differences in soil properties, plant trait-based resource use strategies, tolerance or defense strategies to grazing, and shifts in functional group composition are likely to be the key mechanisms for the observed patterns among vegetation types. Conclusions/Significance: Our findings suggest that the enhanced vegetation-type-level N contents by grazing and species compensatory feedbacks may be insufficient to prevent widespread declines in primary productivity in the Inner Mongolia grassland. Hence, it is essential to reduce the currently high stocking rates and restore the vast degraded steppes for sustainable development of arid and semiarid grasslands. Citation: Zheng S, Ren H, Li W, Lan Z (2012) Scale-Dependent Effects of Grazing on Plant C: N: P Stoichiometry and Linkages to Ecosystem Functioning in the Inner Mongolia Grassland. PLoS ONE 7(12): e51750. doi:10.1371/journal.pone.0051750	[Zheng, Shuxia; Ren, Haiyan; Li, Wenhuai; Lan, Zhichun] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Zheng, SX (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	zsx@ibcas.ac.cn	Li, Wenhuai/A-1268-2015	Li, Wenhuai/0000-0002-1113-2020	State Key Basic Research Development Program of China [2009CB421102]; National Natural Science Foundation of China [30900193]	State Key Basic Research Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the State Key Basic Research Development Program of China (2009CB421102) and the National Natural Science Foundation of China (30900193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Augustine DJ, 2006, ECOSYSTEMS, V9, P1242, DOI 10.1007/s10021-005-0020-y; Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF., 2000, ACTA PHYTOECOLOGICA, V24, P667, DOI DOI 10.3321/J.ISSN:1005-264X.2000.06.005; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; BRYANT JP, 1991, ANNU REV ECOL SYST, V22, P431, DOI 10.1146/annurev.es.22.110191.002243; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Craine JM, 2001, OIKOS, V93, P274, DOI 10.1034/j.1600-0706.2001.930210.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Frank DA, 1998, ECOLOGY, V79, P2229, DOI 10.1890/0012-9658(1998)079[2229:UVLCOS]2.0.CO;2; Frank DA, 2005, OECOLOGIA, V143, P629, DOI 10.1007/s00442-005-0019-2; Frank DA, 1997, ECOLOGY, V78, P2238, DOI 10.1890/0012-9658(1997)078[2238:EONGOG]2.0.CO;2; Franzluebbers AJ, 2000, SOIL BIOL BIOCHEM, V32, P469, DOI 10.1016/S0038-0717(99)00176-5; Golluscio RA, 2009, ECOSYSTEMS, V12, P686, DOI 10.1007/s10021-009-9252-6; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; HOLLAND EA, 1990, ECOLOGY, V71, P1040, DOI 10.2307/1937372; Holland JN, 1996, OECOLOGIA, V107, P87, DOI 10.1007/BF00582238; Jiang GM, 2006, AMBIO, V35, P269, DOI 10.1579/06-S-158.1; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; McCully ME, 1999, ANNU REV PLANT PHYS, V50, P695, DOI 10.1146/annurev.arplant.50.1.695; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P1617, DOI 10.2307/1938024; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Pan QM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020078; PASTOR J, 1992, AM NAT, V139, P690, DOI 10.1086/285353; Pastor J, 2006, LARGE HERBIVORE ECOL, P289, DOI DOI 10.1017/CO09780511617461; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; Sasaki T, 2008, J ECOL, V96, P145, DOI 10.1111/j.1365-2745.2007.01315.x; Semmartin M, 2004, OIKOS, V107, P148, DOI 10.1111/j.0030-1299.2004.13153.x; Shan YM, 2011, SOIL BIOL BIOCHEM, V43, P1943, DOI 10.1016/j.soilbio.2011.06.002; Tian H, 2009, EUR J SOIL BIOL, V45, P321, DOI 10.1016/j.ejsobi.2009.05.003; TILMAN D, 1988; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; White R., 2000, PILOT ANAL GLOBAL EC; Wu HH, 2011, PLANT SOIL, V340, P127, DOI 10.1007/s11104-010-0575-z; Zheng SX, 2010, BIOGEOSCIENCES, V7, P1117, DOI 10.5194/bg-7-1117-2010; Zheng SX, 2011, PLANT SOIL, V340, P141, DOI 10.1007/s11104-010-0369-3; Zhou ZY, 2011, PLANT SOIL, V341, P257, DOI 10.1007/s11104-010-0641-6	55	43	47	4	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51750	10.1371/journal.pone.0051750	http://dx.doi.org/10.1371/journal.pone.0051750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272158	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800078
J	Benamrouz, S; Guyot, K; Gazzola, S; Mouray, A; Chassat, T; Delaire, B; Chabe, M; Gosset, P; Viscogliosi, E; Dei-Cas, E; Creusy, C; Conseil, V; Certad, G				Benamrouz, Sadia; Guyot, Karine; Gazzola, Sophie; Mouray, Anthony; Chassat, Thierry; Delaire, Baptiste; Chabe, Magali; Gosset, Pierre; Viscogliosi, Eric; Dei-Cas, Eduardo; Creusy, Colette; Conseil, Valerie; Certad, Gabriela			Cryptosporidium parvum Infection in SCID Mice Infected with Only One Oocyst: qPCR Assessment of Parasite Replication in Tissues and Development of Digestive Cancer	PLOS ONE			English	Article							FULMINANT CRYPTOSPORIDIOSIS; MOUSE; ADENOCARCINOMA; INTENSITY; STRAIN; CATTLE; MODEL; ASSAY	Dexamethasone (Dex) treated Severe Combined Immunodeficiency (SCID) mice were previously described as developing digestive adenocarcinoma after massive infection with Cryptosporidium parvum as soon as 45 days post-infection (P. I.). We aimed to determine the minimum number of oocysts capable of inducing infection and thereby gastrointestinal tumors in this model. Mice were challenged with calibrated oocyst suspensions containing intended doses of: 1, 10, 100 or 10(5) oocysts of C. parvum Iowa strain. All administered doses were infective for animals but increasing the oocyst challenge lead to an increase in mice infectivity (P = 0.01). Oocyst shedding was detected at 7 days P. I. after inoculation with more than 10 oocysts, and after 15 days in mice challenged with one oocyst. In groups challenged with lower inocula, parasite growth phase was significantly higher (P = 0.005) compared to mice inoculated with higher doses. After 45 days P. I. all groups of mice had a mean of oocyst shedding superior to 10,000 oocyst/g of feces. The most impressive observation of this study was the demonstration that C. parvum-induced digestive adenocarcinoma could be caused by infection with low doses of Cryptosporidium, even with only one oocyst: in mice inoculated with low doses, neoplastic lesions were detected as early as 45 days P. I. both in the stomach and ileo-caecal region, and these lesions could evolve in an invasive adenocarcinoma. These findings show a great amplification effect of parasites in mouse tissues after challenge with low doses as confirmed by quantitative PCR. The ability of C. parvum to infect mice with one oocyst and to develop digestive adenocarcinoma suggests that other mammalian species including humans could be also susceptible to this process, especially when they are severely immunocompromised. Citation: Benamrouz S, Guyot K, Gazzola S, Mouray A, Chassat T, et al. (2012) Cryptosporidium parvum Infection in SCID Mice Infected with Only One Oocyst: qPCR Assessment of Parasite Replication in Tissues and Development of Digestive Cancer. PLoS ONE 7(12): e51232. doi:10.1371/journal.pone.0051232	[Benamrouz, Sadia; Guyot, Karine; Gazzola, Sophie; Chabe, Magali; Viscogliosi, Eric; Dei-Cas, Eduardo; Conseil, Valerie; Certad, Gabriela] Univ Lille N France, CNRS,UMR 8402, Inst Pasteur Lille,INSERM,U1019, Ctr Infect & Immun Lille,Lab Biol & Divers Pathog, Lille, France; [Benamrouz, Sadia; Conseil, Valerie] Univ Lille N France, Fac Libre Sci & Technol Lille, Lab Environm & Sante, Lille, France; [Mouray, Anthony; Chassat, Thierry] Inst Pasteur, Plateforme Expt & Hautes Technol Anim, F-59019 Lille, France; [Delaire, Baptiste; Gosset, Pierre; Creusy, Colette] Univ Lille N France, Grp Hosp Univ Catholique Lille, Serv Anat & Cytol Pathol, Lille, France; [Chabe, Magali] Univ Lille N France, Fac Pharm, Lille, France; [Dei-Cas, Eduardo] Univ Lille N France, Fac Med, Lille, France; [Dei-Cas, Eduardo] Ctr Hosp Reg & Univ Lille, Ctr Biol & Pathol, Lab Parasitol Mycol, F-59037 Lille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite Catholique de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Certad, G (corresponding author), Univ Lille N France, CNRS,UMR 8402, Inst Pasteur Lille,INSERM,U1019, Ctr Infect & Immun Lille,Lab Biol & Divers Pathog, Lille, France.	gabriela.certad@pasteur-lille.fr	B, S/HGC-3038-2022; Chabe, Magali/H-6045-2017	B, S/0000-0003-1791-4389; Viscogliosi, Eric/0000-0002-5805-7179; Chabe, Magali/0000-0002-6732-6772	Catholic Institute of Lille (ICL); Ministry of Research, France [EA3609/4547]; Federative Institute of Research (Institut Pasteur de Lille) [142]; French National Research Agency [ANR-09-ALIA-009, ANR-10-ALIA-004]	Catholic Institute of Lille (ICL); Ministry of Research, France(Ministry of Research, France); Federative Institute of Research (Institut Pasteur de Lille); French National Research Agency(French National Research Agency (ANR))	Specific support was provided by Catholic Institute of Lille (ICL) including a grant for Sadia Benamrouz. This work was supported by the Ministry of Research, France (EA3609/4547 Universite de Lille 2), Federative Institute of Research 142 (Institut Pasteur de Lille), and the French National Research Agency (grants No. ANR-09-ALIA-009 and ANR-10-ALIA-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat EM, 1997, J EUKARYOT MICROBIOL, V44, p41S, DOI 10.1111/j.1550-7408.1997.tb05765.x; Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Marcon GEB, 2011, MEM I OSWALDO CRUZ, V106, P85, DOI 10.1590/S0074-02762011000100014; Bulckaen H, 2008, AM J PHYSIOL-HEART C, V294, pH1562, DOI 10.1152/ajpheart.00241.2007; Certad G, 2012, APPL ENVIRON MICROB, V78, P1746, DOI 10.1128/AEM.06457-11; Certad G, 2010, INT J PARASITOL, V40, P1469, DOI 10.1016/j.ijpara.2010.07.007; Certad G, 2010, AM J TROP MED HYG, V82, P257, DOI 10.4269/ajtmh.2010.09-0309; Certad Gabriela, 2007, Infect Agent Cancer, V2, P22, DOI 10.1186/1750-9378-2-22; Chappell CL, 1996, J INFECT DIS, V173, P232, DOI 10.1093/infdis/173.1.232; Chappell CL, 2006, AM J TROP MED HYG, V75, P851, DOI 10.4269/ajtmh.2006.75.851; Chen ZG, 2011, VET PARASITOL, V181, P113, DOI 10.1016/j.vetpar.2011.04.037; DOLAN TT, 1984, INT J PARASITOL, V14, P89, DOI 10.1016/0020-7519(84)90017-1; Fontaine M, 2002, FEMS MICROBIOL LETT, V214, P13, DOI 10.1111/j.1574-6968.2002.tb11318.x; Guyot K, 2000, WATER SCI TECHNOL, V41, P189, DOI 10.2166/wst.2000.0132; HAAS CN, 1994, P AM WAT WORKS ASS 1, P517; Huang K, 2003, J PARASITOL, V89, P620, DOI 10.1645/0022-3395(2003)089[0620:DOPIII]2.0.CO;2; Levine N. D., 1973, PROTOZOAN PARASITES, P156; MAHONEY DF, 1979, INT J PARASITOL, V9, P297, DOI 10.1016/0020-7519(79)90078-X; Ramirez NE, 2004, MICROBES INFECT, V6, P773, DOI 10.1016/j.micinf.2004.02.021; Rochelle PA, 2002, APPL ENVIRON MICROB, V68, P3809, DOI 10.1128/AEM.68.8.3809-3817.2002; Shebl FM, 2012, AIDS RES HUM RETROVI; Sulzyc-Bielicka Violetta, 2012, Pol Przegl Chir, V84, P348, DOI 10.2478/v10035-012-0058-4; Yang RC, 2011, VET PARASITOL, V179, P22, DOI 10.1016/j.vetpar.2011.02.011; Yang SG, 2000, J PARASITOL, V86, P884, DOI 10.1645/0022-3395(2000)086[0884:IOICAM]2.0.CO;2; Yoder JS, 2010, EXP PARASITOL, V124, P31, DOI 10.1016/j.exppara.2009.09.020	25	39	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51232	10.1371/journal.pone.0051232	http://dx.doi.org/10.1371/journal.pone.0051232			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272093	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600020
J	Peltan, A; Briggs, L; Matthews, G; Sweeney, ST; Smith, DF				Peltan, Adam; Briggs, Laura; Matthews, Gareth; Sweeney, Sean T.; Smith, Deborah F.			Identification of Drosophila Gene Products Required for Phagocytosis of Leishmania donovani	PLOS ONE			English	Article							WIDE RNAI ANALYSIS; BREFELDIN-A; GUANINE-NUCLEOTIDE; AMASTIGOTE STAGES; CELL-LINES; IN-VIVO; GENOME; REVEALS; ENTRY; INTERFERENCE	The identity and function of host factors required for efficient phagocytosis and intracellular maintenance of the protozoan parasite Leishmania donovani are poorly understood. Utilising the phagocytic capability of Drosophila S2 cells, together with available tools for modulating gene expression by RNAi, we have developed an experimental system in which to identify host proteins of this type on a genome-wide scale. We have shown that L. donovani amastigotes can be phagocytosed by S2 cells, in which they replicate and are maintained in a compartment with features characteristic of mammalian phagolysosomes. Screening with dsRNAs from 1920 conserved metazoan genes has identified transcripts that, when reduced in expression, cause either increased or decreased phagocytosis. Focussing on genes in the latter class, RNA-imediated knockdown of the small GTPase Rab5, the prenylated SNARE protein YKT6, one sub-unit of serine palmitoyltransferase (spt2/lace), the Rac1-associated protein Sra1 and the actin cytoskeleton regulatory protein, SCAR, all lead to a significant reduction in parasite phagocytosis. A role for the lace mammalian homologue in amastigote uptake by mammalian macrophages has been verified using the serine palmitoyltransferase inhibitor, myriocin. These observations suggest that this experimental approach has the potential to identify a large number of host effectors required for efficient parasite uptake and maintenance.	[Peltan, Adam; Matthews, Gareth; Smith, Deborah F.] Univ York, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Peltan, Adam; Briggs, Laura; Sweeney, Sean T.; Smith, Deborah F.] Univ York, Hull York Med Sch, Dept Biol, York YO10 5DD, N Yorkshire, England	University of York - UK; University of Hull; University of York - UK	Smith, DF (corresponding author), Univ York, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England.	deborah.smith@york.ac.uk	Matthews, Gareth/GZK-6840-2022	Sweeney, Sean/0000-0003-2673-9578; Matthews, Gareth/0000-0001-8353-4806	UK BBSRC; UK EPSRC; UK MRC [G0400580]; Wellcome Trust [077503]; MRC [G0400580] Funding Source: UKRI; Medical Research Council [G0400580] Funding Source: researchfish	UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK BBSRC (pre-doctoral studentship to AP), the UK EPSRC (vacation studentship to GM), the UK MRC (project grant G0400580 to LB and STS) and the Wellcome Trust (programme grant 077503 to DFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; ASHFORD RW, 1992, PARASITOL TODAY, V8, P104, DOI 10.1016/0169-4758(92)90249-2; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHANNON JY, 1984, IMMUNOLOGY, V53, P345; Chappuis F, 2007, NAT REV MICRO; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203; Courret N, 2002, J CELL SCI, V115, P2303; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Duclos S, 2000, J CELL SCI, V113, P3531; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elwell C, 2005, CELL MICROBIOL, V7, P725, DOI 10.1111/j.1462-5822.2005.00508.x; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Flockhart I, 2006, NUCLEIC ACIDS RES, V34, pD489, DOI 10.1093/nar/gkj114; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; GUY RA, 1993, INFECT IMMUN, V61, P1553, DOI 10.1128/IAI.61.4.1553-1558.1993; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Isgandarova S, 2007, J BIOL CHEM, V282, P30466, DOI 10.1074/jbc.M704117200; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Kwiatkowska K, 2003, J CELL SCI, V116, P537, DOI 10.1242/jcs.00254; LANG T, 1994, J CELL SCI, V107, P2137; Lodge R, 2006, EUR J IMMUNOL, V36, P2735, DOI 10.1002/eji.200636089; Love DC, 1998, EXP PARASITOL, V88, P161, DOI 10.1006/expr.1998.4232; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Maganto-Garcia E, 2008, TRAFFIC, V9, P1299, DOI 10.1111/j.1600-0854.2008.00760.x; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Morehead J, 2002, INFECT IMMUN, V70, P4571, DOI 10.1128/IAI.70.8.4571-4580.2002; Nagy A, 2003, NAT GENET, V33, P276, DOI 10.1038/ng1115; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Phillips R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000813; Prina E, 2004, J CELL SCI, V117, P315, DOI 10.1242/jcs.00860; Qin QM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000110; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Siqueira-Neto JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000675; St-Denis A, 1999, J IMMUNOL, V163, P5505; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x	70	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51831	10.1371/journal.pone.0051831	http://dx.doi.org/10.1371/journal.pone.0051831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272175	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386600043
J	Grimsley, JMS; Shanbhag, SJ; Palmer, AR; Wallace, MN				Grimsley, Jasmine M. S.; Shanbhag, Sharad J.; Palmer, Alan R.; Wallace, Mark N.			Processing of Communication Calls in Guinea Pig Auditory Cortex	PLOS ONE			English	Article							SPECIES-SPECIFIC VOCALIZATIONS; SQUIRREL-MONKEYS; PURR CALL; CONSPECIFIC VOCALIZATIONS; FUNCTIONAL SPECIALIZATION; CORTICAL DISCRIMINATION; NEURAL REPRESENTATION; SOCIAL VOCALIZATIONS; SINGLE NEURONS; RHESUS-MONKEY	Vocal communication is an important aspect of guinea pig behaviour and a large contributor to their acoustic environment. We postulated that some cortical areas have distinctive roles in processing conspecific calls. In order to test this hypothesis we presented exemplars from all ten of their main adult vocalizations to urethane anesthetised animals while recording from each of the eight areas of the auditory cortex. We demonstrate that the primary area (AI) and three adjacent auditory belt areas contain many units that give isomorphic responses to vocalizations. These are the ventrorostral belt (VRB), the transitional belt area (T) that is ventral to AI and the small area (area S) that is rostral to AI. Area VRB has a denser representation of cells that are better at discriminating among calls by using either a rate code or a temporal code than any other area. Furthermore, 10% of VRB cells responded to communication calls but did not respond to stimuli such as clicks, broadband noise or pure tones. Area S has a sparse distribution of call responsive cells that showed excellent temporal locking, 31% of which selectively responded to a single call. AI responded well to all vocalizations and was much more responsive to vocalizations than the adjacent dorsocaudal core area. Areas VRB, AI and S contained units with the highest levels of mutual information about call stimuli. Area T also responded well to some calls but seems to be specialized for low sound levels. The two dorsal belt areas are comparatively unresponsive to vocalizations and contain little information about the calls. AI projects to areas S, VRB and T, so there may be both rostral and ventral pathways for processing vocalizations in the guinea pig.	[Grimsley, Jasmine M. S.; Palmer, Alan R.; Wallace, Mark N.] MRC, Inst Hearing Res, Nottingham, England; [Grimsley, Jasmine M. S.; Shanbhag, Sharad J.] NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA	Northeast Ohio Medical University (NEOMED)	Wallace, MN (corresponding author), MRC, Inst Hearing Res, Nottingham, England.	markw@ihr.mrc.ac.uk	Wallace, Mark/ABC-1573-2020	Wallace, Mark/0000-0001-6894-4903; Palmer, Alan/0000-0001-5893-4525; Grimsley, Jasmine/0000-0002-7993-9699	Medical Research Council (MRC) Institute; MRC; MRC [MC_U135097126] Funding Source: UKRI; Medical Research Council [MC_U135097126] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000937] Funding Source: NIH RePORTER	Medical Research Council (MRC) Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was undertaken in a Medical Research Council (MRC) Institute by staff who are permanently employed by the MRC or were in receipt of an MRC Studentship (JMSG). No external funding was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRYMAN JC, 1976, Z TIERPSYCHOL, V41, P80; Bolhuis JJ, 2003, ANIM BIOL, V53, P129, DOI 10.1163/157075603769700331; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; BULLOCK DC, 1988, MED BIOL ENG COMPUT, V26, P669, DOI 10.1007/BF02447511; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Chase SM, 2006, J NEUROSCI, V26, P3889, DOI 10.1523/JNEUROSCI.4986-05.2006; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; Edeline JM, 2001, EUR J NEUROSCI, V14, P1865, DOI 10.1046/j.0953-816x.2001.01821.x; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Eisenberg J. F., 1974, Symposia of the Zoological Society of London, P211; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Gadziola MA, 2012, J NEUROPHYSIOL, V107, P1047, DOI 10.1152/jn.00422.2011; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GLASS I, 1979, EXP BRAIN RES, V34, P489; Grimsley JMS, 2011, HEARING RES, V277, P134, DOI 10.1016/j.heares.2011.01.018; Grimsley JMS, 2011, NEUROREPORT, V22, P613, DOI 10.1097/WNR.0b013e3283495ae9; Horikawa J, 2001, NEUROREPORT, V12, P3335, DOI 10.1097/00001756-200110290-00038; Horikawa J, 2003, NEUROSCI RES, V46, pS160; Hosokawa Y, 2004, NEUROREPORT, V15, P1093, DOI 10.1097/00001756-200405190-00002; HUBEL DH, 1982, NATURE, V299, P515, DOI 10.1038/299515a0; Huetz C, 2011, HEARING RES, V271, P147, DOI 10.1016/j.heares.2010.01.010; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Issa EB, 2008, J NEUROSCI, V28, P14467, DOI 10.1523/JNEUROSCI.3086-08.2008; Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005; Kaas JH, 2011, AUDITORY CORTEX, P407, DOI 10.1007/978-1-4419-0074-6_19; Kusmierek P, 2009, J NEUROPHYSIOL, V102, P1606, DOI 10.1152/jn.00167.2009; Kyuhou S, 1999, NEUROSCI LETT, V260, P113, DOI 10.1016/S0304-3940(98)00956-2; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Narayan R, 2007, NAT NEUROSCI, V10, P1601, DOI 10.1038/nn2009; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; Nelken I, 2007, HEARING RES, V229, P94, DOI 10.1016/j.heares.2007.01.012; NEWMAN JD, 1973, BRAIN RES, V54, P287, DOI 10.1016/0006-8993(73)90050-4; NEWMAN JD, 1973, EXP NEUROL, V40, P821, DOI 10.1016/0014-4886(73)90116-7; Nishimura M, 2007, J NEUROPHYSIOL, V97, P927, DOI 10.1152/jn.00689.2006; Pelleg-Toiba R., 1991, Journal of Basic and Clinical Physiology and Pharmacology, V2, P257; Peterson DC, 2012, NEUROSCIENCE, V217, P154, DOI 10.1016/j.neuroscience.2012.04.069; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Philibert B, 2005, HEARING RES, V209, P97, DOI 10.1016/j.heares.2005.07.004; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Recanzone GH, 2008, J NEUROSCI, V28, P13184, DOI 10.1523/JNEUROSCI.3619-08.2008; REDIES H, 1989, J COMP NEUROL, V282, P473, DOI 10.1002/cne.902820402; Remedios R, 2009, J NEUROSCI, V29, P1034, DOI 10.1523/JNEUROSCI.4089-08.2009; Romanski LM, 2009, ANNU REV NEUROSCI, V32, P315, DOI 10.1146/annurev.neuro.051508.135431; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Rutkowski RG, 2000, HEARING RES, V145, P177, DOI 10.1016/S0378-5955(00)00087-3; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Suta D, 2003, J NEUROPHYSIOL, V90, P3794, DOI 10.1152/jn.01175.2002; Suta D, 2008, PHYSIOL RES, V57, pS149, DOI 10.33549/physiolres.931608; Suta D, 2007, EXP BRAIN RES, V183, P377, DOI 10.1007/s00221-007-1056-3; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; TANAKA H, 1991, JPN J PHYSIOL, V41, P817, DOI 10.2170/jjphysiol.41.817; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wallace MN, 2011, HEARING RES, V274, P142, DOI 10.1016/j.heares.2010.05.012; Wallace MN, 2009, EXP BRAIN RES, V194, P395, DOI 10.1007/s00221-009-1714-8; Wallace MN, 2005, NEUROREPORT, V16, P2001, DOI 10.1097/00001756-200512190-00006; Wallace MN, 1999, NEUROREPORT, V10, P2095, DOI 10.1097/00001756-199907130-00019; Wallace MN, 2000, EXP BRAIN RES, V132, P445, DOI 10.1007/s002210000362; Wallace MN, 2005, HEARING RES, V204, P115, DOI 10.1016/j.heares.2005.01.007; Wallace MN, 2002, EXP BRAIN RES, V143, P106, DOI 10.1007/s00221-001-0973-9; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; WINTER P, 1973, EXP BRAIN RES, V18, P489; WOLLBERG Z, 1972, SCIENCE, V175, P212, DOI 10.1126/science.175.4018.212	71	33	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51646	10.1371/journal.pone.0051646	http://dx.doi.org/10.1371/journal.pone.0051646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251604	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200154
J	Kats, LB; Bucciarelli, GM; Schlais, DE; Blaustein, AR; Han, BA				Kats, Lee B.; Bucciarelli, Gary M.; Schlais, David E.; Blaustein, Andrew R.; Han, Barbara A.			Ultraviolet Radiation Influences Perch Selection by a Neotropical Poison-Dart Frog	PLOS ONE			English	Article							DENDROBATES-PUMILIO; B RADIATION; TERRITORIAL BEHAVIOR; AMPHIBIAN DECLINES; SENSITIVITY; VERTEBRATES; AVOIDANCE; VISION	Ambient ultraviolet-B radiation can harm amphibian eggs, larvae and adults. However, some amphibians avoid UV-B radiation when given the opportunity. The strawberry poison dart frog, Oophaga pumilio, is diurnal and males vocalize throughout the day in light gaps under forest canopies that expose them to solar radiation. Previous studies have demonstrated that males calling from high perches are more successful at mating than those at lower perches. We investigated whether frogs at higher perches receive more ultraviolet-B than those calling from lower perches. We also investigated whether frogs on perches receiving relatively low ultraviolet-B levels maintained their positions for longer compared to individuals calling from perches receiving higher levels of ultraviolet-B. Finally, since it has been hypothesized that some animals utilize levels of UV-A as a visual cue to avoid UV-B damage, we artificially elevated ultraviolet-A levels to examine whether males exposed to artificially elevated ultraviolet-A abandoned their perches sooner compared to males exposed to visible light. We found that frogs called from perches receiving low ultraviolet-B regardless of perch height, and that frogs maintain their positions longer on perches receiving low ultraviolet-B compared to perches receiving even slightly higher ultraviolet-B levels. Exposing the frogs to artificially elevated levels of ultraviolet-A radiation caused males to move off of their perches faster than when they were exposed to a control light source. These experiments suggest that ultraviolet radiation plays an important role in frog behavior related to perch selection, even in rainforests where much of the solar radiation is shielded by the forest canopy.	[Kats, Lee B.; Schlais, David E.] Pepperdine Univ, Div Nat Sci, Malibu, CA 90265 USA; [Bucciarelli, Gary M.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Blaustein, Andrew R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Han, Barbara A.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	Pepperdine University; University of California System; University of California Los Angeles; Oregon State University; University System of Georgia; University of Georgia	Kats, LB (corresponding author), Pepperdine Univ, Div Nat Sci, Malibu, CA 90265 USA.	lee.kats@pepperdine.edu	Han, Barbara A/H-9363-2015	Han, Barbara A/0000-0002-9948-3078; Bucciarelli, Gary/0000-0003-3345-1361	National Fish and Wildlife Foundation; National Science Foundation; Pepperdine University; Budweiser	National Fish and Wildlife Foundation; National Science Foundation(National Science Foundation (NSF)); Pepperdine University; Budweiser	The work was partially supported by a Budweiser Conservation Scholarship from the National Fish and Wildlife Foundation and Anheuser-Busch and a Postdoctoral Research Fellowship in Biology from the National Science Foundation. Additional funding came from Pepperdine University in the form of the Frank R. Seaver Chair (LBK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One author received funding from a commercial source (Budweiser); however, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data or materials.	Bancroft BA, 2008, CONSERV BIOL, V22, P987, DOI 10.1111/j.1523-1739.2008.00966.x; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Blaustein AR, 2003, EVOL DEV, V5, P89, DOI 10.1046/j.1525-142X.2003.03014.x; BUNNELL P, 1973, COPEIA, P277; Croteau MC, 2008, PHYSIOL BIOCHEM ZOOL, V81, P743, DOI 10.1086/591949; Cummings ME, 2008, J EXP BIOL, V211, P1203, DOI 10.1242/jeb.012963; DONNELLY MA, 1989, ECOL MONOGR, V59, P207, DOI 10.2307/1942599; GOVARDOVSKII VI, 1974, VISION RES, V14, P1317, DOI 10.1016/0042-6989(74)90003-0; Han BA, 2007, BIOTROPICA, V39, P433, DOI 10.1111/j.1744-7429.2007.00268.x; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Kats LB, 2000, ETHOLOGY, V106, P921, DOI 10.1046/j.1439-0310.2000.00608.x; KIMELDORF DJ, 1974, ENVIRON PHYSIOL BIOC, V4, P40; MCVEY ME, 1981, COPEIA, P1; Middleton EM, 2001, CONSERV BIOL, V15, P914, DOI 10.1046/j.1523-1739.2001.015004914.x; POORTER L, 1995, AM J BOT, V82, P1257, DOI 10.2307/2446248; Prohl H, 2005, J HERPETOL, V39, P354, DOI 10.1670/162-04A.1; Prohl H, 1999, BEHAV ECOL SOCIOBIOL, V46, P215, DOI 10.1007/s002650050612; ROITHMAIR ME, 1994, COPEIA, P107; Secondi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030391; Shi YS, 2003, P NATL ACAD SCI USA, V100, P8308, DOI 10.1073/pnas.1532535100; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; SILBERGLIED RE, 1979, ANNU REV ECOL SYST, V10, P373, DOI 10.1146/annurev.es.10.110179.002105; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Summers K, 1999, P ROY SOC B-BIOL SCI, V266, P2141, DOI 10.1098/rspb.1999.0900; Wong S, 2009, BIOTROPICA, V41, P74, DOI 10.1111/j.1744-7429.2008.00452.x	25	9	9	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51364	10.1371/journal.pone.0051364	http://dx.doi.org/10.1371/journal.pone.0051364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251505	gold, Green Published			2022-12-27	WOS:000313236200094
J	Llorens, I; Untereiner, G; Jaillard, D; Gouget, B; Chapon, V; Carriere, M				Llorens, Isabelle; Untereiner, Guillaume; Jaillard, Danielle; Gouget, Barbara; Chapon, Virginie; Carriere, Marie			Uranium Interaction with Two Multi-Resistant Environmental Bacteria: Cupriavidus metallidurans CH34 and Rhodopseudomonas palustris	PLOS ONE			English	Article							RAY-ABSORPTION SPECTROSCOPY; SPECIATION; ACCUMULATION; REDUCTION; EXAFS; COMPLEXES; ION; TRANSLOCATION; MICROSCOPY; CITRATE	Depending on speciation, U environmental contamination may be spread through the environment or inversely restrained to a limited area. Induction of U precipitation via biogenic or non-biogenic processes would reduce the dissemination of U contamination. To this aim U oxidation/reduction processes triggered by bacteria are presently intensively studied. Using X-ray absorption analysis, we describe in the present article the ability of Cupriavidus metallidurans CH34 and Rhodopseudomonas palustris, highly resistant to a variety of metals and metalloids or to organic pollutants, to withstand high concentrations of U and to immobilize it either through biosorption or through reduction to non-uraninite U(IV)-phosphate or U(IV)-carboxylate compounds. These bacterial strains are thus good candidates for U bioremediation strategies, particularly in the context of multi-pollutant or mixed-waste contaminations.	[Llorens, Isabelle] Polygone Sci Louis Neel, ESRF CRG FAME, Grenoble, France; [Llorens, Isabelle] CEA DSM INAC, Lab Nanostruct & Rayonnement Synchrotron, Grenoble, France; [Untereiner, Guillaume] UMR 3299 CEA CNRS, CEA DSM IRAMIS SIS2M, Lab Struct & Dynam Resonance Magnet, Gif Sur Yvette, France; [Jaillard, Danielle] UMR 8195 CNRS Univ Paris Sud, Ctr Commun Microscopie Elect, Orsay, France; [Gouget, Barbara] Direct Sci Labs, ANSES, Maisons Alfort, France; [Chapon, Virginie] CEA DSV IBEB, Lab Interact Prot Met, St Paul Les Durance, France; [Chapon, Virginie] CNRS, UMR 7265, St Paul Les Durance, France; [Chapon, Virginie] Univ Aix Marseille, St Paul Les Durance, France; [Carriere, Marie] UMR E3 CEA Univ Joseph Fourier, CEA DSM INAC SCIB, Lab Les Acides Nucle, Grenoble, France	CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Carriere, M (corresponding author), UMR E3 CEA Univ Joseph Fourier, CEA DSM INAC SCIB, Lab Les Acides Nucle, Grenoble, France.	marie.carriere@cea.fr	chapon, virginie/AAY-1669-2021; BM30, Beamline FAME/G-9313-2012; carriere, marie/F-2149-2011	chapon, virginie/0000-0002-2365-3464; carriere, marie/0000-0001-8446-6462	CEA through the Toxicology Program	CEA through the Toxicology Program	This work was funded by CEA through the Toxicology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PG, 1996, INORG CHEM, V35, P784, DOI 10.1021/ic9508536; Bailey EH, 2005, CHEM GEOL, V216, P1, DOI 10.1016/j.chemgeo.2004.10.011; Barkleit A, 2011, DALTON T, V40, P9868, DOI 10.1039/c1dt10546a; Bernier-Latmani R, 2010, ENVIRON SCI TECHNOL, V44, P9456, DOI 10.1021/es101675a; Boyanov MI, 2011, ENVIRON SCI TECHNOL, V45, P8336, DOI 10.1021/es2014049; Carriere M, 2005, NUCL INSTRUM METH B, V231, P268, DOI 10.1016/j.nimb.2005.01.069; Carriere M, 2008, J BIOL INORG CHEM, V13, P655, DOI 10.1007/s00775-008-0350-2; Carriere M, 2006, CHEM RES TOXICOL, V19, P1637, DOI 10.1021/tx060206z; Cologgi DL, 2011, P NATL ACAD SCI USA, V108, P15248, DOI 10.1073/pnas.1108616108; Dusausoy Y, 1996, EUR J MINERAL, V8, P667; Fletcher KE, 2010, ENVIRON SCI TECHNOL, V44, P4705, DOI 10.1021/es903636c; FRANCIS AJ, 1994, ENVIRON SCI TECHNOL, V28, P636, DOI 10.1021/es00053a016; Gavrilescu M, 2009, J HAZARD MATER, V163, P475, DOI 10.1016/j.jhazmat.2008.07.103; Geipel G, 2000, NATO SCI S 1 DISARM, V29, P323; Gianguzza A, 2005, J CHEM ENG DATA, V50, P1576, DOI 10.1021/je050040o; Hennig C, 2001, RADIOCHIM ACTA, V89, P625, DOI 10.1524/ract.2001.89.10.625; Hennig C, 2010, DALTON T, V39, P3744, DOI 10.1039/b922624a; Hu QH, 2010, J ENVIRON RADIOACTIV, V101, P426, DOI 10.1016/j.jenvrad.2008.08.004; Hudson EA, 1996, PHYS REV B, V54, P156, DOI 10.1103/PhysRevB.54.156; Kelly SD, 2002, GEOCHIM COSMOCHIM AC, V66, P3855, DOI 10.1016/S0016-7037(02)00947-X; Kelly SD, 2007, GEOCHIM COSMOCHIM AC, V71, P821, DOI 10.1016/j.gca.2006.10.013; Kelly SD, 2010, ENVIRON SCI TECHNOL, V44, P236, DOI 10.1021/es902191s; Khijniak TV, 2005, APPL ENVIRON MICROB, V71, P6423, DOI 10.1128/AEM.71.10.6423-6426.2005; Laurette J, 2012, ENVIRON EXP BOT, V77, P96, DOI 10.1016/j.envexpbot.2011.11.007; Laurette J, 2012, ENVIRON EXP BOT, V77, P87, DOI 10.1016/j.envexpbot.2011.11.005; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Merroun M, 2003, RADIOCHIM ACTA, V91, P583, DOI 10.1524/ract.91.10.583.22477; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Mondani L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025771; Proux O, 2006, J SYNCHROTRON RADIAT, V13, P59, DOI 10.1107/S0909049505037441; Proux O, 2005, PHYS SCRIPTA, VT115, P970; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Sarret G, 2005, APPL ENVIRON MICROB, V71, P2331, DOI 10.1128/AEM.71.5.2331-2337.2005; Sasikala C, 1998, ADV MICROB PHYSIOL, V39, P339; Sharp JO, 2011, GEOCHIM COSMOCHIM AC, V75, P6497, DOI 10.1016/j.gca.2011.08.022; Sheppard SC, 2005, J ENVIRON RADIOACTIV, V79, P55, DOI 10.1016/j.jenvrad.2004.05.015; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; Suzuki Y, 2006, J MINER PETROL SCI, V101, P299, DOI 10.2465/jmps.060322; von Rozycki T, 2009, ANTON LEEUW INT J G, V96, P115, DOI 10.1007/s10482-008-9284-5	40	21	22	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51783	10.1371/journal.pone.0051783	http://dx.doi.org/10.1371/journal.pone.0051783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251623	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200165
J	Peng, YM; Cai, J; Wang, W; Su, B				Peng, Yingmei; Cai, Jing; Wang, Wen; Su, Bing			Multiple Inter-Kingdom Horizontal Gene Transfers in the Evolution of the Phosphoenolpyruvate Carboxylase Gene Family	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; NUCLEAR GENE; ENDOSYMBIOSIS; BACTERIAL	Pepcase is a gene encoding phosphoenolpyruvate carboxylase that exists in bacteria, archaea and plants, playing an important role in plant metabolism and development. Most plants have two or more pepcase genes belonging to two gene sub-families, while only one gene exists in other organisms. Previous research categorized one plant pepcase gene as plant-type pepcase (PTPC) while the other as bacteria-type pepcase (BTPC) because of its similarity with the pepcase gene found in bacteria. Phylogenetic reconstruction showed that PTPC is the ancestral lineage of plant pepcase, and that all bacteria, protistpepcase and BTPC in plants are derived from a lineage of pepcase closely related with PTPC in algae. However, their phylogeny contradicts the species tree and traditional chronology of organism evolution. Because the diversification of bacteria occurred much earlier than the origin of plants, presumably all bacterialpepcase derived from the ancestral PTPC of algal plants after divergingfrom the ancestor of vascular plant PTPC. To solve this contradiction, we reconstructed the phylogeny of pepcase gene family. Our result showed that both PTPC and BTPC are derived from an ancestral lineage of gamma-proteobacteriapepcases, possibly via an ancient inter-kingdom horizontal gene transfer (HGT) from bacteria to the eukaryotic common ancestor of plants, protists and cellular slime mold. Our phylogenetic analysis also found 48other pepcase genes originated from inter-kingdom HGTs. These results imply that inter-kingdom HGTs played important roles in the evolution of the pepcase gene family and furthermore that HGTsare a more frequent evolutionary event than previouslythought.	[Peng, Yingmei; Wang, Wen; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Cai, Jing] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Cai, Jing] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Cai, Jing] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Peng, Yingmei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	wwang@mail.kiz.ac.cn; sub@mail.kiz.ac.cn	Wang, Wen/AAP-9873-2020	Cai, Jing/0000-0002-2496-4731				Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faguy DM, 1999, CURR BIOL, V9, pR883; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HENZE K, 1995, P NATL ACAD SCI USA, V92, P9122, DOI 10.1073/pnas.92.20.9122; Huang JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r88; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2005, NUCLEIC ACIDS RES, V33, P7120, DOI 10.1093/nar/gki1020; Lercher MJ, 2008, MOL BIOL EVOL, V25, P559, DOI 10.1093/molbev/msm283; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Sanchez R, 2003, PLANT PHYSIOL, V132, P949, DOI 10.1104/pp.102.019653; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wagner A, 2008, MOL GENET GENOMICS, V280, P397, DOI 10.1007/s00438-008-0373-y	27	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51159	10.1371/journal.pone.0051159	http://dx.doi.org/10.1371/journal.pone.0051159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251445	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200066
J	Jansen, T; Campbell, A; Kelly, C; Hatun, H; Payne, MR				Jansen, Teunis; Campbell, Andrew; Kelly, Ciaran; Hatun, Hjalmar; Payne, Mark R.			Migration and Fisheries of North East Atlantic Mackerel (Scomber scombrus) in Autumn and Winter	PLOS ONE			English	Article							SUBPOLAR GYRE; SCOTLAND; IMPACT; OCEAN; SEA	It has been suggested that observed spatial variation in mackerel fisheries, extending over several hundreds of kilometers, is reflective of climate-driven changes in mackerel migration patterns. Previous studies have been unable to clearly demonstrate this link. In this paper we demonstrate correlation between temperature and mackerel migration/distribution as proxied by mackerel catch data from both scientific bottom trawl surveys and commercial fisheries. We show that mackerel aggregate and migrate distances of up to 500 km along the continental shelf edge from mid-November to early March. The path of this migration coincides with the location of the relatively warm shelf edge current and, as a consequence of this affinity, mackerel are guided towards the main spawning area in the south. Using a simulated time series of temperature of the shelf edge current we show that variations in the timing of the migration are significantly correlated to temperature fluctuations within the current. The proposed proxies for mackerel distribution were found to be significantly correlated. However, the correlations were weak and only significant during periods without substantial legislative or technical developments. Substantial caution should therefore be exercised when using such data as proxies for mackerel distribution. Our results include a new temperature record for the shelf edge current obtained by embedding the available hydrographic observations within a statistical model needed to understand the migration through large parts of the life of adult mackerel and for the management of this major international fishery.	[Jansen, Teunis; Payne, Mark R.] Tech Univ Denmark, DTU AQUA Natl Inst Aquat Resources, Charlottenlund, Denmark; [Campbell, Andrew; Kelly, Ciaran] Inst Marine, Fisheries Ecosyst Advisory Serv, Galway, Ireland; [Payne, Mark R.] ETHZ Swiss Fed Inst Technol, Zurich, Switzerland	Technical University of Denmark; Marine Institute Ireland; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jansen, T (corresponding author), Tech Univ Denmark, DTU AQUA Natl Inst Aquat Resources, Charlottenlund, Denmark.	tej@aqua.dtu.dk	Payne, Mark/C-6844-2008	Payne, Mark/0000-0001-5795-2481; Hatun, Hjalmar/0000-0002-9312-7355; Jansen, Teunis/0000-0001-8722-4493	EURO-BASIN of the European Union [264933]	EURO-BASIN of the European Union	The research was funded by EURO-BASIN of the European Union's 7th Framework Program (Grant Agreement #264933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Eden C, 2001, J CLIMATE, V14, P2266, DOI 10.1175/1520-0442(2001)014<2266:MOITDV>2.0.CO;2; Graham CT, 2009, J FISH BIOL, V74, P1143, DOI 10.1111/j.1095-8649.2009.02180.x; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Hatun H, 2009, CAN J FISH AQUAT SCI, V66, P759, DOI 10.1139/F09-037; Hughes K, 2012, ICES J MAR IN PRESS; ICES, 1995, 1995ASSESS2 ICES CM; ICES, 2005, 2005ACFM08 ICES CM; ICES, 2012, ICES HYDR DAT; ICES, 2019, ICES SCI REPORTS, V1, DOI 10.17895/ices.pub.4982; ICES, 2008, ICES, P10; ICES: Report of the working group on assessment of new MoU species (WGNEW), 2012, 2012ACOM20 ICES CM; Jansen T., 2012, PLOS ONE, V7; Jansen T, 2012, THESIS DTU AQUA; Jansen T, 2011, CONT SHELF RES, V31, P64, DOI 10.1016/j.csr.2010.11.003; Kauker F, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002624; Larsen KMH, 2012, ICES J MAR SCI, V69, P802, DOI 10.1093/icesjms/fss028; Lockwood SJ, 1988, MACKEREL ITS BIOL AS; Madsen H, 1998, TIDSRAEKKEANALYSE, P145; Norges Sildesalgslag, 2009, BLANK SKJERM MAKR FI; Orvik KA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017932; Payne MR, 2012, MAR BIOL RES, V8, P475, DOI 10.1080/17451000.2011.639778; Punzon A, 2009, CONT SHELF RES, V29, P1195, DOI 10.1016/j.csr.2008.12.024; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Rayner NA, 2006, J CLIMATE, V19, P446, DOI 10.1175/JCLI3637.1; Reid D.G., 2006, 2006B14 ICES CM; Reid DG, 1997, ICES J MAR SCI, V54, P168, DOI 10.1006/jmsc.1996.0202; Reid DG, 2001, FISH RES, V50, P141, DOI 10.1016/S0165-7836(00)00247-2; Reid DG, 2003, 2006Q19 ICES CM; Trenkel VM, 2012, PROG OCEANO IN PRESS; Utne KR, 2012, MAR BIOL RES, V8, P420, DOI 10.1080/17451000.2011.640937; WALSH M, 1995, ICES J MAR SCI, V52, P925, DOI 10.1006/jmsc.1995.0089; Walsh M., 1986, 1986H17 ICES CM; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	35	24	24	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51541	10.1371/journal.pone.0051541	http://dx.doi.org/10.1371/journal.pone.0051541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251570	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900100
J	Lundh, SH; Soylu, R; Petersen, A				Lundh, Sofia Hult; Soylu, Rana; Petersen, Asa			Expression of Mutant Huntingtin in Leptin Receptor-Expressing Neurons Does Not Control the Metabolic and Psychiatric Phenotype of the BACHD Mouse	PLOS ONE			English	Article							DEPRESSION-RELATED BEHAVIOR; FULL-LENGTH HUNTINGTIN; BODY-WEIGHT; NEUROENDOCRINE CHANGES; DISEASE PROGRESSION; MICE; MODELS; HYPOTHALAMUS; DYSFUNCTION; DISORDERS	Metabolic and psychiatric disturbances occur early on in the clinical manifestation of Huntington's disease (HD), a neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin (HTT) gene. Hypothalamus has emerged as an important site of pathology and alterations in this area and its neuroendocrine circuits may play a role in causing early non-motor symptoms and signs in HD. Leptin is a hormone that controls energy homeostasis by signaling through leptin receptors in the hypothalamus. Disturbed leptin action is implicated in both obesity and depression and altered circulating levels of leptin have been reported in both clinical HD and rodent models of the disease. Pathological leptin signaling may therefore be involved in causing the metabolic and psychiatric disturbances of HD. Here we tested the hypothesis that expression of mutant HTT in leptin receptor carrying neurons plays a role in the development of the non-motor phenotype in the BACHD mouse model. Our results show that inactivation of mutant HTT in leptin receptor-expressing neurons in the BACHD mouse using cross-breeding based on a cre-loxP system did not have an effect on the metabolic phenotype or anxiety-like behavior. The data suggest that mutant HTT disrupts critical hypothalamic pathways by other mechanisms than interfering with intracellular leptin signaling.	[Lundh, Sofia Hult; Soylu, Rana; Petersen, Asa] Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden	Lund University	Lundh, SH (corresponding author), Lund Univ, Dept Expt Med Sci, Translat Neuroendocrine Res Unit, Lund, Sweden.	sofia.hult@med.lu.se		Soylu Kucharz, Rana/0000-0002-7872-5322	Swedish Medical Research Council [K2009-61X-21520-01-1, K2011-62X-20404-05-6]; Torsten and Ragnar Soderberg foundation; province of Skane state grants; Bagadilico	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Torsten and Ragnar Soderberg foundation; province of Skane state grants; Bagadilico	This work was supported by grants from the Swedish Medical Research Council (K2009-61X-21520-01-1 and K2011-62X-20404-05-6 to A.P.), the Torsten and Ragnar Soderberg foundation, the province of Skane state grants, and Bagadilico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; Bode FJ, 2009, BEHAV BRAIN RES, V205, P175, DOI 10.1016/j.bbr.2009.06.031; Chiu CT, 2011, NEUROPSYCHOPHARMACOL, V36, P2406, DOI 10.1038/npp.2011.128; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Duff K, 2010, NEUROLOGY, V75, P500, DOI 10.1212/WNL.0b013e3181eccfa2; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; Finger BC, 2010, PSYCHOPHARMACOLOGY, V210, P559, DOI 10.1007/s00213-010-1858-z; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Hult S, 2010, CURR DRUG TARGETS, V11, P1237, DOI 10.2174/1389450111007011237; Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3; Labad J, 2012, PSYCHOSOM MED, V74, P39, DOI 10.1097/PSY.0b013e31823ba8af; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; Lawson EA, 2012, CLIN ENDOCRINOL, V76, P520, DOI 10.1111/j.1365-2265.2011.04182.x; Leinninger GM, 2011, PHYSIOL BEHAV, V104, P572, DOI 10.1016/j.physbeh.2011.04.060; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Liu J, 2010, PSYCHOPHARMACOLOGY, V207, P535, DOI 10.1007/s00213-009-1684-3; Lu XY, 2007, CURR OPIN PHARMACOL, V7, P648, DOI 10.1016/j.coph.2007.10.010; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Orvoen S, 2012, NEUROSCI LETT, V507, P127, DOI 10.1016/j.neulet.2011.11.063; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Petersen A, 2009, NEURODEGENER DIS, V6, P154, DOI 10.1159/000225377; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; Pouladi MA, 2009, BRAIN, V132, P919, DOI 10.1093/brain/awp006; Reedeker W, 2012, PSYCHOSOMATICS, V53, P220, DOI 10.1016/j.psym.2011.12.010; Renoir T, 2012, BRIT J PHARMACOL, V165, P1375, DOI 10.1111/j.1476-5381.2011.01567.x; Renoir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022133; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Sturrock A, 2010, J GERIATR PSYCH NEUR, V23, P243, DOI 10.1177/0891988710383573; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004; Zeman M, 2009, NEUROENDOCRINOL LETT, V30, P387	51	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51168	10.1371/journal.pone.0051168	http://dx.doi.org/10.1371/journal.pone.0051168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251447	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900050
J	Rezende, AM; Folador, EL; Resende, DD; Ruiz, JC				Rezende, Antonio M.; Folador, Edson L.; Resende, Daniela de M.; Ruiz, Jeronimo C.			Computational Prediction of Protein-Protein Interactions in Leishmania Predicted Proteomes	PLOS ONE			English	Article							HIERARCHICAL ORGANIZATION; INTERACTION NETWORKS; DATA INTEGRATION; GENE ONTOLOGY; DATABASE; GENOME; SCALE; IDENTIFICATION; INFORMATION; MODULARITY	The Trypanosomatids parasites Leishmania braziliensis, Leishmania major and Leishmania infantum are important human pathogens. Despite of years of study and genome availability, effective vaccine has not been developed yet, and the chemotherapy is highly toxic. Therefore, it is clear just interdisciplinary integrated studies will have success in trying to search new targets for developing of vaccines and drugs. An essential part of this rationale is related to protein-protein interaction network (PPI) study which can provide a better understanding of complex protein interactions in biological system. Thus, we modeled PPIs for Trypanosomatids through computational methods using sequence comparison against public database of protein or domain interaction for interaction prediction (Interolog Mapping) and developed a dedicated combined system score to address the predictions robustness. The confidence evaluation of network prediction approach was addressed using gold standard positive and negative datasets and the AUC value obtained was 0.94. As result, 39,420, 43,531 and 45,235 interactions were predicted for L. braziliensis, L. major and L. infantum respectively. For each predicted network the top 20 proteins were ranked by MCC topological index. In addition, information related with immunological potential, degree of protein sequence conservation among orthologs and degree of identity compared to proteins of potential parasite hosts was integrated. This information integration provides a better understanding and usefulness of the predicted networks that can be valuable to select new potential biological targets for drug and vaccine development. Network modularity which is a key when one is interested in destabilizing the PPIs for drug or vaccine purposes along with multiple alignments of the predicted PPIs were performed revealing patterns associated with protein turnover. In addition, around 50% of hypothetical protein present in the networks received some degree of functional annotation which represents an important contribution since approximately 60% of Leishmania predicted proteomes has no predicted function.	[Rezende, Antonio M.; Folador, Edson L.; Resende, Daniela de M.; Ruiz, Jeronimo C.] Fiocruz MS, Lab Parasitol Celular & Mol, Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil; [Rezende, Antonio M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Folador, Edson L.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Resende, Daniela de M.] Univ Fed Ouro Preto, Lab Pesquisas Clin, Ouro Preto, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto	Rezende, AM (corresponding author), Fiocruz MS, Lab Parasitol Celular & Mol, Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil.	am.rezende@cpqrr.fiocruz.br; jeronimo@cpqrr.fiocruz.br	Rezende, Antonio M/S-2126-2018; Resende, Daniela M/E-7476-2011	Rezende, Antonio M/0000-0003-4775-1779; Resende, Daniela M/0000-0002-5139-3022; /0000-0002-1361-9721; Folador, Edson Luiz/0000-0002-6752-9334	Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) [APQ-02382-10, APQ-01835-10]; CNPq (National Counsel of Technological and Scientific Development) [476539/2010-2]; GENOPROT (Rede Integrada de Estudos Genomicos e Proteomicos) [560943/2010-5]; CPqRR - FIOCRUZ (Centro de Pesquisas Rene Rachou - FIOCRUZ); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior)	Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); GENOPROT (Rede Integrada de Estudos Genomicos e Proteomicos); CPqRR - FIOCRUZ (Centro de Pesquisas Rene Rachou - FIOCRUZ); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) grant APQ-02382-10 and APQ-01835-10. CNPq (National Counsel of Technological and Scientific Development) grant 476539/2010-2 and GENOPROT (Rede Integrada de Estudos Genomicos e Proteomicos) grant 560943/2010-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank for the following agencies for their past and current support for our research: CPqRR - FIOCRUZ (Centro de Pesquisas Rene Rachou - FIOCRUZ); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) grant APQ-02382-10 and APQ-01835-10. CNPq (National Counsel of Technological and Scientific Development) grant 476539/2010-2, GENOPROT (Rede Integrada de Estudos Genomicos e Proteomicos) grant 560943/2010-5.	[Anonymous], 1990, J MOL BIOL, V5, P7; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2003, LECT NOTES PHYS, V625, P46; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Florez AF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-484; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Garlick PJ, 1980, BRIT MED J, V281; Gomez SM, 2003, BIOINFORMATICS, V19, P1875, DOI 10.1093/bioinformatics/btg352; Gong S, 2005, BIOINFORMATICS, V21, P2541, DOI 10.1093/bioinformatics/bti366; Hadighi R, 2007, PARASITOL RES, V101, P1319, DOI 10.1007/s00436-007-0638-0; Harrington ED, 2008, FEBS LETT, V582, P1251, DOI 10.1016/j.febslet.2008.02.033; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Haynes C, 2006, NUCLEIC ACIDS RES, V34, P305, DOI 10.1093/nar/gkj424; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim JG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-41; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Muley VY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042057; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Oldfield CJ, 2007, BMC GENOMICS, V9; Pawlowski Krzysztof, 2008, Briefings in Functional Genomics & Proteomics, V7, P283, DOI 10.1093/bfgp/eln033; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Qi YJ, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P531; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Rojas R, 2006, J INFECT DIS, V193, P1375, DOI 10.1086/503371; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Sauer U, 2007, SCIENCE, V316, P550, DOI 10.1126/science.1142502; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Skrabanek L, 2008, MOL BIOTECHNOL, V38, P1, DOI 10.1007/s12033-007-0069-2; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vilella AJ, 2005, BIOINFORMATICS, V21, P2791, DOI 10.1093/bioinformatics/bti403; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wuchty S, 2004, GENOME RES, V14, P1310, DOI 10.1101/gr.2300204; Wuchty S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-122; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Yu HY, 2004, GENOME RES, V14; Zhang LV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-38	70	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51304	10.1371/journal.pone.0051304	http://dx.doi.org/10.1371/journal.pone.0051304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251492	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900065
J	Abraham, NM; Guerin, D; Bhaukaurally, K; Carleton, A				Abraham, Nixon M.; Guerin, Delphine; Bhaukaurally, Khaleel; Carleton, Alan			Similar Odor Discrimination Behavior in Head-Restrained and Freely Moving Mice	PLOS ONE			English	Article							NEURAL CIRCUITRY; TRANSGENIC MICE; OLFACTORY-BULB; VISUAL-CORTEX; ACCURACY; SNIFF; SPEED; REPRESENTATIONS; ACTIVATION; NEURONS	A major challenge in neuroscience is relating neuronal activity to animal behavior. In olfaction limited techniques are available for these correlation studies in freely moving animals. To solve this problem, we developed an olfactory behavioral assay in head-restrained mice where we can monitor behavioral responses with high temporal precision. Mice were trained on a go/no-go operant conditioning paradigm to discriminate simple monomolecular odorants, as well as complex odorants such as binary mixtures of monomolecular odorants or natural odorants. Mice learned to discriminate both simple and complex odors in a few hundred trials with high accuracy. We then compared the discrimination performance of head-restrained mice to the performance observed in freely moving mice. Discrimination accuracies were comparable in both behavioral paradigms. In addition, discrimination times were measured while the animals performed well. In both tasks, mice discriminated simple odors in a few hundred milliseconds and took additional time to discriminate the complex mixtures. In conclusion, mice showed similar and efficient discrimination behavior while head-restrained compared with freely moving mice. Therefore, the head-restrained paradigm offers a relevant approach to monitor neuronal activity while animals are actively engaged in olfactory discrimination behaviors. Citation: Abraham NM, Guerin D, Bhaukaurally K, Carleton A (2012) Similar Odor Discrimination Behavior in Head-Restrained and Freely Moving Mice. PLoS ONE 7(12): e51789. doi:10.1371/journal.pone.0051789	[Abraham, Nixon M.; Guerin, Delphine; Bhaukaurally, Khaleel; Carleton, Alan] Univ Geneva, Sch Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Abraham, Nixon M.; Guerin, Delphine; Bhaukaurally, Khaleel; Carleton, Alan] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland	University of Geneva; University of Geneva	Abraham, NM (corresponding author), Univ Geneva, Sch Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	nixon.abraham@unige.ch; alan.carleton@unige.ch	Abraham, Nixon/R-8381-2016; Carleton, Alan/C-9721-2010	Abraham, Nixon/0000-0001-8523-716X; Carleton, Alan/0000-0001-5633-9159	University of Geneva; Swiss National Science Foundation [PP0033_119169, PP00P3_139189, 51AU40_125759]; National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases''; European Research Council [ERC-2009-StG-243344-NEUROCHEMS]; Novartis foundation for medical research; Carlos & Elsie de Reuter foundation; Ernst & Lucie Schmidheiny foundation; European Molecular Biology Organization	University of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases''(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); Novartis foundation for medical research; Carlos & Elsie de Reuter foundation; Ernst & Lucie Schmidheiny foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This research was supported by the University of Geneva, the Swiss National Science Foundation (SNF professor grant numbers: PP0033_119169 and PP00P3_139189), the National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases'' financed by the Swiss National Science Foundation (no 51AU40_125759), the European Research Council (contract number ERC-2009-StG-243344-NEUROCHEMS), the Novartis foundation for medical research, the Carlos & Elsie de Reuter foundation, the Ernst & Lucie Schmidheiny foundation and the European Molecular Biology Organization (A.C. young investigator program, N.A. long-term postdoctoral fellowship program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bathellier B, 2007, NEUROIMAGE, V34, P1020, DOI 10.1016/j.neuroimage.2006.10.038; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Frederick DE, 2011, BEHAV NEUROSCI, V125, P588, DOI 10.1037/a0024371; Friedrich RW, 2006, TRENDS NEUROSCI, V29, P40, DOI 10.1016/j.tins.2005.10.004; Gschwend O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030155; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kerr JND, 2012, CURR OPIN NEUROBIOL, V22, P45, DOI 10.1016/j.conb.2011.12.002; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Kurt S, 2010, P NATL ACAD SCI USA, V107, P8481, DOI 10.1073/pnas.0912357107; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Lepousez G, 2011, JOVE-J VIS EXP, DOI 10.3791/3380; Lin JY, 2012, PROG BRAIN RES, V196, P29, DOI 10.1016/B978-0-444-59426-6.00002-1; Luce R. D, 1986, OXFORD PSYCHOL SERIE, V8; Mainen ZF, 2006, CURR OPIN NEUROBIOL, V16, P429, DOI 10.1016/j.conb.2006.06.003; Morita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020437; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Populin LC, 2011, J NEUROPHYSIOL, V106, P2000, DOI 10.1152/jn.00331.2011; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Vincis R, 2012, NAT NEUROSCI, V15, P537, DOI 10.1038/nn.3057; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	44	29	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51789	10.1371/journal.pone.0051789	http://dx.doi.org/10.1371/journal.pone.0051789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272168	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300029
J	Jaiswal, D; Trivedi, S; Singh, R; Dada, R; Singh, K				Jaiswal, Deepika; Trivedi, Sameer; Singh, Rajendra; Dada, Rima; Singh, Kiran			Association of the IL1RN Gene VNTR Polymorphism with Human Male Infertility	PLOS ONE			English	Article							IL-1 RECEPTOR ANTAGONIST; RAT LEYDIG-CELLS; CYTOKINE SYNTHESIS; HUMAN MONOCYTES; INTERLEUKIN-1; EXPRESSION; STEROIDOGENESIS; BLOCKADE	Interleukin-1 (IL-1) is a regulatory cytokine that plays an important role in the maintenance of the immune environment of the testis, regulation of junction dynamics and cell differentiation during spermatogenesis. Members of the IL-1 family are pleiotropic cytokines that are involved in inflammation, immunoregulation and other homeostatic functions in the body. IL-1 alpha, IL-1 beta, and the IL-1 receptor antagonistic molecule (IL-1 Ra) are expressed in the testis under normal homeostasis and they further increase upon infection/inflammation. In the present study we have examined the association of Variable Number Tandem Repeats (VNTR) polymorphism of the Interleukin-1 receptor antagonist gene (IL1RN) with human male infertility. The case-control study comprised of two groups: 331 idiopathic infertile patients and 358 fertile healthy men. The study indicates risk of IL1RN2 variant with male infertility (OR: 1.43, CI: 1.1546 to 1.7804, P = 0.001). To our best knowledge, this is the first report that links IL1RN VNTR polymorphism with human male infertility.	[Jaiswal, Deepika; Singh, Kiran] Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India; [Trivedi, Sameer] Banaras Hindu Univ, Inst Med Sci, Dept Urol, Varanasi 221005, Uttar Pradesh, India; [Singh, Rajendra] Cent Drug Res Inst, Div Endocrinol, Lucknow 226001, Uttar Pradesh, India; [Dada, Rima] All India Inst Med Sci, Dept Anat, New Delhi 110029, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, K (corresponding author), Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India.	singhk4@rediffmail.com	trivedi, sameer/AAN-3656-2020; Singh, Rajender/ABE-3512-2020	trivedi, sameer/0000-0001-8308-9220; SINGH, KIRAN/0000-0002-2592-6534	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance in the form of Junior Research Fellowship by Council of Scientific and Industrial Research (CSIR), New Delhi, India to the first author is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0; Cudicini C, 1997, J CLIN ENDOCR METAB, V82, P1426, DOI 10.1210/jc.82.5.1426; Ganaiem M, 2009, ENDOCRINOLOGY, V150, P295, DOI 10.1210/en.2008-0848; Genc MR, 2002, AM J OBSTET GYNECOL, V187, P157, DOI 10.1067/mob.2002.122407; Gopichandran N, 2006, REPRODUCTION, V131, P613, DOI 10.1530/rep.1.00959; GRANOWITZ EV, 1992, BLOOD, V79, P2356; GRANOWITZ EV, 1992, BLOOD, V79, P2364; Gremlich S, 2008, HUM REPROD, V23, P1200, DOI 10.1093/humrep/den034; Gruschwitz MS, 1996, J ANDROL, V17, P159; HALES DB, 1992, ENDOCRINOLOGY, V131, P2165, DOI 10.1210/en.131.5.2165; Holstein Adolf-Friedrich, 2003, Reprod Biol Endocrinol, V1, P107, DOI 10.1186/1477-7827-1-107; Korthagen NM, 2012, IMMUNOGENETICS, V64, P371, DOI 10.1007/s00251-012-0604-6; Li MWM, 2009, CYTOKINE GROWTH F R, V20, P329, DOI 10.1016/j.cytogfr.2009.07.007; Rozwadowska N, 2007, GENES IMMUN, V8, P100, DOI 10.1038/sj.gene.6364356; Soder O, 2000, ANDROLOGIA, V32, P52; Vamvakopoulos J, 2002, EUR J IMMUNOL, V32, P2988, DOI 10.1002/1521-4141(2002010)32:10<2988::AID-IMMU2988>3.0.CO;2-9; VERHOEVEN G, 1988, MOL CELL ENDOCRINOL, V57, P51, DOI 10.1016/0303-7207(88)90031-7; WARREN DW, 1990, J ANDROL, V11, P353	18	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51899	10.1371/journal.pone.0051899	http://dx.doi.org/10.1371/journal.pone.0051899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251650	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800106
J	Kazakoff, SH; Imelfort, M; Edwards, D; Koehorst, J; Biswas, B; Batley, J; Scott, PT; Gresshoff, PM				Kazakoff, Stephen H.; Imelfort, Michael; Edwards, David; Koehorst, Jasper; Biswas, Bandana; Batley, Jacqueline; Scott, Paul T.; Gresshoff, Peter M.			Capturing the Biofuel Wellhead and Powerhouse: The Chloroplast and Mitochondrial Genomes of the Leguminous Feedstock Tree Pongamia pinnata	PLOS ONE			English	Article							PLANT; STABILITY	Pongamia pinnata (syn. Millettia pinnata) is a novel, fast-growing arboreal legume that bears prolific quantities of oil-rich seeds suitable for the production of biodiesel and aviation biofuel. Here, we have used Illumina (R) 'Second Generation DNA Sequencing (2GS)' and a new short-read de novo assembler, SaSSY, to assemble and annotate the Pongamia chloroplast (152,968 bp; cpDNA) and mitochondrial (425,718 bp; mtDNA) genomes. We also show that SaSSY can be used to accurately assemble 2GS data, by re-assembling the Lotus japonicus cpDNA and in the process assemble its mtDNA (380,861 bp). The Pongamia cpDNA contains 77 unique protein-coding genes and is almost 60% gene-dense. It contains a 50 kb inversion common to other legumes, as well as a novel 6.5 kb inversion that is responsible for the non-disruptive, re-orientation of five protein-coding genes. Additionally, two copies of an inverted repeat firmly place the species outside the subclade of the Fabaceae lacking the inverted repeat. The Pongamia and L. japonicus mtDNA contain just 33 and 31 unique protein-coding genes, respectively, and like other angiosperm mtDNA, have expanded intergenic and multiple repeat regions. Through comparative analysis with Vigna radiata we measured the average synonymous and non-synonymous divergence of all three legume mitochondrial (1.59% and 2.40%, respectively) and chloroplast (8.37% and 8.99%, respectively) protein-coding genes. Finally, we explored the relatedness of Pongamia within the Fabaceae and showed the utility of the organellar genome sequences by mapping transcriptomic data to identify up- and down-regulated stress-responsive gene candidates and confirm in silico predicted RNA editing sites. Citation: Kazakoff SH, Imelfort M, Edwards D, Koehorst J, Biswas B, et al. (2012) Capturing the Biofuel Wellhead and Powerhouse: The Chloroplast and Mitochondrial Genomes of the Leguminous Feedstock Tree Pongamia pinnata. PLoS ONE 7(12): e51687. doi:10.1371/journal.pone.0051687	[Kazakoff, Stephen H.; Koehorst, Jasper; Biswas, Bandana; Batley, Jacqueline; Scott, Paul T.; Gresshoff, Peter M.] Univ Queensland, Australian Res Council Ctr Excellence Integrat Le, Brisbane, Qld, Australia; [Imelfort, Michael] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld, Australia; [Edwards, David] Univ Queensland, Australian Ctr Plant Funct Genom, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Gresshoff, PM (corresponding author), Univ Queensland, Australian Res Council Ctr Excellence Integrat Le, Brisbane, Qld, Australia.	p.gresshoff@uq.edu.au	Batley, Jacqueline/A-5723-2008; Edwards, David/H-3710-2015; Koehorst, Jasper Jan/Z-1697-2019	Batley, Jacqueline/0000-0002-5391-5824; Edwards, David/0000-0001-7599-6760; Koehorst, Jasper Jan/0000-0001-8172-8981	BioEnergy Plantation Australia; Australian Research Council Centre of Excellence grant; BES Pty Ltd	BioEnergy Plantation Australia; Australian Research Council Centre of Excellence grant(Australian Research Council); BES Pty Ltd	The authors thank BioEnergy Plantation Australia for research support in Pongamia, BES Pty Ltd. for university liaison. Research was also funded by an Australian Research Council Centre of Excellence grant to PMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This reasearch was funded in part by BioEnergy Plantation Australia and BES Pty Ltd. BioEnergy Plantation Australia is developing critical technology platforms for the genetic, genomic and biotechnology application to the legume tree Pongamia pinnata. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Bally J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025289; Biswas B, 2011, J PLANT PHYSL, DOI [10.1016/j.jclepro.2009.04.004, DOI 10.1016/J.JCLEPRO.2009.04.004]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; Du PF, 2008, J THEOR BIOL, V253, P579, DOI 10.1016/j.jtbi.2008.04.006; Du PF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-135; Gottipati R, 2011, J FUEL CHEM TECHNOL, DOI [10.1016/S1872-5813(11)60021-2, DOI 10.1016/S1872-5813(11)60021-2]; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Kato T, 2000, DNA RES, V7, P323, DOI 10.1093/dnares/7.6.323; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murphy HT, 2012, BIOENERG RES, V5, P778, DOI 10.1007/s12155-012-9190-6; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Scott PT, 2008, BIOENERG RES, V1, P2, DOI 10.1007/s12155-008-9003-0; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wojiechowski MF, 2004, AM J BOT, DOI [10.3732/ajb.91.11.1846, DOI 10.3732/AJB.91.11.1846]; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	37	55	57	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51687	10.1371/journal.pone.0051687	http://dx.doi.org/10.1371/journal.pone.0051687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272141	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800065
J	Ungureanu, M; Stoliar, P; Llopis, R; Casanova, F; Hueso, LE				Ungureanu, Mariana; Stoliar, Pablo; Llopis, Roger; Casanova, Felix; Hueso, Luis E.			Non-Hebbian Learning Implementation in Light-Controlled Resistive Memory Devices	PLOS ONE			English	Article							MEMRISTOR; DOPAMINE; PLASTICITY; SYNAPSES; NEURONS	Non-Hebbian learning is often encountered in different bio-organisms. In these processes, the strength of a synapse connecting two neurons is controlled not only by the signals exchanged between the neurons, but also by an additional factor external to the synaptic structure. Here we show the implementation of non-Hebbian learning in a single solid-state resistive memory device. The output of our device is controlled not only by the applied voltages, but also by the illumination conditions under which it operates. We demonstrate that our metal/oxide/semiconductor device learns more efficiently at higher applied voltages but also when light, an external parameter, is present during the information writing steps. Conversely, memory erasing is more efficiently at higher applied voltages and in the dark. Translating neuronal activity into simple solid-state devices could provide a deeper understanding of complex brain processes and give insight into non-binary computing possibilities. Citation: Ungureanu M, Stoliar P, Llopis R, Casanova F, Hueso LE (2012) Non-Hebbian Learning Implementation in Light-Controlled Resistive Memory Devices. PLoS ONE 7(12): e52042. doi:10.1371/journal.pone.0052042	[Ungureanu, Mariana; Stoliar, Pablo; Llopis, Roger; Casanova, Felix; Hueso, Luis E.] CIC nanoGUNE Consolider, Donostia San Sebastian, Spain; [Stoliar, Pablo] CNRS UPS, LPS, Orsay, France; [Stoliar, Pablo] UNSAM, ECyT, San Martin, Buenos Aires, Argentina; [Casanova, Felix; Hueso, Luis E.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Basque Foundation for Science	Ungureanu, M (corresponding author), CIC nanoGUNE Consolider, Donostia San Sebastian, Spain.	m.ungureanu@nanogune.eu; l.hueso@nanogune.eu	Hueso, Luis E/C-8713-2009; Casanova, Felix/B-4639-2013; Stoliar, Pablo/H-3395-2012; Llorens, Roger Llopis/S-1403-2019	Hueso, Luis E/0000-0002-7918-8047; Casanova, Felix/0000-0003-0316-2163; Stoliar, Pablo/0000-0003-3065-2942; Llorens, Roger Llopis/0000-0002-5172-2690; nanoGUNE, CIC/0000-0001-7874-5254	Juan de la Cierva Program [JCI-2010-07837, MAT2009-08494]; Consolider-Ingenio from the Spanish Ministry of Science [CSD2006-53]; Marie Curie Reintegration Grant from the European Commission; ETORTEK Program from the Basque Government [IE06-172]	Juan de la Cierva Program; Consolider-Ingenio from the Spanish Ministry of Science; Marie Curie Reintegration Grant from the European Commission; ETORTEK Program from the Basque Government	This work was supported by the Juan de la Cierva Program JCI-2010-07837 and by MAT2009-08494 and Consolider-Ingenio CSD2006-53 projects all from the Spanish Ministry of Science, by the Marie Curie Reintegration Grant 2009 ITAMOSCINOM from the European Commission and by the ETORTEK Program IE06-172 from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Hebb Donald O., 1949, ORG BEHAV; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/NMAT3054, 10.1038/nmat3054]; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pershin YV, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021926; Porr B, 2007, NEURAL COMPUT, V19, P2694, DOI 10.1162/neco.2007.19.10.2694; Potjans W, 2010, FRONTIERS COMPUTATIO, V4, P1411; Ramon y Cajal S, 1899, IMPRENTA NACL B OFIC, VI, P20; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Sawa A, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70119-6; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Scott JC, 2007, ADV MATER, V19, P1452, DOI 10.1002/adma.200602564; Seo K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254023; Sherrington C.S., 1906, INTEGRATIVE ACTION N; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Ungureanu M, 2012, ADV MATER, V24, P2496, DOI 10.1002/adma.201200382; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Zamarreno-Ramos C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00026	22	2	2	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52042	10.1371/journal.pone.0052042	http://dx.doi.org/10.1371/journal.pone.0052042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251679	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800132
J	Mahs, A; Ischebeck, T; Heilig, Y; Stenzel, I; Hempel, F; Seiler, S; Heilmann, I				Maehs, Anette; Ischebeck, Till; Heilig, Yvonne; Stenzel, Irene; Hempel, Franziska; Seiler, Stephan; Heilmann, Ingo			The Essential Phosphoinositide Kinase MSS-4 Is Required for Polar Hyphal Morphogenesis, Localizing to Sites of Growth and Cell Fusion in Neurospora crassa	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASES; INOSITOL PHOSPHOLIPID KINASE; POLLEN-TUBE GROWTH; PLASMA-MEMBRANE; DEPENDENT ENDOCYTOSIS; GENOME SEQUENCE; TIP GROWTH; ARABIDOPSIS; PROTEIN; YEAST	Fungal hyphae and plant pollen tubes are among the most highly polarized cells known and pose extraordinary requirements on their cell polarity machinery. Cellular morphogenesis is driven through the phospholipid-dependent organization at the apical plasma membrane. We characterized the contribution of phosphoinositides (PIs) in hyphal growth of the filamentous ascomycete Neurospora crassa. MSS-4 is an essential gene and its deletion resulted in spherically growing cells that ultimately lyse. Two conditional mss-4-mutants exhibited altered hyphal morphology and aberrant branching at restrictive conditions that were complemented by expression of wild type MSS-4. Recombinant MSS-4 was characterized as a phosphatidylinositolmonophosphate-kinase phosphorylating phosphatidylinositol 4-phosphate (PtdIns4P) to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2). PtdIns3P was also used as a substrate. Sequencing of two conditional mss-4 alleles identified a single substitution of a highly conserved Y750 to N. The biochemical characterization of recombinant protein variants revealed Y750 as critical for PI4P 5-kinase activity of MSS-4 and of plant PI4P 5-kinases. The conditional growth defects of mss-4 mutants were caused by severely reduced activity of MSS-4(Y750N), enabling the formation of only trace amounts of PtdIns(4,5)P-2. In N. crassa hyphae, PtdIns(4,5)P-2 localized predominantly in the plasma membrane of hyphae and along septa. Fluorescence-tagged MSS-4 formed a subapical collar at hyphal tips, localized to constricting septa and accumulated at contact points of fusing N. crassa germlings, indicating MSS-4 is responsible for the formation of relevant pools of PtdIns(4,5)P-2 that control polar and directional growth and septation. N. crassa MSS-4 differs from yeast, plant and mammalian PI4P 5-kinases by containing additional protein domains. The N-terminal domain of N. crassa MSS-4 was required for correct membrane association. The data presented for N. crassa MSS-4 and its roles in hyphal growth are discussed with a comparative perspective on PI-control of polar tip growth in different organismic kingdoms.	[Heilig, Yvonne; Seiler, Stephan] Univ Gottingen, Inst Microbiol & Genet, Gottingen, Germany; [Maehs, Anette; Ischebeck, Till; Stenzel, Irene; Hempel, Franziska; Heilmann, Ingo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Gottingen, Germany	University of Gottingen; University of Gottingen	Seiler, S (corresponding author), Univ Freiburg, Inst Biol Mol Plant Physiol 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	stephan.seiler@biologie.uni-freiburg.de; ingo.heilmann@biochemtech.uni-halle.de	Ischebeck, Till/AAM-4327-2020	Ischebeck, Till/0000-0003-0737-3822	German Research Foundation (DFG) through the Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB) [He3424/1, SE1054/3-2, GSC 226/1]; Neurospora program grant [PO1 GM068087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER	German Research Foundation (DFG) through the Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB)(German Research Foundation (DFG)); Neurospora program grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the German Research Foundation (DFG) [Emmy-Noether grant He3424/1 to I.H., grant SE1054/3-2 to S.S. and grant GSC 226/1 through the Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB)]. The authors acknowledge the FGSC and the Neurospora program grant PO1 GM068087 for continuous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand A, 2009, CURR OPIN MICROBIOL, V12, P350, DOI 10.1016/j.mib.2009.05.007; Camacho L, 2009, J CELL SCI, V122, P4383, DOI 10.1242/jcs.053488; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Cho MH, 1995, METHODS CELL BIOL, V49, P543, DOI 10.1016/S0091-679X(08)61479-X; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Dowd PE, 2006, PLANT CELL, V18, P1438, DOI 10.1105/tpc.106.041582; Drobak BK, 1999, INT REV CYTOL, V189, P95, DOI 10.1016/S0074-7696(08)61386-8; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Echauri-Espinosa RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038237; Elge S, 2001, PLANT J, V26, P561, DOI 10.1046/j.1365-313x.2001.01051.x; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fischer U, 2004, CURR OPIN PLANT BIOL, V7, P670, DOI 10.1016/j.pbi.2004.09.007; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Harris SD, 2011, MOL MICROBIOL, V79, P1123, DOI 10.1111/j.1365-2958.2010.07525.x; Heilmann I, 2009, TRENDS PLANT SCI, V14, P171, DOI 10.1016/j.tplants.2008.12.002; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Hur HS, 2006, J MICROBIOL, V44, P523; Ischebeck T, 2011, PLANT J, V65, P453, DOI 10.1111/j.1365-313X.2010.04435.x; Ischebeck T, 2010, MOL PLANT, V3, P870, DOI 10.1093/mp/ssq031; Ischebeck T, 2010, PROTOPLASMA, V240, P13, DOI 10.1007/s00709-009-0093-0; Ischebeck T, 2008, PLANT CELL, V20, P3312, DOI 10.1105/tpc.108.059568; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Konig S, 2008, ANAL BIOCHEM, V378, P197, DOI 10.1016/j.ab.2008.03.052; Kost B, 1999, J CELL BIOL, V145, P317, DOI 10.1083/jcb.145.2.317; Kunz J, 2002, J BIOL CHEM, V277, P5611, DOI 10.1074/jbc.M110775200; Kusano H, 2008, PLANT CELL, V20, P367, DOI 10.1105/tpc.107.056119; Maerz S, 2012, MOL CELL BIOL, V32, P2083, DOI 10.1128/MCB.06263-11; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Markham JE, 2011, PLANT CELL, V23, P2362, DOI 10.1105/tpc.110.080473; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Mei Y, 2012, CELL RES, V22, P581, DOI 10.1038/cr.2011.150; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Orlando K, 2008, J BIOL CHEM, V283, P14205, DOI 10.1074/jbc.M708178200; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Perera IY, 2005, FEBS LETT, V579, P3427, DOI 10.1016/j.febslet.2005.05.018; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Read Nick D., 2012, Fungal Biology Reviews, V26, P1, DOI 10.1016/j.fbr.2012.02.003; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; Seiler S, 2010, MOL MICROBIOL, V78, P1058, DOI 10.1111/j.1365-2958.2010.07392.x; Sousa E, 2008, PLANT CELL, V20, P3050, DOI 10.1105/tpc.108.058826; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; STENZEL I, 2012, FRONT PLANT SCI, V2, pNIL93, DOI DOI 10.3389/fpls.2011.00114; Stenzel I, 2008, PLANT CELL, V20, P124, DOI 10.1105/tpc.107.052852; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Takeshita N, 2012, MOL MICROBIOL, V83, P1136, DOI 10.1111/j.1365-2958.2012.07996.x; Thole JM, 2008, CURR OPIN PLANT BIOL, V11, P620, DOI 10.1016/j.pbi.2008.10.010; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Zhao Y, 2010, PLANT CELL, V22, P4031, DOI 10.1105/tpc.110.076760; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	71	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51454	10.1371/journal.pone.0051454	http://dx.doi.org/10.1371/journal.pone.0051454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272106	Green Published, gold			2022-12-27	WOS:000312386600026
J	Buchanan, RM; Tetland, S; Wilson, HL				Buchanan, Rachelle M.; Tetland, Sherry; Wilson, Heather L.			Low Dose Antigen Exposure for a Finite Period in Newborn Rats Prevents Induction of Mucosal Tolerance	PLOS ONE			English	Article							IMMUNE-RESPONSES; ORAL TOLERANCE; DENDRITIC CELLS; PROTEIN ANTIGENS; EARLY-LIFE; B-CELLS; IMMUNOGLOBULIN; ABSORPTION; SYSTEM; MICE	Background: In adult rats, initial exposure to antigens by a mucosal route triggers tolerance such that any subsequent re-exposure, even by a systemic route, results in suppression of immunity. The newborn's gut is semi-permeable for a finite period to allow maternal antibodies to enter the newborn's circulation. We propose that antigens introduced in extreme early life can readily traverse the gut wall and therefore circumvent induction of mucosal tolerance. Methodology/Principle Findings: Rat pups were gavaged with low-doses of ovalbumin (OVA; oral exposure group) or saline (parenteral control group) every second day for several weeks followed by an intraperitoneal (i.p.) injection at 1 month of age. When gavage was initiated the day after birth, newborn oral exposure pups responded with significantly higher anti-OVA IgA, IgM, IgG2a, and IgG1 titres in their serum and anti-OVA IgA, IgG2a and IgG1 titres in their lungs compared to negative control pups. Oral exposure alone failed to induce immunity. Pups exposed to the same treatment regimen starting at 14 days of age showed induction of mucosal tolerance after i.p. immunization. Newborn oral exposure groups subjected to secondary i.p. immunization responded with significantly increased humoral immunity in lung and sera suggesting that once antigen-specific mucosal tolerance if circumvented, it persists. Lymphocytes derived from mesenteric lymph node cells re-simulated with OVA ex vivo, from newborn oral exposure pups exposed to secondary immunization produced significantly higher IFN-gamma expression and lymphocyte proliferation relative to control pups indicating prevention of tolerance in the cell-mediated immune system. Conclusions/Significance: This work demonstrates that newborns may be uniquely qualified to prevent induction of mucosal tolerance to oral antigens. These results should be further explored to establish whether prevention of tolerance by early life oral vaccination can be exploited to prime for mucosal as well as systemic immunity and thus protect this susceptible population against infectious diseases.	[Buchanan, Rachelle M.; Tetland, Sherry; Wilson, Heather L.] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada	University of Saskatchewan	Wilson, HL (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	heather.wilson@usask.ca		Wilson, Heather/0000-0002-1261-0901	Saskatchewan Agriculture Development Fund	Saskatchewan Agriculture Development Fund	This research was funded by a grant to HLW from the Saskatchewan Agriculture Development Fund (www.agriculture.gov.sk.ca/ADF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpan O, 2001, J IMMUNOL, V166, P4843, DOI 10.4049/jimmunol.166.8.4843; APPLEBY P, 1983, J REPROD IMMUNOL, V5, P203, DOI 10.1016/0165-0378(83)90236-X; BRANDTZAEG P, 1991, GASTROENTEROL CLIN N, V20, P397; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P383, DOI 10.1016/S0167-5699(99)01498-X; Cesta MF, 2006, TOXICOL PATHOL, V34, P599, DOI 10.1080/01926230600865531; CORNES JS, 1965, P ROY SOC MED, V58, P716, DOI 10.1177/003591576505800930; Corthesy B, 2010, FUTURE MICROBIOL, V5, P817, DOI 10.2217/FMB.10.39; Czerkinsky C, 2010, MUCOSAL IMMUNOL, V3, P545, DOI 10.1038/mi.2010.55; Daskalakis NP, 2012, PHYSIOL BEHAV, V106, P707, DOI 10.1016/j.physbeh.2012.01.015; Duizer E, 1999, TOXICOL APPL PHARM, V155, P117, DOI 10.1006/taap.1998.8589; El-Merhibi A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/396232; Elahi S, 2005, INFECT IMMUN, V73, P3636, DOI 10.1128/IAI.73.6.3636-3645.2005; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faria AMC, 2003, J AUTOIMMUN, V20, P135, DOI 10.1016/S0896-8411(02)00112-9; FERGUSON A, 1972, CLIN EXP IMMUNOL, V12, P477; Garlapati S, 2010, VACCINE, V28, P8306, DOI 10.1016/j.vaccine.2010.09.080; Gerdts V, 2000, NAT MED, V6, P929, DOI 10.1038/78699; Gerdts V, 2002, J IMMUNOL, V168, P1877, DOI 10.4049/jimmunol.168.4.1877; Griebel PJ, 1996, DEV IMMUNOL, V4, P263; HALLIDAY R, 1955, PROC R SOC SER B-BIO, V143, P408, DOI 10.1098/rspb.1955.0020; HANSON DG, 1981, J IMMUNOL, V127, P1518; Harris SP, 2011, VET IMMUNOL IMMUNOP, V141, P312, DOI 10.1016/j.vetimm.2011.03.015; Inskeep TK, 2010, CLIN VACCINE IMMUNOL, V17, P1163, DOI 10.1128/CVI.00078-10; JAKOBSSON I, 1989, ACTA PAEDIATR SCAND, P42; Jensen AR, 2001, J NUTR, V131, P3259, DOI 10.1093/jn/131.12.3259; JORDAN SM, 1968, AUST J EXP BIOL MED, V46, P465, DOI 10.1038/icb.1968.39; Kovacs-Nolan J, 2009, VACCINE, V27, P2055, DOI 10.1016/j.vaccine.2009.01.118; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; LEE WY, 1977, NATURE, V267, P618, DOI 10.1038/267618a0; Lorenz RG, 2004, ANN NY ACAD SCI, V1029, P44, DOI 10.1196/annals.1309.006; Mapletoft JW, 2008, J GEN VIROL, V89, P250, DOI 10.1099/vir.0.83300-0; MCGHEE JR, 1994, REPROD FERT DEVELOP, V6, P369, DOI 10.1071/RD9940369; Medina E, 2000, FEMS IMMUNOL MED MIC, V27, P305, DOI 10.1111/j.1574-695X.2000.tb01444.x; MESTECKY J, 1987, J CLIN IMMUNOL, V7, P265, DOI 10.1007/BF00915547; MILLER A, 1991, J EXP MED, V174, P791, DOI 10.1084/jem.174.4.791; MILLER A, 1994, EUR J IMMUNOL, V24, P1026, DOI 10.1002/eji.1830240503; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; PENG HJ, 1989, PEDIATR RES, V26, P486, DOI 10.1203/00006450-198911000-00025; POLLARD M, 1970, Infection and Immunity, V2, P96; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; ROBERTON DM, 1982, ARCH DIS CHILD, V57, P369, DOI 10.1136/adc.57.5.369; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; SMITH MW, 1980, PROC R SOC SER B-BIO, V206, P411, DOI 10.1098/rspb.1980.0005; STOTT GH, 1979, J DAIRY SCI, V62, P1632, DOI 10.3168/jds.S0022-0302(79)83472-4; STROBEL S, 1984, PEDIATR RES, V18, P588, DOI 10.1203/00006450-198407000-00004; Strobel S, 1996, ANN NY ACAD SCI, V778, P88, DOI 10.1111/j.1749-6632.1996.tb21118.x; Strobel S, 2001, P NUTR SOC, V60, P437, DOI 10.1079/PNS2001119; Tezuka H, 2010, IMMUNOL REV, V234, P247, DOI 10.1111/j.0105-2896.2009.00872.x; Tobagus IT, 2004, J IMMUNOL, V172, P2274, DOI 10.4049/jimmunol.172.4.2274; VUKAVIC T, 1984, J PEDIATR GASTR NUTR, V3, P700, DOI 10.1097/00005176-198411000-00011; Wenzl HH, 2001, DIGEST DIS SCI, V46, P1120, DOI 10.1023/A:1010734717218; Wilson HL, 2010, VACCINE, V28, P8288, DOI 10.1016/j.vaccine.2010.10.006; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	56	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51437	10.1371/journal.pone.0051437	http://dx.doi.org/10.1371/journal.pone.0051437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251533	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200108
J	Shao, JB; Zhu, HP; Yao, HY; Stallones, L; Yeates, K; Wheeler, K; Xiang, HY				Shao, Jianbo; Zhu, Huiping; Yao, Hongyan; Stallones, Lorann; Yeates, Keith; Wheeler, Krista; Xiang, Huiyun			Characteristics and Trends of Pediatric Traumatic Brain Injuries Treated at a Large Pediatric Medical Center in China, 2002-2011	PLOS ONE			English	Article							COMMON OUTCOME MEASURES; UNIQUE FEATURES; YOUNG-CHILDREN; UNITED-STATES; HEAD TRAUMA; EPIDEMIOLOGY; HOSPITALIZATION; RECOMMENDATIONS; COMPLICATIONS; MECHANISMS	Background: Pediatric traumatic brain injuries (TBIs) have not been well studied in China. This study investigated characteristics and trends of hospitalized TBIs sustained by Chinese children. Methods and Findings: We analyzed 2002-2011 hospitalized TBI patients (0-17 years of age) treated at a large pediatric medical center in China. TBIs were defined using the International Classification of Diseases, Tenth Revision (ICD-10) codes. We examined age patterns across external causes of TBIs. We reported the trend of traffic-related TBIs for each year from 2002 to 2011. Of 4,230 TBI patients, 67.1% (95% CI: 65.4%-68.8%) were city residents and 28.8% (95% CI: 26.3%-31.3%) came from rural villages. Males had disproportionately more TBIs than females (65.2% vs. 34.8%). Falls, struck by/against objects, and traffic collisions were the top three external causes of TBIs for all age groups. Falls were the leading cause of TBI for all ages but peaked at 2 years of age. There were 125 TBIs in 0-2 year olds (5.9% of all TBIs in this age group) that were caused by suspected child abuse. Suspected child abuse was significantly more likely to occur in 0-1 year olds. The proportion of traffic -related TBIs increased significantly from 12.99% in 2002 to 19.68% in 2008 but dropped each subsequent year until it reached a level of 8.91% in 2011. Conclusions: Our study confirms that falls, struck by/against objects and traffic collisions are the top external causes of TBIs in Chinese children. When compared with national data from the developed countries, gender patterns are similar, but the ranking of external causes is different. This is the first study to highlight the important role of suspected child abuse in causing TBIs in infants in China. TBIs caused by child abuse warrant further research and government attention as a social and medical problem in China.	[Shao, Jianbo] Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China; [Zhu, Huiping] Capital Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Yao, Hongyan] Chinese Ctr Dis Control & Prevent, Off Epidemiol, Beijing, Peoples R China; [Stallones, Lorann] Colorado State Univ, Dept Psychol, Colorado Injury Control Res Ctr, Ft Collins, CO 80523 USA; [Yeates, Keith] Ohio State Univ, Ctr Biobehav Hlth, Res Inst, Natl Childrens Hosp, Columbus, OH 43210 USA; [Yeates, Keith; Wheeler, Krista; Xiang, Huiyun] Ohio State Univ, Ctr Injury Res & Policy, Res Inst, Natl Childrens Hosp, Columbus, OH 43210 USA	Capital Medical University; Chinese Center for Disease Control & Prevention; Colorado State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Shao, JB (corresponding author), Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China.	jbshao2005@yahoo.com.cn; huiyun.xiang@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020; Stallones, Lorann/AAC-6248-2021; Xiang, Huiyun/E-4335-2011	Stallones, Lorann/0000-0001-7616-582X; Wheeler, Krista/0000-0003-3728-8928; Yeates, Keith Owen/0000-0001-7680-2892	USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International Center [1D43TW007257-01A2]; FOGARTY INTERNATIONAL CENTER [D43TW007257] Funding Source: NIH RePORTER	USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Drs. Stallones and Xiang were supported by the USA-China Agricultural Injury Research Training Project, funded by the National Institutes of Health Fogarty International Center (PIs: L Stallones and H Xiang; Grant #: 1D43TW007257-01A2). The views expressed here are those of the authors and do not necessarily reflect the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EE, 2012, DEV NEUROREHABIL, V15, P26, DOI 10.3109/17518423.2011.633570; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Bo Liu, 2005, J NEURO NEUROREHABIL, V2, P179; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen Hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P307; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Deb S, 1999, AM J PSYCHIAT, V156, P374; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Harrison J E, 2012, BRAIN INJ, P1; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kuang JG, 2011, JIANGXI MED J, V46, P299; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Murgio A, 1999, CHILD NERV SYST, V15, P318, DOI 10.1007/s003810050401; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Redelmeier DA, 2003, LANCET, V361, P2177, DOI 10.1016/S0140-6736(03)13770-1; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sun Y, 2006, INJURY, V37, P416, DOI 10.1016/j.injury.2005.12.002; Tieves Kelly S, 2005, WMJ, V104, P22; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 1994, INT CLASS DIS REL HL; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang SZ, 2002, CHIN J CLIN NEUROSCI, V10, P155; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Zhang XJ, 2011, TRAFFIC INJ PREV, V12, P614, DOI 10.1080/15389588.2011.609925; Zhao YD, 2001, WORLD J SURG, V25, P1202	46	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51634	10.1371/journal.pone.0051634	http://dx.doi.org/10.1371/journal.pone.0051634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251600	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200151
J	Larsen, S; Mancini, L; Pace, G; Scalici, M; Tancioni, L				Larsen, Stefano; Mancini, Laura; Pace, Giorgio; Scalici, Massimiliano; Tancioni, Lorenzo			Weak Concordance between Fish and Macroinvertebrates in Mediterranean Streams	PLOS ONE			English	Article							NESTED SPECIES ASSEMBLAGES; FRESH-WATER FISH; COMMUNITY CONCORDANCE; SPATIAL SCALES; LAND-USE; BENTHIC MACROINVERTEBRATES; CONSERVATION BIOLOGY; ECOLOGICAL QUALITY; EUROPEAN STREAMS; BIOTIC INTEGRITY	Although anthropogenic degradation of riverine systems stimulated a multi-taxon bioassessment of their ecological integrity in EU countries, specific responses of different taxonomic groups to human pressure are poorly investigated in Mediterranean rivers. Here, we assess if richness and composition of macroinvertebrate and fish assemblages show concordant variation along a gradient of anthropogenic pressure in 31 reaches across 13 wadeable streams in central Italy. Fish and invertebrate taxonomic richness was not correlated across sites. However, Mantel test showed that the two groups were significantly, albeit weakly, correlated even after statistically controlling for the effect of environmental variables and site proximity. Variance partitioning with partial Canonical Correspondence Analysis showed that the assemblages of the two groups were influenced by different set of environmental drivers: invertebrates were influenced by water organic content, channel and substratum features, while fish were related to stream temperature (mirroring elevation) and local land-use. Variance partitioning revealed the importance of biotic interactions between the two groups as a possible mechanisms determining concordance. Although significant, the congruence between the groups was weak, indicating that they should not be used as surrogate of each other for environmental assessments in these Mediterranean catchments. Indeed, both richness and patterns in nestedness (i.e. where depauperate locations host only a subset of taxa found in richer locations) appeared influenced by different environmental drivers suggesting that the observed concordance did not result from a co-loss of taxa along similar environmental gradients. As fish and macroinvertebrates appeared sensitive to different environmental factors, we argue that monitoring programmes should consider a multi-assemblage assessment, as also required by the Water Framework Directive.	[Larsen, Stefano] Leibniz Inst Freshwater Ecol, Berlin, Germany; [Mancini, Laura; Pace, Giorgio] Natl Inst Hlth, Dept Environm & Primary Prevent, Rome, Italy; [Scalici, Massimiliano] Roma Tre Univ, Dept Biol, Rome, Italy; [Tancioni, Lorenzo] Tor Vergata Univ, Dept Biol, Rome, Italy	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Istituto Superiore di Sanita (ISS); Roma Tre University; University of Rome Tor Vergata	Larsen, S (corresponding author), Leibniz Inst Freshwater Ecol, Berlin, Germany.	larsen@igb-berlin.de	Pace, Giorgio/AAP-4430-2020; Larsen, Stefano/I-5061-2012; Larsen, Stefano/A-5454-2016	Pace, Giorgio/0000-0003-4231-5644; Larsen, Stefano/0000-0002-6774-1407; SCALICI, Massimiliano/0000-0002-5677-8837; mancini, laura/0000-0003-3667-5221	Provincia di Roma	Provincia di Roma	This study was funded by Provincia di Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts BGW, 2003, HYDROBIOLOGIA, V500, P157, DOI 10.1023/A:1024638726162; Abell R, 2002, CONSERV BIOL, V16, P1435, DOI 10.1046/j.1523-1739.2002.01532.x; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Angradi TR, 1999, J N AM BENTHOL SOC, V18, P49, DOI 10.2307/1468008; APAT, 2003, MET AN ACQ; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Beche LA, 2007, FRESHWATER BIOL, V52, P2317, DOI 10.1111/j.1365-2427.2007.01859.x; Belfiore C, 1983, EPHEMEROPTERA GUIDA; Belpaire C, 2000, HYDROBIOLOGIA, V434, P17, DOI 10.1023/A:1004026121254; Bistoni MA, 2002, BRAZ J BIOL, V62, P753, DOI 10.1590/S1519-69842002000500004; Bonada N, 2006, J N AM BENTHOL SOC, V25, P32, DOI 10.1899/0887-3593(2006)25[32:BMAAMC]2.0.CO;2; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; BOWLBY JN, 1986, ECOLOGY, V67, P1670, DOI 10.2307/1939099; Buffagni A, 2000, HYDROBIOLOGIA, V435, P213, DOI 10.1023/A:1004124717508; Buffagni A, 2004, HYDROBIOLOGIA, V516, P313, DOI 10.1023/B:HYDR.0000025273.15958.6a; Buffagni A., 2007, IRSA CNR NOTIZIARIO, V1, P101; Campaioli S, 1999, MANUALE RICONOSCIMEN, P484; Carneiro FM, 2010, ECOL INDIC, V10, P249, DOI 10.1016/j.ecolind.2009.05.004; Cheimonopoulou MT, 2011, ENVIRON MANAGE, V47, P279, DOI 10.1007/s00267-010-9598-8; Clarke A, 2008, FRESHWATER BIOL, V53, P1707, DOI 10.1111/j.1365-2427.2008.02041.x; Clavero M, 2010, DIVERS DISTRIB, V16, P744, DOI 10.1111/j.1472-4642.2010.00680.x; Consiglio C, 1980, PLECOPTERA GUIDA RIC; Cook RR, 2004, OECOLOGIA, V140, P639, DOI 10.1007/s00442-004-1618-z; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dolph CL, 2011, FRESHWATER BIOL, V56, P1652, DOI 10.1111/j.1365-2427.2011.02589.x; Dudgeon D, 2011, CURRENT OPINION ENV, V2, P422; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; European Communities, 2000, OFFICIAL J EUROPEA L, VL 327; Fernandez-Juricic E, 2002, OECOLOGIA, V131, P269, DOI 10.1007/s00442-002-0883-y; Fleishman E, 2007, LANDSCAPE URBAN PLAN, V81, P271, DOI 10.1016/j.landurbplan.2007.02.002; Gandolfi G., 1991, PESCI ACQUE INTERNE; Ganzhorn JU, 2001, BASIC APPL ECOL, V2, P87, DOI 10.1078/1439-1791-00040; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Ghetti P.F., 1997, MACROINVERTEBRATI NE; Grenouillet G, 2008, DIVERS DISTRIB, V14, P592, DOI 10.1111/j.1472-4642.2007.00443.x; Hammer O., 2001, PALAENTOLOGIA ELECT, V4; Hecnar SJ, 2002, J BIOGEOGR, V29, P475, DOI 10.1046/j.1365-2699.2002.00686.x; Heino J, 2007, BIOL CONSERV, V137, P78, DOI 10.1016/j.biocon.2007.01.017; Heino J, 2010, ECOSCIENCE, V17, P345, DOI 10.2980/17-4-3263; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Heino J, 2009, BIODIVERS CONSERV, V18, P3085, DOI 10.1007/s10531-009-9626-2; Hering D, 2006, FRESHWATER BIOL, V51, P1757, DOI 10.1111/j.1365-2427.2006.01610.x; Hermoso V, 2011, MAR FRESHWATER RES, V62, P244, DOI 10.1071/MF09300; Hermoso V, 2010, ECOL INDIC, V10, P1152, DOI 10.1016/j.ecolind.2010.03.018; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; JACKSON DA, 1993, CAN J FISH AQUAT SCI, V50, P2641, DOI 10.1139/f93-287; Johnson RK, 2010, ECOL APPL, V20, P978, DOI 10.1890/08-1153.1; Larsen S, 2009, FRESHWATER BIOL, V54, P203, DOI 10.1111/j.1365-2427.2008.02093.x; Larsen S, 2010, BIOL CONSERV, V143, P2638, DOI 10.1016/j.biocon.2010.07.006; Larsen S, 2010, ENVIRON MANAGE, V45, P261, DOI 10.1007/s00267-009-9419-0; Lasne E, 2007, RIVER RES APPL, V23, P877, DOI 10.1002/rra.1030; Leps J, 2003, MULTIVARIATE ANAL EC; Lopes PM, 2011, ECOL INDIC, V11, P1171, DOI 10.1016/j.ecolind.2010.12.017; Louzada J, 2010, BIOL CONSERV, V143, P1102, DOI 10.1016/j.biocon.2010.02.003; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Malmqvist B, 2002, ENVIRON CONSERV, V29, P134, DOI 10.1017/S0376892902000097; Mancini L, 2005, BIODIVERS CONSERV, V14, P351, DOI 10.1007/s10531-004-5355-8; Marques MMGSM, 1999, REV BRASILERA BIOL, V54, P1; Moretti G, 1983, TRICHOPTERA GUIDA RI; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Ormerod SJ, 2009, AQUAT CONSERV, V19, P609, DOI 10.1002/aqc.1062; ORMEROD SJ, 1994, FRESHWATER BIOL, V32, P309, DOI 10.1111/j.1365-2427.1994.tb01128.x; Oster M, 2008, BASIC APPL ECOL, V9, P514, DOI 10.1016/j.baae.2007.11.006; Paavola R, 2006, ECOL APPL, V16, P368, DOI 10.1890/03-5410; Pace G, ECOLOGICAL IN PRESS; Pace G, 2011, ECOL INDIC, V11, P688, DOI 10.1016/j.ecolind.2010.09.008; Paszkowski CA, 2000, FRESHWATER BIOL, V43, P421, DOI 10.1046/j.1365-2427.2000.00512.x; Pik AJ, 1999, AUST J ECOL, V24, P555, DOI 10.1046/j.1442-9993.1999.01003.x; Pinto P, 2006, HYDROBIOLOGIA, V566, P75, DOI 10.1007/s10750-006-0069-4; POWER ME, 1992, ECOLOGY, V73, P1675, DOI 10.2307/1940019; RAHEL FJ, 1991, T AM FISH SOC, V120, P319, DOI 10.1577/1548-8659(1991)120<0319:FAAHGI>2.3.CO;2; Richter BD, 1997, CONSERV BIOL, V11, P1081, DOI 10.1046/j.1523-1739.1997.96236.x; Robinson JL, 2005, ECOL FRESHW FISH, V14, P14, DOI 10.1111/j.1600-0633.2005.00063.x; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Saetersdal M, 2011, J APPL ECOL, V48, P1236, DOI 10.1111/j.1365-2664.2011.02027.x; Sanchez-Fernandez D, 2006, BIODIVERS CONSERV, V15, P4507, DOI 10.1007/s10531-005-5101-x; Sandin L, 2004, HYDROBIOLOGIA, V516, P129, DOI 10.1023/B:HYDR.0000025262.98511.46; Sansoni G, 1988, ATLANTE RICONOSCIMEN; Scardi M, 2007, PROTOCOLLO CAMPIONAM; Scardi M, 2008, ECOL INFORM, V3, P55, DOI 10.1016/j.ecoinf.2007.10.001; Schouten MA, 2007, J BIOGEOGR, V34, P1938, DOI 10.1111/j.1365-2699.2007.01742.x; Snyder CD, 2003, LANDSCAPE ECOL, V18, P647, DOI 10.1023/B:LAND.0000004178.41511.da; Statzner B, 2001, BASIC APPL ECOL, V2, P73, DOI 10.1078/1439-1791-00039; Summerville KS, 2002, OIKOS, V97, P195, DOI 10.1034/j.1600-0706.2002.970205.x; Tancioni Lorenzo, 2006, P47, DOI 10.1002/0470863781.ch4; Tolonen KT, 2005, BIODIVERS CONSERV, V14, P961, DOI 10.1007/s10531-004-8414-2; Vila-Gispert A, 2002, AQUAT SCI, V64, P163, DOI 10.1007/s00027-002-8064-y; Villasenor JL, 2005, CONSERV BIOL, V19, P232, DOI 10.1111/j.1523-1739.2005.00264.x; Walsh C., 2007, HIERARCHICAL PARTITI; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; WATERS TF, 1995, AFS MONOGRAPHS; Wolters V, 2006, ECOLOGY, V87, P1886, DOI 10.1890/0012-9658(2006)87[1886:RATSRO]2.0.CO;2	93	38	39	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51115	10.1371/journal.pone.0051115	http://dx.doi.org/10.1371/journal.pone.0051115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251432	Green Published, gold			2022-12-27	WOS:000312201900042
J	Zhu, XF; Peng, JJ; Zou, HD; Fu, J; Wang, WW; Xu, X; Zhang, X				Zhu, Xiao-feng; Peng, Jin-juan; Zou, Hai-dong; Fu, Jiong; Wang, Wei-wei; Xu, Xun; Zhang, Xi			Prevalence and Risk Factors of Idiopathic Epiretinal Membranes in Beixinjing Blocks, Shanghai, China	PLOS ONE			English	Article							POSTERIOR VITREOUS DETACHMENT; OPTICAL COHERENCE TOMOGRAPHY; PRERETINAL MACULAR FIBROSIS; BLUE MOUNTAINS EYE; DIABETIC-RETINOPATHY; JAPANESE POPULATION; ADULT-POPULATION; LOS-ANGELES; HANDAN EYE; ASSOCIATIONS	Background: To determine the prevalence and risk factors associated with idiopathic epiretinal membranes (iERM) in a Chinese population aged 60 years or older in Beixinjing Blocks, Shanghai. Methods: This population-based study consisted of 3727 participants (89.7% of the eligible). It was performed to describe the prevalence of iERM and possible demographic, systemic, and ocular factors associated with iERM. Each participant underwent a standardized interview and comprehensive ophthalmic examination. iERM was identified and graded from retinal photographs. Then, a case-control study comparing the participants with vs. without iERM was performed to further study the associations between iERM and blood biochemical test results (including fasting plasma glucose, serum creatinine, total cholesterol, and triglyceride), ocular biological parameters (including the axial length, corneal curvature, refractive diopter, intraocular press, and anterior chamber depth), and the data of optical coherence tomography. Results: The prevalence of iERM was 1.02%. iERM was significantly associated with diabetes (OR: 2.457; 95% CI: 1.137, 5.309) and a higher level of education (OR: 1.48; 95% CI: 1.123, 1.952). Blood biochemical test results and ocular biological parameters showed no significant differences between the iERM and control groups, whereas the incidence of posterior vitreous detachment in the iERM group was much higher than in the control group (26.5% vs. 8.8%), but this difference was not statistically significant. Moreover, the eyes with iERM had poorer visual acuity than the eyes without iERM (P<0.05). Conclusions: In Beixinjing Blocks, Shanghai, iERM was relatively rare, was associated with diabetes and a higher level of education, and caused a substantial decrease in visual acuity.	[Zhu, Xiao-feng; Peng, Jin-juan; Zou, Hai-dong; Xu, Xun; Zhang, Xi] Affiliated Shanghai Jiaotong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai, Peoples R China; [Fu, Jiong; Wang, Wei-wei] Beixinjing Community Hlth Serv Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Affiliated Shanghai Jiaotong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai, Peoples R China.	zouhaidong@hotmail.com		Zou, Haidong/0000-0002-6831-7560	Shanghai Health Bureau [20114007]; Shanghai Leading Talent Reserve Program [40311]	Shanghai Health Bureau; Shanghai Leading Talent Reserve Program	Funding was provided by a key grant from the Shanghai Health Bureau (20114007) and a grant from the Shanghai Leading Talent Reserve Program (40311). No conflicting relationship exists for any author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPIAH AP, 1989, OPHTHALMOLOGY, V96, P389, DOI 10.1016/S0161-6420(89)32881-8; APPIAH AP, 1988, AM J OPHTHALMOL, V106, P533, DOI 10.1016/0002-9394(88)90581-8; Arichika S, 2010, RETINA-J RET VIT DIS, V30, P503, DOI 10.1097/IAE.0b013e3181bd2d65; Bouwens M, 2008, GRAEF ARCH CLIN EXP, V246, P1693, DOI 10.1007/s00417-008-0909-1; CLARKSON JG, 1977, AM J OPHTHALMOL, V84, P1; Council MD, 2005, OPHTHALMOLOGY, V112, P1218, DOI 10.1016/j.ophtha.2005.01.051; Duan XR, 2009, INVEST OPHTH VIS SCI, V50, P2018, DOI 10.1167/iovs.08-2624; FOOS RY, 1977, INVEST OPHTH VIS SCI, V16, P416; FOOS RY, 1980, OPHTHALMOLOGY, V87, P122; Fraser-Bell S, 2004, INVEST OPHTH VIS SCI, V45, P1732, DOI 10.1167/iovs.03-1295; Fraser-Bell S, 2003, OPHTHALMOLOGY, V110, P34, DOI 10.1016/S0161-6420(02)01443-4; Gandorfer A, 2002, BRIT J OPHTHALMOL, V86, P902, DOI 10.1136/bjo.86.8.902; Gatto NM, 2012, OPHTHAL EPIDEMIOL, V19, P127, DOI 10.3109/09286586.2011.615452; Ghazi-Nouri SMS, 2006, BRIT J OPHTHALMOL, V90, P559, DOI 10.1136/bjo.2005.085142; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P698, DOI 10.1136/bjo.68.10.698; Huang X.Z.H., 2009, INT J OPHTHALMOL-CHI, V9, P1321; Huang Xiao-bo, 2009, Zhonghua Yan Ke Za Zhi, V45, P786; Jahn CE, 2001, J CATARACT REFR SURG, V27, P753, DOI 10.1016/S0886-3350(00)00686-6; Johnson Mark W, 2005, Trans Am Ophthalmol Soc, V103, P537; Johnson MW, 2010, AM J OPHTHALMOL, V149, P371, DOI 10.1016/j.ajo.2009.11.022; Kawasaki R, 2008, BRIT J OPHTHALMOL, V92, P1320, DOI 10.1136/bjo.2008.144626; Kawasaki R, 2009, EYE, V23, P1045, DOI 10.1038/eye.2008.238; Khaja HA, 2008, ARCH OPHTHALMOL-CHIC, V126, P632, DOI 10.1001/archopht.126.5.632; Kishi S, 1996, AM J OPHTHALMOL, V122, P622, DOI 10.1016/S0002-9394(14)70480-5; KISHI S, 1994, AM J OPHTHALMOL, V118, P451, DOI 10.1016/S0002-9394(14)75795-2; Kita T, 2007, DIABETES, V56, P231, DOI 10.2337/db06-0581; Klein R, 1994, Trans Am Ophthalmol Soc, V92, P403; Koh V, 2012, INVEST OPHTH VIS SCI, V53, P1018, DOI 10.1167/iovs.11-8557; KRAUSHAR MF, 1988, OPHTHALMIC SURG LAS, V19, P843; Li R, 2012, DIABETES CARE, V35, P1028, DOI 10.2337/dc11-1212; Liang YB, 2008, OPHTHALMOLOGY, V115, P1965, DOI 10.1016/j.ophtha.2008.05.030; McCarty DJ, 2005, AM J OPHTHALMOL, V140, P288, DOI 10.1016/j.ajo.2005.03.032; Mitchell P, 1997, OPHTHALMOLOGY, V104, P1033, DOI 10.1016/S0161-6420(97)30190-0; Miyazaki M, 2003, GRAEF ARCH CLIN EXP, V241, P642, DOI 10.1007/s00417-003-0723-8; MOSS SE, 1989, INVEST OPHTH VIS SCI, V30, P823; Ng CH, 2011, OPHTHALMOLOGY, V118, P694, DOI 10.1016/j.ophtha.2010.08.009; Okamoto F, 2009, AM J OPHTHALMOL, V147, P869, DOI 10.1016/j.ajo.2008.11.018; Peng JJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-250; Sabanayagam C, 2011, INVEST OPHTH VIS SCI, V52, P2397, DOI 10.1167/iovs.10-6373; Shanghai Bureau of Statistics, 2011, STAT B NAT EC SOC DE; SIDD RJ, 1982, AM J OPHTHALMOL, V94, P44, DOI 10.1016/0002-9394(82)90189-1; SMIDDY WE, 1989, OPHTHALMOLOGY, V96, P811; Snead DRJ, 2008, EYE, V22, P1310, DOI 10.1038/eye.2008.36; Wilkins JR, 1996, OPHTHALMOLOGY, V103, P2142, DOI 10.1016/S0161-6420(96)30377-1; Yamashita T, 2008, GRAEF ARCH CLIN EXP, V246, P333, DOI 10.1007/s00417-007-0745-8; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yazici AT, 2011, RETINA-J RET VIT DIS, V31, P779, DOI 10.1097/IAE.0b013e3181ef8786; You Q, 2008, EYE, V22, P874, DOI 10.1038/sj.eye.6702786; ZAUBERMAN H, 1981, INVEST OPHTH VIS SCI, V21, P248	49	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51445	10.1371/journal.pone.0051445	http://dx.doi.org/10.1371/journal.pone.0051445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251536	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900087
J	Simons, DJ; Chabris, CF				Simons, Daniel J.; Chabris, Christopher F.			Common (Mis)Beliefs about Memory: A Replication and Comparison of Telephone and Mechanical Turk Survey Methods	PLOS ONE			English	Article								Incorrect beliefs about memory have wide-ranging implications. We recently reported the results of a survey showing that a substantial proportion of the United States public held beliefs about memory that conflicted with those of memory experts. For that survey, respondents answered recorded questions using their telephone keypad. Although such robotic polling produces reliable results that accurately predicts the results of elections, it suffers from four major drawbacks: (1) telephone polling is costly, (2) typically, less than 10 percent of calls result in a completed survey, (3) calls do not reach households without a landline, and (4) calls oversample the elderly and undersample the young. Here we replicated our telephone survey using Amazon Mechanical Turk (MTurk) to explore the similarities and differences in the sampled demographics as well as the pattern of results. Overall, neither survey closely approximated the demographics of the United States population, but they differed in how they deviated from the 2010 census figures. After weighting the results of each survey to conform to census demographics, though, the two approaches produced remarkably similar results: In both surveys, people averaged over 50% agreement with statements that scientific consensus shows to be false. The results of this study replicate our finding of substantial discrepancies between popular beliefs and those of experts and shows that surveys conducted on MTurk can produce a representative sample of the United States population that generates results in line with more expensive survey techniques.	[Simons, Daniel J.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Simons, Daniel J.] Univ Illinois, Beckman Inst, Champaign, IL 61820 USA; [Chabris, Christopher F.] Union Coll, Dept Psychol, Schenectady, NY 12308 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Union College	Simons, DJ (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61820 USA.	dsimons@illinois.edu	Simons, Daniel J./P-3625-2019					Benton TR, 2006, APPL COGNITIVE PSYCH, V20, P115, DOI 10.1002/acp.1171; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chabris Christopher, 2010, INVISIBLE GORILLA OT; Germine L, 2012, PSYCHON B REV; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Herculano-Houzel S, 2002, NEUROSCIENTIST, V8, P98, DOI 10.1177/107385840200800206; Ipeirotis PG, 2010, CEDER WORKING PAPERS; Kassin SM, 2001, AM PSYCHOL, V56, P405, DOI 10.1037//0003-066X.56.5.405; Kraut R, 2004, AM PSYCHOL, V59, P105, DOI 10.1037/0003-066X.59.2.105; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Magnussen S, 2006, MEMORY, V14, P595, DOI 10.1080/09658210600646716; Magnussen S, 2010, APPL COGNITIVE PSYCH, V24, P122, DOI 10.1002/acp.1550; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Read JD, 2009, APPL COGNITIVE PSYCH, V23, P301, DOI 10.1002/acp.1459; Schmechel RS, 2006, JURIMETRICS, V46, P177, DOI DOI 10.1371/J0URNAL.P0NE.0022757; Simons DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022757; Taylor AK, 2004, PSYCHOL REC, V54, P15, DOI 10.1007/BF03395459	18	130	130	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51876	10.1371/journal.pone.0051876	http://dx.doi.org/10.1371/journal.pone.0051876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272183	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300038
J	Katnani, HA; Van Opstal, AJ; Gandhi, NJ				Katnani, Husam A.; Van Opstal, A. J.; Gandhi, Neeraj J.			Blink Perturbation Effects on Saccades Evoked by Microstimulation of the Superior Colliculus	PLOS ONE			English	Article							PONTINE OMNIPAUSE NEURONS; EYE-MOVEMENTS; ELECTRICAL-STIMULATION; GENERATION; MONKEY; MOTOR; PARAMETERS; SYSTEM; CAT	Current knowledge of saccade-blink interactions suggests that blinks have paradoxical effects on saccade generation. Blinks suppress saccade generation by attenuating the oculomotor drive command in structures like the superior colliculus (SC), but they also disinhibit the saccadic system by removing the potent inhibition of pontine omnipause neurons (OPNs). To better characterize these effects, we evoked the trigeminal blink reflex by delivering an air puff to one eye as saccades were evoked by sub-optimal stimulation of the SC. For every stimulation site, the peak and average velocities of stimulation with blink movements (SwBMs) were lower than stimulation-only saccades (SoMs), supporting the notion that the oculomotor drive is weakened in the presence of a blink. In contrast, the duration of the SwBMs was longer, consistent with the hypothesis that the blink-induced inhibition of the OPNs could prolong the window of time available for oculomotor commands to drive an eye movement. The amplitude of the SwBM could also be larger than the SoM amplitude obtained from the same site, particularly for cases in which blink-associated eye movements exhibited the slowest kinematics. The results are interpreted in terms of neural signatures of saccade-blink interactions. Citation: Katnani HA, Van Opstal AJ, Gandhi NJ (2012) Blink Perturbation Effects on Saccades Evoked by Microstimulation of the Superior Colliculus. PLoS ONE 7(12): e51843. doi:10.1371/journal.pone.0051843	[Katnani, Husam A.; Gandhi, Neeraj J.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Katnani, Husam A.; Gandhi, Neeraj J.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Gandhi, Neeraj J.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; [Katnani, Husam A.; Gandhi, Neeraj J.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Van Opstal, A. J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Biophys, Nijmegen, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Radboud University Nijmegen	Katnani, HA (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	hkatnani@gmail.com	van Opstal, John/D-1907-2010	van Opstal, John/0000-0001-5957-5712	National Institute of General Medical Science [T32 GM081760]; Nation Science Foundation [DGE-0549352]; National Eye Institute [R01 EY015485, P30 EY008098]; National Institute of Deafness and Communication Disorders [P30 DC0025205]; Radboud University Nijmegen; Dutch NWO [805.05.003]; NATIONAL EYE INSTITUTE [P30EY008098, R01EY015485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081760] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nation Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Radboud University Nijmegen; Dutch NWO(Netherlands Organization for Scientific Research (NWO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H.A.K. is supported by an institutional training grant from the National Institute of General Medical Science (T32 GM081760) and institutional training grant from the Nation Science Foundation (DGE-0549352). N.J.G. is supported by the National Eye Institute (R01 EY015485, P30 EY008098) and National Institute of Deafness and Communication Disorders (P30 DC0025205). A.J.V.O. is supported by the Radboud University Nijmegen and by a VICI grant from the Dutch NWO (ALW grant 805.05.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; Basso MA, 1996, J NEUROSCI, V16, P7308, DOI 10.1523/jneurosci.16-22-07308.1996; Breznen B, 1996, EXP BRAIN RES, V111, P337; Bryant CL, 2005, J NEUROSCI METH, V142, P193, DOI 10.1016/j.jneumeth.2004.08.019; Edelman JA, 2001, J NEUROPHYSIOL, V86, P676, DOI 10.1152/jn.2001.86.2.676; Gandhi N. J., 2011, OXFORD HDB EYE MOVEM, P323; Gandhi NJ, 2012, EXP BRAIN RES, V216, P321, DOI 10.1007/s00221-011-2937-z; Gandhi NJ, 2011, ANNU REV NEUROSCI, V34, P205, DOI 10.1146/annurev-neuro-061010-113728; Gandhi NJ, 2005, J NEUROPHYSIOL, V93, P1718, DOI 10.1152/jn.00854.2004; Gnadt JW, 1997, EXP BRAIN RES, V116, P389, DOI 10.1007/PL00005767; Goossens HHLM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002508; Goossens HHLM, 2010, J NEUROPHYSIOL, V103, P1685, DOI 10.1152/jn.00788.2009; Goossens HHLM, 2006, J NEUROPHYSIOL, V95, P2326, DOI 10.1152/jn.00889.2005; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3430, DOI 10.1152/jn.2000.83.6.3430; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3411, DOI 10.1152/jn.2000.83.6.3411; Groh JM, 2011, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00130; Groh JM, 2001, BIOL CYBERN, V85, P159, DOI 10.1007/s004220100249; HUERTA MF, 1981, BRAIN RES, V211, P1, DOI 10.1016/0006-8993(81)90063-9; Katnani HA, 2012, J NEUROPHYSIOL, V108, P528, DOI 10.1152/jn.00257.2012; Katnani HA, 2012, J NEUROPHYSIOL, V107, P2442, DOI 10.1152/jn.00992.2011; KELLER EL, 1974, J NEUROPHYSIOL, V37, P316, DOI 10.1152/jn.1974.37.2.316; Missal M, 1996, EXP BRAIN RES, V107, P382; Ndiaye A, 2002, J COMP NEUROL, V448, P373, DOI 10.1002/cne.10269; OTTES FP, 1986, VISION RES, V26, P857, DOI 10.1016/0042-6989(86)90144-6; Paul K, 2006, VISION RES; Rambold H, 2002, J NEUROPHYSIOL, V88, P1220, DOI 10.1152/jn.2002.88.3.1220; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Rottach KG, 1998, J NEUROPHYSIOL, V79, P2895, DOI 10.1152/jn.1998.79.6.2895; Schultz KP, 2010, J NEUROPHYSIOL, V103, P2255, DOI 10.1152/jn.01150.2009; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; TAKADA M, 1984, NEUROSCI LETT, V50, P251, DOI 10.1016/0304-3940(84)90494-4; Van Horn MR, 2010, J NEUROSCI, V30, P10905, DOI 10.1523/JNEUROSCI.0393-10.2010; van Opstal AJ, 2008, BIOL CYBERN, V98, P561, DOI 10.1007/s00422-008-0219-z; VANOPSTAL AJ, 1990, EXP BRAIN RES, V79, P299, DOI 10.1007/BF00608239; Williamson SS, 2005, J NEUROPHYSIOL, V93, P627, DOI 10.1152/jn.00820.2004; Yoshida K, 1999, J NEUROPHYSIOL, V82, P1198, DOI 10.1152/jn.1999.82.3.1198	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51843	10.1371/journal.pone.0051843	http://dx.doi.org/10.1371/journal.pone.0051843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251639	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800096
J	Khan, SN; Danishuddin, M; Varshney, B; Lal, SK; Khan, AU				Khan, Shahper N.; Danishuddin, Mohd; Varshney, Bhavna; Lal, Sunil K.; Khan, Asad U.			Inhibition of N-Terminal Lysines Acetylation and Transcription Factor Assembly by Epirubicin Induced Deranged Cell Homeostasis	PLOS ONE			English	Article							HISTONE ACETYLATION; CRYSTAL-STRUCTURE; DNA; BINDING; PROTEIN; DAUNOMYCIN; CHROMATIN; CYCLE; SITE	Epirubicin (EPI), an anthracycline antitumour antibiotic, is a known intercalating and DNA damaging agent. Here, we study the molecular interaction of EPI with histones and other cellular targets. EPI binding with histone core protein was predicted with spectroscopic and computational techniques. The molecular distance r, between donor (histone H3) and acceptor (EPI) was estimated using Forster's theory of non-radiation energy transfer and the detailed binding phenomenon is expounded. Interestingly, the concentration dependent reduction in the acetylated states of histone H3 K9/K14 was observed suggesting more repressed chromatin state on EPI treatment. Its binding site near N-terminal lysines is further characterized by thermodynamic determinants and molecular docking studies. Specific DNA binding and inhibition of transcription factor (Tf)-DNA complex formation implicates EPI induced transcriptional inhibition. EPI also showed significant cell cycle arrest in drug treated cells. Chromatin fragmentation and loss of membrane integrity in EPI treated cells is suggestive of their commitment to cell death. This study provides an analysis of nucleosome dynamics during EPI treatment and provides a novel insight into its action. Citation: Khan SN, Danishuddin M, Varshney B, Lal SK, Khan AU (2012) Inhibition of N-Terminal Lysines Acetylation and Transcription Factor Assembly by Epirubicin Induced Deranged Cell Homeostasis. PLoS ONE 7(12): e51850. doi: 10.1371/journal.pone.0051850	[Khan, Shahper N.; Danishuddin, Mohd; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Varshney, Bhavna; Lal, Sunil K.] Int Ctr Genet Engn & Biotechnol, New Delhi, India	Aligarh Muslim University; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Khan, AU (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	Khan, Asad U/K-8157-2013	Khan, Asad U/0000-0001-9191-9423; Khan, Shahper N./0000-0002-3931-6702	internal funds of Biotechnology Unit, A.M.U., Aligarh Muslim University; CSIR	internal funds of Biotechnology Unit, A.M.U., Aligarh Muslim University; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was suppoprted by internal funds of Biotechnology Unit, A.M.U., Aligarh Muslim University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Barbara Jacobs, Taussig Cancer Institute, USA; for critical reading of the manuscript. Author acknowledges the central facilities of Interdisciplinary Biotechnology Unit, AMU, Aligarh and Dr. Shahid Jameel for accessibility to the central facilities in virology section, ICGEB, New Delhi. SNK acknowledges CSIR for Senior Research Fellowship	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROGGINI M, 1994, ANTI-CANCER DRUG DES, V9, P373; Chen Y., 2005, MOL IMAGING FRET MIC, P126; CHEN YH, 1971, BIOCHEM BIOPH RES CO, V44, P1285, DOI 10.1016/S0006-291X(71)80225-5; Clifford J, 1996, EMBO J, V15, P4142, DOI 10.1002/j.1460-2075.1996.tb00789.x; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; Forster T., 1996, MODERN QUANTUM CHEM, V3; Gao H, 2004, J PHOTOCH PHOTOBIO A, V167, P213, DOI 10.1016/j.jphotochem.2004.05.017; Gottesfeld JM, 2000, GENE EXPRESSION, V9, P77; GRANA X, 1995, ONCOGENE, V11, P211; Gray S. G., 2001, Current Molecular Medicine (Hilversum), V1, P401, DOI 10.2174/1566524013363537; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; Hu YJ, 2004, J PHARMACEUT BIOMED, V36, P915, DOI 10.1016/j.jpba.2004.08.021; KESSEL D, 1979, MOL PHARMACOL, V16, P306; Khan SN, 2011, CELL BIOCHEM BIOPHYS, V60, P209, DOI 10.1007/s12013-010-9141-9; Khan SN, 2010, CLIN CHIM ACTA, V411, P1401, DOI 10.1016/j.cca.2010.06.020; Khan SN, 2008, J PHARMACEUT BIOMED, V48, P1096, DOI 10.1016/j.jpba.2008.08.030; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Koyama Y, 2007, CHEM PHARM BULL, V55, P520, DOI 10.1248/cpb.55.520; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Larouche K, 1996, BIOTECHNIQUES, V20, P439; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Liu YQ, 2008, CANCER INVEST, V26, P575, DOI 10.1080/07357900701837168; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Mahlknecht U, 2000, MOL MED, V6, P623, DOI 10.1007/BF03402044; MILES JL, 1962, J BIOL CHEM, V237, P1319; Mir MA, 2004, BIOPHYS CHEM, V109, P121, DOI 10.1016/j.bpc.2003.10.023; Munishkina LA, 2004, J MOL BIOL, V342, P1305, DOI 10.1016/j.jmb.2004.06.094; MURPHREE SA, 1976, BIOCHEM PHARMACOL, V25, P1227, DOI 10.1016/0006-2952(76)90374-9; Nafisi S, 2005, DNA CELL BIOL, V24, P634, DOI 10.1089/dna.2005.24.634; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; PONTICELLI AS, 1990, MOL CELL BIOL, V10, P2832, DOI 10.1128/MCB.10.6.2832; Priebe W, 2001, METHOD ENZYMOL, V340, P529; Rabbani A, 2004, BIOCHEMISTRY-US, V43, P16497, DOI 10.1021/bi048524p; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; STURM RA, 1991, CELL GROWTH DIFFER, V2, P519; THOMSON JAF, 1993, PIGM CELL RES, V6, P13, DOI 10.1111/j.1600-0749.1993.tb00576.x; Tyagi S, 2002, J BIOL CHEM, V277, P22759, DOI 10.1074/jbc.M200185200; Tyagi S, 2000, BIOCHEM BIOPH RES CO, V277, P589, DOI 10.1006/bbrc.2000.3720; Umov FD, 2003, ANN NY ACAD SCI, V983, P5; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882	45	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51850	10.1371/journal.pone.0051850	http://dx.doi.org/10.1371/journal.pone.0051850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251640	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800097
J	Kobayashi, M; Kashino, M				Kobayashi, Maori; Kashino, Makio			Effect of Flanking Sounds on the Auditory Continuity Illusion	PLOS ONE			English	Article							AUDIOVISUAL SIMULTANEITY; ATTENTIONAL BLINK; INDUCTION; MASKING; MOTION; TASK	Background: The auditory continuity illusion or the perceptual restoration of a target sound briefly interrupted by an extraneous sound has been shown to depend on masking. However, little is known about factors other than masking. Methodology/Principal Findings: We examined whether a sequence of flanking transient sounds affects the apparent continuity of a target tone alternated with a bandpass noise at regular intervals. The flanking sounds significantly increased the limit of perceiving apparent continuity in terms of the maximum target level at a fixed noise level, irrespective of the frequency separation between the target and flanking sounds: the flanking sounds enhanced the continuity illusion. This effect was dependent on the temporal relationship between the flanking sounds and noise bursts. Conclusions/Significance: The spectrotemporal characteristics of the enhancement effect suggest that a mechanism to compensate for exogenous attentional distraction may contribute to the continuity illusion.	[Kobayashi, Maori] Meiji Univ, Dept Sci & Technol, Kawasaki, Kanagawa, Japan; [Kashino, Makio] NTT Corp, NTT, Commun Sci Labs, Atsugi, Kanagawa, Japan; [Kashino, Makio] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan	Meiji University; Nippon Telegraph & Telephone Corporation; Tokyo Institute of Technology	Kobayashi, M (corresponding author), Meiji Univ, Dept Sci & Technol, Kawasaki, Kanagawa, Japan.	te11001@meiji.ac.jp			MEXT [22700268]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the MEXT Grant-in-Aid for Young Scientists (B) (No. 22700268) awarded to MKO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnell KM, 2004, PERCEPT PSYCHOPHYS, V66, P1147, DOI 10.3758/BF03196842; BACON SP, 1987, J ACOUST SOC AM, V81, P1073, DOI 10.1121/1.395125; Bregman A.S., 1994, AUDITORY SCENE ANAL; Drake C, 1999, J ACOUST SOC AM, V106, P3529, DOI 10.1121/1.428206; Durlach NI, 2003, J ACOUST SOC AM, V113, P2984, DOI 10.1121/1.1570435; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Heinrich A, 2011, J COGNITIVE NEUROSCI, V23, P2675, DOI 10.1162/jocn.2011.21627; HOUTGAST T, 1972, J ACOUST SOC AM, V51, P1885, DOI 10.1121/1.1913048; Kashino M, 1996, PERCEPT PSYCHOPHYS, V58, P899, DOI 10.3758/BF03205491; Kobayashi M, 2007, PERCEPT PSYCHOPHYS, V69, P393, DOI 10.3758/BF03193760; Micheyl C, 2003, J COGNITIVE NEUROSCI, V15, P747, DOI 10.1162/089892903322307456; MILLER GA, 1950, J ACOUST SOC AM, V22, P167, DOI 10.1121/1.1906584; Moore BC, 2012, INTRO PSYCHOL HEARIN; Neff DL, 1993, J ACOUST SOC AM, V94, P3111; Petkov CI, 2007, NEURON, V54, P153, DOI 10.1016/j.neuron.2007.02.031; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Riecke L, 2008, PERCEPT PSYCHOPHYS, V70, P1, DOI 10.3758/PP.70.1.1; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Tse CY, 2006, PSYCHOPHYSIOLOGY, V43, P172, DOI 10.1111/j.1469-8986.2006.389.x; Warren R. M., 1999, AUDITORY PERCEPTION; WARREN RM, 1972, SCIENCE, V176, P1149, DOI 10.1126/science.176.4039.1149; Watanabe K, 1998, PERCEPTION, V27, P1041, DOI 10.1068/p271041; YANTIS S, 1994, CAN J EXP PSYCHOL, V48, P182, DOI 10.1037/1196-1961.48.2.182; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329	26	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51969	10.1371/journal.pone.0051969	http://dx.doi.org/10.1371/journal.pone.0051969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251666	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800121
J	Xu, XH; Sun, HY; Zhang, YH; Wu, W; Chen, KH; Liu, Y; Deng, CY; Yu, XY; Jin, MW; Li, GR				Xu, Xiao-Hui; Sun, Hai-Ying; Zhang, Yan-Hui; Wu, Wei; Chen, Kui-Hao; Liu, Yi; Deng, Chun-Yu; Yu, Xi-Yong; Jin, Man-Wen; Li, Gui-Rong			Allitridi Inhibits Multiple Cardiac Potassium Channels Expressed in HEK 293 Cells	PLOS ONE			English	Article							GARLIC ALLIUM-SATIVUM; TRANSIENT OUTWARD CURRENT; KV4.3 K+ CHANNEL; J WAVE SYNDROMES; DIALLYL TRISULFIDE; CANCER CELLS; CARDIOPROTECTIVE ACTIONS; CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; DOWN-REGULATION	Allitridi (diallyl trisulfide) is an active compound (volatile oil) from garlic. The previous studies reported that allitridi had antiarrhythmic effect. The potential ionic mechanisms are, however, not understood. The present study was designed to determine the effects of allitridi on cardiac potassium channels expressed in HEK 293 cells using a whole-cell patch voltage-clamp technique and mutagenesis. It was found that allitridi inhibited hKv4.3 channels (IC50 = 11.4 mu M) by binding to the open channel, shifting availability potential to hyperpolarization, and accelerating closed-state inactivation of the channel. The hKv4.3 mutants T366A, T367A, V392A, and I395A showed a reduced response to allitridi with IC(50)s of 35.5 mu M, 44.7 mu M, 23.7 mu M, and 42.4 mu M. In addition, allitridi decreased hKv1.5, hERG, hKCNQ1/hKCNE1 channels stably expressed in HEK 293 cells with IC(50)s of 40.2 mu M, 19.6 mu M and 17.7 mu M. However, it slightly inhibited hKir2.1 current (100 mu M, inhibited by 9.8% at -120 mV). Our results demonstrate for the first time that allitridi preferably blocks hKv4.3 current by binding to the open channel at T366 and T367 of P-loop helix, and at V392 and I395 of S6 domain. It has a weak inhibition of hKv1.5, hERG, and hKCNQ1/hKCNE1 currents. These effects may account for its anti-arrhythmic effect observed in experimental animal models.	[Xu, Xiao-Hui; Chen, Kui-Hao; Liu, Yi; Jin, Man-Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China; [Sun, Hai-Ying; Zhang, Yan-Hui; Wu, Wei; Li, Gui-Rong] Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Deng, Chun-Yu; Yu, Xi-Yong] Guangdong Gen Hosp, Res Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Gui-Rong] Univ Hong Kong, Dept Physiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	Huazhong University of Science & Technology; University of Hong Kong; Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Hong Kong	Jin, MW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China.	mwjin@mail.tjmu.edu.cn; grli@hkucc.hku.hk	Zhang, Yanhui/L-5680-2017; Li, Gui-Rong/C-4341-2009; , 李贵荣（沧海一粟）/AAZ-4335-2020	Zhang, Yanhui/0000-0002-2179-2065; , 李贵荣（沧海一粟）/0000-0002-9437-2280	Sun Chieh Yeh Heart Foundation of Hong Kong	Sun Chieh Yeh Heart Foundation of Hong Kong	This work was supported in part by a grant from the Sun Chieh Yeh Heart Foundation of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Antony ML, 2011, INDIAN J EXP BIOL, V49, P805; Antzelevitch C, 2012, CIRC J, V76, P1054, DOI 10.1253/circj.CJ-12-0284; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Bai CX, 2005, CIRCULATION, V112, P1701, DOI 10.1161/CIRCULATIONAHA.104.523217; Calvo-Gomez O, 2004, J CHROMATOGR A, V1036, P91, DOI 10.1016/j.chroma.2004.02.072; [程伟 Cheng Wei], 2002, [中国中医基础医学杂志, Chinese Journal of Basic Medicine in Traditional Chinese Medicine], V8, P35; Decher N, 2006, MOL PHARMACOL, V70, P1204, DOI 10.1124/mol.106.026203; Deng CY, 2011, CLIN EXP PHARMACOL P, V38, P323, DOI 10.1111/j.1440-1681.2011.05511.x; Di Diego JM, 2002, CIRCULATION, V106, P2004, DOI 10.1161/01.CIR.0000032002.22105.7A; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Dong MQ, 2006, J MEMBRANE BIOL, V210, P183, DOI 10.1007/s00232-006-0006-5; Dong MQ, 2010, BBA-BIOMEMBRANES, V1798, P995, DOI 10.1016/j.bbamem.2010.01.010; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Ginter E, 2010, BRATISL MED J, V111, P452; Giudicessi JR, 2012, HUM MUTAT, V33, P989, DOI 10.1002/humu.22058; ISENSEE H, 1993, ARZNEIMITTEL-FORSCH, V43-1, P94; Jeong I, 2011, BRIT J PHARMACOL, V163, P510, DOI 10.1111/j.1476-5381.2011.01210.x; Lan H, 2004, ACTA PHARMACOL SIN, V25, P219; Li GR, 2000, AM J PHYSIOL-HEART C, V279, pH130, DOI 10.1152/ajpheart.2000.279.1.H130; LI GR, 1995, AM J PHYSIOL-HEART C, V269, pH463, DOI 10.1152/ajpheart.1995.269.2.H463; Li GR, 2003, CARDIOVASC RES, V58, P89, DOI 10.1016/S0008-6363(02)00859-3; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Li GR, 2008, CIRCULATION, V117, P2449, DOI 10.1161/CIRCULATIONAHA.108.769554; Li GR, 2010, ADV PHARMACOL, V59, P93, DOI 10.1016/S1054-3589(10)59004-5; LIU DW, 1993, CIRC RES, V72, P671, DOI 10.1161/01.RES.72.3.671; Liu S, 2010, FEMS MICROBIOL LETT, V303, P183, DOI 10.1111/j.1574-6968.2009.01877.x; Lu XN, 2011, APPL ENVIRON MICROB, V77, P5257, DOI 10.1128/AEM.02845-10; MARTIN N, 1994, J ETHNOPHARMACOL, V43, P1, DOI 10.1016/0378-8741(94)90109-0; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Mukherjee S, 2009, J AGR FOOD CHEM, V57, P7137, DOI 10.1021/jf901301w; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Predmore BL, 2012, AM J PHYSL HEART CIR; RAABGRAHAM KF, 1994, NEUROREPORT, V5, P2501, DOI 10.1097/00001756-199412000-00024; Rahman K, 2006, J NUTR, V136, p736S, DOI 10.1093/jn/136.3.736S; Rahman K, 2001, J NUTR, V131, p977S, DOI 10.1093/jn/131.3.977S; Ried K, 2010, MATURITAS, V67, P144, DOI 10.1016/j.maturitas.2010.06.001; RIETZ B, 1993, MOL CELL BIOCHEM, V119, P143, DOI 10.1007/BF00926865; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Seki T, 2008, ASIA PAC J CLIN NUTR, V17, P249; Sener G, 2007, MOL NUTR FOOD RES, V51, P1345, DOI 10.1002/mnfr.200700078; Shukla Y, 2007, CANCER LETT, V247, P167, DOI 10.1016/j.canlet.2006.05.009; SNYDERS DJ, 1995, CIRC RES, V77, P575, DOI 10.1161/01.RES.77.3.575; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Sungnoon R, 2008, NUTRITION, V24, P711, DOI 10.1016/j.nut.2008.03.003; Sungnoon R, 2008, INT J CARDIOL, V126, P143, DOI 10.1016/j.ijcard.2007.01.083; Tang Q, 2007, BIOCHEM PHARMACOL, V74, P1596, DOI 10.1016/j.bcp.2007.07.042; Wang HC, 2012, NUTR CANC; Wang YB, 2010, PHYTOMEDICINE, V17, P363, DOI 10.1016/j.phymed.2009.07.019; Wu HJ, 2011, J MOL CELL CARDIOL, V51, P966, DOI 10.1016/j.yjmcc.2011.08.022; Xiao D, 2006, CARCINOGENESIS, V27, P533, DOI 10.1093/carcin/bgi228; Xiao D, 2006, NUTR CANCER, V55, P94, DOI 10.1207/s15327914nc5501_12; Xing Y, 2011, J ETHNOPHARMACOL; Zhang DY, 2008, CELL SIGNAL, V20, P1815, DOI 10.1016/j.cellsig.2008.06.006; Zhang DY, 2009, PFLUG ARCH EUR J PHY, V457, P1275, DOI 10.1007/s00424-008-0608-0; Zhang YH, 2012, CARDIOVASC RES, V93, P424, DOI 10.1093/cvr/cvr347	58	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51550	10.1371/journal.pone.0051550	http://dx.doi.org/10.1371/journal.pone.0051550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272117	Green Published, gold			2022-12-27	WOS:000312386800052
J	Ambrosini, E; Ciavarro, M; Pelle, G; Perrucci, MG; Galati, G; Fattori, P; Galletti, C; Committeri, G				Ambrosini, Ettore; Ciavarro, Marco; Pelle, Gina; Perrucci, Mauro Gianni; Galati, Gaspare; Fattori, Patrizia; Galletti, Claudio; Committeri, Giorgia			Behavioral Investigation on the Frames of Reference Involved in Visuomotor Transformations during Peripheral Arm Reaching	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SPATIAL REPRESENTATIONS; EFFECTOR INFORMATION; VISUAL SPACE; OPTIC ATAXIA; EYE; HAND; INTEGRATION; TARGETS; ERRORS	Background: Several psychophysical experiments found evidence for the involvement of gaze-centered and/or body-centered coordinates in arm-movement planning and execution. Here we aimed at investigating the frames of reference involved in the visuomotor transformations for reaching towards visual targets in space by taking target eccentricity and performing hand into account. Methodology/Principal Findings: We examined several performance measures while subjects reached, in complete darkness, memorized targets situated at different locations relative to the gaze and/or to the body, thus distinguishing between an eye-centered and a body-centered frame of reference involved in the computation of the movement vector. The errors seem to be mainly affected by the visual hemifield of the target, independently from its location relative to the body, with an overestimation error in the horizontal reaching dimension (retinal exaggeration effect). The use of several target locations within the perifoveal visual field allowed us to reveal a novel finding, that is, a positive linear correlation between horizontal overestimation errors and target retinal eccentricity. In addition, we found an independent influence of the performing hand on the visuomotor transformation process, with each hand misreaching towards the ipsilateral side. Conclusions: While supporting the existence of an internal mechanism of target-effector integration in multiple frames of reference, the present data, especially the linear overshoot at small target eccentricities, clearly indicate the primary role of gaze-centered coding of target location in the visuomotor transformation for reaching.	[Ambrosini, Ettore; Pelle, Gina; Perrucci, Mauro Gianni; Committeri, Giorgia] Univ G dAnnunzio, Dept Neurosci & Imaging, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy; [Ambrosini, Ettore; Ciavarro, Marco; Pelle, Gina; Perrucci, Mauro Gianni; Committeri, Giorgia] Fdn G dAnnunzio, Inst Adv Biomed Technol ITAB, Chieti, Italy; [Ciavarro, Marco; Fattori, Patrizia; Galletti, Claudio] Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy; [Ciavarro, Marco; Fattori, Patrizia; Galletti, Claudio] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Galati, Gaspare] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Galati, Gaspare] Fdn Santa Lucia, Neuropsychol Lab, Rome, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Bologna; University of Bologna; Sapienza University Rome; IRCCS Santa Lucia	Committeri, G (corresponding author), Univ G dAnnunzio, Dept Neurosci & Imaging, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy.	gcommitteri@unich.it	Fattori, Patrizia/Q-8947-2017; Perrucci, Mauro Gianni/J-8446-2016; Galati, Gaspare/F-3277-2011; Committeri, Giorgia/AAC-1035-2022; Ambrosini, Ettore/AAH-5525-2019; Ciavarro, Marco/AAA-7142-2022; Ambrosini, Ettore/K-5882-2016	Fattori, Patrizia/0000-0002-0079-3755; Perrucci, Mauro Gianni/0000-0002-5725-1623; Galati, Gaspare/0000-0002-0640-4247; Ambrosini, Ettore/0000-0002-1439-5491; Ciavarro, Marco/0000-0001-6611-6266; Ambrosini, Ettore/0000-0002-1439-5491; GALLETTI, CLAUDIO/0000-0001-8927-3408	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2006055034_002, 2006055034_001]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) to GC (prot. 2006055034_002) and CG (prot. 2006055034_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATISTA A, 2005, HETEROGENEOUS COORDI; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Bernier PM, 2010, NEURON, V68, P776, DOI 10.1016/j.neuron.2010.11.002; Beurze SM, 2007, J NEUROPHYSIOL, V97, P188, DOI 10.1152/jn.00456.2006; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; Blangero A, 2009, NEUROPSYCHOLOGIA, V47, P1500, DOI 10.1016/j.neuropsychologia.2008.11.030; Blohm G, 2007, J VIS, V7, P1; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; Carrozzo M, 1999, EXP BRAIN RES, V129, P201, DOI 10.1007/s002210050890; Chang SWC, 2010, P NATL ACAD SCI USA, V107, P7951, DOI 10.1073/pnas.0913209107; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Crawford J D, 2003, Strabismus, V11, P33, DOI 10.1076/stra.11.1.33.14094; Dijkerman HC, 2006, NEUROPSYCHOLOGIA, V44, P2766, DOI 10.1016/j.neuropsychologia.2005.10.018; ENRIGHT JT, 1995, VISION RES, V35, P1611, DOI 10.1016/0042-6989(94)00260-S; Fiehler K, 2010, EXP BRAIN RES, V203, P485, DOI 10.1007/s00221-010-2251-1; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Galati G, 2011, EUR J NEUROSCI, V34, P1871, DOI 10.1111/j.1460-9568.2011.07885.x; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Harrar V, 2009, EXP BRAIN RES, V198, P403, DOI 10.1007/s00221-009-1884-4; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2002, PROG BRAIN RES, V140, P329; Henriques DYP, 2000, EXP BRAIN RES, V132, P179, DOI 10.1007/s002210000340; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; Khan AZ, 2007, J VISION, V7, DOI 10.1167/7.5.8; Khan AZ, 2005, CEREB CORTEX, V15, P1547, DOI 10.1093/cercor/bhi033; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; McGuire LMM, 2011, J NEUROSCI, V31, P6661, DOI 10.1523/JNEUROSCI.2921-10.2011; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Medendorp WP, 2002, NEUROREPORT, V13, P633, DOI 10.1097/00001756-200204160-00019; Neely KA, 2008, EXP BRAIN RES, V186, P375, DOI 10.1007/s00221-007-1238-z; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Poljac E, 2005, EXP BRAIN RES, V163, P457, DOI 10.1007/s00221-004-2201-x; Poljac E, 2003, EXP BRAIN RES, V151, P501, DOI 10.1007/s00221-003-1498-1; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Sorrento GU, 2008, J NEUROPHYSIOL, V99, P2968, DOI 10.1152/jn.90225.2008; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290	49	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51856	10.1371/journal.pone.0051856	http://dx.doi.org/10.1371/journal.pone.0051856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272180	Green Submitted, gold, Green Published			2022-12-27	WOS:000312386600045
J	Campbell, LJ; Willoughby, JJ; Jensen, AM				Campbell, Leah J.; Willoughby, John J.; Jensen, Abbie M.			Two Types of Tet-On Transgenic Lines for Doxycycline-Inducible Gene Expression in Zebrafish Rod Photoreceptors and a Gateway-Based Tet-On Toolkit	PLOS ONE			English	Article							SYSTEM; CELLS	The ability to control transgene expression within specific tissues is an important tool for studying the molecular and cellular mechanisms of development, physiology, and disease. We developed a Tet-On system for spatial and temporal control of transgene expression in zebrafish rod photoreceptors. We generated two transgenic lines using the Xenopus rhodopsin promoter to drive the reverse tetracycline-controlled transcriptional transactivator (rtTA), one with self-reporting GFP activity and one with an epitope tagged rtTA. The self-reporting line includes a tetracycline response element (TRE)-driven GFP and, in the presence of doxycycline, expresses GFP in larval and adult rods. A time-course of doxycycline treatment demonstrates that maximal induction of GFP expression, as determined by the number of GFP-positive rods, is reached within approximately 24 hours of drug treatment. The epitope-tagged transgenic line eliminates the need for the self-reporting GFP activity by expressing a FLAG-tagged rtTA protein. Both lines demonstrate strong induction of TRE-driven transgenes from plasmids microinjected into one-cell embryos. These results show that spatial and temporal control of transgene expression can be achieved in rod photoreceptors. Additionally, system components are constructed in Gateway compatible vectors for the rapid cloning of doxycycline-inducible transgenes and use in other areas of zebrafish research.	[Campbell, Leah J.; Willoughby, John J.; Jensen, Abbie M.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Jensen, Abbie M.] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Jensen, AM (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	ajensen@bio.umass.edu		Campbell, Leah/0000-0002-1666-2143	National Institutes of Health, National Eye Institute [EY015420]; NATIONAL EYE INSTITUTE [R56EY015420, R01EY015420] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health, National Eye Institute (EY015420 to AMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeletti B, 2003, INVEST OPHTH VIS SCI, V44, P755, DOI 10.1167/iovs.02-0340; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Chang MA, 2000, INVEST OPHTH VIS SCI, V41, P4281; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Hsu YC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-60; Huang CJ, 2005, DEV DYNAM, V233, P1294, DOI 10.1002/dvdy.20485; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Koga A, 2008, DEV DYNAM, V237, P2466, DOI 10.1002/dvdy.21688; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Newman Morgan, 2010, BMC Res Notes, V3, P282, DOI 10.1186/1756-0500-3-282; Ohnaka M, 2012, J NEUROCHEM; Ohno-Matsui K, 2002, AM J PATHOL, V160, P711, DOI 10.1016/S0002-9440(10)64891-2; Okoye G, 2003, J NEUROSCI, V23, P4164; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; ROHLICH P, 1989, EXP EYE RES, V49, P999, DOI 10.1016/S0014-4835(89)80022-3; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE	31	24	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51270	10.1371/journal.pone.0051270	http://dx.doi.org/10.1371/journal.pone.0051270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251476	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200079
J	Cao, L; Li, LL; Lin, DW; Zuo, ZY				Cao, Lin; Li, Liaoliao; Lin, Daowei; Zuo, Zhiyi			Isoflurane Induces Learning Impairment That Is Mediated by Interleukin 1 beta in Rodents	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; ALZHEIMERS-DISEASE; AGED RATS; LIDOCAINE; CYTOKINE; BRAIN; MICE; DECLINE; INJURY; NEUROPROTECTION	Postoperative cognitive decline is a clinical syndrome. Volatile anesthetics are commonly used during surgery. It is conceivable that volatile anesthetics may contribute to postoperative cognitive decline. Isoflurane can impair cognitive functions of animals under certain conditions. However, the mechanisms for this impairment are not clear. Here, male 18-month old Fisher 344 rats or 10-week old mice were exposed to 1.2 or 1.4% isoflurane for 2 h. Our studies showed that isoflurane impaired the cognitive functions of the rats in Barnes maze. Isoflurane-exposed rats had reduced freezing behavior during the training sessions in the fear conditioning test. This isoflurane effect was attenuated by lidocaine, a local anesthetic with anti-inflammatory property. Rats that had training sessions and were exposed to isoflurane 30 min later had freezing behavior similar to that of control animals. Isoflurane increased the expression of interleukin 1 beta (IL-1 beta), interleukin-6 and activated caspase 3 in the hippocampus of the 18-month old rats. IL-1 beta positive staining was co-localized with that of NeuN, a neuronal marker. The increase of IL-1 beta and activated caspase 3 but not interleukin-6 was attenuated by lidocaine. Isoflurane also impaired the cognitive functions of 10-week old C57BL/6J mice and increased IL-1 beta in their hippocampi. However, isoflurane did not affect the cognitive functions of IL-1 beta deficient mice. Our results suggest that isoflurane impairs the learning but may not affect the recall of the aged rats. IL-1 beta may play an important role in this isoflurane effect.	[Cao, Lin; Li, Liaoliao; Lin, Daowei; Zuo, Zhiyi] Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22903 USA; [Cao, Lin; Lin, Daowei; Zuo, Zhiyi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	University of Virginia; Sun Yat Sen University	Zuo, ZY (corresponding author), Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22903 USA.	zz3c@virginia.edu	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047	National Institutes of Health, Bethesda, Maryland [R01 GM065211]; International Anesthesia Research Society, Cleveland, Ohio; American Heart Association Mid-Atlantic Affiliate, Baltimore, Maryland [10GRNT3900019]; Robert M. Epstein Professorship endowment, University of Virginia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065211, R01GM098308] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Anesthesia Research Society, Cleveland, Ohio; American Heart Association Mid-Atlantic Affiliate, Baltimore, Maryland(American Heart Association); Robert M. Epstein Professorship endowment, University of Virginia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant (R01 GM065211 to ZZ) from the National Institutes of Health, Bethesda, Maryland, by a grant from the International Anesthesia Research Society (2007 Frontiers in Anesthesia Research Award to ZZ), Cleveland, Ohio, by a Grant-in-Aid from the American Heart Association Mid-Atlantic Affiliate (10GRNT3900019 to ZZ), Baltimore, Maryland, and the Robert M. Epstein Professorship endowment, University of Virginia. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; DICKSTEIN RA, 1984, J LEUKOCYTE BIOL, V36, P621, DOI 10.1002/jlb.36.5.621; Fidalgo AR, 2012, ACTA ANAESTH SCAND, V56, P1052, DOI 10.1111/j.1399-6576.2012.02691.x; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; KOMATSU H, 1993, ANESTH ANALG, V76, P609; Lahat A, 2008, CLIN EXP IMMUNOL, V152, P320, DOI 10.1111/j.1365-2249.2008.03636.x; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li LL, 2008, EUR J PHARMACOL, V586, P106, DOI 10.1016/j.ejphar.2008.02.073; Lin DW, 2012, BEHAV BRAIN RES, V228, P319, DOI 10.1016/j.bbr.2011.12.010; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; PARDRIDGE WM, 1983, J CLIN INVEST, V71, P900, DOI 10.1172/JCI110844; Caracas HCPM, 2009, J DENT, V37, P93, DOI 10.1016/j.jdent.2008.10.005; Rammes G, 2009, NEUROPHARMACOLOGY, V56, P626, DOI 10.1016/j.neuropharm.2008.11.002; Sanderson DJ, 2009, BEHAV BRAIN RES, V201, P103, DOI 10.1016/j.bbr.2009.01.038; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Silva AC, 2006, J ORAL MAXIL SURG, V64, P1385, DOI 10.1016/j.joms.2006.05.024; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Stratmann G, 2010, ANESTHESIOLOGY, V112, P305, DOI 10.1097/ALN.0b013e3181ca33a1; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Vizcaychipi MP, 2011, ANESTHESIOLOGY, V114, P891, DOI 10.1097/ALN.0b013e31820ad3ce; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Wright Clinton B, 2006, J Stroke Cerebrovasc Dis, V15, P34, DOI 10.1016/j.jstrokecerebrovasdis.2005.08.009; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zhao P, 2004, ANESTHESIOLOGY, V101, P695, DOI 10.1097/00000542-200409000-00018; Zheng SQ, 2004, MOL PHARMACOL, V65, P1172, DOI 10.1124/mol.65.5.1172; Zhou ZH, 2005, AM J RESP CRIT CARE, V172, P344, DOI 10.1164/rccm.200503-343OC	36	100	109	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51431	10.1371/journal.pone.0051431	http://dx.doi.org/10.1371/journal.pone.0051431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251531	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200106
J	Duch, J; Zeng, XHT; Sales-Pardo, M; Radicchi, F; Otis, S; Woodruff, TK; Amaral, LAN				Duch, Jordi; Zeng, Xiao Han T.; Sales-Pardo, Marta; Radicchi, Filippo; Otis, Shayna; Woodruff, Teresa K.; Amaral, Luis A. Nunes			The Possible Role of Resource Requirements and Academic Career-Choice Risk on Gender Differences in Publication Rate and Impact	PLOS ONE			English	Article							WOMENS UNDERREPRESENTATION; SEX-DIFFERENCES; BABIES MATTER; SCIENCE; PRODUCTIVITY; INDEX; GAP; METAANALYSIS; LEADERSHIP; MEDICINE	Many studies demonstrate that there is still a significant gender bias, especially at higher career levels, in many areas including science, technology, engineering, and mathematics (STEM). We investigated field-dependent, gender-specific effects of the selective pressures individuals experience as they pursue a career in academia within seven STEM disciplines. We built a unique database that comprises 437,787 publications authored by 4,292 faculty members at top United States research universities. Our analyses reveal that gender differences in publication rate and impact are discipline-specific. Our results also support two hypotheses. First, the widely-reported lower publication rates of female faculty are correlated with the amount of research resources typically needed in the discipline considered, and thus may be explained by the lower level of institutional support historically received by females. Second, in disciplines where pursuing an academic position incurs greater career risk, female faculty tend to have a greater fraction of higher impact publications than males. Our findings have significant, field-specific, policy implications for achieving diversity at the faculty level within the STEM disciplines.	[Duch, Jordi; Zeng, Xiao Han T.; Sales-Pardo, Marta; Otis, Shayna; Amaral, Luis A. Nunes] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Duch, Jordi] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain; [Sales-Pardo, Marta; Radicchi, Filippo] Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain; [Radicchi, Filippo; Amaral, Luis A. Nunes] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA; [Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Woodruff, Teresa K.] Northwestern Univ, Inst Womens Hlth Res, Chicago, IL 60611 USA; [Amaral, Luis A. Nunes] Northwestern Univ, NW Inst Complex Syst, Evanston, IL USA	Northwestern University; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Howard Hughes Medical Institute; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Amaral, LAN (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	amaral@northwestern.edu	Sales-Pardo, Marta/C-1725-2008; Duch, Jordi/A-7000-2008; Sales-Pardo, Marta/O-9797-2019; Amaral, Luis N./C-5485-2009; Radicchi, Filippo/B-4407-2009; Amaral, LAN/A-4980-2008	Sales-Pardo, Marta/0000-0002-8140-6525; Duch, Jordi/0000-0003-2639-6333; Sales-Pardo, Marta/0000-0002-8140-6525; Amaral, LAN/0000-0002-3762-789X; Woodruff, Teresa/0000-0002-1197-3399; Radicchi, Filippo/0000-0002-8352-1287; Zeng, Xiaohan/0000-0001-8771-9314	NSF [SBE 0624318, IIS 0830388]	NSF(National Science Foundation (NSF))	The authors acknowledge the support of NSF awards SBE 0624318 and IIS 0830388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2010, US NEWS; Association of American Medical Colleges, 2008, TECHNICAL REPORT; Beaman L, 2012, SCIENCE, V335, P582, DOI 10.1126/science.1212382; Bornmann L, 2007, J AM SOC INF SCI TEC, V58, P1381, DOI 10.1002/asi.20609; Bornmann L, 2007, J INFORMETR, V1, P226, DOI 10.1016/j.joi.2007.03.001; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Carnes M, 2008, J WOMENS HEALTH, V17, P1453, DOI 10.1089/jwh.2007.0688; CaseWestern Reserve University Equity Study Committee, 2003, TECHNICAL REPORT; Cech EA, 2010, SOC PROBL, V57, P371, DOI 10.1525/sp.2010.57.3.371; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Ceci SJ, 2009, PSYCHOL BULL, V135, P218, DOI 10.1037/a0014412; Cole J. R., 1984, ADV MOTIVATION ACHIE, V2, P217; Committee on Women Faculty in the School of Science, 1999, TECHNICAL REPORT; Doucet C, 2012, RELAT IND-IND RELAT, V67, P51, DOI 10.7202/1008195ar; Etzkowitz H., 2011, BRUSSELS EC REV, V54, P131; Furnham A, 2011, J SOCIO-ECON, V40, P623, DOI 10.1016/j.socec.2011.04.019; Ginther D. K., 2003, B SCI TECHNOL SOC, V23, P21, DOI DOI 10.1177/0270467602239767; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Heilman ME, 2001, J SOC ISSUES, V57, P657, DOI 10.1111/0022-4537.00234; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Kaminski D, 2012, SCIENCE, V335, P864, DOI 10.1126/science.1214844; Lariviere V, 2011, SCIENTOMETRICS, V87, P483, DOI 10.1007/s11192-011-0369-y; LONG JS, 1992, SOC FORCES, V71, P159, DOI 10.2307/2579971; Mason MA, 2004, ACADEME, V90, P10, DOI 10.2307/40252699; Mason MA, 2002, ACADEME, V88, P21, DOI 10.2307/40252436; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; National Research Council, 2001, TECHNICAL REPORT; Petersen AM, 2012, P NATL ACAD SCI USA, V109, P5213, DOI 10.1073/pnas.1121429109; Petersen AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00181; Princeton University, 2003, TECHNICAL REPORT; Prpic K, 2002, SCIENTOMETRICS, V55, P27, DOI 10.1023/A:1016046819457; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; ROSSITER MW, 1993, SOC STUD SCI, V23, P325, DOI 10.1177/030631293023002004; Rovner SL, 2011, CHEM ENG NEWS, V89, P42; Sarfaty S, 2007, J WOMENS HEALTH, V16, P235, DOI 10.1089/jwh.2006.0037; Stringer M., 2008, PLOS ONE, V3, P1; Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127; University of Pennsylvania Gender Equity Committee, 2001, TECHNICAL REPORT; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; Xie Y, 1998, AM SOCIOL REV, V63, P847, DOI 10.2307/2657505; Xie Y., 2003, WOMEN SCI CAREER PRO	42	133	135	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51332	10.1371/journal.pone.0051332	http://dx.doi.org/10.1371/journal.pone.0051332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251502	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200092
J	Nettle, D; Nott, K; Bateson, M				Nettle, Daniel; Nott, Kenneth; Bateson, Melissa			'Cycle Thieves, We Are Watching You': Impact of a Simple Signage Intervention against Bicycle Theft	PLOS ONE			English	Article							CRIME DISPLACEMENT; PREVENTION; CUES; COOPERATION; CCTV	Background: Bicycle theft is a serious problem in many countries, and there is a lack of evidence concerning effective prevention strategies. Displaying images of 'watching eyes' has been shown to make people behave in more socially desirable ways in a number of settings, but it is not yet clear if this effect can be exploited for purposes of crime prevention. We report the results of a simple intervention on a university campus where signs featuring watching eyes and a related verbal message were displayed above bicycle racks. Methodology and Principal Findings: We installed durable signs at three locations which had experienced high levels of bicycle theft, and used the rest of the university campus as a control location. Reported thefts were monitored for 12 months before and after the intervention. Bicycle thefts decreased by 62% at the experimental locations, but increased by 65% in the control locations, suggesting that the signs were effective, but displaced offending to locations with no signs. The Odds Ratio for the effect of the intervention was 4.28 (95% confidence interval 2.04-8.98), a large effect compared to other place-based crime prevention interventions. Conclusions and Significance: The effectiveness of this extremely cheap and simple intervention suggests that there can be considerable crime-reduction benefits to engaging the psychology of surveillance, even in the absence of surveillance itself. Simple interventions for high-crime locations based on this principle should be considered as an adjunct to other measures, although a possible negative consequence is displacement of offending.	[Nettle, Daniel; Bateson, Melissa] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nettle, Daniel; Bateson, Melissa] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nott, Kenneth] Newcastle Univ, Estate Secur Serv, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Nettle, D (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	daniel.nettle@ncl.ac.uk	Bateson, Melissa/B-1874-2008; Bateson, Melissa/AAE-7075-2022	Bateson, Melissa/0000-0002-0861-0191; Bateson, Melissa/0000-0002-0861-0191; Nettle, Daniel/0000-0001-9089-2599	Newcastle University	Newcastle University	The only funding received for this study was a small amount of money from Newcastle University for the making of signs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, POLICE ORACLE; [Anonymous], 2006, SCI WORLD; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bourrat P, 2011, EVOL PSYCHOL-US, V9, P193, DOI 10.1177/147470491100900206; Burnham TC, 2003, J ECON BEHAV ORGAN, V50, P133, DOI 10.1016/S0167-2681(02)00044-6; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Clarke R. V., 1995, CRIME JUSTICE, V19, P91, DOI 10.1086/449230; CORNISH DB, 1987, CRIMINOLOGY, V25, P933, DOI 10.1111/j.1745-9125.1987.tb00826.x; Dolan P, 2012, J ECON PSYCHOL, V33, P264, DOI 10.1016/j.joep.2011.10.009; Ekstrom M, 2012, EXP ECON, V15, P530, DOI 10.1007/s10683-011-9312-6; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Francey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037397; GABOR T, 1990, CAN J CRIMINOL, V32, P41; Guerette RT, 2009, CRIMINOLOGY, V47, P1331, DOI 10.1111/j.1745-9125.2009.00177.x; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Izuma K, 2012, NEUROSCI RES, V72, P283, DOI 10.1016/j.neures.2012.01.003; Kahneman D., 2011, THINKING FAST SLOW; MCNEES MP, 1976, J APPL BEHAV ANAL, V9, P399, DOI 10.1901/jaba.1976.9-399; Nettle D, 2013, EVOLUTION HUMAN BEHA; Oda R, 2011, EVOL HUM BEHAV, V32, P166, DOI 10.1016/j.evolhumbehav.2010.11.002; ONS, 2012, CRIM ENGL WAL Q 1 RE; Powell KL, 2012, ETHOLOGY, V118, P1096, DOI 10.1111/eth.12011; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Sidebottom A, 2009, EUR J CRIMINOL, V6, P267, DOI 10.1177/1477370809102168; Thaler R.H., 2021, NUDGE FINAL EDITION; van Dijk J., 2007, PANOPTICON TIJDSCHRI; Welsh BC, 2005, CAN J CRIMINOL CRIM, V47, P337, DOI 10.3138/cjccj.47.2.337; Welsh BC, 2001, ANN AM ACAD POLIT SS, V578, P158, DOI 10.1177/0002716201578001010; Welsh BC, 2009, JUSTICE Q, V26, P716, DOI 10.1080/07418820802506206; Wilson D, 2004, AUST NZ J CRIMINOL, V37, P211	30	85	87	30	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51738	10.1371/journal.pone.0051738	http://dx.doi.org/10.1371/journal.pone.0051738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251615	Green Published, gold			2022-12-27	WOS:000313236200161
J	Chiu, YT; Liu, J; Tang, KD; Wong, YC; Khanna, KK; Ling, MT				Chiu, Yung-Tuen; Liu, Ji; Tang, Kaidun; Wong, Yong-Chuan; Khanna, Kum Kum; Ling, Ming-Tat			Inactivation of ATM/ATR DNA Damage Checkpoint Promotes Androgen Induced Chromosomal Instability in Prostate Epithelial Cells	PLOS ONE			English	Article							DEPENDENT DEGRADATION; ATM; ACTIVATION; SENESCENCE; FUSION; KINASE; P53; PHOSPHORYLATION; BARRIER; REPAIR	The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some missense variants of the ATM gene have been shown to confer a moderate increased risk of prostate cancer. However, whether inactivation of this checkpoint contributes directly to prostate specific cancer predisposition is still unknown. Here, we show that exposure of non-malignant prostate epithelial cells (HPr-1AR) to androgen led to activation of the ATM/ATR DNA damage response and induction of cellular senescence. Notably, knockdown of the ATM gene expression in HPr-1AR cells can promote androgen-induced TMPRSS2: ERG rearrangement, a prostate-specific chromosome translocation frequently found in prostate cancer cells. Intriguingly, unlike the non-malignant prostate epithelial cells, the ATM/ATR DNA damage checkpoint appears to be defective in prostate cancer cells, since androgen treatment only induced a partial activation of the DNA damage response. This mechanism appears to preserve androgen induced autophosphorylation of ATM and phosphorylation of H2AX, lesion processing and repair pathway yet restrain ATM/CHK1/CHK2 and p53 signaling pathway. Our findings demonstrate that ATM/ATR inactivation is a crucial step in promoting androgen-induced genomic instability and prostate carcinogenesis.	[Liu, Ji; Tang, Kaidun; Ling, Ming-Tat] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Chiu, Yung-Tuen] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wong, Yong-Chuan] Univ Hong Kong, Dept Pathol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Khanna, Kum Kum] Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4006, Australia	Queensland University of Technology (QUT); University of Hong Kong; University of Hong Kong; QIMR Berghofer Medical Research Institute	Ling, MT (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	mingtat.ling@qut.edu.au	Khanna, Kum Kum/I-1747-2013	Khanna, Kum Kum/0000-0001-8650-5381	National Health and Medical Research Council [APP1031221, APP1031228]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council grants (APP1031221 and APP1031228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele S, 2004, BRIT J CANCER, V91, P783, DOI 10.1038/sj.bjc.6602007; Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bastus NC, CANC RES, V70, P9544; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chiu YT, 2009, J MOL BIOL, V385, P446, DOI 10.1016/j.jmb.2008.10.070; Choo CK, 1999, PROSTATE, V40, P150, DOI 10.1002/(SICI)1097-0045(19990801)40:3<150::AID-PROS2>3.0.CO;2-7; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Fan C, 2006, BBA-MOL CELL RES, V1763, P1090, DOI 10.1016/j.bbamcr.2006.08.026; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Isoda M, 2009, MOL BIOL CELL, V20, P2186, DOI 10.1091/mbc.E09-01-0008; Khanna KK, 2004, J MAMMARY GLAND BIOL, V9, P247, DOI 10.1023/B:JOMG.0000048772.92326.a1; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Ling MT, 2008, J MOL BIOL, V382, P34, DOI 10.1016/j.jmb.2007.06.020; Luk SU, INT J CANC; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Meyer A, 2007, RADIOTHER ONCOL, V83, P283, DOI 10.1016/j.radonc.2007.04.029; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Rickman DS, 2009, CANCER RES, V69, P2734, DOI 10.1158/0008-5472.CAN-08-4926; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; te Poele RH, 2002, CANCER RES, V62, P1876; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsihlias J, 2000, ONCOGENE, V19, P670, DOI 10.1038/sj.onc.1203369; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	39	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51108	10.1371/journal.pone.0051108	http://dx.doi.org/10.1371/journal.pone.0051108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272087	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300016
J	Tassin, A; Leroy, B; Laoudj-Chenivesse, D; Wauters, A; Vanderplanck, C; Le Bihan, MC; Coppee, F; Wattiez, R; Belayew, A				Tassin, Alexandra; Leroy, Baptiste; Laoudj-Chenivesse, Dalila; Wauters, Armelle; Vanderplanck, Celine; Le Bihan, Marie-Catherine; Coppee, Frederique; Wattiez, Ruddy; Belayew, Alexandra			FSHD Myotubes with Different Phenotypes Exhibit Distinct Proteomes	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; COILED-COIL PROTEIN; NONMUSCLE MYOSIN-II; MYOBLAST FUSION; SKELETAL-MUSCLE; CANDIDATE GENE; NUCLEAR ACTIN; EXPRESSION; D4Z4; LOCUS	Facioscapulohumeral muscular dystrophy (FSHD) is a progressive muscle disorder linked to a contraction of the D4Z4 repeat array in the 4q35 subtelomeric region. This deletion induces epigenetic modifications that affect the expression of several genes located in the vicinity. In each D4Z4 element, we identified the double homeobox 4 (DUX4) gene. DUX4 expresses a transcription factor that plays a major role in the development of FSHD through the initiation of a large gene dysregulation cascade that causes myogenic differentiation defects, atrophy and reduced response to oxidative stress. Because miRNAs variably affect mRNA expression, proteomic approaches are required to define the dysregulated pathways in FSHD. In this study, we optimized a differential isotope protein labeling (ICPL) method combined with shotgun proteomic analysis using a gel-free system (2DLC-MS/MS) to study FSHD myotubes. Primary CD56(+) FSHD myoblasts were found to fuse into myotubes presenting various proportions of an atrophic or a disorganized phenotype. To better understand the FSHD myogenic defect, our improved proteomic procedure was used to compare predominantly atrophic or disorganized myotubes to the same matching healthy control. FSHD atrophic myotubes presented decreased structural and contractile muscle components. This phenotype suggests the occurrence of atrophy-associated proteolysis that likely results from the DUX4-mediated gene dysregulation cascade. The skeletal muscle myosin isoforms were decreased while non-muscle myosin complexes were more abundant. In FSHD disorganized myotubes, myosin isoforms were not reduced, and increased proteins were mostly involved in microtubule network organization and myofibrillar remodeling. A common feature of both FSHD myotube phenotypes was the disturbance of several caveolar proteins, such as PTRF and MURC. Taken together, our data suggest changes in trafficking and in the membrane microdomains of FSHD myotubes. Finally, the adjustment of a nuclear fractionation compatible with mass spectrometry allowed us to highlight alterations of proteins involved in mRNA processing and stability.	[Tassin, Alexandra; Wauters, Armelle; Vanderplanck, Celine; Coppee, Frederique; Belayew, Alexandra] Univ Mons, Mol Biol Lab, Res Inst Hlth Sci & Technol, B-7000 Mons, Belgium; [Leroy, Baptiste; Wattiez, Ruddy] Univ Mons, Dept Prote & Microbiol, Res Inst Hlth Sci & Technol, B-7000 Mons, Belgium; [Laoudj-Chenivesse, Dalila] CHU A Villeneuve, INSERM Physiol & Med Expt Coeur & Muscle U1046, Montpellier, France; [Le Bihan, Marie-Catherine] Univ Paris 06, UM 76, INSERM U974, Inst Myol,CNRS UMR 7215, Paris, France	University of Mons; University of Mons; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Belayew, A (corresponding author), Univ Mons, Mol Biol Lab, Res Inst Hlth Sci & Technol, B-7000 Mons, Belgium.	alexandra.belayew@umons.ac.be	BELAYEW, Alexandra/D-5205-2013	BELAYEW, Alexandra/0000-0001-5115-2424; Leroy, Baptiste/0000-0001-7166-4478; wattiez, ruddy/0000-0003-2071-4310	AFM: Association Francaise contre les Myopathies [13120, 13294]; ABMM : Association Belge contre les Maladies neuro-Musculaires; FNRS (National Fund for Scientific Research, Belgium); FRIA (Fund for Research in Industry and Agriculture) [2007/V 3/5/180-F/3/5/5-IB/CAV-8864]; FSHD Global Research Foundation, Australia	AFM: Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); ABMM : Association Belge contre les Maladies neuro-Musculaires; FNRS (National Fund for Scientific Research, Belgium)(Fonds de la Recherche Scientifique - FNRS); FRIA (Fund for Research in Industry and Agriculture)(Fonds de la Recherche Scientifique - FNRS); FSHD Global Research Foundation, Australia	This study was funded by the AFM: Association Francaise contre les Myopathies (http://www.afm-telethon.fr), grant A.B.#13120, pre-doctoral fellowship A.T.#13294; the ABMM : Association Belge contre les Maladies neuro-Musculaires (http://www.abmm.be), A. T. pre-doctoral fellowship; the FNRS (National Fund for Scientific Research, Belgium) and the FRIA (Fund for Research in Industry and Agriculture) (http://www1.frs-fnrs.be), A. T. post-doctoral fellowship #2007/V 3/5/180-F/3/5/5-IB/CAV-8864, C. V. pre-doctoral fellowships; the FSHD Global Research Foundation, Australia (http://www.fshdglobal.org/), C. V. pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev PV, 2011, BIOPOLYMERS CELL; Dzijak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030529; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Feasson L, 2002, J PHYSIOL-LONDON, V543, P297, DOI 10.1113/jphysiol.2002.018689; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Goudenege S, 2007, PROTEOMICS, V7, P3289, DOI 10.1002/pmic.200700124; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Leroy B, 2010, PROTEOMICS, V10, P2281, DOI 10.1002/pmic.200900286; Mastroleo F, 2009, ISME J, V3, P1402, DOI 10.1038/ismej.2009.74; Mermelstein CS, 2005, CELL TISSUE RES, V319, P289, DOI 10.1007/s00441-004-1004-5; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Oldfors A, 2007, NEUROMUSCULAR DISORD, V17, P355, DOI 10.1016/j.nmd.2007.02.008; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Park I, 2011, BIOCHEM J, V434, P171, DOI 10.1042/BJ20101473; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; Richards M, 2011, HUM GENET, DOI 10.1007/s00439-011-1100-z; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Sakurai T, 2005, FASEB J, V19, P1199, DOI 10.1096/fj.04-3060fje; Shi Y, 2007, PROTEOMICS, V7, P4589, DOI 10.1002/pmic.200700425; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Swailes NT, 2006, J CELL SCI, V119, P3561, DOI 10.1242/jcs.03096; Tagawa M, 2008, AM J PHYSIOL-CELL PH, V295, pC490, DOI 10.1152/ajpcell.00188.2008; Tassin A, 2012, J CELL MOL IN PRESS; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Tupler R, 1999, P NATL ACAD SCI USA, V96, P12650, DOI 10.1073/pnas.96.22.12650; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	57	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51865	10.1371/journal.pone.0051865	http://dx.doi.org/10.1371/journal.pone.0051865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272181	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300036
J	Aggarwal, M; Tapas, S; Preeti; Siwach, A; Kumar, P; Kuhn, RJ; Tomar, S				Aggarwal, Megha; Tapas, Satya; Preeti; Siwach, Anjul; Kumar, Pravindra; Kuhn, Richard J.; Tomar, Shailly			Crystal Structure of Aura Virus Capsid Protease and Its Complex with Dioxane: New Insights into Capsid-Glycoprotein Molecular Contacts	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; MULTIPLE SEQUENCE ALIGNMENT; CYTOPLASMIC DOMAIN; SERINE PROTEINASE; ANTIVIRAL AGENTS; SPIKE PROTEIN; CORE PROTEIN; ALPHAVIRUS; E2; MUTATIONS	The nucleocapsid core interaction with endodomains of glycoproteins plays a critical role in the alphavirus life cycle that is essential to virus budding. Recent cryo-electron microscopy (cryo-EM) studies provide structural insights into key interactions between capsid protein (CP) and trans-membrane glycoproteins E1 and E2. CP possesses a chymotrypsin-like fold with a hydrophobic pocket at the surface responsible for interaction with glycoproteins. In the present study, crystal structures of the protease domain of CP from Aura virus and its complex with dioxane were determined at 1.81 and 1.98 angstrom resolution respectively. Due to the absence of crystal structures, homology models of E1 and E2 from Aura virus were generated. The crystal structure of CP and structural models of E1 and E2 were fitted into the cryo-EM density map of Venezuelan equine encephalitis virus (VEEV) for detailed analysis of CP-glycoprotein interactions. Structural analysis revealed that the E2 endodomain consists of a helix-loop-helix motif where the loop region fits into the hydrophobic pocket of CP. Our studies suggest that Cys397, Cys418 and Tyr401 residues of E2 are involved in stabilizing the structure of E2 endodomain. Density map fitting analysis revealed that Pro405, a conserved E2 residue is present in the loop region of the E2 endodomain helix-loop-helix structure and makes intermolecular hydrophobic contacts with the capsid. In the Aura virus capsid protease (AVCP)-dioxane complex structure, dioxane occupies the hydrophobic pocket on CP and structurally mimics the hydrophobic pyrollidine ring of Pro405 in the loop region of E2.	[Aggarwal, Megha; Tapas, Satya; Preeti; Siwach, Anjul; Kumar, Pravindra; Tomar, Shailly] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kuhn, Richard J.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tomar, S (corresponding author), Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India.	shailfbt@iitr.ernet.in	KUMAR, PRAVINDRA/AAF-2859-2020; Kuhn, Richard/AAR-2722-2021; Aggarwal, Megha/AAC-9406-2019	KUMAR, PRAVINDRA/0000-0003-2128-7736; Kuhn, Richard/0000-0003-4148-1026; 	Defence Research and Development Organization (DRDO), Government of India	Defence Research and Development Organization (DRDO), Government of India(Defence Research & Development Organisation (DRDO))	This research was supported by the Defence Research and Development Organization (DRDO), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2011, ACTA CRYSTALLOGR F, V67, P1394, DOI 10.1107/S174430911103404X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTH BU, 1992, J VIROL, V66, P7560, DOI 10.1128/JVI.66.12.7560-7564.1992; CHENG RH, 1995, CELL, V80, P621; Choi HK, 1997, PROTEINS, V27, P345, DOI 10.1002/(SICI)1097-0134(199703)27:3<345::AID-PROT3>3.0.CO;2-C; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; Choi HK, 1996, J MOL BIOL, V262, P151, DOI 10.1006/jmbi.1996.0505; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAHN CS, 1985, P NATL ACAD SCI USA, V82, P4648, DOI 10.1073/pnas.82.14.4648; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong EM, 2006, J VIROL, V80, P8848, DOI 10.1128/JVI.00619-06; IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993; Jose J, 2012, J VIROL, V86, P2585, DOI 10.1128/JVI.05860-11; KAIL M, 1991, EMBO J, V10, P2343, DOI 10.1002/j.1460-2075.1991.tb07773.x; Kielian M, 2002, MOL CELL, V9, P454, DOI 10.1016/S1097-2765(02)00492-6; Kim HY, 2007, BIOORGAN MED CHEM, V15, P2667, DOI 10.1016/j.bmc.2007.01.040; Kim HY, 2005, BIOORG MED CHEM LETT, V15, P3207, DOI 10.1016/j.bmcl.2005.05.013; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE H, 1994, VIROLOGY, V204, P471, DOI 10.1006/viro.1994.1557; Lee SY, 1998, PROTEINS, V33, P311, DOI 10.1002/(SICI)1097-0134(19981101)33:2<311::AID-PROT13>3.0.CO;2-N; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Levine B, 1996, J VIROL, V70, P1255, DOI 10.1128/JVI.70.2.1255-1260.1996; LOPEZ S, 1994, J VIROL, V68, P1316, DOI 10.1128/JVI.68.3.1316-1323.1994; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; METSIKKO K, 1990, J VIROL, V64, P4678; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen KE, 1996, J VIROL, V70, P2757, DOI 10.1128/JVI.70.5.2757-2763.1996; Owen KE, 1997, VIROLOGY, V230, P187, DOI 10.1006/viro.1997.8480; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reichert E, 2009, BIOSECUR BIOTERROR, V7, P413, DOI 10.1089/bsp.2009.0032; RUMENAPF T, 1994, J VIROL, V68, P56; Ryan C, 1998, VIROLOGY, V243, P380, DOI 10.1006/viro.1998.9074; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHERMAN LA, 1990, J VIROL, V64, P2041, DOI 10.1128/JVI.64.5.2041-2046.1990; Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1; Sjoberg M, 2003, J VIROL, V77, P3441, DOI 10.1128/JVI.77.6.3441-3450.2003; Skoging U, 1996, STRUCTURE, V4, P519, DOI 10.1016/S0969-2126(96)00058-5; Skoging-Nyberg U, 2000, ARCH VIROL, V145, P1225, DOI 10.1007/s007050070121; STRAUSS JH, 1995, TRENDS MICROBIOL, V3, P346, DOI 10.1016/S0966-842X(00)88973-8; SUOMALAINEN M, 1992, J VIROL, V66, P4737, DOI 10.1128/JVI.66.8.4737-4747.1992; Tang JL, 2011, NATURE, V473, P414, DOI 10.1038/473414a; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TONG L, 1993, J MOL BIOL, V230, P228, DOI 10.1006/jmbi.1993.1139; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VAUX DJT, 1988, NATURE, V336, P36, DOI 10.1038/336036a0; WEISS B, 1989, J VIROL, V63, P5310, DOI 10.1128/JVI.63.12.5310-5318.1989; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang R, 2011, EMBO J, V30, P3854, DOI 10.1038/emboj.2011.261; ZHAO HX, 1994, EMBO J, V13, P4204, DOI 10.1002/j.1460-2075.1994.tb06740.x	58	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51288	10.1371/journal.pone.0051288	http://dx.doi.org/10.1371/journal.pone.0051288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251484	Green Published, gold			2022-12-27	WOS:000312386800039
J	Geller, J; Nazarova, L; Katargina, O; Jarvekulg, L; Fomenko, N; Golovljova, I				Geller, Julia; Nazarova, Lidia; Katargina, Olga; Jaervekuelg, Lilian; Fomenko, Natalya; Golovljova, Irina			Detection and Genetic Characterization of Relapsing Fever Spirochete Borrelia miyamotoi in Estonian Ticks	PLOS ONE			English	Article							IXODES-RICINUS TICKS; LYME-DISEASE AGENT; SP-NOV; VECTOR; PERSULCATUS; RUSSIA; TRANSMISSION; BURGDORFERI; PREVALENCE; DIVERSITY	During the years 2008-2010 I. ricinus and I. persulcatus ticks were collected from 64 sites in mainland Estonia and on the island Saaremaa. Presence of B. miyamotoi was found in 0.9% (23/2622) of ticks. The prevalence in I. persulcatus and I. ricinus ticks differed significantly, 2.7% (15/561) and 0.4% (8/2061), respectively. The highest prevalence rates were in found South-Eastern Estonia in an area of I. persulcatus and I. ricinus sympatry and varied from 1.4% (1/73) to 2.8% (5/178). Co-infections with B. burgdorferi s.l. group spirochetes and tick-borne encephalitis virus were also revealed. Genetic characterization of partial 16S rRNA, p66 and glpQ genes demonstrated that Estonian sequences belong to two types of B. miyamotoi and cluster with sequences from Europe and the European part of Russia, as well as with sequences from Siberia, Asia and Japan, here designated as European and Asian types, respectively. Estonian sequences of the European type were obtained from I. ricinus ticks only, whereas the Asian type of B. miyamotoi was shown for both tick species in the sympatric regions.	[Geller, Julia; Nazarova, Lidia; Katargina, Olga; Golovljova, Irina] Natl Inst Hlth Dev, Tallinn, Estonia; [Geller, Julia; Nazarova, Lidia; Jaervekuelg, Lilian] Tallinn Univ Technol, Fac Sci, Dept Gene Technol, Tallinn, Estonia; [Fomenko, Natalya] JSC VECTOR BEST, Novosibirsk, Russia; [Fomenko, Natalya] Inst Chem Biol & Fundamental Med SB RAS, Novosibirsk, Russia	National Institute for Health Development - Estonia; Tallinn University of Technology; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Geller, J (corresponding author), Natl Inst Hlth Dev, Tallinn, Estonia.	julia.geller@tai.ee	Geller, Julia/A-7889-2019	Geller, Julia/0000-0001-6496-9687	Estonian Science Foundation [ETF 8691]; Estonian Ministry of Education and Research [SF0940033s09]; European Regional Development Fund (Estonian Research Council) [ZoonRisk 3.2.1002.11-0002]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund (Estonian Research Council)	This work was supported by Estonian Science Foundation (www.hm.ee) (Grant ETF 8691), Estonian Ministry of Education and Research (www.etf.ee) (project SF0940033s09) and the European Regional Development Fund (Estonian Research Council (www.etag.ee), programme TerVE, project ZoonRisk 3.2.1002.11-0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AG, 2005, TICK-BORNE DISEASES OF HUMANS, P268; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Borgoiakov V, 2011, PARAZITOLOGIIA, V44, P543; Bunikis J, 2004, EMERG INFECT DIS, V10, P1661, DOI 10.3201/eid1009.040236; Caporale DA, 1995, MOL PHYLOGENET EVOL, V4, P361, DOI 10.1006/mpev.1995.1033; Davis S, 2011, J THEOR BIOL, V269, P96, DOI 10.1016/j.jtbi.2010.10.011; [Фоменко Н.В. Fomenko N.V.], 2010, [Молекулярная медицина, Molekulyarnaya meditsina], P28; Fomenko N V, 2011, Mol Gen Mikrobiol Virusol, P12; Fomenko N. V., 2010, Parazitologiya (St. Petersburg), V44, P201; Fraenkel CJ, 2002, J CLIN MICROBIOL, V40, P3308, DOI 10.1128/JCM.40.9.3308-3312.2002; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; FUKUNAGA M, 1995, FEMS MICROBIOL LETT, V134, P255, DOI 10.1111/j.1574-6968.1995.tb07947.x; Karan L. S., 2010, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P72; Korotkov Yu. S., 2008, Parazitologiya (St. Petersburg), V42, P441; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; PASTER BJ, 1991, J BACTERIOL, V173, P6101, DOI 10.1128/JB.173.19.6101-6109.1991; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Richter D, 2003, EMERG INFECT DIS, V9, P697; Richter D, 2012, VECTOR-BORNE ZOONOT, V12, P21, DOI 10.1089/vbz.2011.0668; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Scott MC, 2010, J MED ENTOMOL, V47, P1238, DOI 10.1603/ME10075; Skarpaas T, 2006, EMERG INFECT DIS, V12, P1136, DOI 10.3201/eid1207.051567; Steere AC, 2005, TICK-BORNE DISEASES OF HUMANS, P176; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10	27	65	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51914	10.1371/journal.pone.0051914	http://dx.doi.org/10.1371/journal.pone.0051914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251652	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800108
J	Li, HYS; Greeley, N; Sugimoto, N; Liu, YJ; Watowich, SS				Li, Haiyan S.; Greeley, Nathaniel; Sugimoto, Naoshi; Liu, Yong-Jun; Watowich, Stephanie S.			miR-22 Controls Irf8 mRNA Abundance and Murine Dendritic Cell Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2-2; IN-VIVO; SUBSET DEVELOPMENT; CUTTING EDGE; TARGET GENES; FLT3 LIGAND; STEM-CELLS; T-CELLS; EXPRESSION; MICRORNA	MicroRNAs (miRNAs) have emerged as critical regulators of many cellular responses, through the action of miRNA-induced silencing complex (miRISC)- or. miRNA ribonucleoprotein complex (miRNP)-mediated gene repression. Here we studied the role of miRNAs in the development of dendritic cells (DCs), an important immune cell type that is divided into conventional DC (cDC) and plasmacytoid DC (pDC) subsets. We found that miR-22 was highly expressed in mouse CD11c(+) CD11b(+) B220(-) cDCs compared to pDCs, and was induced in DC progenitor cell cultures with GM-CSF, which stimulate CD11c(+) CD11b(+) B220(-) cDC differentiation. Enforced overexpression of miR-22 during DC development enhanced CD11c(+) CD11b(+) B220(-) cDC generation at the expense of pDCs, while miR-22 knockdown demonstrated opposite effects. Moreover, overexpression and knockdown of miR-22 showed significant effects on the mRNA abundance of Irf8, which encodes the transcription factor IRF8 that plays essential roles in DC development. Luciferase reporter assays confirmed that miR-22 binds directly to the 3'UTR of the mouse Irf8 mRNA. Collectively, these results suggest that miR-22 targets Irf8 mRNA for posttranscriptional repression and controls DC subset differentiation.	[Li, Haiyan S.; Greeley, Nathaniel; Liu, Yong-Jun; Watowich, Stephanie S.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sugimoto, Naoshi; Liu, Yong-Jun] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX USA; [Greeley, Nathaniel; Watowich, Stephanie S.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Baylor Scott & White Health; Baylor University Medical Center; University of Texas System; University of Texas Health Science Center Houston	Li, HYS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	haiyanli@mdanderson.org; swatowic@mdanderson.org		Watowich, Stephanie/0000-0003-1969-659X	National Institutes of Health [AI073587, AI098099]; MD Anderson Center for Cancer Epigenetics; R.E. Bob Smith Education Fund; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098099, R21AI073587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Center for Cancer Epigenetics; R.E. Bob Smith Education Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI073587 and AI098099, SSW), the MD Anderson Center for Cancer Epigenetics (SSW), and the R.E. Bob Smith Education Fund (HSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Belver L, 2011, CURR OPIN IMMUNOL, V23, P368, DOI 10.1016/j.coi.2011.02.001; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuipers H, 2010, MOL IMMUNOL, V48, P333, DOI 10.1016/j.molimm.2010.07.007; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li HYS, 2012, J LEUKOCYTE BIOL, V92, P445, DOI 10.1189/jlb.0212052; Li HS, 2011, BLOOD, V118, P3879, DOI 10.1182/blood-2011-04-349761; Li HS, 2012, BLOOD IN PRESS; Li J, 2012, ONCOL REP, V27, P1835, DOI 10.3892/or.2012.1744; Li XQ, 2010, BRIT J HAEMATOL, V148, P69, DOI 10.1111/j.1365-2141.2009.07920.x; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2010, METHODS MOL BIOL, V595, P167, DOI 10.1007/978-1-60761-421-0_10; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; PAGLIA P, 1993, J EXP MED, V178, P1893, DOI 10.1084/jem.178.6.1893; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Seillet C, 2012, BLOOD, V119, P454, DOI 10.1182/blood-2011-08-371831; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Takata A, 2011, BIOCHEM BIOPH RES CO, V411, P826, DOI 10.1016/j.bbrc.2011.07.048; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tan GY, 2012, BIOCHEM BIOPH RES CO, V417, P546, DOI 10.1016/j.bbrc.2011.11.160; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Zanoni I, 2010, J MOL MED, V88, P873, DOI 10.1007/s00109-010-0638-x; Zhou L, 2009, P NATL ACAD SCI USA, V106, P10266, DOI 10.1073/pnas.0811119106	64	24	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52341	10.1371/journal.pone.0052341	http://dx.doi.org/10.1371/journal.pone.0052341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251709	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800161
J	Pichard, V; Aubert, D; Boni, S; Battaglia, S; Ivacik, D; Nguyen, TH; Arbuthnot, P; Ferry, N				Pichard, Virginie; Aubert, Dominique; Boni, Sebastien; Battaglia, Severine; Ivacik, Dejana; Tuan Huy Nguyen; Arbuthnot, Patrick; Ferry, Nicolas			Specific Micro RNA-Regulated TetR-KRAB Transcriptional Control of Transgene Expression in Viral Vector-Transduced Cells	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-I; GENE-TRANSFER; LENTIVIRAL VECTORS; IMMUNE-RESPONSE; MAMMALIAN-CELLS; HEMOPHILIA-A; MURINE MODEL; PROMOTERS; THERAPY; LIVER	Precise control of transgene expression in a tissue-specific and temporally regulated manner is desirable for many basic and applied investigations gene therapy applications. This is important to regulate dose of transgene products and minimize unwanted effects. Previously described methods have employed tissue specific promoters, miRNA-based transgene silencing or tetR-KRAB-mediated suppression of transgene promoters. To improve on versatility of transgene expression control, we have developed expression systems that use combinations of a tetR-KRAB artificial transgene-repressor, endogenous miRNA silencing machinery and tissue specific promoters. Precise control of transgene expression was demonstrated in liver-, macrophage- and muscle-derived cells. Efficiency was also demonstrated in vivo in murine muscle. This multicomponent and modular regulatory system provides a robust and easily adaptable method for achieving regulated transgene expression in different tissue types. The improved precision of regulation will be useful for many gene therapy applications requiring specific spatiotemporal transgene regulation.	[Pichard, Virginie; Boni, Sebastien; Tuan Huy Nguyen; Ferry, Nicolas] INSERM, Unite Mixte Rech UMR 948, Nantes, France; [Aubert, Dominique] INSERM, UMR 1089, Nantes, France; [Battaglia, Severine] INSERM, UMR 957, Nantes, France; [Pichard, Virginie; Tuan Huy Nguyen] INSERM, UMR 1064, Nantes, France; [Ivacik, Dejana; Arbuthnot, Patrick] Univ Witwatersrand, Sch Pathol, Antiviral Gene Therapy Res Unit, Johannesburg, South Africa	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Witwatersrand	Pichard, V (corresponding author), INSERM, Unite Mixte Rech UMR 948, Nantes, France.	Virginie.pichard@univ-nantes.fr	BATTAGLIA, Severine/K-8715-2015		Association Francaise contre les Myopathies (AFM) [RAE10092NNA]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by grants from the Association Francaise contre les Myopathies (AFM) (RAE10092NNA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Andrianaki A, 2010, GENE THER, V17, P380, DOI 10.1038/gt.2009.147; Aubert D, 2002, MOL THER, V5, P388, DOI 10.1006/mthe.2002.0561; Barde I, 2009, J VIROL, V83, P5574, DOI 10.1128/JVI.00001-09; Bovia F, 2003, BLOOD, V101, P1727, DOI 10.1182/blood-2001-12-0249; Brown BD, 2004, J THROMB HAEMOST, V2, P111, DOI 10.1111/j.1538-7836.2004.00552.x; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Di Domenico C, 2006, HUM GENE THER, V17, P1112; Di Domenico C, 2005, HUM GENE THER, V16, P81; Gao GP, 2009, HUM GENE THER, V20, P930, DOI 10.1089/hum.2009.060; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Greger IH, 1998, NUCLEIC ACIDS RES, V26, P1294, DOI 10.1093/nar/26.5.1294; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hoffman BE, 2011, MOL THER, V19, P1263, DOI 10.1038/mt.2011.33; Kootstra NA, 2003, MOL THER, V7, P623, DOI 10.1016/S1525-0016(03)00073-X; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Laurenti E, 2010, STEM CELLS, V28, P1390, DOI 10.1002/stem.460; Le Guiner C, 2007, CURR GENE THER, V7, P334; Matsui H, 2011, MOL THER, V19, P723, DOI 10.1038/mt.2010.290; Nicklin SA, 2001, HYPERTENSION, V38, P65, DOI 10.1161/01.HYP.38.1.65; Pastore L, 1999, HUM GENE THER, V10, P1773, DOI 10.1089/10430349950017455; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; Rittner K, 1997, J VIROL, V71, P3307, DOI 10.1128/JVI.71.4.3307-3311.1997; Schmitt F, 2010, GASTROENTEROLOGY, V139, P999, DOI 10.1053/j.gastro.2010.05.008; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200	33	15	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51952	10.1371/journal.pone.0051952	http://dx.doi.org/10.1371/journal.pone.0051952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251659	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800114
J	Wei, JCC; Hung, KS; Hsu, YW; Wong, RH; Huang, CH; Jan, MS; Wu, SJ; Juan, YS; Chang, WC				Wei, James Cheng-Chung; Hung, Kuo-Sheng; Hsu, Yu-Wen; Wong, Ruey-Hong; Huang, Chun-Huang; Jan, Ming-Shiou; Wu, Shyh-Jong; Juan, Yung-Shun; Chang, Wei-Chiao			Genetic Polymorphisms of Stromal Interaction Molecule 1 Associated with the Erythrocyte Sedimentation Rate and C-Reactive Protein in HLA-B27 Positive Ankylosing Spondylitis Patients	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; DISEASE-ACTIVITY; CANCER-CELLS; ACTIVATION; CHANNELS; STIM1; IMMUNODEFICIENCY; AUTOIMMUNITY; POPULATION; TAIWAN	Ankylosing spondylitis (AS) is a chronic inflammation of the sacroiliac joints, spine and peripheral joints. The development of ankylosing spondylitis is still unclear. Genetics factors such as human leukocyte antigen HLA-B27 and ERAP1 have been widely reported to associate to AS susceptibility. In this study, we enrolled 361 AS patients and selected four tagging single nucleotides polymorphisms (tSNPs) at STIM1 gene. The correlation between STIM1 genetic polymorphisms and AS activity index (BASDAI, BASFI, BAS-G) as well as laboratory parameters of inflammation (erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)) were tested. Our results indicated that HLA-B27 positive AS patients who are carrying the minor allele homozygous G/G genotype of SNP rs3750996 significantly associated with a higher level of ESR in serum. Furthermore, rs3750996/rs3750994 pairwise allele analysis indicated that G-C haplotypes also significantly correlated with higher level of ESR as well as CRP. These findings provide a better understanding of STIM1 genetic contribution to the pathogenesis of AS. Citation: Wei JC-C, Hung K-S, Hsu Y-W, Wong R-H, Huang C-H, et al. (2012) Genetic Polymorphisms of Stromal Interaction Molecule 1 Associated with the Erythrocyte Sedimentation Rate and C-Reactive Protein in HLA-B27 Positive Ankylosing Spondylitis Patients. PLoS ONE 7(12): e49698. doi:10.1371/journal.pone.0049698	[Hsu, Yu-Wen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Taichung, Taiwan; [Wei, James Cheng-Chung; Huang, Chun-Huang] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Med Ctr, Grad Inst Injury Prevent & Control, Ctr Excellence Clin Trial & Res,Dept Neurosurg, Taipei, Taiwan; [Wong, Ruey-Hong] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Jan, Ming-Shiou] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Wu, Shyh-Jong] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Juan, Yung-Shun] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Urol, Kaohsiung, Taiwan; [Juan, Yung-Shun] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei, Taiwan	Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw	Wei, James Cheng-Chung/AAL-8947-2020	Wei, James Cheng-Chung/0000-0002-1235-0679; Chang, Wei-Chiao/0000-0002-8573-5924				Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; BREWERTON DA, 1973, LANCET, V1, P904; Calin A, 1999, LANCET, V354, P1687, DOI 10.1016/S0140-6736(99)03219-5; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Chou CT, 2001, J IMMUNOL METHODS, V255, P15, DOI 10.1016/S0022-1759(01)00414-8; Chou YH, 2011, J UROLOGY, V185, P1742, DOI 10.1016/j.juro.2010.12.094; de Vries MK, 2009, ARTHRIT RHEUM-ARTHR, V61, P1484, DOI 10.1002/art.24838; Fedida-Metula S, 2012, CARCINOGENESIS, V33, P740, DOI 10.1093/carcin/bgs021; Feske S, 2011, ANN NY ACAD SCI, V1238, P74, DOI 10.1111/j.1749-6632.2011.06240.x; GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927; Guo ZS, 2010, INT J IMMUNOGENET, V37, P33, DOI 10.1111/j.1744-313X.2009.00889.x; Huang WC, 2011, CELL CALCIUM, V50, P27, DOI 10.1016/j.ceca.2011.04.004; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; Lee WY, 2010, TISSUE ANTIGENS, V75, P119, DOI 10.1111/j.1399-0039.2009.01411.x; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; McCarl CA, 2010, J IMMUNOL, V185, P5845, DOI 10.4049/jimmunol.1001796; Obermayer-Pietsch BM, 2003, OSTEOPOROSIS INT, V14, P995, DOI 10.1007/s00198-003-1501-5; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ruof J, 1999, J RHEUMATOL, V26, P966; Safrany E, 2009, SCAND J IMMUNOL, V70, P68, DOI 10.1111/j.1365-3083.2009.02265.x; vanderHeijde D, 1997, J RHEUMATOL, V24, P2225; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wang JY, 2012, CELL SIGNAL, V24, P162, DOI 10.1016/j.cellsig.2011.08.017; Wei JCC, 2007, CLIN RHEUMATOL, V26, P1685, DOI 10.1007/s10067-007-0573-6; Wei JCC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020426; Wei JCC, 2004, RHEUMATOLOGY, V43, P839, DOI 10.1093/rheumatology/keh193; Yildirim K, 2004, SOUTH MED J, V97, P350, DOI 10.1097/01.SMJ.0000066946.56322.3C	31	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49698	10.1371/journal.pone.0049698	http://dx.doi.org/10.1371/journal.pone.0049698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272049	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800007
J	Zhou, SM; Lyons, RA; Brophy, S; Gravenor, MB				Zhou, Shang-Ming; Lyons, Ronan A.; Brophy, Sinead; Gravenor, Mike B.			Constructing Compact Takagi-Sugeno Rule Systems: Identification of Complex Interactions in Epidemiological Data	PLOS ONE			English	Article							AREA-BASED DEPRIVATION; UNIVERSAL APPROXIMATION; EDUCATIONAL-ATTAINMENT; FUZZY; HEALTH; INTERPRETABILITY; CLASSIFIERS; SELECTION	The Takagi-Sugeno (TS) fuzzy rule system is a widely used data mining technique, and is of particular use in the identification of non-linear interactions between variables. However the number of rules increases dramatically when applied to high dimensional data sets (the curse of dimensionality). Few robust methods are available to identify important rules while removing redundant ones, and this results in limited applicability in fields such as epidemiology or bioinformatics where the interaction of many variables must be considered. Here, we develop a new parsimonious TS rule system. We propose three statistics: R, L, and omega-values, to rank the importance of each TS rule, and a forward selection procedure to construct a final model. We use our method to predict how key components of childhood deprivation combine to influence educational achievement outcome. We show that a parsimonious TS model can be constructed, based on a small subset of rules, that provides an accurate description of the relationship between deprivation indices and educational outcomes. The selected rules shed light on the synergistic relationships between the variables, and reveal that the effect of targeting specific domains of deprivation is crucially dependent on the state of the other domains. Policy decisions need to incorporate these interactions, and deprivation indices should not be considered in isolation. The TS rule system provides a basis for such decision making, and has wide applicability for the identification of non-linear interactions in complex biomedical data. Citation: Zhou S-M, Lyons RA, Brophy S, Gravenor MB (2012) Constructing Compact Takagi-Sugeno Rule Systems: Identification of Complex Interactions in Epidemiological Data. PLoS ONE 7(12): e51468. doi:10.1371/journal.pone.0051468	[Zhou, Shang-Ming; Lyons, Ronan A.; Brophy, Sinead; Gravenor, Mike B.] Swansea Univ, Coll Med, Ctr Hlth Informat Res & Evaluat, Swansea, W Glam, Wales	Swansea University	Zhou, SM (corresponding author), Swansea Univ, Coll Med, Ctr Hlth Informat Res & Evaluat, Swansea, W Glam, Wales.	smzhou@ieee.org	Zhou, Shang-Ming/A-8443-2008	Zhou, Shang-Ming/0000-0002-0719-9353; Lyons, Ronan/0000-0001-5225-000X; Brophy, Sinead/0000-0001-7417-2858	Wellcome Trust; ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson D., 1998, INDEPENDENT INQUIRY; Adams P, 2003, J ECONOMETRICS, V112, P3, DOI 10.1016/S0304-4076(02)00145-8; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; BEZDEK JC, 1995, NEURAL NETWORKS, V8, P729, DOI 10.1016/0893-6080(95)00024-T; Black SE, 2007, Q J ECON, V122, P409, DOI 10.1162/qjec.122.1.409; Blanc PD, 2006, EUR RESPIR J, V27, P85, DOI 10.1183/09031936.06.00061205; Blanden J, 2004, OXFORD REV ECON POL, V20, P245, DOI 10.1093/oxrep/grh014; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Gan Q, 1999, IEEE T SYST MAN CY B, V29, P559, DOI 10.1109/3477.775275; Gentle J. E., 1998, STATIST COMP, P87; Golub G. H., 1976, TR456 U MAR DEP COMP; Guillaume S, 2001, IEEE T FUZZY SYST, V9, P426, DOI 10.1109/91.928739; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; Rey MI, 2011, IEEE INT CONF FUZZY, P1271; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; KANJILAL PP, 1995, IEEE T NEURAL NETWOR, V6, P1061, DOI 10.1109/72.410351; Kiriakidis K., 1999, Proceedings of the 38th IEEE Conference on Decision and Control (Cat. No.99CH36304), P4361, DOI 10.1109/CDC.1999.833228; Laha A, 2001, IEEE T SYST MAN CY B, V31, P881, DOI 10.1109/3477.969492; Li CS, 2006, INT J COMPUT SCI NET, V6, P21; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Malacova E, 2008, AM J EPIDEMIOL, V168, P21, DOI 10.1093/aje/kwn085; MAMDANI EH, 1977, IEEE T COMPUT, V26, P1182, DOI 10.1109/TC.1977.1674779; Picciotto S, 2006, J EPIDEMIOL COMMUN H, V60, P37, DOI 10.1136/jech.2005.037846; Schools Analysis and Research Division D. F. C. S. A. F, 2009, DEPR ED EV PUP ENGL; Setnes M, 2001, IEEE T SYST MAN CY C, V31, P199, DOI 10.1109/5326.941843; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Steenland K, 2004, AM J EPIDEMIOL, V159, P1047, DOI 10.1093/aje/kwh129; Struthers AD, 2000, HEART, V83, P12, DOI 10.1136/heart.83.1.12; Tachibana K, 2002, INT J INTELL SYST, V17, P495, DOI 10.1002/int.10034; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399; Torra V, 2002, INT J INTELL SYST, V17, P531, DOI 10.1002/int.10036; Visweswaran S, 2010, J BIOMED INFORM, V43, P669, DOI 10.1016/j.jbi.2010.04.009; Wang D., 2006, INT J COMPUT COGN, V4, P18; Wang D, 2009, IEEE T FUZZY SYST, V17, P468, DOI 10.1109/TFUZZ.2009.2014940; Wang LX, 1998, FUZZY SET SYST, V93, P223, DOI 10.1016/S0165-0114(96)00197-2; Welsh Statistical Directorate, 2008, TECHNICAL REPORT; Yan SY, 2010, P AMER CONTR CONF, P6472; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90046-8; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhou SM, 2008, FUZZY SET SYST, V159, P3091, DOI 10.1016/j.fss.2008.05.016; Zhou SM, 2007, IEEE T FUZZY SYST, V15, P398, DOI 10.1109/TFUZZ.2006.882464; Zhou SM, 2009, IEEE T KNOWL DATA EN, V21, P1191, DOI 10.1109/TKDE.2008.208; Zhou SM, 2006, FUZZY SET SYST, V157, P1057, DOI 10.1016/j.fss.2005.08.004	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51468	10.1371/journal.pone.0051468	http://dx.doi.org/10.1371/journal.pone.0051468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23272108	Green Published, gold			2022-12-27	WOS:000312386800047
J	Borchers, S; Bremm, M; Lehrnbecher, T; Dammann, E; Pabst, B; Wolk, B; Esser, R; Yildiz, M; Eder, M; Stadler, M; Bader, P; Martin, H; Jarisch, A; Schneider, G; Klingebiel, T; Ganser, A; Weissinger, EM; Koehl, U				Borchers, Sylvia; Bremm, Melanie; Lehrnbecher, Thomas; Dammann, Elke; Pabst, Brigitte; Woelk, Benno; Esser, Ruth; Yildiz, Meral; Eder, Matthias; Stadler, Michael; Bader, Peter; Martin, Hans; Jarisch, Andrea; Schneider, Gisbert; Klingebiel, Thomas; Ganser, Arnold; Weissinger, Eva M.; Koehl, Ulrike			Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation	PLOS ONE			English	Article							CD8(+) T-LYMPHOCYTES; IFN-GAMMA CD8(+); SINGLE-PLATFORM; IMMUNE-RESPONSES; PP65 ANTIGENEMIA; PROTEIN PP65; RECONSTITUTION; RECIPIENTS; IDENTIFICATION; EPITOPE	Background: Reconstitution of cytomegalovirus- specific CD3(+) CD8(+) T cells (CMV-CTLs) after allogeneic hematopoietic stem cell transplantation (HSCT) is necessary to bring cytomegalovirus (CMV) reactivation under control. However, the parameters determining protective CMV-CTL reconstitution remain unclear to date. Design and Methods: In a prospective tri-center study, CMV-CTL reconstitution was analyzed in the peripheral blood from 278 patients during the year following HSCT using 7 commercially available tetrameric HLA-CMV epitope complexes. All patients included could be monitored with at least CMV-specific tetramer. Results: CMV-CTL reconstitution was detected in 198 patients (71%) after allogeneic HSCT. Most importantly, reconstitution with 1 CMV-CTL per mu l blood between day +50 and day +75 post-HSCT discriminated between patients with and without CMV reactivation in the R+/D+ patient group, independent of the CMV-epitope recognized. In addition, CMV-CTLs expanded more daramtaically in patients experiencing only one CMV-reactivation than those without or those with multiple CMV reactivations. Monitoring using at least 2 tetramers was possible in 63% (n = 176) of the patients. The combinations of particular HLA molecules influenced the numbers of CMV-CTLs detected. The highest CMV-CTL count obtained for an individual tetramer also changed over time in 11% of these patients (n = 19) resulting in higher levels of HLA-B*0801 (IE-1) recognizing CMV-CTLs in 14 patients. Conclusions: Our results indicate that 1 CMV-CTL per ml blood between day +50 to +75 marks the beginning of an immune response against CMV in the R+/D+ group. Detection of CMV-CTL expansion thereafter indicates successful resolution of the CMV reactivation. Thus, sequential monitoring of CMV-CTL reconstitution can be used to predict patients at risk for recurrent CMV reactivation. Citation: Borchers S, Bremm M, Lehrnbecher T, Dammann E, Pabst B, et al. (2012) Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation. PLoS ONE 7(12): e50248. doi:10.1371/journal.pone.0050248	[Bremm, Melanie; Lehrnbecher, Thomas; Esser, Ruth; Yildiz, Meral; Bader, Peter; Martin, Hans; Jarisch, Andrea; Klingebiel, Thomas; Koehl, Ulrike] Goethe Univ Frankfurt, Frankfurt, Germany; [Borchers, Sylvia; Dammann, Elke; Eder, Matthias; Stadler, Michael; Ganser, Arnold; Weissinger, Eva M.] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-3000 Hannover, Germany; [Pabst, Brigitte] Hannover Med Sch, Inst Human Genet, D-3000 Hannover, Germany; [Woelk, Benno] Hannover Med Sch, Inst Virol, D-3000 Hannover, Germany; [Schneider, Gisbert] Swiss Fed Inst Technol, Inst Pharmaceut Sci & Biostat, Zurich, Switzerland; [Koehl, Ulrike] Hannover Med Sch, Inst Cellular Therapeut, IFB Tx, D-3000 Hannover, Germany	Goethe University Frankfurt; Hannover Medical School; Hannover Medical School; Hannover Medical School; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hannover Medical School	Bremm, M (corresponding author), Goethe Univ Frankfurt, Frankfurt, Germany.	melanie.bremm@kgu.de; koehl.ulrike@mh-hannover.de		Koehl, Ulrike/0000-0002-8159-9160; Schneider, Gisbert/0000-0001-6706-1084	DZIF [23]; German Ministry of Education and Research [01EO0802]; DFG [GK1172]; Hilfe fur Krebskranke Kinder Frankfurt e.V.; Alfred and Angelika Gutermuth-Stiftung; Dieter-Schlag-Stiftung; OEWE Center for Cell and Gene Therapy Frankfurt (Hessisches Ministerium fur Wissenschaft und Kunst) [III L4-518/17.004, 2010]	DZIF; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Hilfe fur Krebskranke Kinder Frankfurt e.V.; Alfred and Angelika Gutermuth-Stiftung; Dieter-Schlag-Stiftung; OEWE Center for Cell and Gene Therapy Frankfurt (Hessisches Ministerium fur Wissenschaft und Kunst)	This work was supported in part by project 23 (DZIF), (EMW and M. Messerle, Institute of Virology, MHH) and by ref. number: 01EO0802 (IFB-Tx), both funded by the German Ministry of Education and Research. In addition, the work was supported by the GK1172 (DFG), by 'Hilfe fur Krebskranke Kinder Frankfurt e.V., the 'Alfred and Angelika Gutermuth-Stiftung', the Dieter-Schlag-Stiftung and by the LOEWE Center for Cell and Gene Therapy Frankfurt (Hessisches Ministerium fur Wissenschaft und Kunst, ref. number: III L4-518/17.004, 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2004, IMMUNOL LETT, V95, P199, DOI 10.1016/j.imlet.2004.07.010; Akiyama Y, 2002, IMMUNOL LETT, V83, P21, DOI 10.1016/S0165-2478(02)00073-1; Battiwalla M, 2007, BIOL BLOOD MARROW TR, V13, P765, DOI 10.1016/j.bbmt.2007.03.009; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Boeckh M, 1997, TRANSPLANTATION, V64, P108, DOI 10.1097/00007890-199707150-00020; Borchers S, 2011, TRANSPL INFECT DIS, V13, P222, DOI 10.1111/j.1399-3062.2011.00626.x; Brooimans RA, 2008, CYTOM PART A, V73A, P992, DOI 10.1002/cyto.a.20641; Brown JA, 2010, BLOOD, V115, P4111, DOI 10.1182/blood-2009-09-244145; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; Cantoni N, 2010, BIOL BLOOD MARROW TR; Chen FE, 2002, CYTOTHERAPY, V4, P41, DOI 10.1080/146532402317251518; Cwynarski K, 2001, BLOOD, V97, P1232, DOI 10.1182/blood.V97.5.1232; Gallez-Hawkins G, 2005, BIOL BLOOD MARROW TR, V11, P890, DOI 10.1016/j.bbmt.2005.07.008; Giest S, 2010, BRIT J HAEMATOL, V148, P311, DOI 10.1111/j.1365-2141.2009.07969.x; Gondo H, 2004, INT J HEMATOL, V80, P441, DOI 10.1532/IJH97.04109; Gratama JW, 2010, BLOOD, V116, P1655, DOI 10.1182/blood-2010-03-273508; Gratama JW, 2001, BLOOD, V98, P1358, DOI 10.1182/blood.V98.5.1358; Hebart H, 2004, HUM IMMUNOL, V65, P432, DOI 10.1016/j.humimm.2004.02.022; Heijnen IAFM, 2004, CYTOM PART B-CLIN CY, V62B, P1, DOI 10.1002/cyto.b.20028; Khan N, 2007, J IMMUNOL, V178, P4455, DOI 10.4049/jimmunol.178.7.4455; Koehl U, 2008, KLIN PADIATR, V220, P348, DOI 10.1055/s-0028-1086029; Koehl U, 2008, INT J HEMATOL, V87, P98, DOI 10.1007/s12185-007-0018-7; Koenig M, 2010, BONE MARROW TRANSPL, V45, P613, DOI 10.1038/bmt.2009.204; Lacey SF, 2003, HUM IMMUNOL, V64, P440, DOI 10.1016/S0198-8859(03)00028-4; Lilleri D, 2009, CLIN IMMUNOL, V131, P395, DOI 10.1016/j.clim.2009.02.002; Lilleri D, 2009, J INFECT DIS, V199, P829, DOI 10.1086/597123; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Ljungman P, 2006, HAEMATOLOGICA, V91, P78; Masuoka M, 2001, VIRAL IMMUNOL, V14, P369, DOI 10.1089/08828240152716619; Mori T, 2010, INT J HEMATOL, V91, P588, DOI 10.1007/s12185-010-0569-x; Morita Y, 2005, BONE MARROW TRANSPL, V36, P803, DOI 10.1038/sj.bmt.1705133; Olkinuora HA, 2010, PEDIATR TRANSPLANT, V14, P242, DOI 10.1111/j.1399-3046.2009.01226.x; Provenzano M, 2002, J IMMUNOTHER, V25, P342, DOI 10.1097/00002371-200207000-00006; Sacre K, 2008, J VIROL, V82, P10143, DOI 10.1128/JVI.00688-08; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Tormo N, 2010, BONE MARROW TRANSPL, V45, P543, DOI 10.1038/bmt.2009.172; Tormo N, 2010, J MED VIROL, V82, P1208, DOI 10.1002/jmv.21799; Torres HA, 2008, CLIN MICROBIOL INFEC, V14, P1160, DOI 10.1111/j.1469-0691.2008.02106.x; van Burik JAH, 2007, BIOL BLOOD MARROW TR, V13, P1487, DOI 10.1016/j.bbmt.2007.08.049; Verboom M, 2007, TISSUE ANTIGENS, V70, P338, DOI 10.1111/j.1399-0039.2007.00919.x; Yao JX, 2008, CLIN INFECT DIS, V46, pE96, DOI 10.1086/587749	41	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50248	10.1371/journal.pone.0050248	http://dx.doi.org/10.1371/journal.pone.0050248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272059	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386600010
J	Howman, RA; Charles, AK; Jacques, A; Doherty, DA; Simmer, K; Strunk, T; Richmond, PC; Cole, CH; Burgner, DP				Howman, Rebecca A.; Charles, Adrian K.; Jacques, Angela; Doherty, Dorota A.; Simmer, Karen; Strunk, Tobias; Richmond, Peter C.; Cole, Catherine H.; Burgner, David P.			Inflammatory and Haematological Markers in the Maternal, Umbilical Cord and Infant Circulation in Histological Chorioamnionitis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PRETERM PREMATURE RUPTURE; PROCALCITONIN; INFECTION; BLOOD; SERUM; BIRTH	Background: The relationship between histological chorioamnionitis and haematological and biochemical markers in mothers and infants at delivery, and in infants postnatally, is incompletely characterised. These markers are widely used in the diagnosis of maternal and neonatal infection. Our objective was to investigate the effects of histological chorioamnionitis (HCA) on haematological and biochemical inflammatory markers in mothers and infants at delivery, and in infants post-delivery. Methods: Two hundred and forty seven mothers, delivering 325 infants, were recruited at the only tertiary perinatal centre in Western Australia. Placentae were assessed for evidence of HCA using a semi-quantitative scoring system. Maternal high sensitivity C-reactive protein (hsCRP), procalcitonin, and umbilical cord hsCRP, procalcitonin, white cell count and absolute neutrophil count were measured at delivery. In infants where sepsis was clinically suspected, postnatal CRP, white cell count and absolute neutrophil count were measured up to 48 hours of age. The effect of HCA on maternal, cord and neonatal markers was evaluated by multivariable regression analysis. Results: The median gestational age was 34 weeks and HCA was present in 26 of 247 (10.5%) placentae. Mothers whose pregnancies were complicated by HCA had higher hsCRP (median 26 (range 2-107) versus 5.6 (0-108) mg/L; P<0.001). Histological chorioamnionitis was associated with higher umbilical cord hsCRP (75th percentile 2.91 mg/L (range 0-63.9) versus 75th percentile 0 mg/L (0-45.6); P<0.001) and procalcitonin (median 0.293 (range 0.05-27.37) versus median 0.064 (range 0.01-5.24) ug/L; P<0.001), with a sustained increase in neonatal absolute neutrophil count (median 4.5 (0.1-26.4) x 10(9)/L versus 3.0 (0.1-17.8) x 10(9)/L), and CRP up to 48 hours post-partum (median 10 versus 6.5 mg/L) (P<0.05 for each). Conclusion: Histological chorioamnionitis is associated with modest systemic inflammation in maternal and cord blood. These systemic changes may increase postnatally, potentially undermining their utility in the diagnosis of early-onset neonatal infection.	[Howman, Rebecca A.; Charles, Adrian K.; Simmer, Karen; Strunk, Tobias; Richmond, Peter C.; Cole, Catherine H.; Burgner, David P.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Charles, Adrian K.; Jacques, Angela] Women & Infants Res Fdn, Perth, WA, Australia; [Doherty, Dorota A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Burgner, David P.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Burgner, David P.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	University of Western Australia; University of Western Australia; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Burgner, DP (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	david.burgner@mcri.edu.au	Strunk, Tobias/AIE-3407-2022; Simmer, Karen N/H-5834-2014; Richmond, Peter C/G-3379-2012	Strunk, Tobias/0000-0001-7079-2339; Richmond, Peter C/0000-0001-7562-7228; Burgner, David/0000-0002-8304-4302; Jacques, Angela/0000-0002-0461-681X; Charles, Adrian/0000-0002-3193-1065; Simmer, Karen/0000-0003-4777-9069	Princess Margaret Hospital Foundation; Women and Infant's Research Foundation Western Australia; Clive and Vera Ramaciotti Medical Research Foundation; University of Western Australia; Rebecca Cooper Medical Research Foundation; Channel 7 Telethon; European Society for Paediatric Infectious Diseases; National Health and Medical Research Council Australia [572548]; Deutsche Forschungsgemeinschaft [STR1022/1-1]; National Health and Medical Research Council Clinical Career Development Fellowship; Victorian Government's Operational Infrastructure Support Program	Princess Margaret Hospital Foundation; Women and Infant's Research Foundation Western Australia; Clive and Vera Ramaciotti Medical Research Foundation; University of Western Australia; Rebecca Cooper Medical Research Foundation; Channel 7 Telethon; European Society for Paediatric Infectious Diseases; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council Clinical Career Development Fellowship; Victorian Government's Operational Infrastructure Support Program	The project was funded by Princess Margaret Hospital Foundation, Women and Infant's Research Foundation Western Australia, Clive and Vera Ramaciotti Medical Research Foundation, University of Western Australia, Rebecca Cooper Medical Research Foundation, Channel 7 Telethon, European Society for Paediatric Infectious Diseases and the National Health and Medical Research Council Australia (Project grant #572548). TS was supported by a Research Fellowship of the Deutsche Forschungsgemeinschaft (STR1022/1-1) and an International Postgraduate Research Scholarship of the University of Western Australia. DPB is supported by a National Health and Medical Research Council Clinical Career Development Fellowship and the research was supported by the Victorian Government's Operational Infrastructure Support Program. BRAHMS (Thermo Fisher Scientific) provided the procalcitonin assays without charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; BARAK M, 1992, ACTA PAEDIATR, V81, P760, DOI 10.1111/j.1651-2227.1992.tb12098.x; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; Becker KL, 2008, CRIT CARE MED, V36, P941, DOI 10.1097/CCM.0B013E318165BABB; Czikk MJ, 2011, CLIN MICROBIOL INFEC, V17, P1304, DOI 10.1111/j.1469-0691.2011.03574.x; De Dooy J, 2003, PEDIATR RES, V54, P113, DOI 10.1203/01.PDR.0000069702.25801.D1; DEVILLIERS WJ, 1990, BRIT J OBSTET GYNAEC, V97, P725, DOI 10.1111/j.1471-0528.1990.tb16247.x; FISK NM, 1987, BRIT J OBSTET GYNAEC, V94, P1159, DOI 10.1111/j.1471-0528.1987.tb02316.x; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Greksova K, 2009, BRATISL MED J, V110, P623; Hecht JL, 2011, PEDIATR RES, V69, P68, DOI 10.1203/PDR.0b013e3181fed334; ISAACS D, 1995, MED J AUSTRALIA, V162, P198, DOI 10.5694/j.1326-5377.1995.tb126024.x; Jackson GL, 2004, PEDIATRICS, V113, P1173, DOI 10.1542/peds.113.5.1173; Janota J, 2001, EUR J CLIN INVEST, V31, P978, DOI 10.1046/j.1365-2362.2001.00912.x; Kordek A, 2008, CLIN CHEM LAB MED, V46, P1143, DOI 10.1515/CCLM.2008.214; Loukovaara MJ, 2003, EUR J OBSTET GYN R B, V110, P26, DOI 10.1016/S0301-2115(03)00084-8; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Miyano A, 1998, PEDIATR DEVEL PATHOL, V1, P513, DOI 10.1007/s100249900070; Nagamatsu T, 2009, HUM REPROD, V24, P3160, DOI 10.1093/humrep/dep308; Nijsten MWN, 2000, CRIT CARE MED, V28, P458, DOI 10.1097/00003246-200002000-00028; Oh KJ, 2011, PLACENTA, V32, P732, DOI 10.1016/j.placenta.2011.07.080; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Simon P, 2008, CRIT CARE, V12, DOI 10.1186/cc7124; Skogstrand K, 2008, OBSTET GYNECOL, V111, P1118, DOI 10.1097/AOG.0b013e31817057fb; Smulian JC, 1999, OBSTET GYNECOL, V94, P1000, DOI 10.1016/S0029-7844(99)00416-0; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Trochez-Martinez RD, 2007, BJOG-INT J OBSTET GY, V114, P796, DOI 10.1111/j.1471-0528.2007.01385.x; van de Beek C, 2004, HORM BEHAV, V46, P663, DOI 10.1016/j.yhbeh.2004.06.010; van Rossum AMC, 2004, LANCET INFECT DIS, V4, P620, DOI 10.1016/S1473-3099(04)01146-6; Yoon B H, 2003, J Matern Fetal Neonatal Med, V14, P85	35	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51836	10.1371/journal.pone.0051836	http://dx.doi.org/10.1371/journal.pone.0051836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272177	Green Published, gold			2022-12-27	WOS:000312386600044
J	Edwards, S; Vanhooydonck, B; Herrel, A; Measey, GJ; Tolley, KA				Edwards, Shelley; Vanhooydonck, Bieke; Herrel, Anthony; Measey, G. John; Tolley, Krystal A.			Convergent Evolution Associated with Habitat Decouples Phenotype from Phylogeny in a Clade of Lizards	PLOS ONE			English	Article							HEAD SHAPE EVOLUTION; LACERTID LIZARDS; DWARF CHAMELEONS; MICROHABITAT USE; DNA SEQUENCES; BRADYPODION; SPEED; PERFORMANCE; SQUAMATA; POPULATIONS	Convergent evolution can explain similarity in morphology between species, due to selection on a fitness-enhancing phenotype in response to local environmental conditions. As selective pressures on body morphology may be strong, these have confounded our understanding of the evolutionary relationships between species. Within the speciose African radiation of lacertid lizards (Eremiadini), some species occupy a narrow habitat range (e. g. open habitat, cluttered habitat, strictly rupicolous, or strictly psammophilic), which may exert strong selective pressures on lizard body morphology. Here we show that the overall body plan is unrelated to shared ancestry in the African radiation of Eremiadini, but is instead coupled to habitat use. Comprehensive Bayesian and likelihood phylogenies using multiple representatives from all genera (2 nuclear, 2 mitochondrial markers) show that morphologically convergent species thought to represent sister taxa within the same genus are distantly related evolutionary lineages (Ichnotropis squamulosa and Ichnotropis spp.; Australolacerta rupicola and A. australis). Hierarchical clustering and multivariate analysis of morphological characters suggest that body, and head, width and height (stockiness), all of which are ecologically relevant with respect to movement through habitat, are similar between the genetically distant species. Our data show that convergence in morphology, due to adaptation to similar environments, has confounded the assignment of species leading to misidentification of the taxonomic position of I. squamulosa and the Australolacerta species.	[Edwards, Shelley; Measey, G. John; Tolley, Krystal A.] S African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, South Africa; [Edwards, Shelley; Tolley, Krystal A.] Univ Stellenbosch, Dept Bot & Zool, Matieland, South Africa; [Vanhooydonck, Bieke] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Herrel, Anthony] UMR 7179 CNRS MNHN, Dept Ecol & Gest Biodivers, Paris, France; [Measey, G. John] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa	South African National Biodiversity Institute; Stellenbosch University; University of Antwerp; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Nelson Mandela University	Edwards, S (corresponding author), S African Natl Biodivers Inst, Appl Biodivers Res Div, Cape Town, South Africa.	s.edwards@sanbi.org.za	Herrel, Anthony/C-3712-2013; Edwards, Shelley/AAV-9259-2021; Tolley, Krystal A/D-9738-2011; Measey, John/F-2028-2010	Herrel, Anthony/0000-0003-0991-4434; Edwards, Shelley/0000-0002-0962-6523; Measey, John/0000-0001-9939-7615; Tolley, Krystal/0000-0002-7778-1963	National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative-SABI, Key International Science Collaboration-KISC); International Foundation of Science (IFS) of Sweden [D/5009-1]; Oppenheimer Sons; NRF [74973]; SABI	National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative-SABI, Key International Science Collaboration-KISC); International Foundation of Science (IFS) of Sweden; Oppenheimer Sons; NRF; SABI	The authors thank the National Research Foundation (NRF) of South Africa (South African Biosystematics Initiative-SABI, Key International Science Collaboration-KISC) and the International Foundation of Science (IFS) of Sweden (D/5009-1) and Oppenheimer & Sons for funding this work. SE was supported by NRF Free-standing (Grant no: 74973) and SABI Grant-holder linked bursaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold E.N., 2004, P11; Arnold E.N., 1989, Bulletin of the British Museum (Natural History) Zoology, V55, P209; ARNOLD EN, 1995, J ZOOL, V235, P351, DOI 10.1111/j.1469-7998.1995.tb01758.x; Arnold EN, 2002, J MORPHOL, V252, P145, DOI 10.1002/jmor.1096; ARNOLD EN, 1994, PHILOS T ROY SOC B, V344, P277, DOI 10.1098/rstb.1994.0066; Barros FC, 2011, J EVOLUTION BIOL, V24, P2423, DOI 10.1111/j.1420-9101.2011.02372.x; Bauer AM, 2005, AFR J HERPETOL, V54, P105, DOI 10.1080/21564574.2005.9635525; Bauer AM, 1993, BIOL RELATIONSHIPS A, P245; BAUWENS D, 1995, EVOLUTION, V49, P848, DOI 10.1111/j.1558-5646.1995.tb02321.x; Becker R, 1988, COMPUTER SCI SERIES; Bonine KE, 1999, J ZOOL, V248, P255, DOI 10.1111/j.1469-7998.1999.tb01201.x; BRANCH W, 1998, FIELD GUIDE SNAKES O, P160; Branch WR, 2006, BIODIVERSITY SERIES, V5; BROADLEY DG, 1979, S AFR J ZOOL, V14, P133; Bruford Michael W., 1992, P225; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fitzsimons Vivian F., 1943, TRANSVAAL MUS MEM, V1, P1; Gifford ME, 2003, HERPETOLOGICAL NATUR, V9, P15; Glor RE, 2003, EVOLUTION, V57, P2383; Goldberg SR, 2008, TEX J SCI, V60, P1; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harmon LJ, 2005, EVOLUTION, V59, P409; Harris DJ, 1998, P ROY SOC B-BIOL SCI, V265, P1939, DOI 10.1098/rspb.1998.0524; Herrel A, 2002, BIOL J LINN SOC, V77, P149, DOI 10.1046/j.1095-8312.2002.00101.x; Herrel A, 2011, BIOL J LINN SOC, V104, P692, DOI 10.1111/j.1095-8312.2011.01764.x; Herrel Anthony, 2011, Breviora, P1; Herrel Anthony, 2008, Bulletin of the Museum of Comparative Zoology, V159, P213, DOI 10.3099/0027-4100-159.4.213; Hopkins KP, 2011, BIOL J LINN SOC, V102, P878, DOI 10.1111/j.1095-8312.2011.01618.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irschick DJ, 2008, EVOL ECOL RES, V10, P177; Jacobsen N.H.G., 1987, Journal of the Herpetological Association of Africa, V33, P13; Kapli Paschalia, 2011, Basic and Applied Herpetology, V25, P97; Kearney M, 2004, P ROY SOC B-BIOL SCI, V271, P1677, DOI 10.1098/rspb.2004.2771; Kohlsdorf T, 2008, J EVOLUTION BIOL, V21, P781, DOI 10.1111/j.1420-9101.2008.01516.x; Leache Adam D., 2009, Bonner Zoologische Beitraege, V56, P273; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Losos JB, 2002, ANIM BEHAV, V64, P313, DOI 10.1006/anbe.2002.3051; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Mayer W, 2007, MOL PHYLOGENET EVOL, V44, P1155, DOI 10.1016/j.ympev.2007.05.015; Measey GJ, 2009, ZOOLOGY, V112, P217, DOI 10.1016/j.zool.2008.09.005; Melville J, 2000, BIOL J LINN SOC, V70, P667; Palumbi Stephen R., 1996, P205; Portik DM, 2012, CONSERV GENET RESOUR, V4, P1, DOI 10.1007/s12686-011-9460-1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER VERSION 1 5 C; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Revell LJ, 2007, EVOLUTION, V61, P2898, DOI 10.1111/j.1558-5646.2007.00225.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stayton CT, 2006, EVOLUTION, V60, P824; Suzuki R, 2004, 15 INT C GEN INF, P34; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Templeton AR, 1996, EVOLUTION, V50, P909, DOI 10.1111/j.1558-5646.1996.tb03899.x; Tolley KA, 2006, MOL ECOL, V15, P781, DOI 10.1111/j.1365-294X.2006.02836.x; Tolley KA, 2004, MOL PHYLOGENET EVOL, V30, P354, DOI 10.1016/S1055-7903(03)00211-2; Tolley KA, 2008, J BIOGEOGR, V35, P1402, DOI 10.1111/j.1365-2699.2008.01889.x; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Townsend TM, 2011, BIOL LETTERS, V7, P225, DOI 10.1098/rsbl.2010.0701; Vanhooydonck B, 1999, EVOL ECOL RES, V1, P785; Vanhooydonck B, 2002, J EXP BIOL, V205, P1037; Vanhooydonck B, 2001, EVOLUTION, V55, P1040, DOI 10.1554/0014-3820(2001)055[1040:SASTOI]2.0.CO;2; Vitt LJ, 1997, P NATL ACAD SCI USA, V94, P3828, DOI 10.1073/pnas.94.8.3828; Whiting AS, 2003, MOL PHYLOGENET EVOL, V29, P582, DOI 10.1016/S1055-7903(03)00142-8; Wiens JJ, 2001, EVOLUTION, V55, P2303; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	75	32	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51636	10.1371/journal.pone.0051636	http://dx.doi.org/10.1371/journal.pone.0051636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251601	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200152
J	Groger, CJ; Grubinger, M; Waldhor, T; Vierlinger, K; Mikulits, W				Groeger, Christian J.; Grubinger, Markus; Waldhoer, Thomas; Vierlinger, Klemens; Mikulits, Wolfgang			Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer Progression	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LEUKOCYTE PROTEASE INHIBITOR; SQUAMOUS-CELL; IN-VITRO; CARCINOMA-CELLS; TUMOR INVASION; EMT; METASTASIS; MIGRATION; RUNX2	The epithelial to mesenchymal transition (EMT) represents a crucial event during cancer progression and dissemination. EMT is the conversion of carcinoma cells from an epithelial to a mesenchymal phenotype that associates with a higher cell motility as well as enhanced chemoresistance and cancer stemness. Notably, EMT has been increasingly recognized as an early event of metastasis. Numerous gene expression studies (GES) have been conducted to obtain transcriptome signatures and marker genes to understand the regulatory mechanisms underlying EMT. Yet, no meta-analysis considering the multitude of GES of EMT has been performed to comprehensively elaborate the core genes in this process. Here we report the meta-analysis of 18 independent and published GES of EMT which focused on different cell types and treatment modalities. Computational analysis revealed clustering of GES according to the type of treatment rather than to cell type. GES of EMT induced via transforming growth factor-beta and tumor necrosis factor-alpha treatment yielded uniformly defined clusters while GES of models with alternative EMT induction clustered in a more complex fashion. In addition, we identified those up-and downregulated genes which were shared between the multitude of GES. This core gene list includes well known EMT markers as well as novel genes so far not described in this process. Furthermore, several genes of the EMT-core gene list significantly correlated with impaired pathological complete response in breast cancer patients. In conclusion, this meta-analysis provides a comprehensive survey of available EMT expression signatures and shows fundamental insights into the mechanisms that are governing carcinoma progression.	[Groeger, Christian J.; Grubinger, Markus; Mikulits, Wolfgang] Med Univ Vienna, Ctr Comprehens Canc, Div Inst Canc Res, Dept Med 1, Vienna, Austria; [Waldhoer, Thomas] Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria; [Vierlinger, Klemens] Austrian Inst Technol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Austrian Institute of Technology (AIT)	Mikulits, W (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Div Inst Canc Res, Dept Med 1, Vienna, Austria.	wolfgang.mikulits@meduniwien.ac.at	Mikulits, Wolfgang/AAH-4043-2021	Mikulits, Wolfgang/0000-0003-4612-7106	European Union [HEALTH-F4-2008-202047]	European Union(European Commission)	This work was supported by the European Union, FP7 Health Research, project number HEALTH-F4-2008-202047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiano NO, 2012, J CELL PHYSL; Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Chen LM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-377; Chimge NO, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3073; Choi BD, 2011, INT J MOL MED, V28, P527, DOI 10.3892/ijmm.2011.726; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Chou RH, 2012, ONCOL REP, V27, P238, DOI 10.3892/or.2011.1497; Day A, 2007, HEATMAP PLUS HEATMAP; Diamandis EP, 2011, CLIN CANCER RES, V17, P2395, DOI 10.1158/1078-0432.CCR-10-3024; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay ED, 1995, ACTA ANAT, V154, P8; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hills CE, 2010, MOL ENDOCRINOL, V24, P822, DOI 10.1210/me.2009-0391; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Junnila S, 2010, GENE CHROMOSOME CANC, V49, P28, DOI 10.1002/gcc.20715; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Ke XS, 2011, EXP CELL RES, V317, P234, DOI 10.1016/j.yexcr.2010.10.009; Kuk C, 2010, CLIN BIOCHEM, V43, P355, DOI 10.1016/j.clinbiochem.2009.10.012; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Lascorz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018867; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Leshem O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021650; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Mandal S, 2011, CANCER-AM CANCER SOC, V117, P5509, DOI 10.1002/cncr.26219; Marr HS, 2003, MATRIX BIOL, V22, P259, DOI 10.1016/S0945-053X(03)00036-2; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Micalizzi DS, 2010, CANCER RES, V70, P10371, DOI 10.1158/0008-5472.CAN-10-1354; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Nakada M, 2001, CANCER RES, V61, P8896; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Papageorgis P, 2010, CANCER RES, V70, P968, DOI 10.1158/0008-5472.CAN-09-1872; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Sung YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007445; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Talieri M, 2011, TUMOR BIOL, V32, P737, DOI 10.1007/s13277-011-0175-4; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tay PN, 2010, INT J ONCOL, V37, P909, DOI 10.3892/ijo_00000742; Thernau T, 2012, PACKAGE SURVIVAL ANA; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; van Zijl F, 2011, MOL CANCER THER, V10, P850, DOI 10.1158/1535-7163.MCT-10-0917; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Warnes G., 2011, GDATA VARIOUS R PROG; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Wen J, 2011, AM J PATHOL, V178, P2866, DOI 10.1016/j.ajpath.2011.02.017; Yamamoto H, 2011, BIOL PHARM BULL, V34, P324, DOI 10.1248/bpb.34.324; Yamamoto H, 2009, BIOL PHARM BULL, V32, P1148, DOI 10.1248/bpb.32.1148; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	70	110	111	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51136	10.1371/journal.pone.0051136	http://dx.doi.org/10.1371/journal.pone.0051136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251436	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900045
J	Linnerth-Petrik, NM; Santry, LA; Yu, DL; Wootton, SK				Linnerth-Petrik, Nicolle M.; Santry, Lisa A.; Yu, Darrick L.; Wootton, Sarah K.			Adeno-Associated Virus Vector Mediated Expression of an Oncogenic Retroviral Envelope Protein Induces Lung Adenocarcinomas in Immunocompetent Mice	PLOS ONE			English	Article							JAAGSIEKTE SHEEP RETROVIRUS; GROWTH-FACTOR RECEPTOR; HUMAN BRONCHIOLOALVEOLAR CARCINOMA; P38-ALPHA MAP KINASE; CELL-PROLIFERATION; PROGNOSTIC-SIGNIFICANCE; INDUCED TRANSFORMATION; SIGNAL TRANSDUCER; RODENT FIBROBLAST; CYTOPLASMIC TAIL	Lung cancer is the most common cause of cancer-related death worldwide. A poor overall survival rate of 16% necessitates the need for novel treatment strategies. Mouse models of lung cancer are important tools for analyzing the significance of somatic mutations in the initiation and progression of lung cancer. Of additional importance, however, are animal models of virally induced cancers. JSRV is a simple betaretrovirus that causes contagious lung cancer in sheep known as ovine pulmonary adenocarcinoma and closely resembles human lung adenocarcinoma. Previously we showed that expression of the JSRV envelope (Env) from an AAV vector induced lung tumors in immunodeficient mice, but not in immunocompetent mice. Because of the importance of studying lung cancer in the context of an intact immune system we sought to improve our mouse model. In this report, we employed the use of a strong JSRV enhancer-promoter combination to express Env at high levels and demonstrate for the first time, lung tumor induction in immunocompetent mice. This occurred despite a robust Env-specific antibody-mediated immune response. The PI3K/Akt and MAPK pathways were activated in both immunocompetent and immunodeficient mice, however, differential activation of PTEN, GSK alpha, p70S6K, p38MAPK, ATF2 and STAT5 was observed. A JSRV Env lung tumor-derived cell line was shown to have a similar signal transduction activation profile as Env-induced lung tumors in C57BL/6 mice. Given the similarities between our model and pulmonary adenocarcinomas in humans, and the ease with which tumors can be induced in any transgenic mouse, this system can be used to uncover novel mechanisms involved lung tumorigenesis.	[Linnerth-Petrik, Nicolle M.; Santry, Lisa A.; Yu, Darrick L.; Wootton, Sarah K.] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada	University of Guelph	Wootton, SK (corresponding author), Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada.	kwootton@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Cancer Research Society (CRS); Canada Foundation for Innovation Leader's Opportunity Fund (CFI LOF); Ontario Veterinary College (OVC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cancer Research Society (CRS); Canada Foundation for Innovation Leader's Opportunity Fund (CFI LOF)(Canada Foundation for Innovation); Ontario Veterinary College (OVC)	This work was supported by funding from the Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca/index_eng. asp), the Cancer Research Society (CRS; http://www.src-crs.ca/en-CA), and the Canada Foundation for Innovation Leader's Opportunity Fund (CFI LOF; http://www.innovation.ca/OurFunds/CFIFunds/LeadersOpportunityFund). DLY and LAS were supported by Ontario Veterinary College (OVC) PhD and MSc Fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Allen JM, 2000, MOL THER, V1, P88, DOI 10.1006/mthe.1999.0010; Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brown JR, 2004, CLIN CANCER RES, V10, p4266S, DOI 10.1158/1078-0432.CCR-040014; Caporale M, 2006, J VIROL, V80, P8030, DOI 10.1128/JVI.00474-06; Castelao JE, 2003, ANN THORAC SURG, V76, P1327, DOI 10.1016/S0003-4975(03)00334-5; Chitra E, 2009, VIROLOGY, V393, P120, DOI 10.1016/j.virol.2009.07.023; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dakessian RM, 2007, VIRUS GENES, V35, P73, DOI 10.1007/s11262-006-0031-6; Dalwadi H, 2005, CLIN CANCER RES, V11, P7674, DOI 10.1158/1078-0432.CCR-05-1205; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De las Heras M, 2000, EUR RESPIR J, V16, P330, DOI 10.1034/j.1399-3003.2000.16b23.x; De las Heras M, 2006, J COMP PATHOL, V135, P1, DOI 10.1016/j.jcpa.2006.02.002; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Ganti AK, 2010, CANCER INVEST, V28, P515, DOI 10.3109/07357900903476760; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Griffiths DJ, 2010, J COMP PATHOL, V142, P260, DOI 10.1016/j.jcpa.2009.12.013; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Hull S, 2006, J VIROL, V80, P8069, DOI 10.1128/JVI.00013-06; Johnson C, 2010, J VIROL, V84, P5379, DOI 10.1128/JVI.02323-09; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; LACKNER AA, 1988, J VIROL, V62, P2134, DOI 10.1128/JVI.62.6.2134-2142.1988; Liu SL, 2005, J VIROL, V79, P927, DOI 10.1128/JVI.79.2.927-933.2005; Liu SL, 2003, J VIROL, V77, P7924, DOI 10.1128/JVI.77.14.7924-7935.2003; Maeda N, 2005, J VIROL, V79, P4440, DOI 10.1128/JVI.79.7.4440-4450.2005; Marsit CJ, 2005, HUM PATHOL, V36, P768, DOI 10.1016/j.humpath.2005.05.006; Mornex JF, 2003, CURR TOP MICROBIOL, V275, P225; Mountzios G, 2008, CLIN CANCER RES, V14, P4096, DOI 10.1158/1078-0432.CCR-07-4150; Palmarini M, 1999, J VIROL, V73, P6964, DOI 10.1128/JVI.73.8.6964-6972.1999; Palmarini M, 2001, J VIROL, V75, P11002, DOI 10.1128/JVI.75.22.11002-11009.2001; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; Rocca S, 2008, HUM PATHOL, V39, P303, DOI 10.1016/j.humpath.2007.10.008; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarid R, 2011, CANCER LETT, V305, P218, DOI 10.1016/j.canlet.2010.09.011; Schlecht-Louf G, 2010, P NATL ACAD SCI USA, V107, P3782, DOI 10.1073/pnas.0913122107; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Suau F, 2006, EUR RESPIR J, V27, P1175, DOI 10.1183/09031936.06.00125105; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Tsurutani J, 2007, LUNG CANCER, V55, P115, DOI 10.1016/j.lungcan.2006.09.026; Varela M, 2008, VIROLOGY, V371, P206, DOI 10.1016/j.virol.2007.09.041; Vaughan AE, 2012, MOL CANCER RES, V10, P86, DOI 10.1158/1541-7786.MCR-11-0285; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walsh SR, 2010, VIRUS RES, V151, P74, DOI 10.1016/j.virusres.2010.04.002; Wolff H, 1998, CANCER RES, V58, P4997; Wootton SK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-94; Wootton SK, 2005, NATURE, V434, P904, DOI 10.1038/nature03492; Yu DL, 2011, J VIROL, V85, P7535, DOI 10.1128/JVI.00400-11; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zavala G, 2003, VIROLOGY, V312, P95, DOI 10.1016/S0042-6822(03)00205-8; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	72	16	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51400	10.1371/journal.pone.0051400	http://dx.doi.org/10.1371/journal.pone.0051400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251519	gold, Green Submitted, Green Published			2022-12-27	WOS:000312201900079
J	Orlowski, K; Bley, CR; Zimmermann, M; Vuong, V; Hug, D; Soltermann, A; Broggini-Tenzer, A; Pruschy, M				Orlowski, Katrin; Bley, Carla Rohrer; Zimmermann, Martina; Van Vuong; Hug, Daniel; Soltermann, Alex; Broggini-Tenzer, Angela; Pruschy, Martin			Dynamics of Tumor Hypoxia in Response to Patupilone and Ionizing Radiation	PLOS ONE			English	Article							GENE-EXPRESSION; EPOTHILONE B; MITOTIC EXIT; CANCER-CELLS; OXYGEN; CARCINOMA; AGENTS; RADIOSENSITIZATION; RADIOTHERAPY; ANGIOGENESIS	Tumor hypoxia is one of the most important parameters that determines treatment sensitivity and is mainly due to insufficient tumor angiogenesis. However, the local oxygen concentration in a tumor can also be shifted in response to different treatment modalities such as cytotoxic agents or ionizing radiation. Thus, combined treatment modalities including microtubule stabilizing agents could create an additional challenge for an effective treatment response due to treatment-induced shifts in tumor oxygenation. Tumor hypoxia was probed over a prolonged observation period in response to treatment with different cytotoxic agents, using a non-invasive bioluminescent ODD-Luc reporter system, in which part of the oxygen-dependent degradation (ODD) domain of HIF-1 alpha is fused to luciferase. As demonstrated in vitro, this system not only detects hypoxia at an ambient oxygen concentration of 1% O-2, but also discriminates low oxygen concentrations in the range from 0.2 to 1% O-2. Treatment of A549 lung adenocarcinoma-derived tumor xenografts with the microtubule stabilizing agent patupilone resulted in a prolonged increase in tumor hypoxia, which could be used as marker for its antitumoral treatment response, while irradiation did not induce detectable changes in tumor hypoxia. Furthermore, despite patupilone-induced hypoxia, the potency of ionizing radiation (IR) was not reduced as part of a concomitant or adjuvant combined treatment modality.	[Orlowski, Katrin; Zimmermann, Martina; Van Vuong; Hug, Daniel; Broggini-Tenzer, Angela; Pruschy, Martin] Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland; [Bley, Carla Rohrer] Univ Zurich, Div Radiat Oncol, Vetsuisse Fac, Zurich, Switzerland; [Soltermann, Alex] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Orlowski, Katrin; Pruschy, Martin] Univ Zurich, KFSP Tumor Oxygenat, CH-8006 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich	Pruschy, M (corresponding author), Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland.	martin.pruschy@usz.ch	Rohrer Bley, Carla/G-1192-2013; Soltermann, Alex/AAE-3012-2020	Rohrer Bley, Carla/0000-0002-5733-2722; Soltermann, Alex/0000-0001-9509-6938; Pruschy, Martin/0000-0002-3124-9015	Swiss Cancer League; Swiss National Science Foundation; Vontobel-Stiftung; KFSP Tumor Oxygenation of the University Zurich	Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Vontobel-Stiftung; KFSP Tumor Oxygenation of the University Zurich	This work was supported by the Swiss Cancer League, the Swiss National Science Foundation, the Vontobel-Stiftung (all to MP) and the KFSP Tumor Oxygenation of the University Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann KH, 2007, CHEMMEDCHEM, V2, P396, DOI 10.1002/cmdc.200600206; Altmann KH, 2000, BBA-REV CANCER, V1470, pM79, DOI 10.1016/S0304-419X(00)00009-3; Bley CR, 2011, LUNG CANCER, V73, P294, DOI 10.1016/j.lungcan.2011.01.010; Bley CR, 2009, CLIN CANCER RES, V15, P1335, DOI 10.1158/1078-0432.CCR-08-0969; BOLLAG DM, 1995, CANCER RES, V55, P2325; Bonomi P, 2000, J CLIN ONCOL, V18, P623, DOI 10.1200/JCO.2000.18.3.623; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Chao SK, 2011, P NATL ACAD SCI USA, V108, P391, DOI 10.1073/pnas.1016962108; CHAPMAN JD, 1974, INT J RADIAT BIOL, V26, P383, DOI 10.1080/09553007414551361; Chen JG, 2003, CANCER RES, V63, P7891; Dubois L, 2004, BRIT J CANCER, V91, P1947, DOI 10.1038/sj.bjc.6602219; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Ferretti S, 2005, CLIN CANCER RES, V11, P7773, DOI 10.1158/1078-0432.CCR-05-1165; Fogh S, 2010, INT J RADIAT ONCOL, V77, P1009, DOI 10.1016/j.ijrobp.2009.06.050; GATENBY RA, 1988, INT J RADIAT ONCOL, V14, P831, DOI 10.1016/0360-3016(88)90002-8; Goldman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018269; Gradishar W, 2009, DRUG DES DEV THER, V3, P163; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Hofstetter B, 2005, CLIN CANCER RES, V11, P1588, DOI 10.1158/1078-0432.CCR-04-1800; Jordan MA, 1996, CANCER RES, V56, P816; Kamath K, 2006, MOL CANCER THER, V5, P2225, DOI 10.1158/1535-7163.MCT-06-0113; Kim HA, 2007, J CONTROL RELEASE, V121, P218, DOI 10.1016/j.jconrel.2007.05.036; Knocke TH, 1999, RADIOTHER ONCOL, V53, P99, DOI 10.1016/S0167-8140(99)00139-5; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Lehmann S, 2009, P NATL ACAD SCI USA, V106, P14004, DOI 10.1073/pnas.0901194106; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Melichar B, 2011, BRIT J CANCER, V105, P1646, DOI 10.1038/bjc.2011.438; Milas L, 1996, RADIOTHER ONCOL, V40, P163, DOI 10.1016/0167-8140(96)01778-1; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nordsmark M, 2004, ACTA ONCOL, V43, P396, DOI 10.1080/02841860410026189; Oehler C, 2011, NEURO-ONCOLOGY, V13, P1000, DOI 10.1093/neuonc/nor069; Oehler-Janne C, 2007, MOL CANCER THER, V6, P2496, DOI 10.1158/1535-7163.MCT-07-0253; Ogasawara M, 2001, BIOL PHARM BULL, V24, P720, DOI 10.1248/bpb.24.720; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Riesterer O, 2006, CLIN CANCER RES, V12, P3518, DOI 10.1158/1078-0432.CCR-05-2816; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sparano J A, 2000, Clin Breast Cancer, V1, P32, DOI 10.3816/CBC.2000.n.002; Sparano JA, 2000, CLIN BREAST CANCER, V1, P41; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Stupp R, 2011, ANN ONCOL, V22, P2144, DOI 10.1093/annonc/mdq729; Viola RJ, 2008, AM J ROENTGENOL, V191, P1779, DOI 10.2214/AJR.07.4060; Wachsberger P, 2003, CLIN CANCER RES, V9, P1957; WALDMAN T, 1995, CANCER RES, V55, P5187; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Westerlund A, 1997, CLIN EXP METASTAS, V15, P318, DOI 10.1023/A:1018481617275; Yaromina A, 2011, INT J RADIAT ONCOL, V80, P1205, DOI 10.1016/j.ijrobp.2011.02.015	53	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51476	10.1371/journal.pone.0051476	http://dx.doi.org/10.1371/journal.pone.0051476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251549	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000312201900093
J	Ribel-Madsen, R; Fraga, MF; Jacobsen, S; Bork-Jensen, J; Lara, E; Calvanese, V; Fernandez, AF; Friedrichsen, M; Vind, BF; Hojlund, K; Beck-Nielsen, H; Esteller, M; Vaag, A; Poulsen, P				Ribel-Madsen, Rasmus; Fraga, Mario F.; Jacobsen, Stine; Bork-Jensen, Jette; Lara, Ester; Calvanese, Vincenzo; Fernandez, Agustin F.; Friedrichsen, Martin; Vind, Birgitte F.; Hojlund, Kurt; Beck-Nielsen, Henning; Esteller, Manel; Vaag, Allan; Poulsen, Pernille			Genome-Wide Analysis of DNA Methylation Differences in Muscle and Fat from Monozygotic Twins Discordant for Type 2 Diabetes	PLOS ONE			English	Article							SKELETAL-MUSCLE; INSULIN-RESISTANCE; PANCREATIC-ISLETS; GENE-EXPRESSION; GLUCOSE; SUSCEPTIBILITY; VARIANTS; LOCI; DYSREGULATION; PGC-1-ALPHA	Background: Monozygotic twins discordant for type 2 diabetes constitute an ideal model to study environmental contributions to type 2 diabetic traits. We aimed to examine whether global DNA methylation differences exist in major glucose metabolic tissues from these twins. Methodology/Principal Findings: Skeletal muscle (n = 11 pairs) and subcutaneous adipose tissue (n = 5 pairs) biopsies were collected from 53-80 year-old monozygotic twin pairs discordant for type 2 diabetes. DNA methylation was measured by microarrays at 26,850 cytosine-guanine dinucleotide (CpG) sites in the promoters of 14,279 genes. Bisulfite sequencing was applied to validate array data and to quantify methylation of intergenic repetitive DNA sequences. The overall intra-pair variation in DNA methylation was large in repetitive (LINE1, D4Z4 and NBL2) regions compared to gene promoters (standard deviation of intra-pair differences: 10% points vs. 4% points, P<0.001). Increased variation of LINE1 sequence methylation was associated with more phenotypic dissimilarity measured as body mass index (r = 0.77, P = 0.007) and 2-hour plasma glucose (r = 0.66, P = 0.03) whereas the variation in promoter methylation did not associate with phenotypic differences. Validated methylation changes were identified in the promoters of known type 2 diabetes-related genes, including PPARGC1A in muscle (13.9+/-6.2% vs. 9.0+/-4.5%, P = 0.03) and HNF4A in adipose tissue (75.2+/-3.8% vs. 70.5+/-3.7%, P<0.001) which had increased methylation in type 2 diabetic individuals. A hypothesis-free genome-wide exploration of differential methylation without correction for multiple testing identified 789 and 1,458 CpG sites in skeletal muscle and adipose tissue, respectively. These methylation changes only reached some percentage points, and few sites passed correction for multiple testing. Conclusions/Significance: Our study suggests that likely acquired DNA methylation changes in skeletal muscle or adipose tissue gene promoters are quantitatively small between type 2 diabetic and non-diabetic twins. The importance of methylation changes in candidate genes such as PPARGC1A and HNF4A should be examined further by replication in larger samples.	[Ribel-Madsen, Rasmus; Jacobsen, Stine; Bork-Jensen, Jette; Friedrichsen, Martin; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Ribel-Madsen, Rasmus] Univ Copenhagen, Sect Metab Genet, Novo Nordisk Fdn, Ctr Basic Metab Res,Fac Hlth & Med Sci, Copenhagen, Denmark; [Fraga, Mario F.] CSIC, Dept Immunol & Oncol, Natl Biotechnol Ctr, CNB, Madrid, Spain; [Lara, Ester; Calvanese, Vincenzo] Spanish Natl Canc Res Ctr, Dept Canc Epigenet, Madrid, Spain; [Fernandez, Agustin F.] Univ Oviedo, Canc Epigenet Lab, Inst Univ Oncol Principado Asturias, HUCA, Oviedo, Spain; [Vind, Birgitte F.; Hojlund, Kurt; Beck-Nielsen, Henning] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Vaag, Allan] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Poulsen, Pernille] Novo Nordisk AS, Soborg, Denmark	Steno Diabetes Center; Novo Nordisk Foundation; University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Oncologicas (CNIO); Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Southern Denmark; Odense University Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Rigshospitalet; University of Copenhagen; Novo Nordisk	Ribel-Madsen, R (corresponding author), Steno Diabet Ctr, DK-2820 Gentofte, Denmark.	rrm@sund.ku.dk	Friedrichsen, Martin/A-3638-2015; Calvanese, Vincenzo/E-1145-2016; Fraga, Mario F/H-7824-2017; Esteller, Manel/L-5956-2014; Fernandez, Agustin F./N-7302-2014; Calvanese, Vincenzo/AAO-4311-2020	Friedrichsen, Martin/0000-0003-3383-9593; Calvanese, Vincenzo/0000-0002-7937-1511; Fraga, Mario F/0000-0001-8450-2603; Esteller, Manel/0000-0003-4490-6093; Fernandez, Agustin F./0000-0002-3792-4085; Calvanese, Vincenzo/0000-0002-7937-1511; Vaag, Allan Arthur/0000-0002-3690-2191; Hojlund, Kurt/0000-0002-0891-4224	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The Danish Council for Strategic Research (http://en.fi.dk), the EXGENESIS (Health benefits of exercise: identification of genes and signalling pathways involved in effects of exercise on insulin resistance, obesity and the metabolic syndrome) 6th Framework EU Programme (http://cordis.europa.eu/fp6), the Danish Diabetes Association (http://www.diabetes.dk), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk), and the Danish Council for Independent Research (http://en.fi.dk). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Buford TW, 2009, EUR J APPL PHYSIOL, V107, P463, DOI 10.1007/s00421-009-1145-z; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Einstein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008887; Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jacobsen SC, 2012, DIABETOLOGIA, V55, P3341, DOI 10.1007/s00125-012-2717-8; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Pettersson AT, 2010, DIABETES, V59, P564, DOI 10.2337/db09-0997; Poulsen P, 2009, DIABETES, V58, P1350, DOI 10.2337/db08-1714; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; VAAG A, 1995, J CLIN INVEST, V95, P690, DOI 10.1172/JCI117715; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zierath JR, 1998, ENDOCRINOLOGY, V139, P5034, DOI 10.1210/en.139.12.5034	49	135	143	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51302	10.1371/journal.pone.0051302	http://dx.doi.org/10.1371/journal.pone.0051302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251491	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900064
J	Mahadevan, NR; Anufreichik, V; Rodvold, JJ; Chiu, KT; Sepulveda, H; Zanetti, M				Mahadevan, Navin R.; Anufreichik, Veronika; Rodvold, Jeffrey J.; Chiu, Kevin T.; Sepulveda, Homero; Zanetti, Maurizio			Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8(+) T Cell Priming	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; SUPPRESSOR-CELLS; IN-SITU; ANTIGEN; INFLAMMATION; ACTIVATION; TOLERANCE; XBP-1	Tumor-infiltrating myeloid cells, such as dendritic cells (BMDC), are key regulators of tumor growth. However, the tumor-derived signals polarizing BMDC to a phenotype that subverts cell-mediated anti-tumor immunity have yet to be fully elucidated. Addressing this unresolved problem we show that the tumor unfolded protein response (UPR) can function in a cell-extrinsic manner via the transmission of ER stress (TERS) to BMDC. TERS-imprinted BMDC upregulate the production of pro-inflammatory, tumorigenic cytokines but also the immunosuppressive enzyme arginase. Importantly, they downregulate cross-presentation of high-affinity antigen and fail to effectively cross-prime CD8(+) T cells, causing T cell activation without proliferation and similarly dominantly suppress cross-priming by bystander BMDC. Lastly, TERS-imprinted BMDC facilitate tumor growth in vivo with fewer tumor-infiltrating CD8(+) T cells. In sum, we demonstrate that tumor-borne ER stress imprints ab initio BMDC to a phenotype that recapitulates several of the inflammatory/suppressive characteristics ascribed to tumor-infiltrating myeloid cells, highlighting the tumor UPR as a critical controller of anti-tumor immunity and a new target for immune modulation in cancer.	[Mahadevan, Navin R.; Anufreichik, Veronika; Rodvold, Jeffrey J.; Chiu, Kevin T.; Zanetti, Maurizio] Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA; [Mahadevan, Navin R.; Anufreichik, Veronika; Rodvold, Jeffrey J.; Chiu, Kevin T.; Zanetti, Maurizio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Sepulveda, Homero] BD Biosci, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Zanetti, M (corresponding author), Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA.	mzanetti@ucsd.edu			UCSD Academic Senate; UCSD MSTP (University of California, San Diego Medical Scientist Training Program); NIDA (National Institute Drug of Abuse) T32 Training Grant [DA007315 07A2]; Frank H. and Eva B. Buck Foundation; UCSD IMSD (University of California, San Diego Initiative for Maximizing Student Diversity) program; NIH [GM083275]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083275, T32GM007198] Funding Source: NIH RePORTER	UCSD Academic Senate; UCSD MSTP (University of California, San Diego Medical Scientist Training Program); NIDA (National Institute Drug of Abuse) T32 Training Grant; Frank H. and Eva B. Buck Foundation; UCSD IMSD (University of California, San Diego Initiative for Maximizing Student Diversity) program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the UCSD Academic Senate. N.R.M. acknowledges support from the UCSD MSTP (University of California, San Diego Medical Scientist Training Program) and NIDA (National Institute Drug of Abuse) T32 Training Grant DA007315 07A2. J.J.R. acknowledges support from the Frank H. and Eva B. Buck Foundation and the UCSD IMSD (University of California, San Diego Initiative for Maximizing Student Diversity) program, funded by NIH R25 Grant GM083275. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JC, 2000, EUR J IMMUNOL, V30, P3699, DOI 10.1002/1521-4141(200012)30:12<3699::AID-IMMU3699>3.0.CO;2-2; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Caron E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.68; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Daniel C, 2011, ADV IMMUNOL, V112, P177, DOI 10.1016/B978-0-12-387827-4.00005-X; Deeths MJ, 1999, J IMMUNOL, V163, P102; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Filaci G, 2007, J IMMUNOL, V179, P4323, DOI 10.4049/jimmunol.179.7.4323; Franco A, 2010, CELL IMMUNOL, V266, P1, DOI 10.1016/j.cellimm.2010.09.006; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HUARD B, 1994, IMMUNOGENETICS, V39, P213; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kruger K, 2001, EUR J IMMUNOL, V31, P138, DOI 10.1002/1521-4141(200101)31:1<138::AID-IMMU138>3.0.CO;2-P; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Luo B, 2012, ONCOGENE; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mahadevan NR, 2011, J IMMUNOL, V187, P4403, DOI 10.4049/jimmunol.1101531; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marzo AL, 1999, J IMMUNOL, V162, P5838; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Park BY, 2004, IMMUNITY, V20, P71, DOI 10.1016/S1074-7613(03)00355-8; Pellicciotta I, 2008, CANCER RES, V68, P8085, DOI 10.1158/0008-5472.CAN-08-1014; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; PREHN RT, 1972, SCIENCE, V176, P170, DOI 10.1126/science.176.4031.170; Redmond WL, 2007, J IMMUNOL, V179, P7244, DOI 10.4049/jimmunol.179.11.7244; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Spiotto MT, 2010, CANCER RES, V70, P78, DOI 10.1158/0008-5472.CAN-09-2747; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	65	92	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51845	10.1371/journal.pone.0051845	http://dx.doi.org/10.1371/journal.pone.0051845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272178	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300034
J	Vink, JM; Bartels, M; van Beijsterveldt, TCEM; van Dongen, J; van Beek, JHDA; Distel, MA; de Moor, MHM; Smit, DJA; Minica, CC; Ligthart, L; Geels, LM; Abdellaoui, A; Middeldorp, CM; Hottenga, JJ; Willemsen, G; de Geus, EJC; Boomsma, DI				Vink, Jacqueline M.; Bartels, Meike; van Beijsterveldt, Toos C. E. M.; van Dongen, Jenny; van Beek, Jenny H. D. A.; Distel, Marijn A.; de Moor, Marleen H. M.; Smit, Dirk J. A.; Minica, Camelia C.; Ligthart, Lannie; Geels, Lot M.; Abdellaoui, Abdel; Middeldorp, Christel M.; Hottenga, Jouke Jan; Willemsen, Gonneke; de Geus, Eco J. C.; Boomsma, Dorret I.			Sex Differences in Genetic Architecture of Complex Phenotypes?	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; MODEL	We examined sex differences in familial resemblance for a broad range of behavioral, psychiatric and health related phenotypes (122 complex traits) in children and adults. There is a renewed interest in the importance of genotype by sex interaction in, for example, genome-wide association (GWA) studies of complex phenotypes. If different genes play a role across sex, GWA studies should consider the effect of genetic variants separately in men and women, which affects statistical power. Twin and family studies offer an opportunity to compare resemblance between opposite-sex family members to the resemblance between same-sex relatives, thereby presenting a test of quantitative and qualitative sex differences in the genetic architecture of complex traits. We analyzed data on lifestyle, personality, psychiatric disorder, health, growth, development and metabolic traits in dizygotic (DZ) same-sex and opposite-sex twins, as these siblings are perfectly matched for age and prenatal exposures. Sample size varied from slightly over 300 subjects for measures of brain function such as EEG power to over 30,000 subjects for childhood psychopathology and birth weight. For most phenotypes, sample sizes were large, with an average sample size of 9027 individuals. By testing whether the resemblance in DZ opposite-sex pairs is the same as in DZ same-sex pairs, we obtain evidence for genetic qualitative sex-differences in the genetic architecture of complex traits for 4% of phenotypes. We conclude that for most traits that were examined, the current evidence is that same the genes are operating in men and women.	[Vink, Jacqueline M.; Bartels, Meike; van Beijsterveldt, Toos C. E. M.; van Dongen, Jenny; van Beek, Jenny H. D. A.; Distel, Marijn A.; de Moor, Marleen H. M.; Smit, Dirk J. A.; Minica, Camelia C.; Ligthart, Lannie; Geels, Lot M.; Abdellaoui, Abdel; Middeldorp, Christel M.; Hottenga, Jouke Jan; Willemsen, Gonneke; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Netherlands Twin Register, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Vink, JM (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Netherlands Twin Register, Amsterdam, Netherlands.	jm.vink@vu.nl	Middeldorp, Christel M/L-7728-2017; de Moor, Marleen/J-7434-2019; de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020; Bartels, Meike/D-4492-2014	Middeldorp, Christel M/0000-0002-6218-0428; de Moor, Marleen/0000-0001-7177-5637; de Geus, Eco J.C./0000-0001-6022-2666; Bartels, Meike/0000-0002-9667-7555; Smit, Dirk/0000-0001-8301-8860; Ligthart, Lannie/0000-0002-6570-3319; van Dongen, Jenny/0000-0003-2063-8741; Minica, Camelia/0000-0001-7140-8167; van Beijsterveldt, Toos/0000-0002-6617-4201; Willemsen, Gonneke/0000-0003-3755-0236	Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression [904-61-090]; Genetics of individual differences in smoking initiation and persistence [NWO 985-10-002]; Resolving cause and effect in the association between exercise and well-being [904-61-193]; Twin family database for behavior genomics studies [480-04-004]; Twin research focusing on behavior [400-05-717]; Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder [Addiction-31160008]; Genotype/phenotype database for behavior genetic and genetic epidemiological studies [911-09-032]; Spinozapremie [SPI 56-464-14192]; VU University: Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); European Research Council (ERC) Genetics of Mental Illness [230374]; Genetic influences on stability and change in psychopathology from childhood to young adulthood [ZonMW 912-10-020]; ERC [284167]; NWO-VENI [NWO 916-76-125]	Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression; Genetics of individual differences in smoking initiation and persistence; Resolving cause and effect in the association between exercise and well-being(Estonian Research Council); Twin family database for behavior genomics studies; Twin research focusing on behavior; Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder; Genotype/phenotype database for behavior genetic and genetic epidemiological studies; Spinozapremie; VU University: Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); European Research Council (ERC) Genetics of Mental Illness(European Research Council (ERC)); Genetic influences on stability and change in psychopathology from childhood to young adulthood; ERC(European Research Council (ERC)European Commission); NWO-VENI(Netherlands Organization for Scientific Research (NWO))	Funding was obtained from the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression (904-61-090); Genetics of individual differences in smoking initiation and persistence (NWO 985-10-002); Resolving cause and effect in the association between exercise and well-being (904-61-193); Twin family database for behavior genomics studies (480-04-004); Twin research focusing on behavior (400-05-717); Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder (Addiction-31160008); Genotype/phenotype database for behavior genetic and genetic epidemiological studies (911-09-032); Spinozapremie (SPI 56-464-14192); the VU University: Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); the European Research Council (ERC) Genetics of Mental Illness (230374); Genetic influences on stability and change in psychopathology from childhood to young adulthood (ZonMW 912-10-020). JV was supported by ERC starting grant 284167. CMM was supported by NWO-VENI (NWO 916-76-125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels M, 2007, TWIN RES HUM GENET, V10, P3, DOI 10.1375/twin.10.1.3; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Eaves L, 2000, BEHAV GENET, V30, P321, DOI 10.1023/A:1026553518272; EAVES L, 1976, HEREDITY, V36, P205, DOI 10.1038/hdy.1976.25; Eaves LJ, 1997, J CHILD PSYCHOL PSYC, V38, P965, DOI 10.1111/j.1469-7610.1997.tb01614.x; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; Falconer DS, 1996, QUANTITATIVE GENETIC; Falconer DS, 1996, QUANTITATIVE GENETIC; Haberstick BC, 2011, ADDICTION, V106, P215, DOI 10.1111/j.1360-0443.2010.03129.x; Hindorff L, 2012, CATALOG PUBLISHED GE; Jacquard A., 1974, GENETIC STRUCTURE PO; Lynch M., 1998, GENETICS ANAL QUANTI; Meier MH, 2011, J ABNORM PSYCHOL, V120, P377, DOI 10.1037/a0022303; Mook-Kanamori DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039901; Neale M. C., 2006, MX STAT MODELING, V7th; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Randall JC, SEX STRATIFIED GENOM, V270; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Smit DJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036896; Tackett JL, 2011, J AM ACAD CHILD PSY, V50, P818, DOI 10.1016/j.jaac.2011.05.007; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; van Soelen ILC, 2012, TWIN RES HUM GENET, V15, P453, DOI 10.1017/thg.2012.4; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Willemsen G, 2010, TWIN RES HUM GENET, V13, P231, DOI 10.1375/twin.13.3.231	25	55	55	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e47371	10.1371/journal.pone.0047371	http://dx.doi.org/10.1371/journal.pone.0047371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272036	Green Published, gold			2022-12-27	WOS:000312483300001
J	Chen, GF; Liu, XQ; Zhang, YL; Lin, SZ; Yang, ZJ; Johansson, J; Rising, A; Meng, Q				Chen, Gefei; Liu, Xiangqin; Zhang, Yunlong; Lin, Senzhu; Yang, Zijiang; Johansson, Jan; Rising, Anna; Meng, Qing			Full-Length Minor Ampullate Spidroin Gene Sequence	PLOS ONE			English	Article							SPIDER SILK PROTEINS; EGG CASE SILK; MECHANICAL-PROPERTIES; NEPHILA-CLAVIPES; DRAGLINE SILK; MESSENGER-RNA; EVOLUTION; FIBERS; FLAGELLIFORM; EXPRESSION	Spider silk includes seven protein based fibers and glue-like substances produced by glands in the spider's abdomen. Minor ampullate silk is used to make the auxiliary spiral of the orb-web and also for wrapping prey, has a high tensile strength and does not supercontract in water. So far, only partial cDNA sequences have been obtained for minor ampullate spidroins (MiSps). Here we describe the first MiSp full-length gene sequence from the spider species Araneus ventricosus, using a multidimensional PCR approach. Comparative analysis of the sequence reveals regulatory elements, as well as unique spidroin gene and protein architecture including the presence of an unusually large intron. The spliced full-length transcript of MiSp gene is 5440 bp in size and encodes 1766 amino acid residues organized into conserved nonrepetitive N- and C-terminal domains and a central predominantly repetitive region composed of four units that are iterated in a non regular manner. The repeats are more conserved within A. ventricosus MiSp than compared to repeats from homologous proteins, and are interrupted by two nonrepetitive spacer regions, which have 100% identity even at the nucleotide level.	[Johansson, Jan; Rising, Anna] Karolinska Inst, KI Alzheimer Dis Res Ctr, NVS Neurobiol Care Sci & Soc Dept, Stockholm, Sweden; [Chen, Gefei; Zhang, Yunlong; Lin, Senzhu; Yang, Zijiang; Meng, Qing] Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China; [Liu, Xiangqin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Johansson, Jan; Rising, Anna] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Johansson, Jan] Tallinn Univ, Inst Math & Nat Sci, Tallinn, Estonia	Karolinska Institutet; Donghua University; Dalhousie University; Swedish University of Agricultural Sciences; Tallinn University	Rising, A (corresponding author), Karolinska Inst, KI Alzheimer Dis Res Ctr, NVS Neurobiol Care Sci & Soc Dept, Stockholm, Sweden.	anna.rising@ki.se; mengqing@dhu.edu.cn	Rising, Anna/ABE-8822-2020; Chen, Gefei/J-2919-2013	Rising, Anna/0000-0002-1872-1207; Chen, Gefei/0000-0002-5543-5963; Johansson, Jan/0000-0002-8719-4703	Chinese National High Technology Research and Development Program 863 [2006AA03Z451]; Chinese National Natural Science Foundation [31070698]; Shanghai key projects of basic research [10JC1400300]; Swedish Research Council [10371]; Karolinska Institutet research funds	Chinese National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai key projects of basic research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet research funds	This work was supported by Chinese National High Technology Research and Development Program 863 [no. 2006AA03Z451], the Chinese National Natural Science Foundation [no. 31070698], the Shanghai key projects of basic research [no. 10JC1400300], the Swedish Research Council [no. 10371] and Karolinska Institutet research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Beckwitt R, 1998, INSECT BIOCHEM MOLEC, V28, P121, DOI 10.1016/S0965-1748(97)00083-0; Bittencourt D, 2007, COMP BIOCHEM PHYS B, V147, P597, DOI 10.1016/j.cbpb.2007.03.013; Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378; Bram A, 1997, J APPL CRYSTALLOGR, V30, P390, DOI 10.1107/S0021889896012344; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Foelix RF, 1996, BIOL SPIDERS; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0; Geurts P, 2010, BIOMACROMOLECULES, V11, P3495, DOI 10.1021/bm101002w; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Guinea GV, 2012, BIOMACROMOLECULES, V13, P2087, DOI 10.1021/bm3004644; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; Jaudzems K, 2012, J MOL BIOL, V422, P477, DOI 10.1016/j.jmb.2012.06.004; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; La Mattina C, 2008, BIOCHEMISTRY-US, V47, P4692, DOI 10.1021/bi800140q; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; Marais G, 2005, GENETICS, V170, P481, DOI 10.1534/genetics.104.037333; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; Patterton HG, 2000, BIOINFORMATICS, V16, P652, DOI 10.1093/bioinformatics/16.7.652; Perry DJ, 2010, BIOMACROMOLECULES, V11, P3000, DOI 10.1021/bm1007585; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pouchkina-Stantcheva NN, 2004, COMP BIOCHEM PHYS B, V138, P371, DOI 10.1016/j.cbpc.2004.04.020; Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Sakharkar MK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-67; Sakharkar MK, 2002, BIOINFORMATICS, V18, P1266, DOI 10.1093/bioinformatics/18.9.1266; Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048; STAUFFER SL, 1994, J ARACHNOL, V22, P5; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Viney C, 2000, J TEXT I, V91, P2, DOI 10.1080/00405000008659539; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g	56	63	73	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52293	10.1371/journal.pone.0052293	http://dx.doi.org/10.1371/journal.pone.0052293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251707	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800159
J	Lan, ML; Acharya, MM; Tran, KK; Bahari-Kashani, J; Patel, NH; Strnadel, J; Giedzinski, E; Limoli, CL				Lan, Mary L.; Acharya, Munjal M.; Tran, Katherine K.; Bahari-Kashani, Jessica; Patel, Neal H.; Strnadel, Jan; Giedzinski, Erich; Limoli, Charles L.			Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem Cells	PLOS ONE			English	Article							NEURAL PRECURSOR CELLS; APOPTOSIS; ARREST; STATE	The potential capability of stem cells to restore functionality to diseased or aged tissues has prompted a surge of research, but much work remains to elucidate the response of these cells to genotoxic agents. To more fully understand the impact of irradiation on different stem cell types, the present study has analyzed the radioresponse of human pluripotent and multipotent stem cells. Human embryonic stem (ES) cells, human induced pluripotent (iPS) cells, and iPS-derived human neural stem cells (iPS-hNSCs) cells were irradiated and analyzed for cell survival parameters, differentiation, DNA damage and repair and oxidative stress at various times after exposure. While irradiation led to dose-dependent reductions in survival, the fraction of surviving cells exhibited dose-dependent increases in metabolic activity. Irradiation did not preclude germ layer commitment of ES cells, but did promote neuronal differentiation. ES cells subjected to irradiation exhibited early apoptosis and inhibition of cell cycle progression, but otherwise showed normal repair of DNA double-strand breaks. Cells surviving irradiation also showed acute and persistent increases in reactive oxygen and nitrogen species that were significant at nearly all post-irradiation times analyzed. We suggest that stem cells alter their redox homeostasis to adapt to adverse conditions and that radiation-induced oxidative stress plays a role in regulating the function and fate of stem cells within tissues compromised by radiation injury. Citation: Lan ML, Acharya MM, Tran KK, Bahari-Kashani J, Patel NH, et al. (2012) Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem Cells. PLoS ONE 7(12): e50048. doi:10.1371/journal.pone.0050048	[Lan, Mary L.; Acharya, Munjal M.; Tran, Katherine K.; Bahari-Kashani, Jessica; Patel, Neal H.; Giedzinski, Erich; Limoli, Charles L.] Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA 92717 USA; [Strnadel, Jan] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California San Diego	Limoli, CL (corresponding author), Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA 92717 USA.	climoli@uci.edu	Strnadel, Jan/Y-5172-2018; Limoli, Charles/AAW-1748-2020	Strnadel, Jan/0000-0002-7233-6537; Limoli, Charles/0000-0002-1321-4142	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS) [R01 NS074388]; California Institute for Regenerative Medicine (CIRM) [RS1-00413]; CIRM Training Grant [TG2-0115]; NASA Grant [NNX09AK25G]; Office of Science (BER) U.S. Department of Energy [DE-FG02-09ER64798]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074388] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); CIRM Training Grant; NASA Grant(National Aeronautics & Space Administration (NASA)); Office of Science (BER) U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS) grant R01 NS074388 (C.L.L.), California Institute for Regenerative Medicine (CIRM) Grant RS1-00413 (C.L.L.), CIRM Training Grant TG2-0115 (M.M.A.), NASA Grant NNX09AK25G (C.L.L.) and Office of Science (BER) U.S. Department of Energy grant no. DE-FG02-09ER64798 (C.L.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya MM, 2010, FREE RADIC BIOL MED; Barani IJ, 2007, INT J RADIAT ONCOL, V68, P324, DOI 10.1016/j.ijrobp.2007.01.033; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Giedzinski E, 2005, RADIAT RES, V164, P540, DOI 10.1667/RR3369.1; Globus RK, 2012, OXID STRESS APPL BAS, P169, DOI 10.1007/978-1-61779-397-4_9; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Jamal M, 2010, CLIN CANCER RES, V16, P6049, DOI 10.1158/1078-0432.CCR-10-2435; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Limoli CL, 2007, RADIAT ENVIRON BIOPH, V46, P167, DOI 10.1007/s00411-006-0077-9; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Pereira A, 2010, PROG NEUROBIOL, V92, P405, DOI 10.1016/j.pneurobio.2010.07.001; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46; Tan JH, 2006, CANCER RES, V66, P2320, DOI 10.1158/0008-5472.CAN-05-2700; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Yazlovitskaya EM, 2006, CANCER RES, V66, P11179, DOI 10.1158/0008-5472.CAN-06-2740; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	26	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50048	10.1371/journal.pone.0050048	http://dx.doi.org/10.1371/journal.pone.0050048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272054	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800011
J	Nedbal, J; Hobson, PS; Fear, DJ; Heintzmann, R; Gould, HJ				Nedbal, Jakub; Hobson, Philip S.; Fear, David J.; Heintzmann, Rainer; Gould, Hannah J.			Comprehensive FISH Probe Design Tool Applied to Imaging Human Immunoglobulin Class Switch Recombination	PLOS ONE			English	Article							IN-SITU; DNA; HYBRIDIZATION; TRANSCRIPTS; INDUCTION; EPIDEMIC; ANTIBODY; ASTHMA; GENE; IGE	We present a web engine boosted fluorescence in-situ hybridization (webFISH) algorithm using a genome-wide sequence similarity search to design target-specific single-copy and repetitive DNA FISH probes. The webFISH algorithm featuring a user-friendly interface (http://www.webfish2.org/) maximizes the coverage of the examined sequences with FISH probes by considering locally repetitive sequences absent from the remainder of the genome. The highly repetitive human immunoglobulin heavy chain sequence was analyzed using webFISH to design three sets of FISH probes. These allowed direct simultaneous detection of class switch recombination in both immunoglobulin-heavy chain alleles in single cells from a population of cultured primary B cells. It directly demonstrated asynchrony of the class switch recombination in the two alleles in structurally preserved nuclei while permitting parallel readout of protein expression by immunofluorescence staining. This novel technique offers the possibility of gaining unprecedented insight into the molecular mechanisms involved in class switch recombination. Citation: Nedbal J, Hobson PS, Fear DJ, Heintzmann R, Gould HJ (2012) Comprehensive FISH Probe Design Tool Applied to Imaging Human Immunoglobulin Class Switch Recombination. PLoS ONE 7(12): e51675. doi:10.1371/journal.pone.0051675	[Nedbal, Jakub; Hobson, Philip S.; Heintzmann, Rainer; Gould, Hannah J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Nedbal, Jakub; Hobson, Philip S.; Fear, David J.; Gould, Hannah J.] Guys Hosp, MRC, London SE1 9RT, England; [Nedbal, Jakub; Hobson, Philip S.; Fear, David J.; Gould, Hannah J.] Guys Hosp, Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England; [Fear, David J.] Guys Hosp, Div Asthma Allergy & Lung Biol, London SE1 9RT, England; [Heintzmann, Rainer] Inst Photon Technol, Jena, Germany; [Heintzmann, Rainer] Univ Jena, Inst Phys Chem, D-6900 Jena, Germany	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena	Nedbal, J (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	jakub.nedbal@kcl.ac.uk; hannah.gould@kcl.ac.uk	Heintzmann, Rainer/AAY-4849-2020	Heintzmann, Rainer/0000-0002-4950-1936; Gould, Hannah/0000-0003-0411-688X; Fear, David/0000-0003-0239-8385	Medical Research Council; Asthma UK Centre in Allergic Mechanisms of Asthma; Medical Research Council [G0501494]; Biotechnology and Biological Sciences Research Council [BB/H019634/1]; Engineering and Physical Sciences Research Council [EP/F069731/1]; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; BBSRC [BB/H019634/1] Funding Source: UKRI; MRC [G0400106, G0501494] Funding Source: UKRI; Medical Research Council [G0400106, G1000758B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK Centre in Allergic Mechanisms of Asthma; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been supported by a Medical Research Council and Asthma UK Centre in Allergic Mechanisms of Asthma PhD studentship to J.N., by the Medical Research Council [grant G0501494, www.mrc.ac.uk] to H.J.G et al.; by Biotechnology and Biological Sciences Research Council [grant BB/H019634/1, www.bbsrc.ac.uk] to D.J.F. and H.J.G.; and by Engineering and Physical Sciences Research Council [grant EP/F069731/1, www.epsrc.ac.uk] to R.H. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre [www.biomedicalresearchcentre.org] award to Guy's St Thomas' National Health Service Foundation Trust in partnership with King's College London and King's College Hospital National Health Service Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Brown JM, 2010, METHODS MOL BIOL, V659, P33, DOI 10.1007/978-1-60761-789-1_3; Capron A, 1999, MICROBES INFECT, V1, P485, DOI 10.1016/S1286-4579(99)80086-0; Cremer Marion, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4723; Daly J, 2007, EMBO J, V26, P4273, DOI 10.1038/sj.emboj.7601846; Dayal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024571; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; IRSCH J, 1993, EUR J IMMUNOL, V23, P481, DOI 10.1002/eji.1830230227; Isolauri E, 2004, CLIN EXP ALLERGY, V34, P1007, DOI 10.1111/j.1365-2222.2004.01999.x; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kraan Jaennelle, 2002, Methods Mol Biol, V204, P143, DOI 10.1385/1-59259-300-3:143; LICHTER P, 1990, NATURE, V345, P93, DOI 10.1038/345093a0; Lichter P, 2006, BASIC METHODS MICROS, P223; LIN LC, 1981, P NATL ACAD SCI-BIOL, V78, P504, DOI 10.1073/pnas.78.1.504; Martin-Subero JI, 2006, CANCER RES, V66, P10332, DOI 10.1158/0008-5472.CAN-06-1992; McCloskey N, 1999, EUR J IMMUNOL, V29, P3236, DOI 10.1002/(SICI)1521-4141(199910)29:10<3236::AID-IMMU3236>3.0.CO;2-T; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Navin N, 2006, BIOINFORMATICS, V22, P2437, DOI 10.1093/bioinformatics/btl273; Ozcan E, 2008, J ALLERGY CLIN IMMUN, V122, P1054, DOI 10.1016/j.jaci.2008.10.023; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; PARDUE ML, 1969, P NATL ACAD SCI USA, V64, P600, DOI 10.1073/pnas.64.2.600; Perez-Duran P, 2007, CARCINOGENESIS, V28, P2427, DOI 10.1093/carcin/bgm201; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rozen S, 2000, Methods Mol Biol, V132, P365; RUDKIN GT, 1977, NATURE, V265, P472, DOI 10.1038/265472a0; TAGARRO I, 1994, HUM GENET, V93, P383; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Vaandrager JW, 2000, BLOOD, V96, P1947, DOI 10.1182/blood.V96.5.1947.h8001947_1947_1952; Vaandrager JW, 1998, BLOOD, V92, P2871, DOI 10.1182/blood.V92.8.2871.420k08_2871_2878; Yamada NA, 2010, CYTOGENET GENOME RES, V132; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	32	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51675	10.1371/journal.pone.0051675	http://dx.doi.org/10.1371/journal.pone.0051675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272136	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800062
J	Papadopoulos, P; Gutierrez, L; van der Linden, R; Kong-A-San, J; Maas, A; Drabek, D; Patrinos, GP; Philipsen, S; Grosveld, F				Papadopoulos, Petros; Gutierrez, Laura; van der Linden, Reinier; Kong-A-San, John; Maas, Alex; Drabek, Dubravka; Patrinos, George P.; Philipsen, Sjaak; Grosveld, Frank			A Dual Reporter Mouse Model of the Human beta-Globin Locus: Applications and Limitations	PLOS ONE			English	Article							FETAL-HEMOGLOBIN; TRANSGENIC MICE; GENE; EXPRESSION; CELLS; TRANSCRIPTION; INDUCERS; ADULT; ERYTHROPOIESIS; MATURATION	The human beta-globin locus contains the beta-like globin genes (i.e. fetal gamma-globin and adult beta-globin), which heterotetramerize with alpha-globin subunits to form fetal or adult hemoglobin. Thalassemia is one of the commonest inherited disorders in the world, which results in quantitative defects of the globins, based on a number of genome variations found in the globin gene clusters. Hereditary persistence of fetal hemoglobin (HPFH) also caused by similar types of genomic alterations can compensate for the loss of adult hemoglobin. Understanding the regulation of the human gamma-globin gene expression is a challenge for the treatment of thalassemia. A mouse model that facilitates high-throughput assays would simplify such studies. We have generated a transgenic dual reporter mouse model by tagging the gamma- and beta-globin genes with GFP and DsRed fluorescent proteins respectively in the endogenous human beta-globin locus. Erythroid cell lines derived from this mouse model were tested for their capacity to reactivate the gamma-globin gene. Here, we discuss the applications and limitations of this fluorescent reporter model to study the genetic basis of red blood cell disorders and the potential use of such model systems in high-throughput screens for hemoglobinopathies therapeutics.	[Papadopoulos, Petros; Gutierrez, Laura; van der Linden, Reinier; Kong-A-San, John; Maas, Alex; Drabek, Dubravka; Patrinos, George P.; Philipsen, Sjaak; Grosveld, Frank] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Patrinos, George P.] Univ Patras, Dept Pharm, Patras, Greece	Erasmus University Rotterdam; Erasmus MC; University of Patras	Grosveld, F (corresponding author), Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands.	f.grosveld@erasmusmc.nl	Gutiérrez, Laura/P-9367-2019; Papadopoulos, Petros/B-1913-2015; Gutiérrez, Laura/B-3780-2016	Papadopoulos, Petros/0000-0002-8342-329X; Gutiérrez, Laura/0000-0001-8443-900X; van der Linden, Reinier/0000-0001-7437-8901	NIH [5 RO1 HL 73455]; NWO-CW [700.55.006]; ZonMW DN [82-301]; NWO-VENI [863.09.012]; EMBO ASTF [15-2010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO-CW(Netherlands Organization for Scientific Research (NWO)); ZonMW DN; NWO-VENI(Netherlands Organization for Scientific Research (NWO)); EMBO ASTF(European Molecular Biology Organization (EMBO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH 5 RO1 HL 73455, NWO-CW 700.55.006, ZonMW DN 82-301, NWO-VENI 863.09.012, and EMBO ASTF 15-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzenani MK, 2011, MOL CELL BIOL, V31, P4119, DOI 10.1128/MCB.01304-10; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; Chan KS, 2012, FASEB J; Chin J, 2009, EXP HEMATOL, V37, P1131, DOI 10.1016/j.exphem.2009.06.007; CONSTANTOULAKIS P, 1991, BLOOD, V77, P1326; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fraser ST, 2007, BLOOD, V109, P343, DOI 10.1182/blood-2006-03-006569; Fraser ST, 2010, METHOD ENZYMOL, V476, P403, DOI 10.1016/S0076-6879(10)76022-5; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Gutierrez L, 2005, EXP HEMATOL, V33, P1083, DOI 10.1016/j.exphem.2005.06.014; Haley JD, 2003, BIOCHEM PHARMACOL, V66, P1755, DOI 10.1016/S0006-2952(03)00542-2; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Heck S, 2003, BLOOD, V101, P903, DOI 10.1182/blood-2002-06-1861; Imam AMA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e65; Isern J, 2008, P NATL ACAD SCI USA, V105, P6662, DOI 10.1073/pnas.0802032105; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang J, 2006, BLOOD, V108, P1077, DOI 10.1182/blood-2006-01-008912; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Mankidy R, 2006, BLOOD, V108, P3179, DOI 10.1182/blood-2005-12-010934; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Rupon JW, 2006, P NATL ACAD SCI USA, V103, P6617, DOI 10.1073/pnas.0509322103; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; SAUVAGE C, 1993, BRIT J HAEMATOL, V84, P492, DOI 10.1111/j.1365-2141.1993.tb03106.x; Skarpidi E, 2000, BLOOD, V96, P321, DOI 10.1182/blood.V96.1.321.013k48_321_326; Spangrude GJ, 2006, STEM CELLS, V24, P2045, DOI 10.1634/stemcells.2006-0013; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Tewari R, 1996, DEVELOPMENT, V122, P3991; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Vadolas J, 2002, BLOOD, V100, P4209, DOI 10.1182/blood-2001-12-0365; van Dijk TB, 2010, BLOOD, V116, P4349, DOI 10.1182/blood-2010-03-274399; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; Zhang CJ, 2010, J HEPATOL, V53, P889, DOI 10.1016/j.jhep.2010.05.012; ZIJLSTRA WG, 1987, COMP BIOCHEM PHYS B, V88, P251; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633; ZIJLSTRA WG, 1983, J APPL PHYSIOL, V54, P1287, DOI 10.1152/jappl.1983.54.5.1287	40	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51272	10.1371/journal.pone.0051272	http://dx.doi.org/10.1371/journal.pone.0051272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272095	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800037
J	Stefanidis, A; Spencer, SJ				Stefanidis, Aneta; Spencer, Sarah J.			Effects of Neonatal Overfeeding on Juvenile and Adult Feeding and Energy Expenditure in the Rat	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; EARLY OVERNUTRITION; METABOLIC SYNDROME; WEIGHT-GAIN; BODY-FAT; OBESITY; LEPTIN; FOOD; EXPRESSION; GENDER	Overfeeding during perinatal life leads to an overweight phenotype that persists throughout the juvenile stage and into adulthood, however, the mechanim(s) underlying this effect are poorly understood. We hypothesized that obesity due to neonatal overfeeding is maintained by changes in energy expenditure and that these changes differ between males and females. We investigated feeding, physical activity, hormonal and metabolic alterations that occur in adult rats made obese by having been nursed in small litters (SL) compared with those from control litters (CL). There were no differences in absolute food intake between the groups, and juvenile and adult SL rats ate less chow per gram body weight than the CL did in the dark (active) phase. Juvenile, but not adult SL rats did have reduced whole body energy expenditure, but there were no differences between the groups by the time they reached adulthood. Adult SL females (but not males) had reduced brown adipose tissue (BAT) temperatures compared with CL in the first half of the dark phase. Our results indicate a persistent overweight phenotype in rats overfed as neonates is not associated with hyperphagia at any stage, but is reflected in reduced energy expenditure into the juvenile phase. The reduced dark phase BAT activity in adult SL females is not sufficient to reduce total energy expenditure at this stage of life and there is an apparently compensatory effect that prevents SL and CL from continuing to diverge in weight that appears between the juvenile and adult stages.	[Stefanidis, Aneta; Spencer, Sarah J.] Monash Univ, Fac Med, Dept Physiol, Melbourne, Vic 3004, Australia; [Spencer, Sarah J.] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Spencer, Sarah J.] RMIT Univ, Hlth Innovat Res Inst HIRI, Melbourne, Vic, Australia	Monash University; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Spencer, SJ (corresponding author), Monash Univ, Fac Med, Dept Physiol, Melbourne, Vic 3004, Australia.	sarah.spencer@rmit.edu.au	Spencer, Sarah J/D-5777-2018	Spencer, Sarah/0000-0001-8832-4824	Australian Research Council (ARC) [DP109339]; NHMRC Peter Doherty Research Fellowship [465167]; Endocrine Society of Australia	Australian Research Council (ARC)(Australian Research Council); NHMRC Peter Doherty Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Endocrine Society of Australia	This work was supported by a Discovery Project Grant from the Australian Research Council to SJS (ARC; DP109339). SJS was supported by an NHMRC Peter Doherty Research Fellowship (465167) and an Endocrine Society of Australia Postdoctoral Fellowship, she is also an ARC Future Fellow (FT110100084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorntorp P, 1996, INT J OBESITY, V20, P291; Bulfin LJ, 2011, PSYCHONEUROENDOCRINO, V36, P1080, DOI 10.1016/j.psyneuen.2011.01.006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clarke MA, 2011, J NEUROENDOCRINOL; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Justo R, 2005, LIFE SCI, V76, P1147, DOI 10.1016/j.lfs.2004.08.019; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Lee JM, 2008, ARCH PEDIAT ADOL MED, V162, P682, DOI 10.1001/archpedi.162.7.682; Lopez M, 2007, INT J OBESITY, V31, P371, DOI 10.1038/sj.ijo.0803425; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Masaki T, 2000, AM J PHYSIOL-REG I, V279, pR1305, DOI 10.1152/ajpregu.2000.279.4.R1305; Mathieu P, 2008, INT J BIOCHEM CELL B, V40, P821, DOI 10.1016/j.biocel.2007.12.001; MCCANCE RA, 1962, LANCET, V2, P671; Mozes S, 2004, PHYSIOL RES, V53, P177; OSCAI LB, 1978, AM J PHYSIOL, V235, pR141, DOI 10.1152/ajpregu.1978.235.3.R141; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Quevedo S, 1998, PFLUG ARCH EUR J PHY, V436, P689, DOI 10.1007/s004240050690; Ramsey JJ, 1996, COMP BIOCHEM PHYS B, V113, P461, DOI 10.1016/0305-0491(95)02071-3; Razzouk L, 2009, CURR HYPERTENS REP, V11, P127, DOI 10.1007/s11906-009-0023-8; Remmers F, 2008, BRIT J NUTR, V99, P1149, DOI 10.1017/S0007114507843546; Robinson WR, 2009, AM J CLIN NUTR, V89, P1204, DOI 10.3945/ajcn.2007.25751; Rodrigues AL, 2007, J ENDOCRINOL, V195, P485, DOI 10.1677/JOE-07-0046; Rodrigues AL, 2009, J PHYSIOL-LONDON, V587, P2647, DOI 10.1113/jphysiol.2009.169045; Rodriguez AM, 2001, OBES RES, V9, P579, DOI 10.1038/oby.2001.75; Shaw NJ, 2007, ARCH DIS CHILD, V92, P872, DOI 10.1136/adc.2007.117911; Spencer SJ, 2007, AM J PHYSIOL-REG I, V293, pR581, DOI 10.1152/ajpregu.00262.2007; Spencer SJ, 2009, PSYCHONEUROENDOCRINO, V34, P1133, DOI 10.1016/j.psyneuen.2009.02.013; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Valle A, 2007, CELL PHYSIOL BIOCHEM, V19, P195, DOI 10.1159/000099207; Xiao XQ, 2007, ENDOCRINOLOGY, V148, P4150, DOI 10.1210/en.2007-0373	32	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52130	10.1371/journal.pone.0052130	http://dx.doi.org/10.1371/journal.pone.0052130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251693	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800145
J	Tereshchenko, LG; McNitt, S; Han, L; Berger, RD; Zareba, W				Tereshchenko, Larisa G.; McNitt, Scott; Han, Lichy; Berger, Ronald D.; Zareba, Wojciech			ECG Marker of Adverse Electrical Remodeling Post-Myocardial Infarction Predicts Outcomes in MADIT II Study	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; LEFT-VENTRICULAR HYPERTROPHY; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; MYOCARDIAL-INFARCTION; RISK STRATIFICATION; HIBERNATING MYOCARDIUM; QRS DURATION; HEART; ARRHYTHMIAS; VARIABILITY	Background: Post-myocardial infarction (MI) structural remodeling is characterized by left ventricular dilatation, fibrosis, and hypertrophy of the non-infarcted myocardium. Objective: The goal of our study was to quantify post-MI electrical remodeling by measuring the sum absolute QRST integral (SAI QRST). We hypothesized that adverse electrical remodeling predicts outcomes in MADIT II study participants. Methods: Baseline orthogonal ECGs of 750 MADIT II study participants (448 [59.7%] ICD arm) were analyzed. SAI QRST was measured as the arithmetic sum of absolute QRST integrals over all three orthogonal ECG leads. The primary endpoint was defined as sudden cardiac death (SCD) or sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) with appropriate ICD therapies. All-cause mortality served as a secondary endpoint. Results: Adverse electrical remodeling in post-MI patients was characterized by wide QRS, increased magnitudes of spatial QRS and T vectors, J-point deviation, and QTc prolongation. In multivariable Cox regression analysis after adjustment for age, QRS duration, atrial fibrillation, New York Heart Association heart failure class and blood urea nitrogen, SAI QRST predicted SCD/VT/VF (HR 1.33 per 100 mV*ms (95% CI 1.11-1.59); P = 0.002), and all-cause death (HR 1.27 per 100 mV*ms (95% CI 1.03-1.55), P = 0.022) in both arms. No interaction with therapy arm and bundle branch block (BBB) status was found. Conclusions: In MADIT II patients, increased SAI QRST is associated with increased risk of sustained VT/VF with appropriate ICD therapies and all-cause death in both ICD and in conventional medical therapy arms, and in patients with and without BBB. Further studies of SAI QRST are warranted. Citation: Tereshchenko LG, McNitt S, Han L, Berger RD, Zareba W (2012) ECG Marker of Adverse Electrical Remodeling Post-Myocardial Infarction Predicts Outcomes in MADIT II Study. PLoS ONE 7(12): e51812. doi:10.1371/journal.pone.0051812	[Tereshchenko, Larisa G.; Berger, Ronald D.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [McNitt, Scott; Zareba, Wojciech] Univ Rochester, Med Ctr, Div Cardiol, Rochester, NY 14642 USA; [Han, Lichy] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD USA	Johns Hopkins University; University of Rochester; Johns Hopkins University	Tereshchenko, LG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	lteresh1@jhmi.edu	Tereshchenko, Larisa/X-4253-2019	Tereshchenko, Larisa/0000-0002-6976-1313	American Heart Association [AHA 10CRP2600257]; Open Access Promotion Fund of the Johns Hopkins University Libraries	American Heart Association(American Heart Association); Open Access Promotion Fund of the Johns Hopkins University Libraries	This project was partially supported by the American Heart Association, grant AHA 10CRP2600257 (PI Larisa Tereshchenko). Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bacharova L, 2007, ANN NONINVAS ELECTRO, V12, P260, DOI 10.1111/j.1542-474X.2007.00170.x; Bacharova L, 2010, J ELECTROCARDIOL, V43, P200, DOI 10.1016/j.jelectrocard.2009.07.014; Berkowitsch A, 2004, ANN NONINVAS ELECTRO, V9, P270, DOI 10.1111/j.1542-474X.2004.93600.x; Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; BRODY DA, 1956, CIRC RES, V4, P731, DOI 10.1161/01.RES.4.6.731; Bunch TJ, 2007, CIRCULATION, V115, P2451, DOI 10.1161/CIRCULATIONAHA.106.683235; Canty JM, 2004, CIRC RES, V94, P1142, DOI 10.1161/01.RES.0000125628.57672.CF; CHIANG BN, 1970, CIRCULATION, V41, P31, DOI 10.1161/01.CIR.41.1.31; Connelly KA, 2012, CARDIOVASC IN PRESS; Couderc JP, 2007, EUROPACE, V9, P717, DOI 10.1093/europace/eum131; COX MM, 1991, J MOL CELL CARDIOL, V23, P127, DOI 10.1016/0022-2828(91)90100-Z; Dhar R, 2008, HEART RHYTHM, V5, P807, DOI 10.1016/j.hrthm.2008.02.013; Fallavollita JA, 2010, J NUCL CARDIOL, V17, P85, DOI 10.1007/s12350-009-9164-z; Fast VG, 1996, CIRC RES, V79, P115, DOI 10.1161/01.RES.79.1.115; Florian A, 2012, JACC-CARDIOVASC IMAG, V5, P1003, DOI 10.1016/j.jcmg.2012.02.018; GULRAJANI RM, 1983, CIRC RES, V52, P45, DOI 10.1161/01.RES.52.1.45; Haigney MC, 2009, HEART RHYTHM, V6, P180, DOI 10.1016/j.hrthm.2008.10.045; Haigney MC, 2004, J AM COLL CARDIOL, V44, P1481, DOI 10.1016/j.jacc.2004.06.063; KANNEL WB, 1985, J AM COLL CARDIOL, V5, pB141, DOI 10.1016/S0735-1097(85)80545-3; Morales C, 2002, CARDIOVASC PATHOL, V11, P339, DOI 10.1016/S1054-8807(02)00115-1; Morin DP, 2009, EUR HEART J, V30, P2908, DOI 10.1093/eurheartj/ehp321; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Myerburg RJ, 2008, NEW ENGL J MED, V359, P2245, DOI 10.1056/NEJMra0803409; Obreztchikova MN, 2003, CIRCULATION, V108, P1389, DOI 10.1161/01.CIR.0000086461.86642.22; Okin PM, 2009, J ELECTROCARDIOL, V42, P584, DOI 10.1016/j.jelectrocard.2009.06.020; OKIN PM, 1995, HYPERTENSION, V25, P242, DOI 10.1161/01.HYP.25.2.242; Ostman-Smith I, 2010, EUR HEART J, V31, P439, DOI 10.1093/eurheartj/ehp443; Peters NS, 1998, CIRCULATION, V97, P1746, DOI 10.1161/01.CIR.97.17.1746; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pietrasik G, 2007, AM J CARDIOL, V100, P583, DOI 10.1016/j.amjcard.2007.03.063; PYE MP, 1992, CARDIOVASC RES, V26, P740, DOI 10.1093/cvr/26.8.740; Sipido KR, 2000, CIRCULATION, V102, P2137, DOI 10.1161/01.CIR.102.17.2137; Spach MS, 2004, HEART RHYTHM, V1, P500, DOI 10.1016/j.hrthm.2004.06.010; SPACH MS, 1994, J CARDIOVASC ELECTR, V5, P182, DOI 10.1111/j.1540-8167.1994.tb01157.x; Stevenson WG, 1997, J AM COLL CARDIOL, V29, P1180, DOI 10.1016/S0735-1097(97)00065-X; Tereshchenko LG, 2011, J ELECTROCARDIOL, V44, P208, DOI 10.1016/j.jelectrocard.2010.08.012; Tereshchenko LG, 2010, HEART RHYTHM, V7, P1606, DOI 10.1016/j.hrthm.2010.08.022; Tereshchenko LG, 2010, J ELECTROCARDIOL, V43, P548, DOI 10.1016/j.jelectrocard.2010.07.013; Tereshchenko LG, 2011, HEART RHYTHM, V8, pS130; URSELL PC, 1985, CIRC RES, V56, P436, DOI 10.1161/01.RES.56.3.436; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Wachtell K, 2007, CIRCULATION, V116, P700, DOI 10.1161/CIRCULATIONAHA.106.666594; Yeh CC, 2012, J CELL BIOC IN PRESS; Zareba W, 2003, J ELECTROCARDIOL, V36, P101, DOI 10.1016/j.jelectrocard.2003.09.022; Zong W, 2003, COMPUT CARDIOL, V30, P737, DOI 10.1109/CIC.2003.1291261; Zong W, 2006, COMPUT CARDIOL, V33, P377	46	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51812	10.1371/journal.pone.0051812	http://dx.doi.org/10.1371/journal.pone.0051812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251630	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800089
J	Zach, L; Guez, D; Last, D; Daniels, D; Grober, Y; Nissim, O; Hoffmann, C; Nass, D; Talianski, A; Spiegelmann, R; Cohen, ZR; Mardor, Y				Zach, Leor; Guez, David; Last, David; Daniels, Dianne; Grober, Yuval; Nissim, Ouzi; Hoffmann, Chen; Nass, Dvora; Talianski, Alisa; Spiegelmann, Roberto; Cohen, Zvi R.; Mardor, Yael			Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues in Primary and Metastatic Brain Tumors	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MAGNETIC-RESONANCE PERFUSION; RADIATION NECROSIS; MALIGNANT GLIOMA; GLIOBLASTOMA; PSEUDOPROGRESSION; RADIOTHERAPY; RECURRENCE; TEMOZOLOMIDE; DIFFERENTIATION	The current standard of care for newly diagnosed glioblastoma multiforme (GBM) is resection followed by radiotherapy with concomitant and adjuvant temozolomide. Recent studies suggest that nearly half of the patients with early radiological deterioration post treatment do not suffer from tumor recurrence but from pseudoprogression. Similarly, a significant number of patients with brain metastases suffer from radiation necrosis following radiation treatments. Conventional MRI is currently unable to differentiate tumor progression from treatment-induced effects. The ability to clearly differentiate tumor from non-tumoral tissues is crucial for appropriate patient management. Ten patients with primary brain tumors and 10 patients with brain metastases were scanned by delayed contrast extravasation MRI prior to surgery. Enhancement subtraction maps calculated from high resolution MR images acquired up to 75 min after contrast administration were used for obtaining stereotactic biopsies. Histological assessment was then compared with the pre-surgical calculated maps. In addition, the application of our maps for prediction of progression was studied in a small cohort of 13 newly diagnosed GBM patients undergoing standard chemoradiation and followed up to 19.7 months post therapy. The maps showed two primary enhancement populations: the slow population where contrast clearance from the tissue was slower than contrast accumulation and the fast population where clearance was faster than accumulation. Comparison with histology confirmed the fast population to consist of morphologically active tumor and the slow population to consist of non-tumoral tissues. Our maps demonstrated significant correlation with perfusion-weighted MR data acquired simultaneously, although contradicting examples were shown. Preliminary results suggest that early changes in the fast volumes may serve as a predictor for time to progression. These preliminary results suggest that our high resolution MRI-based delayed enhancement subtraction maps may be applied for clear depiction of tumor and non-tumoral tissues in patients with primary brain tumors and patients with brain metastases. Citation: Zach L, Guez D, Last D, Daniels D, Grober Y, et al. (2012) Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues in Primary and Metastatic Brain Tumors. PLoS ONE 7(12): e52008. doi: 10.1371/journal.pone.0052008	[Guez, David; Last, David; Daniels, Dianne; Mardor, Yael] Sheba Med Ctr, Adv Technol Ctr, Ramat Gan, Israel; [Zach, Leor; Talianski, Alisa] Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel; [Grober, Yuval; Nissim, Ouzi; Spiegelmann, Roberto; Cohen, Zvi R.] Sheba Med Ctr, Dept Neurosurg, Ramat Gan, Israel; [Hoffmann, Chen] Sheba Med Ctr, Inst Radiol, Ramat Gan, Israel; [Nass, Dvora] Sheba Med Ctr, Inst Pathol, Ramat Gan, Israel; [Zach, Leor; Daniels, Dianne; Hoffmann, Chen; Spiegelmann, Roberto; Cohen, Zvi R.; Mardor, Yael] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Mardor, Y (corresponding author), Sheba Med Ctr, Adv Technol Ctr, Ramat Gan, Israel.	yael.mardor@sheba.health.gov.il	Zach, Leor/HGU-0915-2022	Daniels, Dianne/0000-0002-0912-8719; guez, david/0000-0002-9143-2575	Kamin program of the Israeli Ministry of Industry and Commerce	Kamin program of the Israeli Ministry of Industry and Commerce	This research is supported by the Kamin program of the Israeli Ministry of Industry and Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2012, CURR ONCOL REP, V14, P79, DOI 10.1007/s11912-011-0201-0; Aronen HJ, 2002, NEUROIMAG CLIN N AM, V12, P501, DOI 10.1016/S1052-5149(02)00026-6; Barajas RF, 2009, RADIOLOGY, V253, P486, DOI 10.1148/radiol.2532090007; Barboriak DP, 2008, J MAGN RESON IMAGING, V27, P1388, DOI 10.1002/jmri.21344; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Brandsma D, 2009, CURR OPIN NEUROL, V22, P633, DOI 10.1097/WCO.0b013e328332363e; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Chamberlain MC, 2007, J NEURO-ONCOL, V82, P81, DOI 10.1007/s11060-006-9241-y; Chan YL, 2003, J COMPUT ASSIST TOMO, V27, P674, DOI 10.1097/00004728-200309000-00003; Chaskis C, 2009, SURG NEUROL, V72, P423, DOI 10.1016/j.surneu.2008.09.023; Covarrubias DJ, 2004, ONCOLOGIST, V9, P528, DOI 10.1634/theoncologist.9-5-528; de Wit MCY, 2004, NEUROLOGY, V63, P535, DOI 10.1212/01.WNL.0000133398.11870.9A; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Fink J, 2011, CURR TREAT OPTION ON, V12, P240, DOI 10.1007/s11864-011-0157-1; FORSYTH PA, 1995, J NEUROSURG, V82, P436, DOI 10.3171/jns.1995.82.3.0436; Gahramanov S, 2011, INT J RADIAT ONCOL, V79, P514, DOI 10.1016/j.ijrobp.2009.10.072; Gasparetto EL, 2009, RADIOLOGY, V250, P887, DOI 10.1148/radiol.2502071444; Hazle JD, 1997, JMRI-J MAGN RESON IM, V7, P1084, DOI 10.1002/jmri.1880070622; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; Hu LS, 2012, NEUROONCOL; Israeli D, 2011, INT J BIOL SCI, V7, P1; Jahangiri A, 2012, NEUROSURG CLIN N AM, V23, P277, DOI 10.1016/j.nec.2012.01.002; Kim JH, 2012, AM J SURG PATHOL, V36, P620, DOI 10.1097/PAS.0b013e318246040c; Kim YH, 2010, CLIN NEUROL NEUROSUR, V112, P758, DOI 10.1016/j.clineuro.2010.06.005; Kunz M, 2011, NEURO-ONCOLOGY, V13, P307, DOI 10.1093/neuonc/noq196; Lacerda S, 2009, NEUROIMAG CLIN N AM, V19, P527, DOI 10.1016/j.nic.2009.08.007; Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653; Mangla R, 2010, RADIOLOGY, V256, P575, DOI 10.1148/radiol.10091440; Matsusue E, 2010, NEURORADIOLOGY, V52, P297, DOI 10.1007/s00234-009-0613-9; Mills SJ, 2010, AM J NEURORADIOL, V31, P726, DOI 10.3174/ajnr.A1925; MOSES LE, 1952, PSYCHOL BULL, V49, P122, DOI 10.1037/h0056813; Narang J, 2011, NEURO-ONCOLOGY, V13, P1037, DOI 10.1093/neuonc/nor075; Nelson SJ, 2011, NMR BIOMED, V24, P734, DOI 10.1002/nbm.1669; Perry A, 2006, ACTA NEUROPATHOL, V111, P197, DOI 10.1007/s00401-005-0023-y; Peto R, 1972, J ROY STAT SOC A STA, V135, P195; Rane N, 2012, CLIN RADIOL, V67, P61, DOI 10.1016/j.crad.2011.01.010; Ricci PE, 1998, AM J NEURORADIOL, V19, P407; Rock JP, 2004, NEUROSURGERY, V54, P1111, DOI 10.1227/01.NEU.0000119328.56431.A7; Russell SM, 2009, SURG NEUROL, V72, P242, DOI 10.1016/j.surneu.2008.11.012; Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6; Stadnik TW, 2001, AM J NEURORADIOL, V22, P969; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sugahara T, 2000, AM J NEURORADIOL, V21, P901; Taal W, 2008, CANCER, V113, P405, DOI 10.1002/cncr.23562; Tihan T, 2006, HUM PATHOL, V37, P272, DOI 10.1016/j.humpath.2005.11.010; Tonn JC, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mds363; Tsuyuguchi N, 2004, ANN NUCL MED, V18, P291, DOI 10.1007/BF02984466; van den Bent MJ, 2009, J CLIN ONCOL, V27, P2905, DOI 10.1200/JCO.2009.22.4998; Varallyay CG, 2009, J CEREBR BLOOD F MET, V29, P853, DOI 10.1038/jcbfm.2008.162; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Xu JL, 2010, NEURORADIOLOGY, V52, P1193, DOI 10.1007/s00234-010-0731-4; Young RJ, 2011, NEUROLOGY, V76, P1918, DOI 10.1212/WNL.0b013e31821d74e7; Zeng QS, 2007, J NEURO-ONCOL, V84, P63, DOI 10.1007/s11060-007-9341-3	54	26	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52008	10.1371/journal.pone.0052008	http://dx.doi.org/10.1371/journal.pone.0052008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251672	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800127
J	Zhao, L; Hoi, SCH; Wong, LS; Hamp, T; Li, JY				Zhao, Liang; Hoi, Steven C. H.; Wong, Limsoon; Hamp, Tobias; Li, Jinyan			Structural and Functional Analysis of Multi-Interface Domains	PLOS ONE			English	Article							PROTEIN-STRUCTURE ALIGNMENT; SITES; PREDICTION; INTERFACES; COOPERATIVITY; COMPLEXES; CONSENSUS; FAMILIES; DATABASE; ANCHOR	A multi-interface domain is a domain that can shape multiple and distinctive binding sites to contact with many other domains, forming a hub in domain-domain interaction networks. The functions played by the multiple interfaces are usually different, but there is no strict bijection between the functions and interfaces as some subsets of the interfaces play the same function. This work applies graph theory and algorithms to discover fingerprints for the multiple interfaces of a domain and to establish associations between the interfaces and functions, based on a huge set of multi-interface proteins from PDB. We found that about 40% of proteins have the multi-interface property, however the involved multi-interface domains account for only a tiny fraction (1.8%) of the total number of domains. The interfaces of these domains are distinguishable in terms of their fingerprints, indicating the functional specificity of the multiple interfaces in a domain. Furthermore, we observed that both cooperative and distinctive structural patterns, which will be useful for protein engineering, exist in the multiple interfaces of a domain. Citation: Zhao L, Hoi SCH, Wong L, Hamp T, Li J (2012) Structural and Functional Analysis of Multi-Interface Domains. PLoS ONE 7(12): e50821. doi:10.1371/journal.pone.0050821	[Zhao, Liang; Hoi, Steven C. H.] Nanyang Technol Univ, Sch Comp Engn, Singapore, Singapore; [Wong, Limsoon] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore; [Hamp, Tobias] Tech Univ Munich, Munich, Germany; [Li, Jinyan] Univ Technol Sydney, Adv Analyt Inst, Sydney, NSW 2007, Australia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Technical University of Munich; University of Technology Sydney	Hoi, SCH (corresponding author), Nanyang Technol Univ, Sch Comp Engn, Singapore, Singapore.	chhoi@ntu.edu.sg; Jinyan.Li@uts.edu.au	Wong, Limsoon/E-5033-2010; Wong, Limsoon/W-3611-2019; HOI, Steven C. H./A-3736-2011	Wong, Limsoon/0000-0003-1241-5441; Wong, Limsoon/0000-0003-1241-5441; Hoi, Steven/0000-0002-4584-3453; Li, Jinyan/0000-0003-1833-7413	Nanyang Technological University Tier-1 [RG66/07]	Nanyang Technological University Tier-1(Nanyang Technological University)	This work was supported in part by Nanyang Technological University Tier-1 grant RG66/07. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A. K., 2009, CELLULAR MOL IMMUNOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjorkholm P, 2009, BIOINFORMATICS, V25, P3020, DOI 10.1093/bioinformatics/btp522; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Cho KI, 2006, PROTEINS, V65, P593, DOI 10.1002/prot.21056; Crowley PB, 2008, BIOCHEMISTRY-US, V47, P6583, DOI 10.1021/bi800125h; Dasgupta B, 2011, J MOL BIOL, V411, P713, DOI 10.1016/j.jmb.2011.06.027; de Araujo AFP, 2005, PROTEIN PEPTIDE LETT, V12, P223, DOI 10.2174/0929866053587101; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; Greenbaum JA, 2007, J MOL RECOGNIT, V20, P75, DOI 10.1002/jmr.815; Guntas G, 2010, P NATL ACAD SCI USA, V107, P19296, DOI 10.1073/pnas.1006528107; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hu J, 2010, PROTEIN PEPTIDE LETT, V17, P1450, DOI 10.2174/0929866511009011450; Huan, 2004, P 8 ANN INT C RES CO, P308; Huan J, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P549; Huang J, 2008, P NATL ACAD SCI USA, V105, P6578, DOI 10.1073/pnas.0801097105; Itzhaki Z, 2010, BIOINFORMATICS, V26, P2564, DOI 10.1093/bioinformatics/btq495; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kinjo AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031437; Kinjo AR, 2010, J MOL BIOL, V399, P526, DOI 10.1016/j.jmb.2010.04.028; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Li YL, 2005, STRUCTURE, V13, P297, DOI 10.1016/j.str.2004.12.012; Meinl T, 2006, ECEASST, V1; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Narayan V, 2011, J BIOL CHEM, V286, P14291, DOI 10.1074/jbc.M110.204602; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Shulman-Peleg A, 2008, NUCLEIC ACIDS RES, V36, pW260, DOI 10.1093/nar/gkn185; Tropsha A, 2003, METHOD ENZYMOL, V374, P509, DOI 10.1016/S0076-6879(03)74022-1; Tyagi M, 2009, PROTEIN SCI, V18, P1674, DOI 10.1002/pro.181; Uno Takeaki, 2005, P 1 INT WORKSHOP OPE, P77, DOI DOI 10.1145/1133905.1133916; Vishveshwara S., 2002, J THEOR COMPUT CHEM, V1, P187, DOI DOI 10.1142/S0219633602000117; Wangikar PP, 2003, J MOL BIOL, V326, P955, DOI 10.1016/S0022-2836(02)01384-0; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x; Zhao L, 2009, IEEE INT C BIO BIO W, P163; Zhao L, 2011, IEEE ACM T COMPUT BI, V8, P1483, DOI 10.1109/TCBB.2011.49; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	54	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50821	10.1371/journal.pone.0050821	http://dx.doi.org/10.1371/journal.pone.0050821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272073	Green Published, gold			2022-12-27	WOS:000312386800017
J	Chambers, MC; Song, KH; Schneider, DS				Chambers, Moria C.; Song, Kyung Han; Schneider, David S.			Listeria monocytogenes Infection Causes Metabolic Shifts in Drosophila melanogaster	PLOS ONE			English	Article							IMMUNE FUNCTION; URATE OXIDASE; TRADE-OFFS; PROVIDES; DEFENSE; MODEL	Immunity and metabolism are intimately linked; manipulating metabolism, either through diet or genetics, has the power to alter survival during infection. However, despite metabolism's powerful ability to alter the course of infections, little is known about what being "sick'' means metabolically. Here we describe the metabolic changes occurring in a model system when Listeria monocytogenes causes a lethal infection in Drosophila melanogaster. L. monocytogenes infection alters energy metabolism; the flies gradually lose both of their energy stores, triglycerides and glycogen, and show decreases in both intermediate metabolites and enzyme message for the two main energy pathways, beta-oxidation and glycolysis. L. monocytogenes infection also causes enzymatic reduction in the anti-oxidant uric acid, and knocking out the enzyme uric oxidase has a complicated effect on immunity. Free amino acid levels also change during infection, including a drop in tyrosine levels which may be due to robust L. monocytogenes induced melanization.	[Chambers, Moria C.; Song, Kyung Han; Schneider, David S.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Schneider, DS (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	dschneider@stanford.edu		Chambers, Moria/0000-0002-2577-549X	National Institutes of Health Directors Pioneer Award [8DP1AT007753-02]; Ellison Medical Foundation; National Center for Complementary & Integrative Health [DP1AT007753] Funding Source: NIH RePORTER	National Institutes of Health Directors Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Directors Pioneer Award 8DP1AT007753-02 and a Senior Scholar in Aging Award from the Ellison Medical Foundation; http://www.ellisonfoundation.org/program/aging-senior-scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2010, ANIM BEHAV, V79, P3, DOI 10.1016/j.anbehav.2009.10.012; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Brown AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004490; Chambers MC, 2012, PLOS PATHOG IN PRESS; Cherry S, 2006, PLOS PATHOG, V2, P900, DOI 10.1371/journal.ppat.0020102; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Il'yasova D, 2010, CANCER EPIDEM BIOMAR, V19, P1506, DOI 10.1158/1055-9965.EPI-10-0211; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; Sun Y, 2010, INFECT IMMUN, V78, P4667, DOI 10.1128/IAI.00546-10; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854	20	68	70	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50679	10.1371/journal.pone.0050679	http://dx.doi.org/10.1371/journal.pone.0050679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272066	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386600013
J	Park, SC; Kim, YH; Ji, CY; Park, S; Jeong, JC; Lee, HS; Kwak, SS				Park, Sung-Chul; Kim, Yun-Hee; Ji, Chang Yoon; Park, Seyeon; Jeong, Jae Cheol; Lee, Haeng-Soon; Kwak, Sang-Soo			Stable Internal Reference Genes for the Normalization of Real-Time PCR in Different Sweetpotato Cultivars Subjected to Abiotic Stress Conditions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; PHOSPHOLIPASE-D; HOUSEKEEPING GENES; EXPRESSION; SELECTION; VALIDATION; IDENTIFICATION; INVOLVEMENT; ROOTS	Reverse transcription quantitative real-time PCR (RT-qPCR) has become one of the most widely used methods for gene expression analysis, but its successful application depends on the stability of suitable reference genes used for data normalization. In plant studies, the choice and optimal number of reference genes must be experimentally determined for the specific conditions, plant species, and cultivars. In this study, ten candidate reference genes of sweetpotato (Ipomoea batatas) were isolated and the stability of their expression was analyzed using two algorithms, geNorm and NormFinder. The samples consisted of tissues from four sweetpotato cultivars subjected to four different environmental stress treatments, i.e., cold, drought, salt and oxidative stress. The results showed that, for sweetpotato, individual reference genes or combinations thereof should be selected for use in data normalization depending on the experimental conditions and the particular cultivar. In general, the genes ARF, UBI, COX, GAP and RPL were validated as the most suitable reference gene set for every cultivar across total tested samples. Interestingly, the genes ACT and TUB, although widely used, were not the most suitable reference genes in different sweetpotato sample sets. Taken together, these results provide guidelines for reference gene(s) selection under different experimental conditions. In addition, they serve as a foundation for the more accurate and widespread use of RT-qPCR in various sweetpotato cultivars.	[Park, Sung-Chul; Kim, Yun-Hee; Ji, Chang Yoon; Park, Seyeon; Jeong, Jae Cheol; Lee, Haeng-Soon; Kwak, Sang-Soo] Korea Res Inst Biosci & Biotechnol, Environm Biotechnol Res Ctr, Taejon, South Korea; [Park, Sung-Chul; Ji, Chang Yoon; Park, Seyeon; Lee, Haeng-Soon; Kwak, Sang-Soo] Univ Sci & Technol, Dept Green Chem & Environm Biotechnol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kwak, SS (corresponding author), Korea Res Inst Biosci & Biotechnol, Environm Biotechnol Res Ctr, Taejon, South Korea.	sskwak@kribb.re.kr			National Center for GM Crops [PJ008097]; Systems & Synthetic Agrobiotech Center [PJ008119]; Biogreen21 Project for Next Generation Rural Development Administration, Korea; KRIBB initiative program	National Center for GM Crops; Systems & Synthetic Agrobiotech Center; Biogreen21 Project for Next Generation Rural Development Administration, Korea; KRIBB initiative program	This work was supported by grants from the National Center for GM Crops (PJ008097) and the Systems & Synthetic Agrobiotech Center (PJ008119), Biogreen21 Project for Next Generation Rural Development Administration, Korea and the KRIBB initiative program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kim KY, 1999, MOL GEN GENET, V261, P941, DOI 10.1007/s004380051041; Kim SH, 2009, BMB REP, V42, P271, DOI 10.5483/BMBRep.2009.42.5.271; Kim YH, 2011, PLANT PHYSIOL BIOCH, V49, P1436, DOI 10.1016/j.plaphy.2011.09.002; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Oki T, 2002, J FOOD SCI, V67, P1752, DOI 10.1111/j.1365-2621.2002.tb08718.x; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Park SC, 2011, PLANTA, V233, P621, DOI 10.1007/s00425-010-1326-3; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Teow CC, 2007, FOOD CHEM, V103, P829, DOI 10.1016/j.foodchem.2006.09.033; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; UEKI J, 1995, PLANT CELL PHYSIOL, V36, P903, DOI 10.1093/oxfordjournals.pcp.a078837; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Xu LW, 1997, PLANT PHYSIOL, V115, P387, DOI 10.1104/pp.115.2.387; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044	41	58	69	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51502	10.1371/journal.pone.0051502	http://dx.doi.org/10.1371/journal.pone.0051502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251557	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200124
J	Badr, G; Al-Sadoon, MK; Abdel-Maksoud, MA; Rabah, DM; El-Toni, AM				Badr, Gamal; Al-Sadoon, Mohamed K.; Abdel-Maksoud, Mostafa A.; Rabah, Danny M.; El-Toni, Ahmed M.			Cellular and Molecular Mechanisms Underlie the Anti-Tumor Activities Exerted by Walterinnesia aegyptia Venom Combined with Silica Nanoparticles against Multiple Myeloma Cancer Cell Types	PLOS ONE			English	Article							VIPERA-LEBETINA-TURANICA; CHEMOKINE RECEPTORS; IN-VIVO; KAPPA-B; APOPTOSIS; GROWTH; INDUCTION; TOXIN; THERAPY; CXCR4	Multiple myeloma (MM) is a clonal disease of plasma cells that remains incurable despite the advent of several novel therapeutics. In this study, we aimed to delineate the impact of snake venom extracted from Walterinnesia aegyptia (WEV) alone or in combination with silica nanoparticles (WEV+NP) on primary MM cells isolated from patients diagnosed with MM as well as on two MM cell lines, U266 and RPMI 8226. The IC50 values of WEV and WEV+NP that significantly decreased MM cell viability without affecting the viability of normal peripheral mononuclear cells (PBMCs) were determined to be 25 ng/ml and 10 ng/ml, respectively. Although both WEV (25 ng/ml) and WEV+NP (10 ng/ml) decreased the CD54 surface expression without affecting the expression of CXCR4 (CXCL12 receptor) on MM cells, they significantly reduced the ability of CXC chemokine ligand 12 (CXCL12) to induce actin cytoskeleton rearrangement and the subsequent reduction in chemotaxis. It has been established that the binding of CXCL12 to its receptor CXCR4 activates multiple intracellular signal transduction pathways that regulate MM cell chemotaxis, adhesion, and proliferation. We found that WEV and WEV+NP clearly decreased the CXCL12/CXCR4-mediated activation of AKT, ERK, NF kappa B and Rho-A using western blot analysis; abrogated the CXCL12-mediated proliferation of MM cells using the CFSE assay; and induced apoptosis in MM cell as determined by PI/annexin V double staining followed by flow cytometry analysis. Monitoring the expression of B-cell CCL/Lymphoma 2 (Bcl-2) family members and their role in apoptosis induction after treatment with WEV or WEV+NP revealed that the combination of WEV with NP robustly decreased the expression of the anti-apoptotic effectors Bcl-2, Bcl(XL) and Mcl-1; conversely increased the expression of the pro-apoptotic effectors Bak, Bax and Bim; and altered the mitochondrial membrane potential in MM cells. Taken together, our data reveal the biological effects of WEV and WEV+NP and the underlying mechanisms against myeloma cancer cells.	[Badr, Gamal; Rabah, Danny M.] King Saud Univ, Coll Med, Princess Johara Alibrahim Ctr Canc Res, Prostate Canc Res Chair, Riyadh 11461, Saudi Arabia; [Badr, Gamal] Assiut Univ, Fac Sci, Dept Zool, Immunol & Mol Biol Lab, Assiut, Egypt; [Al-Sadoon, Mohamed K.; Abdel-Maksoud, Mostafa A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11461, Saudi Arabia; [Rabah, Danny M.] King Saud Univ, Coll Med, Dept Urol Surg, Riyadh 11461, Saudi Arabia; [El-Toni, Ahmed M.] King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh 11461, Saudi Arabia; [El-Toni, Ahmed M.] CMRDI, Helwan, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Assiut University; King Saud University; King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); Central Metallurgical Research & Development Institute (CMRDI); Helwan University	Badr, G (corresponding author), King Saud Univ, Coll Med, Princess Johara Alibrahim Ctr Canc Res, Prostate Canc Res Chair, Riyadh 11461, Saudi Arabia.	badr73@yahoo.com	Badr, Gamal/I-4891-2014; Rabah, Danny/J-2709-2018; El-Toni, Ahmed/D-1594-2015	Badr, Gamal/0000-0002-6157-7319; Rabah, Danny/0000-0002-0092-5789; El-Toni, Ahmed/0000-0002-3667-8812; Abdel-Maksoud, Mostafa A./0000-0002-6964-4846	National Plan for Science and Technology; King Abdulaziz City for Science and Technology [10-BIO969-02]	National Plan for Science and Technology; King Abdulaziz City for Science and Technology	This work was supported by the National Plan for Science and Technology (http://npst.ksu.edu.sa/index.php?module=news&page=details_en&id=40) funded by King Abdulaziz City for Science and Technology (http://www.kacst.edu.sa/en/Pages/default.aspx) through project number 10-BIO969-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2006, EXP HEMATOL, V34, P1289, DOI 10.1016/j.exphem.2006.06.017; Al-Sadoon MK, 2012, CELL PHYSIOL BIOCHEM, V30, P653, DOI 10.1159/000341446; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Arya M, 2003, CURR MED RES OPIN, V19, P557, DOI 10.1185/030079903125002216; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Badr G, 2005, J IMMUNOL, V175, P302, DOI 10.4049/jimmunol.175.1.302; Badr G, 2012, LIPIDS HLTH DIS, V15, P11; Badr G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023741; Barratt G, 2003, CELL MOL LIFE SCI, V60, P21, DOI 10.1007/s000180300002; Bruckheimer EM, 2000, CELL TISSUE RES, V301, P153, DOI 10.1007/s004410000196; Chen DZ, 2012, INT J NANOMED, V7, P4973, DOI 10.2147/IJN.S35140; Coleman EJ, 2006, J IMMUNOTHER, V29, P489, DOI 10.1097/01.cji.0000210079.52554.c3; D'Souza M.J., 2012, J DRUG TARGET; dos Santos T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024438; El-Toni AM, 2012, J COLLOID INTERF SCI, V378, P83, DOI 10.1016/j.jcis.2012.04.006; Francis S., 2001, HAEMOSTASIS, V31, P183; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gao Q, 2012, MOL MED REP, V5, P1409, DOI 10.3892/mmr.2012.840; Haque F, 2012, NANO TODAY, V7, P245, DOI 10.1016/j.nantod.2012.06.010; Helferman MJ, 2010, ANTICANCER RES, V30, P73; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Ishii Y, 2006, CANCER GENET CYTOGEN, V167, P131, DOI 10.1016/j.cancergencyto.2006.01.002; Johrer K, 2012, EXPERT OPIN BIOL TH, V12, P425, DOI 10.1517/14712598.2012.664128; Koo H, 2011, ACCOUNTS CHEM RES, V44, P1018, DOI 10.1021/ar2000138; Koppolu B, 2012, J BIOMED NANOTECHNOL, V8, P983, DOI 10.1166/jbn.2012.1465; Kouri FM, 2012, SCI WORLD J, P1, DOI 10.1100/2012/838916; Kozako T, 2012, INT J NANOMED, V7, P4943, DOI 10.2147/IJN.S30726; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Lam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040152; Lim SM, 2011, BIOMATERIALS, V32, P3538, DOI 10.1016/j.biomaterials.2011.01.054; Luhmann T, 2008, BIOCONJUGATE CHEM, V19, P1907, DOI 10.1021/bc800206r; Menu E, 2006, HAEMATOLOGICA, V91, P605; Moller C, 2003, LEUKEMIA, V17, P203, DOI 10.1038/sj.leu.2402717; Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018; Nishihori T, 2011, CANCER CONTROL, V18, P258, DOI 10.1177/107327481101800406; Oliva IB, 2007, TOXICON, V50, P1053, DOI 10.1016/j.toxicon.2007.07.016; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Park MH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-228; Park MH, 2009, ARCH PHARM RES, V32, P1545, DOI 10.1007/s12272-009-2106-0; Pelus LM, 2002, CRIT REV ONCOL HEMAT, V43, P257, DOI 10.1016/S1040-8428(01)00202-5; Picot J, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15410; Rossi M, 2012, CURR CANCER DRUG TAR, V12, P757, DOI 10.2174/156800912802429300; Salido M, 2007, MOL CANCER THER, V6, P1292, DOI 10.1158/1535-7163.MCT-06-0681; Son DJ, 2007, MOL CANCER THER, V6, P675, DOI 10.1158/1535-7163.MCT-06-0328; Song JH, 2012, CANCER RES, V72, P294, DOI 10.1158/0008-5472.CAN-11-3240; Song JK, 2012, ARCH PHARM RES, V35, P867, DOI 10.1007/s12272-012-0512-1; Sun H, 2012, ANTI-CANCER DRUG, V23, P1039, DOI 10.1097/CAD.0b013e32835679b8; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tiberio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039968; Tuchman SA, 2012, ADV HEMATOL, V2012; Wang JQ, 2010, CURR DRUG METAB, V11, P129, DOI 10.2174/138920010791110827; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9; Zhang Aiqun, 2004, Neuroembryology, V3, P47, DOI 10.1159/000085404; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039870; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhao WR, 2005, J AM CHEM SOC, V127, P8916, DOI 10.1021/ja051113r	57	15	15	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51661	10.1371/journal.pone.0051661	http://dx.doi.org/10.1371/journal.pone.0051661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251606	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900113
J	Lamothe, B; Lai, YJ; Hur, L; Orozco, NM; Wang, J; Campos, AD; Xie, M; Schneider, MD; Lockworth, CR; Jakacky, J; Tran, D; Ho, M; Dawud, S; Dong, C; Lin, HK; Hu, P; Estrov, Z; Bueso-Ramos, CE; Darnay, BG				Lamothe, Betty; Lai, YunJu; Hur, Lana; Orozco, Natalia Martin; Wang, Jing; Campos, Alejandro D.; Xie, Min; Schneider, Michael D.; Lockworth, Cynthia R.; Jakacky, Jared; Tran, Diep; Ho, Michael; Dawud, Sity; Dong, Chen; Lin, Hui-Kuan; Hu, Peter; Estrov, Zeev; Bueso-Ramos, Carlos E.; Darnay, Bryant G.			Deletion of TAK1 in the Myeloid Lineage Results in the Spontaneous Development of Myelomonocytic Leukemia in Mice	PLOS ONE			English	Article							NF-KAPPA-B; CHROMOSOMAL INSTABILITY; SIGNALING PATHWAYS; KINASE ACTIVATION; IKK-BETA; CANCER; REGULATOR; APOPTOSIS; PHOSPHORYLATION; DIFFERENTIATION	Previous studies of the conditional ablation of TGF-beta activated kinase 1 (TAK1) in mice indicate that TAK1 has an obligatory role in the survival and/or development of hematopoietic stem cells, B cells, T cells, hepatocytes, intestinal epithelial cells, keratinocytes, and various tissues, primarily because of these cells' increased apoptotic sensitivity, and have implicated TAK1 as a critical regulator of the NF-kappa B and stress kinase pathways and thus a key intermediary in cellular survival. Contrary to this understanding of TAK1's role, we report a mouse model in which TAK1 deletion in the myeloid compartment that evoked a clonal myelomonocytic cell expansion, splenomegaly, multi-organ infiltration, genomic instability, and aggressive, fatal myelomonocytic leukemia. Unlike in previous reports, simultaneous deletion of TNF receptor 1 (TNFR1) failed to rescue this severe phenotype. We found that the features of the disease in our mouse model resemble those of human chronic myelomonocytic leukemia (CMML) in its transformation to acute myeloid leukemia (AML). Consequently, we found TAK1 deletion in 13 of 30 AML patients (43%), thus providing direct genetic evidence of TAK1's role in leukemogenesis.	[Lamothe, Betty; Lai, YunJu; Hur, Lana; Campos, Alejandro D.; Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Orozco, Natalia Martin; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Wang, Jing; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xie, Min] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, London, England; [Lockworth, Cynthia R.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Jakacky, Jared; Tran, Diep; Ho, Michael; Dawud, Sity; Hu, Peter] Univ Texas MD Anderson Canc Ctr, Sch Hlth Profess, Houston, TX 77030 USA; [Estrov, Zeev] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Bueso-Ramos, Carlos E.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Imperial College London; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Darnay, BG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	bdarnay@mdanderson.org	dong, chen/B-3181-2009; Lai, Yun-Ju/AAV-7018-2021	dong, chen/0000-0002-0084-9130; Lai, Yun-Ju/0000-0003-0802-937X; Schneider, Michael/0000-0001-9645-1938	National Institutes of Health through the MD Anderson Cancer Center Support Grant [CA016672]; National Institutes of Health [R01AR053540]; Ladies Leukemia Foundation; National Cancer Institute (NCI Leukemia SPORE) [P50 CA100632-06]; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053540] Funding Source: NIH RePORTER	National Institutes of Health through the MD Anderson Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ladies Leukemia Foundation; National Cancer Institute (NCI Leukemia SPORE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported in part by the National Institutes of Health through the MD Anderson Cancer Center Support Grant (CA016672); National Institutes of Health grant R01AR053540 (BGD), the Ladies Leukemia Foundation (BGD), and the National Cancer Institute (NCI Leukemia SPORE P50 CA100632-06 to CB-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dohner K, 2008, HAEMATOL-HEMATOL J, V93, P976, DOI 10.3324/haematol.13345; Eftychi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031550; Fan YH, 2011, CELL SIGNAL, V23, P660, DOI 10.1016/j.cellsig.2010.11.017; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Germing U, 2004, LEUKEMIA LYMPHOMA, V45, P1311, DOI 10.1080/1042819042000207271; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gunnell LM, 2010, J BONE MINER RES, V25, P1784, DOI 10.1002/jbmr.79; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Liu W, 2007, CLIN CANCER RES, V13, P5028, DOI 10.1158/1078-0432.CCR-07-0300; Mankan AK, 2011, P NATL ACAD SCI USA, V108, P6567, DOI 10.1073/pnas.1018331108; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Sakurai H, 2012, TRENDS PHARM SCI; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wiktor AE, 2006, GENET MED, V8, P16, DOI 10.1097/01.gim.0000195645.00446.61; Wu M, 2012, CANCER RES, V72, P2833, DOI 10.1158/0008-5472.CAN-11-2724; Xiao Y, 2011, BLOOD; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387	52	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51228	10.1371/journal.pone.0051228	http://dx.doi.org/10.1371/journal.pone.0051228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251462	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900055
J	Martinez-Martinez, E; Zaragoza, ML; Solano, E; Figueroa, B; Zuniga, P; Laclette, JP				Martinez-Martinez, Eduardo; Luisa Zaragoza, Maria; Solano, Elmer; Figueroa, Brenda; Zuniga, Patricia; Laclette, Juan P.			Health Research Funding in Mexico: The Need for a Long-Term Agenda	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; INSTITUTES-OF-HEALTH; SETTING PRIORITIES; RESEARCH SYSTEMS; BURDEN; DISEASE; REFORM	Background: The legal framework and funding mechanisms of the national health research system were recently reformed in Mexico. A study of the resource allocation for health research is still missing. We identified the health research areas funded by the National Council on Science and Technology (CONACYT) and examined whether research funding has been aligned to national health problems. Methods and Findings: We collected the information to create a database of research grant projects supported through the three main Sectoral Funds managed by CONACYT between 2003 and 2010. The health-related projects were identified and classified according to their methodological approach and research objective. A correlation analysis was carried out to evaluate the association between disease-specific funding and two indicators of disease burden. From 2003 to 2010, research grant funding increased by 32% at a compound annual growth rate of 3.5%. By research objective, the budget fluctuated annually resulting in modest increments or even decrements during the period under analysis. The basic science category received the largest share of funding (29%) while the less funded category was violence and accidents (1.4%). The number of deaths (rho = 0.51; P < 0.001) and disability-adjusted life years (DALYs; rho = 0.33; P = 0.004) were weakly correlated with the funding for health research. Considering the two indicators, poisonings and infectious and parasitic diseases were among the most overfunded conditions. In contrast, congenital anomalies, road traffic accidents, cerebrovascular disease, and chronic obstructive pulmonary disease were the most underfunded conditions. Conclusions: Although the health research funding has grown since the creation of CONACYT sectoral funds, the financial effort is still low in comparison to other Latin American countries with similar development. Furthermore, the great diversity of the funded topics compromises the efficacy of the investment. Better mechanisms of research priority-setting are required to adjust the research portfolio to the new health panorama of Mexican population.	[Martinez-Martinez, Eduardo; Luisa Zaragoza, Maria; Solano, Elmer; Figueroa, Brenda; Zuniga, Patricia; Laclette, Juan P.] Foro Consult Cient & Tecnol AC, Coordinac Estadist & Proyectos, Benito Juarez, DF, Mexico; [Laclette, Juan P.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Coyoacan, DF, Mexico	Universidad Nacional Autonoma de Mexico	Laclette, JP (corresponding author), Foro Consult Cient & Tecnol AC, Coordinac Estadist & Proyectos, Benito Juarez, DF, Mexico.	laclette@biomedicas.unam.mx	Martínez, Eduardo Martínez/A-2558-2009	Martínez, Eduardo Martínez/0000-0002-9020-559X				Abbasi K, 2004, BRIT MED J, V329, P1258, DOI 10.1136/bmj.329.7477.1258; Alano JR, 2000, TRACKING COUNTRY RES; Alger J, 2009, REV PANAM SALUD PUBL, V26, P447; Alvarez M, 2010, MEDICC REV, V12, P15, DOI 10.37757/MR2010.V12.N4.4; Aoun S, 2004, AUST NZ J PUBL HEAL, V28, P80, DOI 10.1111/j.1467-842X.2004.tb00637.x; Arundel A, 2010, OECD J GEN PAPERS, V2009, P113; Becerra-Posada F, 2009, SALUD PUBLICA MEXICO, V51, P86; de Arenas JL, 2002, SCIENTOMETRICS, V53, P39; Vianna CMD, 2007, B WORLD HEALTH ORGAN, V85, P124, DOI 10.2471/BLT.06.032383; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Luna-Morales ME, 2009, J AM SOC INF SCI TEC, V60, P1337, DOI 10.1002/asi.21065; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; FRENK J, 1992, SOC SCI MED, V35, P1397, DOI 10.1016/0277-9536(92)90043-P; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Frenk J, 2009, B WORLD HEALTH ORGAN, V87, P542, DOI 10.2471/BLT.08.053199; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Global Forum for Health Research, 2002, 10 90 REP HLTH RES 2; Gonzalez-Block Miguel Angel, 2009, Health Res Policy Syst, V7, P22, DOI 10.1186/1478-4505-7-22; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Lamarre-Cliche M, 2001, CLIN INVEST MED, V24, P83; Maass G., 2004, OECD J BUDGETING, V3, P41; Maceira D, 2009, MONITORING FINANCIAL; Maceira D, 2010, REV PANAM SALUD PUBL, V27, P442; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matthews KRW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029738; Mexico. Secretaria de Salud, 2001, PROGR ACC INV SAL; Mexico Secretaria de Salud, 2001, PROGR ACC INV SAL; Nuyens Y, 2007, B WORLD HEALTH ORGAN, V85, P319, DOI 10.2471/BLT.06.032375; Perez-Nunez R, 2007, MONITORING FINANCIAL; Perez-Tamayo Ruy, 2004, Gac Med Mex, V140 Suppl 1, pS37; Ranson Michael K, 2009, Health Res Policy Syst, V7, P27, DOI 10.1186/1478-4505-7-27; Rudan I, 2012, PUBLIC HEALTH, V126, P237, DOI 10.1016/j.puhe.2011.12.001; Rudan I, 2008, CROAT MED J, V49, P307, DOI 10.3325/cmj.2008.3.307; Singer Hans., 1970, SUSSEX MANIFESTO SCI; Tomlinson M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-19; Guerra ST, 2009, REV PANAM SALUD PUBL, V26, P46, DOI 10.1590/S1020-49892009000700007; Tugwell P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-151; Uribe-Esquivel M, 2007, HLTH SCI PRODUCTION; Vianna CM, 2009, MONITORING FINANCIAL; World Health Organization, 2008, GLOB BURD DIS 2004 U	42	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51195	10.1371/journal.pone.0051195	http://dx.doi.org/10.1371/journal.pone.0051195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	052ML	23251451	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900053
J	Rodrigues, AA; Clemente, TM; dos Santos, MA; Machado, FC; Gomes, RGB; Moreira, HHT; Cruz, MC; Brigido, PC; dos Santos, PCF; Martins, FA; Bahia, D; Maricato, JT; Janini, LMR; Reboredo, EH; Mortara, RA; da Silva, CV				Rodrigues, Adele A.; Clemente, Tatiana M.; dos Santos, Marlus A.; Machado, Fabricio C.; Gomes, Rafael G. B.; Moreira, Heline Hellen T.; Cruz, Mario C.; Brigido, Paula C.; dos Santos, Paulo C. F.; Martins, Flavia A.; Bahia, Diana; Maricato, Juliana T.; Janini, Luiz M. R.; Reboredo, Eduardo H.; Mortara, Renato A.; da Silva, Claudio V.			A Recombinant Protein Based on Trypanosoma cruzi P21 Enhances Phagocytosis	PLOS ONE			English	Article							ACTIVATION; AKT; RECEPTOR; MACROPHAGES; ENDOCYTOSIS; CHEMOTAXIS; RESPONSES; INVASION; PATHWAY; CXCR4	Background: P21 is a secreted protein expressed in all developmental stages of Trypanosoma cruzi. The aim of this study was to determine the effect of the recombinant protein based on P21 (P21-His(6)) on inflammatory macrophages during phagocytosis. Findings: Our results showed that P21-His(6) acts as a phagocytosis inducer by binding to CXCR4 chemokine receptor and activating actin polymerization in a way dependent on the PI3-kinase signaling pathway. Conclusions: Thus, our results shed light on the notion that native P21 is a component related to T. cruzi evasion from the immune response and that CXCR4 may be involved in phagocytosis. P21-His(6) represents an important experimental control tool to study phagocytosis signaling pathways of different intracellular parasites and particles.	[Rodrigues, Adele A.; Clemente, Tatiana M.; dos Santos, Marlus A.; Machado, Fabricio C.; Gomes, Rafael G. B.; Brigido, Paula C.; dos Santos, Paulo C. F.; Martins, Flavia A.; da Silva, Claudio V.] Univ Fed Uberlandia, Inst Ciencias Biomed, BR-38400 Uberlandia, MG, Brazil; [Cruz, Mario C.; Bahia, Diana; Maricato, Juliana T.; Janini, Luiz M. R.; Mortara, Renato A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Moreira, Heline Hellen T.; Reboredo, Eduardo H.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	da Silva, CV (corresponding author), Univ Fed Uberlandia, Inst Ciencias Biomed, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	silva_cv@yahoo.com.br	Mortara, Renato A./C-1864-2012; 4, INCT/H-4499-2013; Maricato, Juliana/F-1608-2012; Cruz, Mario/V-7522-2019; da Silva, Claudio Vieira/AAK-1485-2021; Santos, Paulo César/I-3997-2014; Inbeqmedi, Inct/I-1929-2013; Bahia, Diana/W-3974-2019; Gomes, Rafael Gonçalves Barbosa/W-8926-2019	Mortara, Renato A./0000-0002-2311-8349; da Silva, Claudio Vieira/0000-0002-5052-3139; Gomes, Rafael Gonçalves Barbosa/0000-0002-1428-7685; Janini, Luiz Mario/0000-0002-6186-6284; Machado, Fabricio C/0000-0001-8658-8471; Teixeira Moreira, Heline Hellen/0000-0003-2640-505X; Mordente clemente, Tatiana/0000-0002-0817-7711	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-00621-11]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [23038005295/2011-40]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Process number: APQ-00621-11), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Process number: 23038005295/2011-40) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA A, 1980, EXP PARASITOL, V50, P1, DOI 10.1016/0014-4894(80)90002-8; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Atayde VD, 2008, MELANOMA RES, V18, P172, DOI 10.1097/CMR.0b013e3282feeaab; Barbero S, 2003, CANCER RES, V63, P1969; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Beemiller P, 2010, MOL BIOL CELL, V21, P470, DOI 10.1091/mbc.E08-05-0494; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; da Silva CV, 2009, MICROBES INFECT, V11, P563, DOI 10.1016/j.micinf.2009.03.007; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Elvin SJ, 2004, NATURE, V430, P417, DOI 10.1038/nature02822; Garcia-Exposito L, 2011, MOL BIOL CELL, V22, P1148, DOI 10.1091/mbc.E10-08-0722; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; KAHN S, 1995, J EXP MED, V182, P1243, DOI 10.1084/jem.182.5.1243; Krauss M, 2011, REV PHYSIOL BIOCH P, V161, P45, DOI 10.1007/112_2008_2; Lee EJ, 2011, BIOCHEM BIOPH RES CO, V414, P384, DOI 10.1016/j.bbrc.2011.09.083; Maganto-Garcia E, 2008, TRAFFIC, V9, P1299, DOI 10.1111/j.1600-0854.2008.00760.x; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Okada M, 2012, BIOCHEM BIOPH RES CO, V420, P479, DOI 10.1016/j.bbrc.2012.03.057; Park H, 2011, ARCH BIOCHEM BIOPHYS, V510, P101, DOI 10.1016/j.abb.2011.02.019; Riyahi TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027311; Schwartz V, 2012, EUR J CELL BIOL, V91, P435, DOI 10.1016/j.ejcb.2011.08.006; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vieira M, 2002, HISTOCHEM CELL BIOL, V118, P491, DOI 10.1007/s00418-002-0477-0; Woolsey AM, 2003, J CELL SCI, V116, P3611, DOI 10.1242/jcs.00666	26	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51384	10.1371/journal.pone.0051384	http://dx.doi.org/10.1371/journal.pone.0051384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251513	gold, Green Submitted, Green Published			2022-12-27	WOS:000312201900075
J	Hezel, F; Thalhammer, C; Waiczies, S; Schulz-Menger, J; Niendorf, T				Hezel, Fabian; Thalhammer, Christof; Waiczies, Sonia; Schulz-Menger, Jeanette; Niendorf, Thoralf			High Spatial Resolution and Temporally Resolved T-2* Mapping of Normal Human Myocardium at 7.0 Tesla: An Ultrahigh Field Magnetic Resonance Feasibility Study	PLOS ONE			English	Article							THALASSEMIA MAJOR PATIENTS; CORONARY-ARTERY STENOSIS; NORMAL HUMAN HEART; IN-VIVO; IRON OVERLOAD; CARDIAC MRI; HUMAN BRAIN; BOLD-MRI; OXYGENATION; CAPILLARY	Myocardial tissue characterization using T-2* relaxation mapping techniques is an emerging application of (pre)clinical cardiovascular magnetic resonance imaging. The increase in microscopic susceptibility at higher magnetic field strengths renders myocardial T-2* mapping at ultrahigh magnetic fields conceptually appealing. This work demonstrates the feasibility of myocardial T-2* imaging at 7.0 T and examines the applicability of temporally-resolved and high spatial resolution myocardial T-2* mapping. In phantom experiments single cardiac phase and dynamic (CINE) gradient echo imaging techniques provided similar T-2* maps. In vivo studies showed that the peak-to-peak B-0 difference following volume selective shimming was reduced to approximately 80 Hz for the four chamber view and mid-ventricular short axis view of the heart and to 65 Hz for the left ventricle. No severe susceptibility artifacts were detected in the septum and in the lateral wall for T-2* weighting ranging from TE = 2.04 ms to TE = 10.2 ms. For TE > 7 ms, a susceptibility weighting induced signal void was observed within the anterior and inferior myocardial segments. The longest T-2* values were found for anterior (T-2* = 14.0 ms), anteroseptal (T-2* = 17.2 ms) and inferoseptal (T-2* = 16.5 ms) myocardial segments. Shorter T-2* values were observed for inferior (T-2* = 10.6 ms) and inferolateral (T-2* = 11.4 ms) segments. A significant difference (p = 0.002) in T-2* values was observed between end-diastole and end-systole with T-2* changes of up to approximately 27% over the cardiac cycle which were pronounced in the septum. To conclude, these results underscore the challenges of myocardial T-2* mapping at 7.0 T but demonstrate that these issues can be offset by using tailored shimming techniques and dedicated acquisition schemes.	[Hezel, Fabian; Thalhammer, Christof; Waiczies, Sonia; Schulz-Menger, Jeanette; Niendorf, Thoralf] Max Delbrueck Ctr Mol Med, Berlin Ultrahigh Field Facil BUFF, Berlin, Germany; [Waiczies, Sonia; Schulz-Menger, Jeanette; Niendorf, Thoralf] Expt & Clin Res Ctr, Berlin, Germany; [Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helios Kliniken	Niendorf, T (corresponding author), Max Delbrueck Ctr Mol Med, Berlin Ultrahigh Field Facil BUFF, Berlin, Germany.	Thoralf.Niendorf@mdc-berlin.de	Niendorf, Thoralf/H-7738-2013; Waiczies, Sonia/H-4181-2012	Niendorf, Thoralf/0000-0001-7584-6527; Waiczies, Sonia/0000-0002-9916-9572; Schulz-Menger, Jeanette/0000-0003-3100-1092	Max Delbruck Centrum for Molecular Medicine	Max Delbruck Centrum for Molecular Medicine	This study was founded through institutional funding provided by the Max Delbruck Centrum for Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, IEC60601233; Bauer WR, 1999, MAGN RESON MED, V42, P1004, DOI 10.1002/(SICI)1522-2594(199912)42:6<1004::AID-MRM2>3.0.CO;2-M; Bauer WR, 1999, MAGN RESON MED, V41, P51, DOI 10.1002/(SICI)1522-2594(199901)41:1<51::AID-MRM9>3.0.CO;2-G; Carpenter JP, 2011, CIRCULATION, V123, P1519, DOI 10.1161/CIRCULATIONAHA.110.007641; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Dharmakumar R, 2008, J MAGN RESON IMAGING, V27, P1037, DOI 10.1002/jmri.21345; Donahue MJ, 2011, NMR BIOMED, V24, P25, DOI 10.1002/nbm.1552; Egred M, 2006, EUR J INTERN MED, V17, P551, DOI 10.1016/j.ejim.2006.04.015; Frauenrath T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-67; Frauenrath T, 2009, INVEST RADIOL, V44, P539, DOI 10.1097/RLI.0b013e3181b4c15e; Friedrich MG, 2010, JACC-CARDIOVASC IMAG, V3, P385, DOI 10.1016/j.jcmg.2010.02.001; Friedrich MG, 2003, CIRCULATION, V108, P2219, DOI 10.1161/01.CIR.0000095271.08248.EA; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; He T, 2008, MAGN RESON MED, V60, P350, DOI 10.1002/mrm.21625; He TG, 2007, J MAGN RESON IMAGING, V25, P1205, DOI 10.1002/jmri.20929; Heinrichs U, 2009, MAGN RESON MED, V62, P822, DOI 10.1002/mrm.22054; Hernando D, 2011, MAGN RESON MED; Hetherington HP, 2010, MAGN RESON MED, V63, P9, DOI 10.1002/mrm.22182; Jahnke C, 2010, JACC-CARDIOVASC IMAG, V3, P375, DOI 10.1016/j.jcmg.2009.12.008; Karamitsos TD, 2010, CIRC-CARDIOVASC IMAG, V3, P32, DOI 10.1161/CIRCIMAGING.109.860148; Kirk P, 2010, J MAGN RESON IMAGING, V32, P315, DOI 10.1002/jmri.22245; Kohler S, 2003, MAGNET RESON MED, V49, P371, DOI 10.1002/mrm.10346; Li DB, 1996, MAGNET RESON MED, V36, P16, DOI 10.1002/mrm.1910360105; Manka R, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-54; Mavrogeni S, 2011, HELL J CARDIOL, V52, P385; Meloni A, 2012, MAGN RESON MED, V68, P543, DOI 10.1002/mrm.23236; Meloni A, 2011, J MAGN RESON IMAGING, V33, P348, DOI 10.1002/jmri.22417; Modell B, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-42; O'Regan DP, 2008, EUR RADIOL, V18, P800, DOI 10.1007/s00330-007-0814-8; Pan JW, 2012, MAGN RESON MED, V68, P1007, DOI 10.1002/mrm.24122; Pennell DJ, 2011, HAEMATOL-HEMATOL J, V96, P48, DOI 10.3324/haematol.2010.031468; Pennell DJ, 2010, CIRC-CARDIOVASC IMAG, V3, P2, DOI 10.1161/CIRCIMAGING.109.932079; Pepe A, 2006, J MAGN RESON IMAGING, V23, P662, DOI 10.1002/jmri.20566; Positano V, 2007, NMR BIOMED, V20, P578, DOI 10.1002/nbm.1121; Ramazzotti A, 2008, HEMOGLOBIN, V32, P97, DOI 10.1080/03630260701879514; Reeder SB, 1998, MAGNET RESON MED, V39, P988, DOI 10.1002/mrm.1910390617; REESE TG, 1995, MAGNET RESON MED, V34, P786, DOI 10.1002/mrm.1910340603; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Restaino G, 2011, MAGN RESON MED, V65, P764, DOI 10.1002/mrm.22640; Schar M, 2010, MAGN RESON MED, V63, P419, DOI 10.1002/mrm.22234; Schar M, 2004, MAGN RESON MED, V51, P1091, DOI 10.1002/mrm.20123; Schar M, 2004, MAGN RESON MED, V51, P799, DOI 10.1002/mrm.20024; Shah S, 2009, P INT SOC MAG RESON, V17, P566; Smith GC, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-21; Tanner MA, 2006, HAEMATOLOGICA, V91, P1388; Thalhammer C, 2012, J MAGN RESON IMAGING, V36, P847, DOI 10.1002/jmri.23724; Tsaftaris SA, 2011, P INT SOC MAG RESON; Tsaftaris SA, 2012, J MAGN RESON IMAGING, V35, P1338, DOI 10.1002/jmri.23577; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; Utz W, 2005, ARTERIOSCL THROM VAS, V25, P1408, DOI 10.1161/01.ATV.0000170131.13683.d7; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; Vohringer M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-20; Wacker CM, 1999, MAGN RESON MATER PHY, V8, P48; Wacker CM, 2003, J AM COLL CARDIOL, V41, P834, DOI 10.1016/S0735-1097(02)02931-5; Wacker CM, 1999, MAGN RESON MED, V41, P686, DOI 10.1002/(SICI)1522-2594(199904)41:4<686::AID-MRM6>3.0.CO;2-9; Winter L, 2012, EUR RADIOL, V22, P2211, DOI 10.1007/s00330-012-2487-1; Wu MT, 2006, CIRCULATION, V114, P1036, DOI 10.1161/CIRCULATIONAHA.105.545863; Ziener CH, 2012, MAGN RESON IMAGING, V30, P540, DOI 10.1016/j.mri.2011.12.006	59	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52324	10.1371/journal.pone.0052324	http://dx.doi.org/10.1371/journal.pone.0052324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251708	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000312386800160
J	Cao, SC; Li, BW; Yi, XJ; Chang, B; Zhu, BB; Lian, ZZ; Zhang, ZR; Zhao, G; Liu, HL; Zhang, H				Cao, Shicheng; Li, Bowen; Yi, Xuejie; Chang, Bo; Zhu, Beibei; Lian, Zhenzhen; Zhang, Zhaoran; Zhao, Gang; Liu, Huili; Zhang, He			Effects of Exercise on AMPK Signaling and Downstream Components to PI3K in Rat with Type 2 Diabetes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; STREPTOZOTOCIN-TREATED RAT; INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; PHOSPHATIDYLINOSITOL 3-KINASE; MITOCHONDRIAL BIOGENESIS; ENDURANCE EXERCISE; GLUT4 TRAFFICKING	Exercise can increase skeletal muscle sensitivity to insulin, improve insulin resistance and regulate glucose homeostasis in rat models of type 2 diabetes. However, the potential mechanism remains poorly understood. In this study, we established a male Sprague-Dawley rat model of type 2 diabetes, with insulin resistance and beta cell dysfunction, which was induced by a high-fat diet and low-dose streptozotocin to replicate the pathogenesis and metabolic characteristics of type 2 diabetes in humans. We also investigated the possible mechanism by which chronic and acute exercise improves metabolism, and the phosphorylation and expression of components of AMP-activated protein kinase (AMPK) and downstream components of phosphatidylinositol 3-kinase (PI3K) signaling pathways in the soleus. As a result, blood glucose, triglyceride, total cholesterol, and free fatty acid were significantly increased, whereas insulin level progressively declined in diabetic rats. Interestingly, chronic and acute exercise reduced blood glucose, increased phosphorylation and expression of AMPK alpha 1/2 and the isoforms AMPK alpha 1 and AMPK alpha 2, and decreased phosphorylation and expression of AMPK substrate, acetyl CoA carboxylase (ACC). Chronic exercise upregulated phosphorylation and expression of AMPK upstream kinase, LKB1. But acute exercise only increased LKB1 expression. In particular, exercise reversed the changes in protein kinase C (PKC)zeta/lambda phosphorylation, and PKC zeta phosphorylation and expression. Additionally, exercise also increased protein kinase B (PKB)/Akt1, Akt2 and GLUT4 expression, but AS160 protein expression was unchanged. Chronic exercise elevated Akt (Thr(308)) and (Ser(473)) and AS160 phosphorylation. Finally, we found that exercise increased peroxisome proliferator-activated receptor-c coactivator 1 (PGC1) mRNA expression in the soleus of diabetic rats. These results indicate that both chronic and acute exercise influence the phosphorylation and expression of components of the AMPK and downstream to PIK3 (aPKC, Akt), and improve GLUT4 trafficking in skeletal muscle. These data help explain the mechanism how exercise regulates glucose homeostasis in diabetic rats.	[Cao, Shicheng; Li, Bowen; Lian, Zhenzhen; Zhang, Zhaoran; Zhao, Gang; Liu, Huili; Zhang, He] China Med Univ, Coll Basic Med Sci, Dept Sport Med, Shenyang, Liaoning Provin, Peoples R China; [Yi, Xuejie; Chang, Bo] Shenyang Sport Univ, Dept Exercise Sci, Shenyang, Liaoning Provin, Peoples R China; [Zhu, Beibei] Univ Kentucky, Dept Med, Div Endocrinol, Lexington, KY 40506 USA; [Zhu, Beibei] Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Lexington, KY USA	China Medical University; Shenyang Sport University; University of Kentucky; University of Kentucky	Cao, SC (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Sport Med, Shenyang, Liaoning Provin, Peoples R China.	caoshicheng@tom.com			National Natural Science Foundation of China [30971414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 30971414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Braiman L, 2001, MOL CELL BIOL, V21, P7852, DOI 10.1128/MCB.21.22.7852-7861.2001; Brandt N, 2010, AM J PHYSIOL-ENDOC M, V299, pE215, DOI 10.1152/ajpendo.00098.2010; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Chibalin AV, 2000, P NATL ACAD SCI USA, V97, P38, DOI 10.1073/pnas.97.1.38; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; FOLLI F, 1992, J BIOL CHEM, V267, P22171; Frosig C, 2009, OBESITY, V17, pS15, DOI 10.1038/oby.2009.383; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; GOODYEAR LJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE987, DOI 10.1152/ajpendo.1995.268.5.E987; Hawley JA, 2008, ACTA PHYSIOL, V192, P127, DOI 10.1111/j.1748-1716.2007.01783.x; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; Herr HJ, 2005, J PHYSIOL-LONDON, V565, P627, DOI 10.1113/jphysiol.2005.086694; Hodgkinson CP, 2005, DIABETOLOGIA, V48, P1627, DOI 10.1007/s00125-005-1819-y; Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kanoh Y, 2003, ENDOCRINOLOGY, V144, P947, DOI 10.1210/en.2002-221017; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Kim CH, 2000, AM J PHYSIOL-ENDOC M, V278, pE977, DOI 10.1152/ajpendo.2000.278.6.E977; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; KRAEGEN EW, 1989, AM J PHYSIOL, V256, pE242, DOI 10.1152/ajpendo.1989.256.2.E242; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavigne C, 2001, AM J PHYSIOL-ENDOC M, V281, pE62, DOI 10.1152/ajpendo.2001.281.1.E62; Lessard SJ, 2007, DIABETES, V56, P1856, DOI 10.2337/db06-1065; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Luciano E, 2002, EUR J ENDOCRINOL, V147, P149, DOI 10.1530/eje.0.1470149; Maarbjerg SJ, 2011, ACTA PHYSIOL, V202, P323, DOI 10.1111/j.1748-1716.2011.02267.x; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Richter EA, 2004, J PHYSIOL-LONDON, V560, P909, DOI 10.1113/jphysiol.2004.071373; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Sriwijitkamol A, 2006, AM J PHYSIOL-ENDOC M, V290, pE925, DOI 10.1152/ajpendo.00429.2005; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; TREADWAY JL, 1989, AM J PHYSIOL, V256, pE138, DOI 10.1152/ajpendo.1989.256.1.E138; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wojtaszewski JFP, 2006, ESSAYS BIOCHEM, V42, P31, DOI 10.1042/bse0420031; Yaspelkis BB, 2007, AM J PHYSIOL-ENDOC M, V293, pE941, DOI 10.1152/ajpendo.00230.2007; Ye JM, 2006, DIABETES, V55, P2797, DOI 10.2337/db05-1315; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9; Zhang M, 2008, EXP DIABETES RES, DOI 10.1155/2008/704045	55	30	33	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51709	10.1371/journal.pone.0051709	http://dx.doi.org/10.1371/journal.pone.0051709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272147	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600038
J	Eckert, T; Le, DTV; Link, S; Friedmann, L; Woehlke, G				Eckert, Thomas; Doan Tuong-Van Le; Link, Susanne; Friedmann, Lena; Woehlke, Guenther			Spastin's Microtubule-Binding Properties and Comparison to Katanin	PLOS ONE			English	Article							PARAPLEGIA PROTEIN; KINESIN ATPASE; MOTOR DOMAIN; TUBULIN; SITE; MECHANISM; SEVERS; NECK; PROCESSIVITY; RECOGNITION	Spastin and katanin are ring-shaped hexameric AAA ATPases that sever microtubules, and thus crucially depend on a physical interaction with microtubules. For the first time, we report here the microtubule binding properties of spastin at the single-molecule level, and compare them to katanin. Microscopic fluorescence assays showed that human spastin bound to microtubules by ionic interactions, and diffused along microtubules with a diffusion coefficient comparable to katanin. The microscopic measurement of landing and dissociation rates demonstrated the ionic character of the interaction, which could be mapped to a patch of three lysine residues outside of the catalytic domain of human spastin. This motif is not conserved in Drosophila spastin or katanin, which also bound by non-catalytic parts of the protein. The binding affinities of spastin and katanin were nucleotide-sensitive, with the lowest affinities under ADP,, the highest under ATP-gamma S conditions. These changes correlated with the formation of higher oligomeric states, as shown in biochemical experiments and electron microscopic images. Vice versa, the artificial dimerization of human spastin by addition of a coiled coil led to a constitutively active enzyme. These observations suggest that dimer formation is a crucial step in the formation of the active complex, and thus the severing process by spastin. Citation: Eckert T, Le DT-V, Link S, Friedmann L, Woehlke G (2012) Spastin's Microtubule-Binding Properties and Comparison to Katanin. PLoS ONE 7(12): e50161. doi:10.1371/journal.pone.0050161	[Eckert, Thomas; Doan Tuong-Van Le; Link, Susanne; Friedmann, Lena; Woehlke, Guenther] Tech Univ Munich, Dept Phys Biophys E22, D-8046 Garching, Germany	Technical University of Munich	Woehlke, G (corresponding author), Tech Univ Munich, Dept Phys Biophys E22, D-8046 Garching, Germany.	guenther.woehlke@mytum.de		Woehlke, Gunther/0000-0001-8462-9962	Deutsche Forschungsgemeinschaft [DFG WO 614/4-1, DFG SFB 863, B7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft: DFG WO 614/4-1; DFG SFB 863 project B7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Adio S, 2009, FEBS J, V276, P3641, DOI 10.1111/j.1742-4658.2009.07083.x; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Eckert T, 2012, J BIOL CHEM; GILBERT SP, 1994, BIOCHEMISTRY-US, V33, P1951, DOI 10.1021/bi00173a044; Hahlen K, 2006, J BIOL CHEM, V281, P18868, DOI 10.1074/jbc.M508019200; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HYMAN AA, 1991, J CELL SCI, P125; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Ramey VH, 2011, MOL BIOL CELL, V22, P457, DOI 10.1091/mbc.E10-10-0841; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Salinas S, 2005, J NEUROCHEM, V95, P1411, DOI 10.1111/j.1471-4159.2005.03472.x; Schilling J, 2004, REV SCI INSTRUM, V75, P2822, DOI 10.1063/1.1783598; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; Stoppin-Mellet V, 2007, PLANT PHYSIOL BIOCH, V45, P867, DOI 10.1016/j.plaphy.2007.09.005; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor E.W., 1972, Muscle Biol, V1, P47; Verbrugge S, 2009, BIOPHYS J, V97, P173, DOI 10.1016/j.bpj.2009.02.073; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	42	39	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50161	10.1371/journal.pone.0050161	http://dx.doi.org/10.1371/journal.pone.0050161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272056	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600007
J	Brants, J; Semenchenko, K; Wasylyk, C; Robert, A; Carles, A; Zambrano, A; Pradeau-Aubreton, K; Birck, C; Schalken, JA; Poch, O; de Mey, J; Wasylyk, B				Brants, Jan; Semenchenko, Kostyantyn; Wasylyk, Christine; Robert, Aude; Carles, Annaick; Zambrano, Alberto; Pradeau-Aubreton, Karine; Birck, Catherine; Schalken, Jack A.; Poch, Olivier; de Mey, Jan; Wasylyk, Bohdan			Tubulin Tyrosine Ligase Like 12, a TTLL Family Member with SET- and TTL-Like Domains and Roles in Histone and Tubulin Modifications and Mitosis	PLOS ONE			English	Article							PROTEIN LYSINE METHYLTRANSFERASES; CELL-CYCLE; CHROMOSOME SEGREGATION; MAMMALIAN-CELLS; POSTTRANSLATIONAL MODIFICATIONS; CONSTITUTIVE HETEROCHROMATIN; MICROTUBULE CYTOSKELETON; METHYLATION; PR-SET7; ENZYMES	hTTLL12 is a member of the tubulin tyrosine ligase (TTL) family that is highly conserved in phylogeny. It has both SET-like and TTL-like domains, suggesting that it could have histone methylation and tubulin tyrosine ligase activities. Altered expression of hTTLL12 in human cells leads to specific changes in H4K20 trimethylation, and tubulin detyrosination, hTTLL12 does not catalyse histone methylation or tubulin tyrosination in vitro, as might be expected from the lack of critical amino acids in its SET-like and TTLL-like domains. hTTLL12 misexpression increases mitotic duration and chromosome numbers. These results suggest that hTTLL12 has non-catalytic functions related to tubulin and histone modification, which could be linked to its effects on mitosis and chromosome number stability.	[Brants, Jan; Semenchenko, Kostyantyn; Wasylyk, Christine; Carles, Annaick; Zambrano, Alberto; Pradeau-Aubreton, Karine; Birck, Catherine; Poch, Olivier; Wasylyk, Bohdan] Inst Genet & Biol Mol & Cellulaire, UMR CNRS UDS INSERM 7104 U964, Illkirch Graffenstaden, France; [Robert, Aude; de Mey, Jan] Univ Strasbourg, Ecole Super Biotechnol Strasbourg CNRS UMR7100, Equipe Microtubules & Morphogenese, Illkirch Graffenstaden, France; [Schalken, Jack A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Radboud University Nijmegen	Wasylyk, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, UMR CNRS UDS INSERM 7104 U964, Illkirch Graffenstaden, France.	boh@igbmc.fr	Wasylyk, Bohdan/ABG-6778-2020; Schalken, Jack A/B-1277-2014; Zambrano, Alberto/Q-6188-2019; Zambrano, Alberto/A-1580-2013; robert, aude/F-9584-2015	Wasylyk, Bohdan/0000-0002-1718-1237; Schalken, Jack A/0000-0001-8274-7797; Zambrano, Alberto/0000-0001-5677-2999; Zambrano, Alberto/0000-0001-5677-2999; robert, aude/0000-0003-3095-4190	European Union [QLK6-2000-00159, 504587]; Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Haut-Rhin); Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Bas-Rhin); Association pour la Recherche sur le Cancer; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Canceropole Grand-Est; INCa [PL099]	European Union(European Commission); Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Haut-Rhin); Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Bas-Rhin); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canceropole Grand-Est(Region Grand-Est); INCa(Institut National du Cancer (INCA) France)	The authors are thankful for the financial support from the European Union (FP5 Procure project QLK6-2000-00159 and FP6 Prima project #504587), the Ligue Nationale Francaise contre le Cancer, the Ligues Departementales de Lutte contre le Cancer (Haut- and Bas-Rhin), the Association pour la Recherche sur le Cancer, the Centre National de la Recherche Scientifique, and the Institut National de la Sante et de la Recherche Medicale, the Canceropole Grand-Est (Axe IV and DKFZ-CGE projects) and INCa (PL099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2011, PROG MOL BIOL TRANSL, V101, P105, DOI 10.1016/B978-0-12-387685-0.00004-4; Artymiuk PJ, 1996, NAT STRUCT BIOL, V3, P128, DOI 10.1038/nsb0296-128; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bianchi DW, 2010, EARLY HUM DEV, V86, P747, DOI 10.1016/j.earlhumdev.2010.08.001; Brustel J, 2011, TRENDS CELL BIOL, V21, P452, DOI 10.1016/j.tcb.2011.04.006; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; De Koning L, 2009, EMBO MOL MED, V1, P178, DOI 10.1002/emmm.200900022; Dideberg O, 1998, TRENDS BIOCHEM SCI, V23, P57, DOI 10.1016/S0968-0004(97)01149-3; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; FORREST GL, 1978, J CELL BIOL, V78, P441, DOI 10.1083/jcb.78.2.441; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gardiner J, 2011, J EXP BOT, V62, P89, DOI 10.1093/jxb/erq278; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; GUNDERSEN GG, 1986, J CELL BIOL, V102, P1118, DOI 10.1083/jcb.102.3.1118; Hastie AR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm894; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hebben M, 2007, PROTEIN EXPRES PURIF, V56, P269, DOI 10.1016/j.pep.2007.08.003; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KELLUM R, 1995, J CELL SCI, V108, P1419; Koide K, 2011, HUM GENET, V129, P295, DOI 10.1007/s00439-010-0923-3; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Morgunkova A, 2006, CELL CYCLE, V5, P1308, DOI 10.4161/cc.5.12.2820; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shiio Y, 2006, MOL CELL BIOL, V26, P1386, DOI 10.1128/MCB.26.4.1386-1397.2006; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Wasylyk C, 2010, INT J CANCER, V127, P2542, DOI 10.1002/ijc.25261; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Xu DZ, 2009, CELL CYCLE, V8, P3688, DOI 10.4161/cc.8.22.9908; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yang HB, 2009, BIOCHEM CELL BIOL, V87, P151, DOI 10.1139/O08-131; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	59	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51258	10.1371/journal.pone.0051258	http://dx.doi.org/10.1371/journal.pone.0051258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251473	Green Submitted, gold, Green Published			2022-12-27	WOS:000313236200078
J	Ferrari, MCO; Brown, GE; Chivers, DP				Ferrari, Maud C. O.; Brown, Grant E.; Chivers, Douglas P.			Temperature-Mediated Changes in Rates of Predator Forgetting in Woodfrog Tadpoles	PLOS ONE			English	Article							MEMORY; RECOGNITION; INFORMATION; ANIMALS; ECOLOGY; TROUT; RISK; FISH	Hundreds of studies have investigated the sources and nature of information that prey gather about their predators and the ways in which prey use this information to mediate their risk of predation. However, relatively little theoretical or empirical work has considered the question of how long information should be maintained and used by prey animals in making behavioural decisions. Here, we tested whether the size of the memory window associated with predator recognition could be affected by an intrinsic factor, such as size and growth rate of the prey. We maintained groups of predator-naive woodfrog, Lithobates sylvaticus, tadpoles at different temperatures for 8 days to induce differences in tadpole size. We then conditioned small and large tadpoles to recognize the odour of a predatory tiger salamander, Ambystoma tigrinum. Tadpoles were then maintained either on a high or low growth trajectory for another 8 days, after which they were tested for their response to the predator. Our results suggest that the memory window related to predator recognition of tadpoles is determined by both their size and/or growth rate at the time of learning and their subsequent growth rate post-learning.	[Ferrari, Maud C. O.] Univ Saskatchewan, Western Coll Vet Med, Dept Biomed Sci, Saskatoon, SK, Canada; [Brown, Grant E.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Chivers, Douglas P.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; Concordia University - Canada; University of Saskatchewan	Ferrari, MCO (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Biomed Sci, Saskatoon, SK, Canada.	maud.ferrari@usask.ca	Brown, Grant E/B-7182-2013	Brown, Grant E/0000-0003-3493-3477; Chivers, Douglas/0000-0002-9497-4329	NSERC (Natural Science and Engineering Research Council)	NSERC (Natural Science and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded through NSERC (Natural Science and Engineering Research Council) Discovery Grants to DPC and GEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUTON ME, 1994, J EXP PSYCHOL-ANIM B, V20, P219, DOI 10.1037/0097-7403.20.3.219; Brown GE, 1998, CAN J FISH AQUAT SCI, V55, P611, DOI 10.1139/cjfas-55-3-611; Brown GE, 2011, BEHAV ECOL SOCIOBIOL, V65, P1267, DOI 10.1007/s00265-011-1140-3; Brydges NM, 2008, ANIM BEHAV, V75, P935, DOI 10.1016/j.anbehav.2007.08.005; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dukas R, 1999, J THEOR BIOL, V197, P41, DOI 10.1006/jtbi.1998.0856; Ferrari MCO, 2008, BEHAV ECOL, V19, P980, DOI 10.1093/beheco/arn056; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2010, P ROY SOC B-BIOL SCI, V277, P2205, DOI 10.1098/rspb.2009.2117; Ferrari MCO, ANIMAL COGN IN PRESS; Gonzalo A, 2009, ANIM COGN, V12, P745, DOI 10.1007/s10071-009-0232-1; Hazlett BA, 2002, J CRUSTACEAN BIOL, V22, P439, DOI 10.1651/0278-0372(2002)022[0439:DIMCII]2.0.CO;2; Hirvonen H, 1999, ECOL MODEL, V115, P177, DOI 10.1016/S0304-3800(98)00191-4; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; MANGEL M, 1990, J THEOR BIOL, V146, P317, DOI 10.1016/S0022-5193(05)80742-8; MCNAMARA JM, 1987, J THEOR BIOL, V125, P385, DOI 10.1016/S0022-5193(87)80209-6; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Mirza RS, 2000, CAN J ZOOL, V78, P2198, DOI 10.1139/cjz-78-12-2198; Neisser U, 2004, DEV REV, V24, P154, DOI 10.1016/j.dr.2003.09.002; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Sangha S, 2003, NEUROBIOL LEARN MEM, V80, P130, DOI 10.1016/S1074-7427(03)00065-0; Shettleworth, 2010, COGNITION EVOLUTION; Van Buskirk J, 2000, J EXP BIOL, V203, P2149	24	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51143	10.1371/journal.pone.0051143	http://dx.doi.org/10.1371/journal.pone.0051143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251438	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200061
J	Halsey, LG; Watkins, DAR; Duggan, BM				Halsey, Lewis G.; Watkins, David A. R.; Duggan, Brendan M.			The Energy Expenditure of Stair Climbing One Step and Two Steps at a Time: Estimations from Measures of Heart Rate	PLOS ONE			English	Article							EXERCISE; HEALTH; COSTS; WOMEN	Stairway climbing provides a ubiquitous and inconspicuous method of burning calories. While typically two strategies are employed for climbing stairs, climbing one stair step per stride or two steps per stride, research to date has not clarified if there are any differences in energy expenditure between them. Fourteen participants took part in two stair climbing trials whereby measures of heart rate were used to estimate energy expenditure during stairway ascent at speeds chosen by the participants. The relationship between rate of oxygen consumption ((V) over dotO(2)) and heart rate was calibrated for each participant using an inclined treadmill. The trials involved climbing up and down a 14.05 m high stairway, either ascending one step per stride or ascending two stair steps per stride. Single-step climbing used 8.5 +/- 0.1 kcal min(-1), whereas double step climbing used 9.2 +/- 0.1 kcal min(-1). These estimations are similar to equivalent measures in all previous studies, which have all directly measured (V) over dotO(2) : The present study findings indicate that (1) treadmill-calibrated heart rate recordings can be used as a valid alternative to respirometry to ascertain rate of energy expenditure during stair climbing; (2) two step climbing invokes a higher rate of energy expenditure; however, one step climbing is energetically more expensive in total over the entirety of a stairway. Therefore to expend the maximum number of calories when climbing a set of stairs the single-step strategy is better.	[Halsey, Lewis G.; Watkins, David A. R.] Univ Roehampton, Dept Life Sci, London, England; [Duggan, Brendan M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	Roehampton University; University of Edinburgh	Halsey, LG (corresponding author), Univ Roehampton, Dept Life Sci, London, England.	l.halsey@roehampton.ac.uk	Halsey, Lewis/B-8498-2011	Halsey, Lewis/0000-0002-0786-7585				Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Aziz Abdul Rashid, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P253, DOI 10.2114/jpa.24.253; Bassett DR, 1997, MED SCI SPORT EXER, V29, P1250, DOI 10.1097/00005768-199709000-00019; Benedict FG, 1928, AM J PHYSIOL, V84, P675, DOI 10.1152/ajplegacy.1928.84.3.675; Biewener AA., 2007, ANIMAL LOCOMOTION; Boreham CAG, 2000, PREV MED, V30, P277, DOI 10.1006/pmed.2000.0634; BUTTS NK, 1993, MED SCI SPORT EXER, V25, P378; FARDY PS, 1975, MED SCI SPORT EXER, V7, P91; Franks B.D., 1998, FITNESS LEADERS HDB; Gottschall JS, 2010, J STRENGTH COND RES, V24, P2558, DOI 10.1519/JSC.0b013e3181e83a6f; Green JA, 2001, J EXP BIOL, V204, P673; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P247, DOI 10.1016/j.cbpa.2011.01.001; HERMANSEN L, 1972, ERGONOMICS, V15, P15, DOI 10.1080/00140137208924403; Kang JIE, 2004, RES SPORTS MED, V12, p:251; Minetti AE, 2011, SCAND J MED SCI SPOR, V21, P293, DOI 10.1111/j.1600-0838.2009.01043.x; Myers J, 2003, CIRCULATION, V107, pE2, DOI 10.1161/01.CIR.0000048890.59383.8D; Nejat EJ, 2010, MATURITAS, V65, P106, DOI 10.1016/j.maturitas.2009.09.006; OCONNELL ER, 1986, J OCCUP ENVIRON MED, V28, P282; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; *SPORTS COUNC HLTH, 1992, ALL DUNB NAT FITN SU; Teh KC, 2002, MED SCI SPORT EXER, V34, P695, DOI 10.1097/00005768-200204000-00021; WENZEL C, 1990, INT ARCH OCC ENV HEA, V62, P101, DOI 10.1007/BF00397856	24	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51213	10.1371/journal.pone.0051213	http://dx.doi.org/10.1371/journal.pone.0051213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251455	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200070
J	Li, J; Zhao, GZ; Varma, A; Qin, S; Xiong, Z; Huang, HY; Zhu, WY; Zhao, LX; Xu, LH; Zhang, S; Li, WJ				Li, Jie; Zhao, Guo-Zhen; Varma, Ajit; Qin, Sheng; Xiong, Zhi; Huang, Hai-Yu; Zhu, Wen-Yong; Zhao, Li-Xing; Xu, Li-Hua; Zhang, Si; Li, Wen-Jun			An Endophytic Pseudonocardia Species Induces the Production of Artemisinin in Artemisia annua	PLOS ONE			English	Article							GENE-EXPRESSION; SP NOV.; AMORPHA-4,11-DIENE SYNTHASE; PAENIBACILLUS-POLYMYXA; PIRIFORMOSPORA-INDICA; ANTIMALARIAL-DRUG; HAIRY ROOTS; BIOSYNTHESIS; ACTINOBACTERIA; STIMULATION	Endophytic actinobacteria colonize internal tissues of their host plants and are considered as a rich and reliable source of diverse species and functional microorganisms. In this study, endophytic actinobacterial strain YIM 63111 was isolated from surface-sterilized tissue of the medicinal plant Artemisia annua. We identified strain YIM 63111 as a member of the genus Pseudonocardia. A. annua seedlings grown under both sterile and greenhouse conditions were inoculated with strain YIM 63111. The growth of A. annua seedlings was strongly reduced when YIM 63111 was inoculated at higher concentrations under sterile conditions. However, no growth inhibition was observed when A. annua was grown under greenhouse conditions. Using an enhanced green fluorescent protein (EGFP) expressing YIM 63111 strain, we also observed the endophytic colonization of A. annua seedling using confocal laser-scanning microscopy. The transcription levels of the key genes involved in artemisinin biosynthesis were investigated using real time RT-PCR, revealing that cytochrome P450 monooxygenase (CYP71AV1) and cytochrome P450 oxidoreductase (CPR) expression were up-regulated in A. annua upon inoculation with strain YIM 63111 under certain conditions. The up-regulation of these genes was associated with the increased accumulation of artemisinin. These results suggest that endophytic actinobacteria effectively stimulate certain plant defense responses. Our data also demonstrate the use of Pseudonocardia sp. strain YIM 63111 as a promising means to enhance artemisinin production in plants.	[Li, Jie; Zhao, Guo-Zhen; Huang, Hai-Yu; Zhu, Wen-Yong; Zhao, Li-Xing; Xu, Li-Hua; Li, Wen-Jun] Yunnan Univ, Key Lab Microbial Divers SW China, Minist Educ, Kunming, Peoples R China; [Li, Jie; Zhao, Guo-Zhen; Huang, Hai-Yu; Zhu, Wen-Yong; Zhao, Li-Xing; Xu, Li-Hua; Li, Wen-Jun] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Yunnan Inst Microbiol, Kunming, Peoples R China; [Li, Jie; Zhang, Si] Chinese Acad Sci, Key Lab Marine Bioresource Sustainable Utilizat C, Guangdong Key Lab Marine Mat Med, S China Sea Inst Oceanol,RNAM Ctr Marine Microbio, Guangzhou, Guangdong, Peoples R China; [Varma, Ajit] Amity Univ Uttar Pradesh, Amity Inst Microbial Technol, Noida, India; [Qin, Sheng] Jiangsu Normal Univ, Key Lab Biotechnol Med Plant Jiangsu Prov, Xuzhou, Peoples R China; [Xiong, Zhi] SW Forestry Univ, Sch Forestry Resources, Kunming, Peoples R China; [Li, Wen-Jun] Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land CAS, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China	Yunnan University; Yunnan University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Amity University Noida; Jiangsu Normal University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Li, WJ (corresponding author), Yunnan Univ, Key Lab Microbial Divers SW China, Minist Educ, Kunming, Peoples R China.	wjli@ynu.edu.cn	xu, li/GNH-3667-2022; 秦, 盛/D-9911-2018		National Basic Research Program of China [2010CB833801]; Key Project of International Cooperation of Ministry of Science & Technology (MOST) [S2012ZR0069]; National Natural Science Foundation of China [U0932601]; Yunnan Provincial Natural Science Foundation [2009AC017, 2009DA002]; Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); Key Project of International Cooperation of Ministry of Science & Technology (MOST); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Natural Science Foundation(Natural Science Foundation of Yunnan Province); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (No. 2010CB833801), Key Project of International Cooperation of Ministry of Science & Technology (MOST) (No. S2012ZR0069), National Natural Science Foundation of China (No. U0932601), and Yunnan Provincial Natural Science Foundation (Nos. 2009AC017, 2009DA002). W-J Li was also supported by the 'Hundred Talents Program' of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdin MZ, 2003, PLANTA MED, V69, P289, DOI 10.1055/s-2003-38871; Banyai W, 2011, PLANT GROWTH REGUL, V63, P45, DOI 10.1007/s10725-010-9510-9; Bouwmeester HJ, 1999, PHYTOCHEMISTRY, V52, P843, DOI 10.1016/S0031-9422(99)00206-X; Caretto S, 2011, PLANT BIOLOGY, V13, P51, DOI 10.1111/j.1438-8677.2009.00306.x; CHAPPELL J, 1995, PLANT PHYSIOL, V107, P1, DOI 10.1145/224057.224059; Chaudhary V, 2008, APPL SOIL ECOL, V40, P174, DOI 10.1016/j.apsoil.2008.04.003; Chen HH, 2009, INT J SYST EVOL MICR, V59, P559, DOI 10.1099/ijs.0.64740-0; Conn VM, 2008, MOL PLANT MICROBE IN, V21, P208, DOI 10.1094/MPMI-21-2-0208; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Duangmal K, 2009, INT J SYST EVOL MICR, V59, P1487, DOI 10.1099/ijs.0.007724-0; DUKE SO, 1987, WEED SCI, V35, P499, DOI 10.1017/S0043174500060458; Durante M, 2011, APPL MICROBIOL BIOT, V90, P1905, DOI 10.1007/s00253-011-3232-4; EVTUSHENKO LI, 1989, INT J SYST BACTERIOL, V39, P72, DOI 10.1099/00207713-39-1-72; GORDON RE, 1974, INT J SYST BACTERIOL, V24, P54, DOI 10.1099/00207713-24-1-54; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Jessing KK, 2009, ENVIRON TOXICOL CHEM, V28, P701, DOI 10.1897/08-153R.1; Kapoor R, 2007, MYCORRHIZA, V17, P581, DOI 10.1007/s00572-007-0135-4; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Kogel KH, 2006, CURR OPIN PLANT BIOL, V9, P358, DOI 10.1016/j.pbi.2006.05.001; Lal S, 2009, INDIAN J MICROBIOL, V49, P2, DOI 10.1007/s12088-009-0008-y; Li J, 2012, ANTON LEEUW INT J G, V101, P515, DOI 10.1007/s10482-011-9661-3; Li WJ, 2007, INT J SYST EVOL MICR, V57, P1424, DOI 10.1099/ijs.0.64749-0; Mercke P, 2000, ARCH BIOCHEM BIOPHYS, V381, P173, DOI 10.1006/abbi.2000.1962; Oelmuller R, 2009, SYMBIOSIS, V49, P1, DOI 10.1007/s13199-009-0009-y; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Satheesan J, 2012, MYCORRHIZA, V22, P195, DOI 10.1007/s00572-011-0394-y; Schulz Barbara J. E., 2006, V9, P1; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Smibert Robert M., 1994, P607; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Sun JH, 1999, MICROBIOL-UK, V145, P2221, DOI 10.1099/00221287-145-9-2221; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Varma A, 2012, AGR RES, V1, P117, DOI 10.1007/s40003-012-0019-5; Wang HH, 2010, IND CROP PROD, V31, P214, DOI 10.1016/j.indcrop.2009.10.008; Wang JW, 2009, APPL MICROBIOL BIOT, V85, P285, DOI 10.1007/s00253-009-2090-9; Wang JW, 2001, BIOTECHNOL LETT, V23, P857, DOI 10.1023/A:1010535001943; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Yang RY, 2008, PLANTA MED, V74, P1510, DOI 10.1055/s-2008-1081333; Yin Lulu, 2008, Chinese Journal of Applied and Environmental Biology, V14, P1; Yuan ZL, 2007, AFR J BIOTECHNOL, V6, P1266; Zeng QP, 2008, SCI CHINA SER C, V51, P232, DOI 10.1007/s11427-008-0032-x; Zhang B, 2010, AFR J BIOTECHNOL, V9, P3437	46	37	43	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51410	10.1371/journal.pone.0051410	http://dx.doi.org/10.1371/journal.pone.0051410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251523	Green Submitted, gold, Green Published			2022-12-27	WOS:000313236200103
J	Liu, KN; Meng, HX; Hou, JX				Liu, Kaining; Meng, Huanxin; Hou, Jianxia			Activity of 25-Hydroxylase in Human Gingival Fibroblasts and Periodontal Ligament Cells	PLOS ONE			English	Article							VITAMIN-D 25-HYDROXYLASE; TOLL-LIKE RECEPTORS; STEROL 27-HYDROXYLASE; HUMAN-SKIN; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; CEREBROTENDINOUS XANTHOMATOSIS; AGGRESSIVE PERIODONTITIS; CYTOCHROME P450SCC; HUMAN MACROPHAGES; PROSTATE CELLS	Background: We previously demonstrated that 25-hydroxyvitamin D-3 concentrations in gingival crevicular fluid are 300 times higher than those in the plasma of patients with aggressive periodontitis. Here we explored whether 25-hydroxyvitamin D-3 can be synthesized by periodontal soft tissue cells. We also investigated which of the two main kinds of hydroxylases, CYP27A1 and CYP2R1, is the key 25-hydroxylase in periodontal soft tissue cells. Methodology/Principal Findings: Primary cultures of human gingival fibroblasts and periodontal ligament cells from 5 individual donors were established. CYP27A1 mRNA, CYP2R1 mRNA and CYP27A1 protein were detected in human gingival fibroblasts and periodontal ligament cells, whereas CYP2R1 protein was not. After incubation with the 25-hydroxylase substrate vitamin D-3, human gingival fibroblasts and periodontal ligament cells generated detectable 25-hydroxyvitamin D-3 that resulted in the production of 1 alpha,25-dihydroxyvitamin D-3. Specific knockdown of CYP27A1 in human gingival fibroblasts and periodontal ligament cells using siRNA resulted in a significant reduction in both 25-hydroxyvitamin D-3 and 1 alpha,25-dihydroxyvitamin D-3 production. Knockdown of CYP2R1 did not significantly influence 25-hydroxyvitamin D-3 synthesis. Sodium butyrate did not influence significantly CYP27A1 mRNA expression; however, interleukin-1 beta and Porphyromonas gingivalis lipopolysaccharide strongly induced CYP27A1 mRNA expression in human gingival fibroblasts and periodontal ligament cells. Conclusions: The activity of 25-hydroxylase was verified in human gingival fibroblasts and periodontal ligament cells, and CYP27A1 was identified as the key 25-hydroxylase in these cells.	[Liu, Kaining; Meng, Huanxin; Hou, Jianxia] Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing 100871, Peoples R China	Peking University	Meng, HX (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing 100871, Peoples R China.	kqhxmeng@bjmu.edu.cn	hou, joye/AAT-9545-2020		National Natural Science Foundations of China [30772420, 81100749]; Beijing Natural Science Foundation [7102164]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research was funded by National Natural Science Foundations of China (http://www.nsfc.gov.cn/Portal0/default152.htm) (30772420, 81100749) and Beijing Natural Science Foundation (http://www.bjkw.gov.cn/n1143/n1240/n1465/n2276/index.html) (7102164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba I, 2006, STEROIDS, V71, P849, DOI 10.1016/j.steroids.2006.04.009; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bashutski JD, 2011, J DENT RES, V90, P1007, DOI 10.1177/0022034511407771; Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; BIKLE DD, 1986, BIOCHEMISTRY-US, V25, P1545, DOI 10.1021/bi00355a013; BIKLE DD, 1986, J CLIN INVEST, V78, P557, DOI 10.1172/JCI112609; BJORKHEM I, 1978, J BIOL CHEM, V253, P842; BJORKHEM I, 1994, P NATL ACAD SCI USA, V91, P8592, DOI 10.1073/pnas.91.18.8592; CALI JJ, 1991, J BIOL CHEM, V266, P7774; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Flanagan JN, 2006, ANTICANCER RES, V26, P2567; Garcia MN, 2011, J PERIODONTOL, V82, P25, DOI 10.1902/jop.2010.100207; Gupta RP, 2004, J BONE MINER RES, V19, P680, DOI 10.1359/JBMR.0301257; Hansson M, 2005, BBA-MOL CELL BIOL L, V1687, P44, DOI 10.1016/j.bbalip.2004.11.002; Hatakeyama J, 2003, ORAL MICROBIOL IMMUN, V18, P14, DOI 10.1034/j.1399-302X.2003.180103.x; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; HOLICK MF, 1981, J INVEST DERMATOL, V77, P51, DOI 10.1111/1523-1747.ep12479237; HOLICK MF, 1978, FED PROC, V37, P2567; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Kurita-Ochiai T, 2002, INFECT IMMUN, V70, P2361, DOI 10.1128/IAI.70.5.2361-2367.2002; Lehmann B, 1998, J DERMATOL SCI, V18, P118, DOI 10.1016/S0923-1811(98)00033-4; Lehmann B, 2000, EXP DERMATOL, V9, P97, DOI 10.1034/j.1600-0625.2000.009002097.x; Li Qi-qiang, 2005, Zhonghua Kou Qiang Yi Xue Za Zhi, V40, P208; Liu KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039878; Liu KN, 2010, J PERIODONTOL, V81, P260, DOI 10.1902/jop.2009.090355; Liu KN, 2009, J PERIODONTOL, V80, P1114, DOI 10.1902/jop.2009.080675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Rui-fang, 2008, Zhonghua Kou Qiang Yi Xue Za Zhi, V43, P664; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; McMahon L, 2011, INFECT IMMUN, V79, P2250, DOI 10.1128/IAI.00099-11; OKUDA KI, 1995, J LIPID RES, V36, P1641; Quinn CM, 2005, BIOCHEM J, V385, P823, DOI 10.1042/BJ20041776; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Schuessler M, 2001, STEROIDS, V66, P399, DOI 10.1016/S0039-128X(00)00229-4; SKREDE S, 1986, J CLIN INVEST, V78, P729, DOI 10.1172/JCI112633; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; Tang WJ, 2007, ARCH BIOCHEM BIOPHYS, V462, P13, DOI 10.1016/j.abb.2007.04.001; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Yamasaki T, 2004, J BIOL CHEM, V279, P22848, DOI 10.1074/jbc.M311346200	48	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e52053	10.1371/journal.pone.0052053	http://dx.doi.org/10.1371/journal.pone.0052053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251684	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200174
J	Styner, M; Meyer, MB; Galior, K; Case, N; Xie, ZH; Sen, B; Thompson, WR; Pike, JW; Rubin, J				Styner, Maya; Meyer, Mark B.; Galior, Kornelia; Case, Natasha; Xie, Zhihui; Sen, Buer; Thompson, William R.; Pike, John Wesley; Rubin, Janet			Mechanical Strain Downregulates C/EBP beta in MSC and Decreases Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MESENCHYMAL STEM-CELLS; ACTIVATED-RECEPTOR-GAMMA; MARROW STROMAL CELLS; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; INHIBITS ADIPOGENESIS; PPAR-GAMMA; ER STRESS; BONE	Exercise prevents marrow mesenchymal stem cell (MSC) adipogenesis, reversing trends that accompany aging and osteoporosis. Mechanical input, the in-vitro analogue to exercise, limits PPAR gamma expression and adipogenesis in MSC. We considered whether C/EBP beta might be mechanoresponsive as it is upstream to PPAR gamma, and also is known to upregulate endoplasmic reticulum (ER) stress. MSC (C3H10T1/2 pluripotent cells as well as mouse marrow-derived MSC) were cultured in adipogenic media and a daily mechanical strain regimen was applied. We demonstrate herein that mechanical strain represses C/EBP beta mRNA (0.6-fold +/- 0.07, p<0.05) and protein (0.4-fold +/- 0.1, p<0.01) in MSC. SiRNA silencing of beta-catenin prevented mechanical repression of C/EBP beta. C/EBP beta overexpression did not override strain's inhibition of adipogenesis, which suggests that mechanical control of C/EBP beta is not the primary site at which adipogenesis is regulated. Mechanical inhibition of C/EBP beta, however, might be critical for further processes that regulate MSC health. Indeed, overexpression of C/EBP beta in MSC induced ER stress evidenced by a dose-dependent increase in the pro-apoptotic CHOP (protein 4-fold +/- 0.5, p<0.05) and a threshold reduction in the chaperone BiP (protein 0.6-fold +/- 0.1, p = 0.2; mRNA 0.3-fold +/- 0.1, p<0.01). ChIP-seq demonstrated a significant association between C/EBP beta and both CHOP and BiP genes. The strain regimen, in addition to decreasing C/EBP beta mRNA (0.5-fold +/- 0.09, p<0.05), expanded ER capacity as measured by an increase in BiP mRNA (2-fold +/- 0.2, p<0.05) and protein. Finally, ER stress induced by tunicamycin was ameliorated by mechanical strain as demonstrated by decreased C/EBP beta, increased BiP and decreased CHOP protein expression. Thus, C/EBP beta is a mechanically responsive transcription factor and its repression should counter increases in marrow fat as well as improve skeletal resistance to ER stress.	[Styner, Maya; Galior, Kornelia; Case, Natasha; Xie, Zhihui; Sen, Buer; Thompson, William R.; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Meyer, Mark B.; Pike, John Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison	Styner, M (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	mstyner@med.unc.edu	Thompson, William R./B-2658-2009; Styner, Maya/I-2044-2019	Thompson, William R./0000-0002-7022-585X; Styner, Maya/0000-0001-9790-8645	National Institutes of Health [5K12HD001441, 1K08AR062097, AR056655, AR042360, DK072281]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR042360, R01AR042360, K08AR062097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following National Institutes of Health awards: 5K12HD001441, 1K08AR062097, AR056655 and AR042360, DK072281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Blanco-Gelaz MA, 2010, STEM CELL REV REP, V6, P462, DOI 10.1007/s12015-010-9135-4; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Bezy O, 2005, J BIOL CHEM, V280, P11432, DOI 10.1074/jbc.M411741200; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Case N, 2010, J ORTHOP RES, V28, P1531, DOI 10.1002/jor.21156; Cho YM, 2009, EXP MOL MED, V41, P440, DOI 10.3858/emm.2009.41.6.049; DALSKY GP, 1988, ANN INTERN MED, V108, P824, DOI 10.7326/0003-4819-108-6-824; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fretz JA, 2006, MOL ENDOCRINOL, V20, P2215, DOI 10.1210/me.2006-0102; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hirasawa H, 2010, FEBS LETT, V584, P745, DOI 10.1016/j.febslet.2009.12.028; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kim Y, 2010, BRAIN RES, V1317, P13, DOI 10.1016/j.brainres.2009.12.062; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEICHTER I, 1989, J ORTHOPAED RES, V7, P86, DOI 10.1002/jor.1100070112; Liu J, 2011, J BONE MINERAL RES; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Menuki K, 2008, BONE, V43, P613, DOI 10.1016/j.bone.2008.04.022; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; MINAIRE P, 1984, CALCIFIED TISSUE INT, V36, P338, DOI 10.1007/BF02405340; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sen B, 2010, J BIOMECH; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Styner M, 2010, J CELL BIOCH; Styner M, 2010, J CELL BIOCHEM, V111, P1042, DOI 10.1002/jcb.22793; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Thompson WR, 2012, GENE; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	53	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51613	10.1371/journal.pone.0051613	http://dx.doi.org/10.1371/journal.pone.0051613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251594	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200146
J	Mi, DH; Zhang, LQ; Wang, CX; Liu, LP; Pu, YH; Zhao, XQ; Wang, YL; Wang, YJ				Mi, Donghua; Zhang, Liqun; Wang, Chunxue; Liu, Liping; Pu, Yuehua; Zhao, Xingquan; Wang, Yilong; Wang, Yongjun			Impact of Metabolic Syndrome on the Prognosis of Ischemic Stroke Secondary to Symptomatic Intracranial Atherosclerosis in Chinese Patients	PLOS ONE			English	Article							ARTERY STENOSIS; DISEASE; RISK; RACE; PROGRESSION; PREVALENCE; COMPONENTS; DIAGNOSIS; EVENTS; SEX	Objectives: To analyze the effect of metabolic syndrome (MetS) on prognosis of ischemic stroke secondary to intracranial stenosis in Chinese patients. Methods: A prospective cohort of 701 patients with ischemic stroke, caused by intracranial stenosis, were followed at 3-month intervals for 1 year to monitor development of recurrent stroke or death. Imaging was performed using magnetic resonance angiography. MetS was defined using International Diabetes Federation (IDF) criteria. Results: MetS was identified in 26.0% of the cohort of stroke patients. Patients with MetS were more likely to be female, nonsmokers, and more likely to have a prior history of diabetes mellitus, high blood glucose and a family history of stroke than patients without MetS. During 1-year follow-up, patients with MetS had a non-significantly higher rate of stroke recurrence (7.1%) than patients without MetS (3.9%; P = 0.07). There was no difference in mortality (3.3% versus 3.5%, respectively). Multivariate Cox proportional hazards analysis (adjusting for gender, BMI, smoking, diabetes, and LDL-C) identified an association between that 1-year stroke recurrence and the presence of MetS (hazard ratio 2.30; 95% CI: 1.01-5.22) and large waist circumference (hazard ratio: 2.39; 95% CI: 1.05-5.42). However, multivariable analysis adjusting for the individual components of MetS found no significant associations between MetS and stroke recurrence. There were no associations between these parameters and mortality. Conclusions: Chinese patients with symptomatic intracranial atherosclerosis who have MetS, are at higher risk of recurrent stroke than those without MetS. However, MetS was not predictive of stroke recurrence beyond its individual components and one-year mortality.	[Mi, Donghua; Wang, Chunxue; Liu, Liping; Pu, Yuehua; Zhao, Xingquan; Wang, Yilong; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Liqun] St George Hosp, Dept Neurol, London, England	Capital Medical University; St Georges University London	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	liu, li/HGC-0900-2022	zhang, liqun/0000-0001-6983-7915	Research Special Fund For Public Welfare Industry of Health [200902004]; Ministry of Science and Technology; Ministry of Health of the People's Republic of China [2011BAI08B02]	Research Special Fund For Public Welfare Industry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China	This study was funded by the Research Special Fund For Public Welfare Industry of Health (200902004), the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China (2011BAI08B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2003, ASS AH HEART DIS STR; Arenillas JF, 2001, STROKE, V32, P2898, DOI 10.1161/hs1201.099652; Arenillas JF, 2007, STROKE, V38, P2196, DOI 10.1161/STROKEAHA.106.480004; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Bonora E, 2003, DIABETES CARE, V26, P1251, DOI 10.2337/diacare.26.4.1251; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Grundy S, 2008, ARTERIOSCL THROM VAS, V28, P8; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; Lee WY, 2004, DIABETES RES CLIN PR, V65, P143, DOI 10.1016/j.diabres.2003.12.007; Liou CW, 2008, EUR J NEUROL, V15, P802, DOI 10.1111/j.1468-1331.2008.02181.x; Mazighi M, 2006, NEUROLOGY, V66, P1187, DOI 10.1212/01.wnl.0000208404.94585.b2; Ovbiagele B, 2006, NEUROLOGY, V66, P1344, DOI 10.1212/01.wnl.0000210530.46058.5c; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Thijs VN, 2000, NEUROLOGY, V55, P490, DOI 10.1212/WNL.55.4.490; Turkoglu C, 2003, OBES SURG, V13, P699, DOI 10.1381/096089203322509255; Wityk RJ, 1996, STROKE, V27, P1974, DOI 10.1161/01.STR.27.11.1974; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong KS, 2002, STROKE, V33, P532, DOI 10.1161/hs0202.102602; Wu G, 2002, CHIN J PREV MED CHIN, V36, P298	27	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51421	10.1371/journal.pone.0051421	http://dx.doi.org/10.1371/journal.pone.0051421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251528	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900086
J	Bonte, B; Mathias, JD; Duboz, R				Bonte, Bruno; Mathias, Jean-Denis; Duboz, Raphael			Moment Approximation of Infection Dynamics in a Population of Moving Hosts	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; EPIDEMIOLOGIC MODELS; SCRAPIE EPIDEMIOLOGY; NETWORK STRUCTURE; TRANSMISSION; H5N1; CONTACT; PROPAGATION; PERSISTENCE; OUTBREAKS	The modelling of contact processes between hosts is of key importance in epidemiology. Current studies have mainly focused on networks with stationary structures, although we know these structures to be dynamic with continuous appearance and disappearance of links over time. In the case of moving individuals, the contact network cannot be established. Individual-based models (IBMs) can simulate the individual behaviours involved in the contact process. However, with very large populations, they can be hard to simulate and study due to the computational costs. We use the moment approximation (MA) method to approximate a stochastic IBM with an aggregated deterministic model. We illustrate the method with an application in animal epidemiology: the spread of the highly pathogenic virus H5N1 of avian influenza in a poultry flock. The MA method is explained in a didactic way so that it can be reused and extended. We compare the simulation results of three models: 1. an IBM, 2. a MA, and 3. a mean-field (MF). The results show a close agreement between the MA model and the IBM. They highlight the importance for the models to capture the displacement behaviours and the contact processes in the study of disease spread. We also illustrate an original way of using different models of the same system to learn more about the system itself, and about the representation we build of it. Citation: Bonte B, Mathias J-D, Duboz R (2012) Moment Approximation of Infection Dynamics in a Population of Moving Hosts. PLoS ONE 7(12): e51760. doi:10.1371/journal.pone.0051760	[Bonte, Bruno; Mathias, Jean-Denis] French Natl Res Inst Sci & Tech Environm & Agr IR, Lab Engn Complex Syst LISC, Aubiere, France; [Bonte, Bruno; Duboz, Raphael] French Ctr Int Cooperat Agr Res & Dev CIRAD, Anim & Integrated Risk Management AGIRs Res Unit, Montpellier, France; [Duboz, Raphael] Asian Inst Technol, Comp Sci & Informat Management CSIM Dept, Pathum Thani, Thailand	INRAE; CIRAD; Asian Institute of Technology	Mathias, JD (corresponding author), French Natl Res Inst Sci & Tech Environm & Agr IR, Lab Engn Complex Syst LISC, Aubiere, France.	jean-denis.mathias@irstea.fr	Bonté, Bruno/GNP-1909-2022; Mathias, Jean-Denis/R-5391-2016; Bonté, Bruno/GNP-4017-2022	Bonté, Bruno/0000-0002-7325-0495; Mathias, Jean-Denis/0000-0002-6172-9079; 				Amouroux E, 2008, LECT NOTES ARTIF INT, V5357, P26, DOI 10.1007/978-3-540-89674-6_6; Barthelemy M, 2005, J THEOR BIOL, V235, P275, DOI 10.1016/j.jtbi.2005.01.011; Bobashev Georgiy V., 2007, 2007 Winter Simulation Conference, P1532, DOI 10.1109/WSC.2007.4419767; Bolker BM, 1999, B MATH BIOL, V61, P849, DOI 10.1006/bulm.1999.0115; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Choisy M, 2007, ENCY INFECT DIS MODE; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Duboz R, 2010, ECOL MODEL, V221, P840, DOI 10.1016/j.ecolmodel.2009.11.023; Durand B, 2004, ECOL MODEL, V179, P515, DOI 10.1016/j.ecolmodel.2004.05.015; Eames KTD, 2009, EPIDEMICS-NETH, V1, P70, DOI 10.1016/j.epidem.2008.12.001; Filipe JAN, 2004, B MATH BIOL, V66, P373, DOI 10.1016/j.bulm.2003.09.002; Filipe JAN, 2001, B MATH BIOL, V63, P603, DOI 10.1006/bulm.2001.0234; Franc A, 2004, ECOL COMPLEX, V1, P49, DOI 10.1016/j.ecocom.2003.10.002; Fuentes MA, 1999, PHYSICA A, V267, P471, DOI 10.1016/S0378-4371(99)00027-8; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HENEBRY GM, 1995, ECOL MODEL, V82, P75, DOI 10.1016/0304-3800(94)00074-R; Horm VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034160; House T, 2011, J R SOC INTERFACE, V8, P67, DOI 10.1098/rsif.2010.0179; Keeling M, 2005, THEOR POPUL BIOL, V67, P1, DOI 10.1016/j.tpb.2004.08.002; Keeling M. J., 2007, MODELLING INFECT DIS; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kuperman MN, 1999, PHYSICA A, V272, P206, DOI 10.1016/S0378-4371(99)00284-8; Law R, 2003, ECOLOGY, V84, P252, DOI 10.1890/0012-9658(2003)084[0252:PGISAT]2.0.CO;2; Noordegraaf AV, 2003, EUR J OPER RES, V146, P433, DOI 10.1016/S0377-2217(02)00257-6; Pautasso M, 2008, ECOL COMPLEX, V5, P1, DOI 10.1016/j.ecocom.2007.07.001; Perkins SE, 2009, J ANIM ECOL, V78, P1015, DOI 10.1111/j.1365-2656.2009.01557.x; Sabatier P, 2004, ECOL MODEL, V180, P233, DOI 10.1016/j.ecolmodel.2004.05.012; Schimit PHT, 2009, ECOL MODEL, V220, P1034, DOI 10.1016/j.ecolmodel.2009.01.014; Shirley MDF, 2005, ECOL COMPLEX, V2, P287, DOI 10.1016/j.ecocom.2005.04.005; Thulke HH, 1999, ECOL MODEL, V117, P179, DOI 10.1016/S0304-3800(98)00198-7; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Tsukamoto K, 2007, AVIAN DIS, V51, P129, DOI 10.1637/0005-2086(2007)051[0129:IODHCO]2.0.CO;2; Turechek WW, 2001, ECOL MODEL, V144, P77, DOI 10.1016/S0304-3800(01)00350-7; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Walker P, 2012, J R SOC INTERFACE, V9, P1836, DOI 10.1098/rsif.2012.0022	36	4	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51760	10.1371/journal.pone.0051760	http://dx.doi.org/10.1371/journal.pone.0051760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272160	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300026
J	Rahman, S; Czernik, PJ; Lu, YL; Lecka-Czernik, B				Rahman, Sima; Czernik, Piotr J.; Lu, Yalin; Lecka-Czernik, Beata			beta-Catenin Directly Sequesters Adipocytic and Insulin Sensitizing Activities but Not Osteoblastic Activity of PPAR gamma 2 in Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; INHIBITS ADIPOGENESIS; BONE-FORMATION; WNT; EXPRESSION; DIFFERENTIATION; LIGAND; MASS; PHOSPHORYLATION	Lineage allocation of the marrow mesenchymal stem cells (MSCs) to osteoblasts and adipocytes is dependent on both Wnt signaling and PPAR gamma 2 activity. Activation of PPAR gamma 2, an essential regulator of energy metabolism and insulin sensitivity, stimulates adipocyte and suppresses osteoblast differentiation and bone formation, and correlates with decreased bone mass and increased fracture rate. In contrast, activation of Wnt signaling promotes osteoblast differentiation, augments bone accrual and reduces total body fat. This study examined the cross-talk between PPAR gamma 2 and beta-catenin, a key mediator of canonical Wnt signaling, on MSC lineage determination. Rosiglitazone-activated PPAR gamma 2 induced rapid proteolytic degradation of beta-catenin, which was prevented by either inhibiting glycogen synthase kinase 3 beta (GSK3 beta) activity, or blocking pro-adipocytic activity of PPAR gamma 2 using selective antagonist GW9662 or mutation within PPAR gamma 2 protein. Stabilization of beta-catenin suppressed PPAR gamma 2 pro-adipocytic but not anti-osteoblastic activity. Moreover, beta-catenin stabilization decreased PPAR gamma 2-mediated insulin signaling as measured by insulin receptor and FoxO1 gene expression, and protein levels of phosphorylated Akt (pAkt). Cellular knockdown of beta-catenin with siRNA increased expression of adipocyte but did not affect osteoblast gene markers. Interestingly, the expression of Wnt10b was suppressed by anti-osteoblastic, but not by pro-adipocytic activity of PPAR gamma 2. Moreover, beta-catenin stabilization in the presence of activated PPAR gamma 2 did not restore Wnt10b expression indicating a dominant role of PPAR gamma 2 in negative regulation of pro-osteoblastic activity of Wnt signaling. In conclusion, beta-catenin and PPAR gamma 2 are in cross-talk which results in sequestration of pro-adipocytic and insulin sensitizing activity. The anti-osteoblastic activity of PPAR gamma 2 is independent of this interaction.	[Rahman, Sima; Czernik, Piotr J.; Lu, Yalin; Lecka-Czernik, Beata] Univ Toledo, Dept Orthopaed Surg, Coll Med, Toledo, OH 43606 USA; [Lecka-Czernik, Beata] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, Toledo, OH 43606 USA; [Rahman, Sima; Lecka-Czernik, Beata] Univ Toledo, Ctr Diabet & Endocrine Res, Coll Med, Toledo, OH 43606 USA	University of Toledo; University of Toledo; University of Toledo	Lecka-Czernik, B (corresponding author), Univ Toledo, Dept Orthopaed Surg, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	beata.leckaczernik@utoledo.edu			NIH/NIA [AG028935]; American Diabetes Association [1-09-RA95]; Amaranth Diabetes Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028935] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Diabetes Association(American Diabetes Association); Amaranth Diabetes Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by a grant from NIH/NIA AG028935, (www.nia.nih.gov) and American Diabetes Association grant 1-09-RA95 (www.diabetes.org) funded by Amaranth Diabetes Fund (www.amaranth.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Aslanidi G, 2007, AM J PHYSIOL-ENDOC M, V293, pE726, DOI 10.1152/ajpendo.00248.2007; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Bruedigam C, 2008, FEBS LETT, V582, P1618, DOI 10.1016/j.febslet.2008.04.012; Bruedigam C, 2010, STEM CELLS, V28, P916, DOI 10.1002/stem.405; Case N, 2011, J BIOL CHEM, V286, P39450, DOI 10.1074/jbc.M111.265330; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Costa V, 2010, PPAR RES, V2010, DOI 10.1155/2010/409168; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lazarenko OP, 2006, BONE, V38, P74, DOI 10.1016/j.bone.2005.07.008; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MARCUS SL, 1993, P NATL ACAD SCI USA, V90, P5723, DOI 10.1073/pnas.90.12.5723; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Rhee EJ, 2007, EXP MOL MED, V39, P696, DOI 10.1038/emm.2007.76; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720	49	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51746	10.1371/journal.pone.0051746	http://dx.doi.org/10.1371/journal.pone.0051746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272157	Green Submitted, gold, Green Published			2022-12-27	WOS:000312483300024
J	Aime, P; Hegoburu, C; Jaillard, T; Degletagne, C; Garcia, S; Messaoudi, B; Thevenet, M; Lorsignol, A; Duchamp, C; Mouly, AM; Julliard, AK				Aime, Pascaline; Hegoburu, Chloe; Jaillard, Tristan; Degletagne, Cyril; Garcia, Samuel; Messaoudi, Belkacem; Thevenet, Marc; Lorsignol, Anne; Duchamp, Claude; Mouly, Anne-Marie; Julliard, Andree Karyn			A Physiological Increase of Insulin in the Olfactory Bulb Decreases Detection of a Learned Aversive Odor and Abolishes Food Odor-Induced Sniffing Behavior in Rats	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CHRONIC INTRACEREBROVENTRICULAR INFUSION; BODY-WEIGHT; CEREBROSPINAL-FLUID; EVOKED ACTIVITY; RECEPTOR; MODULATION; DISCRIMINATION; RESPONSES; SECRETION	Insulin is involved in multiple regulatory mechanisms, including body weight and food intake, and plays a critical role in metabolic disorders such as obesity and diabetes. An increasing body of evidence indicates that insulin is also involved in the modulation of olfactory function. The olfactory bulb (OB) contains the highest level of insulin and insulin receptors (IRs) in the brain. However, a role for insulin in odor detection and sniffing behavior remains to be elucidated. Using a behavioral paradigm based on conditioned olfactory aversion (COA) to isoamyl-acetate odor, we demonstrated that an intracerebroventricular (ICV) injection of 14 mU insulin acutely decreased olfactory detection of fasted rats to the level observed in satiated animals. In addition, whereas fasted animals demonstrated an increase in respiratory frequency upon food odor detection, this effect was absent in fasted animals receiving a 14 mU insulin ICV injection as well as in satiated animals. In parallel, we showed that the OB and plasma insulin levels were increased in satiated rats compared to fasted rats, and that a 14 mU insulin ICV injection elevated the OB insulin level of fasted rats to that of satiated rats. We further quantified insulin receptors (IRs) distribution and showed that IRs are preferentially expressed in the caudal and lateral parts of the main OB, with the highest labeling found in the mitral cells, the main OB projection neurons. Together, these data suggest that insulin acts on the OB network to modulate olfactory processing and demonstrate that olfactory function is under the control of signals involved in energy homeostasis regulation and feeding behaviors. Citation: Aime P, Hegoburu C, Jaillard T, Degletagne C, Garcia S, et al. (2012) A Physiological Increase of Insulin in the Olfactory Bulb Decreases Detection of a Learned Aversive Odor and Abolishes Food Odor-Induced Sniffing Behavior in Rats. PLoS ONE 7(12): e51227. doi:10.1371/journal.pone.0051227	[Aime, Pascaline; Hegoburu, Chloe; Garcia, Samuel; Messaoudi, Belkacem; Thevenet, Marc; Mouly, Anne-Marie; Julliard, Andree Karyn] Univ Lyon 1, Ctr Rech Neurosci Lyon, Team Olfact,CNRS UMR 5292, INSERM U1028, F-69365 Lyon, France; [Jaillard, Tristan; Lorsignol, Anne] Univ Toulouse 3, CNRS UMR 5241, F-31062 Toulouse, France; [Jaillard, Tristan; Lorsignol, Anne] Univ Toulouse 3, CNRS UMR 5273, INSERM, EFS,U1031,STROMALab, F-31062 Toulouse, France; [Degletagne, Cyril; Duchamp, Claude] Univ Lyon 1, CNRS UMR 5023, LEHNA, F-69622 Villeurbanne, France; [Aime, Pascaline] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Columbia University	Julliard, AK (corresponding author), Univ Lyon 1, Ctr Rech Neurosci Lyon, Team Olfact,CNRS UMR 5292, INSERM U1028, F-69365 Lyon, France.	julliard@olfac.univ-lyon1.fr	MOULY, Anne-Marie/G-7302-2017; Julliard, Andrée Karyn/N-8082-2017	MOULY, Anne-Marie/0000-0002-9005-8788; Julliard, Andrée Karyn/0000-0002-3464-7529; LORSIGNOL, Anne/0000-0001-7662-1872	Agence Nationale de la Recherche [ANR-05-PNRA 1E07 Aromalim]; Ministere de la recherche et des nouvelles technologies	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de la recherche et des nouvelles technologies	This work was supported by Agence Nationale de la Recherche Grant ANR-05-PNRA 1E07 Aromalim and by the Ministere de la recherche et des nouvelles technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Aime P, 2007, BEHAV BRAIN RES, V179, P258, DOI 10.1016/j.bbr.2007.02.012; Air EL, 2002, PHARMACOL BIOCHEM BE, V72, P423, DOI 10.1016/S0091-3057(01)00780-8; Apelbaum AF, 2003, CHEM SENSES, V28, P389, DOI 10.1093/chemse/28.5.389; Banks WA, 1997, PEPTIDES, V18, P1257, DOI 10.1016/S0196-9781(97)00198-8; Banks WA, 2004, EUR J PHARMACOL, V490, P5, DOI 10.1016/j.ejphar.2004.02.040; Banks WA, 1999, PEPTIDES, V20, P373, DOI 10.1016/S0196-9781(99)00045-5; BASKIN DG, 1983, ENDOCRINOLOGY, V112, P898, DOI 10.1210/endo-112-3-898; Bowlby MR, 1997, J GEN PHYSIOL, V110, P601, DOI 10.1085/jgp.110.5.601; BRIEF DJ, 1984, BRAIN RES BULL, V12, P571, DOI 10.1016/0361-9230(84)90174-6; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Buonviso N, 2006, CHEM SENSES, V31, P145, DOI 10.1093/chemse/bjj010; BURDACH KJ, 1984, PERCEPT PSYCHOPHYS, V36, P205, DOI 10.3758/BF03206360; CAIN DP, 1975, BRAIN RES, V99, P69, DOI 10.1016/0006-8993(75)90609-5; CHAPUT M, 1976, CHEM SENS FLAV, V2, P189, DOI 10.1093/chemse/2.2.189; Clegg DJ, 2005, AM J PHYSIOL-REG I, V288, pR981, DOI 10.1152/ajpregu.00675.2004; Courtiol E, 2011, J NEUROPHYSIOL, V106, P2813, DOI 10.1152/jn.00672.2011; Delattre E, 1999, CLIN EXP PHARMACOL P, V26, P505, DOI 10.1046/j.1440-1681.1999.03073.x; DUFFY KR, 1987, BRAIN RES, V420, P32, DOI 10.1016/0006-8993(87)90236-8; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Fadool DA, 1998, J NEUROSCI, V18, P6126; Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332; FRANK HJL, 1986, DIABETES, V35, P654, DOI 10.2337/diabetes.35.6.654; Haj-ali V, 2009, BEHAV NEUROSCI, V123, P1309, DOI 10.1037/a0017722; Hegoburu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00025; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HILL JM, 1986, NEUROSCIENCE, V17, P1127, DOI 10.1016/0306-4522(86)90082-5; Jaillard T, 2009, DIABETES, V58, P1544, DOI 10.2337/db08-1039; Johnson BA, 2007, J COMP NEUROL, V502, P468, DOI 10.1002/cne.21322; Julliard AK, 2007, BEHAV BRAIN RES, V183, P123, DOI 10.1016/j.bbr.2007.05.033; Julliard AK, 1998, NEUROSCIENCE, V84, P1135, DOI 10.1016/S0306-4522(97)00544-7; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Ketterer C, 2011, INT J OBESITY, V35, P1135, DOI 10.1038/ijo.2010.251; Lacroix MC, 2008, J NEUROENDOCRINOL, V20, P1176, DOI 10.1111/j.1365-2826.2008.01777.x; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MANIN M, 1988, J NEUROCHEM, V51, P1689, DOI 10.1111/j.1471-4159.1988.tb01146.x; Marks DR, 2009, J NEUROSCI, V29, P6734, DOI 10.1523/JNEUROSCI.1350-09.2009; MARKS JL, 1989, NEUROSCIENCE, V30, P551, DOI 10.1016/0306-4522(89)90272-8; MARKS JL, 1990, ENDOCRINOLOGY, V127, P3234, DOI 10.1210/endo-127-6-3234; MATSUMOTO H, 1990, J NEUROCHEM, V54, P347, DOI 10.1111/j.1471-4159.1990.tb13321.x; Mickley GA, 2004, BRAIN RES, V1016, P79, DOI 10.1016/j.brainres.2004.04.071; MONOD B, 1989, BEHAV BRAIN RES, V33, P51, DOI 10.1016/S0166-4328(89)80018-X; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mori K, 2003, BIOCHEM SOC T, V31, P134, DOI 10.1042/bst0310134; PAGER J, 1972, PHYSIOL BEHAV, V9, P573, DOI 10.1016/0031-9384(72)90014-5; PAGER J, 1974, PHYSIOL BEHAV, V13, P523, DOI 10.1016/0031-9384(74)90283-2; Palouzier-Paulignan B, 2012, CHEM SENSES, V37, P769, DOI 10.1093/chemse/bjs059; Park CR, 2000, PHYSIOL BEHAV, V68, P509, DOI 10.1016/S0031-9384(99)00220-6; Park CR, 2001, NEUROSCI BIOBEHAV R, V25, P311, DOI 10.1016/S0149-7634(01)00016-1; PLATASALAMAN CR, 1986, PHYSIOL BEHAV, V37, P735, DOI 10.1016/0031-9384(86)90178-2; PLATASALAMAN CR, 1986, PHYSIOL BEHAV, V37, P717, DOI 10.1016/0031-9384(86)90177-0; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; Prud'homme MJ, 2009, NEUROSCIENCE, V162, P1287, DOI 10.1016/j.neuroscience.2009.05.043; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Ruijschop RMAJ, 2010, CHEM SENSES, V35, P91, DOI 10.1093/chemse/bjp086; Ruijschop RMAJ, 2009, J AGR FOOD CHEM, V57, P9888, DOI 10.1021/jf901445z; Ruijschop RMAJ, 2009, CHEM SENSES, V34, P395, DOI 10.1093/chemse/bjp011; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; SCHWARTZ MW, 1990, AM J PHYSIOL, V259, pE378, DOI 10.1152/ajpendo.1990.259.3.E378; SCHWARZBERG H, 1989, NEUROPEPTIDES, V13, P79, DOI 10.1016/0143-4179(89)90002-4; Scott JW, 2007, J NEUROPHYSIOL, V97, P1941, DOI 10.1152/jn.01305.2006; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; SITREN HS, 1978, J NUTR, V108, P1393, DOI 10.1093/jn/108.9.1393; Slotnick BM, 1997, ANIM LEARN BEHAV, V25, P357, DOI 10.3758/BF03199093; Sobel N, 2000, CHEM SENSES, V25, P1, DOI 10.1093/chemse/25.1.1; Sokal RR, 1981, BIOMETRY PRINCIPALS; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; STRUBBE JH, 1988, PHYSIOL BEHAV, V44, P205, DOI 10.1016/0031-9384(88)90139-4; Tong J, 2011, J NEUROSCI, V31, P5841, DOI 10.1523/JNEUROSCI.5680-10.2011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; UNGER J, 1989, NEUROSCIENCE, V31, P143, DOI 10.1016/0306-4522(89)90036-5; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; WOODS SC, 1977, AM J PHYSIOL, V233, pE331, DOI 10.1152/ajpendo.1977.233.4.E331; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4	83	40	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51227	10.1371/journal.pone.0051227	http://dx.doi.org/10.1371/journal.pone.0051227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251461	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800031
J	Fonseca, MB; Nunes, AF; Morgado, AL; Sola, S; Rodrigues, CMP				Fonseca, Maria B.; Nunes, Ana F.; Morgado, Ana L.; Sola, Susana; Rodrigues, Cecilia M. P.			TAp63 gamma Demethylation Regulates Protein Stability and Cellular Distribution during Neural Stem Cell Differentiation	PLOS ONE			English	Article							SELF-RENEWAL; NS CELLS; P63; P73; P53; MOUSE; TRANSCRIPTION; MAINTENANCE; APOPTOSIS; DEATH	p63 is a close relative of the p53 tumor suppressor and transcription factor that modulates cell fate. The full-length isoform of p63, containing a transactivation (TA) domain (TAp63) is an essential proapoptotic protein in neural development. The role of p63 in epithelial development is also well established; however, its precise function during neural differentiation remains largely controversial. Recently, it has been demonstrated that several conserved elements of apoptosis are also integral components of cellular differentiation; p53 directly interacts with key regulators of neurogenesis. The aim of this study was to evaluate the role of p63 during mouse neural stem cell (NSC) differentiation and test whether the histone H3 lysine 27-specific demethylase JMJD3 interacts with p63 to redirect NSCs to neurogenesis. Our results showed that JMJD3 and TAp63 gamma are coordinately regulated to establish neural-specific gene expression programs in NSCs undergoing differentiation. JMJD3 overexpression increased TAp63 gamma levels in a demethylase activity-dependent manner. Importantly, overexpression of TAp63 gamma increased beta-III tubulin whereas downregulation of TAp63 gamma by specific p63 siRNA decreased beta-III tubulin. Immunoprecipitation assays demonstrated direct interaction between TAp63 gamma and JMJD3, and modulation of TAp63 gamma methylation status by JMJD3-demethylase activity. Importantly, the demethylase activity of JMJD3 influenced TAp63 gamma protein stabilization and cellular distribution, as well as TAp63 gamma-regulated neurogenesis. These findings clarify the role of p63 in adult neural progenitor cells and reveal TAp63 gamma as a direct target for JMJD3-mediated neuronal commitment.	[Fonseca, Maria B.; Nunes, Ana F.; Morgado, Ana L.; Sola, Susana; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Sola, Susana; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Rodrigues, CMP (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal.	cmprodrigues@ff.ul.pt	Solá, Susana/M-5251-2013; Morgado, Ana Luísa/A-8683-2015; Solá, Susana/AAI-4580-2021; Rodrigues, Cecilia MP/M-3572-2013; iMed.ULisboa, CellFun/A-4244-2014	Solá, Susana/0000-0003-2036-797X; Morgado, Ana Luísa/0000-0003-3153-4665; Solá, Susana/0000-0003-2036-797X; Rodrigues, Cecilia MP/0000-0002-4829-754X; 	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/SAU-NMC/117877/2010, Pest-OE/SAU/UI4013/2011, SFRH/BD/43959/2008, SFRH/BPD/34603/2007]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grants PTDC/SAU-NMC/117877/2010 and Pest-OE/SAU/UI4013/2011, and fellowships SFRH/BD/43959/2008 (M.B.F.) and SFRH/BPD/34603/2007 (A.F.N.) from Fundacao para a Ciencia e a Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2010, BIOCHEM BIOPH RES CO, V403, P13, DOI 10.1016/j.bbrc.2010.10.087; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Aranha MM, 2009, J CELL BIOCHEM, V107, P748, DOI 10.1002/jcb.22172; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Hernandez-Acosta NC, 2011, BRAIN RES, V1372, P29, DOI 10.1016/j.brainres.2010.11.041; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Courtois S, 2004, ONCOGENE, V23, P631, DOI 10.1038/sj.onc.1206929; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Dietz S, 2002, FEBS LETT, V525, P93, DOI 10.1016/S0014-5793(02)03093-4; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Fonseca MB, 2012, J ALZHEIMERS DIS, V28, P685, DOI 10.3233/JAD-2011-111547; Fujitani M, 2010, CURR BIOL, V20, P2058, DOI 10.1016/j.cub.2010.10.029; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Gonzalez-Cano L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.87; Holembowski L, 2011, CELL CYCLE, V10, P680, DOI 10.4161/cc.10.4.14859; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Marcel V, 2012, CELL DEATH DIFFER, V19, P816, DOI 10.1038/cdd.2011.152; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Nicotera P, 2005, NEURON, V48, P707, DOI 10.1016/j.neuron.2005.11.023; Paris M, 2012, CELL DEATH DIFFER, V19, P186, DOI 10.1038/cdd.2011.181; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Spiliotopoulos D, 2009, NEUROBIOL DIS, V34, P320, DOI 10.1016/j.nbd.2009.02.007; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Talos F, 2010, CELL DEATH DIFFER, V17, P1816, DOI 10.1038/cdd.2010.131; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Ying HQ, 2005, MOL CELL BIOL, V25, P6154, DOI 10.1128/MCB.25.14.6154-6164.2005; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	39	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52417	10.1371/journal.pone.0052417	http://dx.doi.org/10.1371/journal.pone.0052417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251711	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800163
J	Layton, A; Reap, J; Bras, B; Weissburg, M				Layton, Astrid; Reap, John; Bras, Bert; Weissburg, Marc			Correlation between Thermodynamic Efficiency and Ecological Cyclicity for Thermodynamic Power Cycles	PLOS ONE			English	Article							INDUSTRIAL ECOLOGY	A sustainable global community requires the successful integration of environment and engineering. In the public and private sectors, designing cyclical ("closed loop") resource networks increasingly appears as a strategy employed to improve resource efficiency and reduce environmental impacts. Patterning industrial networks on ecological ones has been shown to provide significant improvements at multiple levels. Here, we apply the biological metric cyclicity to 28 familiar thermodynamic power cycles of increasing complexity. These cycles, composed of turbines and the like, are scientifically very different from natural ecosystems. Despite this difference, the application results in a positive correlation between the maximum thermal efficiency and the cyclic structure of the cycles. The immediate impact of these findings results in a simple method for comparing cycles to one another, higher cyclicity values pointing to those cycles which have the potential for a higher maximum thermal efficiency. Such a strong correlation has the promise of impacting both natural ecology and engineering thermodynamics and provides a clear motivation to look for more fundamental scientific connections between natural and engineered systems. Citation: Layton A, Reap J, Bras B, Weissburg M (2012) Correlation between Thermodynamic Efficiency and Ecological Cyclicity for Thermodynamic Power Cycles. PLoS ONE 7(12): e51841. doi:10.1371/journal.pone.0051841	[Layton, Astrid; Bras, Bert] Georgia Inst Technol, George W Woodruff Sch Mech Engn Sustainable Desig, Atlanta, GA 30332 USA; [Reap, John] Quinnipiac Univ, Sch Business & Engn, Hamden, CT USA; [Weissburg, Marc] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Bras, Bert; Weissburg, Marc] Georgia Inst Technol, Ctr Biol Inspired Design, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Quinnipiac University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Layton, A (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn Sustainable Desig, Atlanta, GA 30332 USA.	alayton6@gatech.edu		Layton, Astrid/0000-0003-3790-2916	National Science Foundation [CMMI-0600243, 0628190];  [CBET-0967536]; Direct For Education and Human Resources [1022778] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [0967536] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This material is based upon work supported by the National Science Foundation under Grant Nos. CMMI-0600243 and 0628190, and CBET-0967536. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2005, OIKOS, V110, P164, DOI 10.1111/j.0030-1299.2005.13082.x; [Anonymous], 1999, ENERGY RESOURCES OCC; Borrett SR, 2007, J THEOR BIOL, V245, P98, DOI 10.1016/j.jtbi.2006.09.024; Brokowiski ME, 1998, IMPROVING AIR STANDA; Brundtland G.H., 1987, OUR COMMON FUTURE, DOI DOI 10.1080/07488008808408783; Ehrenfeld J., 1997, J IND ECOL, V1, P67, DOI [10.1162/jiec.1997.1.1.67, DOI 10.1162/JIEC.1997.1.1.67]; European Parliament, 2003, OFF J EUR UNION; Fath BD, 1998, NETWORK ANAL FDN EXT; Fath BD, 2007, ECOL MODEL, V208, P391, DOI 10.1016/j.ecolmodel.2007.06.013; Fath BD, 2007, ECOL MODEL, V208, P17, DOI 10.1016/j.ecolmodel.2007.04.020; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; FROSCH RA, 1992, P NATL ACAD SCI USA, V89, P800, DOI 10.1073/pnas.89.3.800; FROSCH RA, 1989, SCI AM, V261, P144, DOI 10.1038/scientificamerican0989-144; Garmestani AS, 2006, ENVIRON DEV ECON, V11, P533, DOI 10.1017/S1355770X06003081; GRAEDEL T. E., 1995, IND ECOLOGY; Hardy Catherine, 2002, Journal of Industrial Ecology, V6, P29, DOI 10.1162/108819802320971623; HO MW, 1998, RAINBOW WORM; JELINSKI LW, 1992, P NATL ACAD SCI USA, V89, P793, DOI 10.1073/pnas.89.3.793; Kadem L, 2007, VAPOR COMBINED POWER, P6; LEWIS ER, 1995, BIOSYSTEMS, V34, P47, DOI 10.1016/0303-2647(94)01456-H; MULLER F, 1998, ECO TARGETS GOAL FUN; Naish J, 2008, ECOLOGIST, V38, P36; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; OSTER G, 1971, NATURE, V234, P393, DOI 10.1038/234393a0; Reap, 2009, HOLISTIC BIOMIMICRY; SCHNEIDER ED, 1994, MATH COMPUT MODEL, V19, P25, DOI 10.1016/0895-7177(94)90188-0; Sonntag RE., 2003, FUNDAMENTALS THERMOD	27	33	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51841	10.1371/journal.pone.0051841	http://dx.doi.org/10.1371/journal.pone.0051841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251638	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800095
J	Yagound, B; Blacher, P; Chameron, S; Chaline, N				Yagound, Boris; Blacher, Pierre; Chameron, Stephane; Chaline, Nicolas			Social Context and Reproductive Potential Affect Worker Reproductive Decisions in a Eusocial Insect	PLOS ONE			English	Article							APIS-MELLIFERA-CAPENSIS; BUMBLEBEE BOMBUS-TERRESTRIS; COMPLEX SOCIOGENETIC ORGANIZATION; DIVISION-OF-LABOR; HONEYBEE WORKERS; INTRASPECIFIC PARASITISM; LASIOGLOSSUM-MALACHURUM; QUEEN INFLUENCE; SWEAT BEE; COLONIES	Context-dependent decision-making conditions individual plasticity and is an integrant part of alternative reproductive strategies. In eusocial Hymenoptera (ants, bees and wasps), the discovery of worker reproductive parasitism recently challenged the view of workers as a homogeneous collective entity and stressed the need to consider them as autonomous units capable of elaborate choices which influence their fitness returns. The reproductive decisions of individual workers thus need to be investigated and taken into account to understand the regulation of reproduction in insect societies. However, we know virtually nothing about the proximate mechanisms at the basis of worker reproductive decisions. Here, we test the hypothesis that the capacity of workers to reproduce in foreign colonies lies in their ability to react differently according to the colonial context and whether this reaction is influenced by a particular internal state. Using the bumble bee Bombus terrestris, we show that workers exhibit an extremely high reproductive plasticity which is conditioned by the social context they experience. Fertile workers reintroduced into their mother colony reverted to sterility, as expected. On the contrary, a high level of ovary activity persisted in fertile workers introduced into a foreign nest, and this despite more frequent direct contacts with the queen and the brood than control workers. Foreign workers' reproductive decisions were not affected by the resident queen, their level of fertility being similar whether or not the queen was removed from the host colony. Workers' physiological state at the time of introduction is also of crucial importance, since infertile workers failed to develop a reproductive phenotype in a foreign nest. Therefore, both internal and environmental factors appear to condition individual reproductive strategies in this species, suggesting that more complex decision-making mechanisms are involved in the regulation of worker reproduction than previously thought. Citation: Yagound B, Blacher P, Chameron S, Chaline N (2012) Social Context and Reproductive Potential Affect Worker Reproductive Decisions in a Eusocial Insect. PLoS ONE 7(12): e52217. doi:10.1371/journal.pone.0052217	[Yagound, Boris; Blacher, Pierre; Chameron, Stephane; Chaline, Nicolas] Univ Paris 13, EA 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France	Universite Paris 13	Yagound, B (corresponding author), Univ Paris 13, EA 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France.	boris.yagound@leec.univ-paris13.fr	Chaline, Nicolas/J-7276-2012; Yagound, Boris/C-7956-2018	Chaline, Nicolas/0000-0001-6714-9297; Yagound, Boris/0000-0003-0466-8326; Chaline, Nicolas/0000-0002-4905-5702	French National Research Agency [ANR-09-JCJC-0031-01 SEUILS]	French National Research Agency(French National Research Agency (ANR))	This work was supported by the French National Research Agency (ANR-09-JCJC-0031-01 SEUILS to NC), www.agence-nationale-recherche.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRE R D, 1976, Journal of the Kansas Entomological Society, V49, P63; Alaux C, 2004, INSECT SOC, V51, P287, DOI 10.1007/s00040-004-0741-5; Alaux C, 2007, BEHAV ECOL SOCIOBIOL, V62, P213, DOI 10.1007/s00265-007-0455-6; Alaux C, 2006, BEHAV ECOL SOCIOBIOL, V60, P439, DOI 10.1007/s00265-006-0184-2; Alves DA, 2009, MOL ECOL, V18, P4102, DOI 10.1111/j.1365-294X.2009.04323.x; Amsalem E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018238; [Anonymous], 1971, INSECT SOC; Beekman M, 2008, ANNU REV ENTOMOL, V53, P19, DOI 10.1146/annurev.ento.53.103106.093515; Birmingham AL, 2004, CAN J ZOOL, V82, P1843, DOI 10.1139/Z04-181; Bloch G, 1999, BEHAV ECOL SOCIOBIOL, V45, P125, DOI 10.1007/s002650050546; Bloch G, 1999, P ROY SOC B-BIOL SCI, V266, P2465, DOI 10.1098/rspb.1999.0947; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; Bourke AFG, 2001, P ROY SOC B-BIOL SCI, V268, P347, DOI 10.1098/rspb.2000.1381; CAMERON SA, 1989, ETHOLOGY, V80, P137, DOI 10.1111/j.1439-0310.1989.tb00735.x; Cepeda OI, 2006, APIDOLOGIE, V37, P175, DOI 10.1051/apido:2006018; Chapman NC, 2010, BEHAV ECOL SOCIOBIOL, V64, P419, DOI 10.1007/s00265-009-0858-7; Cnaani J, 2000, BEHAV ECOL SOCIOBIOL, V47, P346, DOI 10.1007/s002650050675; DUCHATEAU MJ, 1989, ENTOMOL EXP APPL, V51, P199, DOI 10.1007/BF00347883; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; Foster RL, 2004, PHYSIOL ENTOMOL, V29, P327, DOI 10.1111/j.0307-6962.2004.00388.x; Hartel S, 2006, INSECT SOC, V53, P183, DOI 10.1007/s00040-005-0857-2; Hammond RL, 2004, PLOS BIOL, V2, P1472, DOI 10.1371/journal.pbio.0020248; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; LIN N, 1972, Q REV BIOL, V47, P131, DOI 10.1086/407216; Lopez-Vaamonde C, 2004, NATURE, V430, P557, DOI 10.1038/nature02769; Martin SJ, 2002, NATURE, V415, P163, DOI 10.1038/415163a; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Nanork P, 2007, MOL ECOL, V16, P1107, DOI 10.1111/j.1365-294X.2006.03207.x; Nanork P, 2005, NATURE, V437, P829, DOI 10.1038/437829a; Neumann P, 2003, APIDOLOGIE, V34, P585, DOI 10.1051/apido:2003048; Neumann P, 2001, BEHAV ECOL, V12, P419, DOI 10.1093/beheco/12.4.419; Paxton RJ, 2002, MOL ECOL, V11, P2405, DOI 10.1046/j.1365-294X.2002.01620.x; Pfeiffer KJ, 1998, INSECT SOC, V45, P151, DOI 10.1007/s000400050076; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Roseler P.-F., 1973, Apidologie, V4, P267, DOI 10.1051/apido:19730303; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; Soro A, 2009, INSECT SOC, V56, P55, DOI 10.1007/s00040-008-1037-y; Sumner S, 2007, CURR BIOL, V17, P140, DOI 10.1016/j.cub.2006.11.064; Takahashi J, 2010, J ETHOL, V28, P61, DOI 10.1007/s10164-009-0155-y; VANDOORN A, 1986, INSECT SOC, V33, P3, DOI 10.1007/BF02224031; Wenseleers T, 2006, AM NAT, V168, pE163, DOI 10.1086/508619; Zanette LRS, 2012, EVOLUTION, V66, P3765, DOI 10.1111/j.1558-5646.2012.01709.x	45	16	16	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52217	10.1371/journal.pone.0052217	http://dx.doi.org/10.1371/journal.pone.0052217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251701	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800152
J	Cheng, XF; Wang, S; Dai, X; Shi, CB; Wen, YF; Zhu, M; Zhan, SW; Meng, JH				Cheng, Xianfeng; Wang, Song; Dai, Xing; Shi, Chengbo; Wen, Yufeng; Zhu, Ming; Zhan, Shenwei; Meng, Jihong			Rabbit as a Novel Animal Model for Hepatitis E Virus Infection and Vaccine Evaluation	PLOS ONE			English	Article							CROSS-SPECIES INFECTION; CIS-REACTIVE ELEMENT; PATHOGENESIS; PIGS; IDENTIFICATION; REPLICATION; COUNTRIES; CHICKENS; PRIMATES; HEV	Background: The identification of hepatitis E virus (HEV) from rabbits motivated us to assess the possibility of using rabbits as a non-human primate animal model for HEV infection and vaccine evaluation. Methodology/Principal Findings: First, 75 rabbits were inoculated with seven strains of genotypes 1, 3, 4, and rabbit HEV, to determine the appropriate strain, administrative route and viral dosage. Second, 15 rabbits were randomly divided into three groups and vaccinated with 0 mu g (placebo), 10 mu g and 20 mu g of HEV candidate vaccine, HEV p179, respectively. After three doses of the vaccination, the rabbits were challenged with 3.3x10(5) genome equivalents of genotype 4 HEV strain H4-NJ703. The strain of genotype 1 HEV was not found to be infectious for rabbits. However, approximately 80% of the animals were infected by two rabbit HEV strains. All rabbits inoculated with a genotype 3 strain were seroconverted but did not show viremia or fecal viral shedding. Although two genotype 4 strains, H4-NJ153 and H4-NJ112, only resulted in part of rabbits infected, another strain of genotype 4, H4-NJ703, had an infection rate of 100% (five out of five) when administrated intravenously. However, only two out of fifteen rabbits showed virus excretion and seroconversion when inoculated orally with H4-NJ703 of three different dosages. In the vaccine evaluation study, rabbits vaccinated with 20 mg of the HEV p179 produced anti-HEV with titers of 1:10(4)-1:10(5) and were completely protected from infection. Rabbits vaccinated with 10 mg produced anti-HEV with titers of 1:10(3)-1:10(4) and were protected from hepatitis, but two out of the five rabbits showed virus shedding. Conclusions/Significance: Rabbits may be served as an alternative to the non-human primate models for HEV infection and vaccine evaluation when certain virus strains, appropriate viral dosages, and the intravenous route of inoculation are selected.	[Cheng, Xianfeng; Wang, Song; Meng, Jihong] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Dai, Xing] Southeast Univ, Affiliated Zhongda Hosp, Sch Med, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Shi, Chengbo; Meng, Jihong] Changchun Inst Biol Prod Co Ltd, Changchun, Jilin, Peoples R China; [Wen, Yufeng] Wannan Med Coll, Dept Prevent Med, Wuhu, Anhui, Peoples R China; [Zhu, Ming; Zhan, Shenwei] Ctr Dis Control & Prevent Ma Anshan, Maanshan, Anhui, Peoples R China	Southeast University - China; Southeast University - China; Wannan Medical College	Meng, JH (corresponding author), Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China.	jihongmeng@163.com	Wang, Song/GRS-5358-2022	Wang, Song/0000-0001-7122-013X	National High Technology Research and Development Program of China ("863'' Program) [2006AA02A235]; Science and Technology Support Program of Jiangsu province, China [BE2009664]	National High Technology Research and Development Program of China ("863'' Program); Science and Technology Support Program of Jiangsu province, China	This work was supported by the National High Technology Research and Development Program of China ("863'' Program 2006AA02A235), and the Science and Technology Support Program of Jiangsu province, China (BE2009664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Billam P, 2005, J VIROL, V79, P3429, DOI 10.1128/JVI.79.6.3429-3437.2005; Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dong C, 2006, J CELL MOL IMMUNOL C, V22, P339; Dong C, 2007, VACCINE, V25, P1662, DOI 10.1016/j.vaccine.2006.11.001; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Emerson SU, 2001, P NATL ACAD SCI USA, V98, P15270, DOI 10.1073/pnas.251555098; Feagins AR, 2008, J MED VIROL, V80, P1379, DOI 10.1002/jmv.21223; Geng YS, 2011, INFECT GENET EVOL, V11, P476, DOI 10.1016/j.meegid.2010.12.012; Graff J, 2005, J VIROL, V79, P6680, DOI 10.1128/JVI.79.11.6680-6689.2005; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Huang F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-93; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Krawczynski K, 2011, VIRUS RES, V161, P78, DOI 10.1016/j.virusres.2011.03.007; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Ma HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009160; Maneerat Y, 1996, J MED VIROL, V48, P121; Meng JH, 2001, VIROLOGY, V288, P203, DOI 10.1006/viro.2001.1093; Meng XJ, 2010, J VIRAL HEPATITIS, V17, P153, DOI 10.1111/j.1365-2893.2009.01257.x; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Obriadina A, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS360, DOI 10.1046/j.1440-1746.17.s3.28.x; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Purcell R H, 2001, ILAR J, V42, P161; Purdy MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014376; TSAREV SA, 1993, J INFECT DIS, V167, P1302, DOI 10.1093/infdis/167.6.1302; Tsarev SA, 1997, VACCINE, V15, P1834, DOI 10.1016/S0264-410X(97)00145-X; van der Poel WHM, 2001, EMERG INFECT DIS, V7, P970, DOI 10.3201/eid0706.010608; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Yu C, 2010, J VIROL, V84, P11264, DOI 10.1128/JVI.01205-10; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	34	37	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51616	10.1371/journal.pone.0051616	http://dx.doi.org/10.1371/journal.pone.0051616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272124	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600030
J	Eto, K; Watanabe, S; Kawabata, H				Eto, Keisuke; Watanabe, Shigeru; Kawabata, Hideaki			Economic Profits Enhance Trust, Perceived Integrity and Memory of Fairness in Interpersonal Judgment	PLOS ONE			English	Article							TRUSTWORTHINESS JUDGMENTS; UNITED-STATES; DECISION; PERSONALITY; COMMITMENT; ACTIVATION; AWARENESS; FACES; MODEL	Does money lead to trust in personality and intention of others? Humans have a strong tendency to judge the intention of others from their sequent behaviors. In general, people trust others who behave fairly, but not always. Here we show that judgments of both intentional aspects and memory of intentional behavior are automatically influenced by unintentional benefits from the behaviors of others. We conducted a reward-manipulated and repeated trust game by using real participants interacting with moving image partners on a computer screen. The participants assessed likability, trustworthiness, and perceived integrity of the partners in pre- and post-game questionnaires. The results of judgments of all three dimensions and the memory of frequency of each partner's fair behavior (sharing) were strongly influenced by profitability in the trust game, even though all partners shared 75% of the profit and participants were told that profitability was randomly assigned to each partner. Furthermore, these effects were moderated by the gender of the participants: males were more sensitive to monetary profits than were females. The results reveal that humans automatically trust, approve the integrity of, and recall well the fair behavior of others who provide affectively positive outcomes such as monetary profits. We call this phenomenon the "affect ripple effect".	[Eto, Keisuke; Watanabe, Shigeru; Kawabata, Hideaki] Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan	Keio University	Kawabata, H (corresponding author), Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan.	kawabata@flet.keio.ac.jp			Ministry of Education, Science, and Culture, Japan [24680029]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Grant-in-Aid for Scientific Research (No. 24680029) of the Ministry of Education, Science, and Culture, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GR, 1977, J PSYCHOL, V96, P287, DOI 10.1080/00223980.1977.9915911; ANDERSON NH, 1962, SCIENCE, V138, P817, DOI 10.1126/science.138.3542.817; BARGH JA, 1982, J PERS SOC PSYCHOL, V43, P437, DOI 10.1037/0022-3514.43.3.437; Bell R, 2010, COGNITION, V117, P261, DOI 10.1016/j.cognition.2010.08.020; Buchan NR, 2008, J ECON BEHAV ORGAN, V68, P466, DOI 10.1016/j.jebo.2007.10.006; Chang LJ, 2010, COGNITIVE PSYCHOL, V61, P87, DOI 10.1016/j.cogpsych.2010.03.001; Colquitt JA, 2007, J APPL PSYCHOL, V92, P909, DOI 10.1037/0021-9010.92.4.909; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Fichman M, 2003, J ORGAN BEHAV, V24, P133, DOI 10.1002/job.189; Frith CD, 2008, PHILOS T R SOC B, V363, P3875, DOI 10.1098/rstb.2008.0156; GILBERT DT, 1995, PSYCHOL BULL, V117, P21, DOI 10.1037/0033-2909.117.1.21; HIGGINS ET, 1995, J EXP SOC PSYCHOL, V31, P218, DOI 10.1006/jesp.1995.1011; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LOMBARDI WJ, 1987, PERS SOC PSYCHOL B, V13, P411, DOI 10.1177/0146167287133009; Mather M, 2000, PSYCHOL SCI, V11, P132, DOI 10.1111/1467-9280.00228; Mayer RC, 1999, J APPL PSYCHOL, V84, P123, DOI 10.1037/0021-9010.84.1.123; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; ROSENBER.S, 1968, J PERS SOC PSYCHOL, V9, P283, DOI 10.1037/h0026086; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; Wegener DT, 1997, ADV EXP SOC PSYCHOL, V29, P141, DOI 10.1016/S0065-2601(08)60017-9; Winkielman P, 1997, COGNITION EMOTION, V11, P433, DOI 10.1080/026999397379872; WINTER L, 1984, J PERS SOC PSYCHOL, V47, P237, DOI 10.1037/0022-3514.47.2.237; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; Yamagishi T, 1998, AM J SOCIOL, V104, P165, DOI 10.1086/210005; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	34	0	1	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51484	10.1371/journal.pone.0051484	http://dx.doi.org/10.1371/journal.pone.0051484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251552	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200119
J	Heng, WL; Lim, CH; Tan, BH; Chlebicki, MP; Lee, WHL; Seck, T; Lim, YP				Heng, Wee Ling; Lim, Chong Hee; Tan, Ban Hock; Chlebicki, Maciej Piotr; Lee, Winnie Hui Ling; Seck, Tracy; Lim, Yeong Phang			From Penicillin-Streptomycin to Amikacin-Vancomycin: Antibiotic Decontamination of Cardiovascular Homografts in Singapore	PLOS ONE			English	Article							RESISTANCE	Background: In February 2012, the National Cardiovascular Homograft Bank (NCHB) became the first tissue bank outside of North America to receive accreditation from the American Association of Tissue Banks. From 2008 to 2009, NCHB had been decontaminating its cardiovascular homografts with penicillin and streptomycin. The antibiotic decontamination protocol was changed in January 2010 as amikacin and vancomycin were recommended, in order to cover bacteria isolated from post-recovery and post-antibiotic incubation tissue cultures. Aim: The objective of this study is to determine the optimal incubation conditions for decontamination of homografts by evaluating the potencies of amikacin and vancomycin in different incubation conditions. Retrospective reviews of microbiological results were also performed for homografts recovered from 2008 to 2012, to compare the effectiveness of penicillin-streptomycin versus the amikacin-vancomycin regimens. Methods: Based on microbiological assays stated in United States Pharmacopeia 31, potency of amikacin was evaluated by turbidimetric assay using Staphylococcus aureus, while vancomycin was by diffusion assay using Bacillus subtilis sporulate. Experiments were performed to investigate the potencies of individual antibiotic 6-hours post incubation at 4 degrees C and 37 degrees C and 4 degrees C for 24 hours, after the results suggested that amikacin was more potent at lower temperature. Findings: Tissue incubation at 4 degrees C for 24 hours is optimal for both antibiotics, especially for amikacin, as its potency falls drastically at 37 degrees C. Conclusion: The decontamination regimen of amikacin-vancomycin at 4 degrees C for 24 hours is effective. Nevertheless, it is imperative to monitor microbiological trends closely and evaluate the efficacy of current antibiotics regimen against emerging strains of micro-organisms.	[Heng, Wee Ling; Lim, Chong Hee; Seck, Tracy; Lim, Yeong Phang] Natl Heart Ctr Singapore, Dept Cardiothorac Surg, Natl Cardiovasc Homograft Bank, Singapore, Singapore; [Tan, Ban Hock; Chlebicki, Maciej Piotr] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore	National Heart Centre Singapore; Singapore General Hospital	Heng, WL (corresponding author), Natl Heart Ctr Singapore, Dept Cardiothorac Surg, Natl Cardiovasc Homograft Bank, Singapore, Singapore.	heng.wee.ling@nhcs.com.sg			Ministry of Health Singapore's Health Service Development Programme (HSDP) grant	Ministry of Health Singapore's Health Service Development Programme (HSDP) grant	The funders, Ministry of Health Singapore's Health Service Development Programme (HSDP) grant, had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander Karen, 2006, Cell and Tissue Banking, V7, P23, DOI 10.1007/s10561-005-3393-4; BENEDICT RG, 1945, J BACTERIOL, V49, P85, DOI 10.1128/JB.49.1.85-95.1945; BROCKBANK KGM, 2001, DISINFECTION STERILI, P1011; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Gad GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017224; GALL K, 1995, J THORAC CARDIOV SUR, V110, P680, DOI 10.1016/S0022-5223(95)70099-4; GAVIN JJ, 1957, APPL MICROBIOL, V5, P235, DOI 10.1128/AEM.5.4.235-243.1957; Germain M, 2010, CELL TISSUE BANK, V11, P197, DOI 10.1007/s10561-009-9155-y; Gilbert DN, 1999, CLINICAL INFECTIOUS DISEASES, P273; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Leeming JP, 2005, J HOSP INFECT, V60, P231, DOI 10.1016/j.jhin.2004.12.022; Parker R, 2010, ESSENTIALS OF TISSUE BANKING, P69, DOI 10.1007/978-90-481-9142-0_5; Pezzella C, 2004, ANTIMICROB AGENTS CH, V48, P903, DOI 10.1128/AAC.48.3.903-908.2004; Prescott LM, 2003, MICROBIOLOGY, P805; Sulaiman AS, 1999, CLINICAL INFECTIOUS DISEASES, P285; TRAUB WH, 1995, J ANTIMICROB CHEMOTH, V35, P149, DOI 10.1093/jac/35.1.149; Verghese Susan, 2004, Indian Heart J, V56, P299; WATANAKUNAKORN C, 1984, J ANTIMICROB CHEMOTH, V14, P7, DOI 10.1093/jac/14.suppl_D.7	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51605	10.1371/journal.pone.0051605	http://dx.doi.org/10.1371/journal.pone.0051605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251592	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200144
J	Kutty, S; Wu, JF; Hammel, JM; Xie, F; Gao, SJ; Drvol, LK; Lof, J; Radio, SJ; Therrien, SL; Danford, DA; Porter, TR				Kutty, Shelby; Wu, Juefei; Hammel, James M.; Xie, Feng; Gao, Shunji; Drvol, Lucas K.; Lof, John; Radio, Stanley J.; Therrien, Stacey L.; Danford, David A.; Porter, Thomas R.			Microbubble Mediated Thrombus Dissolution with Diagnostic Ultrasound for the Treatment of Chronic Venous Thrombi	PLOS ONE			English	Article							CAVITATIONAL MECHANISMS; DIALYSIS GRAFTS; THROMBOEMBOLISM; COMPLICATIONS; THERAPY	Background: Central venous catheter (CVC) thrombi result in significant morbidity in children, and currently available treatments are associated with significant risk. We sought to investigate the therapeutic efficacy of microbubble (MB) enhanced sonothrombolysis for aged CVC associated thrombi in vivo. Methods and Results: A model of chronic indwelling CVC in the low superior vena cava with thrombus in situ was established after feasibility and safety testing in 7 pigs; and subsequently applied for repeated, sonothrombolytic treatments in 9 pigs (total 24 treatments). Baseline intracardiac echocardiography (ICE, 10.5F, Siemens), fluoroscopy and saline flushing confirmed the absence of any pre-existing CVC thrombus. A thrombus was then allowed to form and age over 24 hours. The created thrombus was localized and measured by ICE, and transthoracic image guided high mechanical index (MI) two-dimensional US treatments (1.1-1.7 MI; iE33, Philips) applied intermittently whenever intravenously infused MBs (3% MRX-801; NuVox) were visualized near the thrombus (n = 10; Group A). Control pigs (n = 10; Group B) received US without MB. All treatments were randomized. Post-treatment thrombus area by ICE planimetry was compared with pretreatment measurements. Thrombus area measurements before and after treatment were 0.22 and 0.10 cm(2) respectively in Group A; compared to 0.24 and 0.21 cm(2) in Group B (p = 0.0003). Effectiveness of longer duration US and MB thrombolytic treatments were studied (n = 4), which suggested that near complete thrombus dissolution is possible. No pulmonary emboli, alterations in oxygen saturation, or hemodynamics occurred with either treatment. Conclusions: Guided high MI diagnostic US+systemic MB facilitates reduction of aged CVC associated thrombi in vivo. MB enhanced sonothrombolytic therapy may be a non-invasive safe alternative to thrombolytic agents in treating thrombotic CVC occlusions.	[Kutty, Shelby; Danford, David A.] Creighton Univ, Childrens Hosp & Med Ctr, Univ Nebraska Coll Med, Joint Div Pediat Cardiol, Omaha, NE 68178 USA; [Wu, Juefei; Xie, Feng; Gao, Shunji; Drvol, Lucas K.; Lof, John; Therrien, Stacey L.; Porter, Thomas R.] Univ Nebraska Med Ctr, Dept Internal Med, Cardiol Sect, Omaha, NE USA; [Hammel, James M.] Univ Nebraska Med Ctr, Div Cardiovasc Surg, Omaha, NE USA; [Radio, Stanley J.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	Creighton University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Porter, TR (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Cardiol Sect, Omaha, NE USA.	trporter@unmc.edu	Wu, Juefei/GRE-7093-2022	KUTTY, SHELBY/0000-0001-9428-0979	American College of Cardiology Foundation; Edna Ittner Foundation; National Institutes of Health NIH/NIBIB [R01 EB009050-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009050] Funding Source: NIH RePORTER	American College of Cardiology Foundation(General Electric); Edna Ittner Foundation; National Institutes of Health NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The study was supported by grants from the American College of Cardiology Foundation (SK), the Edna Ittner Foundation (SK) and the National Institutes of Health NIH/NIBIB R01 EB009050-01 (FX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birnbaum Y, 1998, CIRCULATION, V97, P130, DOI 10.1161/01.CIR.97.2.130; Boersma RS, 2008, ANN ONCOL, V19, P433, DOI 10.1093/annonc/mdm350; Chan AK, 2003, J THROMB HAEMOST, V1, P1443, DOI 10.1046/j.1538-7836.2003.00308.x; Culp WC, 2003, J VASC INTERV RADIOL, V14, P343, DOI 10.1097/01.RVI.0000058409.01661.B4; Culp WC, 2001, CARDIOVASC INTER RAD, V24, P407, DOI 10.1007/s00270-001-0052-4; Everbach EC, 2000, ULTRASOUND MED BIOL, V26, P1153, DOI 10.1016/S0301-5629(00)00250-7; Journeycake JM, 2006, J CLIN ONCOL, V24, P4575, DOI 10.1200/JCO.2005.05.5343; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF182, DOI 10.1136/fn.82.3.F182; Kutty S, 2012, EUR HEART J-CARD IMG, V13, P500, DOI 10.1093/ejechocard/jer287; Kutty S, 2010, J AM SOC ECHOCARDIOG, V23, P1001, DOI 10.1016/j.echo.2010.06.024; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Meairs Stephen, 2009, Cerebrovasc Dis, V27 Suppl 2, P55, DOI 10.1159/000203127; Monagle P, 2000, PEDIATR RES, V47, P763, DOI 10.1203/00006450-200006000-00013; Monagle P, 2008, CHEST, V133, p887S, DOI 10.1378/chest.08-0762; Parasuraman S, 2006, CIRCULATION, V113, pE12, DOI 10.1161/CIRCULATIONAHA.105.583773; Porter TR, 2009, CARDIOVASC RES, V83, P636, DOI 10.1093/cvr/cvp206; Porter TR, 2001, J ULTRAS MED, V20, P1313, DOI 10.7863/jum.2001.20.12.1313; Prokop AF, 2007, ULTRASOUND MED BIOL, V33, P924, DOI 10.1016/j.ultrasmedbio.2006.11.022; Raffini L, 2009, PEDIATRICS, V124, P1001, DOI 10.1542/peds.2009-0768; Shivakumar SP, 2009, J CLIN ONCOL, V27, P4858, DOI 10.1200/JCO.2009.22.6126; Xie F, 2011, ULTRASOUND MED BIOL, V37, P280, DOI 10.1016/j.ultrasmedbio.2010.10.022; Xie F, 2009, JACC-CARDIOVASC IMAG, V2, P511, DOI 10.1016/j.jcmg.2009.02.002	22	19	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51453	10.1371/journal.pone.0051453	http://dx.doi.org/10.1371/journal.pone.0051453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251539	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200112
J	Lev, S; Desmarini, D; Chayakulkeeree, M; Sorrell, TC; Djordjevic, JT				Lev, Sophie; Desmarini, Desmarini; Chayakulkeeree, Methee; Sorrell, Tania C.; Djordjevic, Julianne T.			The Crz1/Sp1 Transcription Factor of Cryptococcus neoformans Is Activated by Calcineurin and Regulates Cell Wall Integrity	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; FISSION YEAST; FUNCTIONAL-CHARACTERIZATION; SIGNALING PATHWAY; INHIBITOR AGENTS; GENE-EXPRESSION; FULL VIRULENCE; GROWTH	Cryptococcus neoformans survives host temperature and regulates cell wall integrity via a calcium-dependent phosphatase, calcineurin. However, downstream effectors of C. neoformans calcineurin are largely unknown. In S. cerevisiae and other fungal species, a calcineurin-dependent transcription factor Crz1, translocates to nuclei upon activation and triggers expression of target genes. We now show that the C. neoformans Crz1 ortholog (Crz1/Sp1), previously identified as a protein kinase C target during starvation, is a bona fide target of calcineurin under non-starvation conditions, during cell wall stress and growth at high temperature. Both the calcineurin-defective mutant, Delta cna1, and a CRZ1/SP1 mutant (Delta crz1) were susceptible to cell wall perturbing agents. Furthermore, expression of the chitin synthase encoding gene, CHS6, was reduced in both mutants. We tracked the subcellular localization of Crz1-GFP in WT C. neoformans and Delta cna1 in response to different stimuli, in the presence and absence of the calcineurin inhibitor, FK506. Exposure to elevated temperature (30-37 degrees C vs 25 degrees C) and extracellular calcium caused calcineurin-dependent nuclear accumulation of Crz1-GFP. Unexpectedly, 1M salt and heat shock triggered calcineurin-independent Crz1-GFP sequestration within cytosolic and nuclear puncta. To our knowledge, punctate cytosolic distribution, as opposed to nuclear targeting, is a unique feature of C. neoformans Crz1. We conclude that Crz1 is selectively activated by calcium/calcineurin-dependent and independent signals depending on the environmental conditions.	[Lev, Sophie; Desmarini, Desmarini; Sorrell, Tania C.; Djordjevic, Julianne T.] Univ Sydney, Ctr Infect Dis & Microbiol, Sydney Med Sch, Westmead, NSW 2145, Australia; [Lev, Sophie; Desmarini, Desmarini; Sorrell, Tania C.; Djordjevic, Julianne T.] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Chayakulkeeree, Methee] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand	University of Sydney; University of Sydney; Westmead Institute for Medical Research; Mahidol University	Djordjevic, JT (corresponding author), Univ Sydney, Ctr Infect Dis & Microbiol, Sydney Med Sch, Westmead, NSW 2145, Australia.	julianne.djordjevic@sydney.edu.au	Sorrell, Tania/AAZ-5286-2020; Chayakulkeeree, Methee/AAT-8461-2020; Chayakulkeeree, Methee/W-2944-2019	Chayakulkeeree, Methee/0000-0002-4582-4914; Lev, Sophie/0000-0003-3511-457X; Sorrell, Tania/0000-0001-9460-0960; Djordjevic, Julianne/0000-0003-4207-4115; Desmarini, Desmarini/0000-0001-9322-3198	University of Sydney; National Health and Medical Research Council of Australia; Sydney Medical School Foundation; SMS Foundation	University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School Foundation; SMS Foundation	This work was supported by a University of Sydney Bridging grant (for SL), a National Health and Medical Research Council of Australia grant and a Sydney Medical School Foundation Fellowship and grant from the SMS Foundation to the Sydney Institute for Emerging Infections and Biosecurity, University of Sydney (for TCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobakar EF, 2011, EUKARYOT CELL; Adler A, 2011, J BIOL CHEM, V286, P20977, DOI 10.1074/jbc.M111.230268; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; Cruz MC, 2001, EMBO J, V20, P1020, DOI 10.1093/emboj/20.5.1020; Cruz MC, 2000, ANTIMICROB AGENTS CH, V44, P143, DOI 10.1128/AAC.44.1.143-149.2000; Del Poeta M, 2000, ANTIMICROB AGENTS CH, V44, P739, DOI 10.1128/AAC.44.3.739-746.2000; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kim S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000909; Kontoyiannis DP, 2008, ANTIMICROB AGENTS CH, V52, P735, DOI 10.1128/AAC.00990-07; Kozubowski L, 2011, EUKARYOT CELL; Kozubowski L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025280; Kraus PR, 2004, EUKARYOT CELL, V3, P1249, DOI 10.1128/EC.3.5.1249-1260.2004; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Santos M, 2005, CURR GENET, V48, P88, DOI 10.1007/s00294-005-0003-8; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; Singh N, 2007, J INFECT DIS, V195, P756, DOI 10.1086/511438; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Takeuchi K, 2007, STRUCTURE, V15, P587, DOI 10.1016/j.str.2007.03.015; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Williams KE, 2001, EMBO J, V20, P3473, DOI 10.1093/emboj/20.13.3473; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x	39	60	63	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51403	10.1371/journal.pone.0051403	http://dx.doi.org/10.1371/journal.pone.0051403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251520	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200101
J	Medema-Wijnveen, JS; Onono, M; Bukusi, EA; Miller, S; Cohen, CR; Turan, JM				Medema-Wijnveen, Jose S.; Onono, Maricianah; Bukusi, Elizabeth A.; Miller, Suellen; Cohen, Craig R.; Turan, Janet M.			How Perceptions of HIV-Related Stigma Affect Decision-Making Regarding Childbirth in Rural Kenya	PLOS ONE			English	Article							MATERNITY CARE; SKILLED ATTENDANCE; HEALTH FACILITIES; HIV/AIDS STIGMA; PREGNANT-WOMEN; DELIVERY; BIRTH; DISCRIMINATION; ATTITUDES; TRANSMISSION	Introduction: HIV prevalence among pregnant women in Kenya is high. Furthermore, there is a high risk of maternal mortality, as many women do not give birth with a skilled healthcare provider. Previous research suggests that fears of HIV testing and unwanted disclosure of HIV status may be important barriers to utilizing maternity services. We explored relationships between women's perceptions of HIV-related stigma and their attitudes and intentions regarding facility-based childbirth. Methods: 1,777 pregnant women were interviewed at their first antenatal care visit. We included socio-demographic characteristics, stigma scales, HIV knowledge measures, and an 11-item scale measuring health facility birth attitudes (HFBA). HFBA includes items on cost, transport, comfort, interpersonal relations, and services during delivery at a health facility versus at home. A higher mean HFBA score indicates a more positive attitude towards facility-based childbirth. The mean HFBA score was dichotomized at the median and analyses were conducted with this dichotomized HFBA score using mixed effects logit models. Results: Women who anticipated HIV-related stigma from their male partner had lower adjusted odds of having positive attitudes about giving birth at the health facility (adjusted OR = .63, 95% CI 0.50-0.78) and less positive attitudes about health facility birth were strongly related to women's intention to give birth outside a health facility (adjusted OR = 5.56, 95% CI 2.69-11.51). Conclusions: In this sample of pregnant women in rural Kenya, those who anticipated HIV-related stigma were less likely to have positive attitudes towards facility-based childbirth. Furthermore, negative attitudes about facility-based childbirth were associated with the intention to deliver outside a health facility. Thus, HIV-related stigma reduction efforts might result in more positive attitudes towards facility-based childbirth, and thereby lead to an increased level of skilled birth attendance, and reductions in maternal and infant mortality.	[Medema-Wijnveen, Jose S.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Medema-Wijnveen, Jose S.; Bukusi, Elizabeth A.; Miller, Suellen; Cohen, Craig R.; Turan, Janet M.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Onono, Maricianah; Bukusi, Elizabeth A.] Kenya Med Res Inst KEMRI, Ctr Microbiol Res, Res Care & Training Program, Nairobi, Kenya; [Miller, Suellen; Cohen, Craig R.] Univ Calif San Francisco, Global Hlth Inst, Ctr Expertise Womens Hlth & Empowerment, San Francisco, CA 94143 USA; [Turan, Janet M.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA	University of Groningen; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham	Medema-Wijnveen, JS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	j.s.wijnveen@umcg.nl		Turan, Janet/0000-0002-7802-6206	Marco Polo Fonds; Groninger Universiteitsfonds; J.K. de Cock Stichting; Hendrik Muller Vaderlandsch Fonds; National Institute of Mental Health (NIMH), National Institutes of Health (NIH) [K01MH081777]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH081777] Funding Source: NIH RePORTER	Marco Polo Fonds; Groninger Universiteitsfonds; J.K. de Cock Stichting; Hendrik Muller Vaderlandsch Fonds; National Institute of Mental Health (NIMH), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the Marco Polo Fonds, the Groninger Universiteitsfonds, the J.K. de Cock Stichting (www.decockstichting.nl) and the Hendrik Muller Vaderlandsch Fonds (www.mullerfonds.nl) for supporting the work of Jose Medema-Wijnveen. The project described was supported by Award Number K01MH081777 from the National Institute of Mental Health (NIMH), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdool Karim Q, 2010, LANCET, V375, P1948, DOI 10.1016/S0140-6736(10)60747-7; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Byamugisha R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-52; Danforth EJ, 2009, J HEALTH POPUL NUTR, V27, P696; Family Care International Kenya, 2007, TEST APPR INCR SKILL; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gage AJ, 1998, POP STUD-J DEMOG, V52, P21, DOI 10.1080/0032472031000150156; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Gyimah SO, 2006, SOC SCI MED, V62, P2930, DOI 10.1016/j.socscimed.2005.11.034; Kasenga F, 2010, MIDWIFERY, V26, P27, DOI 10.1016/j.midw.2008.04.007; Kenya National Bureau of Statistics (KNBS) ICF Macro, 2010, DEM HLTH SURV 2008 2; Kruk ME, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.087973; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mbaruku G, 2009, INT J GYNECOL OBSTET, V107, P8, DOI 10.1016/j.ijgo.2009.05.008; Medema-Wijnveen JS, 2011, INT AIDS SOC C 2011; Miller S, 2003, INT J GYNECOL OBSTET, V82, P89, DOI 10.1016/S0020-7292(03)00148-6; Nangendo S. M., 2006, AFRICAN STUDIES MONO, V27, P145; NASCOP, 2002, NAT GUID PREV MOTH T; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Peltzer K, 2009, AFR J TRADIT COMPLEM, V6, P155; SPSS, 2008, SPSS WIND REL 16 0 2; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; StataCorp, 2021, STATA STAT SOFTWARE; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Switzer GE, 1999, SOC PSYCH PSYCH EPID, V34, P399, DOI 10.1007/s001270050161; Thorsen VC, 2008, DEV WORLD BIOETH, V8, P43, DOI 10.1111/j.1471-8847.2008.00227.x; Turan JM, 2008, AIDS CARE, V20, P938, DOI 10.1080/09540120701767224; Turan JM, 2008, JOGNN-J OBST GYN NEO, V37, P588, DOI 10.1111/j.1552-6909.2008.00281.x; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; Ujiji OA, 2011, CULT HEALTH SEX, V13, P829, DOI 10.1080/13691058.2011.583682; Ujiji OA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-151; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Vittinghof E, 2005, ANONYMOUS REGRESSION; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO, 2010, TRENDS MAT MORT 1990; Wild K, 2010, SOC SCI MED, V71, P2038, DOI 10.1016/j.socscimed.2010.09.012; World Health Organization, 1999, RED MAT MORT	45	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51492	10.1371/journal.pone.0051492	http://dx.doi.org/10.1371/journal.pone.0051492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251555	Green Published, gold			2022-12-27	WOS:000313236200122
J	Miller, KA; Williams, LH; Rose, E; Kuiper, M; Dahl, HHM; Manji, SSM				Miller, Kerry A.; Williams, Louise H.; Rose, Elizabeth; Kuiper, Michael; Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.			Inner Ear Morphology Is Perturbed in Two Novel Mouse Models of Recessive Deafness	PLOS ONE			English	Article							MYOSIN VIIA GENE; ENU MUTAGENESIS; HEARING-LOSS; MOLECULAR-GENETICS; MUTATION; MYO7A; EXPRESSION; DOMAIN; PHENOTYPE; DYNAMICS	Human MYO7A mutations can cause a variety of conditions involving the inner ear. These include dominant and recessive non-syndromic hearing loss and syndromic conditions such as Usher syndrome. Mouse models of deafness allow us to investigate functional pathways involved in normal and abnormal hearing processes. We present two novel mouse models with mutations in the Myo7a gene with distinct phenotypes. The mutation in Myo7a(I487N/I487N) ewaso is located within the head motor domain of Myo7a. Mice exhibit a profound hearing loss and manifest behaviour associated with a vestibular defect. A mutation located in the linker region between the coiled-coil and the first MyTH4 domains of the protein is responsible in Myo7a(F947I/F947I) dumbo. These mice show a less severe hearing loss than in Myo7a(I487N/I487N) ewaso; their hearing loss threshold is elevated at 4 weeks old, and progressively worsens with age. These mice show no obvious signs of vestibular dysfunction, although scanning electron microscopy reveals a mild phenotype in vestibular stereocilia bundles. The Myo7a(F947I/F947I) dumbo strain is therefore the first reported Myo7a mouse model without an overt vestibular phenotype; a possible model for human DFNB2 deafness. Understanding the molecular basis of these newly identified mutations will provide knowledge into the complex genetic pathways involved in the maintenance of hearing, and will provide insight into recessively inherited sensorineural hearing loss in humans.	[Miller, Kerry A.; Williams, Louise H.; Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Rose, Elizabeth; Manji, Shehnaaz S. M.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Otolaryngol, Melbourne, Vic, Australia; [Kuiper, Michael] Univ Melbourne, Victorian Life Sci Computat Initiat, Melbourne, Vic, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.] Univ Melbourne, HEARing CRC Audiol Hearing & Speech Sci, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Miller, KA (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	kerry.miller@mcri.edu.au			NHMRC [284550, 436944]; J. & J. Calvert-Jones; Victorian Government; HEARing CRC; Australian Government's Cooperative Research Centers Program	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); J. & J. Calvert-Jones; Victorian Government; HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centers Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by NHMRC grants #284550 and #436944, J. & J. Calvert-Jones and the Victorian Government's Operational Infrastructure Support (OIS) Program. The authors acknowledge the financial support from the HEARing CRC, established and supported under the Australian Government's Cooperative Research Centers Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Ahituv N, 2002, TRENDS MOL MED, V8, P447, DOI 10.1016/S1471-4914(02)02388-2; Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Avraham KB, 2003, EAR HEARING, V24, P332, DOI 10.1097/01.AUD.0000079840.96472.DB; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Bharadwaj AK, 2000, EXP EYE RES, V71, P173, DOI 10.1006/exer.2000.0863; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; BORODOVSKY M, 1993, BIOSYSTEMS, V30, P161, DOI 10.1016/0303-2647(93)90068-N; Caspary T, 2010, METHOD ENZYMOL, V477, P313, DOI 10.1016/S0076-6879(10)77016-6; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Hoyne GF, 2006, IMMUNOL REV, V210, P27, DOI 10.1111/j.0105-2896.2006.00363.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaijo T, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045377; Keats BJB, 1999, AM J MED GENET, V89, P158, DOI 10.1002/(SICI)1096-8628(19990924)89:3<158::AID-AJMG6>3.3.CO;2-R; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kikkawa Y, 2003, HUM MOL GENET, V12, P453, DOI 10.1093/hmg/ddg042; KITAMURA K, 1991, ACTA OTO-LARYNGOL, V111, P61, DOI 10.3109/00016489109137355; KITAMURA K, 1992, ACTA OTO-LARYNGOL, V112, P622, DOI 10.3109/00016489209137451; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Luijendijk MWJ, 2004, HUM GENET, V115, P149, DOI 10.1007/s00439-004-1137-3; Manji SSM, 2011, AM J PATHOL, V179, P903, DOI 10.1016/j.ajpath.2011.04.002; Manji SSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017607; Manji SSM, 2006, J NEUROSCI RES, V83, P181, DOI 10.1002/jnr.20721; Mburu Philomena, 1997, Genes and Function, V1, P191; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nolan Patrick M., 2002, Briefings in Functional Genomics & Proteomics, V1, P278, DOI 10.1093/bfgp/1.3.278; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piatto Vania B, 2005, Braz J Otorhinolaryngol, V71, P216; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reardon W, 1996, J MED GENET, V33, P1037, DOI 10.1136/jmg.33.12.1037; Rhodes CR, 2004, MAMM GENOME, V15, P686, DOI 10.1007/s00335-004-2344-x; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Tamagawa Y, 2002, LARYNGOSCOPE, V112, P292, DOI 10.1097/00005537-200202000-00017; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; Wu L, 2011, SCIENCE, V331, P757, DOI 10.1126/science.1198848	57	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51284	10.1371/journal.pone.0051284	http://dx.doi.org/10.1371/journal.pone.0051284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251483	Green Published, gold			2022-12-27	WOS:000313236200085
J	Pedersen, M; Pedersen, KK; Bruunsgaard, H; Krabbe, KS; Thomsen, C; Faerch, K; Pedersen, BK; Mortensen, EL				Pedersen, Maria; Pedersen, Karin Kaereby; Bruunsgaard, Helle; Krabbe, Karen Suarez; Thomsen, Carsten; Faerch, Kristine; Pedersen, Bente Klarlund; Mortensen, Erik Lykke			Cognitive Functions in Middle Aged Individuals Are Related to Metabolic Disturbances and Aerobic Capacity: A Cross-Sectional Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; CENTRAL OBESITY; INCREASED RISK; DEMENTIA; SENSITIVITY; DYSFUNCTION; EXERCISE; PEOPLE	Aims: Metabolic disturbances may contribute to cognitive dysfunction in patients with type 2 diabetes. We investigated the relation between cognitive impairment and metabolic deteriorations, low physical fitness, low-grade inflammation and abdominal obesity in middle aged individuals. Methods: We conducted a cross-sectional study including 40 to 65 year-old patients with type 2 diabetes and limited co morbidity (N = 56), age-matched individuals with impaired glucose tolerance (N = 56) as well as age-matched controls with normal glucose tolerance (N = 72). Specific cognitive functions were assessed with focus on verbal memory, processing speed, executive functions, and a composite overall mean score. Oral glucose tolerance test, VO(2)max test, systemic inflammation, DXA scanning and abdominal MRI were measured. Results: Multiple linear regression analyses adjusting for age, gender and verbal intelligence demonstrated that a low score in processing speed, executive functions and overall cognitive function were related to high fasting C-peptide, as well as low insulin sensitivity, beta-cell function and VO(2)max. Measurements of blood glucose, obesity and inflammation were not associated with cognitive function. Conclusion: Low cognitive scores are seen in middle aged individuals with hyperinsulinemia, low insulin sensitivity, beta-cell function and low aerobic capacity. These findings emphasize the importance of appropriate lifestyle and not only blood glucose control in prevention of cognitive disability.	[Pedersen, Maria; Pedersen, Karin Kaereby; Bruunsgaard, Helle; Krabbe, Karen Suarez; Pedersen, Bente Klarlund] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Bruunsgaard, Helle] Univ Copenhagen, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Thomsen, Carsten] Univ Copenhagen, Rigshosp, Dept Radiol, DK-2100 Copenhagen, Denmark; [Faerch, Kristine] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; University of Copenhagen	Pedersen, M (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-2100 Copenhagen, Denmark.	mariapedersen@dadlnet.dk	Bruunsgaard, Helle/AAY-3293-2020; Pedersen, Bente Klarlund/AGR-3217-2022	Bruunsgaard, Helle/0000-0003-2330-0834; Pedersen, Bente Klarlund/0000-0001-6508-6288; Faerch, Kristine/0000-0002-6127-0448; Mortensen, Erik Lykke/0000-0002-6985-451X	Danish National Research Foundation [02-512-55]; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55)(http://www.dg.dk/en/). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation (http://foodfitnesspharma.ku.dk/). CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724) (http://en.fi.dk/councils-commissions/the-danish-council-for-strategic-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aastrand, 1986, TXB WORK PHYSL; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Angevaren M, 2008, COCHRANE DATABASE SY; Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Cholerton B, 2011, DIABETIC MED, V28, P1463, DOI 10.1111/j.1464-5491.2011.03464.x; Cooray G, 2011, PSYCHONEUROENDOCRINO, V36, P77, DOI 10.1016/j.psyneuen.2010.06.009; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; DeFronzo RA, 2010, DIABETOLOGIA, V53, P435, DOI 10.1007/s00125-009-1614-2; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Grodstein F, 2001, DIABETES CARE, V24, P1060, DOI 10.2337/diacare.24.6.1060; Hartmann P, 2007, WAIS IIIDK WECHSLER; International Diabetes Federation (IDF), 2006, DEF DIAGN DIAB MELL; Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Lennon OC, 2012, DISABIL REHABIL, V34, P1149, DOI 10.3109/09638288.2011.635748; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Marioni RE, 2010, DIABETES, V59, P710, DOI 10.2337/db09-1163; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGurn B, 2004, NEUROLOGY, V62, P1184, DOI 10.1212/01.WNL.0000103169.80910.8B; Miles WR, 1922, ARCH INTERN MED, V30, P767, DOI 10.1001/archinte.1922.00110120086003; Mortensen EL, 2011, GEROPSYCHOLOGY PSYCH, P65; Nelson HE., 1982, NATL ADULT READING T; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V109, P96, DOI 10.1046/j.0001-690X.2003.00231.x; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pedersen BK, 2012, NAT REV ENDOCRINOL, V10; Pradhan A, 2007, NUTR REV, V65, pS152, DOI [10.1111/j.1753-4887.2007.tb00354.x, 10.1301/nr.2007.dec.S152-S156]; Ryan CM, 2000, DIABETES CARE, V23, P1486, DOI 10.2337/diacare.23.10.1486; Sommerfield AJ, 2004, DIABETES CARE, V27, P2335, DOI 10.2337/diacare.27.10.2335; Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263	40	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51132	10.1371/journal.pone.0051132	http://dx.doi.org/10.1371/journal.pone.0051132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251434	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200060
J	Winbanks, CE; Beyer, C; Qian, HW; Gregorevic, P				Winbanks, Catherine E.; Beyer, Claudia; Qian, Hongwei; Gregorevic, Paul			Transduction of Skeletal Muscles with Common Reporter Genes Can Promote Muscle Fiber Degeneration and Inflammation	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; DUCHENNE MUSCULAR-DYSTROPHY; IMMUNE-RESPONSES; EFFICIENT TRANSDUCTION; VIRAL VECTORS; IN-VIVO; EXPRESSION; AAV; DELIVERY; CONSTRUCTS	Recombinant adeno-associated viral vectors (rAAV vectors) are promising tools for delivering transgenes to skeletal muscle, in order to study the mechanisms that control the muscle phenotype, and to ameliorate diseases that perturb muscle homeostasis. Many studies have employed rAAV vectors carrying reporter genes encoding for beta-galactosidase (beta-gal), human placental alkaline phosphatase (hPLAP), and green fluorescent protein (GFP) as experimental controls when studying the effects of manipulating other genes. However, it is not clear to what extent these reporter genes can influence signaling and gene expression signatures in skeletal muscle, which may confound the interpretation of results obtained in experimentally manipulated muscles. Herein, we report a strong pro-inflammatory effect of expressing reporter genes in skeletal muscle. Specifically, we show that the administration of rAAV6:hPLAP vectors to the hind limb muscles of mice is associated with dose-and time-dependent macrophage recruitment, and skeletal muscle damage. Dose-dependent expression of hPLAP also led to marked activity of established pro-inflammatory IL-6/Stat3, TNF alpha, IKK beta and JNK signaling in lysates obtained from homogenized muscles. These effects were independent of promoter type, as expression cassettes featuring hPLAP under the control of constitutive CMV and muscle-specific CK6 promoters both drove cellular responses when matched for vector dose. Importantly, the administration of rAAV6: GFP vectors did not induce muscle damage or inflammation except at the highest doses we examined, and administration of a transgene-null vector (rAAV6:MCS) did not cause damage or inflammation at any of the doses tested, demonstrating that GFP-expressing, or transgene-null vectors may be more suitable as experimental controls. The studies highlight the importance of considering the potential effects of reporter genes when designing experiments that examine gene manipulation in vivo.	[Winbanks, Catherine E.; Beyer, Claudia; Qian, Hongwei; Gregorevic, Paul] Baker IDI Heart & Diabet Inst, Div Metab & Obes, Melbourne, Vic, Australia; [Gregorevic, Paul] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA; [Gregorevic, Paul] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Gregorevic, Paul] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; University of Washington; University of Washington Seattle; Monash University; University of Melbourne	Gregorevic, P (corresponding author), Baker IDI Heart & Diabet Inst, Div Metab & Obes, Melbourne, Vic, Australia.	paul.gregorevic@bakeridi.edu.au	Gregorevic, Paul/AAH-6040-2021	Gregorevic, Paul/0000-0002-7418-8945	National Health & Medical Research Council, Australia [526648, 586649]; Muscular Dystrophy Association, United States of America [69684]; Pfizer Australia; Operational Infrastructure Support Program of the Victorian Government	National Health & Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Muscular Dystrophy Association, United States of America(Muscular Dystrophy Association); Pfizer Australia(PfizerPfizer Australia); Operational Infrastructure Support Program of the Victorian Government	This work was supported by funding from the National Health & Medical Research Council, Australia (grants# 526648 and 586649, http://www.nhmrc.gov.au/) and from the Muscular Dystrophy Association, United States of America (grant# 69684, http://mdausa.org/) awarded to PG. PG is supported by a Senior Research Fellowship sponsored by Pfizer Australia (http://www.pfizer.com.au/sites/au/research_and_development/Pages/default.aspx). The Baker IDI Heart & Diabetes Institute is supported in part by the Operational Infrastructure Support Program of the Victorian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoli M, 2006, GENE THER, V13, P20, DOI 10.1038/sj.gt.3302594; Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Brockstedt DG, 1999, CLIN IMMUNOL, V92, P67, DOI 10.1006/clim.1999.4724; Cordier L, 2001, HUM GENE THER, V12, P205, DOI 10.1089/104303401750061267; Dressman D, 2002, HUM GENE THER, V13, P1631, DOI 10.1089/10430340260201725; Ghosh A, 2011, HUM GENE THER, V22, P77, DOI 10.1089/hum.2010.122; Gonin P, 2005, J GENE MED, V7, P782, DOI 10.1002/jgm.716; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Gregorevic P, 2009, MOL THER, V17, P1427, DOI 10.1038/mt.2009.116; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hartigan-O'Connor D, 2001, MOL THER, V4, P525, DOI 10.1006/mthe.2001.0496; Hauser MA, 2000, MOL THER, V2, P16, DOI 10.1006/mthe.2000.0089; Manning WC, 1997, J VIROL, V71, P7960, DOI 10.1128/JVI.71.10.7960-7962.1997; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Ohshima S, 2009, MOL THER, V17, P73, DOI 10.1038/mt.2008.225; Qiao CP, 2010, HUM GENE THER, V21, P1343, DOI 10.1089/hum.2010.003; Rafael JA, 1996, J CELL BIOL, V134, P93, DOI 10.1083/jcb.134.1.93; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rasband W., 2006, IMAGEJ; Ren C, 2005, HUM GENE THER, V16, P1047, DOI 10.1089/hum.2005.16.1047; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Sarukhan A, 2001, J VIROL, V75, P269, DOI 10.1128/JVI.75.1.269-277.2001; Song S, 1998, P NATL ACAD SCI USA, V95, P14384, DOI 10.1073/pnas.95.24.14384; Subramanian IV, 2009, J CARDIOVASC TRANSL, V2, P81, DOI 10.1007/s12265-008-9063-8; Vandenberghe LH, 2007, CURR GENE THER, V7, P325, DOI 10.2174/156652307782151416; Wang LX, 2005, BLOOD, V105, P4226, DOI 10.1182/blood-2004-03-0848; Wang MP, 2001, GENE, V279, P99, DOI 10.1016/S0378-1119(01)00754-5; Wang ZJ, 2007, HUM GENE THER, V18, P18, DOI 10.1089/hum.2006.093; Wang ZJ, 2010, MOL THER, V18, P617, DOI 10.1038/mt.2009.294; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Winbanks CE, 2012, J CELL BIOL; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Yuasa K, 2007, GENE THER, V14, P1249, DOI 10.1038/sj.gt.3302984; Yuasa K, 2002, GENE THER, V9, P1576, DOI 10.1038/sj.gt.3301829	37	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51627	10.1371/journal.pone.0051627	http://dx.doi.org/10.1371/journal.pone.0051627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251598	Green Published, gold			2022-12-27	WOS:000313236200150
J	Wojcik, EA; Brzostek, A; Bacolla, A; Mackiewicz, P; Vasquez, KM; Korycka-Machala, M; Jaworski, A; Dziadek, J				Wojcik, Ewelina A.; Brzostek, Anna; Bacolla, Albino; Mackiewicz, Pawel; Vasquez, Karen M.; Korycka-Machala, Malgorzata; Jaworski, Adam; Dziadek, Jaroslaw			Direct and Inverted Repeats Elicit Genetic Instability by Both Exploiting and Eluding DNA Double-Strand Break Repair Systems in Mycobacteria	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; REPLICATION PROTEIN REPB; ESCHERICHIA-COLI; PLASMID PAL5000; HUMAN-DISEASE; CHROMOSOMAL TRANSLOCATIONS; MOLECULAR-BIOLOGY; TRIPLET REPEATS; OPEN SOFTWARE; HUMAN-CELLS	Repetitive DNA sequences with the potential to form alternative DNA conformations, such as slipped structures and cruciforms, can induce genetic instability by promoting replication errors and by serving as a substrate for DNA repair proteins, which may lead to DNA double-strand breaks (DSBs). However, the contribution of each of the DSB repair pathways, homologous recombination (HR), non-homologous end-joining (NHEJ) and single-strand annealing (SSA), to this sort of genetic instability is not fully understood. Herein, we assessed the genome-wide distribution of repetitive DNA sequences in the Mycobacterium smegmatis, Mycobacterium tuberculosis and Escherichia coli genomes, and determined the types and frequencies of genetic instability induced by direct and inverted repeats, both in the presence and in the absence of HR, NHEJ, and SSA. All three genomes are strongly enriched in direct repeats and modestly enriched in inverted repeats. When using chromosomally integrated constructs in M. smegmatis, direct repeats induced the perfect deletion of their intervening sequences similar to 1,000-fold above background. Absence of HR further enhanced these perfect deletions, whereas absence of NHEJ or SSA had no influence, suggesting compromised replication fidelity. In contrast, inverted repeats induced perfect deletions only in the absence of SSA. Both direct and inverted repeats stimulated excision of the constructs from the attB integration sites independently of HR, NHEJ, or SSA. With episomal constructs, direct and inverted repeats triggered DNA instability by activating nucleolytic activity, and absence of the DSB repair pathways (in the order NHEJ>HR>SSA) exacerbated this instability. Thus, direct and inverted repeats may elicit genetic instability in mycobacteria by 1) directly interfering with replication fidelity, 2) stimulating the three main DSB repair pathways, and 3) enticing L5 site-specific recombination.	[Wojcik, Ewelina A.; Brzostek, Anna; Korycka-Machala, Malgorzata; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Wojcik, Ewelina A.; Jaworski, Adam] Univ Lodz, Inst Microbiol & Immunol, Dept Genet Microorganisms, PL-90131 Lodz, Poland; [Bacolla, Albino; Vasquez, Karen M.] Univ Texas Austin, Div Pharmacol & Toxicol, Dell Pediat Res Inst, Austin, TX 78712 USA; [Mackiewicz, Pawel] Univ Wroclaw, Dept Genom, Fac Biotechnol, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Lodz; University of Texas System; University of Texas Austin; University of Wroclaw	Dziadek, J (corresponding author), Polish Acad Sci, Inst Med Biol, Lodz, Poland.	jdziadek@cbm.pan.pl	Bacolla, Albino/AAP-1727-2020; Bacolla, Albino/N-3877-2013	Bacolla, Albino/0000-0003-0206-8423; Bacolla, Albino/0000-0003-0206-8423; Wojcik, Ewelina/0000-0002-9743-9268; Dziadek, Jaroslaw/0000-0003-1427-884X	State Committee for Scientific Research [N303 3582 33]; European Regional Development Fund under the Operational Programme Innovative Economy [POIG.01.01.02-10-107/09]; National Cancer Institute/National Institutes of Health [HHSN261200800001E, CA093729]; European Social Fund; national budget of Poland; NATIONAL CANCER INSTITUTE [R01CA093729] Funding Source: NIH RePORTER	State Committee for Scientific Research(Polish State Committee for Scientific Research); European Regional Development Fund under the Operational Programme Innovative Economy; National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Social Fund(European Social Fund (ESF)); national budget of Poland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the State Committee for Scientific Research (contract N303 3582 33), European Regional Development Fund under the Operational Programme Innovative Economy, grant POIG.01.01.02-10-107/09, and in part from the National Cancer Institute/National Institutes of Health contract HHSN261200800001E and CA093729. E. W. was partially supported by the European Social Fund and the national budget of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bacolla A, 2001, J BIOL CHEM, V276, P18597, DOI 10.1074/jbc.M100845200; Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Basu A, 2002, J BACTERIOL, V184, P2204, DOI 10.1128/JB.184.8.2204-2214.2002; Basu A, 2012, J BACTERIOL, V194, P1331, DOI 10.1128/JB.06218-11; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; BOWATER RP, 1994, BIOCHEMISTRY-US, V33, P9266, DOI 10.1021/bi00197a030; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Caimi K, 2004, COMP FUNCT GENOM, V5, P116, DOI 10.1002/cfg.380; Campbell NH, 2009, BIOCHEMISTRY-US, V48, P1675, DOI 10.1021/bi802233v; Chayot R, 2010, P NATL ACAD SCI USA, V107, P2141, DOI 10.1073/pnas.0906355107; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; Cooper DN, 2011, HUM MUTAT, V32, P1075, DOI 10.1002/humu.21557; Coros A, 2008, J BACTERIOL, V190, P3408, DOI 10.1128/JB.00009-08; Courcelle J, 2001, P NATL ACAD SCI USA, V98, P8196, DOI 10.1073/pnas.121008898; Dahle UR, 2003, J CLIN MICROBIOL, V41, P2968, DOI 10.1128/JCM.41.7.2968-2973.2003; DAYN A, 1992, NUCLEIC ACIDS RES, V20, P5991, DOI 10.1093/nar/20.22.5991; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Dennehy M, 2005, VACCINE, V23, P1209, DOI 10.1016/j.vaccine.2004.08.039; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Griffin S, 2009, TUBERCULOSIS, V89, P225, DOI 10.1016/j.tube.2009.03.006; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; JAWORSKI A, 1987, SCIENCE, V238, P773, DOI 10.1126/science.3313728; JAWORSKI A, 1989, J MOL BIOL, V207, P513, DOI 10.1016/0022-2836(89)90461-0; Kha DT, 2010, J MOL BIOL, V398, P471, DOI 10.1016/j.jmb.2010.03.035; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Korycka-Machala M, 2006, FEMS MICROBIOL LETT, V258, P83, DOI 10.1111/j.1574-6968.2006.00199.x; Krishna R, 2007, J MOL BIOL, V367, P1130, DOI 10.1016/j.jmb.2007.01.058; Kumar P, 2011, NUCLEIC ACIDS RES, V39, P8005, DOI 10.1093/nar/gkr536; Kurahashi H, 2006, CELL CYCLE, V5, P1297, DOI 10.4161/cc.5.12.2809; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lewis JA, 2003, J MOL BIOL, V326, P805, DOI 10.1016/S0022-2836(02)01475-4; Lin YF, 2011, CELL CYCLE, V10, P611, DOI 10.4161/cc.10.4.14729; Lin YF, 2009, MOL CARCINOGEN, V48, P350, DOI 10.1002/mc.20488; Liu GQ, 2007, MOL CELL BIOL, V27, P7828, DOI 10.1128/MCB.01276-07; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Madiraju MVVS, 2000, LETT APPL MICROBIOL, V30, P38, DOI 10.1046/j.1472-765x.2000.00619.x; Majchrzak M, 2006, J MOL BIOL, V364, P612, DOI 10.1016/j.jmb.2006.08.093; MCDONALD JP, 1994, GENETICS, V137, P393; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; Muttucumaru DGN, 2004, CURR ISSUES MOL BIOL, V6, P145; Napierala M, 2005, J BIOL CHEM, V280, P37366, DOI 10.1074/jbc.M508065200; Oh DB, 2002, P NATL ACAD SCI USA, V99, P16666, DOI 10.1073/pnas.262672699; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pawelczyk J, 2011, J BACTERIOL, V193, P6960, DOI 10.1128/JB.05638-11; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pitcher RS, 2006, MOL CELL, V23, P743, DOI 10.1016/j.molcel.2006.07.009; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Raghavan SC, 2004, CELL CYCLE, V3, P762; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Seier T, 2011, GENETICS, V188, P247, DOI 10.1534/genetics.111.127746; Seriola A, 2011, HUM MOL GENET, V20, P176, DOI 10.1093/hmg/ddq456; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Sinden RR, 1999, ANN NY ACAD SCI, V870, P173, DOI 10.1111/j.1749-6632.1999.tb08878.x; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Springer B, 2001, INT J MED MICROBIOL, V290, P669; Sreenu VB, 2007, J BIOSCIENCES, V32, P3, DOI 10.1007/s12038-007-0002-7; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stolt P, 1997, NUCLEIC ACIDS RES, V25, P3840, DOI 10.1093/nar/25.19.3840; Voineagu I, 2009, MOL CARCINOGEN, V48, P309, DOI 10.1002/mc.20512; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; Wang GL, 2007, FRONT BIOSCI-LANDMRK, V12, P4424, DOI 10.2741/2399; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Wang GL, 2009, MOL CARCINOGEN, V48, P286, DOI 10.1002/mc.20508; Wang XM, 2008, TUBERCULOSIS, V88, P399, DOI 10.1016/j.tube.2008.02.003; WELLS R D, 1974, P41; Wells R.D., 2006, GENETIC INSTABILITIE; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 1997, AM J PSYCHIAT, V154, P887; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wojciechowska M, 2006, J BIOL CHEM, V281, P24531, DOI 10.1074/jbc.M603888200; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	93	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51064	10.1371/journal.pone.0051064	http://dx.doi.org/10.1371/journal.pone.0051064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251422	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900036
J	Veremyev, A; Boginski, V; Krokhmal, PA; Jeffcoat, DE				Veremyev, Alexander; Boginski, Vladimir; Krokhmal, Pavlo A.; Jeffcoat, David E.			Dense Percolation in Large-Scale Mean-Field Random Networks Is Provably "Explosive''	PLOS ONE			English	Article							K-CORE; GRAPH; CLIQUES; COMPLEXES	Recent reports suggest that evolving large-scale networks exhibit "explosive percolation'': a large fraction of nodes suddenly becomes connected when sufficiently many links have formed in a network. This phase transition has been shown to be continuous (second-order) for most random network formation processes, including classical mean-field random networks and their modifications. We study a related yet different phenomenon referred to as dense percolation, which occurs when a network is already connected, but a large group of nodes must be dense enough, i.e., have at least a certain minimum required percentage of possible links, to form a "highly connected'' cluster. Such clusters have been considered in various contexts, including the recently introduced network modularity principle in biological networks. We prove that, contrary to the traditionally defined percolation transition, dense percolation transition is discontinuous (first-order) under the classical mean-field network formation process (with no modifications); therefore, there is not only quantitative, but also qualitative difference between regular and dense percolation transitions. Moreover, the size of the largest dense (highly connected) cluster in a mean-field random network is explicitly characterized by rigorously proven tight asymptotic bounds, which turn out to naturally extend the previously derived formula for the size of the largest clique (a cluster with all possible links) in such a network. We also briefly discuss possible implications of the obtained mathematical results on studying first-order phase transitions in real-world linked systems.	[Veremyev, Alexander; Boginski, Vladimir] Univ Florida, Dept Ind & Syst Engn, Gainesville, FL 32611 USA; [Boginski, Vladimir; Jeffcoat, David E.] Univ Florida, REEF, Shalimar, FL USA; [Krokhmal, Pavlo A.] Univ Iowa, Dept Mech & Ind Engn, Iowa City, IA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Iowa	Boginski, V (corresponding author), Univ Florida, Dept Ind & Syst Engn, Gainesville, FL 32611 USA.	vb@ufl.edu			Air Force Research Laboratory [FA8651-08-D-0108]; Air Force Office of Scientific Research [FA9550-12-1-0142]; Defense Threat Reduction Agency [HDTRA1-09-1-0056]; National Science Foundation [EPS1101284]	Air Force Research Laboratory; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Science Foundation(National Science Foundation (NSF))	The work was supported by the following: Air Force Research Laboratory, Contract # FA8651-08-D-0108 http://www.eglin.af.mil/units/afrlmunitionsdirectorate/index.asp; Air Force Office of Scientific Research, Grant # FA9550-12-1-0142 http://www.afosr.af.mil/; Defense Threat Reduction Agency, Grant # HDTRA1-09-1-0056 http://www.dtra.mil/Research.aspx; and National Science Foundation, Grant # EPS1101284 http://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello J., 1999, External Memory Algorithms. DIMACS Workshop External Memory Algorithms and Visualization, P119; Abello J, 2002, LECT NOTES COMPUT SC, V2286, P598, DOI 10.1007/3-540-45995-2_51; Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; Aiello W, 2001, EXP MATH, V10, P53, DOI 10.1080/10586458.2001.10504428; ALBA RD, 1973, J MATH SOCIOL, V3, P113, DOI 10.1080/0022250X.1973.9989826; Alon N., 2004, PROBABILISTIC METHOD, VSecond; [Anonymous], 2010, FIC TM XPRESS OPTIMI; Araujo NAM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.035701; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bailey-Kellogg C, 2005, J COMPUT BIOL, V12, P569, DOI 10.1089/cmb.2005.12.569; Balasundaram B, 2005, J COMB OPTIM, V10, P23, DOI 10.1007/s10878-005-1857-x; Balasundaram B, 2011, OPER RES, V59, P133, DOI 10.1287/opre.1100.0851; Bhattacharyya M, 2009, PROCEEDINGS 2009 INTERNATIONAL CONFERENCE ON ADAPTIVE AND INTELLIGENT SYSTEMS, ICAIS 2009, P194, DOI 10.1109/ICAIS.2009.39; Boginski V, 2006, COMPUT OPER RES, V33, P3171, DOI 10.1016/j.cor.2005.01.027; Boginski V, 2005, COMPUT STAT DATA AN, V48, P431, DOI 10.1016/j.csda.2004.02.004; BOLLOBAS B, 1976, MATH PROC CAMBRIDGE, V80, P419, DOI 10.1017/S0305004100053056; Bollobas B., 2001, RANDOM GRAPHS; Bourjolly JM, 2002, EUR J OPER RES, V138, P21, DOI 10.1016/S0377-2217(01)00133-3; Brunato M, 2008, LECT NOTES COMPUT SC, V5313, P41, DOI 10.1007/978-3-540-92695-5_4; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; CRENSON MA, 1978, AM J POLIT SCI, V22, P578, DOI 10.2307/2110462; D'Souza RM, 2009, NAT PHYS, V5, P627, DOI 10.1038/nphys1390; da Costa RA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.255701; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; ERDOS P, 1947, B AM MATH SOC, V53, P292, DOI 10.1090/S0002-9904-1947-08785-1; ERDOS P, 1960, B INT STATIST INST, V38, P343; Erdos P, 1974, PROBABILISTIC METHOD; Fan JF, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061110; Grassberger P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225701; GRIMMETT GR, 1975, MATH PROC CAMBRIDGE, V77, P313, DOI 10.1017/S0305004100051124; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang WQ, 2009, PHYSICA A, V388, P2956, DOI 10.1016/j.physa.2009.03.028; JANSON S, 2000, WIL INT S D, pR5; Janson S, 2008, ANN APPL PROBAB, V18, P1085, DOI 10.1214/07-AAP478; Janson S, 2007, COMB PROBAB COMPUT, V16, P757, DOI 10.1017/S0963548306008236; Krzakala F, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/57005; LUCZAK T, 1991, DISCRETE MATH, V91, P61, DOI 10.1016/0012-365X(91)90162-U; Matsuda H, 1999, THEOR COMPUT SCI, V210, P305, DOI 10.1016/S0304-3975(98)00091-7; Matula DW, 1970, COMBINATORY MATH ITS, P356; MCKAY BD, 1989, ADV APPL PROBAB, V21, P475, DOI 10.2307/1427172; MOKKEN RJ, 1979, QUAL QUANT, V13, P161, DOI 10.1007/BF00139635; Nagler J, 2011, NAT PHYS, V7, P265, DOI [10.1038/nphys1860, 10.1038/NPHYS1860]; Pattillo J, 2013, DISCRETE APPL MATH, V161, P244, DOI 10.1016/j.dam.2012.07.019; Pei J., 2005, P 11 ACM SIGKDD INT, P228, DOI DOI 10.1145/1081870.1081898; Pittel B, 1996, J COMB THEORY B, V67, P111, DOI 10.1006/jctb.1996.0036; Radicchi F, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036110; Radicchi F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168701; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Riordan O, 2012, ANN APPL PROBAB, V22, P1450, DOI 10.1214/11-AAP798; Riordan O, 2011, SCIENCE, V333, P322, DOI 10.1126/science.1206241; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Scott J., 2007, SOCIAL NETWORK ANAL; SEIDMAN SB, 1978, J MATH SOCIOL, V6, P139, DOI 10.1080/0022250X.1978.9989883; Sim K, 2006, IEEE DATA MINING, P1059; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Veremyev A., 2012, DYNAMICS INFORM SYST, P137; Veremyev A, 2012, EUR J OPER RES, V218, P316, DOI 10.1016/j.ejor.2011.10.027; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Ziff RM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045701	59	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51883	10.1371/journal.pone.0051883	http://dx.doi.org/10.1371/journal.pone.0051883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272185	Green Submitted, gold, Green Published			2022-12-27	WOS:000312483300039
J	El-kereamy, A; Bi, YM; Ranathunge, K; Beatty, PH; Good, AG; Rothstein, SJ				El-kereamy, Ashraf; Bi, Yong-Mei; Ranathunge, Kosala; Beatty, Perrin H.; Good, Allen G.; Rothstein, Steven J.			The Rice R2R3-MYB Transcription Factor OsMYB55 Is Involved in the Tolerance to High Temperature and Modulates Amino Acid Metabolism	PLOS ONE			English	Article							HEAT-STRESS RESPONSE; ASCORBATE PEROXIDASE; ENHANCED TOLERANCE; GENE FAMILY; PLANTS; TOBACCO; ACCUMULATION; PROTEINS; PROLINE; GROWTH	Temperatures higher than the optimum negatively affects plant growth and development. Tolerance to high temperature is a complex process that involves several pathways. Understanding this process, especially in crops such as rice, is essential to prepare for predicted climate changes due to global warming. Here, we show that OsMYB55 is induced by high temperature and overexpression of OsMYB55 resulted in improved plant growth under high temperature and decreased the negative effect of high temperature on grain yield. Transcriptome analysis revealed an increase in expression of several genes involved in amino acids metabolism. We demonstrate that OsMYB55 binds to the promoter regions of target genes and directly activates expression of some of those genes including glutamine synthetase (OsGS1;2) glutamine amidotransferase (GAT1) and glutamate decarboxylase 3 (GAD3). OsMYB55 overexpression resulted in an increase in total amino acid content and of the individual amino acids produced by the activation of the above mentioned genes and known for their roles in stress tolerance, namely L-glutamic acid, GABA and arginine especially under high temperature condition. In conclusion, overexpression of OsMYB55 improves rice plant tolerance to high temperature, and this high tolerance is associated with enhanced amino acid metabolism through transcription activation. Citation: El-kereamy A, Bi Y-M, Ranathunge K, Beatty PH, Good AG, et al. (2012) The Rice R2R3-MYB Transcription Factor OsMYB55 Is Involved in the Tolerance to High Temperature and Modulates Amino Acid Metabolism. PLoS ONE 7(12): e52030. doi: 10.1371/journal.pone.0052030	[El-kereamy, Ashraf; Bi, Yong-Mei; Ranathunge, Kosala; Rothstein, Steven J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Beatty, Perrin H.; Good, Allen G.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [El-kereamy, Ashraf] Ain Shams Univ, Fac Agr, Dept Hort, Cairo, Egypt	University of Guelph; University of Alberta; Egyptian Knowledge Bank (EKB); Ain Shams University	Rothstein, SJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rothstei@uoguelph.ca	EL-KEREAMY, ASHRAF/GON-9302-2022; Rothstein, Steven J/A-4947-2013; Ranathunge, Kosala/AAH-9849-2021; Beatty, Perrin H./H-6487-2019	Rothstein, Steven J/0000-0003-0737-1878; Beatty, Perrin H./0000-0002-9240-447X; Ranathunge, Kosala/0000-0003-2826-9936	Ontario Research Fund - Research Excellence program; Natural Sciences and Engineering Research Council of Canada; Syngenta Biotech Inc.	Ontario Research Fund - Research Excellence program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Syngenta Biotech Inc.(Syngenta)	The research was supported by Ontario Research Fund - Research Excellence program; Natural Sciences and Engineering Research Council of Canada; and Syngenta Biotech Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partly funded by Syngenta Biotech Inc. The authors thank Shannon McDonald, from Syngenta Biotechnology Inc., (North Carolina, United States of America) for performed microarray hybridization. There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abraham E, 2010, METHODS MOL BIOL, V639, P317, DOI 10.1007/978-1-60761-702-0_20; Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Alia, 1998, PLANT J, V16, P155, DOI 10.1046/j.1365-313x.1998.00284.x; ASHRAF M, 1994, ENVIRON EXP BOT, V34, P275, DOI 10.1016/0098-8472(94)90048-5; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; BECKER TW, 1986, PHOTOSYNTH RES, V8, P267, DOI 10.1007/BF00037134; Cheng L, 2009, J INTEGR PLANT BIOL, V51, P489, DOI 10.1111/j.1744-7909.2009.00816.x; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Feng CP, 2004, PLANT SCI, V167, P1099, DOI 10.1016/j.plantsci.2004.06.014; Guijin Z, 1997, PHYTOCHEMISTRY, V44, P1007, DOI DOI 10.1016/S0031-9422(96)00626-7; Holden HM, 1998, CURR OPIN STRUC BIOL, V8, P679, DOI 10.1016/S0959-440X(98)80086-9; Hozayn M., 2010, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P95; IPCC, 2007, CLIM CHANG PHYS SCI, V9, P1; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Ko CB, 2007, PLANT PHYSIOL BIOCH, V45, P722, DOI 10.1016/j.plaphy.2007.07.010; Kolupaev YE, 2005, RUSS J PLANT PHYSL+, V52, P199, DOI 10.1007/s11183-005-0030-9; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Lee U, 2007, PLANT J, V49, P115, DOI 10.1111/j.1365-313X.2006.02940.x; Lin CJ, 2010, J AGR FOOD CHEM, V58, P10545, DOI 10.1021/jf101575j; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maestri E, 2002, PLANT MOL BIOL, V48, P667, DOI 10.1023/A:1014826730024; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Miki D, 2005, PLANT PHYSIOL, V138, P1903, DOI 10.1104/pp.105.063933; Morita S, 2005, ANN BOT-LONDON, V95, P695, DOI 10.1093/aob/mci071; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Mu RL, 2009, CELL RES, V19, P1291, DOI 10.1038/cr.2009.83; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; Negrotto D, 2000, PLANT CELL REP, V19, P798, DOI 10.1007/s002999900187; Ogweno JO, 2008, J PLANT GROWTH REGUL, V27, P49, DOI 10.1007/s00344-007-9030-7; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Rivero RM, 2004, PLANT BIOLOGY, V6, P702, DOI 10.1055/s-2004-821293; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Shi WM, 2001, GENE, V273, P23, DOI 10.1016/S0378-1119(01)00566-2; Singh Amanjot, 2008, Physiology and Molecular Biology of Plants, V14, P155, DOI 10.1007/s12298-008-0014-2; Smolen GA, 2002, GENETICS, V161, P1235; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sugimoto K, 2000, PLANT CELL, V12, P2511, DOI 10.1105/tpc.12.12.2511; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wen XP, 2008, TRANSGENIC RES, V17, P251, DOI 10.1007/s11248-007-9098-7; Yang XH, 2005, PLANT PHYSIOL, V138, P2299, DOI 10.1104/pp.105.063164; Yang YO, 1996, P NATL ACAD SCI USA, V93, P14972, DOI 10.1073/pnas.93.25.14972; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x	55	109	129	17	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52030	10.1371/journal.pone.0052030	http://dx.doi.org/10.1371/journal.pone.0052030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251677	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800130
J	Lacsina, JR; Marks, OA; Liu, XF; Reid, DW; Jagannathan, S; Nicchitta, CV				Lacsina, Joshua R.; Marks, Odessa A.; Liu, Xiongfei; Reid, David W.; Jagannathan, Sujatha; Nicchitta, Christopher V.			Premature Translational Termination Products Are Rapidly Degraded Substrates for MHC Class I Presentation	PLOS ONE			English	Article							PEPTIDYL-TRANSFER-RNA; DEFECTIVE RIBOSOMAL PRODUCTS; NEWLY SYNTHESIZED PROTEINS; GENOME-WIDE ANALYSIS; ESCHERICHIA-COLI; METABOLIC ROLE; VIABLE CELLS; DEGRADATION; PROTEASOME; GENERATION	Nearly thirty percent of all newly synthesized polypeptides are targeted for rapid proteasome-mediated degradation. These rapidly degraded polypeptides (RDPs) are a source of antigenic substrates for the MHC class I presentation pathway, allowing for immunosurveillance of newly synthesized proteins by cytotoxic T lymphocytes. Despite the recognized role of RDPs in MHC I presentation, it remains unclear what molecular characteristics distinguish RDPs from their more stable counterparts. It has been proposed that premature translational termination products may constitute a form of RDP; indeed, in prokaryotes translational drop-off products are normal by-products of protein synthesis and are subsequently rapidly degraded. To study the cellular fate of premature termination products, we used the antibiotic puromycin as a means to experimentally manipulate prematurely terminated polypeptide production in human cells. At low concentrations, puromycin enhanced flux into rapidly degraded polypeptide pools, with small polypeptides being markedly more labile then high molecular weight puromycin adducts. Immunoprecipitation experiments using anti-puromycin antisera demonstrated that the majority of peptidyl-puromycins are rapidly degraded in a proteasome-dependent manner. Low concentrations of puromycin increased the recovery of cell surface MHC I-peptide complexes, indicating that prematurely terminated polypeptides can be processed for presentation via the MHC I pathway. In the continued presence of puromycin, however, MHC I export to the cell surface was inhibited, coincident with the accumulation of polyubiquitinated proteins. The time-and dose-dependent effects of puromycin suggest that the pool of peptidyl-puromycin adducts differ in their targeting to various proteolytic pathways that, in turn, differ in the efficiency with which they access the MHC I presentation machinery. These studies highlight the diversity of cellular proteolytic pathways necessary for the metabolism and immunosurveillance of prematurely terminated polypeptides that are, by their nature, highly heterogeneous.	[Lacsina, Joshua R.; Nicchitta, Christopher V.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Lacsina, Joshua R.; Liu, Xiongfei; Jagannathan, Sujatha; Nicchitta, Christopher V.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27706 USA; [Marks, Odessa A.] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA; [Reid, David W.; Nicchitta, Christopher V.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27706 USA	Duke University; Duke University; University of North Carolina; North Carolina State University; Duke University	Nicchitta, CV (corresponding author), Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA.	christopher.nicchitta@duke.edu	Lacsina, Joshua/AAV-5282-2020	Lacsina, Joshua/0000-0002-9956-8039; Jagannathan, Sujatha/0000-0001-9039-2631	National Institutes of Health (NIH) [R01GM077382, F31GM086127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086127, R01GM101533, R01GM077382] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by National Institutes of Health (NIH) R01GM077382 (CVN) and NIH F31GM086127 (JRL). Details available at http://report.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Cardinaud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008692; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096; Dolan BP, 2010, J IMMUNOL, V185, P6728, DOI 10.4049/jimmunol.1002543; Farfan-Arribas DJ, 2012, P NATL ACAD SCI USA, V109, P16998, DOI 10.1073/pnas.1210271109; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gileadi U, 1999, J IMMUNOL, V163, P6045; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; Golovina TN, 2005, J IMMUNOL, V174, P2763, DOI 10.4049/jimmunol.174.5.2763; Huang L, 2011, EMBO J, V30, P1634, DOI 10.1038/emboj.2011.62; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishii T, 2006, EMBO J, V25, P5492, DOI 10.1038/sj.emboj.7601418; JORGENSEN F, 1990, J MOL BIOL, V215, P511, DOI 10.1016/S0022-2836(05)80164-0; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Lev A, 2010, P NATL ACAD SCI USA, V107, P6964, DOI 10.1073/pnas.0910997107; MANLEY JL, 1978, J MOL BIOL, V125, P407, DOI 10.1016/0022-2836(78)90308-X; Marcilla M, 2007, MOL CELL PROTEOMICS, V6, P923, DOI 10.1074/mcp.M600302-MCP200; McCallum CD, 2000, J CELL BIOL, V149, P591, DOI 10.1083/jcb.149.3.591; MENNINGER JR, 1976, J BIOL CHEM, V251, P3392; MENNINGER JR, 1979, J BACTERIOL, V137, P694, DOI 10.1128/JB.137.1.694-696.1979; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Qian Shu-Bing, 2005, V301, P271; Qian SB, 2010, J BIOL CHEM, V285, P27385, DOI 10.1074/jbc.M110.120295; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; SUGAWARA S, 1987, J IMMUNOL METHODS, V100, P83; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; TSUNG K, 1989, J BIOL CHEM, V264, P4428; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; Vazquez D, 1979, Mol Biol Biochem Biophys, V30, pi; Vazquez D, 1979, MOL BIOL BIOCH BIOPH, V30, P1, DOI 10.1007/978-3-642-81309-2; Wherry EJ, 2006, J IMMUNOL, V176, P2249, DOI 10.4049/jimmunol.176.4.2249; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 1996, J IMMUNOL, V157, P1823	45	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51968	10.1371/journal.pone.0051968	http://dx.doi.org/10.1371/journal.pone.0051968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251665	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800120
J	Press, C; Catmur, C; Cook, R; Widmann, H; Heyes, C; Bird, G				Press, Clare; Catmur, Caroline; Cook, Richard; Widmann, Hannah; Heyes, Cecilia; Bird, Geoffrey			fMRI Evidence of 'Mirror' Responses to Geometric Shapes	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; INFERIOR FRONTAL GYRUS; AUTOMATIC IMITATION; MOTOR; NEURONS; EXPERIENCE; REPETITION; BRAIN; REPRESENTATION; ORGANIZATION	Mirror neurons may be a genetic adaptation for social interaction [1]. Alternatively, the associative hypothesis [2,3] proposes that the development of mirror neurons is driven by sensorimotor learning, and that, given suitable experience, mirror neurons will respond to any stimulus. This hypothesis was tested using fMRI adaptation to index populations of cells with mirror properties. After sensorimotor training, where geometric shapes were paired with hand actions, BOLD response was measured while human participants experienced runs of events in which shape observation alternated with action execution or observation. Adaptation from shapes to action execution, and critically, observation, occurred in ventral premotor cortex (PMv) and inferior parietal lobule (IPL). Adaptation from shapes to execution indicates that neuronal populations responding to the shapes had motor properties, while adaptation to observation demonstrates that these populations had mirror properties. These results indicate that sensorimotor training induced populations of cells with mirror properties in PMv and IPL to respond to the observation of arbitrary shapes. They suggest that the mirror system has not been shaped by evolution to respond in a mirror fashion to biological actions; instead, its development is mediated by stimulus-general processes of learning within a system adapted for visuomotor control.	[Press, Clare; Widmann, Hannah; Bird, Geoffrey] Birkbeck Coll, Dept Psychol Sci, London, England; [Press, Clare] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Catmur, Caroline] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England; [Cook, Richard] City Univ London, Dept Psychol, London EC1V 0HB, England; [Heyes, Cecilia] Univ Oxford, All Souls Coll, Oxford, England; [Bird, Geoffrey] UCL, Inst Cognit Neurosci, London, England	University of London; Birkbeck University London; University of London; University College London; University of Surrey; City University London; University of Oxford; University of London; University College London	Bird, G (corresponding author), Birkbeck Coll, Dept Psychol Sci, London, England.	g.bird@bbk.ac.uk	Bird, Geoff/AAA-3652-2020; Heyes, Cecilia/F-8262-2014; Catmur, Caroline/J-5413-2013	Bird, Geoffrey/0000-0002-2310-0202; Catmur, Caroline/0000-0001-6996-4295; Press, Clare/0000-0002-4777-2249	Interdisciplinary Postdoctoral Fellowship; ESRC (Economic and Social Research Council) [G0800071, RES-538-28-1001]; MRC (Medical Research Council); Medical Research Council [G0800071] Funding Source: researchfish; MRC [G0800071] Funding Source: UKRI	Interdisciplinary Postdoctoral Fellowship; ESRC (Economic and Social Research Council); MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CP was funded by an Interdisciplinary Postdoctoral Fellowship awarded by the MRC (Medical Research Council) (www.mrc.ac.uk) and ESRC (Economic and Social Research Council) (www.esrc.ac.uk, grant no. G0800071). CC was funded by the ESRC (grant no. RES-538-28-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Bonini L, 2011, ANN NY ACAD SCI, V1225, P166, DOI 10.1111/j.1749-6632.2011.06002.x; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Catmur C, 2008, EUR J NEUROSCI, V28, P1208, DOI 10.1111/j.1460-9568.2008.06419.x; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Catmur C, 2011, J COGNITIVE NEUROSCI, V23, P2352, DOI 10.1162/jocn.2010.21590; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; Cook R, 2012, BIOL LETTERS, V8, P856, DOI 10.1098/rsbl.2012.0192; Cook R, 2012, J EXP PSYCHOL GEN, V141, P774, DOI 10.1037/a0027561; Cook R, 2010, J EXP PSYCHOL HUMAN, V36, P840, DOI 10.1037/a0019256; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Del Giudice M, 2009, DEVELOPMENTAL SCI, V12, P350, DOI 10.1111/j.1467-7687.2008.00783.x; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Ferrari PF, 2005, J COGNITIVE NEUROSCI, V17, P212, DOI 10.1162/0898929053124910; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gillmeister H, 2008, BRAIN RES, V1217, P157, DOI 10.1016/j.brainres.2007.12.076; Glenberg AM, 2010, FRONT HUM NEUROSCI, V4, DOI [10.3389/fnhum.2010.00204, 10.3389/fnhum.2010.00206]; Gough PM, 2005, J NEUROSCI, V25, P8010, DOI 10.1523/JNEUROSCI.2307-05.2005; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hamilton AFD, 2009, HUM BRAIN MAPP, V30, P2898, DOI 10.1002/hbm.20717; Hartwigsen G, 2010, NEUROPSYCHOLOGIA, V48, P3155, DOI 10.1016/j.neuropsychologia.2010.06.032; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Landmann C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026859; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Malach R, 2012, NEUROIMAGE, V62, P1163, DOI 10.1016/j.neuroimage.2012.01.002; MITZ AR, 1991, J NEUROSCI, V11, P1855; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petroni A, 2010, J NEUROPHYSIOL, V104, P1867, DOI 10.1152/jn.00386.2010; Pinker S., 1997, MIND WORKS; Press C, 2007, P ROY SOC B-BIOL SCI, V274, P2509, DOI 10.1098/rspb.2007.0774; Press C, 2012, NEUROIMAGE, V60, P1671, DOI 10.1016/j.neuroimage.2012.01.118; Ray E, 2011, DEVELOPMENTAL SCI, V14, P92, DOI 10.1111/j.1467-7687.2010.00961.x; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; SHANKS DR, 1991, MEM COGNITION, V19, P353, DOI 10.3758/BF03197139; Steffener J, 2010, NEUROIMAGE, V49, P2113, DOI 10.1016/j.neuroimage.2009.11.014; Waddington C., 1957, STRATEGY GENES; Wiggett AJ, 2011, BRAIN COGNITION, V76, P87, DOI 10.1016/j.bandc.2011.02.014	56	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51934	10.1371/journal.pone.0051934	http://dx.doi.org/10.1371/journal.pone.0051934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251653	Green Accepted, Green Published, gold			2022-12-27	WOS:000312386800109
J	Scantlebury, M; Haim, A				Scantlebury, Michael; Haim, Abraham			Environmental Challenges and Physiological Solutions: Comparative Energetic Daily Rhythms of Field Mice Populations from Different Ecosystems	PLOS ONE			English	Article							SPINY MOUSE ACOMYS; BODY-TEMPERATURE RHYTHMS; HEAT-PRODUCTION; METABOLIC-RATE; NONSHIVERING THERMOGENESIS; COLD-ACCLIMATION; APODEMUS-SYLVATICUS; OXYGEN-CONSUMPTION; LONG-SCOTOPHASE; WATER ECONOMY	Daily and seasonal variations in physiological characteristics of mammals can be considered adaptations to temporal habitat variables. Across different ecosystems, physiological adjustments are expected to be sensitive to different environmental signals such as changes in photoperiod, temperature or water and food availability; the relative importance of a particular signal being dependent on the ecosystem in question. Energy intake, oxygen consumption (VO2) and body temperature (T-b) daily rhythms were compared between two populations of the broad-toothed field mouse Apodemus mystacinus, one from a Mediterranean and another from a sub-Alpine ecosystem. Mice were acclimated to short-day (SD) 'winter' and long-day (LD) 'summer' photoperiods under different levels of salinity simulating osmotic challenges. Mediterranean mice had higher VO2 values than sub-Alpine mice. In addition, mice exposed to short days had higher VO2 values when given water with a high salinity compared with mice exposed to long days. By comparison, across both populations, increasing salinity resulted in a decreased T-b in SD- but not in LD-mice. Thus, SD-mice may conserve energy by decreasing T-b during ('winter') conditions which are expected to be cool, whereas LD-mice might do the opposite and maintain a higher T-b during ('summer') conditions which are expected to be warm. LD-mice behaved to reduce energy expenditure, which might be considered a useful trait during 'summer' conditions. Overall, increasing salinity was a clear signal for Mediterranean-mice with resultant effects on VO2 and T-b daily rhythms but had less of an effect on sub-Alpine mice, which were more responsive to changes in photoperiod. Results provide an insight into how different populations respond physiologically to various environmental challenges. Citation: Scantlebury M, Haim A (2012) Environmental Challenges and Physiological Solutions: Comparative Energetic Daily Rhythms of Field Mice Populations from Different Ecosystems. PLoS ONE 7(12): e51247. doi:10.1371/journal.pone.0051247	[Scantlebury, Michael; Haim, Abraham] Univ Haifa, Dept Biol, Tivon, Israel; [Scantlebury, Michael] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Haim, Abraham] Univ Haifa, Israeli Ctr Interdisciplinary Res Chronobiol, Har Hakarmel, Israel	University of Haifa; Queens University Belfast; University of Haifa	Scantlebury, M (corresponding author), Univ Haifa, Dept Biol, Oranim Campus, Tivon, Israel.	m.scantlebury@qub.ac.uk			Royal Society Postdoctoral Visiting Research Fellowship [PDFs00/AU/nvb]; University of Haifa Research Authorities	Royal Society Postdoctoral Visiting Research Fellowship; University of Haifa Research Authorities	This project was funded by a Royal Society Postdoctoral Visiting Research Fellowship to MS, PDFs00/AU/nvb (http://royalsociety.org/), and by the University of Haifa Research Authorities to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CS, 2001, J EXP BIOL, V204, P1729; ANGEL K, 1974, J ECOL, V62, P429; Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; Aschoff J., 1982, COMPANION ANIMAL PHY, P173; Bacigalupe LD, 2004, PHYSIOL BIOCHEM ZOOL, V77, P805, DOI 10.1086/422229; BANIN D, 1994, J THERM BIOL, V19, P55, DOI 10.1016/0306-4565(94)90009-4; Bartholomew G.A., 1987, P11; BATES P. J. J., 1991, MAMMALS ARABIA; BATES PJJ, 1994, ISRAEL J ZOOL, V40, P199; BENNETT NC, 1992, J ARID ENVIRON, V23, P189, DOI 10.1016/S0140-1963(18)30530-5; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; BOZINOVIC F, 1989, FUNCT ECOL, V3, P173, DOI 10.2307/2389298; Buckley LB, 2008, AM NAT, V171, pE1, DOI 10.1086/523949; DEPOCAS F, 1957, J APPL PHYSIOL, V10, P388, DOI 10.1152/jappl.1957.10.3.388; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; Geiser F, 2003, J COMP PHYSIOL B, V173, P437, DOI 10.1007/s00360-003-0352-x; GEISER F, 1987, J COMP PHYSIOL B, V157, P335, DOI 10.1007/BF00693360; Goldreich Y., 2012, CLIMATE ISRAEL OBSER; Grammatikopoulos G, 1999, AUST J PLANT PHYSIOL, V26, P587, DOI 10.1071/PP98142; GROSS JE, 1985, J MAMMAL, V66, P661, DOI 10.2307/1380792; HAIM A, 1990, PHYSIOL ZOOL, V63, P795, DOI 10.1086/physzool.63.4.30158177; Haim A, 2005, CHRONOBIOL INT, V22, P59, DOI 10.1081/CBI-200038144; Haim A, 2001, COLLOQ SEMI, P365; HAIM A, 1984, J COMP PHYSIOL, V154, P145, DOI 10.1007/BF00684138; HAIM A, 1990, J EXP ZOOL, V256, P237, DOI 10.1002/jez.1402560302; HAIM A, 1995, J THERM BIOL, V20, P437, DOI 10.1016/0306-4565(95)00002-E; HAIM A, 1982, J THERM BIOL, V7, P193, DOI 10.1016/0306-4565(82)90023-7; HAIM A, 1982, J COMP PHYSIOL, V148, P77, DOI 10.1007/BF00688890; HAIM A, 1995, PHYSIOL BEHAV, V58, P775, DOI 10.1016/0031-9384(95)00126-4; HAIM A, 1981, J COMP PHYSIOL, V142, P445, DOI 10.1007/BF00688974; HAIM A, 1987, S AFR J SCI, V83, P639; HAIM A, 1995, J EXP BIOL, V198, P561; HAIM A, 1993, J COMP PHYSIOL B, V163, P602, DOI 10.1007/BF00302120; Haim Abraham, 1994, Polish Ecological Studies, V20, P357; HELDMAIER G, 1989, J BIOL RHYTHM, V4, P251, DOI 10.1177/074873048900400211; HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; IBM Corp, 2013, IBM SPSS STAT WINDOW; INGRAM DL, 1985, COMP BIOCHEM PHYS A, V82, P1, DOI 10.1016/0300-9629(85)90695-4; Jaffe S., 1988, ZOOGEOGRAPHY ISRAEL, P79; JORGENSEN CB, 1983, COMP BIOCHEM PHYS A, V75, P5, DOI 10.1016/0300-9629(83)90034-8; Klingenspor M, 1996, BIOCHEM J, V316, P607, DOI 10.1042/bj3160607; Li XS, 2005, J COMP PHYSIOL B, V175, P593, DOI 10.1007/s00360-005-0022-2; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; LYNCH GR, 1970, AM ZOOL, V10, P308; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1989, TRENDS ECOL EVOL, V4, P111, DOI 10.1016/0169-5347(89)90060-8; Mendelssohn H., 1999, FAUNA PALAESTINA MAM; MINORS DS, 1989, BIOL RHYTHMS CLIN PR, P272; Morgan E, 2004, BIOL RHYTHM RES, V35, P3, DOI 10.1080/09291010412331313205; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Neuman A, 2005, COMP BIOCHEM PHYS A, V142, P297, DOI 10.1016/j.cbpa.2005.07.005; Nir R, 2006, ISR J ECOL EVOL, V52, P74; Palgi N, 2003, J ARID ENVIRON, V55, P727, DOI 10.1016/S0140-1963(02)00284-7; Peek MS, 2002, OECOLOGIA, V132, P175, DOI 10.1007/s00442-002-0954-0; R Core Team, 2020, R LANG ENV STAT COMP; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Ron U, 2001, ISR J ZOOL, V47, P15, DOI 10.1560/Y6AH-6JWH-NNR8-DHVP; RUBAL A, 1992, CHRONOBIOL INT, V9, P341, DOI 10.3109/07420529209064545; Scantlebury M, 2004, COMP BIOCHEM PHYS A, V137, P419, DOI 10.1016/j.cbpb.2003.11.004; Scantlebury M, 2003, FUNCT ECOL, V17, P178, DOI 10.1046/j.1365-2435.2003.00717.x; Scantlebury M, 2002, J COMP PHYSIOL B, V172, P1, DOI 10.1007/s003600100220; Scantlebury M, 2005, J ZOOL LOND, V267, P1; Scantlebury M, 2009, COMP BIOCHEM PHYS A, V154, P551, DOI 10.1016/j.cbpa.2009.08.021; Shanas U, 2003, J ZOOL, V261, P7, DOI 10.1017/S095283690300390X; Shanas U, 2002, COMP BIOCHEM PHYS A, V132, P287, DOI 10.1016/S1095-6433(02)00033-8; Speakman JR, 2000, ADV ECOLOGICAL RES; Tchernov E., 1988, ZOOGEOGRAPHY ISRAEL; Vohralik V, 2002, ISRAEL J ZOOL, V48, P135, DOI 10.1560/DTU7-19TH-T79T-9FDH; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang DH, 2003, FOLIA ZOOL, V52, P51; WEISSENBERG S, 1994, ISRAEL J ZOOL, V40, P135; Wilmer P, 2005, ENV PHYSL ANIMALS; Workman JL, 2008, BEHAV BRAIN RES, V187, P109, DOI 10.1016/j.bbr.2007.08.033; Wube T, 2008, J ARID ENVIRON, V72, P440, DOI 10.1016/j.jaridenv.2007.06.014; Zhang XY, 2006, HORM BEHAV, V50, P61, DOI 10.1016/j.yhbeh.2006.01.005; Zubidat AE, 2010, CHRONOBIOL INT, V27, P487, DOI 10.3109/07420521003678577; Zubidat AE, 2007, CHRONOBIOL INT, V24, P269, DOI 10.1080/07420520701284675; Zuur Alain F., 2009, P1	80	2	2	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51247	10.1371/journal.pone.0051247	http://dx.doi.org/10.1371/journal.pone.0051247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251469	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800035
J	van der Meulen, T; Xie, RY; Kelly, OG; Vale, WW; Sander, M; Huising, MO				van der Meulen, Talitha; Xie, Ruiyu; Kelly, Olivia G.; Vale, Wylie W.; Sander, Maike; Huising, Mark O.			Urocortin 3 Marks Mature Human Primary and Embryonic Stem Cell-Derived Pancreatic Alpha and Beta Cells	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; IN-VIVO; ISLET ARCHITECTURE; PROGENITOR CELLS; GLUCOSE; EXPRESSION; FETAL; DIFFERENTIATION; MATURATION; CONVERSION	The peptide hormone Urocortin 3 (Ucn 3) is abundantly and exclusively expressed in mouse pancreatic beta cells where it regulates insulin secretion. Here we demonstrate that Ucn 3 first appears at embryonic day (E) 17.5 and, from approximately postnatal day (p) 7 and onwards throughout adult life, becomes a unifying and exclusive feature of mouse beta cells. These observations identify Ucn 3 as a potential beta cell maturation marker. To determine whether Ucn 3 is similarly restricted to beta cells in humans, we conducted comprehensive immunohistochemistry and gene expression experiments on macaque and human pancreas and sorted primary human islet cells. This revealed that Ucn 3 is not restricted to the beta cell lineage in primates, but is also expressed in alpha cells. To substantiate these findings, we analyzed human embryonic stem cell (hESC)-derived pancreatic endoderm that differentiates into mature endocrine cells upon engraftment in mice. Ucn 3 expression in hESC-derived grafts increased robustly upon differentiation into mature endocrine cells and localized to both alpha and beta cells. Collectively, these observations confirm that Ucn 3 is expressed in adult beta cells in both mouse and human and appears late in beta cell differentiation. Expression of Pdx1, Nkx6.1 and PC1/3 in hESC-derived Ucn 3(+) beta cells supports this. However, the expression of Ucn 3 in primary and hESC-derived alpha cells demonstrates that human Ucn 3 is not exclusive to the beta cell lineage but is a general marker for both the alpha and beta cell lineages. Ucn 3(+) hESC-derived alpha cells do not express Nkx6.1, Pdx1 or PC1/3 in agreement with the presence of a separate population of Ucn 3(+) alpha cells. Our study highlights important species differences in Ucn 3 expression, which have implications for its utility as a marker to identify mature beta cells in (re) programming strategies.	[van der Meulen, Talitha; Vale, Wylie W.; Huising, Mark O.] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Xie, Ruiyu; Sander, Maike] Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA; [Kelly, Olivia G.] ViaCyte Inc, San Diego, CA USA; [Huising, Mark O.] Salk Inst Biol Studies, Salk Ctr Nutr Genom, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute	Huising, MO (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	huising@salk.edu	Huising, Mark O./H-3885-2019; Sander, Maike/N-6615-2016	Huising, Mark O./0000-0002-6594-2205; Xie, Ruiyu/0000-0003-0518-2897; Sander, Maike/0000-0001-5308-7785	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P01 DK026741-31]; Juvenile Diabetes Research Foundation (JDRF); Clayton Medical Research Foundation, Inc.; Salk Center for Nutritional Genomics; Leona M. & Harry B. Helmsley Charitable Trust; NIH/NIDDK [U01 DK089567, R01 DK068471]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089567, R01DK068471, P01DK026741] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Clayton Medical Research Foundation, Inc.; Salk Center for Nutritional Genomics; Leona M. & Harry B. Helmsley Charitable Trust; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.O.H. is supported by award P01 DK026741-31 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the Juvenile Diabetes Research Foundation (JDRF), the Clayton Medical Research Foundation, Inc., the Salk Center for Nutritional Genomics and the Leona M. & Harry B. Helmsley Charitable Trust. M.S. is supported by the NIH/NIDDK grants U01 DK089567 and R01 DK068471. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; FREINKEL N, 1984, DIABETES, V33, P1028, DOI 10.2337/diabetes.33.11.1028; Halban PA, 2010, J CLIN ENDOCR METAB, V95, P1034, DOI 10.1210/jc.2009-1819; HOLE RL, 1988, AM J PHYSIOL, V254, pE167, DOI 10.1152/ajpendo.1988.254.2.E167; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Huising MO, 2011, ENDOCRINOLOGY, V152, P138, DOI 10.1210/en.2010-0791; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; Huising MO, 2008, ENCY NEUROSCIENCE; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kuperman Y, 2008, TRENDS ENDOCRIN MET, V19, P122, DOI 10.1016/j.tem.2007.12.002; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li C, 2003, ENDOCRINOLOGY, V144, P3216, DOI 10.1210/en.2002-0087; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Nagaya M, 2009, J ENDOCRINOL, V201, P37, DOI 10.1677/JOE-08-0482; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Rafael E, 1999, CELL TRANSPLANT, V8, P317, DOI 10.1177/096368979900800302; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; RORSMAN P, 1989, P NATL ACAD SCI USA, V86, P4505, DOI 10.1073/pnas.86.12.4505; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Weir GC, 2011, GENOME MED, V3, DOI 10.1186/gm277; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10299, DOI 10.1073/pnas.162352799	42	63	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52181	10.1371/journal.pone.0052181	http://dx.doi.org/10.1371/journal.pone.0052181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251699	gold, Green Published			2022-12-27	WOS:000312386800150
J	Alcaide, M; Messina, E; Richter, M; Bargiela, R; Peplies, J; Huws, SA; Newbold, CJ; Golyshin, PN; Simon, MA; Lopez, G; Yakimov, MM; Ferrer, M				Alcaide, Maria; Messina, Enzo; Richter, Michael; Bargiela, Rafael; Peplies, Joerg; Huws, Sharon A.; Newbold, Charles J.; Golyshin, Peter N.; Simon, Miguel A.; Lopez, Guillermo; Yakimov, Michail M.; Ferrer, Manuel			Gene Sets for Utilization of Primary and Secondary Nutrition Supplies in the Distal Gut of Endangered Iberian Lynx	PLOS ONE			English	Article							BACTERIAL DIVERSITY; MICROBIAL DIVERSITY; PHYLOGENETIC ANALYSIS; CENTRIC METAGENOMICS; RNA GENES; METAPOPULATION; LANDSCAPE; DATABASE; MANNOSE; SYSTEM	Recent studies have indicated the existence of an extensive trans-genomic trans-mural co-metabolism between gut microbes and animal hosts that is diet-, host phylogeny- and provenance-influenced. Here, we analyzed the biodiversity at the level of small subunit rRNA gene sequence and the metabolic composition of 18 Mbp of consensus metagenome sequences and activity characteristics of bacterial intra-cellular extracts, in wild Iberian lynx (Lynx pardinus) fecal samples. Bacterial signatures (14.43% of all of the Firmicutes reads and 6.36% of total reads) related to the uncultured anaerobic commensals Anaeroplasma spp., which are typically found in ovine and bovine rumen, were first identified. The lynx gut was further characterized by an over-representation of 'presumptive' aquaporin aqpZ genes and genes encoding 'active' lysosomal-like digestive enzymes that are possibly needed to acquire glycerol, sugars and amino acids from glycoproteins, glyco(amino) lipids, glyco(amino) glycans and nucleoside diphosphate sugars. Lynx gut was highly enriched (28% of the total glycosidases) in genes encoding alpha-amylase and related enzymes, although it exhibited low rate of enzymatic activity indicative of starch degradation. The preponderance of beta-xylosidase activity in protein extracts further suggests lynx gut microbes being most active for the metabolism of beta-xylose containing plant N-glycans, although beta-xylosidases sequences constituted only 1.5% of total glycosidases. These collective and unique bacterial, genetic and enzymatic activity signatures suggest that the wild lynx gut microbiota not only harbors gene sets underpinning sugar uptake from primary animal tissues (with the monotypic dietary profile of the wild lynx consisting of 80-100% wild rabbits) but also for the hydrolysis of prey-derived plant biomass. Although, the present investigation corresponds to a single sample and some of the statements should be considered qualitative, the data most likely suggests a tighter, more coordinated and complex evolutionary and nutritional ecology scenario of carnivore gut microbial communities than has been previously assumed.	[Alcaide, Maria; Bargiela, Rafael; Ferrer, Manuel] CSIC, Inst Catalysis, Dept Appl Biocatalysis, Madrid, Spain; [Messina, Enzo; Yakimov, Michail M.] Natl Res Council CNR, Inst Coastal Marine Environm IAMC, Messina, Italy; [Richter, Michael; Peplies, Joerg] Ribocon GmbH, Bremen, Germany; [Huws, Sharon A.; Newbold, Charles J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Newbold, Charles J.; Golyshin, Peter N.] Bangor Univ Partnership CIRRE, Aberystwyth Univ, Ctr Integrated Res Rural Environm, Aberystwyth, Ceredigion, Wales; [Golyshin, Peter N.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Simon, Miguel A.] Consejeria Medio Ambiente Junta Andalucia, Jaen, Spain; [Lopez, Guillermo] Agencia Medio Ambiente & Agua Andalucia, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Aberystwyth University; Bangor University	Ferrer, M (corresponding author), CSIC, Inst Catalysis, Dept Appl Biocatalysis, Madrid, Spain.	mferrer@icp.csic.es	Huws, Sharon/A-7768-2015; Bargiela, Rafael/K-6783-2014; Yakimov, Michail/H-1829-2016; Ferrer, Manuel/K-4535-2014	Huws, Sharon/0000-0002-0966-5354; Bargiela, Rafael/0000-0003-1442-3269; Messina, Enzo/0000-0001-9042-0014; Huws, Sharon/0000-0002-9284-2453; Golyshin, Peter/0000-0002-5433-0350; Yakimov, Michail/0000-0003-1418-363X; Ferrer, Manuel/0000-0003-4962-4714	Ministerio de Agricultura, Alimentacion y Medio Ambiente; LIFE-Nature project "Conservacion y Reintroduccion del Lince Iberico (Lynx pardinus) en Andalucia"; European Regional Development Fund (ERDF) funds; Bangor-Aberystwyth Strategic Alliance partnership in frames of Centre for Integrated Research in the Rural Environment (CIRRE); Biosciences, Environment and Agriculture Alliance (BEAA);  [CSD2007-00005]; Biotechnology and Biological Sciences Research Council [BBS/E/W/10964A01C, BBS/E/W/10964A01B, BBS/E/W/10964A01A] Funding Source: researchfish; BBSRC [BBS/E/W/10964A01A, BBS/E/W/10964A01C, BBS/E/W/10964A01B] Funding Source: UKRI	Ministerio de Agricultura, Alimentacion y Medio Ambiente; LIFE-Nature project "Conservacion y Reintroduccion del Lince Iberico (Lynx pardinus) en Andalucia"; European Regional Development Fund (ERDF) funds; Bangor-Aberystwyth Strategic Alliance partnership in frames of Centre for Integrated Research in the Rural Environment (CIRRE); Biosciences, Environment and Agriculture Alliance (BEAA); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors greatly acknowledge Ministerio de Agricultura, Alimentacion y Medio Ambiente (former Ministerio de Medio Ambiente, Medio Rural y Marino), and the LIFE-Nature project "Conservacion y Reintroduccion del Lince Iberico (Lynx pardinus) en Andalucia" for their support and collaboration. This research was supported by the Spanish CSD2007-00005 and by European Regional Development Fund (ERDF) funds. The Regional Government of Environment of the Junta de Andalucia provided permission for the collection of samples (permit SGYB/FOA/AFR/CFS) during routine conservation management works. SAH, PNG and CJN acknowledge the support of Bangor-Aberystwyth Strategic Alliance partnership in frames of Centre for Integrated Research in the Rural Environment (CIRRE) and Biosciences, Environment and Agriculture Alliance (BEAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bencur P, 2005, BIOCHEM J, V388, P515, DOI 10.1042/BJ20042091; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bohle LA, 2011, FEMS MICROBIOL LETT, V325, P123, DOI 10.1111/j.1574-6968.2011.02419.x; Brooks SPJ, 2003, CAN J MICROBIOL, V49, P589, DOI 10.1139/W03-075; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Dehnhard M, 2010, GEN COMP ENDOCR, V167, P287, DOI 10.1016/j.ygcen.2010.03.023; Delibes M., 2000, ACTION PLAN CONSERVA; Ferrer M, 2004, CONSERV BIOL, V18, P344, DOI 10.1111/j.1523-1739.2004.00096.x; Ferreras P, 1997, J ZOOL, V243, P163, DOI 10.1111/j.1469-7998.1997.tb05762.x; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; Frey JC, 2006, APPL ENVIRON MICROB, V72, P3788, DOI 10.1128/AEM.72.5.3788-3792.2006; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Garnier M, 2001, CR ACAD SCI III-VIE, V324, P923, DOI 10.1016/S0764-4469(01)01372-5; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guzman JN, 2004, LINCE IBERICO; Helbling DE, 2012, ISME J, V6, P902, DOI [10.1038/ISMEJ.2011.158, 10.1038/ismej.2011.158]; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; IUCN, 2012, IUCN RED LIST THREAT; Jimenez I, 2006, ARCH ANDROLOGY, V52, P455, DOI 10.1080/01485010600694690; Jung HK, 2008, BIOTECHNOL LETT, V30, P1545, DOI 10.1007/s10529-008-9732-3; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kolmeder CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029913; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Leon-Quinto T, 2009, ANIM REPROD SCI, V112, P347, DOI 10.1016/j.anireprosci.2008.05.070; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Meli ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004744; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Millan J, 2008, SCI TOTAL ENVIRON, V399, P193, DOI 10.1016/j.scitotenv.2008.03.038; Millan J, 2009, VECTOR-BORNE ZOONOT, V9, P549, DOI 10.1089/vbz.2008.0081; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Naumoff DG, 2004, MOL BIOL+, V38, P388, DOI 10.1023/B:MBIL.0000032210.97006.de; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; PALOMARES F, 2001, WILDLIFE MONOGRAPHS; Pan D, 2000, MOL GENET METAB, V70, P170, DOI 10.1006/mgme.2000.3012; Patton TG, 2009, VET MICROBIOL, V136, P285, DOI 10.1016/j.vetmic.2008.10.032; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C., 2006, THESIS; Regan SL, 2010, BIOPHARM DRUG DISPOS, V31, P367, DOI 10.1002/bdd.720; Richter M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-177; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Rodriguez A, 2002, ECOGRAPHY, V25, P314, DOI 10.1034/j.1600-0587.2002.250308.x; ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Scupham AJ, 2007, ENVIRON MICROBIOL, V9, P1801, DOI 10.1111/j.1462-2920.2007.01300.x; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; Simon MA, 2012, CONSERV BIOL, V26, P731, DOI 10.1111/j.1523-1739.2012.01871.x; Simon Miguel A., 2009, P42; Singh KM, 2011, MOL BIOL REP; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Vargas A., 2008, International Zoo Yearbook, V42, P190, DOI 10.1111/j.1748-1090.2007.00036.x; Wells JE, 1996, J DAIRY SCI, V79, P1487, DOI 10.3168/jds.S0022-0302(96)76508-6; Yang LY, 2010, MOL BIOL REP, V37, P553, DOI 10.1007/s11033-009-9794-x; Yang SL, 2010, MOL BIOL REP, V37, P2063, DOI 10.1007/s11033-009-9664-6; Zhang HH, 2010, MOL BIOL REP, V37, P4013, DOI 10.1007/s11033-010-0060-z; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	72	18	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51521	10.1371/journal.pone.0051521	http://dx.doi.org/10.1371/journal.pone.0051521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251564	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200130
J	Cavallo, F; Graziani, G; Antinozzi, C; Feldman, DR; Houldsworth, J; Bosl, GJ; Chaganti, RSK; Moynahan, ME; Jasin, M; Barchi, M				Cavallo, Francesca; Graziani, Grazia; Antinozzi, Cristina; Feldman, Darren R.; Houldsworth, Jane; Bosl, George J.; Chaganti, Raju S. K.; Moynahan, Mary Ellen; Jasin, Maria; Barchi, Marco			Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition	PLOS ONE			English	Article							CROSS-LINK REPAIR; POLY(ADP-RIBOSE) POLYMERASE; DNA-REPAIR; VASCULAR INVASION; CANCER CELLS; REPLICATION; DEFICIENCY; DAMAGE; BRCA1; STAGE	Testicular Germ Cell Tumors (TGCT) and patient-derived cell lines are extremely sensitive to cisplatin and other interstrand cross-link (ICL) inducing agents. Nevertheless, a subset of TGCTs are either innately resistant or acquire resistance to cisplatin during treatment. Understanding the mechanisms underlying TGCT sensitivity/resistance to cisplatin as well as the identification of novel strategies to target cisplatin-resistant TGCTs have major clinical implications. Herein, we have examined the proficiency of five embryonal carcinoma (EC) cell lines to repair cisplatin-induced ICLs. Using gamma H2AX staining as a marker of double strand break formation, we found that EC cell lines were either incapable of or had a reduced ability to repair ICL-induced damage. The defect correlated with reduced Homologous Recombination (HR) repair, as demonstrated by the reduction of RAD51 foci formation and by direct evaluation of HR efficiency using a GFP-reporter substrate. HR-defective tumors cells are known to be sensitive to the treatment with poly(ADP-ribose) polymerase (PARP) inhibitor. In line with this observation, we found that EC cell lines were also sensitive to PARP inhibitor monotherapy. The magnitude of sensitivity correlated with HR-repair reduced proficiency and with the expression levels and activity of PARP1 protein. In addition, we found that PARP inhibition strongly enhanced the response of the most resistant EC cells to cisplatin, by reducing their ability to overcome the damage. These results point to a reduced proficiency of HR repair as a source of sensitivity of ECs to ICL-inducing agents and PARP inhibitor monotherapy, and suggest that pharmacological inhibition of PARP can be exploited to target the stem cell component of the TGCTs (namely ECs) and to enhance the sensitivity of cisplatin-resistant TGCTs to standard treatments.	[Cavallo, Francesca; Antinozzi, Cristina; Barchi, Marco] Univ Roma Tor Vergata, Sect Anat, Dept Biomed & Prevent, Rome, Italy; [Cavallo, Francesca; Moynahan, Mary Ellen; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; [Graziani, Grazia] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Feldman, Darren R.; Bosl, George J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Houldsworth, Jane; Chaganti, Raju S. K.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA	University of Rome Tor Vergata; Memorial Sloan Kettering Cancer Center; University of Rome Tor Vergata; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Barchi, M (corresponding author), Univ Roma Tor Vergata, Sect Anat, Dept Biomed & Prevent, Rome, Italy.	marco.barchi@uniroma2.it	; GRAZIANI, GRAZIA/G-5747-2012	Bosl, George/0000-0002-7842-6584; GRAZIANI, GRAZIA/0000-0002-0221-768X; Moynahan, Mary Ellen/0000-0002-0167-1020; Barchi, Marco/0000-0003-1104-6234; Feldman, Darren/0000-0003-2424-4635	Associazione Italiana per la Ricerca sul Cancro (AIRC) [4765]; Ministry of Education, Universities and Research of Italy [CII11RLETZ]; AIRC; Byrne Foundation	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministry of Education, Universities and Research of Italy(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro); Byrne Foundation	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) grant n. 4765 to MB) and from Ministry of Education, Universities and Research of Italy (Cooperlink grant 2011, n. CII11RLETZ, to MB). FC was supported by AIRC Fellowship for abroad 2010, and Byrne Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Al-Minawi AZ, 2009, NUCLEIC ACIDS RES, V37, P6400, DOI 10.1093/nar/gkp705; ANDREWS PW, 1994, LAB INVEST, V71, P243; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Bhagwat NR, 2009, CANCER RES, V69, P6831, DOI 10.1158/0008-5472.CAN-09-1237; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; DAMJANOV I, 1993, LAB INVEST, V68, P220; Di Vizio D, 2005, ONCOGENE, V24, P1882, DOI 10.1038/sj.onc.1208368; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; Hegan DC, 2010, P NATL ACAD SCI USA, V107, P2201, DOI 10.1073/pnas.0904783107; Heidenreich A, 1998, CANCER, V83, P1002, DOI 10.1002/(SICI)1097-0142(19980901)83:5<1002::AID-CNCR27>3.3.CO;2-F; Inbar-Rozensal D, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2445; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Koster R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.33; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Loser DA, 2010, MOL CANCER THER, V9, P1775, DOI 10.1158/1535-7163.MCT-09-1027; Mangerich A, 2011, INT J CANCER, V128, P251, DOI 10.1002/ijc.25683; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Masters JRW, 1996, EUR J CANCER, V32A, P1248, DOI 10.1016/0959-8049(96)00033-0; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; MOUL JW, 1994, CANCER RES, V54, P362; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nakanishi K, 2011, NAT STRUCT MOL BIOL, V18, P500, DOI 10.1038/nsmb.2029; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; PERA MF, 1989, DIFFERENTIATION, V42, P10, DOI 10.1111/j.1432-0436.1989.tb00602.x; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pierce AJ, 2005, METH MOL B, V291, P373; PONT J, 1990, J CLIN ONCOL, V8, P16, DOI 10.1200/JCO.1990.8.1.16; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Tentori L, 2007, EUR J CANCER, V43, P2124, DOI 10.1016/j.ejca.2007.07.010; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Urien S, 2004, BRIT J CLIN PHARMACO, V57, P756, DOI 10.1111/j.1365-2125.2004.02082.x; Usanova S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-248; Verma R, 2010, BIOCHEM PHARMACOL, V79, P565, DOI 10.1016/j.bcp.2009.09.020; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Welsh C, 2004, INT J CANCER, V110, P352, DOI 10.1002/ijc.20134; YAGI T, 1983, MUTAT RES, V112, P59, DOI 10.1016/0167-8817(83)90024-X; Yuan SSF, 1999, CANCER RES, V59, P3547; Zaremba T, 2009, BRIT J CANCER, V101, P256, DOI 10.1038/sj.bjc.6605166	57	70	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51563	10.1371/journal.pone.0051563	http://dx.doi.org/10.1371/journal.pone.0051563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251575	gold, Green Published			2022-12-27	WOS:000313236200133
J	Freund, P; Schneider, T; Nagy, Z; Hutton, C; Weiskopf, N; Friston, KJ; Wheeler-Kingshott, CA; Thompson, AJ				Freund, Patrick; Schneider, Torben; Nagy, Zoltan; Hutton, Chloe; Weiskopf, Nikolaus; Friston, Karl J.; Wheeler-Kingshott, Claudia A.; Thompson, Alan J.			Degeneration of the Injured Cervical Cord Is Associated with Remote Changes in Corticospinal Tract Integrity and Upper Limb Impairment	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SPINAL-CORD; MULTIPLE-SCLEROSIS; WHITE-MATTER; WALLERIAN DEGENERATION; MRI; MOTOR; ATROPHY; PATHWAYS; RECOVERY	Background: Traumatic spinal cord injury (SCI) leads to disruption of axons and macroscopic tissue loss. Using diffusion tensor imaging (DTI), we assessed degeneration of the corticospinal tract (CST) in the cervical cord above a traumatic lesion and explored its relationship with cervical atrophy, remote axonal changes within the cranial CST and upper limb function. Methods: Nine cervical injured volunteers with bilateral motor and sensory impairment and ten controls were studied. DTI of the cervical cord and brain provided measurements of fractional anisotropy (FA), while anatomical MRI assessed cross-sectional spinal cord area (i.e. cord atrophy). Spinal and central regions of interest (ROI) included the bilateral CST in the cervical cord and brain. Regression analysis identified correlations between spinal FA and cranial FA in the CST and disability. Results: In individuals with SCI, FA was significantly lower in both CSTs throughout the cervical cord and brain when compared with controls (p <= 0.05). Reduced FA of the cervical cord in patients with SCI was associated with smaller cord area (p = 0.002) and a lower FA of the cranial CST at the internal capsule level (p = 0.001). Lower FA in the cervical CST also correlated with impaired upper limb function, independent of cord area (p = 0.03). Conclusion: Axonal degeneration of the CST in the atrophic cervical cord, proximal to the site of injury, parallels cranial CST degeneration and is associated with disability. This DTI protocol can be used in longitudinal assessment of microstructural changes immediately following injury and may be utilised to predict progression and monitor interventions aimed at promoting spinal cord repair.	[Freund, Patrick; Thompson, Alan J.] UCL, Inst Neurol, Dept Brain Repair & Rehabil, London, England; [Freund, Patrick; Nagy, Zoltan; Hutton, Chloe; Weiskopf, Nikolaus; Friston, Karl J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Freund, Patrick] UCL, Royal Natl Orthopaed Hosp, Spinal Cord Injury Ctr, London, England; [Freund, Patrick] Swiss Parapleg Res, Nottwil, Switzerland; [Schneider, Torben; Wheeler-Kingshott, Claudia A.] UCL, Inst Neurol, Dept Neuroinflammat, NMR Res Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Swiss Paraplegic Research; University of London; University College London	Freund, P (corresponding author), UCL, Inst Neurol, Dept Brain Repair & Rehabil, London, England.	p.freund@ucl.ac.uk	Weiskopf, Nikolaus/B-9357-2008; Freund, Patrick/D-4193-2013; Friston, Karl/D-9230-2011; Thompson, Alan J/C-2654-2008; Nagy, Zoltan/AAI-2485-2019; Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019	Weiskopf, Nikolaus/0000-0001-5239-1881; Freund, Patrick/0000-0002-4851-2246; Friston, Karl/0000-0001-7984-8909; Thompson, Alan J/0000-0002-4333-8496; Nagy, Zoltan/0000-0001-6611-6362; Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300	Swiss National Science Foundation [PBFR33-120920]; Schweizerische Stiftung fur medizinische und biologische Stipendien [PASMP3-124194]; Swiss Paraplegic Research (Nottwil); Wellcome Trust; Department of Health's National Institute for Health Research Biomedical Research Centers funding scheme	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schweizerische Stiftung fur medizinische und biologische Stipendien; Swiss Paraplegic Research (Nottwil); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health's National Institute for Health Research Biomedical Research Centers funding scheme	This study was supported by the Swiss National Science Foundation (Grant No: PBFR33-120920), Schweizerische Stiftung fur medizinische und biologische Stipendien (Grant No: PASMP3-124194), the Swiss Paraplegic Research (Nottwil) and the Wellcome Trust. This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centers funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Buss A, 2005, BRAIN, V128, P356, DOI 10.1093/brain/awh355; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Cook PA, 2007, J MAGN RESON IMAGING, V25, P1051, DOI 10.1002/jmri.20905; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Ellaway PH, 2011, BRAIN RES BULL, V84, P343, DOI 10.1016/j.brainresbull.2010.08.007; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1976, DOI 10.3174/ajnr.A1272; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, EUR J NEUROSCI, V34, P1839, DOI 10.1111/j.1460-9568.2011.07895.x; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180; Freund PAB, 2010, J MAGN RESON IMAGING, V32, P1242, DOI 10.1002/jmri.22340; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GOODKIN DE, 1988, ARCH PHYS MED REHAB, V69, P850; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Granert O, 2011, NEUROIMAGE, V54, P32, DOI 10.1016/j.neuroimage.2010.08.013; Hoogervorst ELJ, 2002, ARCH NEUROL-CHICAGO, V59, P113, DOI 10.1001/archneur.59.1.113; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kakulas B A, 1984, Cent Nerv Syst Trauma, V1, P117; Lee JE, 2009, NEUROIMAGE, V44, P870, DOI 10.1016/j.neuroimage.2008.09.041; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lundell H, 2011, SPINAL CORD, V49, P70, DOI 10.1038/sc.2010.87; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Schneider T, 2011, 19 ANN SCI M EXH 201, P4556; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wheeler-Kingshott CAM, 2002, NEUROIMAGE, V16, P93, DOI 10.1006/nimg.2001.1022; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072	39	42	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51729	10.1371/journal.pone.0051729	http://dx.doi.org/10.1371/journal.pone.0051729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251612	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200158
J	Oyola, SO; Evans, KJ; Smith, TK; Smith, BA; Hilley, JD; Mottram, JC; Kaye, PM; Smith, DF				Oyola, Samuel O.; Evans, Krystal J.; Smith, Terry K.; Smith, Barbara A.; Hilley, James D.; Mottram, Jeremy C.; Kaye, Paul M.; Smith, Deborah F.			Functional Analysis of Leishmania Cyclopropane Fatty Acid Synthetase	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; MYCOLIC ACIDS; TRYPANOSOMA-BRUCEI; MOLECULAR-CLONING; INFECTIVE STAGES; DRUG-RESISTANCE; GENE-EXPRESSION; SYNTHASE; DONOVANI	The single gene encoding cyclopropane fatty acid synthetase (CFAS) is present in Leishmania infantum, L. mexicana and L. braziliensis but absent from L. major, a causative agent of cutaneous leishmaniasis. In L. infantum, usually causative agent of visceral leishmaniasis, the CFAS gene is transcribed in both insect (extracellular) and host (intracellular) stages of the parasite life cycle. Tagged CFAS protein is stably detected in intracellular L. infantum but only during the early log phase of extracellular growth, when it shows partial localisation to the endoplasmic reticulum. Lipid analyses of L. infantum wild type, CFAS null and complemented parasites detect a low abundance CFAS-dependent C19 Delta fatty acid, characteristic of a cyclopropanated species, in wild type and add-back cells. Sub-cellular fractionation studies locate the C19 Delta fatty acid to both ER and plasma membrane-enriched fractions. This fatty acid is not detectable in wild type L. major, although expression of the L. infantum CFAS gene in L. major generates cyclopropanated fatty acids, indicating that the substrate for this modification is present in L. major, despite the absence of the modifying enzyme. Loss of the L. infantum CFAS gene does not affect extracellular parasite growth, phagocytosis or early survival in macrophages. However, while endocytosis is also unaffected in the extracellular CFAS nulls, membrane transporter activity is defective and the null parasites are more resistant to oxidative stress. Following infection in vivo, L. infantum CFAS nulls exhibit lower parasite burdens in both the liver and spleen of susceptible hosts but it has not been possible to complement this phenotype, suggesting that loss of C19 Delta fatty acid may lead to irreversible changes in cell physiology that cannot be rescued by re-expression. Aberrant cyclopropanation in L. major decreases parasite virulence but does not influence parasite tissue tropism.	[Oyola, Samuel O.; Evans, Krystal J.; Smith, Barbara A.; Kaye, Paul M.; Smith, Deborah F.] Univ York, Dept Biol, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Smith, Terry K.] Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland; [Hilley, James D.; Mottram, Jeremy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Hull; University of York - UK; University of St Andrews; University of Glasgow	Smith, DF (corresponding author), Univ York, Dept Biol, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	deborah.smith@york.ac.uk		Oyola, Samuel O./0000-0002-6425-7345; Kaye, Paul/0000-0002-8796-4755; Mottram, Jeremy/0000-0001-5574-3766	Wellcome Trust [076355, 067441, 086658, 085349]; Medical Research Council [G1000230] Funding Source: researchfish; MRC [G1000230] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Wellcome Trust programme grant 076355 to DFS, JCM, PMK. TKS is supported by a Wellcome Trust Senior Research Fellowship (067441) and Wellcome Trust project grant 086658. The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2003, INFECT IMMUN, V71, P401, DOI 10.1128/IAI.71.1.401-410.2003; Alce TM, 1999, MOL BIOCHEM PARASIT, V102, P191, DOI 10.1016/S0166-6851(99)00074-2; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; BANGS JD, 1993, J CELL SCI, V105, P1101; Bao XM, 2003, J BIOL CHEM, V278, P12846, DOI 10.1074/jbc.M212464200; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BEIL W, 1994, GUT, V35, P1176, DOI 10.1136/gut.35.9.1176; Brannigan JA, 2010, J MOL BIOL, V396, P985, DOI 10.1016/j.jmb.2009.12.032; BUTTON LL, 1988, J EXP MED, V167, P724, DOI 10.1084/jem.167.2.724; Chang YY, 2000, J BACTERIOL, V182, P4288, DOI 10.1128/JB.182.15.4288-4294.2000; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Courtois F, 2005, BIOCHEMISTRY-US, V44, P13583, DOI 10.1021/bi051159x; Courtois F, 2004, EUR J BIOCHEM, V271, P4769, DOI 10.1111/j.1432-1033.2004.04441.x; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; El-Fadili AK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.51; FISH WR, 1981, MOL BIOCHEM PARASIT, V3, P103, DOI 10.1016/0166-6851(81)90010-4; FLINN HM, 1994, MOL BIOCHEM PARASIT, V65, P259, DOI 10.1016/0166-6851(94)90077-9; Grandvalet C, 2008, MICROBIOL-SGM, V154, P2611, DOI 10.1099/mic.0.2007/016238-0; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Haque M, 1996, J BACTERIOL, V178, P2065, DOI 10.1128/jb.178.7.2065-2070.1996; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hsiao CHC, 2008, MOL BIOCHEM PARASIT, V157, P148, DOI 10.1016/j.molbiopara.2007.10.008; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Ilgoutz SC, 1999, EMBO J, V18, P3643, DOI 10.1093/emboj/18.13.3643; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jones SE, 2011, GUT MICROBES, V2, P69, DOI 10.4161/gmic.2.2.15282; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; KNIVETT VA, 1965, BIOCHEM J, V96, P771, DOI 10.1042/bj0960771; KUIPER PJC, 1972, PLANT PHYSIOL, V49, P307, DOI 10.1104/pp.49.3.307; Lang T, 2005, CELL MICROBIOL, V7, P383, DOI 10.1111/j.1462-5822.2004.00468.x; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Lipoldova M, 2006, NAT REV GENET, V7, P294, DOI 10.1038/nrg1832; Liu Y, 2006, GENETICS, V172, P873, DOI 10.1534/genetics.105.045542; Mazareb S, 1999, EXP PARASITOL, V91, P341, DOI 10.1006/expr.1998.4391; McKean PG, 2001, CELL MICROBIOL, V3, P511, DOI 10.1046/j.1462-5822.2001.00135.x; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Mukherjee P, 2003, IMMUNOL LETT, V86, P131, DOI 10.1016/S0165-2478(03)00021-X; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; OUDEJANS RCHM, 1976, COMP BIOCHEM PHYS B, V54, P227, DOI 10.1016/0305-0491(76)90147-4; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Price HP, 2007, MOL BIOL CELL, V18, P864, DOI 10.1091/mbc.E06-08-0736; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; Sadlova J, 2010, CELL MICROBIOL, V12, P1765, DOI 10.1111/j.1462-5822.2010.01507.x; Shabala L, 2008, RES MICROBIOL, V159, P458, DOI 10.1016/j.resmic.2008.04.011; Smith DF, 2007, INT J PARASITOL, V37, P1173, DOI 10.1016/j.ijpara.2007.05.015; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; TAYLOR FR, 1979, BIOCHEMISTRY-US, V18, P3292, DOI 10.1021/bi00582a015; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Yuan Y, 1998, J BIOL CHEM, V273, P21282, DOI 10.1074/jbc.273.33.21282; ZILBERSTEIN D, 1984, MOL BIOCHEM PARASIT, V12, P327, DOI 10.1016/0166-6851(84)90089-6; ZILBERSTEIN D, 1985, P NATL ACAD SCI USA, V82, P1716, DOI 10.1073/pnas.82.6.1716	61	20	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51300	10.1371/journal.pone.0051300	http://dx.doi.org/10.1371/journal.pone.0051300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251490	Green Published, Green Accepted, gold			2022-12-27	WOS:000312201900063
J	Lipina, TV; Haque, FN; McGirr, A; Boutros, PC; Berger, T; Mak, TW; Roder, JC; Wong, AHC				Lipina, Tatiana V.; Haque, Fahmida Nipa; McGirr, Alexander; Boutros, Paul C.; Berger, Thorsten; Mak, Tak W.; Roder, John C.; Wong, Albert H. C.			Prophylactic Valproic Acid Treatment Prevents Schizophrenia-Related Behaviour in Disc1-L100P Mutant Mice	PLOS ONE			English	Article							PREPULSE INHIBITION; HISTONE DEACETYLASE; LATENT INHIBITION; MOOD STABILIZERS; INBRED STRAINS; LIPOCALIN 2; DISC1; ADULT; DISRUPTION; PROTEIN	Background: Schizophrenia is a neurodevelopmental disorder with onset early in adulthood. Disrupted-In-Schizophrenia-1 (DISC1) is a susceptibility gene for schizophrenia and other psychiatric disorders. Disc1-L100P mutant mice show behaviors relevant to schizophrenia at 12 weeks, but not at 8 weeks of age, and may be useful for investigating the onset of schizophrenia in early adulthood. Methods: We investigated whether early valproic acid treatment would prevent behavioral, cellular and gene expression abnormalities in Disc1-L100P mutants. Results: Valproic acid prevented hyperactivity and deficits in prepulse inhibition and latent inhibition in Disc1-L100P mice. Genome-wide transcription profiling identified Lcn2 (lipocalin2) transcripts as being elevated by the Disc1 mutation and corrected by valproate. Disc1-L100P mice also had increased glial cell numbers in the subventricular zone, which was normalized by valproate. Genetic deletion of Lcn2 normalized glial cell numbers and behavior in Disc1-L100P mutants. Conclusions: Pharmacological treatments are a feasible way of preventing abnormal behaviour in a genetic model of schizophrenia. Lcn2 is a potential novel drug target for early intervention in schizophrenia.	[Haque, Fahmida Nipa; Wong, Albert H. C.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Lipina, Tatiana V.; McGirr, Alexander; Roder, John C.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Berger, Thorsten; Mak, Tak W.] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, UHN, Toronto, ON M4X 1K9, Canada; [Roder, John C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Roder, John C.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; [Wong, Albert H. C.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Wong, AHC (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON, Canada.	albert.wong@utoronto.ca	Lipina, Tatiana/G-9148-2014; Berger, Thorsten/J-7632-2012; Roder, John/G-6468-2013	McGirr, Alexander/0000-0002-8425-3958; Boutros, Paul/0000-0003-0553-7520; Wong, Albert/0000-0002-9753-3182	Canadian Institutes for Health Research (CIHR) [GMH79044]; NARSAD; OMHF Mid-career Investigator Fellowship	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NARSAD(NARSAD); OMHF Mid-career Investigator Fellowship	The study was supported by a Canadian Institutes for Health Research (CIHR) operating grant GMH79044 and a CIHR Clinician-Scientist Fellowship to AHCW, who also holds a NARSAD Independent Investigator Award and an OMHF Mid-career Investigator Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Ayhan Y, 2011, MOL PSYCHIATR, V16, P293, DOI 10.1038/mp.2009.144; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Bolton MM, 2009, CURR OPIN NEUROBIOL, V19, P491, DOI 10.1016/j.conb.2009.09.007; Boutros PC, 2005, BRIEFINGS B IN PRESS, V6; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Broome MR, 2005, SCHIZOPHR RES, V79, P23, DOI 10.1016/j.schres.2005.02.007; Brown SM, 2012, MOL PSYCHIATR, V17, P469, DOI 10.1038/mp.2011.27; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Cairns JM, 2008, BIOINFORMATICS, V24, P2921, DOI 10.1093/bioinformatics/btn557; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Choi J, 2011, J NEUROL SCI, V305, P28, DOI 10.1016/j.jns.2011.03.023; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Delcourt N, 2005, MOL CELL PROTEOMICS, V4, P1085, DOI 10.1074/mcp.M500040-MCP200; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Edwards D, 2003, BIOINFORMATICS, V19, P825, DOI 10.1093/bioinformatics/btg083; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Flood DG, 2009, PSYCHOPHARMACOLOGY, V205, P369, DOI 10.1007/s00213-009-1547-y; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kirkbride JB, 2011, SCHIZOPHRENIA BULL, V37, P262, DOI 10.1093/schbul/sbq120; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Lawrie SM, 2008, SCHIZOPHRENIA BULL, V34, P330, DOI 10.1093/schbul/sbm158; Lee FHF, 2011, J NEUROSCI, V31, P3197, DOI 10.1523/JNEUROSCI.4219-10.2011; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lin SM, 2008, NUCLEIC ACIDS RES, V11, P36; Lipina TV, 2010, GENES BRAIN BEHAV, V9, P777, DOI 10.1111/j.1601-183X.2010.00615.x; Lipina TV, 2011, SYNAPSE, V65, P234, DOI 10.1002/syn.20839; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marshall M, 2011, COCHRANE DB SYST REV, DOI [10.1093/schbul/sbr110, 10.1002/14651858.CD004718.pub3]; Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95; Papaleo F, 2011, NEUROPHARMACOLOGY; Perucca E, 2011, LANCET NEUROL, V10, P446, DOI 10.1016/S1474-4422(11)70047-3; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Piontkewitz Y, 2011, SCHIZOPHRENIA BULL, V37, P1257, DOI 10.1093/schbul/sbq040; Porteous DJ, 2011, TRENDS MOL MED, V17, P699, DOI 10.1016/j.molmed.2011.09.002; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; Schnieder TP, 2011, BIOL PSYCHIAT, V69, P134, DOI 10.1016/j.biopsych.2010.08.027; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Semeralul MO, 2006, J NEUROBIOL, V66, P1646, DOI 10.1002/neu.20302; Shoji Hirotaka, 2012, BMC Res Notes, V5, P108, DOI 10.1186/1756-0500-5-108; Tremolizzo L, 2005, BIOL PSYCHIAT, V57, P500, DOI 10.1016/j.biopsych.2004.11.046; Umeda K, 2006, EUR J PHARMACOL, V553, P157, DOI 10.1016/j.ejphar.2006.09.050; WALKER EF, 1994, SCHIZOPHRENIA BULL, V20, P441, DOI 10.1093/schbul/20.3.441; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Willott JF, 2003, BEHAV NEUROSCI, V117, P716, DOI 10.1037/0735-7044.117.4.716; Woods SW, 2009, SCHIZOPHRENIA BULL, V35, P894, DOI 10.1093/schbul/sbp027; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zuckerman L, 2003, PSYCHOPHARMACOLOGY, V169, P298, DOI 10.1007/s00213-003-1460-8; Zuckerman L, 2003, PSYCHOPHARMACOLOGY, V169, P308, DOI 10.1007/s00213-003-1461-7	58	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51562	10.1371/journal.pone.0051562	http://dx.doi.org/10.1371/journal.pone.0051562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272119	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300018
J	Hoekstra, EJ; von Oerthel, L; van der Linden, AJA; Smidt, MP				Hoekstra, Elisa J.; von Oerthel, Lars; van der Linden, Annemarie J. A.; Smidt, Marten P.			Phox2b Influences the Development of a Caudal Dopaminergic Subset	PLOS ONE			English	Article							HOMEOBOX GENE PHOX2B; NEUROTRANSMITTER BIOSYNTHETIC GENES; TRANSCRIPTION FACTOR LMX1B; HOMEODOMAIN PROTEIN; ISTHMIC ORGANIZER; WNT1 EXPRESSION; MOTOR-NEURON; DIFFERENTIATION; SPECIFICATION; PHENOTYPE	The developing mesodiencephalic dopaminergic (mdDA) neuronal field can be subdivided into several molecularly distinct domains that arise due to spatiotemporally distinct origins of the neurons and distinct transcriptional pathways controlling these neuronal subsets. Two large anatomically and functionally different subdomains are formed that eventually give rise to the SNc and VTA, but more subsets exist which require detailed characterization in order to better understand the development of the functionally different mdDA subsets, and subset-specific vulnerability. In this study, we aimed to characterize the role of transcription factor Phox2b in the development of mdDA neurons. We provide evidence that Phox2b is co-expressed with TH in a dorsal-caudal subset of neurons in the mdDA neuronal field during embryonic development. Moreover, Phox2b transcripts were identified in FAC-sorted Pitx3 positive neurons. Subsequent analysis of Phox2b mutant embryos revealed that in the absence of Phox2b, a decrease of TH expression occurred specifically in the midbrain neuronal subset that normally co-expresses Phox2b with TH. Our data suggest that Phox2b is, next to the known role in the development of the oculomotor complex, involved in the development of a specific caudal mdDA neuronal subset.	[Hoekstra, Elisa J.; van der Linden, Annemarie J. A.; Smidt, Marten P.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Hoekstra, Elisa J.; von Oerthel, Lars; van der Linden, Annemarie J. A.; Smidt, Marten P.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam	Smidt, MP (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	m.p.smidt@uva.nl		Smidt, Marten/0000-0002-8815-747X	TIPharma grant (Netherlands) [T5-207]; NWO VICI grant (Netherlands) [865.09.002]	TIPharma grant (Netherlands); NWO VICI grant (Netherlands)	This work was supported by a TIPharma grant (T5-207, Netherlands) and by an NWO VICI grant (865.09.002, Netherlands) to M.P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KA, 2000, DEVELOPMENT, V127, P1857; Asbreuk CHJ, 2002, MOL CELL NEUROSCI, V21, P410, DOI 10.1006/mcne.2002.1182; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Coppola E, 2005, EMBO J, V24, P4392, DOI 10.1038/sj.emboj.7600897; Coppola E, 2010, DEVELOPMENT, V137, P4211, DOI 10.1242/dev.056747; Dai JX, 2008, J COMP NEUROL, V509, P341, DOI 10.1002/cne.21759; Deng QL, 2011, DEVELOPMENT, V138, P3399, DOI 10.1242/dev.065482; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Dubreuil W, 2002, DEVELOPMENT, V129, P5241; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Hasan KB, 2010, DEVELOPMENT, V137, P1205, DOI 10.1242/dev.041251; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2000, MOL CELL NEUROSCI, V15, P235, DOI 10.1006/mcne.1999.0826; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pla P, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-14; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; Swanson DJ, 2000, J BIOL CHEM, V275, P2911, DOI 10.1074/jbc.275.4.2911; Yang CY, 1998, J NEUROCHEM, V71, P1813; Zellmer E, 1995, J NEUROSCI, V15, P8109	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52118	10.1371/journal.pone.0052118	http://dx.doi.org/10.1371/journal.pone.0052118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251691	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800143
J	Huang, CW; Hales, BF				Huang, Chunwei; Hales, Barbara F.			Effects of Exposure to a DNA Damaging Agent on the Hypoxia Inducible Factors in Organogenesis Stage Mouse Limbs	PLOS ONE			English	Article							CULTURED RAT EMBRYOS; BUD MESENCHYME; FACTOR 1-ALPHA; CELL-DEATH; MICE; DIFFERENTIATION; HIF-1-ALPHA; EXPRESSION; HIF1-ALPHA; P53	Hypoxia plays a critical role in coordinating cell survival, differentiation and death in normal embryogenesis; during limb pattern formation, hypoxia affects two key processes, chondrogenesis and cell death. Hypoxia promotes chondrocyte differentiation and cartilage matrix synthesis and suppresses terminal differentiation. Depending on the context, hypoxia may induce cell cycle arrest, pro- or anti-apoptotic genes, or autophagy. The response to hypoxia is controlled by hypoxia inducible transcription factors, specifically Hif1a, Hif2a and Hif3a. Under normoxia, the hypoxia-inducible factors respond to a variety of stimuli that include several well established teratogens, such as retinoic acid, heavy metals and hyperglycemia. We hypothesize that teratogenic exposures disrupt limb development by altering the hypoxia signalling pathway. To test this hypothesis, we assessed the effects of a DNA damaging alkylating agent, 4-hydroperoxycyclophosphamide, on the hypoxia inducible factor (HIF) transcription factors and on hypoxia in the murine limb bud culture system. 4-Hydroperoxycyclophosphamide exposure increased HIF1 DNA binding activity and HIF1A and HIF2A, but not HIF3A, protein concentrations. HIF1A and HIF2A immunoreactivities were detected in the apical ectodermal ridge and interdigital regions, where cell death sculpts the limb; 4-hydroperoxycyclophosphamide treatment enhanced their immunoreactivities, specifically in these regions. In contrast, hypoxia was localized to areas of chondrogenesis, the cartilaginous anlagen of the developing long bone and phalanges, and was not enhanced by drug exposure. Thus, the exposure of limb buds in vitro to a DNA damaging teratogen triggered a hypoxia signalling response that was associated with cell death. During limb development the HIFs have oxygen-independent functions.	[Huang, Chunwei; Hales, Barbara F.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University	Hales, BF (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	barbara.hales@mcgill.ca			Canadian Institutes of Health Research [MOP-86511]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant MOP-86511 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Amati F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-497; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Araldi E, 2011, NAT MED, V17, P25, DOI 10.1038/nm0111-25; Fernandez-Martinez AB, 2011, INT J BIOCHEM CELL B, V43, P1198, DOI 10.1016/j.biocel.2011.04.013; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; HALES BF, 1986, TERATOLOGY, V34, P303, DOI 10.1002/tera.1420340310; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Huang CW, 2009, REPROD TOXICOL, V27, P103, DOI 10.1016/j.reprotox.2009.01.014; Huang CW, 2002, TERATOLOGY, V66, P288, DOI 10.1002/tera.10100; Ito T, 2012, TOHOKU J EXP MED, V226, P37, DOI 10.1620/tjem.226.37; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Lin Q, 2011, MOL CANCER RES, V9, P757, DOI 10.1158/1541-7786.MCR-11-0053; MIRKES PE, 1985, TERATOGEN CARCIN MUT, V5, P75, DOI 10.1002/tcm.1770050202; Moallem SA, 1998, DEVELOPMENT, V125, P3225; MORRISS GM, 1979, J EMBRYOL EXP MORPH, V54, P17; Ornoy A, 2010, BIRTH DEFECTS RES B, V89, P106, DOI 10.1002/bdrb.20230; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schipani E, 2001, GENE DEV, V15, P2865; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Shum Lillian, 2003, Birth Defects Research, V69, P102, DOI 10.1002/bdrc.10012; Tal R, 2010, AM J PATHOL, V177, P2950, DOI 10.2353/ajpath.2010.090800; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; Xu Y, 2012, ARCH TOXICOL, V86, P947, DOI 10.1007/s00204-012-0810-x; Yamashita T, 2008, MOL CELL BIOL, V28, P1285, DOI 10.1128/MCB.01332-07	39	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51937	10.1371/journal.pone.0051937	http://dx.doi.org/10.1371/journal.pone.0051937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251655	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800111
J	Levis, B; Burri, A; Hudson, M; Baron, M; Thombs, BD				Levis, Brooke; Burri, Andrea; Hudson, Marie; Baron, Murray; Thombs, Brett D.		Canadian Scleroderma Res Grp CSRG	Sexual Activity and Impairment in Women with Systemic Sclerosis Compared to Women from a General Population Sample	PLOS ONE			English	Article							FUNCTION INDEX FSFI; PREVALENCE; SCLERODERMA; VALIDATION; DISEASE; ASSOCIATION; DYSFUNCTION; HEALTH; PAIN	Objective: Reports of low sexual activity rates and high impairment rates among women with chronic diseases have not included comparisons to general population data. The objective of this study was to compare sexual activity and impairment rates of women with systemic sclerosis (SSc) to general population data and to identify domains of sexual function driving impairment in SSc. Methods: Canadian women with SSc were compared to women from a UK population sample. Sexual activity and, among sexually active women, sexual impairment were evaluated with a 9-item version of the Female Sexual Function Index (FSFI). Results: Among women with SSc (mean age = 57.0 years), 296 of 730 (41%) were sexually active, 181 (61%) of whom were sexually impaired, resulting in 115 of 730 (16%) who were sexually active without impairment. In the UK population sample (mean age = 55.4 years), 956 of 1,498 women (64%) were sexually active, 420 (44%) of whom were impaired, with 536 of 1,498 (36%) sexually active without impairment. Adjusting for age and marital status, women with SSc were significantly less likely to be sexually active (OR = 0.34, 95% CI = 0.28-0.42) and, among sexually active women, significantly more likely to be sexually impaired (OR = 1.88, 95% CI = 1.42-2.49) than general population women. Controlling for total FSFI scores, women with SSc had significantly worse lubrication and pain scores than general population women. Conclusions: Sexual functioning is a problem for many women with scleroderma and is associated with pain and poor lubrication. Evidence-based interventions to support sexual activity and function in women with SSc are needed.	[Levis, Brooke; Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Burri, Andrea] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Burri, Andrea] Univ Zurich, Inst Psychol, Zurich, Switzerland; [Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ H3T 1E2, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3T 1E2, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counseling Psychol, Montreal, PQ H3T 1E2, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; University of London; King's College London; University of Zurich; McGill University; McGill University; McGill University; McGill University; McGill University	Thombs, BD (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	brett.thombs@mcgill.ca	Pope, Janet/G-3342-2011; Baron, Murray/AAF-9486-2019	Pope, Janet/0000-0003-1479-5302; Thombs, Brett D./0000-0002-5644-8432; Burri, Andrea/0000-0002-4705-3551	Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis; Skin Health and Arthritis Across the Lifespan [SMA 112834]; Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc. (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH (Neuried, Germany); Fonds de la recherche en sante du Quebec (FRSQ); Canadian Arthritis Network; Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer; Actelion pharmaceuticals; Wellcome Trust; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award with King's College London; Chronic Disease Research Foundation; Euroimmun; Mikrogen GmbH; Pfizer Inc.; CIHR [FRN 83518]; INOVA Diagnostics Inc	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis; Skin Health and Arthritis Across the Lifespan; Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc. (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH (Neuried, Germany); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network; Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer(Pfizer); Actelion pharmaceuticals; Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award with King's College London; Chronic Disease Research Foundation; Euroimmun; Mikrogen GmbH; Pfizer Inc.(Pfizer); CIHR(Canadian Institutes of Health Research (CIHR)); INOVA Diagnostics Inc	Ms. Levis' work was supported by a Canadian Institutes of Health Research, Institute of Musculoskeletal Health and Arthritis, Studentship in Mobility, Musculoskeletal, Oral, and Skin Health and Arthritis Across the Lifespan (# SMA 112834). Drs. Thombs and Hudson were supported by New Investigator Awards from the Canadian Institutes of Health Research. The CSRG was funded by the CIHR (grant # FRN 83518), the Scleroderma Society of Canada and its provincial chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, CA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Germany), Fonds de la recherche en sante du Quebec (FRSQ), the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC. The CSRG has also received eductional grants from Pfizer and Actelion pharmaceuticals. The UK Adult Twins registry received financial support from the Wellcome Trust, the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London, and the Chronic Disease Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Canadian Scleroderma Research Group (CSRG) has received commercial funding from INOVA Diagnostics Inc, Dr. Fooke Laboratorien GmbH, Euroimmun, Mikrogen GmbH, Actelion Pharmaceuticals and Pfizer Inc. For the present study, the authors used data collected via the CSRG Registry. Apart from this, no commercial funding was used to conduct the present study, and the commercial funders of the CSRG have no knowledge that the present study was conducted. Nonetheless, for full transparency, the authors declare that INOVA Diagnostics Inc, Dr. Fooke Laboratorien GmbH, Euroimmun, Mikrogen GmbH, Actelion Pharmaceuticals and Pfizer Inc. have provided unrestricted educational and research funds to the Canadian Scleroderma Research Group. The commercial funding that provides support to the CSRG does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anderson E, 2009, CURR RHEUMATOL REV, V5, P126, DOI 10.2174/157339709788298446; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; BHADAURIA S, 1995, AM J OBSTET GYNECOL, V172, P580, DOI 10.1016/0002-9378(95)90576-6; Burri A, 2011, J SEX MED, V8, P2420, DOI 10.1111/j.1743-6109.2011.02341.x; Burri AV, 2009, J SEX MED, V6, P1930, DOI 10.1111/j.1743-6109.2009.01297.x; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Dunn KM, 2005, BIOL LETT-UK, V1, P260, DOI 10.1098/rsbl.2005.0308; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Impens AJ, 2009, CLIN EXP RHEUMATOL, V27, pS38; Jewett LR, 2010, ARTHRIT CARE RES, V62, P1779, DOI 10.1002/acr.20307; Knafo R, 2011, RHEUMATOLOGY, V50, P1125, DOI 10.1093/rheumatology/keq443; Knafo R, 2009, RHEUMATOLOGY, V48, P1300, DOI 10.1093/rheumatology/kep240; LEROY EC, 1988, J RHEUMATOL, V15, P202; Levis B, 2012, ARTHRIT CARE RES, V64, P340, DOI 10.1002/acr.20696; Lutfey KE, 2009, ARCH SEX BEHAV, V38, P514, DOI 10.1007/s10508-007-9290-0; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; Meston CM, 2003, J SEX MARITAL THER, V29, P39, DOI 10.1080/713847100; Meston CM, 2002, J SEX MARITAL THER, V28, P155, DOI 10.1080/00926230252851276; Meyer-Bahlburg HFL, 2007, J SEX MARITAL THER, V33, P217, DOI 10.1080/00926230701267852; Nusbaum MRH, 2003, AM FAM PHYSICIAN, V67, P347; Razykov I, 2009, ARTHRIT RHEUM-ARTHR, V61, P1765, DOI 10.1002/art.25010; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Saad SC, 1996, J SEX RES, V33, P215, DOI 10.1080/00224499609551837; Saad SC, 1999, SEX DISABIL, V17, P103, DOI 10.1023/A:1021468216623; Sampaio-Barros PD, 2000, CLIN RHEUMATOL, V19, P184, DOI 10.1007/s100670050152; Schieir O, 2010, ARTHRIT CARE RES, V62, P409, DOI 10.1002/acr.20108; Schouffoer AA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1601, DOI 10.1002/art.24728; SCHOVER LR, 1988, SEXUALITY CHRONIC IL; SEIBOLD J, 2005, KELLEYS TXB RHEUMATO; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Thombs BD, 2007, ARTHRIT RHEUM-ARTHR, V57, P1089, DOI 10.1002/art.22910; Thombs BD, 2010, ARTHRIT CARE RES, V62, P1181, DOI 10.1002/acr.20187; Thombs BD, 2009, ARTHRIT RHEUM-ARTHR, V61, P966, DOI 10.1002/art.24614; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206	34	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52129	10.1371/journal.pone.0052129	http://dx.doi.org/10.1371/journal.pone.0052129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251692	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000312386800144
J	van Waas, M; Neggers, SJCMM; Raat, H; van Rij, CM; Pieters, R; van den Heuvel-Eibrink, MM				van Waas, Marjolein; Neggers, Sebastian J. C. M. M.; Raat, Hein; van Rij, Caroline M.; Pieters, Rob; van den Heuvel-Eibrink, Marry M.			Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors	PLOS ONE			English	Article							LONG-TERM SURVIVORS; RISK-FACTORS; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; CHILDHOOD-CANCER; BODY-COMPOSITION; ADULT SURVIVORS; ADIPOSE-TISSUE; CELL FUNCTION; OBESITY	Background: Reports on metabolic syndrome in nephroblastoma and neuroblastoma survivors are scarce. Aim was to evaluate the occurrence of and the contribution of treatment regimens to the metabolic syndrome. Patients and Methods: In this prospective study 164 subjects participated (67 adult long-term nephroblastoma survivors (28 females), 36 adult long-term neuroblastoma survivors (21 females) and 61 control subjects (28 females)). Controls were recruited cross-sectionally. Waist and hip circumference as well as blood pressure were measured. Body composition and abdominal fat were assessed by dual energy X-ray absorptiometry (DXA-scan). Laboratory measurements included fasting triglyceride, high density lipoprotein-cholesterol (HDL-C), glucose, insulin, low-density lipoprotein-cholesterol (LDL-C) and free fatty acids (FFA) levels. Results: Median age at follow-up was 30 (range 19-51) years in survivors and 32 (range 18-62) years in controls. Median follow-up time in survivors was 26 (6-49) years. Nephroblastoma (OR = 5.2, P<0.0001) and neuroblastoma (OR 6.5, P<0.001) survivors had more components of the metabolic syndrome than controls. Survivors treated with abdominal irradiation had higher blood pressure, triglycerides, LDL-C, FFA and lower waist circumference. The latter can not be regarded as a reliable factor in these survivors as radiation affects the waist circumference. When total fat percentage was used as a surrogate marker of adiposity the metabolic syndrome was three times more frequent in abdominally irradiated survivors (27.5%) than in non-irradiated survivors (9.1%, P = 0.018). Conclusions: Nephroblastoma and neuroblastoma survivors are at increased risk for developing components of metabolic syndrome, especially after abdominal irradiation. We emphasize that survivors treated with abdominal irradiation need alternative adiposity measurements for assessment of metabolic syndrome. Citation: van Waas M, Neggers SJCMM, Raat H, van Rij CM, Pieters R, et al. (2012) Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors. PLoS ONE 7(12): e52237. doi:10.1371/journal.pone.0052237	[van Waas, Marjolein; Neggers, Sebastian J. C. M. M.; Pieters, Rob; van den Heuvel-Eibrink, Marry M.] Erasmus MC Sophia Childrens Hosp Rotterdam, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Neggers, Sebastian J. C. M. M.] Erasmus Univ, Med Ctr Rotterdam, Dept Med, Endocrinol Sect, Rotterdam, Netherlands; [Raat, Hein] Erasmus Univ, Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [van Rij, Caroline M.] Erasmus Univ, Med Ctr Rotterdam, Dept Radiat Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van den Heuvel-Eibrink, MM (corresponding author), Erasmus MC Sophia Childrens Hosp Rotterdam, Dept Pediat Oncol Hematol, Rotterdam, Netherlands.	m.vandenheuvel@erasmusmc.nl			KiKa (Kinderen Kankervrij) [2009-030]; KOCR (Kinderoncologisch Centrum Rotterdam)	KiKa (Kinderen Kankervrij); KOCR (Kinderoncologisch Centrum Rotterdam)	The authors thank KiKa (Kinderen Kankervrij) (Grant number 2009-030) and KOCR (Kinderoncologisch Centrum Rotterdam) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein L, 1999, CANC INCIDENCE SURVI, P79; BERNSTEIN ML, 1992, J CLIN ONCOL, V10, P323, DOI 10.1200/JCO.1992.10.2.323; Blijdorp K, 2011, PEDIAT BLOOD CANC; Blokstra A, 1997, MONITORING RISICOFAC; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Vathaire F, LANCET ONCOL; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Geenen MM, 2010, PEDIATR BLOOD CANCER, V55, P690, DOI 10.1002/pbc.22518; Hermans MP, 1999, DIABETES, V48, P1779, DOI 10.2337/diabetes.48.9.1779; Hermans MP, 1999, DIABETOLOGIA, V42, P678, DOI 10.1007/s001250051215; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; KHOSLA T, 1967, BRIT J PREV SOC MED, V21, P122; Laverdiere C, 2005, PEDIATR BLOOD CANCER, V45, P324, DOI 10.1002/pbc.20331; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mackay J, 2004, ATLAS HEART DIS STRO; Marette A, 2003, INT J OBESITY, V27, pS46, DOI 10.1038/sj.ijo.0802500; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meacham LR, 2010, CANCER EPIDEM BIOMAR, V19, P170, DOI 10.1158/1055-9965.EPI-09-0555; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Pimenta N, 2010, REV PORT CARDIOL, V29, P1163; Radiation CotBEoI, 1990, HLTH EFF EXP LOW LEV; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sasso G, 2010, J PEDIAT HEMATOL ONC, V32, pE264, DOI 10.1097/MPH.0b013e3181e7931a; SHIMIZU Y, 1990, RADIAT RES, V121, P120, DOI 10.2307/3577495; van Beek RD, 2009, J CLIN ENDOCR METAB, V94, P1904, DOI 10.1210/jc.2008-0622; van der Sluis IM, 2002, ARCH DIS CHILD, V87, P341, DOI 10.1136/adc.87.4.341; van Dijk IWEM, 2010, INT J RADIAT ONCOL, V78, P370, DOI 10.1016/j.ijrobp.2009.08.016; van Waas M, 2010, ANN ONCOL, V21, P1121, DOI 10.1093/annonc/mdp414; van Waas M, 2011, ANN ONCOL; Van Waas M, 2012, EUROPEAN J CANC; van Waas M, 2010, J PEDIAT HEMATOL ONC, V32, P171, DOI 10.1097/MPH.0b013e3181d419c3; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; World Health Organization, 2008, WAIST CIRCUMFERENCE; Wright KD, 2009, PEDIATR HEMAT ONCOL, V26, P407, DOI [10.1080/08880010903019344, 10.3109/08880010903019344]; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	38	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52237	10.1371/journal.pone.0052237	http://dx.doi.org/10.1371/journal.pone.0052237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251703	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800154
J	Eriksson, EM; Keh, CE; Deeks, SG; Martin, JN; Hecht, FM; Nixon, DF				Eriksson, Emily M.; Keh, Chris E.; Deeks, Steven G.; Martin, Jeffrey N.; Hecht, Frederick M.; Nixon, Douglas F.			Differential Expression of CD96 Surface Molecule Represents CD8(+) T Cells with Dissimilar Effector Function during HIV-1 Infection	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; IMMUNE ACTIVATION; NK-CELL; LYMPHOCYTE ACTIVATION; ADHESION MOLECULE; VIRAL SUPPRESSION; RESPONSES; PLASMA; DNAM-1; CD226	During HIV-1 infection, immune dysregulation and aberrant lymphocyte functions are well-established characteristics. Cell surface molecules are important for immunological functions and changes in expression can affect lymphocyte effector functions, thereby contributing to pathogenesis and disease progression. In this study we have focused on CD96, a member of the IgG superfamily receptors that have generated increasing recent interest due to their adhesive and co-stimulatory functions in addition to immunoregulatory capacity. CD96 is expressed by both T and NK cells. Although the function of CD96 is not completely elucidated, it has been shown to have adhesive functions and enhance cytotoxicity. Interestingly, CD96 may also have inhibitory functions due to its immunoreceptor tyrosine-based inhibitory motif (ITIM). The clinical significance of CD96 is still comparatively limited although it has been associated with chronic Hepatitis B infection and disease progression. CD96 has not previously been studied in the context of HIV-1 infection, but due to its potential importance in immune regulation and relevance to chronic disease, we examined CD96 expression in relation to HIV-1 pathogenesis. In a cross-sectional analysis, we investigated the CD8(+) T cell expression of CD96 in cohorts of untreated HIV-1 infected adults with high viral loads (non-controllers) and low viral loads ("elite'' controllers). We demonstrated that elite controllers have significantly higher CD96 mean fluorescence intensity on CD8(+) T cells compared to HIV-1 non-controllers and CD96 expression was positively associated with CD4(+) T cell counts. Functional assessment showed that CD8(+) T cells lacking CD96 expression represented a population that produced both perforin and IFN-gamma following stimulation. Furthermore, CD96 expression on CD8(+) T cells was decreased in presence of lipopolysaccharide in vitro. Overall, these findings indicate that down-regulation of CD96 is an important aspect of HIV-1 pathogenesis and differential expression is related to cell effector functions and HIV-1 disease course.	[Eriksson, Emily M.; Keh, Chris E.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Deeks, Steven G.; Hecht, Frederick M.] Univ Calif San Francisco, Dept Med, HIV AIDS Program, San Francisco, CA USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Eriksson, EM (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	eriksson@wehi.edu.au	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Eriksson, Emily/0000-0002-7851-973X; Hecht, Frederick/0000-0002-5782-1171	National Institutes of Health (NIH) [AI68498, 2T2AI060530-06]; NIAID [RO1 AI087145, K24AI069994]; UCSF CFAR [P30 AI27763]; UCSF CTSI [UL1 RR024131]; Cleveland Immunopathogenesis Consortium [AI 76174]; CFAR Network of Integrated Systems [R24 AI067039]; American-Scandinavian Foundation; NIH UCSF-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI27763]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI069994, T32AI060530, R24AI067039, R01AI087145, R01AI068498, P30AI027763, P01AI076174] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCSF CFAR; UCSF CTSI; Cleveland Immunopathogenesis Consortium; CFAR Network of Integrated Systems; American-Scandinavian Foundation; NIH UCSF-Gladstone Institute of Virology & Immunology Center for AIDS Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) grant AI68498. The SCOPE cohort was supported in part by the NIAID (RO1 AI087145, K24AI069994), the UCSF CFAR (P30 AI27763), the UCSF CTSI (UL1 RR024131), the Cleveland Immunopathogenesis Consortium (AI 76174) and CFAR Network of Integrated Systems (R24 AI067039). EME was supported by a fellowship from the American-Scandinavian Foundation and NIH UCSF-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30 AI27763. CEK was supported by T32 translational HIV training grant from the NIH (2T2AI060530-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gong J, 2009, CLIN EXP IMMUNOL, V155, P207, DOI 10.1111/j.1365-2249.2008.03829.x; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Klingstrom J, 2006, AIDS, V20, P125, DOI 10.1097/01.aids.0000196170.57927.e1; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; O'Connell KA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-63; Onlamoon N, 2012, CYTOM PART B-CLIN CY, V82B, P35, DOI 10.1002/cyto.b.20616; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; RINALDO C, 1995, J VIROL, V69, P5838, DOI 10.1128/JVI.69.9.5838-5842.1995; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; TSUBOTA H, 1989, J EXP MED, V169, P1421, DOI 10.1084/jem.169.4.1421; WANG PL, 1992, J IMMUNOL, V148, P2600; Ye XH, 2006, VIRAL IMMUNOL, V19, P576, DOI 10.1089/vim.2006.19.576	31	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51696	10.1371/journal.pone.0051696	http://dx.doi.org/10.1371/journal.pone.0051696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272144	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600037
J	Li, YJ; Jiang, WQ; Rao, HL; Huang, JJ; Xia, Y; Huang, HQ; Lin, TY; Xia, ZJ; Li, S; Li, ZM				Li, Ya-Jun; Jiang, Wen-Qi; Rao, Hui-Lan; Huang, Jia-Jia; Xia, Yi; Huang, Hui-Qiang; Lin, Tong-Yu; Xia, Zhong-Jun; Li, Su; Li, Zhi-Ming			Expression of BAFF and BAFF-R in Follicular Lymphoma: Correlation with Clinicopathologic Characteristics and Survival Outcomes	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; B-CELL LYMPHOMA; BLYS; TACI; APOPTOSIS; APRIL; ACTIVATION; STIMULATOR; RECEPTORS; FEATURES	Background: B-cell activation factor (BAFF) and BAFF-receptor (BAFF-R) play crucial roles in the viability and proliferation of malignant lymphoma cells. Limited information exists regarding expression profiles and the prognostic role of BAFF and BAFF-R in follicular lymphoma (FL). We sought to determine the expression profiles of BAFF and BAFF-R in FL and to evaluate the correlation of BAFF and BAFF-R expression with clinicopathologic characteristics and outcome of FL. Correlation between expression levels of BAFF detected by immunohistochemical (IHC) and serum levels of BAFF was also evaluated. Methods: Paraffin-embedded specimens from 115 patients were immunohistochemically examined for BAFF and BAFF-R expression. Expression levels were dichotomized into low versus high categories based on immunostaining intensity. The correlation of BAFF and BAFF-R expression with clinicopathologic characteristics and patient outcome was assessed. Serum levels of BAFF in 35 of the 115 patients with IHC data were measured by Enzyme-linked Immunosorbent assay (ELISA). Results: BAFF and BAFF-R were expressed in 88.7% (102/115) and 87.8% (101/115) of the cases, respectively. BAFF expression was significantly correlated with only one clinicopathologic feature: Ann Arbor stage. No significant correlation was found between expression levels of BAFF detected by IHC and serum levels of BAFF detected by ELISA. High expression of BAFF-R, but not BAFF, was significantly correlated with inferior progression-free survival (PFS; P = 0.013) and overall survival (OS; P = 0.03). High expression of BAFF-R, bulky disease, and elevated lactate dehydrogenase were correlated with inferior PFS and OS in multivariate analysis. A prognostic scoring system incorporating these 3 risk factors identified 3 distinct prognostic groups with 5-year PFS of 59.4%, 41.9%, and 10.7% and OS of 91.3%, 79.7%, and 45.8%, respectively. Conclusions: Most patients with FL variably express BAFF and BAFF-R. High expression of BAFF-R, but not BAFF, may be an independent risk factor for PFS and OS in FL.	[Li, Ya-Jun; Jiang, Wen-Qi; Rao, Hui-Lan; Huang, Jia-Jia; Xia, Yi; Huang, Hui-Qiang; Lin, Tong-Yu; Xia, Zhong-Jun; Li, Su; Li, Zhi-Ming] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Li, Ya-Jun; Jiang, Wen-Qi; Huang, Jia-Jia; Xia, Yi; Huang, Hui-Qiang; Lin, Tong-Yu; Li, Su; Li, Zhi-Ming] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Rao, Hui-Lan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Zhong-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, ZM (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	lzmlzmlzm@yahoo.com	jiang, wen/GYI-9662-2022		National Natural Science Foundation of China [81071950]; Fundamental Research Funds for the Central Universities [10ykpy36]; National-Eleventh Five Technology Major Project [2008ZX09312-002, 2012ZX09301]; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National-Eleventh Five Technology Major Project; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	This work was supported by National Natural Science Foundation of China (81071950), Fundamental Research Funds for the Central Universities (10ykpy36), National-Eleventh Five Technology Major Project (2008ZX09312-002, 2012ZX09301), and Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Biagi JJ, 2002, BLOOD, V99, P4265, DOI 10.1182/blood.V99.12.4265; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Federico M, 2009, J CLIN ONCOL, V27, P4555, DOI 10.1200/JCO.2008.21.3991; Fu LC, 2006, BLOOD, V107, P4540, DOI 10.1182/blood-2005-10-4042; Fu LC, 2009, BLOOD, V113, P4627, DOI 10.1182/blood-2008-10-183467; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; He XH, 2012, CHIN J CANCER, V31, P306, DOI 10.5732/cjc.011.10420; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Kim SJ, 2008, EUR J HAEMATOL, V81, P177, DOI 10.1111/j.1600-0609.2008.01099.x; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Moreaux J, 2004, BLOOD, V103, P3148, DOI 10.1182/blood-2003-06-1984; Nakamura N, 2005, VIRCHOWS ARCH, V447, P53, DOI 10.1007/s00428-005-1275-6; Novak AJ, 2004, BLOOD, V104, P2247, DOI 10.1182/blood-2004-02-0762; Novak AJ, 2002, BLOOD, V100, P2973, DOI 10.1182/blood-2002-02-0558; Oki Y, 2007, HAEMATOLOGICA, V92, P269, DOI 10.3324/haematol.10678; Parameswaran R, 2010, CANCER RES, V70, P4346, DOI 10.1158/0008-5472.CAN-10-0300; Paterson JC, 2006, HAEMATOLOGICA, V91, P772; Rodig SJ, 2005, HUM PATHOL, V36, P1113, DOI 10.1016/j.humpath.2005.08.005; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Song Yan, 2010, Chin J Cancer, V29, P781; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tecchio C, 2007, BRIT J HAEMATOL, V137, P553, DOI 10.1111/j.1365-2141.2007.06615.x; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wada K, 2009, HISTOPATHOLOGY, V54, P221, DOI 10.1111/j.1365-2559.2008.03203.x; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	31	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50936	10.1371/journal.pone.0050936	http://dx.doi.org/10.1371/journal.pone.0050936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272079	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600015
J	Pradel, R; Choquet, R; Bechet, A				Pradel, Roger; Choquet, Remi; Bechet, Arnaud			Breeding Experience Might Be a Major Determinant of Breeding Probability in Long-Lived Species: The Case of the Greater Flamingo	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; REPRODUCTIVE SUCCESS; PHOENICOPTERUS-RUBER; MARKED ANIMALS; AGE; POPULATION; SURVIVAL; COSTS; HETEROGENEITY; PERFORMANCE	The probability of breeding is known to increase with age early in life in many long-lived species. This increase may be due to experience accumulated through past breeding attempts. Recent methodological advances allowing accounting for unobserved breeding episodes, we analyzed the encounter histories of 14716 greater flamingos over 25 years to get a detailed picture of the interactions of age and experience. Survival did not improve with experience, seemingly ruling out the selection hypothesis. Breeding probability varied within three levels of experience : no breeding experience, 1 experience, 2+ experiences. We fitted models with and without among-individual differences in breeding probabilities by including or not an additive individual random effect. Including the individual random effect improved the model fit less than including experience but the best model retained both. However, because modeling individual heterogeneity by means of an additive static individual random effect is currently criticized and may not be appropriate, we discuss the results with and without random effect. Without random effect, breeding probability of inexperienced birds was always > 3 times lower than that of same age experienced birds, and breeding probability increased more with one additional experience than with one additional year of age. With random effects, the advantage of experience was unequivocal only after age 9 while in young having > 1 experience was penalizing. Another pattern, that breeding probability of birds with < 2 experiences dropped after some age (8 without random effect; up to 11 with it), may point to differences in the timing of reproductive senescence or to the existence of a sensitive period for acquiring behavioral skills. Overall, the role of experience appears strong in this long-lived species. We argue that overlooking the role of experience may hamper detection of trade-offs and assessment of individual heterogeneity. However, manipulative experiments are desirable to confirm our finding. Citation: Pradel R, Choquet R, Bechet A (2012) Breeding Experience Might Be a Major Determinant of Breeding Probability in Long-Lived Species: The Case of the Greater Flamingo. PLoS ONE 7(12): e51016. doi:10.1371/journal.pone.0051016	[Pradel, Roger] CNRS, Ctr Ecol Fonct & Evolut, Roger Pradel Biostat & Populat Biol Grp, F-34033 Montpellier, France; [Choquet, Remi] CNRS, Ctr Ecol Fonct & Evolut, Remi Choquet Biostat & Populat Biol Grp, F-34033 Montpellier, France; [Bechet, Arnaud] Ctr Rech Tour Valat, Arnaud Bechet Populat Dynam Response Human Act, Arles, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Pradel, R (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, Roger Pradel Biostat & Populat Biol Grp, F-34033 Montpellier, France.	roger.pradel@cefe.cnrs.fr	Pradel, Roger/A-8666-2008; Béchet, Arnaud/AAA-4398-2021; Choquet, Remi/F-6462-2011	Pradel, Roger/0000-0002-2684-9251; Béchet, Arnaud/0000-0002-0330-6342; Choquet, Remi/0000-0003-0434-9085				Balkiz, 2006, THESIS U MONPELLIER; Balkiz O, 2010, J ANIM ECOL, V79, P1045, DOI 10.1111/j.1365-2656.2010.01721.x; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Beauplet G, 2006, OIKOS, V112, P430, DOI 10.1111/j.0030-1299.2006.14412.x; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Broussard DR, 2008, J MAMMAL, V89, P145, DOI 10.1644/06-MAMM-A-357.1; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cam E, 1998, ECOLOGY, V79, P2917, DOI 10.1890/0012-9658(1998)079[2917:AANPPT]2.0.CO;2; Cam E, 2013, OIKOS, V122, P739, DOI 10.1111/j.1600-0706.2012.20532.x; Cezilly F, 1996, ECOLOGY, V77, P1143, DOI 10.2307/2265583; Cezilly F, 1997, IBIS, V139, P331, DOI 10.1111/j.1474-919X.1997.tb04632.x; Charlesworth B, 1994, CAMBRIDGE STUDIES MA, V2; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Chuei JY, 2007, ZOO BIOL, V26, P275, DOI 10.1002/zoo.20137; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Desprez M, 2011, P ROY SOC B-BIOL SCI, V278, P3060, DOI 10.1098/rspb.2011.0189; Dugdale HL, 2011, MOL ECOL, V20, P3261, DOI 10.1111/j.1365-294X.2011.05167.x; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Gimenez O, 2010, ECOLOGY, V91, P951, DOI 10.1890/09-1903.1; GROOTHUIS T, 1992, ANIM BEHAV, V43, P1, DOI 10.1016/S0003-3472(05)80067-3; Hamel S, 2010, ECOL LETT, V13, P915, DOI 10.1111/j.1461-0248.2010.01478.x; HEPP GR, 1993, ECOLOGY, V74, P2027, DOI 10.2307/1940848; Johnson A, 2007, GREATER FLAMINGO; Kendall WL, 2002, ECOLOGY, V83, P3276; Kendall WL, 2001, BIOMETRICS, V57, P1113, DOI 10.1111/j.0006-341X.2001.01113.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lebreton JD, 2009, ADV ECOL RES, V41, P87, DOI 10.1016/S0065-2504(09)00403-6; Lee DE, 2011, J MAMMAL, V92, P517, DOI 10.1644/10-MAMM-A-042.1; Mauck RA, 2004, EVOLUTION, V58, P880, DOI 10.1554/03-147; Nevoux M, 2007, J ANIM ECOL, V76, P159, DOI 10.1111/j.1365-2656.2006.01191.x; Newton I, 1989, LIFETIME REPROD BIRD; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; NOL E, 1987, J ANIM ECOL, V56, P301, DOI 10.2307/4816; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; POLLOCK KH, 1981, BIOMETRICS, V37, P521, DOI 10.2307/2530565; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Pradel R, 1997, ECOLOGY, V78, P1431; Pyle P, 2001, J ANIM ECOL, V70, P1088, DOI 10.1046/j.0021-8790.2001.00567.x; Pyle P, 1997, BEHAV ECOL, V8, P140, DOI 10.1093/beheco/8.2.140; Reed E. T., 2004, Animal Biodiversity and Conservation, V27, P35; Rendon MA, 2001, BEHAV ECOL SOCIOBIOL, V50, P55, DOI 10.1007/s002650100326; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Rouan L, 2009, J AGR BIOL ENVIR ST, V14, P338, DOI 10.1198/jabes.2009.06108; Sanz-Aguilar A, 2008, ECOLOGY, V89, P3195, DOI 10.1890/08-0431.1; Schmaltz L, 2011, J AVIAN BIOL, V42, P178, DOI 10.1111/j.1600-048X.2010.05112.x; Sedinger JS, 2001, J ANIM ECOL, V70, P798, DOI 10.1046/j.0021-8790.2001.00535.x; Stearns S.C., 1992, pi; Steiner UK, 2012, P NATL ACAD SCI USA, V109, P4684, DOI 10.1073/pnas.1018096109; Tavecchia G, 2005, J ANIM ECOL, V74, P201, DOI 10.1111/j.1365-2656.2005.00916.x; Tavecchia G, 2001, ECOLOGY, V82, P165, DOI 10.1890/0012-9658(2001)082[0165:SAARVI]2.0.CO;2; Tuljapurkar S, 2009, ECOL LETT, V12, P93, DOI 10.1111/j.1461-0248.2008.01262.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; WEIMERSKIRCH H, 1990, J ANIM ECOL, V59, P867, DOI 10.2307/5019; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson S, 2007, P ROY SOC B-BIOL SCI, V274, P2539, DOI 10.1098/rspb.2007.0643; WOOLLER RD, 1990, J ANIM ECOL, V59, P161, DOI 10.2307/5165; Wynne-Edwards VC, 1939, P ZOOL SOC LOND A-GE, V109, P127, DOI 10.1111/j.1096-3642.1939.tb03357.x	63	17	18	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51016	10.1371/journal.pone.0051016	http://dx.doi.org/10.1371/journal.pone.0051016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272085	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386600017
J	Le Port, A; Gueguen, A; Kesse-Guyot, E; Melchior, M; Lemogne, C; Nabi, H; Goldberg, M; Zins, M; Czernichow, S				Le Port, Agnes; Gueguen, Alice; Kesse-Guyot, Emmanuelle; Melchior, Maria; Lemogne, Cedric; Nabi, Hermann; Goldberg, Marcel; Zins, Marie; Czernichow, Sebastien			Association between Dietary Patterns and Depressive Symptoms Over Time: A 10-Year Follow-Up Study of the GAZEL Cohort	PLOS ONE			English	Article							FOOD-CONSUMPTION FREQUENCY; GENDER-DIFFERENCE; PERCEIVED STRESS; MOOD; OMEGA-3-FATTY-ACIDS; STUDENTS; QUALITY; ADULTS	Background: Data on the association between dietary patterns and depression are scarce. The objective of this study was to examine the longitudinal association between dietary patterns and depressive symptoms assessed repeatedly over 10 years in the French occupational GAZEL cohort. Methods: A total of 9,272 men and 3,132 women, aged 45-60 years in 1998, completed a 35-item Food Frequency Questionnaire (FFQ) at baseline. Dietary patterns were derived by Principal Component Analysis. Depressive symptoms were assessed by the Center for Epidemiologic Studies Depression scale (CES-D) in 1999, 2002, 2005 and 2008. The main outcome measure was the repeated measures of CES-D. Longitudinal analyses were performed with logistic regression based on generalized estimating equations. Principal Findings: The highest quartile of low-fat, western, high snack and high fat-sweet diets in men and low-fat and high snack diets in women were associated with higher likelihood of depressive symptoms at the start of the follow-up compared to the lowest quartile (OR between 1.16 and 1.50). Conversely, the highest quartile of traditional diet (characterized by fish and fruit consumption) was associated with a lower likelihood of depressive symptoms in women compared to the lowest quartile, with OR = 0.63 [95% CI, 0.50 to 0.80], as the healthy pattern (characterized by vegetables consumption) with OR = 0.72 [95% CI, 0.63 to 0.83] and OR = 0.75 [95% CI, 0.61 to 0.93] in men and women, respectively. However, there was probably a reverse causality effect for the healthy pattern. Conclusion: This longitudinal study shows that several dietary patterns are associated with depressive symptoms and these associations track over time.	[Le Port, Agnes; Gueguen, Alice; Melchior, Maria; Lemogne, Cedric; Nabi, Hermann; Goldberg, Marcel; Zins, Marie; Czernichow, Sebastien] Univ Versailles St Quentin, Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Kesse-Guyot, Emmanuelle] Univ Paris 13, Conservatoire Natl Arts & Metiers, INSERM, UMR,U557,INRA,U1125, Bobigny, France; [Lemogne, Cedric] Hop Univ Paris Ouest, APHP, Serv Univ Psychiat Adulte & Sujet Age, Paris, France; [Lemogne, Cedric] Univ Paris 05, Fac Med, Paris, France; [Czernichow, Sebastien] Hop Ambroise Pare, APHP, Dept Nutr, Boulogne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Le Port, A (corresponding author), Univ Versailles St Quentin, Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France.	agnesleport@yahoo.fr	Goldberg, Marcel/I-7834-2012; Lemogne, Cédric/Q-6091-2019; Zins, Marie/AAX-6551-2021; Kesse-Guyot, Emmanuelle/F-2692-2017; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Melchior, Maria/E-3992-2017; Kesse-Guyot, Emmanuelle/K-4689-2012	Goldberg, Marcel/0000-0002-6161-5880; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Le Port, Agnes/0000-0002-8337-6569; Nabi, Hermann/0000-0002-7832-0413	Caisse Centrale d'Activite Sociale des Entreprises Electriques et Gazieres (CCAS); Caisses Mutuelles Complementaires d'Activite Sociale des Entreprises Electriques et Gazieres (CMCAS); EDF-GDF; INSERM; Cohortes Sante TGIR Program; Agence nationale de la recherche (ANR); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET)	Caisse Centrale d'Activite Sociale des Entreprises Electriques et Gazieres (CCAS); Caisses Mutuelles Complementaires d'Activite Sociale des Entreprises Electriques et Gazieres (CMCAS); EDF-GDF; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Cohortes Sante TGIR Program; Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET)	The GAZEL study is supported by the Caisse Centrale d'Activite Sociale des Entreprises Electriques et Gazieres (CCAS) and the Caisses Mutuelles Complementaires d'Activite Sociale des Entreprises Electriques et Gazieres (CMCAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Agnes Le Port had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors express their thanks to EDF-GDF, especially to the Service General de Medecine de Controle, and to the "Caisse centrale d'action sociale du personnel des industries electrique et gaziere". We also wish to acknowledge the Population-based Cohort Platform, Epidemiology and Public Health Research Center, UMRS INSERM Versailles St-Quentin University 1018, - responsible for the GAZEL data base management. The GAZEL Cohort Study was funded by EDF-GDF and INSERM, and received grants from the 'Cohortes Sante TGIR Program', Agence nationale de la recherche (ANR) and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET).	Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Angst J, 1997, J AFFECT DISORDERS, V45, P31, DOI 10.1016/S0165-0327(97)00057-8; Appleton KM, 2007, J AFFECT DISORDERS, V104, P217, DOI 10.1016/j.jad.2007.03.012; Chavance M, 2000, REV EPIDEMIOL SANTE, V48, P389; Cottrell G, 2009, REV EPIDEMIOL SANTE, V57, P361, DOI 10.1016/j.respe.2009.04.011; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; Drewnowski A, 1995, ADDICT BEHAV, V20, P733, DOI 10.1016/0306-4603(95)00105-0; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954, DOI 10.4088/JCP.v67n1217; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gertsik L, 2012, J CLIN PSYCHOPHARM, V32, P61, DOI 10.1097/JCP.0b013e31823f3b5f; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Jacka FN, 2010, AUST NZ J PSYCHIAT, V44, P435, DOI 10.3109/00048670903571598; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kiecolt-Glaser JK, 2010, PSYCHOSOM MED, V72, P365, DOI 10.1097/PSY.0b013e3181dbf489; Kurland BF, 2009, STAT SCI, V24, P211, DOI 10.1214/09-STS293; Lepine JP, 2005, ENCEPHALE, V31, P182; LIPSITZ SR, 1994, STAT MED, V13, P1149, DOI 10.1002/sim.4780131106; Liu CH, 2007, PHYSIOL BEHAV, V92, P748, DOI 10.1016/j.physbeh.2007.05.068; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; McDowell I., 2006, MEASURING HLTH GUIDE; Melchior M, 2010, PSYCHIAT RES, V177, P92, DOI 10.1016/j.psychres.2009.08.002; Melchior M, 2009, AM J PUBLIC HEALTH, V99, P1417, DOI 10.2105/AJPH.2008.142273; Mikolajczyk RT, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-31; Murakami K, 2010, MOL NUTR FOOD RES, V54, P471, DOI 10.1002/mnfr.200900157; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Niedhammer I, 1998, SCAND J WORK ENV HEA, V24, P197, DOI 10.5271/sjweh.299; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROLLS BJ, 1991, HEALTH PSYCHOL, V10, P133, DOI 10.1037/0278-6133.10.2.133; Rosenstrom T, 2012, PSYCHOL MED, V30, P1; Sabia S, 2011, ADDICTION, V106, P93, DOI 10.1111/j.1360-0443.2010.03106.x; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Tiemeier H, 2003, EPIDEMIOLOGY, V14, P103, DOI 10.1097/00001648-200301000-00025; Weng TT, 2012, PUBLIC HEALTH NUTR, V15, P673, DOI 10.1017/S1368980011003077; WHO, 2001, WORLD HLTH REP MENT; Yanovski S, 2003, J NUTR, V133, p835S, DOI 10.1093/jn/133.3.835S	40	101	103	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51593	10.1371/journal.pone.0051593	http://dx.doi.org/10.1371/journal.pone.0051593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251585	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200141
J	Pamenter, ME; Perkins, GA; McGinness, AK; Gu, XQ; Ellisman, MH; Haddad, GG				Pamenter, Matthew E.; Perkins, Guy A.; McGinness, Anelah K.; Gu, Xiang Q.; Ellisman, Mark H.; Haddad, Gabriel G.			Autophagy and Apoptosis Are Differentially Induced in Neurons and Astrocytes Treated with an In Vitro Mimic of the Ischemic Penumbra	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; ARTERY OCCLUSION; UP-REGULATION; CYTOCHROME-C; INFARCT RIM; BLOOD-FLOW; BRAIN; STROKE	The development of clinical stroke therapies remains elusive. The neuroprotective efficacies of thousands of molecules and compounds have not yet been determined; however, screening large volumes of potential targets in vivo is severely rate limiting. High throughput screens (HTS) may be used to discover promising candidates, but this approach has been hindered by the lack of a simple in vitro model of the ischemic penumbra, a clinically relevant region of stroke-afflicted brain. Recently, our laboratory developed such a mimic (ischemic solution: IS) suitable for HTS, but the etiology of stress pathways activated by this model are poorly understood. The aim of the present study was to determine if the cell death phenotype induced by IS accurately mimics the in vivo penumbra and thus whether our model system is suitable for use in HTS. We treated cultured neuron and astrocyte cell lines with IS for up to 48 hrs and examined cellular energy state ([ATP]), cell and organelle morphology, and gene and molecular profiles related to stress pathways. We found that IS-treated cells exhibited a phenotype of mixed apoptosis/autophagy characteristic of the in vivo penumbra, including: (1) short-term elevation of [ATP] followed by progressive ATP depletion and Poly ADP Ribose Polymerase cleavage, (2) increased vacuole number in the cytoplasm, (3) mitochondrial rupture, decreased mitochondrial and cristae density, release of cytochrome C and apoptosis inducing factor, (4) chromatin condensation, nuclear lamin A and DNA cleavage, fragmentation of the nuclear envelope, and (5) altered expression of mRNA and proteins consistent with autophagy and apoptosis. We conclude that our in vitro model of the ischemic penumbra induces autophagy and apoptosis in cultured neuron and astrocyte cell lines and that this mimic solution is suitable for use in HTS to elucidate neuroprotective candidates against ischemic penumbral cell death.	[Pamenter, Matthew E.; McGinness, Anelah K.; Gu, Xiang Q.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ellisman, Mark H.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Pamenter, ME (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	mpamenter@ucsd.edu	Pamenter, Matt/R-9216-2019	Pamenter, Matt/0000-0003-4035-9555; Perkins, Guy/0000-0002-1834-6646	National Institutes of Health [5P01HD032573, P30 NS047101]; Heart and Stroke Foundation of Canada fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada fellowship(Heart & Stroke Foundation of Canada); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants 5P01HD032573 to GGH and P30 NS047101 to the University of California San Diego Neurosciences Microscopy Shared Facility, and a Heart and Stroke Foundation of Canada fellowship to MEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanda N, 2006, BIOPHYS J, V90, P4405, DOI 10.1529/biophysj.105.080028; Anderson R E, 1999, J Stroke Cerebrovasc Dis, V8, P368, DOI 10.1016/S1052-3057(99)80044-5; Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160; Banasiak KJ, 1999, MOL BRAIN RES, V72, P214, DOI 10.1016/S0169-328X(99)00189-8; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; Benchoua A, 2001, J NEUROSCI, V21, P7127, DOI 10.1523/JNEUROSCI.21-18-07127.2001; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; BRANSTON NM, 1974, EXP NEUROL, V45, P195, DOI 10.1016/0014-4886(74)90112-5; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Chae HJ, 2000, PHARMACOL RES, V42, P373, DOI 10.1006/phrs.2000.0700; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; del Zoppo GJ, 2012, J CEREBR BLOOD F MET, V32, P919, DOI 10.1038/jcbfm.2012.11; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; FADOK VA, 1992, J IMMUNOL, V148, P2207; Ferrer I, 2003, NEUROPATH APPL NEURO, V29, P472, DOI 10.1046/j.1365-2990.2003.00485.x; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gelot A, 2009, DEV NEUROSCI-BASEL, V31, P459, DOI 10.1159/000232564; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hattori K, 2010, ANTIOXID REDOX SIGN, V13, P1157, DOI 10.1089/ars.2010.3290; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Ju WK, 2009, MOL VIS, V15, P120; Kalinowska M, 2005, APOPTOSIS, V10, P821, DOI 10.1007/s10495-005-0410-9; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Krupinski J, 2000, NEUROBIOL DIS, V7, P332, DOI 10.1006/nbdi.2000.0310; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matsushita K, 1998, NEUROSCIENCE, V83, P439, DOI 10.1016/S0306-4522(97)00391-6; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Morin D, 2004, BIOCHEM PHARMACOL, V68, P2065, DOI 10.1016/j.bcp.2004.07.006; OLSEN TS, 1983, STROKE, V14, P332, DOI 10.1161/01.STR.14.3.332; Pamenter ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043995; Pamenter ME, 2012, BRAIN RES, V1452, P165, DOI 10.1016/j.brainres.2012.03.004; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rami A, 2008, AUTOPHAGY, V4, P422, DOI 10.4161/auto.5778; Rami A, 2008, AUTOPHAGY, V4, P227, DOI 10.4161/auto.5339; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; ROBERTON AM, 1968, BIOCHEM J, V108, P445, DOI 10.1042/bj1080445; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Weinstein PR, 2004, STROKE, V35, P2666, DOI 10.1161/01.STR.0000144052.10644.ed; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Yao H, 2001, MOL BRAIN RES, V91, P112, DOI 10.1016/S0169-328X(01)00135-8; Yao H, 2007, J NEUROCHEM, V103, P1644, DOI 10.1111/j.1471-4159.2007.04879.x; Yao H, 2007, J NEUROCHEM, V100, P1224, DOI 10.1111/j.1471-4159.2006.04299.x; Yao H, 2009, J NEUROCHEM, V108, P835, DOI 10.1111/j.1471-4159.2008.05838.x; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	62	36	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51469	10.1371/journal.pone.0051469	http://dx.doi.org/10.1371/journal.pone.0051469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251543	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200114
J	Fernandez-Sirera, L; Cabezon, O; Allepuz, A; Rosell, R; Riquelme, C; Serrano, E; Lavin, S; Marco, I				Fernandez-Sirera, Laura; Cabezon, Oscar; Allepuz, Alberto; Rosell, Rosa; Riquelme, Cristina; Serrano, Emmanuel; Lavin, Santiago; Marco, Ignasi			Two Different Epidemiological Scenarios of Border Disease in the Populations of Pyrenean chamois (Rupicapra p. pyrenaica) after the First Disease Outbreaks	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; PESTIVIRUS INFECTION; ROE DEER; SHEEP; WILD; SEROPREVALENCE; ANIMALS; CATTLE	Since 2001 several outbreaks of a new disease associated with Border disease virus (BDV) infection have caused important declines in Pyrenean chamois (Rupicapra pyrenaica) populations in the Pyrenees. The goal of this study was to analyze the post-outbreak BDV epidemiology in the first two areas affected by disease with the aim to establish if the infection has become endemic. We also investigated if BDV infected wild and domestic ruminants sharing habitat with chamois. Unexpectedly, we found different epidemiological scenarios in each population. Since the disease outbreaks, some chamois populations recuperated quickly, while others did not recover as expected. In chamois from the first areas, prevalence was high (73.47%) and constant throughout the whole study period and did not differ between chamois born before and after the BDV outbreak; in all, BDV was detected by RT-PCR in six chamois. In the other areas, prevalence was lower (52.79%) and decreased during the study period; as well, prevalence was significantly lower in chamois born after the disease outbreak. No BDV were detected in this population. A comparative virus neutralisation test performed with four BDV strains and one Bovine viral diarrhoea virus (BVDV) strain showed that all the chamois had BDV-specific antibodies. Pestivirus antibodies were detected in all the rest of analyzed species, with low prevalence values in wild ruminants and moderate values in domestic ruminants. No viruses were detected in these species. These results confirm the hypothesis that outbreaks of BDV infection only affect the Pyrenean chamois, although other wild ruminants can occasionally be infected. In conclusion, two different scenarios have appeared since the first border disease outbreaks in Pyrenean chamois: on the one hand frequent BDV circulation with possible negative impact on population dynamics in some areas and on the other, lack of virus circulation and quick recovery of the chamois population.	[Fernandez-Sirera, Laura; Cabezon, Oscar; Serrano, Emmanuel; Lavin, Santiago; Marco, Ignasi] Univ Autonoma Barcelona, Fac Vet, Servei Ecopatol Fauna Salvatge SEFaS, E-08193 Barcelona, Spain; [Fernandez-Sirera, Laura; Cabezon, Oscar; Allepuz, Alberto; Rosell, Rosa; Riquelme, Cristina] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA, E-08193 Barcelona, Spain; [Allepuz, Alberto] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Rosell, Rosa] Dept Agr Alimentacio & Accio Rural, Barcelona, Spain; [Serrano, Emmanuel] Univ Lleida, Dept Matemat, Lleida, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Universitat de Lleida	Fernandez-Sirera, L (corresponding author), Univ Autonoma Barcelona, Fac Vet, Servei Ecopatol Fauna Salvatge SEFaS, E-08193 Barcelona, Spain.	laura@montx.com	Marco, Ignasi/E-8633-2015; Cabezón, Oscar/AAV-7876-2020; SERRANO-FERRON, Emmanuel/J-4489-2013; Cabezon, Oscar/L-3812-2014; Allepuz, Alberto/N-2398-2014; Lavín, Santiago/L-5975-2014	Marco, Ignasi/0000-0001-7479-3419; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Cabezon, Oscar/0000-0001-7543-8371; Allepuz, Alberto/0000-0003-3518-1991; Lavín, Santiago/0000-0001-5655-588X; Rosell, Rosa/0000-0002-8294-1159	University Teaching Grant (FPU: Formacion de Profesorado Universitario) from the Spanish Ministry of Education (Ministerio de Educacion); Beatriu de Pinos programme (BP-DGR) of the Catalan Science and Technology System; Spanish government [CGL2006-11518/BOS, CGL2009-09071/BOS]	University Teaching Grant (FPU: Formacion de Profesorado Universitario) from the Spanish Ministry of Education (Ministerio de Educacion); Beatriu de Pinos programme (BP-DGR) of the Catalan Science and Technology System; Spanish government(Spanish GovernmentEuropean Commission)	The PhD studies of LFS are funded by a University Teaching Grant (FPU: Formacion de Profesorado Universitario) from the Spanish Ministry of Education (Ministerio de Educacion) and ES by the Beatriu de Pinos programme (BP-DGR 2011) of the Catalan Science and Technology System. This research was supported by grant CGL2006-11518/BOS and CGL2009-09071/BOS from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba A, 2008, SMALL RUMINANT RES, V78, P80, DOI 10.1016/j.smallrumres.2008.05.004; Altman DG, 2000, BRIT MED J, P116; Arnal MC, 2004, J GEN VIROL, V85, P3653, DOI 10.1099/vir.0.80235-0; Cabezon O, 2011, J GEN VIROL, V92, P2494, DOI 10.1099/vir.0.034595-0; Chappuis G, 1984, EPIDEMIOL SANTE ANIM, V6, P117; COLLETT MS, 1988, VIROLOGY, V165, P200, DOI 10.1016/0042-6822(88)90673-3; Fernandez-Sirera L, 2012, EUR J WILDLIFE RES, V58, P425, DOI 10.1007/s10344-011-0591-1; Fernandez-Sirera L, 2012, J WILDL DIS IN PRESS; Fischer S, 1998, J WILDLIFE DIS, V34, P47, DOI 10.7589/0090-3558-34.1.47; FROLICH K, 1995, J WILDLIFE DIS, V31, P243; Gaffuri A, 2006, J WILDLIFE DIS, V42, P685, DOI 10.7589/0090-3558-42.3.685; Garcia-Perez AL, 2009, RES VET SCI, V86, P345, DOI 10.1016/j.rvsc.2008.07.004; Hurtado A, 2004, J WILDLIFE DIS, V40, P796, DOI 10.7589/0090-3558-40.4.796; Krametter R, 2004, J WILDLIFE DIS, V40, P791, DOI 10.7589/0090-3558-40.4.791; Krametter-Froetscher R, 2010, VET J, V186, P342, DOI 10.1016/j.tvjl.2009.09.006; Lillehaug A, 2003, J WILDLIFE DIS, V39, P779, DOI 10.7589/0090-3558-39.4.779; LOKEN T, 1995, VET CLIN N AM-FOOD A, V11, P597, DOI 10.1016/S0749-0720(15)30469-2; Marco I, 2008, RES VET SCI, V87, P149; Marco I, 2008, VET MICROBIOL, V127, P29, DOI 10.1016/j.vetmic.2007.08.015; Marco I, 2007, VET MICROBIOL, V120, P33, DOI 10.1016/j.vetmic.2006.10.007; Marco I, 2009, EMERG INFECT DIS, V15, P448, DOI 10.3201/eid1503.081155; Martin C, 2011, VET MICROBIOL, V147, P320, DOI 10.1016/j.vetmic.2010.07.010; Monies RJ, 2004, VET REC, V155, P765; Nettleton P F, 1990, Rev Sci Tech, V9, P131; NETTLETON PF, 1995, BRIT VET J, V151, P615, DOI 10.1016/S0007-1935(95)80145-6; Nettleton PF, 1998, VET RES, V29, P327; NEUMANN W, 1980, DEUT TIERARZTL WOCH, V87, P94; Nielsen SS, 2000, J WILDLIFE DIS, V36, P584, DOI 10.7589/0090-3558-36.3.584; OIE, 2008, MAN DIAGN TESTS VACC; REED L. J., 1938, AMER JOUR HYG, V27, P493; Registration dossier N&DEGASBVD6 Version n&DEG8 BVD p80 Ag Mono Indirect, 2012, REG DOSS ASBVD6 VERS; Riekerink RGMO, 2005, VET MICROBIOL, V108, P297, DOI 10.1016/j.vetmic.2005.04.014; ROMVARY J, 1965, ACTA VET ACAD SCI H, V15, P451; Rothman KJ, 2002, EPIDEMIOLOGY INTRO, P130; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHELLNER HP, 1977, TIERARZTL UMSCHAU, V32, P225; Schirrmeier H, 2004, J GEN VIROL, V85, P3647, DOI 10.1099/vir.0.80238-0; Valdazo-Gonzalez B, 2007, VET J, V174, P316, DOI 10.1016/j.tvjl.2006.10.002; Validation Data Report, 2011, POURQUIER ELISA BVD; Vilcek S, 2006, VET MICROBIOL, V116, P1, DOI 10.1016/j.vetmic.2006.06.003; Vilcek S, 1997, J GEN VIROL, V78, P725, DOI 10.1099/0022-1317-78-4-725; VILCEK S, 1994, ARCH VIROL, V136, P309, DOI 10.1007/BF01321060	42	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51031	10.1371/journal.pone.0051031	http://dx.doi.org/10.1371/journal.pone.0051031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251417	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900034
J	Hajrezaie, M; Golbabapour, S; Hassandarvish, P; Gwaram, NS; Hadi, AHA; Ali, HM; Majid, N; Abdulla, MA				Hajrezaie, Maryam; Golbabapour, Shahram; Hassandarvish, Pouya; Gwaram, Nura Suleiman; Hadi, A. Hamid A.; Ali, Hapipah Mohd; Majid, Nazia; Abdulla, Mahmood Ameen			Acute Toxicity and Gastroprotection Studies of a New Schiff Base Derived Copper (II) Complex against Ethanol-Induced Acute Gastric Lesions in Rats	PLOS ONE			English	Article							ANTI-ULCEROGENIC ACTIVITY; PROCUMBENS LEAF EXTRACT; MUCOSAL INJURY; LIPID-PEROXIDATION; ANTIULCER ACTIVITY; STRESS; ANTIOXIDANT; ULCER; HEAT-SHOCK-PROTEIN-70; STOMACH	Background: Copper is an essential element in various metabolisms. The investigation was carried out to evaluate acute gastroprotective effects of the Copper (II) complex against ethanol-induced superficial hemorrhagic mucosal lesions in rats. Methodology/Principal Findings: Rats were divided into 7 groups. Groups 1 and 2 were orally administered with Tween 20 (10% v/v). Group 3 was orally administered with 20 mg/kg omeprazole (10% Tween 20). Groups 4-7 received 10, 20, 40, and 80 mg/kg of the complex (10% Tween 20), respectively. Tween 20 (10% v/v) was given orally to group 1 and absolute ethanol was given orally to groups 2-7, respectively. Rats were sacrificed after 1 h. Group 2 exhibited severe superficial hemorrhagic mucosal lesions. Gastric wall mucus was significantly preserved by the pre-treatment complex. The results showed a significant increase in glutathione (GSH), superoxide dismutase (SOD), nitric oxide (NO), and Prostaglandin E2 (PGE(2)) activities and a decrease in malondialdehyde (MDA) level. Histology showed marked reduction of hemorrhagic mucosal lesions in groups 4-7. Immunohistochemical staining showed up-regulation of Hsp70 and down-regulation of Bax proteins. PAS staining of groups 4-7 showed intense stain uptake of gastric mucosa. The acute toxicity revealed the nontoxic nature of the compound. Conclusions/Significance: The gastroprotective effect of the Copper (II) complex may possibly be due to preservation of gastric wall mucus; increase in PGE(2) synthesis; GSH, SOD, and NO up-regulation of Hsp70 protein; decrease in MDA level; and down-regulation of Bax protein.	[Hajrezaie, Maryam; Golbabapour, Shahram; Hassandarvish, Pouya; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Gwaram, Nura Suleiman; Hadi, A. Hamid A.; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia; [Hajrezaie, Maryam; Golbabapour, Shahram; Majid, Nazia] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	MAJID, NAZIA ABDUL/B-9215-2010; Hassandarvish, Pouya/K-8112-2012; Gwaram, Nura Suleiman/AEQ-1882-2022; Gwaram, Nura/F-6667-2011	MAJID, NAZIA ABDUL/0000-0002-6817-8046; Hassandarvish, Pouya/0000-0003-0364-5587; Gwaram, Nura Suleiman/0000-0002-8423-6111; Golbabapour, Shahram/0000-0001-8790-0316	University of Malaya [RG373/11HTM]; HIR-MOHE [F000009-21001]	University of Malaya(Universiti Malaya); HIR-MOHE	The authors would like to thank the University of Malaya for funding this research, RG373/11HTM and HIR-MOHE (F000009-21001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Abdulla MA, 2009, BIOMED RES-INDIA, V20, P35; AJITHA M, 2001, INDIAN DRUGS, V38, P545; Al Mofleh Ibrahim A, 2008, Saudi J Gastroenterol, V14, P128, DOI [10.1159/000106092, 10.4103/1319-3767.41731]; ARAUJO DAOV, 2011, BRAZILIAN J PHARMACO, V21, P721, DOI DOI 10.1590/S0102-695X2011005000117; Bagchi K, 1998, E MEDITERRANEAN HLTH, V4, P60; Bagchi M, 1999, NUTR RES, V19, P1189, DOI 10.1016/S0271-5317(99)00080-9; Behmer O, 1976, MANUAL HISTOLOGIA NO, P225; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski T, 2005, WORLD J GASTROENTERO, V11, P6450, DOI 10.3748/wjg.v11.i41.6450; Chen W, 2010, EUR J MED CHEM, V45, P4473, DOI 10.1016/j.ejmech.2010.07.007; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Creaven BS, 2010, INORG CHIM ACTA, V363, P4048, DOI 10.1016/j.ica.2010.08.009; Creaven BS, 2010, POLYHEDRON, V29, P813, DOI 10.1016/j.poly.2009.11.002; DOLLWET HHA, 1985, TRACE ELEM MED, V2, P80; Dursun H, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-36; Ei-Sherif AA, 2011, SPECTROCHIM ACTA A, V79, P1803, DOI 10.1016/j.saa.2011.05.062; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Gwaram NS, 2011, ACTA CRYSTALLOGR E, V67, pM931, DOI 10.1107/S1600536811022045; HAWKEY CJ, 1985, GASTROENTEROLOGY, V89, P1162, DOI 10.1016/0016-5085(85)90225-2; Ketuly KA, 2011, J MED PLANTS RES, V5, P514; Khazaei M., 2006, IRAN J PHARM THER, V5, P43; Kobayashi T, 2001, PHARMACOL RES, V43, P23, DOI 10.1006/phrs.2000.0748; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mahmood AA, 2010, J MED PLANTS RES, V4, P685; Mcmanus J, 1964, PAS REACTION STAININ; Mehmood A, 2010, INT J APPL BIOL PHAR, V1, P1337; MILLER TA, 1985, AM J PHYSIOL, V249, pG137, DOI 10.1152/ajpgi.1985.249.1.G137; Mradul Goswami, 2011, Journal of Applied Pharmaceutical Science, V1, P69; Mustafa IM, 2009, POLYHEDRON, V28, P3993, DOI 10.1016/j.poly.2009.10.004; NAGELE A, 1994, BIOCHEM PHARMACOL, V47, P555, DOI 10.1016/0006-2952(94)90188-0; OBERRINGER M, 1995, BIOCHEM BIOPH RES CO, V214, P1009, DOI 10.1006/bbrc.1995.2386; OECD Guideline for testing of chemicals, 2005, OECD GUID TEST CHEM; Polat B, 2010, CHEM-BIOL INTERACT, V186, P82, DOI 10.1016/j.cbi.2010.03.041; Qui BS, 2004, WORLD J GASTROENTERO, V10, P594, DOI 10.3748/wjg.v10.i4.594; Raman N, 2011, SPECTROCHIM ACTA A, V79, P873, DOI 10.1016/j.saa.2011.03.017; Raman N, 2010, EUR J MED CHEM, V45, P5438, DOI 10.1016/j.ejmech.2010.09.004; ROCKCLIFFE DA, 1995, J MOL CATAL A-CHEM, V99, P87, DOI 10.1016/1381-1169(95)00032-1; Salga MS, 2011, MOLECULES, V16, P8654, DOI 10.3390/molecules16108654; Schneeweiss S, 2006, CLIN PHARMACOL THER, V79, P379, DOI 10.1016/j.clpt.2005.12.304; Shichijo K, 2003, DIGEST DIS SCI, V48, P340, DOI 10.1023/A:1021939829515; Takeuchi K., 2002, GASTROINTESTINAL MUC, P227; Tarnawski A, 2001, J PHYSIOL-PARIS, V95, P337, DOI 10.1016/S0928-4257(01)00046-8; Tuchinda P, 2002, PHYTOCHEMISTRY, V59, P169, DOI 10.1016/S0031-9422(01)00451-4; Umamaheswari M, 2007, J ETHNOPHARMACOL, V109, P547, DOI 10.1016/j.jep.2006.08.020; Vandenplas Y, 2000, WORLD J GASTROENTERO, V6, P20, DOI 10.3748/wjg.v6.i1.20; Wasman SQ, 2011, INDIAN J EXP BIOL, V49, P767; Xiong RG, 1997, POLYHEDRON, V16, P2315; Yildirim A, 2007, J PHYSIOL PHARMACOL, V58, P105; Zahra AA, 2011, J MED PLANTS RES, V5, P2551; Zhao W, 2009, ACTA BIOCH BIOPH SIN, V41, P301, DOI 10.1093/abbs/gmp014	54	54	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51537	10.1371/journal.pone.0051537	http://dx.doi.org/10.1371/journal.pone.0051537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251568	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900098
J	Huang, H; Li, YJ; Liu, JH; Zheng, MH; Feng, YL; Hu, KH; Huang, YW; Huang, QD				Huang, He; Li, Yujie; Liu, Jihong; Zheng, Minghui; Feng, Yanling; Hu, Kunhua; Huang, Yongwen; Huang, Qidan			Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers	PLOS ONE			English	Article							MICROENVIRONMENT; PROTEOMICS	Objective: The ability to predict responses to chemotherapy for serous epithelial ovarian cancer (EOC) would be valuable since intrinsically chemoresistant EOC patients (persistent or recurrent disease within 6 months) gain little benefit from standard chemotherapy. The aim of this study was to screen and identify distinctive biomarkers in ascites of serous EOC associated with intrinsic chemoresistance. Methods: Protein samples from ascites of 12 chemosensitive and 7 intrinsically chemoresistant serous EOC patients were analyzed using two-dimensional fluorescence difference in gel electrophoresis (2-D DIGE) coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/TOF MS). Furthermore, the identified proteins were validated by ELISA in ascites samples from 19 chemosensitive and 9 intrinsically chemoresistant EOC patients. Results: The number of spots detected in all 2-D DIGE gels ranged from 1523-1711 using DeCyder software analysis. Thirty-four spots were differentially expressed based on the criteria of an average ratio of more than 1.5 and a student t-test P value <0.05. After MALDI-TOF/TOF MS analysis, 11 differentially expressed proteins, including 3 up-regulated and 8 down-regulated proteins, in ascites of chemoresistant tumors were successfully identified. Of the four selected proteins (ceruloplasmin, apoliprotein A-IV, transthyretin and haptoglobin) in ascites tested by ELISA, only ceruloplasmin was present at significantly different levels between the chemoresistant and chemosensitive ascites samples with average concentrations of 192.2 mu g/ml and 157.5 mg/ml, respectively (P = 0.001). Conclusion: The significantly up-regulated level of ceruloplasmin in the ascites fluid of intrinsic chemoresistant serous EOC patients suggests its potential as a prognostic biomarker for responses to chemotherapy. This finding prompts further investigation with a larger study in order to validate the clinical utility of ceruloplasmin. Citation: Huang H, Li Y, Liu J, Zheng M, Feng Y, et al. (2012) Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers. PLoS ONE 7(12): e51256. doi:10.1371/journal.pone.0051256	[Huang, He; Li, Yujie; Liu, Jihong; Feng, Yanling; Huang, Yongwen; Huang, Qidan] Sun Yat Sen Univ, Dept Gynecol Oncol, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Minghui] Sun Yat Sen Univ, Dept Clin Lab, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Kunhua] Sun Yat Sen Univ, Prote Ctr, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Liu, JH (corresponding author), Sun Yat Sen Univ, Dept Gynecol Oncol, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	Liujh@sysucc.org.cn	Li, YuJie/HGT-8657-2022; Li, yu/HHZ-5236-2022	Liu, Jihong/0000-0003-3464-2901	Natural Science Foundation of Guangdong Province, China [7001535]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by a grant from the Natural Science Foundation of Guangdong Province, China (No. 7001535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RA, 2004, J AM COLL SURGEONS, V198, P999, DOI 10.1016/j.jamcollsurg.2004.01.035; Ahn WS, 2005, CANCER SCI, V96, P197, DOI 10.1111/j.1349-7006.2005.00029.x; Altinoz MA, 2004, NEOPLASMA, V51, P239; Bachvarov D, 2006, INT J ONCOL, V29, P919; Berek J., 2010, BEREK HACKERS GYNECO; CHAKRAVARTY PK, 1986, ACTA MED OKAYAMA, V40, P103; Cox C, 2001, LARYNGOSCOPE, V111, P696, DOI 10.1097/00005537-200104000-00024; Good DM, 2007, J PROTEOME RES, V6, P4549, DOI 10.1021/pr070529w; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Hall MD, 2004, J INORG BIOCHEM, V98, P1614, DOI 10.1016/j.jinorgbio.2004.05.017; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Hu LM, 2002, AM J PATHOL, V161, P1917, DOI 10.1016/S0002-9440(10)64467-7; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Kassis J, 2005, DIAGN CYTOPATHOL, V33, P316, DOI 10.1002/dc.20280; Kluger HM, 2004, LAB INVEST, V84, P320, DOI 10.1038/labinvest.3700044; Kuk C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/mcp.M800313-MCP200; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liu W, 2009, PROTEOMICS, V9, P3712, DOI 10.1002/pmic.200800979; Nayak Shivananda B, 2003, Indian J Physiol Pharmacol, V47, P108; Onizuka Keiichiro, 1999, Fukuoka Acta Medica, V90, P46; Petricoin EF, 2002, J MAMMARY GLAND BIOL, V7, P433, DOI 10.1023/A:1024042200521; Redman BG, 2003, CLIN CANCER RES, V9, P1666; Spriggs D, 2003, GYNECOL ONCOL, V90, pS39, DOI 10.1016/S0090-8258(03)00471-2	24	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51256	10.1371/journal.pone.0051256	http://dx.doi.org/10.1371/journal.pone.0051256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251472	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900059
J	Hoermann, S; Franz, EA; Regenbrecht, H				Hoermann, Simon; Franz, Elizabeth A.; Regenbrecht, Holger			Referred Sensations Elicited by Video-Mediated Mirroring of Hands	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; VISUAL FEEDBACK; SYNDROME TYPE-1; CORTICAL REORGANIZATION; VIRTUAL-REALITY; PHANTOM LIMBS; BOX THERAPY; INJURY; BRAIN; TOUCH	Humans readily perceive ownership of a limb even when it is artificially induced as in the case of using a mirror reflection. However, mirror reflections are very constrained perceptions which do not allow transformations and varied contexts as often occurs in real life. The extent to which perceived limb ownership occurs with video-mediated manipulations is not known, particularly given the perception would no longer be a precise copy (reflection) of a person's own limb. The present study directly compared referred sensations of the limbs with the use of a mirror reflection to those obtained with a new video-mediated setup to assess perceived ownership. Manipulations that could not be performed with a standard mirror reflection, such as reversal of the spatial positions of the limbs, were also investigated to examine how far the perceived ownership effects could be pushed. Across a series of experiments, data on the quality, intensity and location of referred sensations were collected and analyzed together with measures of hand ownership and participants' experience of the two setups. Results reveal that participants felt referred sensations in both the optical and the video-mediated setup, and that video-mediated manipulations of hand-position reversals produced equal to stronger effects of ownership compared with the mirror reflection. These findings open up new possibilities for scientific experimentation and therapy that are discussed in the paper.	[Hoermann, Simon; Regenbrecht, Holger] Univ Otago, Dept Informat Sci, Dunedin, New Zealand; [Franz, Elizabeth A.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago; University of Otago	Hoermann, S (corresponding author), Univ Otago, Dept Informat Sci, Dunedin, New Zealand.	shoermann@infoscience.otago.ac.nz	Hoermann, Simon/AAT-2334-2021	Hoermann, Simon/0000-0002-4201-844X	University of Otago [106961.01.R.DL]	University of Otago	Parts of this research have been funded by a University of Otago Research Grant (106961.01.R.DL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acerra NE, 2005, NEUROLOGY, V65, P751, DOI 10.1212/01.wnl.0000178745.11996.8c; Altschuler EL, 1999, LANCET, V353, P2035, DOI 10.1016/S0140-6736(99)00920-4; Altschuler EL, 2008, SCAND J PLAST RECONS, V42, P110, DOI 10.1080/02844310701510355; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Durgin FH, 2007, PSYCHOL SCI, V18, P152, DOI 10.1111/j.1467-9280.2007.01865.x; Franz EA, 2004, EXP BRAIN RES, V157, P174, DOI 10.1007/s00221-004-1831-3; Franz EA, 2004, J MOTOR BEHAV, V36, P71, DOI 10.3200/JMBR.36.1.71-81; IJsselsteijn WA, 2006, PRESENCE-TELEOP VIRT, V15, P455, DOI 10.1162/pres.15.4.455; Karmarkar A, 2006, ANAESTHESIA, V61, P412, DOI 10.1111/j.1365-2044.2006.04605.x; Kraemer HH, 2008, EUR J PAIN, V12, P128, DOI 10.1016/j.ejpain.2007.02.005; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; McCabe CS, 2008, CURR PAIN HEADACHE R, V12, P103, DOI 10.1007/s11916-008-0020-7; McCabe CS, 2003, RHEUMATOLOGY, V42, P1067, DOI 10.1093/rheumatology/keg298; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Moore CI, 2000, P NATL ACAD SCI USA, V97, P14703, DOI 10.1073/pnas.250348997; Moseley GL, 2004, PAIN, V108, P192, DOI 10.1016/j.pain.2004.01.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pescatore A, 2008, P 11 ANN INT WORKSH; Ramachandran VS, 2010, MED HYPOTHESES, V75, P495, DOI 10.1016/j.mehy.2010.07.003; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Regenbrecht HT, 2011, PRESENCE-TELEOP VIRT, V20, P559, DOI 10.1162/PRES_a_00082; Sathian K, 2000, NEUROLOGY, V54, P1866, DOI 10.1212/WNL.54.9.1866; Selles RW, 2008, J REHABIL MED, V40, P312, DOI 10.2340/16501977-0158; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; Takasugi J, 2011, PSYCHOL RES-PSYCH FO, V75, P54, DOI 10.1007/s00426-010-0287-2; Tichelaar YIGV, 2007, INT J REHABIL RES, V30, P181, DOI 10.1097/MRR.0b013e32813a2e4b; [No title captured]	30	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50942	10.1371/journal.pone.0050942	http://dx.doi.org/10.1371/journal.pone.0050942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272080	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300014
J	Blouet, C; Schwartz, GJ				Blouet, Clemence; Schwartz, Gary J.			Duodenal Lipid Sensing Activates Vagal Afferents to Regulate Non-Shivering Brown Fat Thermogenesis in Rats	PLOS ONE			English	Article							ADIPOSE-TISSUE; FOS EXPRESSION; FOOD-INTAKE; ATTENUATES SUPPRESSION; NUTRIENT INFUSIONS; SMALL-INTESTINE; CHOLECYSTOKININ; NEURONS; RECEPTORS; NUCLEUS	Previous evidence indicates that duodenal lipid sensing engages gut-brain neurocircuits to determine food intake and hepatic glucose production, but a potential role for gut-brain communication in the control of energy expenditure remains to be determined. Here, we tested the hypothesis that duodenal lipid sensing activates a gut-brain-brown adipose tissue neuraxis to regulate thermogenesis. We demonstrate that direct administration of lipids into the duodenum increases brown fat temperature. Co-infusion of the local anesthetic tetracaine with duodenal lipids abolished the lipid-induced increase in brown fat temperature. Systemic administration of the CCKA receptor antagonist devazepide blocked the ability of duodenal lipids to increase brown fat thermogenesis. Parenchymal administration of the N-methyl-d-aspartate receptor blocker MK-801 directly into the caudomedial nucleus of the solitary tract also abolished duodenal lipid-induced activation of brown fat thermogenesis. These findings establish that duodenal lipid sensing activates a gut-brain-brown fat axis to determine brown fat temperature, and thereby reveal a previously unappreciated pathway that regulates thermogenesis. Citation: Blouet C, Schwartz GJ (2012) Duodenal Lipid Sensing Activates Vagal Afferents to Regulate Non-Shivering Brown Fat Thermogenesis in Rats. PLoS ONE 7(12): e51898. doi:10.1371/journal.pone.0051898	[Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Albert Einstein Coll Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Neurosci, Albert Einstein Coll Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Schwartz, GJ (corresponding author), Albert Einstein Coll Med, Dept Med, Albert Einstein Coll Med, Bronx, NY 10467 USA.	gary.schwartz@einstein.yu.edu		Blouet, Clemence/0000-0002-1752-1270	National Institutes of Health (NIH) New York Obesity Research Center [DK026667]; NIH Albert Einstein Diabetes Research and Training Center [DK020541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026667, P60DK020541, P30DK020541] Funding Source: NIH RePORTER	National Institutes of Health (NIH) New York Obesity Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Albert Einstein Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) DK026667 New York Obesity Research Center and NIH DK020541 Albert Einstein Diabetes Research and Training Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher SA, 1999, NEUROSCIENCE, V91, P119, DOI 10.1016/S0306-4522(98)00530-2; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Berthoud HR, 1996, ACTA ANAT, V156, P123; Berthoud HR, 2001, BRAIN RES, V915, P143, DOI 10.1016/S0006-8993(01)02826-8; Blouet C, 2012, CELL METAB; BRENNER L, 1993, AM J PHYSIOL, V264, pR972, DOI 10.1152/ajpregu.1993.264.5.R972; Campos CA, 2012, ENDOCRINOLOGY; Cao WH, 2010, AM J PHYSIOL-REG I, V299, pR277, DOI 10.1152/ajpregu.00039.2010; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Czaja K, 2006, BRAIN RES, V1119, P86, DOI 10.1016/j.brainres.2006.08.042; DINDA PK, 1969, CAN J PHYSIOL PHARM, V47, P445, DOI 10.1139/y69-079; GREEN GM, 1989, AM J PHYSIOL, V256, pG1016, DOI 10.1152/ajpgi.1989.256.6.G1016; GREENBERG D, 1990, AM J PHYSIOL, V259, pR110, DOI 10.1152/ajpregu.1990.259.1.R110; Guard DB, 2009, BRAIN RES, V1266, P37, DOI 10.1016/j.brainres.2009.02.003; Kang YH, 2012, NEUROSCIENCE, V209, P39, DOI 10.1016/j.neuroscience.2012.02.025; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Madden CJ, 2005, J PHYSIOL-LONDON, V566, P559, DOI 10.1113/jphysiol.2005.086322; Matzinger D, 1999, AM J PHYSIOL-REG I, V277, pR1718, DOI 10.1152/ajpregu.1999.277.6.R1718; Monnikes H, 1997, BRAIN RES, V770, P277, DOI 10.1016/S0006-8993(97)00865-2; Monnikes H, 1997, AM J PHYSIOL-REG I, V273, pR2059, DOI 10.1152/ajpregu.1997.273.6.R2059; MORAN TH, 1990, BRAIN RES, V526, P95, DOI 10.1016/0006-8993(90)90253-8; Nakamura K, 2005, NEUROSCI RES, V51, P1, DOI 10.1016/j.neures.2004.09.007; Phifer CB, 1998, AM J PHYSIOL-REG I, V274, pR1725, DOI 10.1152/ajpregu.1998.274.6.R1725; Rasmussen BA, 2012, GASTROENTEROLOGY, V142, P834, DOI 10.1053/j.gastro.2011.12.053; Reidelberger RD, 2003, AM J PHYSIOL-REG I, V284, pR389, DOI 10.1152/ajpregu.00529.2002; Ritter S, 2000, BRAIN RES, V856, P37, DOI 10.1016/S0006-8993(99)02327-6; Sabbatini M, 2008, NEUROSCIENCE, V152, P449, DOI 10.1016/j.neuroscience.2008.01.008; SCHUTZ Y, 1984, AM J CLIN NUTR, V40, P542, DOI 10.1093/ajcn/40.3.542; Schwartz GJ, 1999, AM J PHYSIOL-REG I, V277, pR1144, DOI 10.1152/ajpregu.1999.277.4.R1144; SHIBATA H, 1987, J APPL PHYSIOL, V63, P465, DOI 10.1152/jappl.1987.63.2.465; SIMS EAH, 1987, J CLIN INVEST, V79, P1019, DOI 10.1172/JCI112913; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P5351, DOI 10.1210/en.2009-0804; STEWART A, 1988, ANESTH ANALG, V67, P833; TAMURA CS, 1994, AM J PHYSIOL, V267, pR561, DOI 10.1152/ajpregu.1994.267.2.R561; TANSY MF, 1972, J PHARM SCI, V61, P1141, DOI 10.1002/jps.2600610723; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Westerterp Klaas R, 2004, Nutr Metab (Lond), V1, P5; Wright J, 2011, AM J PHYSIOL-REG I, V301, pR448, DOI 10.1152/ajpregu.00026.2011; YOX DP, 1988, AM J PHYSIOL, V255, pR569, DOI 10.1152/ajpregu.1988.255.4.R569	42	55	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51898	10.1371/journal.pone.0051898	http://dx.doi.org/10.1371/journal.pone.0051898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251649	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800105
J	Misra, UK; Pizzo, SV				Misra, Uma K.; Pizzo, Salvatore V.			Receptor-Recognized alpha(2)-Macroglobulin Binds to Cell Surface-Associated GRP78 and Activates mTORC1 and mTORC2 Signaling in Prostate Cancer Cells	PLOS ONE			English	Article							CARBOXYL-TERMINAL DOMAIN; UNFOLDED PROTEIN RESPONSE; MAMMALIAN TARGET; RAPAMYCIN MTOR; GENE-EXPRESSION; KINASE B; AKT; PHOSPHORYLATION; LIGATION; RICTOR	Objective: Tetrameric alpha(2)-macroglobulin (alpha M-2), a plasma panproteinase inhibitor, is activated upon interaction with a proteinase, and undergoes a major conformational change exposing a receptor recognition site in each of its subunits. Activated alpha M-2 (alpha M-2*) binds to cancer cell surface GRP78 and triggers proliferative and antiapoptotic signaling. We have studied the role of alpha M-2* in the regulation of mTORC1 and TORC2 signaling in the growth of human prostate cancer cells. Methods: Employing immunoprecipitation techniques and Western blotting as well as kinase assays, activation of the mTORC1 and mTORC2 complexes, as well as down stream targets were studied. RNAi was also employed to silence expression of Raptor, Rictor, or GRP78 in parallel studies. Results: Stimulation of cells with alpha M-2* promotes phosphorylation of mTOR, TSC2, S6-Kinase, 4EBP, Akt(T308), and Akt(S473) in a concentration and time-dependent manner. Rheb, Raptor, and Rictor also increased. alpha M-2* treatment of cells elevated mTORC1 kinase activity as determined by kinase assays of mTOR or Raptor immunoprecipitates. mTORC1 activity was sensitive to LY294002 and rapamycin or transfection of cells with GRP78 dsRNA. Down regulation of Raptor expression by RNAi significantly reduced alpha M-2*-induced S6-Kinase phosphorylation at T389 and kinase activity in Raptor immunoprecipitates. alpha M-2*-treated cells demonstrate about a twofold increase in mTORC2 kinase activity as determined by kinase assay of Akt(S473) phosphorylation and levels of p-Akt (S473) in mTOR and Rictor immunoprecipitates. mTORC2 activity was sensitive to LY294002 and transfection of cells with GRP78 dsRNA, but insensitive to rapamycin. Down regulation of Rictor expression by RNAi significantly reduces alpha M-2*-induced phosphorylation of Akt(S473) phosphorylation in Rictor immunoprecipitates. Conclusion: Binding of alpha M-2* to prostate cancer cell surface GRP78 upregulates mTORC1 and mTORC2 activation and promotes protein synthesis in the prostate cancer cells.	[Misra, Uma K.; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	salvatore.pizzo@duke.edu						Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feldman ME, 2009, PLOS BIOL, P03781; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Liao YD, 2003, INT J CANCER, V107, P676, DOI 10.1002/ijc.11471; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2010, BIOCHEM BIOPH RES CO, V392, P538, DOI 10.1016/j.bbrc.2010.01.058; Misra UK, 2010, APOPTOSIS, V15, P173, DOI 10.1007/s10495-009-0430-y; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Misra UK, 1998, BBA-MOL CELL RES, V1401, P121, DOI 10.1016/S0167-4889(97)00123-7; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J BIOL CHEM, V280, P38276, DOI 10.1074/jbc.M507332200; Misra UK, 2005, J IMMUNOL, V175, P2525, DOI 10.4049/jimmunol.175.4.2525; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2004, CELL SIGNAL, V16, P487, DOI 10.1016/j.cellsig.2003.09.010; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2002, J BIOL CHEM, V277, P36509, DOI 10.1074/jbc.M203543200; Misra UK, 2007, BIOCHEM BIOPH RES CO, V391, P272; Misra UK, 2012, J CELL BIOCHEM, V113, P1488, DOI 10.1002/jcb.24018; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2008, J CELL BIOCHEM, V104, P96, DOI 10.1002/jcb.21607; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Otto A, 1998, J UROLOGY, V159, P297, DOI 10.1016/S0022-5347(01)64085-0; PIZZO SV, 2006, HEMOSTASIS THROMBOSE, P395; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Smorenburg SM, 1996, HEPATOLOGY, V23, P560; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Wu S. M., 2000, HEMOSTASIS THROMBOSI, P367; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Yu H, 1999, J La State Med Soc, V151, P209; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	68	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51735	10.1371/journal.pone.0051735	http://dx.doi.org/10.1371/journal.pone.0051735			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272152	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800073
J	Ran, WQ; Higgs, PG				Ran, Wenqi; Higgs, Paul G.			Contributions of Speed and Accuracy to Translational Selection in Bacteria	PLOS ONE			English	Article							CODON USAGE BIAS; ESCHERICHIA-COLI; GENE-EXPRESSION; PROTEIN EXPRESSION; ADAPTATION INDEX; TRANSFER-RNAS; EVOLUTION; GENOME; GROWTH; YEAST	Among bacteria, we have previously shown that species that are capable of rapid growth have stronger selection on codon usage than slow growing species, and possess higher numbers of rRNA and tRNA genes. This suggests that fast-growers are adapted for fast protein synthesis. There is also considerable evidence that codon usage is influenced by accuracy of translation, and some authors have argued that accuracy is more important than speed. Here we compare the strength of the two effects by studying the codon usages in high and low expression genes and on conserved and variable sites within high expression genes. We introduce a simple statistical method that can be used to assess the significance and the strength of the two types of bias in the same sets of sequences. We compare our statistical measure of codon bias to the common used codon adaptation index, and show that the new measure is preferable for three reasons for the purposes of this analysis. Across a large sample of bacterial genomes, both effects from speed and accuracy are clearly visible, although the speed effect appears to be much stronger than the accuracy effect and is found to be significant in a larger proportion of genomes. It is also difficult to explain the correlation of codon bias in the high expression genes with growth rates and numbers of copies of tRNA and rRNA genes on the basis of selection for accuracy. Hence we conclude that selection for translational speed is a dominant effect in driving codon usage bias in fast-growing bacteria, with selection for accuracy playing a small supplementary role. Citation: Ran W, Higgs PG (2012) Contributions of Speed and Accuracy to Translational Selection in Bacteria. PLoS ONE 7(12): e51652. doi:10.1371/journal.pone. 0051652	[Ran, Wenqi; Higgs, Paul G.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Ran, Wenqi] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	McMaster University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Ran, WQ (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	wenqi.ran@nih.gov; higgsp@mcmaster.ca		Higgs, Paul/0000-0001-5220-9760	Natural Sciences and Engineering Research Council of Canada; Intramural Program of National Library of Medicine, National Center for Biotechnology Information, National Institutes of Health	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Intramural Program of National Library of Medicine, National Center for Biotechnology Information, National Institutes of Health	This work was supported by the Natural Sciences and Engineering Research Council of Canada. Wenqi Ran is supported by The Intramural Program of National Library of Medicine, National Center for Biotechnology Information, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; Akashi H, 2003, GENETICS, V164, P1291; BULMER M, 1991, GENETICS, V129, P897; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Higgs PG, 2008, MOL BIOL EVOL, V25, P2279, DOI 10.1093/molbev/msn173; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kloster M, 2008, NUCLEIC ACIDS RES, V36, P3819, DOI 10.1093/nar/gkn288; KURLAND CG, 1991, FEBS LETT, V285, P165, DOI 10.1016/0014-5793(91)80797-7; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Roth A, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P189; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Thomas SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002103; Wang R, 2005, GENOME RES, V15, P1118, DOI 10.1101/gr.3994105; Zhang Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-43	29	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51652	10.1371/journal.pone.0051652	http://dx.doi.org/10.1371/journal.pone.0051652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272132	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800060
J	Sato, S; Drake, AW; Tsuji, I; Fan, JH				Sato, Shuji; Drake, Andrew W.; Tsuji, Isamu; Fan, Jinhong			A Potent Anti-HB-EGF Monoclonal Antibody Inhibits Cancer Cell Proliferation and Multiple Angiogenic Activities of HB-EGF	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DIPHTHERIA-TOXIN-RECEPTOR; OVARIAN-CANCER; ATHEROSCLEROTIC PLAQUES; TERMINAL FRAGMENT; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; TGF-ALPHA; BINDING; EXPRESSION	Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the epidermal growth factor family and has a variety of physiological and pathological functions. Modulation of HB-EGF activity might have a therapeutic potential in the oncology area. We explored the therapeutic possibilities by characterizing the in vitro biological activity of anti-HB-EGF monoclonal antibody Y-142. EGF receptor (EGFR) ligand and species specificities of Y-142 were tested. Neutralizing activities of Y-142 against HB-EGF were evaluated in EGFR and ERBB4 signaling. Biological activities of Y-142 were assessed in cancer cell proliferation and angiogenesis assays and compared with the anti-EGFR antibody cetuximab, the HB-EGF inhibitor CRM197, and the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab. The binding epitope was determined with alanine scanning. Y-142 recognized HB-EGF as well as the EGFR ligand amphiregulin, and bound specifically to human HB-EGF, but not to rodent HB-EGF. In addition, Y-142 neutralized HB-EGF-induced phosphorylation of EGFR and ERBB4, and blocked their downstream ERK1/2 and AKT signaling. We also found that Y-142 inhibited HB-EGF-induced cancer cell proliferation, endothelial cell proliferation, tube formation, and VEGF production more effectively than cetuximab and CRM197 and that Y-142 was superior to bevacizumab in the inhibition of HB-EGF-induced tube formation. Six amino acids in the EGF-like domain were identified as the Y-142 binding epitope. Among the six amino acids, the combination of F115 and Y123 determined the amphiregulin cross-reactivity and that F115 accounted for the species selectivity. Furthermore, it was suggested that the potent neutralizing activity of Y-142 was derived from its recognition of R142 and Y123 and its high affinity to HB-EGF. Y-142 has a potent HB-EGF neutralizing activity that modulates multiple biological activities of HB-EGF including cancer cell proliferation and angiogenic activities. Y-142 may have a potential to be developed into a therapeutic agent for the treatment of HB-EGF-dependent cancers.	[Tsuji, Isamu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan; [Sato, Shuji; Drake, Andrew W.; Fan, Jinhong] Takeda San Francisco Inc, San Francisco, CA USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc	Sato, S (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	shuji.sato@takeda.com		Sato, Shuji/0000-0002-8423-9750	Takeda San Francisco, Inc.; Takeda Pharmaceutical Company Limited	Takeda San Francisco, Inc.; Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	The authors have the following interests. This study was funded by Takeda San Francisco, Inc. and Takeda Pharmaceutical Company Limited. All authors were employees of Takeda San Francisco, Inc. or Takeda Pharmaceutical Company Limited and were paid as such. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abramovitch R, 1998, FEBS LETT, V425, P441, DOI 10.1016/S0014-5793(98)00283-X; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Blake RC, 2003, BIOCHEMISTRY-US, V42, P497, DOI 10.1021/bi0267339; Brooke JS, 1998, BIOCHEM BIOPH RES CO, V248, P297, DOI 10.1006/bbrc.1998.8953; Buzzi S, 2004, CANCER IMMUNOL IMMUN, V53, P1041, DOI 10.1007/s00262-004-0546-4; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; DAS SK, 1994, DEVELOPMENT, V120, P1071; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; ENGLER DA, 1992, J BIOL CHEM, V267, P2274; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Hamaoka M, 2010, J BIOCHEM, V148, P55, DOI 10.1093/jb/mvq033; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; HOMMEL U, 1992, J MOL BIOL, V227, P271, DOI 10.1016/0022-2836(92)90697-I; Hoskins JT, 2008, BIOCHEM BIOPH RES CO, V375, P506, DOI 10.1016/j.bbrc.2008.08.062; Inui S, 1997, J CELL PHYSIOL, V171, P291, DOI 10.1002/(SICI)1097-4652(199706)171:3<291::AID-JCP7>3.0.CO;2-J; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jin P, 2009, MOL MED, V15, P11, DOI 10.2119/molmed.2008.00103; Jones JT, 1998, J BIOL CHEM, V273, P11667, DOI 10.1074/jbc.273.19.11667; Keizer RJ, 2010, CLIN PHARMACOKINET, V49, P493, DOI 10.2165/11531280-000000000-00000; Khong TF, 2000, KIDNEY INT, V58, P1098, DOI 10.1046/j.1523-1755.2000.00267.x; Kinugasa Y, 2007, J BIOL CHEM, V282, P14797, DOI 10.1074/jbc.M611036200; KOBRIN MS, 1994, BIOCHEM BIOPH RES CO, V202, P1705, DOI 10.1006/bbrc.1994.2131; KOIDE H, 1992, BIOCHIM BIOPHYS ACTA, V1120, P257, DOI 10.1016/0167-4838(92)90245-9; McIntyre E, 2010, BREAST CANCER RES TR, V122, P105, DOI 10.1007/s10549-009-0536-5; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; MIYAGAWA J, 1995, J CLIN INVEST, V95, P404, DOI 10.1172/JCI117669; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Miyamoto S, 2011, CLIN CANCER RES, V17, P6733, DOI 10.1158/1078-0432.CCR-11-1029; Naef M, 1996, INT J CANCER, V66, P315; Nakagawa M, 2009, CANCER SCI, V100, P654, DOI 10.1111/j.1349-7006.2009.01089.x; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; O-Charoenrat P, 2000, INT J CANCER, V88, P759, DOI 10.1002/1097-0215(20001201)88:5<759::AID-IJC12>3.0.CO;2-0; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P6547, DOI 10.1073/pnas.92.14.6547; POWELL PP, 1993, AM J PATHOL, V143, P784; Raab G, 1996, DEVELOPMENT, V122, P637; Ruck A, 1998, ANTICANCER RES, V18, P1447; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; TADAKI DK, 1993, J BIOL CHEM, V268, P10114; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Thogersen VB, 2001, CANCER RES, V61, P6227; Thomas SM, 2005, NEOPLASIA, V7, P426, DOI 10.1593/neo.04454; Torring N, 2000, ANTICANCER RES, V20, P91; Tsuji I, 2012, MABS; Tsujioka H, 2011, ANTICANCER RES, V31, P2461; Ushiro S, 1996, JPN J CANCER RES, V87, P68, DOI 10.1111/j.1349-7006.1996.tb00202.x; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Yu LL, 2011, BIOCHEM BIOPH RES CO, V408, P276, DOI 10.1016/j.bbrc.2011.04.014	59	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51964	10.1371/journal.pone.0051964	http://dx.doi.org/10.1371/journal.pone.0051964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251664	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800119
J	Sonnewald, S; Priller, JPR; Schuster, J; Glickmann, E; Hajirezaei, MR; Siebig, S; Mudgett, MB; Sonnewald, U				Sonnewald, Sophia; Priller, Johannes P. R.; Schuster, Julia; Glickmann, Eric; Hajirezaei, Mohammed-Reza; Siebig, Stefan; Mudgett, Mary Beth; Sonnewald, Uwe			Regulation of Cell Wall-Bound Invertase in Pepper Leaves by Xanthomonas campestris pv. vesicatoria Type Three Effectors	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; PAMP-TRIGGERED IMMUNITY; IN-SOURCE LEAVES; POTATO-VIRUS-Y; III EFFECTORS; EXTRACELLULAR INVERTASE; SYMPTOM DEVELOPMENT; PRIMARY METABOLISM; SINK METABOLISM; INNATE IMMUNITY	Xanthomonas campestris pv. vesicatoria (Xcv) possess a type 3 secretion system (T3SS) to deliver effector proteins into its Solanaceous host plants. These proteins are involved in suppression of plant defense and in reprogramming of plant metabolism to favour bacterial propagation. There is increasing evidence that hexoses contribute to defense responses. They act as substrates for metabolic processes and as metabolic semaphores to regulate gene expression. Especially an increase in the apoplastic hexose-to-sucrose ratio has been suggested to strengthen plant defense. This shift is brought about by the activity of cell wall-bound invertase (cw-Inv). We examined the possibility that Xcv may employ type 3 effector (T3E) proteins to suppress cw-Inv activity during infection. Indeed, pepper leaves infected with a T3SS-deficient Xcv strain showed a higher level of cw-Inv mRNA and enzyme activity relative to Xcv wild type infected leaves. Higher cw-Inv activity was paralleled by an increase in hexoses and mRNA abundance for the pathogenesis-related gene PRQ. These results suggest that Xcv suppresses cw-Inv activity in a T3SS-dependent manner, most likely to prevent sugar-mediated defense signals. To identify Xcv T3Es that regulate cw-Inv activity, a screen was performed with eighteen Xcv strains, each deficient in an individual T3E. Seven Xcv T3E deletion strains caused a significant change in cw-Inv activity compared to Xcv wild type. Among them, Xcv lacking the xopB gene (Xcv Delta xopB) caused the most prominent increase in cw-Inv activity. Deletion of xopB increased the mRNA abundance of PRQ in Xcv Delta xopB-infected pepper leaves, but not of Pti5 and Acre31, two PAMP-triggered immunity markers. Inducible expression of XopB in transgenic tobacco inhibited Xcv-mediated induction of cw-Inv activity observed in wild type plants and resulted in severe developmental phenotypes. Together, these data suggest that XopB interferes with cw-Inv activity in planta to suppress sugar-enhanced defense responses during Xcv infection. Citation: Sonnewald S, Priller JPR, Schuster J, Glickmann E, Hajirezaei M-R, et al. (2012) Regulation of Cell Wall-Bound Invertase in Pepper Leaves by Xanthomonas campestris pv. vesicatoria Type Three Effectors. PLoS ONE 7(12): e51763. doi:10.1371/journal.pone.0051763	[Sonnewald, Sophia; Priller, Johannes P. R.; Schuster, Julia; Siebig, Stefan; Sonnewald, Uwe] Univ Erlangen Nurnberg, Lehrstuhl Biochem, D-91054 Erlangen, Germany; [Glickmann, Eric; Hajirezaei, Mohammed-Reza] Inst Pflanzengenet & Kulturpflanzenforsch, Gatersleben, Germany; [Mudgett, Mary Beth] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Erlangen Nuremberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Stanford University	Sonnewald, S (corresponding author), Univ Erlangen Nurnberg, Lehrstuhl Biochem, D-91054 Erlangen, Germany.	ssonne@biologie.uni-erlangen.de	Sonnewald, Uwe/J-7875-2012	Sonnewald, Uwe/0000-0003-1835-5339; Priller, Josef/0000-0001-7596-0979	Deutsche Forschungsgemeinschaft in frame of the collaborative research centre "reprogramming of host cells by microbial effectors'' [SBF796]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068886] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft in frame of the collaborative research centre "reprogramming of host cells by microbial effectors''(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly supported by a grant from the Deutsche Forschungsgemeinschaft in frame of the collaborative research centre "reprogramming of host cells by microbial effectors'' (SBF796) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Bartetzko V, 2009, MOL PLANT MICROBE IN, V22, P655, DOI 10.1094/MPMI-22-6-0655; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Biemelt S, 2006, J PLANT PHYSIOL, V163, P307, DOI 10.1016/j.jplph.2005.10.011; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Bonfig KB, 2010, MOL PLANT, V3, P1037, DOI 10.1093/mp/ssq053; Brown I, 1995, MOL PLANT MICROBE IN, V8, P825, DOI 10.1094/MPMI-8-0825; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Buttner D, 2002, J BACTERIOL, V184, P2389, DOI 10.1128/JB.184.9.2389-2398.2002; Caddick MX, 1998, NAT BIOTECHNOL, V16, P177, DOI 10.1038/nbt0298-177; Canteros B, 1990, DIVERSITY PLASMIDS P; Chen S, 2003, PLANT J, V36, P731, DOI 10.1046/j.1365-313X.2003.01914.x; Chou HM, 2000, MOL PLANT PATHOL, V1, P99, DOI 10.1046/j.1364-3703.2000.00013.x; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Ehness R, 1997, PLANT CELL, V9, P1825; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Ferreira SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-93; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Godt DE, 1997, PLANT PHYSIOL, V115, P273, DOI 10.1104/pp.115.1.273; Hajirezaei MR, 2003, J EXP BOT, V54, P477, DOI 10.1093/jxb/erg040; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Herbers K, 1996, PLANT CELL, V8, P793, DOI 10.1105/tpc.8.5.793; Herbers K, 1996, FEBS LETT, V397, P239, DOI 10.1016/S0014-5793(96)01183-0; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; Hofius D, 2007, J VIROL, V81, P11870, DOI 10.1128/JVI.01525-07; HORSFALL J. G., 1957, Zeitschrift fur Pflanzenkrankheiten, Pflanzenpathologie und Pflanzenschutz, V64, P415; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Huang LF, 2007, FUNCT PLANT BIOL, V34, P499, DOI 10.1071/FP06227; Huguet E, 1998, MOL MICROBIOL, V29, P1379, DOI 10.1046/j.1365-2958.1998.01019.x; JAKOBEK JL, 1993, PLANT CELL, V5, P57, DOI 10.1105/tpc.5.1.57; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Keshavarzi M, 2004, MOL PLANT MICROBE IN, V17, P805, DOI 10.1094/MPMI.2004.17.7.805; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Kocal N, 2008, PLANT PHYSIOL, V148, P1523, DOI 10.1104/pp.108.127977; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Mason G, 2008, PLANT MOL BIOL REP, V26, P156, DOI 10.1007/s11105-008-0031-x; Metz M, 2005, PLANT J, V41, P801, DOI 10.1111/j.1365-313X.2005.02338.x; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Noel L, 2003, J BACTERIOL, V185, P7092, DOI 10.1128/JB.185.24.7092-7102.2003; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Rausch T, 2004, BBA-PROTEINS PROTEOM, V1696, P253, DOI 10.1016/j.bbapap.2003.09.017; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; Rodriguez LM, 2010, XANTHOMONAS RESOURCE; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; ROSAHL S, 1987, EMBO J, V6, P1155, DOI 10.1002/j.1460-2075.1987.tb02348.x; Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; Seo Y.S., 2007, PLANT STRESS, V1, P42; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Stall R. E., 1995, PATHOGENESIS HOST SP, P167; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Taylor KW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002768; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Zhao BY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002408	83	40	41	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51763	10.1371/journal.pone.0051763	http://dx.doi.org/10.1371/journal.pone.0051763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272161	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800079
J	Weiss, RF; Miller, MG; Cronin, JF; Hensley, HH; Joshi, ID; Smith, MR				Weiss, Robert F.; Miller, Merlin G.; Cronin, John F.; Hensley, Harvey H.; Joshi, Indira D.; Smith, Mitchell R.			Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma	PLOS ONE			English	Article							ANTISENSE OLIGONUCLEOTIDES COMPLEMENTARY; BCL-2/IMMUNOGLOBULIN FUSION TRANSCRIPT; IMMUNOGLOBULIN SEQUENCES; TREATMENT STRATEGIES; FOLLICULAR LYMPHOMA; APOPTOSIS; RITUXIMAB; EFFICACY; ANTIBODY	The development and clinical testing of drug combinations for the treatment of Non-Hodgkin Lymphoma (NHL) and other cancers has recently shown great promise. However, determining the optimum combination and its associated dosages for maximum efficacy and minimum side effects is still a challenge. This paper describes a parametric analysis of the dynamics of malignant B-cells and the effects of an anti-sense oligonucleotide targeted to BCL-2 (as-bcl-2), anti-CD-20 (rituximab) and their combination, for a SCID mouse human lymphoma xenograft model of NHL. Our parametric model is straightforward. Several mechanisms of malignant B-cell birth and death in the nodal micro-environment are simulated. Cell death is accelerated by hypoxia and starvation induced by tumor scale, by modification of anti-apoptosis with as-bcl-2, and by direct kill effects of rituximab (cell kill by cytotoxic immune cells is not included, due to the absence of an immune system in the corresponding experiments). We show that the cell population dynamics in the control animals are primarily determined by K*, the ratio of rate constants for malignant cell death, K-d, and cell birth, K-b. Tumor growth with independent treatments is reproduced by the model, and is used to predict their effect when administered in combination. Malignant cell lifetimes are derived to provide a quantitative comparison of the efficacy of these treatments. Future experimental and clinical applications of the model are discussed.	[Weiss, Robert F.; Miller, Merlin G.] Back Bay Biosci, Boston, MA USA; [Cronin, John F.] Phys Sci Inc, Comp Serv, Andover, MA 01810 USA; [Hensley, Harvey H.; Joshi, Indira D.; Smith, Mitchell R.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Physical Sciences Inc.; Fox Chase Cancer Center	Weiss, RF (corresponding author), Back Bay Biosci, Boston, MA USA.	RFDWeiss@gmail.com		Smith, Mitchell/0000-0003-1428-8765	National Cancer Institute [CA-006927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The following core facilities at Fox Chase Cancer Center contributed to this study: Laboratory Animal Facility and the Biological Imaging Facility, Small Animal Imaging Component, supported by grant CA-006927 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Ackler S, 2010, CANCER CHEMOTH PHARM, V66, P869, DOI 10.1007/s00280-009-1232-1; Cheson BD, 2011, BEST PRACT RES CL HA, V24, P305, DOI 10.1016/j.beha.2011.03.006; Collins-Burow B, 2007, EXPERT REV ANTICANC, V7, P257, DOI 10.1586/14737140.7.3.257; Mumenthaler SM, 2011, MOL PHARMACEUT, V8, P2069, DOI 10.1021/mp200270v; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Pollack A, 2012, NY TIMES; Smith MR, 2004, MOL CANCER THER, V3, P1693; Smith MR, 2001, CLIN CANCER RES, V7, P400; Smith MR, 2000, BRIT J HAEMATOL, V111, P1087, DOI 10.1046/j.1365-2141.2000.02431.x; Stolz C, 2008, BLOOD, V112, P3312, DOI 10.1182/blood-2007-11-124487; Tse C, 2008, ABT 263 POTENT ORALL; van Oers MHJ, 2011, BEST PRACT RES CL HA, V24, P187, DOI 10.1016/j.beha.2011.03.003	13	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51736	10.1371/journal.pone.0051736	http://dx.doi.org/10.1371/journal.pone.0051736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272153	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800074
J	Zhang, CZ; Liu, LL; Cai, MY; Pan, YH; Fu, J; Cao, Y; Yun, JP				Zhang, Chris Zhiyi; Liu, Lili; Cai, Muyan; Pan, Yinghua; Fu, Jia; Cao, Yun; Yun, Jingping			Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; TUMOR-SUPPRESSOR; CELL-DEATH; DEACETYLATION; METABOLISM; DIAGNOSIS; BIOMARKER; SIRTUINS; PROTEIN; GROWTH	SIRT3, a mitochondrial sirtuin belonging to nicotinamide adenine nucleotide (NAD) dependent deacetylases, is implicated in metabolism, longevity and carcinogenesis. SIRT3 expression and its significance in hepatocellular carcinoma (HCC) remain largely unclear. In this study, we demonstrated that SIRT3 expression in HCC tissue was much lower than that in paracarcinoma tissue, at both mRNA and protein levels. The cutoff value for low SIRT3 expression in HCC was defined according to receiver operating characteristic curve (ROC) analysis. As disclosed by immunohistochemistry (IHC) results, low SIRT3 expression was present in 67.3% (167/248) of HCC cases. Furthermore, low expression of SIRT3 was significantly correlated to differentiation (P = 0.013), clinical stage (P = 0.005), serum AFP level (P<0.01), tumor multiplicity (P = 0.026) and relapse (P = 0.028). Moreover, Kaplan-Meier analysis indicated that low SIRT3 expression associated with unfavorable overall survival (P<0.01) and recurrence-free survival (P = 0.004). The prognostic impact of SIRT3 was further confirmed by stratified survival analysis. Importantly, multivariate analysis revealed that low SIRT3 expression was an independent poor prognostic marker for overall survival (Hazard Ratio (HR) 0.555, 95% confidence interval (95% CI) 0.344-0.897, P = 0.016). Collectively, we conclude that SIRT3 is decreased in HCC and is a novel unfavorable marker for prognosis of patients with this fatal disease.	[Zhang, Chris Zhiyi; Liu, Lili; Cai, Muyan; Fu, Jia; Cao, Yun; Yun, Jingping] Sun Yat Sen Univ, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Chris Zhiyi; Liu, Lili; Cai, Muyan; Fu, Jia; Cao, Yun; Yun, Jingping] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Yinghua] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yun, JP (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	yunjp@sysucc.org.cn	Zhang, Chris Zhiyi/F-9862-2013; Liu, Lili/HHC-6357-2022		National Natural Science Foundation of China [81172345]; China Postdoctoral Science Foundation [2012M511867]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (no. 81172345) and China Postdoctoral Science Foundation (no. 2012M511867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Alhazzazi TY, 2011, CANCER-AM CANCER SOC, V117, P1670, DOI 10.1002/cncr.25676; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cai MY, 2010, CANCER SCI, V101, P1543, DOI 10.1111/j.1349-7006.2010.01560.x; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; Erichsen R, 2008, EUR J GASTROEN HEPAT, V20, P104, DOI 10.1097/MEG.0b013e3282f17517; Fan ST, 2011, ANN SURG, V254, P569, DOI 10.1097/SLA.0b013e3182300a1d; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Huang C, 2012, CLIN CANCER RES, V18, P3042, DOI 10.1158/1078-0432.CCR-12-0183; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaseb AO, 2011, J CLIN ONCOL, V29, P3892, DOI 10.1200/JCO.2011.36.0636; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kozyreva ON, 2011, ONCOLOGIST, V16, P310, DOI 10.1634/theoncologist.2010-0223; Kyrylenko S, 2010, CURR MED CHEM, V17, P2921, DOI 10.2174/092986710792065009; Li SiDe, 2010, PLoS One, V5, pe10486, DOI 10.1371/journal.pone.0010486; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Nomura F, 2012, BIOCHEM BIOPH RES CO, V421, P837, DOI 10.1016/j.bbrc.2012.04.099; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Sceusi EL, 2011, HPB, V13, P369, DOI 10.1111/j.1477-2574.2011.00303.x; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Villalba JM, 2012, BIOFACTORS; Wang HN, 2012, ONCOL REP, V28, P311, DOI 10.3892/or.2012.1788; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wu M, 2012, MED ONCOL; Xia L, 2012, HEPATOLOGY; Zhang CZY, 2012, HISTOPATHOLOGY, V60, P1114, DOI 10.1111/j.1365-2559.2011.04136.x; Zhang YY, 2012, BIOCHEM BIOPH RES CO, V423, P26, DOI 10.1016/j.bbrc.2012.05.053; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zlobec I, 2007, J CLIN PATHOL, V60, P1112, DOI 10.1136/jcp.2006.044537	45	57	60	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51703	10.1371/journal.pone.0051703	http://dx.doi.org/10.1371/journal.pone.0051703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272146	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800068
J	Nachat-Kappes, R; Pinel, A; Combe, K; Lamas, B; Farges, MC; Rossary, A; Goncalves-Mendes, N; Caldefie-Chezet, F; Vasson, MP; Basu, S				Nachat-Kappes, Rachida; Pinel, Alexandre; Combe, Kristell; Lamas, Bruno; Farges, Marie-Chantal; Rossary, Adrien; Goncalves-Mendes, Nicolas; Caldefie-Chezet, Florence; Vasson, Marie-Paule; Basu, Samar			Effects of Enriched Environment on COX-2, Leptin and Eicosanoids in a Mouse Model of Breast Cancer	PLOS ONE			English	Article							CATALYZED LIPID-PEROXIDATION; MAMMARY-GLAND; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; SOCIAL-ISOLATION; C57BL/6J MICE; GROWTH-FACTOR; TUMOR-GROWTH; LIFE STRESS; ADIPONECTIN	Cyclooxygenase-2 (COX-2) and adipokines have been implicated in breast cancer. This study investigated a possible link between COX-2 and adipokines in the development of mammary tumors. A model of environmental enrichment (EE), known to reduce tumor growth was used for a syngeneic murine model of mammary carcinoma. 3-week-old, female C57BL/6 mice were housed in standard environment (SE) or EE cages for 9 weeks and transplanted orthotopically with syngeneic EO771 adenocarcinoma cells into the right inguinal mammary fat pad. EE housing influenced mammary gland development with a decrease in COX-2 expressing cells and enhanced side-branching and advanced development of alveolar structures of the mammary gland. Tumor volume and weight were decreased in EE housed mice and were associated with a reduction in COX-2 and Ki67 levels, and an increase in caspase-3 levels. In tumors of SE mice, high COX-2 expression correlated with enhanced leptin detection. Non-tumor-bearing EE mice showed a significant increase in adiponectin levels but no change in those of leptin, F-2-isoprostanes, PGF(2 alpha), IL-6, TNF-alpha, PAI-1, and MCP-1 levels. Both tumor-bearing groups (SE and EE housing) had increased resistin, IL-6, TNF-alpha, PAI-1 and MCP-1 levels irrespective of the different housing environment demonstrating higher inflammatory response due to the presence of the tumor. This study demonstrates that EE housing influenced normal mammary gland development and inhibited mammary tumor growth resulting in a marked decrease in intratumoral COX-2 activity and an increase in the plasma ratio of adiponectin/leptin levels.	[Nachat-Kappes, Rachida; Pinel, Alexandre; Combe, Kristell; Lamas, Bruno; Farges, Marie-Chantal; Rossary, Adrien; Goncalves-Mendes, Nicolas; Caldefie-Chezet, Florence; Vasson, Marie-Paule; Basu, Samar] Univ Auvergne, Chaire Excellence Program, Equipe ECRIN,CLARA,CRNH Auvergne, Unite Nutr Humaine, Clermont Ferrand, France; [Nachat-Kappes, Rachida; Pinel, Alexandre; Combe, Kristell; Lamas, Bruno; Farges, Marie-Chantal; Rossary, Adrien; Goncalves-Mendes, Nicolas; Caldefie-Chezet, Florence; Vasson, Marie-Paule; Basu, Samar] CRNH Auvergne, INRA, UMR, UNH, Clermont Ferrand, France; [Vasson, Marie-Paule] Ctr Lutte Canc Jean Perrin, Unite Nutr, Clermont Ferrand, France; [Vasson, Marie-Paule] CHU Clermont Ferrand, Serv Nutr, Clermont Ferrand, France; [Basu, Samar] Uppsala Univ, Fac Med, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Universite Clermont Auvergne (UCA); INRAE; UNICANCER; Centre Jean Perrin; CHU Clermont Ferrand; Uppsala University	Basu, S (corresponding author), Univ Auvergne, Chaire Excellence Program, Equipe ECRIN,CLARA,CRNH Auvergne, Unite Nutr Humaine, Clermont Ferrand, France.	samar.basu@udamail.fr	FLORENCE, CALDEFIE-CHEZET FCC/U-3378-2018; vasson, marie-paule/ABA-2486-2021; Rossary, Adrien ad_ro/A-2863-2011	, blamas/0000-0002-7777-2127; Nachat Kappes, Rachida/0000-0001-7523-3560; rossary, adrien/0000-0001-8311-2419	Conseil Regional d'Auvergne; University d'Auvergne, Clermont-Ferrand	Conseil Regional d'Auvergne(Region Auvergne-Rhone-Alpes); University d'Auvergne, Clermont-Ferrand	This work was supported by grants from the Conseil Regional d'Auvergne and University d'Auvergne, Clermont-Ferrand, as a 'Chaire d'Excellence' Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Baroncelli L, 2010, CELL DEATH DIFFER, V17, P1092, DOI 10.1038/cdd.2009.193; Base S, 2011, PROSTAG LEUKOTR ESS, V84, P123, DOI 10.1016/j.plefa.2010.11.006; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P319, DOI 10.1016/S0952-3278(98)90042-4; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P347, DOI 10.1016/S0952-3278(98)90070-9; Basu S, 2012, ANTIOXIDANTS REDOX S; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Basu S, 2007, MED RES REV, V27, P435, DOI 10.1002/med.20098; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Bechard A, 2011, J AM ASSOC LAB ANIM, V50, P171; Boyd AL, 2010, CANCER PREV RES, V3, P1398, DOI 10.1158/1940-6207.CAPR-10-0111; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Casadesus G, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-2; Chen HC, 2002, J LIPID RES, V43, P986; Chua ACL, 2010, DEVELOPMENT, V137, P4229, DOI 10.1242/dev.059261; Cleary Margot P, 2009, Front Biosci (Schol Ed), V1, P329, DOI 10.2741/e30; De Lorenzo MS, 2011, CARCINOGENESIS, V32, P1381, DOI 10.1093/carcin/bgr107; DUNHAM LJ, 1953, JNCI-J NATL CANCER I, V13, P1299; Eskelinen M, 2010, ANTICANCER RES, V30, P4303; Ewens A, 2005, ANTICANCER RES, V25, P3905; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Garonna E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018823; Gil A, 2011, INT J PEDIATR OBES, V6, P13, DOI 10.3109/17477166.2011.604326; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Gu JW, 2011, CANC BIOL THERAPY, P11; Hasen NS, 2010, CANCER PREV RES, V3, P620, DOI 10.1158/1940-6207.CAPR-09-0225; Hector J, 2007, HORM METAB RES, V39, P250, DOI 10.1055/s-2007-973075; Henry J, 2011, FASEB J, V25, P1567, DOI 10.1096/fj.10-168658; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Hue-Beauvais C, 2011, DEV DYNAM, V240, P347, DOI 10.1002/dvdy.22536; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Jarde T, 2011, EUR J CANCER, V47, P33, DOI 10.1016/j.ejca.2010.09.005; Jeong YJ, 2011, J BREAST CANCER, V14, P96, DOI 10.4048/jbc.2011.14.2.96; Jonasson S, 2009, PROSTAG LEUKOTR ESS, V80, P1, DOI 10.1016/j.plefa.2008.10.001; Kamikawa A, 2009, DEV DYNAM, V238, P1092, DOI 10.1002/dvdy.21947; Lewis MT, 2009, J MAMMARY GLAND BIOL, V14, P365, DOI 10.1007/s10911-009-9162-4; Lin EJD, 2011, BEHAV BRAIN RES, V216, P349, DOI 10.1016/j.bbr.2010.08.019; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Liu SW, 2011, CRIT CARE MED, V39, P1935, DOI 10.1097/CCM.0b013e31821b85db; Macias H, 2011, DEV CELL, V20, P827, DOI 10.1016/j.devcel.2011.05.012; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Mauro L, 2007, CANCER RES, V67, P3412, DOI 10.1158/0008-5472.CAN-06-2890; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nkhata KJ, 2009, ONCOL REP, V21, P1611, DOI 10.3892/or_00000395; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ogunwobi O, 2006, ENDOCRINOLOGY, V147, P4505, DOI 10.1210/en.2006-0224; Polotsky VY, 2001, AM J RESP CRIT CARE, V164, P1470, DOI 10.1164/ajrccm.164.8.2101100; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Ruhl CE, 2001, AM J CLIN NUTR, V74, P295; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Schuler LA, 2010, CANCER PREV RES, V3, P1365, DOI 10.1158/1940-6207.CAPR-10-0238; Singh-Ranger G, 2008, BREAST CANCER RES TR, V109, P189, DOI 10.1007/s10549-007-9641-5; Solinas M, 2010, PROG NEUROBIOL, V92, P572, DOI 10.1016/j.pneurobio.2010.08.002; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Sztainberg Y, 2010, NAT PROTOC, V5, P1535, DOI 10.1038/nprot.2010.114; Tsai PP, 2002, LAB ANIM-UK, V36, P411, DOI 10.1258/002367702320389071; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Williams JB, 2009, CANCER PREV RES, V2, P850, DOI 10.1158/1940-6207.CAPR-08-0238; Wu KK, 1996, J LAB CLIN MED, V128, P242, DOI 10.1016/S0022-2143(96)90023-2; Zaias J, 2008, J AM ASSOC LAB ANIM, V47, P30; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	65	47	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51525	10.1371/journal.pone.0051525	http://dx.doi.org/10.1371/journal.pone.0051525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272114	gold, Green Published			2022-12-27	WOS:000312386600028
J	Arora, PK				Arora, Pankaj Kumar			Decolourization of 4-Chloro-2-Nitrophenol by a Soil Bacterium, Bacillus subtilis RKJ 700	PLOS ONE			English	Article							AEROBIC CONDITIONS; DEGRADATION; BIODEGRADATION; BIOTRANSFORMATION; STRAINS	A 4-Chloro-2-nitrophenol (4C2NP) decolourizing strain RKJ 700 was isolated from soil collected from a pesticide contaminated site of India and identified as Bacillus subtilis on the basis of the 16S rRNA gene sequence analysis. Bacillus subtilis RKJ 700 decolourized 4C2NP up to concentration of 1.5 mM in the presence of additional carbon source. The degradation pathway of 4C2NP was studied and 4-chloro-2-aminophenol, 4-chloro-2-acetaminophenol and 5-chloro-2-methylbenzoxazole (5C2MBZ) were identified as metabolites by high performance liquid chromatography and gas chromatography-mass spectrometry. Resting cell studies showed that Bacillus subtilis RKJ 700 depleted 4C2NP completely with stoichiometric formation of 5C2MBZ. This is the first report of (i) the degradation of 4C2NP at high concentration (1.5 mM) and, (ii) the formation of 5C2MBZ by a soil bacterium.	CSIR Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Arora, PK (corresponding author), CSIR Inst Microbial Technol, Chandigarh, India.	arora484@gmail.com	ARORA, PANKAJ K/F-9418-2014	ARORA, PANKAJ K/0000-0002-4106-8859	Council of Scientific and Industrial Research, New Delhi; University Grants Commission, New Delhi, India	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi and the University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PK, 2013, ANN MICROBIOL, V63, P913, DOI 10.1007/s13213-012-0544-2; Arora PK, 2013, 3 BIOTECH, V3, P29, DOI 10.1007/s13205-012-0066-4; Arora PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038676; Arora PK, 2012, BIODEGRADATION, V23, P325, DOI 10.1007/s10532-011-9512-y; Arora PK, 2012, APPL MICROBIOL BIOT, V93, P2265, DOI 10.1007/s00253-012-3927-1; Arora PK, 2011, INT J SYST EVOL MICR, V61, P1859, DOI 10.1099/ijs.0.023184-0; BEUNINK J, 1990, APPL MICROBIOL BIOT, V34, P108, DOI 10.1007/BF00170933; BRUHN C, 1988, ARCH MICROBIOL, V150, P171, DOI 10.1007/BF00425158; CORBETT MD, 1981, APPL ENVIRON MICROB, V41, P942, DOI 10.1128/AEM.41.4.942-949.1981; Das K, 2007, BIORESOURCE TECHNOL, V98, P1339, DOI 10.1016/j.biortech.2006.05.032; Donlon D, 1995, APPL ENVIRON MICROB, V61, P3889; Gharbani P, 2010, INT J ENVIRON SCI TE, V7, P377, DOI 10.1007/BF03326147; GILCREASE PC, 1995, APPL ENVIRON MICROB, V61, P4209, DOI 10.1128/AEM.61.12.4209-4214.1995; Lendenmann U, 1996, J BACTERIOL, V178, P6227, DOI 10.1128/jb.178.21.6227-6232.1996; Mathur HB, 2005, 212005 CSEPMLPR; Mehrizad A, 2012, IRAN J ENVIRON HEALT, V9, DOI 10.1186/1735-2746-9-5; Myresiotis CK, 2012, BIODEGRADATION, V23, P297, DOI 10.1007/s10532-011-9509-6; Noguera DR, 1996, APPL ENVIRON MICROB, V62, P2257, DOI 10.1128/AEM.62.7.2257-2263.1996; Park HS, 1999, APPL ENVIRON MICROB, V65, P1083; Perreault NN, 2012, BIODEGRADATION, V23, P287, DOI 10.1007/s10532-011-9508-7; Saritha P, 2007, J HAZARD MATER, V149, P609, DOI 10.1016/j.jhazmat.2007.06.111; Vryzas Z, 2012, CHEMOSPHERE, V89, P1330, DOI 10.1016/j.chemosphere.2012.05.087; Zang SY, 2010, J ENVIRON SCI, V22, P669, DOI 10.1016/S1001-0742(09)60161-3; Zissi U, 1997, J IND MICROBIOL BIOT, V19, P49, DOI 10.1038/sj.jim.2900418	24	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e52012	10.1371/journal.pone.0052012	http://dx.doi.org/10.1371/journal.pone.0052012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251673	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200172
J	Davidson, DC; Hirschman, MP; Sun, A; Singh, MV; Kasischke, K; Maggirwar, SB				Davidson, Donna C.; Hirschman, Michael P.; Sun, Anita; Singh, Meera V.; Kasischke, Karl; Maggirwar, Sanjay B.			Excess Soluble CD40L Contributes to Blood Brain Barrier Permeability In Vivo: Implications for HIV-Associated Neurocognitive Disorders	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TAT PROTEIN; PLATELET ACTIVATION; IMMUNE-RESPONSES; TARGETING CD40L; MONOCYTE SUBSET; LIGAND; INFLAMMATION; INFECTION; CD40-CD40L	Despite the use of anti-retroviral therapies, a majority of HIV-infected individuals still develop HIV-Associated Neurocognitive Disorders (HAND), indicating that host inflammatory mediators, in addition to viral proteins, may be contributing to these disorders. Consistently, we have previously shown that levels of the inflammatory mediator soluble CD40L (sCD40L) are elevated in the circulation of HIV-infected, cognitively impaired individuals as compared to their infected, non-impaired counterparts. Recent studies from our group suggest a role for the CD40/CD40L dyad in blood brain barrier (BBB) permeability and interestingly, sCD40L is thought to regulate BBB permeability in other inflammatory disorders of the CNS. Using complementary multiphoton microscopy and quantitative analyses in wild-type and CD40L deficient mice, we now reveal that the HIV transactivator of transcription (Tat) can induce BBB permeability in a CD40L-dependent manner. This permeability of the BBB was found to be the result of aberrant platelet activation induced by Tat, since depletion of platelets prior to treatment reversed Tat-induced BBB permeability. Furthermore, Tat treatment led to an increase in granulocyte antigen 1 (Gr1) positive monocytes, indicating an expansion of the inflammatory subset of cells in these mice, which were found to adhere more readily to the brain microvasculature in Tat treated animals. Exploring the mechanisms by which the BBB becomes compromised during HIV infection has the potential to reveal novel therapeutic targets, thereby aiding in the development of adjunct therapies for the management of HAND, which are currently lacking.	[Davidson, Donna C.; Hirschman, Michael P.; Singh, Meera V.; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Sun, Anita; Kasischke, Karl] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Kasischke, Karl] Univ Ulm, Dept Neurol, Med Ctr, D-89069 Ulm, Germany	University of Rochester; University of Rochester; Ulm University	Maggirwar, SB (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	sanjay_maggirwar@urmc.rochester.edu		Kasischke, Karl/0000-0003-0582-4319	National Institutes of Health [RO1NS054578, RO1NS066801]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066801, R01NS054578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants: RO1NS054578 and RO1NS066801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Avison MJ, 2004, J NEUROVIROL, V10, P223, DOI 10.1080/13550280490463532; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Beck WS, 1991, HEMATOLOGY, Vxvi; Beland JL, 1998, BLOOD, V92, P4472, DOI 10.1182/blood.V92.11.4472.423k47_4472_4478; Bergmeier W, 2000, BLOOD, V95, P886, DOI 10.1182/blood.V95.3.886.003k45_886_893; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chakrabarti S, 2007, J BIOL CHEM, V282, P18307, DOI 10.1074/jbc.M700211200; CHAMBERLAIN KG, 1990, AM J HEMATOL, V34, P161, DOI 10.1002/ajh.2830340302; Chen CY, 2008, BLOOD, V112, P3205, DOI 10.1182/blood-2008-03-143479; Chen L, 2012, NEUROBIOL AGING; Chen L, 2009, J NEUROSCI RES, V87, P1718, DOI 10.1002/jnr.21973; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Cui ZR, 2004, VACCINE, V22, P2631, DOI 10.1016/j.vaccine.2003.12.013; D Kanmogne G, 2007, J CEREBR BLOOD F MET, V27, P123, DOI 10.1038/sj.jcbfm.9600330; D'Aversa TG, 2002, AM J PATHOL, V160, P559, DOI 10.1016/S0002-9440(10)64875-4; Daoussis D, 2004, CLIN DIAGN LAB IMMUN, V11, P635, DOI 10.1128/CDLI.11.4.635-641.2004; Davidson DC, 2011, J IMMUNOL, V186, P584, DOI 10.4049/jimmunol.1001911; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Del Sorbo L, 2001, EUR J IMMUNOL, V31, P376, DOI 10.1002/1521-4141(200102)31:2<376::AID-IMMU376>3.0.CO;2-5; Del Sorbo L, 1999, EUR J IMMUNOL, V29, P1513, DOI 10.1002/(SICI)1521-4141(199905)29:05<1513::AID-IMMU1513>3.3.CO;2-O; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Fiala M, 1997, MOL MED, V3, P553, DOI 10.1007/BF03401701; Flaujac C, 2010, CELL MOL LIFE SCI, V67, P545, DOI 10.1007/s00018-009-0209-x; Gannon P, 2011, CURR OPIN NEUROL, V24, P275, DOI 10.1097/WCO.0b013e32834695fb; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Giunta B, 2010, CNS NEUROL DISORD-DR, V9, P149, DOI 10.2174/187152710791012099; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hermann A, 2001, PLATELETS, V12, P74, DOI 10.1080/09537100020031207; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Hurst RD, 2001, BRAIN RES, V894, P181, DOI 10.1016/S0006-8993(01)01992-8; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; Law CL, 2009, ADV EXP MED BIOL, V647, P8, DOI 10.1007/978-0-387-89520-8_2; Lazarevic V, 2003, IMMUNITY, V19, P823, DOI 10.1016/S1074-7613(03)00324-8; Li GR, 2005, BIOCHEM PHARMACOL, V69, P233, DOI 10.1016/j.bcp.2004.10.003; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Liu YY, 2010, J IMMUNOL, V185, P2773, DOI 10.4049/jimmunol.1000772; Lu SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023915; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; MAZZEI GJ, 1995, J BIOL CHEM, V270, P7025, DOI 10.1074/jbc.270.13.7025; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nieswandt B, 2000, BLOOD, V96, P2520; O'Dea KP, 2011, AM J PHYSIOL-LUNG C, V301, pL812, DOI 10.1152/ajplung.00092.2011; Otterdal K, 2004, THROMB RES, V114, P167, DOI 10.1016/j.thromres.2004.05.007; Perry SW, 2010, J NEUROSCI, V30, P14153, DOI 10.1523/JNEUROSCI.1042-10.2010; Piguet PF, 2001, AM J PATHOL, V159, P733, DOI 10.1016/S0002-9440(10)61744-0; Polesskaya O, 2012, JOVE-J VIS EXP, DOI 10.3791/3466; Polesskaya O, 2011, BRAIN RES, V1373, P91, DOI 10.1016/j.brainres.2010.12.017; Ragin AB, 2011, J NEUROVIROL, V17, P487, DOI 10.1007/s13365-011-0053-2; Ramirez SH, 2010, J NEUROSCI, V30, P9454, DOI 10.1523/JNEUROSCI.5796-09.2010; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Rieg G, 2007, AIDS RES HUM RETROV, V23, P1257, DOI 10.1089/aid.2006.0311; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Rumbaugh J, 2006, FASEB J, V20, P1736, DOI 10.1096/fj.05-5619fje; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Schifitto G, 2006, NEUROLOGY, V66, P919, DOI 10.1212/01.wnl.0000204294.28189.03; Schulze C, 1997, J NEUROCHEM, V68, P991; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Singh MV, 2012, J VIROL METHODS; STADDON JM, 1995, J CELL SCI, V108, P609; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Tan J, 1999, J NEUROIMMUNOL, V97, P77, DOI 10.1016/S0165-5728(99)00053-3; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Toneatto S, 1999, AIDS, V13, P2343, DOI 10.1097/00002030-199912030-00005; Torre D, 2008, CURR HIV RES, V6, P411, DOI 10.2174/157016208785861140; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Wachtman LM, 2007, ARCH NEUROL-CHICAGO, V64, P1264, DOI 10.1001/archneur.64.9.1264; Wang J, 2011, J THROMB HAEMOST, V9, P562, DOI 10.1111/j.1538-7836.2010.04168.x; Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yacoub D, 2010, ARTERIOSCL THROM VAS, V30, P2424, DOI 10.1161/ATVBAHA.110.216143; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	97	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51793	10.1371/journal.pone.0051793	http://dx.doi.org/10.1371/journal.pone.0051793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251626	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200167
J	Dhanik, A; McMurray, JS; Kavraki, LE				Dhanik, Ankur; McMurray, John S.; Kavraki, Lydia E.			Binding Modes of Peptidomimetics Designed to Inhibit STAT3	PLOS ONE			English	Article							MOLECULAR DOCKING PROGRAMS; SIGNAL TRANSDUCER; FLUORESCENCE POLARIZATION; DYNAMICS SIMULATIONS; PROTEIN FLEXIBILITY; AUTOMATED DOCKING; GENETIC ALGORITHM; DRUG DISCOVERY; LIGAND DOCKING; HYDROGEN-BONDS	STAT3 is a transcription factor that has been found to be constitutively activated in a number of human cancers. Dimerization of STAT3 via its SH2 domain and the subsequent translocation of the dimer to the nucleus leads to transcription of anti-apoptotic genes. Prevention of the dimerization is thus an attractive strategy for inhibiting the activity of STAT3. Phosphotyrosine-based peptidomimetic inhibitors, which mimic pTyr-Xaa-Yaa-Gln motif and have strong to weak binding affinities, have been previously investigated. It is well-known that structures of protein-inhibitor complexes are important for understanding the binding interactions and designing stronger inhibitors. Experimental structures of inhibitors bound to the SH2 domain of STAT3 are, however, unavailable. In this paper we describe a computational study that combined molecular docking and molecular dynamics to model structures of 12 peptidomimetic inhibitors bound to the SH2 domain of STAT3. A detailed analysis of the modeled structures was performed to evaluate the characteristics of the binding interactions. We also estimated the binding affinities of the inhibitors by combining MMPB/GBSA-based energies and entropic cost of binding. The estimated affinities correlate strongly with the experimentally obtained affinities. Modeling results show binding modes that are consistent with limited previous modeling studies on binding interactions involving the SH2 domain and phosphotyrosine(pTyr)-based inhibitors. We also discovered a stable novel binding mode that involves deformation of two loops of the SH2 domain that subsequently bury the C-terminal end of one of the stronger inhibitors. The novel binding mode could prove useful for developing more potent inhibitors aimed at preventing dimerization of cancer target protein STAT3.	[Dhanik, Ankur; Kavraki, Lydia E.] Rice Univ, Dept Comp Sci, Houston, TX 77251 USA; [McMurray, John S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Rice University; University of Texas System; UTMD Anderson Cancer Center	Kavraki, LE (corresponding author), Rice Univ, Dept Comp Sci, Houston, TX 77251 USA.	kavraki@rice.edu	Kavraki, Lydia E/N-6325-2018	Kavraki, Lydia E/0000-0003-0699-8038	Keck Center Computational Cancer Biology Training Program of the Gulf Coast Consortia [CPRIT RP101489]; Texas Higher Education Coordinating Board [NHARP 01907]; National Cancer Institute [RO1 CA096652]; John and Ann Doerr Fund for Computational Biomedicine at Rice University; National Science Foundation [CNS-0821727]; NATIONAL CANCER INSTITUTE [R01CA096652] Funding Source: NIH RePORTER	Keck Center Computational Cancer Biology Training Program of the Gulf Coast Consortia; Texas Higher Education Coordinating Board; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); John and Ann Doerr Fund for Computational Biomedicine at Rice University; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported in part by a training fellowship from the Keck Center Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT RP101489), The Texas Higher Education Coordinating Board (NHARP 01907), The National Cancer Institute (RO1 CA096652), The John and Ann Doerr Fund for Computational Biomedicine at Rice University, and the Cyberinfrastructure for Computational Research funded by National Science Foundation under Grant CNS-0821727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhasin D, 2008, BIOORG MED CHEM LETT, V18, P391, DOI 10.1016/j.bmcl.2007.10.031; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Buettner R, 2002, CLIN CANCER RES, V8, P945; Case D.A., 2022, AMBER 2020; Cavasotto CN, 2007, CURR TOP MED CHEM, V7, P1006, DOI 10.2174/156802607780906753; Cavasotto CN, 2004, J MOL BIOL, V337, P209, DOI 10.1016/j.jmb.2004.01.003; Chang MW, 2007, J CHEM INF MODEL, V47, P1258, DOI 10.1021/ci700044s; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Cross JB, 2009, J CHEM INF MODEL, V49, P1455, DOI 10.1021/ci900056c; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dhanik A., 2012, Proceedings of the 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW), P48, DOI 10.1109/BIBMW.2012.6470370; Dhanik A, 2012, PROTEIN LIGAND INTER, DOI [10.1002/9780470015902.a0004105.pub2, DOI 10.1002/9780470015902.A0004105.PUB2]; Dhanik A, 2011, IEEE ENG MED BIO, P3229, DOI 10.1109/IEMBS.2011.6090878; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Erickson JA, 2004, J MED CHEM, V47, P45, DOI 10.1021/jm030209y; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garcia-Nieto R, 2000, J COMPUT AID MOL DES, V14, P147, DOI 10.1023/A:1008110924479; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Jain AN, 2000, J COMPUT AID MOL DES, V14, P199, DOI 10.1023/A:1008100132405; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kaushik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026251; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Khalil IG, 2005, CURR OPIN ONCOL, V17, P44, DOI 10.1097/01.cco.0000150951.38222.16; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kubinyi H, 2006, SUCCESS STORIES COMP, P377, DOI [10.1002/0470037237.ch16, DOI 10.1002/0470037237.CH16]; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010126; Li X, 2010, J COMPUT CHEM, V31, P2109, DOI 10.1002/jcc.21498; Mandal PK, 2011, J MED CHEM, V54, P3549, DOI 10.1021/jm2000882; Mandal PK, 2009, J MED CHEM, V52, P6126, DOI 10.1021/jm901105k; Mandal PK, 2009, J MED CHEM, V52, P2429, DOI 10.1021/jm801491w; Mangoni R, 1999, PROTEINS, V35, P153, DOI 10.1002/(SICI)1097-0134(19990501)35:2<153::AID-PROT2>3.0.CO;2-E; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matter H, 2011, APPL SUCCESS STORIES, P319, DOI [10.1002/9783527633326.ch12, DOI 10.1002/9783527633326.CH12]; McMurray JS, 2008, BIOPOLYMERS, V90, P69, DOI 10.1002/bip.20901; Moasser MM, 2007, ONCOGENE, V26, P6577, DOI 10.1038/sj.onc.1210478; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Okimoto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000528; Onodera K, 2007, J CHEM INF MODEL, V47, P1609, DOI 10.1021/ci7000378; Owicki JC, 2000, J BIOMOL SCREEN, V5, P297, DOI 10.1177/108705710000500501; Panigrahi SK, 2007, PROTEINS, V67, P128, DOI 10.1002/prot.21253; Park In-Hee, 2011, J Mol Recognit, V24, P254, DOI 10.1002/jmr.1047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce AC, 2002, PROTEINS, V49, P567, DOI 10.1002/prot.10259; Plewczynski D, 2010, J COMPUT CHEM, V32, P1; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Projan SJ, 2007, NAT REV DRUG DISCOV, V6, P115; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Schust J, 2004, ANAL BIOCHEM, V330, P114, DOI 10.1016/j.ab.2004.03.024; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; SHOICHET BK, 1991, J MOL BIOL, V221, P327, DOI 10.1016/0022-2836(91)80222-G; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Terstappen GC, 2001, TRENDS PHARMACOL SCI, V22, P23, DOI 10.1016/S0165-6147(00)01584-4; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WADE RC, 1993, J MED CHEM, V36, P148, DOI 10.1021/jm00053a019; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Xing L, 2011, J MED CHEM, V54, P1211, DOI 10.1021/jm101382t; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	85	20	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51603	10.1371/journal.pone.0051603	http://dx.doi.org/10.1371/journal.pone.0051603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251591	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200143
J	Espada, L; Meo-Evoli, N; Sancho, P; Real, S; Fabregat, I; Ambrosio, S; Tauler, A				Espada, Lilia; Meo-Evoli, Nathalie; Sancho, Patricia; Real, Sebastian; Fabregat, Isabel; Ambrosio, Santiago; Tauler, Albert			ROS Production Is Essential for the Apoptotic Function of E2F1 in Pheochromocytoma and Neuroblastoma Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2F1; CYTOCHROME-C RELEASE; NEURONAL APOPTOSIS; BAX TRANSLOCATION; COPPER CHAPERONE; OXIDATIVE STRESS; DEATH DECISIONS; REACTIVE OXYGEN; CANCER-THERAPY; ACTIVATION	In this study we demonstrate that accumulation of reactive oxygen species (ROS) is essential for E2F1 mediated apoptosis in ER-E2F1 PC12 pheochromocytoma, and SH-SY5Y and SK-N-JD neuroblastoma stable cell lines. In these cells, the ER-E2F1 fusion protein is expressed in the cytosol; the addition of 4-hydroxytamoxifen (OHT) induces its translocation to the nucleus and activation of E2F1target genes. Previously we demonstrated that, in ER-E2F1 PC12 cells, OHT treatment induced apoptosis through activation of caspase-3. Here we show that caspase-8 activity did not change upon treatment with OHT. Moreover, over-expression of Bcl-xL arrested OHT-induced apoptosis; by contrast, over-expression of c-FLIP, did not have any effect on OHT-induced apoptosis. OHT addition induces BimL expression, its translocation to mitochondria and activation of Bax, which is paralleled by diminished mitochondrial enrichment of Bcl-xL. Treatment with a Bax-inhibitory peptide reduced OHT-induced apoptosis. These results point out the essential role of mitochondria on the apoptotic process driven by E2F1. ROS accumulation followed E2F1 induction and treatment with the antioxidant N-acetylcysteine, inhibited E2F1-induced Bax translocation to mitochondria and subsequent apoptosis. The role of ROS in mediating OHT-induced apoptosis was also studied in two neuroblastoma cell lines, SH-SY5Y and SK-N-JD. In SH-SY5Y cells, activation of E2F1 by the addition of OHT induced ROS production and apoptosis, whereas over-expression of E2F1 in SK-N-JD cells failed to induce either response. Transcriptional profiling revealed that many of the genes responsible for scavenging ROS were down-regulated following E2F1-induction in SH-SY5Y, but not in SK-N-JD cells. Finally, inhibition of GSK3 beta blocked ROS production, Bax activation and the down regulation of ROS scavenging genes. These findings provide an explanation for the apparent contradictory role of E2F1 as an apoptotic agent versus a cell cycle activator.	[Espada, Lilia; Meo-Evoli, Nathalie; Real, Sebastian; Tauler, Albert] Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, E-08028 Barcelona, Catalunya, Spain; [Meo-Evoli, Nathalie; Tauler, Albert] Bellvitge Biomed Res Inst IDIBELL, Canc & Metab Grp, Lhospitalet De Llobregat, Catalunya, Spain; [Sancho, Patricia; Fabregat, Isabel] Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Lhospitalet De Llobregat, Catalunya, Spain; [Fabregat, Isabel; Ambrosio, Santiago] Univ Barcelona, Campus Univ Bellvitge IDIBELL, Fac Med, Unitat Bioquim,Dept Ciencies Fisiol 2, Lhospitalet De Llobregat, Catalunya, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Tauler, A (corresponding author), Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, E-08028 Barcelona, Catalunya, Spain.	tauler@ub.edu	Ambrosio, Santiago/ABC-8753-2021; Sancho, Patricia/ABH-5258-2020; Tauler, Albert/D-5183-2014; Fabregat, Isabel/H-7038-2015	Sancho, Patricia/0000-0002-1092-5395; Tauler, Albert/0000-0003-0193-0667; Fabregat, Isabel/0000-0003-0136-8440; Espada, Lilia/0000-0002-6218-7785	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain [BFU2009-09933]; Universitat de Barcelona; Generalitat de Catalunya; Ministerio de Asuntos Exteriores	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universitat de Barcelona; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Asuntos Exteriores	This work was supported by Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion, Spain (BFU2009-09933) and the publication cost was provided by Vicerectorat de Politica Docent i Cientifica de la Universitat de Barcelona. Lilia Espada, Nathalie Meo-Evoli and Sebastian Real were the recipients of a fellowship from Universitat de Barcelona, Generalitat de Catalunya and Ministerio de Asuntos Exteriores, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Calvisi DF, 2005, J HEPATOL, V42, P842, DOI 10.1016/j.jhep.2005.01.029; Cao QY, 2004, J IMMUNOL, V173, P1111, DOI 10.4049/jimmunol.173.2.1111; Chen MJ, 2007, BIOCHEM BIOPH RES CO, V358, P559, DOI 10.1016/j.bbrc.2007.04.167; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; De Simoni S, 2008, NEUROSCI LETT, V433, P219, DOI 10.1016/j.neulet.2007.12.068; Dittmann LM, 2012, ONCOGENE, V31, P3409, DOI 10.1038/onc.2011.513; Espada L, 2007, J NEUROCHEM, V102, P2020, DOI 10.1111/j.1471-4159.2007.04686.x; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Ganguly A, 2010, MOL VIS, V16, P1292; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Gomez-Lazaro M, 2007, MOL PHARMACOL, V71, P736, DOI 10.1124/mol.106.030718; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hou ST, 2002, J BIOL CHEM, V277, P48764, DOI 10.1074/jbc.M206336200; Hou ST, 2001, J NEUROCHEM, V78, P287, DOI 10.1046/j.1471-4159.2001.00402.x; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; O'Hare MJ, 2000, J BIOL CHEM, V275, P25358, DOI 10.1074/jbc.M001725200; Ochiai T, 2004, NEUROSCI LETT, V362, P61, DOI 10.1016/j.neulet.2004.02.067; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Pickrell AM, 2010, METHODS MOL BIOL, V648, P63, DOI 10.1007/978-1-60761-756-3_4; Poole Leslie B, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0709s49; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Qin Q, 2004, NEUROSCI LETT, V372, P17, DOI 10.1016/j.neulet.2004.08.075; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Turanov AA, 2010, BIOCHEM J, V430, P285, DOI 10.1042/BJ20091378; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Wang XD, 2001, GENE DEV, V15, P2922; Wang XW, 2009, FEBS LETT, V583, P1873, DOI 10.1016/j.febslet.2009.04.045; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200	56	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51544	10.1371/journal.pone.0051544	http://dx.doi.org/10.1371/journal.pone.0051544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251571	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200132
J	Holm, L; Engel, S; Schrater, P				Holm, Linus; Engel, Stephen; Schrater, Paul			Object Learning Improves Feature Extraction but Does Not Improve Feature Selection	PLOS ONE			English	Article							ATTENTION; GUIDANCE	A single glance at your crowded desk is enough to locate your favorite cup. But finding an unfamiliar object requires more effort. This superiority in recognition performance for learned objects has at least two possible sources. For familiar objects observers might: 1) select more informative image locations upon which to fixate their eyes, or 2) extract more information from a given eye fixation. To test these possibilities, we had observers localize fragmented objects embedded in dense displays of random contour fragments. Eight participants searched for objects in 600 images while their eye movements were recorded in three daily sessions. Performance improved as subjects trained with the objects: The number of fixations required to find an object decreased by 64% across the 3 sessions. An ideal observer model that included measures of fragment confusability was used to calculate the information available from a single fixation. Comparing human performance to the model suggested that across sessions information extraction at each eye fixation increased markedly, by an amount roughly equal to the extra information that would be extracted following a 100% increase in functional field of view. Selection of fixation locations, on the other hand, did not improve with practice.	[Holm, Linus] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Engel, Stephen; Schrater, Paul] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Schrater, Paul] Univ Minnesota, Dept Comp Sci, Minneapolis, MN 55455 USA	Umea University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Holm, L (corresponding author), Umea Univ, Dept Psychol, S-90187 Umea, Sweden.	Linus.Holm@psy.umu.se			Swedish research council [435-2008-421]	Swedish research council(Swedish Research CouncilEuropean Commission)	The project was partly funded by post doc grant 435-2008-421 from Swedish research council. (http://www.vr.se/) No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Droll JA, 2009, J VISION, V9, DOI 10.1167/9.2.18; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gilchrist ID, 2000, CURR BIOL, V10, P1209, DOI 10.1016/S0960-9822(00)00729-6; Hochberg J., 1964, PERCEPTION; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Melcher D, 2001, VISION RES, V41, P3597, DOI 10.1016/S0042-6989(01)00203-6; Mondloch CJ, 2006, PSYCHOL SCI, V17, P930, DOI 10.1111/j.1467-9280.2006.01806.x; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; POTTER MC, 1975, NATURE, V253, P437, DOI 10.1038/253437a0; Renninger LW, 2007, J VISION, V7, DOI 10.1167/7.3.6; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	17	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51325	10.1371/journal.pone.0051325	http://dx.doi.org/10.1371/journal.pone.0051325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251499	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200090
J	Ketola, K; Kallioniemi, O; Iljin, K				Ketola, Kirsi; Kallioniemi, Olli; Iljin, Kristiina			Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells	PLOS ONE			English	Article							IN-VITRO; INHIBITOR; GROWTH; DOCETAXEL; BREAST; SURVIVAL	Background: Current treatment options for castration- and treatment-resistant prostate cancer are limited and novel approaches are desperately needed. Our recent results from a systematic chemical biology sensitivity screen covering most known drugs and drug-like molecules indicated that aldehyde dehydrogenase inhibitor disulfiram is one of the most potent cancer-specific inhibitors of prostate cancer cell growth, including TMPRSS2-ERG fusion positive cancers. However, the results revealed that disulfiram alone does not block tumor growth in vivo nor induce apoptosis in vitro, indicating that combinatorial approaches may be required to enhance the anti-neoplastic effects. Methods and Findings: In this study, we utilized a chemical biology drug sensitivity screen to explore disulfiram mechanistic details and to identify compounds potentiating the effect of disulfiram in TMPRSS2-ERG fusion positive prostate cancer cells. In total, 3357 compounds including current chemotherapeutic agents as well as drug-like small molecular compounds were screened alone and in combination with disulfiram. Interestingly, the results indicated that androgenic and antioxidative compounds antagonized disulfiram effect whereas inhibitors of receptor tyrosine kinase, proteasome, topoisomerase II, glucosylceramide synthase or cell cycle were among compounds sensitizing prostate cancer cells to disulfiram. The combination of disulfiram and an antiangiogenic agent sunitinib was studied in more detail, since both are already in clinical use in humans. Disulfiram-sunitinib combination induced apoptosis and reduced androgen receptor protein expression more than either of the compounds alone. Moreover, combinatorial exposure reduced metastatic characteristics such as cell migration and 3D cell invasion as well as induced epithelial differentiation shown as elevated E-cadherin expression. Conclusions: Taken together, our results propose novel combinatorial approaches to inhibit prostate cancer cell growth. Disulfiram-sunitinib combination was identified as one of the potent synergistic approaches. Since sunitinib alone has been reported to lack efficacy in prostate cancer clinical trials, our results provide a rationale for novel combinatorial approach to target prostate cancer more efficiently.	[Ketola, Kirsi; Iljin, Kristiina] Univ Turku, VTT Tech Res Ctr Finland, Turku, Finland; [Ketola, Kirsi; Iljin, Kristiina] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Kallioniemi, Olli] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland	University of Turku; VTT Technical Research Center Finland; University of Turku; University of Helsinki	Ketola, K (corresponding author), Univ Turku, VTT Tech Res Ctr Finland, Turku, Finland.	kirsi.h.ketola@gmail.com	Ketola, Kirsi/O-1071-2016; Kallioniemi, Olli P/H-5111-2011	Ketola, Kirsi/0000-0001-6484-9861; Kallioniemi, Olli P/0000-0002-3231-0332; Iljin, Kristiina/0000-0002-5161-0584	EU-PRIMA project [LSHC-CT-204-504587]; Cancer Organizations of Finland; Sigrid Juselius Foundation; Academy of Finland	EU-PRIMA project; Cancer Organizations of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	Funding was provided by EU-PRIMA project (contract # LSHC-CT-204-504587), the Cancer Organizations of Finland, Sigrid Juselius Foundation and Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Brar SS, 2004, MOL CANCER THER, V3, P1049; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Cumashi A, 2008, CANCER LETT, V270, P229, DOI 10.1016/j.canlet.2008.05.007; Dayyani F, 2011, JNCI-J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Gotink KJ, 2010, ANGIOGENESIS, V13, P1, DOI 10.1007/s10456-009-9160-6; Guerin O, 2008, J CANCER RES CLIN, V134, P51, DOI 10.1007/s00432-007-0247-4; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Iljin K, 2009, CLIN CANCER RES, V15, P6070, DOI 10.1158/1078-0432.CCR-09-1035; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong CW, 2013, UROL ONCOL-SEMIN ORI, V31, P1448, DOI 10.1016/j.urolonc.2012.03.022; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Ketola K, 2012, OXIDATIVE STRESS DIS; Ketola K, 2010, MOL CANCER THER, V9, P3175, DOI 10.1158/1535-7163.MCT-10-0368; Korenchuk S, 2001, IN VIVO, V15, P163; Kutikov A, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.07.1384; Lin JQ, 2011, PROSTATE, V71, P333, DOI 10.1002/pros.21247; Lovborg H, 2006, INT J CANCER, V118, P1577, DOI 10.1002/ijc.21534; Marijon H, 2011, J HEPATOL, V54, P1073, DOI 10.1016/j.jhep.2010.11.011; Morrison BW, 2010, MELANOMA RES, V20, P11, DOI 10.1097/CMR.0b013e328334131d; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Ortholan C, 2010, EUR J CANCER, V46, P3022, DOI 10.1016/j.ejca.2010.07.021; OTTO T, 1993, UROL RES, V21, P359, DOI 10.1007/BF00296837; Papaetis GS, 2009, BIODRUGS, V23, P377, DOI 10.2165/11318860-000000000-00000; Platz EA, 2011, NOVEL 2 STAGE TRANSD; Sauna ZE, 2005, MOL BIOSYST, V1, P127, DOI 10.1039/b504392a; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Wickstrom M, 2007, BIOCHEM PHARMACOL, V73, P25, DOI 10.1016/j.bcp.2006.08.016; Yakisich JS, 2001, BIOCHEM BIOPH RES CO, V289, P586, DOI 10.1006/bbrc.2001.6027; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126	33	25	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51470	10.1371/journal.pone.0051470	http://dx.doi.org/10.1371/journal.pone.0051470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251544	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200115
J	Mathyssek, CM; Olino, TM; Verhulst, FC; van Oort, FVA				Mathyssek, Christina M.; Olino, Thomas M.; Verhulst, Frank C.; van Oort, Floor V. A.			Childhood Internalizing and Externalizing Problems Predict the Onset of Clinical Panic Attacks over Adolescence: The TRAILS Study	PLOS ONE			English	Article							ANXIETY; PHENOMENOLOGY; EPIDEMIOLOGY; SYMPTOMS; DISORDER; SAMPLE	Background: Panic attacks are a source of individual suffering and are an independent risk factor for later psychopathology. However, much less is known about risk factors for the development of panic attacks, particularly during adolescence when the incidence of panic attacks increases dramatically. We examined whether internalizing and externalizing problems in childhood predict the onset of panic attacks in adolescence. Method: This study is part of the TRacking Adolescents' Individual Lives Survey (TRAILS), a Dutch longitudinal population cohort study (N = 1,584). Internalizing and Externalizing Problems were collected using the Youth Self-Report (YSR) and the parent-report Child Behavior Checklist (CBCL) at baseline (age 10-12). At age 18-20, DSM-IV defined panic attacks since baseline were assessed with the Composite International Diagnostic Interview (CIDI). We investigated whether early adolescent Internalizing and Externalizing Problems predicted panic attacks between ages 10-20 years, using survival analysis in univariate and multivariate models. Results: There were N = 314 (19.8%) cases who experienced at least one DSM-IV defined panic attack during adolescence and N = 18 (1.2%) who developed panic disorder during adolescence. In univariate analyses, CBCL Total Problems, Internalizing Problems and three of the eight syndrome scales predicted panic attack onset, while on the YSR all broad-band problem scales and each narrow-band syndrome scale predicted panic attack onset. In multivariate analyses, CBCL Social Problems (HR 1.19, p<.05), and YSR Thought Problems (HR 1.15, p<.05) and Social Problems (HR 1.26, p<.01) predicted panic attack onset. Conclusion: Risk indicators of panic attack include the wide range of internalizing and externalizing problems. Yet, when adjusted for co-occurring problem behaviors, Social Problems were the most consistent risk factor for panic attack onsets in adolescence.	[Mathyssek, Christina M.; Verhulst, Frank C.; van Oort, Floor V. A.] Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Olino, Thomas M.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	van Oort, FVA (corresponding author), Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands.	f.vanoort@erasmusmc.nl	Olino, Thomas/H-8377-2019; van Oort, Floor/G-2811-2013	Olino, Thomas/0000-0001-5139-8571; 	Netherlands Organization for Scientific Research (NWO), Medical Research Council [GB-MW 940-38-011]; Netherlands Organization for Scientific Research (NWO), ZonMW [100-001-004, 60-60600-97-118, 261-98-710]; Netherlands Organization for Scientific Research (NWO), Social Sciences Council [GB-MaGW 480-01-006, GB-MaGW 480-07-001, GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research (NWO) [175.010.2003.005, 481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]	Netherlands Organization for Scientific Research (NWO), Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO), ZonMW(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO), Social Sciences Council(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL	TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research (NWO; Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), and the participating universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2003, MANUAL ASEBA ADULT F; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; ANGST J, 1995, EUR PSYCHIAT, V10, pS57, DOI 10.1016/0924-9338(96)80325-7; BRADLEY SJ, 1993, J AM ACAD CHILD PSY, V32, P826, DOI 10.1097/00004583-199307000-00018; Craske MG, 2010, DEPRESS ANXIETY, V27, P93, DOI 10.1002/da.20654; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Goldstein RB, 1997, ARCH GEN PSYCHIAT, V54, P271; Goodwin RD, 2004, AM J PSYCHIAT, V161, P2207, DOI 10.1176/appi.ajp.161.12.2207; Goodwin RD, 2004, ACTA PSYCHIAT SCAND, V109, P216, DOI 10.1046/j.1600-0447.2003.00255.x; Goodwin RD, 2002, PSYCHIAT RES, V109, P71, DOI 10.1016/S0165-1781(01)00357-2; Hayward C, 2004, J AM ACAD CHILD PSY, V43, P613, DOI 10.1097/00004583-200405000-00015; HAYWARD C, 1989, AM J PSYCHIAT, V146, P1061; Hayward C, 1997, J ANXIETY DISORD, V11, P17, DOI 10.1016/S0887-6185(96)00032-1; Hayward C, 2000, J AM ACAD CHILD PSY, V39, P207, DOI 10.1097/00004583-200002000-00021; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kinley DJ, 2011, DEPRESS ANXIETY, V28, P412, DOI 10.1002/da.20809; Macaulay J. L., 1989, J ANXIETY DIORD, V3, P221, DOI DOI 10.1016/0887-6185(89)90016-9; Mattis SG, 2002, J ANXIETY DISORD, V16, P351, DOI 10.1016/S0887-6185(01)00085-8; Muthen B., 2010, MPLUS USERS GUIDE; Nederhof E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-93; NORTON GR, 1992, CLIN PSYCHOL REV, V12, P121, DOI 10.1016/0272-7358(92)90110-T; OLLENDICK TH, 1994, J CHILD PSYCHOL PSYC, V35, P113, DOI 10.1111/j.1469-7610.1994.tb01134.x; Reed V, 1998, J PSYCHIAT RES, V32, P335, DOI 10.1016/S0022-3956(98)00014-4; Roza SJ, 2003, AM J PSYCHIAT, V160, P2116, DOI 10.1176/appi.ajp.160.12.2116; Schmidt NB, 2006, J PSYCHIATR RES, V40, P691, DOI 10.1016/j.jpsychires.2006.07.009; Schumacher J, 2011, J MED GENET, V48, P361, DOI 10.1136/jmg.2010.086876; Scocco P, 2007, PSYCHOPATHOLOGY, V40, P8, DOI 10.1159/000096384; Svanborg C, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-52; Valentiner DP, 2004, J ANXIETY DISORD, V18, P573, DOI 10.1016/j.janxdis.2003.04.001; van Oort FVA, 2011, DEPRESS ANXIETY, V28, P485, DOI 10.1002/da.20818; Verhulst F.C., 1996, HANDLEIDING CBCL4 18; Verhulst F. C., 1997, HANDLEIDING YOUTH SE; World Health Organization, 1990, COMP INT DIAGN INT C	37	15	15	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51564	10.1371/journal.pone.0051564	http://dx.doi.org/10.1371/journal.pone.0051564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251576	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200134
J	Hinz, C; Gebhardt, K; Hartmann, AK; Sigman, L; Gerlach, G				Hinz, Cornelia; Gebhardt, Katharina; Hartmann, Alexander K.; Sigman, Lauren; Gerlach, Gabriele			Influence of Kinship and MHC Class II Genotype on Visual Traits in Zebrafish Larvae (Danio rerio)	PLOS ONE			English	Article							KIN RECOGNITION; IFN-GAMMA; CELLS; PREFERENCES; STICKLEBACK	Kin recognition can drive kin selection and the evolution of social behaviour. In zebrafish (Danio rerio, Hamilton 1822), kin recognition is based on olfactory and visual imprinting processes. If larvae are exposed to visual and chemical cues of kin at day 5 and 6 post fertilization they will recognize kin throughout life, while exposure to non-kin fails to trigger any recognition. Chemical imprinting signals are transcribed by polymorphic genes of the major histocompatibility complex (MHC) code; however, the underlying mechanism for visual imprinting remains unclear. Here we provide evidence for the existence of family-specific differences in morphometry and pigmentation pattern of six day old zebrafish larvae. While rump, tail and body pigmentation were dependent on relatedness, iris pigmentation and morphometry were also influenced by MHC class II genotype. Our study revealed that the MHC not only influences the chemical signature of individuals, but also their visual appearance.	[Hinz, Cornelia; Gebhardt, Katharina; Gerlach, Gabriele] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, D-2900 Oldenburg, Germany; [Hartmann, Alexander K.] Carl von Ossietzky Univ Oldenburg, Inst Phys, D-2900 Oldenburg, Germany; [Sigman, Lauren] Marine Biol Lab, Woods Hole, MA 02543 USA	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Marine Biological Laboratory - Woods Hole	Hinz, C (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, D-2900 Oldenburg, Germany.	cornelia.hinz@uni-oldenburg.de	Gerlach, Gabriele/K-5919-2012		DFG [GE 842/5-1, SPP 1392]	DFG(German Research Foundation (DFG))	The project is funded by the DFG (GE 842/5-1) and is part of the SPP 1392 (integrative analysis of olfaction). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, COMMUN INTEGR BIOL, DOI DOI 10.4161/CIB.3.1.10118; Bolhuis JJ, 1999, BEHAV BRAIN RES, V98, P245, DOI 10.1016/S0166-4328(98)00090-4; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Eifuku S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018913; Eluvathingal LM, 2009, J BIOSCIENCES, V34, P435, DOI 10.1007/s12038-009-0050-2; Gerlach G, 2008, P ROY SOC B-BIOL SCI, V275, P2165, DOI 10.1098/rspb.2008.0647; Hartmann A. K., 2009, PRACTICAL GUIDE COMP; Hepper PG., 1991, KIN RECOGNITION; Jager I, 2007, J EVOLUTION BIOL, V20, P2005, DOI 10.1111/j.1420-9101.2007.01366.x; Jain AK., 1988, TECHNOMETRICS; Kuroda N, 2002, IMMUNOGENETICS, V54, P418, DOI 10.1007/s00251-002-0473-5; Le Vin AL, 2010, ANIM BEHAV, V79, P1109, DOI 10.1016/j.anbehav.2010.02.006; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; LIVERSIDGE JM, 1988, CLIN EXP IMMUNOL, V73, P489; Maaswinkel H, 2003, J EXP BIOL, V206, P2201, DOI 10.1242/jeb.00397; Makhoul M, 2012, ACTA OPHTHALMOL, V90, pE38, DOI 10.1111/j.1755-3768.2011.02241.x; Mateo JM, 2003, J MAMMAL, V84, P1163, DOI 10.1644/BLe-011; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Patterson L, 2008, ANIM BEHAV, V76, P717, DOI 10.1016/j.anbehav.2008.03.018; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Press WH, 1995, NUMERICAL RECIPES C; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; Setchell JM, 2009, INT J PRIMATOL, V30, P825, DOI 10.1007/s10764-009-9371-0; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Whitehorn PR, 2009, APIDOLOGIE, V40, P627, DOI 10.1051/apido/2009050	27	11	11	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51182	10.1371/journal.pone.0051182	http://dx.doi.org/10.1371/journal.pone.0051182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251449	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900051
J	Phillips, JM; Everling, S				Phillips, Jessica M.; Everling, Stefan			Neural Activity in the Macaque Putamen Associated with Saccades and Behavioral Outcome	PLOS ONE			English	Article							MONKEY CAUDATE NEURONS; FRONTAL EYE FIELD; PRIMATE PREFRONTAL CORTEX; BASAL GANGLIA; ANTERIOR CINGULATE; FUNCTIONAL-PROPERTIES; REWARD EXPECTATION; CORTICOSTRIATAL PROJECTIONS; INTERNAL GENERATION; DIFFERENTIAL ROLES	It is now widely accepted that the basal ganglia nuclei form segregated, parallel loops with neocortical areas. The prevalent view is that the putamen is part of the motor loop, which receives inputs from sensorimotor areas, whereas the caudate, which receives inputs from frontal cortical eye fields and projects via the substantia nigra pars reticulata to the superior colliculus, belongs to the oculomotor loop. Tracer studies in monkeys and functional neuroimaging studies in human subjects, however, also suggest a potential role for the putamen in oculomotor control. To investigate the role of the putamen in saccadic eye movements, we recorded single neuron activity in the caudal putamen of two rhesus monkeys while they alternated between short blocks of pro- and anti-saccades. In each trial, the instruction cue was provided after the onset of the peripheral stimulus, thus the monkeys could either generate an immediate response to the stimulus based on the internal representation of the rule from the previous trial, or alternatively, could await the visual rule-instruction cue to guide their saccadic response. We found that a subset of putamen neurons showed saccade-related activity, that the preparatory mode (internally-versus externally-cued) influenced the expression of task-selectivity in roughly one third of the task-modulated neurons, and further that a large proportion of neurons encoded the outcome of the saccade. These results suggest that the caudal putamen may be part of the neural network for goal-directed saccades, wherein the monitoring of saccadic eye movements, context and performance feedback may be processed together to ensure optimal behavioural performance and outcomes are achieved during ongoing behaviour.	[Phillips, Jessica M.; Everling, Stefan] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Everling, Stefan] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Everling, Stefan] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Everling, Stefan] Robarts Res Inst, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Everling, S (corresponding author), Univ Western Ontario, Grad Program Neurosci, London, ON, Canada.	severlin@uwo.ca	Everling, Stefan/K-5208-2013; Everling, Stefan/AAR-8687-2020	Everling, Stefan/0000-0001-9714-9757; Phillips, Jessica M/0000-0002-8240-7327	Canadian Institutes of Health Research (CIHR) [44067]; province of Ontario	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); province of Ontario	The work was funded by a grant to SE from Canadian Institutes of Health Research (CIHR #44067 www.cihr.ca) and a scholarship to JMP from the province of Ontario. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichert DS, 2012, PSYCHOPHYSIOLOGY, V49, P345, DOI 10.1111/j.1469-8986.2011.01306.x; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amador N, 1998, J NEUROPHYSIOL, V80, P1775, DOI 10.1152/jn.1998.80.4.1775; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; AOSAKI T, 1994, J NEUROSCI, V14, P3969; APICELLA P, 1992, J NEUROPHYSIOL, V68, P945, DOI 10.1152/jn.1992.68.3.945; APICELLA P, 1991, EXP BRAIN RES, V85, P491; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Brovelli A, 2011, NEUROIMAGE, V57, P1580, DOI 10.1016/j.neuroimage.2011.05.059; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Calzavara R, 2007, EUR J NEUROSCI, V26, P2005, DOI 10.1111/j.1460-9568.2007.05825.x; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Deffains M, 2010, J NEUROPHYSIOL, V104, P1355, DOI 10.1152/jn.00355.2010; Dejardin S, 1998, EUR J NEUROSCI, V10, P2328, DOI 10.1046/j.1460-9568.1998.00245.x; Dyckman KA, 2007, NEUROIMAGE, V36, P774, DOI 10.1016/j.neuroimage.2007.03.023; Emeric EE, 2010, J NEUROPHYSIOL, V104, P1523, DOI 10.1152/jn.01001.2009; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ford KA, 2009, J NEUROPHYSIOL, V102, P2334, DOI 10.1152/jn.00125.2009; Ford KA, 2009, NEUROIMAGE, V45, P470, DOI 10.1016/j.neuroimage.2008.12.009; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Gagnon D, 2002, BRAIN, V125, P123, DOI 10.1093/brain/awf005; Gerardin E, 2003, CEREB CORTEX, V13, P162, DOI 10.1093/cercor/13.2.162; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hatanaka N, 2003, J COMP NEUROL, V462, P121, DOI 10.1002/cne.10720; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1989, REV NEUROL, V145, P580; HIKOSAKA O, 1986, EXP BRAIN RES, V63, P659, DOI 10.1007/BF00237489; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Histed MH, 2009, NEURON, V63, P244, DOI 10.1016/j.neuron.2009.06.019; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; Hori Y, 2009, J NEUROPHYSIOL, V102, P3530, DOI 10.1152/jn.00104.2009; Hutchison R.M., 2012, HUM BRAIN MAPP; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; JOHNSON TN, 1971, EXP NEUROL, V33, P584, DOI 10.1016/0014-4886(71)90129-4; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Krebs RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008691; Kunimatsu J, 2010, J NEUROSCI, V30, P5108, DOI 10.1523/JNEUROSCI.0406-10.2010; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lehericy S, 2004, CEREB CORTEX, V14, P1302, DOI 10.1093/cercor/bhh091; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Muranishi M, 2011, EXP BRAIN RES, V209, P235, DOI 10.1007/s00221-011-2545-y; Neggers SFW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029517; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; PARENT A, 1984, BRAIN RES, V303, P385, DOI 10.1016/0006-8993(84)91224-1; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Petit L, 1996, J NEUROSCI, V16, P3714; PETIT L, 1993, J NEUROPHYSIOL, V69, P1009, DOI 10.1152/jn.1993.69.4.1009; Phillips JM, 2011, J COGNITIVE NEUROSCI, V23, P481, DOI 10.1162/jocn.2010.21482; Ravel S, 2001, J NEUROSCI, V21, P5730, DOI 10.1523/JNEUROSCI.21-15-05730.2001; ROMO R, 1992, EXP BRAIN RES, V91, P385, DOI 10.1007/BF00227835; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; SCHULTZ W, 1988, EXP BRAIN RES, V71, P431; Seifert S, 2011, J NEUROSCI, V31, P3375, DOI 10.1523/JNEUROSCI.6242-10.2011; SELEMON LD, 1985, J NEUROSCI, V5, P776; Simo LS, 2005, CEREB CORTEX, V15, P1982, DOI 10.1093/cercor/bhi073; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; SZABO J, 1967, EXP NEUROL, V19, P463, DOI 10.1016/0014-4886(67)90166-5; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2004, NAT NEUROSCI, V7, P1173, DOI 10.1038/nn1104-1173; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Watanabe K, 1998, J NEUROPHYSIOL, V79, P2568, DOI 10.1152/jn.1998.79.5.2568; Watanabe M, 2011, EUR J NEUROSCI, V33, P2070, DOI 10.1111/j.1460-9568.2011.07691.x; Watanabe M, 2011, J COGNITIVE NEUROSCI, V23, P1794, DOI 10.1162/jocn.2010.21554; Watanabe M, 2010, J NEUROSCI, V30, P10144, DOI 10.1523/JNEUROSCI.1738-10.2010; Watanabe M, 2010, J NEUROSCI, V30, P2700, DOI 10.1523/JNEUROSCI.5011-09.2010; Watanabe M, 2009, EUR J NEUROSCI, V30, P2165, DOI 10.1111/j.1460-9568.2009.06998.x; Womelsdorf T, 2010, P NATL ACAD SCI USA, V107, P5248, DOI 10.1073/pnas.0906194107; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	97	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51596	10.1371/journal.pone.0051596	http://dx.doi.org/10.1371/journal.pone.0051596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251586	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900106
J	Arthurs, E; Steele, RJ; Hudson, M; Baron, M; Thombs, BD				Arthurs, Erin; Steele, Russell J.; Hudson, Marie; Baron, Murray; Thombs, Brett D.		Canadian Scleroderma Res Grp	Are Scores on English and French Versions of the PHQ-9 Comparable? An Assessment of Differential Item Functioning	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE; CONFIRMATORY FACTOR-ANALYSIS; MENTAL-STATE-EXAMINATION; SYSTEMIC-SCLEROSIS; REPORTED OUTCOMES; PSYCHOMETRIC PROPERTIES; DEPRESSIVE SYMPTOMS; LANGUAGE VERSIONS; RESPONSE THEORY; FIT INDEXES	Background: Medical research increasingly utilizes patient-reported outcome measures administered and scored in different languages. In order to pool or compare outcomes from different language versions, instruments should be measurement equivalent across linguistic groups. The objective of this study was to examine the cross-language measurement equivalence of the Patient Health Questionnaire-9 (PHQ-9) between English- and French-speaking Canadian patients with systemic sclerosis (SSc). Methods: The sample consisted of 739 English- and 221 French-speaking SSc patients. Multiple-Indicator Multiple-Cause (MIMIC) modeling was used to identify items displaying possible differential item functioning (DIF). Results: A one-factor model for the PHQ-9 fit the data well in both English- and French-speaking samples. Statistically significant DIF was found for 3 of 9 items on the PHQ-9. However, the overall estimate in depression latent scores between English- and French-speaking respondents was not influenced substantively by DIF. Conclusions: Although there were several PHQ-9 items with evidence of minor DIF, there was no evidence that these differences influenced overall scores meaningfully. The PHQ-9 can reasonably be used without adjustment in Canadian English- and French-speaking samples. Analyses assessing measurement equivalence should be routinely conducted prior to pooling data from English and French versions of patient-reported outcome measures. Citation: Arthurs E, Steele RJ, Hudson M, Baron M, Thombs BD, et al. (2012) Are Scores on English and French Versions of the PHQ-9 Comparable? An Assessment of Differential Item Functioning. PLoS ONE 7(12): e52028. doi: 10.1371/journal.pone.0052028	[Arthurs, Erin; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Steele, Russell J.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Dept Med, Div Rheumatol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada; [Arthurs, Erin; Steele, Russell J.; Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University	Thombs, BD (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Steele, Russell J/G-6926-2017; Baron, Murray/AAF-9486-2019	Thombs, Brett D./0000-0002-5644-8432	Canadian Institutes of Health Research; Scleroderma Society of Canada; Actelion Pharmaceuticals; Pfizer Inc.; Canadian Institutes of Health Research and Etablissement de Jeunes Chercheurs; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Canada; Actelion Pharmaceuticals; Pfizer Inc.(Pfizer); Canadian Institutes of Health Research and Etablissement de Jeunes Chercheurs(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	Dr. Baron is the director of the Canadian Scleroderma Research Group, which receives grant funding from the Canadian Institutes of Health Research, the Scleroderma Society of Canada and its provincial chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, the Ontario Arthritis Society, and educational grants from Actelion Pharmaceuticals and Pfizer Inc. Drs. Thombs and Hudson are supported by New Investigator Awards from the Canadian Institutes of Health Research and Etablissement de Jeunes Chercheurs awards from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Actelion Pharmaceuticals and Pfizer Inc. have provided unrestricted educational and research funds to the Canadian Scleroderma Research Group. The commercial funding that provides support to the CSRG does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P1189, DOI 10.1016/S0895-4356(98)00111-5; Boers M, 1998, J RHEUMATOL, V25, P198; Bren Linda, 2006, FDA Consum, V40, P26; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; BYRNE BM, 1994, APPL PSYCHOL-INT REV, V43, P33, DOI 10.1111/j.1464-0597.1994.tb00808.x; Cameron IM, 2008, BRIT J GEN PRACT, V58, P32, DOI 10.3399/bjgp08X263794; Carballeira Y, 2007, PSYCHOL PSYCHOTHER-T, V80, P69, DOI 10.1348/147608306X103641; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Clements PJ, 2004, SEMIN ARTHRITIS RHEU, V33, P249, DOI 10.1053/S0049-0172(03)00135-5; Couture S, 2010, EUR EAT DISORD REV, V18, P234, DOI 10.1002/erv.996; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; Dorans NJ, 2006, MED CARE, V44, pS107, DOI 10.1097/01.mlr.0000245182.36914.4a; DRASGOW F, 1985, J APPL PSYCHOL, V70, P662, DOI 10.1037/0021-9010.70.4.662; Edelen MO, 2006, MED CARE, V44, pS134, DOI 10.1097/01.mlr.0000245251.83359.8c; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Fairclough DL, 2004, STAT METHODS MED RES, V13, P115, DOI 10.1191/0962280204sm357ra; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Gregorich SE, 2006, MED CARE, V44, pS78, DOI 10.1097/01.mlr.0000245454.12228.8f; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jones RN, 2006, MED CARE, V44, pS124, DOI 10.1097/01.mlr.0000245250.50114.0f; Kojima M, 2001, J PSYCHOSOM RES, V51, P487, DOI 10.1016/S0022-3999(01)00253-7; Krause JS, 2008, REHABIL PSYCHOL, V53, P513, DOI 10.1037/a0013354; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lotrakul M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-46; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Meyer JP, 2004, J EDUC MEAS, V41, P331, DOI 10.1111/j.1745-3984.2004.tb01169.x; Milette K, 2010, RHEUMATOLOGY, V49, P789, DOI 10.1093/rheumatology/kep443; Mokkink L B, 2006, BMC Med Res Methodol, V6, P2, DOI 10.1186/1471-2288-6-2; Muthen B., 2010, MPLUS USERS GUIDE; O'Rourke N, 2003, CAN J AGING, V22, P323, DOI 10.1017/S0714980800003937; Omoro SAO, 2006, INT J PSYCHIAT MED, V36, P367, DOI 10.2190/8W7Y-0TPM-JVGV-QW6M; Petersen MA, 2003, QUAL LIFE RES, V12, P373, DOI 10.1023/A:1023488915557; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Richardson EJ, 2008, REHABIL PSYCHOL, V53, P243, DOI 10.1037/0090-5550.53.2.243; Rumsfeld JS, 2005, CIRCULATION, V111, P250, DOI 10.1161/01.CIR.0000154573.62822.89; SEIBOLD J, 2005, KELLEYS TXB RHEUMATO; Steen VD, 1997, ARTHRITIS RHEUM, V40, P1984, DOI 10.1002/art.1780401110; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stephenson Randolph, 1999, Scandinavian Journal of Behaviour Therapy, V28, P58; Teresi JA, 2006, MED CARE, V44, pS39, DOI 10.1097/01.mlr.0000245452.48613.45; Teresi JA, 2006, MED CARE, V44, pS152, DOI 10.1097/01.mlr.0000245142.74628.ab; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P504, DOI 10.1002/art.23524; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Wells G, 2008, ANN RHEUM DIS, V67, P260, DOI 10.1136/ard.2007.069690; Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004; Yeung A, 2008, COMPR PSYCHIAT, V49, P211, DOI 10.1016/j.comppsych.2006.06.002	53	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52028	10.1371/journal.pone.0052028	http://dx.doi.org/10.1371/journal.pone.0052028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251676	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800129
J	Palacin, A; Gomez-Casado, C; Rivas, LA; Aguirre, J; Tordesillas, L; Bartra, J; Blanco, C; Carrillo, T; Cuesta-Herranz, J; de Frutos, C; Alvarez-Eire, GG; Fernandez, FJ; Gamboa, P; Munoz, R; Sanchez-Monge, R; Sirvent, S; Torres, MJ; Varela-Losada, S; Rodriguez, R; Parro, V; Blanca, M; Salcedo, G; Diaz-Perales, A				Palacin, Arantxa; Gomez-Casado, Cristina; Rivas, Luis A.; Aguirre, Jacobo; Tordesillas, Leticia; Bartra, Joan; Blanco, Carlos; Carrillo, Teresa; Cuesta-Herranz, Javier; de Frutos, Consolacion; Garcia Alvarez-Eire, Genoveva; Fernandez, Francisco J.; Gamboa, Pedro; Munoz, Rosa; Sanchez-Monge, Rosa; Sirvent, Sofia; Torres, Maria J.; Varela-Losada, Susana; Rodriguez, Rosalia; Parro, Victor; Blanca, Miguel; Salcedo, Gabriel; Diaz-Perales, Araceli			Graph Based Study of Allergen Cross-Reactivity of Plant Lipid Transfer Proteins (LTPs) Using Microarray in a Multicenter Study	PLOS ONE			English	Article							COMPONENT-RESOLVED DIAGNOSIS; MAJOR ALLERGEN; FOOD ALLERGY; POLLEN; PROFILIN; IDENTIFICATION; NETWORKS; CLONING; FRUITS; PEACH	The study of cross-reactivity in allergy is key to both understanding. the allergic response of many patients and providing them with a rational treatment In the present study, protein microarrays and a co-sensitization graph approach were used in conjunction with an allergen microarray immunoassay. This enabled us to include a wide number of proteins and a large number of patients, and to study sensitization profiles among members of the LTP family. Fourteen LTPs from the most frequent plant food-induced allergies in the geographical area studied were printed into a microarray specifically designed for this research. 212 patients with fruit allergy and 117 food-tolerant pollen allergic subjects were recruited from seven regions of Spain with different pollen profiles, and their sera were tested with allergen microarray. This approach has proven itself to be a good tool to study cross-reactivity between members of LTP family, and could become a useful strategy to analyze other families of allergens. Citation: Palacin A, Gomez-Casado C, Rivas LA, Aguirre J, Tordesillas L, et al. (2012) Graph Based Study of Allergen Cross-Reactivity of Plant Lipid Transfer Proteins (LTPs) Using Microarray in a Multicenter Study. PLoS ONE 7(12): e50799. doi:10.1371/journal.pone.0050799	[Palacin, Arantxa; Gomez-Casado, Cristina; Tordesillas, Leticia; Sanchez-Monge, Rosa; Diaz-Perales, Araceli] Ctr Biotecnol & Genom Plantas UPM INIA, Madrid, Spain; [Rivas, Luis A.; Aguirre, Jacobo; Parro, Victor] Ctr Astrobiol INTA CSIC, Dept Evoluc Mol, Madrid, Spain; [Bartra, Joan; Munoz, Rosa] Univ Barcelona, Unitat Alergia Serv Pneumol & Alergia Resp, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedad Resp CIBERS, Barcelona, Spain; [Blanco, Carlos; de Frutos, Consolacion] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IP, Serv Alergia, Madrid, Spain; [Carrillo, Teresa] Hosp Univ Gran Canaria Dr Negrin, Serv Alergol, Las Palmas Gran Canaria, Spain; [Cuesta-Herranz, Javier] Fdn Jimenez Diaz, Unidad Serv Alergia, E-28040 Madrid, Spain; [Fernandez, Francisco J.] Miguel Hernandez Univ, Gen Univ Hosp, Allergy Sect, Elche, Spain; [Garcia Alvarez-Eire, Genoveva; Varela-Losada, Susana] Complexo Hosp, Unidad Alergol, Orense, Spain; [Torres, Maria J.; Blanca, Miguel] Hosp Civil, Carlos Haya Hosp, Fdn IMABIS, Res Lab, Malaga, Spain; [Gamboa, Pedro] Hosp Basurto, Serv Alergia, Bilbao, Spain; [Sirvent, Sofia; Rodriguez, Rosalia] Univ Complutense, Fac Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain; [Salcedo, Gabriel] Univ Politecn Madrid, ETSI Agronomos, Dept Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad Miguel Hernandez de Elche; FIMABIS; Hospital Carlos Haya; Basurto Hospital; Complutense University of Madrid; Universidad Politecnica de Madrid	Diaz-Perales, A (corresponding author), Ctr Biotecnol & Genom Plantas UPM INIA, Campus Montegancedo, Madrid, Spain.	araceli.diaz@upm.es	Parro, Victor/K-3788-2014; Gomez-Casado, Cristina/AAE-4826-2021; Muñoz, Rosa/AAC-7288-2020; Aguirre, Jacobo/K-5855-2014; RODRIGUEZ, ROSALIA/K-4993-2014; Díaz-Perales, Araceli/D-8433-2016; Fernandez, Javier/B-6425-2018; Blanco, Carlos/B-3895-2012; Cano, Rosa Munoz/K-9413-2014; Torres, Maria/GVU-3391-2022; Torres, María José/T-3518-2017; Bartra, Joan/L-4550-2014; Sirvent, Sofia/L-4339-2014; Gomez-Casado, Cristina/K-4031-2016	Muñoz, Rosa/0000-0001-8566-8285; Aguirre, Jacobo/0000-0003-2196-5103; RODRIGUEZ, ROSALIA/0000-0002-4280-3691; Díaz-Perales, Araceli/0000-0002-1093-3627; Fernandez, Javier/0000-0003-1065-7199; Blanco, Carlos/0000-0002-2893-6594; Cano, Rosa Munoz/0000-0001-8566-8285; Torres, María José/0000-0001-5228-471X; Bartra, Joan/0000-0001-7767-4730; Gomez-Casado, Cristina/0000-0002-7707-6367; Rivas, Luis Alfonso/0000-0001-8392-3000; Parro, Victor/0000-0003-3738-0724	Ministerio de Ciencia e Innovacion [BIO2009-07050, SAF2008-04053, FIS2011-27569]; FIS-Thematic Networks; Co-operative Research Centers: RIRAAF [RD07/0064]; Spanish Government (FPI programme, MEC); Spanish Government (FPU programme, MEC); Comunidad de Madrid, R&D Program of Activities [MODELICO-CM S2009ESP-1691]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FIS-Thematic Networks; Co-operative Research Centers: RIRAAF; Spanish Government (FPI programme, MEC)(German Research Foundation (DFG)); Spanish Government (FPU programme, MEC); Comunidad de Madrid, R&D Program of Activities(Comunidad de Madrid)	Ministerio de Ciencia e Innovacion (projects BIO2009-07050 and SAF2008-04053) and FIS-Thematic Networks, and Co-operative Research Centers: RIRAAF (RD07/0064). C Gomez Casado and L Tordesillas have been supported by training grants from the Spanish Government (FPI and FPU programmes, MEC, respectively). J Aguirre has been supported by the Ministerio de Ciencia e Innovacion (project FIS2011-27569) and Comunidad de Madrid, R&D Program of Activities, grant MODELICO-CM S2009ESP-1691. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2011, ALLERGY, V66, P1261, DOI 10.1111/j.1398-9995.2011.02656.x; Aguirre J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026324; Ahrazem O, 2005, INT ARCH ALLERGY IMM, V137, P201, DOI 10.1159/000086332; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Barber D, 2009, CLIN EXP ALLERGY, V39, P1764, DOI 10.1111/j.1365-2222.2009.03351.x; Bernardi ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027856; Beyer K, 2005, CURR OPIN ALLERGY CL, V5, P261, DOI 10.1097/01.all.0000168792.27948.f9; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Crameri R, 2007, EXPERT REV VACCINES, V6, P991, DOI 10.1586/14760584.6.6.991; Cuesta-Herranz J, 2010, INT ARCH ALLERGY IMM, V153, P182, DOI 10.1159/000312636; Diaz-Perales A, 2003, J ALLERGY CLIN IMMUN, V112, P1002, DOI 10.1016/j.jaci.2003.07.006; Diaz-Perales A, 2002, CLIN EXP ALLERGY, V32, P87, DOI 10.1046/j.0022-0477.2001.01257.x; Diaz-Perales A, 2000, CLIN EXP ALLERGY, V30, P1403, DOI 10.1046/j.1365-2222.2000.00909.x; Dreborg S., 1989, ALLERGY S10, V44, P31; Rivas MF, 2009, J INVEST ALLERG CLIN, V19, P37; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hartz C, 2007, MOL IMMUNOL, V44, P2820, DOI 10.1016/j.molimm.2007.01.030; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Holgate ST, 2006, ALLERGY; Huber W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S8; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lauer I, 2007, CLIN EXP ALLERGY, V37, P261, DOI 10.1111/j.1365-2222.2007.02653.x; Le LQ, 2006, PLANT BIOTECHNOL J, V4, P231, DOI 10.1111/j.1467-7652.2005.00175.x; Lopez-Torrejon G, 2005, CLIN EXP ALLERGY, V35, P1065, DOI 10.1111/j.1365-2222.2005.02303.x; Palacin A, 2008, CLIN EXP ALLERGY, V38, P1220, DOI 10.1111/j.1365-2222.2007.02927.x; Palacin A, 2009, CLIN EXP ALLERGY, V39, P1267, DOI 10.1111/j.1365-2222.2009.03280.x; Palacin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044088; Palacin A, 2006, J ALLERGY CLIN IMMUN, V117, P1423, DOI 10.1016/j.jaci.2006.01.026; Pastorello EA, 2004, J ALLERGY CLIN IMMUN, V114, P908, DOI 10.1016/j.jaci.2004.06.020; Pastorello EA, 2010, J AGR FOOD CHEM, V58, P4513, DOI 10.1021/jf100213g; Rivas LA, 2011, ENVIRON MICROBIOL, V13, P1421, DOI 10.1111/j.1462-2920.2011.02442.x; Salcedo G, 2007, BBA-MOL CELL BIOL L, V1771, P781, DOI 10.1016/j.bbalip.2007.01.001; Salcedo G, 2004, CLIN EXP ALLERGY, V34, P1336, DOI 10.1111/j.1365-2222.2004.02018.x; Salcedo G, 2010, CLIN EXP ALLERGY, V40, P836, DOI 10.1111/j.1365-2222.2010.03506.x; Sanz ML, 2011, CURR OPIN ALLERGY CL, V11, P204, DOI 10.1097/ACI.0b013e3283466fe4; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Shreffler WG, 2011, J ALLERGY CLIN IMMUN, V127, P843, DOI 10.1016/j.jaci.2011.02.011; Sirvent S, 2009, CLIN EXP ALLERGY, V39, P1929, DOI 10.1111/j.1365-2222.2009.03382.x; Tordesillas L, 2011, INT ARCH ALLERGY IMM, V156, P291, DOI 10.1159/000323503; Valenta R, 1999, CLIN EXP ALLERGY, V29, P896	41	44	45	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50799	10.1371/journal.pone.0050799	http://dx.doi.org/10.1371/journal.pone.0050799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272072	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000312386800016
J	Sirakova, TD; Deb, C; Daniel, J; Singh, HD; Maamar, H; Dubey, VS; Kolattukudy, PE				Sirakova, Tatiana D.; Deb, Chirajyoti; Daniel, Jaiyanth; Singh, Harminder D.; Maamar, Hedia; Dubey, Vinod S.; Kolattukudy, Pappachan E.			Wax Ester Synthesis is Required for Mycobacterium tuberculosis to Enter In Vitro Dormancy	PLOS ONE			English	Article							ACYL-COA REDUCTASE; FATTY ALCOHOL; DIACYLGLYCEROL ACYLTRANSFERASES; GENE; TRIACYLGLYCEROL; PURIFICATION; EXPRESSION; STARVATION; ACIDS; BIOSYNTHESIS	Mycobacterium tuberculosis (Mtb) is known to produce wax esters (WE) when subjected to stress. However, nothing is known about the enzymes involved in biosynthesis of WE and their role in mycobacterial dormancy. We report that two putative Mtb fatty acyl-CoA reductase genes (fcr) expressed in E. coli display catalytic reduction of fatty acyl-CoA to fatty aldehyde and fatty alcohol. Both enzymes (FCR1/Rv3391) and FCR2/Rv1543) showed a requirement for NADPH as the reductant, a preference for oleoyl-CoA over saturated fatty acyl-CoA and were inhibited by thiol-directed reagents. We generated Mtb gene-knockout mutants for each reductase. Metabolic incorporation of C-14-oleate into fatty alcohols and WE was severely diminished in the mutants under dormancy-inducing stress conditions that are thought to be encountered by the pathogen in the host. The fatty acyl-CoA reductase activity in cell lysates of the mutants under nitric oxide stress was significantly reduced when compared with the wild type. Complementation restored the lost activity completely in the Delta fcr1 mutant and partially in the Delta fcr2 mutant. WE synthesis was inhibited in both Delta fcr mutants. The Dfcr mutants exhibited faster growth rates, an increased uptake of C-14-glycerol suggesting increased permeability of the cell wall, increased metabolic activity levels and impaired phenotypic antibiotic tolerance under dormancy-inducing combined multiple stress conditions. Complementation of the mutants did not restore the development of antibiotic tolerance to wild-type levels. Transcript analysis of Dfcr mutants showed upregulation of genes involved in energy generation and transcription, indicating the inability of the mutants to become dormant. Our results indicate that the fcr1 and fcr2 gene products are involved in WE synthesis under in vitro dormancy-inducing conditions and that WE play a critical role in reaching a dormant state. Drugs targeted against the Mtb reductases may inhibit its ability to go into dormancy and therefore increase susceptibility of Mtb to currently used antibiotics thereby enhancing clearance of the pathogen from patients. Citation: Sirakova TD, Deb C, Daniel J, Singh HD, Maamar H, et al. (2012) Wax Ester Synthesis is Required for Mycobacterium tuberculosis to Enter In Vitro Dormancy. PLoS ONE 7(12): e51641. doi:10.1371/journal.pone.0051641	[Sirakova, Tatiana D.; Deb, Chirajyoti; Daniel, Jaiyanth; Singh, Harminder D.; Maamar, Hedia; Dubey, Vinod S.; Kolattukudy, Pappachan E.] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Kolattukudy, PE (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	pk@mail.ucf.edu			National Institutes of Health [AI46582, AI35272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046582, R01AI035272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI46582 and AI35272 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL VP, 1978, ARCH BIOCHEM BIOPHYS, V191, P452, DOI 10.1016/0003-9861(78)90384-3; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Asselineau J., 1966, BACTERIAL LIPIDS; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bates L, 2004, LANCET INFECT DIS, V4, P368, DOI 10.1016/S1473-3099(04)01047-3; Belisle ST, 1998, MYCOBACTERIA PROTOCO; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; BISHOP JE, 1981, J BIOL CHEM, V256, P9542; Buckner JS, 1976, CHEM BIOCH NATURAL W, P148; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hofvander P, 2011, FEBS LETT, V585, P3538, DOI 10.1016/j.febslet.2011.10.016; HUANG AHC, 1978, PLANT PHYSIOL, V61, P339, DOI 10.1104/pp.61.3.339; Ishige T, 2003, CURR OPIN MICROBIOL, V6, P244, DOI 10.1016/S1369-5274(03)00053-5; KOLATTUK.PE, 1970, BIOCHEMISTRY-US, V9, P1095, DOI 10.1021/bi00807a007; Kolattukudy P. E., 1980, The biochemistry of plants. A comprehensive treatise. Volume 4. Lipids: structure and function., P571; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W, P1; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W, P290; KOLATTUKUDY PE, 1986, J LIPID RES, V27, P404; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; MOORE C, 1982, ARCH BIOCHEM BIOPHYS, V214, P489, DOI 10.1016/0003-9861(82)90052-2; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; NYKA W, 1967, J BACTERIOL, V93, P1458, DOI 10.1128/JB.93.4.1458-1460.1967; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; OHLROGGE JB, 1978, LIPIDS, V13, P203, DOI 10.1007/BF02533401; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Sargent JR, 1976, MARINE WAXES, P50; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Velayati AA, 2009, CHEMOTHERAPY, V55, P303, DOI 10.1159/000226425; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; Waltermann M, 2007, BIOCHIMIE, V89, P230, DOI 10.1016/j.biochi.2006.07.013; WANG L, 1972, BIOCHIM BIOPHYS ACTA, V260, P41; Willis RM, 2011, BIOCHEMISTRY-US, V50, P10550, DOI 10.1021/bi2008646	48	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51641	10.1371/journal.pone.0051641	http://dx.doi.org/10.1371/journal.pone.0051641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272127	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800058
J	Voxeur, A; Andre, A; Breton, C; Lerouge, P				Voxeur, Aline; Andre, Aurelie; Breton, Christelle; Lerouge, Patrice			Identification of Putative Rhamnogalacturonan-II Specific Glycosyltransferases in Arabidopsis Using a Combination of Bioinformatics Approaches	PLOS ONE			English	Article							3-DEOXY-D-MANNO-2-OCTULOSONIC ACID KDO; POLLEN-TUBE GROWTH; PLANT-CELL; PECTIC POLYSACCHARIDE; FUCOSYL-TRANSFERASE; CRYSTAL-STRUCTURE; PROTEIN; GENE; BIOSYNTHESIS; DATABASE	Rhamnogalacturonan-II (RG-II) is a complex plant cell wall polysaccharide that is composed of an a(1,4)-linked homogalacturonan backbone substituted with four side chains. It exists in the cell wall in the form of a dimer that is cross-linked by a borate di-ester. Despite its highly complex structure, RG-II is evolutionarily conserved in the plant kingdom suggesting that this polymer has fundamental functions in the primary wall organisation. In this study, we have set up a bioinformatics strategy aimed at identifying putative glycosyltransferases (GTs) involved in RG-II biosynthesis. This strategy is based on the selection of candidate genes encoding type II membrane proteins that are tightly coexpressed in both rice and Arabidopsis with previously characterised genes encoding enzymes involved in the synthesis of RG-II and exhibiting an up-regulation upon isoxaben treatment. This study results in the final selection of 26 putative Arabidopsis GTs, including 10 sequences already classified in the CAZy database. Among these CAZy sequences, the screening protocol allowed the selection of alpha-galacturonosyltransferases involved in the synthesis of alpha 4-GalA oligogalacturonides present in both homogalacturonans and RG-II, and two sialyltransferase-like sequences previously proposed to be involved in the transfer of Kdo and/or Dha on the pectic backbone of RG-II. In addition, 16 non-CAZy GT sequences were retrieved in the present study. Four of them exhibited a GT-A fold. The remaining sequences harbored a GT-B like fold and a fucosyltransferase signature. Based on homologies with glycosyltransferases of known functions, putative roles in the RG-II biosynthesis are proposed for some GT candidates. Citation: Voxeur A, Andre A, Breton C, Lerouge P (2012) Identification of Putative Rhamnogalacturonan-II Specific Glycosyltransferases in Arabidopsis Using a Combination of Bioinformatics Approaches. PLoS ONE 7(12): e51129. doi: 10.1371/journal.pone.0051129	[Voxeur, Aline; Andre, Aurelie; Lerouge, Patrice] Univ Rouen, Inst Rech & Innovat Biotechnol, EA 4358, Lab Glyco MEV, Mont St Aignan, France; [Breton, Christelle] Univ Grenoble 1, CERMAV CNRS, Grenoble, France	Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lerouge, P (corresponding author), Univ Rouen, Inst Rech & Innovat Biotechnol, EA 4358, Lab Glyco MEV, Mont St Aignan, France.	patrice.lerouge@univ-rouen.fr	Voxeur, Aline/O-7149-2015	Voxeur, Aline/0000-0001-9452-6756	Universities of Grenoble 1; Rouen	Universities of Grenoble 1; Rouen	This research was supported by the Universities of Grenoble 1 and Rouen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atmodjo MA, 2011, P NATL ACAD SCI USA, V108, P20225, DOI 10.1073/pnas.1112816108; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Caffall KH, 2009, MOL PLANT, V2, P1000, DOI 10.1093/mp/ssp062; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cavalier DM, 2006, J BIOL CHEM, V281, P34197, DOI 10.1074/jbc.M606379200; Chazalet V, 2001, J BACTERIOL, V183, P7067, DOI 10.1128/JB.183.24.7067-7075.2001; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; Deng Y, 2010, J INTEGR PLANT BIOL, V52, P829, DOI 10.1111/j.1744-7909.2010.00963.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Egelund J, 2004, PLANT PHYSIOL, V136, P2609, DOI 10.1104/pp.104.042978; Egelund J, 2006, PLANT CELL, V18, P2593, DOI 10.1105/tpc.105.036566; Egelund J, 2011, ANNU PLANT REV, V41, P213, DOI 10.1002/9781444391015.ch7; Eudes R, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-2; Fangel JU, 2011, PLANT SCI, V180, P470, DOI 10.1016/j.plantsci.2010.11.002; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Gilbert L, 2009, PLANT J, V60, P499, DOI 10.1111/j.1365-313X.2009.03972.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; Hansen SF, 2009, J PROTEOME RES, V8, P743, DOI 10.1021/pr800808m; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Imberty A, 2011, GLYCOSYLATION DIVERS, P25; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Kobayashi M, 2011, PLANT CELL PHYSIOL, V52, P1832, DOI 10.1093/pcp/pcr120; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lalanne E, 2004, GENETICS, V167, P1975, DOI 10.1534/genetics.104.030270; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Liu XL, 2011, PLANT J, V65, P647, DOI 10.1111/j.1365-313X.2010.04452.x; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Manfield IW, 2004, PLANT J, V40, P260, DOI 10.1111/j.1365-313X.2004.02208.x; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Obayashi T, 2010, J PLANT RES, V123, P311, DOI 10.1007/s10265-010-0333-6; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Oikawa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015481; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Perez S, 2003, BIOCHIMIE, V85, P109, DOI 10.1016/S0300-9084(03)00053-1; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Reuhs BL, 2004, PLANTA, V219, P147, DOI 10.1007/s00425-004-1205-x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Seveno M, 2004, NAT BIOTECHNOL, V22, P1351, DOI 10.1038/nbt1104-1351; Seveno M, 2010, GLYCOBIOLOGY, V20, P617, DOI 10.1093/glycob/cwq011; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Suzuki N, 2010, J BIOL CHEM, V285, P5178, DOI 10.1074/jbc.M109.018663; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Voxeur A, 2011, J BIOL CHEM, V286, P8014, DOI 10.1074/jbc.M110.198614; Yin Y, 2011, PLOS ONE, V11; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	76	14	50	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51129	10.1371/journal.pone.0051129	http://dx.doi.org/10.1371/journal.pone.0051129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272088	gold, Green Published			2022-12-27	WOS:000312386800027
J	Weng, CH; Hu, CC; Lin, JL; Lin-Tan, DT; Huang, WH; Hsu, CW; Yen, TH				Weng, Cheng-Hao; Hu, Ching-Chih; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Huang, Wen-Hung; Hsu, Ching-Wei; Yen, Tzung-Hai			Sequential Organ Failure Assessment Score Can Predict Mortality in Patients with Paraquat Intoxication	PLOS ONE			English	Article							PULSE THERAPY; ACUTE PHYSIOLOGY; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PLASMA; PROGNOSIS; MODERATE; SYSTEM	Introduction: Paraquat poisoning is characterized by multi-organ failure and pulmonary fibrosis with respiratory failure, resulting in high mortality and morbidity. The objective of this study was to identify predictors of mortality in cases of paraquat poisoning. Furthermore, we sought to determine the association between these parameters. Methods: A total of 187 patients were referred for management of intentional paraquat ingestion between January 2000 and December 2010. Demographic, clinical, and laboratory data were recorded. Sequential organ failure assessment (SOFA) and acute kidney injury network (AKIN) scores were collected, and predictors of mortality were analyzed. Results: Overall hospital mortality for the entire population was 54% (101/187). Using a multivariate logistic regression model, it was found that age, time to hospitalization, blood paraquat level, estimated glomerular filtration rate at admission (eGFR (first day)), and the SOFA(48-h) score, but not the AKIN(48-h) score, were significant predictors of mortality. For predicting the in-hospital mortality, SOFA(48-h) scores displayed a good area under the receiver operating characteristic curve (AUROC) (0.795 +/- 0.033, P<0.001). The cumulative survival rate differed significantly between patients with SOFA(48-h) scores <3 and those >= 3 (P<0.001). A modified SOFA (mSOFA) score was further developed by using the blood paraquat level, and this new score also demonstrated a better AUROC (0.848 +/- 0.029, P<0.001) than the original SOFA score. Finally, the cumulative survival rate also differed significantly between patients with mSOFA scores <4 and >= 4 (P<0.001). Conclusion: The analytical data demonstrate that SOFA and mSOFA scores, which are based on the extent of organ function or rate of organ failure, help to predict mortality after intentional paraquat poisoning.	[Weng, Cheng-Hao; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Huang, Wen-Hung; Hsu, Ching-Wei; Yen, Tzung-Hai] Chang Gung Mem Hosp, Dept Nephrol, Linkou Med Ctr, Taipei 10591, Taiwan; [Hu, Ching-Chih] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Keelung, Taiwan; [Hu, Ching-Chih] Chang Gung Mem Hosp, Liver Res Unit, Keelung, Taiwan; [Weng, Cheng-Hao; Hu, Ching-Chih; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Huang, Wen-Hung; Hsu, Ching-Wei; Yen, Tzung-Hai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Yen, TH (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Linkou Med Ctr, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	m19570@adm.cgmh.org.tw	huang, wen/GXW-0661-2022; Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505	Chang Gung Memorial Hospital	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Funding: Chang Gung Memorial Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan BSH, 1996, HUM EXP TOXICOL, V15, P949, DOI 10.1177/096032719601501202; Chan BSH, 1998, PHARMACOL THERAPEUT, V79, P193, DOI 10.1016/S0163-7258(98)00015-1; Chang MW, 2008, AM J MED SCI, V335, P451, DOI 10.1097/MAJ.0b013e318157cb6d; Cholongitas E, 2012, LIVER TRANSPLANT, V18, P405, DOI 10.1002/lt.23370; Craig DGN, 2011, ALIMENT PHARM THER, V34, P219, DOI 10.1111/j.1365-2036.2011.04687.x; HAMPSON ECGM, 1988, MED TOXICOL ADV DRUG, V3, P64, DOI 10.1007/BF03259932; Hsu HH, 2003, J TOXICOL-CLIN TOXIC, V41, P89, DOI 10.1081/CLT-120018278; Huang NC, 2006, CLIN TOXICOL, V44, P99, DOI 10.1080/15563650500514251; Jones AL, 1999, QJM-MON J ASSOC PHYS, V92, P573, DOI 10.1093/qjmed/92.10.573; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Lin JL, 1995, ARCH ENVIRON HEALTH, V50, P432, DOI 10.1080/00039896.1995.9935979; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 2006, CRIT CARE MED, V34, P368, DOI 10.1097/01.CCM.0000195013.47004.A8; Lin JL, 1996, THORAX, V51, P661, DOI 10.1136/thx.51.7.661; Lin NC, 2003, J TOXICOL-CLIN TOXIC, V41, P877, DOI 10.1081/CLT-120025356; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036576; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Min YG, 2011, CLIN TOXICOL, V49, P840, DOI 10.3109/15563650.2011.619137; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; PROUDFOOT AT, 1979, LANCET, V2, P330; SAWADA Y, 1988, LANCET, V1, P1333; SCHERRMANN JM, 1987, HUM TOXICOL, V6, P91, DOI 10.1177/096032718700600116; SELLERO IS, 1993, ANAL LETT, V26, P1891, DOI 10.1080/00032719308017438; SUZUKI K, 1989, HUM TOXICOL, V8, P33, DOI 10.1177/096032718900800106; SUZUKI K, 1991, HUM EXP TOXICOL, V10, P21, DOI 10.1177/096032719101000104; TALBOT AR, 1988, HUM TOXICOL, V7, P325, DOI 10.1177/096032718800700405; Tsai TY, 2011, HUM EXP TOXICOL, V30, P71, DOI 10.1177/0960327110368419; VALE JA, 1987, HUM TOXICOL, V6, P41, DOI 10.1177/096032718700600107; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x; Yen TH, 2010, AM J EMERG MED, V28, P728, DOI 10.1016/j.ajem.2009.06.001	31	48	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51743	10.1371/journal.pone.0051743	http://dx.doi.org/10.1371/journal.pone.0051743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272154	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800075
J	Xu, H; Krolikowski, JG; Jones, DW; Ge, ZD; Pagel, PS; Pritchard, KA; Weihrauch, D				Xu, Hao; Krolikowski, John G.; Jones, Deron W.; Ge, Zhi-Dong; Pagel, Paul S.; Pritchard, Kirkwood A., Jr.; Weihrauch, Dorothee			4F Decreases IRF5 Expression and Activation in Hearts of Tight Skin Mice	PLOS ONE			English	Article							REGULATORY FACTOR 5; MIMETIC PEPTIDE; FIBRILLIN-1 EXPRESSION; SYSTEMIC-SCLEROSIS; INDUCED APOPTOSIS; OXIDATIVE STRESS; MOUSE MODEL; APOA-I; PROTEIN; CELLS	The apoAI mimetic 4F was designed to inhibit atherosclerosis by improving HDL. We reported that treating tight skin (Tsk(-/+)) mice, a model of systemic sclerosis (SSc), with 4F decreases inflammation and restores angiogenic potential in Tsk(-/+) hearts. Interferon regulating factor 5 (IRF5) is important in autoimmunity and apoptosis in immune cells. However, no studies were performed investigating IRF5 in myocardium. We hypothesize that 4F differentially modulates IRF5 expression and activation in Tsk(-/+) hearts. Posterior wall thickness was significantly increased in Tsk(-/+) compared to C57Bl/6J (control) and Tsk(-/+) mice with 4F treatment assessed by echoradiography highlighting reduction of fibrosis in 4F treated Tsk(-/+) mice. IRF5 in heart lysates from control and Tsk/+ with and without 4F treatment (sc, 1 mg/kg/d, 6-8 weeks) was determined. Phosphoserine, ubiquitin, ubiquitin K-63 on IRF5 were determined on immunoprecipitates of IRF5. Immunofluorescence and TUNEL assays in heart sections were used to determine positive nuclei for IRF5 and apoptosis, respectively. Fluorescence-labeled streptavidin (SA) was used to determine endothelial cell uptake of biotinylated 4F. SA-agarose pulldown and immunoblotting for IRF5 were used to determine 4F binding IRF5 in endothelial cell cytosolic fractions and to confirm biolayer interferometry studies. IRF5 levels in Tsk(-/+) hearts were similar to control. 4F treatments decrease IRF5 in Tsk(-/+) hearts and decrease phosphoserine and ubiquitin K 63 but increase total ubiquitin on IRF5 in Tsk(-/+) compared with levels on IRF5 in control hearts. 4F binds IRF5 by mechanisms favoring association over dissociation strong enough to pull down IRF5 from a mixture of endothelial cell cytosolic proteins. IRF5 positive nuclei and apoptotic cells in Tsk(-/+) hearts were increased compared with controls. 4F treatments decreased both measurements in Tsk(-/+) hearts. IRF5 activation in Tsk(-/+) hearts is increased. 4F treatments decrease IRF5 expression and activation in Tsk(-/+) hearts by a mechanism related to 4F's ability to bind IRF5. Citation: Xu H, Krolikowski JG, Jones DW, Ge Z-D, Pagel PS, et al. (2012) 4F Decreases IRF5 Expression and Activation in Hearts of Tight Skin Mice. PLoS ONE 7(12): e52046. doi:10.1371/journal.pone.0052046	[Krolikowski, John G.; Ge, Zhi-Dong; Weihrauch, Dorothee] Childrens Res Inst, Dept Surg, Div Anesthesiol, Milwaukee, WI USA; [Xu, Hao; Jones, Deron W.; Pritchard, Kirkwood A., Jr.] Childrens Res Inst, Dept Surg, Div Pediat Surg, Milwaukee, WI USA; [Pagel, Paul S.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA		Weihrauch, D (corresponding author), Childrens Res Inst, Dept Surg, Div Anesthesiol, Milwaukee, WI USA.	dorothee@mcw.edu			Hao Xu's start-up funds from Dept. Surgery, Div. Pediatric Surgery [HL-089779, HL-102836, HL-102996]; departmental funds from the Department of Anesthesiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089779, R21HL102996, R01HL112270, R01HL102836] Funding Source: NIH RePORTER	Hao Xu's start-up funds from Dept. Surgery, Div. Pediatric Surgery; departmental funds from the Department of Anesthesiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dorothee Weihrauch HL-089779, Kirkwood A. Pritchard Jr. HL-102836 and HL-102996, Hao Xu's start-up funds from Dept. Surgery, Div. Pediatric Surgery, and departmental funds from the Department of Anesthesiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SS, 2006, ARTHRITIS RHEUM-US, V54, P2250, DOI 10.1002/art.21952; Amour J, 2009, ANESTHESIOLOGY, V110, P317, DOI 10.1097/ALN.0b013e3181942cb4; Anda KS, 2011, AUTOIMMUNITY REVIEWS; Balkhi MY, 2010, CELL SIGNAL, V22, P117, DOI 10.1016/j.cellsig.2009.09.021; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; BOCCHIERI MH, 1991, ARTHRITIS RHEUM, V34, P599, DOI 10.1002/art.1780340512; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Charles-Schoeman C, 2008, CLIN IMMUNOL, V127, P234, DOI 10.1016/j.clim.2008.01.016; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Handattu SP, 2009, NEUROBIOL DIS, V34, P525, DOI 10.1016/j.nbd.2009.03.007; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kozyrev SV, 2007, AUTOIMMUNITY, V40, P591, DOI 10.1080/08916930701510905; Krolikowski J, 2012, ATHEROSCLEROSIS THRO, P32; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Navab M, 2007, J CLIN LIPIDOL, V1, P142, DOI 10.1016/j.jacl.2007.03.002; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Orikasa C, 2002, P NATL ACAD SCI USA, V99, P3306, DOI 10.1073/pnas.052707299; Ou JS, 2003, CIRCULATION, V107, P2337, DOI 10.1161/01.CIR.0000070589.61860.A9; PARDRIDGE WM, 1991, FEBS LETT, V288, P30, DOI 10.1016/0014-5793(91)80996-G; Sgonc R, 1996, J CLIN INVEST, V98, P785, DOI 10.1172/JCI118851; Sharif R, 2012, ANN RHEUMATIC DIS; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Singh K, 2011, J BIOL CHEM, V286, P3839, DOI 10.1074/jbc.M110.176719; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Van Lenten BJ, 2008, J LIPID RES, V49, P2302, DOI 10.1194/jlr.M800075-JLR200; Vecoli C, 2011, J CELL BIOCHEM, V112, P2616, DOI 10.1002/jcb.23188; Weihrauch D, 2004, CIRCULATION, V109, P2343, DOI 10.1161/01.CIR.0000129225.67353.1F; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Wool GD, 2009, J LIPID RES, V50, P1889, DOI 10.1194/jlr.M900151-JLR200; Xu H, 2011, AM J PHYSIOL-CELL PH, V300, pC550, DOI 10.1152/ajpcell.00123.2010	38	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52046	10.1371/journal.pone.0052046	http://dx.doi.org/10.1371/journal.pone.0052046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251680	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800133
J	Buffa, V; Klein, K; Fischetti, L; Shattock, RJ				Buffa, Viviana; Klein, Katja; Fischetti, Lucia; Shattock, Robin J.			Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice	PLOS ONE			English	Article							FEMALE GENITAL-TRACT; IMMUNE-RESPONSES; SUBLINGUAL IMMUNIZATION; VACCINE; ANTIBODIES; DELIVERY; CHITOSAN; IMMUNOTHERAPY; TOLERANCE; ANTIGENS	In the present study we investigate the impact of a range of TLR ligands and chitosan as potential adjuvants for different routes of mucosal immunisation (sublingual (SL), intranasal (IN), intravaginal (IVag) and a parenteral route (subcutaneous (SC)) in the murine model. We assess their ability to enhance antibody responses to HIV-1 CN54gp140 (gp140) and Tetanus toxoid (TT) in systemic and vaginal compartments. A number of trends were observed by route of administration. For non-adjuvanted antigen, SC>SL>IN immunisation with respect to systemic IgG responses, where endpoint titres were greater for TT than for gp140. In general, co-administration with adjuvants increased specific IgG responses where IN = SC>SL, while in the vaginal compartment IN>SL>SC for specific IgA. In contrast, for systemic and mucosal IgA responses to antigen alone SL>IN = SC. A number of adjuvants increased specific systemic IgA responses where in general IN>SL>SC immunisation, while for mucosal responses IN = SL>SC. In contrast, direct intravaginal immunisation failed to induce any detectable systemic or mucosal responses to gp140 even in the presence of adjuvant. However, significant systemic IgG responses to TT were induced by intravaginal immunisation with or without adjuvant, and detectable mucosal responses IgG and IgA were observed when TT was administered with FSL-1 or Poly I:C. Interestingly some TLRs displayed differential activity dependent upon the route of administration. MPLA (TLR4) suppressed systemic responses to SL immunisation while enhancing responses to IN or SC immunisation. CpG B enhanced SL and IN responses, while having little or no impact on SC immunisation. These data demonstrate important route, antigen and adjuvant effects that need to be considered in the design of mucosal vaccine strategies.	[Buffa, Viviana; Klein, Katja; Fischetti, Lucia; Shattock, Robin J.] St Georges Univ London, London, England	St Georges University London	Shattock, RJ (corresponding author), St Georges Univ London, London, England.	r.shattock@imperial.ac.uk			National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Division of AIDS (DAIDS); United States Department of Health and Human Services (HHS); Center for HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854-05]; Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of AIDS (DAIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Health and Human Services (HHS); Center for HIV/AIDS Vaccine Immunology (CHAVI); Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Division of AIDS (DAIDS), United States Department of Health and Human Services (HHS) and Center for HIV/AIDS Vaccine Immunology (CHAVI) # U19 AI067854-05. The authors gratefully acknowledge an equipment grant from Dormeur Investment Service Ltd. that provided funding to purchase the plate reader and washer used in these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca HC, 2009, EXPERT REV VACCINES, V8, P937, DOI [10.1586/erv.09.47, 10.1586/ERV.09.47]; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Black CA, 2000, J IMMUNOL, V165, P5077, DOI 10.4049/jimmunol.165.9.5077; Chadwick S, 2009, EXPERT OPIN BIOL TH, V9, P427, DOI [10.1517/14712590902849224 , 10.1517/14712590902849224]; Cranage MP, 2010, MUCOSAL IMMUNOL, V3, P57, DOI 10.1038/mi.2009.110; Cranage MP, 2011, VACCINE, V29, P1421, DOI 10.1016/j.vaccine.2010.12.034; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Huo ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033736; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kweon MN, 2011, CYTOKINE, V54, P1, DOI 10.1016/j.cyto.2010.12.014; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Levine MM, 2000, J PEDIATR GASTR NUTR, V31, P336, DOI 10.1097/00005176-200010000-00003; Mapletoft JW, 2010, CLIN VACCINE IMMUNOL, V17, P23, DOI 10.1128/CVI.00250-09; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McCluskie MJ, 2001, CRIT REV IMMUNOL, V21, P103; Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Negri DRM, 2010, VACCINE, V28, P4175, DOI 10.1016/j.vaccine.2010.04.013; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Novak N, 2008, TRENDS MOL MED, V14, P191, DOI 10.1016/j.molmed.2008.03.001; Pfaar O, 2011, INT ARCH ALLERGY IMM, V154, P336, DOI 10.1159/000321826; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; Senti G, 2009, CURR OPIN ALLERGY CL, V9, P537, DOI 10.1097/ACI.0b013e3283310ff7; Staines NA, 1996, CLIN EXP IMMUNOL, V103, P368; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107; Tomai MA, 2007, EXPERT REV VACCINES, V6, P835, DOI 10.1586/14760584.6.5.835; van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5; Warshakoon HJ, 2009, HUM VACCINES, V5, P381, DOI 10.4161/hv.5.6.8175; Wegmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015861; Wright PF, 2011, AM J REPROD IMMUNOL, V65, P248, DOI 10.1111/j.1600-0897.2010.00954.x; Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034	41	48	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50529	10.1371/journal.pone.0050529	http://dx.doi.org/10.1371/journal.pone.0050529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272062	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600012
J	Qian, CP; Ma, JH; Zhang, PH; Luo, AT; Wang, C; Ren, ZQ; Kong, LH; Zhang, S; Wang, XJ; Wu, Y				Qian, Chunping; Ma, Jihua; Zhang, Peihua; Luo, Antao; Wang, Chao; Ren, Zhiqiang; Kong, Linghao; Zhang, Shuo; Wang, Xiaojing; Wu, Ying			Resveratrol Attenuates the Na+-Dependent Intracellular Ca2+ Overload by Inhibiting H2O2-Induced Increase in Late Sodium Current in Ventricular Myocytes	PLOS ONE			English	Article							SPIN-RESONANCE SPECTROSCOPY; FREE-RADICAL GENERATION; HYDROGEN-PEROXIDE; RED WINE; MYOCARDIAL-ISCHEMIA; THERAPEUTIC TARGET; REPERFUSION INJURY; CARDIAC MYOCYTES; OXIDATIVE STRESS; FRENCH PARADOX	Background/Aims: Resveratrol has been demonstrated to be protective in the cardiovascular system. The aim of this study was to assess the effects of resveratrol on hydrogen peroxide (H2O2)-induced increase in late sodium current (I-Na.L) which augmented the reverse Na+-Ca2+ exchanger current (I-NCX), and the diastolic intracellular Ca2+ concentration in ventricular myocytes. Methods: I-Na.L, I-NCX, L-type Ca2+ current (I-Ca.L) and intracellular Ca2+ properties were determined using whole-cell patch-clamp techniques and dual-excitation fluorescence photomultiplier system (IonOptix), respectively, in rabbit ventricular myocytes. Results: Resveratrol (10, 20, 40 and 80 mu M)decreased I-Na.L in myocytes both in the absence and presence of H2O2 (300 mu M) in a concentration dependent manner. Ranolazine (3-9 mu M) and tetrodotoxin (TTX, 4 mu M), I-Na.L inhibitors, decreased I-Na.L in cardiomyocytes in the presence of 300 mu M H2O2. H2O2 (300 mu M) increased the reverse I-NCX and this increase was significantly attenuated by either 20 mu M resveratrol or 4 mu M ranolazine or 4 mu M TTX. In addition, 10 mu M resveratrol and 2 mu M TTX significantly depressed the increase by 150 mu M H2O2 of the diastolic intracellular Ca2+ fura-2 fluorescence intensity (FFI), fura-fluorescence intensity change (Delta FFI), maximal velocity of intracellular Ca2+ transient rise and decay. As expected, 2 mu M TTX had no effect on I-Ca.L. Conclusion: Resveratrol protects the cardiomyocytes by inhibiting the H2O2-induced augmentation of I-Na.L and may contribute to the reduction of ischemia-induced lethal arrhythmias. Citation: Qian C, Ma J, Zhang P, Luo A, Wang C, et al. (2012) Resveratrol Attenuates the Na+-Dependent Intracellular Ca2+ Overload by Inhibiting H2O2-Induced Increase in Late Sodium Current in Ventricular Myocytes. PLoS ONE 7(12): e51358. doi:10.1371/journal.pone.0051358	[Qian, Chunping; Ma, Jihua; Zhang, Peihua; Luo, Antao; Wang, Chao; Ren, Zhiqiang; Kong, Linghao; Zhang, Shuo; Wang, Xiaojing; Wu, Ying] Wuhan Univ Sci & Technol, Coll Med, Cardioelectrophysiol Res Lab, Wuhan, Hubei, Peoples R China	Wuhan University of Science & Technology	Ma, JH (corresponding author), Wuhan Univ Sci & Technol, Coll Med, Cardioelectrophysiol Res Lab, Wuhan, Hubei, Peoples R China.	mjhua@wust.edu.cn			National Natural Science Foundation of China [81072637]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81072637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; ARROYO CM, 1987, FREE RADICAL BIO MED, V3, P313, DOI 10.1016/S0891-5849(87)80037-0; BAKER JE, 1988, P NATL ACAD SCI USA, V85, P2786, DOI 10.1073/pnas.85.8.2786; Barry WH, 2010, AM J PHYSIOL-HEART C, V298, pH102, DOI 10.1152/ajpheart.00316.2009; Belardinelli L, 2006, HEART, V92, P6, DOI 10.1136/hrt.2005.078790; BHATNAGAR A, 1990, CIRC RES, V67, P535, DOI 10.1161/01.RES.67.3.535; BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; BORASO A, 1994, AM J PHYSIOL, V267, pH1010, DOI 10.1152/ajpheart.1994.267.3.H1010; Chen L, 2001, J CHROMATOGR A, V907, P343, DOI 10.1016/S0021-9673(00)00960-2; Constant J, 1997, CORONARY ARTERY DIS, V8, P645, DOI 10.1097/00019501-199710000-00007; Das DK, 1999, DRUG EXP CLIN RES, V25, P115; El-Ani D, 2011, LIFE SCI, V89, P7, DOI 10.1016/j.lfs.2011.04.017; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; GARLICK PB, 1987, CIRC RES, V61, P757, DOI 10.1161/01.RES.61.5.757; Hale SL, 2006, J PHARMACOL EXP THER, V318, P418, DOI 10.1124/jpet.106.103242; Harnmarstrom AKM, 2002, EUR BIOPHYS J BIOPHY, V31, P323, DOI 10.1007/s00249-002-0218-2; Hegyi B, 2012, PFLUG ARCH EUR J PHY, V464, P167, DOI 10.1007/s00424-012-1114-y; Hing LM, 2001, FREE RADICAL BIO MED, V30, P877, DOI 10.1016/S0891-5849(01)00474-9; Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4; JOSEPHSON RA, 1991, J BIOL CHEM, V266, P2354; Ju YK, 1996, J PHYSIOL-LONDON, V497, P337, DOI 10.1113/jphysiol.1996.sp021772; KIYOSUE T, 1989, CIRC RES, V64, P389, DOI 10.1161/01.RES.64.2.389; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Liu H, 2010, J CARDIOVASC PHARM, V55, P227, DOI 10.1097/FJC.0b013e3181cb599f; Liu Zheng, 2005, Shengli Xuebao, V57, P599; Luo AT, 2007, CELL PHYSIOL BIOCHEM, V19, P9, DOI 10.1159/000099188; Ma JH, 2005, ACTA PHARMACOL SIN, V26, P828, DOI 10.1111/j.1745-7254.2005.00154.x; Olas B, 2002, THROMB RES, V107, P141, DOI 10.1016/S0049-3848(02)00273-6; Parikh A, 2012, HEART RHYTHM, V9, P953, DOI 10.1016/j.hrthm.2012.01.010; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Richardt G, 1997, Z KARDIOL, V86, P23; Saint DA, 2008, BRIT J PHARMACOL, V153, P1133, DOI 10.1038/sj.bjp.0707492; Saint David A, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS96, DOI 10.1111/j.1540-8167.2006.00390.x; Sato H, 2009, ACTA PHARMACOL SIN, V30, P78, DOI 10.1038/aps.2008.4; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Song Y, 2006, J PHARMACOL EXP THER, V318, P214, DOI 10.1124/jpet.106.101832; Sossalla S, 2008, J MOL CELL CARDIOL, V45, P32, DOI 10.1016/j.yjmcc.2008.03.006; Sossalla S, 2012, PHARMACOL THERAPEUT, V133, P311, DOI 10.1016/j.pharmthera.2011.11.003; Sun LH, 2010, CELL PHYSIOL BIOCHEM, V26, P421, DOI 10.1159/000320584; Tang Q, 2012, PFLUG ARCH EUR J PHY, V463, P513, DOI 10.1007/s00424-011-1070-y; Undrovinas Albertas, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P348, DOI 10.2174/187152508785909447; Undrovinas Albertas I, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS169; Wagner S, 2003, CARDIOVASC RES, V60, P404, DOI 10.1016/j.cardiores.2003.08.006; Wallace CHR, 2006, BRIT J PHARMACOL, V149, P657, DOI 10.1038/sj.bjp.0706897; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Wang WP, 2007, PFLUG ARCH EUR J PHY, V454, P461, DOI 10.1007/s00424-007-0219-1; Wasserstrom JA, 2009, J PHARMACOL EXP THER, V331, P382, DOI 10.1124/jpet.109.156471; Wood LG, 2010, ANTIOXID REDOX SIGN, V13, P1535, DOI 10.1089/ars.2009.3064; Yang KT, 2004, FASEB J, V18, P1442, DOI 10.1096/fj.03-1038fje; Zhang S, 2012, J CARDIOVASC PHARM; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353	51	31	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51358	10.1371/journal.pone.0051358	http://dx.doi.org/10.1371/journal.pone.0051358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272101	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386600024
J	Mobashir, M; Schraven, B; Beyer, T				Mobashir, Mohammad; Schraven, Burkhart; Beyer, Tilo			Simulated Evolution of Signal Transduction Networks	PLOS ONE			English	Article							IN-SILICO EVOLUTION; KINASE CASCADE; ROBUSTNESS; ERK; DYNAMICS; PATHWAY; NOISE	Signal transduction is the process of routing information inside cells when receiving stimuli from their environment that modulate the behavior and function. In such biological processes, the receptors, after receiving the corresponding signals, activate a number of biomolecules which eventually transduce the signal to the nucleus. The main objective of our work is to develop a theoretical approach which will help to better understand the behavior of signal transduction networks due to changes in kinetic parameters and network topology. By using an evolutionary algorithm, we designed a mathematical model which performs basic signaling tasks similar to the signaling process of living cells. We use a simple dynamical model of signaling networks of interacting proteins and their complexes. We study the evolution of signaling networks described by mass-action kinetics. The fitness of the networks is determined by the number of signals detected out of a series of signals with varying strength. The mutations include changes in the reaction rate and network topology. We found that stronger interactions and addition of new nodes lead to improved evolved responses. The strength of the signal does not play any role in determining the response type. This model will help to understand the dynamic behavior of the proteins involved in signaling pathways. It will also help to understand the robustness of the kinetics of the output response upon changes in the rate of reactions and the topology of the network.	[Mobashir, Mohammad; Schraven, Burkhart; Beyer, Tilo] Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Schraven, Burkhart] Helmholtz Ctr Infect Dis HZI, Dept Immune Control, Braunschweig, Germany	Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research	Mobashir, M (corresponding author), Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany.	mohammad.mobashir@med.ovgu.de	Mobashir, Mohammad/ABC-2994-2021	Mobashir, Mohammad/0000-0002-5385-4048	German Ministry of Education and Research (BMBF FORSYS program) [0313922]; State of Sachsen-Anhalt (Dynamic Systems) [XD3639HP/0306]; European Union (SYBILLA) [HEALTH-F4-2008-201106]	German Ministry of Education and Research (BMBF FORSYS program)(Federal Ministry of Education & Research (BMBF)); State of Sachsen-Anhalt (Dynamic Systems); European Union (SYBILLA)(European Commission)	This work was supported in part by grants from the German Ministry of Education and Research (BMBF FORSYS program) [0313922], the State of Sachsen-Anhalt (Dynamic Systems) [XD3639HP/0306] and the European Union (SYBILLA) [HEALTH-F4-2008-201106]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2005, J CLIN ONCOL, V23, P5386, DOI 10.1200/JCO.2005.23.648; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bluthgen N, 2008, ESSAYS BIOCHEM, V45, P95, DOI 10.1042/BSE0450095; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Deckard A, 2004, CHEMBIOCHEM, V5, P1423, DOI 10.1002/cbic.200400178; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Ghiglione C, 2005, DEV BIOL, V99, P181; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Paladugu SR, 2006, IEE P SYST BIOL, V153, P223, DOI 10.1049/ip-syb:20050096; Papin JA, 2004, J THEOR BIOL, V227, P283, DOI 10.1016/j.jtbi.2003.11.016; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	28	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50905	10.1371/journal.pone.0050905	http://dx.doi.org/10.1371/journal.pone.0050905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23272078	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200047
J	Oppenheim, FG; Helmerhorst, EJ; Lendenmann, U; Offner, GD				Oppenheim, Frank G.; Helmerhorst, Eva J.; Lendenmann, Urs; Offner, Gwynneth D.			Anti-Candidal Activity of Genetically Engineered Histatin Variants with Multiple Functional Domains	PLOS ONE			English	Article							HISTIDINE-RICH POLYPEPTIDES; HUMAN-PAROTID SECRETION; SALIVARY MUCIN MUC7; ANTIMICROBIAL PEPTIDES; ANTICANDIDAL ACTIVITY; FUNGICIDAL ACTIVITY; MOLECULAR-CLONING; INNATE IMMUNITY; ALBICANS; ANTIFUNGAL	The human bodily defense system includes a wide variety of innate antimicrobial proteins. Histatins are small molecular weight proteins produced by the human salivary glands that exhibit antifungal and antibacterial activities. While evolutionarily old salivary proteins such as mucins and proline-rich proteins contain large regions of tandem repeats, relatively young proteins like histatins do not contain such repeated domains. Anticipating that domain duplications have a functional advantage, we genetically engineered variants of histatin 3 with one, two, three, or four copies of the functional domain by PCR and splice overlap. The resulting proteins, designated reHst3 1-mer, reHist3 2-mer, reHis3 3-mer and reHist3 4-mer, exhibited molecular weights of 4,062, 5,919, 7,777, and 9,634 Da, respectively. The biological activities of these constructs were evaluated in fungicidal assays toward Candida albicans blastoconidia and germinated cells. The antifungal activities per mole of protein increased concomitantly with the number of functional domains present. This increase, however, was higher than could be anticipated from the molar concentration of functional domains present in the constructs. The demonstrated increase in antifungal activity may provide an evolutionary explanation why such domain multiplication is a frequent event in human salivary proteins.	[Oppenheim, Frank G.; Helmerhorst, Eva J.; Lendenmann, Urs; Offner, Gwynneth D.] Boston Univ, Dept Periodontol & Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA; [Offner, Gwynneth D.] Boston Univ, Med Ctr, Dept Med, Boston, MA USA	Boston University; Boston University	Oppenheim, FG (corresponding author), Boston Univ, Dept Periodontol & Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA.	fropp@bu.edu		Offner, Gwynneth/0000-0002-3687-9809; Helmerhorst, Eva/0000-0002-4803-3018	NIH [DE05672, DE07652, AI087803, DE14080, DE11691]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE005672, R01DE011691, R37DE005672, R01DE014080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The studies were supported by NIH Grants DE05672 (FO), DE07652 (FO), AI087803 (EH), DE14080 (GO) and DE11691 (GO). (http://www.nih.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEN EA, 1978, NATURE, V273, P775, DOI 10.1038/273775a0; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; BRUSILOW SW, 1959, AM J PHYSIOL, V196, P831, DOI 10.1152/ajplegacy.1959.196.4.831; Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200; Driscoll J, 1996, GENE, V177, P29, DOI 10.1016/0378-1119(96)00265-X; Edgerton M, 2000, Adv Dent Res, V14, P16; Helmerhorst EJ, 1997, BIOCHEM J, V326, P39, DOI 10.1042/bj3260039; Helmerhorst EJ, 1999, FEBS LETT, V449, P105, DOI 10.1016/S0014-5793(99)00411-1; Helmerhorst EJ, 1999, ANTIMICROB AGENTS CH, V43, P702, DOI 10.1128/AAC.43.3.702; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035478; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033818; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Kumar R, 2011, J BIOL CHEM, V286, P43748, DOI 10.1074/jbc.M111.311175; LAMKIN MS, 1993, CRIT REV ORAL BIOL M, V4, P251, DOI 10.1177/10454411930040030101; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1986, J BIOL CHEM, V261, P1177; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; RAJ PA, 1990, J BIOL CHEM, V265, P3898; RAYHAN R, 1992, ORAL MICROBIOL IMMUN, V7, P51, DOI 10.1111/j.1399-302X.1992.tb00020.x; Rothstein David M, 2002, Expert Opin Emerg Drugs, V7, P47, DOI 10.1517/14728214.7.1.47; SABATINI LM, 1989, J DENT RES, V68, P1138, DOI 10.1177/00220345890680070101; Situ H, 2000, ANTIMICROB AGENTS CH, V44, P1485, DOI 10.1128/AAC.44.6.1485-1493.2000; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Troxler RF, 1997, GLYCOBIOLOGY, V7, P965, DOI 10.1093/glycob/7.7.965; Tsai H, 1997, ANTIMICROB AGENTS CH, V41, P2224, DOI 10.1128/AAC.41.10.2224; VANDERSPEK JC, 1990, ARCH ORAL BIOL, V35, P137, DOI 10.1016/0003-9969(90)90175-A; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; XU T, 1990, J DENT RES, V69, P1717, DOI 10.1177/00220345900690110301; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zasloff M, 2002, LANCET, V360, P1116, DOI 10.1016/S0140-6736(02)11239-6; ZUO Y, 1995, GENE, V161, P87, DOI 10.1016/0378-1119(95)00237-Z	36	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51479	10.1371/journal.pone.0051479	http://dx.doi.org/10.1371/journal.pone.0051479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251551	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200118
J	Petrov, Y; Nador, J; Qian, JH				Petrov, Yury; Nador, Jeffrey; Qian, Jiehui			VEP Correlates of Feedback in Human Cortex	PLOS ONE			English	Article							INFEROTEMPORAL CORTEX; RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; STRIATE CORTEX; MACAQUE MONKEY; V1; NEURONS; CONDUCTIVITY; CONNECTIONS; TISSUE	It is known that neural responses become less dependent on the stimulus size and location along the visual pathway. This study aimed to use this property to find evidence of neural feedback in visually evoked potentials (VEP). High-density VEPs evoked by a contrast reversing checkerboard were collected from 15 normal observers using a 128-channel EEG system. Surface Laplacian method was used to calculate skull-scalp currents corresponding to the measured scalp potentials. This allowed us to identify several distinct foci of skull-scalp currents and to analyse their individual time-courses. Response nonlinearity as a function of the stimulus size increased markedly from the occipital to temporal loci. Similarly, the nonlinearity of reactivations (late evoked response peaks) over the occipital, lateral-occipital, and frontal scalp regions increased with the peak latency. Response laterality (contralateral vs. ipsilateral) was analysed in lateral-occipital and temporal loci. Early lateral-occipital responses were strongly contralateral but the response laterality decreased and then disappeared for later peaks. Responses in temporal loci did not differ significantly between contralateral and ipsilateral stimulation. Overall, the results suggest that feedback from higher-tier visual areas, e. g., those in temporal cortices, may significantly contribute to reactivations in early visual areas.	[Petrov, Yury; Nador, Jeffrey; Qian, Jiehui] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA	Northeastern University	Petrov, Y (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	y.petrov@neu.edu	Nador, Jeffrey/AAF-3783-2021	Nador, Jeffrey/0000-0002-6502-7226				Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bair W, 2003, J NEUROSCI, V23, P7690; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Haueisen J, 2002, NEUROIMAGE, V15, P159, DOI 10.1006/nimg.2001.0962; Hillyard S, 1987, ELECTROPHYSIOLOGY CO; Hoekema R, 2003, BRAIN TOPOGR, V16, P29, DOI 10.1023/A:1025606415858; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Juan CH, 2003, EXP BRAIN RES, V150, P259, DOI 10.1007/s00221-003-1478-5; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; Petrov Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011917; Petrov Y, 2009, J VISION, V9, DOI 10.1167/9.1.21; Picton T W, 1980, Prog Brain Res, V54, P17, DOI 10.1016/S0079-6123(08)61604-0; Reagan D, 1989, HUMAN BRAIN ELECTROP; ROCHAMIRANDA CE, 1975, J NEUROPHYSIOL, V38, P475, DOI 10.1152/jn.1975.38.3.475; Rugg M., 1995, ELECTROPHYSIOLOGY MI; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; SANDELL JH, 1982, J NEUROPHYSIOL, V48, P38, DOI 10.1152/jn.1982.48.1.38; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Silvanto J, 2005, CEREB CORTEX, V15, P1736, DOI 10.1093/cercor/bhi050; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Wingeier BM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051916; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51791	10.1371/journal.pone.0051791	http://dx.doi.org/10.1371/journal.pone.0051791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251625	Green Submitted, gold, Green Published			2022-12-27	WOS:000313236200166
J	Wu, ZH; Lu, MK; Hu, LY; Li, XT				Wu, Zhen Hua; Lu, Ming-ke; Hu, Long Yu; Li, Xiaotong			Praziquantel Synergistically Enhances Paclitaxel Efficacy to Inhibit Cancer Cell Growth	PLOS ONE			English	Article							X-LINKED-INHIBITOR; COLORECTAL-CANCER; MITOTIC ARREST; SCHISTOSOMA-MANSONI; APOPTOSIS-PROTEIN; TUMOR-CELLS; ARTEMISININ; DRUGS; ANTICANCER; CYTOTOXICITY	The major challenges we are facing in cancer therapy with paclitaxel (PTX) are the drug resistance and severe side effects. Massive efforts have been made to overcome these clinical challenges by combining PTX with other drugs. In this study, we reported the first preclinical data that praziquantel (PZQ), an anti-parasite agent, could greatly enhance the anticancer efficacy of PTX in various cancer cell lines, including PTX-resistant cell lines. Based on the combination index value, we demonstrated that PZQ synergistically enhanced PTX-induced cell growth inhibition. The co-treatment of PZQ and PTX also induced significant mitotic arrest and activated the apoptotic cascade. Moreover, PZQ combined with PTX resulted in a more pronounced inhibition of tumor growth compared with either drug alone in a mouse xenograft model. We tried to investigate the possible mechanisms of this synergistic efficacy induced by PZQ and PTX, and we found that the co-treatment of the two drugs could markedly decrease expression of X-linked inhibitor of apoptosis protein (XIAP), an antiapoptotic protein. Our data further demonstrated that down-regulation of XIAP was required for the synergistic interaction between PZQ and PTX. Together, this study suggested that the combination of PZQ and PTX may represent a novel and effective anticancer strategy for optimizing PTX therapy.	[Wu, Zhen Hua; Lu, Ming-ke; Hu, Long Yu; Li, Xiaotong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China	Xiamen University	Li, XT (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	xtli@xmu.edu.cn	Li, xiaotong/GYV-4890-2022		National Foundation for Fostering Talents of Basic Science, China [J1030626]; Key Project of Fujian Provincial Programs for Science and Technology [2011Y0050]; Technology Innovation Foundation of Science and Technology Bureau of Xiamen, China [2011S0567]	National Foundation for Fostering Talents of Basic Science, China; Key Project of Fujian Provincial Programs for Science and Technology; Technology Innovation Foundation of Science and Technology Bureau of Xiamen, China	This work was supported by the National Foundation for Fostering Talents of Basic Science, China (J1030626) (http://www.nsfc.gov.cn/Portal0/default152.htm); The Key Project of Fujian Provincial Programs for Science and Technology (2011Y0050); and The Technology Innovation Foundation of Science and Technology Bureau of Xiamen, China (2011S0567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2008, GASTROENTEROLOGY, V134, P131, DOI 10.1053/j.gastro.2007.10.008; Aoki D, 2009, CLIN CANCER RES, V15, P1473, DOI 10.1158/1078-0432.CCR-08-1274; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Boguski MS, 2009, SCIENCE, V324, P1394, DOI 10.1126/science.1169920; BRINDLEY PJ, 1987, J IMMUNOL, V139, P215; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Efferth T, 2001, INT J ONCOL, V18, P767; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Fromberg A, 2011, CANCER CHEMOTH PHARM, V67, P1157, DOI 10.1007/s00280-010-1418-6; GONNERT R, 1977, Z PARASITENKD, V52, P129, DOI 10.1007/BF00389899; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Haanen C, 2001, Curr Opin Investig Drugs, V2, P677; HARASAWA R, 1993, RES MICROBIOL, V144, P489, DOI 10.1016/0923-2508(93)90057-9; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Ichim TE, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-25; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Joseph S, 2004, J INFECT DIS, V190, P835, DOI 10.1086/422604; Keiser J, 2007, TRENDS PARASITOL, V23, P555, DOI 10.1016/j.pt.2007.07.012; Le XF, 2011, JNCI-J NATL CANCER I, V103, P1403, DOI 10.1093/jnci/djr280; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Nakase I, 2008, INT J PHARM, V354, P28, DOI 10.1016/j.ijpharm.2007.09.003; O'Connor CL, 2008, BBA-MOL CELL RES, V1783, P1903, DOI 10.1016/j.bbamcr.2008.05.025; Posner GH, 2003, J MED CHEM, V46, P1060, DOI 10.1021/jm020461q; Qi YF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031539, 10.1371/journal.pone.0033859]; Rodriguez-Antona C, 2010, PHARMACOGENOMICS, V11, P621, DOI 10.2217/PGS.10.32; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Takeuchi H, 2005, CLIN CANCER RES, V11, P7621, DOI 10.1158/1078-0432.CCR-05-0479; Tang J, 1999, IN VITRO CELL DEV-AN, V35, P1; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; Wu ZH, 2012, ASSAY DRUG DEV TECHN, V10, P344, DOI 10.1089/adt.2011.416; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023	38	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51721	10.1371/journal.pone.0051721	http://dx.doi.org/10.1371/journal.pone.0051721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251610	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200156
J	Hayette, S; Thomas, X; Jallades, L; Chabane, K; Charlot, C; Tigaud, I; Gazzo, S; Morisset, S; Cornillet-Lefebvre, P; Plesa, A; Huet, S; Renneville, A; Salles, G; Nicolini, FE; Magaud, JP; Michallet, M				Hayette, Sandrine; Thomas, Xavier; Jallades, Laurent; Chabane, Kaddour; Charlot, Carole; Tigaud, Isabelle; Gazzo, Sophie; Morisset, Stephane; Cornillet-Lefebvre, Pascale; Plesa, Adriana; Huet, Sarah; Renneville, Aline; Salles, Gilles; Nicolini, Franck Emmanuel; Magaud, Jean-Pierre; Michallet, Mauricette			High DNA Methyltransferase DNMT3B Levels: A Poor Prognostic Marker in Acute Myeloid Leukemia	PLOS ONE			English	Article							FUSION GENE TRANSCRIPTS; MYELODYSPLASTIC SYNDROMES; ICF SYNDROME; AML PATIENTS; MUTATIONS; METHYLATION; EVI1; EXPRESSION; CANCER; DIFFERENTIATION	It has been recently shown that DNA methyl transferase overexpression is correlated with unfavourable prognosis in human malignancies while methylation deregulation remains a hallmark that defines acute myeloid leukemia (AML). The oncogenic transcription factor EVI1 is involved in methylation deregulation and its overexpression plays a major role for predicting an adverse outcome. Moreover, the identification of DNMT3A mutations in AML patients has recently been described as a poor prognostic indicator. In order to clarify relationship between these key actors in methylation mechanisms and their potential impact on patient outcomes, we analysed 195 de novo AML patients for the expression of DNMT3A, 3B (and its non-catalytic variant 3B(NC)) and their correlations with the outcome and the expression of other common prognostic genetic biomarkers (EVI1, NPM1, FLT3ITD/TKD and MLL) in adult AML. The overexpression of DNMT3B/3B(NC) is (i) significantly correlated with a shorter overall survival, and (ii) inversely significantly correlated with event-free survival and DNMT3A expression level. Moreover, multivariate analysis showed that a high expression level of DNMT3B/3B(NC) is statistically a significant independent poor prognostic indicator. This study represents the first report showing that the overexpression of DNMT3B/3B(NC) is an independent predictor of poor survival in AML. Its quantification should be implemented to the genetic profile used to stratify patients for therapeutical strategies and should be useful to identify patients who may benefit from therapy based on demethylating agents.	[Hayette, Sandrine; Jallades, Laurent; Chabane, Kaddour; Charlot, Carole; Tigaud, Isabelle; Gazzo, Sophie; Plesa, Adriana; Huet, Sarah; Magaud, Jean-Pierre] Hosp Civils Lyon, Serv Hematol Biol, Ctr Hosp Lyon Sud, Lyon, France; [Hayette, Sandrine; Jallades, Laurent; Chabane, Kaddour; Gazzo, Sophie; Huet, Sarah; Salles, Gilles; Magaud, Jean-Pierre] Univ Lyon 1, Pathol Cellules Lymphoides UMR5239, F-69365 Lyon, France; [Thomas, Xavier; Morisset, Stephane; Salles, Gilles; Nicolini, Franck Emmanuel; Michallet, Mauricette] Hosp Civils Lyon, Serv Hematol, Clin Ctr Hosp Lyon Sud, Lyon, France; [Cornillet-Lefebvre, Pascale] CHU, Lab Hematol, Reims, France; [Renneville, Aline] CHRU Lille, Ctr Biol Pathol, Lab Hematol, Lille, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; CHU Lyon; CHU de Reims; Universite de Lille - ISITE; CHU Lille	Hayette, S (corresponding author), Hosp Civils Lyon, Serv Hematol Biol, Ctr Hosp Lyon Sud, Lyon, France.	sandrine.hayette@chu-lyon.fr	Salles, Gilles/Z-2336-2019; HAYETTE, sandrine/Z-2283-2019; Renneville, Aline/AAW-5451-2020; Morisset, Stephane/B-9629-2019	Salles, Gilles/0000-0002-9541-8666; Renneville, Aline/0000-0003-0805-9640; Morisset, Stephane/0000-0002-7747-113X	Pense a moelle; Cent pour sang la vie	Pense a moelle; Cent pour sang la vie	This work was supported by "Pense a moelle" and "Cent pour sang la vie" associations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Arai S, 2011, BLOOD, V117, P6304, DOI 10.1182/blood-2009-07-234310; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; ARBER DA, 2008, WHO CLASSIFICATION T, P110; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Boissel N, 2005, BLOOD, V106, P3618, DOI 10.1182/blood-2005-05-2174; Boissel N, 2002, LEUKEMIA, V16, P1699, DOI 10.1038/sj.leu.2402622; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Ehrlich M, 2003, CLIN IMMUNOL, V109, P17, DOI 10.1016/S1521-6616(03)00201-8; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Groschel S, 2010, J CLIN ONCOL, V28, P2101, DOI 10.1200/JCO.2009.26.0646; Hlady RA, 2012, J CLIN INVEST, V122, P163, DOI 10.1172/JCI57292; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; LaRochelle O, 2011, ONCOTARGET, V2, P850; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; Moarefi AH, 2011, J MOL BIOL, V409, P758, DOI 10.1016/j.jmb.2011.04.050; Nucifora G, 2006, GENE, V368, P1, DOI 10.1016/j.gene.2005.09.020; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Ostler KR, 2012, CANCER RES, V72, P4714, DOI 10.1158/0008-5472.CAN-12-0886; Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009; Poirel H, 1996, BLOOD, V87, P2496, DOI 10.1182/blood.V87.6.2496.bloodjournal8762496; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Renneville A, 2012, LEUKEMIA; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Senyuk V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020793; Shah MY, 2010, CANCER RES, V70, P5840, DOI 10.1158/0008-5472.CAN-10-0847; Thol F, 2011, HAEMATOL-HEMATOL J, V96, P1870, DOI 10.3324/haematol.2011.045559; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894; Thomas X, 2011, BLOOD, V118, P1754, DOI 10.1182/blood-2011-04-349258; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Van Emburgh BO, 2011, NUCLEIC ACIDS RES, V39, P4984, DOI 10.1093/nar/gkr116; Vazquez I, 2011, HAEMATOL-HEMATOL J, V96, P1448, DOI 10.3324/haematol.2011.040535; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang J, 2006, CANCER RES, V66, P8361, DOI 10.1158/0008-5472.CAN-06-2031; Weisser M, 2004, LEUKEMIA, V18, P1551, DOI 10.1038/sj.leu.2403438; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Zhang JJ, 2012, CLIN TRANSL ONCOL, V14, P116, DOI 10.1007/s12094-012-0770-x	46	46	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51527	10.1371/journal.pone.0051527	http://dx.doi.org/10.1371/journal.pone.0051527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251566	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900097
J	Jegla, T; Marlow, HQ; Chen, BH; Simmons, DK; Jacobo, SM; Martindale, MQ				Jegla, Timothy; Marlow, Heather Q.; Chen, Bihan; Simmons, David K.; Jacobo, Sarah M.; Martindale, Mark Q.			Expanded Functional Diversity of Shaker K+ Channels in Cnidarians Is Driven by Gene Expansion	PLOS ONE			English	Article							POTASSIUM CHANNELS; ALPHA-SUBUNITS; GENOME; EVOLUTION; INACTIVATION; SHAB; STOICHIOMETRY; RECOGNITION; MODULATION; ACTIVATION	The genome of the cnidarian Nematostella vectensis (starlet sea anemone) provides a molecular genetic view into the first nervous systems, which appeared in a late common ancestor of cnidarians and bilaterians. Nematostella has a surprisingly large and diverse set of neuronal signaling genes including paralogs of most neuronal signaling molecules found in higher metazoans. Several ion channel gene families are highly expanded in the sea anemone, including three subfamilies of the Shaker K+ channel gene family: Shaker (Kv1), Shaw (Kv3) and Shal (Kv4). In order to better understand the physiological significance of these voltage-gated K+ channel expansions, we analyzed the function of 18 members of the 20 gene Shaker subfamily in Nematostella. Six of the Nematostella Shaker genes express functional homotetrameric K+ channels in vitro. These include functional orthologs of bilaterian Shakers and channels with an unusually high threshold for voltage activation. We identified 11 Nematostella Shaker genes with a distinct "silent" or "regulatory" phenotype; these encode subunits that function only in heteromeric channels and serve to further diversify Nematostella Shaker channel gating properties. Subunits with the regulatory phenotype have not previously been found in the Shaker subfamily, but have evolved independently in the Shab (Kv2) family in vertebrates and the Shal family in a cnidarian. Phylogenetic analysis indicates that regulatory subunits were present in ancestral cnidarians, but have continued to diversity at a high rate after the split between anthozoans and hydrozoans. Comparison of Shaker family gene complements from diverse metazoan species reveals frequent, large scale duplication has produced highly unique sets of Shaker channels in the major metazoan lineages.	[Jegla, Timothy] Penn State Univ, Dept Biol, Eberly Coll Sci, University Pk, PA 16802 USA; [Jegla, Timothy] Penn State Univ, Huck Inst Life Sci, Eberly Coll Sci, University Pk, PA 16802 USA; [Marlow, Heather Q.; Simmons, David K.; Martindale, Mark Q.] Univ Hawaii, Kewalo Marine Lab, Honolulu, HI 96822 USA; [Chen, Bihan; Jacobo, Sarah M.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Hawaii System; Scripps Research Institute	Jegla, T (corresponding author), Penn State Univ, Dept Biol, Eberly Coll Sci, University Pk, PA 16802 USA.	tjj3@psu.edu		Jacobo, Sarah Melissa/0000-0002-1341-7222; Jegla, Timothy/0000-0001-8616-2390	Penn State Department of Biology; National Institute of Neurological Disorders and Stroke (NINDS); National Science Foundation (NSF); NASA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093116] Funding Source: NIH RePORTER	Penn State Department of Biology; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation (NSF)(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TJ is supported by grants from Penn State Department of Biology and the National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/). MQM is supported by grants from the National Science Foundation (NSF) (http://www.nsf.gov/) and NASA (http://www.nasa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON PAV, 1977, SCIENCE, V197, P186, DOI 10.1126/science.17918; Bardien-Kruger S, 2002, EUR J HUM GENET, V10, P36, DOI 10.1038/sj.ejhg.5200739; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Dodson PD, 2002, J NEUROSCI, V22, P6953; Finnerty JR, 2003, EVOL DEV, V5, P331, DOI 10.1046/j.1525-142X.2003.03041.x; Garm A, 2009, J EXP BIOL, V212, P3951, DOI 10.1242/jeb.031559; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jegla T, 1995, J NEUROSCI, V15, P7989; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Lin Yi-Chan James, 2001, Invertebrate Neuroscience, V4, P65; Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155; MACKIE GO, 1985, NATURE, V313, P791, DOI 10.1038/313791a0; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Nitabach MN, 2001, P NATL ACAD SCI USA, V98, P705, DOI 10.1073/pnas.031446198; Ogawa Y, 2008, J NEUROSCI, V28, P5731, DOI 10.1523/JNEUROSCI.4431-07.2008; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Piraino S, 2011, J COMP NEUROL, V519, P1931, DOI 10.1002/cne.22614; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reissner KJ, 2008, J NEUROCHEM, V105, P1006, DOI 10.1111/j.1471-4159.2007.05202.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Satterlie RA, 2011, J EXP BIOL, V214, P1215, DOI 10.1242/jeb.043687; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TSENGCRANK J, 1993, J GEN PHYSIOL, V102, P1057, DOI 10.1085/jgp.102.6.1057; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	64	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51366	10.1371/journal.pone.0051366	http://dx.doi.org/10.1371/journal.pone.0051366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251506	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900072
J	Chen, YC; Yip, PK; Huang, YL; Sun, Y; Wen, LL; Chu, YM; Chen, TF				Chen, Yen-Ching; Yip, Ping-Keung; Huang, Yi-Ling; Sun, Yu; Wen, Li-Li; Chu, Yi-Min; Chen, Ta-Fu			Sequence Variants of Toll Like Receptor 4 and Late-Onset Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TLR4 POLYMORPHISMS; PROSTATE-CANCER; RISK; TOLL-LIKE-RECEPTOR-4; POPULATION; SUSCEPTIBILITY; HYPERTENSION; INFLAMMATION; AGREEMENT	Background: Toll like receptor 4 (TLR4) has been related to inflammation and beta-amyloid deposition in Alzheimer's disease (AD) brain. No study has explored the association between haplotype-tagging single nucleotide polymorphisms (htSNPs) of TLR4 and AD risk previously and ApoE e4 status alone showed low sensitivity in identifying late-onset AD (LOAD) patients. Methods: A total of 269 LOAD patients were recruited from three hospitals in northern Taiwan (2007-2010). Controls (n = 449) were recruited from elderly health checkup and volunteers of the hospital during the same period of time. Five common (frequency >= 5%) TLR4 htSNPs were selected to assess the association between TLR4 polymorphisms and the risk of LOAD in the Chinese ethnic population. Results: Homozygosity of TLR4 rs1927907 was significantly associated with an increased risk of LOAD [ TT vs. CC: adjusted odds ratio (AOR) = 2.45, 95% confidence interval (CI) = 1.30-4.64]. After stratification, the association increased further in ApoE e4 non-carriers (AOR = 3.07) and in hypertensive patients (AOR = 3.60). Haplotype GACGG was associated with a decreased risk of LOAD (1 vs. 0 copies: AOR = 0.59, 95% CI = 0.36-0.96; 2 vs. 0 copies: AOR = 0.31, 95% CI = 0.14-0.67) in ApoE e4 non-carriers. ApoE e4 status significantly modified this association (p(interaction) = 0.01). These associations remained significant after correction for multiple tests. Conclusions: Sequence variants of TLR4 were associated with an increased risk of LOAD, especially in ApoE e4 non-carriers and in hypertensive patients. The combination of TLR4 rs1927907 and ApoE e4 significantly increased the screening sensitivity in identifying LOAD patients from 0.4 to 0.7.	[Chen, Yen-Ching; Huang, Yi-Ling] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Yip, Ping-Keung] Cardinal Tien Hosp, Ctr Neurol Med, Taipei, Taiwan; [Sun, Yu] En Chu Kong Hosp, Dept Neurol, Taipei, Taiwan; [Yip, Ping-Keung] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Lab Med, Taipei, Taiwan; [Chu, Yi-Min] Cardinal Tien Hosp, Dept Lab Med, Taipei, Taiwan; [Chen, Ta-Fu] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Chen, YC (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	karenchen@ntu.edu.tw	Huang, YiLing/ABH-8788-2020; Chen, Yen-Ching/D-1098-2010	Chen, Ta-Fu/0000-0003-1988-6924; Chen, Yen-Ching/0000-0002-8159-7202	National Science Council [96-2314-B-002-197, 97-2314-B-002-168-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	Funding for the study was provided by National Science Council grants 96-2314-B-002-197 and 97-2314-B-002-168-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Balistreri CR, 2008, CURR PHARM DESIGN, V14, P2672, DOI 10.2174/138161208786264089; Balistreri CR, 2011, MECH AGEING DEV, V132, P86, DOI 10.1016/j.mad.2010.12.005; Balistreri CR, 2009, J CLIN IMMUNOL, V29, P406, DOI 10.1007/s10875-009-9297-5; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Eissler R, 2011, HYPERTENS RES, V34, P551, DOI 10.1038/hr.2010.270; El Fakiri F, 2007, J CLIN EPIDEMIOL, V60, P1271, DOI 10.1016/j.jclinepi.2007.02.014; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Fuh Jong-Ling, 2008, Acta Neurol Taiwan, V17, P153; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hajjar IM, 2008, AM J ALZHEIMERS DIS, V23, P77, DOI 10.1177/1533317507309803; Hang JQ, 2004, J ENDOTOXIN RES, V10, P238, DOI 10.1177/09680519040100040601; Harold D, 2009, NATURE GENETICS; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; HOLM S, 1979, SCAND J STAT, V6, P65; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V59, P1; Lambert JC, 2009, NATURE GENETICS; Li NC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5465; Liao PY, 2010, BIOCHEM ENG J, V49, P149, DOI 10.1016/j.bej.2009.12.021; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Minoretti P, 2006, NEUROSCI LETT, V391, P147, DOI 10.1016/j.neulet.2005.08.047; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Roman Gustavo C, 2005, Cerebrovasc Dis, V20 Suppl 2, P91, DOI 10.1159/000089361; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; St Sauver JL, 2005, MAYO CLIN PROC, V80, P203; Stozicka Z, 2007, ACTA VIROL, V51, P205; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Streit WJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3423; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wang LZ, 2011, BRAIN RES, V1381, P202, DOI 10.1016/j.brainres.2011.01.007; Wang M, 2010, NEUROSCI LETT, V482, P260, DOI 10.1016/j.neulet.2010.07.051; Zheng SL, 2006, PROSTATE, V66, P1556, DOI 10.1002/pros.20496	47	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50771	10.1371/journal.pone.0050771	http://dx.doi.org/10.1371/journal.pone.0050771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272070	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300012
J	Mendes, PAD; Thomsen, L				Mendes, Pedro A. de Jesus; Thomsen, Laurenz			Effects of Ocean Acidification on the Ballast of Surface Aggregates Sinking through the Twilight Zone	PLOS ONE			English	Article							BENTHIC BOUNDARY-LAYER; PRESSURE; CARBONATE; BACTERIA; SEAWATER	The dissolution of CaCO3 is one of the ways ocean acidification can, potentially, greatly affect the ballast of aggregates. A diminution of the ballast could reduce the settling speed of aggregates, resulting in a change in the carbon flux to the deep sea. This would mean lower amounts of more refractory organic matter reaching the ocean floor. This work aimed to determine the effect of ocean acidification on the ballast of sinking surface aggregates. Our hypothesis was that the decrease of pH will increase the dissolution of particulate inorganic carbon ballasting the aggregates, consequently reducing their settling velocity and increasing their residence time in the upper twilight zone. Using a new methodology for simulation of aggregate settling, our results suggest that future pCO(2) conditions can significantly change the ballast composition of sinking aggregates. The change in aggregate composition had an effect on the size distribution of the aggregates, with a shift to smaller aggregates. A change also occurred in the settling velocity of the particles, which would lead to a higher residence time in the water column, where they could be continuously degraded. In the environment, such an effect would result in a reduction of the carbon flux to the deep-sea. This reduction would impact those benthic communities, which rely on the vertical flow of carbon as primary source of energy.	[Mendes, Pedro A. de Jesus; Thomsen, Laurenz] Jacobs Univ Bremen gGmbH, OceanLab, Bremen, Germany	Jacobs University	Mendes, PAD (corresponding author), Jacobs Univ Bremen gGmbH, OceanLab, Bremen, Germany.	p.mendes@jacobs-university.de			German project Biological Impacts of Ocean ACIDification (BIOACID); Federal Ministry of Education and Research (BMBF) [FKZ 03F0608B]	German project Biological Impacts of Ocean ACIDification (BIOACID); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Support by the German project Biological Impacts of Ocean ACIDification (BIOACID), funded by the Federal Ministry of Education and Research (BMBF, FKZ 03F0608B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Balch WM, 2008, J PLANKTON RES, V30, P119, DOI 10.1093/plankt/fbm097; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; COOKE RC, 1980, GEOCHIM COSMOCHIM AC, V44, P1077, DOI 10.1016/0016-7037(80)90061-7; COOKE RC, 1977, MAR CHEM, V5, P75; DRAPEAU DT, 1994, LIMNOL OCEANOGR, V39, P723, DOI 10.4319/lo.1994.39.3.0723; Ehrhardt M, 1999, METHODS SEAWATER ANA, P437, DOI DOI 10.1002/9783527613984.CH17; Engel A, 2009, DEEP-SEA RES PT II, V56, P1396, DOI 10.1016/j.dsr2.2008.11.027; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Gattuso J, 2010, BIOGEOSCIENCE DISCUS, V6, P4413; Gattuso JP, 2009, BIOGEOSCIENCES, V6, P2121, DOI 10.5194/bg-6-2121-2009; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; Hamm CE, 2002, LIMNOL OCEANOGR, V47, P1790, DOI 10.4319/lo.2002.47.6.1790; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Kiorboe T, 2001, MAR ECOL PROG SER, V211, P1, DOI 10.3354/meps211001; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Mendes PADJ, 2007, MAR GEOL, V246, P165, DOI 10.1016/j.margeo.2007.05.012; Passow U, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002579; Passow U, 2012, MAR CHEM, V128, P72, DOI 10.1016/j.marchem.2011.10.004; Ploug H, 1999, MAR ECOL PROG SER, V176, P279, DOI 10.3354/meps176279; PYTKOWICZ RM, 1963, DEEP-SEA RES, V10, P633, DOI 10.1016/0011-7471(63)90004-4; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Ritzrau W, 1997, J MARINE SYST, V10, P415, DOI 10.1016/S0924-7963(96)00073-5; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tamburini C, 2006, AQUAT MICROB ECOL, V43, P267, DOI 10.3354/ame043267; Thomsen L, 2000, DEEP-SEA RES PT I, V47, P1881, DOI 10.1016/S0967-0637(00)00003-0; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; TURLEY CM, 1993, DEEP-SEA RES PT I, V40, P2193; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972; Wolf-Gladrow DA, 2001, CO2 SEAWATER EQUILIB, V65; Ziveri P, 2007, DEEP-SEA RES PT II, V54, P659, DOI 10.1016/j.dsr2.2007.01.006	35	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50865	10.1371/journal.pone.0050865	http://dx.doi.org/10.1371/journal.pone.0050865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272075	Green Accepted, gold, Green Published			2022-12-27	WOS:000312483300013
J	Bushlin, I; Gupta, A; Stockton, SD; Miller, LK; Devi, LA				Bushlin, Ittai; Gupta, Achla; Stockton, Steven D., Jr.; Miller, Lydia K.; Devi, Lakshmi A.			Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; PERIPHERAL-NERVE INJURY; ANTIDEPRESSANT-LIKE; UP-REGULATION; PREFRONTAL CORTEX; SCIATIC-NERVE; SPINAL-CORD; MORPHINE ANALGESIA; TACTILE ALLODYNIA; CB1 RECEPTORS	The diversity of receptor signaling is increased by receptor heteromerization leading to dynamic regulation of receptor function. While a number of studies have demonstrated that family A G-protein-coupled receptors are capable of forming heteromers in vitro, the role of these heteromers in normal physiology and disease has been poorly explored. In this study, direct interactions between CB1 cannabinoid and delta opioid receptors in the brain were examined. Additionally, regulation of heteromer levels and signaling in a rodent model of neuropathic pain was explored. First we examined changes in the expression, function and interaction of these receptors in the cerebral cortex of rats with a peripheral nerve lesion that resulted in neuropathic pain. We found that, following the peripheral nerve lesion, the expression of both cannabinoid type 1 receptor (CB1R) and the delta opioid receptor (DOR) are increased in select brain regions. Concomitantly, an increase in CB1R activity and decrease in DOR activity was observed. We hypothesize that this decrease in DOR activity could be due to heteromeric interactions between these two receptors. Using a CB1R-DOR heteromer-specific antibody, we found increased levels of CB1R-DOR heteromer protein in the cortex of neuropathic animals. We subsequently examined the functionality of these heteromers by testing whether low, non-signaling doses of CB1R ligands influenced DOR signaling in the cortex. We found that, in cortical membranes from animals that experienced neuropathic pain, non-signaling doses of CB1R ligands significantly enhanced DOR activity. Moreover, this activity is selectively blocked by a heteromer-specific antibody. Together, these results demonstrate an important role for CB1R-DOR heteromers in altered cortical function of DOR during neuropathic pain. Moreover, they suggest the possibility that a novel heteromer-directed therapeutic strategy for enhancing DOR activity, could potentially be employed to reduce anxiety associated with chronic pain. Citation: Bushlin I, Gupta A, Stockton SD Jr, Miller LK, Devi LA (2012) Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain. PLoS ONE 7(12): e49789. doi:10.1371/journal.pone.0049789	[Bushlin, Ittai; Gupta, Achla; Stockton, Steven D., Jr.; Miller, Lydia K.; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Bushlin, Ittai; Stockton, Steven D., Jr.; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Bushlin, Ittai; Stockton, Steven D., Jr.; Devi, Lakshmi A.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Devi, LA (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	lakshmi.devi@mssm.edu	Devi P, Lakshmi/GXM-5982-2022	Devi P, Lakshmi/0000-0001-9274-4776	NIH [DA008863, DA019521, 1P50GM071558-01A27398]; Integrated Pharmacological Sciences Training Program [T32GM062754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754, P50GM071558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008863, R37DA008863, K05DA019521, R56DA008863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Pharmacological Sciences Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants DA008863, DA019521 to LAD and 1P50GM071558-01A27398 (Systems Biology Center of New York) to LAD. Ittai Bushlin was a trainee in the Integrated Pharmacological Sciences Training Program supported by grant T32GM062754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Husn NS, 2007, BRIT J PHARMACOL, V151, P877, DOI 10.1038/sj.bjp.0707277; Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; BAUSCH SB, 1995, J CHEM NEUROANAT, V8, P175, DOI 10.1016/0891-0618(94)00044-T; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Berg KA, 2012, MOL PHARMACOL, V81, P264, DOI 10.1124/mol.111.072702; Berrendero F, 2003, EUR J NEUROSCI, V18, P2197, DOI 10.1046/j.1460-9568.2003.02951.x; Berrendero F, 2002, PSYCHOPHARMACOLOGY, V163, P111, DOI 10.1007/s00213-002-1144-9; BESSE D, 1992, NEUROSCIENCE, V50, P921, DOI 10.1016/0306-4522(92)90215-N; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Bushlin I, 2010, CURR OPIN PHARMACOL, V10, P80, DOI 10.1016/j.coph.2009.09.009; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chung JM, 2004, METH MOLEC MED, P35; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Datta S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-7; DEFONSECA FR, 1994, LIFE SCI, V54, P159, DOI 10.1016/0024-3205(94)00585-0; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dubois D, 2010, EUR J NEUROSCI, V32, P1921, DOI 10.1111/j.1460-9568.2010.07466.x; Ferre S, 2010, PROG MOL BIOL TRANSL, V91, P41, DOI 10.1016/S1877-1173(10)91002-8; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gomes I, 2012, METHODS ENZ IN PRESS; Gomes I, 2011, MOL PHARMACOL, V79, P1044, DOI 10.1124/mol.110.070847; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hohmann AG, 1999, BRAIN RES, V822, P17, DOI 10.1016/S0006-8993(98)01321-3; Holdridge SV, 2007, EUR J PAIN, V11, P685, DOI 10.1016/j.ejpain.2006.10.008; Hoot MR, 2010, BRAIN RES, V1339, P18, DOI 10.1016/j.brainres.2010.03.105; Hungund BL, 2004, MOL PSYCHIATR, V9, P184, DOI 10.1038/sj.mp.4001376; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Ji RR, 1995, J NEUROSCI, V15, P8156; Jutkiewicz EM, 2006, EUR J PHARMACOL, V531, P151, DOI 10.1016/j.ejphar.2005.12.002; Kabli N, 2007, PAIN, V127, P84, DOI 10.1016/j.pain.2006.08.003; Kathmann M, 2006, N-S ARCH PHARMACOL, V372, P354, DOI 10.1007/s00210-006-0033-x; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Knerlich-Lukoschus F, 2011, J NEUROTRAUM, V28, P619, DOI 10.1089/neu.2010.1652; Lazareno S, 1999, Methods Mol Biol, V106, P231; Li JL, 1996, NEUROSCI LETT, V214, P91, DOI 10.1016/0304-3940(96)12894-9; Lim G, 2003, PAIN, V105, P275, DOI 10.1016/S0304-3959(03)00242-2; Lim MP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.52; Lin HC, 2009, CEREB CORTEX, V19, P165, DOI 10.1093/cercor/bhn075; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Maldonado R, 2003, EUR NEUROPSYCHOPHARM, V13, P401, DOI 10.1016/j.euroneuro.2003.08.001; Manzanares J, 1999, TRENDS PHARMACOL SCI, V20, P287, DOI 10.1016/S0165-6147(99)01339-5; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Narita M, 2006, J NEUROCHEM, V97, P1369, DOI 10.1111/j.1471-4159.2006.03824.x; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Obara I, 2009, PAIN, V141, P283, DOI 10.1016/j.pain.2008.12.006; Ozaki S, 2003, NEUROSCIENCE, V116, P89, DOI 10.1016/S0306-4522(02)00699-1; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Parolaro D, 2010, CURR DRUG TARGETS, V11, P393, DOI 10.2174/138945010790980367; Paszcuk AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024034; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Perrine SA, 2006, BRIT J PHARMACOL, V147, P864, DOI 10.1038/sj.bjp.0706686; Pertwee RG, 2005, AAPS J, V7, pE625, DOI 10.1208/aapsj070364; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Porreca F, 1998, BRAIN RES, V795, P197, DOI 10.1016/S0006-8993(98)00292-3; Puehler W, 2004, NEUROSCIENCE, V129, P473, DOI 10.1016/j.neuroscience.2004.06.086; Rashid MH, 2004, J PHARMACOL EXP THER, V309, P380, DOI 10.1124/jpet.103.060582; Rea K, 2007, BRIT J PHARMACOL, V152, P633, DOI 10.1038/sj.bjp.0707440; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Robertson B, 1999, EUR J PAIN, V3, P115, DOI 10.1053/eujp.1998.0104; Rozenfeld R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029239; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Saade NE, 2008, PROG NEUROBIOL, V86, P22, DOI 10.1016/j.pneurobio.2008.06.002; Saitoh A, 2005, PSYCHOPHARMACOLOGY, V182, P327, DOI 10.1007/s00213-005-0112-6; Saitoh A, 2004, J PHARMACOL SCI, V95, P374, DOI 10.1254/jphs.FPJ04014X; Saitoh A, 2011, BEHAV BRAIN RES, V223, P271, DOI 10.1016/j.bbr.2011.04.041; Salio C, 2002, NEUROSCIENCE, V110, P755, DOI 10.1016/S0306-4522(01)00584-X; Scott DA, 2004, PAIN, V109, P124, DOI 10.1016/j.pain.2004.01.020; Seifert F, 2009, CELL MOL LIFE SCI, V66, P375, DOI 10.1007/s00018-008-8428-0; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; STEVENS CW, 1991, PAIN, V46, P315, DOI 10.1016/0304-3959(91)90114-D; Stone LS, 2004, NEUROSCI LETT, V361, P208, DOI 10.1016/j.neulet.2003.12.067; Suzuki T, 2007, ANESTH ANALG, V104, P1570, DOI 10.1213/01.ane.0000261514.19946.66; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Truong W, 2003, ANN NEUROL, V53, P366, DOI 10.1002/ana.10465; Tseng TJ, 2008, NEUROSCIENCE, V156, P758, DOI 10.1016/j.neuroscience.2008.08.010; Uriguen L, 2005, EUR J NEUROSCI, V22, P2106, DOI 10.1111/j.1460-9568.2005.04372.x; Vinod KY, 2005, BIOL PSYCHIAT, V57, P480, DOI 10.1016/j.biopsych.2004.11.033; Walczak JS, 2005, NEUROSCIENCE, V132, P1093, DOI 10.1016/j.neuroscience.2005.02.010; Wang S, 2007, PAIN, V131, P96, DOI 10.1016/j.pain.2006.12.019; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; Welch SP, 2009, INT REV PSYCHIATR, V21, P143, DOI 10.1080/09540260902782794; Wilson-Poe AR, 2012, NEUROSCIENCE, V213, P191, DOI 10.1016/j.neuroscience.2012.03.038; Wu G, 2001, J NEUROSCI, V21; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	96	58	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49789	10.1371/journal.pone.0049789	http://dx.doi.org/10.1371/journal.pone.0049789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272051	Green Submitted, gold, Green Published			2022-12-27	WOS:000312386800010
J	Jia, J; Zhang, W; Liu, JY; Chen, G; Liu, H; Zhong, HY; Liu, B; Cai, Y; Zhang, JL; Zhao, YF				Jia, Jun; Zhang, Wei; Liu, Jian-Ying; Chen, Gang; Liu, Hui; Zhong, Hao-Yan; Liu, Bing; Cai, Yu; Zhang, Jia-Li; Zhao, Yi-Fang			RETRACTED: Epithelial Mesenchymal Transition Is Required for Acquisition of Anoikis Resistance and Metastatic Potential in Adenoid Cystic Carcinoma (Retracted article. See vol. 9, e108117, 2014)	PLOS ONE			English	Article; Retracted Publication							CIRCULATING TUMOR-CELLS; BREAST-CANCER PATIENTS; HEPATOCYTE GROWTH-FACTOR; STEM-CELL; PERIPHERAL-BLOOD; EGFR; PATHWAYS; LUNG; INVASION; SLUG	Human adenoid cystic carcinoma (ACC) is characterized by diffused invasion of the tumor into adjacent organs and early distant metastasis. Anoikis resistance and epithelial mesenchymal transition (EMT) are considered prerequisites for cancer cells to metastasize. Exploring the relationship between these processes and their underlying mechanism of action is a promising way to better understand ACC tumors. We initially established anoikis-resistant sublines of ACC cells; the variant cells revealed a mesenchymal phenotype through Slug-mediated EMT-like transformation and displayed enhanced metastatic potential both in vitro and in vivo. Suppression of EMT by knockdown of Slug significantly impaired anoikis resistance, migration, and invasion of the variant cells. With overexpression of Slug and Twist, we determined that induction of EMT in normal ACC cells could prevent anoikis, albeit partially. These findings strongly suggest that EMT is indispensable in anoikis resistance, at least in ACC cells. Furthermore, we found that the EGFR/PI3K/Akt pathway acts as the common regulator for EMT-like transformation and anoikis resistance, as confirmed by their specific inhibitors. Gefitinib and LY294003 restored the sensibilities of anoikis-resistant cells to anoikis and simultaneously impaired their metastatic potential. In addition, the results from our in vivo model of metastasis suggest that pretreatment with gefitinib promotes mouse survival by alleviating pulmonary metastasis. Most importantly, immunohistochemistry of human ACC specimens showed a correlation between the overexpression of Slug and EGFR staining. This study has demonstrated that Slug-mediated EMT-like transformation is required by human ACC cells to achieve anoikis resistance and their metastatic potential. Targeting the EGFR/PI3K/Akt pathway holds potential as a preventive strategy against distant metastasis of ACC.	[Jia, Jun; Zhang, Wei; Liu, Jian-Ying; Chen, Gang; Liu, Hui; Zhong, Hao-Yan; Cai, Yu; Zhang, Jia-Li; Zhao, Yi-Fang] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China; [Jia, Jun; Zhang, Wei; Liu, Jian-Ying; Chen, Gang; Liu, Hui; Zhong, Hao-Yan; Cai, Yu; Zhang, Jia-Li; Zhao, Yi-Fang] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Jia, Jun; Zhang, Wei; Chen, Gang; Zhong, Hao-Yan; Liu, Bing; Cai, Yu; Zhao, Yi-Fang] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430072, Peoples R China; [Zhang, Jia-Li] Wuhan Univ, Sch & Hosp Stomatol, Dept Pathol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University	Zhao, YF (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China.	yifang@whuss.com			National Natural Science Foundation of China [81102054, 30973330, 81170977]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from The National Natural Science Foundation of China (81102054, 30973330, 81170977). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MK, 2003, CLIN CANCER RES, V9, P4865; Bonnomet A, 2011, ONCOGENE; Catalano A, 2004, J BIOL CHEM, V279, P46706, DOI 10.1074/jbc.M406696200; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Claperon A, 2011, ONCOGENE; Danila DC, 2011, CANCER J, V17, P438, DOI 10.1097/PPO.0b013e31823e69ac; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Dong L, 2011, J DENT RES, V90, P804, DOI 10.1177/0022034511401407; Ellington CL, 2012, CANCER-AM CANCER SOC, V118, P4444, DOI 10.1002/cncr.27408; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gaafar RM, 2011, EUR J CANCER, V47, P2331, DOI 10.1016/j.ejca.2011.06.045; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Guan XF, 1997, INT J ORAL MAX SURG, V26, P116, DOI 10.1016/S0901-5027(05)80830-6; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hung CM, 2011, J AGR FOOD CHEM, V59, P9683, DOI 10.1021/jf2021489; Ito FA, 2009, ANAL QUANT CYTOL, V31, P280; Jiang JA, 2010, ORAL SURG ORAL MED O, V110, P764, DOI 10.1016/j.tripleo.2010.06.015; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kang M, 2012, BIOCHEM J; Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099; Khan AJ, 2001, INT J CANCER, V96, P149, DOI 10.1002/ijc.1013; Komatsubara Hideki, 2005, Kobe Journal of Medical Sciences, V51, P67; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Pallier K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029954; Park S, 2011, BIOCHEM BIOPH RES CO, V407, P680, DOI 10.1016/j.bbrc.2011.03.075; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Paz-Ares L, 2010, J CELL MOL MED, V14, P51, DOI 10.1111/j.1582-4934.2009.00991.x; Perez-Losada J, 2003, ONCOGENE, V22, P4205, DOI 10.1038/sj.onc.1206467; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Riethdorf S, 2008, PATHOBIOLOGY, V75, P140, DOI 10.1159/000123852; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031093; Sun ZJ, 2011, MOL PHARMACOL, V79, P106, DOI 10.1124/mol.110.066910; Sun ZJ, 2010, APOPTOSIS, V15, P850, DOI 10.1007/s10495-010-0497-5; Tang YL, 2010, J ORAL PATHOL MED, V39, P775, DOI 10.1111/j.1600-0714.2010.00913.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Zhou CC, 2012, J ORAL PATHOL MED, V41, P424, DOI 10.1111/j.1600-0714.2011.01114.x; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175	47	30	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51549	10.1371/journal.pone.0051549	http://dx.doi.org/10.1371/journal.pone.0051549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272116	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800051
J	Monzo, C; Urbaneja, A; Ximenez-Embun, M; Garcia-Fernandez, J; Garcia, JL; Castanera, P				Monzo, Cesar; Urbaneja, Alberto; Ximenez-Embun, Miguel; Garcia-Fernandez, Julia; Luis Garcia, Jose; Castanera, Pedro			Selection of Ceratitis capitata (Diptera: Tephritidae) Specific Recombinant Monoclonal Phage Display Antibodies for Prey Detection Analysis	PLOS ONE			English	Article							PREDATION; GUT; LEPIDOPTERA; LIBRARIES; SPIDER; ELISA; ASSAY	Several recombinant antibodies against the Mediterranean fruit fly, Ceratitis capitata (Wiedemann) (Diptera: Tephritidae), one of the most important pests in agriculture worldwide, were selected for the first time from a commercial phage display library of human scFv antibodies. The specificity and sensitivity of the selected recombinant antibodies were compared with that of a rabbit polyclonal serum raised in parallel using a wide range of arthropod species as controls. The selected recombinant monoclonal antibodies had a similar or greater specificity when compared with classical monoclonal antibodies. The selected recombinant antibodies were successfully used to detect the target antigen in the gut of predators and the scFv antibodies were sequenced and compared. These results demonstrate the potential for recombinant scFv antibodies to be used as an alternative to the classical monoclonal antibodies or even molecular probes in the post-mortem analysis studies of generalist predators. Citation: Monzo C, Urbaneja A, Ximenez-Embun M, Garcia-Fernandez J, Garcia JL, et al. (2012) Selection of Ceratitis capitata (Diptera: Tephritidae) Specific Recombinant Monoclonal Phage Display Antibodies for Prey Detection Analysis. PLoS ONE 7(12): e51440. doi:10.1371/journal.pone.0051440	[Monzo, Cesar; Ximenez-Embun, Miguel; Garcia-Fernandez, Julia; Luis Garcia, Jose; Castanera, Pedro] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain; [Urbaneja, Alberto; Castanera, Pedro] Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, CSIC, Unidad Asociada Entomol IVIA CIB, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto Valenciano de Investigaciones Agrarias (IVIA)	Castanera, P (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain.	castan@cib.csic.es	Urbaneja, Alberto/C-9071-2011; Ximenez-Embun, Miguel/AAE-4290-2021; URBANEJA, ALBERTO/AAW-6198-2020; Monzo, C./O-5248-2019; castanera, pedro/G-2165-2015; Monzo, Cesar/L-7055-2014; Garcia Lopez, Jose Luis/G-9139-2015	Urbaneja, Alberto/0000-0001-5986-3685; Ximenez-Embun, Miguel/0000-0002-2137-7937; URBANEJA, ALBERTO/0000-0001-5986-3685; Monzo, C./0000-0003-3247-7412; Monzo, Cesar/0000-0003-3247-7412; Garcia-Fernandez, Julia/0000-0002-6937-6394; Garcia Lopez, Jose Luis/0000-0002-9238-2485	Comision Interministerial de Ciencia y Tecnologia (CICYT) [AGL2006-13346-C02-01]; Centro de Investigaciones Biologicas, CSIC	Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Centro de Investigaciones Biologicas, CSIC	This work was supported by grants from Comision Interministerial de Ciencia y Tecnologia (CICYT) (AGL2006-13346-C02-01). CM was recipient of a PhD grant from the Centro de Investigaciones Biologicas, CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAN N, 1994, P NATL ACAD SCI USA, V91, P1604, DOI 10.1073/pnas.91.5.1604; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P4457, DOI 10.1073/pnas.89.10.4457; BOREHAM PFL, 1978, B ENTOMOL RES, V68, P171, DOI 10.1017/S0007485300007264; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooke M. M., 1946, JOUR NATION MALARIA SOC, V5, P45; BUCHHOLZ U, 1994, BIOCHEM SYST ECOL, V22, P671, DOI 10.1016/0305-1978(94)90053-1; Cann A., 2005, PRINCIPLES MOL VIROL, V4th; Chen Y, 2000, MOL ECOL, V9, P1887, DOI 10.1046/j.1365-294x.2000.01100.x; GREENSTONE MH, 1989, ANN ENTOMOL SOC AM, V82, P45, DOI 10.1093/aesa/82.1.45; Greenstone MH, 1996, ECOLOGY AGR PESTS BI, P265; Hagler JR, 2005, BIOCONTROL SCI TECHN, V15, P321, DOI 10.1080/09583150500086474; Harlow E., 1988, ANTIBODIES LAB MANUA; Harwood JD, 2001, MOL ECOL, V10, P2049, DOI 10.1046/j.0962-1083.2001.01349.x; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Karu AE, 1995, ILAR J, V37, P3; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; LERNER RA, 1992, SCIENCE, V258, P1313, DOI 10.1126/science.1455226; Lim UT, 1994, ENVIRON ENTOMOL, V28, P1177; Malecki M, 2002, P NATL ACAD SCI USA, V99, P213, DOI 10.1073/pnas.261567298; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; MILLER MC, 1981, ANN ENTOMOL SOC AM, V74, P279, DOI 10.1093/aesa/74.3.279; Monzo C, 2010, B ENTOMOL RES, V100, P145, DOI 10.1017/S0007485309006920; Monzo C, 2009, BIOCONTROL, V54, P393, DOI 10.1007/s10526-008-9199-0; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; RAGSDALE DW, 1981, ENVIRON ENTOMOL, V10, P402, DOI 10.1093/ee/10.3.402; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sigsgaard L, 2002, BIOCONTROL, V47, P151, DOI 10.1023/A:1014577114915; Staden R, 2003, STADEN PACKAGE 2003; SUNDERLAND KD, 1988, ANN APPL BIOL, V112, P201, DOI 10.1111/j.1744-7348.1988.tb02056.x; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Symondson WOC, 1996, SYST ASSOC, P323; Symondson WOC, 2000, MOL ECOL, V9, P1279, DOI 10.1046/j.1365-294x.2000.01006.x; Symondson WOC, 1999, INSECT BIOCHEM MOLEC, V29, P873, DOI 10.1016/S0965-1748(99)00063-6; Thomas RS, 2009, ECOL ENTOMOL, V34, P569, DOI 10.1111/j.1365-2311.2009.01104.x; Tijssen P., 1985, PRACTICE THEORY ENZY; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245	43	1	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51440	10.1371/journal.pone.0051440	http://dx.doi.org/10.1371/journal.pone.0051440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272105	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800045
J	Oz, S; Ivashko-Pachima, Y; Gozes, I				Oz, Saar; Ivashko-Pachima, Yanina; Gozes, Illana			The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; REDUCES TAU HYPERPHOSPHORYLATION; PROGRESSIVE SUPRANUCLEAR PALSY; III BETA-TUBULIN; ALZHEIMERS-DISEASE; NEURONAL DIFFERENTIATION; AXON FORMATION; DETYROSINATED MICROTUBULES; NEUROFIBRILLARY TANGLES; POLYADP-RIBOSYLATION	Microtubules (MTs), key cytoskeletal elements in living cells, are critical for axonal transport, synaptic transmission, and maintenance of neuronal morphology. NAP (NAPVSIPQ) is a neuroprotective peptide derived from the essential activity-dependent neuroprotective protein (ADNP). In Alzheimer's disease models, NAP protects against tauopathy and cognitive decline. Here, we show that NAP treatment significantly affected the alpha tubulin tyrosination cycle in the neuronal differentiation model, rat pheochromocytoma (PC12) and in rat cortical astrocytes. The effect on tubulin tyrosination/detyrosination was coupled to increased MT network area (measured in PC12 cells), which is directly related to neurite outgrowth. Tubulin beta3, a marker for neurite outgrowth/neuronal differentiation significantly increased after NAP treatment. In rat cortical neurons, NAP doubled the area of dynamic MT invasion (Tyr-tubulin) into the neuronal growth cone periphery. NAP was previously shown to protect against zinc-induced MT/neurite destruction and neuronal death, here, in PC12 cells, NAP treatment reversed zinc-decreased tau-tubulin-MT interaction and protected against death. NAP effects on the MT pool, coupled with increased tau engagement on compromised MTs imply an important role in neuronal plasticity, protecting against free tau accumulation leading to tauopathy. With tauopathy representing a major pathological hallmark in Alzheimer's disease and related disorders, the current findings provide a mechanistic basis for further development. NAP (davunetide) is in phase 2/3 clinical trial in progressive supranuclear palsy, a disease presenting MT deficiency and tau pathology. Citation: Oz S, Ivashko-Pachima Y, Gozes I (2012) The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities. PLoS ONE 7(12): e51458. doi:10.1371/journal.pone.0051458	[Oz, Saar; Ivashko-Pachima, Yanina; Gozes, Illana] Tel Aviv Univ, Adams Super Ctr Brain Studies, IL-69978 Tel Aviv, Israel; [Oz, Saar; Ivashko-Pachima, Yanina; Gozes, Illana] Tel Aviv Univ, Lily & Avraham Gildor Chair Invest Growth Factors, IL-69978 Tel Aviv, Israel; [Oz, Saar; Ivashko-Pachima, Yanina; Gozes, Illana] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, Elton Lab Neuroendocrinol, IL-69978 Tel Aviv, Israel; [Gozes, Illana] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Gozes, I (corresponding author), Tel Aviv Univ, Adams Super Ctr Brain Studies, IL-69978 Tel Aviv, Israel.	igozes@post.tau.ac.il	Oz, Saar/ABB-4496-2020	Oz, Saar/0000-0002-3377-0584; Ivashko-Pachima, Yanina/0000-0002-1773-7127	Allon Therapeutics Inc.; AMN Foundation; Montreal Circle of Canadian Friends of TAU (CFTAU); Oberfeld family; Adams family	Allon Therapeutics Inc.; AMN Foundation; Montreal Circle of Canadian Friends of TAU (CFTAU); Oberfeld family; Adams family	Funding was provided by Allon Therapeutics Inc., AMN Foundation, Montreal Circle of Canadian Friends of TAU (CFTAU), Joseph and Grace Alter, Barbara and Donald Seal, the Oberfeld family and the Adams family. Overall, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The valuable input and discussions of the Allon Therapeutics Science Team is appropriately acknowledged.; We would like to thank the Allon Therapeutics team including Drs. Michael Gold, Alistair Stewart, Bruce Morimoto, Jacqueline Tiong and Catherine Campbell for valuable input and discussions. We would like to thank Dr. Eliezer Giladi for help with biochemical analysis. This work is in partial fulfillment of the Ph.D. thesis requirements of Mr. Saar Oz and graduate thesis requirements of Mrs. Yanina Ivashko-Pachima. Professor Illana Gozes is the incumbent of the Lily and Avraham Gildor Chair for the Investigation of Growth Factors, and the Director of the Adams Super Center for Brain Studies, the Levie-Edersheim-Gitter Institute for Functional Brain Imaging and the Dr. Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology at Tel Aviv University. We thank AMN Foundation, Israel, Montreal Circle of Canadian Friends of TAU (CFTAU), Joseph and Grace Alter, Barbara and Donald Seal, the Oberfeld family and the Adams family for their support and encouragement.	Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; ARREGUI C, 1991, J NEUROSCI RES, V28, P171, DOI 10.1002/jnr.490280204; BAAS PW, 1993, J NEUROSCI, V13, P2177; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; BANCHER C, 1987, ACTA NEUROPATHOL, V74, P39, DOI 10.1007/BF00688336; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Boom A, 2009, BBA-MOL CELL RES, V1793, P1058, DOI 10.1016/j.bbamcr.2008.11.011; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; CHAUDHRY V, 1994, ANN NEUROL, V35, P304, DOI 10.1002/ana.410350310; Chen SZ, 2008, P NATL ACAD SCI USA, V105, P19962, DOI 10.1073/pnas.0807758105; Davis DA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000208; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Divinski I, 2004, J BIOL CHEM, V279, P28531, DOI 10.1074/jbc.M403197200; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Fukushima N, 2006, BRAIN RES, V1094, P65, DOI 10.1016/j.brainres.2006.04.007; GALLOWAY PG, 1988, NEUROSCI LETT, V91, P148, DOI 10.1016/0304-3940(88)90759-8; GARD DL, 1985, J CELL BIOL, V100, P764, DOI 10.1083/jcb.100.3.764; Goldberg S, 2009, J NEUROCHEM, V111, P72, DOI 10.1111/j.1471-4159.2009.06296.x; Gozes I, 1997, DEV BRAIN RES, V99, P167, DOI 10.1016/S0165-3806(96)00215-5; Gozes I, 2003, J MOL NEUROSCI, V20, P315, DOI 10.1385/JMN:20:3:315; GOZES I, 1981, NATURE, V294, P477, DOI 10.1038/294477a0; GOZES I, 1978, NATURE, V276, P411, DOI 10.1038/276411a0; Gozes I, 2007, CURR ALZHEIMER RES, V4, P507, DOI 10.2174/156720507783018208; Gozes I, 2009, CURR ALZHEIMER RES, V6, P455, DOI 10.2174/156720509789207895; Gozes Illana, 2006, Current Alzheimer Research, V3, P197; Guo JY, 2011, BRAIN RES, V1420, P8, DOI 10.1016/j.brainres.2011.08.066; Guo JY, 2010, CYTOSKELETON, V67, P431, DOI 10.1002/cm.20455; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Huang XD, 2000, J NUTR, V130, p1488S, DOI 10.1093/jn/130.5.1488S; Idan-Feldman A., 2012, INT J ALZHEIMERS DIS, V2012; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; JIANG YQ, 1992, J CELL SCI, V103, P643; Jouroukhin Y, 2012, J MOL NEUROSCI, V48, P597, DOI 10.1007/s12031-012-9882-6; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Lagreze WA, 2005, INVEST OPHTH VIS SCI, V46, P933, DOI 10.1167/iovs.04-0766; Lee G, 1998, J CELL SCI, V111, P3167; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; LIPTON RB, 1989, NEUROLOGY, V39, P368, DOI 10.1212/WNL.39.3.368; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lotjonen J, 2011, NEUROIMAGE, V56, P185, DOI 10.1016/j.neuroimage.2011.01.062; Luduena RF, 1998, INT REV CYTOL, V178, P207; Mandel S, 2008, J MOL NEUROSCI, V35, P127, DOI 10.1007/s12031-007-9013-y; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; MANSFIELD SG, 1991, J NEUROCYTOL, V20, P654, DOI 10.1007/BF01187067; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Matsuoka Y, 2007, J MOL NEUROSCI, V31, P165, DOI 10.1385/JMN/31:02:165; Melli G, 2006, NEUROBIOL DIS, V24, P525, DOI 10.1016/j.nbd.2006.08.014; Merenlender-Wagner A, 2010, PEPTIDES, V31, P1368, DOI 10.1016/j.peptides.2010.04.011; Michaelis ML, 2002, J MOL NEUROSCI, V19, P289, DOI 10.1385/JMN:19:3:289; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Pascual M, 2007, J NEUROCHEM, V103, P557, DOI 10.1111/j.1471-4159.2007.04761.x; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Pontecorvo MJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt70; Raspaglio G, 2010, CANCER RES, V70, P5891, DOI 10.1158/0008-5472.CAN-09-4656; ROBSON SJ, 1989, CELL MOTIL CYTOSKEL, V12, P273, DOI 10.1002/cm.970120408; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Sanchez-Martin FJ, 2010, BRAIN RES BULL, V81, P458, DOI 10.1016/j.brainresbull.2009.11.008; Saragoni L, 2000, NEUROCHEM RES, V25, P59, DOI 10.1023/A:1007587315630; Shea TB, 1999, BRAIN RES BULL, V48, P255, DOI 10.1016/S0361-9230(98)00019-7; Shemesh OA, 2011, NEUROBIOL DIS, V43, P163, DOI 10.1016/j.nbd.2011.03.008; Shiryaev N, 2011, CURR PHARM DESIGN, V17, P2603, DOI 10.2174/138161211797416093; Shiryaev N, 2009, NEUROBIOL DIS, V34, P381, DOI 10.1016/j.nbd.2009.02.011; Silva DFF, 2011, J ALZHEIMERS DIS, V26, P565, DOI 10.3233/JAD-2011-110423; Smith-Swintosky VL, 2005, J MOL NEUROSCI, V25, P225, DOI 10.1385/JMN:25:3:225; Smoter M, 2011, CANCER CHEMOTH PHARM, V68, P553, DOI 10.1007/s00280-011-1696-7; Sudo H, 2011, HUM MOL GENET, V20, P763, DOI 10.1093/hmg/ddq521; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Vassal E, 2006, J BIOMOL SCREEN, V11, P377, DOI 10.1177/1087057106286210; Visochek L, 2005, J NEUROSCI, V25, P7420, DOI 10.1523/JNEUROSCI.0333-05.2005; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; Yoshiyama Y, 2003, J NEUROSCI, V23, P10662; Zemlyak I, 2000, REGUL PEPTIDES, V96, P39, DOI 10.1016/S0167-0115(00)00198-1; Zemlyak I, 2009, J NEURAL TRANSM, V116, P1411, DOI 10.1007/s00702-009-0252-7; Zemlyak I, 2009, EUR J PHARMACOL, V618, P9, DOI 10.1016/j.ejphar.2009.07.013; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zia H, 1999, LIFE SCI, V66, P379	94	67	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51458	10.1371/journal.pone.0051458	http://dx.doi.org/10.1371/journal.pone.0051458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272107	Green Submitted, gold, Green Published			2022-12-27	WOS:000312386800046
J	Parenica, J; Nemec, P; Tomandl, J; Ondrasek, J; Pavkova-Goldbergova, M; Tretina, M; Jarkovsky, J; Littnerova, S; Poloczek, M; Pokorny, P; Spinar, J; Cermakova, Z; Miklik, R; Malik, P; Pes, O; Lipkova, J; Tomandlova, M; Kala, P				Parenica, Jiri; Nemec, Petr; Tomandl, Josef; Ondrasek, Jiri; Pavkova-Goldbergova, Monika; Tretina, Martin; Jarkovsky, Jiri; Littnerova, Simona; Poloczek, Martin; Pokorny, Petr; Spinar, Jindrich; Cermakova, Zdenka; Miklik, Roman; Malik, Petr; Pes, Ondrej; Lipkova, Jolana; Tomandlova, Marie; Kala, Petr			Prognostic Utility of Biomarkers in Predicting of One-Year Outcomes in Patients with Aortic Stenosis Treated with Transcatheter or Surgical Aortic Valve Implantation	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; REPLACEMENT; EUROSCORE; MORTALITY; PLASMA; SCORE	Objectives: The aim of the work was to find biomarkers identifying patients at high risk of adverse clinical outcomes after TAVI and SAVR in addition to currently used predictive model (EuroSCORE). Background: There is limited data about the role of biomarkers in predicting prognosis, especially when TAVI is available. Methods: The multi-biomarker sub-study included 42 consecutive high-risk patients (average age 82.0 years; logistic EuroSCORE 21.0%) allocated to TAVI transfemoral and transapical using the Edwards-Sapien valve (n = 29), or SAVR with the Edwards Perimount bioprosthesis (n = 13). Standardized endpoints were prospectively followed during the 12-month follow-up. Results: The clinical outcomes after both TAVI and SAVR were comparable. Malondialdehyde served as the best predictor of a combined endpoint at 1 year with AUC (ROC analysis) = 0.872 for TAVI group, resp. 0.765 (p<0.05) for both TAVI and SAVR groups. Increased levels of MDA, matrix metalloproteinase 2, tissue inhibitor of metalloproteinase (TIMP1), ferritin-reducing ability of plasma, homocysteine, cysteine and 8-hydroxy-2-deoxyguanosine were all predictors of the occurrence of combined safety endpoints at 30 days (AUC 0.750-0.948; p<0.05 for all). The addition of MDA to a currently used clinical model (EuroSCORE) significantly improved prediction of a combined safety endpoint at 30 days and a combined endpoint (0-365 days) by the net reclassification improvement (NRI) and the integrated discrimination improvement (IDI) (p<0.05). Cystatin C, glutathione, cysteinylglycine, asymmetric dimethylarginine, nitrite/nitrate and MMP9 did not prove to be significant. Total of 14.3% died during 1-year follow-up. Conclusion: We identified malondialdehyde, a marker of oxidative stress, as the most promising predictor of adverse outcomes during the 30-day and 1-year follow-up in high-risk patients with symptomatic, severe aortic stenosis treated with TAVI. The development of a clinical "TAVIscore" would be highly appreciated. Such dedicated scoring system would enable further testing of adjunctive value of various biomarkers. Citation: Parenica J, Nemec P, Tomandl J, Ondrasek J, Pavkova-Goldbergova M, et al. (2012) Prognostic Utility of Biomarkers in Predicting of One-Year Outcomes in Patients with Aortic Stenosis Treated with Transcatheter or Surgical Aortic Valve Implantation. PLoS ONE 7(12): e48851. doi:10.1371/journal.pone.0048851	[Parenica, Jiri; Poloczek, Martin; Spinar, Jindrich; Miklik, Roman; Kala, Petr] Univ Hosp Brno, Brno, Czech Republic; [Tomandl, Josef; Pes, Ondrej; Tomandlova, Marie] Masaryk Univ, Fac Med, Inst Biochem, Brno, Czech Republic; [Parenica, Jiri; Nemec, Petr; Spinar, Jindrich] Univ Hosp St Annes, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic; [Nemec, Petr; Ondrasek, Jiri; Tretina, Martin; Pokorny, Petr; Malik, Petr] Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic; [Pavkova-Goldbergova, Monika; Lipkova, Jolana] Masaryk Univ, Fac Med, Inst Pathol Physiol, Brno, Czech Republic; [Jarkovsky, Jiri] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic; [Cermakova, Zdenka] Fac Hosp Brno, Dept Biochem, Brno, Czech Republic; [Cermakova, Zdenka] Masaryk Univ, Inst Lab Methods, Brno, Czech Republic	University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Institute of Biostatistics & Analyses; Masaryk University Brno; University Hospital Brno; Masaryk University Brno	Kala, P (corresponding author), Univ Hosp Brno, Brno, Czech Republic.	kalapetr@yahoo.com	Tomandl, Josef/B-7492-2009; Lipkova, Jolana/GRS-3000-2022; Tomandlova, Marie/E-3319-2012; Goldbergova, Monika Pavkova/G-3512-2013; Jarkovsky, Jiri/G-5494-2017	Tomandl, Josef/0000-0001-6554-3733; Tomandlova, Marie/0000-0003-2944-9605; Goldbergova, Monika Pavkova/0000-0002-3471-8702; Cermakova, Zdenka/0000-0002-0859-7409	European Regional Development Fund - Project of International Clinical Research Center; St.Anne's University Hospital Brno, Czech Republic [CZ.1.05/1.1.00/02.0123]; project (Ministry of Health, Czech Republic) for conceptual development of research organization (University Hospital Brno, Brno, Czech Republic) [65269705]	European Regional Development Fund - Project of International Clinical Research Center; St.Anne's University Hospital Brno, Czech Republic; project (Ministry of Health, Czech Republic) for conceptual development of research organization (University Hospital Brno, Brno, Czech Republic)	This work was supported by the European Regional Development Fund - Project of International Clinical Research Center, St.Anne's University Hospital Brno, Czech Republic (No. CZ.1.05/1.1.00/02.0123) and by the project (Ministry of Health, Czech Republic) for conceptual development of research organization 65269705 (University Hospital Brno, Brno, Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Dor I, 2011, CARDIOVASC REVASCULA, V12, P345, DOI 10.1016/j.carrev.2011.04.005; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Conradi L, 2012, J THORAC CARDIOV SUR, V143, P64, DOI 10.1016/j.jtcvs.2011.08.047; Cribier A, 2009, HERZ, V34, P347, DOI 10.1007/s00059-009-3264-z; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Himbert D, 2009, J AM COLL CARDIOL, V54, P303, DOI 10.1016/j.jacc.2009.04.032; Kefer J, 2010, AM J CARDIOL, V106, P1782, DOI 10.1016/j.amjcard.2010.07.051; Khoschsorur GA, 2000, CHROMATOGRAPHIA, V52, P181, DOI 10.1007/BF02490453; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Mack Michael J, 2011, Curr Cardiol Rep, V13, P107, DOI 10.1007/s11886-010-0167-9; Michel P, 2003, EUR J CARDIO-THORAC, V23, P684, DOI 10.1016/S1010-7940(03)00074-5; Nemec P, 2012, COR VASA, V54, pE76, DOI 10.1016/j.crvasa.2012.02.003; Nuis RJ, 2012, NETH HEART J, V20, P16, DOI 10.1007/s12471-011-0224-z; Pickering JW, 2012, CLIN J AM SOC NEPHRO, V7, P1355, DOI 10.2215/CJN.09590911; Pilgrim T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027556; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Sinning JM, 2010, JACC-CARDIOVASC INTE, V3, P1141, DOI 10.1016/j.jcin.2010.09.009; Solbiati M, 2011, INTERN EMERG MED, V6, P161, DOI 10.1007/s11739-011-0545-3; Spargias K, 2011, J INTERV CARDIOL, V24, P462, DOI 10.1111/j.1540-8183.2011.00654.x; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Velagaleti RS, 2010, ARTERIOSCL THROM VAS, V30, P2283, DOI 10.1161/ATVBAHA.110.208462; VESTER B, 1991, EUR J CLIN CHEM CLIN, V29, P549; Walther T, 2007, CIRCULATION, V116, pI240, DOI 10.1161/CIRCULATIONAHA.106.677237; Walther T, 2009, ANN THORAC SURG, V87, P276, DOI 10.1016/j.athoracsur.2008.08.017; Watanabe E, 2006, J CARD FAIL, V12, P527, DOI 10.1016/j.cardfail.2006.05.011; Zhou X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040424	26	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e48851	10.1371/journal.pone.0048851	http://dx.doi.org/10.1371/journal.pone.0048851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272045	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800004
J	Regenbogen, C; De Vos, M; Debener, S; Turetsky, BI; Mossnang, C; Finkelmeyer, A; Habel, U; Neuner, I; Kellermann, T				Regenbogen, Christina; De Vos, Maarten; Debener, Stefan; Turetsky, Bruce I.; Moessnang, Carolin; Finkelmeyer, Andreas; Habel, Ute; Neuner, Irene; Kellermann, Thilo			Auditory Processing under Cross-Modal Visual Load Investigated with Simultaneous EEG-fMRI	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY MMN; WORKING-MEMORY; ATTENTIONAL LOAD; SELECTIVE-ATTENTION; MR SCANNER; DYNAMICS; REMOVAL; BRAIN; PERFORMANCE	Cognitive task demands in one sensory modality (T1) can have beneficial effects on a secondary task (T2) in a different modality, due to reduced top-down control needed to inhibit the secondary task, as well as crossmodal spread of attention. This contrasts findings of cognitive load compromising a secondary modality's processing. We manipulated cognitive load within one modality (visual) and studied the consequences of cognitive demands on secondary (auditory) processing. 15 healthy participants underwent a simultaneous EEG-fMRI experiment. Data from 8 participants were obtained outside the scanner for validation purposes. The primary task (T1) was to respond to a visual working memory (WM) task with four conditions, while the secondary task (T2) consisted of an auditory oddball stream, which participants were asked to ignore. The fMRI results revealed fronto-parietal WM network activations in response to T1 task manipulation. This was accompanied by significantly higher reaction times and lower hit rates with increasing task difficulty which confirmed successful manipulation of WM load. Amplitudes of auditory evoked potentials, representing fundamental auditory processing showed a continuous augmentation which demonstrated a systematic relation to cross-modal cognitive load. With increasing WM load, primary auditory cortices were increasingly deactivated while psychophysiological interaction results suggested the emergence of auditory cortices connectivity with visual WM regions. These results suggest differential effects of crossmodal attention on fundamental auditory processing. We suggest a continuous allocation of resources to brain regions processing primary tasks when challenging the central executive under high cognitive load. Citation: Regenbogen C, De Vos M, Debener S, Turetsky BI, Mossnang C, et al. (2012) Auditory Processing under Cross-Modal Visual Load Investigated with Simultaneous EEG-fMRI. PLoS ONE 7(12): e52267. doi:10.1371/journal.pone.0052267	[Regenbogen, Christina; Moessnang, Carolin; Finkelmeyer, Andreas; Habel, Ute; Neuner, Irene; Kellermann, Thilo] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Sch Med, Aachen, Germany; [Regenbogen, Christina; Moessnang, Carolin; Habel, Ute; Neuner, Irene; Kellermann, Thilo] Carl von Ossietzky Univ Oldenburg, JARA Translat Brain Med, D-2900 Oldenburg, Germany; [De Vos, Maarten; Debener, Stefan] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Neuropsychol Lab, D-2900 Oldenburg, Germany; [De Vos, Maarten] Katholieke Univ Leuven, ESAT SCD, Dept Elect Engn, Louvain, Belgium; [Debener, Stefan] Univ Hosp Jena, Biomagnet Ctr, Dept Neurol, Jena, Germany; [Turetsky, Bruce I.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Finkelmeyer, Andreas] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	RWTH Aachen University; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; KU Leuven; Friedrich Schiller University of Jena; University of Pennsylvania; Newcastle University - UK	Regenbogen, C (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Sch Med, Aachen, Germany.	cregenbogen@ukaachen.de	Kellermann, Thilo/B-1712-2012; Regenbogen, Christina/A-9691-2016; Neuner, Irene/J-6619-2013; Moessnang, Carolin/V-8095-2017	Kellermann, Thilo/0000-0003-4081-5581; Regenbogen, Christina/0000-0001-5950-798X; Moessnang, Carolin/0000-0003-4357-2706; Habel, Ute/0000-0003-0703-7722; Finkelmeyer, Andreas/0000-0001-7491-5113; Neuner, Irene/0000-0002-5164-8873	Deutsche Forschungsgemeinschaft [DFG: IRTG1328, KFO-112/TP9: Ha3202/2-2]; Interdisciplinary Center for Clinical Research of the Medical Faculty of the RWTH Aachen University [N2-6, N4-4]; Research Council KUL (GOA MaNet); Flemish Government [FWO G.0427.10N]; DFG [IRTG1328]; Alexander von Humboldt stipend	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research of the Medical Faculty of the RWTH Aachen University; Research Council KUL (GOA MaNet); Flemish Government(European Commission); DFG(German Research Foundation (DFG)); Alexander von Humboldt stipend(Alexander von Humboldt Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG: IRTG1328, KFO-112/TP9: Ha3202/2-2), the Interdisciplinary Center for Clinical Research of the Medical Faculty of the RWTH Aachen University (N2-6, N4-4), the Research Council KUL (GOA MaNet), and the Flemish Government (FWO G.0427.10N, Integrated EEG-fMRI).CR is supported by a start-up grant of the IRTG1328 (DFG). MDV is supported by an Alexander von Humboldt stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bendixen A, 2010, NEUROPSYCHOLOGIA, V48, P2130, DOI 10.1016/j.neuropsychologia.2010.04.004; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Fockert JW, 2011, COGNITION, V121, P400, DOI 10.1016/j.cognition.2011.08.016; De Vos M, 2011, SIGNAL PROCESS, V91, P1963, DOI 10.1016/j.sigpro.2011.02.019; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Debener S, 2007, NEUROIMAGE, V34, P587, DOI 10.1016/j.neuroimage.2006.09.031; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; ERNST RR, 1966, REV SCI INSTRUM, V37, P93, DOI 10.1063/1.1719961; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gallinat J, 2002, NEUROIMAGE, V17, P110, DOI 10.1006/nimg.2002.1213; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; HARI R, 1980, EXP BRAIN RES, V40, P237, DOI 10.1007/BF00237543; Haroush K, 2011, J NEUROSCI, V31, P922, DOI 10.1523/JNEUROSCI.0420-10.2011; Haroush K, 2010, J COGNITIVE NEUROSCI, V22, P1440, DOI 10.1162/jocn.2009.21284; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Janson Jolanda, 2011, Adv Cogn Psychol, V7, P92, DOI 10.2478/v10053-008-0089-x; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Karns CM, 2009, J COGNITIVE NEUROSCI, V21, P669, DOI 10.1162/jocn.2009.21037; Kranczioch C, 2007, NEUROIMAGE, V37, P947, DOI 10.1016/j.neuroimage.2007.05.044; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lazeyras F, 2001, J MAGN RESON IMAGING, V13, P943, DOI 10.1002/jmri.1135; Leavitt VM, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00023; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Mayhew SD, 2010, NEUROIMAGE, V49, P849, DOI 10.1016/j.neuroimage.2009.06.080; Mijovic B, 2012, NEUROIMAGE, V60, P1171, DOI 10.1016/j.neuroimage.2012.01.063; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; Mulert C., 2009, EEG FMRI PHYSL BASIS; Muller-Gass A, 2007, BRAIN RES, V1170, P71, DOI 10.1016/j.brainres.2007.07.023; Munka L, 2006, NEUROSCI LETT, V396, P177, DOI 10.1016/j.neulet.2005.11.035; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Neuner I, 2010, HUM BRAIN MAPP, V31, P1675, DOI 10.1002/hbm.20965; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otten LJ, 2000, NEUROREPORT, V11, P875, DOI 10.1097/00001756-200003200-00043; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Picton TW, 1999, AUDIOL NEURO-OTOL, V4, P64, DOI 10.1159/000013823; Restuccia D, 2005, COGNITIVE BRAIN RES, V25, P891, DOI 10.1016/j.cogbrainres.2005.09.023; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Tellinghuisen DJ, 2003, PERCEPT PSYCHOPHYS, V65, P817, DOI 10.3758/BF03194817; Thorne JD, 2011, J NEUROSCI, V31, P3853, DOI 10.1523/JNEUROSCI.6176-10.2011; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ullsperger M., 2010, SIMULTANEOUS EEG FMR; Vanderperren K, 2010, NEUROIMAGE, V50, P920, DOI 10.1016/j.neuroimage.2010.01.010; Warbrick T, 2008, INT J PSYCHOPHYSIOL, V67, P169, DOI 10.1016/j.ijpsycho.2007.05.014; Zhang P, 2006, NEUROIMAGE, V33, P715, DOI 10.1016/j.neuroimage.2006.07.015; Zimmer U, 2010, EUR J NEUROSCI, V31, P1744, DOI 10.1111/j.1460-9568.2010.07229.x	64	22	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52267	10.1371/journal.pone.0052267	http://dx.doi.org/10.1371/journal.pone.0052267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251704	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800155
J	Wlodzimirow, KA; Eslami, S; Chamuleau, RAFM; Nieuwoudt, M; Abu-Hanna, A				Wlodzimirow, Kama A.; Eslami, Saeid; Chamuleau, Robert A. F. M.; Nieuwoudt, Martin; Abu-Hanna, Ameen			Prediction of Poor Outcome in Patients with Acute Liver Failure-Systematic Review of Prediction Models	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; COLLEGE-HOSPITAL CRITERIA; KINGS-COLLEGE; EARLY INDICATORS; PROGNOSTIC CRITERIA; DISEASE SCORE; ORGAN FAILURE; MELD; TRANSPLANTATION; SURVIVAL	Introduction: Acute liver failure is a rare disease with high mortality and liver transplantation is the only life saving therapy. Accurate prognosis of ALF is crucial for proper intervention. Aim: To identify and characterize newly developed prognostic models of mortality for ALF patients, assess study quality, identify important variables and provide recommendations for the development of improved models in the future. Methods: The online databases MEDLINE (R) (1950-2012) and EMBASE (R) (1980-2012) were searched for English-language articles that reported original data from clinical trials or observational studies on prognostic models in ALF patients. Studies were included if they developed a new model or modified existing prognostic models. The studies were evaluated based on an existing framework for scoring the methodological and reporting quality of prognostic models. Results: Twenty studies were included, of which 18 reported on newly developed models, 1 on modification of the Kings College Criteria (KCC) and 1 on the Model for End-Stage Liver Disease (MELD). Ten studies compared the newly developed models to previously existing models (e.g. KCC); they all reported that the new models were superior. In the 12-point methodological quality score, only one study scored full points. On the 38-point reporting score, no study scored full points. There was a general lack of reporting on missing values. In addition, none of the studies used performance measures for calibration and accuracy (e.g. Hosmer-Lemeshow statistics, Brier score), and only 5 studies used the AUC as a measure of discrimination. Conclusions: There are many studies on prognostic models for ALF but they show methodological and reporting limitations. Future studies could be improved by better reporting and handling of missing data, the inclusion of model calibration aspects, use of absolute risk measures, explicit considerations for variable selection, the use of a more extensive set of reference models and more thorough validation. Citation: Wlodzimirow KA, Eslami S, Chamuleau RAFM, Nieuwoudt M, Abu-Hanna A (2012) Prediction of Poor Outcome in Patients with Acute Liver Failure-Systematic Review of Prediction Models. PLoS ONE 7(12): e50952. doi:10.1371/journal.pone.0050952	[Wlodzimirow, Kama A.; Eslami, Saeid; Abu-Hanna, Ameen] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Eslami, Saeid] Mashhad Univ Med Sci, Sch Pharm, Pharmaceut Res Ctr, Mashhad, Iran; [Chamuleau, Robert A. F. M.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Nieuwoudt, Martin] StIAS, S African DST NRF Ctr Excellence Epidemiol Modell, Stellenbosch, South Africa	University of Amsterdam; Mashhad University Medical Science; University of Amsterdam; Academic Medical Center Amsterdam	Wlodzimirow, KA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.a.wlodzimirow@amc.uva.nl	Eslami, Saeid/AAZ-6005-2020	Eslami, Saeid/0000-0003-3755-1212; Abu-Hanna, Ameen/0000-0003-4324-7954; Nieuwoudt, Martin/0000-0002-6354-799X	Fonds NutsOhra; Fonds NutsOhra	Fonds NutsOhra; Fonds NutsOhra	No current external funding sources for this study. Grant support: KW is financially supported by a grant from insurance company Fonds NutsOhra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r KW is financially supported by a grant from insurance company Fonds NutsOhra. The authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Acharya SK, 1996, HEPATOLOGY, V23, P1448, DOI 10.1053/jhep.1996.v23.pm0008675163; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Anand AC, 1997, J HEPATOL, V26, P62, DOI 10.1016/S0168-8278(97)80010-4; Aydin C, 2003, HEPATOLOGY, V38, p554A; Bailey B, 2003, CRIT CARE MED, V31, P299, DOI 10.1097/00003246-200301000-00048; BERNUAU J, 1986, HEPATOLOGY, V6, P648, DOI 10.1002/hep.1840060417; Bretherick A, 2011, QJM-INT J MED, V104, P945, DOI 10.1093/qjmed/hcr098; Cholongitas EB, 2006, HEPATOLOGY, V43, P881, DOI 10.1002/hep.21121; Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824; Cholongitas E, 2012, LIVER TRANSPLANT, V18, P405, DOI 10.1002/lt.23370; CHRISTENSEN E, 1984, SCAND J GASTROENTERO, V19, P90, DOI 10.1080/00365521.1984.12005691; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Craig DGN, 2010, ALIMENT PHARM THER, V31, P1064, DOI 10.1111/j.1365-2036.2010.04279.x; Dabos KJ, 2005, TRANSPLANTATION, V80, P1712, DOI 10.1097/01.tp.0000187879.51616.e0; Dabos KJ, 2004, TRANSPLANTATION, V77, P200, DOI 10.1097/01.TP.0000100466.22441.37; Dhiman RK, 2007, LIVER TRANSPLANT, V13, P814, DOI 10.1002/lt.21050; Farmer DG, 2003, ANN SURG, V237, P666, DOI 10.1097/00000658-200305000-00009; Hadem J, 2008, CLIN GASTROENTEROL H, V6, P339, DOI 10.1016/j.cgh.2007.12.039; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Huo TI, 1996, J GASTROEN HEPATOL, V11, P560, DOI 10.1111/j.1440-1746.1996.tb01703.x; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kremers WK, 2004, HEPATOLOGY, V39, P764, DOI 10.1002/hep.20083; Kumar R, 2010, HEPATOLOGY, V51, P1665, DOI 10.1002/hep.23534; Leushuis E, 2009, HUM REPROD UPDATE, V15, P537, DOI 10.1093/humupd/dmp013; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; McPhail MJW, 2010, J HEPATOL, V53, P492, DOI 10.1016/j.jhep.2010.03.023; Medlock S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023441; Minne L, 2011, J AM GERIATR SOC, V59, P1110, DOI 10.1111/j.1532-5415.2011.03411.x; Miyake Y, 2005, TRANSPLANTATION, V80, P930, DOI 10.1097/01.tp.0000173651.39645.35; Newman DA, 2003, ORGAN RES METHODS, V6, P328, DOI 10.1177/1094428103254673; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; PAUWELS A, 1993, J HEPATOL, V17, P124, DOI 10.1016/S0168-8278(05)80532-X; Pelaez-Luna M, 2006, TRANSPL P, V38, P927, DOI 10.1016/j.transproceed.2006.02.034; Schmidt LE, 2006, CRIT CARE MED, V34, P337, DOI 10.1097/01.CCM.0000194724.70031.B6; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; Taylor RM, 2006, HEPATOLOGY, V44, P1589, DOI 10.1002/hep.21439; Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879; Wlodzimirow KA, 2012, ALIMENT PHARM THER, V35, P1245, DOI 10.1111/j.1365-2036.2012.05097.x; Yamagishi Y, 2009, J GASTROENTEROL, V44, P615, DOI 10.1007/s00535-009-0045-7; Yantorno SE, 2007, LIVER TRANSPLANT, V13, P822, DOI 10.1002/lt.21104	40	34	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50952	10.1371/journal.pone.0050952	http://dx.doi.org/10.1371/journal.pone.0050952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272081	Green Published, gold			2022-12-27	WOS:000312386800022
J	Wostenberg, C; Lary, JW; Sahu, D; Acevedo, R; Quarles, KA; Cole, JL; Showalter, SA				Wostenberg, Christopher; Lary, Jeffrey W.; Sahu, Debashish; Acevedo, Roderico; Quarles, Kaycee A.; Cole, James L.; Showalter, Scott A.			The Role of Human Dicer-dsRBD in Processing Small Regulatory RNAs	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DSRNA-BINDING DOMAIN; PROTEIN INTERACTIONS; STRUCTURAL INSIGHTS; RIBONUCLEASE-III; MOLECULAR-BASIS; RECOGNITION; DYNAMICS; RELAXATION; MICRORNAS	One of the most exciting recent developments in RNA biology has been the discovery of small non-coding RNAs that affect gene expression through the RNA interference (RNAi) mechanism. Two major classes of RNAs involved in RNAi are small interfering RNA (siRNA) and microRNA (miRNA). Dicer, an RNase III enzyme, plays a central role in the RNAi pathway by cleaving precursors of both of these classes of RNAs to form mature siRNAs and miRNAs, which are then loaded into the RNA-induced silencing complex (RISC). miRNA and siRNA precursors are quite structurally distinct; miRNA precursors are short, imperfect hairpins while siRNA precursors are long, perfect duplexes. Nonetheless, Dicer is able to process both. Dicer, like the majority of RNase III enzymes, contains a dsRNA binding domain (dsRBD), but the data are sparse on the exact role this domain plays in the mechanism of Dicer binding and cleavage. To further explore the role of human Dicer-dsRBD in the RNAi pathway, we determined its binding affinity to various RNAs modeling both miRNA and siRNA precursors. Our study shows that Dicer-dsRBD is an avid binder of dsRNA, but its binding is only minimally influenced by a single-stranded - double-stranded junction caused by large terminal loops observed in miRNA precursors. Thus, the Dicer-dsRBD contributes directly to substrate binding but not to the mechanism of differentiating between pre-miRNA and pre-siRNA. In addition, NMR spin relaxation and MD simulations provide an overview of the role that dynamics contribute to the binding mechanism. We compare this current study with our previous studies of the dsRBDs from Drosha and DGCR8 to give a dynamic profile of dsRBDs in their apo-state and a mechanistic view of dsRNA binding by dsRBDs in general.	[Wostenberg, Christopher; Sahu, Debashish; Acevedo, Roderico; Quarles, Kaycee A.; Showalter, Scott A.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Wostenberg, Christopher; Sahu, Debashish; Acevedo, Roderico; Quarles, Kaycee A.; Showalter, Scott A.] Penn State Univ, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Lary, Jeffrey W.; Cole, James L.] Univ Connecticut, Natl Analyt Ultracentrifugat Facil, Storrs, CT USA; [Cole, James L.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Cole, James L.] Univ Connecticut, Dept Chem, Storrs, CT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Connecticut; University of Connecticut; University of Connecticut	Showalter, SA (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sas76@psu.edu	Showalter, Scott A/A-1655-2012; Sahu, Debashish/G-8325-2018	Showalter, Scott A/0000-0001-5179-032X; Sahu, Debashish/0000-0002-5890-813X	National Institutes of Health [R01-GM098451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health grant R01-GM098451 to Scott A. Showalter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Carlson CB, 2003, BIOPOLYMERS, V70, P86, DOI 10.1002/bip.10413; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dominguez C, 2011, PROG NUCL MAG RES SP, V58, P1, DOI 10.1016/j.pnmrs.2010.10.001; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Ma E, 2012, J MOL BIOL; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Nicholson AW, 2011, NUCLEIC ACIDS MOL BI, V26, P269, DOI 10.1007/978-3-642-21078-5_11; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Prompers JJ, 2002, J AM CHEM SOC, V124, P4522, DOI 10.1021/ja012750u; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Showalter SA, 2007, J CHEM THEORY COMPUT, V3, P961, DOI 10.1021/ct7000045; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Song LP, 2011, PROTEIN CELL, V2, P273, DOI 10.1007/s13238-011-1037-y; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Ucci JW, 2007, BIOCHEMISTRY-US, V46, P55, DOI 10.1021/bi061531o; Ucci JW, 2004, BIOPHYS CHEM, V108, P127, DOI 10.1016/j.bpc.2003.10.033; van Rij RP, 2009, TRENDS MICROBIOL, V17, P163, DOI 10.1016/j.tim.2009.01.003; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang ZH, 2011, STRUCTURE, V19, P999, DOI 10.1016/j.str.2011.03.022; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Wong CJ, 2011, METHOD ENZYMOL, P59, DOI 10.1016/B978-0-12-381268-1.00003-3; Wostenberg C, 2010, BIOCHEMISTRY-US, V49, P10728, DOI 10.1021/bi1015716; Wostenberg C, 2010, BIOPHYS J, V99, P248, DOI 10.1016/j.bpj.2010.04.010; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	64	37	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51829	10.1371/journal.pone.0051829	http://dx.doi.org/10.1371/journal.pone.0051829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272173	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600041
J	Yang, YL; Zhi, F; He, XZ; Moore, ML; Kang, XZ; Chao, DM; Wang, R; Kim, DH; Xia, Y				Yang, Yilin; Zhi, Feng; He, Xiaozhou; Moore, Meredith L.; Kang, Xuezhi; Chao, Dongman; Wang, Rong; Kim, Dong H.; Xia, Ying			delta-Opioid Receptor Activation and MicroRNA Expression of the Rat Cortex in Hypoxia	PLOS ONE			English	Article							NEUROPROTECTIVE ROLE; CORTICAL-NEURONS; K+ HOMEOSTASIS; NA+ CHANNELS; CELL-DEATH; INJURY; BRAIN; PROLIFERATION; ISCHEMIA; PROTECTS	Prolonged hypoxic/ischemic stress may cause cortical injury and clinically manifest as a neurological disability. Activation of the delta-opioid receptor (DOR) may induce cortical protection against hypoxic/ischemic insults. However, the mechanisms underlying DOR protection are not clearly understood. We have recently found that DOR activation modulates the expression of microRNAs (miRNAs) in the kidney exposed to hypoxia, suggesting that DOR protection may involve a miRNA mechanism. To determine if the miRNAs expressed in the cortex mediated DOR neuroprotection, we examined 19 miRNAs that were previously identified as hypoxia-and DOR-regulated miRNAs in the kidney, in the rat cortex treated with UFP-512, a potent and specific DOR agonist under hypoxic condition. Of the 19 miRNAs tested, 17 were significantly altered by hypoxia and/or DOR activation with the direction and amplitude varying depending on hypoxic duration and times of DOR treatment. Expression of several miRNAs such as miR-29b, -101b, -298, 324-3p, -347 and 466b was significantly depressed after 24 hours of hypoxia. Similar changes were seen in normoxic condition 24 hours after DOR activation with one-time treatment of UFP-512. In contrast, some miRNAs were more tolerant to hypoxic stress and showed significant reduction only with 5-day (e.g., miR-31 and -186) or 10-day (e. g., miR-29a, let-7f and -511) exposures. In addition, these miRNAs had differential responses to DOR activation. Other miRNAs like miRs-363* and -370 responded only to the combined exposure to hypoxia and DOR treatment, with a notable reduction of >70% in the 5-day group. These data suggest that cortical miRNAs are highly yet differentially sensitive to hypoxia. DOR activation can modify, enhance or resolve the changes in miRNAs that target HIF, ion transport, axonal guidance, free radical signaling, apoptosis and many other functions.	[Moore, Meredith L.; Chao, Dongman; Kim, Dong H.; Xia, Ying] Univ Texas Houston, Med Sch Houston, Houston, TX 77030 USA; [Yang, Yilin; Zhi, Feng; He, Xiaozhou; Wang, Rong] Soochow Univ, Clin Coll 3, Changzhou, Jiangsu, Peoples R China; [Kang, Xuezhi] Shanghai Res Ctr Acupuncture & Meridians, Shanghai, Peoples R China; [Chao, Dongman; Xia, Ying] Yale Univ, Sch Med, New Haven, CT USA	University of Texas System; University of Texas Health Science Center Houston; Soochow University - China; Yale University	Xia, Y (corresponding author), Univ Texas Houston, Med Sch Houston, Houston, TX 77030 USA.	Ying.Xia@UTH.TMC.edu	Kang, Xuezhi/L-6719-2016	Kang, Xuezhi/0000-0002-0582-2244; Kim, Dong/0000-0002-1523-6396	National Institutes of Health [HD-034852, AT-004422]; Vivian L. Smith Neurologic Foundation; National Science Foundation of China [31071046]; Changzhou Science Development Project [CS20102010]; Changzhou Health Bureau [ZD201007]; National Basic Research Project [09CB522901, 12CB518502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vivian L. Smith Neurologic Foundation; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Science Development Project; Changzhou Health Bureau; National Basic Research Project(National Basic Research Program of China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by grants of National Institutes of Health (HD-034852; AT-004422), Vivian L. Smith Neurologic Foundation, National Science Foundation of China (31071046), Changzhou Science Development Project (CS20102010), Changzhou Health Bureau (ZD201007), and National Basic Research Project (09CB522901; 12CB518502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Chao D, 2009, CELL MOL LIFE SCI, V66, P1105, DOI 10.1007/s00018-009-8759-5; Chao DM, 2008, CEREB CORTEX, V18, P2217, DOI 10.1093/cercor/bhm247; Chao DM, 2007, J CELL PHYSIOL, V212, P60, DOI 10.1002/jcp.21000; Chao DM, 2007, J CEREBR BLOOD F MET, V27, P356, DOI 10.1038/sj.jcbfm.9600352; Chao DM, 2012, EXP NEUROL, V236, P228, DOI 10.1016/j.expneurol.2012.05.006; Chao DM, 2010, PROG NEUROBIOL, V90, P439, DOI 10.1016/j.pneurobio.2009.12.007; Charron C, 2008, PHYSIOL BEHAV, V93, P502, DOI 10.1016/j.physbeh.2007.10.015; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; Dharap A, 2010, J NEUROCHEM, V113, P1685, DOI 10.1111/j.1471-4159.2010.06735.x; Feng YA, 2011, CHINESE J PHYSIOL, V54, P118, DOI 10.4077/CJP.2011.AMM047; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Horiuchi T, 2008, J ANESTH, V22, P32, DOI 10.1007/s00540-007-0576-0; Kang XZ, 2009, CELL MOL LIFE SCI, V66, P3505, DOI 10.1007/s00018-009-0136-x; Lim YJ, 2004, ANESTHESIOLOGY, V100, P562, DOI 10.1097/00000542-200403000-00015; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; Matsuo N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-240; Narita M, 2006, J NEUROCHEM, V97, P1494, DOI 10.1111/j.1471-4159.2006.03849.x; Pamenter ME, 2008, J EXP BIOL, V211, P3512, DOI 10.1242/jeb.021949; Persson AI, 2003, MOL CELL NEUROSCI, V23, P360, DOI 10.1016/S1044-7431(03)00061-7; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Rao VLR, 2002, J NEUROCHEM, V83, P1072, DOI 10.1046/j.1471-4159.2002.01208.x; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; SHAHABI NA, 1995, ADV EXP MED BIOL, V373, P29; Shi GD, 2012, EXP BRAIN RES, V216, P225, DOI 10.1007/s00221-011-2925-3; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Wang SY, 2011, EUR J PHARMACOL, V658, P140, DOI 10.1016/j.ejphar.2011.02.006; White NMA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-65; Xia Y, 1999, NEUROSCIENCE, V94, P1231, DOI 10.1016/S0306-4522(99)00375-9; XIA Y, 1993, PEDIATR RES, V34, P634, DOI 10.1203/00006450-199311000-00015; XIA Y, 1995, BRAIN RES, V675, P224, DOI 10.1016/0006-8993(95)00079-6; Yang L, 2011, BRAIN RES, V1383, P307, DOI 10.1016/j.brainres.2011.01.083; Yang YL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-55; Zhang JH, 2006, STROKE, V37, P1094, DOI 10.1161/01.STR.0000206444.29930.18; Zhang JH, 2002, AM J PHYSIOL-CELL PH, V282, pC1225, DOI 10.1152/ajpcell.00226.2001; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zhu M, 2009, BRAIN RES, V1252, P183, DOI 10.1016/j.brainres.2008.11.030; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	45	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51524	10.1371/journal.pone.0051524	http://dx.doi.org/10.1371/journal.pone.0051524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272113	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600027
J	Al-Daghri, NM; Bindahman, LS; Al-Attas, OS; Saleem, TH; Alokail, MS; Alkharfy, KM; Draz, HM; Yakout, S; Mohamed, AO; Harte, AL; McTernan, PG				Al-Daghri, Nasser M.; Bindahman, Lotfi S.; Al-Attas, Omar S.; Saleem, Tahia H.; Alokail, Majed S.; Alkharfy, Khalid M.; Draz, Hossam M.; Yakout, Sobhy; Mohamed, Amany O.; Harte, Alison L.; McTernan, Philip G.			Increased Circulating ANG II and TNF-alpha Represents Important Risk Factors in Obese Saudi Adults with Hypertension Irrespective of Diabetic Status and BMI	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RENIN-ANGIOTENSIN SYSTEM; INSULIN-RESISTANCE; ADIPOSE-TISSUE; BLOOD-PRESSURE; BODY-MASS; LEPTIN; INFLAMMATION; ADIPONECTIN; EXPRESSION	Central adiposity is a significant determinant of obesity-related hypertension risk, which may arise due to the pathogenic inflammatory nature of the abdominal fat depot. However, the influence of pro-inflammatory adipokines on blood pressure in the obese hypertensive phenotype has not been well established in Saudi subjects. As such, our study investigated whether inflammatory factors may represent useful biomarkers to delineate hypertension risk in a Saudi cohort with and without hypertension and/or diabetes mellitus type 2 (DMT2). Subjects were subdivided into four groups: healthy lean controls (age: 47.9 +/- 5.1 yr; BMI: 22.9 +/- 2.1 Kg/m(2)), non-hypertensive obese (age: 46.1 +/- 5.0 yr; BMI: 33.7 +/- 4.2 Kg/m(2)), hypertensive obese (age: 48.6 +/- 6.1 yr; BMI: 36.5 +/- 7.7 Kg/m(2)) and hypertensive obese with DMT2 (age: 50.8 +/- 6.0 yr; BMI: 35.3 +/- 6.7 Kg/m(2)). Anthropometric data were collected from all subjects and fasting blood samples were utilized for biochemical analysis. Serum angiotensin II (ANG II) levels were elevated in hypertensive obese (p<0.05) and hypertensive obese with DMT2 (p<0.001) compared with normotensive controls. Systolic blood pressure was positively associated with BMI (p<0.001), glucose (p<0.001), insulin (p<0.05), HOMA-IR (p<0.001), leptin (p<0.01), TNF-alpha (p<0.001) and ANG II (p<0.05). Associations between ANG II and TNF-alpha with systolic blood pressure remained significant after controlling for BMI. Additionally CRP (p<0.05), leptin (p<0.001) and leptin/adiponectin ratio (p<0.001) were also significantly associated with the hypertension phenotype. In conclusion our data suggests that circulating pro-inflammatory adipokines, particularly ANG II and, TNF-alpha, represent important factors associated with a hypertension phenotype and may directly contribute to predicting and exacerbating hypertension risk.	[Al-Daghri, Nasser M.; Bindahman, Lotfi S.; Al-Attas, Omar S.; Alokail, Majed S.; Draz, Hossam M.; Yakout, Sobhy] King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia; [Al-Attas, Omar S.] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh 11451, Saudi Arabia; [Bindahman, Lotfi S.; Saleem, Tahia H.; Mohamed, Amany O.] Assiut Univ, Fac Med, Dept Biochem, Assiut, Egypt; [Alkharfy, Khalid M.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh 11451, Saudi Arabia; [Draz, Hossam M.] Natl Res Ctr, Dept Biochem, Cairo, Egypt; [Harte, Alison L.; McTernan, Philip G.] Univ Warwick, Univ Hosp Coventry & Warwickshire Trust, Div Metab & Vasc Hlth, CSRL,Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); Assiut University; King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Warwick	Al-Daghri, NM (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia.	aldaghri2011@gmail.com; a.harte@warwick.ac.uk	Al-Daghri, Nasser/A-8360-2011; Al-Daghri, Nasser/G-7736-2011; yakout, sobhy/E-7509-2019; Bin Dahman, Lotfi Saeed/AAQ-5741-2021; Al-okail, Majed S/E-5565-2016	Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; Bin Dahman, Lotfi Saeed/0000-0002-1526-4952; Al-okail, Majed S/0000-0001-8147-3499; Draz, Hossam/0000-0002-7351-3339; Mohamed, Amany/0000-0003-3131-3846; McTernan, Philip/0000-0001-9023-0261	National Plan for Science and Technology (NPST), Riyadh, Saudi Arabia [08-MED-603-2]; British Heart Foundation	National Plan for Science and Technology (NPST), Riyadh, Saudi Arabia; British Heart Foundation(British Heart Foundation)	This study was supported by a grant from National Plan for Science and Technology (NPST), (08-MED-603-2) Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the primary care physicians and nurses who recruited and collected the data of the subjects. We also thank the British Heart Foundation for the intermediate Fellowship to support Dr Alison Harte. Special thanks is also noted to Mr. Benjamin Vinodson and Saim Ul-Haq Quddusi for the statistical analysis of data.	Adamczak M, 2003, AM J HYPERTENS, V16, P72, DOI 10.1016/S0895-7061(02)03197-7; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Al-Daghri NM, 2010, ADV MED SCI-POLAND, V55, P179, DOI 10.2478/v10039-010-0052-1; Al-Daghri N, 2010, ANN SAUDI MED, V30, P209, DOI 10.4103/0256-4947.62835; Al-Homrany MA, 2008, SAUDI J KIDNEY DIS T, V19, P990; Alhyas Layla, 2011, JRSM Short Rep, V2, P55, DOI 10.1258/shorts.2011.011019; Androulakis ES, 2009, CARDIOL REV, V17, P216, DOI 10.1097/CRD.0b013e3181b18e03; Asferg C, 2011, BLOOD PRESSURE, V20, P362, DOI 10.3109/00365599.2011.586248; Asferg C, 2010, AM J HYPERTENS, V23, P327, DOI 10.1038/ajh.2009.244; Baden MY, 2012, CLIN ENDOCRINOL OXF; Bautista LE, 2005, J HUM HYPERTENS, V19, P149, DOI 10.1038/sj.jhh.1001785; Bertoni AG, 2010, DIABETES CARE, V33, P804, DOI 10.2337/dc09-1679; Carlyle M, 2002, HYPERTENSION, V39, P496, DOI 10.1161/hy0202.104398; Celoria Bruno M J, 2010, Clin Cardiol, V33, pE61, DOI 10.1002/clc.20657; Chamarthi B, 2011, AM J HYPERTENS, V24, P1143, DOI 10.1038/ajh.2011.113; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; do Carmo JM, 2011, HYPERTENSION, V57, P918, DOI 10.1161/HYPERTENSIONAHA.110.161349; Feber J, 2010, CLIN SCI, V119, P151, DOI 10.1042/CS20090544; Fogari R, 2005, HYPERTENS RES, V28, P209, DOI 10.1291/hypres.28.209; Fowler JD, 2009, AM J PHYSIOL-ENDOC M, V296, pE343, DOI 10.1152/ajpendo.90693.2008; Galletti F, 2008, J CLIN ENDOCR METAB, V93, P3922, DOI 10.1210/jc.2008-1280; Galletti F, 2012, NUTR METAB CARDIOVAS, V22, P300, DOI 10.1016/j.numecd.2011.05.007; Gao X, 2007, FASEB J, V21, pA1198; Goodwin BL, 2007, AM J PHYSIOL-HEART C, V293, pH1115, DOI 10.1152/ajpheart.01100.2006; Gurantz D, 1999, CIRC RES, V85, P272, DOI 10.1161/01.RES.85.3.272; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Harte A, 2005, CIRCULATION, V111, P1954, DOI 10.1161/01.CIR.0000161954.17870.5D; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Itani H, 2009, HYPERTENSION, V53, P1070, DOI 10.1161/HYPERTENSIONAHA.109.130633; Kalra D, 2002, CIRCULATION, V105, P2198, DOI 10.1161/01.CIR.0000015603.84788.47; Kalupahana NS, 2012, OBES REV, V13, P136, DOI 10.1111/j.1467-789X.2011.00942.x; Kotchen TA, 2010, AM J HYPERTENS, V23, P1170, DOI 10.1038/ajh.2010.172; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; Ma D, 2009, HYPERTENSION, V53, P473, DOI 10.1161/HYPERTENSIONAHA.108.118133; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; Patel JV, 2009, ANN MED, V41, P291, DOI 10.1080/07853890802672839; Pruijm M, 2012, J HUM HYPERTENS; Sabo RT, 2012, OBESITY SILVER SPRIN; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Summer Ross, 2011, Pulm Circ, V1, P440, DOI 10.4103/2045-8932.93542; Takeshita Y, 2008, EUR J PHARMACOL, V579, P426, DOI 10.1016/j.ejphar.2007.11.016; Taube A, 2012, AM J PHYSL HEART CIR; Tohidi M, 2011, J HUM HYPERTENS; Vlasova M, 2010, ACTA PHYSIOL, V200, P107, DOI 10.1111/j.1748-1716.2010.02171.x; Wago T, 2010, HYPERTENS RES, V33, P796, DOI 10.1038/hr.2010.107; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263; Zhang HR, 2010, WORLD J CARDIOL, V2, P370, DOI 10.4330/wjc.v2.i11.370	52	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51255	10.1371/journal.pone.0051255	http://dx.doi.org/10.1371/journal.pone.0051255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251471	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200076
J	Anderson, RC; Klofstad, CA				Anderson, Rindy C.; Klofstad, Casey A.			Preference for Leaders with Masculine Voices Holds in the Case of Feminine Leadership Roles	PLOS ONE			English	Article							PITCH	Human voice pitch research has focused on perceptions of attractiveness, strength, and social dominance. Here we examine the influence of pitch on selection of leaders, and whether this influence varies by leadership role. Male and female leaders with lower-pitched (i.e., masculine) voices are generally preferred by both men and women. We asked whether this preference shifts to favor higher-pitch (i.e., feminine) voices within the specific context of leadership positions that are typically held by women (i.e., feminine leadership roles). In hypothetical elections for two such positions, men and women listened to pairs of male and female voices that differed only in pitch, and were asked which of each pair they would vote for. As in previous studies, men and women preferred female candidates with masculine voices. Likewise, men preferred men with masculine voices. Women, however, did not discriminate between male voices. Overall, contrary to research showing that perceptions of voice pitch can be influenced by social context, these results suggest that the influence of voice pitch on perceptions of leadership capacity is largely consistent across different domains of leadership.	[Anderson, Rindy C.] Duke Univ, Dept Biol, Durham, NC USA; [Klofstad, Casey A.] Univ Miami, Dept Polit Sci, Coral Gables, FL 33124 USA	Duke University; University of Miami	Klofstad, CA (corresponding author), Univ Miami, Dept Polit Sci, Coral Gables, FL 33124 USA.	klofstad@gmail.com						Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Nishio M, 2008, FOLIA PHONIATR LOGO, V60, P120, DOI 10.1159/000118510; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Titze IR, 1994, PRINCIPLES VOICE PRO; TRAUNMULLER H, 1990, J ACOUST SOC AM, V88, P97, DOI 10.1121/1.399849; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5	12	34	36	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51216	10.1371/journal.pone.0051216	http://dx.doi.org/10.1371/journal.pone.0051216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251457	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200072
J	Coltharp, C; Kessler, RP; Xiao, J				Coltharp, Carla; Kessler, Rene P.; Xiao, Jie			Accurate Construction of Photoactivated Localization Microscopy (PALM) Images for Quantitative Measurements	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; FLUORESCENT PROTEIN; SUPERRESOLUTION; PROBES; CELLS; FTSZ; ORGANIZATION; COEFFICIENTS; PERFORMANCE; SYSTEM	Localization-based superresolution microscopy techniques such as Photoactivated Localization Microscopy (PALM) and Stochastic Optical Reconstruction Microscopy (STORM) have allowed investigations of cellular structures with unprecedented optical resolutions. One major obstacle to interpreting superresolution images, however, is the overcounting of molecule numbers caused by fluorophore photoblinking. Using both experimental and simulated images, we determined the effects of photoblinking on the accurate reconstruction of superresolution images and on quantitative measurements of structural dimension and molecule density made from those images. We found that structural dimension and relative density measurements can be made reliably from images that contain photoblinking-related overcounting, but accurate absolute density measurements, and consequently faithful representations of molecule counts and positions in cellular structures, require the application of a clustering algorithm to group localizations that originate from the same molecule. We analyzed how applying a simple algorithm with different clustering thresholds (t(Thresh) and d(Thresh)) affects the accuracy of reconstructed images, and developed an easy method to select optimal thresholds. We also identified an empirical criterion to evaluate whether an imaging condition is appropriate for accurate superresolution image reconstruction with the clustering algorithm. Both the threshold selection method and imaging condition criterion are easy to implement within existing PALM clustering algorithms and experimental conditions. The main advantage of our method is that it generates a superresolution image and molecule position list that faithfully represents molecule counts and positions within a cellular structure, rather than only summarizing structural properties into ensemble parameters. This feature makes it particularly useful for cellular structures of heterogeneous densities and irregular geometries, and allows a variety of quantitative measurements tailored to specific needs of different biological systems.	[Coltharp, Carla; Kessler, Rene P.; Xiao, Jie] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Xiao, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	xiao@jhmi.edu		Xiao, Jie/0000-0003-1433-5437	National Science Foundation EArly-concept Grants for Exploratory Research (EAGER) Grant [MCB-1019000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086447] Funding Source: NIH RePORTER	National Science Foundation EArly-concept Grants for Exploratory Research (EAGER) Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation EArly-concept Grants for Exploratory Research (EAGER) Grant MCB-1019000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Baddeley D, 2010, MICROSC MICROANAL, V16, P64, DOI 10.1017/S143192760999122X; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; Chien FC, 2011, SMALL, V7, P2906, DOI 10.1002/smll.201100753; David CC, 2012, PHOTOCHEMICAL PHOTOB, P11; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Endesfelder U, 2011, MOLECULES, V16, P3106, DOI 10.3390/molecules16043106; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; FU G, 2010, PLOS ONE, V0005; Garcia-Parajo MF, 2001, P NATL ACAD SCI USA, V98, P14392, DOI 10.1073/pnas.251525598; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hsu CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023586; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; JACKSON DA, 1989, AM NAT, V133, P436, DOI 10.1086/284927; Jennings PC, 2011, MICRON, V42, P336, DOI 10.1016/j.micron.2010.09.003; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; Lelek M, 2012, P NATL ACAD SCI; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wolter S, 2011, OPT EXPRESS, V19, P7020, DOI 10.1364/OE.19.007020; Yeow EKL, 2006, J PHYS CHEM A, V110, P1726, DOI 10.1021/jp055496r	45	42	42	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51725	10.1371/journal.pone.0051725	http://dx.doi.org/10.1371/journal.pone.0051725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251611	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200157
J	Wiech, M; Olszewski, MB; Tracz-Gaszewska, Z; Wawrzynow, B; Zylicz, M; Zylicz, A				Wiech, Milena; Olszewski, Maciej B.; Tracz-Gaszewska, Zuzanna; Wawrzynow, Bartosz; Zylicz, Maciej; Zylicz, Alicja			Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; HEAT-SHOCK PROTEINS; UBIQUITIN LIGASE; CORE DOMAIN; GENE AMPLIFICATION; DEPENDENT MANNER; ATP HYDROLYSIS; RNA-POLYMERASE; BREAST-CANCER; BINDING-SITE	Numerous p53 missense mutations possess gain-of-function activities. Studies in mouse models have demonstrated that the stabilization of p53 R172H (R175H in human) mutant protein, by currently unknown factors, is a prerequisite for its oncogenic gain-of-function phenotype such as tumour progression and metastasis. Here we show that MDM2-dependent ubiquitination and degradation of p53 R175H mutant protein in mouse embryonic fibroblasts is partially inhibited by increasing concentration of heat shock protein 70 (HSP70/HSPA1-A). These phenomena correlate well with the appearance of HSP70-dependent folding intermediates in the form of dynamic cytoplasmic spots containing aggregate-prone p53 R175H and several molecular chaperones. We propose that a transient but recurrent interaction with HSP70 may lead to an increase in mutant p53 protein half-life. In the presence of MDM2 these pseudoaggregates can form stable amyloid-like structures, which occasionally merge into an aggresome. Interestingly, formation of folding intermediates is not observed in the presence of HSC70/HSPA8, the dominant-negative K71S variant of HSP70 or HSP70 inhibitor. In cancer cells, where endogenous HSP70 levels are already elevated, mutant p53 protein forms nuclear aggregates without the addition of exogenous HSP70. Aggregates containing p53 are also visible under conditions where p53 is partially unfolded: 37 degrees C for temperature-sensitive variant p53 V143A and 42 degrees C for wild-type p53. Refolding kinetics of p53 indicate that HSP70 causes transient exposure of p53 aggregate-prone domain(s). We propose that formation of HSP70- and MDM2-dependent protein coaggregates in tumours with high levels of these two proteins could be one of the mechanisms by which mutant p53 is stabilized. Moreover, sequestration of p73 tumour suppressor protein by these nuclear aggregates may lead to gain-of-function phenotypes.	[Wiech, Milena; Olszewski, Maciej B.; Tracz-Gaszewska, Zuzanna; Wawrzynow, Bartosz; Zylicz, Maciej; Zylicz, Alicja] Int Inst Mol & Cell Biol Warsaw, Dept Mol Biol, Warsaw, Poland; [Wiech, Milena] PAS, Nencki Inst Expt Biol, Warsaw, Poland; [Tracz-Gaszewska, Zuzanna] PAS, Inst Biochem & Biophys, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zylicz, M (corresponding author), Int Inst Mol & Cell Biol Warsaw, Dept Mol Biol, Warsaw, Poland.	mzylicz@iimcb.gov.pl; alicja.zylicz@iimcb.gov.pl	Olszewski, Maciej/G-8396-2016; Olszewski, Maciej/C-2021-2015; Wiech, Milena/AAC-5188-2020	Olszewski, Maciej/0000-0003-0961-0801; Olszewski, Maciej/0000-0003-0961-0801; Wiech, Milena/0000-0003-4388-1648; Zylicz, Alicja/0000-0003-4174-3073; Tracz-Gaszewska, Zuzanna/0000-0003-1340-6379	National Center of Science [NN 302621838, 2011/01/N/NZ1/00202]; Foundation for Polish Science [Ventures/2010-6/8]	National Center of Science(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	The work was funded by the National Center of Science - grants NN 302621838 (AZ) and 2011/01/N/NZ1/00202 (MW) and by the Foundation for Polish Science - project Ventures/2010-6/8 (ZTG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin S, 2011, J PATHOL, V225, P479, DOI 10.1002/path.2971; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; [Anonymous], J BIOL CHEM; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; BARTEK J, 1991, ONCOGENE, V6, P1699; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Coates PJ, 2006, J PATHOL, V210, P385, DOI 10.1002/path.2080; CORDONCARDO C, 1994, CANCER RES, V54, P794; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dreiseidler M, 2012, METHODS MOL BIOL, V832, P473, DOI 10.1007/978-1-61779-474-2_34; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Fortun J, 2003, J NEUROSCI, V23, P10672; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gajjar M, 2012, CANCER CELL, V21, P25, DOI 10.1016/j.ccr.2011.11.016; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LADANYI M, 1993, CANCER RES, V53, P16; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lo Nigro C, 2012, BRIT J CANCER, V106, P397, DOI 10.1038/bjc.2011.464; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Mathew R, 2002, EUR J CANCER, V38, P832, DOI 10.1016/S0959-8049(02)00007-2; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; SHEIKH MS, 1993, CANCER RES, V53, P3226; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; Steiner K, 2006, LEUKEMIA, V20, P2076, DOI 10.1038/sj.leu.2404391; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Suh YA, 2011, CANCER RES, V71, P7168, DOI 10.1158/0008-5472.CAN-11-0459; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Trbusek M, 2011, J CLIN ONCOL, V29, P2703, DOI 10.1200/JCO.2011.34.7872; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI 10.2217/FON.09.30; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volloch VZ, 1999, ONCOGENE, V18, P3648, DOI 10.1038/sj.onc.1202525; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Walerych D, 2010, J BIOL CHEM, V285, P32020, DOI 10.1074/jbc.M110.112110; Wallace M, 2006, AM BOOK REV, V27, P3, DOI 10.1353/abr.2006.0081; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Winklhofer KF, 2001, J BIOL CHEM, V276, P45160, DOI 10.1074/jbc.M104873200; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhu QZ, 2001, J BIOL CHEM, V276, P29695, DOI 10.1074/jbc.M102634200; ZIEMIENOWICZ A, 1993, J BIOL CHEM, V268, P25425; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634; ZYLICZ M, 1983, P NATL ACAD SCI-BIOL, V80, P6431, DOI 10.1073/pnas.80.21.6431	89	81	85	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51426	10.1371/journal.pone.0051426	http://dx.doi.org/10.1371/journal.pone.0051426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251530	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200105
J	Wang, Y; Wong, HC; Gullen, EA; Lam, W; Yang, XM; Shi, Q; Lee, KH; Cheng, YC				Wang, Ying; Wong, Hui-Chyn; Gullen, Elizabeth A.; Lam, Wing; Yang, Xiaoming; Shi, Qian; Lee, Kuo-Hsiung; Cheng, Yung-Chi			Cryptopleurine Analogs with Modification of E Ring Exhibit Different Mechanism to Rac-Cryptopleurine and Tylophorine	PLOS ONE			English	Article							INHIBITION; ALKALOIDS; CANCER	Tylophorine analogs exhibit a broad range of pharmacological activities, including anti-cancer, anti-inflammatory, anti-autoimmune, and anti-virus effects. Structure-activity relationship study of different structure tylophorine analogs can provide further understanding of their biological activity. Modifications on the E ring of the quinolizidine moiety of cryptopleurine analogs changed the potency and the selective inhibitory effect on NF-kappa B, AP-1, and CRE signaling pathways. Functional cryptopleurine analogs showed potent inhibition of NF-kappa B signaling pathway in both HepG2 and HEK-293 cell lines. The E ring structure analogs also differed in suppression of protein translation, and expression of cyclin D1. Our results showed that DCB-3503 or Rac-cryptopleurine could be a scaffold for modification to yield compounds with different mechanisms of action.	[Yang, Xiaoming; Shi, Qian; Lee, Kuo-Hsiung] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA; [Wang, Ying; Wong, Hui-Chyn; Gullen, Elizabeth A.; Lam, Wing; Cheng, Yung-Chi] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan	University of North Carolina; University of North Carolina Chapel Hill; Yale University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, KH (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA.	khlee@unc.edu; yccheng@yale.edu	Wang, Ying/T-9438-2018	Wang, Ying/0000-0002-1407-2668	National Science Fellowship (NSF) by the Ministry of Science, Technology and Innovation of Malaysia (MOSTI) foundation; National Cancer Institute of National Institute of Health of USA [PO1 CA-154295]; National Institute of Health of USA [RO1 CA-17625-32]; Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence [DOH100-TD-C-111-005]; NATIONAL CANCER INSTITUTE [P01CA154295, R01CA017625] Funding Source: NIH RePORTER	National Science Fellowship (NSF) by the Ministry of Science, Technology and Innovation of Malaysia (MOSTI) foundation; National Cancer Institute of National Institute of Health of USA; National Institute of Health of USA; Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. David C. Baker for providing the compound DCB-3503. They thank Dr. Susan L. Morris-Natschke and Eileen Belding for proof reading of the manuscript. Yung-Chi Cheng is a fellow of the National Foundation for Cancer Research. Hui-Chyn Wong is partially supported by the National Science Fellowship (NSF) awarded by the Ministry of Science, Technology and Innovation of Malaysia (MOSTI) foundation. This work was supported by grants PO1 CA-154295 funded by National Cancer Institute of National Institute of Health of USA (YCC) and RO1 CA-17625-32 funded by National Institute of Health of USA (KHL). This study was also supported in part by the Taiwan Department of Health, China Medical University Hospital Cancer Research Center of Excellence (DOH100-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Chen BC, 2004, J BIOL CHEM, V279, P20889, DOI 10.1074/jbc.M311279200; Choi JY, 2006, ARTHRITIS RHEUM, V54, P3277, DOI 10.1002/art.22119; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Gao W, 2008, BIOORG MED CHEM LETT, V18, P704, DOI 10.1016/j.bmcl.2007.11.054; Gao WL, 2007, BIOORG MED CHEM LETT, V17, P4338, DOI 10.1016/j.bmcl.2007.05.021; Gao WL, 2004, CANCER RES, V64, P678, DOI 10.1158/0008-5472.CAN-03-1904; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; RAINA V, 1980, BIOCHEM BIOPH RES CO, V94, P1074, DOI 10.1016/0006-291X(80)90528-8; Shiah HS, 2006, MOL CANCER THER, V5, P2484, DOI 10.1158/1535-7163.MCT-06-0146; Wang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011607; Yang CW, 2007, BIOCHEM BIOPH RES CO, V354, P942, DOI 10.1016/j.bbrc.2007.01.065; Yang XM, 2012, J MED CHEM, V55, P6751, DOI 10.1021/jm3001218; Yang XM, 2011, J MED CHEM, V54, P5097, DOI 10.1021/jm200330s; Yang XM, 2010, ORG LETT, V12, P1416, DOI 10.1021/ol902819j; You X, 2006, ARTHRITIS RHEUM-US, V54, P877, DOI 10.1002/art.21640	17	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51138	10.1371/journal.pone.0051138	http://dx.doi.org/10.1371/journal.pone.0051138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251437	gold, Green Submitted, Green Published			2022-12-27	WOS:000312201900046
J	Floyd, AM; Zhou, X; Evans, C; Rompala, OJ; Zhu, LX; Wang, MW; Chen, Y				Floyd, Anne M.; Zhou, Xu; Evans, Christopher; Rompala, Olivia J.; Zhu, Lingxiang; Wang, Mingwu; Chen, Yin			Mucin Deficiency Causes Functional and Structural Changes of the Ocular Surface	PLOS ONE			English	Article							DRY EYE; SJOGREN-SYNDROME; D-DOMAINS; EXPRESSION; MUC5AC; CORNEAL; GENES; MICE; CLASSIFICATION; EPITHELIUM	MUC5AC is the most abundant gel-forming mucin in the ocular system. However, the specific function is unknown. In the present study, a Muc5ac knockout (KO) mouse model was subject to various physiological measurements as compared to its wide-type (WT) control. Interestingly, when KO mice were compared to WT mice, the mean tear break up time (TBUT) values were significantly lower and corneal fluorescein staining scores were significantly higher. But the tear volume was not changed. Despite the lack of Muc5ac expression in the conjunctiva of KO mice, Muc5b expression was significantly increased in these mice. Corneal opacification, varying in location and severity, was found in a few KO mice but not in WT mice. The present results suggest a significant difference in the quality, but not the quantity, of tear fluid in the KO mice compared to WT mice. Dry eye disease is multifactorial and therefore further evaluation of the varying components of the tear film, lacrimal unit and corneal structure of these KO mice may help elucidate the role of mucins in dry eye disease. Because Muc5ac knockout mice have clinical features of dry eye, this mouse model will be extremely useful for further studies regarding the pathophysiology of the ocular surface in dry eye in humans.	[Floyd, Anne M.; Wang, Mingwu] Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ 85721 USA; [Floyd, Anne M.; Zhou, Xu; Rompala, Olivia J.; Zhu, Lingxiang; Chen, Yin] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Zhou, Xu] China Med Univ, Dept Ophthalmol, Affiliated Hosp 4, Shenyang, Peoples R China; [Evans, Christopher] Univ Colorado, Dept Med, Aurora, CO USA	University of Arizona; University of Arizona; China Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus	Wang, MW (corresponding author), Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ 85721 USA.	mingwuwang@hotmail.com; ychen@pharmacy.arizona.edu		Evans, Christopher/0000-0001-5600-7314	Arizona Biomedical Research Commission; NIH [RO1AI061695]; institutional Research to Prevent Blindness Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061695] Funding Source: NIH RePORTER	Arizona Biomedical Research Commission; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); institutional Research to Prevent Blindness Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by an Arizona Biomedical Research Commission grant, an NIH grant RO1AI061695, and an institutional Research to Prevent Blindness Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Bell SL, 1998, EUR J BIOCHEM, V253, P123, DOI 10.1046/j.1432-1327.1998.2530123.x; Copin MC, 2001, FRONT BIOSCI, V6, pD1264, DOI 10.2741/Copin; de Bolos C, 2001, FRONT BIOSCI-LANDMRK, V6, pD1256, DOI 10.2741/Bolos; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; Gipson IK, 2003, INT REV CYTOL, V231, P1, DOI 10.1016/S0074-7696(03)31001-0; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Gum JR, 1995, BIOCHEM SOC T, V23, P795, DOI 10.1042/bst0230795; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Katsumi A, 2000, J BIOL CHEM, V275, P25585, DOI 10.1074/jbc.M002654200; Zorzi GK, 2011, MOL PHARMACEUT, V8, P1783, DOI 10.1021/mp200155t; Lin ZR, 2011, MOL VIS, V17, P257; Mataftsi A, 2011, MOL VIS, V17, P1624; McKenzie RW, 2000, INVEST OPHTH VIS SCI, V41, P703; Moniaux N, 2001, FRONT BIOSCI-LANDMRK, V6, pD1192, DOI 10.2741/Moniaux; Nischal KK, 2007, EYE, V21, P1326, DOI 10.1038/sj.eye.6702840; Offner G D, 2000, Adv Dent Res, V14, P69; Pauly A, 2007, INVEST OPHTH VIS SCI, V48, P5473, DOI 10.1167/iovs.06-0728; Peral A, 2008, DRUG NEWS PERSPECT, V21, P166, DOI 10.1358/dnp.2008.21.3.1203413; Perez-Vilar J, 1998, J BIOL CHEM, V273, P34527, DOI 10.1074/jbc.273.51.34527; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; Spurr-Michaud S, 2007, EXP EYE RES, V84, P939, DOI 10.1016/j.exer.2007.01.018; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; Tao SS, 2012, AM J RESP CELL MOL, V46, P660, DOI 10.1165/rcmb.2011-0340OC; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Van Seuningen I, 2001, FRONT BIOSCI-LANDMRK, V6, pD1216; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vemuganti GK, 2009, INT REV CEL MOL BIO, V275, P133, DOI 10.1016/S1937-6448(09)75005-1; Wang IJ, 2009, MOL VIS, V15, P108; Yu DF, 2008, EXP EYE RES, V86, P403, DOI 10.1016/j.exer.2007.11.013; Yu DF, 2011, AM J PHYSIOL-LUNG C, V301, pL31, DOI 10.1152/ajplung.00301.2010; Zhu LX, 2011, AM J RESP CELL MOL, V45, P348, DOI 10.1165/rcmb.2010-0312OC	32	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50704	10.1371/journal.pone.0050704	http://dx.doi.org/10.1371/journal.pone.0050704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272068	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300011
J	Basak, S; Jiang, RR				Basak, Souvik; Jiang, Rongrong			Enhancing E-coli Tolerance towards Oxidative Stress via Engineering Its Global Regulator cAMP Receptor Protein (CRP)	PLOS ONE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; HYDROGEN-PEROXIDE; TRANSCRIPTIONAL REGULATION; CRYSTAL-STRUCTURE; NADH OXIDASE; SALMONELLA-TYPHIMURIUM; H-NS; MUTAGENESIS; GENE; PROTECTION	Oxidative damage to microbial hosts often occurs under stressful conditions during bioprocessing. Classical strain engineering approaches are usually both time-consuming and labor intensive. Here, we aim to improve E. coli performance under oxidative stress via engineering its global regulator cAMP receptor protein (CRP), which can directly or indirectly regulate redox-sensing regulators SoxR and OxyR, and other similar to 400 genes in E. coli. Error-prone PCR technique was employed to introduce modifications to CRP, and three mutants (OM1 similar to OM3) were identified with improved tolerance via H2O2 enrichment selection. The best mutant OM3 could grow in 12 mM H2O2 with the growth rate of 0.6 h(-1), whereas the growth of wild type was completely inhibited at this H2O2 concentration. OM3 also elicited enhanced thermotolerance at 48 degrees C as well as resistance against cumene hydroperoxide. The investigation about intracellular reactive oxygen species (ROS), which determines cell viability, indicated that the accumulation of ROS in OM3 was always lower than in WT with or without H2O2 treatment. Genome-wide DNA microarray analysis has shown not only CRP-regulated genes have demonstrated great transcriptional level changes (up to 8.9-fold), but also RpoS- and OxyR-regulated genes (up to 7.7-fold). qRT-PCR data and enzyme activity assay suggested that catalase (katE) could be a major antioxidant enzyme in OM3 instead of alkyl hydroperoxide reductase or superoxide dismutase. To our knowledge, this is the first work on improving E. coli oxidative stress resistance by reframing its transcription machinery through its native global regulator. The positive outcome of this approach may suggest that engineering CRP can be successfully implemented as an efficient strain engineering alternative for E. coli. Citation: Basak S, Jiang R (2012) Enhancing E. coli Tolerance towards Oxidative Stress via Engineering Its Global Regulator cAMP Receptor Protein (CRP). PLoS ONE 7(12): e51179. doi:10.1371/journal.pone.0051179	[Basak, Souvik; Jiang, Rongrong] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Jiang, RR (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.	rrjiang@ntu.edu.sg	Jiang, Rongrong/G-6217-2010	Basak, Souvik/0000-0003-0380-6264	National Research Foundation, Singapore [NRF-CRP5-2009-03]	National Research Foundation, Singapore(National Research Foundation, Singapore)	This work is supported by National Research Foundation (NRF-CRP5-2009-03), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna LG, 2009, ARCH MICROBIOL, V191, P473, DOI 10.1007/s00203-009-0473-z; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Asad NR, 1998, MUTAT RES-DNA REPAIR, V407, P253, DOI 10.1016/S0921-8777(98)00010-X; BAIRD L, 1990, J BACTERIOL, V172, P1587, DOI 10.1128/jb.172.3.1587-1594.1990; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Basak S, 2012, PROCESS BIOCHEM, V47, P2152, DOI 10.1016/j.procbio.2012.08.006; BECKERHAPAK M, 1995, FEMS MICROBIOL LETT, V134, P39, DOI 10.1111/j.1574-6968.1995.tb07911.x; Campoy S, 2002, MICROBIOL-SGM, V148, P1039, DOI 10.1099/00221287-148-4-1039; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; CHAPON C, 1982, J BACTERIOL, V150, P722, DOI 10.1128/JB.150.2.722-729.1982; Chen TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016228; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Dalmau M, 2008, BIOTECHNOL BIOENG, V101, P654, DOI 10.1002/bit.21988; Dalmau M, 2009, BIOMACROMOLECULES, V10, P3199, DOI 10.1021/bm900674v; DELANEY JM, 1990, J GEN MICROBIOL, V136, P2113, DOI 10.1099/00221287-136-10-2113; DEMPLE B, 1983, NATURE, V304, P466, DOI 10.1038/304466a0; Freitas SS, 2007, MOL BIOTECHNOL, V36, P151, DOI 10.1007/s12033-007-0028-y; Fukui K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019053; Gao CJ, 2010, APPL MICROBIOL BIOT, V87, P1821, DOI 10.1007/s00253-010-2648-6; Gerard F, 1999, MICROBIOL-UK, V145, P1547, DOI 10.1099/13500872-145-7-1547; GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997; GonzalezFlecha B, 1997, J BACTERIOL, V179, P6181, DOI 10.1128/jb.179.19.6181-6186.1997; GOTTESMAN S, 1984, ANNU REV GENET, V18, P415; GREENBERG JT, 1988, EMBO J, V7, P2611, DOI 10.1002/j.1460-2075.1988.tb03111.x; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Hong SH, 2010, MICROB BIOTECHNOL, V3, P717, DOI 10.1111/j.1751-7915.2010.00220.x; Hong SH, 2010, MICROB BIOTECHNOL, V3, P344, DOI 10.1111/j.1751-7915.2010.00164.x; Huang L, 2008, PROTEIN EXPRES PURIF, V61, P168, DOI 10.1016/j.pep.2008.05.016; Huang L, 2009, APPL MICROBIOL BIOT, V84, P301, DOI 10.1007/s00253-009-1982-z; JENKINS DE, 1988, J BACTERIOL, V170, P3910, DOI 10.1128/jb.170.9.3910-3914.1988; Jiang RR, 2005, ADV SYNTH CATAL, V347, P1139, DOI 10.1002/adsc.200505063; Jiang RR, 2004, TETRAHEDRON-ASYMMETR, V15, P2939, DOI 10.1016/j.tetasy.2004.07.057; Kim IS, 2009, MOL CELLS, V28, P479, DOI 10.1007/s10059-009-0168-y; Klein-Marcuschamer D, 2009, APPL ENVIRON MICROB, V75, P2705, DOI 10.1128/AEM.01888-08; Kota S, 2006, APPL MICROBIOL BIOT, V72, P790, DOI 10.1007/s00253-006-0340-7; Kumar P, 2010, BIOPHYS J, V98, P305, DOI 10.1016/j.bpj.2009.10.016; Kumari S, 2009, MOL BIOTECHNOL, V42, P195, DOI 10.1007/s12033-009-9153-0; Lee JY, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn449; Li M, 2005, PROTEIN EXPRES PURIF, V42, P85, DOI 10.1016/j.pep.2005.03.027; Lim S, 2004, FEMS MICROBIOL LETT, V238, P101, DOI 10.1111/j.1574-6968.2004.tb09743.x; Lim S, 2009, EXTREMOPHILES, V13, P191, DOI 10.1007/s00792-008-0209-z; Lountos GT, 2006, BIOCHEMISTRY-US, V45, P9648, DOI 10.1021/bi060692p; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Macphee DG, 1999, J GENET, V78, P29, DOI 10.1007/BF02994700; Matuszewska E, 2008, MICROBIOL-SGM, V154, P1739, DOI 10.1099/mic.0.2007/014696-0; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; McArthur GH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/459760; MOORE J, 1992, J BACTERIOL, V174, P8030, DOI 10.1128/JB.174.24.8030-8035.1992; Mulder MA, 1999, MICROBIOL-UK, V145, P2011, DOI 10.1099/13500872-145-8-2011; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; O'Donnell A, 2007, BIOTECHNOL LETT, V29, P895, DOI 10.1007/s10529-007-9336-3; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Patil S, 2011, J APPL MICROBIOL, V111, P136, DOI 10.1111/j.1365-2672.2011.05021.x; Patnaik R, 2008, BIOTECHNOL PROGR, V24, P38, DOI 10.1021/bp0701214; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; PRIETOALAMO MJ, 1993, CARCINOGENESIS, V14, P237, DOI 10.1093/carcin/14.2.237; Rudolph B, 2010, J BIOL CHEM, V285, P19029, DOI 10.1074/jbc.M110.103374; Schroder I, 2004, J BACTERIOL, V186, P7680, DOI 10.1128/JB.186.22.7680-7689.2004; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092; Song H, 2006, ACS CHEM BIOL, V1, P681, DOI 10.1021/cb6004596; Song H, 2007, BIOPHYS J, V92, P3407, DOI 10.1529/biophysj.106.096891; Song H, 2011, BIOTECHNOL J, V6, P837, DOI 10.1002/biot.201100132; Song H, 2009, NAT CHEM BIOL, V5, P929, DOI 10.1038/nchembio.244; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Wang JQ, 2012, BIOTECHNOL BIOENG, V109, P3133, DOI 10.1002/bit.24574; Wang L, 2012, APPL MICROBIOL BIOT, V96, P1265, DOI 10.1007/s00253-012-3919-1; Wang L, 2012, APPL MICROBIOL BIOT, V94, P1233, DOI 10.1007/s00253-011-3699-z; Wang L, 2012, J MOL CATAL B-ENZYM, V76, P9, DOI 10.1016/j.molcatb.2011.11.016; Wang LA, 2011, J MOL CATAL B-ENZYM, V69, P120, DOI 10.1016/j.molcatb.2011.01.005; Wang LA, 2010, J BIOTECHNOL, V150, P57, DOI 10.1016/j.jbiotec.2010.07.005; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Yu YY, 2011, CHEM COMMUN, V47, P12825, DOI 10.1039/c1cc15874k; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zhang HF, 2012, APPL MICROBIOL BIOT, V94, P1107, DOI 10.1007/s00253-012-4012-5; Zhang HF, 2012, BIOTECHNOL BIOENG, V109, P1165, DOI 10.1002/bit.24411; Zhang HF, 2010, APPL MICROBIOL BIOT, V88, P117, DOI 10.1007/s00253-010-2735-8; Zhao Xinqing, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P1312; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhu Caiqing, 2003, Weishengwu Xuebao, V43, P460	89	40	47	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51179	10.1371/journal.pone.0051179	http://dx.doi.org/10.1371/journal.pone.0051179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251448	gold, Green Published			2022-12-27	WOS:000312386800029
J	Fehrholz, M; Bersani, I; Kramer, BW; Speer, CP; Kunzmann, S				Fehrholz, Markus; Bersani, Iliana; Kramer, Boris W.; Speer, Christian P.; Kunzmann, Steffen			Synergistic Effect of Caffeine and Glucocorticoids on Expression of Surfactant Protein B (SP-B) mRNA	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; THYROID TRANSCRIPTION FACTOR; HUMAN FETAL LUNG; GENE-EXPRESSION; IN-VITRO; II CELLS; BRONCHOPULMONARY DYSPLASIA; PROMOTER; RECEPTOR; THERAPY	Administration of glucocorticoids and caffeine is a common therapeutic intervention in the neonatal period, but possible interactions between these substances are still unclear. The present study investigated the effect of caffeine and different glucocorticoids on expression of surfactant protein (SP)-B, crucial for the physiological function of pulmonary surfactant. We measured expression levels of SP-B, various SP-B transcription factors including erythroblastic leukemia viral oncogene homolog 4 (ErbB4) and thyroid transcription factor-1 (TTF-1), as well as the glucocorticoid receptor (GR) after administering different doses of glucocorticoids, caffeine, cAMP, or the phosphodiesterase-4 inhibitor rolipram in the human airway epithelial cell line NCl-H441. Administration of dexamethasone (1 mu M) or caffeine (5 mM) stimulated SP-B mRNA expression with a maximal of 38.8 +/- 11.1-fold and 5.2 +/- 1.4-fold increase, respectively. Synergistic induction was achieved after co-administration of dexamethasone (1 mM) in combination with caffeine (10 mM) (206 +/- 59.7-fold increase, p<0.0001) or cAMP (1 mM) (213 +/- 11.1-fold increase, p = 0.0108). SP-B mRNA was synergistically induced also by administration of caffeine with hydrocortisone (87.9 +/- 39.0), prednisolone (154 +/- 66.8), and betamethasone (123 +/- 6.4). Rolipram also induced SP-B mRNA (64.9 +/- 21.0-fold increase). We detected a higher expression of ErbB4 and GR mRNA (7.0- and 1.7-fold increase, respectively), whereas TTF-1, Jun B, c-Jun, SP1, SP3, and HNF-3 alpha mRNA expression was predominantly unchanged. In accordance with mRNA data, mature SP-B was induced significantly by dexamethasone with caffeine (13.8 +/- 9.0-fold increase, p = 0.0134). We found a synergistic upregulation of SP-B mRNA expression induced by co-administration of various glucocorticoids and caffeine, achieved by accumulation of intracellular cAMP. This effect was mediated by a caffeine-dependent phosphodiesterase inhibition and by upregulation of both ErbB4 and the GR. These results suggested that caffeine is able to induce the expression of SP-transcription factors and affects the signaling pathways of glucocorticoids, amplifying their effects. Co-administration of caffeine and corticosteroids may therefore be of benefit in surfactant homeostasis.	[Fehrholz, Markus; Speer, Christian P.; Kunzmann, Steffen] Univ Wurzburg, Childrens Hosp, Wurzburg, Germany; [Bersani, Iliana] Univ Cattolica Sacro Cuore, A Gemelli Hosp, I-00168 Rome, Italy; [Kramer, Boris W.] Univ Hosp Maastricht, Dept Pediat, Maastricht, Netherlands	University of Wurzburg; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Maastricht University; Maastricht University Medical Centre (MUMC)	Fehrholz, M (corresponding author), Univ Wurzburg, Childrens Hosp, Wurzburg, Germany.	markus.fehrholz@uni-wuerzburg.de	BERSANI, ILIANA/AAC-9723-2022; Kramer, Boris/AAO-3183-2021		German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock Ian M, 2004, Proc Am Thorac Soc, V1, P247, DOI 10.1513/pats.200402-001MS; Alam MN, 2002, GENE, V282, P103, DOI 10.1016/S0378-1119(01)00844-7; Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; BALLARD PL, 1991, ENDOCRINOLOGY, V128, P2916, DOI 10.1210/endo-128-6-2916; Barnes Peter J, 2005, Proc Am Thorac Soc, V2, P334, DOI 10.1513/pats.200504-024SR; Bates SR, 2002, AM J PHYSIOL-LUNG C, V282, pL267, DOI 10.1152/ajplung.00227.2001; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Berhane K, 2001, GENE, V268, P141, DOI 10.1016/S0378-1119(01)00417-6; Bersani I, 2012, EXPERT REV ANTI-INFE, V10, P573, DOI [10.1586/eri.12.34, 10.1586/ERI.12.34]; Boggaram V, 2003, FRONT BIOSCI-LANDMRK, V8, pD751, DOI 10.2741/1062; BOGGARAM V, 1991, MOL ENDOCRINOL, V5, P414, DOI 10.1210/mend-5-3-414; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; BROWER M, 1986, CANCER RES, V46, P798; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; de Visser YP, 2012, AM J PHYSIOL-LUNG C, V302, P23; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; FLOROS J, 1991, AM J RESP CELL MOL, V4, P449, DOI 10.1165/ajrcmb/4.5.449; Focking M, 2005, BIOCHEM BIOPH RES CO, V337, P435, DOI 10.1016/j.bbrc.2005.09.067; FREY FJ, 1994, STEROIDS, V59, P74, DOI 10.1016/0039-128X(94)90079-5; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Gupta S, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/315642; HARRIS MC, 1983, J PEDIATR-US, V103, P303, DOI 10.1016/S0022-3476(83)80372-2; Henderson-Smart DJ, 2010, COCHRANE DATABASE SY, P8; Kolla V, 2007, AM J RESP CELL MOL, V36, P213, DOI 10.1165/rcmb.2006-0207OC; Lamontagne F, 2010, J CRIT CARE, V25, P420, DOI 10.1016/j.jcrc.2009.08.009; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LILEY HG, 1989, J CLIN INVEST, V83, P1191, DOI 10.1172/JCI114000; Liu W, 2010, BBA-MOL CELL RES, V1803, P832, DOI 10.1016/j.bbamcr.2010.03.003; Liu W, 2009, EXP LUNG RES, V35, P29, DOI 10.1080/01902140802395757; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losada A, 2000, ENDOCRINOLOGY, V141, P2166, DOI 10.1210/en.141.6.2166; MARGANA RK, 1995, AM J PHYSIOL-LUNG C, V268, pL481, DOI 10.1152/ajplung.1995.268.3.L481; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Mukwevho E, 2008, AM J PHYSIOL-ENDOC M, V294, P15; Ochs M, 2010, CELL PHYSIOL BIOCHEM, V25, P27, DOI 10.1159/000272061; OREILLY MA, 1991, AM J PHYSIOL, V260, pL37, DOI 10.1152/ajplung.1991.260.2.L37; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; PILOTMATIAS TJ, 1989, DNA-J MOLEC CELL BIO, V8, P75, DOI 10.1089/dna.1.1989.8.75; Roberts D, 2006, COCHRANE DATABASE SY, V19; Salinas D, 2003, AM J PHYSIOL-LUNG C, V285, pL1153, DOI 10.1152/ajplung.00084.2003; Sanz MJ, 2005, PHARMACOL THERAPEUT, V106, P269, DOI 10.1016/j.pharmthera.2004.12.001; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schmidt B, 2008, NEONATOLOGY, V93, P284, DOI 10.1159/000121453; Speer CP, 2011, NEONATOLOGY, V99, P316, DOI 10.1159/000326619; SPEER CP, 1992, PEDIATRICS, V89, P13; Takahashi Y, 2011, AM J PHYSIOL-LUNG C, V300, pL453, DOI 10.1152/ajplung.00100.2010; Thomas W, 2008, NEONATOLOGY, V94, P150, DOI 10.1159/000143719; Tissing WJE, 2006, BLOOD, V108, P1045, DOI 10.1182/blood-2006-01-0261; Valdez RC, 2011, J PEDIATR-US, V158, P38, DOI 10.1016/j.jpeds.2010.06.051; Vidaeff A C, 2004, J Matern Fetal Neonatal Med, V15, P155, DOI 10.1080/14767050410001668248; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Whitsett JA, 1998, BBA-MOL BASIS DIS, V1408, P303, DOI 10.1016/S0925-4439(98)00076-3; Whitsett JA, 2006, PEDIATR CLIN N AM, V53, P873, DOI 10.1016/j.pcl.2006.08.009; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Woyda K, 2009, EUR RESPIR J, V33, P861, DOI 10.1183/09031936.00109008; Yan C, 1997, J BIOL CHEM, V272, P17327, DOI 10.1074/jbc.272.28.17327; Zscheppang K, 2007, AM J PHYSIOL-LUNG C, V293, pL429, DOI 10.1152/ajplung.00451.2006; Zscheppang K, 2011, AM J RESP CELL MOL, V45, P761, DOI 10.1165/rcmb.2010-0179OC	64	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51575	10.1371/journal.pone.0051575	http://dx.doi.org/10.1371/journal.pone.0051575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272120	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800054
J	Majumdar, S; Farris, CL; Kabat, BE; Jung, DO; Ellsworth, BS				Majumdar, Sreeparna; Farris, Corrie L.; Kabat, Brock E.; Jung, Deborah O.; Ellsworth, Buffy S.			Forkhead Box O1 Is Present in Quiescent Pituitary Cells during Development and Is Increased in the Absence of p27(Kip1)	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; BETA-GENE-EXPRESSION; LUTEINIZING-HORMONE; ANTERIOR-PITUITARY; GONADOTROPE DIFFERENTIATION; PERSISTENT EXPRESSION; CYCLE CONTROL; PROLIFERATION; GROWTH; HES1	Congenital pituitary hormone deficiencies have been reported in approximately one in 4,000 live births, however studies reporting mutations in some widely studied transcription factors account for only a fraction of congenital hormone deficiencies in humans. Anterior pituitary hormones are required for development and function of several glands including gonads, adrenals, and thyroid. In order to identify additional factors that contribute to human congenital hormone deficiencies, we are investigating the forkhead transcription factor, FOXO1, which has been implicated in development of several organs including ovary, testis, and brain. We find that FOXO1 is present in the nuclei of non-dividing pituitary cells during embryonic development, consistent with a role in limiting proliferation and/or promoting differentiation. FOXO1 is present in a subset of differentiated cells at e18.5 and in adult with highest level of expression in somatotrope cells. We detected FOXO1 in p27(Kip1) -positive cells at e14.5. In the absence of p27(Kip1) the number of pituitary cells containing FOXO1 is significantly increased at e14.5 suggesting that a feedback loop regulates the interplay between FOXO1 and p27(Kip1)	[Majumdar, Sreeparna; Farris, Corrie L.; Kabat, Brock E.; Jung, Deborah O.; Ellsworth, Buffy S.] So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Ellsworth, BS (corresponding author), So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA.	bellsworth@siumed.edu		Jung, Deborah/0000-0002-8307-8772; Majumdar, Sreeparna/0000-0002-3564-3853	National Institute of Child Health and Human Development [R15HD063469]; Southern Illinois University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD063469] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Southern Illinois University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funding from a National Institute of Child Health and Human Development Grant R15HD063469 (B.S.E.) as well as a REACH Award (B.E.K.), startup funds (B.S.E.), an ORDA Faculty Seed Grant (B.S.E.), and a Central Research Committee Award (B.S..) from Southern Illinois University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADASHI EY, 1981, ENDOCRINOLOGY, V108, P1441, DOI 10.1210/endo-108-4-1441; Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Aujla PK, 2011, DEV BIOL, V353, P61, DOI 10.1016/j.ydbio.2011.02.018; Bilodeau S, 2009, MOL CELL BIOL; Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010; Buggs C, 2006, MOL CELL ENDOCRINOL, V249, P99, DOI 10.1016/j.mce.2006.02.001; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; Cushman LJ, 2001, MAMM GENOME, V12, P485, DOI 10.1007/s003350040002; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Davis SW, 2007, DEV BIOL, V305, P145, DOI 10.1016/j.ydbio.2007.02.001; Davis SW, 2011, DEV BIOL, V352, P215, DOI 10.1016/j.ydbio.2011.01.010; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Drouin J, 2010, FRONT HORM RES, V38, P15, DOI 10.1159/000318490; Ericson J, 1998, DEVELOPMENT, V125, P1005; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; GAGE PJ, 1995, ENDOCRINOLOGY, V136, P1161, DOI 10.1210/en.136.3.1161; Gage PJ, 1996, MOL ENDOCRINOL, V10, P1570, DOI 10.1210/me.10.12.1570; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Himes AD, 2009, DEV BIOL, V325, P151, DOI 10.1016/j.ydbio.2008.10.010; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Kita A, 2007, MOL ENDOCRINOL, V21, P1458, DOI 10.1210/me.2007-0039; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, ENDOCR J, V54, P507, DOI 10.1507/endocrj.KR-109; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Lees SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1238, DOI 10.1152/ajpcell.00349.2008; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mehta A, 2008, BEST PRACT RES CL EN, V22, P191, DOI 10.1016/j.beem.2007.07.007; Monahan P, 2012, MECH DEVELOP, V128, P640, DOI 10.1016/j.mod.2011.11.002; Monahan P, 2009, ENDOCRINOLOGY, V150, P4386, DOI 10.1210/en.2009-0206; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Raetzman LT, 2007, DEV BIOL, V304, P455, DOI 10.1016/j.ydbio.2006.11.010; Raetzman LT, 2006, MOL ENDOCRINOL, V20, P2898, DOI 10.1210/me.2005-0394; Reynaud R, 2006, J CLIN ENDOCR METAB, V91, P3329, DOI 10.1210/jc.2005-2173; Savage JJ, 2003, GENE, V319, P1, DOI 10.1016/S0378-1119(03)00804-7; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SOLDANI R, 1995, FERTIL STERIL, V64, P634, DOI 10.1016/S0015-0282(16)57804-2; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Tulipano G, 2012, ENDOCRINE; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vesper AH, 2006, ENDOCRINOLOGY, V147, P1654, DOI 10.1210/en.2005-1080; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	56	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52136	10.1371/journal.pone.0052136	http://dx.doi.org/10.1371/journal.pone.0052136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251696	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800147
J	Choumet, V; Attout, T; Chartier, L; Khun, H; Sautereau, J; Robbe-Vincent, A; Brey, P; Huerre, M; Bain, O				Choumet, Valerie; Attout, Tarik; Chartier, Loic; Khun, Huot; Sautereau, Jean; Robbe-Vincent, Annie; Brey, Paul; Huerre, Michel; Bain, Odile			Visualizing Non Infectious and Infectious Anopheles gambiae Blood Feedings in Naive and Saliva-Immunized Mice	PLOS ONE			English	Article							PLASMODIUM-BERGHEI SPOROZOITES; AEDES-AEGYPTI; MOSQUITO BITES; INFLAMMATORY RESPONSE; WUCHERERIA-BANCROFTI; CHEMOTACTIC FACTOR; DIPTERA-CULICIDAE; MALARIA PARASITES; ANTIBODY-RESPONSE; VECTOR	Background: Anopheles gambiae is a major vector of malaria and lymphatic filariasis. The arthropod-host interactions occurring at the skin interface are complex and dynamic. We used a global approach to describe the interaction between the mosquito (infected or uninfected) and the skin of mammals during blood feeding. Methods: Intravital video microscopy was used to characterize several features during blood feeding. The deposition and movement of Plasmodium berghei sporozoites in the dermis were also observed. We also used histological techniques to analyze the impact of infected and uninfected feedings on the skin cell response in naive mice. Results: The mouthparts were highly mobile within the skin during the probing phase. Probing time increased with mosquito age, with possible effects on pathogen transmission. Repletion was achieved by capillary feeding. The presence of sporozoites in the salivary glands modified the behavior of the mosquitoes, with infected females tending to probe more than uninfected females (86% versus 44%). A white area around the tip of the proboscis was observed when the mosquitoes fed on blood from the vessels of mice immunized with saliva. Mosquito feedings elicited an acute inflammatory response in naive mice that peaked three hours after the bite. Polynuclear and mast cells were associated with saliva deposits. We describe the first visualization of saliva in the skin by immunohistochemistry (IHC) with antibodies directed against saliva. Both saliva deposits and sporozoites were detected in the skin for up to 18 h after the bite. Conclusion: This study, in which we visualized the probing and engorgement phases of Anopheles gambiae blood meals, provides precise information about the behavior of the insect as a function of its infection status and the presence or absence of anti-saliva antibodies. It also provides insight into the possible consequences of the inflammatory reaction for blood feeding and pathogen transmission.	[Choumet, Valerie; Sautereau, Jean; Robbe-Vincent, Annie; Brey, Paul] Inst Pasteur, Unite Biochim & Biol Mol Insectes, Paris, France; [Attout, Tarik; Bain, Odile] Museum Natl Hist Nat, Unite Parasitol, UMR CNRS 7205, F-75231 Paris, France; [Chartier, Loic] Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, Paris, France; [Khun, Huot; Huerre, Michel] Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Choumet, V (corresponding author), Inst Pasteur, Unite Biochim & Biol Mol Insectes, Paris, France.	valerie.choumet@pasteur.fr						Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Anderson RA, 1999, P ROY SOC B-BIOL SCI, V266, P1729, DOI 10.1098/rspb.1999.0839; Beghdadi W, 2008, J EXP MED, V205, P395, DOI 10.1084/jem.20071548; BOS JD, 1986, IMMUNOL TODAY, V7, P235, DOI 10.1016/0167-5699(86)90111-8; BURKOT TR, 1990, PARASITOLOGY, V100, P369, DOI 10.1017/S003118200007863X; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Chadee DD, 1997, ANN TROP MED PARASIT, V91, P199, DOI 10.1080/00034983.1997.11813130; Chadee DD, 2002, J VECTOR ECOL, V27, P172; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932; DIAGNE M, 1990, ANN PARASIT HUM COMP, V65, P193, DOI 10.1051/parasite/1990654193; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; GARCIA ES, 1994, EXP PARASITOL, V78, P287, DOI 10.1006/expr.1994.1030; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; GORDON R. M., 1939, ANN TROP MED AND PARASITOL, V33, P259; GRIFFITHS RB, 1952, ANN TROP MED PARASIT, V46, P311, DOI 10.1080/00034983.1952.11685536; Gueirard P, P NATL ACAD SCI US, V107, P18640; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Isawa H, 2007, INSECT BIOCHEM MOLEC, V37, P466, DOI 10.1016/j.ibmb.2007.02.002; Kebaier C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000399; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Landau I., 2002, Parassitologia (Rome), V44, P111; Lardeux F, 1996, J MED ENTOMOL, V33, P516, DOI 10.1093/jmedent/33.4.516; Lefevre T, 2007, PROTEOMICS, V7, P1908, DOI 10.1002/pmic.200601021; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Mellor AL, 2006, IMMUNOL REV, V213, P5, DOI 10.1111/j.1600-065X.2006.00443.x; Metenou S, 2009, J IMMUNOL, V183, P916, DOI 10.4049/jimmunol.0900257; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Muturi EJ, 2008, PARASITOL RES, V102, P175, DOI 10.1007/s00436-007-0779-1; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Owhashi M, 2001, PARASITOL RES, V87, P376, DOI 10.1007/s004360000355; Owhashi M, 2008, PARASITOL RES, V102, P357, DOI 10.1007/s00436-007-0769-3; PETIT G, 1985, ANN PARASIT HUM COMP, V60, P247, DOI 10.1051/parasite/1985603247; Pumpuni CB, 1997, J PARASITOL, V83, P652, DOI 10.2307/3284242; Qiu YT, 2011, MED VET ENTOMOL, V25, P247, DOI 10.1111/j.1365-2915.2010.00924.x; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; ROBINSON G. G., 1939, PARASITOLOGY, V31, P212, DOI 10.1017/S0031182000012774; Rosinski-Chupin I, 2007, CELL MICROBIOL, V9, P708, DOI 10.1111/j.1462-5822.2006.00822.x; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; ROSSIGNOL PA, 1985, P NATL ACAD SCI USA, V82, P7725, DOI 10.1073/pnas.82.22.7725; ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; WEKESA JW, 1992, AM J TROP MED HYG, V47, P484, DOI 10.4269/ajtmh.1992.47.484; WILSON AB, 1965, INT ARCH ALLER A IMM, V26, P294, DOI 10.1159/000229580; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x	55	61	61	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50464	10.1371/journal.pone.0050464	http://dx.doi.org/10.1371/journal.pone.0050464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272060	gold, Green Published			2022-12-27	WOS:000312386600011
J	Ellis, DA; Jenkins, R				Ellis, David A.; Jenkins, Rob			Weekday Affects Attendance Rate for Medical Appointments: Large-Scale Data Analysis and Implications	PLOS ONE			English	Article							MISSED APPOINTMENTS; OUTPATIENT CLINICS; PRIMARY-CARE; VIEWS	The financial cost of missed appointments is so great that even a small percentage reduction in Did Not Attend (DNA) rate could save significant sums of money. Previous studies have identified many factors that predict DNA rate, including patient age, gender, and transport options. However, it is not obvious how healthcare providers can use this information to improve attendance, as such factors are not under their control. One factor that is under administrative control is appointment scheduling. Here we asked whether DNA rate could be reduced by altering scheduling policy. In Study 1, we examined attendance records for 4,538,294 outpatient hospital appointments across Scotland between January 1st 2008 and December 31st 2010. DNA rate was highest for Mondays (11%), lowest for Fridays (9.7%), and decreased monotonically over the week (Monday-Friday comparison [chi(2)(1, N = 1,585,545) = 722.33, p<0.0001]; Relative Risk Reduction 11.8%). This weekly decline was present for male and female patient groups of all ages, but was steeper for younger age groups. In Study 2, we examined attendance records for 10,895 appointments at a single GP clinic in Glasgow. Here again, DNA rate was highest for Mondays (6.2%), lowest for Fridays (4.2%), and decreased monotonically over the week (Monday-Friday comparison [chi(2)(1, N = 4767) = 9.20, p<0.01]; Relative Risk Reduction 32.3%). In two very different settings, appointments at the beginning of the week were more likely to be missed than appointments at the end of the week. We suggest that DNA rate could be significantly reduced by preferentially loading appointments onto high-attendance days. Citation: Ellis DA, Jenkins R (2012) Weekday Affects Attendance Rate for Medical Appointments: Large- Scale Data Analysis and Implications. PLoS ONE 7(12): e51365. doi: 10.1371/journal.pone.0051365	[Ellis, David A.; Jenkins, Rob] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland	University of Glasgow	Jenkins, R (corresponding author), Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland.	rob.jenkins@glasgow.ac.uk	Jenkins, Rob/C-5289-2008; Ellis, David/A-8322-2011	Ellis, David/0000-0001-6172-3323	Economic and Social Research Council (ESRC)	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by the Economic and Social Research Council (ESRC), http://www.esrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchant S, 1997, BR J HEALTHCARE MANA, V3, P523; Casey RG, 2007, IRISH J MED SCI, V176, P305, DOI 10.1007/s11845-007-0028-8; Cashman SB, 2004, J HEALTH CARE POOR U, V15, P474, DOI 10.1353/hpu.2004.0037; Committee of Public Accounts, 1995, 42 REP NAT HLTH SERV; Ellis DA, 2011, EXP PSYCH SOC JUL 6; Farley Robyn L, 2003, Eur J Cardiovasc Nurs, V2, P205; FRANKEL S, 1989, BRIT MED J, V298, P1343, DOI 10.1136/bmj.298.6684.1343; Goldbart Aviv D, 2009, BMC Pulm Med, V9, P12, DOI 10.1186/1471-2466-9-12; Gucciardi E, 2008, CAN J DIABETES, V32, P53, DOI 10.1016/S1499-2671(08)21011-7; Hasvold PE, 2011, J TELEMED TELECARE, V17, P358, DOI 10.1258/jtt.2011.110707; Hussain-Gambles M, 2004, BRIT J GEN PRACT, V54, P108; Killaspy H, 2000, BRIT J PSYCHIAT, V176, P160, DOI 10.1192/bjp.176.2.160; Lacy NL, 2004, ANN FAM MED, V2, P541, DOI 10.1370/afm.123; Lawson VL, 2005, J HEALTH PSYCHOL, V10, P409, DOI 10.1177/1359105305051426; Lehmann TNO, 2007, PUBLIC HEALTH, V121, P790, DOI 10.1016/j.puhe.2007.01.007; Martin C, 2005, FAM PRACT, V22, P638, DOI 10.1093/fampra/cmi076; MASON C, 1992, J ADV NURS, V17, P554, DOI 10.1111/j.1365-2648.1992.tb02832.x; Masuda Yumi, 2006, Environmental Health and Preventive Medicine, V11, P115, DOI 10.1265/ehpm.11.115; McCarthy K., 2000, PSYCHOL HEALTH MED, V5, DOI [10.1080/713690194, DOI 10.1080/713690194]; Murdock A, 2002, J ROY SOC MED, V95, P284, DOI 10.1258/jrsm.95.6.284; Neal Richard D, 2005, BMC Fam Pract, V6, P47, DOI 10.1186/1471-2296-6-47; Nielsen KM, 2008, EUR J PUBLIC HEALTH, V18, P479, DOI 10.1093/eurpub/ckn060; Paterson B., 2010, J NURSING HEALTHCARE, V2, P63, DOI [DOI 10.1111/J.1752-9824.2010.01048.X, 10.1111/j.1752-9824.2010.01048.x]; Sharp D, 2001, BRIT MED J, V323, P1081, DOI 10.1136/bmj.323.7321.1081; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Waller J, 2000, FAM PRACT, V17, P252, DOI 10.1093/fampra/17.3.252; Weinger K, 2005, DIABETES CARE, V28, P1791, DOI 10.2337/diacare.28.7.1791; Woodward V, 1998, J CLIN NURS, V7, P380, DOI 10.1046/j.1365-2702.1998.00183.x	28	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51365	10.1371/journal.pone.0051365	http://dx.doi.org/10.1371/journal.pone.0051365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272102	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600025
J	Tran, BX; Ohinmaa, A; Mills, S; Duong, AT; Nguyen, LT; Jacobs, P; Houston, S				Bach Xuan Tran; Ohinmaa, Arto; Mills, Steve; Anh Thuy Duong; Long Thanh Nguyen; Jacobs, Philip; Houston, Stan			Multilevel Predictors of Concurrent Opioid Use during Methadone Maintenance Treatment among Drug Users with HIV/AIDS	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOCIAL ECOLOGICAL MODEL; COST-EFFECTIVENESS; SUBSTANCE USE; HIV TREATMENT; RETENTION; THERAPY; RISK; COHORT; MANAGEMENT	Background: Ongoing drug use during methadone maintenance treatment (MMT) negatively affects outcomes of HIV/AIDS care and treatment for drug users. This study assessed changes in opioid use, and longitudinal predictors of continued opioid use during MMT among HIV-positive drug users in Vietnam, with the aim of identifying changes that might enhance program efficacy. Methods: We analyze data of 370 HIV-positive drug users (mean age 29.5; 95.7% male) taking MMT at multi-sites. Opioid use was assessed at baseline, 3, 6, and 9 months using interviews and heroin confirmatory urine tests. A social ecological model was applied to explore multilevel predictors of continued opioid use, including individual, interpersonal, community and service influences. Generalized estimating equations (GEE) statistical models were constructed to adjust for intra-individual correlations. Results: Over 9 month follow-up, self-reported opioid use and positive heroin urine test substantially decreased to 14.6% and 14.4%. MMT helped improve referrals and access to health care and social services. However, utilization of social integration services was small. GEE models determined that participants who were older (Adjusted Odd Ratio -AOR = 0.97 for 1 year increase), had economic dependents (AOR = 0.33), or were referred to TB treatment (AOR = 0.53) were less likely to continue opioid use. Significant positive predictors of ongoing opioid use included frequency of opioid use prior to MMT, peer pressure, living with sexual partners, taking antiretroviral treatment, other health concerns and TB treatment. Conclusion: These findings show that MMT in the Vietnamese context can dramatically reduce opioid use, which is known to be associated with reduced antiretroviral (ART) adherence. Disease stage and drug interactions between antiretrovirals or TB drugs and MMT could explain some of the observed predictors of ongoing drug use; these findings could inform changes in MMT program design and implementation.	[Bach Xuan Tran; Ohinmaa, Arto; Houston, Stan] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Bach Xuan Tran] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Ohinmaa, Arto; Jacobs, Philip] Inst Hlth Econ, Edmonton, AB, Canada; [Mills, Steve] Family Hlth Int, Hanoi, Vietnam; [Anh Thuy Duong; Long Thanh Nguyen] Minist Hlth, Adm HIV AIDS Control, Hanoi, Vietnam; [Jacobs, Philip; Houston, Stan] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta; Hanoi Medical University; University of Alberta	Tran, BX (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	bach@hmu.edu.vn	Duong, Anh/GPW-9558-2022					Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041062; Tran BX, 2012, AIDS CARE, V24, P1187, DOI 10.1080/09540121.2012.658752; Tran BX, 2012, QUAL LIFE RES, V21, P613, DOI 10.1007/s11136-011-9963-y; Tran BX, 2012, AIDS CARE, V24, P283, DOI 10.1080/09540121.2011.608420; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Banta-Green CJ, 2009, ADDICTION, V104, P775, DOI 10.1111/j.1360-0443.2009.02538.x; Bao YP, 2009, AM J DRUG ALCOHOL AB, V35, P28, DOI 10.1080/00952990802342899; Bell J, 2009, ADDICTION, V104, P1193, DOI 10.1111/j.1360-0443.2009.02627.x; Bruce RD, 2006, JAIDS-J ACQ IMM DEF, V41, P563, DOI 10.1097/01.qai.0000219769.89679.ec; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; Do TN, 2012, CLIN INFECT DIS, V54, pS306, DOI 10.1093/cid/cir1045; El-Bassel N, 2006, J URBAN HEALTH, V83, P602, DOI 10.1007/s11524-006-9075-0; Fareed A, 2009, J PSYCHIATR PRACT, V15, P227, DOI 10.1097/01.pra.0000351884.83377.e2; Havens JR, 2009, J SUBST ABUSE TREAT, V36, P306, DOI 10.1016/j.jsat.2008.07.002; Larios SE, 2009, AIDS CARE, V21, P1335, DOI 10.1080/09540120902803190; Latkin CA, 2005, AIDS CARE, V17, pS102, DOI 10.1080/09540120500121185; Lawrinson P, 2008, ADDICTION, V103, P1484, DOI 10.1111/j.1360-0443.2008.02249.x; Lin C, 2011, PUBLIC HEALTH, V125, P269, DOI 10.1016/j.puhe.2011.01.009; Liu EW, 2009, INT J DRUG POLICY, V20, P304, DOI 10.1016/j.drugpo.2008.09.004; Ministry of Health, 2012, ANN REP HIV AIDS 201; Naar-King S, 2006, J CONSULT CLIN PSYCH, V74, P785, DOI 10.1037/0022-006X.74.4.785; Nosyk B, 2010, J SUBST ABUSE TREAT, V39, P22, DOI 10.1016/j.jsat.2010.03.008; Palepua A, 2006, DRUG ALCOHOL DEPEN, V84, P188, DOI 10.1016/j.drugalcdep.2006.02.003; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Raffa JD, 2007, DRUG ALCOHOL DEPEN, V89, P306, DOI 10.1016/j.drugalcdep.2007.02.007; Roux P, 2009, CLIN INFECT DIS, V49, P1433, DOI 10.1086/630209; Shah NG, 2006, DRUG ALCOHOL DEPEN, V83, P147, DOI 10.1016/j.drugalcdep.2005.11.007; Soyka M, 2008, INT J NEUROPSYCHOPH, V11, P641, DOI 10.1017/S146114570700836X; Tran BX, 2012, GLOBAL PUBLIC HLTH, P7; Villafranca SW, 2006, DRUG ALCOHOL DEPEN, V83, P218, DOI 10.1016/j.drugalcdep.2005.11.020; Wang PW, 2012, AM J DRUG ALCOHOL AB, V38, P213, DOI 10.3109/00952990.2011.649222; White B, 2007, AIDS CARE, V19, P441, DOI 10.1080/09540120701192837; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed	35	28	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51569	10.1371/journal.pone.0051569	http://dx.doi.org/10.1371/journal.pone.0051569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251580	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200137
J	Bock, JR; Maewal, A; Gough, DA				Bock, Joel R.; Maewal, Akhilesh; Gough, David A.			Hitting Is Contagious in Baseball: Evidence from Long Hitting Streaks	PLOS ONE			English	Article							HOT HAND; EMOTIONAL CONTAGION	Data analysis is used to test the hypothesis that "hitting is contagious". A statistical model is described to study the effect of a hot hitter upon his teammates' batting during a consecutive game hitting streak. Box score data for entire seasons comprising 28 streaks of length L >= 30 games, including a total 4,496 observations were compiled. Treatment and control sample groups (n = 151) were constructed from core lineups of players on the streaking batter's team. The percentile method bootstrap was used to calculate 95% confidence intervals for statistics representing differences in the mean distributions of two batting statistics between groups. Batters in the treatment group (hot streak active) showed statistically significant improvements in hitting performance, as compared against the control. Mean BA for the treatment group was found to be 1: 6 to 20 percentage points higher during hot streaks (mean difference increased 11: 1 points), while the batting heat index Q introduced here was observed to increase by 32 points. For each performance statistic, the null hypothesis was rejected at the alpha = 0: 05 significance level. We conclude that the evidence suggests the potential existence of a "statistical contagion effect". Psychological mechanisms essential to the empirical results are suggested, as several studies from the scientific literature lend credence to contagious phenomena in sports. Causal inference from these results is difficult, but we suggest and discuss several latent variables that may contribute to the observed results, and offer possible directions for future research.	[Bock, Joel R.; Maewal, Akhilesh] Scalaton, La Mesa, CA USA; [Gough, David A.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Bock, JR (corresponding author), Scalaton, La Mesa, CA USA.	sauerkraut@gmail.com						Albert J, 2008, J QUANTITATIVE ANAL, V4; ALBRIGHT SC, 1993, J AM STAT ASSOC, V88, P1175; Bar-Eli M, 2006, PSYCHOL SPORT EXERC, V7, P525, DOI 10.1016/j.psychsport.2006.03.001; Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; DiGiovanna M., 2011, LOS ANGELES TIMES; Duda R. O., 1973, PATTERN CLASSIFICATI; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B., 1981, CANADIAN J STATISTIC, V9, P139, DOI [10.1093/jtm/taab016, DOI 10.1093/jtm/taab016]; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Gray R, 2011, J EXP PSYCHOL-APPL, V17, P49, DOI 10.1037/a0022846; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Hesterberg T, 2003, BOOTSTRAP METHODS PE; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; La Fond T, 2010, P 19 INT C WORLD WID, P601, DOI DOI 10.1145/1772690.1772752; Lee C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026016; Moll T, 2010, J SPORT SCI, V28, P983, DOI 10.1080/02640414.2010.484068; Office of the Surgeon General, 1964, TECHN REP PUBL HLTH; Parascandola M, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-1; Peng R.D, 2008, SIMPLEBOOT SIMPLE BO; Quintana FA, 2008, BAYESIAN ANAL, V3, P317, DOI 10.1214/08-BA312; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raab M, 2012, J EXP PSYCHOL-APPL, V18, P81, DOI 10.1037/a0025951; Ribeiro HV, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.022102; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Schilling C, 2011, 38 PITCHES CURT SCHI; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Totterdell P, 2000, J APPL PSYCHOL, V85, P848, DOI 10.1037/0021-9010.85.6.848; Ver Steeg G, 2010, NIPSWORKSHOP SOC COM; Yaari G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024532	31	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51367	10.1371/journal.pone.0051367	http://dx.doi.org/10.1371/journal.pone.0051367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251507	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200095
J	Frisch, AJ; Cole, AJ; Hobbs, JPA; Rizzari, JR; Munkres, KP				Frisch, Ashley J.; Cole, Andrew J.; Hobbs, Jean-Paul A.; Rizzari, Justin R.; Munkres, Katherine P.			Effects of Spearfishing on Reef Fish Populations in a Multi-Use Conservation Area	PLOS ONE			English	Article							GREAT-BARRIER-REEF; TAKE MARINE RESERVES; CORAL-REEFS; MANAGEMENT; FISHERIES; BIOMASS	Although spearfishing is a popular method of capturing fish, its ecological effects on fish populations are poorly understood, which makes it difficult to assess the legitimacy and desirability of spearfishing in multi-use marine reserves. Recent management changes within the Great Barrier Reef Marine Park (GBRMP) fortuitously created a unique scenario by which to quantify the effects of spearfishing on fish populations. As such, we employed underwater visual surveys and a before-after-control-impact experimental design to investigate the effects of spearfishing on the density and size structure of target and non-target fishes in a multi-use conservation park zone (CPZ) within the GBRMP. Three years after spearfishing was first allowed in the CPZ, there was a 54% reduction in density and a 27% reduction in mean size of coral trout (Plectropomus spp.), the primary target species. These changes were attributed to spearfishing because benthic habitat characteristics and the density of non-target fishes were stable through time, and the density and mean size of coral trout in a nearby control zone (where spearfishing was prohibited) remained unchanged. We conclude that spearfishing, like other forms of fishing, can have rapid and substantial negative effects on target fish populations. Careful management of spearfishing is therefore needed to ensure that conservation obligations are achieved and that fishery resources are harvested sustainably. This is particularly important both for the GBRMP, due to its extraordinarily high conservation value and world heritage status, and for tropical island nations where people depend on spearfishing for food and income. To minimize the effects of spearfishing on target species and to enhance protection of functionally important fishes (herbivores), we recommend that fishery managers adjust output controls such as size-and catch-limits, rather than prohibit spearfishing altogether. This will preserve the cultural and social importance of spearfishing in coastal communities where it is practised.	[Frisch, Ashley J.; Cole, Andrew J.; Rizzari, Justin R.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Cole, Andrew J.; Rizzari, Justin R.; Munkres, Katherine P.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia	James Cook University; James Cook University; University of Western Australia; University of Western Australia	Frisch, AJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	ashley.frisch@jcu.edu.au	cole, andrew J/L-5764-2013; Hobbs, Jean-Paul/I-8743-2012; Cole, Andrew/G-5220-2011	Hobbs, Jean-Paul/0000-0003-0331-354X; 	Australian Research Council; Great Barrier Reef Marine Park Authority; Project AWARE; PADI Foundation	Australian Research Council(Australian Research Council); Great Barrier Reef Marine Park Authority; Project AWARE; PADI Foundation	Financial support was provided by the Australian Research Council, the Great Barrier Reef Marine Park Authority, Project AWARE, and the PADI Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, FISHERIES MANAGEMENT; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; Dalzell P., 1996, REEF FISHERIES, V20, P161, DOI [DOI 10.1007/978-94-015-8779-2, 10.1007/978-94-015-8779-2\_7.500]; Davis KLF, 2004, COAST MANAGE, V32, P373, DOI 10.1080/08920750490487223; Day J, 2008, GREAT BARRIER REEF B, P114; Eckersley Y, 1997, GEO AUSTRALASIA, V19, P18; Evans RD, 2004, AQUAT CONSERV, V14, P505, DOI 10.1002/aqc.631; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; FERREIRA BP, 1994, FISH B-NOAA, V92, P46; FERREIRA BP, 1992, AUST J MAR FRESH RES, V43, P1301; Frisch AJ, 2008, CORAL REEFS, V27, P85, DOI 10.1007/s00338-007-0293-z; Gillett R., 2006, SPEARFISHING PACIFIC; Godoy N, 2010, ECOL APPL, V20, P1504, DOI 10.1890/09-1806.1; GOEDEN GB, 1982, BIOL CONSERV, V22, P273, DOI 10.1016/0006-3207(82)90022-2; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings Simon, 1996, Fish and Fisheries Series, V20, P193; Mapstone BD, 1996, GREAT BARRIER REEF S, V2, P196; Meyer CG, 2007, FISH RES, V84, P301, DOI 10.1016/j.fishres.2006.11.004; Rousseau Y, 2010, CYBIUM, V34, P243; Sadovy YJ, 2003, WHILE STOCKS LAST LI; Sadovy Yvonne J., 1996, Fish and Fisheries Series, V20, P15; Tobin A, 2010, 11 J COOK U FISH FIS; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	30	40	40	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51938	10.1371/journal.pone.0051938	http://dx.doi.org/10.1371/journal.pone.0051938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251656	Green Published, gold, Green Accepted			2022-12-27	WOS:000313236200171
J	Ukena, SN; Velaga, S; Goudeva, L; Ivanyi, P; Olek, S; Falk, CS; Ganser, A; Franzke, A				Ukena, Sya N.; Velaga, Sarvari; Goudeva, Lilia; Ivanyi, Philipp; Olek, Sven; Falk, Christine S.; Ganser, Arnold; Franzke, Anke			Human Regulatory T Cells of G-CSF Mobilized Allogeneic Stem Cell Donors Qualify for Clinical Application	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PERIPHERAL-BLOOD; BONE-MARROW; SUPPRESSION; GENERATION; EXPANSION; EXPRESSION; RECEPTOR; IMPACT; FOXP3	Recent clinical studies demonstrate the high potency of regulatory T cells (Tregs) to control graft-versus-host disease in hematopoietic stem cell transplantation (SCT). However, the adoptive transfer of Tregs is limited by their low frequency in unstimulated donors and considerable concerns that G-CSF induced SC mobilization might have negative effects on the stability and function of Tregs. The isolation of Tregs from the G-CSF mobilized SC grafts would extend this novel strategy for tolerance induction to the unrelated setting and simplify global clinical application. We characterized CD4(+)CD25(high)CD127(-) Tregs from SC donors before and after G-CSF mobilization for their phenotype, function, and stability. After G-CSF application the Treg cell yield increased significantly. Donor Tregs retained their cytokine profile, phenotypic characteristics and in vitro expansion capacity after SC mobilization. Most importantly, in vivo G-CSF stimulated Tregs remained highly suppressive on the proliferation of effector T cells, also after in vitro expansion, and displayed a stable phenotype in epigenetic studies. The surface expression of CXCR3 is transiently reduced. However, donor-derived Tregs maintain their migratory properties after G-CSF stimulation. Therefore, the adoptive transfer of Tregs from G-CSF mobilized SC donors seems to be a feasible and safe strategy for clinical application in allogeneic SCT.	[Ukena, Sya N.; Velaga, Sarvari; Ivanyi, Philipp; Ganser, Arnold; Franzke, Anke] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Goudeva, Lilia] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Falk, Christine S.] Hannover Med Sch, Inst Transplant Immunol, IFB Tx, Hannover, Germany; [Olek, Sven] Epiontis GmbH, Berlin, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Epiontis GmbH	Franzke, A (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	franzke.anke@mh-hannover.de	Ivanyi, Philipp/ABE-8130-2020; Falk, Christine/Q-4143-2016; Franzke, Anke/AAE-7883-2021; Ivanyi, Philipp/G-5983-2019	Ivanyi, Philipp/0000-0002-2862-7302; Falk, Christine/0000-0003-1376-7318; Ivanyi, Philipp/0000-0002-2862-7302	German Federal Ministry of Education and Research [01EO0802]; Helmholz Alliance for Immunotherapy;  [SFB738]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholz Alliance for Immunotherapy; 	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO0802) and by the SFB738 (CF) and the Helmholz Alliance for Immunotherapy (CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlini P, 2008, BLOOD, V111, P1767, DOI 10.1182/blood-2007-07-097543; Arpinati M, 2000, BLOOD, V95, P2484, DOI 10.1182/blood.V95.8.2484; Boneberg EM, 2000, BLOOD, V95, P270, DOI 10.1182/blood.V95.1.270; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Franzke A, 2003, BLOOD, V102, P734, DOI 10.1182/blood-2002-04-1200; Franzke A, 2006, CYTOKINE GROWTH F R, V17, P235, DOI 10.1016/j.cytogfr.2006.05.002; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; HARTUNG T, 1995, BLOOD, V85, P2482, DOI 10.1182/blood.V85.9.2482.bloodjournal8592482; Hippen KL, 2011, AM J TRANSPLANT, V11, P1148, DOI 10.1111/j.1600-6143.2011.03558.x; Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Kean LS, 2011, BLOOD, V118, P6580, DOI 10.1182/blood-2011-06-359331; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Klangsinsirikul P, 2002, EXP HEMATOL, V30, P495, DOI 10.1016/S0301-472X(02)00785-3; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Mielcarek M, 1997, BLOOD, V89, P1629, DOI 10.1182/blood.V89.5.1629; Mielcarek M, 1998, BLOOD, V92, P215, DOI 10.1182/blood.V92.1.215.413k10_215_222; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nguyen VH, 2008, BLOOD, V111, P945, DOI 10.1182/blood-2007-07-103895; PAN LY, 1995, BLOOD, V86, P4422, DOI 10.1182/blood.V86.12.4422.bloodjournal86124422; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Rutella S, 2004, EUR J IMMUNOL, V34, P1291, DOI 10.1002/eji.200324651; Rutella S, 2002, BLOOD, V100, P2562, DOI 10.1182/blood-2001-12-0291; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Ukena SN, 2011, BLOOD, V118, pE82, DOI 10.1182/blood-2011-05-352708; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Zeng D, 1997, J ALLERGY CLIN IMMUN, V99, P1900; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	36	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51644	10.1371/journal.pone.0051644	http://dx.doi.org/10.1371/journal.pone.0051644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251603	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200153
J	Farhat, YM; Al-Maliki, AA; Chen, T; Juneja, SC; Schwarz, EM; O'Keefe, RJ; Awad, HA				Farhat, Youssef M.; Al-Maliki, Alaa A.; Chen, Tony; Juneja, Subhash C.; Schwarz, Edward M.; O'Keefe, Regis J.; Awad, Hani A.			Gene Expression Analysis of the Pleiotropic Effects of TGF-beta 1 in an In Vitro Model of Flexor Tendon Healing	PLOS ONE			English	Article							BETA SIGNAL-TRANSDUCTION; TGF-BETA; FIBROBLAST CONTRACTION; NEUTRALIZING ANTIBODY; ADHESION FORMATION; STEM-CELLS; COLLAGEN; SCLERAXIS; REPAIR; TENDINOPATHY	Flexor tendon injuries are among the most challenging problems for hand surgeons and tissue engineers alike. Not only do flexor tendon injuries heal with poor mechanical strength, they can also form debilitating adhesions that may permanently impair hand function. While TGF-beta 1 is a necessary factor for regaining tendon strength, it is associated with scar and adhesion formation in the flexor tendons and other tissues as well as fibrotic diseases. The pleiotropic effects of TGF-beta 1 on tendon cells and tissue have not been characterized in detail. The goal of the present study was to identify the targets through which the effects of TGF-beta 1 on tendon healing could be altered. To accomplish this, we treated flexor tendon tenocytes cultured in pinned collagen gels with 1, 10 or 100 ng/mL of TGF-beta 1 and measured gel contraction and gene expression using RT-PCR up to 48 hours after treatment. Specifically, we studied the effects of TGF-beta 1 on the expression of collagens, fibronectin, proteoglycans, MMPs, MMP inhibitors, and the neotendon transcription factors, Scleraxis and Mohawk. Area contraction of the gels was not dose-dependent with the TGF-beta 1 concentrations tested. We observed dose-dependent downregulation of MMP-16 (MT3-MMP) and decorin, and upregulation of biglycan, collagen V, collagen XII, PAI-1, Scleraxis, and Mohawk by TGF-beta 1. Inter-gene analyses were also performed to further characterize the expression of ECM and MMP genes in the tenocyte-seeded collagen gels. These analyses illustrate that TGF-beta 1 tilts the balance of gene expression in favor of ECM synthesis rather than the matrix-remodeling MMPs, a possible means by which TGF-beta 1 promotes adhesion formation.	[Farhat, Youssef M.; Chen, Tony; Awad, Hani A.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA; [Farhat, Youssef M.; Al-Maliki, Alaa A.; Chen, Tony; Juneja, Subhash C.; Schwarz, Edward M.; O'Keefe, Regis J.; Awad, Hani A.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Schwarz, Edward M.; O'Keefe, Regis J.; Awad, Hani A.] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Awad, HA (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.	hani_awad@urmc.rochester.edu	Mostafa, Taymour/H-6834-2019; Awad, Hani A/G-6976-2014	Mostafa, Taymour/0000-0003-3627-0662; Awad, Hani A/0000-0003-2197-2610; Juneja, Subhash/0000-0002-8536-5724	National Institutes of Health [T32 GM07356]; National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health [R01AR056696]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053459, R01AR056696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Youssef Farhat is a trainee in the Medical Scientist Training Program funded by National Institutes of Health T32 GM07356. The study was supported by Grant Number R01AR056696 from National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2002, MATRIX BIOL, V21, P243, DOI 10.1016/S0945-053X(02)00005-7; Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B; Bagchi RA, 2012, BBA-MOL CELL RES, V1823, P1936, DOI 10.1016/j.bbamcr.2012.07.002; Bal S, 2011, AM J PHYS MED REHAB, V90, P17, DOI 10.1097/PHM.0b013e3181fc7a46; Campbell BH, 2004, BIOMECH MODEL MECHAN, V2, P239, DOI [10.1007/s10237-004-0041-z, 10.1007/S10237-004-0041-Z]; Caulfield RH, 2008, J HAND SURG-EUR VOL, V33E, P412, DOI 10.1177/1753193408090758; Chan KM, 2008, WOUND REPAIR REGEN, V16, P399, DOI 10.1111/j.1524-475X.2008.00379.x; Chang J, 2000, PLAST RECONSTR SURG, V105, P148, DOI 10.1097/00006534-200001000-00025; Cordeiro MF, 2000, INVEST OPHTH VIS SCI, V41, P756; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fu SC, 2008, J ORTHOP RES, V26, P374, DOI 10.1002/jor.20483; GELBERMAN RH, 1986, J ORTHOPAED RES, V4, P119, DOI 10.1002/jor.1100040116; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Gorvy DA, 2005, AM J PATHOL, V167, P1005, DOI 10.1016/S0002-9440(10)61190-X; Hou Y, 2009, MATRIX BIOL, V28, P324, DOI 10.1016/j.matbio.2009.04.007; Ingraham JM, 2003, PLAST RECONSTR SURG, V112, P844, DOI 10.1097/01.PRS.0000070180.62037.FC; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; John J, 2010, ANN BIOMED ENG, V38, P658, DOI 10.1007/s10439-009-9856-1; Jorgensen HG, 2005, CYTOKINE, V30, P195, DOI 10.1016/j.cyto.2004.12.017; Jung JC, 2009, CELL TISSUE RES, V336, P79, DOI 10.1007/s00441-009-0755-4; Katzel EB, 2011, J ORTHOP RES, V29, P684, DOI 10.1002/jor.21235; Khanna A, 2009, BRIT MED BULL, V90, P85, DOI 10.1093/bmb/ldp013; Kopp J, 2005, J BIOL CHEM, V280, P21570, DOI 10.1074/jbc.m502071200; Leask A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1976; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Margulis A, 2009, AM J PHYSIOL-LUNG C, V296, pL236, DOI 10.1152/ajplung.90462.2008; Mendias CL, 2012, MUSCLE NERVE, V45, P55, DOI 10.1002/mus.22232; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Moustakas A, 2001, J CELL SCI, V114, P4359; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Oshiro W, 2003, J HAND SURG-AM, V28A, P814, DOI 10.1016/S0363-5023(03)00366-6; Parkinson J, 2011, J MUSCULOSKEL NEURON, V11, P86; PERCIVAL NJ, 1989, J HAND SURG-BRIT EUR, V14B, P412, DOI 10.1016/0266-7681(89)90157-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; SHAH M, 1995, J CELL SCI, V108, P985; SHAH M, 1994, J CELL SCI, V107, P1137; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; [Statistics BoL Labor USDo], 2010, NONF OCC INJ ILLN RE; Tempfer H, 2009, HISTOCHEM CELL BIOL, V131, P733, DOI 10.1007/s00418-009-0581-5; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002; WILLIAMS IF, 1984, CONNECT TISSUE RES, V12, P211, DOI 10.3109/03008208409013684; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhu YK, 2001, IN VITRO CELL DEV-AN, V37, P10	60	58	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51411	10.1371/journal.pone.0051411	http://dx.doi.org/10.1371/journal.pone.0051411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251524	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900081
J	Wake-Buck, AK; Gatenby, JC; Gore, JC				Wake-Buck, Amanda K.; Gatenby, J. Christopher; Gore, John C.			Hemodynamic Characteristics of the Vertebrobasilar System Analyzed Using MRI-Based Models	PLOS ONE			English	Article							WALL SHEAR-STRESS; HUMAN CAROTID BIFURCATION; PULSATILE FLOW; PHASE-CONTRAST; ENTRY FLOW; ARTERY; DYNAMICS; PATTERNS; STEADY; ATHEROSCLEROSIS	The vertebrobasilar system (VBS) is unique in human anatomy in that two arteries merge into a single vessel, and it is especially important because it supplies the posterior circulation of the brain. Atherosclerosis develops in this region, and atherosclerotic plaques in the vertebrobasilar confluence can progress with catastrophic consequences, including artery occlusion. Quantitative assessments of the flow characteristics in the VBS could elucidate the factors that influence flow patterns in this confluence, and deviations from normal patterns might then be used to predict locations to monitor for potential pathological changes, to detect early signs of disease, and to evaluate treatment options and efficacy. In this study, high-field MRI was used in conjunction with computational fluid dynamics (CFD) modeling to investigate the hemodynamics of subject-specific confluence models (n = 5) and to identify different geometrical classes of vertebrobasilar systems (n = 12) of healthy adult subjects. The curvature of the vessels and their mutual orientation significantly affected flow parameters in the VBS. The basilar artery geometry strongly influenced both skewing of the velocity profiles and the wall shear stress distributions in the VBS. All five subjects modeled possessed varying degrees of vertebral asymmetry, and helical flow was observed in four cases, suggesting that factors other than vertebral asymmetry influence mixing of the vertebral artery flow contributions. These preliminary studies verify that quantitative, MR imaging techniques in conjunction with subject-specific CFD models of healthy adult subjects may be used to characterize VBS hemodynamics and to predict flow features that have been related to the initiation and development of atherosclerosis in large arteries. This work represents an important first step towards applying this approach to study disease initiation and progression in the VBS.	[Wake-Buck, Amanda K.; Gore, John C.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA; [Gatenby, J. Christopher] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Gore, John C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Gore, John C.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA	Vanderbilt University; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wake-Buck, AK (corresponding author), Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA.	amanda.buck@vanderbilt.edu	Buck, Amanda Kathleen Wake/GYK-0734-2022	Buck, Amanda/0000-0003-1042-6374	American Heart Association (AHA) [10POST3450046]; National Institutes of Health (NIH) NIH/NIBIB [5T32 EB001628-07]; NIH/NCRR [UL1 RR024975-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001628] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH) NIH/NIBIB; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	American Heart Association (AHA) 10POST3450046 (www.heart.org), National Institutes of Health (NIH) NIH/NIBIB 5T32 EB001628-07 (www.nih.gov), and NIH/NCRR UL1 RR024975-01 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2007, J MAGN RESON IMAGING, V25, P1120, DOI 10.1002/jmri.20928; BASSIOUNY HS, 1992, J VASC SURG, V15, P708, DOI 10.1016/0741-5214(92)90019-5; BHARADVAJ BK, 1982, J BIOMECH, V15, P349, DOI 10.1016/0021-9290(82)90057-4; Boussel L, 2009, MAGN RESON MED, V61, P409, DOI 10.1002/mrm.21861; Caro C. G., 2012, MECH CIRCULATION, VSecond; CHONG BW, 1994, AM J NEURORADIOL, V15, P733; CRAWSHAW HM, 1980, ARCH SURG-CHICAGO, V115, P1280; Dammers R, 2002, ULTRASOUND MED BIOL, V28, P1015, DOI 10.1016/S0301-5629(02)00544-6; Dean WR, 1928, PHILOS MAG, V5, P673; Dean WR, 1927, PHILOS MAG, V4, P208; Dur O, 2011, CARDIOVASC ENG TECHN, V2, P35, DOI DOI 10.1007/S13239-010-0029-Z; Ford MD, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2900724; Ford MD, 2005, PHYSIOL MEAS, V26, P477, DOI 10.1088/0967-3334/26/4/013; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; Hong JM, 2009, J NEUROL NEUROSUR PS, V80, P1087, DOI 10.1136/jnnp.2008.169805; Jozwik K, 2010, J BIOMECH, V43, P177, DOI 10.1016/j.jbiomech.2009.09.026; Kobayashi N, 2010, J NEUROSURG, V113, P810, DOI 10.3171/2010.1.JNS09575; Korn SDI, 2010, ISR MED ASSOC J, V12, P671; Kornet L, 2000, J VASC RES, V37, P112, DOI 10.1159/000025722; KRIJGER JKB, 1992, J BIOMECH, V25, P1451, DOI 10.1016/0021-9290(92)90058-9; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; MASARYK TJ, 1990, MAGNET RESON MED, V14, P308, DOI 10.1002/mrm.1910140215; MOORE JE, 1994, ATHEROSCLEROSIS, V110, P225, DOI 10.1016/0021-9150(94)90207-0; NAYLER GL, 1986, J COMPUT ASSIST TOMO, V10, P715, DOI 10.1097/00004728-198609000-00001; OJHA M, 1990, J VASC SURG, V12, P747, DOI 10.1067/mva.1990.24365; Oshinski JN, 2006, J CARDIOVASC MAGN R, V8, P717, DOI 10.1080/10976640600723839; Pekkan K, 2008, MED BIOL ENG COMPUT, V46, P1139, DOI 10.1007/s11517-008-0377-0; PELC N J, 1991, Magnetic Resonance Quarterly, V7, P229; Ravensbergen J, 1996, J BIOMECH, V29, P281, DOI 10.1016/0021-9290(95)00064-X; Ravensbergen J, 1997, J BIOMECH ENG-T ASME, V119, P195, DOI 10.1115/1.2796080; Ravensbergen J, 1998, ARTERIOSCL THROM VAS, V18, P708, DOI 10.1161/01.ATV.18.5.708; Rayz VL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2970056; RUGGIERI PM, 1989, RADIOLOGY, V171, P785, DOI 10.1148/radiology.171.3.2717753; Samijo SK, 1997, ULTRASOUND MED BIOL, V23, P583, DOI 10.1016/S0301-5629(97)00044-6; Schonewille WJ, 2005, J NEUROL NEUROSUR PS, V76, P1238, DOI 10.1136/jnnp.2004.049924; SINGH MP, 1974, J FLUID MECH, V65, P517, DOI 10.1017/S0022112074001522; SMITH AS, 1995, AM J NEURORADIOL, V16, P1587; Steinman DA, 2002, ANN BIOMED ENG, V30, P483, DOI 10.1114/1.1467679; STRONY J, 1993, AM J PHYSIOL, V265, pH1787; Tang DL, 2004, J BIOMECH ENG-T ASME, V126, P363, DOI 10.1115/1.1762898; Tropea Bradford I., 1997, P107; YAO LS, 1975, J FLUID MECH, V67, P177, DOI 10.1017/S0022112075000237; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	44	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51346	10.1371/journal.pone.0051346	http://dx.doi.org/10.1371/journal.pone.0051346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251503	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900071
J	Cruz, MC; Souza-Melo, N; da Silva, CV; DaRocha, WD; Bahia, D; Araujo, PR; Teixeira, SR; Mortara, RA				Cruz, Mario C.; Souza-Melo, Normanda; da Silva, Claudio Vieira; DaRocha, Wanderson Duarte; Bahia, Diana; Araujo, Patricia R.; Teixeira, Santuza R.; Mortara, Renato A.			Trypanosoma cruzi: Role of delta-Amastin on Extracellular Amastigote Cell Invasion and Differentiation	PLOS ONE			English	Article							FAMILY ENCODING AMASTIN; GENE FAMILY; VIRULENCE EVOLUTION; SURFACE-PROTEINS; PARASITE; INFECTION; BINDING; CHAGAS; TRYPOMASTIGOTES; IDENTIFICATION	Trypanosoma cruzi is a protozoan parasite that comprises different phylogenetic groups and is the causative agent of Chagas' disease. Different T. cruzi strains present differences in infectivity in in vitro and in vivo experimental models, which are likely related to the expression of different virulence factors. Amastin is a surface glycoprotein abundantly expressed on the intracellular mammalian amastigote form of the parasite. In this study, we showed that a highly infective strain (G strain) of extracellular amastigote (EA) invasive forms expressed reduced RNA levels of amastin compared to a less infective strain (CL). The treatment of HeLa cells with recombinant delta-amastin reduced infectivity of EA forms. However, the ectopic expression of delta-amastin accelerated amastigote differentiation into trypomastigotes. Corroborating the virulence behavior in association with amastin expression, the EAs overexpressing amastin were precociously and robustly observed in the liver of susceptible mouse strains (A/JUnib), whereas parasitemia was never detected in in vivo assays. This is the first report on the regulatory role of amastin in the course of both in vitro and in vivo T. cruzi infection. Citation: Cruz MC, Souza- Melo N, da Silva CV, DaRocha WD, Bahia D, et al. (2012) Trypanosoma cruzi: Role of delta-Amastin on Extracellular Amastigote Cell Invasion and Differentiation. PLoS ONE 7(12): e51804. doi:10.1371/journal.pone.0051804	[Cruz, Mario C.; Bahia, Diana; Mortara, Renato A.] Escola Paulista Med UNIFESP, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Souza-Melo, Normanda; DaRocha, Wanderson Duarte] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil; [da Silva, Claudio Vieira] Univ Fed Uberlandia, Disciplina Imunol, Inst Ciencias Biomed, BR-38400 Uberlandia, MG, Brazil; [Araujo, Patricia R.; Teixeira, Santuza R.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Parana; Universidade Federal de Uberlandia; Universidade Federal de Minas Gerais	Mortara, RA (corresponding author), Escola Paulista Med UNIFESP, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	ramortara@unifesp.br	Mortara, Renato A./C-1864-2012; DaRocha, Wanderson Duarte/AAB-9319-2021; da Silva, Claudio Vieira/AAK-1485-2021; DaRocha, Wanderson/A-8918-2013; Bahia, Diana/W-3974-2019	Mortara, Renato A./0000-0002-2311-8349; DaRocha, Wanderson Duarte/0000-0002-8722-5143; da Silva, Claudio Vieira/0000-0002-5052-3139; DaRocha, Wanderson/0000-0002-8722-5143; 	FAPESP [2006/61450-0, 2011/51475-3, 07/50551-2]; CNPq fellowships; Fundacao Araucaria; CAPES/Reuni; PPSUS/MS; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); CAPES/Reuni(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PPSUS/MS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPESP (grants 2006/61450-0 and 2011/51475-3); RAM and ST are recipients of CNPq fellowships; DB is supported by FAPESP (07/50551-2) and is a CNPq fellow. WDDR and NSM were supported by Fundacao Araucaria, CAPES/Reuni, PPSUS/MS and CNPq and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Araujo PR, 2011, PARASITOL INT, V60, P161, DOI 10.1016/j.parint.2011.01.006; Azizi H, 2009, PARASITOLOGY, V136, P723, DOI 10.1017/S0031182009005873; BEHBEHANI K, 1973, PARASITOLOGY, V66, P343, DOI 10.1017/S0031182000045273; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; Burleigh BA, 1998, CURR OPIN MICROBIOL, V1, P461, DOI 10.1016/S1369-5274(98)80066-0; Cerqueira GC, 2008, MOL BIOCHEM PARASIT, V157, P65, DOI 10.1016/j.molbiopara.2007.10.002; Claser C, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-68; da Costa SCG, 2002, HISTOL HISTOPATHOL, V17, P837, DOI 10.14670/HH-17.837; da Silva CV, 2009, MICROBES INFECT, V11, P563, DOI 10.1016/j.micinf.2009.03.007; da Silva CV, 2006, MICROBES INFECT, V8, P2120, DOI 10.1016/j.micinf.2006.03.016; DaRocha WD, 2004, PARASITOL RES, V92, P113, DOI 10.1007/s00436-003-1004-5; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Fernandes AB, 2004, MICROBES INFECT, V6, P460, DOI 10.1016/j.micinf.2004.01.009; Fernandes AB, 2006, PARASITOL RES, V100, P59, DOI 10.1007/s00436-006-0236-6; Fernandes MC, 2007, INT J PARASITOL, V37, P1431, DOI 10.1016/j.ijpara.2007.04.025; Jackson AP, 2010, MOL BIOL EVOL, V27, P33, DOI 10.1093/molbev/msp214; KAHN S, 1995, J EXP MED, V182, P1243, DOI 10.1084/jem.182.5.1243; LEY V, 1988, J EXP MED, V168, P649, DOI 10.1084/jem.168.2.649; Lima FM, 2010, NEW BIOTECHNOL, V27, P837, DOI 10.1016/j.nbt.2010.02.003; Mackinnon MJ, 2008, VACCINE, V26, pC42, DOI 10.1016/j.vaccine.2008.04.012; Maeda FY, 2011, ACTA TROP, V120, P231, DOI 10.1016/j.actatropica.2011.09.001; MCDANIEL JP, 1993, MOL BIOCHEM PARASIT, V57, P213, DOI 10.1016/0166-6851(93)90197-6; Moore DD, 1995, GLOB MOB SURV; Mortara RA, 2005, AN ACAD BRAS CIENC, V77, P77, DOI 10.1590/S0001-37652005000100006; MORTARA RA, 1991, EXP PARASITOL, V73, P1, DOI 10.1016/0014-4894(91)90002-E; Mortara Renato A., 2008, V47, P101; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Neira I, 2002, INT J PARASITOL, V32, P405, DOI 10.1016/S0020-7519(02)00004-8; NOGUEIRA N, 1976, J EXP MED, V143, P1402, DOI 10.1084/jem.143.6.1402; Rafati S, 2006, CLIN VACCINE IMMUNOL, V13, P1104, DOI 10.1128/CVI.00188-06; Rochette A, 2005, MOL BIOCHEM PARASIT, V140, P205, DOI 10.1016/j.molbiopara.2005.01.006; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Rodrigues AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001598; Salotra P, 2006, MICROBES INFECT, V8, P637, DOI 10.1016/j.micinf.2005.08.018; Santos MAM, 1997, MOL BIOCHEM PARASIT, V86, P1, DOI 10.1016/S0166-6851(96)02840-X; Staquicini DI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000613; Stecconi-Silva RB, 2003, MEM I OSWALDO CRUZ, V98, P953, DOI 10.1590/S0074-02762003000700016; Stober CB, 2006, VACCINE, V24, P2602, DOI 10.1016/j.vaccine.2005.12.012; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; Wu Y, 2000, MOL BIOCHEM PARASIT, V110, P345, DOI 10.1016/S0166-6851(00)00290-5; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Yoshida Nobuko, 2008, V47, P82	47	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51804	10.1371/journal.pone.0051804	http://dx.doi.org/10.1371/journal.pone.0051804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272170	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300030
J	Liboska, R; Ligasova, A; Strunin, D; Rosenberg, I; Koberna, K				Liboska, Radek; Ligasova, Anna; Strunin, Dmytro; Rosenberg, Ivan; Koberna, Karel			Most Anti-BrdU Antibodies React with 2 '-Deoxy-5-Ethynyluridine - The Method for the Effective Suppression of This Cross-Reactivity	PLOS ONE			English	Article							DNA-REPLICATION; NUCLEAR-ORGANIZATION; MAMMALIAN-CELLS; S-PHASE	5-Bromo-2'-deoxyuridine (BrdU) and 2'-deoxy-5-ethynyluridine (EdU) are widely used as markers of replicated DNA. While BrdU is detected using antibodies, the click reaction typically with fluorescent azido-dyes is used for EdU localisation. We have performed an analysis of ten samples of antibodies against BrdU with respect to their reactivity with EdU. Except for one sample all the others evinced reactivity with EdU. A high level of EdU persists in nuclear DNA even after the reaction of EdU with fluorescent azido-dyes if the common concentration of dye is used. Although a ten-time increase of azido-dye concentration resulted in a decrease of the signal provided by anti-BrdU antibodies, it also resulted in a substantial increase of the non-specific signal. We have shown that this unwanted reactivity is effectively suppressed by non-fluorescent azido molecules. In this respect, we have tested two protocols of the simultaneous localisation of incorporated BrdU and EdU. They differ in the mechanism of the revelation of incorporated BrdU for the reaction with antibodies. The first one was based on the use of hydrochloric acid, the second one on the incubation of samples with copper(I) ions. The use of hydrochloric acid resulted in a significant increase of the non-specific signal. In the case of the second method, no such effect was observed.	[Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] ASCR, Inst Biophys, Dept Mol Cytol & Cytometry, Vvi, Brno, Czech Republic; [Liboska, Radek; Rosenberg, Ivan] ASCR, Oligonucleotide Grp, Inst Organ Chem & Biochem, Vvi, Prague, Czech Republic; [Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] ASCR, Dept RNA Biol, Inst Mol Genet, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Ligasova, A (corresponding author), ASCR, Inst Biophys, Dept Mol Cytol & Cytometry, Vvi, Brno, Czech Republic.	ligasova@gmail.com	Liboska, Radek/I-5715-2014; KOBERNA, Karel/G-5551-2019; Rosenberg, Ivan/G-5602-2014; Ligasová, Anna/P-5460-2015	KOBERNA, Karel/0000-0002-7375-4298; Ligasová, Anna/0000-0002-1564-3768	Czech Science Foundation [204/09/0973, P302/12/G157]; Grant Agency of the Academy of Sciences of the Czech Republic [KAN 200520801, AV0Z50520514, AV0Z50040702]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	This work has been supported by the Czech Science Foundation (204/09/0973, P302/12/G157) and the Grant Agency of the Academy of Sciences of the Czech Republic (KAN 200520801, AV0Z50520514 and AV0Z50040702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; BARR PJ, 1981, J MED CHEM, V24, P1385, DOI 10.1021/jm00144a003; BEHRENS CH, 1985, J ORG CHEM, V50, P5696, DOI 10.1021/jo00350a051; Bradford JA, 2011, CURR PROTOC CYTOM, V55, P1; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Ligasova A, 2012, PLOS ONE IN PRESS; Ligasova A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq619; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Qu DZ, 2011, ANAL BIOCHEM, V417, P112, DOI 10.1016/j.ab.2011.05.037; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Stanojcic S, 2008, MOL CELL BIOL, V28, P5265, DOI 10.1128/MCB.00181-08; Wu JC, 2010, J ORG CHEM, V75, P8604, DOI 10.1021/jo1019267	16	42	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51679	10.1371/journal.pone.0051679	http://dx.doi.org/10.1371/journal.pone.0051679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272138	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300023
J	Comuzzie, AG; Cole, SA; Laston, SL; Voruganti, VS; Haack, K; Gibbs, RA; Butte, NF				Comuzzie, Anthony G.; Cole, Shelley A.; Laston, Sandra L.; Voruganti, V. Saroja; Haack, Karin; Gibbs, Richard A.; Butte, Nancy F.			Novel Genetic Loci Identified for the Pathophysiology of Childhood Obesity in the Hispanic Population	PLOS ONE			English	Article							VIVA LA FAMILIA; QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; FASTING GLUCOSE-LEVELS; BODY-MASS INDEX; XERODERMA-PIGMENTOSUM; EUROPEAN POPULATIONS; PHYSICAL-ACTIVITY; ENERGY-BALANCE; CHILDREN	Genetic variants responsible for susceptibility to obesity and its comorbidities among Hispanic children have not been identified. The VIVA LA FAMILIA Study was designed to genetically map childhood obesity and associated biological processes in the Hispanic population. A genome-wide association study (GWAS) entailed genotyping 1.1 million single nucleotide polymorphisms (SNPs) using the Illumina Infinium technology in 815 children. Measured genotype analysis was performed between genetic markers and obesity-related traits i.e., anthropometry, body composition, growth, metabolites, hormones, inflammation, diet, energy expenditure, substrate utilization and physical activity. Identified genome-wide significant loci: 1) corroborated genes implicated in other studies (MTNR1B, ZNF259/APOA5, XPA/FOXE1 (TTF-2), DARC, CCR3, ABO); 2) localized novel genes in plausible biological pathways (PCSK2, ARHGAP11A, CHRNA3); and 3) revealed novel genes with unknown function in obesity pathogenesis (MATK, COL4A1). Salient findings include a nonsynonymous SNP (rs1056513) in INADL (p = 1.2E-07) for weight; an intronic variant in MTNR1B associated with fasting glucose (p = 3.7E-08); variants in the APOA5-ZNF259 region associated with triglycerides (p = 2.5-4.8E-08); an intronic variant in PCSK2 associated with total antioxidants (p = 7.6E-08); a block of 23 SNPs in XPA/FOXE1 (TTF-2) associated with serum TSH (p = 5.5E-08 to 1.0E-09); a nonsynonymous SNP (p = 1.3E-21), an intronic SNP (p = 3.6E-13) in DARC identified for MCP-1; an intronic variant in ARHGAP11A associated with sleep duration (p = 5.0E-08); and, after adjusting for body weight, variants in MATK for total energy expenditure (p = 2.7E-08) and in CHRNA3 for sleeping energy expenditure (p = 6.0E-08). Unprecedented phenotyping and high-density SNP genotyping enabled localization of novel genetic loci associated with the pathophysiology of childhood obesity.	[Butte, Nancy F.] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA; [Comuzzie, Anthony G.; Cole, Shelley A.; Laston, Sandra L.; Voruganti, V. Saroja; Haack, Karin] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Texas Biomedical Research Institute; Baylor College of Medicine	Butte, NF (corresponding author), Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA.	nbutte@bcm.edu			National Institutes of Health (NIH) [DK080457]; USDA/ARS [6250-51000-053]; National Center for Research Resources, NIH [C06 RR013556, C06 RR017515]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017515, C06RR013556] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080457] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (NIH) (DK080457), and the USDA/ARS (Cooperative Agreement 6250-51000-053). Work performed at the Texas Biomedical Research Institute in San Antonio, Texas was conducted in facilities constructed with support from the Research Facilities Improvement Program of the National Center for Research Resources, NIH (C06 RR013556, C06 RR017515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; BENNETT BD, 1994, J BIOL CHEM, V269, P1068; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Bouatia-Naji N, 2009, M S-MED SCI, V25, P897, DOI 10.1051/medsci/20092511897; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Brautbar A, 2011, ATHEROSCLEROSIS, V219, P737, DOI 10.1016/j.atherosclerosis.2011.08.015; Butte NF, 2007, OBESITY, V15, P3056, DOI 10.1038/oby.2007.364; Butte NF, 2007, MED SCI SPORT EXER, V39, P1257, DOI 10.1249/mss.0b013e3180621fb6; Butte NF, 2007, AM J CLIN NUTR, V85, P1478, DOI 10.1093/ajcn/85.6.1478; Butte NF, 2006, AM J CLIN NUTR, V84, P646, DOI 10.1093/ajcn/84.3.646; Butte NF, 2005, PEDIATR RES, V58, P1243, DOI 10.1203/01.pdr.0000185272.46705.18; Cai G, 2008, INT J OBESITY, V32, P579, DOI 10.1038/ijo.2008.20; Cai G, 2007, J CLIN ENDOCR METAB, V92, P4893, DOI 10.1210/jc.2007-1695; Cai GW, 2006, OBESITY, V14, P1596, DOI 10.1038/oby.2006.184; Cai GW, 2008, CYTOKINE, V44, P242, DOI 10.1016/j.cyto.2008.08.006; Cai GW, 2004, DIABETES, V53, P1369, DOI 10.2337/diabetes.53.5.1369; Cole SA, 2010, AM J CLIN NUTR, V91, P191, DOI 10.3945/ajcn.2009.28514; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Fisher JO, 2007, OBESITY, V15, P1484, DOI 10.1038/oby.2007.177; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hakonarson H, 2011, DIABETES-METAB RES, V27, P685, DOI 10.1002/dmrr.1221; Holzapfel C, 2011, EUR J ENDOCRINOL, V164, P205, DOI 10.1530/EJE-10-0588; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Johnson RK, 1996, J AM DIET ASSOC, V96, P1140, DOI 10.1016/S0002-8223(96)00293-3; Kelliny C, 2009, DIABETES, V58, P2939, DOI 10.2337/db09-0374; Kelly-Pieper K, 2011, MINERVA PEDIATR, V63, P473; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; Medici M, 2011, EUR J ENDOCRINOL, V164, P781, DOI 10.1530/EJE-10-1130; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Muller MJ, 2010, OBES REV, V11, P612, DOI 10.1111/j.1467-789X.2010.00734.x; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; O'Rahilly S, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.239; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Reinehr T, 2011, PEDIATR DIABETES, V12, P435, DOI 10.1111/j.1399-5448.2010.00738.x; Rull A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/326580; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; Sobel E, 1996, AM J HUM GENET, V58, P1323; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; States JC, 1998, HUM MUTAT, V12, P103, DOI 10.1002/(SICI)1098-1004(1998)12:2<103::AID-HUMU5>3.0.CO;2-6; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; Torrado M, 2007, AM J MED GENET A, V143A, P460, DOI 10.1002/ajmg.a.31520; Voruganti VS, 2007, PEDIATR RES, V62, P445, DOI 10.1203/PDR.0b013e31813cbf02; Wende H, 2000, IMMUNOGENETICS, V51, P703, DOI 10.1007/s002510000187; WOOLF NJ, 1986, BRAIN RES BULL, V16, P603, DOI 10.1016/0361-9230(86)90134-6; Zhao JH, 2011, J OBES, V2011, DOI 10.1155/2011/845148; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c	63	252	256	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51954	10.1371/journal.pone.0051954	http://dx.doi.org/10.1371/journal.pone.0051954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251661	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800116
J	Saha, RK; Karmakar, S; Roy, M				Saha, Ratan K.; Karmakar, Subhajit; Roy, Madhusudan			Computational Investigation on the Photoacoustics of Malaria Infected Red Blood Cells	PLOS ONE			English	Article							HEMOZOIN PRODUCTION; DIAGNOSIS	A computer simulation study on the possibility of using photoacoustic (PA) technique to differentiate intraerythrocytic stages of malarial parasite is reported. This parasite during its development substantially converts hemoglobin into hemozoin. This conversion is expected to alter the cellular absorption leading to changes in the PA emission of a red blood cell (RBC) at certain incident optical wavelengths. The PA signals from blood samples corresponding to ring, trophozoite and schizont stages were computed and compared with that of normal blood. A Monte Carlo algorithm was implemented generating random locations of RBCs in 3D to simulate blood samples. The average PA amplitude for wide bandwidth signals decreases for 434 nm incident radiation, but increases for 700 nm as the parasite matures. The spectral power at 7.5 MHz for the blood sample at the schizont stage compared to the normal blood is nearly reduced by 6 dB and enhanced by 22 dB at those incident wavelengths, respectively. Bandlimited signals for transducers of 15 and 50 MHz center frequencies were studied and found to exhibit similar characteristics. The presence of hemozoin inside the cells was examined and an excellent estimation was made. The simulation results suggest that intraerythrocytic stages of malarial parasite may be assessed using the PA technique. Citation: Saha RK, Karmakar S, Roy M (2012) Computational Investigation on the Photoacoustics of Malaria Infected Red Blood Cells. PLoS ONE 7(12): e51774. doi:10.1371/journal.pone.0051774	[Saha, Ratan K.] Saha Inst Nucl Phys, Ratan K Saha Appl Mat Sci Div, Kolkata, W Bengal, India; [Karmakar, Subhajit] Saha Inst Nucl Phys, Subhajit Karmakar Appl Nucl Phys Div, Kolkata, W Bengal, India; [Roy, Madhusudan] Saha Inst Nucl Phys, Madhusudan Roy Appl Mat Sci Div, Kolkata, W Bengal, India	Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics	Saha, RK (corresponding author), Saha Inst Nucl Phys, Ratan K Saha Appl Mat Sci Div, Kolkata, W Bengal, India.	ratank.saha@saha.ac.in						BALASUBRAMANIAN D, 1984, SCIENCE, V223, P828, DOI 10.1126/science.6695185; BALASUBRAMANIAN D, 1983, BIOSCIENCE REP, V3, P981, DOI 10.1007/BF01121025; Belisle JM, 2008, BIOPHYS J, V94, pL26, DOI 10.1529/biophysj.107.125443; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; BERRYMAN JG, 1983, PHYS REV A, V27, P1053, DOI 10.1103/PhysRevA.27.1053; Bracewell RN, 2003, FOURIER TRANSFORM IT, P329; Diebold GJ, 2009, OPT SCI ENG-CRC, V144, P3; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Fox S. I., 2008, HUMAN PHYSL, P388; HINRICHSEN EL, 1990, PHYS REV A, V41, P4199, DOI 10.1103/PhysRevA.41.4199; Hysi E, 2012, BIOMED OPT EXPRESS, V3, P2326, DOI 10.1364/BOE.3.002326; Ishimaru A, 1978, WAVE PROPAGATION SCA, P69; JODREY WS, 1985, PHYS REV A, V32, P2347, DOI 10.1103/PhysRevA.32.2347; Makler MT, 1998, ANN TROP MED PARASIT, V92, P419, DOI 10.1080/00034989859401; MURRAY CK, 2009, INTERDISCIP PERSPECT; Newman DM, 2008, BIOPHYS J, V95, P994, DOI 10.1529/biophysj.107.128140; NORRIS CL, 1993, BIOPHYS J, V65, P1660, DOI 10.1016/S0006-3495(93)81223-2; ORJIH AU, 1993, BIOCHIM BIOPHYS ACTA, V1157, P270, DOI 10.1016/0304-4165(93)90109-L; Orjih AU, 2001, EXP BIOL MED, V226, P746, DOI 10.1177/153537020222600806; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Prahl S., TABULATED DATA VARIO; Saha RK, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.055002; Saha RK, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655355; Saha RK, 2011, IEEE T ULTRASON FERR, V58, P2118, DOI 10.1109/TUFFC.2011.2061; Saha RK, 2011, J ACOUST SOC AM, V129, P2935, DOI 10.1121/1.3570946; Saha RK, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061919; Samson EB, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/6/065302; SHUNG KK, 1984, J ACOUST SOC AM, V75, P1265, DOI 10.1121/1.390733; Shung KK, 1993, ULTRASOUND SCATTERIN, P1; Szabo TL, 2004, DIAGNOSTIC ULTRASOUN, P97; Toubal M, 1999, PHYS MED BIOL, V44, P1277, DOI 10.1088/0031-9155/44/5/313; Wang LV, 2008, MED PHYS, V35, P5758, DOI 10.1118/1.3013698; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	36	22	24	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51774	10.1371/journal.pone.0051774	http://dx.doi.org/10.1371/journal.pone.0051774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272166	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800082
J	Bao, B; Ali, S; Ahmad, A; Azmi, AS; Li, YW; Banerjee, S; Kong, DJ; Sethi, S; Aboukameel, A; Padhye, SB; Sarkar, FH				Bao, Bin; Ali, Shadan; Ahmad, Aamir; Azmi, Asfar S.; Li, Yiwei; Banerjee, Sanjeev; Kong, Dejuan; Sethi, Seema; Aboukameel, Amro; Padhye, Subhash B.; Sarkar, Fazlul H.			Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment	PLOS ONE			English	Article							PROSTATE-CANCER; STEM-CELLS; DRUG-RESISTANCE; CLINICAL-TRIALS; TUMOR HYPOXIA; ANALOG CDF; CURCUMIN; MICRORNAS; GROWTH; INTERLEUKIN-6	Hypoxia is known to play critical roles in cell survival, angiogenesis, tumor invasion, and metastasis. Hypoxia mediated overexpression of hypoxia-inducible factor (HIF) has been shown to be associated with therapeutic resistance, and contributes to poor prognosis of cancer patients. Emerging evidence suggest that hypoxia and HIF pathways contributes to the acquisition of epithelial-to-mesenchymal transition (EMT), maintenance of cancer stem cell (CSC) functions, and also maintains the vicious cycle of inflammation-all which lead to therapeutic resistance. However, the precise molecular mechanism(s) by which hypoxia/HIF drives these events are not fully understood. Here, we show, for the first time, that hypoxia leads to increased expression of VEGF, IL-6, and CSC signature genes Nanog, Oct4 and EZH2 consistent with increased cell migration/invasion and angiogenesis, and the formation of pancreatospheres, concomitant with increased expression of miR-21 and miR-210 in human pancreatic cancer (PC) cells. The treatment of PC cells with CDF, a novel synthetic compound inhibited the production of VEGF and IL-6, and down-regulated the expression of Nanog, Oct4, EZH2 mRNAs, as well as miR-21 and miR-210 under hypoxia. CDF also led to decreased cell migration/invasion, angiogenesis, and formation of pancreatospheres under hypoxia. Moreover, CDF decreased gene expression of miR-21, miR-210, IL-6, HIF-1 alpha, VEGF, and CSC signatures in vivo in a mouse orthotopic model of human PC. Collectively, these results suggest that the anti-tumor activity of CDF is in part mediated through deregulation of tumor hypoxic pathways, and thus CDF could become a novel, and effective anti-tumor agent for PC therapy. Citation: Bao B, Ali S, Ahmad A, Azmi AS, Li Y, et al. (2012) Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment. PLoS ONE 7(12): e50165. doi:10.1371/journal.pone.0050165	[Bao, Bin; Ahmad, Aamir; Azmi, Asfar S.; Li, Yiwei; Banerjee, Sanjeev; Kong, Dejuan; Sethi, Seema; Aboukameel, Amro; Sarkar, Fazlul H.] Wayne State Univ, Karmanos Canc Inst, Dept Pathol, Detroit, MI 48202 USA; [Ali, Shadan; Sarkar, Fazlul H.] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA; [Padhye, Subhash B.] Abeda Inamdar Senior Coll Arts Sci & Commerce, MCE Soc, ISTRA, Dept Chem, Pune, Maharashtra, India	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sarkar, FH (corresponding author), Wayne State Univ, Karmanos Canc Inst, Dept Pathol, Detroit, MI 48202 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723; AZMI, ASFAR/0000-0003-1178-9505	National Cancer Institute, National Institutes of Health [R01CA131151, R01CA132794, R01CA154321]; Department of Defense Exploration-Hypothesis Development Award [PC101482]; NATIONAL CANCER INSTITUTE [P30CA022453, R01CA131151, R01CA132794, R01CA154321, R01CA140314] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Exploration-Hypothesis Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute, National Institutes of Health grants R01CA131151, R01CA132794 and R01CA154321 awarded to FHS, and Department of Defense Exploration-Hypothesis Development Award PC101482 awarded to Bin Bao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Bao B, 2012, CANC PREV RES PHILA; Bao B, 2012, BIOCH BIOPHYS ACTA; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Conze D, 2001, CANCER RES, V61, P8851; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Kondo S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-268; Kong D, 2008, CANCER RES, V68, P1927, DOI 10.1158/0008-5472.CAN-07-3241; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; MOULDER JE, 1987, CANCER METAST REV, V5, P313, DOI 10.1007/BF00055376; Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003; Narayan S, 2004, J MOL HISTOL, V35, P301, DOI 10.1023/B:HIJO.0000032361.98815.bb; Nie Y, 2011, INT J BIOL SCI, V7, P762, DOI 10.7150/ijbs.7.762; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Padhye S, 2010, MINI-REV MED CHEM, V10, P372, DOI 10.2174/138955710791330891; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; Pocock R, 2011, PFLUG ARCH EUR J PHY, V461, P307, DOI 10.1007/s00424-010-0910-5; Quero L, 2011, RADIOTHER ONCOL; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sarkar FH, 2010, CURR PHARM DESIGN, V16, P1801, DOI 10.2174/138161210791208956; Sarkar FH, 2009, CANCER TREAT REV, V35, P597, DOI 10.1016/j.ctrv.2009.07.001; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wang ZW, 2008, LIFE SCI, V83, P293, DOI 10.1016/j.lfs.2008.06.017; Wang ZW, 2011, J CELL BIOCHEM, V112, P78, DOI 10.1002/jcb.22770; Yi H, 2012, KOREAN J PHYSIOL PHA, V16, P11, DOI 10.4196/kjpp.2012.16.1.11	50	114	118	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50165	10.1371/journal.pone.0050165	http://dx.doi.org/10.1371/journal.pone.0050165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272057	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600008
J	Fanin, N; Barantal, S; Fromin, N; Schimann, H; Schevin, P; Hattenschwiler, S				Fanin, Nicolas; Barantal, Sandra; Fromin, Nathalie; Schimann, Heidy; Schevin, Patrick; Haettenschwiler, Stephan			Distinct Microbial Limitations in Litter and Underlying Soil Revealed by Carbon and Nutrient Fertilization in a Tropical Rainforest	PLOS ONE			English	Article							PHOSPHORUS LIMITATION; NITROGEN ADDITIONS; TEMPERATURE SENSITIVITY; COMMUNITY COMPOSITION; ELEVATED CO2; DECOMPOSITION; RESPIRATION; ECOSYSTEM; CLIMATE; DIVERSITY	Human-caused alterations of the carbon and nutrient cycles are expected to impact tropical ecosystems in the near future. Here we evaluated how a combined change in carbon (C), nitrogen (N) and phosphorus (P) availability affects soil and litter microbial respiration and litter decomposition in an undisturbed Amazonian rainforest in French Guiana. In a fully factorial C (as cellulose), N (as urea), and P (as phosphate) fertilization experiment we analyzed a total of 540 litterbag-soil pairs after a 158-day exposure in the field. Rates of substrate-induced respiration (SIR) measured in litter and litter mass loss were similarly affected by fertilization showing the strongest stimulation when N and P were added simultaneously. The stimulating NP effect on litter SIR increased considerably with increasing initial dissolved organic carbon (DOC) concentrations in litter, suggesting that the combined availability of N, P, and a labile C source has a particularly strong effect on microbial activity. Cellulose fertilization, however, did not further stimulate the NP effect. In contrast to litter SIR and litter mass loss, soil SIR was reduced with N fertilization and showed only a positive effect in response to P fertilization that was further enhanced with additional C fertilization. Our data suggest that increased nutrient enrichment in the studied Amazonian rainforest can considerably change microbial activity and litter decomposition, and that these effects differ between the litter layer and the underlying soil. Any resulting change in relative C and nutrient fluxes between the litter layer and the soil can have important consequences for biogeochemical cycles in tropical forest ecosystems. Citation: Fanin N, Barantal S, Fromin N, Schimann H, Schevin P, et al. (2012) Distinct Microbial Limitations in Litter and Underlying Soil Revealed by Carbon and Nutrient Fertilization in a Tropical Rainforest. PLoS ONE 7(12): e49990. doi: 10.1371/journal.pone.0049990	[Fanin, Nicolas; Barantal, Sandra; Fromin, Nathalie; Schevin, Patrick; Haettenschwiler, Stephan] CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; [Schimann, Heidy] UMR Ecol Forets Guyane EcoFoG, Kourou, French Guiana; [Fanin, Nicolas] Univ Montpellier 2, Montpellier, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Montpellier	Fromin, N (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France.	nathalie.fromin@cefe.cnrs.fr	Schimann, Heidy/AAN-5252-2020; Fanin, Nicolas/H-5501-2019	Schimann, Heidy/0000-0002-9139-920X; Fanin, Nicolas/0000-0003-4195-855X; Fromin, Nathalie/0000-0003-3752-7503	CNRS "PIR Amazonie II"; CNRS "EC2CO"; French Research and Education Ministry; University of Montpellier II	CNRS "PIR Amazonie II"; CNRS "EC2CO"; French Research and Education Ministry; University of Montpellier II	This research was funded through CNRS "PIR Amazonie II" and "EC2CO" grants. N. Fanin received a Ph. D. grant from the French Research and Education Ministry and from the University of Montpellier II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barantal S, 2012, ECOSYSTEMS, V15, P1039, DOI 10.1007/s10021-012-9564-9; Bates D., 2010, LINEAR MIXED MODEL I; BEARE MH, 1990, SOIL BIOL BIOCHEM, V22, P585, DOI 10.1016/0038-0717(90)90002-H; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Brown ALP, 2009, MICROB ECOL, V57, P14, DOI 10.1007/s00248-008-9461-0; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chambers JQ, 2004, ECOL APPL, V14, pS72; Cherif M, 2009, P ROY SOC B-BIOL SCI, V276, P487, DOI 10.1098/rspb.2008.0560; Cleveland CC, 2006, ECOLOGY, V87, P492, DOI 10.1890/05-0525; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Coq S, 2010, ECOLOGY, V91, P2080, DOI 10.1890/09-1076.1; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Cusack DF, 2011, BIOGEOCHEMISTRY, V104, P203, DOI 10.1007/s10533-010-9496-4; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Cusack DF, 2010, GLOBAL CHANGE BIOL, V16, P2555, DOI 10.1111/j.1365-2486.2009.02131.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Angelis P, 2000, PLANT SOIL, V224, P31, DOI 10.1023/A:1004790328560; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; ENRIQUEZ S, 1993, OECOLOGIA, V94, P457, DOI 10.1007/BF00566960; Epron D, 2004, FOREST ECOL MANAG, V202, P149, DOI 10.1016/j.foreco.2004.07.019; Fanin N, 2011, SOIL BIOL BIOCHEM, V43, P1014, DOI 10.1016/j.soilbio.2011.01.018; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; GALLARDO A, 1994, SOIL BIOL BIOCHEM, V26, P1409, DOI 10.1016/0038-0717(94)90225-9; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gnankambary Z, 2008, SOIL BIOL BIOCHEM, V40, P350, DOI 10.1016/j.soilbio.2007.08.015; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Gourlet-Fleury S, 2000, FOREST ECOL MANAG, V131, P269, DOI 10.1016/S0378-1127(99)00212-1; Grace J., 2001, TERRESTRIAL GLOBAL P, P401; Hattenschwiler S, 2008, NEW PHYTOL, V179, P165, DOI 10.1111/j.1469-8137.2008.02438.x; Hattenschwiler S, 2011, NEW PHYTOL, V189, P950, DOI 10.1111/j.1469-8137.2010.03483.x; Hattenschwiler S, 2010, J ECOL, V98, P754, DOI 10.1111/j.1365-2745.2010.01671.x; Hattenschwiler S, 2004, GLOBAL CHANGE BIOL, V10, P1899, DOI 10.1111/j.1365-2486.2004.00856.x; Henry HAL, 2005, OECOLOGIA, V142, P465, DOI 10.1007/s00442-004-1713-1; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Ilstedt U, 2005, SOIL BIOL BIOCHEM, V37, P1407, DOI 10.1016/j.soilbio.2005.01.002; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Joergensen RG, 1999, SOIL BIOL BIOCHEM, V31, P859, DOI 10.1016/S0038-0717(98)00185-0; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; KORNER C, 1994, OECOLOGIA, V99, P343, DOI 10.1007/BF00627748; Krashevska V, 2010, OIKOS, V119, P1020, DOI 10.1111/j.1600-0706.2009.18169.x; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; McGlynn TP, 2007, BIOTROPICA, V39, P50, DOI 10.1111/j.1744-7429.2006.00241.x; Milcu A, 2011, ECOSYSTEMS, V14, P710, DOI 10.1007/s10021-011-9440-z; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Okin GS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002145; Orwin KH, 2006, ECOLOGY, V87, P580, DOI 10.1890/05-0383; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Pinheiro J., 2011, PACKAGE R SOFTWARE S, P21; Priess JA, 2001, SOIL BIOL BIOCHEM, V33, P503, DOI 10.1016/S0038-0717(00)00191-7; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; Reed SC, 2011, BIOGEOCHEMISTRY, V106, P323, DOI 10.1007/s10533-010-9522-6; Roy J, 2005, NATO SCI S SS IV EAR, V55, P337; Sayer EJ, 2010, SOIL BIOL BIOCHEM, V42, P347, DOI 10.1016/j.soilbio.2009.11.014; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schreeg L, 2012, ECOLOGY IN PRESS; Silver WL, 2005, GLOBAL CHANGE BIOL, V11, P290, DOI 10.1111/j.1365-2486.2005.00903.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Townsend AR, 2011, FRONT ECOL ENVIRON, V9, P9, DOI 10.1890/100047; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Ushio M, 2008, SOIL BIOL BIOCHEM, V40, P2699, DOI 10.1016/j.soilbio.2008.06.023; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1; Yang XD, 2009, SOIL BIOL BIOCHEM, V41, P910, DOI 10.1016/j.soilbio.2008.12.028; Yuste JC, 2005, TREE PHYSIOL, V25, P609, DOI 10.1093/treephys/25.5.609	82	38	38	5	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e49990	10.1371/journal.pone.0049990	http://dx.doi.org/10.1371/journal.pone.0049990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272052	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386600005
J	Jin, L; Zhang, MW; Ma, JD; Zhang, J; Zhou, CW; Liu, YK; Wang, T; Jiang, AA; Chen, L; Wang, JY; Jiang, ZR; Zhu, L; Shuai, SR; Li, RQ; Li, MZ; Li, XW				Jin, Long; Zhang, Mingwang; Ma, Jideng; Zhang, Jie; Zhou, Chaowei; Liu, Yingkai; Wang, Tao; Jiang, An-an; Chen, Lei; Wang, Jinyong; Jiang, Zhongrong; Zhu, Li; Shuai, Surong; Li, Ruiqiang; Li, Mingzhou; Li, Xuewei			Mitochondrial DNA Evidence Indicates the Local Origin of Domestic Pigs in the Upstream Region of the Yangtze River	PLOS ONE			English	Article							MULTIPLE MATERNAL ORIGINS; PHYLOGEOGRAPHIC STRUCTURE; WILD BOARS; DIVERSITY	Previous studies have indicated two main domestic pig dispersal routes in East Asia: one is from the Mekong region, through the upstream region of the Yangtze River (URYZ) to the middle and upstream regions of the Yellow River, the other is from the middle and downstream regions of the Yangtze River to the downstream region of the Yellow River, and then to northeast China. The URYZ was regarded as a passageway of the former dispersal route; however, this assumption remains to be further investigated. We therefore analyzed the hypervariable segements of mitochondrial DNA from 513 individual pigs mainly from Sichuan and the Tibet highlands and 1,394 publicly available sequences from domestic pigs and wild boars across Asia. From the phylogenetic tree, most of the samples fell into a mixed group that was difficult to distinguish by breed or geography. The total network analysis showed that the URYZ pigs possessed a dominant position in haplogroup A and domestic pigs shared the same core haplotype with the local wild boars, suggesting that pigs in group A were most likely derived from the URYZ pool. In addition, a region-wise network analysis determined that URYZ contains 42 haplotypes of which 22 are unique indicating the high diversity in this region. In conclusion, our findings confirmed that pigs from the URYZ were domesticated in situ. Citation: Jin L, Zhang M, Ma J, Zhang J, Zhou C, et al. (2012) Mitochondrial DNA Evidence Indicates the Local Origin of Domestic Pigs in the Upstream Region of the Yangtze River. PLoS ONE 7(12): e51649. doi:10.1371/journal.pone.0051649	[Jin, Long; Zhang, Mingwang; Ma, Jideng; Zhang, Jie; Zhou, Chaowei; Liu, Yingkai; Wang, Tao; Jiang, An-an; Zhu, Li; Shuai, Surong; Li, Mingzhou] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Jiang, Zhongrong] Anim Husb Inst Ganze Tibetan Autonomous Prefectur, Kangding, Sichuan, Peoples R China; [Li, Ruiqiang; Li, Mingzhou] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Li, Ruiqiang; Li, Mingzhou] Peking Univ, Peking Tsinghua Ctr Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China	Sichuan Agricultural University; Peking University; Peking University	Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China.	mingzhou.li@163.com; xuewei.li@sicau.edu.cn		Li, Mingzhou/0000-0001-8681-7684	Specialized Research Fund of Ministry of Agriculture of China [NYCYTX-009]; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province [2011YZGG15]; International Science & Technology Cooperation Program of China [2011DFB30340]; National Special Foundation for Transgenic Species of China [2011ZX08006-003]; National Natural Science Foundation of China [30901024]; Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences	Specialized Research Fund of Ministry of Agriculture of China; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province; International Science & Technology Cooperation Program of China; National Special Foundation for Transgenic Species of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences	This work was supported by grants from the Specialized Research Fund of Ministry of Agriculture of China (NYCYTX-009), the Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province (2011YZGG15), the International Science & Technology Cooperation Program of China (2011DFB30340) and the National Special Foundation for Transgenic Species of China (2011ZX08006-003) to X.L., the National Natural Science Foundation of China (30901024) and the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences to M.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	B?k?nyi S., 1974, HIST DOMESTIC MAMMAL; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; CLUTTONBROCK J, 1987, NATURAL HIST DOMESTI, P70; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Giuffra E, 2000, GENETICS, V154, P1785; Jing Y, 2002, ANTIQUITY, V76, P724, DOI 10.1017/S0003598X00091171; Jing Y, 2008, ANTIQUITY, V82, P351, DOI 10.1017/S0003598X0009685X; Lai SJ, 2007, ANIM GENET, V38, P77, DOI 10.1111/j.1365-2052.2007.01555.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YP, 2009, J ANIM BREED GENET, V126, P80, DOI 10.1111/j.1439-0388.2008.00737.x; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Lum JK, 2006, P NATL ACAD SCI USA, V103, P17190, DOI 10.1073/pnas.0608220103; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Scandura M, 2011, MAMMAL REV, V41, P125, DOI 10.1111/j.1365-2907.2010.00182.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wei DY, 1982, ARCHAEOLOGY, V2, P181; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245; Yang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028215	32	19	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51649	10.1371/journal.pone.0051649	http://dx.doi.org/10.1371/journal.pone.0051649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272130	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386600033
J	Macdonald, IK; Murray, A; Healey, GF; Parsy-Kowalska, CB; Allen, J; McElveen, J; Robertson, C; Sewell, HF; Chapman, CJ; Robertson, JFR				Macdonald, Isabel K.; Murray, Andrea; Healey, Graham F.; Parsy-Kowalska, Celine B.; Allen, Jared; McElveen, Jane; Robertson, Chris; Sewell, Herbert F.; Chapman, Caroline J.; Robertson, John F. R.			Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT (R)-Lung Test	PLOS ONE			English	Article							ALPHA-ENOLASE; AUTOANTIBODY TEST; LUNG-CANCER; EXPRESSION; PROTEIN; CYTOKERATIN-20; IDENTIFICATION; VALIDATION; CELLS; MYC	Background: The National Lung Screening Trial showed that CT screening for lung cancer led to a 20% reduction in mortality. However, CT screening has a number of disadvantages including low specificity. A validated autoantibody assay is available commercially (EarlyCDT (R)-Lung) to aid in the early detection of lung cancer and risk stratification in patients with pulmonary nodules detected by CT. Recent advances in high throughput (HTP) cloning and expression methods have been developed into a discovery pipeline to identify biomarkers that detect autoantibodies. The aim of this study was to demonstrate the successful clinical application of this strategy to add to the EarlyCDT-Lung panel in order to improve its sensitivity and specificity (and hence positive predictive value, (PPV)). Methods and Findings: Serum from two matched independent cohorts of lung cancer patients were used (n = 100 and n = 165). Sixty nine proteins were initially screened on an abridged HTP version of the autoantibody ELISA using protein prepared on small scale by a HTP expression and purification screen. Promising leads were produced in shake flask culture and tested on the full assay. These results were analyzed in combination with those from the EarlyCDT-Lung panel in order to provide a set of re-optimized cut-offs. Five proteins that still displayed cancer/normal differentiation were tested for reproducibility and validation on a second batch of protein and a separate patient cohort. Addition of these proteins resulted in an improvement in the sensitivity and specificity of the test from 38% and 86% to 49% and 93% respectively (PPV improvement from 1 in 16 to 1 in 7). Conclusion: This is a practical example of the value of investing resources to develop a HTP technology. Such technology may lead to improvement in the clinical utility of the EarlyCDT-Lung test, and so further aid the early detection of lung cancer. Citation: Macdonald IK, Murray A, Healey GF, Parsy-Kowalska CB, Allen J, et al. (2012) Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT (R)-Lung Test. PLoS ONE 7(12): e51002. doi:10.1371/journal.pone.0051002	[Macdonald, Isabel K.; Murray, Andrea; Healey, Graham F.; Parsy-Kowalska, Celine B.; Allen, Jared; McElveen, Jane; Sewell, Herbert F.; Chapman, Caroline J.; Robertson, John F. R.] Oncimmune Ltd, City Hosp Nottingham, Nottingham, England; [Robertson, Chris] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Sewell, Herbert F.; Chapman, Caroline J.; Robertson, John F. R.] Univ Nottingham, Ctr Excellence Autoimmun Canc, Nottingham NG7 2RD, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Strathclyde; University of Nottingham	Macdonald, IK (corresponding author), Oncimmune Ltd, City Hosp Nottingham, Nottingham, England.	Isabel.Macdonald@nottingham.ac.uk		Allen, Jared/0000-0002-4061-3704	Oncimmune	Oncimmune	This work was funded by Oncimmune. The funders had no role to play in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BALDWIN RW, 1966, INT J CANCER, V1, P257, DOI 10.1002/ijc.2910010305; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Canelle L, 2005, J IMMUNOL METHODS, V299, P77, DOI 10.1016/j.jim.2005.01.015; Chapman CJ, 2012, TUMOR BIOL      0411; Desmetz C, 2011, J CELL MOL MED, V15, P2013, DOI 10.1111/j.1582-4934.2011.01355.x; Geyer C, 1999, MARKOV CHAIN MONTE C, P241; HEMBROUGH TA, 1995, J CELL SCI, V108, P1071; Ingvarsson S, 1990, Semin Cancer Biol, V1, P359; Jett JR, 2011, J THORAC ONCOL, V6, pS1387; Krause P, 2003, J IMMUNOL METHODS, V283, P261, DOI 10.1016/j.jim.2003.09.014; Lam S, 2011, CANCER PREV RES, V4, P1126, DOI 10.1158/1940-6207.CAPR-10-0328; Lee KH, 2003, ARTHRITIS RHEUM, V48, P2025, DOI 10.1002/art.11074; Leong AS-Y, 2003, MANUAL DIAGNOSTIC CY, P177; Macdonald IK, 2012, DEV VALIDATION HIGH; MOLL R, 1993, DIFFERENTIATION, V53, P75, DOI 10.1111/j.1432-0436.1993.tb00648.x; MOLL R, 1992, AM J PATHOL, V140, P427; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; Moriya T, 2006, MED MOL MORPHOL, V39, P8, DOI 10.1007/s00795-006-0309-8; Murray A, 2010, ANN ONCOL, V21, P1687, DOI 10.1093/annonc/mdp606; Nahm DH, 2006, J ALLERGY CLIN IMMUN, V118, P376, DOI 10.1016/j.jaci.2006.04.002; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Parsy CB, 2007, J CHROMATOGR B, V853, P314, DOI 10.1016/j.jchromb.2007.03.046; ROBERTSON NG, 1991, NUCLEIC ACIDS RES, V19, P3129, DOI 10.1093/nar/19.11.3129; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; van Klaveren R J, 2009, Eur J Cancer, V45 Suppl 1, P375, DOI 10.1016/S0959-8049(09)70054-1; Yoneda M, 2007, J NEUROIMMUNOL, V185, P195, DOI 10.1016/j.jneuroim.2007.01.018	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51002	10.1371/journal.pone.0051002	http://dx.doi.org/10.1371/journal.pone.0051002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272083	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600016
J	Miyadera, K; Brierley, I; Aguirre-Hernandez, J; Mellersh, CS; Sargan, DR				Miyadera, Keiko; Brierley, Ian; Aguirre-Hernandez, Jesus; Mellersh, Cathryn S.; Sargan, David R.			Multiple Mechanisms Contribute to Leakiness of a Frameshift Mutation in Canine Cone-Rod Dystrophy	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; MINIATURE LONGHAIRED DACHSHUND; TRANSCRIPTIONAL SLIPPAGE; ESCHERICHIA-COLI; GENE-THERAPY; RPGRIP1; IDENTIFICATION; SEQUENCES; PROTEIN; DNA	Mutations in RPGRIP1 are associated with early onset retinal degenerations in humans and dogs. Dogs homozygous for a 44 bp insertion including a polyA(29) tract potentially leading to premature truncation of the protein, show cone rod degeneration. This is rapid and blinding in a colony of dogs in which the mutation was characterised but in dogs with the same mutation in the pet population there is very variable disease severity and rate of progression. Objective: We hypothesized that this variability must be associated with leakiness of the RPGRIP1 mutation, allowing continued RPGRIP1 production. The study was designed to discover mechanisms that might allow such leakiness. Methods: We analysed alternate start sites and splicing of RPGRIP1 transcripts; variability of polyA(n) length in the insertion and slippage at polyA(n) during transcription/translation. Results and Significance: We observed a low rate of use of alternative start codons having potential to allow forms of transcript not including the insertion, with the possibility of encoding truncated functional RPGRIP1 protein isoforms. Complex alternative splicing was observed, but did not increase this potential. Variable polyA(n) length was confirmed in DNA from different RPGRIP1(-/-) dogs, yet polyA(n) variability did not correspond with the clinical phenotypes and no individual was found that carried a polyA(n) tract capable of encoding an in-frame variant. Remarkably though, in luciferase reporter gene assays, out-of-frame inserts still allowed downstream reporter gene expression at some 40% of the efficiency of in-frame controls. This indicates a major role of transcriptional or translational frameshifting in RPGRIP1 expression. The known slippage of reverse transcriptases as well as RNA polymerases and thermostable DNA polymerases on oligoA homopolymers meant that we could not distinguish whether the majority of slippage was transcriptional or translational. This leakiness at the mutation site may allow escape from severe effects of the mutation for some dogs.	[Miyadera, Keiko; Aguirre-Hernandez, Jesus; Sargan, David R.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Brierley, Ian] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Mellersh, Cathryn S.] Anim Hlth Trust, Canine Genet Sect, Newmarket, Suffolk, England	University of Cambridge; University of Cambridge; Animal Health Trust	Sargan, DR (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	drs20@cam.ac.uk	Miyadera, Keiko/AAQ-8196-2020; Aguirre-Hernandez, Jesus/M-7955-2018	Aguirre-Hernandez, Jesus/0000-0002-2715-6422; Sargan, David Richard/0000-0001-9897-2489	Kennel Club Charitable Trust; Japan Kennel Club; BBSRC [CCC55]; BBSRC [BBS/E/T/000PR6193, BB/G008205/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BB/G008205/1] Funding Source: researchfish	Kennel Club Charitable Trust; Japan Kennel Club; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from from the Kennel Club Charitable Trust (http://www.thekennelclub.org.uk/charitabletrust) and the Japan Kennel Club (http://www.jkc.or.jp/). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The sequencing study providing results in Table S1 was performed by The Genome Analysis Centre, supported by the BBSRC, grant CCC55. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson KF, 2004, NUCLEIC ACIDS RES, V32, P6327, DOI 10.1093/nar/gkh974; Boylan JP, 2000, HUM MOL GENET, V9, P2085, DOI 10.1093/hmg/9.14.2085; Brierley I, 2010, NUCLEIC ACIDS MOL BI, V24, P149, DOI 10.1007/978-0-387-89382-2_7; Castagnet P, 2003, HUM MOL GENET, V12, P1847, DOI 10.1093/hmg/ddg202; Chung DC, 2009, J AAPOS, V13, P587, DOI 10.1016/j.jaapos.2009.10.004; CURTIS R, 1993, BRIT VET J, V149, P71, DOI 10.1016/S0007-1935(05)80211-8; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Gerber S, 2001, EUR J HUM GENET, V9, P561, DOI 10.1038/sj.ejhg.5200689; Grentzmann G, 1998, RNA, V4, P479; Gurvich OL, 2003, EMBO J, V22, P5941, DOI 10.1093/emboj/cdg561; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Kelkar YD, 2010, GENOME BIOL EVOL, V2, P620, DOI 10.1093/gbe/evq046; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Kuznetsova T, 2011, INVEST OPHTH VIS SCI, V52, P2989, DOI 10.1167/iovs.10-6094; Larsen B, 2000, P NATL ACAD SCI USA, V97, P1683, DOI 10.1073/pnas.97.4.1683; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Lheriteau E, 2009, MOL VIS, V15, P349; Linton MF, 1997, J BIOL CHEM, V272, P14127, DOI 10.1074/jbc.272.22.14127; Lu XR, 2005, INVEST OPHTH VIS SCI, V46, P1882, DOI 10.1167/iovs.04-1286; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; Miyadera K, 2012, MAMM GENOME, V23, P212, DOI 10.1007/s00335-011-9384-9; Miyadera K, 2009, MOL VIS, V15, P2287; Paoloni-Giacobino A, 2001, HUM GENET, V109, P40, DOI 10.1007/s004390100541; Penno C, 2006, MOL MICROBIOL, V62, P1460, DOI 10.1111/j.1365-2958.2006.05456.x; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Strathern JN, 2012, BBA-GENE REGUL MECH, V1819, P694, DOI 10.1016/j.bbagrm.2012.02.005; Tamas I, 2008, P NATL ACAD SCI USA, V105, P14934, DOI 10.1073/pnas.0806554105; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Turney C, 2007, INVEST OPHTH VIS SCI, V48, P4240, DOI 10.1167/iovs.04-0737; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529; Zhou Y, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-95	34	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51598	10.1371/journal.pone.0051598	http://dx.doi.org/10.1371/journal.pone.0051598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251588	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200142
J	Wu, L; Yang, JZ				Wu, Liang; Yang, Jinzeng			Identifications of Captive and Wild Tilapia Species Existing in Hawaii by Mitochondrial DNA Control Region Sequence	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PACIFIC THREADFIN; MICROSATELLITE; HETEROCHROMATIN; HYBRIDIZATION; POPULATIONS; CHROMOSOMES; TELEOSTEI; MARKERS; AFRICA	Background: The tilapia family of the Cichlidae includes many fish species, which live in freshwater and saltwater environments. Several species, such as O. niloticus, O. aureus, and O. mossambicus, are excellent for aquaculture because these fish are easily reproduced and readily adapt to diverse environments. Historically, tilapia species, including O. mossambicus, S. melanotheron, and O. aureus, were introduced to Hawaii many decades ago, and the state of Hawaii uses the import permit policy to prevent O. niloticus from coming into the islands. However, hybrids produced from O. niloticus may already be present in the freshwater and marine environments of the islands. The purpose of this study was to identify tilapia species that exist in Hawaii using mitochondrial DNA analysis. Methodology/Principal Findings: In this study, we analyzed 382 samples collected from 13 farm (captive) and wild tilapia populations in Oahu and the Hawaii Islands. Comparison of intraspecies variation between the mitochondrial DNA control region (mtDNA CR) and cytochrome c oxidase I (COI) gene from five populations indicated that mtDNA CR had higher nucleotide diversity than COI. A phylogenetic tree of all sampled tilapia was generated using mtDNA CR sequences. The neighbor-joining tree analysis identified seven distinctive tilapia species: O. aureus, O. mossambicus, O. niloticus, S. melanotheron, O. urolepies, T. redalli, and a hybrid of O. massambicus and O. niloticus. Of all the populations examined, 10 populations consisting of O. aureus, O. mossambicus, O. urolepis, and O. niloticus from the farmed sites were relatively pure, whereas three wild populations showed some degree of introgression and hybridization. Conclusions/Significance: This DNA-based tilapia species identification is the first report that confirmed tilapia species identities in the wild and captive populations in Hawaii. The DNA sequence comparisons of mtDNA CR appear to be a valid method for tilapia species identification. The suspected tilapia hybrids that consist of O. niloticus are present in captive and wild populations in Hawaii.	[Wu, Liang; Yang, Jinzeng] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA; [Yang, Jinzeng] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China	University of Hawaii System; University of Hawaii Manoa; Huazhong Agricultural University	Yang, JZ (corresponding author), Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA.	jinzeng@hawaii.edu			Center for Tropical and Subtropical Aquaculture through a United States Department of Agriculture (USDA) [2010-38500-20948]; USDA Hatch Project [HAW00244-R]	Center for Tropical and Subtropical Aquaculture through a United States Department of Agriculture (USDA); USDA Hatch Project	This work was supported by Center for Tropical and Subtropical Aquaculture through a United States Department of Agriculture (USDA) grant (No. 2010-38500-20948) and the USDA Hatch Project (HAW00244-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese JF, 1999, J FISH BIOL, V54, P1119; B-Rao C, 1998, J FISH BIOL, V52, P1199, DOI 10.1111/j.1095-8649.1998.tb00966.x; Beardmore JA, 2001, AQUACULTURE, V197, P283, DOI 10.1016/S0044-8486(01)00590-7; Brummett RE, 2004, AQUACULTURE, V242, P157, DOI 10.1016/j.aquaculture.2004.01.036; Canapa A, 2002, CHROMOSOME RES, V10, P297, DOI 10.1023/A:1016519708187; Ch'ang MT, 1971, SOVIET GENETICS, V7, P1550; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; D'Amato ME, 2007, CONSERV GENET, V8, P475, DOI 10.1007/s10592-006-9186-x; Devick WS, 1991, NEW DIRECTIONS RES M, P199; Falk TM, 2003, MOL PHYLOGENET EVOL, V27, P81, DOI 10.1016/S1055-7903(02)00369-X; Gupta M. V., 2004, Aquaculture Asia Magazine, V9, P7; Hsieh CH, 2010, FOOD CHEM, V121, P1305, DOI 10.1016/j.foodchem.2010.02.004; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; Kyle CJ, 2007, FORENSIC SCI INT, V166, P68, DOI 10.1016/j.forsciint.2006.03.025; Laoong-u-thai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019959; Martins C, 2004, AQUACULTURE, V231, P37, DOI 10.1016/j.aquaculture.2003.08.017; Nagl S, 2001, MOL PHYLOGENET EVOL, V20, P361, DOI 10.1006/mpev.2001.0979; Oliveira C, 1998, CHROMOSOME RES, V6, P205, DOI 10.1023/A:1009211701829; Pan G, 2010, INT J BIOL SCI, V6, P827; RANDALL JE, 1987, B MAR SCI, V41, P490; Rasmussen RS, 2009, J AGR FOOD CHEM, V57, P8379, DOI 10.1021/jf901618z; Romana-Eguia MRR, 2004, AQUACULTURE, V236, P131, DOI 10.1016/j.aquaculture.2004.01.026; Song HongMei, 2009, Chinese Journal of Agricultural Biotechnology, V6, P119, DOI 10.1017/S1479236209990258; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tave D, 1988, ICLARM C P, V15, P285; THORNE JL, 1991, J MOL EVOL, V33, P114, DOI 10.1007/BF02193625; TREWAVAS E, 1982, AQUACULTURE, V27, P79, DOI 10.1016/0044-8486(82)90112-0; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Wang H, 2010, J WORLD AQUACULT SOC, V41, P640, DOI 10.1111/j.1749-7345.2010.00405.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Watanabe WO, 1997, SALTWATER CULTURE FL, V1, P54; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]; Zhang JB, 2011, BIOCHEM SYST ECOL, V39, P31, DOI 10.1016/j.bse.2010.12.017	34	21	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51731	10.1371/journal.pone.0051731	http://dx.doi.org/10.1371/journal.pone.0051731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251613	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200159
J	Yang, XL; Wu, F; Lin, XL; Du, XQ; Chong, K; Gramzow, L; Schilling, S; Becker, A; Theissen, G; Meng, Z				Yang, Xuelian; Wu, Feng; Lin, Xuelei; Du, Xiaoqiu; Chong, Kang; Gramzow, Lydia; Schilling, Susanne; Becker, Annette; Theissen, Guenter; Meng, Zheng			Live and Let Die - The B-sister MADS-Box Gene OsMADS29 Controls the Degeneration of Cells in Maternal Tissues during Seed Development of Rice (Oryza sativa)	PLOS ONE			English	Article							PHYLOGENETIC INFERENCE; DEATH; DNA; PROTEIN; FAMILY; PLANT; EVOLUTION; CARYOPSIS; NUCELLUS; IDENTITY	B-sister genes have been identified as the closest relatives of class B floral homeotic genes. Previous studies have shown that B-sister genes from eudicots are involved in cell differentiation during ovule and seed development. However, the complete function of B-sister genes in eudicots is masked by redundancy with other genes and little is known about the function of B-sister genes in monocots, and about the evolution of B-sister gene functions. Here we characterize OsMADS29, one of three MADS-box B-sister genes in rice. Our analyses show that OsMADS29 is expressed in female reproductive organs including the ovule, ovule vasculature, and the whole seed except for the outer layer cells of the pericarp. Knock-down of OsMADS29 by double-stranded RNA-mediated interference (RNAi) results in shriveled and/or aborted seeds. Histological analyses of the abnormal seeds at 7 days after pollination (DAP) indicate that the symplastic continuity, including the ovular vascular trace and the nucellar projection, which is the nutrient source for the filial tissue at early development stages, is affected. Moreover, degeneration of all the maternal tissues in the transgenic seeds, including the pericarp, ovular vascular trace, integuments, nucellar epidermis and nucellar projection, is blocked as compared to control plants. Our results suggest that OsMADS29 has important functions in seed development of rice by regulating cell degeneration of maternal tissues. Our findings provide important insights into the ancestral function of B-sister genes.	[Yang, Xuelian; Wu, Feng; Lin, Xuelei; Du, Xiaoqiu; Chong, Kang; Meng, Zheng] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Yang, Xuelian; Lin, Xuelei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Gramzow, Lydia; Schilling, Susanne; Theissen, Guenter] Univ Jena, Dept Genet, Jena, Germany; [Becker, Annette] Univ Giessen, Plant Evo Devo Grp, Inst Bot, D-35390 Giessen, Germany	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Friedrich Schiller University of Jena; Justus Liebig University Giessen	Theissen, G (corresponding author), Univ Jena, Dept Genet, Jena, Germany.	guenter.theissen@uni-jena.de; zhmeng@ibcas.ac.cn	Becker, Annette/F-2355-2014; Becker, Annette/AAD-5156-2019	Becker, Annette/0000-0002-3229-2162; Becker, Annette/0000-0002-3229-2162; Gramzow, Lydia/0000-0003-1919-6077; Lin, Xuelei/0000-0002-7472-5202	Ministry of Science and Technology of China [2011CB100405, 2011ZX08009-004]; National Nature Science Foundation of China [31100867, 31121065]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Ministry of Science and Technology of China (grants 2011CB100405; 2011ZX08009-004) and National Nature Science Foundation of China (grants 31100867 and 31121065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Becker A, 2000, MOL BIOL EVOL, V17, P1425, DOI 10.1093/oxfordjournals.molbev.a026243; Becker A, 2002, MOL GENET GENOMICS, V266, P942, DOI 10.1007/s00438-001-0615-8; Cho SC, 1999, PLANT MOL BIOL, V40, P419, DOI 10.1023/A:1006273127067; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; de Folter S, 2006, PLANT J, V47, P934, DOI 10.1111/j.1365-313X.2006.02846.x; Deng MJ, 2011, FEBS J, V278, P4797, DOI 10.1111/j.1742-4658.2011.08380.x; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dominguez F, 2001, PLANTA, V213, P352, DOI 10.1007/s004250000517; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Erdmann R, 2010, PLANT J, V63, P914, DOI 10.1111/j.1365-313X.2010.04290.x; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; Fujita M, 2010, PLANT CELL PHYSIOL, V51, P2060, DOI 10.1093/pcp/pcq165; Fukuda H, 1997, CELL DEATH DIFFER, V4, P684, DOI 10.1038/sj.cdd.4400310; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; Hoshikawa K., 1993, SCI RICE PLANT, P339; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jwa NS, 2001, BIOCHEM BIOPH RES CO, V286, P973, DOI 10.1006/bbrc.2001.5507; Kaufmann K, 2005, MOL GENET GENOMICS, V274, P103, DOI 10.1007/s00438-005-0010-y; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Krishnan S, 2003, J BIOSCIENCES, V28, P455, DOI 10.1007/BF02705120; Lee S, 2003, PLANT CELL PHYSIOL, V44, P1403, DOI 10.1093/pcp/pcg156; Mizzotti C, 2012, PLANT J, V70, P409, DOI 10.1111/j.1365-313X.2011.04878.x; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Ohmori S, 2009, PLANT CELL, V21, P3008, DOI 10.1105/tpc.109.068742; OPARKA KJ, 1984, PLANT GROWTH REGUL, V2, P297, DOI 10.1007/BF00027289; OPARKA KJ, 1981, PLANTA, V151, P561, DOI 10.1007/BF00387436; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prasad K, 2010, PLANT J, V62, P203, DOI 10.1111/j.1365-313X.2010.04139.x; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Radchuk V, 2011, J EXP BOT, V62, P1217, DOI 10.1093/jxb/erq348; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Riechmann JL, 1997, BIOL CHEM, V378, P1079; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Yamada K, 2009, PLANT MOL BIOL, V71, P1, DOI 10.1007/s11103-009-9504-z; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854; Zhou ZQ, 2009, PROTOPLASMA, V236, P49, DOI 10.1007/s00709-009-0046-7	48	52	60	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51435	10.1371/journal.pone.0051435	http://dx.doi.org/10.1371/journal.pone.0051435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251532	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200107
J	Choudhury, KR; Raychaudhuri, S; Bhattacharyya, NP				Choudhury, Kamalika Roy; Raychaudhuri, Swasti; Bhattacharyya, Nitai P.			Identification of HYPK-Interacting Proteins Reveals Involvement of HYPK in Regulating Cell Growth, Cell Cycle, Unfolded Protein Response and Cell Death	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; HUNTINGTONS-DISEASE; MOLECULAR CHAPERONES; EMBRYONIC LETHALITY; COMPLEX; AGGREGATION; APOPTOSIS; DISORDER; NETWORK; REPEAT	Huntingtin Yeast Two-Hybrid Protein K (HYPK) is an intrinsically unstructured huntingtin (HTT)-interacting protein with chaperone-like activity. To obtain more information about the function(s) of the protein, we identified 27 novel interacting partners of HYPK by pull-down assay coupled with mass spectrometry and, further, 9 proteins were identified by co-localization and co-immunoprecipitation (co-IP) assays. In neuronal cells, (EEF1A1 and HSPA1A), (HTT and LMNB2) and (TP53 and RELA) were identified in complex with HYPK in different experiments. Various Gene Ontology (GO) terms for biological processes, like protein folding (GO: 0006457), response to unfolded protein (GO: 0006986), cell cycle arrest (GO: 0007050), anti-apoptosis (GO: 0006916) and regulation of transcription (GO: 0006355) were significantly enriched with the HYPK-interacting proteins. Cell growth and the ability to refold heat-denatured reporter luciferase were decreased, but cytotoxicity was increased in neuronal cells where HYPK was knocked-down using HYPK antisense DNA construct. The proportion of cells in different phases of cell cycle was also altered in cells with reduced levels of HYPK. These results show that HYPK is involved in several biological processes, possibly through interaction with its partners.	[Choudhury, Kamalika Roy; Raychaudhuri, Swasti; Bhattacharyya, Nitai P.] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India	Saha Institute of Nuclear Physics	Bhattacharyya, NP (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India.	nitai_sinp@yahoo.com	Raychaudhuri, Swasti/AAZ-2748-2020	Roy Choudhury, Kamalika/0000-0003-1298-9875	Department of Atomic Energy (DAE), Govt. of India	Department of Atomic Energy (DAE), Govt. of India(Department of Atomic Energy (DAE))	The Department of Atomic Energy (DAE), Govt. of India, funded this work as Institutional grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza A, 2003, J BIOL CHEM, V278, P27844, DOI 10.1074/jbc.M304522200; Arnesen T, 2010, MOL CELL BIOL, V30, P1898, DOI 10.1128/MCB.01199-09; Bao J, 1996, P NATL ACAD SCI USA, V93, P5037, DOI 10.1073/pnas.93.10.5037; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Bhattacharya D, 2010, PROTEOM CLIN APPL, V4, P480, DOI 10.1002/prca.200900073; Bhattacharyya NP, 2011, HUNTINGTIN INTERACTI, P39; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Ghose J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023837; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; Helmbrecht K, 2000, CELL PROLIFERAT, V33, P341, DOI 10.1046/j.1365-2184.2000.00189.x; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Majumder P, 2007, CELL MOL NEUROBIOL, V27, P1127, DOI 10.1007/s10571-007-9220-7; Mitsui K, 2002, J NEUROSCI, V22, P9267; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Novoselova TV, 2005, J NEUROCHEM, V94, P597, DOI 10.1111/j.1471-4159.2005.03119.x; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Raychaudhuri S, 2008, PROTEINS, V71, P1686, DOI 10.1002/prot.21856; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040727; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	40	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51415	10.1371/journal.pone.0051415	http://dx.doi.org/10.1371/journal.pone.0051415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23272104	gold, Green Submitted, Green Published			2022-12-27	WOS:000312201900083
J	Liu, CL; Gao, M; Jin, GZ; Zhen, XC				Liu, Chang-Liang; Gao, Ming; Jin, Guo-Zhang; Zhen, Xuechu			GABA Neurons in the Ventral Tegmental Area Responding to Peripheral Sensory Input	PLOS ONE			English	Article							DOPAMINE NEURONS; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; REWARD; INHIBITION; VTA; PREPULSES; RESPONSES; DISRUPTS; PROJECT	Dopamine (DA) neurons in the ventral tegmental area (VTA) not only participate in reward processing, but also respond to aversive stimuli. Although GABA neurons in this area are actively involved in regulating the firing of DA neurons, few data exist concerning the responses of these neurons to aversive sensory input. In this study, by employing extracellular single-unit recording and spectral analysis techniques in paralyzed and ventilated rats, we found that the firing pattern in 44% (47 of 106) of GABA cells in the VTA was sensitive to the sensory input produced by the ventilation, showing a significant ventilation-associated oscillation in the power spectra. Detailed studies revealed that most ventilation-sensitive GABA neurons (38 of 47) were excited by the stimuli, whereas most ventilation-sensitive DA neurons (11 of 14) were inhibited. When the animals were under anesthesia or the sensory pathways were transected, the ventilation-associated oscillation failed to appear. Systemic administration of non-competitive N-methyl-D-aspartase (NMDA) receptor antagonist MK-801 completely disrupted the association between the firing of GABA neurons and the ventilation. Interestingly, local MK-801 injection into the VTA dramatically enhanced the sensitivity of GABA neurons to the ventilation. Our data demonstrate that both GABA and DA neurons in the VTA can be significantly modulated by sensory input produced by the ventilation, which may indicate potential functional roles of VTA in processing sensation-related input.	[Liu, Chang-Liang; Gao, Ming; Jin, Guo-Zhang; Zhen, Xuechu] Chinese Acad Sci, Dept Pharmacol, State Key Lab Drug Res, Shanghai Inst Biol Sci,Inst Mat Med, Shanghai, Peoples R China; [Zhen, Xuechu] Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Suzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Soochow University - China	Zhen, XC (corresponding author), Chinese Acad Sci, Dept Pharmacol, State Key Lab Drug Res, Shanghai Inst Biol Sci,Inst Mat Med, Shanghai, Peoples R China.	xczhen@mail.shcnc.ac.cn	Liu, Changliang/H-6531-2017	Liu, Changliang/0000-0002-0915-8408; zhen, xuechu/0000-0001-7458-2566	National Basic Research Program of China [2009CB522000, 2011CB5C4403]; National Natural Science Foundation of China [30825042, 81130023]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	The authors gratefully acknowledge the financial support from National Basic Research Program of China (2009CB522000, 2011CB5C4403) and the National Natural Science Foundation of China (30825042, 81130023). The support from the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions is also appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DW, 2006, SYNAPSE, V60, P20, DOI 10.1002/syn.20272; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; CAMPEAU S, 1995, PSYCHOPHARMACOLOGY, V117, P267, DOI 10.1007/BF02246101; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; DAVIS M, 1990, PSYCHOPHARMACOLOGY, V102, P1, DOI 10.1007/BF02245735; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; Gao M, 2007, J NEUROSCI, V27, P5414, DOI 10.1523/JNEUROSCI.5347-06.2007; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lee RS, 2001, J NEUROSCI, V21, P1757; LEMOAL M, 1991, PHYSIOL REV, V71, P155, DOI 10.1152/physrev.1991.71.1.155; Li W, 2012, J NEUROPHYSIOL; LJUNGBERG T, 1976, EXP NEUROL, V53, P585, DOI 10.1016/0014-4886(76)90140-0; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; MARSHALL JF, 1980, J COMP PHYSIOL PSYCH, V94, P833, DOI 10.1037/h0077825; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; NAGAI T, 1983, J COMP NEUROL, V218, P220, DOI 10.1002/cne.902180209; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011	34	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51507	10.1371/journal.pone.0051507	http://dx.doi.org/10.1371/journal.pone.0051507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251560	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900095
J	Lorenzi, V; Earley, RL; Grober, MS				Lorenzi, Varenka; Earley, Ryan L.; Grober, Matthew S.			Differential Responses of Brain, Gonad and Muscle Steroid Levels to Changes in Social Status and Sex in a Sequential and Bidirectional Hermaphroditic Fish	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; GROUPER EPINEPHELUS-MERRA; GOBY LYTHRYPNUS-DALLI; AROMATASE-ACTIVITY; PLASMA-CONCENTRATIONS; STOPLIGHT PARROTFISH; TESTOSTERONE LEVELS; PROTOGYNOUS WRASSE; MELOSPIZA-MELODIA; SPARISOMA-VIRIDE	Sex steroids can both modulate and be modulated by behavior, and their actions are mediated by complex interactions among multiple hormone sources and targets. While gonadal steroids delivered via circulation can affect behavior, changes in local brain steroid synthesis also can modulate behavior. The relative steroid load across different tissues and the association of these levels with rates of behavior have not been well studied. The bluebanded goby (Lythrypnus dalli) is a sex changing fish in which social status determines sexual phenotype. We examined changes in steroid levels in brain, gonad and body muscle at either 24 hours or 6 days after social induction of protogynous sex change, and from individuals in stable social groups not undergoing sex change. For each tissue, we measured levels of estradiol (E-2), testosterone (T) and 11-ketotestosterone (KT). Females had more T than males in the gonads, and more E-2 in all tissues but there was no sex difference in KT. For both sexes, E-2 was higher in the gonad than in other tissues while androgens were higher in the brain. During sex change, brain T levels dropped while brain KT increased, and brain E-2 levels did not change. We found a positive relationship between androgens and aggression in the most dominant females but only when the male was removed from the social group. The results demonstrate that steroid levels are responsive to changes in the social environment, and that their concentrations vary in different tissues. Also, we suggest that rapid changes in brain androgen levels might be important in inducing behavioral and/or morphological changes associated with protogynous sex change.	[Lorenzi, Varenka] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; Georgia State Univ, Ctr Behav Neurosci, Atlanta, GA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Lorenzi, V (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	varenka.lorenzi@csulb.edu			Center for Behavioral Neuroscience; STC Program of the NSF [IBN-9876754]; NSF [IBO-0548567]	Center for Behavioral Neuroscience; STC Program of the NSF; NSF(National Science Foundation (NSF))	This work was supported by the Center for Behavioral Neuroscience, an STC Program of the NSF under Agreement No. IBN-9876754 (to MSG and VL), and an NSF grant IBO-0548567 (to MSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON E, 1988, GEN COMP ENDOCR, V72, P394, DOI 10.1016/0016-6480(88)90161-X; AVVAKUMOV GV, 1986, BIOCHIM BIOPHYS ACTA, V881, P489, DOI 10.1016/0304-4165(86)90043-7; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Barnett LAK, 2009, MAR BIOL, V156, P301, DOI 10.1007/s00227-008-1084-y; BEHRENTS KC, 1983, THESIS U SO CALIFORN; Bhandari RK, 2006, ZOOL SCI, V23, P65, DOI 10.2108/zsj.23.65; Bhandari RK, 2005, J EXP ZOOL PART A, V303A, P497, DOI 10.1002/jez.a.178; Black MP, 2005, P ROY SOC B-BIOL SCI, V272, P2435, DOI 10.1098/rspb.2005.3210; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Caldwell JD, 2007, NEUROENDOCRINOLOGY, V86, P84, DOI 10.1159/000107072; CARDWELL JR, 1991, GEN COMP ENDOCR, V81, P7, DOI 10.1016/0016-6480(91)90120-U; CARDWELL JR, 1991, HORM BEHAV, V25, P1, DOI 10.1016/0018-506X(91)90035-G; Carlisle SL, 2000, J FISH BIOL, V57, P445, DOI 10.1006/jfbi.2000.1320; Cornil CA, 2006, BRAIN RES, V1126, P2, DOI 10.1016/j.brainres.2006.07.098; Davis ES, 2003, HORM BEHAV, V44, P185, DOI 10.1016/S0018-506X(03)00128-4; Desjardins JK, 2006, BEHAV ECOL, V17, P149, DOI 10.1093/beheco/arj018; Diotel N, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00137; Elekonich MM, 2000, ETHOLOGY, V106, P493, DOI 10.1046/j.1439-0310.2000.00555.x; Frisch Ashley, 2004, Reviews in Fish Biology and Fisheries, V14, P481, DOI 10.1007/s11160-005-3586-8; GODWIN JR, 1993, GEN COMP ENDOCR, V91, P144, DOI 10.1006/gcen.1993.1114; KAMEL F, 1975, HORM BEHAV, V6, P277, DOI 10.1016/0018-506X(75)90014-8; KOBAYASHI M, 1991, ZOOL SCI, V8, P389; Kroon FJ, 2003, J FISH BIOL, V62, P153, DOI 10.1046/j.1095-8649.2003.00017.x; Kroon FJ, 2000, GEN COMP ENDOCR, V118, P273, DOI 10.1006/gcen.2000.7459; Li GL, 2007, ANIM REPROD SCI, V99, P156, DOI 10.1016/j.anireprosci.2006.05.015; LILEY NR, 1986, GEN COMP ENDOCR, V62, P145, DOI 10.1016/0016-6480(86)90103-6; Lone KP, 2001, J FISH BIOL, V58, P305, DOI 10.1111/j.1095-8649.2001.tb02255.x; Lorenzi V, 2008, GEN COMP ENDOCR, V155, P438, DOI 10.1016/j.ygcen.2007.07.010; MACRIDES F, 1975, SCIENCE, V189, P1104, DOI 10.1126/science.1162363; MAYER I, 1990, GEN COMP ENDOCR, V79, P23, DOI 10.1016/0016-6480(90)90084-Y; Miguel-Queralt S, 2005, MOL CELL ENDOCRINOL, V229, P21, DOI 10.1016/j.mce.2004.10.004; Miguel-Queralt S, 2004, ENDOCRINOLOGY, V145, P5221, DOI 10.1210/en.2004-0678; NAKAMURA M, 1989, ENVIRON BIOL FISH, V24, P117, DOI 10.1007/BF00001282; Neat FC, 1999, J FISH BIOL, V54, P695, DOI 10.1111/j.1095-8649.1999.tb00649.x; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Newman AEM, 2008, GEN COMP ENDOCR, V155, P503, DOI 10.1016/j.ygcen.2007.08.007; Ohta K, 2001, ZOOL SCI, V18, P937, DOI 10.2108/zsj.18.937; Oliveira RF, 2002, COMP BIOCHEM PHYS B, V132, P203, DOI 10.1016/S1096-4959(01)00523-1; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; PASMANIK M, 1986, BIOL REPROD, V35, P838, DOI 10.1095/biolreprod35.4.838; PASMANIK M, 1985, GEN COMP ENDOCR, V60, P244, DOI 10.1016/0016-6480(85)90320-X; Pinxten R, 2003, HORM BEHAV, V44, P103, DOI 10.1016/S0018-506X(03)00120-X; Reavis Robert H., 1999, Acta Ethologica, V2, P51, DOI 10.1007/PL00012232; Remage-Healey L, 2005, HORM BEHAV, V47, P297, DOI 10.1016/j.yhbeh.2004.11.017; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Remage-Healey L, 2006, BRAIN RES, V1126, P27, DOI 10.1016/j.brainres.2006.06.049; Remage-Healey L, 2006, HORM BEHAV, V50, P432, DOI 10.1016/j.yhbeh.2006.05.007; Rodgers EW, 2007, J FISH BIOL, V70, P1660, DOI 10.1111/j.1095-8649.2007.01427.x; Saldanha CJ, 2011, ENDOCR REV, V32, P532, DOI 10.1210/er.2011-0004; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Schultz DR, 2005, J APPL ICHTHYOL, V21, P394, DOI 10.1111/j.1439-0426.2005.00650.x; SCHULZ R, 1991, GEN COMP ENDOCR, V82, P197, DOI 10.1016/0016-6480(91)90184-8; Taves Matthew D, 2011, Front Endocrinol (Lausanne), V2, P39, DOI 10.3389/fendo.2011.00039; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P417, DOI 10.1016/0016-6480(84)90084-4; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; YEUNG WSB, 1987, GEN COMP ENDOCR, V66, P353, DOI 10.1016/0016-6480(87)90244-9	56	29	30	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51158	10.1371/journal.pone.0051158	http://dx.doi.org/10.1371/journal.pone.0051158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251444	Green Published, gold			2022-12-27	WOS:000312201900048
J	Marzinelli, EM; Burrows, MT; Jackson, AC; Mayer-Pinto, M				Marzinelli, Ezequiel M.; Burrows, Michael T.; Jackson, Angus C.; Mayer-Pinto, Mariana			Positive and Negative Effects of Habitat-Forming Algae on Survival, Growth and Intra-Specific Competition of Limpets	PLOS ONE			English	Article							PLANT-HERBIVORE INTERACTIONS; INTERTIDAL ROCK-PLATFORM; PATELLA-VULGATA L.; NEW-SOUTH-WALES; INTERSPECIFIC COMPETITION; INTRASPECIFIC COMPETITION; FIELD EXPERIMENTS; CLIMATE-CHANGE; GASTROPODS; ABUNDANCE	Understanding the effects of environmental change on the distribution and abundance of strongly interacting organisms, such as intertidal macroalgae and their grazers, needs a thorough knowledge of their underpinning ecological relationships. Control of grazer-plant interactions is bi-directional on northwestern European coasts: grazing by limpets structures populations of macroalgae, while macroalgae provide habitat and food for limpets. Scottish shores dominated by the macroalga Fucus vesiculosus support lower densities and larger sizes of limpets Patella vulgata than shores with less Fucus. These patterns may be due to differences in inter-size-class competitive interactions of limpets among shores with different covers of Fucus. To examine this model, densities of small and large limpets were manipulated in plots with and without Fucus. Amounts of biofilm were measured in each plot. The presence of Fucus increased survival but hindered growth of small (15 mm TL) limpets, which were negatively affected by the presence of large limpets (31 mm TL). In contrast, large limpets were not affected by the presence of Fucus or of small limpets. This suggests the occurrence of asymmetric inter-size-class competition, which was influenced by the presence of macroalgae. Macroalgae and increased densities of limpets did not influence amounts of biofilm. Our findings highlight the role of interactions among organisms in generating ecological responses to environmental change.	[Marzinelli, Ezequiel M.; Mayer-Pinto, Mariana] Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Sydney, NSW 2006, Australia; [Burrows, Michael T.] Scottish Marine Inst, Scottish Assoc Marine Sci, Dept Ecol, Oban, Argyll, Scotland; [Jackson, Angus C.] Univ Highlands & Isl, N Highland Coll, Environm Res Inst, Thurso, Caithness, Scotland	University of Sydney; UHI Millennium Institute; UHI Millennium Institute	Marzinelli, EM (corresponding author), Univ New S Wales, Sydney Inst Marine Sci, Sydney, NSW, Australia.	e.marzinelli@unsw.edu.au	Marzinelli, Ezequiel/AAH-2906-2019; Burrows, Michael/ABF-4844-2020	Marzinelli, Ezequiel/0000-0002-3762-3389; Burrows, Michael/0000-0003-4620-5899; Mayer-Pinto, Mariana/0000-0001-9679-7023	Rhum Travelling Fellowship (EICC); International Postgraduate Award (University of Sydney); International Postgraduate Research Scholarship (Australian Government); Oceans 2025 programme; UK Natural Environment Research Council	Rhum Travelling Fellowship (EICC); International Postgraduate Award (University of Sydney)(University of Sydney); International Postgraduate Research Scholarship (Australian Government)(Australian Government); Oceans 2025 programme; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	EMM was supported by funds from the Rhum Travelling Fellowship (EICC), an International Postgraduate Award (University of Sydney) and an International Postgraduate Research Scholarship (Australian Government). MTB was supported by the Oceans 2025 programme funded by the UK Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boaventura D, 2003, J ANIM ECOL, V72, P435, DOI 10.1046/j.1365-2656.2003.00713.x; Boaventura D, 2002, J EXP MAR BIOL ECOL, V271, P171, DOI 10.1016/S0022-0981(02)00044-8; Branch G.M., 1981, Oceanography and Marine Biology an Annual Review, V19, P235; BURROWS MT, 1990, J ANIM ECOL, V59, P723, DOI 10.2307/4891; Chung IK, 2011, J APPL PHYCOL, V23, P877, DOI 10.1007/s10811-010-9604-9; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; CREESE RG, 1982, OECOLOGIA, V53, P337, DOI 10.1007/BF00389010; Darwin C, 1872, ORIGIN SPECIES; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Firth LB, 2009, GLOBAL CHANGE BIOL, V15, P1413, DOI 10.1111/j.1365-2486.2009.01863.x; FISCHERPIETTE E, 1958, CR HEBD ACAD SCI, V246, P1301; FLETCHER WJ, 1987, ECOLOGY, V68, P387, DOI 10.2307/1939270; FLETCHER WJ, 1987, ECOL MONOGR, V57, P89, DOI 10.2307/1942640; HARTNOLL RG, 1985, OPHELIA, V24, P53, DOI 10.1080/00785236.1985.10426619; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; HAWKINS SJ, 1983, OCEANOGR MAR BIOL, V21, P195; HILL AS, 1991, J MAR BIOL ASSOC UK, V71, P403, DOI 10.1017/S0025315400051675; Ivesa L, 2010, MAR ECOL PROG SER, V407, P55, DOI 10.3354/meps08539; Jackson AC, 2009, MAR ECOL PROG SER, V376, P153, DOI 10.3354/meps07807; Jenkins SR, 2001, MAR ECOL PROG SER, V211, P193, DOI 10.3354/meps211193; JERNAKOFF P, 1985, MAR ECOL PROG SER, V23, P71, DOI 10.3354/meps023071; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Mann KH, 2000, ECOLOGY COASTAL WATE; MARSHALL PA, 1994, J EXP MAR BIOL ECOL, V177, P121, DOI 10.1016/0022-0981(94)90147-3; Moore P, 2007, J EXP MAR BIOL ECOL, V344, P170, DOI 10.1016/j.jembe.2006.12.012; Moore P, 2007, MAR ECOL PROG SER, V334, P11, DOI 10.3354/meps334011; Morelissen B, 2007, J EXP MAR BIOL ECOL, V348, P162, DOI 10.1016/j.jembe.2007.04.006; Murphy RJ, 2009, J EXP MAR BIOL ECOL, V380, P68, DOI 10.1016/j.jembe.2009.09.002; Murphy RJ, 2006, MAR ECOL PROG SER, V312, P45, DOI 10.3354/meps312045; Murphy RJ, 2005, J EXP MAR BIOL ECOL, V316, P69, DOI 10.1016/j.jembe.2004.10.006; Notman G.M., 2011, COMP TROPHIC ECOLOGY; ORTON J. H., 1928, JOUR MARINE BIOL ASSOC, V15, P863; PALMER AR, 1982, MALACOLOGIA, V23, P63; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Silva ACF, 2008, J EXP MAR BIOL ECOL, V367, P259, DOI 10.1016/j.jembe.2008.10.010; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; SOUTHWARD A. J., 1964, GRAZING TERRESTRIAL, P265; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Thompson RC, 2000, HYDROBIOLOGIA, V440, P357, DOI 10.1023/A:1004116505004; Thompson RC, 2004, ECOLOGY, V85, P1372, DOI 10.1890/03-0279; Thompson RC, 1999, J MAR BIOL ASSOC UK, V79, P551, DOI 10.1017/S0025315498000678; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Underwood A.J., 1986, P240; Underwood A.J., 1979, Advances in Marine Biology, V16, P111, DOI 10.1016/S0065-2881(08)60293-X; UNDERWOOD AJ, 1983, OECOLOGIA, V56, P202, DOI 10.1007/BF00379692; UNDERWOOD AJ, 1984, J EXP MAR BIOL ECOL, V78, P199, DOI 10.1016/0022-0981(84)90159-X; UNDERWOOD AJ, 1978, OECOLOGIA, V33, P185, DOI 10.1007/BF00344847; UNDERWOOD AJ, 1984, OECOLOGIA, V64, P211, DOI 10.1007/BF00376873; UNDERWOOD AJ, 1976, J EXP MAR BIOL ECOL, V23, P145, DOI 10.1016/0022-0981(76)90138-6; UNDERWOOD AJ, 1992, SYST ASSOC SPEC VOL, V46, P443; UNDERWOOD AJ, 1997, GMAV 5 WINDOWS	53	9	9	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51601	10.1371/journal.pone.0051601	http://dx.doi.org/10.1371/journal.pone.0051601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251589	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900108
J	Suzuki, E; Yamamoto, E; Takao, S; Kawachi, I; Subramanian, SV				Suzuki, Etsuji; Yamamoto, Eiji; Takao, Soshi; Kawachi, Ichiro; Subramanian, S. V.			Clarifying the Use of Aggregated Exposures in Multilevel Models: Self-Included vs. Self-Excluded Measures	PLOS ONE			English	Article							FINNISH PUBLIC-SECTOR; P-ASTERISK MODELS; HEALTH RESEARCH; WORKPLACE REORGANIZATION; SOCIAL NETWORKS; INTERVENTIONS; EPIDEMIOLOGY; PREDICTOR; SMOKING; CONTEXT	Background: Multilevel analyses are ideally suited to assess the effects of ecological (higher level) and individual (lower level) exposure variables simultaneously. In applying such analyses to measures of ecologies in epidemiological studies, individual variables are usually aggregated into the higher level unit. Typically, the aggregated measure includes responses of every individual belonging to that group (i.e. it constitutes a self-included measure). More recently, researchers have developed an aggregate measure which excludes the response of the individual to whom the aggregate measure is linked (i.e. a self-excluded measure). In this study, we clarify the substantive and technical properties of these two measures when they are used as exposures in multilevel models. Methods: Although the differences between the two aggregated measures are mathematically subtle, distinguishing between them is important in terms of the specific scientific questions to be addressed. We then show how these measures can be used in two distinct types of multilevel models-self-included model and self-excluded model-and interpret the parameters in each model by imposing hypothetical interventions. The concept is tested on empirical data of workplace social capital and employees' systolic blood pressure. Results: Researchers assume group-level interventions when using a self-included model, and individual-level interventions when using a self-excluded model. Analytical re-parameterizations of these two models highlight their differences in parameter interpretation. Cluster-mean centered self-included models enable researchers to decompose the collective effect into its within-and between-group components. The benefit of cluster-mean centering procedure is further discussed in terms of hypothetical interventions. Conclusions: When investigating the potential roles of aggregated variables, researchers should carefully explore which type of model-self-included or self-excluded-is suitable for a given situation, particularly when group sizes are relatively small.	[Suzuki, Etsuji; Takao, Soshi] Okayama Univ, Dept Epidemiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Yamamoto, Eiji] Okayama Univ Sci, Fac Informat, Dept Informat Sci, Okayama, Japan; [Kawachi, Ichiro; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Okayama University; Okayama University of Science; Harvard University; Harvard T.H. Chan School of Public Health	Suzuki, E (corresponding author), Okayama Univ, Dept Epidemiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	etsuji-s@cc.okayama-u.ac.jp	Suzuki, Etsuji/B-2342-2011	Suzuki, Etsuji/0000-0002-1290-5793	Robert Wood Johnson Investigator Award in Health Policy Research; National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	Robert Wood Johnson Investigator Award in Health Policy Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SVS is supported by a Robert Wood Johnson Investigator Award in Health Policy Research and by a career development award from the National Institutes of Health (NHLBI K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambra C, 2007, J EPIDEMIOL COMMUN H, V61, P1028, DOI 10.1136/jech.2006.054999; Bingenheimer JB, 2004, ANNU REV PUBL HEALTH, V25, P53, DOI 10.1146/annurev.publhealth.25.050503.153925; Blakely T., 2006, METHODS SOCIAL EPIDE, P316; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P367, DOI 10.1136/jech.54.5.367; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; Desmarais BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030136; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Egan M, 2007, J EPIDEMIOL COMMUN H, V61, P945, DOI 10.1136/jech.2006.054965; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Kaufman J.S., 2008, MODERN EPIDEMIOLOGY, Vthird, P532; Kawachi I, 2008, SOCIAL CAPITAL HLTH, DOI [10.1007/978-0-387-71311-3_1, DOI 10.1007/978-0-387-71311-3_1]; Kawachi I, 2006, INT J EPIDEMIOL, V35, P989, DOI 10.1093/ije/dyl117; Kouvonen A, 2008, ADDICTION, V103, P1857, DOI 10.1111/j.1360-0443.2008.02315.x; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Lakon CM., 2008, SOCIAL CAPITAL HLTH, P63, DOI [10.1007/978-0-387-71311-3_4, DOI 10.1007/978-0-387-71311-3_4]; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Rasbash J., 2010, MLWIN VERSION 2 22; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Schempf AH, 2012, ANN EPIDEMIOL, V22, P683, DOI 10.1016/j.annepidem.2012.06.105; Schwartz S, 1999, ANNU REV PUBL HEALTH, V20, P15, DOI 10.1146/annurev.publhealth.20.1.15; Simpson SL, 2012, NEUROIMAGE, V60, P1117, DOI 10.1016/j.neuroimage.2012.01.071; Simpson SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020039; Subramanian S. V., 2003, Neighborhoods and health, P65; Subramanian SV, 2006, J GERONTOL B-PSYCHOL, V61, pS153, DOI 10.1093/geronb/61.3.S153; Subramanian SV, 2003, HEALTH PLACE, V9, P33, DOI 10.1016/S1353-8292(02)00028-X; Subramanian SV, 2007, MACROSOCIAL DETERMIN, P301, DOI DOI 10.1007/978-0-387-70812-6_15; Susser M, 1996, AM J PUBLIC HEALTH, V86, P674, DOI 10.2105/AJPH.86.5.674; Suzuki E, 2012, SOC SCI MED, V75, P452, DOI 10.1016/j.socscimed.2012.03.036; Suzuki E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-489; Suzuki E, 2010, SOC SCI MED, V70, P1367, DOI 10.1016/j.socscimed.2010.01.014	35	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51717	10.1371/journal.pone.0051717	http://dx.doi.org/10.1371/journal.pone.0051717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	052ML	23251609	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900115
J	Budczies, J; Klauschen, F; Sinn, BV; Gyorffy, B; Schmitt, WD; Darb-Esfahani, S; Denkert, C				Budczies, Jan; Klauschen, Frederick; Sinn, Bruno V.; Gyoerffy, Balazs; Schmitt, Wolfgang D.; Darb-Esfahani, Silvia; Denkert, Carsten			Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization	PLOS ONE			English	Article							TREATMENT-COVARIATE INTERACTIONS; 1 MESSENGER-RNA; ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; OPTIMAL CUTPOINTS; PROGNOSTIC-FACTOR; GENE-EXPRESSION; SURVIVAL; PREDICTOR; SUBSETS	Gene or protein expression data are usually represented by metric or at least ordinal variables. In order to translate a continuous variable into a clinical decision, it is necessary to determine a cutoff point and to stratify patients into two groups each requiring a different kind of treatment. Currently, there is no standard method or standard software for biomarker cutoff determination. Therefore, we developed Cutoff Finder, a bundle of optimization and visualization methods for cutoff determination that is accessible online. While one of the methods for cutoff optimization is based solely on the distribution of the marker under investigation, other methods optimize the correlation of the dichotomization with respect to an outcome or survival variable. We illustrate the functionality of Cutoff Finder by the analysis of the gene expression of estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer tissues. This distribution of these important markers is analyzed and correlated with immunohistologically determined ER status and distant metastasis free survival. Cutoff Finder is expected to fill a relevant gap in the available biometric software repertoire and will enable faster optimization of new diagnostic biomarkers. The tool can be accessed at http://molpath.charite.de/cutoff. Citation: Budczies J, Klauschen F, Sinn BV, Gyorffy B, Schmitt WD, et al. (2012) Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization. PLoS ONE 7(12): e51862. doi: 10.1371/journal.pone.0051862	[Budczies, Jan; Klauschen, Frederick; Sinn, Bruno V.; Schmitt, Wolfgang D.; Darb-Esfahani, Silvia; Denkert, Carsten] Charite, Inst Pathol, D-13353 Berlin, Germany; [Gyoerffy, Balazs] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hungarian Academy of Sciences	Budczies, J (corresponding author), Charite, Inst Pathol, D-13353 Berlin, Germany.	jan.budczies@charite.de	Klauschen, Frederick/C-5637-2015; Budczies, Jan/AAG-8122-2020; Schmitt, Wolfgang D/B-4729-2008; Gyorffy, Balazs/AAA-9135-2021; Denkert, Carsten/AHE-2675-2022	Klauschen, Frederick/0000-0002-9131-2389; Schmitt, Wolfgang D/0000-0002-7870-138X; Gyorffy, Balazs/0000-0002-5772-3766; Denkert, Carsten/0000-0002-2249-0982	European Commission within FP7 [200327, 257669]; OTKA, (Orszagos Tudomanyos Kutatasi Alap Hungarian National Scientific Research Fund) [PD 83154]	European Commission within FP7; OTKA, (Orszagos Tudomanyos Kutatasi Alap Hungarian National Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was funded by the European Commission within FP7, grants #200327 (METAcancer) and #257669 (ARROWS), and by OTKA, (Orszagos Tudomanyos Kutatasi Alap Hungarian National Scientific Research Fund) PD 83154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bonetti M, 2004, BIOSTATISTICS, V5, P465, DOI 10.1093/biostatistics/kxh002; Bonetti M, 2000, STAT MED, V19, P2595, DOI 10.1002/1097-0258(20001015)19:19<2595::AID-SIM562>3.0.CO;2-M; Bonetti M, 2009, STAT MED, V28, P1255, DOI 10.1002/sim.3524; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; CLARK GM, 1983, NEW ENGL J MED, V309, P1343, DOI 10.1056/NEJM198312013092240; Darb-Esfahani S, 2009, ENDOCR-RELAT CANCER, V16, P1229, DOI 10.1677/ERC-08-0338; Dorai-Raj S., 2009, BINOM BINOMIAL CONFI; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faraggi D, 1996, STAT MED, V15, P2203, DOI 10.1002/(SICI)1097-0258(19961030)15:20<2203::AID-SIM357>3.3.CO;2-7; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HALPERN J, 1982, BIOMETRICS, V38, P1017, DOI 10.2307/2529882; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HILSENBECK SG, 1992, BREAST CANCER RES TR, V22, P197, DOI 10.1007/BF01840833; KOZIOL JA, 1991, BIOMETRICS, V47, P1557, DOI 10.2307/2532406; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Leisch F, 2004, J STAT SOFTW, V11, P1, DOI DOI 10.18637/JSS.V011.I08; Lumley T, 2011, R PACKAGE VERSION, V2, P36, DOI DOI 10.HTTP://CRAN.R-PR0JECT.0RG/PACKAGE; Magdelenat H, 1982, Breast Cancer Res Treat, V2, P195, DOI 10.1007/BF01806456; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Muller BM, 2011, DIAGN MOL PATHOL, V20, P1, DOI 10.1097/PDM.0b013e3181e3630c; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; R Core Team, 2021, R LANGUAGE ENV STAT; REMMELE W, 1987, PATHOLOGE, V8, P138; Sinn BV, 2011, HISTOPATHOLOGY, V59, P918, DOI 10.1111/j.1365-2559.2011.04028.x; Sinn BV, 2009, VIRCHOWS ARCH, V455, P461, DOI 10.1007/s00428-009-0851-6; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Urbanek S, 2011, RSERVE BINARY R SERV; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; von Minckwitz G, 2011, J CLIN ONCOL, V29, P2150, DOI 10.1200/JCO.2010.31.9079; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	36	802	814	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51862	10.1371/journal.pone.0051862	http://dx.doi.org/10.1371/journal.pone.0051862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251644	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800100
J	Ferber, M; Zoete, V; Michielin, O				Ferber, Mathias; Zoete, Vincent; Michielin, Olivier			T-Cell Receptors Binding Orientation over Peptide/MHC Class I Is Driven by Long-Range Interactions	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FREE-ENERGY DECOMPOSITION; MOLECULAR-DYNAMICS METHOD; MHC COMPLEX; MM-GBSA; RECOGNITION; ASSOCIATION; SOLVATION; RESIDUES; WATER	Crystallographic data about T-Cell Receptor - peptide - major histocompatibility complex class I (TCRpMHC) interaction have revealed extremely diverse TCR binding modes triggering antigen recognition. Understanding the molecular basis that governs TCR orientation over pMHC is still a considerable challenge. We present a simplified rigid approach applied on all non-redundant TCRpMHC crystal structures available. The CHARMM force field in combination with the FACTS implicit solvation model is used to study the role of long-distance interactions between the TCR and pMHC. We demonstrate that the sum of the coulomb interactions and the electrostatic solvation energies is sufficient to identify two orientations corresponding to energetic minima at 0 degrees and 180 degrees from the native orientation. Interestingly, these results are shown to be robust upon small structural variations of the TCR such as changes induced by Molecular Dynamics simulations, suggesting that shape complementarity is not required to obtain a reliable signal. Accurate energy minima are also identified by confronting unbound TCR crystal structures to pMHC. Furthermore, we decompose the electrostatic energy into residue contributions to estimate their role in the overall orientation. Results show that most of the driving force leading to the formation of the complex is defined by CDR1,2/MHC interactions. This long-distance contribution appears to be independent from the binding process itself, since it is reliably identified without considering neither short-range energy terms nor CDR induced fit upon binding. Ultimately, we present an attempt to predict the TCR/pMHC binding mode for a TCR structure obtained by homology modeling. The simplicity of the approach and the absence of any fitted parameters make it also easily applicable to other types of macromolecular protein complexes.	[Ferber, Mathias; Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Lausanne, Switzerland; [Ferber, Mathias; Michielin, Olivier] Lausanne Univ Hosp CHUV, Multidisciplinary Oncol Ctr, Lausanne, Switzerland	Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Zoete, V (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	vincent.zoete@unil.ch; olivier.michielin@unil.ch	Michielin, Olivier/ABE-7924-2020		Swiss National Science Foundation [3200B0-103173]; OncoSuisse [OCS 01381-08-2003]; National Center of Competence in Research (NCCR); Swiss Institute of Bioinformatics	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); OncoSuisse; National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss Institute of Bioinformatics	Funding was provided by the Swiss National Science Foundation (Grant Number: 3200B0-103173), OncoSuisse (Grant Number: OCS 01381-08-2003), the National Center of Competence in Research (NCCR), and the Swiss Institute of Bioinformatics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2000, J MOL BIOL, V295, P979, DOI 10.1006/jmbi.1999.3358; ALMAGRO JC, 1995, PROTEIN SCI, V4, P1708, DOI 10.1002/pro.5560040906; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Cuendet MA, 2011, PROTEINS, V79, P3007, DOI 10.1002/prot.23104; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; Derre L, 2008, P NATL ACAD SCI USA, V105, P15010, DOI 10.1073/pnas.0807954105; Flower Darren R, 2010, Immunome Res, V6 Suppl 2, pS4, DOI 10.1186/1745-7580-6-S2-S4; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khan JM, 2011, BIOINFORMATICS, V27, P1192, DOI 10.1093/bioinformatics/btr104; Khan JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017194; Leimgruber A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026301; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Michielin O, 2000, J MOL BIOL, V300, P1205, DOI 10.1006/jmbi.2000.3788; Michielin O, 2002, J MOL BIOL, V324, P547, DOI 10.1016/S0022-2836(02)00880-X; Nose S, 2002, MOL PHYS, V100, P191, DOI 10.1080/00268970110089108; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Roomp K, 2011, MOL IMMUNOL, V48, P553, DOI 10.1016/j.molimm.2010.10.014; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Schamel WWA, 2007, P NATL ACAD SCI USA, V104, P16398, DOI 10.1073/pnas.0708462104; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Varani L, 2007, P NATL ACAD SCI USA, V104, P13080, DOI 10.1073/pnas.0703702104; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2010, J MOL RECOGNIT, V23, P142, DOI 10.1002/jmr.1005; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	41	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51943	10.1371/journal.pone.0051943	http://dx.doi.org/10.1371/journal.pone.0051943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251658	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800113
J	Karussis, D; Shor, H; Yachnin, J; Lanxner, N; Amiel, M; Baruch, K; Keren-Zur, Y; Haviv, O; Filippi, M; Petrou, P; Hajag, S; Vourka-Karussis, U; Vaknin-Dembinsky, A; Khoury, S; Abramsky, O; Atlan, H; Cohen, IR; Abulafia-Lapid, R				Karussis, Dimitrios; Shor, Hagai; Yachnin, Julia; Lanxner, Naama; Amiel, Merav; Baruch, Keren; Keren-Zur, Yael; Haviv, Ofra; Filippi, Massimo; Petrou, Panayiota; Hajag, Shalom; Vourka-Karussis, Urania; Vaknin-Dembinsky, Adi; Khoury, Salim; Abramsky, Oded; Atlan, Henri; Cohen, Irun R.; Abulafia-Lapid, Rivka			T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial	PLOS ONE			English	Article							MYELIN-BASIC-PROTEIN; AUTOIMMUNE ENCEPHALOMYELITIS; DEPLETION; RECOGNITION; RESPONSES; DISEASE	Background: T-cell vaccination (TCV) for multiple sclerosis (MS) refers to treatment with autologous anti-myelin T-cells, attenuated by irradiation. Previously published clinical trials have been all open-labeled. Aim: To evaluate the safety and efficacy of TCV in progressive MS, in a double-blind, controlled clinical trial. Methodology: Twenty-six patients with relapsing-progressive MS were enrolled in the study (mean age: 39 +/- 9.8 years; mean EDSS: 4.4 +/- 1.7). T-cell lines reactive to 9 different peptides of the myelin antigens, MBP, MOG and PLP were raised from the patients' peripheral blood. The patients were randomized into two groups: 19 were treated with TCV (four subcutaneous injections of 10-30 x 10(6) T-cells, attenuated by irradiation, on days 1, 30, 90 and 180) and 7 patients were treated with sham injections. Twenty-four patients (17 in the TCV group and 7 in the placebo) were eligible for per-protocol analysis. Results: At one year following the inclusion, an increase in the EDSS (+0.50) and an increase in 10-meter walking time (+0.18 sec), were observed in the placebo group; in the TCV group there was a decrease in the EDSS (-0.44; p<0.01) and in the 10-meter walking time (0.84 sec; p<0.005). Sixteen of the 17 patients (94.1%) in the TCV group remained relapse-free during the year of the study, as compared to 42.9% in the placebo group (p = 0.01 and p = 0.03 with adjustment). The proportion of patients with any relapse during the year of the study in the TCV-group, was reduced by 89.6%., as compared to the placebo-treated group. MRI parameters did not change significantly. Conclusions: This is the first controlled, double-blind trial with TCV in progressive MS. The results demonstrate the feasibility and safety of the procedure, and provide significant indications of clinical efficacy. Further studies with larger groups of subjects are warranted.	[Karussis, Dimitrios; Petrou, Panayiota; Hajag, Shalom; Vourka-Karussis, Urania; Vaknin-Dembinsky, Adi; Khoury, Salim; Abramsky, Oded] Hadassah Hebrew Univ Hosp, Dept Neurol, MS Ctr, Jerusalem, Israel; [Karussis, Dimitrios; Petrou, Panayiota; Hajag, Shalom; Vourka-Karussis, Urania; Vaknin-Dembinsky, Adi; Khoury, Salim; Abramsky, Oded] Hadassah Hebrew Univ Hosp, Agnes Ginges Ctr Neurogenet, Jerusalem, Israel; [Shor, Hagai; Yachnin, Julia; Lanxner, Naama; Amiel, Merav; Baruch, Keren; Keren-Zur, Yael; Haviv, Ofra; Atlan, Henri; Abulafia-Lapid, Rivka] Hadassah Hebrew Univ Hosp, Human Biol Res Ctr, Dept Biophys & Nucl Med, Jerusalem, Israel; [Filippi, Massimo] Hosp San Raffaele, MS Ctr, I-20132 Milan, Italy; [Cohen, Irun R.] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Weizmann Institute of Science	Karussis, D (corresponding author), Hadassah Hebrew Univ Hosp, Dept Neurol, MS Ctr, Jerusalem, Israel.	karus@cc.huji.ac.il; rivka_abulafia@yahoo.com	Haggiag, Shalom/AAL-8385-2021; Filippi, Massimo/K-1755-2018	Haggiag, Shalom/0000-0002-5569-4121; Filippi, Massimo/0000-0002-5485-0479	I. Horowitz Association; Institute for Advanced Therapy, New York, New York, United States of America	I. Horowitz Association; Institute for Advanced Therapy, New York, New York, United States of America	This work was supported by grants from the I. Horowitz Association and the Institute for Advanced Therapy, New York, New York, United States of America. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achiron A, 2004, CLIN IMMUNOL, V113, P155, DOI 10.1016/j.clim.2004.06.004; Achiron A, 1998, NEUROLOGY, V50, P398, DOI 10.1212/WNL.50.2.398; BENNUN A, 1981, NATURE, V292, P60, DOI 10.1038/292060a0; Buenafe AC, 2004, J NEUROSCI RES, V76, P129, DOI 10.1002/jnr.20066; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Correale J, 2000, J NEUROIMMUNOL, V107, P130, DOI 10.1016/S0165-5728(00)00235-6; Hellings N, 2004, AUTOIMMUN REV, V3, P267, DOI 10.1016/j.autrev.2003.10.002; Hellings N, 2002, IMMUNOL RES, V25, P27, DOI 10.1385/IR:25:1:27; Hermans G, 1999, J AUTOIMMUN, V13, P233, DOI 10.1006/jaut.1999.0314; Hermans G, 2000, J NEUROIMMUNOL, V102, P79, DOI 10.1016/S0165-5728(99)00157-5; Hong J, 2006, P NATL ACAD SCI USA, V103, P5024, DOI 10.1073/pnas.0508784103; Jiang H, 1998, P NATL ACAD SCI USA, V95, P4533, DOI 10.1073/pnas.95.8.4533; LIDER O, 1988, SCIENCE, V239, P181, DOI 10.1126/science.2447648; MEDAER R, 1995, LANCET, V346, P807, DOI 10.1016/S0140-6736(95)91622-9; Mimran A, 2005, INT REV IMMUNOL, V24, P159, DOI 10.1080/08830180590934949; Quintana FJ, 2006, SCAND J IMMUNOL, V64, P205, DOI 10.1111/j.1365-3083.2006.01807.x; Quintana FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004026; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stinissen P, 1996, J NEUROSCI RES, V45, P500; Vandenbark AA, 2008, BIODRUGS, V22, P265, DOI 10.2165/00063030-200822040-00006; Vandenbark AA, 2008, IMMUNOLOGY, V123, P66, DOI 10.1111/j.1365-2567.2007.02703.x; Zang YCQ, 2000, EUR J IMMUNOL, V30, P908, DOI 10.1002/1521-4141(200003)30:3<908::AID-IMMU908>3.0.CO;2-1; Zang YCQ, 2000, J IMMUNOL, V164, P4011, DOI 10.4049/jimmunol.164.8.4011; ZHANG JW, 1993, SCIENCE, V261, P1451, DOI 10.1126/science.7690157; Zhang JZ, 2002, J NEUROL, V249, P212, DOI 10.1007/PL00007867	25	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50478	10.1371/journal.pone.0050478	http://dx.doi.org/10.1371/journal.pone.0050478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272061	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800013
J	Mishra, SK; Funair, L; Cressley, A; Gittes, GK; Burns, RC				Mishra, Sanjay K.; Funair, Lacey; Cressley, Alex; Gittes, George K.; Burns, R. Cartland			High-Affinity Dkk1 Receptor Kremen1 Is Internalized by Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN; DISABLED-2 DAB2; BETA-CATENIN; AP2 COMPLEX; COATED PITS; AP-2; CARGO; ADAPTERS; BINDING; CELLS	Kremens are high-affinity receptors for Dickkopf 1 (Dkk1) and regulate the Wnt/beta-catenin signaling pathway by down-regulating the low-density lipoprotein receptor-related protein 6 (LRP6). Dkk1 competes with Wnt for binding to LRP6; binding of Dkk1 inhibits canonical signaling through formation of a ternary complex with Kremen. The majority of downregulated clathrin-mediated endocytic receptors contain short conserved regions that recognize tyrosine or dileucine sorting motifs. In this study, we found that Kremen1 is internalized from the cell surface in a clathrin-dependent manner. Kremen1 contains an atypical dileucine motif with the sequence DXXXLV. Mutation of LV to AA in this motif blocked Kremen1 internalization; as reported previously for other proteins, the aspartic acid residue in Kremen1 is not critical. Inhibition of expression of the adaptor protein 2 (AP-2) or inhibition of clathrin by pitstop 2 also blocked Kremen1 internalization. The novel amino acid sequence identified in Kremen1 is similar to the motif previously identified in hydra, yeast, and other organisms known to signal from the trans-Golgi network to the endosomal compartment. Citation: Mishra SK, Funair L, Cressley A, Gittes GK, Burns RC (2012) High-Affinity Dkk1 Receptor Kremen1 Is Internalized by Clathrin-Mediated Endocytosis. PLoS ONE 7(12): e52190. doi:10.1371/journal.pone.0052190	[Mishra, Sanjay K.; Funair, Lacey; Cressley, Alex; Gittes, George K.] Childrens Hosp Pittsburgh, Dept Pediat Surg, Pittsburgh, PA 15213 USA; [Burns, R. Cartland] Nemours Childrens Hosp, Div Pediat Gen & Thorac Surg, Orlando, FL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mishra, SK (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat Surg, Pittsburgh, PA 15213 USA.	skm25@pitt.edu; Cartland.Burns@nemours.org			Children's Hospital of Pittsburgh; National Institute of Health [R01DK064952, R01DK83541-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064952, R01DK083541] Funding Source: NIH RePORTER	Children's Hospital of Pittsburgh; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Children's Hospital of Pittsburgh, and G.K.G. was supported by funding from National Institute of Health (R01DK064952 and R01DK83541-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Davidson G, 2002, DEVELOPMENT, V129, P5587, DOI 10.1242/dev.00154; Declercq J, 2012, J BIOL CHEM, V287, P9052, DOI 10.1074/jbc.M111.306407; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jiang Y, 2012, EMBO J, V31, P2336, DOI 10.1038/emboj.2012.83; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kestler HA, 2011, J CELL BIOL, V193, P431, DOI 10.1083/jcb.201103167; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kikuchi A, 2007, J BIOCHEM, V141, P443, DOI 10.1093/jb/mvm061; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Mishra SK, 2008, J CELL SCI, V121, P1264, DOI 10.1242/jcs.025833; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MURPHY JE, 1992, J BIOL CHEM, V267, P10850; Nakamura T, 2008, J CELL MOL MED, V12, P391, DOI 10.1111/j.1582-4934.2007.00201.x; Nakamura T, 2001, BBA-GENE STRUCT EXPR, V1518, P63, DOI 10.1016/S0167-4781(01)00168-3; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	48	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52190	10.1371/journal.pone.0052190	http://dx.doi.org/10.1371/journal.pone.0052190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251700	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800151
J	Rhedin, S; Hamrin, J; Naucler, P; Bennet, R; Rotzen-Ostlund, M; Farnert, A; Eriksson, M				Rhedin, Samuel; Hamrin, Johan; Naucler, Pontus; Bennet, Rutger; Rotzen-Ostlund, Maria; Farnert, Anna; Eriksson, Margareta			Respiratory Viruses in Hospitalized Children with Influenza-Like Illness during the H1n1 2009 Pandemic in Sweden	PLOS ONE			English	Article							A H1N1; RHINOVIRUS; INFECTIONS; SYMPTOMS	Background: The swine-origin influenza A(H1N1)pdm09 pandemic of 2009 had a slower spread in Europe than expected. The human rhinovirus (HRV) has been suggested to have delayed the pandemic through viral interference. The importance of co-infections over time during the pandemic and in terms of severity of the disease needs to be assessed. Objective: The aim of this study was to investigate respiratory viruses and specifically the presence of co-infections with influenza A(H1N1) pdm09 (H1N1) in hospitalized children during the H1N1 pandemic. A secondary aim was to investigate if co-infections were associated with severity of disease. Methods: A retrospective study was performed on 502 children with influenza-like illness admitted to inpatient care at a pediatric hospital in Stockholm, Sweden during the 6 months spanning the H1N1 pandemic in 2009. Respiratory samples were analyzed for a panel of 16 viruses by real-time polymerase chain reaction. Results: One or more viruses were detected in 61.6% of the samples. Of these, 85.4% were single infections and 14.6% co-infections (2-4 viruses). The number of co-infections increased throughout the study period. H1N1 was found in 83 (16.5%) children and of these 12 (14.5%) were co-infections. HRV and H1N1 circulated to a large extent at the same time and 6.0% of the H1N1-positive children were also positive for HRV. There was no correlation between co-infections and severity of disease in children with H1N1. Conclusions: Viral co-infections were relatively common in H1N1 infected hospitalized children and need to be considered when estimating morbidity attributed to H1N1. Population-based longitudinal studies with repeated sampling are needed to improve the understanding of the importance of co-infections and viral interference. Citation: Rhedin S, Hamrin J, Naucler P, Bennet R, Rotzen-Ostlund M, et al. (2012) Respiratory Viruses in Hospitalized Children with Influenza-Like Illness during the H1n1 2009 Pandemic in Sweden. PLoS ONE 7(12): e51491. doi:10.1371/journal.pone.0051491	[Rhedin, Samuel; Farnert, Anna] Karolinska Univ Hosp, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Hamrin, Johan; Bennet, Rutger; Eriksson, Margareta] Karolinska Univ Hosp, Dept Women & Child Hlth, Stockholm, Sweden; [Hamrin, Johan; Bennet, Rutger; Eriksson, Margareta] Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Naucler, Pontus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Naucler, Pontus; Farnert, Anna] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Rotzen-Ostlund, Maria] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Rhedin, S (corresponding author), Karolinska Univ Hosp, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.	samuel.rhedin@ki.se; johan.hamrin@karolinska.se	Bennet, Rutger/AAC-1255-2019; Arthur Rhedin, Samuel/H-4653-2019	Bennet, Rutger/0000-0003-0105-1865; Arthur Rhedin, Samuel/0000-0001-5798-2875; Farnert, Anna/0000-0001-7583-282X				Anestad G, 2011, MED HYPOTHESES, V77, P1132, DOI 10.1016/j.mehy.2011.09.021; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; DaPalma T, 2010, VIRUS RES, V149, P1, DOI 10.1016/j.virusres.2010.01.002; Dawood FS, 2011, NEW ENGL J MED, V360, P2605; Esper FP, 2011, J INFECTION, V63, P260, DOI 10.1016/j.jinf.2011.04.004; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; Guan Y, 2010, PROTEIN CELL, V1, P9, DOI 10.1007/s13238-010-0008-z; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Kling S, 2005, CLIN EXP ALLERGY, V35, P672, DOI 10.1111/j.1365-2222.2005.02244.x; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Linde A, 2009, EURO SURVEILL, V40; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Nisii C, 2010, J CLIN MICROBIOL, V48, P3383, DOI 10.1128/JCM.01179-10; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Statistics Sweden, 2009, POP MUN MAR STAT AG; Swedish Institute for Communicable Disease Control, 2010, INFL VECK 1 4 1 10 1; Tanner H, 2012, EUR J CLIN MICROBIOL, V31, P3001, DOI 10.1007/s10096-012-1653-3; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; WAGNER RR, 1960, BACTERIOL REV, V24, P151, DOI 10.1128/MMBR.24.1.151-166.1960; Wang JH, 2009, LARYNGOSCOPE, V119, P1406, DOI 10.1002/lary.20498; Wright PF, 2007, J CLIN MICROBIOL, V45, P2126, DOI 10.1128/JCM.02553-06; Yang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045807	27	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51491	10.1371/journal.pone.0051491	http://dx.doi.org/10.1371/journal.pone.0051491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272110	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800048
J	Arnes, L; Hill, JT; Gross, S; Magnuson, MA; Sussel, L				Arnes, Luis; Hill, Jonathon T.; Gross, Stefanie; Magnuson, Mark A.; Sussel, Lori			Ghrelin Expression in the Mouse Pancreas Defines a Unique Multipotent Progenitor Population	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CELLS; ALPHA-CELLS; ENDOCRINE PANCREAS; ISLET-CELL; INSULIN-SECRETION; DIFFERENTIATION; NKX2.2; ARX; NEUROGENIN3	Pancreatic islet cells provide the major source of counteractive endocrine hormones required for maintaining glucose homeostasis; severe health problems result when these cell types are insufficiently active or reduced in number. Therefore, the process of islet endocrine cell lineage allocation is critical to ensure there is a correct balance of islet cell types. There are four endocrine cell types within the adult islet, including the glucagon-producing alpha cells, insulin-producing beta cells, somatostatin-producing delta cells and pancreatic polypeptide-producing PP cells. A fifth islet cell type, the ghrelin-producing epsilon cells, is primarily found during gestational development. Although hormone expression is generally assumed to mark the final entry to a determined cell state, we demonstrate in this study that ghrelin-expressing epsilon cells within the mouse pancreas do not represent a terminally differentiated endocrine population. Ghrelin cells give rise to significant numbers of alpha and PP cells and rare beta cells in the adult islet. Furthermore, pancreatic ghrelin-producing cells are maintained in pancreata lacking the essential endocrine lineage regulator Neurogenin3, and retain the ability to contribute to cells within the pancreatic ductal and exocrine lineages. These results demonstrate that the islet ghrelin-expressing epsilon cells represent a multi-potent progenitor cell population that delineates a major subgrouping of the islet endocrine cell populations. These studies also provide evidence that many of hormone-producing cells within the adult islet represent heterogeneous populations based on their ontogeny, which could have broader implications on the regulation of islet cell ratios and their ability to effectively respond to fluctuations in the metabolic environment during development.	[Arnes, Luis; Hill, Jonathon T.; Gross, Stefanie; Sussel, Lori] Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; [Magnuson, Mark A.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Magnuson, Mark A.] Vanderbilt Univ, Sch Med, Ctr Stem Cell Biol, Nashville, TN 37212 USA	Columbia University; Vanderbilt University; Vanderbilt University	Sussel, L (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA.	lgs2@columbia.edu	Magnuson, Mark/AAY-7172-2021; Arnes, Luis/K-9911-2016; Magnuson, Mark A/B-1335-2009; Arnes, Luis/AAH-6671-2019	Magnuson, Mark/0000-0002-8824-6499; Arnes, Luis/0000-0002-4158-8301; Magnuson, Mark A/0000-0002-8824-6499; Hill, Jonathon/0000-0003-1190-6302	National Institutes of Health [DK082590, DK089523, BCBC, DK63608];  [T32 DK07328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089523, P30DK063608, R01DK082590, U01DK072473, T32DK007328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health grants DK082590 (LS), DK089523; BCBC (LS and MM) and DK63608 (Columbia DERC). JH was supported by the T32 DK07328 training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andralojc KM, 2009, DIABETOLOGIA, V52, P486, DOI 10.1007/s00125-008-1238-y; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Arnes L, 2012, GENESIS; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; Chanoine JP, 2004, ENDOCRINOLOGY; Chen SX, 2011, DIS MODEL MECH; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Date Y, 2002, DIABETES, V51, P124, DOI 10.2337/diabetes.51.1.124; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; Herrera PL, 2002, ENDOCRINE, V19, P267, DOI 10.1385/ENDO:19:3:267; Hill JT, 2009, REGUL PEPTIDES, V157, P51, DOI 10.1016/j.regpep.2009.02.013; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kaiya H, 2011, PEPTIDES, V32, P2155, DOI 10.1016/j.peptides.2011.04.027; Kopp JL, 2011, CELL CYCLE, V10, P1921, DOI 10.4161/cc.10.12.16010; Kordowich S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-52; Long QM, 2004, GENESIS, V39, P256, DOI 10.1002/gene.20053; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Madsen OD, 2007, CR BIOL, V330, P534, DOI 10.1016/j.crvi.2007.03.006; Mastracci TL, 2011, DEV BIOL, V359, P1, DOI 10.1016/j.ydbio.2011.08.001; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; PICTET R, 1972, DEV EMBRYONIC ENDOCR; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Sakata I, 2009, REGUL PEPTIDES, V155, P91, DOI 10.1016/j.regpep.2009.04.001; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stengel A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00024; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sussel L, 1998, DEVELOPMENT, V125, P2213; TEITELMAN G, 1987, DEV BIOL, V121, P454, DOI 10.1016/0012-1606(87)90182-5; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Volante M, 2002, J CLIN ENDOCR METAB, V87, P1300, DOI 10.1210/jc.87.3.1300; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wierup N, 2004, J HISTOCHEM CYTOCHEM, V52, P301, DOI 10.1177/002215540405200301; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	48	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e52026	10.1371/journal.pone.0052026	http://dx.doi.org/10.1371/journal.pone.0052026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251675	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200173
J	Gonzalez-Avella, JC; Cosenza, MG; San Miguel, M				Carlos Gonzalez-Avella, Juan; Cosenza, Mario G.; San Miguel, Maxi			A Model for Cross-Cultural Reciprocal Interactions through Mass Media	PLOS ONE			English	Article							PHASE-TRANSITION; OPINION DYNAMICS; AXELROD MODEL; PHYSICS	We investigate the problem of cross-cultural interactions through mass media in a model where two populations of social agents, each with its own internal dynamics, get information about each other through reciprocal global interactions. As the agent dynamics, we employ Axelrod's model for social influence. The global interaction fields correspond to the statistical mode of the states of the agents and represent mass media messages on the cultural trend originating in each population. Several phases are found in the collective behavior of either population depending on parameter values: two homogeneous phases, one having the state of the global field acting on that population, and the other consisting of a state different from that reached by the applied global field; and a disordered phase. In addition, the system displays nontrivial effects: (i) the emergence of a largest minority group of appreciable size sharing a state different from that of the applied global field; (ii) the appearance of localized ordered states for some values of parameters when the entire system is observed, consisting of one population in a homogeneous state and the other in a disordered state. This last situation can be considered as a social analogue to a chimera state arising in globally coupled populations of oscillators.	[Carlos Gonzalez-Avella, Juan] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil; [Cosenza, Mario G.] Univ Los Andes, Ctr Fis Fundamental, Merida, Venezuela; [San Miguel, Maxi] CSIC UIB, IFISC, Palma De Mallorca, Spain	Universidade Federal do Rio Grande do Sul; University of Los Andes Venezuela; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona	Cosenza, MG (corresponding author), Univ Los Andes, Ctr Fis Fundamental, Merida, Venezuela.	mcosenza@ula.ve	San Miguel, Maxi/G-3224-2015	San Miguel, Maxi/0000-0001-6237-425X	CNPq, Brazil [150452/2011-0]; Comunitat Autonoma de les Illes Balears; FEDER; MINECO (Spain) [FIS2007-60327]	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Comunitat Autonoma de les Illes Balears; FEDER(European Commission); MINECO (Spain)	J.C.G-A acknowledges support from project CNPq 150452/2011-0, Brazil. M. S. M. acknowledges financial support from Comunitat Autonoma de les Illes Balears, FEDER, and MINECO (Spain) under project FIS2007-60327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.084103; Abrams DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.174102; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Bartolozzi M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046113; Candia J, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/07/P07007; Castellano C, 2000, PHYS REV LETT, V85, P3536, DOI 10.1103/PhysRevLett.85.3536; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; De Sanctis L, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046108; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Elasmar MG, 2003, IMPACT INT TELEVISIO, P127; Elasmar Michael G., 2003, IMPACT INT TELEVISIO; Fuentes MA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158104; Gargiulo F., 2008, ARXIV08073937; Gerbner G., 2002, MEDIA EFFECTS ADV TH, V2nd; Gonzalez-Avella JC, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/013010; Gonzalez-Avella JC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.065102; Gonzalez-Avella JC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046119; Gracia-Lazaro C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056103; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Hagerstrom AM, 2012, NAT PHYS, V8, P658, DOI [10.1038/nphys2372, 10.1038/NPHYS2372]; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Klemm K, 2003, PHYS REV E, V67, DOI 10.1063/1.1571335; Klemm K, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026120; Kovacs HV, 2011, MASS MEDIA COVERAGE; Kuperman MN, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046139; Kuramoto Y., 2002, Nonlinear Phenomena in Complex Systems, V5, P380; Laguna MF, 2003, PHYSICA A, V329, P459, DOI 10.1016/S0378-4371(03)00628-9; Laing CR, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066221; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; Mathews CG, 2006, ETHOLOGY, V112, P286, DOI 10.1111/j.1439-0310.2006.01138.x; Mazzitello KI, 2007, INT J MOD PHYS C, V18, P1475, DOI 10.1142/S0129183107011492; Mikhailov AS, 2002, CELLS SOC MODELS COM; Omelchenko I, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.234102; Peres LR, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38004; Rhee JW, 2010, COMPLICATED CURRENTS: MEDIA FLOWS, SOFT POWER AND EAST ASIA, DOI 10.2104/cc100005; Rodriguez AH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016111; Rodriguez AH, 2009, INT J MOD PHYS C, V20, P1233, DOI 10.1142/S012918310901431X; Shibanai Y, 2001, J CONFLICT RESOLUT, V45, P80, DOI 10.1177/0022002701045001004; Shibata T, 2003, PHYSICA D, V181, P197, DOI 10.1016/S0167-2789(03)00101-5; Stauffer D, 2006, MG SER NONLIN SCI, V1; Suchecki K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036132; TAN AS, 1986, JOURNALISM QUART, V63, P809, DOI 10.1177/107769908606300420; Tinsley MR, 2012, NAT PHYS, V8, P662, DOI [10.1038/nphys2371, 10.1038/NPHYS2371]; Vazquez F, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/18002; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vilone D, 2002, EUR PHYS J B, V30, P399, DOI 10.1140/epjb/e2002-00395-2; Vilone D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00686; WEIDLICH W, 1991, PHYS REP, V204, P1, DOI 10.1016/0370-1573(91)90024-G; WEIMANN G, 1984, INT J INTERCULT REL, V8, P185, DOI 10.1016/0147-1767(84)90038-5; Weisbuch G., 2002, Complexity, V7, P55, DOI 10.1002/cplx.10031; Yaple P, 1989, HDB INT INTERCULTURA; Zaharopoulos T, 1997, WORLD COMMUNICATION, V26, P30; Zhang W, 2011, CHAOS, V21, DOI 10.1063/1.3598450; Zimmermann M.G., 2001, EC HETEROGENEOUS INT, P73; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	58	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51035	10.1371/journal.pone.0051035	http://dx.doi.org/10.1371/journal.pone.0051035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251418	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200054
J	Dueholm, MS; Albertsen, M; Otzen, D; Nielsen, PH				Dueholm, Morten S.; Albertsen, Mads; Otzen, Daniel; Nielsen, Per Halkjaer			Curli Functional Amyloid Systems Are Phylogenetically Widespread and Display Large Diversity in Operon and Protein Structure	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; THIN AGGREGATIVE FIMBRIAE; SALMONELLA-ENTERITIDIS; BIOFILM FORMATION; FIBER BIOGENESIS; BINDING CURLI; FIBRONECTIN; IDENTIFICATION; TYPHIMURIUM; ATTACHMENT	Escherichia coli and a few other members of the Enterobacteriales can produce functional amyloids known as curli. These extracellular fibrils are involved in biofilm formation and studies have shown that they may act as virulence factors during infections. It is not known whether curli fibrils are restricted to the Enterobacteriales or if they are phylogenetically widespread. The growing number of genome-sequenced bacteria spanning many phylogenetic groups allows a reliable bioinformatic investigation of the phylogenetic diversity of the curli system. Here we show that the curli system is phylogenetically much more widespread than initially assumed, spanning at least four phyla. Curli fibrils may consequently be encountered frequently in environmental as well as pathogenic biofilms, which was supported by identification of curli genes in public metagenomes from a diverse range of habitats. Identification and comparison of curli subunit (CsgA/B) homologs show that these proteins allow a high degree of freedom in their primary protein structure, although a modular structure of tightly spaced repeat regions containing conserved glutamine, asparagine and glycine residues has to be preserved. In addition, a high degree of variability within the operon structure of curli subunits between bacterial taxa suggests that the curli fibrils might have evolved to fulfill specific functions. Variations in the genetic organization of curli genes are also seen among different bacterial genera. This suggests that some genera may utilize alternative regulatory pathways for curli expression. Comparison of phylogenetic trees of Csg proteins and the 16S rRNA genes of the corresponding bacteria showed remarkably similar overall topography, suggesting that horizontal gene transfer is a minor player in the spreading of the curli system.	[Dueholm, Morten S.; Albertsen, Mads; Nielsen, Per Halkjaer] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Otzen, Daniel] Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark	Aalborg University; Aarhus University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark.	phn@bio.aau.dk	Dueholm, Morten Simonsen/T-6718-2018; Nielsen, Per Halkjær/T-6796-2018; Albertsen, Mads/T-7358-2018	Dueholm, Morten Simonsen/0000-0003-4135-2670; Nielsen, Per Halkjær/0000-0002-6402-1877; Albertsen, Mads/0000-0002-6151-190X; Otzen, Daniel/0000-0002-2918-8989	Villum Kann Rasmussen Foundation (BioNET); Lundbeck Foundation; Aalborg University	Villum Kann Rasmussen Foundation (BioNET); Lundbeck Foundation(Lundbeckfonden); Aalborg University	The authors are grateful to funding from the Villum Kann Rasmussen Foundation (BioNET), the Lundbeck Foundation and Aalborg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Binnewies Tim T., 2006, Functional & Integrative Genomics, V6, P165, DOI 10.1007/s10142-006-0027-2; Carranza P, 2010, PROTEOMICS, V10, P3248, DOI 10.1002/pmic.200900460; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Collinson SK, 1996, J BACTERIOL, V178, P662, DOI 10.1128/jb.178.3.662-667.1996; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Gibson DL, 2007, MICROBIOL-SGM, V153, P1131, DOI 10.1099/mic.0.2006/000935-0; Hadi N, 2012, INFECT IMMUN, V80, P1351, DOI 10.1128/IAI.06304-11; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Itoh T, 1999, MOL BIOL EVOL, V16, P332, DOI 10.1093/oxfordjournals.molbev.a026114; Kalastavadi Tejas, 2008, BMC Biochemistry, V9, P7, DOI 10.1186/1471-2091-9-7; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Nasr Abdelhakim Ben, 1996, Molecular Microbiology, V20, P927, DOI 10.1111/j.1365-2958.1996.tb02534.x; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Olsen A, 2002, J BIOL CHEM, V277, P34568, DOI 10.1074/jbc.M206353200; OLSEN A, 1993, MOL MICROBIOL, V7, P523, DOI 10.1111/j.1365-2958.1993.tb01143.x; Otzen DE, 2011, STRUCTURE, V19, P1207, DOI 10.1016/j.str.2011.08.005; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Ryu JH, 2004, LETT APPL MICROBIOL, V39, P359, DOI 10.1111/j.1472-765X.2004.01591.x; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; SJOBRING U, 1994, MOL MICROBIOL, V14, P443, DOI 10.1111/j.1365-2958.1994.tb02179.x; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; Taylor JD, 2011, STRUCTURE, V19, P1307, DOI 10.1016/j.str.2011.05.015; Thornley JP, 1997, REV MED MICROBIOL, V8; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Wang X, 2010, P NATL ACAD SCI USA, V107, P163, DOI 10.1073/pnas.0908714107; Xie G, 2003, MICROBIOL MOL BIOL R, V67, P303, DOI 10.1128/MMBR.67.3.303-342.2003; Yang S, 2009, STRUCTURAL BIOINFORM, P561; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	49	92	96	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51274	10.1371/journal.pone.0051274	http://dx.doi.org/10.1371/journal.pone.0051274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251478	gold, Green Published			2022-12-27	WOS:000313236200081
J	Keddy, PGW; Dunlop, K; Warford, J; Samson, ML; Jones, QRD; Rupasinghe, HPV; Robertson, GS				Keddy, Paul G. W.; Dunlop, Kate; Warford, Jordan; Samson, Michel L.; Jones, Quinton R. D.; Rupasinghe, H. P. Vasantha; Robertson, George S.			Neuroprotective and Anti-Inflammatory Effects of the Flavonoid-Enriched Fraction AF4 in a Mouse Model of Hypoxic-Ischemic Brain Injury	PLOS ONE			English	Article							NF-KAPPA-B; OXYGEN-GLUCOSE DEPRIVATION; COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; ERYTHROPOIETIN-MEDIATED NEUROPROTECTION; HIPPOCAMPAL NEURONAL DEATH; CYCLIN-DEPENDENT KINASES; FOCAL CEREBRAL-ISCHEMIA; GREEN TEA POLYPHENOL; X-LINKED INHIBITOR	We report here neuroprotective and anti-inflammatory effects of a flavonoid-enriched fraction isolated from the peel of Northern Spy apples (AF4) in a mouse of model of hypoxic-ischemic (HI) brain damage. Oral administration of AF4 (50 mg/kg, once daily for 3 days) prior to 50 min of HI completely prevented motor performance deficits assessed 14 days later that were associated with marked reductions in neuronal cell loss in the dorsal hippocampus and striatum. Pre-treatment with AF4 (5, 10, 25 or 50 mg/kg, p.o.; once daily for 3 days) produced a dose-dependent reduction in HI-induced hippocampal and striatal neuron cell loss, with 25 mg/kg being the lowest dose that achieved maximal neuroprotection. Comparison of the effects of 1, 3 or 7 doses of AF4 (25 mg/kg; p.o.) prior to HI revealed that at least 3 doses of AF4 were required before HI to reduce neuronal cell loss in both the dorsal hippocampus and striatum. Quantitative RT-PCR measurements revealed that the neuroprotective effects of AF4 (25 mg/kg; p.o.; once daily for 3 days) in the dorsal hippocampus were associated with a suppression of HI-induced increases in the expression of IL-1 beta, TNF-alpha and IL-6. AF4 pre-treatment enhanced mRNA levels for pro-survival proteins such as X-linked inhibitor of apoptosis and erythropoietin following HI in the dorsal hippocampus and striatum, respectively. Primary cultures of mouse cortical neurons incubated with AF4 (1 mu g/ml), but not the same concentrations of either quercetin or quercetin-3-O-glucose or its metabolites, were resistant to cell death induced by oxygen glucose deprivation. These findings suggest that the inhibition of HI-induced brain injury produced by AF4 likely involves a transcriptional mechanism resulting from the co-operative actions of various phenolics in this fraction which not only reduce the expression of pro-inflammatory mediators but also enhance pro-survival gene signalling.	[Keddy, Paul G. W.; Dunlop, Kate; Warford, Jordan; Samson, Michel L.; Jones, Quinton R. D.; Robertson, George S.] Dalhousie Univ, Fac Med, Dept Pharmacol, Halifax, NS, Canada; [Rupasinghe, H. P. Vasantha] Dalhousie Univ, Fac Agr, Dept Environm Sci, Truro, NS, Canada; [Robertson, George S.] Dalhousie Univ, Fac Med, Dept Psychiat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Robertson, GS (corresponding author), Dalhousie Univ, Fac Med, Dept Pharmacol, Halifax, NS, Canada.	George.Robertson@dal.ca	Rupasinghe, H.P. Vasantha/B-6049-2013	Rupasinghe, H.P. Vasantha/0000-0003-3435-0052; Robertson, George/0000-0001-8411-7721; Warford, Jordan/0000-0003-1654-4929	Nova Scotia Heart and Stroke Foundation; Atlantic Innovation Funds; Proof-of-Concept Award (Springboard Atlantic Inc.); Natural Sciences and Engineering Council of Canada; MS Society of Canada	Nova Scotia Heart and Stroke Foundation; Atlantic Innovation Funds; Proof-of-Concept Award (Springboard Atlantic Inc.); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); MS Society of Canada	This work was supported by grants from the Nova Scotia Heart and Stroke Foundation (Robertson), Atlantic Innovation Funds (Rupasinghe), Proof-of-Concept Award (Springboard Atlantic Inc.; Robertson and Rupasinghe), Natural Sciences and Engineering Council of Canada (Rupasinghe) and MS Society of Canada (Robertson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenova MV, 2005, CURR NEUROVASC RES, V2, P73, DOI 10.2174/1567202052773463; Aneja R, 2004, MOL MED, V10, P55, DOI 10.2119/2004-00032.Aneja; Awad MA, 2000, SCI HORTIC-AMSTERDAM, V83, P249, DOI 10.1016/S0304-4238(99)00124-7; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Cassidy A, 2012, STROKE, V43, P946, DOI 10.1161/STROKEAHA.111.637835; Chao JF, 2010, NEUROSCI LETT, V469, P360, DOI 10.1016/j.neulet.2009.12.028; Chen HH, 2007, EXP CELL RES, V313, P3106, DOI 10.1016/j.yexcr.2007.04.026; Chen LS, 1997, DRUG METAB DISPOS, V25, P1045; Cherubini A, 2008, CURR MED CHEM, V15, P1236, DOI 10.2174/092986708784310431; Chinnici F, 2004, J AGR FOOD CHEM, V52, P3, DOI 10.1021/jf030459n; Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fang Lumei, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1051; Furusu A, 2007, J CELL PHYSIOL, V210, P703, DOI 10.1002/jcp.20881; Ge QF, 2007, PHARMACOL RES, V55, P148, DOI 10.1016/j.phrs.2006.11.007; Ginis I, 2000, MOL MED, V6, P1028, DOI 10.1007/BF03402054; Gutierrez-Merino C, 2011, CURR MED CHEM, V18, P1195, DOI 10.2174/092986711795029735; Ha HJ, 2003, BIOL PHARM BULL, V26, P544, DOI 10.1248/bpb.26.544; Haase VH, 2010, KIDNEY INT, V78, P10, DOI 10.1038/ki.2010.112; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Hollman PCH, 2010, J NUTR, V140, P600, DOI 10.3945/jn.109.116632; Honkaniemi J, 1996, RESTOR NEUROL NEUROS, V9, P227, DOI 10.3233/RNN-1996-9405; HOSSMANN KA, 1994, BRAIN PATHOL, V4, P23; Hu K, 2011, ACTA NEUROL BELG, V111, P205; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hwang SL, 2009, J AGR FOOD CHEM, V57, P2576, DOI 10.1021/jf8033607; Inanami O, 1998, FREE RADICAL RES, V29, P359, DOI 10.1080/10715769800300401; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Jeon H, 2007, MOL PHARMACOL, V71, P1676, DOI 10.1124/mol.107.034041; Jones QRD, 2012, TRENDS PHARMACOL SCI, V33, P602, DOI 10.1016/j.tips.2012.08.002; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Kahle K, 2005, MOL NUTR FOOD RES, V49, P797, DOI 10.1002/mnfr.200500064; Kang TH, 2006, NEUROSCI LETT, V391, P122, DOI 10.1016/j.neulet.2005.08.053; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026; Kim J, 2012, NEUROCHEM INT, V60, P466, DOI 10.1016/j.neuint.2012.02.004; Kim SH, 2009, BIOORG MED CHEM LETT, V19, P6009, DOI 10.1016/j.bmcl.2009.09.062; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Kovalenko T M, 2006, Fiziol Zh, V52, P21; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lan XF, 2008, TOHOKU J EXP MED, V216, P117, DOI 10.1620/tjem.216.117; Lapchak PA, 2007, BRAIN RES, V1167, P123, DOI 10.1016/j.brainres.2007.06.072; Lapi D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00032; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee JK, 2011, ACTA NEUROCHIR, V153, P1321, DOI 10.1007/s00701-010-0889-x; Li HY, 2010, EUR J PHARMACOL, V649, P92, DOI 10.1016/j.ejphar.2010.09.023; Li SY, 2012, NEUROBIOL DIS, V45, P624, DOI 10.1016/j.nbd.2011.10.008; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu M, 2009, ANAT REC, V292, P412, DOI 10.1002/ar.20864; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Luke JJ, 2012, CLIN CANCER RES, V18, P2638, DOI 10.1158/1078-0432.CCR-11-3203; Ma L, 2010, NEUROCHEM RES, V35, P130, DOI 10.1007/s11064-009-0038-1; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mandel S, 2004, FREE RADICAL BIO MED, V37, P304, DOI 10.1016/j.freeradbiomed.2004.04.012; Marczylo TH, 2009, CANCER CHEMOTH PHARM, V64, P1261, DOI 10.1007/s00280-009-0996-7; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; McGahan L, 1998, MOL BRAIN RES, V56, P133, DOI 10.1016/S0169-328X(98)00038-2; McGhie TK, 2005, J AGR FOOD CHEM, V53, P3065, DOI 10.1021/jf047832r; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Min JY, 2011, NEUROSCI LETT, V500, P157, DOI 10.1016/j.neulet.2011.05.048; Mizrahi A, 2009, BRIT J NUTR, V102, P1075, DOI 10.1017/S0007114509359097; Morand C, 2000, BIOFACTORS, V12, P169, DOI 10.1002/biof.5520120127; Mursu J, 2008, BRIT J NUTR, V100, P890, DOI 10.1017/S0007114508945694; Newcomb EW, 2004, ANTI-CANCER DRUG, V15, P411, DOI 10.1097/01.cad.0000127332.06439.47; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Nicholson SK, 2008, P NUTR SOC, V67, P42, DOI 10.1017/S0029665108006009; Nijboer CHA, 2008, STROKE, V39, P2129, DOI 10.1161/STROKEAHA.107.504175; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; Olson EE, 2004, J NEUROL SCI, V227, P7, DOI 10.1016/j.jns.2004.07.021; Ossola B, 2009, EXPERT OPIN DRUG SAF, V8, P397, DOI 10.1517/14740330903026944; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Panickars KS, 2009, NUTR NEUROSCI, V12, P105, DOI 10.1179/147683009X423300; Park SS, 2008, J CELL BIOCHEM, V103, P1989, DOI 10.1002/jcb.21588; Peluso MR, 2006, EXP BIOL MED, V231, P1287, DOI 10.1177/153537020623100802; Prasain JK, 2010, MATURITAS, V66, P163, DOI 10.1016/j.maturitas.2010.01.010; Price KR, 1999, FOOD CHEM, V66, P489, DOI 10.1016/S0308-8146(99)00099-0; Pu FL, 2007, J PHARMACOL SCI, V104, P329, DOI 10.1254/jphs.FP0070247; Pu FL, 2004, J PHARMACOL SCI, V94, P393, DOI 10.1254/jphs.94.393; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Qiao HM, 2012, BRAIN RES, V1448, P71, DOI 10.1016/j.brainres.2012.02.003; Reinboth M, 2010, BRIT J NUTR, V104, P198, DOI 10.1017/S000711451000053X; Ritz MF, 2008, BRAIN RES, V1239, P226, DOI 10.1016/j.brainres.2008.08.073; Ritz MF, 2008, J NUTR, V138, P519, DOI 10.1093/jn/138.3.519; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208; Rupasinghe HPV, 2010, J AGR FOOD CHEM, V58, P1233, DOI 10.1021/jf903162k; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Schroeter H, 2000, FREE RADICAL BIO MED, V29, P1222, DOI 10.1016/S0891-5849(00)00415-9; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Simonyi A, 2005, MOL NEUROBIOL, V31, P135, DOI 10.1385/MN:31:1-3:135; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Triantafyllou A, 2007, FREE RADICAL RES, V41, P342, DOI 10.1080/10715760601055324; Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298; Tu XK, 2011, INFLAMMATION, V34, P463, DOI 10.1007/s10753-010-9254-8; Tunon MJ, 2009, CURR DRUG METAB, V10, P256, DOI 10.2174/138920009787846369; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Veberic R, 2005, J SCI FOOD AGR, V85, P1687, DOI 10.1002/jsfa.2113; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vrhovsek U, 2004, J AGR FOOD CHEM, V52, P6532, DOI 10.1021/jf049317z; Wagner C, 2010, ARCH TOXICOL, V84, P89, DOI 10.1007/s00204-009-0482-3; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang XQ, 2011, BRAIN RES BULL, V86, P277, DOI 10.1016/j.brainresbull.2011.07.014; Wang Z, 2007, VASC PHARMACOL, V47, P319, DOI 10.1016/j.vph.2007.09.002; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Weinreb O, 2003, ANN NY ACAD SCI, V993, P351, DOI 10.1111/j.1749-6632.2003.tb07544.x; Weinreb O, 2003, FASEB J, V17, P935, DOI 10.1096/fj.02-0712fje; Wheeler DS, 2004, J NUTR, V134, P1039, DOI 10.1093/jn/134.5.1039; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wilson WJ, 2002, BIOCHEM BIOPH RES CO, V293, P446, DOI 10.1016/S0006-291X(02)00244-9; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Xie KQ, 2009, ACTA PHARMACOL SIN, V30, P889, DOI 10.1038/aps.2009.80; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xu XH, 2005, PLANTA MED, V71, P585, DOI 10.1055/s-2005-871261; Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018; Zhang F, 2007, NEUROBIOL DIS, V25, P45, DOI 10.1016/j.nbd.2006.08.007; Zhang ZJ, 2005, ACTA PHARMACOL SIN, V26, P307, DOI 10.1111/j.1745-7254.2005.00051.x; Zhu JTT, 2009, NEUROSCI LETT, V461, P172, DOI 10.1016/j.neulet.2009.06.010	145	28	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51324	10.1371/journal.pone.0051324	http://dx.doi.org/10.1371/journal.pone.0051324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251498	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200089
J	Xu, TY; Guo, LL; Wang, P; Song, J; Le, YY; Viollet, B; Miao, CY				Xu, Tian-Ying; Guo, Ling-Ling; Wang, Pei; Song, Jie; Le, Ying-Ying; Viollet, Benoit; Miao, Chao-Yu			Chronic Exposure to Nicotine Enhances Insulin Sensitivity through alpha 7 Nicotinic Acetylcholine Receptor-STAT3 Pathway	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; STROKE; RESISTANCE; ROSIGLITAZONE; HYPERTENSION; AUTOPHAGY; RISK; PHOSPHORIBOSYLTRANSFERASE; DETERIORATION; CONTRIBUTES	This study was to investigate the effect of nicotine on insulin sensitivity and explore the underlying mechanisms. Treatment of Sprague-Dawley rats with nicotine (3 mg/kg/day) for 6 weeks reduced 43% body weight gain and 65% blood insulin level, but had no effect on blood glucose level. Both insulin tolerance test and glucose tolerance test demonstrated that nicotine treatment enhanced insulin sensitivity. Pretreatment of rats with hexamethonium (20 mg/kg/day) to antagonize peripheral nicotinic receptors except for alpha 7 nicotinic acetylcholine receptor (alpha 7-nAChR) had no effect on the insulin sensitizing effect of nicotine. However, the insulin sensitizing effect but not the bodyweight reducing effect of nicotine was abrogated in alpha 7-nAChR knockout mice. Further, chronic treatment with PNU-282987 (0.53 mg/kg/day), a selective alpha 7-nAChR agonist, significantly enhanced insulin sensitivity without apparently modifying bodyweight not only in normal mice but also in AMP-activated kinase-alpha 2 knockout mice, an animal model of insulin resistance with no sign of inflammation. Moreover, PNU-282987 treatment enhanced phosphorylation of signal transducer and activator of transcription 3 (STAT3) in skeletal muscle, adipose tissue and liver in normal mice. PNU-282987 treatment also increased glucose uptake by 25% in C2C12 myotubes and this effect was total abrogated by STAT3 inhibitor, S3I-201. All together, these findings demonstrated that nicotine enhanced insulin sensitivity in animals with or without insulin resistance, at least in part via stimulating alpha 7-nAChR- STAT3 pathway independent of inflammation. Our results contribute not only to the understanding of the pharmacological effects of nicotine, but also to the identifying of new therapeutic targets against insulin resistance.	[Xu, Tian-Ying; Guo, Ling-Ling; Wang, Pei; Song, Jie; Miao, Chao-Yu] Second Mil Med Univ, Dept Pharmacol, Shanghai, Peoples R China; [Le, Ying-Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai, Peoples R China; [Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France; [Viollet, Benoit] INSERM, U567, Paris, France	Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Miao, CY (corresponding author), Second Mil Med Univ, Dept Pharmacol, Shanghai, Peoples R China.	cymiao@smmu.edu.cn	Le, Yingying/L-9785-2017; Viollet, Benoit/O-6927-2017; WANG, PEI/AAH-3926-2019; Viollet, Benoit/N-2397-2019	Le, Yingying/0000-0002-7990-3899; Viollet, Benoit/0000-0002-0121-0224; WANG, PEI/0000-0002-1650-3353; Viollet, Benoit/0000-0002-0121-0224; Miao, Chao-Yu/0000-0002-8176-3434	National Natural Science Foundation of China [81102487, 81130061]; National Basic Research Program of China [2009CB521902]; National Science and Technology Major Project [2009ZX09303-002]; Program of Shanghai Subject Chief Scientist [10XD1405300]; Shanghai 'Shu Guang' Project [10GG19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project; Program of Shanghai Subject Chief Scientist; Shanghai 'Shu Guang' Project	This research was supported by grants from the National Natural Science Foundation of China (81102487 to T-YX, 81130061 to C-YM), the National Basic Research Program of China (2009CB521902 to C-YM), the National Science and Technology Major Project (2009ZX09303-002 to C-YM), the Program of Shanghai Subject Chief Scientist (10XD1405300 to C-YM), and the Shanghai 'Shu Guang' Project (10GG19 to C-YM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assali AR, 1999, CLIN CARDIOL, V22, P357, DOI 10.1002/clc.4960220512; Axelsson T, 2001, J INTERN MED, V249, P539, DOI 10.1046/j.1365-2796.2001.00840.x; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; BERTRAND D, 1992, NEUROSCI LETT, V146, P87, DOI 10.1016/0304-3940(92)90179-B; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Echeverria V, 2012, CNS NEUROSCI THER, V18, P517, DOI 10.1111/j.1755-5949.2012.00317.x; Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878; Faulds MH, 2012, CURR OPIN ONCOL, V24, P58, DOI 10.1097/CCO.0b013e32834e0582; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gasparetti AL, 2003, J PHYSIOL-LONDON, V552, P149, DOI 10.1113/jphysiol.2003.050369; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Jiang M, 2010, AUTOPHAGY, V6, P175, DOI 10.4161/auto.6.1.10700; Jorgensen SB, 2009, DIABETOLOGIA, V52, P2395, DOI 10.1007/s00125-009-1483-8; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; [蓝晓红 LAN Xiaohong], 2008, [第二军医大学学报, Academic Journal of Second Military Medical University], V29, P156; LEVINE RR, 1960, J PHARMACOL EXP THER, V129, P296; Li DJ, 2011, HYPERTENSION, V57, P298, DOI 10.1161/HYPERTENSIONAHA.110.160077; Liu C, 2009, CRIT CARE MED, V37, P634, DOI 10.1097/CCM.0b013e31819598f5; Liu RH, 2004, J PHARMACOL EXP THER, V310, P52, DOI 10.1124/jpet.103.065037; Liu RH, 2003, EUR J PHARMACOL, V458, P227, DOI 10.1016/S0014-2999(02)02726-7; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Marrero MB, 2010, J PHARMACOL EXP THER, V332, P173, DOI 10.1124/jpet.109.154633; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Moh A, 2008, DIABETES, V57, P1227, DOI 10.2337/db06-1582; Morgan TM, 2004, METABOLISM, V53, P578, DOI 10.1016/j.metabol.2003.12.006; Orrico KB, 2010, AM J MANAG CARE, V16, pE111; Pavlov VA, 2008, INT J CLIN EXP MED, V1, P203; PERKINS KA, 1989, NEW ENGL J MED, V320, P898, DOI 10.1056/NEJM198904063201404; Psaty BM, 2007, NEW ENGL J MED, V356, P2522, DOI 10.1056/NEJMe078099; Rowe GC, 2011, AM J PHYSIOL-ENDOC M, V301, pE155, DOI 10.1152/ajpendo.00681.2010; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Strader AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE447, DOI 10.1152/ajpendo.00153.2004; Swislocki ALM, 1997, METABOLISM, V46, P1008, DOI 10.1016/S0026-0495(97)90270-5; Swislocki ALM, 2003, METABOLISM, V52, P67, DOI 10.1053/meta.2003.50006; Szwaya J, 2007, J BIOMOL SCREEN, V12, P159, DOI 10.1177/1087057106297787; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; Wada T, 2007, ENDOCRINOLOGY, V148, P790, DOI 10.1210/en.2006-0907; Wang P, 2012, DIABETES, V61, P1051, DOI 10.2337/db11-1180; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang P, 2011, CNS NEUROSCI THER, V17, P327, DOI 10.1111/j.1755-5949.2011.00265.x; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; Wang P, 2010, J PHYSIOL SCI, V60, P317, DOI 10.1007/s12576-010-0103-1; Wang XF, 2011, ENDOCRINOLOGY, V152, P836, DOI 10.1210/en.2010-0855; Waring JF, 2008, NEUROSCI RES, V60, P266, DOI 10.1016/j.neures.2007.11.008; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Winder WW, 2008, DIABETOLOGIA, V51, P1761, DOI 10.1007/s00125-008-1115-8; Xu TY, 2010, CLIN EXP PHARMACOL P, V37, P441, DOI 10.1111/j.1440-1681.2009.05328.x; Yan JG, 2010, AUTOPHAGY, V6, P67, DOI 10.4161/auto.6.1.10437; Yoshida T, 1999, INT J OBESITY, V23, P570, DOI 10.1038/sj.ijo.0800870; Yu JG, 2011, CNS NEUROSCI THER, V17, P577, DOI 10.1111/j.1755-5949.2011.00264.x; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	58	35	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51217	10.1371/journal.pone.0051217	http://dx.doi.org/10.1371/journal.pone.0051217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251458	Green Submitted, gold, Green Published			2022-12-27	WOS:000313236200073
J	Cebecauerova, D; Strautnieks, SS; Byrne, JA; Jirsa, M; Thompson, RJ				Cebecauerova, Dita; Strautnieks, Sandra S.; Byrne, Jane A.; Jirsa, Milan; Thompson, Richard J.			ATP8B1 Gene Expression Is Driven by a Housekeeping-Like Promoter Independent of Bile Acids and Farnesoid X Receptor	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; OPEN READING FRAME; TRANSLATIONAL REGULATION; HEREDITARY CHOLESTASIS; 5'-UNTRANSLATED REGION; CANALICULAR MEMBRANE; UNTRANSLATED REGIONS; EPITHELIAL-CELLS; MESSENGER-RNA; TRANSCRIPTION	Background: Mutations in ATP8B1 gene were identified as a cause of low gamma-glutamyltranspeptidase cholestasis with variable phenotype, ranging from Progressive Familial Intrahepatic Cholestasis to Benign Recurrent Intrahepatic Cholestasis. However, only the coding region of ATP8B1 has been described. The aim of this research was to explore the regulatory regions, promoter and 5'untranslated region, of the ATP8B1 gene. Methodology/Principal Findings: 5'Rapid Amplification of cDNA Ends using human liver and intestinal tissue was performed to identify the presence of 59 untranslated exons. Expression levels of ATP8B1 transcripts were determined by quantitative reverse-transcription PCR and compared with the non-variable part of ATP8B1. Three putative promoters were examined in vitro using a reporter gene assay and the main promoter was stimulated with chenodeoxycholic acid. Four novel untranslated exons located up to 71 kb upstream of the previously published exon 1 and twelve different splicing variants were found both in the liver and the intestine. Multiple transcription start sites were identified within exon -3 and the proximal promoter upstream of this transcription start site cluster was proven to be an essential regulatory element responsible for 70% of total ATP8B1 transcriptional activity. In vitro analysis demonstrated that the main promoter drives constitutive ATP8B1 gene expression independent of bile acids. Conclusions/Significance: The structure of the ATP8B1 gene is complex and the previously published transcription start site is not significant. The basal expression of ATP8B1 is driven by a housekeeping-like promoter located 71 kb upstream of the first protein coding exon.	[Cebecauerova, Dita; Strautnieks, Sandra S.; Byrne, Jane A.; Thompson, Richard J.] Kings Coll Hosp London, Sch Med, Kings Coll London, Inst Liver Studies, London SE5 8RX, England; [Cebecauerova, Dita; Jirsa, Milan] Inst Clin & Expt Med, Lab Expt Hepatol, Prague, Czech Republic	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Institute for Clinical & Experimental Medicine (IKEM)	Cebecauerova, D (corresponding author), Kings Coll Hosp London, Sch Med, Kings Coll London, Inst Liver Studies, London SE5 8RX, England.	dita22@seznam.cz; richard.j.thompson@kcl.ac.uk	Jirsa, Milan/C-9340-2017; Thompson, Richard J/B-7954-2009; Cebecauerova, Dita/N-7612-2017	Jirsa, Milan/0000-0001-7300-6735; Thompson, Richard J/0000-0001-5652-0150; Cebecauerova, Dita/0000-0002-6529-2740	EASL Sheila Sherlock Post-doc Fellowship;  [IKEM MZO 00023001]	EASL Sheila Sherlock Post-doc Fellowship; 	Supported by EASL Sheila Sherlock Post-doc Fellowship (DC) and Institutional grant IKEM MZO 00023001 (MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2004, HUM MOL GENET, V13, P2451, DOI 10.1093/hmg/ddh261; ARRICK BA, 1994, MOL CELL BIOL, V14, P619, DOI 10.1128/MCB.14.1.619; Barker DF, 2006, PHARMACOGENET GENOM, V16, P515, DOI 10.1097/01.fpc.0000215066.29342.26; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cai SY, 2009, GASTROENTEROLOGY, V136, P1060, DOI 10.1053/j.gastro.2008.10.025; Chen F, 2004, GASTROENTEROLOGY, V126, P756, DOI 10.1053/j.gastro.2003.12.013; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Demeilliers C, 2006, HEPATOLOGY, V43, P1125, DOI 10.1002/hep.21160; Diba F, 2001, J CELL BIOCHEM, V81, P149, DOI 10.1002/1097-4644(20010401)81:1<149::AID-JCB1031>3.3.CO;2-N; Frankenberg T, 2008, HEPATOLOGY, V48, P1896, DOI 10.1002/hep.22431; Fusco F, 2006, GENE, V383, P99, DOI 10.1016/j.gene.2006.07.022; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Husain A, 2007, DRUG METAB DISPOS, V35, P1649, DOI 10.1124/dmd.107.016485; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lammich S, 2010, J BIOL CHEM, V285, P15753, DOI 10.1074/jbc.M110.110742; Landry JR, 2001, GENOMICS, V76, P110, DOI 10.1006/geno.2001.6604; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Shibahara S, 2001, J INVEST DERM SYMP P, V6, P99, DOI 10.1046/j.0022-202x.2001.00010.x; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Sobczak K, 2002, J BIOL CHEM, V277, P17349, DOI 10.1074/jbc.M109162200; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Ujhazy P, 2001, HEPATOLOGY, V34, P768, DOI 10.1053/jhep.2001.27663; Van Mil SWC, 2004, PEDIATR RES, V56, P981, DOI 10.1203/01.PDR.0000145564.06791.D1; van Mil SWC, 2001, SEMIN LIVER DIS, V21, P535, DOI 10.1055/s-2001-19034; Verhulst PM, 2010, HEPATOLOGY, V51, P2049, DOI 10.1002/hep.23586; Zhang YY, 2010, MOL PHARMACOL, V77, P237, DOI 10.1124/mol.109.058982; Zhao CY, 2010, J BIOL CHEM, V285, P8552, DOI 10.1074/jbc.M109.070920; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646	38	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51650	10.1371/journal.pone.0051650	http://dx.doi.org/10.1371/journal.pone.0051650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251605	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900112
J	Esezobor, CI; Ladapo, TA; Osinaike, B; Lesi, FEA				Esezobor, Christopher Imokhuede; Ladapo, Taiwo Augustina; Osinaike, Babayemi; Lesi, Foluso Ebun Afolabi			Paediatric Acute Kidney Injury in a Tertiary Hospital in Nigeria: Prevalence, Causes and Mortality Rate	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL CHILDREN; RISK-FACTORS; EPIDEMIOLOGY; LENGTH	Background: The modest decline in child mortality in Africa raises the question whether the pattern of diseases associated with acute kidney injury (AKI) in children in Nigeria has changed. Methods: A database of children, aged between one month and 16 years, with AKI (using modified pediatric RIFLE criteria) was reviewed. The cause of AKI was defined as the major underlying disease. The clinical and laboratory features of children with AKI who survived were compared to those who died. Results: Of the 4 015 children admitted into Lagos University Teaching Hospital between July 2010 and July 2012, 70 episodes of AKI were recorded equalling 17.4 cases per 1000 children. The median age of the children with AKI was 4.8 (range 0.1-14.4) years and 68.6% were males. Acute kidney injury was present in 58 (82.9%) children at admission with 70% in 'failure' category. Primary kidney disease (38.6%), sepsis (25.7%) and malaria (11.4%) were the commonest causes. The primary kidney diseases were acute glomerulonephritis (11) and nephrotic syndrome (8). Nineteen (28.4%) children with AKI died. Need for dialysis [odds ratio: 10.04 (2.94-34.33)], white cell.15 000/mm(3) [odds ratio: 5.72 (1.65-19.89)] and platelet,100 000/mm3 [odds ratio: 9.56 (2.63-34.77)] were associated with death. Conclusion: Acute kidney injury is common in children admitted to hospitals. The common causes remain primary kidney diseases, sepsis and malaria but the contribution of sepsis is rising while malaria and gastroenteritis are declining. Acute kidney injury-related mortality remains high. Citation: Esezobor CI, Ladapo TA, Osinaike B, Lesi FEA (2012) Paediatric Acute Kidney Injury in a Tertiary Hospital in Nigeria: Prevalence, Causes and Mortality Rate. PLoS ONE 7(12): e51229. doi:10.1371/journal.pone.0051229	[Esezobor, Christopher Imokhuede; Lesi, Foluso Ebun Afolabi] Univ Lagos, Dept Paediat, Coll Med, Idi Araba, Lagos State, Nigeria; [Esezobor, Christopher Imokhuede; Ladapo, Taiwo Augustina; Osinaike, Babayemi; Lesi, Foluso Ebun Afolabi] Univ Lagos, Dept Paediat, Teaching Hosp, Idi Araba, Lagos State, Nigeria	University of Lagos; University of Lagos	Esezobor, CI (corresponding author), Univ Lagos, Dept Paediat, Coll Med, Idi Araba, Lagos State, Nigeria.	esezobor@gmail.com	Esezobor, Christopher Imokhuede/AAP-2230-2020	Esezobor, Christopher Imokhuede/0000-0003-1736-4794; Ladapo, Taiwo/0000-0002-9969-6233; Lesi, Foluso/0000-0002-1737-1524	International Pediatric Nephrology Association	International Pediatric Nephrology Association	We acknowledge the contribution of the International Pediatric Nephrology Association which provided sponsorship to CIE and TAL to undertake fellowship training in paediatric nephrology including basic clinical research. We are also grateful to the unit's resident doctors who helped in maintaining the accuracy of the database.	Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Andreoli SP, 2009, PEDIATR NEPHROL, V24, P253, DOI 10.1007/s00467-008-1074-9; Anochie IC, 2005, PEDIATR NEPHROL, V20, P1610, DOI 10.1007/s00467-005-1984-8; [Anonymous], 2004, PEDIATRICS, V114, P22; Assounga A G, 2000, Saudi J Kidney Dis Transpl, V11, P40; Bailey D, 2007, PEDIATR CRIT CARE ME, V8, P29, DOI 10.1097/01.pcc.0000256612.40265.67; Ball EF, 2008, J PAEDIATR CHILD H, V44, P642, DOI 10.1111/j.1440-1754.2008.01373.x; Bresolin N, 2009, PEDIATR NEPHROL, V24, P537, DOI 10.1007/s00467-008-1054-0; Bunchman TE, 2001, PEDIATR NEPHROL, V16, P1067, DOI 10.1007/s004670100029; Chang JW, 2008, CLIN NEPHROL, V70, P485; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Duzova A, 2010, PEDIATR NEPHROL, V25, P1453, DOI 10.1007/s00467-010-1541-y; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hui-Stickle S, 2005, AM J KIDNEY DIS, V45, P96, DOI 10.1053/j.ajkd.2004.09.028; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Olowu WA, 2004, KIDNEY INT, V66, P1541, DOI 10.1111/j.1523-1755.2004.00918.x; Olowu WA, 2003, PEDIATR NEPHROL, V18, P1249, DOI 10.1007/s00467-003-1255-5; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Vachvanichsanong P, 2006, PEDIATRICS, V118, pE786, DOI 10.1542/peds.2006-0557; Van Biljon G, 2008, J TROP PEDIATRICS, V54, P233, DOI 10.1093/tropej/fmm079	21	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51229	10.1371/journal.pone.0051229	http://dx.doi.org/10.1371/journal.pone.0051229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251463	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900056
J	Huang, CY; Chen, CA; Chen, YL; Chiang, CJ; Hsu, TH; Lin, MC; Lai, MS; Chen, CJ; You, SL; Cheng, WF				Huang, Chia-Yen; Chen, Chi-An; Chen, Yu-Li; Chiang, Chun-Ju; Hsu, Tsui-Hsia; Lin, Ming-Chieh; Lai, Mei-Shu; Chen, Chien-Jen; You, San-Lin; Cheng, Wen-Fang			Nationwide Surveillance in Uterine Cancer: Survival Analysis and the Importance of Birth Cohort: 30-Year Population-Based Registry in Taiwan	PLOS ONE			English	Article							CLEAR-CELL-CARCINOMA; ENDOMETRIAL CANCER; BREAST-CANCER; PROGNOSIS; NORWAY; TRENDS; IMPACT; TUMORS; RISK	Introduction: Uterine cancer was the most rapidly increasing malignancy and the second most common gynecologic malignancy in Taiwan. Methods: We analyzed the secular trend of uterine cancer incidence and compare the survival of women with uterine carcinomas and uterine sarcomas in Taiwan. Data on women diagnosed with uterine cancer between 1979 and 2008 were obtained from the Taiwan cancer registry. Survival data were analyzed by using Kaplan-Meier and Cox proportional hazards regression methods. Results: Records of 11,558 women with uterine carcinomas and 1,226 women with uterine sarcomas were analyzed. The age-adjusted incidence rate of endometrioid adenocarcinoma increased from 0.83 per 100,000 women per year between 1979 and 1983 to 7.50 per 100,000 women per year between 2004 and 2008. The 5-year survival rate of women with endometrioid adenocarcinoma (83.2%) was higher than that for women with clear cell carcinoma (58.3%), serous carcinoma (54.4%), and carcinosarcoma (35.2%) (p<0.0001, log-rank test). The 5-year survival rates of women with low grade endometrial stromal sarcoma, endometrial stromal sarcoma, leiomyosarcoma (LMS), and adenosarcoma were 97.5%, 73.5%, 60.1%, and 77.2%, respectively (p<0.0001, log rank test). The histologic type of endometrioid adenocarcinoma, young age, and treatment period after 2000 were independent, favorable prognostic factors in women with uterine carcinomas by multivariate analysis. The histologic type of LMS, old age, and treatment period after 2000 were independent, poor prognostic factors in women with uterine sarcomas by multivariate analysis. Conclusions: An increase over time in the number of patients with endometrioid adenocarcinomas was noted in this 30-year, nationwide, population-based study. Histologic type, age and treatment period were survival factors for uterine cancers. A more comprehensive assessment of uterine cancers and patient care should be undertaken on this increasingly common type of cancer.	[You, San-Lin] Natl Def Med Ctr, Inst Life Sci, Sch Publ Hlth, Taipei, Taiwan; [Huang, Chia-Yen; Chen, Yu-Li] Cathay Gen Hosp, Gynecol Canc Ctr, Taipei, Taiwan; [Chen, Chi-An; Cheng, Wen-Fang] Natl Taiwan Univ, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Chiang, Chun-Ju; Lai, Mei-Shu; Chen, Chien-Jen] Natl Taiwan Univ, Grad Inst Epidemiol, Coll Publ Hlth, Taipei 10764, Taiwan; [Hsu, Tsui-Hsia] Execut Yuan, Bur Hlth Promot, Dept Hlth, Taipei, Taiwan; [Lin, Ming-Chieh] Natl Taiwan Univ, Dept Pathol, Taipei 10764, Taiwan; [You, San-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Grad Inst Oncol, Taipei 10764, Taiwan; [Huang, Chia-Yen; Cheng, Wen-Fang] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan	National Defense Medical Center; Cathay General Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	You, SL (corresponding author), Natl Def Med Ctr, Inst Life Sci, Sch Publ Hlth, Taipei, Taiwan.	yousl1990@ntu.edu.tw; wenfangcheng@yahoo.com	Chen, Chien-Jen/C-6976-2008; Chen, Chien-Jen/N-4723-2019	CHIANG, CHUN-JU/0000-0002-1330-5319; CHENG, WEN-FANG/0000-0002-3282-6304; Lai, Mei-shu/0000-0001-6130-3468; You, San-Lin/0000-0002-3192-3356; CHEN, CHI-AN/0000-0001-6670-7939				Abeler VM, 1996, CANCER, V78, P1740, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO;2-Y; ABELER VM, 1992, INT J GYNECOL CANCER, V2, P9, DOI 10.1046/j.1525-1438.1992.02010009.x; Albrektsen G, 2009, INT J GYNECOL CANCER, V19, P1062, DOI 10.1111/IGC.0b013e3181aaa950; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Boll D, 2012, INT J GYNECOL CANCER, V22, P599, DOI 10.1097/IGC.0b013e318244cedc; BRINTON LA, 1992, AM J OBSTET GYNECOL, V167, P1317, DOI 10.1016/S0002-9378(11)91709-8; Chan JK, 2011, J CLIN ONCOL, V29, P832, DOI 10.1200/JCO.2010.31.2124; Chen CY, 2007, SCI TOTAL ENVIRON, V378, P352, DOI 10.1016/j.scitotenv.2007.02.038; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Creasman WT, 2004, GYNECOL ONCOL, V95, P593, DOI 10.1016/j.ygyno.2004.08.019; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Dijkhuizen FPHLJ, 2000, CANCER, V89, P1765, DOI 10.1002/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F; Evans T, 2011, BRIT J CANCER, V104, P1505, DOI 10.1038/bjc.2011.68; Fang GC, 2004, CHEMOSPHERE, V54, P443, DOI 10.1016/S0045-6535(03)00706-9; Felix AS, 2010, CANCER CAUSE CONTROL, V21, P1851, DOI 10.1007/s10552-010-9612-8; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; HENDRICKSON M, 1982, AM J SURG PATHOL, V6, P93, DOI 10.1097/00000478-198203000-00002; KAY S, 1957, CANCER, V10, P124, DOI 10.1002/1097-0142(195701/02)10:1<124::AID-CNCR2820100118>3.0.CO;2-2; KILGORE LC, 1995, GYNECOL ONCOL, V56, P29, DOI 10.1006/gyno.1995.1005; Lai Fu-Ming, 1996, Proceedings of the National Science Council Republic of China Part B Life Sciences, V20, P71; Lee MM, 2005, CANCER CAUSE CONTROL, V16, P929, DOI 10.1007/s10552-005-4932-9; Lin CH, 2012, INT J CANCER, V130, P2629, DOI 10.1002/ijc.26249; Lin YC, 2003, PREV MED, V37, P233, DOI 10.1016/S0091-7435(03)00119-1; MACMAHON B, 1974, Gynecologic Oncology, V2, P122, DOI 10.1016/0090-8258(74)90003-1; Mariani A, 2000, GYNECOL ONCOL, V76, P348, DOI 10.1006/gyno.1999.5688; McCluggage WG, 2002, INT J GYNECOL CANCER, V12, P687, DOI 10.1046/j.1525-1438.2002.01151.x; Nordal RR, 1997, EUR J CANCER, V33, P907, DOI 10.1016/S0959-8049(97)00040-3; OLAH KS, 1991, EUR J CANCER, V27, P1095, DOI 10.1016/0277-5379(91)90300-3; OLAH KS, 1992, BRIT J OBSTET GYNAEC, V99, P590, DOI 10.1111/j.1471-0528.1992.tb13827.x; PARAZZINI F, 1991, GYNECOL ONCOL, V41, P1, DOI 10.1016/0090-8258(91)90246-2; Park JY, 2011, GYNECOL ONCOL, V122, P255, DOI 10.1016/j.ygyno.2011.04.021; PIVER MS, 1984, OBSTET GYNECOL, V64, P173; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SILVERBERG SG, 1973, CANCER-AM CANCER SOC, V31, P1127, DOI 10.1002/1097-0142(197305)31:5<1127::AID-CNCR2820310514>3.0.CO;2-E; Silverberg SGKR., 1992, AFIP ATLAS SER; Tavassoeli FA, 2003, WHO CLASSIFICATION T; TCRTF, 2009, CANC REG ANN REP; Ueda SM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.075; Yang PS, 1997, BRIT J CANCER, V75, P752, DOI 10.1038/bjc.1997.133	41	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51372	10.1371/journal.pone.0051372	http://dx.doi.org/10.1371/journal.pone.0051372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251510	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900073
J	Jones, SS				Jones, Susan S.			Human Toddlers' Attempts to Match Two Simple Behaviors Provide No Evidence for an Inherited, Dedicated Imitation Mechanism	PLOS ONE			English	Article							RATIONAL IMITATION; MIRROR NEURONS; INFANTS; 12-MONTH-OLD; RECOGNITION; EXPLORATION; PERCEPTION; SYSTEM; FMRI	Influential theories of imitation have proposed that humans inherit a neural mechanism - an "active intermodal matching" (AIM) mechanism or a mirror neuron system - that functions from birth to automatically match sensory input from others' actions to motor programs for performing those same actions, and thus produces imitation. To test these proposals, 160 1- to 2 1/2-year-old toddlers were asked to imitate two simple movements-bending the arm to make an elbow, and moving the bent elbow laterally. Both behaviors were almost certain to be in each child's repertoire, and the lateral movement was goal-directed (used to hit a plastic cup). Thus, one or both behaviors should have been imitable by toddlers with a functioning AIM or mirror neuron system. Each child saw the two behaviors repeated 18 times, and was encouraged to imitate. Children were also asked to locate their own elbows. Almost no children below age 2 imitated either behavior. Instead, younger children gave clear evidence of a developmental progression, from reproducing only the outcome of the models' movements (hitting the object), through trying (but failing) to reproduce the model's arm posture and/or the arm-cup relations they had seen, to accurate imitation of arm bending by age 2 and of both movements by age 2 1/2. Across age levels, almost all children who knew the word 'elbow' imitated both behaviors: very few who did not know the word imitated either behavior. The evidence is most consistent with a view of early imitation as the product of a complex system of language, cognitive, social, and motor competencies that develop in infancy. The findings do not rule out a role for an inherited neural mechanism, but they suggest that such a system would not by itself be sufficient to explain imitation at any age.	Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Jones, SS (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	jones1@indiana.edu	Jones, Susan/AAU-2060-2021					ABRAVANEL E, 1976, CHILD DEV, V47, P1032, DOI 10.2307/1128440; Anisfeld M, 1996, DEV REV, V16, P149, DOI 10.1006/drev.1996.0006; Anisfeld M., 2005, PERSPECTIVES IMITATI, P107; Anisfeld M, 2001, INFANCY, V2, P111, DOI 10.1207/S15327078IN0201_7; Barr R, 1996, INFANT BEHAV DEV, V19, P159, DOI 10.1016/S0163-6383(96)90015-6; Barr R, 2010, DEV REV, V30, P128, DOI 10.1016/j.dr.2010.03.001; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Brownell CA, 2010, CHILD DEV, V81, P797, DOI 10.1111/j.1467-8624.2010.01434.x; Buttelmann D, 2008, CHILD DEV, V79, P609, DOI 10.1111/j.1467-8624.2008.01146.x; Buttelmann D, 2007, DEVELOPMENTAL SCI, V10, pF31, DOI 10.1111/j.1467-7687.2007.00630.x; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Carpenter M, 2005, DEVELOPMENTAL SCI, V8, pF13, DOI 10.1111/j.1467-7687.2004.00385.x; Catmur C, 2008, EUR J NEUROSCI, V28, P1208, DOI 10.1111/j.1460-9568.2008.06419.x; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Collie R, 1999, DEV PSYCHOBIOL, V35, P83, DOI 10.1002/(SICI)1098-2302(199909)35:2<83::AID-DEV1>3.0.CO;2-S; Decety J., 2011, EMPATHY PHILOS PSYCH, P58, DOI DOI 10.1093/ACPROF:OSO/9780199539956.003.0006; Del Giudice M, 2009, DEVELOPMENTAL SCI, V12, P350, DOI 10.1111/j.1467-7687.2008.00783.x; Dinstein I, 2008, CURR BIOL, V18, pR13, DOI 10.1016/j.cub.2007.11.004; Elsner B, 2003, CONSCIOUS COGN, V12, P732, DOI 10.1016/S1053-8100(03)00073-4; Fenson L., 1993, MACARTHUR COMMUNICAT; Ferrari PF, 2009, PHILOS T R SOC B, V364, P2311, DOI 10.1098/rstb.2009.0062; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Gleissner B, 2000, DEVELOPMENTAL SCI, V3, P405, DOI 10.1111/1467-7687.00135; Gottlieb G, 2007, DEVELOPMENTAL SCI, V10, P1, DOI 10.1111/j.1467-7687.2007.00556.x; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Jones S. S., 2011, EARLY DEV BODY REPRE, P207; Jones SS, 2006, INFANT BEHAV DEV, V29, P126, DOI 10.1016/j.infbeh.2005.08.004; Jones SS, 1996, CHILD DEV, V67, P1952, DOI 10.2307/1131603; Jones SS, 2005, PERSPECTIVES IMITATI, V2, P55; Jones SS, 2007, PSYCHOL SCI, V18, P593, DOI 10.1111/j.1467-9280.2007.01945.x; Jones SS, 2009, PHILOS T R SOC B, V364, P2325, DOI 10.1098/rstb.2009.0045; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Lepage JF, 2007, DEVELOPMENTAL SCI, V10, P513, DOI 10.1111/j.1467-7687.2007.00631.x; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Masur EF, 1999, MERRILL PALMER QUART, V45, P392; Meltzoff A., 2010, HDB INFANT DEV, P345, DOI DOI 10.1002/9781444327564.CH11; Meltzoff A.N., 2005, PERSPECTIVES IMITATI, V2, P55; Meltzoff A. N., 1988, SOCIAL LEARNING PSYC, P319; Meltzoff A. N., 2002, IMITATIVE MIND DEV E, P19, DOI DOI 10.1017/CBO9780511489969.002; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meltzoff AN, 2010, WILEY BLACKWELL HDB, P49; Nadel J., 1999, IMITATION INFANCY; Nagy E, 2007, PEDIATR RES, V58, P749; Nehaniv CL, 2002, FROM ANIM ANIMAT, P41; Nielsen M, 2004, INFANT BEHAV DEV, V27, P342, DOI 10.1016/j.infbeh.2003.12.006; Paulus M, 2011, CHILD DEV, V82, P1047, DOI 10.1111/j.1467-8624.2011.01610.x; Pawlby S. J, 1977, STUDIES MOTHER INFAN, P203; Perra O, 2008, BRIT J DEV PSYCHOL, V26, P133, DOI 10.1348/026151007X224442; Piaget J, 1952, PLAY DREAMS IMITATIO; Ray E, 2011, DEVELOPMENTAL SCI, V14, P92, DOI 10.1111/j.1467-7687.2010.00961.x; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Schwier C, 2006, INFANCY, V10, P303, DOI 10.1207/s15327078in1003_6; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Tomasello M, 1998, BEHAV BRAIN SCI, V21, P703, DOI 10.1017/S0140525X98441748; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Van Geert P, 2008, MOD LANG J, V92, P179, DOI 10.1111/j.1540-4781.2008.00713.x; Want SC, 2002, DEVELOPMENTAL SCI, V5, P1, DOI 10.1111/1467-7687.00194; Wood JN, 2007, SCIENCE, V317, P1402, DOI 10.1126/science.1144663; Zmyj N, 2009, INFANCY, V14, P131, DOI 10.1080/15250000802569884	69	2	2	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51326	10.1371/journal.pone.0051326	http://dx.doi.org/10.1371/journal.pone.0051326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	052ML	23251500	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900070
J	Millrud, CR; Kvarnhammar, AM; Uddman, R; Bjornsson, S; Riesbeck, K; Cardell, LO				Millrud, Camilla Rydberg; Kvarnhammar, Anne Mansson; Uddman, Rolf; Bjornsson, Sven; Riesbeck, Kristian; Cardell, Lars Olaf			The Activation Pattern of Blood Leukocytes in Head and Neck Squamous Cell Carcinoma Is Correlated to Survival	PLOS ONE			English	Article							TUMOR-ASSOCIATED NEUTROPHILS; NATURAL-KILLER-CELLS; PERIPHERAL-BLOOD; LYMPHOCYTE RATIO; PREDICTS SURVIVAL; MONOCYTE COUNTS; OVARIAN-CANCER; T-LYMPHOCYTE; CYTOKINES; DISEASE	Head and neck squamous cell carcinoma (HNSCC) is known to cause substantial immunosuppression. The present study was designed to characterize blood leukocyte activation in HNSCC and to investigate if the individual activation pattern could be related to tumor progress and survival. The leukocyte activation profile of HNSCC patients and healthy controls was assessed with flow cytometry. HNSCC patients displayed increased numbers of monocytes, neutrophils and total leukocytes as well as an enhanced neutrophil/lymphocyte ratio. In addition, patients had a higher percentage of CD69(+), CD71(+) and CD98(+) T cell subsets and NK cells, and a reduced expression of L-selectin in CD14(high)CD16(+) monocytes and neutrophils, when compared to controls. These changes could be correlated to both tumor burden and spread to lymph nodes. Among the cancer patients an increased neutrophil/lymphocyte ratio, a low neutrophil and CD14(high) CD16(+) monocyte activation state and an elevated CD4/CD8 ratio were related to poor survival. In contrast, a high percentage of CD98(+) Th cells appeared to be associated with a better outcome. Taken together, the present data indicate that HNSCC causes activation of blood leukocytes and that the individual activation pattern can be linked to prognosis.	[Millrud, Camilla Rydberg; Kvarnhammar, Anne Mansson; Cardell, Lars Olaf] Karolinska Univ Hosp, Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Uddman, Rolf] Lund Univ, Skane Univ Hosp, Dept Otorhinolaryngol, Malmo, Sweden; [Bjornsson, Sven; Riesbeck, Kristian] Lund Univ, Skane Univ Hosp, Dept Lab Med Malmo, Malmo, Sweden	Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Cardell, LO (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Rydberg Millrud, Camilla/0000-0002-5873-2197; Riesbeck, Kristian/0000-0001-6274-6965	Swedish Medical Research Council; Karolinska Institutet; Skane University Hospital in Malmo	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet(Karolinska Institutet); Skane University Hospital in Malmo	The present work was supported by the Swedish Medical Research Council, Karolinska Institutet and Skane University Hospital in Malmo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarstad HJ, 2006, ACTA OTO-LARYNGOL, V126, P1326, DOI 10.1080/00016480600702092; Bose A, 2006, ORAL ONCOL, V42, P161, DOI 10.1016/j.oraloncology.2005.06.025; Bose Anamika, 2008, Cancer Immun, V8, P10; Boucek J, 2009, J CELL MOL MED; Cho H, 2009, CANCER IMMUNOL IMMUN, V58, P15, DOI 10.1007/s00262-008-0516-3; Cho H, 2009, BIOMARKERS, V14, P161, DOI 10.1080/13547500902777616; da Silveira EJD, 2010, EXP MOL PATHOL, V88, P171, DOI 10.1016/j.yexmp.2009.11.009; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Giuntoli RL, 2009, ANTICANCER RES, V29, P2875; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Heimdal JH, 2000, LARYNGOSCOPE, V110, P402, DOI 10.1097/00005537-200003000-00013; Heimdal JH, 1999, EUR ARCH OTO-RHINO-L, V256, P250, DOI 10.1007/s004050050152; HERBERMAN RB, 1981, SCIENCE, V214, P24, DOI 10.1126/science.7025208; Hirashima M, 1998, J CANCER RES CLIN, V124, P329, DOI 10.1007/s004320050178; Karlsson M, 2010, SCAND J IMMUNOL, V71, P362, DOI 10.1111/j.1365-3083.2010.02377.x; Koga Y, 2004, CANCER RES, V64, P1037, DOI 10.1158/0008-5472.CAN-03-1808; Kuss I, 2004, CLIN CANCER RES, V10, P3755, DOI 10.1158/1078-0432.CCR-04-0054; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lathers DMR, 2003, HUM IMMUNOL, V64, P1160, DOI 10.1016/j.humimm.2003.08.024; Pries R, 2006, EXPERT REV ANTICANC, V6, P1195, DOI 10.1586/14737140.6.9.1195; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Sheu BC, 1999, CANCER-AM CANCER SOC, V86, P1537, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1537::AID-CNCR21>3.0.CO;2-D; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Srivastava MK, 2012, IMMUNOTHERAPY-UK, V4, P291, DOI [10.2217/IMT.11.178, 10.2217/imt.11.178]; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Woods KV, 1998, CANCER RES, V58, P3132; Xie L, 2007, INT J MOL MED, V20, P493; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	29	43	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51120	10.1371/journal.pone.0051120	http://dx.doi.org/10.1371/journal.pone.0051120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251433	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900043
J	Otterbein, S; Abel, C; Heinemann, LV; Kaiser, J; Schmidt-Kassow, M				Otterbein, Sascha; Abel, Cornelius; Heinemann, Linda V.; Kaiser, Jochen; Schmidt-Kassow, Maren			P3b Reflects Periodicity in Linguistic Sequences	PLOS ONE			English	Article							ENTRAINMENT; ATTENTION; TIME; REGULARITY; LANGUAGE; SYNTAX	Temporal predictability is thought to affect stimulus processing by facilitating the allocation of attentional resources. Recent studies have shown that periodicity of a tonal sequence results in a decreased peak latency and a larger amplitude of the P3b compared with temporally random, i.e., aperiodic sequences. We investigated whether this applies also to sequences of linguistic stimuli (syllables), although speech is usually aperiodic. We compared aperiodic syllable sequences with two temporally regular conditions. In one condition, the interval between syllable onset was fixed, whereas in a second condition the interval between the syllables' perceptual center (p-center) was kept constant. Event-related potentials were assessed in 30 adults who were instructed to detect irregularities in the stimulus sequences. We found larger P3b amplitudes for both temporally predictable conditions as compared to the aperiodic condition and a shorter P3b latency in the p-center condition than in both other conditions. These findings demonstrate that even in acoustically more complex sequences such as syllable streams, temporal predictability facilitates the processing of deviant stimuli. Furthermore, we provide first electrophysiological evidence for the relevance of the p-center concept in linguistic stimulus processing.	[Otterbein, Sascha; Abel, Cornelius; Heinemann, Linda V.; Kaiser, Jochen; Schmidt-Kassow, Maren] Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany	Goethe University Frankfurt	Schmidt-Kassow, M (corresponding author), Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany.	schmidt.kassow@yahoo.de	Kaiser, Jochen/T-9184-2017	Kaiser, Jochen/0000-0001-6740-5000	German Research Foundation [DFG SCHM 2693/1-1]	German Research Foundation(German Research Foundation (DFG))	MSK was supported by a grant from the German Research Foundation (DFG SCHM 2693/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Boersma Paul, 2002, GLOT INT, V5, P341; Correa A, 2008, J NEUROPHYSIOL, V100, P1649, DOI 10.1152/jn.90656.2008; Coulson S, 1998, LANG COGNITIVE PROC, V13, P653, DOI 10.1080/016909698386410; Cummins F, 1998, J PHONETICS, V26, P145, DOI 10.1006/jpho.1998.0070; DAUER RM, 1983, J PHONETICS, V11, P51, DOI 10.1016/S0095-4470(19)30776-4; Dutoit T., 1997, INTRO TEXT TO SPEECH, DOI [DOI 10.1007/978-94-011-5730-8, 10.1007/978-94-011-5730-8]; Fraisse P., 1982, PSYCHOL MUSIC, V1, P149, DOI [DOI 10.1016/B978-0-12-213562-0.50010-3, 10.1016/B978-0-12-213562-0.50010-3]; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; Janker P., 1996, ELEMENTS GEN PHONETI, V7, P94; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JUSCZYK PW, 1993, CHILD DEV, V64, P675, DOI 10.2307/1131210; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lange K, 2010, INT J PSYCHOPHYSIOL, V78, P231, DOI 10.1016/j.ijpsycho.2010.08.003; Lange K, 2009, BRAIN COGNITION, V69, P127, DOI 10.1016/j.bandc.2008.06.004; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; MORTON J, 1976, PSYCHOL REV, V83, P405, DOI 10.1037/0033-295X.83.5.405; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Schmidt-Kassow M, 2008, BRAIN RES, V1226, P144, DOI 10.1016/j.brainres.2008.06.017; Schmidt-Kassow M, 2009, NEUROREPORT, V20, P1643, DOI 10.1097/WNR.0b013e328333b0c6; Schmidt-Kassow M, 2009, J COGNITIVE NEUROSCI, V21, P1693, DOI 10.1162/jocn.2008.21153; Schmidt-Kassow M, 2009, NEUROREPORT, V20, P31, DOI 10.1097/WNR.0b013e32831b4287; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Scott SK, 1998, PSYCHOL RES-PSYCH FO, V61, P4, DOI 10.1007/PL00008162; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661	32	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51419	10.1371/journal.pone.0051419	http://dx.doi.org/10.1371/journal.pone.0051419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	052ML	23251527	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900085
J	Peng, B; Gu, YX; Xiong, Y; Zheng, GP; He, ZM				Peng, Bo; Gu, Yixue; Xiong, Yan; Zheng, Guopei; He, Zhimin			Microarray-Assisted Pathway Analysis Identifies MT1X & NF kappa B as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; GASTRIC-CANCER; METALLOTHIONEIN; EXPRESSION; GENES; APOPTOSIS; PROTEINS; HEAD; CHEMORESISTANCE; CHEMOTHERAPY	We recently reported that TCRP1, a novel multidrug-resistance associated human gene, can mediate cisplatin resistance in OSCC cells. However, the molecular mechanism underlying this role of TCRP1 remained to be elucidated. In this study, by using Human Toxicology and Drug Resistance Microarray, we identified 30 genes with significantly different expression levels between Tca/PYM and TCRP1 knockdown cell lines. Co-immunoprecipitation experiments and GST-pull down assays showed that metallothionein1X (MT1X) and Akt interact with TCRP1. siRNA-mediated knockdown of TCRP1 and MT1X was found to sensitize cells to cisplatin, leading to increased apoptosis and inhibition of cell proliferation. These functions of TCRP1 may be caused at least in part via activation of the PI3K/Akt/NF-kappa B signaling pathway. Taken together, our findings indicate that TCRP1 may be an important drug target for improvement of the treatment and survival of patients with oral squamous cell carcinoma.	[Peng, Bo; Gu, Yixue; Zheng, Guopei; He, Zhimin] Guangzhou Med Univ, Affiliated Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Peng, Bo; Gu, Yixue; Zheng, Guopei; He, Zhimin] Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Xiong, Yan] Guangzhou Med Univ, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Peng, Bo] Univ S China, Canc Res Inst, Coll Med, Hengyang, Hunan, Peoples R China; [Peng, Bo; Gu, Yixue; Zheng, Guopei; He, Zhimin] Cent S Univ, Xiangya Sch Med, Canc Res Inst, Changsha, Hunan, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; University of South China; Central South University	He, ZM (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp, Guangzhou, Guangdong, Peoples R China.	hezhimin2005@yahoo.com			National Natural Science Foundation of China [30873088]; Nature Science Foundation of Guangdong Province in China [S2012010008995]; Science and Technology Committee of Hunan Province, China [2012SK3157]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Guangdong Province in China; Science and Technology Committee of Hunan Province, China	This research was supported by grants from the National Natural Science Foundation of China (30873088), Nature Science Foundation of Guangdong Province in China (S2012010008995) and the Science and Technology Committee of Hunan Province, China (2012SK3157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir TB, 2006, P NATL ACAD SCI USA, V103, P1699, DOI 10.1073/pnas.0510407103; Chock KL, 2010, CANCER RES, V70, P8782, DOI 10.1158/0008-5472.CAN-10-1352; CHU G, 1994, J BIOL CHEM, V269, P787; Chun JH, 2004, CANCER RES, V64, P4703, DOI 10.1158/0008-5472.CAN-04-1063; Fraser M, 2003, CANCER RES, V63, P7081; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Gu YX, 2011, MOL CELL BIOCHEM, V357, P107, DOI 10.1007/s11010-011-0880-8; Gu YX, 2011, FEBS LETT, V585, P881, DOI 10.1016/j.febslet.2010.12.045; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hebbring SJ, 2008, CYTOGENET GENOME RES, V123, P205, DOI 10.1159/000184710; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Jordan P, 2000, CELL MOL LIFE SCI, V57, P1229, DOI 10.1007/PL00000762; Kang HC, 2004, CLIN CANCER RES, V10, P272, DOI 10.1158/1078-0432.CCR-1025-3; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kim HG, 2009, TOXICOL SCI, V112, P435, DOI 10.1093/toxsci/kfp230; Kim MO, 2008, CANCER LETT, V271, P25, DOI 10.1016/j.canlet.2008.05.034; Kim MJ, 2007, CANCER LETT, V245, P284, DOI 10.1016/j.canlet.2006.01.017; Konkimalla VB, 2008, IN VIVO, V22, P279; Lee JY, 2009, ONCOGENE, V28, P824, DOI 10.1038/onc.2008.451; Lepper ER, 2005, CLIN CANCER RES, V11, P7398, DOI 10.1158/1078-0432.CCR-05-0520; Marsh S, 2009, PHARMACOGENET GENOM, V19, P563, DOI 10.1097/FPC.0b013e32832e0ed7; Meijer C, 2000, INT J CANCER, V85, P777, DOI 10.1002/(SICI)1097-0215(20000315)85:6<777::AID-IJC6>3.0.CO;2-D; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Peng B, 2012, PROTEIN EXPR PURIF; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; SATOH M, 1994, CANCER RES, V54, P5255; Stewart JJ, 2006, MOL CELL PROTEOMICS, V5, P433, DOI 10.1074/mcp.M500140-MCP200; Vernhet L, 2003, J PHARMACOL EXP THER, V304, P145, DOI 10.1124/jpet.102.042176; WINGE DR, 1991, METHOD ENZYMOL, V205, P438; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Yang F, 2007, PROTEIN EXPRES PURIF, V53, P186, DOI 10.1016/j.pep.2006.12.007; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200; Zhang P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-224; Zheng GP, 2012, FEBS LETT, V586, P163, DOI 10.1016/j.febslet.2011.11.034; Zheng GP, 2010, FEBS J, V277, P4506, DOI 10.1111/j.1742-4658.2010.07836.x	37	28	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51413	10.1371/journal.pone.0051413	http://dx.doi.org/10.1371/journal.pone.0051413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251525	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900082
J	Xu, J; Tian, HR; Wang, W; Liang, AH				Xu, Jing; Tian, Huaru; Wang, Wei; Liang, Aihua			The Zinc Finger Protein Zfr1p Is Localized Specifically to Conjugation Junction and Required for Sexual Development in Tetrahymena thermophila	PLOS ONE			English	Article							PROGRAMMED DNA ELIMINATION; GENOME REARRANGEMENT; MACRONUCLEAR ANLAGEN; GENE; EXCHANGE; IDENTIFICATION; TRANSFORMATION; EXPRESSION; ARGONAUTE; SEQUENCE	Conjugation in Tetrahymena thermophila involves a developmental program consisting of three prezygotic nuclear divisions, pronuclear exchange and fusion, and postzygotic and exconjugant stages. The conjugation junction structure appears during the initiation of conjugation development, and disappears during the exconjugant stage. Many structural and functional proteins are involved in the establishment and maintenance of the junction structure in T. thermophila. In the present study, a zinc finger protein-encoding gene ZFR1 was found to be expressed specifically during conjugation and to localize specifically to the conjugation junction region. Truncated Zfr1p localized at the plasma membrane in ordered arrays and decorated Golgi apparatus located adjacent to basal body. The N-terminal zinc finger and C-terminal hydrophobic domains of Zfr1p were found to be required for its specific conjugation junction localization. Conjugation development of ZFR1 somatic knockout cells was aborted at the pronuclear exchange and fusion conjugation stages. Furthermore, Zfr1p was found to be important for conjugation junction stability during the prezygotic nuclear division stage. Taken together, our data reveal that Zfr1p is required for the stability and integrity of the conjugation junction structure and essential for the sexual life cycle of the Tetrahymena cell.	[Xu, Jing; Tian, Huaru; Wang, Wei; Liang, Aihua] Shanxi Univ, Key Lab Chem Biol & Mol Engn, Minist Educ, Inst Biotechnol, Taiyuan, Peoples R China	Shanxi University	Wang, W (corresponding author), Shanxi Univ, Key Lab Chem Biol & Mol Engn, Minist Educ, Inst Biotechnol, Taiyuan, Peoples R China.	gene@sxu.edu.cn			National Natural Scientific Foundation of China [30770295, 31072000]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported by grants from the National Natural Scientific Foundation of China (30770295 and 31072000) to W. Wang. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIS CD, 1982, DEV BIOL, V93, P519, DOI 10.1016/0012-1606(82)90139-7; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bednenko J, 2009, MOL CELL BIOL, V29, P5020, DOI 10.1128/MCB.00076-09; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; CassidyHanley D, 1997, GENETICS, V146, P135; Chiu CF, 2008, EMBO J, V27, P934, DOI 10.1038/emboj.2008.40; Cole ES, 2008, J EUKARYOT MICROBIOL, V55, P245, DOI 10.1111/j.1550-7408.2008.00337.x; Cole ES, 1997, DEV BIOL, V189, P233, DOI 10.1006/dbio.1997.8649; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; DASILVA PP, 1982, CELL, V28, P441, DOI 10.1016/0092-8674(82)90198-2; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Elde NC, 2005, PLOS GENET, V1, P514, DOI 10.1371/journal.pgen.0010052; Gaertig J, 2000, J EUKARYOT MICROBIOL, V47, P590, DOI 10.1111/j.1550-7408.2000.tb00095.x; Gleason EJ, 2006, GENETICS, V172, P145, DOI 10.1534/genetics.105.047340; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; KURZ S, 1993, J EUKARYOT MICROBIOL, V40, P10, DOI 10.1111/j.1550-7408.1993.tb04874.x; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; MCDONALD BB, 1966, J PROTOZOOL, V13, P277, DOI 10.1111/j.1550-7408.1966.tb01908.x; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mochizuki K, 2008, GENE, V425, P79, DOI 10.1016/j.gene.2008.08.007; Noto T, 2010, CELL, V140, P692, DOI 10.1016/j.cell.2010.02.010; ORIAS JD, 1983, SCIENCE, V222, P181, DOI 10.1126/science.6623070; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Pucciarelli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039694; SHASTRY BS, 1984, J BIOL CHEM, V259, P1373; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; SUGANUMA Y, 1984, J ELECTRON MICROSC, V33, P10; Sugiura M, 2001, P NATL ACAD SCI USA, V98, P14446, DOI 10.1073/pnas.221457698; WOLFE J, 1982, J MORPHOL, V172, P159, DOI 10.1002/jmor.1051720204; Xiong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020124; Yin LH, 2010, EUKARYOT CELL, V9, P1343, DOI 10.1128/EC.00089-10; Zweifel E, 2009, EUKARYOT CELL, V8, P899, DOI 10.1128/EC.00342-08	40	5	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e52799	10.1371/journal.pone.0052799	http://dx.doi.org/10.1371/journal.pone.0052799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251712	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900119
J	Bianco, G; Fontanella, B; Severino, L; Quaroni, A; Autore, G; Marzocco, S				Bianco, Giuseppe; Fontanella, Bianca; Severino, Lorella; Quaroni, Andrea; Autore, Giuseppina; Marzocco, Stefania			Nivalenol and Deoxynivalenol Affect Rat Intestinal Epithelial Cells: A Concentration Related Study	PLOS ONE			English	Article							NATURAL OCCURRENCE; FUSARIUM TOXINS; OCHRATOXIN-A; MYCOTOXINS; TRICHOTHECENES; EXPOSURE; SURVIVAL; PROTEIN; FOOD; PHOSPHORYLATION	The integrity of the gastrointestinal tract represents a crucial first level defence against ingested toxins. Among them, Nivalenol is a trichotecenes mycotoxin frequently found on cereals and processed grains; when it contaminates human food and animal feed it is often associated with another widespread contaminant, Deoxynivalenol. Following their ingestion, intestinal epithelial cells are exposed to concentrations of these trichothecenes high enough to cause mycotoxicosis. In this study we have investigated the effects of Nivalenol and Deoxynivalenol on intestinal cells in an in vitro model system utilizing the non-tumorigenic rat intestinal epithelial cell line IEC-6. Both Nivalenol and Deoxynivalenol (5-80 mu M) significantly affected IEC-6 viability through a pro-apoptotic process which mainly involved the following steps: (i) Bax induction; (ii) Bcl-2 inhibition, and (iii) caspase-3 activation. Moreover, treatment with Nivalenol produced a significant cell cycle arrest of IEC-6 cells, primarily at the G(0)/G(1) interphase and in the S phase, with a concomitant reduction in the fraction of cells in G(2). Interestingly, when administered at lower concentrations (0.1-2.5 mu M), both Nivalenol and Deoxynivalenol affected epithelial cell migration (restitution), representing the initial step in gastrointestinal wound healing in the gut. This reduced motility was associated with significant remodelling of the actin cytoskeleton, and changes in expression of connexin-43 and focal adhesion kinase. The concentration range of Nivalenol or Deoxynivalenol we have tested is comparable with the mean estimated daily intake of consumers eating contaminated food. Thus, our results further highlight the risks associated with intake of even low levels of these toxins. Citation: Bianco G, Fontanella B, Severino L, Quaroni A, Autore G, et al. (2012) Nivalenol and Deoxynivalenol Affect Rat Intestinal Epithelial Cells: A Concentration Related Study. PLoS ONE 7(12): e52051. doi:10.1371/journal.pone.0052051	[Bianco, Giuseppe; Autore, Giuseppina; Marzocco, Stefania] Univ Salerno, Sch Pharm, Dept Pharmaceut & Biomed Sci, Fisciano, Italy; [Fontanella, Bianca] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Severino, Lorella] Univ Naples Federico II, Sch Vet Med, Div Toxicol, Dept Pathol & Anim Hlth, Naples, Italy; [Quaroni, Andrea] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	University of Salerno; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Cornell University	Marzocco, S (corresponding author), Univ Salerno, Sch Pharm, Dept Pharmaceut & Biomed Sci, Fisciano, Italy.	smarzocco@unisa.it	Marzocco, Stefania/AAI-1493-2020	Severino, Lorella/0000-0001-8597-0724; SEVERINO, LORELLA/0000-0002-0734-9649	University of Salerno; Fondazione Telethon Funding Source: Custom	University of Salerno; Fondazione Telethon(Fondazione Telethon)	This work was supported by grant from the University of Salerno (FARB 2011). No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBASSAM MA, 1987, VET PATHOL, V24, P427, DOI 10.1177/030098588702400510; AZCONAOLIVERA JI, 1995, TOXICOL APPL PHARM, V133, P109, DOI 10.1006/taap.1995.1132; Bianco G, 2012, TOXICON, V59, P644, DOI 10.1016/j.toxicon.2012.02.010; Bony S, 2007, TOXICOL IN VITRO, V21, P457, DOI 10.1016/j.tiv.2006.10.014; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Bretz M, 2006, J AGR FOOD CHEM, V54, P6445, DOI 10.1021/jf061008g; Cioffi G, 2006, J NAT PROD, V69, P1323, DOI 10.1021/np060257w; EC, 2003, REP TASK SCI COOP; Edwards SG, 2004, TOXICOL LETT, V153, P29, DOI 10.1016/j.toxlet.2004.04.022; Eriksen GS, 2003, FOOD ADDIT CONTAM A, V20, P579, DOI 10.1080/0265203031000102573; Eskola M, 2001, FOOD ADDIT CONTAM A, V18, P707, DOI 10.1080/02652030110047667; GOODENOU.DA, 1974, J CELL BIOL, V61, P557, DOI 10.1083/jcb.61.2.557; GOODENOUGH DA, 1975, AM J CLIN PATHOL, V63, P636; Hao HF, 2009, WORLD J GASTROENTERO, V15, P5916, DOI 10.3748/wjg.15.5916; Hazel CM, 2004, TOXICOL LETT, V153, P51, DOI 10.1016/j.toxlet.2004.04.040; Heussner AH, 2006, TOXICOL IN VITRO, V20, P332, DOI 10.1016/j.tiv.2005.08.003; Hsia CC, 2004, ONCOL REP, V12, P449; HSIA CC, 1988, CANCER DETECT PREV, V13, P79; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Kasuga F, 1998, MYCOPATHOLOGIA, V142, P161, DOI 10.1023/A:1006923808748; Kenichi S, 2006, J GASTROENTEROL, V41, P450; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Larsen JC, 2004, TOXICOL LETT, V153, P1, DOI 10.1016/j.toxlet.2004.04.020; Leaphart CL, 2007, GASTROENTEROLOGY, V132, P2395, DOI 10.1053/j.gastro.2007.03.029; Leblanc JC, 2005, FOOD ADDIT CONTAM, V22, P652, DOI 10.1080/02652030500159938; Luongo D, 2008, TOXICON, V52, P156, DOI 10.1016/j.toxicon.2008.04.162; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Marzocco S, 2010, NEUROCHEM INT, V57, P518, DOI 10.1016/j.neuint.2010.06.016; Marzocco S, 2009, TOXICOL LETT, V189, P21, DOI 10.1016/j.toxlet.2009.04.024; MCGUIRE PG, 1989, J CELL BIOCHEM, V40, P215, DOI 10.1002/jcb.240400210; Meky FA, 2003, FOOD CHEM TOXICOL, V41, P265, DOI 10.1016/S0278-6915(02)00228-4; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Prelusky DB, 1996, FOOD ADDIT CONTAM, V13, P155, DOI 10.1080/02652039609374393; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rotter BA, 1996, J ENVIRON SCI HEAL B, V31, P1279, DOI 10.1080/03601239609373067; RYU JC, 1988, FUND APPL TOXICOL, V11, P38, DOI 10.1016/0272-0590(88)90268-0; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; SHEPHARD GS, 1995, FOOD CHEM TOXICOL, V33, P591, DOI 10.1016/0278-6915(95)00022-T; Speijers GJA, 2004, TOXICOL LETT, V153, P91, DOI 10.1016/j.toxlet.2004.04.046; SUGIURA Y, 1993, APPL ENVIRON MICROB, V59, P3334, DOI 10.1128/AEM.59.10.3334-3338.1993; TANAKA T, 1985, FOOD ADDIT CONTAM, V2, P259, DOI 10.1080/02652038509373554; UENO Y, 1985, CRC CR REV TOXICOL, V14, P99, DOI 10.3109/10408448509089851; Van de Walle J, 2010, TOXICOL APPL PHARM, V245, P291, DOI 10.1016/j.taap.2010.03.012; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Videmann B, 2007, FOOD CHEM TOXICOL, V45, P1938, DOI 10.1016/j.fct.2007.04.011; Zhang HFM, 2006, AM J PHYSIOL-CELL PH, V290, pC1310, DOI 10.1152/ajpcell.00450.2005	55	53	57	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52051	10.1371/journal.pone.0052051	http://dx.doi.org/10.1371/journal.pone.0052051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251682	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800135
J	Wong, LP				Wong, Li Ping			Qualitative Inquiry into Premarital Sexual Behaviours and Contraceptive Use among Multiethnic Young Women: Implications for Education and Future Research	PLOS ONE			English	Article							RISK BEHAVIOR; ADOLESCENTS; ATTITUDES; PARENT; INTERVENTIONS; ACCULTURATION; COMMUNICATION; ASSOCIATIONS; RELIGIOSITY; INTERCOURSE	Background: This study was a qualitative investigation into sexual attitudes and behaviours, and contraceptive use among Malaysian youth, based on constructs from the health belief model, theory of reasoned action, and problem behaviour theory. Methods: A total of 34 focus group discussions with 185 participants were conducted among the Malay (35%), Chinese (34%), and Indian (31%) young females between November, 2010 and April, 2011. The participants were secondary school students and university undergraduates from Selangor and the Federal Territory of Kuala Lumpur. Results: The study found a lack of knowledge about sexual issues and contraception among the participants. Many engaged in unprotected sexual intercourse and relied on periodic abstinence, natural methods, and traditional folk pregnancy preventive practices. The findings also revealed numerous categories of factors influencing sexual attitudes and behaviours: ethnic group and religion, level of religiosity, peer pressure and norms, and parental monitoring. With regard to condom use, factors such as embarrassment about condom acquisition, low perceived susceptibility to sexually transmitted infections (STIs), and perceived efficacy of traditional and folk methods of contraception, were uncovered from the discussions. Conclusion: This study underscores the importance of development of culturally specific interventions that address the identified promoting factors of premarital sex. Behavioral interventions to promote condom use should increase awareness about condom effectiveness against not only unwanted pregnancies but also STIs. Citation: Wong LP (2012) Qualitative Inquiry into Premarital Sexual Behaviours and Contraceptive Use among Multiethnic Young Women: Implications for Education and Future Research. PLoS ONE 7(12): e51745. doi:10.1371/journal.pone.0051745	[Wong, Li Ping] Univ Malaya, Dept Social & Prevent Med, Ctr Populat Hlth CePH, Kuala Lumpur, Malaysia; [Wong, Li Ping] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr Univ Malaya, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Wong, LP (corresponding author), Univ Malaya, Dept Social & Prevent Med, Ctr Populat Hlth CePH, Kuala Lumpur, Malaysia.	wonglp@ummc.edu.my	WONG, LI PING/B-2782-2010	WONG, LI PING/0000-0002-0107-0532	University Malaya (High Impact Research Grant) [UM.C/625/1/HIR/034]	University Malaya (High Impact Research Grant)	This study was funded by University Malaya (High Impact Research Grant UM.C/625/1/HIR/034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckwith Jessica, 2006, Mcgill J Med, V9, P119; Brotto LA, 2005, ARCH SEX BEHAV, V34, P613, DOI 10.1007/s10508-005-7909-6; Browning CR, 2005, AM SOCIOL REV, V70, P758, DOI 10.1177/000312240507000502; Doswell Willa M, 2011, J Pediatr Nurs, V26, pe45, DOI 10.1016/j.pedn.2011.03.007; Downing J, 2011, HEALTH EDUC RES, V26, P808, DOI 10.1093/her/cyr019; ERICKSEN KP, 1994, FAM PLANN PERSPECT, V26, P257, DOI 10.2307/2135891; Fishbein M., 1975, BELIEF ATTITUDE INTE; Forehand R, 2005, PERSPECT SEX REPRO H, V37, P13, DOI 10.1363/3701305; Frost JJ, 2008, PERSPECT SEX REPRO H, V40, P94, DOI 10.1363/4009408; Gillmore MR, 2002, J MARRIAGE FAM, V64, P885, DOI 10.1111/j.1741-3737.2002.00885.x; Glynn JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022840; GORGEN R, 1993, STUD FAMILY PLANN, V24, P283, DOI 10.2307/2939222; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P740, DOI 10.1136/bmj.315.7110.740; Guzman BL, 2003, J COMMUNITY APPL SOC, V13, P269, DOI 10.1002/casp.735; Hahm HC, 2006, PERSPECT SEX REPRO H, V38, P28, DOI 10.1363/3802806; HEROLD ES, 1983, J SCHOOL HEALTH, V53, P19, DOI 10.1111/j.1746-1561.1983.tb04047.x; Holtzman D, 1995, FAM PLANN PERSPECT, V27, P235, DOI 10.2307/2136175; Huang M.S.L., 1999, CASE STUDY MALAYSIA; Jan JM, 2005, NATL STUDY REPROD RI; Janz NK, 2002, HLTH BEHAV HLTH ED T, P45, DOI DOI 10.1177/109019819101800409; Jessor R., 1977, PROBLEM BEHAV PSYCHO; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Larkins SL, 2007, MED J AUSTRALIA, V186, P513, DOI 10.5694/j.1326-5377.2007.tb01025.x; Lee L. K., 2006, SMJ Singapore Medical Journal, V47, P476; Lefkowitz ES, 2004, J SEX RES, V41, P150, DOI 10.1080/00224490409552223; LEIBLUM S., 2003, SEX RELATSH THER, V18, P473, DOI [10.1080/14681990310001609813, DOI 10.1080/14681990310001609813]; Madkour AS, 2010, J ADOLESCENT HEALTH, V47, P389, DOI 10.1016/j.jadohealth.2010.02.008; METZLER CW, 1994, J BEHAV MED, V17, P419, DOI 10.1007/BF01858012; Miller BC, 2002, J SEX RES, V39, P22, DOI 10.1080/00224490209552115; Miller L, 2002, J ADOLESCENT HEALTH, V31, P401, DOI 10.1016/S1054-139X(02)00403-2; Modeste N N, 1993, Int Q Community Health Educ, V14, P273, DOI 10.2190/1W2E-MXYX-GUGT-FYPR; Mohammodi MR, 2006, INT FAM PLAN PERSPEC, V32, P35, DOI 10.1363/3203506; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Noar SM, 2008, AIDS BEHAV, V12, P335, DOI 10.1007/s10461-007-9313-9; Pedlow CT, 2004, ANN BEHAV MED, V27, P172, DOI 10.1207/s15324796abm2703_5; Reid AE, 2011, PSYCHOL HEALTH, V26, P1499, DOI 10.1080/08870446.2011.572259; Romer D, 1999, ARCH PEDIAT ADOL MED, V153, P1055, DOI 10.1001/archpedi.153.10.1055; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; SHEERAN P, 1993, EUR J SOC PSYCHOL, V23, P39, DOI 10.1002/ejsp.2420230104; Stretcher V. J., 1997, HLTH BEHAV HLTH ED T, P113, DOI DOI 10.1111/J.1365-2648.2010.05450.X; Tapia-Aguirre V, 2004, ARCH MED RES, V35, P334, DOI 10.1016/j.arcmed.2004.05.002; Turnbull T, 2008, HEALTH EDUC J, V67, P182, DOI 10.1177/0017896908094636; Wallace SA, 2008, AIDS EDUC PREV, V20, P360, DOI 10.1521/aeap.2008.20.4.360; Whitaker DJ, 2000, J ADOLESCENT RES, V15, P251, DOI 10.1177/0743558400152004; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World Health Organization, 2007, SEX REPR HLTH AD YOU	47	21	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51745	10.1371/journal.pone.0051745	http://dx.doi.org/10.1371/journal.pone.0051745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23272156	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800077
J	Kalle, M; Papareddy, P; Kasetty, G; Morgelin, M; van der Plas, MJA; Rydengard, V; Malmsten, M; Albiger, B; Schmidtchen, A				Kalle, Martina; Papareddy, Praveen; Kasetty, Gopinath; Morgelin, Matthias; van der Plas, Mariena J. A.; Rydengard, Victoria; Malmsten, Martin; Albiger, Barbara; Schmidtchen, Artur			Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; SEPTIC SHOCK; INFECTIONS; LL-37; PATHOPHYSIOLOGY; PROTEINASES; MECHANISMS	Gram-negative sepsis is accompanied by a disproportionate innate immune response and excessive coagulation mainly induced by endotoxins released from bacteria. Due to rising antibiotic resistance and current lack of other effective treatments there is an urgent need for new therapies. We here present a new treatment concept for sepsis and endotoxin-mediated shock, based on host defense peptides from the C-terminal part of human thrombin, found to have a broad and inhibitory effect on multiple sepsis pathologies. Thus, the peptides abrogate pro-inflammatory cytokine responses to endotoxin in vitro and in vivo. Furthermore, they interfere with coagulation by modulating contact activation and tissue factor-mediated clotting in vitro, leading to normalization of coagulation responses in vivo, a previously unknown function of host defense peptides. In a mouse model of Pseudomonas aeruginosa sepsis, the peptide GKY25, while mediating a modest antimicrobial effect, significantly inhibited the pro-inflammatory response, decreased fibrin deposition and leakage in the lungs, as well as reduced mortality. Taken together, the capacity of such thrombin-derived peptides to simultaneously modulate bacterial levels, pro-inflammatory responses, and coagulation, renders them attractive therapeutic candidates for the treatment of invasive infections and sepsis. Citation: Kalle M, Papareddy P, Kasetty G, Morgelin M, van der Plas MJA, et al. (2012) Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis. PLoS ONE 7(12): e51313. doi:10.1371/journal.pone.0051313	[Kalle, Martina; Papareddy, Praveen; Kasetty, Gopinath; van der Plas, Mariena J. A.; Rydengard, Victoria; Albiger, Barbara; Schmidtchen, Artur] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Albiger, Barbara] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden	Lund University; Lund University; Uppsala University; European Centre for Disease Prevention & Control	Kalle, M (corresponding author), Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.	martina.kalle@med.lu.se	van der Plas, Mariena/GYV-3702-2022; Schmidtchen, Artur/F-9507-2015	Malmsten, Martin/0000-0003-0046-5599; Papareddy, Praveen/0000-0002-3872-478X; van der Plas, Mariena/0000-0002-3233-2881	Swedish Research Council [2009-3378, 2009-3009)]; Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; XImmune AB; Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Crafoord Foundation; Osterlund Foundation; Kock Foundation; XImmune AB; Swedish Government Funds for Clinical Research (ALF)	This work was supported by grants from the Swedish Research Council (projects 2009-3378 and 2009-3009), the Welander-Finsen, Knut and Alice Wallenberg, Crafoord, Osterlund, and Kock Foundations, XImmune AB, and the Swedish Government Funds for Clinical Research (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, CRIT CARE MED, V28, pS31, DOI 10.1097/00003246-200009001-00007; Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Brown KL, 2007, TRENDS IMMUNOL, V28, P260, DOI 10.1016/j.it.2007.04.005; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Castellino FJ, 2011, BLOOD, V117, P283, DOI 10.1182/blood-2010-07-299057; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dellinger RP, 2008, J CRIT CARE, V23, P493, DOI 10.1016/j.jcrc.2007.12.022; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Hirsch T, 2008, SHOCK, V30, P117, DOI 10.1097/SHK.0b013e318160de11; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kasetty G, 2011, J INNATE IMMUN, V3, P471, DOI 10.1159/000327016; Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10; Kohler Thilo, 2009, Rev Med Suisse, V5, P732; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lee K. H., 1993, Singapore Medical Journal, V34, P245; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Levi M, 2011, BLOOD REV, V25, P33, DOI 10.1016/j.blre.2010.09.002; Lolis E, 2003, NAT REV DRUG DISCOV, V2, P635, DOI 10.1038/nrd1153; Mackman N, 2006, BLOOD CELL MOL DIS, V36, P104, DOI 10.1016/j.bcmd.2005.12.008; Marshall JC, 2010, CONTRIB NEPHROL, V167, P1, DOI 10.1159/000315914; MESZAROS K, 1994, BLOOD, V83, P2516; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; Oehmcke S, 2009, BLOOD, V114, P444, DOI 10.1182/blood-2008-10-182527; Osterud B, 2010, THROMB RES, V125, pS31, DOI 10.1016/j.thromres.2010.01.032; Page MGP, 2009, CURR OPIN PHARMACOL, V9, P558, DOI 10.1016/j.coph.2009.08.006; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schmidtchen A, 2009, J BIOL CHEM, V284, P17584, DOI 10.1074/jbc.M109.011650; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Semple F, 2011, EUR J IMMUNOL, V41, P3291, DOI 10.1002/eji.201141648; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; van Delden C, 2007, INT J ANTIMICROB AG, V30, pS71, DOI 10.1016/j.ijantimicag.2007.06.015; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Yeaman MR, 2006, CURR TOP MICROBIOL, V306, P111; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U	51	55	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51313	10.1371/journal.pone.0051313	http://dx.doi.org/10.1371/journal.pone.0051313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272096	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386600022
J	Neuzillet, Y; Paoletti, X; Ouerhani, S; Mongiat-Artus, P; Soliman, H; de The, H; Sibony, M; Denoux, Y; Molinie, V; Herault, A; Lepage, ML; Maille, P; Renou, A; Vordos, D; Abbou, CC; Bakkar, A; Asselain, B; Kourda, N; El Gaaied, A; Leroy, K; Laplanche, A; Benhamou, S; Lebret, T; Allory, Y; Radvanyi, F				Neuzillet, Yann; Paoletti, Xavier; Ouerhani, Slah; Mongiat-Artus, Pierre; Soliman, Hany; de The, Hugues; Sibony, Mathilde; Denoux, Yves; Molinie, Vincent; Herault, Aurelie; Lepage, May-Linda; Maille, Pascale; Renou, Audrey; Vordos, Dimitri; Abbou, Claude-Clement; Bakkar, Ashraf; Asselain, Bernard; Kourda, Nadia; El Gaaied, Amel; Leroy, Karen; Laplanche, Agnes; Benhamou, Simone; Lebret, Thierry; Allory, Yves; Radvanyi, Francois			A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer	PLOS ONE			English	Article							UROTHELIAL CELL-CARCINOMA; FACTOR RECEPTOR-3 MUTATIONS; PROGNOSTIC-FACTORS; FUNCTIONAL ASSAY; GENE-MUTATIONS; PATHWAYS; TUMORS; DYSPLASIA; GRADE	TP53 and FGFR3 mutations are the most common mutations in bladder cancers. FGFR3 mutations are most frequent in low-grade low-stage tumours, whereas TP53 mutations are most frequent in high-grade high-stage tumours. Several studies have reported FGFR3 and TP53 mutations to be mutually exclusive events, whereas others have reported them to be independent. We carried out a meta-analysis of published findings for FGFR3 and TP53 mutations in bladder cancer (535 tumours, 6 publications) and additional unpublished data for 382 tumours. TP53 and FGFR3 mutations were not independent events for all tumours considered together (OR = 0.25 [0.18-0.37], p = 0.0001) or for pT1 tumours alone (OR = 0.47 [0.28-0.79], p = 0.0009). However, if the analysis was restricted to pTa tumours or to muscle-invasive tumours alone, FGFR3 and TP53 mutations were independent events (OR = 0.56 [0.23-1.36] (p = 0.12) and OR = 0.99 [0.37-2.7] (p = 0.35), respectively). After stratification of the tumours by stage and grade, no dependence was detected in the five tumour groups considered (pTaG1 and pTaG2 together, pTaG3, pT1G2, pT1G3, pT2-4). These differences in findings can be attributed to the putative existence of two different pathways of tumour progression in bladder cancer: the CIS pathway, in which FGFR3 mutations are rare, and the Ta pathway, in which FGFR3 mutations are frequent. TP53 mutations occur at the earliest stage of the CIS pathway, whereas they occur would much later in the Ta pathway, at the T1G3 or muscle-invasive stage. Citation: Neuzillet Y, Paoletti X, Ouerhani S, Mongiat-Artus P, Soliman H, et al. (2012) A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer. PLoS ONE 7(12): e48993. doi: 10.1371/journal.pone.0048993	[Neuzillet, Yann; Ouerhani, Slah; Herault, Aurelie; Lepage, May-Linda; Radvanyi, Francois] Inst Curie, Ctr Rech, Paris, France; [Neuzillet, Yann; Lebret, Thierry] Univ Versailles, Hop Foch, Dept Urol, Suresnes, France; [Neuzillet, Yann; Ouerhani, Slah; Herault, Aurelie; Lepage, May-Linda; Radvanyi, Francois] CNRS, UMR144, Paris, France; [Paoletti, Xavier; Asselain, Bernard] INSERM, Inst Curie, Dept Biostat, U900, Paris, France; [Ouerhani, Slah; Abbou, Claude-Clement; Allory, Yves] Hop Henri Mondor, INSERM, Unite 855, F-94010 Creteil, France; [Ouerhani, Slah; El Gaaied, Amel] Fac Sci Tunis, Tunis 1060, Tunisia; [Ouerhani, Slah] Inst Pasteur, Tunis, Tunisia; [Mongiat-Artus, Pierre] Univ Paris 07, Hop St Louis, APHP, Dept Urol, Paris, France; [Mongiat-Artus, Pierre; Soliman, Hany] Univ Paris 07, Inst Univ Hematol, INSERM U944, Paris, France; [Soliman, Hany; de The, Hugues] Hop St Louis, APHP, Dept Biochem, Paris, France; [de The, Hugues] Univ Paris 07, CNRS, UMR7151, Paris, France; [Sibony, Mathilde] Hop Tenon, APHP, Dept Pathol, F-75970 Paris, France; [Denoux, Yves] Hop Foch, Dept Pathol, Suresnes, France; [Molinie, Vincent] Hop St Joseph, Dept Pathol, F-75674 Paris, France; [Maille, Pascale; Renou, Audrey; Leroy, Karen; Allory, Yves] Hop Henri Mondor, APHP, Dept Pathol, F-94010 Creteil, France; [Vordos, Dimitri; Abbou, Claude-Clement] Hop Henri Mondor, APHP, Dept Urol, F-94010 Creteil, France; [Bakkar, Ashraf] Sinai Univ, Cairo, Egypt; [Kourda, Nadia] Hop Charles Nicolle, Tunis, Tunisia; [Laplanche, Agnes; Benhamou, Simone] Inst Gustave Roussy, INSERM, CNRS FRE2939, U794, F-94805 Villejuif, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Foch; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Egyptian Knowledge Bank (EKB); Sinai University; Universite de Tunis-El-Manar; Hopital Charles Nicolle; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Radvanyi, F (corresponding author), Inst Curie, Ctr Rech, Paris, France.	francois.radvanyi@curie.fr	Elgaaied, Amel Ben Ammar/AAL-1183-2020; Benhamou, Simone/ABD-2590-2020; Leroy, Karen/E-9235-2011; Bakkar, Ashraf/Q-7089-2019; Benhamou, Simone/K-6554-2015	Leroy, Karen/0000-0002-4379-0140; Radvanyi, Francois/0000-0002-5696-6424; NEUZILLET, Yann/0000-0003-4345-3598; Sibony, Mathilde/0000-0002-1282-8732; ouerhani, slah/0000-0002-3651-4690; BENHAMOU, Simone/0000-0001-5853-8047; Bakkar, Ashraf/0000-0001-8927-9615	Centre National de la Recherche Scientifique (CNRS); Institut Curie; Institut National de la Sante et de la Recherche Medicale (INSERM); Assistance Publique - Hopitaux de Paris (APHP); Ligue Nationale Contre le Cancer (CIT program); Institut National Contre le Cancer (INCa); Canceropole Ile de France; Association pour la Recherche sur le Cancer (ARC)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assistance Publique - Hopitaux de Paris (APHP); Ligue Nationale Contre le Cancer (CIT program); Institut National Contre le Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile de France(Region Ile-de-France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the the Centre National de la Recherche Scientifique (CNRS), Institut Curie, Institut National de la Sante et de la Recherche Medicale (INSERM), Assistance Publique - Hopitaux de Paris (APHP), Ligue Nationale Contre le Cancer (CIT program and YN, SO, AH, M-LL, FR, Equipe labellisee), Institut National Contre le Cancer (INCa) and Canceropole Ile de France. Yann Neuzillet was supported by a fellowship from Association pour la Recherche sur le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkar AA, 2005, CLIN CHEM, V51, P1555, DOI 10.1373/clinchem.2005.049619; Bakkar AA, 2003, CANCER RES, V63, P8108; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Camplejohn RS, 2000, BRIT J CANCER, V82, P1145; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Giedl Johannes, 2006, Verh Dtsch Ges Pathol, V90, P253; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hartmann A, 2002, CANCER RES, V62, P809; Hernandez S, 2005, CLIN CANCER RES, V11, P5444, DOI 10.1158/1078-0432.CCR-05-0122; ISHIOKA C, 1993, NAT GENET, V5, P124, DOI 10.1038/ng1093-124; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kimura T, 2001, CANCER-AM CANCER SOC, V92, P2555, DOI 10.1002/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M; Knowles MA, 2007, WORLD J UROL, V25, P581, DOI 10.1007/s00345-007-0213-4; Lamy A, 2006, J UROLOGY, V176, P2686, DOI 10.1016/j.juro.2006.07.132; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lindgren D, 2006, ONCOGENE, V25, P2685, DOI 10.1038/sj.onc.1209249; Millan-Rodriguez F, 2000, J UROLOGY, V163, P73, DOI 10.1016/S0022-5347(05)67975-X; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ouerhani S, 2009, CANCER INVEST, V27, P998, DOI 10.3109/07357900902849707; Platz CE, 1996, MODERN PATHOL, V9, P1035; Rebouissou S, 2012, J PATHOL, V227, P315, DOI 10.1002/path.4017; Reuter VE, 1999, UROL CLIN N AM, V26, P481, DOI 10.1016/S0094-0143(05)70196-8; Simon R, 2002, ONCOGENE, V21, P2476, DOI 10.1038/sj.onc.1205304; SPRUCK CH, 1994, CANCER RES, V54, P784; Vallot C, 2011, JNCI-J NATL CANCER I, V103, P47, DOI 10.1093/jnci/djq470; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; van Rhijn BSW, 2004, CANCER RES, V64, P1911, DOI 10.1158/0008-5472.CAN-03-2421; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Zieger K, 2005, CLIN CANCER RES, V11, P7709, DOI 10.1158/1078-0432.CCR-05-1130	34	33	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e48993	10.1371/journal.pone.0048993	http://dx.doi.org/10.1371/journal.pone.0048993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272046	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600003
J	Tumwebaze, H; Tumwesigye, E; Baeten, JM; Kurth, AE; Revall, J; Murnane, PM; Chang, LW; Celum, C				Tumwebaze, Henry; Tumwesigye, Elioda; Baeten, Jared M.; Kurth, Ann E.; Revall, Jennifer; Murnane, Pamela M.; Chang, Larry W.; Celum, Connie			Household-Based HIV Counseling and Testing as a Platform for Referral to HIV Care and Medical Male Circumcision in Uganda: A Pilot Evaluation	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTION; INTERVENTION; PREVENTION; DISTRICT; AFRICA; ADULTS	Background: Combination HIV prevention initiatives incorporate evidence-based, biomedical and behavioral interventions appropriate and acceptable to specific populations, aiming to significantly reduce population-level HIV incidence. Knowledge of HIV serostatus is key to linkages to HIV care and prevention. Household-based HIV counseling and testing (HBCT) can achieve high HIV testing rates. We evaluated HBCT as a platform for delivery of combination HIV prevention services in sub-Saharan Africa. Methods: We conducted HBCT in a semi-urban area in southwestern Uganda. All adults received standard HIV prevention messaging. Real-time electronic data collection included a brief risk assessment and prevention triage algorithm for referrals of HIV seropositive persons to HIV care and uncircumcised HIV seronegative men with multiple sex partners to male circumcision. Monthly follow-up visits for 3 months were conducted to promote uptake of HIV care and male circumcision. Results: 855 households received HBCT; 1587 of 1941 (81.8%) adults were present at the HBCT visit, 1557 (98.1% of those present) were tested and received HIV results, of whom, 46.5% were men. A total of 152 (9.8%) were HIV seropositive, for whom the median CD4 count was 456 cells/mu L, and 50.7% were newly-identified as HIV seropositive. Three months after HBCT, 88.5% of HIV seropositive persons had attended an HIV care clinic; among those with CD4 counts < 250 cells/mu L, 71.4% initiated antiretroviral therapy. Among 123 HIV seronegative men with an HIV+ partner or multiple partners, 62.0% were circumcised by month 3. Conclusions: HBCT achieves high levels of knowledge of HIV serostatus and is an effective platform for identifying at-risk persons and achieving higher uptake of HIV prevention and care services through referrals and targeted follow-up than has been accomplished through other single focus strategies. Citation: Tumwebaze H, Tumwesigye E, Baeten JM, Kurth AE, Revall J, et al. (2012) Household-Based HIV Counseling and Testing as a Platform for Referral to HIV Care and Medical Male Circumcision in Uganda: A Pilot Evaluation. PLoS ONE 7(12): e51620. doi:10.1371/journal.pone.0051620	[Baeten, Jared M.; Revall, Jennifer; Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Tumwebaze, Henry; Tumwesigye, Elioda] Integrated Community Based Initiat, Kabwohe, Uganda; [Baeten, Jared M.; Celum, Connie] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Baeten, Jared M.; Murnane, Pamela M.; Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Kurth, Ann E.] NYU, Coll Nursing, New York, NY USA; [Chang, Larry W.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Chang, Larry W.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York University; Johns Hopkins University; Johns Hopkins University	Celum, C (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	ccelum@uw.edu	Kurth, Ann E/A-1615-2013		United States National Institutes of Health [R01 AI083034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083034] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was received from the United States National Institutes of Health (R01 AI083034). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2012, 19 INT AIDS C AIDS 2; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bollinger RC, 2011, INFECT DIS CLIN N AM, V25, P385, DOI 10.1016/j.idc.2011.02.006; Cherutich P, 2010, 17 C RETR OPP INF CR; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Curran K, CURR HIV AI IN PRESS; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; Dalal W, 2012, J ACQUIRED IMMUNE DI; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Gray R, 2012, 19 C RETR OPP INF CR; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Medley A, 2012, AIDS BEHAV; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Molesworth AM, 2010, JAIDS-J ACQ IMM DEF, V55, P625, DOI 10.1097/QAI.0b013e3181f98628; Mugglin C, 2012, 19 C RETR OPP INF CR; Nuwaha F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17423; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sabapathy K, 2012, 19 INT AIDS C AIDS 2; Sekandi JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-730; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; Tanser F, 2012, 19 C RETR OPP INF CR; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; UNAIDS, 2012, JC2215E UNAIDS; Van Rooyen H, 2012, 19 C RETR OPP INF CR; Wachira J, 2012, CLIN INFECT DIS, V54, P275, DOI 10.1093/cid/cir789; World Health Organization, 2012, GUID OR PREEXP PROPH	29	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51620	10.1371/journal.pone.0051620	http://dx.doi.org/10.1371/journal.pone.0051620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272125	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600031
J	Atchley, RA; Strayer, DL; Atchley, P				Atchley, Ruth Ann; Strayer, David L.; Atchley, Paul			Creativity in the Wild: Improving Creative Reasoning through Immersion in Natural Settings	PLOS ONE			English	Article							ATTENTION; BENEFITS	Adults and children are spending more time interacting with media and technology and less time participating in activities in nature. This life-style change clearly has ramifications for our physical well-being, but what impact does this change have on cognition? Higher order cognitive functions including selective attention, problem solving, inhibition, and multi-tasking are all heavily utilized in our modern technology-rich society. Attention Restoration Theory (ART) suggests that exposure to nature can restore prefrontal cortex-mediated executive processes such as these. Consistent with ART, research indicates that exposure to natural settings seems to replenish some, lower-level modules of the executive attentional system. However, the impact of nature on higher-level tasks such as creative problem solving has not been explored. Here we show that four days of immersion in nature, and the corresponding disconnection from multi-media and technology, increases performance on a creativity, problem-solving task by a full 50% in a group of naive hikers. Our results demonstrate that there is a cognitive advantage to be realized if we spend time immersed in a natural setting. We anticipate that this advantage comes from an increase in exposure to natural stimuli that are both emotionally positive and low-arousing and a corresponding decrease in exposure to attention demanding technology, which regularly requires that we attend to sudden events, switch amongst tasks, maintain task goals, and inhibit irrelevant actions or cognitions. A limitation of the current research is the inability to determine if the effects are due to an increased exposure to nature, a decreased exposure to technology, or to other factors associated with spending three days immersed in nature.	[Atchley, Ruth Ann; Atchley, Paul] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA; [Strayer, David L.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	University of Kansas; Utah System of Higher Education; University of Utah	Strayer, DL (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	david.strayer@utah.edu		Atchley, Paul/0000-0002-5261-4130; Strayer, David/0000-0002-1653-730X				[Anonymous], 2011, OFCOM COMM MARK REP; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; CIMPRICH B, 1993, CANCER NURS, V16, P83; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Immordino-Yang MH, 2012, PERSPECT PSYCHOL SCI, V7, P352, DOI 10.1177/1745691612447308; Juster F, CHANGING TIMES AM YO; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; MEDNICK SA, 1968, J CREATIVE BEHAV, V2, P213, DOI 10.1002/j.2162-6057.1968.tb00104.x; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Pergams ORW, 2008, P NATL ACAD SCI USA, V105, P2295, DOI 10.1073/pnas.0709893105; Pergams ORW, 2006, J ENVIRON MANAGE, V80, P387, DOI 10.1016/j.jenvman.2006.02.001; Rideout V.J., 2010, HENRY J KAIS FAM FOU; TENNESSEN CM, 1995, J ENVIRON PSYCHOL, V15, P77, DOI 10.1016/0272-4944(95)90016-0; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009	16	133	135	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51474	10.1371/journal.pone.0051474	http://dx.doi.org/10.1371/journal.pone.0051474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251547	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200116
J	Skalamera, D; Dahmer, M; Purdon, AS; Wilson, BM; Ranall, MV; Blumenthal, A; Gabrielli, B; Gonda, TJ				Skalamera, Dubravka; Dahmer, Mareike; Purdon, Amy S.; Wilson, Benjamin M.; Ranall, Max V.; Blumenthal, Antje; Gabrielli, Brian; Gonda, Thomas J.			Generation of a Genome Scale Lentiviral Vector Library for EF1 alpha Promoter-Driven Expression of Human ORFs and Identification of Human Genes Affecting Viral Titer	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENHANCER-BINDING-PROTEIN; CELL-DEATH; TRANSIENT TRANSFECTION; TRANSGENE EXPRESSION; HEK293T CELLS; CMV PROMOTER; FAMILY; MICROARRAYS; RNA	The bottleneck in elucidating gene function through high-throughput gain-of-function genome screening is the limited availability of comprehensive libraries for gene overexpression. Lentiviral vectors are the most versatile and widely used vehicles for gene expression in mammalian cells. Lentiviral supernatant libraries for genome screening are commonly generated in the HEK293T cell line, yet very little is known about the effect of introduced sequences on the produced viral titer, which we have shown to be gene dependent. We have generated an arrayed lentiviral vector library for the expression of 17,030 human proteins by using the GATEWAY (R) cloning system to transfer ORFs from the Mammalian Gene Collection into an EF1alpha promoter-dependent lentiviral expression vector. This promoter was chosen instead of the more potent and widely used CMV promoter, because it is less prone to silencing and provides more stable long term expression. The arrayed lentiviral clones were used to generate viral supernatant by packaging in the HEK293T cell line. The efficiency of transfection and virus production was estimated by measuring the fluorescence of IRES driven GFP, co-expressed with the ORFs. More than 90% of cloned ORFs produced sufficient virus for downstream screening applications. We identified genes which consistently produced very high or very low viral titer. Supernatants from select clones that were either high or low virus producers were tested on a range of cell lines. Some of the low virus producers, including two previously uncharacterized proteins were cytotoxic to HEK293T cells. The library we have constructed presents a powerful resource for high-throughput gain-of-function screening of the human genome and drug-target discovery. Identification of human genes that affect lentivirus production may lead to improved technology for gene expression using lentiviral vectors.	[Skalamera, Dubravka; Dahmer, Mareike; Purdon, Amy S.; Wilson, Benjamin M.; Ranall, Max V.; Blumenthal, Antje; Gabrielli, Brian; Gonda, Thomas J.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia	University of Queensland	Skalamera, D (corresponding author), Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia.	d.skalamera@uq.edu.au	Blumenthal, Antje/A-3608-2011; Gabrielli, Brian G/B-3655-2011	Blumenthal, Antje/0000-0003-3673-7015; Gabrielli, Brian G/0000-0003-3933-1651; Skalamera, Dubravka/0000-0002-5301-302X; Dahmer-Heath, Mareike/0000-0002-1667-7820	National Health and Medical Research Council of Australia (NHMRC) [ID401608]; Australia Research Council (ARC) [LE0668241]; Australian Cancer Research Foundation (ACRF); University of Queensland Diamantina Institute; Balzan Foundation; University of Queensland [2009001743]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council (ARC)(Australian Research Council); Australian Cancer Research Foundation (ACRF); University of Queensland Diamantina Institute; Balzan Foundation; University of Queensland(University of Queensland)	The funding for this study was provided by the National Health and Medical Research Council of Australia (NHMRC, http://www.nhmrc.gov.au/; grant ID401608), the Australia Research Council (ARC, http://www.arc.gov.au/; grant LE0668241) and the Australian Cancer Research Foundation (ACRF, http://www.acrf.com.au/) and University of Queensland Diamantina Institute. AB is supported by Fellowships funded by the Balzan Foundation and by the University of Queensland (grant 2009001743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeciga-Diaz CJ, 2009, MOL BIOL REP, V36, P1863, DOI 10.1007/s11033-008-9392-3; Ansorge S, 2009, J GENE MED, V11, P868, DOI 10.1002/jgm.1370; Bailey SN, 2006, NAT METHODS, V3, P117, DOI 10.1038/NMETH848; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Bechtel S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-399; Blumenthal A, 2009, CELL HOST MICROBE, V5, P35, DOI 10.1016/j.chom.2008.12.002; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chen HL, 2010, J NEUROSCI RES, V88, P3508, DOI 10.1002/jnr.22506; Chenal A, 2012, J MOL BIOL, V415, P584, DOI 10.1016/j.jmb.2011.11.024; Ching YP, 2002, GENOMICS, V79, P2, DOI 10.1006/geno.2001.6670; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Devitt G, 2007, J VIROL METHODS, V146, P298, DOI 10.1016/j.jviromet.2007.07.011; Dokka S, 2000, INT J PHARM, V206, P97, DOI 10.1016/S0378-5173(00)00531-7; Duan B, 2012, THERIOGENOLOGY, V78, P793, DOI 10.1016/j.theriogenology.2012.03.027; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Haferkamp S, 2008, AGING CELL, V7, P733, DOI 10.1111/j.1474-9726.2008.00422.x; Haferkamp S, 2009, J INVEST DERMATOL, V129, P1983, DOI 10.1038/jid.2009.5; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kamensek U, 2011, MOL IMAGING BIOL, V13, P43, DOI 10.1007/s11307-010-0300-6; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Lamarca V, 2008, EUR J CELL BIOL, V87, P325, DOI 10.1016/j.ejcb.2008.02.004; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Logan AC, 2004, HUM GENE THER, V15, P976, DOI 10.1089/hum.2004.15.976; Mao Gensheng, 2008, Acta Biomed, V79, P192; Marcotte EM, 2009, CELL, V138, P16, DOI 10.1016/j.cell.2009.06.024; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; NOMURA N, 1991, J BIOL CHEM, V266, P8590; Palmer E, 2011, METHODS MOL BIOL, V706, P27, DOI 10.1007/978-1-61737-970-3_3; Palmer EL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-145; Patzel V, 1997, BIOCHEM BIOPH RES CO, V231, P864, DOI 10.1006/bbrc.1997.6205; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Prus W, 2011, AMINO ACIDS, V41, P781, DOI 10.1007/s00726-010-0526-2; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Ramezani A, 2002, MOL BIOL; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Schinzel A, 2004, BBA-MOL CELL RES, V1644, P95, DOI 10.1016/j.bbamcr.2003.09.006; Schuller M, 2005, J NEUROIMMUNOL, V169, P172, DOI 10.1016/j.jneuroim.2005.08.019; Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SUDO T, 1992, GENOMICS, V12, P167, DOI 10.1016/0888-7543(92)90423-P; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tokushige K, 1997, J VIROL METHODS, V64, P73, DOI 10.1016/S0166-0934(96)02143-X; TSURUGI K, 1977, J BIOL CHEM, V252, P3961; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Van de Parre TJL, 2005, BIOCHEM BIOPH RES CO, V327, P356, DOI 10.1016/j.bbrc.2004.12.027; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yudin Y, 2012, MOL CELL ENDOCRINOL, V353, P68, DOI 10.1016/j.mce.2011.10.023; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	59	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51733	10.1371/journal.pone.0051733	http://dx.doi.org/10.1371/journal.pone.0051733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251614	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200160
J	Gruber, EV; Stock, S; Stollenwerk, B				Gruber, Emil Victor; Stock, Stephanie; Stollenwerk, Bjoern			Breast Cancer Attributable Costs in Germany: A Top-Down Approach Based on Sickness Funds Data	PLOS ONE			English	Article							ECONOMIC BURDEN; CARE; PREVALENCE; MAMMOGRAPHY; MORTALITY; ILLNESS; WOMEN	Background: Breast cancer is the leading cause of death from cancer among women in Germany. Despite its clinical and economic relevance, no attributable costs for breast cancer have been reported for Germany so far. The objective of this study is to estimate age-specific breast cancer attributable health expenditures for Germany. Methods: Sickness fund data from 1999 representing about 26 million insured (i.e. 32% of the total German population) have been analysed using generalized additive models and the error propagation law. Costs have been inflated to 2010. Results: Breast cancer attributable costs decreased with age. Among breast cancer patients aged 30-45 years, about 90% of all health expenditures were due to breast cancer, whereas in breast cancer patients aged 80-90 years, about 50% were due to breast cancer. Breast cancer attributable costs amounted to about (sic)9,000 annually for patients below 55 years of age and declined to about (sic)3,000 in 90-year-old breast cancer patients. Conclusion: This analysis provides estimates of attributable breast cancer costs in Germany. Compared with the international literature, the estimates were plausible but had a tendency to underestimate breast cancer attributable costs.	[Gruber, Emil Victor; Stollenwerk, Bjoern] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Stock, Stephanie] Univ Cologne, Inst Hlth Econ & Clin Epidemiol, D-50931 Cologne, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cologne	Stollenwerk, B (corresponding author), Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.	bjoern.stollenwerk@helmholtz-muenchen.de	Stollenwerk, Björn/G-5408-2013	Stollenwerk, Bjorn/0000-0002-3189-409X	Helmholtz Zentrum Munchen; German Research Center for Environmental Health; University of Cologne	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; University of Cologne	Financial support for this study was provided by Helmholtz Zentrum Munchen, German Research Center for Environmental Health and by the University of Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barron JJ, 2008, BREAST CANCER RES TR, V109, P367, DOI 10.1007/s10549-007-9650-4; Baser O, 2012, CURR MED RES OPIN, V28, P419, DOI 10.1185/03007995.2011.628649; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Braun S, 2009, BREAST CARE, V4, P389, DOI 10.1159/000255840; Broekx S, 2011, EUR J HEALTH ECON, V12, P311, DOI 10.1007/s10198-010-0237-3; Calvo A, 2001, INT ELECT J HLTH ED, V4, P19; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Grunfeld E, 1999, BRIT J CANCER, V79, P1227, DOI 10.1038/sj.bjc.6690197; Ihbe-Heffinger A, 2011, ONKOLOGIE, V34, P241, DOI 10.1159/000327711; Katalinic A, 2009, BREAST CARE, V4, P75, DOI 10.1159/000211526; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Khanna R, 2011, J WOMENS HEALTH, V20, P739, DOI 10.1089/jwh.2010.2298; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Lauterbach KW, 2001, MODELL FAIREN WETTBE; Lux MP, 2009, BREAST CANCER RES TR, V117, P305, DOI 10.1007/s10549-008-0294-9; Max W, 2009, BREAST CANCER RES TR, V116, P201, DOI 10.1007/s10549-008-0149-4; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Paterson A, 2008, J INT MED RES, V36, P400, DOI 10.1177/147323000803600304; Pisani P, 2009, BREAST CANC INTERVEN; RAJAN R, 1995, J CLIN ONCOL, V13, P42, DOI 10.1200/JCO.1995.13.1.42; Shenoy AU, 2012, EUR J VASC ENDOVASC, V44, P505, DOI 10.1016/j.ejvs.2012.08.010; Stock S, 2005, EUR RESPIR J, V25, P47, DOI 10.1183/09031936.04.00116203; Stock SAK, 2006, DIABETIC MED, V23, P299, DOI 10.1111/j.1464-5491.2005.01779.x; Stock SAK, 2008, J WOMENS HEALTH, V17, P343, DOI 10.1089/jwh.2007.0422; Stollenwerk B, 2010, MED DECIS MAKING, V30, P304, DOI 10.1177/0272989X09347015; WAHL RL, 1993, J CLIN ONCOL, V11, P2101, DOI 10.1200/JCO.1993.11.11.2101; Wilking N, 2005, PANEUROPEAN COMP REG; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S.N., 2010, MGCV GAMS GCV AIC RE; Zindel S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-192	34	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51312	10.1371/journal.pone.0051312	http://dx.doi.org/10.1371/journal.pone.0051312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251495	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900068
J	Hede, MS; Salimova, E; Piszczek, A; Perlas, E; Winn, N; Nastasi, T; Rosenthal, N				Hede, Marianne Smedegaard; Salimova, Ekaterina; Piszczek, Agnieszka; Perlas, Emarald; Winn, Nadine; Nastasi, Tommaso; Rosenthal, Nadia			E-Peptides Control Bioavailability of IGF-1	PLOS ONE			English	Article							GROWTH-FACTOR-I; (IGF)-I E-PEPTIDES; SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; TRANSGENIC MICE; ACCELERATES MUSCLE; GENE-EXPRESSION; MESSENGER-RNAS; REGENERATION; HYPERTROPHY	Insulin-like growth factor 1 (IGF-1) is a potent cytoprotective growth factor that has attracted considerable attention as a promising therapeutic agent. Transgenic over-expression of IGF-1 propeptides facilitates protection and repair in a broad range of tissues, although transgenic mice over-expressing IGF-1 propeptides display little or no increase in IGF-1 serum levels, even with high levels of transgene expression. IGF-1 propeptides are encoded by multiple alternatively spliced transcripts including C-terminal extension (E) peptides, which are highly positively charged. In the present study, we use decellularized mouse tissue to show that the E-peptides facilitate in vitro binding of murine IGF-1 to the extracellular matrix (ECM) with varying affinities. This property is independent of IGF-1, since proteins consisting of the E-peptides fused to relaxin, a related member of the insulin superfamily, bound equally avidly to decellularized ECM. Thus, the E-peptides control IGF-1 bioavailability by preventing systemic circulation, offering a potentially powerful way to tether IGF-1 and other therapeutic proteins to the site of synthesis and/or administration.	[Hede, Marianne Smedegaard; Salimova, Ekaterina; Piszczek, Agnieszka; Perlas, Emarald; Winn, Nadine; Nastasi, Tommaso; Rosenthal, Nadia] European Mol Biol Lab, Mouse Biol Unit, Rome, Italy; [Salimova, Ekaterina; Rosenthal, Nadia] Monash Univ, Australian Regenerat Med Inst, EMBL Australia, Melbourne, Vic 3004, Australia; [Rosenthal, Nadia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	European Molecular Biology Laboratory (EMBL); Australian Regenerative Medicine Institute; European Molecular Biology Laboratory (EMBL); Monash University; Imperial College London	Salimova, E (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Rome, Italy.	ekaterina.salimova@monash.edu; nadia.rosenthal@monash.edu	Rosenthal, Nadia/O-7009-2015; nastasi, tommaso/AAR-8730-2020; Rosenthal, Nadia/H-4012-2013	, Ekaterina/0000-0002-4362-7108; Rosenthal, Nadia/0000-0002-7599-7365	European Molecular Biology Laboratory; FP7 ENDOSTEM grant from European Commission [HEALTH-2009-1.4-3, 241440]; Novartis	European Molecular Biology Laboratory; FP7 ENDOSTEM grant from European Commission; Novartis(Novartis)	This work was supported by funds from European Molecular Biology Laboratory and the FP7 ENDOSTEM grant from European Commission HEALTH-2009-1.4-3 Grant agreement No. 241440, and by a sponsored research agreement with Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 1996, ENDOCRINOLOGY, V137, P4571, DOI 10.1210/en.137.11.4571; Ates K, 2007, FEBS LETT, V581, P2727, DOI 10.1016/j.febslet.2007.05.030; BACH MA, 1990, MOL ENDOCRINOL, V4, P899, DOI 10.1210/mend-4-6-899; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P7873, DOI 10.1093/nar/14.20.7873; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Carpenter V, 2008, HEART LUNG CIRC, V17, P33, DOI 10.1016/j.hlc.2007.04.013; Casellas A, 2006, DIABETES, V55, P3246, DOI 10.2337/db06-0328; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Cox MM, 2004, LEHNINGER PRINCIPLES; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Flintegaard TV, 2010, ENDOCRINOLOGY, V151, P5326, DOI 10.1210/en.2010-0574; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; Kandalla PK, 2011, MECH AGEING DEV, V132, P154, DOI 10.1016/j.mad.2011.02.007; Machingal MA, 2011, TISSUE ENG PT A, V17, P2291, DOI [10.1089/ten.tea.2010.0682, 10.1089/ten.TEA.2010.0682]; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Pfeffer LA, 2009, MOL BIOL CELL, V20, P3810, DOI 10.1091/mbc.E08-12-1202; Rabinovsky ED, 2002, FASEB J, V16, P53, DOI 10.1096/fj.02-0183fje; ROSENTHAL N, 1989, P NATL ACAD SCI USA, V86, P7780, DOI 10.1073/pnas.86.20.7780; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Santini Maria Paola, 2006, Novartis Found Symp, V274, P228; Santini MP, 2006, NOVART FDN SYMP, V274, P239; Santini MP, 2006, NOVART FDN SYMP, V274, P272; Schertzer JD, 2008, AM J PHYSIOL-CELL PH, V294, pC161, DOI 10.1152/ajpcell.00399.2007; Semenova E, 2008, AM J PATHOL, V173, P1295, DOI 10.2353/ajpath.2008.071177; Shavlakadze T, 2006, GROWTH HORM IGF RES, V16, P157, DOI 10.1016/j.ghir.2005.11.003; Shavlakadze T, 2005, GROWTH HORM IGF RES, V15, P4, DOI 10.1016/j.ghir.2004.11.001; SIMMONS JG, 1993, GROWTH FACTORS, V9, P205, DOI 10.3109/08977199309010833; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Temmerman L, 2010, GROWTH HORM IGF RES, V20, P255, DOI 10.1016/j.ghir.2010.03.002; Wilson HE, 2001, GROWTH HORM IGF RES, V11, P10, DOI 10.1054/ghir.2000.0182; Winn N, 2002, COLD SPRING HARB SYM, V67, P507, DOI 10.1101/sqb.2002.67.507; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	42	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51152	10.1371/journal.pone.0051152	http://dx.doi.org/10.1371/journal.pone.0051152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251442	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900047
J	Selva, N; Hobson, KA; Cortes-Avizanda, A; Zalewski, A; Donazar, JA				Selva, Nuria; Hobson, Keith A.; Cortes-Avizanda, Ainara; Zalewski, Andrzej; Antonio Donazar, Jose			Mast Pulses Shape Trophic Interactions between Fluctuating Rodent Populations in a Primeval Forest	PLOS ONE			English	Article							TISSUE-DIET DISCRIMINATION; DENSITY-DEPENDENCE; MARINE SUBSIDIES; CARBON-ISOTOPE; COMPETITION; DYNAMICS; NITROGEN; RESOURCES; TURNOVER; PROTEIN	How different functional responses of consumers exploiting pulsed resources affect community dynamics is an ongoing question in ecology. Tree masting is a common resource pulse in terrestrial ecosystems that can drive rodent population cycles. Using stable isotope (delta C-13, delta N-15) analyses, we investigated the dietary response of two fluctuating rodent species, the yellow-necked mouse Apodemus flavicollis and the bank vole Myodes glareolus, to mast events in Bialowieza Forest (NE Poland). Rodent hair samples were obtained non-invasively from faeces of their predators for an 11-year period that encompassed two mast events. Spectacular seed crops of deciduous trees, namely oak Quercus robur and hornbeam Carpinus betulus, occur after several intermediate years of moderate seed production, with a post-mast year characterised by a nil crop. While a Bayesian isotopic (SIAR) mixing model showed a variety of potential vegetation inputs to rodent diets, the isotopic niche of the yellow-necked mouse was strongly associated with mast of deciduous trees (>80% of diet), showing no variation among years of different seed crop. However, bank voles showed a strong functional response; in mast years the vole shifted its diet from herbs in deciduous forest (similar to 66% of diet) to mast (similar to 74%). Only in mast years did the isotopic niche of both rodent species overlap. Previous research showed that bank voles, subordinate and more generalist than mice, showed higher fluctuations in numbers in response to masting. This study provides unique data on the functional response of key pulse consumers in forest food webs, and contributes to our understanding of rodent population fluctuations and the mechanisms governing pulse-consumer interactions. Citation: Selva N, Hobson KA, Cortes-Avizanda A, Zalewski A, Donazar JA (2012) Mast Pulses Shape Trophic Interactions between Fluctuating Rodent Populations in a Primeval Forest. PLoS ONE 7(12): e51267. doi:10.1371/journal.pone.0051267	[Selva, Nuria] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada; [Cortes-Avizanda, Ainara; Antonio Donazar, Jose] CSIC, Dept Conservat Biol, Estn Biol Donana, Seville, Spain; [Zalewski, Andrzej] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland	Polish Academy of Sciences; Environment & Climate Change Canada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Selva, N (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	nuriselva@gmail.com	Hobson, Keith/Q-9306-2019; CORTES-AVIZANDA, AINARA/O-3248-2019; Cortés-Avizanda, Ainara/C-6634-2013; Zalewski, Andrzej/K-7271-2012; Selva, Nuria/J-6970-2013	CORTES-AVIZANDA, AINARA/0000-0002-9674-6434; Cortés-Avizanda, Ainara/0000-0002-9674-6434; Zalewski, Andrzej/0000-0003-4518-2787; Selva, Nuria/0000-0003-3389-201X; Donazar, Jose Antonio/0000-0002-9433-9755	Polish-Spanish joint research projects CSIC-PAS [2006PL0013, 2008PL002]; Polish Ministry of Science and Higher Education [NN304294037]; Environment Canada	Polish-Spanish joint research projects CSIC-PAS; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Environment Canada(CGIAR)	This study was partly supported by the Polish-Spanish joint research projects CSIC-PAS (2006PL0013 and 2008PL002), by the Polish Ministry of Science and Higher Education (project NN304294037) and an operating grant by Environment Canada to KAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRZEJEWSKI ROMAN, 1963, ACTA THERIOL, V7, P155; Butet A, 2011, ACTA THERIOL, V56, P297, DOI 10.1007/s13364-011-0049-6; DeMots RL, 2010, CAN J ZOOL, V88, P961, DOI 10.1139/Z10-063; Dhondt A.A., 2012, INTERSPECIFIC COMPET; DUFFY D C, 1986, Colonial Waterbirds, V9, P1, DOI 10.2307/1521138; Eccard JA, 2003, EVOL ECOL, V17, P423, DOI 10.1023/A:1027305410005; GEBCZYNSKA Z, 1976, Acta Theriologica, V21, P223; Hansen TF, 1999, P NATL ACAD SCI USA, V96, P986, DOI 10.1073/pnas.96.3.986; Hansson L, 1985, S ZOOL SOC LOND, V55, P141; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Massey FP, 2008, BIOL LETTERS, V4, P419, DOI 10.1098/rsbl.2008.0106; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Miller JF, 2008, CAN J ZOOL, V86, P685, DOI 10.1139/Z08-042; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Pianka E.R., 1976, P114; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; PUCEK Z, 1993, ACTA THERIOL, V38, P199, DOI 10.4098/AT.arch.93-18; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Samelius G, 2007, J ANIM ECOL, V76, P873, DOI 10.1111/j.1365-2656.2007.01278.x; Sare DTJ, 2005, CAN J ZOOL, V83, P717, DOI 10.1139/Z05-064; Schmidt KA, 2008, J ANIM ECOL, V77, P830, DOI 10.1111/j.1365-2656.2008.01378.x; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Shaner PJL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017970; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Stapp P, 2003, OIKOS, V102, P111, DOI 10.1034/j.1600-0706.2003.12445.x; Stenseth NC, 2002, ACTA THERIOL, V47, P39, DOI 10.1007/BF03192479; WIENS JA, 1993, TRENDS ECOL EVOL, V8, P348, DOI 10.1016/0169-5347(93)90216-C; Willson JD, 2010, OIKOS, V119, P1161, DOI 10.1111/j.1600-0706.2009.17939.x; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; Zalewski A, 2007, ACTA THERIOL, V52, P237, DOI 10.1007/BF03194220	37	33	34	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51267	10.1371/journal.pone.0051267	http://dx.doi.org/10.1371/journal.pone.0051267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251475	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900060
J	Zhang, BL; Yang, YW; Chen, TZ; Yu, WG; Liu, TL; Li, HJ; Fan, XH; Ren, YZ; Shen, DY; Liu, L; Dou, DL; Chang, YH				Zhang, Baolong; Yang, Yuwen; Chen, Tianzi; Yu, Wengui; Liu, Tingli; Li, Hongjuan; Fan, Xiaohui; Ren, Yongzhe; Shen, Danyu; Liu, Li; Dou, Daolong; Chang, Youhong			Island Cotton Gbve1 Gene Encoding A Receptor-Like Protein Confers Resistance to Both Defoliating and Non-Defoliating Isolates of Verticillium dahliae	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GOSSYPIUM-HIRSUTUM L.; LEAF-CRUMPLE-VIRUS; WILT RESISTANCE; CLADOSPORIUM-FULVUM; TOMATO; ARABIDOPSIS; VE; EXPRESSION; CLONING	Verticillium wilt caused by soilborne fungus Verticillium dahliae could significantly reduce cotton yield. Here, we cloned a tomato Ve homologous gene, Gbve1, from an island cotton cultivar that is resistant to Verticillium wilt. We found that the Gbve1 gene was induced by V. dahliae and by phytohormones salicylic acid, jasmonic acid, and ethylene, but not by abscisic acid. The induction of Gbve1 in resistant cotton was quicker and stronger than in Verticillium-susceptible upland cotton following V. dahliae inoculation. Gbve1 promoter-driving GUS activity was found exclusively in the vascular bundles of roots and stems of transgenic Arabidopsis. Virus-induced silencing of endogenous genes in resistant cotton via targeting a fragment of the Gbve1 gene compromised cotton resistance to V. dahliae. Furthermore, we transformed the Gbve1 gene into Arabidopsis and upland cotton through Agrobacterium-mediated transformation. Overexpression of the Gbve1 gene endowed transgenic Arabidopsis and upland cotton with resistance to high aggressive defoliating and non-defoliating isolates of V. dahliae. And HR-mimic cell death was observed in the transgenic Arabidopsis. Our results demonstrate that the Gbve1 gene is responsible for resistance to V. dahliae in island cotton and can be used for breeding cotton varieties that are resistant to Verticillium wilt.	[Zhang, Baolong; Yang, Yuwen; Chen, Tianzi; Yu, Wengui; Fan, Xiaohui; Ren, Yongzhe; Chang, Youhong] Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China; [Liu, Tingli; Li, Hongjuan; Shen, Danyu; Liu, Li; Dou, Daolong] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University	Zhang, BL (corresponding author), Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China.	zhbl2248@yahoo.com.cn; cyh@jaas.ac.cn	Shen, Danyu/AAF-1644-2019; Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642; Chen, Tianzi/0000-0003-2634-6694	National Natural Science Foundation of China [30971830]; fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [cx(12) 2023]; National Science and Technology Major Project for Transgenic Breeding [2009ZX08005-003B]; Natural Science Foundation of Jiangsu Province [BK2009308]; Ministry of Education of China [20090097110032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); fund for Independent Innovation of Agricultural Sciences in Jiangsu Province; National Science and Technology Major Project for Transgenic Breeding; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Ministry of Education of China(Ministry of Education, China)	This work was supported to B.Z. by grants from the National Natural Science Foundation of China (No. 30971830), fund for Independent Innovation of Agricultural Sciences in Jiangsu Province (No. cx(12) 2023) and National Science and Technology Major Project for Transgenic Breeding (No. 2009ZX08005-003B), and D. D. by grants Natural Science Foundation of Jiangsu Province (BK2009308) and Doctoral Fund of Ministry of Education of China (20090097110032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Cai YF, 2009, AFR J BIOTECHNOL, V8, P7363; Chai YR, 2003, DNA SEQUENCE, V14, P375, DOI 10.1080/10425170310001605509; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAAYF F, 1995, EUR J PLANT PATHOL, V101, P69, DOI 10.1007/BF01876095; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Diwan N, 1999, THEOR APPL GENET, V98, P315, DOI 10.1007/s001220051075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fei J, 2004, DNA SEQUENCE, V15, P88, DOI 10.1080/1042517042000199942; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Fritz-Laylin LK, 2005, PLANT PHYSIOL, V138, P611, DOI 10.1104/pp.104.054452; Gao XQ, 2011, PLANT J, V66, P293, DOI 10.1111/j.1365-313X.2011.04491.x; Gayoso C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-232; Gore ME, 2009, CROP PROT, V28, P215, DOI 10.1016/j.cropro.2008.10.004; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Idris AM, 2010, PHYSIOL MOL PLANT P, V75, P13, DOI 10.1016/j.pmpp.2010.07.002; Jefferson R A, 1987, EMBO J, V6, P3901; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Miao WG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-67; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Ochsenbein C, 2006, PLANT J, V47, P445, DOI 10.1111/j.1365-313X.2006.02793.x; Parkhi V, 2010, J PHYTOPATHOL, V158, P822, DOI 10.1111/j.1439-0434.2010.01714.x; Parkhi V, 2010, TRANSGENIC RES, V19, P959, DOI 10.1007/s11248-010-9374-9; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Qin QM, 2008, PLANT DIS, V92, P69, DOI 10.1094/PDIS-92-1-0069; Rajasekaran K, 2005, PLANT BIOTECHNOL J, V3, P545, DOI 10.1111/j.1467-7652.2005.00145.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Tian JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014218; Tohidfar M, 2005, PLANT CELL TISS ORG, V83, P83, DOI 10.1007/s11240-004-6155-2; Tomkins JP, 2001, MOL BREEDING, V8, P255, DOI 10.1023/A:1013798716098; Tuttle JR, 2008, PLANT PHYSIOL, V148, P41, DOI 10.1104/pp.108.123869; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Wang YQ, 2004, PLANT BREEDING, V123, P454, DOI 10.1111/j.1439-0523.2004.01005.x; Wu SJ, 2008, PLANT MOL BIOL REP, V26, P174, DOI 10.1007/s11105-008-0032-9; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Zhang JF, 2012, EUPHYTICA, V187, P147, DOI 10.1007/s10681-011-0549-0; Zhang Y, 2011, PLANT CELL REP, V30, P2085, DOI 10.1007/s00299-011-1115-x	47	69	95	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51091	10.1371/journal.pone.0051091	http://dx.doi.org/10.1371/journal.pone.0051091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251427	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900040
J	Beleigoli, AM; Boersma, E; Diniz, MDH; Lima-Costa, MF; Ribeiro, AL				Beleigoli, Alline M.; Boersma, Eric; Diniz, Maria de Fatima H.; Lima-Costa, Maria Fernanda; Ribeiro, Antonio L.			Overweight and Class I Obesity Are Associated with Lower 10-Year Risk of Mortality in Brazilian Older Adults: The Bambui Cohort Study of Ageing	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; CARDIORESPIRATORY FITNESS; WEIGHT-LOSS; NATRIURETIC PEPTIDE; VISCERAL FAT; FOLLOW-UP; PARADOX; WOMEN; MEN	Background: Prospective studies mostly with European and North-American populations have shown inconsistent results regarding the association of overweight/obesity and mortality in older adults. Our aim was to investigate the relationship between overweight/obesity and mortality in an elderly Brazilian population. Methods and Findings: Participants were 1,450 (90.2% from total) individuals aged 60 years and over from the community-based Bambui (Brazil) Cohort Study of Ageing. From 1997 to 2007, 521 participants died and 89 were lost, leading to 12,905 person-years of observation. Body mass index (BMI) and waist circumference (WC) were assessed at baseline and at the 3rd and 5th years of follow-up. Multiple imputation was performed to deal with missing values. Hazard ratios (HR) of mortality for BMI or WC alone (continuous and categorical), and BMI and WC together (continuous) were estimated by extended Cox regression models, which were fitted for clinical, socioeconomic and behavioral confounders. Adjusted absolute rates of death at 10-year follow-up were estimated for the participants with complete data at baseline. Continuous BMI (HR 0.85; 95% CI 0.80-0.90) was inversely related to mortality, even after exclusion of smokers (HR 0.85; 0.80-0.90), and participants who had weight variation and died within the first 5 years of follow-up (HR 0.83; CI 95% 0.73-0.94). Overweight (BMI 25-30 kg/m(2)) was inversely (HR 0.76; 95% CI 0.61-0.93) and obesity (BMI >= 30 kg/m(2); HR 0.85; 95% CI 0.64-1.14) not significantly associated with mortality. Subjects with BMI between 25-35 kg/m(2) (23.8-25.9%) had the lowest absolute rates of death at 10-years follow-up. The association between WC and death was not significant, except after adjusting WC for BMI levels, when the relationship turned into marginally positive (HR 1.01; CI 95% 1.00-1.02). Conclusions: The usual BMI and WC cut-off points should not be used to guide public health and clinical weight control interventions in elderly in Brazil.	[Beleigoli, Alline M.; Diniz, Maria de Fatima H.; Lima-Costa, Maria Fernanda; Ribeiro, Antonio L.] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Boersma, Eric] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Diniz, Maria de Fatima H.; Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Lima-Costa, Maria Fernanda] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Erasmus University Rotterdam; Erasmus MC; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Beleigoli, AM (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.	beleigoli@yahoo.com	Ribeiro, Ana Cristina/HHN-7466-2022; Ribeiro, Antonio L/C-2707-2009; Iats, Inct/K-2300-2013; Costa, Maria Fernanda Furtado de Lima e/ABE-3779-2021	Ribeiro, Ana Cristina/0000-0002-0493-8376; Ribeiro, Antonio L/0000-0002-2740-0042; Costa, Maria Fernanda Furtado de Lima e/0000-0002-3474-2980; Beleigoli, Alline/0000-0002-7848-3183	Financiadora de Estudos e Projetos, Rio de Janeiro, Brazil; Ministerio da Saude, Brasilia, Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Belo Horizonte, Brazil; Programa de Doutorando com Estagio no Exterior (PDEE) do Conselho de Aperfeicoamento de Pessoal Superior (CAPES), Brazil	Financiadora de Estudos e Projetos, Rio de Janeiro, Brazil(Financiadora de Inovacao e Pesquisa (Finep)); Ministerio da Saude, Brasilia, Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Belo Horizonte, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Programa de Doutorando com Estagio no Exterior (PDEE) do Conselho de Aperfeicoamento de Pessoal Superior (CAPES), Brazil	This work was supported by the Financiadora de Estudos e Projetos, Rio de Janeiro, Brazil; the Ministerio da Saude, Brasilia, Brazil; and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Belo Horizonte, Brazil. M.F. Lima-Costa and A.L. Ribeiro are fellows of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. A.M. Beleigoli was supported by the Programa de Doutorando com Estagio no Exterior (PDEE) do Conselho de Aperfeicoamento de Pessoal Superior (CAPES), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Auyeung TW, 2010, J GERONTOL A-BIOL, V65, P99, DOI 10.1093/gerona/glp099; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250; Beleigoli AM, 2011, PEPTIDES, V32, P1787, DOI 10.1016/j.peptides.2011.08.013; Bouillanne O, 2009, AM J CLIN NUTR, V90, P505, DOI 10.3945/ajcn.2009.27819; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Clark AL, 2011, J CARD FAIL, V17, P374, DOI 10.1016/j.cardfail.2011.01.009; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Denes P, 2007, JAMA-J AM MED ASSOC, V297, P978, DOI 10.1001/jama.297.9.978; Feldman AM, 2000, J AM COLL CARDIOL, V35, P537, DOI 10.1016/S0735-1097(99)00600-2; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012; Guallar-Castillon P, 2009, OBESITY, V17, P2232, DOI 10.1038/oby.2009.115; Harris TB, 2000, ANN NY ACAD SCI, V904, P462; He JH, 2009, INT J ENV RES PUB HE, V6, P3115, DOI 10.3390/ijerph6123115; Hu F., 2008, OBESITY EPIDEMIOLOGY, P53, DOI DOI 10.1093/ACPROF:OSO/9780195312911; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Klebanoff MA, 2008, AM J EPIDEMIOL, V168, P355, DOI 10.1093/aje/kwn071; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Kulminski AM, 2008, J AM GERIATR SOC, V56, P105, DOI 10.1111/j.1532-5415.2007.01494.x; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lima-Costa MF, 2011, INT J EPIDEMIOL, V40, P862, DOI 10.1093/ije/dyq143; Lima-Costa MF, 2010, AM J EPIDEMIOL, V172, P190, DOI 10.1093/aje/kwq106; Dolan CM, 2007, AM J PUBLIC HEALTH, V97, P913, DOI 10.2105/AJPH.2005.084178; McAuley P, 2009, J GERONTOL A-BIOL, V64, P695, DOI 10.1093/gerona/gln039; McAuley PA, 2011, J SPORT SCI, V29, P773, DOI 10.1080/02640414.2011.553965; McAuley PA, 2010, MAYO CLIN PROC, V85, P115, DOI 10.4065/mcp.2009.0562; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Oreopoulos A, 2009, CLIN GERIATR MED, V25, P643, DOI 10.1016/j.cger.2009.07.005; Prineas R., 1982, MINNESOTA CODE MANUA; Rapp K, 2008, ANN ONCOL, V19, P641, DOI 10.1093/annonc/mdm549; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Storti KL, 2006, OBESITY, V14, P244, DOI 10.1038/oby.2006.31; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Tavares E L, 1999, Cad Saude Publica, V15, P759, DOI 10.1590/S0102-311X1999000400010; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; Weber MA, 2001, J AM COLL CARDIOL, V37, P169, DOI 10.1016/S0735-1097(00)01103-7; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005	51	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52111	10.1371/journal.pone.0052111	http://dx.doi.org/10.1371/journal.pone.0052111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251690	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800142
J	Dettai, A; Gallut, C; Brouillet, S; Pothier, J; Lecointre, G; Debruyne, R				Dettai, Agnes; Gallut, Cyril; Brouillet, Sophie; Pothier, Joel; Lecointre, Guillaume; Debruyne, Regis			Conveniently Pre-Tagged and Pre-Packaged: Extended Molecular Identification and Metagenomics Using Complete Metazoan Mitochondrial Genomes	PLOS ONE			English	Article							DNA BARCODES; SPECIES IDENTIFICATION; SEQUENCE EVOLUTION; PURIFICATION; PSEUDOGENES; PERFORMANCE; PHYLOGENETICS; HETEROPLASMY; VARIABILITY; ALIGNMENT	Background: Researchers sorely need markers and approaches for biodiversity exploration (both specimen linked and metagenomics) using the full potential of next generation sequencing technologies (NGST). Currently, most studies rely on expensive multiple tagging, PCR primer universality and/or the use of few markers, sometimes with insufficient variability. Methodology/Principal Findings: We propose a novel approach for the isolation and sequencing of a universal, useful and popular marker across distant, non-model metazoans: the complete mitochondrial genome. It relies on the properties of metazoan mitogenomes for enrichment, on careful choice of the organisms to multiplex, as well as on the wide collection of accumulated mitochondrial reference datasets for post-sequencing sorting and identification instead of individual tagging. Multiple divergent organisms can be sequenced simultaneously, and their complete mitogenome obtained at a very low cost. We provide in silico testing of dataset assembly for a selected set of example datasets. Conclusions/Significance: This approach generates large mitogenome datasets. These sequences are useful for phylogenetics, molecular identification and molecular ecology studies, and are compatible with all existing projects or available datasets based on mitochondrial sequences, such as the Barcode of Life project. Our method can yield sequences both from identified samples and metagenomic samples. The use of the same datasets for both kinds of studies makes for a powerful approach, especially since the datasets have a high variability even at species level, and would be a useful complement to the less variable 18S rDNA currently prevailing in metagenomic studies.	[Dettai, Agnes; Gallut, Cyril; Lecointre, Guillaume] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Systemat 7138, Evolut UPMC CNRS MNHN IRD ENS, F-75231 Paris, France; [Brouillet, Sophie] Univ Paris 06, UMR Systemat Adaptat Evolut 7138, UPMC CNRS MNHN IRD ENS, Paris, France; [Pothier, Joel] Univ Paris 06, UFR 927, Paris, France; [Debruyne, Regis] Museum Natl Hist Nat, Dept Systemat & Evolut, UMS CNRS 2700, MNHN, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN)	Dettai, A (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Systemat 7138, Evolut UPMC CNRS MNHN IRD ENS, F-75231 Paris, France.	adettai@mnhn.fr	Debruyne, Régis/G-7839-2011; Dettai, Agnes/Q-6743-2019	Debruyne, Régis/0000-0002-7002-3940; Gallut, Cyril/0000-0002-6486-0179; Pothier, Joel/0000-0002-4021-6055	Fondation TOTAL (project "Classification des poisons marins: les teleosteens acanthomorphes'')	Fondation TOTAL (project "Classification des poisons marins: les teleosteens acanthomorphes'')	This work was supported by the Fondation TOTAL (project "Classification des poisons marins: les teleosteens acanthomorphes'') (fondation.total.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2012, MITOCHONDR DNA, V23, P84, DOI 10.3109/19401736.2011.653801; Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; [Anonymous], 2012, LIFE TECHNOLOGIES RE; Avise John C., 2004, P1; Beckman K. B., 1993, PROMEGA NOTES, V43, P10; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038215; Brockhurst MA, 2011, MOL ECOL, V20, P972, DOI 10.1111/j.1365-294X.2010.04835.x; Brokeland W, 2009, ZOOTAXA, P6, DOI 10.11646/zootaxa.2096.1.2; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P40, DOI 10.1016/j.dsr2.2009.08.005; Carr SM, 2008, GENETICS, V180, P381, DOI 10.1534/genetics.108.089730; Chan CKK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-215; Chapman A, 2009, NUMBERS LIVING SPECI, P1; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dettai A, 2011, POLAR SCI, V5, P298, DOI 10.1016/j.polar.2011.02.002; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Engel K, 2012, J MICROBIOL METH, V88, P35, DOI 10.1016/j.mimet.2011.10.007; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Foote AD, 2011, MOL ECOL, V20, P629, DOI 10.1111/j.1365-294X.2010.04957.x; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hardy CM, 2011, MAR FRESHWATER RES, V62, P887, DOI 10.1071/MF11027; Harvey JBJ, 2012, J EXP MAR BIOL ECOL, V413, P60, DOI 10.1016/j.jembe.2011.11.022; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Heimeier D, 2010, MAR GENOM, V3, P165, DOI 10.1016/j.margen.2010.09.004; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Lang BF, 2007, NAT PROTOC, V2, P652, DOI 10.1038/nprot.2007.58; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li Y, 2012, PARASITOLOGY, P1; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lopez JV, 1997, MOL BIOL EVOL, V14, P277, DOI 10.1093/oxfordjournals.molbev.a025763; Luddington IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045664; Lysholm Fredrik, 2011, BMC Res Notes, V4, P449, DOI 10.1186/1756-0500-4-449; Magnacca KN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-174; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; MEYERS JA, 1976, J BACTERIOL, V127, P1529, DOI 10.1128/JB.127.3.1529-1537.1976; Min XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000325; Monniot F, 2011, ZOOTAXA, P1; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Nicolas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036586; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Passamonti M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-442; Piganeau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016342; Powell AF, 2012, MOL PHYLOGENET EVOL; Prosdocimi F, 2012, MOL BIOL REP, V39, P2767, DOI 10.1007/s11033-011-1034-5; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Santamaria M, 2007, BIOL CHEM, V388, P943, DOI 10.1515/BC.2007.121; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Sheffield NC, 2010, MITOCHONDR DNA, V21, P87, DOI 10.3109/19401736.2010.500812; Singh TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-534; Sinniger F, 2008, ZOOL SCI, V25, P1253, DOI 10.2108/zsj.25.1253; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; Summerer D, 2009, GENOMICS, V94, P363, DOI 10.1016/j.ygeno.2009.08.012; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teletchea F, 2010, MITOCHONDR DNA, V21, P206, DOI 10.3109/19401736.2010.532212; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; Wang XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002723; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wilson JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010525; Xu JP, 2009, MOL PHYLOGENET EVOL, V52, P157, DOI 10.1016/j.ympev.2009.03.031; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	93	13	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51263	10.1371/journal.pone.0051263	http://dx.doi.org/10.1371/journal.pone.0051263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251474	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800036
J	Invernizzi, G; Aprile, FA; Natalello, A; Ghisleni, A; Penco, A; Relini, A; Doglia, SM; Tortora, P; Regonesi, ME				Invernizzi, Gaetano; Aprile, Francesco A.; Natalello, Antonino; Ghisleni, Andrea; Penco, Amanda; Relini, Annalisa; Doglia, Silvia M.; Tortora, Paolo; Regonesi, Maria E.			The Relationship between Aggregation and Toxicity of Polyglutamine-Containing Ataxin-3 in the Intracellular Environment of Escherichia coli	PLOS ONE			English	Article							INCLUSION-BODY FORMATION; N-TERMINAL HUNTINGTIN; PROTEIN OLIGOMERS; MUTANT HUNTINGTIN; AMYLOID FIBRILS; BODIES; FIBRILLOGENESIS; EXPRESSION; REVEALS; REPEATS	Several neurodegenerative diseases are triggered by proteins containing a polyglutamine (polyQ) stretch expanded beyond a critical threshold. Among these, ataxin-3 (AT3) is the causative agent of spinocerebellar ataxia type-3. We expressed three authentic AT3 variants in Escherichia coli: one normal (AT3-Q24), one expanded (AT3-Q55) and one truncated immediately upstream of the polyQ (AT3-291 Delta). Then, based on growth rate reduction, we quantified protein toxicity. We show that AT3-Q55 and -291 Delta strongly reduced the growth rate in the early stages (2-4 h), unlike AT3-Q24. This correlated well with the appearance of soluble cytosolic oligomers, but not with the amount of insoluble protein in inclusion bodies (IBs). The impact of AT3-291 Delta on cell growth suggests an intrinsic toxicity of the AT3 fragment. Besides the typical Fourier Transform Infrared Spectroscopy (FTIR) signal for intermolecular beta-sheets, the expanded form displayed an additional infrared signature, which was assigned to glutamine side-chain hydrogen bonding and associated with SDS-insoluble fibrils. The elongation of the latter was monitored by Atomic Force Microscopy (AFM). This mirrors the well-known in vitro two-step aggregation pattern of expanded AT3. We also demonstrated that final aggregates of strains expressing expanded or truncated AT3 play a protective role against toxicity. Furthermore, our findings suggest that the mechanisms of toxicity are evolutionarily conserved. Citation: Invernizzi G, Aprile FA, Natalello A, Ghisleni A, Penco A, et al. (2012) The Relationship between Aggregation and Toxicity of Polyglutamine-Containing Ataxin-3 in the Intracellular Environment of Escherichia coli. PLoS ONE 7(12): e51890. doi:10.1371/journal.pone.0051890	[Invernizzi, Gaetano; Aprile, Francesco A.; Natalello, Antonino; Ghisleni, Andrea; Doglia, Silvia M.; Tortora, Paolo; Regonesi, Maria E.] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Penco, Amanda; Relini, Annalisa] Univ Genoa, Dept Phys, Genoa, Italy	University of Milano-Bicocca; University of Genoa	Invernizzi, G (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	gaetano.invernizzi@unimib.it; paolo.tortora@unimib.it	Natalello, Antonino/B-9659-2012; Relini, Annalisa/AHC-3105-2022; invernizzi, gaetano/K-4375-2014	Natalello, Antonino/0000-0002-1489-272X; Tortora, Paolo/0000-0001-5234-601X; Ghisleni, Andrea/0000-0001-8456-5903; RELINI, ANNALISA/0000-0002-4040-9279; Aprile, Francesco Antonio/0000-0002-5040-4420	Fondazione Cariplo (N.O.B.E.L. project); Italian Ministry for Instruction, University and Research, PRIN 2007 project [2007XY59ZJ_004]; Regione Lombardia (Network Enabled Drug Design); University of Genoa (Progetti di Ateneo)	Fondazione Cariplo (N.O.B.E.L. project)(Fondazione Cariplo); Italian Ministry for Instruction, University and Research, PRIN 2007 project(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia (Network Enabled Drug Design)(Regione Lombardia); University of Genoa (Progetti di Ateneo)	This work was supported by the following: Fondazione Cariplo (N.O.B.E.L. project); Italian Ministry for Instruction, University and Research, PRIN 2007 project n. 2007XY59ZJ_004; Regione Lombardia (Network Enabled Drug Design); A.N. and G.I. acknowledge postdoctoral fellowships of the University of Milano-Bicocca. This work was partially supported by University of Genoa (Progetti di Ateneo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami D, 2003, BBA-GEN SUBJECTS, V1624, P6, DOI 10.1016/j.bbagen.2003.09.008; Ami D, 2009, BBA-PROTEINS PROTEOM, V1794, P263, DOI 10.1016/j.bbapap.2008.10.015; Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chow MKM, 2004, J BIOL CHEM, V279, P47643, DOI 10.1074/jbc.M405799200; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dasari M, 2011, CHEMBIOCHEM, V12, P407, DOI 10.1002/cbic.201000602; de Groot NS, 2008, FUTURE MICROBIOL, V3, P423, DOI 10.2217/17460913.3.4.423; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; Dolado I, 2005, J COMB CHEM, V7, P246, DOI 10.1021/cc049849s; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x; Gatti-Lafranconi P, 2011, FEBS J, V278, P2408, DOI 10.1111/j.1742-4658.2011.08163.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Hinz J, 2008, BIOCHEMISTRY-US, V47, P4196, DOI 10.1021/bi800002j; Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P73; Huang LQ, 2010, FASEB J, V24, P3536, DOI 10.1096/fj.09-150987; Hubener J, 2011, BRAIN, V134, P1925, DOI 10.1093/brain/awr118; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Ignatova Z, 2007, J BIOL CHEM, V282, P36736, DOI 10.1074/jbc.M703682200; Invernizzi G, 2008, PROTEIN EXPRES PURIF, V62, P111, DOI 10.1016/j.pep.2008.06.012; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lajoie P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015245; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2002, BIOCHEM SOC T, V30, P548, DOI 10.1042/bst0300548; Masino L, 2011, FASEB J, V25, P45, DOI 10.1096/fj.10-161208; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Nagao Y, 2000, BBA-MOL BASIS DIS, V1502, P247, DOI 10.1016/S0925-4439(00)00047-8; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Onodera O, 1996, FEBS LETT, V399, P135, DOI 10.1016/S0014-5793(96)01301-4; Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Sanchez L, 2011, J AM CHEM SOC, V133, P6505, DOI 10.1021/ja1117123; Santambrogio C, 2012, FEBS J, V279, P451, DOI 10.1111/j.1742-4658.2011.08438.x; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Shehi E, 2003, BIOCHEMISTRY-US, V42, P14626, DOI 10.1021/bi0352825; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang X, 2008, J MOL BIOL, V380, P570, DOI 10.1016/j.jmb.2008.05.019; Wasmer C, 2009, ANGEW CHEM INT EDIT, V48, P4858, DOI 10.1002/anie.200806100; Winkelmann J, 2010, J MOL BIOL, V398, P600, DOI 10.1016/j.jmb.2010.03.030; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	61	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51890	10.1371/journal.pone.0051890	http://dx.doi.org/10.1371/journal.pone.0051890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251648	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800104
J	Kaur, M; Lagopoulos, J; Ward, PB; Watson, TL; Naismith, SL; Hickie, IB; Hermens, DF				Kaur, Manreena; Lagopoulos, Jim; Ward, Philip B.; Watson, Tamara L.; Naismith, Sharon L.; Hickie, Ian B.; Hermens, Daniel F.			Mismatch Negativity/P3a Complex in Young People with Psychiatric Disorders: A Cluster Analysis	PLOS ONE			English	Article							AUDITORY SENSORY MEMORY; MENTAL-HEALTH-SERVICES; BIPOLAR DISORDER; NEUROPHYSIOLOGICAL ENDOPHENOTYPES; ELECTROPHYSIOLOGICAL INDEXES; 1ST-EPISODE SCHIZOPHRENIA; PREATTENTIVE DYSFUNCTION; COGNITIVE DEFICITS; 1ST EPISODE; GLUTAMATE	Background: We have recently shown that the event-related potential biomarkers, mismatch negativity (MMN) and P3a, are similarly impaired in young patients with schizophrenia- and affective-spectrum psychoses as well as those with bipolar disorder. A data driven approach may help to further elucidate novel patterns of MMN/P3a amplitudes that characterise distinct subgroups in patients with emerging psychiatric disorders. Methods: Eighty seven outpatients (16 to 30 years) were assessed: 19 diagnosed with a depressive disorder; 26 with a bipolar disorder; and 42 with a psychotic disorder. The MMN/P3a complex was elicited using a two-tone passive auditory oddball paradigm with duration deviant tones. Hierarchical cluster analysis utilising frontal, central and temporal neurophysiological variables was conducted. Results: Three clusters were determined: the 'globally impaired' cluster (n = 53) displayed reduced frontal and temporal MMN as well as reduced central P3a amplitudes; the 'largest frontal MMN' cluster (n = 17) were distinguished by increased frontal MMN amplitudes and the 'largest temporal MMN' cluster (n = 17) was characterised by increases in temporal MMN only. Notably, 55% of those in the globally impaired cluster were diagnosed with schizophrenia-spectrum disorder, whereas the three patient subgroups were equally represented in the remaining two clusters. The three cluster-groups did not differ in their current symptomatology; however, the globally impaired cluster was the most neuropsychologically impaired, compared with controls. Conclusions: These findings suggest that in emerging psychiatric disorders there are distinct MMN/P3a profiles of patient subgroups independent of current symptomatology. Schizophrenia-spectrum patients tended to show the most global impairments in this neurophysiological complex. Two other subgroups of patients were found to have neurophysiological profiles suggestive of quite different neurobiological (and hence, treatment) implications. Citation: Kaur M, Lagopoulos J, Ward PB, Watson TL, Naismith SL, et al. (2012) Mismatch Negativity/P3a Complex in Young People with Psychiatric Disorders: A Cluster Analysis. PLoS ONE 7(12): e51871. doi:10.1371/journal.pone.0051871	[Kaur, Manreena; Lagopoulos, Jim; Watson, Tamara L.; Naismith, Sharon L.; Hickie, Ian B.; Hermens, Daniel F.] Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia; [Ward, Philip B.] Univ New S Wales, Sch Psychiat, Kensington, NSW 2033, Australia; [Ward, Philip B.] Liverpool Hosp, SW Sydney Local Hlth Network, Schizophrenia Res Unit, Liverpool, Merseyside, England; [Watson, Tamara L.] Univ Western Sydney, Sch Social Sci & Psychol, Kingswood, NSW, Australia	University of Sydney; University of New South Wales Sydney; Western Sydney University	Kaur, M (corresponding author), Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Sydney, NSW 2006, Australia.	manreena.kaur@sydney.edu.au	Ward, Philip/E-3959-2010; Watson, Tamara/AAD-2575-2020; Hickie, Ian B/K-8975-2015; Watson, Tamara/F-9920-2010	Ward, Philip/0000-0002-5779-7722; Hickie, Ian B/0000-0001-8832-9895; Hermens, Daniel/0000-0002-8570-2663; Watson, Tamara/0000-0001-7899-0858; Naismith, Sharon/0000-0001-9076-2778	National Health & Medical Research Council (NHMRC) program grant [566529]; NHMRC Australia Fellowship [464914]; NMHRC Clinical Research Fellowship [464914]; NHRMC Postgraduate Scholarship	National Health & Medical Research Council (NHMRC) program grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NMHRC Clinical Research Fellowship; NHRMC Postgraduate Scholarship	This work was funded by a National Health & Medical Research Council (NHMRC) program grant (No. 566529) and a NHMRC Australia Fellowship (No. 464914) awarded to IBH. SLN was funded by a NMHRC Clinical Research Fellowship (No. 464914). MK was supported by an NHRMC Postgraduate Scholarship. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2008, BIPOLAR DISORD, V10, P888, DOI 10.1111/j.1399-5618.2008.00638.x; Andreasen NC, 1980, BRIT J PSYCHIAT, V33, P1157; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Atkinson RJ, 2012, BIOL PSYCHIAT, V71, P98, DOI 10.1016/j.biopsych.2011.08.023; Babor T.F., 2001, ALCOHOL USE DISORDER; Baldeweg T, 2002, INT J PSYCHOPHYSIOL, V43, P111, DOI 10.1016/S0167-8760(01)00183-0; Bestelmeyer PEG, 2012, PSYCHIAT RES, V197, P140, DOI 10.1016/j.psychres.2011.09.030; BLASHFIELD RK, 1979, COMPR PSYCHIAT, V20, P516, DOI 10.1016/S0010-440X(79)80004-8; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Bonanno G, 2005, J NEUROSCI, V25, P3270, DOI 10.1523/JNEUROSCI.5033-04.2005; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; Craddock N, 2005, BRIT J PSYCHIAT, V186, P364, DOI 10.1192/bjp.186.5.364; de Bartolomeis A, 2012, EUR J PHARMACOL, V682, P1, DOI 10.1016/j.ejphar.2012.02.033; Delano-Wood L, 2009, J INT NEUROPSYCH SOC, V15, P906, DOI 10.1017/S1355617709990257; DINGEMANS PMAJ, 1995, PSYCHOPHARMACOLOGY, V122, P263, DOI 10.1007/BF02246547; Dixon JF, 1998, P NATL ACAD SCI USA, V95, P8363, DOI 10.1073/pnas.95.14.8363; First M. B., 2007, STRUCTURED CLIN INTE; Ford JM, 2012, INT J PSYCHOPHYSIOL, V83, P232, DOI 10.1016/j.ijpsycho.2011.09.004; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Goldstein G, 1990, Arch Clin Neuropsychol, V5, P251, DOI 10.1016/0887-6177(90)90024-J; Hafner H, 2008, EUR ARCH PSY CLIN N, V258, P85, DOI 10.1007/s00406-008-2011-4; Hahn CG, 2004, J CLIN PSYCHIAT, V65, P791; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hermann B, 2007, J INT NEUROPSYCH SOC, V13, P12, DOI 10.1017/S135561770707004X; Hermens DF, 2011, J INT NEUROPSYCH SOC, V17, P267, DOI 10.1017/S1355617710001566; Hermens DF, 2010, PROG NEURO-PSYCHOPH, V34, P822, DOI 10.1016/j.pnpbp.2010.03.019; Hirayasu Y, 1998, AM J PSYCHIAT, V155, P1384, DOI 10.1176/ajp.155.10.1384; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Jahshan C, 2012, BIPOLAR DISORD, V14, P239, DOI 10.1111/j.1399-5618.2012.01008.x; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Jemel B, 2002, BRAIN TOPOGR, V15, P13, DOI 10.1023/A:1019944805499; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P766, DOI 10.1001/archpsyc.60.8.766; Kaur M, 2012, J PSYCHIATR NEUROSCI, V37, P313, DOI 10.1503/jpn.110081; Kaur M, 2011, SCHIZOPHR RES, V130, P203, DOI 10.1016/j.schres.2011.03.025; Kawakubo Y, 2006, PROG NEURO-PSYCHOPH, V30, P1367, DOI 10.1016/j.pnpbp.2006.03.003; Kawakubo Y, 2006, NEUROREPORT, V17, P1043, DOI 10.1097/01.wnr.0000221828.10846.ba; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; Kiang M, 2009, CLIN NEUROPHYSIOL, V120, P1949, DOI 10.1016/j.clinph.2009.08.019; Lagopoulos J, 1997, NEUROL RES, V19, P609; Laruelle M, 2005, CLIN THER, V27, pS16, DOI 10.1016/j.clinthera.2005.07.017; Lepisto T, 2004, CLIN NEUROPHYSIOL, V115, P620, DOI 10.1016/j.clinph.2003.10.020; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; Light GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039434; Mager R, 2005, APPL PSYCHOPHYS BIOF, V30, P233, DOI 10.1007/s10484-005-6380-4; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; McGorry PD, 2006, AUST NZ J PSYCHIAT, V40, P616, DOI 10.1111/j.1440-1614.2006.01860.x; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naismith SL, 2012, J AFFECT DISORDERS, V138, P71, DOI 10.1016/j.jad.2011.12.028; Norusis M.J., 2010, PASW STAT 18 GUIDE D; Oades RD, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-7; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Scott E, 2009, AUSTRALAS PSYCHIATRY, V17, P189, DOI 10.1080/10398560802657322; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; Shinozaki N, 2002, BIOL PSYCHOL, V59, P105, DOI 10.1016/S0301-0511(01)00129-6; Stahl SM, 2007, CNS SPECTRUMS, V12, P265, DOI 10.1017/S1092852900021015; Strauss E, 2006, COMPENDIUM NEUROPSYC; Strelnikov K, 2007, BRAIN COGNITION, V65, P244, DOI 10.1016/j.bandc.2007.04.002; Takei Y, 2010, PROG NEURO-PSYCHOPH, V34, P903, DOI 10.1016/j.pnpbp.2010.04.014; Takei Y, 2009, PSYCHOPHYSIOLOGY, V46, P52, DOI 10.1111/j.1469-8986.2008.00748.x; Thaker GK, 2008, SCHIZOPHRENIA BULL, V34, P760, DOI 10.1093/schbul/sbn049; Thonnessen H, 2008, BIOL PSYCHOL, V77, P205, DOI 10.1016/j.biopsycho.2007.10.009; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Turetsky BI, 2009, PSYCHIAT RES, V165, P27, DOI 10.1016/j.psychres.2008.04.013; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Umbricht DSG, 2006, BIOL PSYCHIAT, V59, P762, DOI 10.1016/j.biopsych.2005.08.030; Wechsler D, 2002, WECHSLER TEST ADULT; Youn T, 2003, SCHIZOPHR RES, V59, P253, DOI 10.1016/S0920-9964(02)00154-8	83	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51871	10.1371/journal.pone.0051871	http://dx.doi.org/10.1371/journal.pone.0051871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251645	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800101
J	Gebremedhin, S; Enquselassie, F; Umeta, M				Gebremedhin, Samson; Enquselassie, Fikre; Umeta, Melaku			Independent and Joint Effects of Prenatal Zinc and Vitamin A Deficiencies on Birthweight in Rural Sidama, Southern Ethiopia: Prospective Cohort Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH; ANTENATAL CARE; CORD SERUM; MALNUTRITION; ASSOCIATION	Background: The effects of prenatal Zinc Deficiency (ZD) and Vitamin A Deficiency (VAD) on birthweight are controversial and their interaction has not been investigated. Objective: To assess the independent and interaction effects of prenatal zinc and vitamin A deficiencies on birthweight in rural Sidama, Southern Ethiopia. Methodology: A community-based prospective cohort study design was employed. Six hundred fifty pregnant women in their second or third trimester were randomly selected and their serum zinc and retinol concentrations were determined. About 575 subjects were successfully followed until delivery and birthweight was measured within 72 hours after delivery. The association between the exposures and birthweight was examined using log-binomial and liner regression analyses. Potential interaction between ZD and VAD was examined using Synergy Index (SI). Results: The mean birthweight (6 standard deviation) was 2896 g (6423). About 16.5% (95% CI: 13.5-19.6%) of the babies had Low Birthweight (LBW). Prenatal ZD and VAD were not significantly associated to LBW with Adjusted Relative Risk (ARR) of 1.25 (95 CI: 0.86-1.82) and 1.27 (95% CI: 0.86-1.87), respectively. Stratified analysis on the basis of gestational trimester showed that the occurrence of the deficiencies neither in the second nor third trimester were associated to LBW. The deficiencies did not show synergetic interaction in causing LBW [SI = 1.04 (95% CI: 0.17-6.28)]. Important risk factors of LBW were maternal illiteracy [RR = 1.80 (95% CI: 1.11-2.93)], female sex of the newborn [RR = 1.79 (95% CI: 1.19-2.67)], primiparity [RR = 1.16 (95% CI: 1.02-1.35)], short maternal stature [RR = 1.63 (95% CI: 1.06-2.51)] and maternal thinness [ RR = 1.52 (95% CI: 1.03-2.25)]. In the linear regression model, elevated CRP was also negatively associated to birthweight. Conclusion: LBW is of public health significance in the locality. The study did not witness any independent or interaction effect of prenatal ZD and VAD on birthweight. Citation: Gebremedhin S, Enquselassie F, Umeta M (2012) Independent and Joint Effects of Prenatal Zinc and Vitamin A Deficiencies on Birthweight in Rural Sidama, Southern Ethiopia: Prospective Cohort Study. PLoS ONE 7(12):e50213. doi:10.1371/journal.pone.0050213	[Gebremedhin, Samson] Hawassa Univ, Coll Agr, Hawassa, Ethiopia; [Enquselassie, Fikre] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Umeta, Melaku] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia	Hawassa University; Addis Ababa University; Addis Ababa University	Gebremedhin, S (corresponding author), Hawassa Univ, Coll Agr, Hawassa, Ethiopia.	samsongmgs@yahoo.com	Gebremedhin, Samson/O-2121-2019	Gebremedhin, Samson/0000-0002-7838-2470	Addis Ababa University, School of Public Health	Addis Ababa University, School of Public Health	The study was funded by Addis Ababa University, School of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Ammar C., 2009, ENCY WOMENS HLTH; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Asefa M, 2004, ETHIOP J HLTH SCI, V14, P13; Barua D, 2009, BANGLADESH J CHILD H, V33, P46; Broek NV, 2010, VITAMIN A SUPPLEMENT, DOI [10.1002/14651858.CD008666.pub2, DOI 10.1002/14651858.CD008666.PUB2]; CoriaSoto IL, 1996, INT J QUAL HEALTH C, V8, P13, DOI 10.1093/intqhc/8.1.13; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Enquoselassie F., 2000, Ethiopian Journal of Health Development, V14, P169; Feleke Y, 1999, E AFR MED J, V76, P468; FerroLuzzi A, 1996, BRIT J NUTR, V75, P3, DOI 10.1079/BJN19960105; Gazala E, 2003, EARLY HUM DEV, V71, P19, DOI 10.1016/S0378-3782(02)00096-8; Gebremariam A, 2005, East Afr Med J, V82, P554; Gebremedhin S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-898; GHEBREMESKEL K, 1994, EARLY HUM DEV, V39, P177, DOI 10.1016/0378-3782(94)90196-1; HIGASHI A, 1988, J PEDIATR GASTR NUTR, V7, P430, DOI 10.1097/00005176-198805000-00020; Hirve S S, 1994, Indian Pediatr, V31, P1221; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Institute of Health Economics, 2001, DET PREV LOW BIRTHW; International Zinc Nutrition Consultative Group, 2007, ASS POP ZINC STAT SE; Khatun S, 2008, J BIOSOC SCI, V40, P321, DOI 10.1017/S0021932007002532; King JC, 2000, AM J CLIN NUTR, V71, p1334S, DOI 10.1093/ajcn/71.5.1334s; KIRKSEY A, 1994, AM J CLIN NUTR, V60, P782, DOI 10.1093/ajcn/60.5.782; Mohanty C, 2006, J TROP PEDIATRICS, V52, P24, DOI 10.1093/tropej/fmi059; Mori R, 2012, ZINC SUPPLEMENTATION, DOI [10.1002/14651858.CD000230.pub4, DOI 10.1002/14651858.CD000230.PUB4]; NEEL NR, 1990, EUR J CLIN NUTR, V44, P207; NEGGERS YH, 1990, AM J CLIN NUTR, V51, P678, DOI 10.1093/ajcn/51.4.678; Nekatibeb Gezahegn, 2007, Ethiop Med J, V45, P195; ORC Macro, 2006, ETH DEM HLTH SURV 20; ORC Macro Central Statistical Agency, 2001, ETH DEM HLTH SURV 20; Pojda J, 2000, 18 ACCSCN; Prasad M, 2002, J Obstet Gynaecol, V22, P513, DOI 10.1080/0144361021000003654; Rah JH, 2006, CHANGE MATERNAL MIDU; Ricalde AE, 1998, REV SAUDE PUBL, V32, P112, DOI 10.1590/S0034-89101998000200002; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Sommer A, 2002, J NUTR, V132, p2845S, DOI 10.1093/jn/132.9.2845S; Tamura T, 1997, ACTA OBSTET GYN SCAN, V76, P63; Tema T, 2006, East Afr Med J, V83, P366; Teshome D, 2006, Cent Afr J Med, V52, P8; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE	41	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50213	10.1371/journal.pone.0050213	http://dx.doi.org/10.1371/journal.pone.0050213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272058	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600009
J	Naumova, EA; Sandulescu, T; Al Khatib, P; Thie, M; Lee, WK; Zimmer, S; Arnold, WH				Naumova, Ella A.; Sandulescu, Tudor; Al Khatib, Philipp; Thie, Michael; Lee, Wing-Kee; Zimmer, Stefan; Arnold, Wolfgang H.			Acute Short-Term Mental Stress Does Not Influence Salivary Flow Rate Dynamics	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ALPHA-AMYLASE; PSYCHOLOGICAL STRESS; SUCROSE CLEARANCE; CORTISOL; ANXIETY; IMPACT; ADULTS	Background: Results of studies that address the influence of stress on salivary flow rate and composition are controversial. The aim of this study was to reveal the influence of stress vulnerability and different phases of stress reactivity on the unstimulated and stimulated salivary flow rate. We examined that acute mental stress does not change the salivary flow rate. In addition, we also examined the salivary cortisol and protein level in relation to acute mental stress stimuli. Methods: Saliva of male subjects was collected for five minutes before, immediately, 10, 30 and 120 min after toothbrushing. Before toothbrushing, the subjects were exposed to acute stress in the form of a 2 min public speech. Salivary flow rate and total protein was measured. The physiological stress marker cortisol was analyzed using enzyme-linked immunosorbent assay. To determine the subjects' psychological stress reaction, the State-Trait-Anxiety Inventory State questionnaire (STAI) data were obtained. The subjects were divided into stress subgroup (S1) (psychological reactivity), stress subgroup (S2) (psychological and physiological reactivity) and a control group. The area under the curve for salivarycortisol concentration and STAI-State scores were calculated. All data underwent statistical analysis using one-way analysis of variance. Results: Immediately after stress exposure, all participants exhibited a psychological stress reaction. Stress exposure did not change the salivary flow rate. Only 69% of the subjects continued to display a physiological stress reaction 20 minutes after the public talk. There was no significant change in the salivary flow rate during the psychological and the physiological stress reaction phases relative to the baseline. Conclusions: Acute stress has no impact on the salivary flow rate; however, there may be other responses through salivary proteins that are increased with the acute stress stimuli. Future studies are needed to examine specific proteins and their possible roles in acute stress responses. Citation: Naumova EA, Sandulescu T, Al Khatib P, Thie M, Lee W-K, et al. (2012) Acute Short-Term Mental Stress Does Not Influence Salivary Flow Rate Dynamics. PLoS ONE 7(12): e51323. doi:10.1371/journal.pone.0051323	[Naumova, Ella A.; Sandulescu, Tudor; Al Khatib, Philipp; Zimmer, Stefan; Arnold, Wolfgang H.] Univ Witten Herdecke, Fac Hlth, Sch Dent, Witten, Germany; [Thie, Michael] Univ Duisburg Essen, Inst Pathol & Neuropathol, Essen, Germany; [Lee, Wing-Kee] Univ Witten Herdecke, Inst Physiol & Pathophysiol, Ctr Biomed Educ & Res, Witten, Germany	Witten Herdecke University; University of Duisburg Essen; Witten Herdecke University	Arnold, WH (corresponding author), Univ Witten Herdecke, Fac Hlth, Sch Dent, Witten, Germany.	wolfgang.arnold@uni-wh.de		Lee, Wing-Kee/0000-0002-7352-4679	Deutsche Gesellschaft fur Zahnerhaltung	Deutsche Gesellschaft fur Zahnerhaltung	This study was supported by Deutsche Gesellschaft fur Zahnerhaltung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balodis IM, 2010, PSYCHONEUROENDOCRINO, V35, P1363, DOI 10.1016/j.psyneuen.2010.03.011; BASS C C, 1954, J La State Med Soc, V106, P57; BAUM BJ, 1993, ANN NY ACAD SCI, V694, P17; Beltzer EK, 2010, PHYSIOL BEHAV, V101, P289, DOI 10.1016/j.physbeh.2010.05.016; Bjorntorp P, 2001, Lakartidningen, V98, P5458; Bosch JA, 2003, PSYCHOSOM MED, V65, P245, DOI 10.1097/01.PSY.0000058376.50240.2D; Bosch JA, 1996, PSYCHOSOM MED, V58, P374, DOI 10.1097/00006842-199607000-00010; Boudarene M, 2002, ENCEPHALE, V28, P139; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Elishoov H, 2005, Refuat Hapeh Vehashinayim (1993), V22, P44; ELISHOOV H, 2005, REFUAT HAPEH VEHASHI, V22, P86; Flink Hakan, 2007, Swed Dent J Suppl, P3; Gibbons CJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-82; Hansen AM, 2008, SCAND J CLIN LAB INV, V68, P448, DOI 10.1080/00365510701819127; Herrmann-Lingen C., 2005, HADS D HOSP ANXIETY; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; King JA, 2000, BEHAV MED, V26, P67, DOI 10.1080/08964280009595753; King Shirley L, 2002, Biol Res Nurs, V4, P92, DOI 10.1177/1099800402238334; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; Kreher DA, 2012, BEHAV NEUROSCI, V126, P157, DOI 10.1037/a0026654; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; LAGERLOF F, 1994, CARIES RES, V28, P348, DOI 10.1159/000262000; Laux L., 1981, DAS STATE TRAIT ANGS; Lenander-Lumikari M, 2000, Adv Dent Res, V14, P40; MIURA H, 1991, J DENT, V19, P189, DOI 10.1016/0300-5712(91)90016-R; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Paris JJ, 2010, HORM BEHAV, V57, P35, DOI 10.1016/j.yhbeh.2009.06.003; Pawlak CR, 1999, BRAIN BEHAV IMMUN, V13, P287, DOI 10.1006/brbi.1999.0553; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Shigeyama C, 2008, ORAL SURG ORAL MED O, V106, P833, DOI 10.1016/j.tripleo.2008.07.005; Siedek V, 2008, MMW Fortschr Med, V150, P31; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Tornhage CJ, 2009, NEUROIMMUNOMODULAT, V16, P284, DOI 10.1159/000216186	36	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51323	10.1371/journal.pone.0051323	http://dx.doi.org/10.1371/journal.pone.0051323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272098	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386600023
J	Barrett, CW; Smith, JJ; Lu, LC; Markham, N; Stengel, KR; Short, SP; Zhang, BL; Hunt, AA; Fingleton, BM; Carnahan, RH; Engel, ME; Chen, X; Beauchamp, RD; Wilson, KT; Hiebert, SW; Reynolds, AB; Williams, CS				Barrett, Caitlyn W.; Smith, J. Joshua; Lu, Lauren C.; Markham, Nicholas; Stengel, Kristy R.; Short, Sarah P.; Zhang, Baolin; Hunt, Aubrey A.; Fingleton, Barbara M.; Carnahan, Robert H.; Engel, Michael E.; Chen, Xi; Beauchamp, R. Daniel; Wilson, Keith T.; Hiebert, Scott W.; Reynolds, Albert B.; Williams, Christopher S.			Kaiso Directs the Transcriptional Corepressor MTG16 to the Kaiso Binding Site in Target Promoters	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-7; CELL PROLIFERATION; PARTNER KAISO; HUMAN BREAST; ETO PROTEIN; N-COR; CANCER; DNA; GENE; FAMILY	Myeloid translocation genes (MTGs) are transcriptional corepressors originally identified in acute myelogenous leukemia that have recently been linked to epithelial malignancy with non-synonymous mutations identified in both MTG8 and MTG16 in colon, breast, and lung carcinoma in addition to functioning as negative regulators of WNT and Notch signaling. A yeast two-hybrid approach was used to discover novel MTG binding partners. This screen identified the Zinc fingers, C2H2 and BTB domain containing (ZBTB) family members ZBTB4 and ZBTB38 as MTG16 interacting proteins. ZBTB4 is downregulated in breast cancer and modulates p53 responses. Because ZBTB33 (Kaiso), like MTG16, modulates Wnt signaling at the level of TCF4, and its deletion suppresses intestinal tumorigenesis in the Apc(Min) mouse, we determined that Kaiso also interacted with MTG16 to modulate transcription. The zinc finger domains of Kaiso as well as ZBTB4 and ZBTB38 bound MTG16 and the association with Kaiso was confirmed using co-immunoprecipitation. MTG family members were required to efficiently repress both a heterologous reporter construct containing Kaiso binding sites (4xKBS) and the known Kaiso target, Matrix metalloproteinase-7 (MMP-7/Matrilysin). Moreover, chromatin immunoprecipitation studies placed MTG16 in a complex occupying the Kaiso binding site on the MMP-7 promoter. The presence of MTG16 in this complex, and its contributions to transcriptional repression both required Kaiso binding to its binding site on DNA, establishing MTG16-Kaiso binding as functionally relevant in Kaiso-dependent transcriptional repression. Examination of a large multi-stage CRC expression array dataset revealed patterns of Kaiso, MTG16, and MMP-7 expression supporting the hypothesis that loss of either Kaiso or MTG16 can de-regulate a target promoter such as that of MMP-7. These findings provide new insights into the mechanisms of transcriptional control by ZBTB family members and broaden the scope of co-repressor functions for the MTG family, suggesting coordinate regulation of transcription by Kaiso/MTG complexes in cancer.	[Barrett, Caitlyn W.; Zhang, Baolin; Williams, Christopher S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA; [Barrett, Caitlyn W.; Markham, Nicholas; Short, Sarah P.; Zhang, Baolin; Fingleton, Barbara M.; Carnahan, Robert H.; Wilson, Keith T.; Reynolds, Albert B.; Williams, Christopher S.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Stengel, Kristy R.; Hunt, Aubrey A.; Hiebert, Scott W.] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA; [Lu, Lauren C.] Vanderbilt Univ, Med Ctr, Sch Sci & Math, Nashville, TN USA; [Beauchamp, R. Daniel] Vanderbilt Univ, Dept Surg, Med Ctr, Sect Surg Sci,Div Surg Oncol, Nashville, TN 37240 USA; [Smith, J. Joshua; Chen, Xi] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Fingleton, Barbara M.; Chen, Xi; Beauchamp, R. Daniel; Wilson, Keith T.; Hiebert, Scott W.; Reynolds, Albert B.; Williams, Christopher S.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Wilson, Keith T.; Williams, Christopher S.] Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN USA; [Engel, Michael E.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Williams, CS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA.	christopher.williams@vanderbilt.edu	Williams, Christopher/W-3524-2019; Markham, Nicholas/AAV-9018-2021; Carnahan, Robert H/N-7429-2013; Smith, Jesse Joshua/AAN-5440-2020	Williams, Christopher/0000-0002-1541-579X; Markham, Nicholas/0000-0002-1348-1267; Carnahan, Robert H/0000-0001-5230-1532; Smith, Jesse Joshua/0000-0003-2538-5456; Short, Sarah/0000-0001-9606-7370; Wilson, Keith/0000-0003-4421-1830; Fingleton, Barbara/0000-0003-1132-0782; Beauchamp, Robert Daniel/0000-0002-8446-4114; Stengel, Kristy/0000-0002-8330-5744	National Center for Research Resources [UL1 RR024975-01]; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; Cellular and Biochemical and Molecular Sciences Training Program [NIH T32 GM08554]; NCI sponsored fellowship [1F31CA167920]; NIDDK [K-08 (5K08DK080221)]; Veterans Administration; American Cancer Society ACS-RSG [116552]; NIH [P30DK058404]; Vanderbilt Ingram Cancer Center shared resources [P30CA068485]; NATIONAL CANCER INSTITUTE [F31CA167920, T32CA009592, R01CA069457, P30CA068485, T32CA009582] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080221, P30DK058404, K08DK080190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Cellular and Biochemical and Molecular Sciences Training Program; NCI sponsored fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Administration(US Department of Veterans Affairs); American Cancer Society ACS-RSG(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center shared resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by National Center for Research Resources, Grant UL1 RR024975-01, and is now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06, the Cellular and Biochemical and Molecular Sciences Training Program (NIH T32 GM08554), an NCI sponsored fellowship (CWB 1F31CA167920), and NIDDK K-08 (CSW 5K08DK080221). Additional funding from the Veterans Administration (CSW & KTW) and the American Cancer Society ACS-RSG 116552 (CSW). Core Services performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by NIH grant P30DK058404 (RMP) and the Vanderbilt Ingram Cancer Center shared resources P30CA068485. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 1999, GUT, V45, P252, DOI 10.1136/gut.45.2.252; Barrett CW, CANC RES, V71, P1302; Bloomston M, 2002, ANN SURG ONCOL, V9, P668, DOI 10.1245/aso.2002.9.7.668; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Buck-Koehntop BA, 2012, FEBS LETT, V586, P734, DOI 10.1016/j.febslet.2012.01.045; Chang MC, BIOCH J, V442, P293; Chevallier N, 2004, BLOOD, V103, P1454, DOI 10.1182/blood-2003-06-2081; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crawford HC, 2001, MOL CELL BIOL, V21, P1370, DOI 10.1128/MCB.21.4.1370-1383.2001; Dai SD, CANC SCI, V102, P95; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Davis JN, 2003, GENE, V303, P1, DOI 10.1016/S0378-1119(02)01172-1; del Valle-Perez B, 2011, J CELL SCI, V124, P2298, DOI 10.1242/jcs.082693; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jiang G, PLOS ONE, V7; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Kochetkova M, 2002, CANCER RES, V62, P4599; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Melnick AM, 2000, MOL CELL BIOL, V20, P2075, DOI 10.1128/MCB.20.6.2075-2086.2000; Moore AC, 2008, MOL CELL BIOL, V28, P977, DOI 10.1128/MCB.01242-07; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Sasai N, NUCL ACIDS RES, V38, P5015; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Soler E, GENES DEV, V24, P277; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; StetlerStevenson WG, 1996, AM J PATHOL, V148, P1345; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Weber A, 2008, EMBO J, V27, P1563, DOI 10.1038/emboj.2008.85; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Williams CS, 2011, J CLIN INVEST, V121, P4056, DOI 10.1172/JCI44228; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008	47	18	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51205	10.1371/journal.pone.0051205	http://dx.doi.org/10.1371/journal.pone.0051205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251453	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200068
J	Makkoch, J; Suwannakarn, K; Payungporn, S; Prachayangprecha, S; Cheiocharnsin, T; Linsuwanon, P; Theamboonlers, A; Poovorawan, Y				Makkoch, Jarika; Suwannakarn, Kamol; Payungporn, Sunchai; Prachayangprecha, Slinporn; Cheiocharnsin, Thaweesak; Linsuwanon, Piyada; Theamboonlers, Apiradee; Poovorawan, Yong			Whole Genome Characterization, Phylogenetic and Genome Signature Analysis of Human Pandemic H1N1 Virus in Thailand, 2009-2012	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; ANTIGENIC EVOLUTION	Background: Three waves of human pandemic influenza occurred in Thailand in 2009-2012. The genome signature features and evolution of pH1N1 need to be characterized to elucidate the aspects responsible for the multiple waves of pandemic. Methodology/Findings: Forty whole genome sequences and 584 partial sequences of pH1N1 circulating in Thailand, divided into 1st, 2nd and 3rd wave and post-pandemic were characterized and 77 genome signatures were analyzed. Phylogenetic trees of concatenated whole genome and HA gene sequences were constructed calculating substitution rate and d(N)/d(S) of each gene. Phylogenetic analysis showed a distinct pattern of pH1N1 circulation in Thailand, with the first two isolates from May, 2009 belonging to clade 5 while clades 5, 6 and 7 co-circulated during the first wave of pH1N1 pandemic in Thailand. Clade 8 predominated during the second wave and different proportions of the pH1N1 viruses circulating during the third wave and post pandemic period belonged to clades 8, 11.1 and 11.2. The mutation analysis of pH1N1 revealed many adaptive mutations which have become the signature of each clade and may be responsible for the multiple pandemic waves in Thailand, especially with regard to clades 11.1 and 11.2 as evidenced with V731I, G154D of PB1 gene, PA I330V, HA A214T S160G and S202T. The substitution rate of pH1N1 in Thailand ranged from 2.53 x 10(-3) +/- 0.02 (M2 genes) to 5.27 x 10(-3) +/- 0.03 per site per year (NA gene). Conclusions: All results suggested that this virus is still adaptive, maybe to evade the host's immune response and tends to remain in the human host although the d(N)/d(S) were under purifying selection in all 8 genes. Due to the gradual evolution of pH1N1 in Thailand, continuous monitoring is essential for evaluation and surveillance to be prepared for and able to control future influenza activities.	[Makkoch, Jarika; Suwannakarn, Kamol; Prachayangprecha, Slinporn; Cheiocharnsin, Thaweesak; Linsuwanon, Piyada; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Payungporn, Sunchai] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand	Chulalongkorn University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	yong.p@chula.ac.th	Linsuwanon, Piyada/AAS-7642-2020; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807	Commission on Higher Education; Ministry of Education; Center of Excellence in Clinical Virology; Chulalongkorn University; Dutsadi Piphat Scholarship; CU Centenary Academic Development Project; King Chulalongkorn Memorial Hospital; Graduate School of Biomedical Science; RGJ PhD program of the Thailand Research Fund; Thailand Research Fund [DPG5480002]; National Research University Project of Thailand; Office of the Higher Education Commission [HR1155A-55]; MK Restaurant Company Limited; NIAID, United States National Institutes of Health, Department of Health and Human Services [HHSN266200700007c]	Commission on Higher Education; Ministry of Education; Center of Excellence in Clinical Virology; Chulalongkorn University(Chulalongkorn University); Dutsadi Piphat Scholarship; CU Centenary Academic Development Project; King Chulalongkorn Memorial Hospital(Chulalongkorn University); Graduate School of Biomedical Science; RGJ PhD program of the Thailand Research Fund; Thailand Research Fund(Thailand Research Fund (TRF)); National Research University Project of Thailand; Office of the Higher Education Commission; MK Restaurant Company Limited; NIAID, United States National Institutes of Health, Department of Health and Human Services	The authors would like to express their gratitude to the Commission on Higher Education, Ministry of Education, the Center of Excellence in Clinical Virology, Chulalongkorn University, Dutsadi Piphat Scholarship, Chulalongkorn University, CU Centenary Academic Development Project, King Chulalongkorn Memorial Hospital, Graduate School of Biomedical Science, Chulalongkorn University, the RGJ PhD program of the Thailand Research Fund, Thailand Research Fund (DPG5480002), National Research University Project of Thailand, Office of the Higher Education Commission (HR1155A-55), MK Restaurant Company Limited and in part with federal funds from the NIAID, United States National Institutes of Health, Department of Health and Human Services, under Contract no. HHSN266200700007c for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YH, 2010, EMERG INFECT DIS, V16, P1162, DOI 10.3201/eid1607.091881; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Chieochansin T, 2009, ASIAN BIOMED, V3, P469; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Espinola Emilio E, 2012, Open Virol J, V6, P59, DOI 10.2174/1874357901206010059; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Naffakh N, 2009, MICROBES INFECT, V11, P725, DOI 10.1016/j.micinf.2009.05.002; Nelson M, 2009, PLOS CURR, V3; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Payungporn S, 2010, ACTA VIROL, V54, P155, DOI 10.4149/av_2010_03_155; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Sarkar M, 2011, ARCH VIROL, V156, P207, DOI 10.1007/s00705-010-0842-6; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suarez DL, 2000, VET MICROBIOL, V74, P15, DOI 10.1016/S0378-1135(00)00161-9; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thai Meteorological Department, 2012, THAIL ANN WEATH SUMM; Thai Ministry of Public Health, 2009, PUBL HLTH ADV 5 SUBJ; WHO, 2012, REC COMP INFL VIR VA; World Health Organization website, 2010, PAND H1N1 2009 UPD 1; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028288; Zhao Jiu-ru, 2011, Virologica Sinica, V26, P418, DOI 10.1007/s12250-011-3228-3	31	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51275	10.1371/journal.pone.0051275	http://dx.doi.org/10.1371/journal.pone.0051275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251479	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200082
J	Mittendorfer-Rutz, E; Rasmussen, F; Lange, T				Mittendorfer-Rutz, Ellenor; Rasmussen, Finn; Lange, Theis			A Life-Course Study on Effects of Parental Markers of Morbidity and Mortality on Offspring's Suicide Attempt	PLOS ONE			English	Article							FAMILIAL PATHWAYS; RISK-FACTORS; BEHAVIOR; POPULATION; DEATH; EPIDEMIOLOGY; ADOLESCENTS; REGISTER; CHILDREN; DENMARK	Background: Research on the temporal relationship of parental risk factors with offspring's suicide attempt is scarce and a life course approach has not been applied to date. We investigated the temporal relationship of parental morbidity and mortality with offspring's suicide attempt and whether any such association was modified by offspring's age at attempt. Methods: We designed a case-control study through linkage of Swedish registers. Cases comprised all individuals in Sweden born 1973-1983 with inpatient care due to suicide attempt (15-31 years of age) and with information on both biological parents (N = 15 193). Ten controls were matched to each case (National Patient register with national complete coverage). Conditional logistic and spline regressions were applied. Results: Particularly for women, most parental markers showed the strongest effect sizes if exposure was short-term (within 2 years after exposure) and related to the mother. Especially short-term exposure to maternal inpatient care due to psychiatric diagnoses had a significantly stronger effect on suicide attempt risk in women compared to men. Regarding exposure to parental inpatient care due to psychiatric diagnoses, short-term as opposed to long-term (exceeding 2 years after exposure) effects were highest during adolescence and decreased significantly with age for female and male offspring, respectively. Conclusions: Although limited by the fact that data on parental morbidity and the outcome of suicidality were based on inpatient data only, the data suggest that the high risks of suicide attempt in case of exposure to parental psychopathology and suicidal behavior particularly during adolescence and the strong short-term effects associated with maternal psychopathology for female offspring are of direct clinical importance.	[Mittendorfer-Rutz, Ellenor] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden; [Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci Child & Adolescent Publ Hlth E, Stockholm, Sweden; [Lange, Theis] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Karolinska Institutet; Karolinska Institutet; University of Copenhagen	Mittendorfer-Rutz, E (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden.	Ellenor.Mittendorfer-Rutz@ki.se		Rasmussen, Finn/0000-0001-7915-7809	Swedish Council for Working Life and Social Research; Swedish Research Council	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by grants from the Swedish Council for Working Life and Social Research and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamowicz M, 2007, STAT MED, V26, P392, DOI 10.1002/sim.2519; [Anonymous], 2005, EUR J EDUC PSYCHOL; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beardslee WR, 2003, PEDIATRICS, V112, pE119, DOI 10.1542/peds.112.2.e119; Bogdanovica I, 2010, SOC PSYCHIAT PSYCHIA; Brent DA, 2002, ARCH GEN PSYCHIAT, V59, P801, DOI 10.1001/archpsyc.59.9.801; Brent DA, 2008, PSYCHIAT CLIN N AM, V31, P157, DOI 10.1016/j.psc.2008.02.001; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Bronisch T, 2008, PSYCHIAT CLIN N AM, V31, P213, DOI 10.1016/j.psc.2008.01.003; Casey BJ, 2010, DEV PSYCHOBIOL, V52, P225, DOI 10.1002/dev.20447; Erikson R, 2006, SOC SCI MED, V62, P2151, DOI 10.1016/j.socscimed.2005.09.009; Jakobsen IS, 2011, J CHILD PSYCHOL PSYC, V52, P176, DOI 10.1111/j.1469-7610.2010.02298.x; Kosidou K, 2010, ACTA PSYCHIAT SCAND, V122, P47, DOI 10.1111/j.1600-0447.2009.01487.x; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Kuramoto SJ, 2010, PEDIATRICS, V126, pE1026, DOI 10.1542/peds.2010-0974; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Melhem NM, 2007, AM J PSYCHIAT, V164, P1364, DOI 10.1176/appi.ajp.2007.06091522; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; Mittendorfer-Rutz E., 2006, J MENS HLTH GENDER, V3, P250; Mittendorfer-Rutz E, 2008, SOC PSYCH PSYCH EPID, V43, P28, DOI 10.1007/s00127-007-0266-0; Niederkrotenthaler T, 2010, J EPIDEMIOL COMMUNIT; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; Ramberg IL, 2000, PSYCHOL MED, V30, P1189, DOI 10.1017/S003329179900238X; SCB, 2001, PROGR BEF FLERG; SCB, 1992, FOLK BOST 1990 DEL 5; Schmidtke A, 2004, SUICIDAL BEHAVIOUR IN EUROPE: RESULTS FROM THE WHO/EURO MULTICENTRE STUDY ON SUICIDAL BEHAVIOUR, P15; SHAFFER D, 1988, J CLIN PSYCHIAT, V49, P36; Socialstyrelsen, 2009, FOLKH; Socialstyrelsen, 2009, DODS PAT; Stenager K, 2008, SOC PSYCH PSYCH EPID, V43, P920, DOI 10.1007/s00127-008-0385-2; Webb RT, 2007, ARCH GEN PSYCHIAT, V64, P345, DOI 10.1001/archpsyc.64.3.345; Wilcox HC, 2010, J AM ACAD CHILD PSY, V49, P514, DOI 10.1016/j.jaac.2010.01.020; [No title captured]	35	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51585	10.1371/journal.pone.0051585	http://dx.doi.org/10.1371/journal.pone.0051585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251584	Green Submitted, gold, Green Published			2022-12-27	WOS:000313236200140
J	Coudeville, L; Garnett, GP				Coudeville, Laurent; Garnett, Geoff P.			Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; PRIMARY-SCHOOL CHILDREN; COST-EFFECTIVENESS; HEMORRHAGIC-FEVER; KAMPHAENG PHET; INFECTION; EPIDEMIOLOGY; BURDEN; MODELS; DETERMINANTS	Background: With approximately 2.5 billion people at risk, dengue is a major international public health concern. Dengue vaccines currently in development should help reduce the burden associated with this disease but the most efficient way of using future dengue vaccines remains to be defined. Mathematical models of transmission can provide insight into the expected impact of different vaccination strategies at a population level and contribute to this definition. Methods and Findings: We developed and analyzed an age-structured, host-vector and serotype-specific compartmental model, including seasonality. We first used this transmission model to identify the immunological interactions between serotypes that affect the risks and consequences of secondary infections (cross-protection, increased susceptibility, increased severity, and increased infectiousness) and reproduce the observed epidemiology of dengue. For populating this model, we used routine surveillance data from Southern Vietnam and the results of a prospective cohort study conducted in the same area. The model provided a good fit to the observed data for age, severity of cases, serotype distribution, and dynamics over time, using two scenarios of immunological interaction : short term cross-protection alone (6-17 months) or a combination of short term cross-protection with cross-enhancement (increased susceptibility, severity and infectiousness in the case of secondary infections). Finally, we explored the potential impact of vaccination for these two scenarios. Both highlighted that vaccination can substantially decrease dengue burden by reducing the magnitude and frequency of outbreaks. Conclusion: Our model suggests that seasonality and short term cross-protection are key factors for explaining dengue dynamics in Southern Vietnam. Vaccination was predicted to significantly reduce the disease burden, even in the situation where immunological cross-enhancement affects the risks and consequences of secondary infections. Citation: Coudeville L, Garnett GP (2012) Transmission Dynamics of the Four Dengue Serotypes in Southern Vietnam and the Potential Impact of Vaccination. PLoS ONE 7(12): e51244. doi:10.1371/journal.pone.0051244	[Coudeville, Laurent] Sanofi Pasteur, Dengue Co, Lyon, France; [Garnett, Geoff P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England	Sanofi-Aventis; Sanofi France; Imperial College London	Coudeville, L (corresponding author), Sanofi Pasteur, Dengue Co, Lyon, France.	laurent.coudeville@sanofipasteur.com	Garnett, Geoffrey P/A-9312-2008		Sanofi Pasteur	Sanofi Pasteur	This work was sponsored by Sanofi Pasteur. LC is an employee of Sanofi Pasteur and contributed with GG to model design, data analysis and preparation of the manuscript.	Adams B, 2006, J THEOR BIOL, V242, P337, DOI 10.1016/j.jtbi.2006.03.002; Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0; Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8; BERRYMAN AA, 1992, ECOLOGY, V73, P1530, DOI 10.2307/1940005; Brockwell P.J., 1991, TIME SERIES THEORY M; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426; Cauchemez S, 2008, J R SOC INTERFACE, V5, P885, DOI 10.1098/rsif.2007.1292; Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616; Chompoosri J, 2012, THAI J VET MED, V42, P185; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2; Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; FISCHER DB, 1970, YALE J BIOL MED, V42, P329; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guy B, 2011, LANCET, V377, P381, DOI 10.1016/S0140-6736(11)60128-1; Guy B, 2010, HUM VACCINES, V6, P696, DOI [10.4161/hv.6.9.12739, 10.4161.hv.6.9.12739]; Ha DQ, 2000, EMERG INFECT DIS, V6, P422; HALLORAN ME, 1989, MATH BIOSCI, V94, P115, DOI 10.1016/0025-5564(89)90074-6; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; Halstead SB, 2002, CURR OPIN INFECT DIS, V15, P471, DOI 10.1097/00001432-200210000-00003; Halstead SB, 2007, LANCET, V369, P1410, DOI 10.1016/S0140-6736(07)60645-X; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Harrus S, 2005, INT J PARASITOL, V35, P1309, DOI 10.1016/j.ijpara.2005.06.005; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Phuong HL, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-123; Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322; Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Lee BY, 2011, AM J TROP MED HYG, V84, P764, DOI 10.4269/ajtmh.2011.10-0624; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Nguyen TKT, 2010, T ROY SOC TROP MED H, V104, P592, DOI 10.1016/j.trstmh.2010.06.003; Paunio M, 2000, EPIDEMIOL INFECT, V124, P263, DOI 10.1017/S0950268899003222; POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895; Pongsumpun P, 2003, MATH COMPUT MODEL, V37, P949, DOI 10.1016/S0895-7177(03)00111-0; Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331; Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Stocki R., 2005, COMPUT ASSIST MECH E, V12, P87; Tapia-Conyer R, 2009, J CLIN VIROL, V46, pS3, DOI 10.1016/S1386-6532(09)70286-0; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407; Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; WHO, 1997, DENG HAEM FEV DIAGN; WHO, 2012, DENG DENG HAEM FEV; Wikramaratna PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012347; Word DP, 2012, J R SOC INTERFACE, V9, P1983, DOI 10.1098/rsif.2011.0829; World Health Organization, 2009, DENGUE GUIDELINES DI	62	51	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51244	10.1371/journal.pone.0051244	http://dx.doi.org/10.1371/journal.pone.0051244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251466	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900058
J	Abraham, S; Pahwa, R; Ye, CT; Choi, JG; Pahwa, S; Jaggaiahgari, S; Raut, A; Chen, SP; Manjunath, N; Shankar, P				Abraham, Sojan; Pahwa, Rajendra; Ye, Chunting; Choi, Jang-gi; Pahwa, Savita; Jaggaiahgari, Shashidhar; Raut, Ashwin; Chen, Shuiping; Manjunath, N.; Shankar, Premlata			Long-Term Engraftment of Human Natural T Regulatory Cells in NOD/SCID IL2r gamma c(null) Mice by Expression of Human IL-2	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; IN-VIVO; MOUSE; PREVENT; SCURFY; MODEL	Regulatory T cells are essential to maintain immune homeostasis and prevent autoimmunity. Therapy with in vitro expanded human nT(Regs) is being tested to prevent graft versus host disease, which is a major cause for morbidity and mortality associated with hematopoietic stem cell transplantation. Their usefulness in therapy will depend on their capacity to survive, migrate appropriately and retain suppressive activity when introduced into a transplant recipient. The lack of a suitable animal model for studying the in vivo reconstitutive capability of human nT(Regs) is a major impediment for investigating the behavior of adoptively transferred nT(Regs) in vivo. We show that injection of a plasmid encoding human IL-2 is necessary and sufficient for long term engraftment of in vitro expanded nT(Regs) in NOD-SCID IL2r gamma c(null) mice. We also demonstrate that these in vivo reconstituted T-Regs traffic to different organs of the body and retain suppressive function. Finally, in an IL-2 accelerated GVHD model, we show that these in vivo reconstituted T-Regs are capable of preventing severe xenogenic response of human PBMCs. Thus, this novel 'hu-T-Reg mouse' model offers a pre-clinical platform to study the in vivo function and stability of human nT(Regs) and their ability to modulate autoimmune diseases and GVHD.	[Abraham, Sojan; Ye, Chunting; Choi, Jang-gi; Raut, Ashwin; Chen, Shuiping; Manjunath, N.; Shankar, Premlata] Texas Tech Univ Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis Res, Paul L Foster Sch Med, El Paso, TX USA; [Pahwa, Rajendra; Jaggaiahgari, Shashidhar] Max Healthcare Super Specialty Hosp, Saket New Delhi, India; [Pahwa, Rajendra; Jaggaiahgari, Shashidhar] Max Res Inst 1, Saket New Delhi, India; [Pahwa, Savita] Univ Miami, Leonard M Miller Sch Med, Dev Ctr AIDS Res Microbiol & Immunol, Miami, FL USA	Texas Tech University System; Texas Tech University Health Science Center; University of Miami	Shankar, P (corresponding author), Texas Tech Univ Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis Res, Paul L Foster Sch Med, El Paso, TX USA.	Premlata.shankar@ttuhsc.edu	Pahwa, Savita/AAA-4900-2019; Choi, Jang-gi/AAP-6339-2020	Pahwa, Savita/0000-0002-4470-4216; Raut, Ashwin/0000-0002-4978-901X; Jaggaiahgari, Shashidhar/0000-0001-7318-3942	National Institutes of Health [RO1 AI071882, R01 AI084795]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071882, P30AI073961, R01AI084795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health RO1 AI071882 and R01 AI084795 to Premlata Shankar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluestone JA, 2008, J CLIN IMMUNOL, V28, P677, DOI 10.1007/s10875-008-9242-z; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Brusko Todd M, 2007, Immunol Invest, V36, P607, DOI 10.1080/08820130701790368; Cao TH, 2009, CELL IMMUNOL, V258, P65, DOI 10.1016/j.cellimm.2009.03.013; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Ferrara JLM, 1996, STEM CELLS, V14, P473, DOI 10.1002/stem.140473; Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Leveque L, 2009, J IMMUNOTHER, V32, P101, DOI 10.1097/CJI.0b013e318195b59e; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; Pahwa R, 2010, J IMMUNOL METHODS, V363, P67, DOI 10.1016/j.jim.2010.10.006; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scheffold A, 2005, EUR J IMMUNOL, V35, P1336, DOI 10.1002/eji.200425887; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51832	10.1371/journal.pone.0051832	http://dx.doi.org/10.1371/journal.pone.0051832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272176	gold, Green Submitted, Green Published			2022-12-27	WOS:000312483300033
J	Wu, H; Tao, N; Liu, XM; Li, X; Tang, J; Ma, CW; Xu, XF; Shao, HT; Hou, BD; Wang, H; Qin, ZH				Wu, Hao; Tao, Ning; Liu, Xiaoman; Li, Xiao; Tang, Jian; Ma, Chungwah; Xu, Xiaofei; Shao, Haitao; Hou, Baidong; Wang, Hui; Qin, Zhihai			Polysaccharide from Lentinus edodes Inhibits the Immunosuppressive Function of Myeloid-Derived Suppressor Cells	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; IMMUNE-RESPONSES; CANCER-PATIENTS; DIFFERENTIATION; INTERLEUKIN-4; POLARIZATION; EXPANSION; IMPROVES; MICE	Reversing the function of immune suppressor cells may improve the efficacy of cancer therapy. Here, we have isolated a novel polysaccharide MPSSS (577.2 Kd) from Lentinus edodes and examined its effects on differentiation and function of myeloid-derived suppressor cells (MDSCs). MPSSS is composed of glucose (75.0%), galactose (11.7%), mannose (7.8%), and xylose (0.4%). In vivo, it inhibits the growth of McgR32 tumor cells, which is correlated with a reduced percentage of MDSCs in peripheral blood. In vitro, it induces both morphological and biophysical changes in MDSCs. Importantly, MPSSS up-regulates MHC II and F4/80 expression on MDSCs, and reverses their inhibition effect on CD4(+) T cells in a dose-dependent manner. The mechanism study shows that MPSSS may stimulate MDSCs through a MyD88 dependent NF-kappa B signaling pathway. Together, we demonstrated for the first time that MPSSS stimulates the differentiation of MDSCs and reverses its immunosuppressive functions, shedding new light on developing novel anti-cancer strategies by targeting MDSCs.	[Shao, Haitao; Hou, Baidong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Wu, Hao; Wang, Hui] Xinxiang Med Univ, Xinxiang, Peoples R China; [Tao, Ning; Liu, Xiaoman; Li, Xiao; Qin, Zhihai] Chinese Acad Sci, Inst Biophys, Prot & Peptide Pharmaceut Lab, Beijing 100080, Peoples R China; [Tang, Jian; Ma, Chungwah; Xu, Xiaofei] Infinitus China Co Ltd, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Xinxiang Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Hou, BD (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	baidong_hou@ibp.ac.cn; wanghui@xxmu.edu.cn; zhihai@ibp.ac.cn	Tao, Ning/AAK-7068-2021	Tao, Ning/0000-0002-0021-4995; wu, hao/0000-0002-6713-7752; Wang, Hui/0000-0002-2454-3814; Hou, Baidong/0000-0002-0892-0181; Qin, Zhihai/0000-0001-9793-7964	Plan for Scientific Innovation Talent of Henan Province [104200510001]; National Natural Science Foundation of China [31071261]	Plan for Scientific Innovation Talent of Henan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by Plan for Scientific Innovation Talent of Henan Province (104200510001), and the National Natural Science Foundation of China (31071261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; CHICHARA G, 1969, NATURE, V222, P687, DOI 10.1038/222687a0; CHIHARA G, 1970, CANCER RES, V30, P2776; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; HAMURO J, 1980, IMMUNOLOGY, V39, P551; Jiang J, 2010, GENE THER, V17, P991, DOI 10.1038/gt.2010.54; Jung HY, 2011, FOOD HYDROCOLLOID, V25, P1291, DOI 10.1016/j.foodhyd.2010.12.002; Kusmartsev S, 2003, CANCER RES, V63, P4441; LADANYI A, 1993, CANCER IMMUNOL IMMUN, V36, P123, DOI 10.1007/BF01754412; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li Xiao-bing, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P363, DOI 10.3736/jcim20100411; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; Li ZG, 2009, CELL MOL IMMUNOL, V6, P415, DOI 10.1038/cmi.2009.53; MAEDA YY, 1973, INT J CANCER, V11, P153, DOI 10.1002/ijc.2910110118; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mirza N, 2006, CANCER RES, V66, P9299, DOI 10.1158/0008-5472.CAN-06-1690; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; PETER G, 1988, IMMUNOPHARM IMMUNOT, V10, P157; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Wang ZB, 2010, J IMMUNOTHER, V33, P167, DOI 10.1097/CJI.0b013e3181bed2ba; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zhang YY, 2011, FOOD HYDROCOLLOID, V25, P196, DOI 10.1016/j.foodhyd.2010.02.001	27	32	36	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51751	10.1371/journal.pone.0051751	http://dx.doi.org/10.1371/journal.pone.0051751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272159	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300025
J	Kim, A; Shin, TH; Shin, SM; Pham, CD; Choi, DK; Kwon, MH; Kim, YS				Kim, Aeyung; Shin, Tae-Hwan; Shin, Seung-Min; Pham, Chuong D.; Choi, Dong-Ki; Kwon, Myung-Hee; Kim, Yong-Sung			Cellular Internalization Mechanism and Intracellular Trafficking of Filamentous M13 Phages Displaying a Cell-Penetrating Transbody and TAT Peptide	PLOS ONE			English	Article							CAVEOLAE-MEDIATED ENDOCYTOSIS; PROTEIN TRANSDUCTION DOMAIN; MAMMALIAN-CELLS; DEPENDENT ENDOCYTOSIS; FUSION PROTEINS; GENE-TRANSFER; IN-VIVO; ANTIBODIES; DNA; BINDING	Cellular internalization of bacteriophage by surface-displayed cell penetrating peptides has been reported, though the underlying mechanism remains elusive. Here we describe in detail the internalization mechanism and intracellular trafficking and stability of filamentous M13 phages, the cellular entry of which is mediated by surface-displayed cell-penetrating light chain variable domain 3D8 VL transbody (3D8 VL-M13) or TAT peptide (TAT-M13). Recombinant 3D8 VL-M13 and TAT-M13 phages were efficiently internalized into living mammalian cells via physiologically relevant, energy-dependent endocytosis and were recovered from the cells in their infective form with the yield of 3D8 VL-M13 being higher (0.005 similar to 0.01%) than that of TAT-M13 (0.001 similar to 0.005%). Biochemical and genetic studies revealed that 3D8 VL-M13 was internalized principally by caveolae-mediated endocytosis via interaction with heparan sulfate proteoglycans as cell surface receptors, whereas TAT-M13 was internalized by clathrin- and caveolae-mediated endocytosis utilizing chondroitin sulfate proteoglycans as cell surface receptors, suggesting that phage internalization occurs by physiological endocytotic mechanism through specific cell surface receptors rather than non-specific transcytotic pathways. Internalized 3D8 VL-M13 phages routed to the cytosol and remained stable for more than 18 h without further trafficking to other subcellular compartments, whereas TAT-M13 phages routed to several subcellular compartments before being degraded in lysosomes even after 2 h of internalization. Our results suggest that the internalizing mechanism and intracellular trafficking of filamentous M13 bacteriophages largely follow the attributes of the displayed cell-penetrating moiety. Efficient internalization and cytosolic localization of 3D8 VL transbody-displayed phages will provide a useful tool for intracellular delivery of polar macromolecules such as proteins, peptides, and siRNAs. Citation: Kim A, Shin T-H, Shin S-M, Pham CD, Choi D-K, et al. (2012) Cellular Internalization Mechanism and Intracellular Trafficking of Filamentous M13 Phages Displaying a Cell-Penetrating Transbody and TAT Peptide. PLoS ONE 7(12): e51813. doi:10.1371/journal.pone.0051813	[Kim, Aeyung; Shin, Tae-Hwan; Shin, Seung-Min; Choi, Dong-Ki; Kim, Yong-Sung] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Pham, Chuong D.; Kwon, Myung-Hee] Ajou Univ, Sch Med, Dept Microbiol, Suwon 441749, South Korea	Ajou University; Ajou University	Kim, YS (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	kimys@ajou.ac.kr	Pham, Dinh-Chuong/L-8930-2018; Shin, Tae Hwan/AAE-4763-2022	Pham, Dinh-Chuong/0000-0002-3074-6941; Shin, Tae Hwan/0000-0001-9686-4556; Kim, Yong-Sung/0000-0003-2673-1509; Shin, Seung-min/0000-0002-3014-502X	Mid-career Researcher Program [2010-0009760]; Priority Research Center Program [2012-0006687]; Global Frontier Project grant from the National Research Foundation [2012M3A6A4054252]; Korea government (MEST)	Mid-career Researcher Program; Priority Research Center Program; Global Frontier Project grant from the National Research Foundation; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	The authors would like to thank Dr. Sang Jick Kim (KRIBB, Korea) for providing the phagemid pDR-D1 vector and bacterial strain ER2738. This work was supported by Mid-career Researcher Program (2010-0009760), the Priority Research Center Program (2012-0006687), and the Global Frontier Project grant (2012M3A6A4054252) grants from the National Research Foundation, funded by the Korea government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, J BIOTECHNOL, V151, P225, DOI 10.1016/j.jbiotec.2010.12.004; Becerril B, 1999, BIOCHEM BIOPH RES CO, V255, P386, DOI 10.1006/bbrc.1999.0177; Burg MA, 2002, CANCER RES, V62, P977; Coia G, 2001, J IMMUNOL METHODS, V251, P187, DOI 10.1016/S0022-1759(01)00300-3; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Eguchi A, 2001, J BIOL CHEM, V276, P26204, DOI 10.1074/jbc.M010625200; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Foged C, 2008, EXPERT OPIN DRUG DEL, V5, P105, DOI 10.1517/17425247.5.1.105; Gao CS, 2002, BIOORGAN MED CHEM, V10, P4057, DOI 10.1016/S0968-0896(02)00340-1; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; HART SL, 1994, J BIOL CHEM, V269, P12468; Imai S, 2008, PHARMAZIE, V63, P760, DOI 10.1691/ph.2008.8132; Ivanenkov VV, 1999, BBA-MOL CELL RES, V1448, P450, DOI 10.1016/S0167-4889(98)00162-1; Ivanenkov VV, 1999, BBA-MOL CELL RES, V1448, P463, DOI 10.1016/S0167-4889(98)00163-3; Jang JY, 2009, CELL MOL LIFE SCI, V66, P1985, DOI 10.1007/s00018-009-9179-2; Jang YJ, 2003, CELL MOL LIFE SCI, V60, P309, DOI 10.1007/s000180300026; Kim A, 2012, ANTIVIR RES, V94, P157, DOI 10.1016/j.antiviral.2012.03.007; Kim A, 2012, BIOTECHNOL BIOPROC E, V17, P413, DOI 10.1007/s12257-011-0609-2; Kim YR, 2006, J BIOL CHEM, V281, P15287, DOI 10.1074/jbc.M600937200; Lee SH, 2010, MOL IMMUNOL, V47, P816, DOI 10.1016/j.molimm.2009.09.041; Lee WR, 2010, NUCLEIC ACIDS RES, V38, P1596, DOI 10.1093/nar/gkp1145; Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x; Marschall ALJ, 2011, MABS-AUSTIN, V3, P3, DOI 10.4161/mabs.3.1.14110; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mukai Y, 2006, BIOL PHARM BULL, V29, P1570, DOI 10.1248/bpb.29.1570; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; O'Donnell V, 2008, J VIROL, V82, P9075, DOI 10.1128/JVI.00732-08; Park SY, 2008, PROTEINS, V71, P2091, DOI 10.1002/prot.22011; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sapinoro R, 2008, VIROLOGY, V373, P274, DOI 10.1016/j.virol.2007.12.013; Shin JS, 2001, MICROBES INFECT, V3, P755, DOI 10.1016/S1286-4579(01)01423-X; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Zhou Y, 2010, J MOL BIOL, V404, P88, DOI 10.1016/j.jmb.2010.09.006	42	37	37	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51813	10.1371/journal.pone.0051813	http://dx.doi.org/10.1371/journal.pone.0051813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251631	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800090
J	Lee, CM; Mudaliar, MAV; Haggart, DR; Wolf, CR; Miele, G; Vass, JK; Higham, DJ; Crowther, D				Lee, Clare M.; Mudaliar, Manikhandan A. V.; Haggart, D. R.; Wolf, C. Roland; Miele, Gino; Vass, J. Keith; Higham, Desmond J.; Crowther, Daniel			Simultaneous Non-Negative Matrix Factorization for Multiple Large Scale Gene Expression Datasets in Toxicology	PLOS ONE			English	Article							BILE-ACIDS; MUSCLE-CONTRACTION; MICROARRAY DATA; DISEASE; DISCOVERY; TROPONIN; RECEPTOR; INHIBITION; ENHANCER; COMPLEX	Non-negative matrix factorization is a useful tool for reducing the dimension of large datasets. This work considers simultaneous non-negative matrix factorization of multiple sources of data. In particular, we perform the first study that involves more than two datasets. We discuss the algorithmic issues required to convert the approach into a practical computational tool and apply the technique to new gene expression data quantifying the molecular changes in four tissue types due to different dosages of an experimental panPPAR agonist in mouse. This study is of interest in toxicology because, whilst PPARs form potential therapeutic targets for diabetes, it is known that they can induce serious side-effects. Our results show that the practical simultaneous non-negative matrix factorization developed here can add value to the data analysis. In particular, we find that factorizing the data as a single object allows us to distinguish between the four tissue types, but does not correctly reproduce the known dosage level groups. Applying our new approach, which treats the four tissue types as providing distinct, but related, datasets, we find that the dosage level groups are respected. The new algorithm then provides separate gene list orderings that can be studied for each tissue type, and compared with the ordering arising from the single factorization. We find that many of our conclusions can be corroborated with known biological behaviour, and others offer new insights into the toxicological effects. Overall, the algorithm shows promise for early detection of toxicity in the drug discovery process. Citation: Lee CM, Mudaliar MAV, Haggart DR, Wolf CR, Miele G, et al. (2012) Simultaneous Non-Negative Matrix Factorization for Multiple Large Scale Gene Expression Datasets in Toxicology. PLoS ONE 7(12): e48238. doi:10.1371/journal.pone.0048238	[Lee, Clare M.; Vass, J. Keith; Higham, Desmond J.] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Mudaliar, Manikhandan A. V.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Wolf, C. Roland] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Wolf, C. Roland] CXR Biosci Ltd, Dundee, Scotland; [Haggart, D. R.; Miele, Gino] Epsistem Ltd, Manchester, Lancs, England; [Crowther, Daniel] Sanofi, Frankfurt, Germany	University of Strathclyde; University of Glasgow; University of Dundee; Sanofi-Aventis	Higham, DJ (corresponding author), Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland.	d.j.higham@strath.ac.uk	Mudaliar, Manikhandan/K-1377-2014	Mudaliar, Manikhandan/0000-0003-1482-840X	Translational Medicine Research Collaboration; Scottish Enterprise; Pfizer; EPSRC [EP/E49370/1]; Knowledge Transfer Account of the University of Strathclyde; DTI grant "New serum Biomarkers for Preclinical and Clinical Drug Safety Assessment"; Engineering and Physical Sciences Research Council of the UK under their Fundamentals of Complexity Science call; Leverhulme Trust; TMRC; Cancer Research UK [10822] Funding Source: researchfish	Translational Medicine Research Collaboration; Scottish Enterprise; Pfizer(Pfizer); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Knowledge Transfer Account of the University of Strathclyde; DTI grant "New serum Biomarkers for Preclinical and Clinical Drug Safety Assessment"; Engineering and Physical Sciences Research Council of the UK under their Fundamentals of Complexity Science call(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); TMRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	This work was supported by the Translational Medicine Research Collaboration-a consortium made up of the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, the four associated NHS Health Boards (Grampian, Tayside, Lothian and Greater Glasgow & Clyde), Scottish Enterprise and Pfizer, by EPSRC Grant EP/E49370/1, by the Knowledge Transfer Account of the University of Strathclyde and by the 2007 DTI grant "New serum Biomarkers for Preclinical and Clinical Drug Safety Assessment". CML and DJH were supported by the Engineering and Physical Sciences Research Council of the UK, under their Fundamentals of Complexity Science call. DJH was funded by a Fellowship from the Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DC was employed by Pfizer and legacy company Wyeth during the course of this work and is now employed by Sanofi. GM was employed by Pfizer and legacy company Wyeth during the course of this work and is now employed by Epistem. CRW is employed by CXR. Pfizer agreed to the publication of this manuscript. MM, DRH and JKV were funded through the TMRC. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, CURR CARDIO RISK REP, V4, P142; Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106; Badea Liviu, 2007, 2007 International Conference on Bioinformatics & Computational Biology (BIOCOMP'07), P127; Badea Liviu, 2008, Pac Symp Biocomput, P267; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-78; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Florvall G, 2006, J GERONTOL A-BIOL, V61, P1262, DOI 10.1093/gerona/61.12.1262; Fogel P, 2007, BIOINFORMATICS, V23, P44, DOI 10.1093/bioinformatics/btl550; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Gao Y, 2005, BIOINFORMATICS, V21, P3970, DOI 10.1093/bioinformatics/bti653; Gervois P, 2001, J BIOL CHEM, V276, P33471, DOI 10.1074/jbc.M102839200; Guo Y, 2007, TOXICOL SCI, V96, P294, DOI 10.1093/toxsci/kfm009; Hall R., 2001, PRINCIPLES METHODS T; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jones D, 2010, NAT REV DRUG DISCOV, V9, P668, DOI 10.1038/nrd3271; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Matsukuma KE, 2006, J LIPID RES, V47, P2754, DOI 10.1194/jlr.M600342-JLR200; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Oldgren J, 2003, EUR HEART J, V24, P86, DOI 10.1016/S0195-668X(02)00312-3; PARMACEK MS, 1990, J BIOL CHEM, V265, P15970; Pascual-Montano A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-366; Perry SV, 2003, J MUSCLE RES CELL M, V24, P593; Redwood City CISI, 2011, ING ING PATHW AN VER; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Scotti E, 2007, CELL MOL LIFE SCI, V64, P2477, DOI 10.1007/s00018-007-7280-y; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	37	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e48238	10.1371/journal.pone.0048238	http://dx.doi.org/10.1371/journal.pone.0048238			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272042	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000312386800003
J	Daneshjoo, A; Mokhtar, AH; Rahnama, N; Yusof, A				Daneshjoo, Abdolhamid; Mokhtar, Abdul Halim; Rahnama, Nader; Yusof, Ashril			The Effects of Comprehensive Warm-Up Programs on Proprioception, Static and Dynamic Balance on Male Soccer Players	PLOS ONE			English	Article							CRUCIATE LIGAMENT; INJURY PREVENTION; MUSCLE STRENGTH; POSITION SENSE; ANKLE; PERFORMANCE; IMPROVEMENTS; BASKETBALL; FATIGUE	Purpose: The study investigated the effects of FIFA 11+ and HarmoKnee, both being popular warm-up programs, on proprioception, and on the static and dynamic balance of professional male soccer players. Methods: Under 21 year-old soccer players (n = 36) were divided randomly into 11+, HarmoKnee and control groups. The programs were performed for 2 months (24 sessions). Proprioception was measured bilaterally at 30 degrees, 45 degrees and 60 degrees knee flexion using the Biodex Isokinetic Dynamometer. Static and dynamic balances were evaluated using the stork stand test and Star Excursion Balance Test (SEBT), respectively. Results: The proprioception error of dominant leg significantly decreased from pre- to post-test by 2.8% and 1.7% in the 11+ group at 45 degrees and 60 degrees knee flexion, compared to 3% and 2.1% in the HarmoKnee group. The largest joint positioning error was in the non-dominant leg at 30 degrees knee flexion (mean error value = 5.047), (p<0.05). The static balance with the eyes opened increased in the 11+ by 10.9% and in the HarmoKnee by 6.1% (p<0.05). The static balance with eyes closed significantly increased in the 11+ by 12.4% and in the HarmoKnee by 17.6%. The results indicated that static balance was significantly higher in eyes opened compared to eyes closed (p = 0.000). Significant improvements in SEBT in the 11+ (12.4%) and HarmoKnee (17.6%) groups were also found. Conclusion: Both the 11+ and HarmoKnee programs were proven to be useful warm-up protocols in improving proprioception at 45 degrees and 60 degrees knee flexion as well as static and dynamic balance in professional male soccer players. Data from this research may be helpful in encouraging coaches or trainers to implement the two warm-up programs in their soccer teams.	[Daneshjoo, Abdolhamid; Yusof, Ashril] Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia; [Mokhtar, Abdul Halim] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia; [Rahnama, Nader] Univ Isfahan, Fac Phys Educ & Sport Sci, Esfahan, Iran	Universiti Malaya; Universiti Malaya; University of Isfahan	Daneshjoo, A (corresponding author), Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia.	daneshjoo.hamid@gmail.com	YUSOF, ASHRIL/B-8252-2010; Daneshjoo, Abdolhamid/B-3225-2013; MOKHTAR, ABDUL HALIM/B-8102-2010	YUSOF, ASHRIL/0000-0002-8117-6440; Daneshjoo, Abdolhamid/0000-0002-6197-2300; MOKHTAR, ABDUL HALIM/0000-0001-8057-313X	University of Malaya [PV076/2011A]	University of Malaya(Universiti Malaya)	This research was supported by the University of Malaya Research Grant (PV076/2011A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akseki D, 2008, ACTA ORTHOP TRAUMATO, V42, P316, DOI 10.3944/AOTT.2009.316; Amiri-Khorasani M, 2011, J STRENGTH COND RES, V25, P1647, DOI 10.1519/JSC.0b013e3181db9f41; Ansems GE, 2006, J PHYSIOL-LONDON, V576, P445, DOI 10.1113/jphysiol.2006.115097; Aydin T, 2002, J SPORT REHABIL, V11, P1; Baljinder SB, 2012, MED SPORTIVA, V8, P1743; BARRACK RL, 1989, AM J SPORT MED, V17, P1, DOI 10.1177/036354658901700101; Beets IAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037687; Bressel E, 2007, J ATHL TRAINING, V42, P42; Chen CY, 2011, CLIN REHABIL, V25, P228, DOI 10.1177/0269215510382849; Davlin-Pater C, 2010, MOTOR CONTROL, V14, P362, DOI 10.1123/mcj.14.3.362; Earl JE, 2001, J SPORT REHABIL, V10, P93, DOI 10.1123/jsr.10.2.93; EFFGEN SK, 1981, PHYS THER, V61, P873, DOI 10.1093/ptj/61.6.873; FIFA, 2006, FIFA BIG COUNT 270 M; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Gear WS, 2011, J SPORT SCI MED, V10, P725; Giagazoglou P, 2009, EUR J APPL PHYSIOL, V107, P571, DOI 10.1007/s00421-009-1163-x; Gribble, 2003, MEAS PHYS ED EXERC S, V7, P89, DOI [10.1207/S15327841MPEE0702_3, DOI 10.1207/S15327841MPEE0702_3]; Gribble PA, 2007, J ATHL TRAINING, V42, P35; Gribble PA, 2009, J SPORT REHABIL, V18, P240, DOI 10.1123/jsr.18.2.240; Hadzic V, 2010, ISOKINET EXERC SCI, V18, P31, DOI 10.3233/IES-2010-0365; Hardy L, 2008, J ATHL TRAINING, V43, P347, DOI 10.4085/1062-6050-43.4.347; Hertel J, 2006, KNEE SURG SPORT TR A, V14, P817, DOI 10.1007/s00167-006-0047-4; Hessari R, 2011, MED SPORT, V15, P56, DOI DOI 10.2478/V10036-011-0010-4]; Holm I, 2004, CLIN J SPORT MED, V14, P88, DOI 10.1097/00042752-200403000-00006; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Hubscher M, 2010, MED SCI SPORT EXER, V42, P413, DOI 10.1249/MSS.0b013e3181b88d37; JUDGE JO, 1993, PHYS THER, V73, P254, DOI 10.1093/ptj/73.4.254; Kato Y, 2000, J SPORT MED PHYS FIT, V40, P126; Kiani A, 2010, ARCH INTERN MED, V170, P43, DOI 10.1001/archinternmed.2009.289; Leavey VJ, 2010, J SPORT REHABIL, V19, P268, DOI 10.1123/jsr.19.3.268; Lee AJY, 2006, J EXERC SCI FIT, V4, P117; Lloyd DG, 2001, J ORTHOP SPORT PHYS, V31, P645, DOI 10.2519/jospt.2001.31.11.645; McCurdy K, 2006, J SPORT SCI MED, V5, P282; McKeon PO, 2008, MED SCI SPORT EXER, V40, P1810, DOI 10.1249/MSS.0b013e31817e0f92; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; Melrose DR, 2007, J STRENGTH COND RES, V21, P481, DOI 10.1519/00124278-200705000-00034; Nashner LM, 1989, PROG BRAIN RES, V80, P395; Niessen MHM, 2009, AM J PHYS MED REHAB, V88, P979, DOI 10.1097/PHM.0b013e3181c1eac1; Nougier V, 1997, GAIT POSTURE, V5, P34, DOI 10.1016/S0966-6362(96)01071-5; Ozenci AM, 2007, KNEE SURG SPORT TR A, V15, P1432, DOI 10.1007/s00167-007-0404-y; Paschalis V, 2010, J SPORT SCI, V28, P33, DOI 10.1080/02640410903334764; Paterno MV, 2004, J ORTHOP SPORT PHYS, V34, P305, DOI 10.2519/jospt.2004.34.6.305; Rahnama N, 2005, ERGONOMICS, V48, P1568, DOI 10.1080/00140130500101585; Ricotti L, 2011, GAIT POSTURE, V33, P462, DOI 10.1016/j.gaitpost.2010.12.026; Safran MR, 1999, J SPORT REHABIL, V8, P304, DOI 10.1123/jsr.8.4.304; Soligard T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2469; Steffen K, 2008, SCAND J MED SCI SPOR, V18, P596, DOI 10.1111/j.1600-0838.2007.00708.x; Subasi SS, 2008, J SPORT REHABIL, V17, P186, DOI 10.1123/jsr.17.2.186; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; TROPP H, 1984, MED SCI SPORT EXER, V16, P64; Tsiganos G, 2008, ISOKINET EXERC SCI, V16, P75, DOI 10.3233/IES-2008-0299	51	67	70	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51568	10.1371/journal.pone.0051568	http://dx.doi.org/10.1371/journal.pone.0051568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251579	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200136
J	Inogwabini, BI; Leader-Williams, N				Inogwabini, Bila-Isia; Leader-Williams, Nigel			Effects of Epidemic Diseases on the Distribution of Bonobos	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; GEOGRAPHIC-DISTRIBUTION; PAN-PANISCUS; GREAT APES; TRANSMISSION; CHIMPANZEES; CONGO; PATHOGENS; OUTBREAKS; WILDLIFE	This study examined how outbreaks and the occurrence of Anthrax, Ebola, Monkeypox and Trypanosomiasis may differentially affect the distribution of bonobos (Pan paniscus). Using a combination of mapping, Jaccard overlapping coefficients and binary regressions, the study determined how each disease correlated with the extent of occurrence of, and the areas occupied by, bonobos. Anthrax has only been reported to occur outside the range of bonobos and so was not considered further. Ebola, Monkeypox and Trypanosomiasis were each reported within the area of occupancy of bonobos. Their respective overlap coefficients were: J = 0.10; Q(alpha = 0.05) = 2.00 (odds ratios = 0.0001, 95% CI = 0.0057; Z = -19.41, significant) for Ebola; J = 1.00; Q(alpha = 0.05) = 24.0 (odds ratios = 1.504, 95% CI = 0.5066-2.6122) for Monkeypox; and, J = 0.33; Q(alpha = 0.05) = 11.5 (Z = 1.14, significant) for Trypanosomiasis. There were significant relationships for the presence and absence of Monkeypox and Trypanosomiasis and the known extent of occurrence of bonobos, based on the equations y = 0.2368Ln(x)+0.8006 (R-2 = 0.9772) and y = -0.2942Ln(x)+0.7155 (R-2 = 0.698), respectively. The positive relationship suggested that bonobos tolerated the presence of Monkeypox. In contrast, the significant negative coefficient suggested that bonobos were absent in areas where Trypanosomiasis is endemic. Our results suggest that large rivers may have prevented Ebola from spreading into the range of bonobos. Meanwhile, Trypanosomiasis has been recorded among humans within the area of occurrence of bonobos, and appears the most important disease in shaping the area of occupancy of bonobos within their overall extent of occupancy.	[Inogwabini, Bila-Isia; Leader-Williams, Nigel] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England	University of Kent	Inogwabini, BI (corresponding author), Swedish Univ Agr Sci, Uppsala, Sweden.	bi4@kentforlife.net		Inogwabini, Bila-Isia/0000-0002-6897-2477	UNESCO Young Scholar Award; AWF Charlotte Grant	UNESCO Young Scholar Award; AWF Charlotte Grant	The research that led to this paper was conducted in UK with funding from UNESCO Young Scholar Award and AWF Charlotte Grant to Bila-Isia Inogwabini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender JB, 2004, JAVMA-J AM VET MED A, V224, P1105, DOI 10.2460/javma.2004.224.1105; Conway KJ, 1999, STAT MODELING USING; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DASZAK P., 2003, J PARASITOL, V89, P78; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Ellis CK, 2008, THESIS KANSAS STATE; Fenart R., 1973, Annales Mus r Afr cent (Ser 8 Sci zool), V204, P1; Formenty Pierre, 2003, P169; Hance J, 2009, ANTHRAX DEAD HIPPO C; Henderson H, 2008, JAVMA-J AM VET MED A, V232, P848, DOI 10.2460/javma.232.6.848; Homsy J., 1999, APE TOURISM HUMAN DI; Horn AD, 1976, THESIS YALE U NEW HA THESIS YALE U NEW HA; Inogwabini BI, 2009, OPEN CONSERV BIOL J, V3, P1; Inogwabini BI, 2007, ORYX, V41, P532, DOI 10.1017/S0030605307414120; Inogwabini Bila-Isia, 2005, Endangered Species Update, V22, P116; Inogwabini BI, 2008, DEV PRIMATOL-PROG PR, P273, DOI 10.1007/978-0-387-74787-3_14; IRCS (International Red Cross and Red Crescent Societies), 2009, DEM REP CONG EB FEV; Kaiser M, 2010, EMERG INFECT DIS, V16, P1956, DOI 10.3201/eid1612.100424; KANO T, 1984, FOLIA PRIMATOL, V43, P36, DOI 10.1159/000156169; KANO T, 1982, Primates, V23, P171, DOI 10.1007/BF02381159; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kortlandt Adriaan, 1996, Primate Conservation, V16, P21; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Leroy EM, 2004, J INFECT DIS, V190, P1895, DOI 10.1086/425421; Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176; Lutumba P, 2005, TROP MED INT HEALTH, V10, P347, DOI 10.1111/j.1365-3156.2005.01391.x; Malenky R.K., 1989, P362; Mugisha L, 2010, J MED PRIMATOL, V39, P123, DOI 10.1111/j.1600-0684.2010.00400.x; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Reinartz GE, 2006, INT J PRIMATOL, V27, P603, DOI 10.1007/s10764-006-9020-9; Remis MJ, 2000, ORYX, V34, P56, DOI 10.1017/S0030605300030908; Ringvall A, 2005, FOREST ECOL MANAG, V212, P109, DOI 10.1016/j.foreco.2005.03.002; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Thompson-Handler N., 1995, ACTION PLAN PAN PANI; Vitousek PM, 1996, AM SCI, V84, P468; Vogel G, 2000, SCIENCE, V287, P2386, DOI 10.1126/science.287.5462.2386; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walsh PD, 2007, AM NAT, V169, P684, DOI 10.1086/513494; Wrangham RW, 1994, CHIMPANZEE CULTURES, P21	43	6	7	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51112	10.1371/journal.pone.0051112	http://dx.doi.org/10.1371/journal.pone.0051112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251431	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200059
J	Li, M; Fu, XY; Ma, G; Sun, XD; Dong, XY; Nagy, T; Xing, CS; Li, J; Dong, JT				Li, Mei; Fu, Xiaoying; Ma, Gui; Sun, Xiaodong; Dong, Xueyuan; Nagy, Tamas; Xing, Changsheng; Li, Jie; Dong, Jin-Tang			Atbf1 Regulates Pubertal Mammary Gland Development Likely by Inhibiting the Pro-Proliferative Function of Estrogen-ER Signaling	PLOS ONE			English	Article							BREAST-CANCER-CELLS; GROWTH-FACTOR-I; MESSENGER-RNA EXPRESSION; DEVELOPING RAT-BRAIN; RECEPTOR-ALPHA; NEURONAL DIFFERENTIATION; STEM-CELLS; REPRESSES TRANSCRIPTION; MYOEPITHELIAL CELLS; CARCINOMA-CELLS	ATBF1 is a candidate tumor suppressor that interacts with estrogen receptor (ER) to inhibit the function of estrogen-ER signaling in gene regulation and cell proliferation control in human breast cancer cells. We therefore tested whether Atbf1 and its interaction with ER modulate the development of pubertal mammary gland, where estrogen is the predominant steroid hormone. In an in vitro model of cell differentiation, i.e., MCF10A cells cultured in Matrigel, ATBF1 expression was significantly increased, and knockdown of ATBF1 inhibited acinus formation. During mouse mammary gland development, Atbf1 was expressed at varying levels at different stages, with higher levels during puberty, lower during pregnancy, and the highest during lactation. Knockout of Atbf1 at the onset of puberty enhanced ductal elongation and bifurcation and promoted cell proliferation in both ducts and terminal end buds of pubertal mammary glands. Enhanced cell proliferation primarily occurred in ER-positive cells and was accompanied by increased expression of ER target genes. Furthermore, inactivation of Atbf1 reduced the expression of basal cell markers (CK5, CK14 and CD44) but not luminal cell markers. These findings indicate that Atbf1 plays a role in the development of pubertal mammary gland likely by modulating the function of estrogen-ER signaling in luminal cells and by modulating gene expression in basal cells.	[Li, Mei; Ma, Gui; Dong, Jin-Tang] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Li, Mei; Fu, Xiaoying; Sun, Xiaodong; Dong, Xueyuan; Xing, Changsheng; Li, Jie; Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Emory Winship Canc Inst, Atlanta, GA 30322 USA; [Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	Nankai University; Emory University; University System of Georgia; University of Georgia	Dong, XY (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Emory Winship Canc Inst, Atlanta, GA 30322 USA.	dxueyua@emory.edu; j.dong@emory.edu	Li, Jie/K-8812-2015	Xing, Changsheng/0000-0001-6582-9037; Dong, Jin-Tang/0000-0003-2349-5782	NIH [CA121459]; NATIONAL CANCER INSTITUTE [R01CA121459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA121459. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Barsky SH, 2005, J MAMMARY GLAND BIOL, V10, P249, DOI 10.1007/s10911-005-9585-5; Barsky SH, 2003, EXP MOL PATHOL, V74, P113, DOI 10.1016/S0014-4800(03)00011-X; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Brisken C, 2002, J MAMMARY GLAND BIOL, V7, P39, DOI 10.1023/A:1015718406329; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Clarke RB, 1997, CANCER RES, V57, P4987; Cleton-Jansen AM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-105; Coppock HA, 2007, CELL PROLIFERAT, V40, P721, DOI 10.1111/j.1365-2184.2007.00463.x; Cunha GR, 1997, J MAMMARY GLAND BIOL, V2, P393, DOI 10.1023/A:1026303630843; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dong XY, 2012, BIOCHEM J, V444, P581, DOI 10.1042/BJ20111890; Dong XY, 2011, J BIOL CHEM, V286, P13879, DOI 10.1074/jbc.M110.187849; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; DUBIK D, 1987, CANCER RES, V47, P6517; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Gudjonsson T, 2002, J CELL SCI, V115, P39; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Huh JI, 2007, ENDOCRINOLOGY, V148, P1266, DOI 10.1210/en.2006-0964; IDO A, 1994, DEV BIOL, V163, P184, DOI 10.1006/dbio.1994.1134; Ishii Y, 2003, J COMP NEUROL, V465, P57, DOI 10.1002/cne.10807; Jones JL, 2003, J PATHOL, V201, P562, DOI 10.1002/path.1483; Jones L, 2008, ONCOGENE, V27, P794, DOI 10.1038/sj.onc.1210674; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Kai K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-262; Kataoka H, 2003, CANCER RES, V63, P5785; Kataoka H, 2000, BIOCHEM BIOPH RES CO, V267, P91, DOI 10.1006/bbrc.1999.1911; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kurley SJ, 2012, DEVELOPMENT, V139, P1754, DOI 10.1242/dev.072769; LaRocca J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024432; Li G, 2002, DEVELOPMENT, V129, P4159; Li W, 2009, P NATL ACAD SCI USA, V106, P4725, DOI 10.1073/pnas.0807640106; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Louderbough Jeanne M V, 2011, Genes Cancer, V2, P771, DOI 10.1177/1947601911428223; Marshall A, 2009, CELL TISSUE RES, V335, P383, DOI 10.1007/s00441-008-0719-0; McBryan J, 2008, J MAMMARY GLAND BIOL, V13, P159, DOI 10.1007/s10911-008-9075-7; MICHELS KM, 1993, ENDOCRINOLOGY, V132, P23, DOI 10.1210/en.132.1.23; Miura Y, 2004, MICROBIOL IMMUNOL, V48, P137, DOI 10.1111/j.1348-0421.2004.tb03491.x; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; MURPHY LJ, 1990, ENDOCR REV, V11, P443, DOI 10.1210/edrv-11-3-443; Nagy T, 2007, J BIOL CHEM, V282, P31766, DOI 10.1074/jbc.M705403200; Nogami S, 2005, J COMP NEUROL, V482, P33, DOI 10.1002/cne.20382; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Qi Y, 2008, P NATL ACAD SCI USA, V105, P2481, DOI 10.1073/pnas.0712196105; Rowzee A, 2008, J MAMMARY GLAND BIOL, V13, P361, DOI 10.1007/s10911-008-9102-8; Roylance R, 2006, ONCOGENE, V25, P6544, DOI 10.1038/sj.onc.1209659; Ruan WF, 1999, ENDOCRINOLOGY, V140, P5075, DOI 10.1210/en.140.11.5075; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; Shao ZM, 1998, EXP CELL RES, V241, P394, DOI 10.1006/excr.1998.4066; Siegel PM, 2010, ONCOGENE, V29, P2753, DOI 10.1038/onc.2010.43; Smith CL, 1998, BIOL REPROD, V58, P627, DOI 10.1095/biolreprod58.3.627; Sternlicht MD, 2008, J MAMMARY GLAND BIOL, V13, P181, DOI 10.1007/s10911-008-9084-6; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Sun X, 2012, GENESIS; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2007, J CANCER RES CLIN, V133, P103, DOI 10.1007/s00432-006-0148-y; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395; Zhang ZH, 2005, CLIN CANCER RES, V11, P193	69	10	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51283	10.1371/journal.pone.0051283	http://dx.doi.org/10.1371/journal.pone.0051283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251482	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200084
J	Lomas, KF; Greenwood, DR; Windmill, JFC; Jackson, JC; Corfield, J; Parsons, S				Lomas, Kathryn F.; Greenwood, David R.; Windmill, James F. C.; Jackson, Joseph C.; Corfield, Jeremy; Parsons, Stuart			Discovery of a Lipid Synthesising Organ in the Auditory System of an Insect	PLOS ONE			English	Article							HEMIDEINA-CRASSIDENS BLANCHARD; BUSH-CRICKETS TETTIGONIIDAE; ZEALAND WETAS ORTHOPTERA; PRIMITIVE ENSIFERAN; SOUND-TRANSMISSION; EVOLUTION; HEARING; GRYLLACRIDOIDEA; STENOPELMATIDAE; MORPHOLOGY	Weta possess typical Ensifera ears. Each ear comprises three functional parts: two equally sized tympanal membranes, an underlying system of modified tracheal chambers, and the auditory sensory organ, the crista acustica. This organ sits within an enclosed fluid-filled channel-previously presumed to be hemolymph. The role this channel plays in insect hearing is unknown. We discovered that the fluid within the channel is not actually hemolymph, but a medium composed principally of lipid from a new class. Three-dimensional imaging of this lipid channel revealed a previously undescribed tissue structure within the channel, which we refer to as the olivarius organ. Investigations into the function of the olivarius reveal de novo lipid synthesis indicating that it is producing these lipids in situ from acetate. The auditory role of this lipid channel was investigated using Laser Doppler vibrometry of the tympanal membrane, which shows that the displacement of the membrane is significantly increased when the lipid is removed from the auditory system. Neural sensitivity of the system, however, decreased upon removal of the lipid-a surprising result considering that in a typical auditory system both the mechanical and auditory sensitivity are positively correlated. These two results coupled with 3D modelling of the auditory system lead us to hypothesize a model for weta audition, relying strongly on the presence of the lipid channel. This is the first instance of lipids being associated with an auditory system outside of the Odentocete cetaceans, demonstrating convergence for the use of lipids in hearing.	[Lomas, Kathryn F.; Greenwood, David R.; Corfield, Jeremy; Parsons, Stuart] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Lomas, Kathryn F.; Greenwood, David R.; Corfield, Jeremy; Parsons, Stuart] Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Windmill, James F. C.; Jackson, Joseph C.] Univ Strathclyde, Dept Elect & Elect Engn, Ctr Ultrason Engn, Glasgow G1 1XW, Lanark, Scotland	University of Auckland; New Zealand Institute for Plant & Food Research Ltd; University of Strathclyde	Greenwood, DR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	david.greenwood@auckland.ac.nz	Greenwood, David R/D-2375-2016; Jackson, Joseph/AAE-1204-2021; Windmill, James F C/I-1117-2019	Greenwood, David R/0000-0001-5280-042X; Windmill, James F C/0000-0003-4878-349X; Parsons, Stuart/0000-0003-1025-5616; Jackson, Joseph/0000-0001-9302-8157	University of Auckland; School of Biological Sciences, University of Auckland; Biotechnology and Biological Sciences Research Council [BB/H004637/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H02848X/1] Funding Source: researchfish; BBSRC [BB/H004637/1] Funding Source: UKRI; EPSRC [EP/H02848X/1] Funding Source: UKRI	University of Auckland; School of Biological Sciences, University of Auckland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding provided by a doctoral scholarship to KFL, University of Auckland and the School of Biological Sciences, University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Autrum Hansjochem, 1940, ZEITSCHR VERGLEICH PHYSIOL, V28, P326, DOI 10.1007/BF00342439; BALL EE, 1981, CELL TISSUE RES, V217, P321, DOI 10.1007/BF00233584; BALL EE, 1981, CELL TISSUE RES, V217, P345, DOI 10.1007/BF00233585; Bangert M, 1998, HEARING RES, V115, P27, DOI 10.1016/S0378-5955(97)00177-9; BEENAKKERS AMT, 1985, PROG LIPID RES, V24, P19; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P525, DOI 10.1046/j.1463-6409.2003.00142.x; EIBL E, 1978, ZOOMORPHOLOGIE, V89, P185, DOI 10.1007/BF00993947; FIELD LH, 1992, J ZOOL, V228, P371, DOI 10.1111/j.1469-7998.1992.tb04442.x; FIELD LH, 1982, INT J INSECT MORPHOL, V11, P39, DOI 10.1016/0020-7322(82)90036-8; FIELD LH, 1993, INT J INSECT MORPHOL, V22, P163, DOI 10.1016/0020-7322(93)90008-O; FIELD LH, 1980, J COMP PHYSIOL, V141, P31, DOI 10.1007/BF00611875; HEINRICH R, 1993, J ACOUST SOC AM, V93, P3481, DOI 10.1121/1.405678; HILL KG, 1981, J COMP PHYSIOL, V142, P169, DOI 10.1007/BF00605735; Imaizumi K, 1999, J NEUROSCI, V19, P1508; Koopman HN, 2006, IEEE J OCEANIC ENG, V31, P95, DOI 10.1109/JOE.2006.872205; LEWIS DB, 1974, J EXP BIOL, V60, P821; Lomas K, 2011, J EXP BIOL, V214, P778, DOI 10.1242/jeb.050187; MASON AC, 1991, J COMP PHYSIOL A, V168, P351; MICHELSEN A, 1978, J COMP PHYSIOL, V123, P193, DOI 10.1007/BF00656872; Mohl B, 1999, J ACOUST SOC AM, V105, P3421, DOI 10.1121/1.426959; Nishino H, 2003, J COMP NEUROL, V464, P327, DOI 10.1002/cne.10780; Norris K S, 1964, MARINE BIOACOUSTICS, P316; NORRIS KS, 1974, J ACOUST SOC AM, V56, P659, DOI 10.1121/1.1903305; Nummela S, 2007, ANAT REC, V290, P716, DOI 10.1002/ar.20528; Trewick SA, 2005, J BIOGEOGR, V32, P295, DOI 10.1111/j.1365-2699.2004.01179.x; Triblehorn JD, 2001, J ZOOL, V254, P27, DOI 10.1017/S095283690100053X; Udayashankar AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031008; VARANASI U, 1975, NATURE, V255, P340, DOI 10.1038/255340a0; VARANASI U, 1982, CHEM PHYS LIPIDS, V31, P237, DOI 10.1016/0009-3084(82)90059-7; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	32	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51486	10.1371/journal.pone.0051486	http://dx.doi.org/10.1371/journal.pone.0051486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251553	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000313236200120
J	Muller, J; Klaus, VH; Kleinebecker, T; Prati, D; Holzel, N; Fischer, M				Mueller, Joerg; Klaus, Valentin H.; Kleinebecker, Till; Prati, Daniel; Hoelzel, Norbert; Fischer, Markus			Impact of Land-Use Intensity and Productivity on Bryophyte Diversity in Agricultural Grasslands	PLOS ONE			English	Article							MONTANE CALCAREOUS FENS; PLANT-SPECIES RICHNESS; VASCULAR PLANTS; CHALK GRASSLAND; FERTILIZER APPLICATION; SEEDLING EMERGENCE; COMMUNITY BIOMASS; INDICATOR VALUES; NITROGEN; VEGETATION	While bryophytes greatly contribute to plant diversity of semi-natural grasslands, little is known about the relationships between land-use intensity, productivity, and bryophyte diversity in these habitats. We recorded vascular plant and bryophyte vegetation in 85 agricultural used grasslands in two regions in northern and central Germany and gathered information on land-use intensity. To assess grassland productivity, we harvested aboveground vascular plant biomass and analyzed nutrient concentrations of N, P, K, Ca and Mg. Further we calculated mean Ellenberg indicator values of vascular plant vegetation. We tested for effects of land-use intensity and productivity on total bryophyte species richness and on the species richness of acrocarpous (small & erect) and pleurocarpous (creeping, including liverworts) growth forms separately. Bryophyte species were found in almost all studied grasslands, but species richness differed considerably between study regions in northern Germany (2.8 species per 16 m(2)) and central Germany (6.4 species per 16 m(2)) due environmental differences as well as land-use history. Increased fertilizer application, coinciding with high mowing frequency, reduced bryophyte species richness significantly. Accordingly, productivity estimates such as plant biomass and nitrogen concentration were strongly negatively related to bryophyte species richness, although productivity decreased only pleurocarpous species. Ellenberg indicator values for nutrients proved to be useful indicators of species richness and productivity. In conclusion, bryophyte composition was strongly dependent on productivity, with smaller bryophytes that were likely negatively affected by greater competition for light. Intensive land-use, however, can also indirectly decrease bryophyte species richness by promoting grassland productivity. Thus, increasing productivity is likely to cause a loss of bryophyte species and a decrease in species diversity.	[Mueller, Joerg; Fischer, Markus] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Klaus, Valentin H.; Kleinebecker, Till; Hoelzel, Norbert] Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany; [Prati, Daniel; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland	University of Potsdam; University of Munster; University of Bern	Muller, J (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	muellerj@uni-potsdam.de	Hölzel, Norbert/H-8753-2013; Fischer, Markus/C-6411-2008	Hölzel, Norbert/0000-0002-6367-3400; Fischer, Markus/0000-0002-5589-5900; Kleinebecker, Till/0000-0003-1121-2861; Klaus, Valentin H./0000-0002-7469-6800	DFG (German Research Foundation) [SSP 1374 (FI 1246/6-1)]; DFG [FI 1246/6-1, FI 1246/9-1, HO 3830/2-1]	DFG (German Research Foundation)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 (FI 1246/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all project members, field teams and managers of the Exploratories, Sonja Gockel, Andreas Hemp and Martin Gorke and Simone Pfeiffer for their work in maintaining the plot and project infrastructure. Furthermore, we thank Franc, ois Buscot, Dominik Hessenmoller, the late Elisabeth Kalko, Eduard Linsenmair, Jens Nieschulze, Ingo Schoning, Ernst-Detlef Schulze and Wolfgang W. Weisser for their role in setting up the Biodiversity Exploratories. Further we thank Ariel Bergamini and Ewald Weber for review and critical remarks on an earlier draft of this manuscript. The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (grants FI 1246/ 6-1, FI 1246/9-1, HO 3830/2-1). Field work permits were obtained from the responsible state environmental offices of Thuringia and Brandenburg (according to 1 72 BbgNatSchG).	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Aude E, 2005, OIKOS, V109, P323, DOI 10.1111/j.0030-1299.2005.13268.x; Austrheim G, 2007, ECOSCIENCE, V14, P178, DOI 10.2980/1195-6860(2007)14[178:IBSRGA]2.0.CO;2; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bergamini A, 2001, J BRYOL, V23, P331, DOI 10.1179/jbr.2001.23.4.331; Bergamini A, 2001, J ECOL, V89, P920, DOI 10.1111/j.1365-2745.2001.00613.x; Bergamini A, 2001, FLORA, V196, P180, DOI 10.1016/S0367-2530(17)30040-3; Beringer J, 2001, J CLIMATE, V14, P3324, DOI 10.1175/1520-0442(2001)014<3324:TROASI>2.0.CO;2; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Bortoluzzi E, 2006, NEW PHYTOL, V172, P708, DOI 10.1111/j.1469-8137.2006.01859.x; Broll G, 1994, VDLUFA SCHR, V38, P915; Chytry M, 2009, APPL VEG SCI, V12, P167, DOI 10.1111/j.1654-109X.2009.01011.x; Cornelissen JHC, 2007, ANN BOT-LONDON, V99, P987, DOI 10.1093/aob/mcm030; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; DURING HJ, 1990, BOT J LINN SOC, V104, P79, DOI 10.1111/j.1095-8339.1990.tb02212.x; Ellenberg H., 2001, SCRIPTA GEOBOT, V18, P1; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Haworth BJ., 2007, WATER AIR SOIL POLLU, V7, P111, DOI [10.1007/s11267-006-9071-0, DOI 10.1007/S11267-006-9071-0]; Hejcman M, 2010, ENVIRON MONIT ASSESS, V166, P653, DOI 10.1007/s10661-009-1030-6; Hill MO., 2007, BRYOATT ATTRIBUTES B; JEFFREY DW, 1973, J ECOL, V61, P85, DOI 10.2307/2258918; KEIZER PJ, 1985, J ECOL, V73, P493, DOI 10.2307/2260489; Klaus VH, 2011, PERSPECT PLANT ECOL, V13, P287, DOI 10.1016/j.ppees.2011.07.001; Klaus VH, 2012, DIRECT INDIREC UNPUB; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; KOPERSKI M., 2000, SCHRIFTENREIHE VEGET, V34, P1; Lobel S, 2006, FOLIA GEOBOT, V41, P377, DOI 10.1007/BF02806555; Losvik MH, 2006, NORWEGIAN J GEOGRAPH, V60, P312; Malson K, 2008, APPL VEG SCI, V11, P99, DOI 10.1111/j.1654-109X.2008.tb00208.x; Mickiewicz J, 1976, POL ECOL STUD, V2, P57; Mundel G, 1997, ARCH AGRON SOIL SCI, V41, P277; Partel M, 1996, OIKOS, V75, P111, DOI 10.2307/3546327; Peintinger M, 2006, PLANT ECOL, V185, P1, DOI 10.1007/s11258-005-9079-y; Poschlod P, 2005, BASIC APPL ECOL, V6, P93, DOI 10.1016/j.baae.2004.12.001; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Socher SA, 2012, J ECOL, V100, P1391, DOI 10.1111/j.1365-2745.2012.02020.x; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Turetsky MR, 2003, BRYOLOGIST, V106, P395, DOI 10.1639/05; van der Wal R, 2005, OECOLOGIA, V142, P159, DOI 10.1007/s00442-004-1706-0; Vanderpoorten A, 2004, BIOL CONSERV, V117, P11, DOI 10.1016/S0006-3207(03)00257-X; VANTOOREN BF, 1990, LINDBERGIA, V16, P153; VANTOOREN BF, 1988, OIKOS, V53, P41, DOI 10.2307/3565661; Venterink HO, 2009, BIOGEOCHEMISTRY, V93, P235, DOI 10.1007/s10533-009-9300-5; Venterink HO, 2003, ECOLOGY, V84, P2191, DOI 10.1890/01-0639; Venterink HO, 2001, J ECOL, V89, P1033, DOI 10.1111/j.1365-2745.2001.00616.x; Virtanen R, 2000, PLANT ECOL, V151, P129, DOI 10.1023/A:1026533418357; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; WATSON EV, 1960, J ECOL, V48, P397, DOI 10.2307/2257525; Zamfir M, 2000, OIKOS, V88, P603, DOI 10.1034/j.1600-0706.2000.880317.x; Zechmeister HG, 2003, BIOL CONSERV, V114, P165, DOI 10.1016/S0006-3207(03)00020-X	50	22	23	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51520	10.1371/journal.pone.0051520	http://dx.doi.org/10.1371/journal.pone.0051520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251563	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200129
J	Sala, JE; Wilson, RP; Quintana, F				Sala, Juan E.; Wilson, Rory P.; Quintana, Flavio			How Much Is Too Much? Assessment of Prey Consumption by Magellanic Penguins in Patagonian Colonies	PLOS ONE			English	Article							FORAGING EFFORT; PYGOSCELIS-ADELIAE; FOOD-CONSUMPTION; JACKASS PENGUINS; ENERGY BUDGETS; BEHAVIOR; TIME; DIGESTION; SEABIRDS; FISH	Penguins are major consumers in the southern oceans although quantification of this has been problematic. One suggestion proposes the use of points of inflection in diving profiles ('wiggles') for this, a method that has been validated for the estimation of prey consumption by Magellanic penguins (Spheniscus magellanicus) by Simeone and Wilson (2003). Following them, we used wiggles from 31 depth logger-equipped Magellanic penguins foraging from four Patagonian colonies; Punta Norte (PN), Bahia Bustamente (BB), Puerto Deseado (PD) and Puerto San Julian (PSJ), all located in Argentina between 42-49 degrees S, to estimate the prey captured and calculate the catch per unit time (CPUT) for birds foraging during the early chick-rearing period. Numbers of prey caught and CPUT were significantly different between colonies. Birds from PD caught the highest number of prey per foraging trip, with CPUT values of 68 +/- 19 prey per hour underwater (almost two times greater than for the three remaining colonies). We modeled consumption from these data and calculate that the world Magellanic penguin population consumes about 2 million tons of prey per year. Possible errors in this calculation are discussed. Despite this, the analysis of wiggles seems a powerful and simple tool to begin to quantify prey consumption by Magellanic penguins, allowing comparison between different breeding sites. The total number of wiggles and/or CPUT do not reflect, by themselves, the availability of food for each colony, as the number of prey consumed by foraging trip is strongly associated with the energy content and wet mass of each colony-specific 'prey type'. Individuals consuming more profitable prey could be optimizing the time spent underwater, thereby optimizing the energy expenditure associated with the dives.	[Sala, Juan E.; Quintana, Flavio] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Wilson, Rory P.] Swansea Univ, Coll Sci, Swansea Moving Anim Res Team, Swansea, W Glam, Wales; [Quintana, Flavio] Wildlife Conservat Soc, Buenos Aires, DF, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Swansea University	Sala, JE (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina.	juansala@cenpat.edu.ar		Quintana, Flavio/0000-0003-0696-2545; Sala, Juan Emilio/0000-0001-9435-1351	Wildlife Conservation Society (WCS); Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica; Rolex Award for Enterprise; CONICET; POGO (Partnership for Observation of the Global Oceans)	Wildlife Conservation Society (WCS); Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Rolex Award for Enterprise; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); POGO (Partnership for Observation of the Global Oceans)	Research was funded by grants from the Wildlife Conservation Society (WCS), Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET), and Agencia Nacional de Promocion Cientifica y Tecnologica to FQ and by a Rolex Award for Enterprise awarded to RPW. JES is supported by a PhD fellowship from CONICET. We also want to thank POGO (Partnership for Observation of the Global Oceans, http://www.ocean-partners.org/) for the award to Juan Emilio Sala to enable him to conduct a training period at Swansea University (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFIK D, 1995, ECOLOGY, V76, P2247, DOI 10.2307/1941699; Ancel A, 1997, J EXP BIOL, V200, P149; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; BANNASCH R, 1994, J EXP BIOL, V194, P83; BirdLife International, 2010, I U C N RED LIST THR; Bost CA, 2007, DEEP-SEA RES PT II, V54, P248, DOI 10.1016/j.dsr2.2006.11.007; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; Ciancio JE, 2007, T AM FISH SOC, V136, P1415, DOI 10.1577/T06-173.1; COOPER J, 1977, Zoologica Africana, V12, P201; Croxall J.P., 1987, P101; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DUFFY D C, 1986, Colonial Waterbirds, V9, P1, DOI 10.2307/1521138; FAO, 2012, GLOB CAPT PROD 1950; Frere E., 1996, NEOTROPICA, V7, P35; FURNESS RW, 1982, MAR ECOL PROG SER, V8, P243, DOI 10.3354/meps008243; Gremillet D, 2004, FUNCT ECOL, V18, P793, DOI 10.1111/j.0269-8463.2004.00914.x; Guerra CG, 1992, 900599 FONDECYT U AN; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; Hilton GM, 2000, J AVIAN BIOL, V31, P36, DOI 10.1034/j.1600-048X.2000.310106.x; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; Ladin ZS, 2011, J WILDLIFE MANAGE, V75, P273, DOI 10.1002/jwmg.58; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; LEBOEUF BJ, 1992, CAN J ZOOL, V70, P786, DOI 10.1139/z92-111; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; NAGY KA, 1984, ECOLOGY, V65, P1648, DOI 10.2307/1939143; Naito Yasuhiko, 2007, Polar Science, V1, P101, DOI 10.1016/j.polar.2007.10.001; Papastamatiou YP, 2004, J EXP BIOL, V207, P225, DOI 10.1242/jeb.00741; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; PUTZ K, 1994, ECOLOGY, V75, P489, DOI 10.2307/1939552; Rey AR, 2012, EMU, V112, P90, DOI 10.1071/MU11065; Rodary D, 2000, POLAR BIOL, V23, P113, DOI 10.1007/s003000050016; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2004, BEHAV ECOL, V15, P824, DOI 10.1093/beheco/arh086; Ropert-Coudert Y, 2001, POLAR BIOL, V24, P460, DOI 10.1007/s003000100234; Ropert-Coudert Yan, 2000, Polar Bioscience, V13, P101; Sala JE, 2012, MAR ECOL PROG SER, V464, P273, DOI 10.3354/meps09887; Schiavini Adrián, 2005, Hornero, V20, P5; Scolaro JA, 1999, WATERBIRDS, V22, P104, DOI 10.2307/1521999; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Takahashi A, 2004, MAR ORNITHOL, V32, P7; WEATHERS WW, 1984, AUK, V101, P459, DOI 10.1093/auk/101.3.459; Williams T.D., 1995, PENGUINS; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2010, AQUAT BIOL, V8, P193, DOI 10.3354/ab00230; Wilson Rory P., 1997, Marine Ornithology, V25, P72; Wilson Rory P., 2007, Marine Ornithology, V35, P109; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; WILSON RP, 1992, J EXP BIOL, V167, P267; WILSON RP, 1995, J EXP BIOL, V198, P1115; Wilson RP, 2005, ECOL MONOGR, V75, P379, DOI 10.1890/04-1238; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067; WILSON RP, 1989, COMP BIOCHEM PHYS A, V94, P461, DOI 10.1016/0300-9629(89)90121-7; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109; Wilson RP, 2004, J EXP BIOL, V207, P1789, DOI 10.1242/jeb.00967; Wilson RP, 2003, MAR ECOL PROG SER, V249, P305, DOI 10.3354/meps249305; WILSON RP, 1986, ARDEA, V74, P211; WILSON RP, 1985, ORNIS SCAND, V16, P77, DOI 10.2307/3676580; Woehler EJ, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P266; Zar JH, 1999, BIOSTATISTICAL ANAL; Zimmer I, 2010, AQUAT BIOL, V8, P269, DOI 10.3354/ab00213; Zuur Alain F., 2009, P1	68	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51487	10.1371/journal.pone.0051487	http://dx.doi.org/10.1371/journal.pone.0051487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251554	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200121
J	Stollar, EJ; Lin, H; Davidson, AR; Forman-Kay, JD				Stollar, Elliott J.; Lin, Hong; Davidson, Alan R.; Forman-Kay, Julie D.			Differential Dynamic Engagement within 24 SH3 Domain: Peptide Complexes Revealed by Co-Linear Chemical Shift Perturbation Analysis	PLOS ONE			English	Article							UNSTRUCTURED REGION; BINDING-AFFINITY; NMR-SPECTROSCOPY; PROTEIN; RECOGNITION; DNA; SPECIFICITY; ALLOSTERY; STATES; VISUALIZATION	There is increasing evidence for the functional importance of multiple dynamically populated states within single proteins. However, peptide binding by protein-protein interaction domains, such as the SH3 domain, has generally been considered to involve the full engagement of peptide to the binding surface with minimal dynamics and simple methods to determine dynamics at the binding surface for multiple related complexes have not been described. We have used NMR spectroscopy combined with isothermal titration calorimetry to comprehensively examine the extent of engagement to the yeast Abp1p SH3 domain for 24 different peptides. Over one quarter of the domain residues display co-linear chemical shift perturbation (CCSP) behavior, in which the position of a given chemical shift in a complex is co-linear with the same chemical shift in the other complexes, providing evidence that each complex exists as a unique dynamic rapidly inter-converting ensemble. The extent the specificity determining sub-surface of AbpSH3 is engaged as judged by CCSP analysis correlates with structural and thermodynamic measurements as well as with functional data, revealing the basis for significant structural and functional diversity amongst the related complexes. Thus, CCSP analysis can distinguish peptide complexes that may appear identical in terms of general structure and percent peptide occupancy but have significant local binding differences across the interface, affecting their ability to transmit conformational change across the domain and resulting in functional differences.	[Stollar, Elliott J.; Lin, Hong; Forman-Kay, Julie D.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Stollar, Elliott J.; Lin, Hong; Davidson, Alan R.; Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Stollar, Elliott J.; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Stollar, EJ (corresponding author), Eastern New Mexico Univ, Dept Phys Sci, Portales, NM USA.	elliott.stollar@enmu.edu; forman@sickkids.ca		Forman-Kay, Julie/0000-0001-8265-972X	Canadian Cancer Society; Canadian Institutes of Health Research [MOP-13609]; National Center for Research Resources [5P20RR016480-12]; National Institute of General Medical Sciences of the National Institutes of Health [8P20GM103451-12]; CIHR Training Program in Protein Folding award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CIHR Training Program in Protein Folding award(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by operating grants from the Canadian Cancer Society (JFK), the Canadian Institutes of Health Research, Grant MOP-13609 (ARD). EJS was supported by grants from the National Center for Research Resources (5P20RR016480-12) and the National Institute of General Medical Sciences (8P20GM103451-12) of the National Institutes of Health as well as a CIHR Training Program in Protein Folding award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Candel AM, 2008, J MOL BIOL, V377, P117, DOI 10.1016/j.jmb.2007.11.060; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Haynes J, 2007, GENETICS, V176, P193, DOI 10.1534/genetics.106.070300; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim JM, 2008, J MOL BIOL, V377, P889, DOI 10.1016/j.jmb.2008.01.063; Kuhlmann UC, 2000, J MOL BIOL, V301, P1163, DOI 10.1006/jmbi.2000.3945; Landry SJ, 2003, BIOCHEMISTRY-US, V42, P4926, DOI 10.1021/bi027070y; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Nohaile M, 1997, J MOL BIOL, V273, P299, DOI 10.1006/jmbi.1997.1296; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; ROHL CA, 1994, BIOCHEMISTRY-US, V33, P7760, DOI 10.1021/bi00191a003; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stefan CJ, 2005, MOL CELL BIOL, V25, P2910, DOI 10.1128/MCB.25.8.2910-2923.2005; Stollar EJ, 2009, J BIOL CHEM, V284, P26918, DOI 10.1074/jbc.M109.028431; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; VUISTER GW, 1992, J BIOMOL NMR, V2, P401, DOI 10.1007/BF01874818; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	43	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51282	10.1371/journal.pone.0051282	http://dx.doi.org/10.1371/journal.pone.0051282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251481	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200083
J	Suppipat, K; Park, CS; Shen, Y; Zhu, X; Lacorazza, HD				Suppipat, Koramit; Park, Chun Shik; Shen, Ye; Zhu, Xiao; Lacorazza, H. Daniel			Sulforaphane Induces Cell Cycle Arrest and Apoptosis in Acute Lymphoblastic Leukemia Cells	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; PROSTATE-CANCER; CRUCIFEROUS VEGETABLES; GENE-EXPRESSION; INHIBITION; ISOTHIOCYANATE; CONSUMPTION; INDUCTION; BROCCOLI; PATHWAY	Acute lymphoblastic leukemia (ALL) is the most common hematological cancer in children. Although risk-adaptive therapy, CNS-directed chemotherapy, and supportive care have improved the survival of ALL patients, disease relapse is still the leading cause of cancer-related death in children. Therefore, new drugs are needed as frontline treatments in high-risk disease and as salvage agents in relapsed ALL. In this study, we report that purified sulforaphane, a natural isothiocyanate found in cruciferous vegetables, has anti-leukemic properties in a broad range of ALL cell lines and primary lymphoblasts from pediatric T-ALL and pre-B ALL patients. The treatment of ALL leukemic cells with sulforaphane resulted in dose-dependent apoptosis and G2/M cell cycle arrest, which was associated with the activation of caspases (3, 8, and 9), inactivation of PARP, p53-independent upregulation of p21(CIP1/WAF1), and inhibition of the Cdc2/Cyclin B1 complex. Interestingly, sulforaphane also inhibited the AKT and mTOR survival pathways in most of the tested cell lines by lowering the levels of both total and phosphorylated proteins. Finally, the administration of sulforaphane to the ALL xenograft models resulted in a reduction of tumor burden, particularly following oral administration, suggesting a potential role as an adjunctive agent to improve the therapeutic response in high-risk ALL patients with activated AKT signaling.	[Suppipat, Koramit] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Suppipat, Koramit] Texas Childrens Hosp, Texas Childrens Hematol Ctr, Houston, TX 77030 USA; [Park, Chun Shik; Shen, Ye; Lacorazza, H. Daniel] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Zhu, Xiao] Baylor Coll Med, Summer Med & Res Training Program, Houston, TX 77030 USA; [Lacorazza, H. Daniel] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lacorazza, HD (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	hdl@bcm.edu		Park, Chun Shik/0000-0002-4329-3953; Lacorazza, Daniel/0000-0003-0660-617X	Gabrielle's Angel Foundation for Cancer Research; Alkek Foundation	Gabrielle's Angel Foundation for Cancer Research; Alkek Foundation	This work was supported by Gabrielle's Angel Foundation for Cancer Research and Alkek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; Bornhauser BC, 2007, BLOOD, V110, P2084, DOI 10.1182/blood-2006-12-060970; Bourquin JP, 2010, CANCER TREAT REV, V36, P298, DOI 10.1016/j.ctrv.2010.02.005; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Case M, 2008, CANCER RES, V68, P6803, DOI 10.1158/0008-5472.CAN-08-0101; Chessells JM, 2003, BRIT J HAEMATOL, V123, P396, DOI 10.1046/j.1365-2141.2003.04584.x; Cornblatt BS, 2007, CARCINOGENESIS, V28, P1485, DOI 10.1093/carcin/bgm049; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Fimognari C, 2002, CARCINOGENESIS, V23, P581, DOI 10.1093/carcin/23.4.581; Fimognari C, 2007, MUTAT RES-REV MUTAT, V635, P90, DOI 10.1016/j.mrrev.2006.10.004; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gasper AV, 2005, AM J CLIN NUTR, V82, P1283, DOI 10.1093/ajcn/82.6.1283; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Herman-Antosiewicz A, 2007, MOL CANCER THER, V6, P1673, DOI 10.1158/1535-7163.MCT-06-0807; Jackson SJT, 2004, CARCINOGENESIS, V25, P219, DOI 10.1093/carcin/bgg192; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joseph MA, 2004, NUTR CANCER, V50, P206, DOI 10.1207/s15327914nc5002_11; Keum YS, 2009, PHARM RES-DORDR, V26, P2324, DOI 10.1007/s11095-009-9948-5; Larson RA, 2007, SEMIN ONCOL, V34, pS13, DOI 10.1053/j.seminoncol.2007.11.002; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maheo K, 1997, CANCER RES, V57, P3649; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Mullighan CG, 2008, GENE DEV, V22, P1411, DOI 10.1101/gad.1673908; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Myzak MC, 2006, CARCINOGENESIS, V27, P811, DOI 10.1093/carcin/bgi265; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Parnaud G, 2004, NUTR CANCER, V48, P198, DOI 10.1207/s15327914nc4802_10; Paulsson K, 2008, GENE CHROMOSOME CANC, V47, P26, DOI 10.1002/gcc.20502; Pham NA, 2004, MOL CANCER THER, V3, P1239; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Probst-Hensch NM, 1998, CANCER EPIDEM BIOMAR, V7, P635; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Rooney CM, 2002, ANN HEMATOL, V81, pS39; Sakao K, 2012, J CELL BIOCHEM, V113, P599, DOI 10.1002/jcb.23386; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Spitz MR, 2000, CANCER EPIDEM BIOMAR, V9, P1017; Tang L, 2008, CANCER EPIDEM BIOMAR, V17, P938, DOI 10.1158/1055-9965.EPI-07-2502; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Traka M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002568; Traka MH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-189; Uddin S, 2004, BIOCHEM BIOPH RES CO, V320, P932, DOI 10.1016/j.bbrc.2004.06.038; Vermeulen M, 2008, J AGR FOOD CHEM, V56, P10505, DOI 10.1021/jf801989e; Wang LH, 1998, ANTICANCER RES, V18, P321; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Weisberg E, 2008, BLOOD, V111, P3723, DOI 10.1182/blood-2007-09-114454; Wells NJ, 1999, J CELL SCI, V112, P3361; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6	62	71	72	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51251	10.1371/journal.pone.0051251	http://dx.doi.org/10.1371/journal.pone.0051251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251470	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200075
J	Butler, EK; Boulware, DR; Bohjanen, PR; Meya, DB				Butler, Elissa K.; Boulware, David R.; Bohjanen, Paul R.; Meya, David B.			Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda	PLOS ONE			English	Article							HIGH-DOSE FLUCONAZOLE; RECONSTITUTION INFLAMMATORY SYNDROME; RANDOMIZED CONTROLLED-TRIAL; COURSE AMPHOTERICIN-B; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; FLUCYTOSINE; COHORT; COMBINATION; PROGRAM	Data presented previously as an abstract at the 2011 CUGH Global Health Conference in Montreal, Canada on 15 Nov 2011. The long-term survival of HIV-infected persons with symptomatic cryptococcal meningitis and asymptomatic, subclinical cryptococcal antigenemia (CRAG+) is unknown. We prospectively enrolled 25 asymptomatic, antiretroviral therapy (ART)-naive CRAG+ Ugandans with CD4<100 cells/mcL who received pre-emptive fluconazole treatment (CRAG+ cohort) and 189 ART-naive Ugandans with symptomatic cryptococcal meningitis treated with amphotericin (CM cohort). The 10-week survival was 84% (95% CI: 70-98%) in the CRAG+ cohort and 57% (95% CI: 50%-64%) in the CM cohort. The CRAG+ cohort had improved five-year survival of 76% (95% CI: 59%-93%) compared to 42% (95% CI: 35%-50%) in the CM cohort (P = 0.001). The two cohorts had similar immunosuppression pre-ART with median CD4 counts of 15 vs. 21 CD4/mcL in the CRAG+ and CM cohorts, respectively (P = 0.45). Despite substantial early mortality, subsequent 5-year survival of persons surviving 6-months was excellent (>88%), demonstrating that long term survival is possible in resource-limited settings. Pre-ART CRAG screening with preemptive fluconazole treatment and improved CM treatment(s) are needed to reduce AIDS-attributable mortality due to cryptococcosis which remains 20-25% in sub-Saharan Africa.	[Butler, Elissa K.; Boulware, David R.; Bohjanen, Paul R.; Meya, David B.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Bohjanen, Paul R.; Meya, David B.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Meya, David B.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda	University of Minnesota System; University of Minnesota Twin Cities; Makerere University; Makerere University	Boulware, DR (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	boulw001@umn.edu	Bohjanen, Paul/B-2329-2015; Boulware, David R/GRS-0999-2022; Boulware, David R/AAF-7124-2021; Boulware, David/I-4533-2013; Meya, David/AAO-2796-2020	Bohjanen, Paul/0000-0002-2772-3597; Boulware, David R/0000-0002-4715-0060; Meya, David/0000-0002-4138-240X; , David/0000-0002-8854-0321	National Institutes of Health [U01AI089244, R21NS065713, K23AI073192, K24AI096925]; University of Minnesota Academic Health Center; Minnesota Medical Foundation; Tibotec REACH Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI089244, K24AI096925, K23AI073192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; Minnesota Medical Foundation; Tibotec REACH Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was made possible through support from the National Institutes of Health (U01AI089244, R21NS065713; K23AI073192, K24AI096925), University of Minnesota Academic Health Center, Minnesota Medical Foundation, and Tibotec REACH Initiative. Fluconazole was provided via the Pfizer Diflucan Donation Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, WORLD AIDS DAY REP; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Bicanic T, 2009, JAIDS-J ACQ IMM DEF, V51, P130, DOI 10.1097/QAI.0b013e3181a56f2e; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Boulware DR, 2010, J INFECT DIS, V202, P962, DOI 10.1086/655785; Chottanapund Suthat, 2007, Journal of the Medical Association of Thailand, V90, P2104; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Jackson AT, 2012, AIDS, V26, P1363, DOI 10.1097/QAD.0b013e328354b419; Jarvis JN, 2012, J INT ASS P IN PRESS; Jarvis JN, 2012, AIDS, V26, P1105, DOI 10.1097/QAD.0b013e3283536a93; Jarvis JN, 2010, CLIN INFECT DIS, V51, P1463, DOI 10.1086/657405; Jarvis JN, 2010, AIDS, V24, P1233, DOI 10.1097/QAD.0b013e3283383aeb; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Manosuthi W, 2008, JAIDS-J ACQ IMM DEF, V48, P508, DOI 10.1097/QAI.0b013e318168573d; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Muzoora CK, 2012, J INFECTION, V64, P76, DOI 10.1016/j.jinf.2011.10.014; Pappas PG, 2009, CLIN INFECT DIS, V48, P1775, DOI 10.1086/599112; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pitisuttithum P, 2001, J INFECTION, V43, P226, DOI 10.1053/jinf.2001.0916; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham R, 2012, CLIN INFECT IN PRESS; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Sloan D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005647.pub2; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	31	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51291	10.1371/journal.pone.0051291	http://dx.doi.org/10.1371/journal.pone.0051291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251485	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900061
J	van Ravensway, J; Benbow, ME; Tsonis, AA; Pierce, SJ; Campbell, LP; Fyfe, JAM; Hayman, JA; Johnson, PDR; Wallace, JR; Qi, JG				van Ravensway, Jenni; Benbow, M. Eric; Tsonis, Anastasios A.; Pierce, Steven J.; Campbell, Lindsay P.; Fyfe, Janet A. M.; Hayman, John A.; Johnson, Paul D. R.; Wallace, John R.; Qi, Jiaguo			Climate and Landscape Factors Associated with Buruli Ulcer Incidence in Victoria, Australia	PLOS ONE			English	Article							MYCOBACTERIUM-ULCERANS; ENVIRONMENTAL-SAMPLES; CILIATE POPULATIONS; RISK-FACTORS; DISEASE; INFECTION; OUTBREAK; ECOLOGY; MODEL; IDENTIFICATION	Background: Buruli ulcer (BU), caused by Mycobacterium ulcerans (M. ulcerans), is a necrotizing skin disease found in more than 30 countries worldwide. BU incidence is highest in West Africa; however, cases have substantially increased in coastal regions of southern Australia over the past 30 years. Although the mode of transmission remains uncertain, the spatial pattern of BU emergence in recent years seems to suggest that there is an environmental niche for M. ulcerans and BU prevalence. Methodology/Principal Findings: Network analysis was applied to BU cases in Victoria, Australia, from 1981-2008. Results revealed a non-random spatio-temporal pattern at the regional scale as well as a stable and efficient BU disease network, indicating that deterministic factors influence the occurrence of this disease. Monthly BU incidence reported by locality was analyzed with landscape and climate data using a multilevel Poisson regression approach. The results suggest the highest BU risk areas occur at low elevations with forested land cover, similar to previous studies of BU risk in West Africa. Additionally, climate conditions as far as 1.5 years in advance appear to impact disease incidence. Warmer and wetter conditions 18-19 months prior to case emergence, followed by a dry period approximately 5 months prior to case emergence seem to favor the occurrence of BU. Conclusions/Significance: The BU network structure in Victoria, Australia, suggests external environmental factors favor M. ulcerans transmission and, therefore, BU incidence. A unique combination of environmental conditions, including land cover type, temperature and a wet-dry sequence, may produce habitat characteristics that support M. ulcerans transmission and BU prevalence. These findings imply that future BU research efforts on transmission mechanisms should focus on potential vectors/reservoirs found in those environmental niches. Further, this study is the first to quantitatively estimate environmental lag times associated with BU outbreaks, providing insights for future transmission investigations.	[van Ravensway, Jenni; Qi, Jiaguo] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [Benbow, M. Eric] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Tsonis, Anastasios A.] Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA; [Pierce, Steven J.] Michigan State Univ, Ctr Stat Training & Consulting, E Lansing, MI 48824 USA; [Campbell, Lindsay P.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Fyfe, Janet A. M.] Victorian Infect Dis Reference Lab, WHO Collaborating Ctr Mycobacterium Ulcerans, Melbourne, Vic, Australia; [Hayman, John A.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Johnson, Paul D. R.] Austin Hlth, Dept Infect Dis, Melbourne, Vic, Australia; [Wallace, John R.] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA 17551 USA; [Qi, Jiaguo] Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA	Michigan State University; University of Dayton; University of Wisconsin System; University of Wisconsin Milwaukee; Michigan State University; University of Kansas; Victorian Infectious Diseases Reference Laboratory; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania; Michigan State University	Qi, JG (corresponding author), Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA.	qi@msu.edu	Qi, Jiaguo/AAC-4106-2020; Benbow, Mark/V-5895-2019; Pierce, Steven J./X-8821-2019	Pierce, Steven J./0000-0002-0679-3019	World Health Organization; National Institutes of Health and Fogarty International Center [NIH - R01TW007550]; NIH [R01TW007550]; FOGARTY INTERNATIONAL CENTER [R01TW007550] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); National Institutes of Health and Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was supported by the World Health Organization and the National Institutes of Health and Fogarty International Center (NIH - R01TW007550). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health. R. W. Merritt is gratefully acknowledged for supporting this research as part of NIH grant R01TW007550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrushchyshyn O, 2003, FRESHWATER BIOL, V48, P548, DOI 10.1046/j.1365-2427.2003.01028.x; Andrushchyshyn OP, 2006, AQUAT MICROB ECOL, V42, P293, DOI 10.3354/ame042293; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P145; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P194; [Anonymous], 2001, MISSING DATA; Baker ME, 2009, ECOLOGY, V90, P145, DOI 10.1890/07-1242.1; Bates D., 2010, LINEAR FIXED EFFECTS; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Benbow ME, 2008, EMERG INFECT DIS, V14, P1247, DOI 10.3201/eid1408.071503; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Brou T, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000271; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Commonwealth of Australia, 2011, REG POP GROWTH AUSTR; Commonwealth of Australia 2012, 2011, MAPS AV COND; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Dobos KM, 1999, EMERG INFECT DIS, V5, P367, DOI 10.3201/eid0503.990307; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; HAYMAN J, 1991, INT J EPIDEMIOL, V20, P1093, DOI 10.1093/ije/20.4.1093; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HUME ID, 1989, P NUTR SOC, V48, P69, DOI 10.1079/PNS19890011; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Johnson PDR, 2009, EMERG INFECT DIS, V15, P614, DOI 10.3201/eid1504.081162; Johnson PDR, 1996, MED J AUSTRALIA, V164, P76, DOI 10.5694/j.1326-5377.1996.tb101352.x; Johnston K, 2003, USING ARCGIS GEOSTAT, P306; Kerle A., 2001, POSSUMS BRUSHTAILS R; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; Kuhn K., 2005, USING CLIMATE PREDIC; Kurtzman D, 1999, CLIMATE RES, V13, P33, DOI 10.3354/cr013033; Lavender CJ, 2008, FEMS MICROBIOL LETT, V287, P250, DOI 10.1111/j.1574-6968.2008.01328.x; Liljeros F, 2001, CONDMAT0106507 ARXIV; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P6296, DOI 10.1128/AEM.70.10.6296-6298.2004; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Mather P., 2004, COMPUTER PROCESSING, V3rd; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Merritt RW, 2005, FRONT ECOL ENVIRON, V3, P323, DOI 10.1890/1540-9295(2005)003[0323:UAEDAW]2.0.CO;2; Meyers WM, 1996, BRIT J DERMATOL, V134, P1116, DOI 10.1111/j.1365-2133.1996.tb07955.x; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; Pouillot R, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000101; Quek TYJ, 2007, EMERG INFECT DIS, V13, P1661, DOI 10.3201/eid1311.061206; R Core Team, 2020, R LANG ENV STAT COMP; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Ross BC, 1997, APPL ENVIRON MICROB, V63, P4135, DOI 10.1128/AEM.63.10.4135-4138.1997; Schowengerdt R. A., 2007, REMOTE SENSING MODEL; Shirley MDF, 2005, ECOL COMPLEX, V2, P287, DOI 10.1016/j.ecocom.2005.04.005; Tobias NJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000553; Tsonis AA, 2008, J CLIMATE, V21, P2990, DOI 10.1175/2007JCLI1907.1; Veitch MGK, 1997, EPIDEMIOL INFECT, V119, P313, DOI 10.1017/S0950268897008273; Wagner T, 2008, ECOHEALTH, V5, P69, DOI 10.1007/s10393-007-0148-7; Wagner T, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-25; Wallace JR, 2010, APPL ENVIRON MICROB, V76, P6215, DOI 10.1128/AEM.00340-10; Watts DJ, 2004, ANNU REV SOCIOL, V30, P243, DOI 10.1146/annurev.soc.30.020404.104342; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williamson HR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000205; World Health Organization, 2007, BUR ULC DIS MYC ULC	62	41	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51074	10.1371/journal.pone.0051074	http://dx.doi.org/10.1371/journal.pone.0051074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251425	Green Published, gold			2022-12-27	WOS:000312201900039
J	Vandenberg, LN; Stevenson, C; Levin, M				Vandenberg, Laura N.; Stevenson, Claire; Levin, Michael			Low Frequency Vibrations Induce Malformations in Two Aquatic Species in a Frequency-, Waveform-, and Direction-Specific Manner	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; LEFT-RIGHT ASYMMETRY; VERTEBRATE DEVELOPMENT; MECHANICAL VIBRATIONS; GENE-EXPRESSION; THYROID-HORMONE; XENOPUS-LAEVIS; T-LYMPHOCYTES; ZEBRAFISH; EXPOSURE	Environmental toxicants such as industrial wastes, air particulates from machinery and transportation vehicles, and pesticide run-offs, as well as many chemicals, have been widely studied for their effects on human and wildlife populations. Yet other potentially harmful environmental pollutants such as electromagnetic pulses, noise and vibrations have remained incompletely understood. Because developing embryos undergo complex morphological changes that can be affected detrimentally by alterations in physical forces, they may be particularly susceptible to exposure to these types of pollutants. We investigated the effects of low frequency vibrations on early embryonic development of two aquatic species, Xenopus laevis (frogs) and Danio rerio (zebrafish), specifically focusing on the effects of varying frequencies, waveforms, and applied direction. We observed treatment-specific effects on the incidence of neural tube defects, left-right patterning defects and abnormal tail morphogenesis in Xenopus tadpoles. Additionally, we found that low frequency vibrations altered left-right patterning and tail morphogenesis, but did not induce neural tube defects, in zebrafish. The results of this study support the conclusion that low frequency vibrations are toxic to aquatic vertebrates, with detrimental effects observed in two important model species with very different embryonic architectures.	[Vandenberg, Laura N.; Stevenson, Claire; Levin, Michael] Tufts Univ, Dept Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA	Tufts University	Levin, M (corresponding author), Tufts Univ, Dept Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA.	michael.levin@tufts.edu	Levin, Michael/A-5918-2011	Levin, Michael/0000-0001-7292-8084	American Heart Association [0740088N]; NIH [R01-GM077425]; NRSA [1F32GM087107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077425, F32GM087107] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Established Investigator Grant 0740088N and NIH grant R01-GM077425 to ML, and NRSA grant 1F32GM087107 to LNV. The funders had no additional role in the study design, data analysis, or decision to submit this manuscript.	Abbate C, 2004, PSYCHOTHER PSYCHOSOM, V73, P375, DOI 10.1159/000080391; Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Aggio RBM, 2012, METABOLOMICS, V8, P670, DOI 10.1007/s11306-011-0360-x; BANTLE JA, 1971, AEROSPACE MED, V42, P1087; Bovenzi M, 1999, INT ARCH OCC ENV HEA, V72, P351, DOI 10.1007/s004200050387; Callery EM, 2006, SEMIN CELL DEV BIOL, V17, P80, DOI 10.1016/j.semcdb.2005.11.001; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; Danilchik MV, 2006, DEVELOPMENT, V133, P4517, DOI 10.1242/dev.02642; Fini JB, 2012, TOXICOL SCI, V125, P359, DOI 10.1093/toxsci/kfr312; Futatsuka M, 1998, IND HEALTH, V36, P127, DOI 10.2486/indhealth.36.127; GAGNON R, 1989, AM J OBSTET GYNECOL, V161, P1479, DOI 10.1016/0002-9378(89)90908-3; Gerhardt K. J, 2000, J PERINATOLOGY, V20, pS20, DOI [10.1038/sj.jp.7200446, DOI 10.1038/SJ.JP.7200446]; Gibert Y, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-4; Gilbert SF, 2006, DEV BIOL; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; HEMMINKI K, 1981, J EPIDEMIOL COMMUN H, V35, P5, DOI 10.1136/jech.35.1.5; Herman GE, 2002, CYTOGENET GENOME RES, V99, P229, DOI 10.1159/000071598; Lewis Marian L, 2002, Adv Space Biol Med, V8, P77; Lewis ML, 2001, FASEB J, V15, P1783, DOI 10.1096/fj.00-0820fje; MCDONALD AD, 1988, BRIT J IND MED, V45, P148; Meunier R, 2012, STUD HIST PHI PART C, V43, P522, DOI 10.1016/j.shpsc.2011.11.013; Morvan-Dubois G, 2008, MOL CELL ENDOCRINOL, V293, P71, DOI 10.1016/j.mce.2008.06.012; NAKAMURA H, 1992, ENVIRON RES, V58, P220, DOI 10.1016/S0013-9351(05)80217-8; Neumann CJ, 2002, SEMIN CELL DEV BIOL, V13, P469, DOI 10.1016/S108495210200099X; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Paschold H.W., 2011, PROF SAF, V56, P30; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Reeder AL, 2005, ENVIRON HEALTH PERSP, V113, P261, DOI 10.1289/ehp.7276; Sabo V., 1982, Pol'nohospodarstvo, V28, P527; SEIDEL H, 1986, INT ARCH OCC ENV HEA, V58, P1, DOI 10.1007/BF00378536; Shannon SG, 1994, EFFECT VIBRATION FRE; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Solecki L, 2010, ANN AGR ENV MED, V17, P243; Strathmann RR, 2000, SEMIN CELL DEV BIOL, V11, P395, DOI 10.1006/scdb.2000.0192; Taggart LC, 1990, EFFECT VIBRATION FRE; Terrien X, 2011, AQUAT TOXICOL, V105, P13, DOI 10.1016/j.aquatox.2011.04.007; TORAASON MA, 1980, ENVIRON RES, V23, P341, DOI 10.1016/0013-9351(80)90069-9; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023306; Vandenberg LN, 2010, DEV DYNAM, V239, P3131, DOI 10.1002/dvdy.22450; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Wenger KH, 2010, BONE, V47, P746, DOI 10.1016/j.bone.2010.07.014; Westerfield M, 1995, ZEBRAFISH BOOK; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012; ZOTIN A. I., 1967, IZV AKAD NAUK SSSR SER BIOL, V6, P879	46	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51473	10.1371/journal.pone.0051473	http://dx.doi.org/10.1371/journal.pone.0051473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251546	gold, Green Published			2022-12-27	WOS:000312201900092
J	Zhu, MX; Wang, J; Liu, M; Du, DS; Xia, CM; Shen, LL; Zhu, DN				Zhu, Minxia; Wang, Jin; Liu, Min; Du, Dongshu; Xia, Chunmei; Shen, Linlin; Zhu, Danian			Upregulation of Protein Phosphatase 2A and NR3A-Pleiotropic Effect of Simvastatin on Ischemic Stroke Rats	PLOS ONE			English	Article							NMDA RECEPTOR; INCREASED PHOSPHORYLATION; NR3A SUBUNIT; NR1 SUBUNIT; KINASE-A; STATINS; CALCIUM; NEUROPROTECTION; EXPRESSION; NEURONS	Ca2+ influxes are regulated by the functional state of N-methyl-D-aspartate receptors (NMDARs). Dephosphorylation of NMDARs subunits decreases Ca2+ influxes. NR3, a novel subunit of NMDARs, also decreases Ca2+ influxes by forming new NMDARs with NR1 and NR2. It is meaningful to uncover whether protein phosphatase 2A (PP2A) and NR3A play a role in the protective effect of Simvastatin on ischemic stroke. In the present study, the Sprague-Dawley rats were pretreated with Simvastatin for 7 days before middle cerebral artery occlusion was performed to mimic ischemic stroke. The results showed that Simvastatin decreased brain ischemic infarct area significantly while increasing the expression levels of PP2A and NR3A, thus dephosphorylating the serine sites of NR1 (ser896 and ser897) along with increased enzymatic activities of PP2A. The protein levels of NR3A decreased as the enzymatic activities of PP2A were inhibited by okadaic acid. The results indicated that Simvastatin could protect the cerebrum from ischemic injury through a signaling mechanism involving elevated levels of PP2A and NR3A, and that PP2A might involve in the regulatory mechanism of NR3A expression.	[Zhu, Minxia; Wang, Jin; Liu, Min; Du, Dongshu; Xia, Chunmei; Shen, Linlin; Zhu, Danian] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Minxia] Tibet Univ Nationalities, Coll Med, Xianyang, Shaanxi, Peoples R China	Fudan University; Xizang Minzu University	Zhu, DN (corresponding author), Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	dnzhu@shmu.edu.cn		Zhu, Minxia/0000-0001-8775-1226	Shanghai Leading Academic Discipline Project [B112]; The Second Major Projects of Science and Technology Department in Tibet Autonomous Region	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); The Second Major Projects of Science and Technology Department in Tibet Autonomous Region	This work was supported by Shanghai Leading Academic Discipline Project (B112), URL: http://www.shmec.gov.cn and The Second Major Projects of Science and Technology Department in Tibet Autonomous Region (No Project Number), URL: http://www.tibetsti.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger C, 2008, BRAIN RES REV, V58, P48, DOI 10.1016/j.brainresrev.2007.10.010; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bickler PE, 2004, J NEUROCHEM, V88, P878, DOI 10.1046/j.1471-4159.2003.02203.x; Bononi Angela, 2011, Enzyme Res, V2011, P329098, DOI 10.4061/2011/329098; Chan SF, 2001, J NEUROSCI, V21, P7985, DOI 10.1523/JNEUROSCI.21-20-07985.2001; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Cheung HH, 2001, J NEUROCHEM, V78, P1179, DOI 10.1046/j.1471-4159.2001.0780051179.x; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Cui LL, 2010, BRAIN RES, V1325, P164, DOI 10.1016/j.brainres.2010.02.036; Garcia-Bonilla L, 2012, J NEUROCHEM, V122, P233, DOI 10.1111/j.1471-4159.2012.07773.x; Henson MA, 2008, CEREB CORTEX, V18, P2560, DOI 10.1093/cercor/bhn017; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Khalessi AA, 2011, WORLD NEUROSURG, V76, P248, DOI 10.1016/j.wneu.2011.06.054; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Laufs U, 2003, ARTERIOSCL THROM VAS, V23, P156, DOI 10.1161/01.ATV.0000051360.79309.4E; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Ma OK, 2004, NEUROREPORT, V15, P1447, DOI 10.1097/01.wnr.0000132773.41720.2d; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; Montaner Joan, 2005, Expert Rev Neurother, V5, P211, DOI 10.1586/14737175.5.2.211; Mueller HT, 2004, SCHIZOPHR RES, V71, P361, DOI 10.1016/j.schres.2004.02.016; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Szczepanska-Szerej A, 2007, PHARMACOL REP, V59, P94; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; Yi KD, 2008, ENDOCRINOLOGY, V149, P5235, DOI 10.1210/en.2008-0610	34	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51552	10.1371/journal.pone.0051552	http://dx.doi.org/10.1371/journal.pone.0051552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251573	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900102
J	Ma, JY; Sun, W; Liu, XN; Chen, FH				Ma, Jian-Ying; Sun, Wei; Liu, Xiao-Ning; Chen, Fa-Hu			Variation in the Stable Carbon and Nitrogen Isotope Composition of Plants and Soil along a Precipitation Gradient in Northern China	PLOS ONE			English	Article							N-15 NATURAL-ABUNDANCE; RAINFALL GRADIENT; MYCORRHIZAL FUNGI; C-4 PLANTS; DISCRIMINATION; DELTA-C-13; PATTERNS; FRACTIONATION; AVAILABILITY; VEGETATION	Water availability is the most influential factor affecting plant carbon (delta C-13) and nitrogen (delta N-15) isotope composition in arid and semi-arid environments. However, there are potential differences among locations and/or species in the sensitivity of plant delta C-13 and delta N-15 to variation in precipitation, which are important for using stable isotope signatures to extract paleo-vegetation and paleo-climate information. We measured delta C-13 and delta N-15 of plant and soil organic matter (SOM) samples collected from 64 locations across a precipitation gradient with an isotherm in northern China. delta C-13 and delta N-15 for both C-3 and C-4 plants decreased significantly with increasing mean annual precipitation (MAP). The sensitivity of delta C-13 to MAP in C-3 plants (-0.6 +/- 0.07 parts per thousand/100 mm) was twice as high as that in C-4 plants (-0.3 +/- 0.08 parts per thousand/100 mm). Species differences in the sensitivity of plant delta C-13 and delta N-15 to MAP were not observed among three main dominant plants. SOM became depleted in C-13 with increasing MAP, while no significant correlations existed between delta N-15 of SOM and MAP. We conclude that water availability is the primary environmental factor controlling the variability of plant delta C-13 and delta N-15 and soil delta C-13 in the studied arid and semi-arid regions. Carbon isotope composition is useful for tracing environmental precipitation changes. Plant nitrogen isotope composition can reflect relative openness of ecosystem nitrogen cycling.	[Sun, Wei] NE Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China; [Ma, Jian-Ying; Liu, Xiao-Ning] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Ma, Jian-Ying; Chen, Fa-Hu] Lanzhou Univ, Key Lab Western Chinas Environm Syst, Minist Educ, Lanzhou 730000, Peoples R China	Northeast Normal University - China; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Lanzhou University	Sun, W (corresponding author), NE Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China.	sunwei@nenu.edu.cn	Fahu, Chen/B-2788-2011	Chen, Fahu/0000-0002-8874-1035	National Basic Research Program of China [2009CB825101, 2009CB421306]; National Natural Science Foundation of China [41071032, 31270445]; Talents Foundation of Cold and Arid Regions Environmental and Engineering Research Institute; West Light Foundation of the Chinese Academy of Science	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talents Foundation of Cold and Arid Regions Environmental and Engineering Research Institute; West Light Foundation of the Chinese Academy of Science(Chinese Academy of Sciences)	This research was supported by National Basic Research Program of China (2009CB825101 and 2009CB421306), National Natural Science Foundation of China (41071032, 31270445), Talents Foundation of Cold and Arid Regions Environmental and Engineering Research Institute (2011) and West Light Foundation of the Chinese Academy of Science (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; AMUNDSON R, 1994, J ARID ENVIRON, V28, P265, DOI 10.1016/S0140-1963(05)80048-5; Anderson JE, 1996, AUST J PLANT PHYSIOL, V23, P311, DOI 10.1071/PP9960311; Aranibar JN, 2008, J ARID ENVIRON, V72, P326, DOI 10.1016/j.jaridenv.2007.06.007; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; BALESDENT J, 1993, ECOLOGY, V74, P1713, DOI 10.2307/1939930; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Ding Y., 1993, SPRINGER NETHERLANDS, DOI DOI 10.1007/978-94-015-8302-2; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1983, AUST J PLANT PHYSIOL, V10, P205, DOI 10.1071/PP9830205; Handley LL, 1999, AUST J PLANT PHYSIOL, V26, P185, DOI 10.1071/PP98146; HANDLEY LL, 1992, PLANT CELL ENVIRON, V15, P965, DOI 10.1111/j.1365-3040.1992.tb01650.x; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; HATTERSLEY PW, 1982, AUST J PLANT PHYSIOL, V9, P139, DOI 10.1071/PP9820139; Hobbie EA, 2003, NEW PHYTOL, V157, P115, DOI 10.1046/j.1469-8137.2003.00657.x; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Kitayama K, 2001, PLANT SOIL, V229, P203, DOI 10.1023/A:1004853915544; Korol RL, 1999, TREE PHYSIOL, V19, P551; Liu WG, 2009, CHINESE SCI BULL, V54, P272, DOI 10.1007/s11434-008-0442-y; Liu WG, 2005, GLOBAL CHANGE BIOL, V11, P1094, DOI 10.1111/j.1365-2486.2005.00969.x; Ma JY, 2007, J ARID ENVIRON, V69, P365, DOI 10.1016/j.jaridenv.2006.11.002; Midwood AJ, 1998, SOIL BIOL BIOCHEM, V30, P1301, DOI 10.1016/S0038-0717(98)00030-3; Miller JM, 2001, FUNCT ECOL, V15, P222, DOI 10.1046/j.1365-2435.2001.00508.x; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Robinson D, 1998, PLANTA, V205, P397, DOI 10.1007/s004250050336; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; SPEAR RW, 1994, ECOL MONOGR, V64, P85, DOI 10.2307/2937056; STEWART GR, 1995, AUST J PLANT PHYSIOL, V22, P51, DOI 10.1071/PP9950051; Swap RJ, 2004, GLOBAL CHANGE BIOL, V10, P350, DOI 10.1111/j.1365-2486.2003.00702.x; Van de Water PK, 2002, OECOLOGIA, V132, P332, DOI 10.1007/s00442-002-0973-x; Wang GA, 2005, PHYSIOL PLANTARUM, V125, P74, DOI 10.1111/j.1399-3054.2005.00549.x; Wang T, 2003, DESERT DESERTIFICATI; Williams DG, 2001, NEW PHYTOL, V150, P285, DOI 10.1046/j.1469-8137.2001.00093.x; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x	41	47	56	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51894	10.1371/journal.pone.0051894	http://dx.doi.org/10.1371/journal.pone.0051894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272186	gold, Green Submitted, Green Published			2022-12-27	WOS:000312483300040
J	Simoes, P; Calabria, G; Picao-Osorio, J; Balanya, J; Pascual, M				Simoes, Pedro; Calabria, Gemma; Picao-Osorio, Joao; Balanya, Joan; Pascual, Marta			The Genetic Content of Chromosomal Inversions across a Wide Latitudinal Gradient	PLOS ONE			English	Article							DROSOPHILA-SUBOBSCURA; LINKAGE DISEQUILIBRIUM; NUCLEOTIDE VARIABILITY; NATURAL-POPULATIONS; POLYMORPHISM; SELECTION; MELANOGASTER; RECOMBINATION; ARRANGEMENTS; SUBDIVISION	There is increasing evidence regarding the role of chromosomal inversions in relevant biological processes such as local adaptation and speciation. A classic example of the adaptive role of chromosomal polymorphisms is given by the clines of inversion frequencies in Drosophila subobscura, repeatable across continents. Nevertheless, not much is known about the molecular variation associated with these polymorphisms. We characterized the genetic content of ca. 600 individuals from nine European populations following a latitudinal gradient by analysing 19 microsatellite loci from two autosomes (J and U) and the sex chromosome (A), taking into account their chromosomal inversions. Our results clearly demonstrate the molecular genetic uniformity within a given chromosomal inversion across a large latitudinal gradient, particularly from Groningen (Netherlands) in the north to Malaga (Spain) in the south, experiencing highly diverse environmental conditions. This low genetic differentiation within the same gene arrangement across the nine European populations is consistent with the local adaptation hypothesis for th evolutionof chromosomal polymorphisms. We also show the effective role of chromosomal inversions in maintaining different genetic pools within these inverted genomic regions even in the presence of high gene flow. Inversions represent thus an important barrier to gene flux and can help maintain specific allelic combinations with positive effects on fitness. Consistent patterns of microsatellite allele-inversion linkage disequilibrium particularly in loci within inversions were also observed. Finally, we identified areas within inversions presenting clinal variation that might be under selection.	[Simoes, Pedro; Calabria, Gemma; Picao-Osorio, Joao; Balanya, Joan; Pascual, Marta] Univ Barcelona, Fac Biol, Dept Genet, Grp Biol Evolutiva IRBio, Barcelona, Spain; [Picao-Osorio, Joao] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Barcelona; University of Sussex	Simoes, P (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	pmsimoes@fc.ul.pt	Pascual, Marta/ABG-3782-2020; /A-8683-2008; Pascual, Marta/M-7626-2015; Simões, Pedro/F-7220-2015	Pascual, Marta/0000-0002-6189-0612; /0000-0002-8236-4101; Pascual, Marta/0000-0002-6189-0612; Simões, Pedro/0000-0002-4253-1200	Ministerio de Ciencia y Tecnologia (MCYT, Spain) [CGL2006-13423-C02-02, CTM2010-22218-C02-02]; Fundacao para Ciencia e a Tecnologia (Portugal) [SFRH/BPD/36829/2007]; Ministerio de Educacion y Ciencia (Spain) [BES-2007-15096]; Generalitat de Catalunya [2009SGR-636]	Ministerio de Ciencia y Tecnologia (MCYT, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacao para Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Research was founded by projects CGL2006-13423-C02-02 and CTM2010-22218-C02-02 from the Ministerio de Ciencia y Tecnologia (MCYT, Spain). Pedro Simoes had a Post-Doctoral grant (SFRH/BPD/36829/2007) from Fundacao para Ciencia e a Tecnologia (Portugal). Gemma Calabria had a FPI doctoral grant (BES-2007-15096) from Ministerio de Educacion y Ciencia (Spain). Authors are part of the research group 2009SGR-636 from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; [Anonymous], 1992, DROSOPHILA INVERSION; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Balanya J, 2004, J ZOOL SYST EVOL RES, V42, P191, DOI 10.1111/j.1439-0469.2004.00274.x; Balanya J, 2003, EVOLUTION, V57, P1837; Balanya J, 2009, HEREDITY, V103, P364, DOI 10.1038/hdy.2009.86; Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Barker JSF, 2011, J EVOLUTION BIOL, V24, P430, DOI 10.1111/j.1420-9101.2010.02180.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; CHARLESWORTH B, 1979, GENETICS, V92, P983; DOBZHANSKY T, 1950, GENETICS, V35, P288; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feder JL, 2011, EVOLUTION, V65, P2157, DOI 10.1111/j.1558-5646.2011.01321.x; Frydenberg J, 2003, MOL ECOL, V12, P2025, DOI 10.1046/j.1365-294X.2002.01882.x; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; Gockel J, 2001, GENETICS, V158, P319; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guerrero RF, 2012, PHILOS T R SOC B, V367, P430, DOI 10.1098/rstb.2011.0246; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Kennington WJ, 2006, GENETICS, V172, P1655, DOI 10.1534/genetics.105.053173; Kennington WJ, 2003, GENETICS, V165, P667; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; KOSKE T, 1954, J GENET, V52, P521, DOI 10.1007/BF02985076; Krimbas CB., 1993, DROSOPHILA SUBOBSCUR; KUNZEMUHL E, 1958, CHROMOSOMA, V9, P559; Laayouni H, 2003, MOL BIOL EVOL, V20, P931, DOI 10.1093/molbev/msg099; LATORRE A, 1992, HEREDITY, V68, P15, DOI 10.1038/hdy.1992.2; LEWONTIN RC, 1964, GENETICS, V49, P49; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LOUKAS M, 1979, GENETICS, V93, P497; MAINX F, 1953, Z INDUKT ABSTAMM VER, V85, P354, DOI 10.1007/BF00309673; McAllister BF, 2002, GENOME, V45, P13, DOI 10.1139/g01-112; McGaugh SE, 2012, PHILOS T R SOC B, V367, P422, DOI 10.1098/rstb.2011.0250; Muller H. J., 1940, The New Systematics Oxford, V1940, P185; Munte A, 2005, GENETICS, V169, P1573, DOI 10.1534/genetics.104.032748; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Navarro A, 1997, GENETICS, V146, P695; Navarro A, 2000, GENETICS, V155, P685; Nobrega C, 2008, MOL BIOL EVOL, V25, P1534, DOI 10.1093/molbev/msn100; Noor MAF, 2000, EVOLUTION, V54, P696, DOI 10.1111/j.0014-3820.2000.tb00071.x; OHTA T, 1982, P NATL ACAD SCI-BIOL, V79, P1940, DOI 10.1073/pnas.79.6.1940; Pascual M, 2000, MOL BIOL EVOL, V17, P1259, DOI 10.1093/oxfordjournals.molbev.a026409; Pascual M, 1997, J ZOOL SYST EVOL RES, V35, P159; Pascual M, 2001, MOL BIOL EVOL, V18, P731, DOI 10.1093/oxfordjournals.molbev.a003855; Pegueroles C, 2010, J EVOLUTION BIOL, V23, P2709, DOI 10.1111/j.1420-9101.2010.02136.x; PREVOSTI A, 1988, P NATL ACAD SCI USA, V85, P5597, DOI 10.1073/pnas.85.15.5597; RodriguezTrelles F, 1996, GENETICS, V142, P179; ROZAS J, 1995, J EVOLUTION BIOL, V8, P355, DOI 10.1046/j.1420-9101.1995.8030355.x; Santos J, 2010, CHROMOSOME RES, V18, P213, DOI 10.1007/s10577-010-9112-4; Santos M, 2009, GENETICS, V181, P803, DOI 10.1534/genetics.108.097857; Schaeffer SW, 2008, EVOLUTION, V62, P3082, DOI 10.1111/j.1558-5646.2008.00504.x; Schaeffer SW, 2005, GENETICS, V171, P1729, DOI 10.1534/genetics.105.041947; Schaeffer SW, 2003, P NATL ACAD SCI USA, V100, P8319, DOI 10.1073/pnas.1432900100; SLATKIN M, 1995, GENETICS, V139, P457; Umina PA, 2006, GENET RES, V87, P13, DOI 10.1017/S0016672306007919; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217	63	18	19	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51625	10.1371/journal.pone.0051625	http://dx.doi.org/10.1371/journal.pone.0051625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272126	gold, Green Submitted, Green Published			2022-12-27	WOS:000312483300019
J	Jung, WH; Jang, JH; Shin, NY; Kim, SN; Choi, CH; An, SK; Kwon, JS				Jung, Wi Hoon; Jang, Joon Hwan; Shin, Na Young; Kim, Sung Nyun; Choi, Chi-Hoon; An, Suk Kyoon; Kwon, Jun Soo			Regional Brain Atrophy and Functional Disconnection in Broca's Area in Individuals at Ultra-High Risk for Psychosis and Schizophrenia	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; RESTING-STATE; WORKING-MEMORY; GLOBAL SIGNAL; MENTAL STATE; CONNECTIVITY; NETWORKS; FMRI; ABNORMALITIES; LANGUAGE	Background: Abnormalities in cognitive abilities such as verbal fluency and in cognitive-related brain regions, particularly Broca's area, have been reported in patients with schizophrenia. Additionally, previous studies have demonstrated that structural and functional abnormalities in Broca's area were associated with clinical symptoms and cognitive deficits in patients with schizophrenia, suggesting that deficits in this area may reflect the core pathology of schizophrenia. Thus, it is important to understand how the structural volume and functional connectivity in this area changes at rest according to the course of the illness. Methods/Principal Findings: We used magnetic resonance imaging (MRI) to measure the structural volume of Broca's area as a region of interest in 16 schizophrenia, 16 ultra-high risk (UHR), and 23 healthy matched controls. We also assessed verbal fluency and analyzed differences across groups in the functional connectivity patterns using resting-state functional MRI. The UHR group showed significantly reduced structural volume in Broca's area and significantly reduced functional connectivity between Broca's area and the lateral and medial frontal cortex as well as decreased cognitive performance. Altered functional connectivity in patients was correlated with their positive symptoms. Conclusions/Significance: Our results suggest the existence of functional disconnections in Broca's area, even during resting-states, among those with schizophrenia as well as those at UHR for this disorder. These alterations may contribute to their clinical symptoms, suggesting that this is one of the key regions involved in the pathophysiology of schizophrenia.	[Jung, Wi Hoon; Shin, Na Young; Kwon, Jun Soo] Seoul Natl Univ, Med Res Ctr, Inst Neurosci, Clin Cognit Neurosci Ctr, Seoul, South Korea; [Jung, Wi Hoon; Kwon, Jun Soo] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul 151742, South Korea; [Jang, Joon Hwan; Kim, Sung Nyun; Kwon, Jun Soo] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul 151742, South Korea; [Choi, Chi-Hoon] Natl Med Ctr, Dept Diagnost Radiol, Seoul, South Korea; [An, Suk Kyoon] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kwon, Jun Soo] Seoul Natl Univ, Coll Nat Sci, World Class Univ Program, Dept Brain & Cognit Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Medical Center - Korea; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Kwon, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Neurosci, Clin Cognit Neurosci Ctr, Seoul, South Korea.	kwonjs@snu.ac.kr	Jung, Wi Hoon/J-4033-2019	Jung, Wi Hoon/0000-0002-8697-9584	Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A090096]	Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A090096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Becker HE, 2010, EUR PSYCHIAT, V25, P105, DOI 10.1016/j.eurpsy.2009.08.003; Bertolino A, 2000, AM J PSYCHIAT, V157, P26, DOI 10.1176/ajp.157.1.26; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Broome MR, 2009, BRIT J PSYCHIAT, V194, P25, DOI 10.1192/bjp.bp.107.046789; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Brugger S, 2011, BIOL PSYCHIAT, V69, P495, DOI 10.1016/j.biopsych.2010.10.004; Byun MS, 2009, PSYCHIAT INVEST, V6, P264, DOI 10.4306/pi.2009.6.4.264; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Ceccherini-Nelli A, 2003, BRIT J PSYCHIAT, V182, P233, DOI 10.1192/bjp.182.3.233; Choi JS, 2011, SCHIZOPHR B IN PRESS; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; DeLisi LE, 2001, SCHIZOPHRENIA BULL, V27, P481, DOI 10.1093/oxfordjournals.schbul.a006889; Farris EA, 2011, NEUROCASE, V17, P425, DOI 10.1080/13554794.2010.532141; Fiehler K, 2009, CEREB CORTEX, V19, P1, DOI 10.1093/cercor/bhn067; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fusar-Poli P, 2007, NEUROSCI BIOBEHAV R, V31, P465, DOI 10.1016/j.neubiorev.2006.11.006; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hill K, 2004, ACTA PSYCHIAT SCAND, V110, P243, DOI 10.1111/j.1600-0447.2004.00376.x; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jang JH, 2010, NEUROSCI LETT, V474, P158, DOI 10.1016/j.neulet.2010.03.031; Jeong B, 2010, PSYCHIAT RES-NEUROIM, V181, P114, DOI 10.1016/j.pscychresns.2009.09.005; Jung WH, 2010, J KOREAN MED SCI, V25, P1700, DOI 10.3346/jkms.2010.25.12.1700; Jung WH, 2011, SCHIZOPHRENIA BULL, V37, P839, DOI 10.1093/schbul/sbp151; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Li XB, 2010, BRAIN IMAGING BEHAV, V4, P109, DOI 10.1007/s11682-010-9090-3; Li XB, 2009, CURR OPIN PSYCHIATR, V22, P131, DOI 10.1097/YCO.0b013e328324bc43; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; MCGUIRE PK, 1993, LANCET, V342, P703, DOI 10.1016/0140-6736(93)91707-S; Mecklinger A, 2000, HUM BRAIN MAPP, V11, P146; Morey RA, 2005, ARCH GEN PSYCHIAT, V62, P254, DOI 10.1001/archpsyc.62.3.254; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Paulus MP, 2002, BIOL PSYCHIAT, V51, P995, DOI 10.1016/S0006-3223(01)01358-0; Shim G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-58; Simon AE, 2007, SCHIZOPHRENIA BULL, V33, P761, DOI 10.1093/schbul/sbm018; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Zhang S, 2012, CEREB CORTEX, V22, P99, DOI 10.1093/cercor/bhr088; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	47	27	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51975	10.1371/journal.pone.0051975	http://dx.doi.org/10.1371/journal.pone.0051975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251669	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800124
J	Weaver, MR; Crozier, I; Eleku, S; Makanga, G; Sebuyira, LM; Nyakake, J; Thompson, M; Willis, K				Weaver, Marcia R.; Crozier, Ian; Eleku, Simon; Makanga, Gyaviira; Sebuyira, Lydia Mpanga; Nyakake, Janepher; Thompson, MaryLou; Willis, Kelly			Capacity-Building and Clinical Competence in Infectious Disease in Uganda: A Mixed-Design Study with Pre/Post and Cluster-Randomized Trial Components	PLOS ONE			English	Article							INTEGRATED MANAGEMENT; HEALTH SYSTEMS; NONPHYSICIAN CLINICIAN; CARE; QUALITY; ILLNESS; TUBERCULOSIS; WORKERS; PERFORMANCE; VIGNETTES	Trial Design: Best practices for training mid-level practitioners (MLPs) to improve global health-services are not well-characterized. Two hypotheses were: 1) Integrated Management of Infectious Disease (IMID) training would improve clinical competence as tested with a single arm, pre-post design, and 2) on-site support (OSS) would yield additional improvements as tested with a cluster-randomized trial. Methods: Thirty-six Ugandan health facilities (randomized 1: 1 to parallel OSS and control arms) enrolled two MLPs each. All MLPs participated in IMID (3-week core course, two 1-week boost sessions, distance learning). After the 3-week course, OSS-arm trainees participated in monthly OSS. Twelve written case scenarios tested clinical competencies in HIV/AIDS, tuberculosis, malaria, and other infectious diseases. Each participant completed different randomly-assigned blocks of four scenarios before IMID (t0), after 3-week course (t1), and after second boost course (t2, 24 weeks after t1). Scoring guides were harmonized with IMID content and Ugandan national policy. Score analyses used a linear mixed-effects model. The primary outcome measure was longitudinal change in scenario scores. Results: Scores were available for 856 scenarios. Mean correct scores at t0, t1, and t2 were 39.3%, 49.1%, and 49.6%, respectively. Mean score increases (95% CI, p-value) for t0-t1 (pre-post period) and t1-t2 (parallel-arm period) were 12.1 ((9.6, 14.6), p<0.001) and -0.6 ((-3.1, +1.9), p = 0.647) percent for OSS arm and 7.5 ((5.0, 10.0), p<0.001) and 1.6 ((-1.0, +4.1), p = 0.225) for control arm. The estimated mean difference in t1 to t2 score change, comparing arm A (participated in OSS) vs. arm B was -2.2 ((-5.8, +1.4), p = 0.237). From t0-t2, mean scores increased for all 12 scenarios. Conclusions: Clinical competence increased significantly after a 3-week core course; improvement persisted for 24 weeks. No additional impact of OSS was observed. Data on clinical practice, facility-level performance and health outcomes will complete assessment of overall impact of IMID and OSS.	[Weaver, Marcia R.; Sebuyira, Lydia Mpanga] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Crozier, Ian] Accordia Global Hlth Fdn, Kampala, Uganda; [Eleku, Simon] Mengo Hosp, Kampala, Uganda; [Makanga, Gyaviira] Mulago Natl Referral Hosp, Kampala, Uganda; [Sebuyira, Lydia Mpanga; Nyakake, Janepher] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Thompson, MaryLou] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Willis, Kelly] Accordia Global Hlth Fdn, Washington, DC USA	University of Washington; University of Washington Seattle; Mulago National Referral Hospital; Makerere University; University of Washington; University of Washington Seattle	Weaver, MR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	mweaver@uw.edu			Accordia Global Health Foundation from the Bill & Melinda Gates Foundation [94298]	Accordia Global Health Foundation from the Bill & Melinda Gates Foundation	This work was supported through grant number 94298 to Accordia Global Health Foundation from the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/Pages/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions contained within the manuscript are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation.	Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Barber SL, 2007, HEALTH AFFAIR, V26, pW352, DOI 10.1377/hlthaff.26.3.w352; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Brentlinger PE, 2010, JAIDS-J ACQ IMM DEF, V55, P351, DOI 10.1097/QAI.0b013e3181e3a4cd; Committee on the US Commitment to Global Health, 2009, US COMM GLOB HLTH RE; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Government of Uganda Ministry of Health, 2010, HLTH SECT STRAT PLAN; Harries AD, 2009, INT J TUBERC LUNG D, V13, P1194; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; Jamvetd G, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000259.pub2, DOI 10.1002/14651858.CD000259.PUB2]; Laserson KF, 2000, INT J TUBERC LUNG D, V4, P673; Leonard KL, 2007, HEALTH AFFAIR, V26, pW380, DOI 10.1377/hlthaff.26.3.w380; Leonard KL, 2010, HEALTH ECON, V19, P1461, DOI 10.1002/hec.1564; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Miceli A, 2012, INT J INFECT DIS, V16, pE708, DOI 10.1016/j.ijid.2012.07.003; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Okero A, 2003, PERSPECTIVES PRACTIC; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Peabody JW, 2007, HEALTH POLICY PLANN, V22, P294, DOI 10.1093/heapol/czm020; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, HEALTH SERV RES, V39, P1951, DOI 10.1111/j.1475-6773.2004.00327.x; Ronald A, 2011, INFECT DIS CLIN N AM, V25, P369, DOI 10.1016/j.idc.2011.02.007; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2011, AM J PUBLIC HEALTH, V101, P2333, DOI 10.2105/AJPH.2010.300068; Sande M, 2008, ACAD MED, V83, P180, DOI 10.1097/ACM.0b013e318160b5cf; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Vasan A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-75; Weaver MR, 2006, J ACQ IMMUN DEF SYND, V43, P292; [World Health Organization Department of Child and Adolescent Health and Development], 2002, IMCI AD GUID GUID ID; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633	35	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51319	10.1371/journal.pone.0051319	http://dx.doi.org/10.1371/journal.pone.0051319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23272097	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800041
J	Xiang, XG; Li, DZ; Jin, XH; Hu, H; Zhou, HL; Jin, WT; Lai, YJ				Xiang, Xiaoguo; Li, Dezhu; Jin, Xiaohua; Hu, Hao; Zhou, Hailang; Jin, Weitao; Lai, Yangjun			Monophyly or Paraphyly - The Taxonomy of Holcoglossum (Aeridinae: Orchidaceae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; EVOLUTIONARY; TAXA; DNA; CLASSIFICATIONS; POLLINATION; ANCESTORS; NUCLEAR; SYSTEM; MODEL	Recently, there have been a lot of intense debates about the acceptance/rejection of paraphyletic groups in biological classification. On the one hand, evolutionary classification states that similarity and common descent are two criteria for biological classification and paraphyletic groups are natural units of biological classification. On the other hand, cladistic classification considers that common descent is the only criterion in biological classification and monophyly should be strictly adhered to. Holcoglossum is used herein as a case to illustrate this problem. Although Holcoglossum is a small orchid genus of less than 20 species, there is little consensus about its generic circumscription since it was established, which leads to confusion in taxonomic treatments in the Aerides-Vanda group. Based on the analyses of molecular and morphological evidence, our results suggest that the clade comprising Holcoglossum s.s., Ascolabium, Penkimia and Ascocentrum himalaicum is strongly supported as a monophyly, and that the three taxa are nested within different subclades of Holcoglossum s.s. Thus, it is reasonable to recognize a monophyletic circumscription of Holcoglossum, which is also well supported by some vegetative and floral characters. The Holcoglossum s.l. would facilitate a better understanding of pollinator-driven floral divergence and vegetative stasis than a paraphyletic and narrowly defined genus. Citation: Xiang X, Li D, Jin X, Hu H, Zhou H, et al. (2012) Monophyly or Paraphyly- The Taxonomy of Holcoglossum (Aeridinae: Orchidaceae). PLoS ONE 7(12): e52050. doi:10.1371/journal.pone.0052050	[Xiang, Xiaoguo; Jin, Xiaohua; Zhou, Hailang; Jin, Weitao; Lai, Yangjun] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Li, Dezhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Hu, Hao] Xian Bot Garden, Xian, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Jin, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	xiaohuajin@ibcas.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Natural Science Foundation of China [31170176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from the National Natural Science Foundation of China (31170176 for Jin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averyanov LV, 1988, BOTANICESKIJ ZH LENI, V73, P101; Bininda-Emonds ORP, 1998, BIOL J LINN SOC, V64, P101; Brummitt RK, 2008, TAXON, V57, P1049, DOI 10.1002/tax.574002; Brummitt RK, 2006, TAXON, V55, P268, DOI 10.2307/25065576; Brummitt RK, 2002, TAXON, V51, P31, DOI 10.2307/1554961; CHRISTENSON E A, 1987, Notes from the Royal Botanic Garden Edinburgh, V44, P249; Christenson Eric A., 1998, Lindleyana, V13, P121; Crisp Michael D., 1996, Telopea, V6, P813; DONOGHUE MJ, 1988, BOT REV, V54, P107, DOI 10.1007/BF02858525; Doyle J. J., 1987, PHYTOCHEM B, P11; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Ebach MC, 2006, TAXON, V55, P831, DOI 10.2307/25065678; Fan J, 2009, TAXON, V58, P849, DOI 10.1002/tax.583013; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Freudenstein JV, 1998, TAXON, V47, P95, DOI 10.2307/1224023; GARAY L A, 1972, BOT MUS LEAFL HARV UNIV, V23, P149; Garay LA, 1974, BOT MUS LEAFL HARVAR, V23, P369; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hidayat T, 2005, J PLANT RES, V118, P271, DOI 10.1007/s10265-005-0217-3; Horandl E, 2007, TAXON, V56, P1; Horandl E, 2010, TAXON, V59, P1641, DOI 10.1002/tax.596001; Horandl E, 2010, TAXON, V59, P345, DOI 10.1002/tax.592001; Horandl E, 2006, TAXON, V55, P564, DOI 10.2307/25065631; HUMPHRIES CJ, 1988, BOT REV, V54, P129, DOI 10.1007/BF02858526; Jin XH, 2005, BOT J LINN SOC, V149, P465, DOI 10.1111/j.1095-8339.2005.00463.x; Jin XH, 2005, PLANT SYST EVOL, V254, P31, DOI 10.1007/s00606-005-0310-z; Jin XH, 2009, FLORA CHINA, V25, P499; Jin XH, 2007, NORDIC J BOT, V25; Jin XH, 2007, BOT J LINN SOC, V154, P283, DOI 10.1111/j.1095-8339.2007.00654.x; Kocyan A, 2008, MOL PHYLOGENET EVOL, V48, P422, DOI 10.1016/j.ympev.2008.02.017; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liu KW, 2006, NATURE, V441, P945, DOI 10.1038/441945a; Liu ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024864; [刘仲健 LIU ZhongJian], 2008, [生态学报, Acta Ecologica Sinica], V28, P2433; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Mayr E, 2002, J ZOOL SYST EVOL RES, V40, P169, DOI 10.1046/j.1439-0469.2002.00211.x; Nordal H, 2005, TAXON, V54, P5; Podani J, 2010, TAXON, V59, P1011, DOI 10.1002/tax.594002; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RIESEBERG LH, 1994, TAXON, V43, P21, DOI 10.2307/1223457; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlechter R., 1919, FEDDES REPERT SPEC N, V4; Schmidt-Lebuhn AN, 2012, CLADISTICS, V28, P174, DOI 10.1111/j.1096-0031.2011.00367.x; Seidenfaden G., 1988, OPERA BOT, V95, P304; SEIDENFADEN G, 1992, OPERA BOT, V114, P441; Stpiczynska M, 2011, ANN BOT-LONDON, V107, P327, DOI 10.1093/aob/mcq246; Stuessy TF, 2008, TAXON, V57, P594, DOI 10.2307/25066026; Stuessy TF, 2010, TAXON, V59, P689, DOI 10.1002/tax.593001; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsi Z.H., 1982, ACTA PHYTOTAX SINICA, V20, P439; van der Cingel N. A., 2001, ATLAS ORCHID POLLINA; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Ying SS, 1977, ORCHIDS TAIWAN, V1, P54	57	14	16	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52050	10.1371/journal.pone.0052050	http://dx.doi.org/10.1371/journal.pone.0052050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251681	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800134
J	Dessombz, A; Meria, P; Bazin, D; Daudon, M				Dessombz, Arnaud; Meria, Paul; Bazin, Dominique; Daudon, Michel			Prostatic Stones: Evidence of a Specific Chemistry Related to Infection and Presence of Bacterial Imprints	PLOS ONE			English	Article							CALCIUM-PHOSPHATE; INFLAMMATION; SPECTROSCOPY; WHITLOCKITE; IMMUNITY; CRYSTAL; CALCULI	Prostatic stones are a common condition in older men in industrialized countries. However, aging appears not to be the unique pathogenesis of these calcifications. Our morpho-constitutional investigation of 23 stone samples suggested that infection has a significant role in the lithogenic process of prostate calcifications, even without detection of infection by clinical investigation. Most stones (83%) showed bacterial imprints and/or chemical composition, suggestive of a long-term infection process. Chronic infection may induce persistent inflammation of the tissue and secondarily, a cancerization process within a few years. Thus, the discovery of prostate calcifications by computerized tomodensitometry, for example, might warrant further investigation and management to search for chronic infection of the prostate gland.	[Dessombz, Arnaud; Bazin, Dominique] Univ Paris 11, CNRS, Phys Solides Lab, F-91405 Orsay, France; [Meria, Paul; Bazin, Dominique] Hop St Louis, AP HP, Serv Urol, Paris, France; [Bazin, Dominique] Univ Paris 06, CNRS, Coll France, Lab Chim Mat Condense Paris, Paris, France; [Daudon, Michel] Hop Tenon, AP HP, Serv Explorat Fonctionnelles, F-75970 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Dessombz, A (corresponding author), Univ Paris 11, CNRS, Phys Solides Lab, F-91405 Orsay, France.	arnaud.dessombz@u-psud.fr	Dessombz, Arnaud/B-7149-2016; , Bazin/C-6306-2014	Dessombz, Arnaud/0000-0002-6610-4879; , Bazin/0000-0002-5112-9061	physic and chemistry institutes of CNRS (Centre National de la Recherche Scientifique); Agence Nationale de la Recheche contract [ANR-09-BLAN-0120-02]	physic and chemistry institutes of CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recheche contract(French National Research Agency (ANR))	This work was supported by the physic and chemistry institutes of CNRS (Centre National de la Recherche Scientifique) and by an Agence Nationale de la Recheche contract (grant number: ANR-09-BLAN-0120-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the supporters have no commercial interests.	Alcaraz A, 2009, EUR UROL, V55, P864, DOI 10.1016/j.eururo.2008.11.011; Bazin D, 2012, CHEM REV, V112, P5092, DOI 10.1021/cr200068d; Bazin D, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/38/383001; Bazin D, 2012, UROLOGY, V79, P786, DOI 10.1016/j.urology.2011.08.054; Carpentier X, 2009, UROLOGY, V73, P968, DOI 10.1016/j.urology.2008.12.049; Daudon M, 2008, NEW ENGL J MED, V359, P100, DOI 10.1056/NEJMc0800990; Dessombz A, 2011, PROG UROL, V21, P940, DOI 10.1016/j.purol.2011.04.003; Dessombz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028007; Dorfmuller P, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/685926; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Estepa L, 1997, BIOSPECTROSCOPY, V3, P347, DOI 10.1002/(SICI)1520-6343(1997)3:5<347::AID-BSPY3>3.0.CO;2-#; Freeman-Cook L, 2005, STAPHYLOCOCCUS AUREU; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hsu THS, 2011, UROL RES, V39, P165, DOI 10.1007/s00240-010-0316-z; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; KATO H, 1987, J UROLOGY, V138, P154, DOI 10.1016/S0022-5347(17)43031-X; Kopans D, 2011, BREAST J, V17, P638, DOI 10.1111/j.1524-4741.2011.01152.x; Lagier R, 2003, PATHOL RES PRACT, V199, P329, DOI 10.1078/0344-0338-00425; Li C, 2003, J BIOMED MATER RES A, V64A, P197, DOI 10.1002/jbm.a.10320; Maurice-Estepa L, 1999, SCAND J UROL NEPHROL, V33, P299, DOI 10.1080/003655999750017365; MCLAUGHLIN JK, 1984, JNCI-J NATL CANCER I, V72, P275; Meares EM, 1974, LAB DIAGN CLIN MANAG, V4, P560; MENDELSOHN R, 1989, CALCIFIED TISSUE INT, V44, P20, DOI 10.1007/BF02556236; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Parker AS, 2004, AM J EPIDEMIOL, V159, P42, DOI 10.1093/aje/kwh014; Quy-Dao N, 1997, INFRARED RAMAN SPECT; REID JD, 1993, ATHEROSCLEROSIS, V101, P213, DOI 10.1016/0021-9150(93)90118-E; Sfanos KS, 2009, P NATL ACAD SCI USA, V106, P3443, DOI 10.1073/pnas.0810473106; SONDERGAARD G, 1987, ACTA PATH MICRO IM A, V95, P141; SUTOR DJ, 1974, BRIT J UROL, V46, P533, DOI 10.1111/j.1464-410X.1974.tb03852.x	32	58	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51691	10.1371/journal.pone.0051691	http://dx.doi.org/10.1371/journal.pone.0051691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272143	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600036
J	Pomeroy, E; Stock, JT; Stanojevic, S; Miranda, JJ; Cole, TJ; Wells, JCK				Pomeroy, Emma; Stock, Jay T.; Stanojevic, Sanja; Jaime Miranda, J.; Cole, Tim J.; Wells, Jonathan C. K.			Trade-Offs in Relative Limb Length among Peruvian Children: Extending the Thrifty Phenotype Hypothesis to Limb Proportions	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; GUANGZHOU-BIOBANK COHORT; CORONARY HEART-DISEASE; BODY-MASS INDEX; LEG LENGTH; HIGH-ALTITUDE; CHILDHOOD CONDITIONS; HYPOXIC ENVIRONMENT; GENETIC ADMIXTURE; ADOLESCENT GROWTH	Background and Methods: Both the concept of 'brain-sparing' growth and associations between relative lower limb length, childhood environment and adult disease risk are well established. Furthermore, tibia length is suggested to be particularly plastic under conditions of environmental stress. The mechanisms responsible are uncertain, but three hypotheses may be relevant. The 'thrifty phenotype' assumes that some components of growth are selectively sacrificed to preserve more critical outcomes, like the brain. The 'distal blood flow' hypothesis assumes that blood nutrients decline with distance from the heart, and hence may affect limbs in relation to basic body geometry. Temperature adaptation predicts a gradient of decreased size along the limbs reflecting decreasing tissue temperature/blood flow. We examined these questions by comparing the size of body segments among Peruvian children born and raised in differentially stressful environments. In a cross-sectional sample of children aged 6 months to 14 years (n = 447) we measured head circumference, head-trunk height, total upper and lower limb lengths, and zeugopod (ulna and tibia) and autopod (hand and foot) lengths. Results: Highland children (exposed to greater stress) had significantly shorter limbs and zeugopod and autopod elements than lowland children, while differences in head-trunk height were smaller. Zeugopod elements appeared most sensitive to environmental conditions, as they were relatively shorter among highland children than their respective autopod elements. Discussion: The results suggest that functional traits (hand, foot, and head) may be partially protected at the expense of the tibia and ulna. The results do not fit the predictions of the distal blood flow and temperature adaptation models as explanations for relative limb segment growth under stress conditions. Rather, our data support the extension of the thrifty phenotype hypothesis to limb growth, and suggest that certain elements of limb growth may be sacrificed under tough conditions to buffer more functional traits.	[Pomeroy, Emma; Stock, Jay T.] Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge, England; [Stanojevic, Sanja] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru; [Cole, Tim J.; Wells, Jonathan C. K.] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of Cambridge; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of London; University College London	Pomeroy, E (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge, England.	emma.pomeroy@cantab.net	Stanojevic, Sanja/A-4243-2010; Cole, Tim J/B-7883-2008; Wells, Jonathan/A-4604-2009; Stock, Jay T/B-6453-2011	Cole, Tim J/0000-0001-5711-8200; Wells, Jonathan/0000-0003-0411-8025; Stock, Jay T/0000-0003-0147-8631; Stanojevic, Sanja/0000-0001-7931-8051; Miranda, J. Jaime/0000-0002-4738-5468; Pomeroy, Emma/0000-0001-6251-2165	Arts and Humanities Research Council (UK); University of Cambridge Centre for Latin American Studies Abbey-Santander Travel Grants; National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; Medical Research Council [G0700961]; MRC [G0700961, MR/J004839/1] Funding Source: UKRI; Medical Research Council [MR/J004839/1] Funding Source: researchfish	Arts and Humanities Research Council (UK)(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); University of Cambridge Centre for Latin American Studies Abbey-Santander Travel Grants; National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EP received Ph.D. funding from the Arts and Humanities Research Council (UK), and fieldwork grants from the University of Cambridge Centre for Latin American Studies Abbey-Santander Travel Grants. JJM is with the CRONICAS Center of Excellence in Chronic Diseases at the Universidad Peruana Cayetano Heredia which is funded by the National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract number HHSN268200900033C. TJC is funded by Medical Research Council grant G0700961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1877, RADICAL REV, V1, P108, DOI DOI 10.1038/SCIENTIFICAMERICAN05251907-26247SUPP; Antonow-Schlorke I, 2011, P NATL ACAD SCI USA, V108, P3011, DOI 10.1073/pnas.1009838108; Auerbach BM, 2011, AM J PHYS ANTHROPOL, V144, P382, DOI 10.1002/ajpa.21418; Bailey SM, 2007, AM J HUM BIOL, V19, P662, DOI 10.1002/ajhb.20667; Baker J, 2010, AM J HUM BIOL, V22, P206, DOI 10.1002/ajhb.20979; Barbiro-Michaely E, 2007, MED SCI MONITOR, V13, pBR211; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barker DJP, 1998, MOTHERS BABIES DIS L; Bergmann C, 1847, GOTTINGER STUDIEN, V1, P595; Bigham AW, 2008, HIGH ALT MED BIOL, V9, P167, DOI 10.1089/ham.2007.1066; Bogin B, 2003, COMP BIOCHEM PHYS A, V136, P71, DOI 10.1016/S1095-6433(02)00294-5; Bogin B, 2001, PERSPECTIVES IN HUMAN GROWTH, DEVELOPMENT AND MATURATION, P205; Bogin B, 2008, INT J EPIDEMIOL, V37, P201, DOI 10.1093/ije/dym254; Bogin B, 2010, INT J ENV RES PUB HE, V7, P1047, DOI 10.3390/ijerph7031047; BROOKE OG, 1984, EARLY HUM DEV, V10, P85, DOI 10.1016/0378-3782(84)90114-2; Brutsaert TD, 2005, AM J PHYSIOL-REG I, V289, pR225, DOI 10.1152/ajpregu.00105.2005; Brutsaert TD, 2004, AM J PHYS ANTHROPOL, V123, P390, DOI 10.1002/ajpa.10319; Brutsaert TD, 2003, J APPL PHYSIOL, V95, P519, DOI 10.1152/japplphysiol.01088.2002; Burrage DM, 2009, J PHYSIOL-LONDON, V587, P611, DOI 10.1113/jphysiol.2008.165944; Cameron N, 2004, METHODS HUMAN GROWTH, P68; Cole, 2010, LMSCHARTMAKER PROGRA; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Coly AN, 2006, J NUTR, V136, P2412, DOI 10.1093/jn/136.9.2412; Eveleth PB, 1990, WORLDWIDE VARIATION; Feldesman MR, 1996, AM J PHYS ANTHROPOL, V100, P207; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Fok TF, 2006, BIOL NEONATE, V89, P25, DOI 10.1159/000088195; FREYRE EA, 1988, J ADOLESCENT HEALTH, V9, P144, DOI 10.1016/0197-0070(88)90061-7; Frisancho A. R, 2008, ANTHROPOMETRIC STAND; Frisancho AR, 2007, AM J HUM BIOL, V19, P703, DOI 10.1002/ajhb.20676; Frisancho AR, 1976, MAN ANDES MULTIDISCI, P180; Giussani DA, 2005, PEDIATR RES, V58, P179, DOI 10.1203/01.PDR.0000169999.66157.C0; Giussani DA, 2011, P NATL ACAD SCI USA, V108, P2641, DOI 10.1073/pnas.1019726108; Goldbourt U, 2002, STROKE, V33, P743, DOI 10.1161/hs0302.103814; Greksa LP, 2006, HIGH ALT MED BIOL, V7, P116, DOI 10.1089/ham.2006.7.116; Gunnell D, 2003, J EPIDEMIOL COMMUN H, V57, P141, DOI 10.1136/jech.57.2.141; Gunnell DJ, 1998, PAEDIATR PERINAT EP, V12, P96, DOI 10.1046/j.1365-3016.1998.0120s1096.x; HAAS JD, 1977, HUM BIOL, V49, P611; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Holliday TW, 2001, AM J PHYS ANTHROPOL, V116, P26, DOI 10.1002/ajpa.1098; [INEI ICF Macro/MEASURE DHS], 2010, PER ENC DEM SAL FAM; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Jantz LM, 1999, AM J PHYS ANTHROPOL, V110, P57, DOI 10.1002/(SICI)1096-8644(199909)110:1<57::AID-AJPA5>3.0.CO;2-1; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Kinra S, 2011, INT J EPIDEMIOL, V40, P1022, DOI 10.1093/ije/dyr074; Krampl E, 2000, ULTRASOUND OBST GYN, V16, P9, DOI 10.1046/j.1469-0705.2000.00156.x; Lampl M, 2005, AM J HUM BIOL, V17, P66, DOI 10.1002/ajhb.20094; Lampl M, 2003, AM J HUM BIOL, V15, P667, DOI 10.1002/ajhb.10204; Lampl M, 2003, A J HUM BIOL, V15; Lausent-Herrera I, 2009, J CHIN OVERSEAS, V5, P115, DOI 10.1163/179325409X434522; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1080, DOI 10.1080/00016340600697447; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; MARTORELL R, 1988, HUM BIOL, V60, P205; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McClung J., 1969, EFFECTS HIGH ALTITUD; Miranda JJ, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-23; Miranda JJ, 2009, THESIS LONDON SCH HY; MUELLER WH, 1980, HUM BIOL, V52, P529; MUELLER WH, 1978, ANN HUM BIOL, V5, P329, DOI 10.1080/03014467800002981; Mulder ALM, 1998, J PHYSIOL-LONDON, V508, P281, DOI 10.1111/j.1469-7793.1998.281br.x; Niermeyer S, 2009, ARCH DIS CHILD, V94, P806, DOI 10.1136/adc.2008.141838; Palomino H, 1978, AM J PHYS ANTHROPOL, V50, P39; POWERS WF, 1977, ACTA PAEDIATR SCAND, V66, P205, DOI 10.1111/j.1651-2227.1977.tb07834.x; Rivera-Ch Maria, 2008, International Journal of Environment and Health, V2, P92, DOI 10.1504/IJENVH.2008.018675; Roberts D. F., 1978, CLIMATE HUMAN VARIAB; Rolian C, 2008, EVOL DEV, V10, P15, DOI 10.1111/j.1525-142X.2008.00211.x; Rolian C, 2009, EVOL BIOL, V36, P100, DOI 10.1007/s11692-009-9049-8; Samaras TT, 2007, HUMAN BODY SIZE LAWS; Sanchez E, 2010, ARTHRITIS RHEUM-US, V62, P3722, DOI 10.1002/art.27753; Sanna E, 2000, AM J HUM BIOL, V12, P782, DOI 10.1002/1520-6300(200011/12)12:6<782::AID-AJHB6>3.0.CO;2-L; Santos JL, 2001, NUTRITION, V17, P305, DOI 10.1016/S0899-9007(00)00551-7; SATYANARAYANA K, 1989, ANN HUM BIOL, V16, P289, DOI 10.1080/03014468900000422; Schooling CM, 2008, J EPIDEMIOL COMMUN H, V62, P607, DOI 10.1136/jech.2007.065003; Schooling CM, 2008, J EPIDEMIOL COMMUN H, V62, P160, DOI 10.1136/jech.2006.058917; Schooling CM, 2007, AM J PUBLIC HEALTH, V97, P1834, DOI 10.2105/AJPH.2006.088096; Serrat MA, 2007, THESIS KENT STATE U; Serrat MA, 2008, P NATL ACAD SCI USA, V105, P19348, DOI 10.1073/pnas.0803319105; Stanojevic S, 2009, AM J RESP CRIT CARE, V180, P547, DOI 10.1164/rccm.200903-0323OC; STECKEL RH, 1987, ANN HUM BIOL, V14, P111, DOI 10.1080/03014468700006852; Stinson S, 2009, AM J HUM BIOL, V21, P606, DOI 10.1002/ajhb.20918; Stockard CR, 1921, AM J ANAT, V28, P115, DOI 10.1002/aja.1000280202; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; TANNER JM, 1982, ANN HUM BIOL, V9, P411, DOI 10.1080/03014468200005951; Tanner JM, 1969, HUMAN BIOL GUIDE FIE; Udjus LG, 1964, ANTHROPOMETRICAL CHA; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Webb E, 2008, J EPIDEMIOL COMMUN H, V62, P351, DOI 10.1136/jech.2006.056457; Wells JCK, 2007, YEARB PHYS ANTHROPOL, V50, P191, DOI 10.1002/ajpa.20735; Wells JCK, 2012, AM J HUM BIOL, V24, P261, DOI 10.1002/ajhb.22253; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; Whitley E, 2010, J EPIDEMIOL COMMUNIT, V24, P24; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Williams SJ, 2005, AM J PHYSIOL-REG I, V288, pR360, DOI 10.1152/ajpregu.00178.2004; World Medical Association, 2008, WMA DECL HELS ETH PR; Young NM, 2005, EVOLUTION, V59, P2691; Zamudio S, 2007, AM J PATHOL, V170, P2171, DOI 10.2353/ajpath.2007.061185	99	78	80	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51795	10.1371/journal.pone.0051795	http://dx.doi.org/10.1371/journal.pone.0051795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272169	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386600040
J	Haeseker, MB; Dukers-Muijrers, NHTM; Hoebe, CJPA; Bruggeman, CA; Cals, JWL; Verbon, A				Haeseker, Michiel B.; Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.; Bruggeman, Cathrien A.; Cals, Jochen W. L.; Verbon, Annelies			Trends in Antibiotic Prescribing in Adults in Dutch General Practice	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; ANTIMICROBIAL CONSUMPTION ESAC; INAPPROPRIATE MEDICATION USE; PRIMARY-CARE; EUROPEAN SURVEILLANCE; UNITED-STATES; OLDER-ADULTS; INFECTIONS; EVENTS; POPULATION	Background: Antibiotic consumption is associated with adverse drug events (ADE) and increasing antibiotic resistance. Detailed information of antibiotic prescribing in different age categories is scarce, but necessary to develop strategies for prudent antibiotic use. The aim of this study was to determine the antibiotic prescriptions of different antibiotic classes in general practice in relation to age. Methodology: Retrospective study of 22 rural and urban general practices from the Dutch Registration Network Family Practices (RNH). Antibiotic prescribing data were extracted from the RNH database from 2000-2009. Trends over time in antibiotic prescriptions were assessed with multivariate logistic regression including interaction terms with age. Registered ADEs as a result of antibiotic prescriptions were also analyzed. Principal Findings: In total 658,940 patients years were analyzed. In 11.5% (n = 75,796) of the patient years at least one antibiotic was prescribed. Antibiotic prescriptions increased for all age categories during 2000-2009, but the increase in elderly patients (>80 years) was most prominent. In 2000 9% of the patients >80 years was prescribed at least one antibiotic to 22% in 2009 (P<0.001). Elderly patients had more ADEs with antibiotics and co-medication was identified as the only independent determinant for ADEs. Conclusion/Discussion: The rate of antibiotic prescribing for patients who made a visit to the GP is increasing in the Netherlands with the most evident increase in the elderly patients. This may lead to more ADEs, which might lead to higher consumption of health care and more antibiotic resistance.	[Haeseker, Michiel B.; Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.; Bruggeman, Cathrien A.; Verbon, Annelies] Maastricht Univ, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands; [Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.] Publ Hlth Serv S Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Cals, Jochen W. L.] Maastricht Univ, Dept Gen Practice, Maastricht, Netherlands; [Haeseker, Michiel B.; Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.; Bruggeman, Cathrien A.; Cals, Jochen W. L.] Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands; [Verbon, Annelies] Erasmus MC, Dept Internal Med Sect, Rotterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Haeseker, MB (corresponding author), Maastricht Univ, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands.	m.haeseker@mumc.nl	Cals, Jochen WL/A-1262-2007; Dukers-Muijrers, Nicole/M-7178-2014	Cals, Jochen WL/0000-0001-9550-5674; Hoebe, Christian/0000-0003-1815-0974; Dukers-Muijrers, Nicole/0000-0003-4896-758X				Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; BEARD K, 1992, DRUG AGING, V2, P356, DOI 10.2165/00002512-199202040-00008; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Cosby JL, 2007, LANCET INFECT DIS, V7, P749, DOI 10.1016/S1473-3099(07)70263-3; Eurostat, 2010, POP PROJ 2010 2060; Faulkner CM, 2005, CLIN INFECT DIS, V40, P997, DOI 10.1086/428125; Feldman C, 2001, MED CLIN N AM, V85, P1441, DOI 10.1016/S0025-7125(05)70390-4; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Finkelstein JA, 2000, ARCH PEDIAT ADOL MED, V154, P395, DOI 10.1001/archpedi.154.4.395; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Goossens H, 2007, CLIN INFECT DIS, V44, P1091, DOI 10.1086/512810; Gulliford M, 2009, J PUBLIC HEALTH-UK, V31, P512, DOI 10.1093/pubmed/fdp081; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; Herring AR, 2007, CLIN GERIATR MED, V23, P481, DOI 10.1016/j.cger.2007.03.009; HofmansOkkes IM, 1996, FAM PRACT, V13, P294, DOI 10.1093/fampra/13.3.294; HUTCHINSON TA, 1986, J CHRON DIS, V39, P533, DOI 10.1016/0021-9681(86)90198-0; KNOTTNERUS JA, 1992, FAM PRACT, V9, P15, DOI 10.1093/fampra/9.1.15; Kuyvenhoven MM, 2003, J ANTIMICROB CHEMOTH, V52, P675, DOI 10.1093/jac/dkg412; Laroche ML, 2007, BRIT J CLIN PHARMACO, V63, P177, DOI 10.1111/j.1365-2125.2006.02831.x; Laube S, 2004, AGEING RES REV, V3, P69, DOI 10.1016/j.arr.2003.08.003; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Linder JA, 2005, AM J MED, V118, P259, DOI 10.1016/j.amjmed.2004.09.015; Majeed A, 1999, BRIT J GEN PRACT, V49, P735; Metsemakers JFM, 1996, INT J BIOMED COMPUT, V42, P43, DOI 10.1016/0020-7101(96)01180-4; Norris P, 2011, J ANTIMICROB CHEMOTH, V66, P1921, DOI 10.1093/jac/dkr194; O'Mahony D, 2008, AGE AGEING, V37, P138, DOI 10.1093/ageing/Afm189; Otters HBM, 2004, J ANTIMICROB CHEMOTH, V53, P361, DOI 10.1093/jac/dkh062; Pan A, 2011, CLIN MICROBIOL INFEC, V17, P1698, DOI 10.1111/j.1469-0691.2011.03500.x; Richards Chesley L., 2004, International Urology and Nephrology, V36, P457, DOI 10.1007/s11255-004-4870-6; SFK, 2010, ANT GROEIT GEST; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; VANDENAKKER M, 2004, GEN PRACTICE GOLD MI	32	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51860	10.1371/journal.pone.0051860	http://dx.doi.org/10.1371/journal.pone.0051860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251643	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200170
J	Kuribayashi-Shigetomi, K; Onoe, H; Takeuchi, S				Kuribayashi-Shigetomi, Kaori; Onoe, Hiroaki; Takeuchi, Shoji			Cell Origami: Self-Folding of Three-Dimensional Cell-Laden Microstructures Driven by Cell Traction Force	PLOS ONE			English	Article							ENCAPSULATION; FABRICATION; DNA	This paper describes a method of generating three-dimensional (3D) cell-laden microstructures by applying the principle of origami folding technique and cell traction force (CTF). We harness the CTF as a biological driving force to fold the microstructures. Cells stretch and adhere across multiple microplates. Upon detaching the microplates from a substrate, CTF causes the plates to lift and fold according to a prescribed pattern. This self-folding technique using cells is highly biocompatible and does not involve special material requirements for the microplates and hinges to induce folding. We successfully produced various 3D cell-laden microstructures by just changing the geometry of the patterned 2D plates. We also achieved mass-production of the 3D cell-laden microstructures without causing damage to the cells. We believe that our methods will be useful for biotechnology applications that require analysis of cells in 3D configurations and for self-assembly of cell-based micro-medical devices.	[Kuribayashi-Shigetomi, Kaori; Onoe, Hiroaki; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Onoe, Hiroaki; Takeuchi, Shoji] Japan Sci & Technol Agcy JST, Takeuchi Biohybrid Innovat Project, Exploratory Res Adv Technol ERATO, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Takeuchi, S (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	takeuchi@iis.u-tokyo.ac.jp	Onoe, Hiroaki/A-3724-2012; Takeuchi, Shoji/J-5349-2019	Takeuchi, Shoji/0000-0001-6946-0409	Takeuchi Biohybrid Innovation Project; Exploratory Research for Advanced Technology (ERATO); Japan Science and Technology (JST), Japan; Ministry of Education, Culture, Sports. Science and Technology (MEXT), Japan [23106005]	Takeuchi Biohybrid Innovation Project; Exploratory Research for Advanced Technology (ERATO)(Japan Science & Technology Agency (JST)); Japan Science and Technology (JST), Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports. Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST), Japan, and Grant-in-Aid for Scientific Research on Innovative Areas "Bio Assembler" (23106005) from the Ministry of Education, Culture, Sports. Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BY, 2010, ADV MATER, V22, P2251, DOI 10.1002/adma.200904232; Azam A, 2011, BIOMED MICRODEVICES, V13, P51, DOI 10.1007/s10544-010-9470-x; Bassik N, 2008, ADV MATER, V20, P4760, DOI 10.1002/adma.200801759; Brittain ST, 2001, J PHYS CHEM B, V105, P347, DOI 10.1021/jp002556e; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Gimi B, 2005, BIOMED MICRODEVICES, V7, P341, DOI 10.1007/s10544-005-6076-9; Green PW, 1995, J MICROELECTROMECH S, V4, P170, DOI 10.1109/84.475543; Guest SD, 1996, J APPL MECH-T ASME, V63, P77, DOI 10.1115/1.2787212; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Ionov L, 2011, SOFT MATTER, V7, P6786, DOI 10.1039/c1sm05476g; Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7; Iwase E, 2006, SENSOR ACTUAT A-PHYS, V127, P310, DOI 10.1016/j.sna.2006.01.025; Jager EWH, 2000, SCIENCE, V290, P1540, DOI 10.1126/science.290.5496.1540; Jamal M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1531; Jamal M, 2010, BIOMATERIALS, V31, P1683, DOI 10.1016/j.biomaterials.2009.11.056; Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64; Kuribayashi K, 2006, MAT SCI ENG A-STRUCT, V419, P131, DOI 10.1016/j.msea.2005.12.016; Leong TG, 2008, LAB CHIP, V8, P1621, DOI 10.1039/b809098j; Leong TG, 2010, SMALL, V6, P792, DOI 10.1002/smll.200901704; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Merali Z, 2011, SCIENCE, V332, P1376, DOI 10.1126/science.332.6036.1376; Miura K., 1993, INT J SPACE STRUCT, V8, P3, DOI 10.1177/0266351193008001-202; Nagayama K, 2011, CELL MOL BIOENG, V4, P348, DOI 10.1007/s12195-011-0166-y; Ohashi Toshiro, 2010, Journal of Biomechanical Science and Engineering, V5, P262, DOI 10.1299/jbse.5.262; Randall CL, 2012, TRENDS BIOTECHNOL, V30, P138, DOI 10.1016/j.tibtech.2011.06.013; Randall CL, 2011, NANOMED-NANOTECHNOL, V7, P686, DOI 10.1016/j.nano.2011.08.020; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Stewart I, 2007, NATURE, V448, P419, DOI 10.1038/448419a; SUZUKI K, 1994, J MICROELECTROMECH S, V3, P4, DOI 10.1109/84.285718; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Taylor R, 2009, ENDOVASULAR TODAY, VI, P27; Zakharchenko S, 2010, SOFT MATTER, V6, P2633, DOI 10.1039/c0sm00088d	32	146	151	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51085	10.1371/journal.pone.0051085	http://dx.doi.org/10.1371/journal.pone.0051085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251426	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200057
J	Parnmen, S; Cking, RL; Lumbsch, HT				Parnmen, Sittiporn; Cking, Robert Lu; Lumbsch, H. Thorsten			Phylogenetic Classification at Generic Level in the Absence of Distinct Phylogenetic Patterns of Phenotypical Variation: A Case Study in Graphidaceae (Ascomycota)	PLOS ONE			English	Article							RIBOSOMAL DNA; MOLECULAR PHYLOGENY; SPECIES-DIVERSITY; MORPHOLOGY; EVOLUTION; TREE; PSEUDOMURIELLA; CHLOROPHYCEAE; BRACTEACOCCUS; DICTYOCOCCUS	Molecular phylogenies often reveal that taxa circumscribed by phenotypical characters are not monophyletic. While re-examination of phenotypical characters often identifies the presence of characters characterizing clades, there is a growing number of studies that fail to identify diagnostic characters, especially in organismal groups lacking complex morphologies. Taxonomists then can either merge the groups or split taxa into smaller entities. Due to the nature of binomial nomenclature, this decision is of special importance at the generic level. Here we propose a new approach to choose among classification alternatives using a combination of morphology-based phylogenetic binning and a multiresponse permutation procedure to test for morphological differences among clades. We illustrate the use of this method in the tribe Thelotremateae focusing on the genus Chapsa, a group of lichenized fungi in which our phylogenetic estimate is in conflict with traditional classification and the morphological and chemical characters do not show a clear phylogenetic pattern. We generated 75 new DNA sequences of mitochondrial SSU rDNA, nuclear LSU rDNA and the protein-coding RPB2. This data set was used to infer phylogenetic estimates using maximum likelihood and Bayesian approaches. The genus Chapsa was found to be polyphyletic, forming four well-supported clades, three of which clustering into one unsupported clade, and the other, supported clade forming two supported subclades. While these clades cannot be readily separated morphologically, the combined binning/multiresponse permutation procedure showed that accepting the four clades as different genera each reflects the phenotypical pattern significantly better than accepting two genera (or five genera if splitting the first clade). Another species within the Thelotremateae, Thelotrema petractoides, a unique taxon with carbonized excipulum resembling Schizotrema, was shown to fall outside Thelotrema. Consequently, the new genera Astrochapsa, Crutarndina, Pseudochapsa, and Pseudotopeliopsis are described here and 39 new combinations are proposed.	[Parnmen, Sittiporn; Cking, Robert Lu; Lumbsch, H. Thorsten] Field Museum, Dept Bot, Chicago, IL USA	Field Museum of Natural History (Chicago)	Lumbsch, HT (corresponding author), Field Museum, Dept Bot, Chicago, IL USA.	tlumbsch@fieldmuseum.org	Parnmen, Sittiporn/B-9203-2014	Lucking, Robert/0000-0002-3431-4636; Parnmen, Sittiporn/0000-0002-0116-9436	National Science Foundation (NSF) [DEB-1025861, 1025861]; NSF [DEB-1025861, DEB-0206125, DEB-0516116, DEB-0715660]; Direct For Biological Sciences [1025861] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding provided by National Science Foundation (NSF), DEB-1025861 to The Field Museum; PI HTL, CoPI RL, "ATM - Assembling a taxonomic monograph: The lichen family Graphidaceae". Website: http://www.nsf.gov/awardsearch/showAward.do?AwardNumber = 1025861. Collection of material and sequencing work for this study was supported by four NSF grants: TICOLICHEN (DEB-0206125 to The Field Museum; PI RL), Phylogeny and Taxonomy of Ostropalean Fungi, with Emphasis on the Lichen-forming Thelotremataceae (DEB-0516116 to The Field Museum; PI HTL; Co-PI RL), Neotropical Epiphytic Microlichens - An Innovative Inventory of a Highly Diverse yet Little Known Group of Symbiotic Organisms (DEB-0715660 to The Field Museum; PI RL), and ATM - Assembling a taxonomic monograph: The lichen family Graphidaceae (DEB-1025861 to The Field Museum; PI HTL, CoPI RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos C. J., 1996; [Anonymous], 1963, ANIMAL SPECIES EVOLU; ARUP U, 1993, LICHENOLOGIST, V25, P61; Barton N. H., 2007, EVOLUTION; Berger SA, 2011, TAXON, V60, P1450, DOI 10.1002/tax.605020; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blanco O, 2004, TAXON, V53, P959, DOI 10.2307/4135563; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Drummond A., 2011, GENEIOUS V5 5; Ertz D, 2008, AM J BOT, V95, P1548, DOI 10.3732/ajb.0800232; Frisch Andreas, 2006, V92, P3; Fucikova K, 2011, J PHYCOL, V47, pS39; Fucikova K, 2011, PHYCOLOGIA, V50, P422, DOI 10.2216/10-69.1; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hibbett DS, 2007, MYCOL RES, V111, P1001, DOI 10.1016/j.mycres.2007.01.012; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Hodkinson BP, 2012, MYCOL PROG, V11, P827, DOI 10.1007/s11557-011-0800-z; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jahns HM, 1994, NATO ADV SCI I SERIE, P57; Kirk P. M., 2009, AINSWORTH BISBYS DIC, V10th; Lee MSY, 2001, MOL BIOL EVOL, V18, P676, DOI 10.1093/oxfordjournals.molbev.a003848; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lumbsch HT, 2007, MYCOL RES, V111, P1064, DOI 10.1016/j.mycres.2007.04.004; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch H. Thorsten, 2010, Fieldiana-Life and Earth Sciences, V1, P1, DOI 10.3158/1557.1; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Mangold A, 2008, TAXON, V57, P476, DOI 10.2307/25066016; McCune B, 2002, ANAL ECOLOGICAL COMM; McCune B., 2011, PC ORD MULTIVARIATE; McLaughlin DJ, 2009, TRENDS MICROBIOL, V17, P488, DOI 10.1016/j.tim.2009.08.001; Mielke P. W., 2001, PERMUTATION METHODS; Moore J, 1997, BIOL REV, V72, P1, DOI 10.1017/S0006323196004926; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Orange A., 2001, MICROCHEMICAL METHOD; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Papong K, 2009, FUNGAL DIVERS, V38, P147; Plata ER, 2012, FUNGAL DIVERS, V52, P107, DOI 10.1007/s13225-011-0135-8; Plata ER, 2011, MOL PHYLOGENET EVOL, V61, P45, DOI 10.1016/j.ympev.2011.04.025; Plata ER, 2010, LICHENOLOGIST, V42, P139, DOI 10.1017/S0024282909990491; Rivas Plata E., 2011, HIST BIOGEOGRAPHY EC; Rivas Plata E, 2012, MYCOKEYS IN PRESS; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seifert B, 2009, MYRMECOL NEWS, V12, P149; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stearns S.C., 2005, EVOLUTION INTRO; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; THOMAS RH, 1993, MOL BIOL EVOL, V10, P362; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Van Sickle John, 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P370; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vilnet AA, 2007, RUSS J GENET+, V43, P1306, DOI 10.1134/S1022795407110142; Wang HY, 2010, SCI CHINA LIFE SCI, V53, P1163, DOI 10.1007/s11427-010-4063-8; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Wiens JJ, 2000, SYST BIOL, V49, P69; Zalar P, 2005, ANTON LEEUW INT J G, V87, P311, DOI 10.1007/s10482-004-6783-x; Zoller S, 1999, LICHENOLOGIST, V31, P511; [No title captured]	63	33	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51392	10.1371/journal.pone.0051392	http://dx.doi.org/10.1371/journal.pone.0051392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251515	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200100
J	Amezquita-Lopez, BA; Quinones, B; Cooley, MB; Leon-Felix, J; Castro-del Campo, N; Mandrell, RE; Jimenez, M; Chaidez, C				Amezquita-Lopez, Bianca A.; Quinones, Beatriz; Cooley, Michael B.; Leon-Felix, Josefina; Castro-del Campo, Nohelia; Mandrell, Robert E.; Jimenez, Maribel; Chaidez, Cristobal			Genotypic Analyses of Shiga Toxin-Producing Escherichia coli O157 and Non-O157 Recovered from Feces of Domestic Animals on Rural Farms in Mexico	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; VARIABLE-NUMBER; IMMUNOMAGNETIC SEPARATION; VIRULENCE GENES; SHEEP; SEROTYPES; CATTLE; PREVALENCE; SLAUGHTER; STRAINS	Shiga toxin-producing Escherichia coli (STEC) are zoonotic enteric pathogens associated with human gastroenteritis worldwide. Cattle and small ruminants are important animal reservoirs of STEC. The present study investigated animal reservoirs for STEC in small rural farms in the Culiacan Valley, an important agricultural region located in Northwest Mexico. A total of 240 fecal samples from domestic animals were collected from five sampling sites in the Culiacan Valley and were subjected to an enrichment protocol followed by either direct plating or immunomagnetic separation before plating on selective media. Serotype O157:H7 isolates with the virulence genes stx2, eae, and ehxA were identified in 40% (26/65) of the recovered isolates from cattle, sheep and chicken feces. Pulse-field gel electrophoresis (PFGE) analysis grouped most O157: H7 isolates into two clusters with 98.6% homology. The use of multiple-locus variable-number tandem repeat analysis (MLVA) differentiated isolates that were indistinguishable by PFGE. Analysis of the allelic diversity of MLVA loci suggested that the O157: H7 isolates from this region were highly related. In contrast to O157: H7 isolates, a greater genotypic diversity was observed in the non-O157 isolates, resulting in 23 PFGE types and 14 MLVA types. The relevant non-O157 serotypes O8:H19, O75:H8, O111:H8 and O146:H21 represented 35.4% (23/65) of the recovered isolates. In particular, 18.5% (12/65) of all the isolates were serotype O75: H8, which was the most variable serotype by both PFGE and MLVA. The non-O157 isolates were predominantly recovered from sheep and were identified to harbor either one or two stx genes. Most non-O157 isolates were ehxA-positive (86.5%, 32/37) but only 10.8% (4/37) harbored eae. These findings indicate that zoonotic STEC with genotypes associated with human illness are present in animals on small farms within rural communities in the Culiacan Valley and emphasize the need for the development of control measures to decrease risks associated with zoonotic STEC.	[Amezquita-Lopez, Bianca A.; Leon-Felix, Josefina; Castro-del Campo, Nohelia; Chaidez, Cristobal] Ctr Invest Alimentac & Desarrollo, Culiacan, Sinaloa, Mexico; [Quinones, Beatriz; Cooley, Michael B.; Mandrell, Robert E.] ARS, USDA, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, Albany, CA USA; [Jimenez, Maribel] Univ Autonoma Sinaloa, Fac Ciencias Quim Biol, Culiacan, Sinaloa, Mexico	CIAD - Centro de Investigacion en Alimentacion y Desarrollo; United States Department of Agriculture (USDA); Universidad Autonoma de Sinaloa	Quinones, B (corresponding author), Ctr Invest Alimentac & Desarrollo, Culiacan, Sinaloa, Mexico.	Beatriz.Quinones@ars.usda.gov; chaqui@ciad.edu.mx	Mandrell, Robert E/O-9814-2018; Félix, Josefina León/U-5369-2019	Félix, Josefina León/0000-0003-3755-881X; Quinones, Beatriz/0000-0001-5010-9889; Jimenez-Edeza, Maribel/0000-0002-9835-9665; Castro-del Campo, Nohelia/0000-0002-0738-492X	U.S. Department of Agriculture, Agricultural Research Service CRIS project [5325-42000-047]; The National Council of Science and Technology in Mexico (CONACyT) [234885]	U.S. Department of Agriculture, Agricultural Research Service CRIS project; The National Council of Science and Technology in Mexico (CONACyT)	This work was supported by the U.S. Department of Agriculture, Agricultural Research Service CRIS project number 5325-42000-047 and by a Postgraduate Studies Scholarship from The National Council of Science and Technology in Mexico (CONACyT grant #234885) to BAAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktan I, 2004, VET MICROBIOL, V102, P43, DOI 10.1016/j.vetmic.2004.04.013; Bettelheim KA, 2007, CRIT REV MICROBIOL, V33, P67, DOI 10.1080/10408410601172172; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; Blanco M, 2003, J CLIN MICROBIOL, V41, P1351, DOI 10.1128/JCM.41.4.1351-1356.2003; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Bolton DJ, 2011, FOODBORNE PATHOG DIS, V8, P357, DOI 10.1089/fpd.2010.0699; Brett KN, 2003, J CLIN MICROBIOL, V41, P926, DOI 10.1128/JCM.41.3.926-936.2003; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Bugarel M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/j.ijfoodmicro.2010.07.010; Bustamante AV, 2010, INT J MED MICROBIOL, V300, P212, DOI 10.1016/j.ijmm.2009.08.020; Callaway TR, 2004, J FOOD PROTECT, V67, P2274, DOI 10.4315/0362-028X-67.10.2274; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Chapman PA, 1997, EPIDEMIOL INFECT, V119, P245, DOI 10.1017/S0950268897007826; CHAPMAN PA, 1994, J MED MICROBIOL, V40, P424, DOI 10.1099/00222615-40-6-424; Cookson AL, 2006, NEW ZEAL VET J, V54, P78, DOI 10.1080/00480169.2006.36616; Cookson AL, 2007, APPL ENVIRON MICROB, V73, P6360, DOI 10.1128/AEM.00316-07; Cookson AL, 2002, J MED MICROBIOL, V51, P1041, DOI 10.1099/0022-1317-51-12-1041; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Coombes BK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00090; Djordjevic SP, 2004, APPL ENVIRON MICROB, V70, P3910, DOI 10.1128/AEM.70.7.3910-3917.2004; Djordjevic SP, 2001, J CLIN MICROBIOL, V39, P2017, DOI 10.1128/JCM.39.5.2017-2021.2001; Doane CA, 2007, J FOOD PROTECT, V70, P6, DOI 10.4315/0362-028X-70.1.6; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576; Fegan N, 1999, LETT APPL MICROBIOL, V28, P335, DOI 10.1046/j.1365-2672.1999.00556.x; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Franci T, 2011, FOODBORNE PATHOG DIS, V8, P1019, DOI 10.1089/fpd.2010.0814; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Fratamico PM, 2011, FOODBORNE PATHOG DIS, V8, P601, DOI 10.1089/fpd.2010.0773; Gallegos M., 2009, Revista Cientifica, Facultad de Ciencias Veterinarias, Universidad del Zulia, V19, P139; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Heuvelink AE, 1998, J CLIN MICROBIOL, V36, P878, DOI 10.1128/JCM.36.4.878-882.1998; Hornitzky MA, 2002, APPL ENVIRON MICROB, V68, P6439, DOI 10.1128/AEM.68.12.6439-6445.2002; Hornitzky MA, 2001, FEMS MICROBIOL LETT, V198, P17, DOI 10.1111/j.1574-6968.2001.tb10613.x; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Hussein HS, 2008, FOODBORNE PATHOG DIS, V5, P227, DOI 10.1089/fpd.2008.0081; Hyytia-Trees E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/fpd.2006.3.118; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Jimenez M, 2011, MICROB ECOL, V61, P811, DOI 10.1007/s00248-010-9792-5; Kalchayanand N, 2007, J FOOD PROTECT, V70, P1811, DOI 10.4315/0362-028X-70.8.1811; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Karmali MA, 2009, KIDNEY INT, V75, pS4, DOI 10.1038/ki.2008.608; Keys C, 2005, J APPL MICROBIOL, V98, P928, DOI 10.1111/j.1365-2672.2004.02532.x; La Ragione RM, 2009, FEMS MICROBIOL REV, V33, P394, DOI 10.1111/j.1574-6976.2008.00138.x; Lindstedt BA, 2004, J MICROBIOL METH, V58, P213, DOI 10.1016/j.mimet.2004.03.016; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lindstedt Bjorn-Arne, 2003, Ann Clin Microbiol Antimicrob, V2, P12, DOI 10.1186/1476-0711-2-12; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Lopez-Saucedo C, 2010, CLIN INFECT DIS, V50, P450, DOI 10.1086/649888; Mandrell RE, 2010, WOODHEAD PUBL FOOD S, P548; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721; Meng JH, 1998, INT J FOOD MICROBIOL, V45, P229, DOI 10.1016/S0168-1605(98)00163-9; Muniesa M, 2006, ENVIRON SCI TECHNOL, V40, P7141, DOI 10.1021/es060927k; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Noller AC, 2003, J CLIN MICROBIOL, V41, P5389, DOI 10.1128/JCM.41.12.5389-5397.2003; Ogden ID, 2005, J APPL MICROBIOL, V98, P646, DOI 10.1111/j.1365-2672.2004.02493.x; Quinones B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00061; Quinones B, 2011, FOODBORNE PATHOG DIS, V8, P705, DOI 10.1089/fpd.2010.0753; Rey J, 2006, INT J FOOD MICROBIOL, V107, P212, DOI 10.1016/j.ijfoodmicro.2005.08.025; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Schmidt H, 1996, J CLIN MICROBIOL, V34, P2364, DOI 10.1128/JCM.34.10.2364-2367.1996; Siller-Cepeda JH, 2009, FOOD SCI TECH-INT SE, P309, DOI 10.1016/B978-0-12-374186-8.00013-6; Sosa Hernandez LA, 2008, RECVET REV ELECT CLI, VIII, P1; Tristao LCS, 2007, VET MICROBIOL, V119, P358, DOI 10.1016/j.vetmic.2006.09.006; Varela-Hernandez JJ, 2007, INT J FOOD MICROBIOL, V113, P237, DOI 10.1016/j.ijfoodmicro.2006.06.028; Verstraete K, 2010, VET MICROBIOL, V145, P106, DOI 10.1016/j.vetmic.2010.03.004; Vettorato MP, 2003, VET MICROBIOL, V95, P103, DOI 10.1016/S0378-1135(03)00153-6; WRIGHT DJ, 1994, EPIDEMIOL INFECT, V113, P31, DOI 10.1017/S0950268800051438	68	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51565	10.1371/journal.pone.0051565	http://dx.doi.org/10.1371/journal.pone.0051565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251577	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900104
J	Arias-Cordero, E; Ping, LY; Reichwald, K; Delb, H; Platzer, M; Boland, W				Arias-Cordero, Erika; Ping, Liyan; Reichwald, Kathrin; Delb, Horst; Platzer, Mathias; Boland, Wilhelm			Comparative Evaluation of the Gut Microbiota Associated with the Below- and Above-Ground Life Stages (Larvae and Beetles) of the Forest Cockchafer, Melolontha hippocastani	PLOS ONE			English	Article							PACHNODA-EPHIPPIATA COLEOPTERA; HUMUS-FEEDING LARVA; BACTERIAL COMMUNITIES; XYLANOLYTIC BACTERIUM; CHEMICAL-COMPOSITION; SP NOV.; HINDGUT; DIGESTION; MICROFLORA; DIVERSITY	A comparison of the diversity of bacterial communities in the larval midgut and adult gut of the European forest cockchafer (Melolontha hippocastani) was carried out using approaches that were both dependent on and independent of cultivation. Clone libraries of the 16S rRNA gene revealed 150 operational taxonomic units (OTUs) that belong to 11 taxonomical classes and two other groups that could be classified only to the phylum level. The most abundant classes were beta, delta and gamma-proteobacteria, Clostridia, Bacilli, Erysipelotrichi and Sphingobacteria. Although the insect's gut is emptied in the prepupal stage and the beetle undergoes a long diapause period, a subset of eight taxonomic classes from the aforementioned eleven were found to be common in the guts of diapausing adults and the larval midguts (L2, L3). Moreover, several bacterial phylotypes belonging to these common bacterial classes were found to be shared by the larval midgut and the adult gut. Despite this, the adult gut bacterial community represented a subset of that found in the larvae midgut. Consequently, the midgut of the larval instars contains a more diverse bacterial community compared to the adult gut. On the other hand, after the bacteria present in the larvae were cultivated, eight bacterial species were isolated. Moreover, we found evidence of the active role of some of the bacterial species isolated in food digestion, namely, the presence of amylase and xylanolytic properties. Finally, fluorescence in situ hybridization allowed us to confirm the presence of selected species in the insect gut and through this, their ecological niche as well as the metagenomic results. The results presented here elucidated the heterogeneity of aerobic and facultative bacteria in the gut of a holometabolous insect species having two different feeding habits.	[Arias-Cordero, Erika; Ping, Liyan; Boland, Wilhelm] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Reichwald, Kathrin; Platzer, Mathias] Leibniz Inst Age Res Fritz Lipmann FLI, Jena, Germany; [Delb, Horst] Forstl Versuchs & Forsch Stalt Baden Wurttemberg, Freiburg, Germany	Max Planck Society; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Boland, W (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Beutenberg Campus, Jena, Germany.	boland@ice.mpg.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank Angelika Berg for laboratory assistance and Eiko Wagenhoff for field assistance. Thanks to Andreas Reinecke for helpful discussions and suggestions. Thanks also to Emily Wheeler for editorial help. This work was supported by the Max Planck Society.	Adams L, 2005, BIORESOURCE TECHNOL, V96, P1592, DOI 10.1016/j.biortech.2004.12.020; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Ammar H, 2004, J SCI FOOD AGR, V84, P197, DOI 10.1002/jsfa.1635; Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Anand AAP, 2004, COMP BIOCHEM PHYS A, V139, P65, DOI 10.1016/j.cbpb.2004.07.006; Andert J, 2008, J INSECT PHYSIOL, V54, P105, DOI 10.1016/j.jinsphys.2007.08.006; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; Biebl H, 2000, ARCH MICROBIOL, V174, P239, DOI 10.1007/s002030000198; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Brune A, 2000, FEMS MICROBIOL REV, V24, P691, DOI 10.1111/j.1574-6976.2000.tb00567.x; Brune A, 2005, PROKARYOTES; Cazemier AE, 2003, ANTON LEEUW INT J G, V83, P135, DOI 10.1023/A:1023325817663; CHESTER B, 1979, J CLIN MICROBIOL, V9, P425; Cuiv PO, 2011, J BACTERIOL, V193, P1288, DOI 10.1128/JB.01328-10; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Emami K, 2002, J BACTERIOL, V184, P4124, DOI 10.1128/JB.184.15.4124-4133.2002; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hongoh Y, 2006, MOL ECOL, V15, P505, DOI 10.1111/j.1365-294X.2005.02795.x; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; Hongoh Y, 2003, FEMS MICROBIOL ECOL, V44, P231, DOI 10.1016/S0168-6496(03)00026-6; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hung WL, 2011, ARCH MICROBIOL, V193, P407, DOI 10.1007/s00203-011-0689-6; JACKSON TA, 2006, COLEOPT SOC MONO DEC, P102, DOI DOI 10.1649/0010-065X(2006)60[102:SAPACP]2.0.CO;2; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Keller S., 1984, TAGES ANZ MAGAZINE, V19, P27; Khianngam S, 2010, INT J SYST EVOL MICR, V60, P2284, DOI 10.1099/ijs.0.015859-0; Kuhnigk T, 1996, SYST APPL MICROBIOL, V19, P139, DOI 10.1016/S0723-2020(96)80039-7; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Lemke T, 2003, APPL ENVIRON MICROB, V69, P6650, DOI 10.1128/AEM.69.11.6650-6658.2003; Leuschner C, 2003, ANN FOREST SCI, V60, P763, DOI 10.1051/forest:2003071; Li HW, 2005, J INVERTEBR PATHOL, V89, P203, DOI 10.1016/j.jip.2005.05.008; Li XZ, 2005, SOIL BIOL BIOCHEM, V37, P107, DOI 10.1016/j.soilbio.2004.06.012; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Park DS, 2007, J MICROBIOL, V45, P394; Ping LY, 2012, SCI WORLD J, P1, DOI 10.1100/2012/504905; Pittman GW, 2008, APPL ENVIRON MICROB, V74, P762, DOI 10.1128/AEM.01831-07; POTRIKUS CJ, 1977, APPL ENVIRON MICROB, V33, P392, DOI 10.1128/AEM.33.2.392-399.1977; RITCHER PO, 1958, ANNU REV ENTOMOL, V3, P311, DOI 10.1146/annurev.en.03.010158.001523; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; ROSSLER ME, 1961, J INSECT PHYSIOL, V6, P62, DOI 10.1016/0022-1910(61)90092-0; Rowell RM, 2005, HANDBOOK OF WOOD CHEMISTRY AND WOOD COMPOSITES, P35; Schloss PD, 2006, ENVIRON ENTOMOL, V35, P625, DOI 10.1603/0046-225X-35.3.625; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Steinhaus EA, 1941, J BACTERIOL, V42, P757, DOI 10.1128/JB.42.6.757-790.1941; Su ZJ, 2010, J ECON ENTOMOL, V103, P1832, DOI 10.1603/EC10142; TERRA WR, 1990, ANNU REV ENTOMOL, V35, P181, DOI 10.1146/annurev.en.35.010190.001145; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Wiegel J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P654, DOI 10.1007/0-387-30744-3_20; Wildbolz T, 1954, MITT SCHWEIZ ENTOMOL, V27, P14; Yoon MH, 2007, J MICROBIOL BIOTECHN, V17, P913; Yu HW, 2008, CURR MICROBIOL, V56, P391, DOI 10.1007/s00284-007-9078-4; Zhou JP, 2009, APPL MICROBIOL BIOT, V85, P323, DOI 10.1007/s00253-009-2081-x	60	51	53	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51557	10.1371/journal.pone.0051557	http://dx.doi.org/10.1371/journal.pone.0051557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251574	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900103
J	Jackman, RW; Wu, CL; Kandarian, SC				Jackman, Robert W.; Wu, Chia-Ling; Kandarian, Susan C.			The ChIP-seq-Defined Networks of Bcl-3 Gene Binding Support Its Required Role in Skeletal Muscle Atrophy	PLOS ONE			English	Article							KAPPA-B P50; ACTIVATION; PATHWAY; PLATFORM; ENCODES; PROTEIN; ALPHA	NF-kappaB transcriptional activation is required for skeletal muscle disuse atrophy. We are continuing to study how the activation of NF-kB regulates the genes that encode the protein products that cause atrophy. Using ChIP-sequencing we found that Bcl-3, an NF-kB transcriptional activator required for atrophy, binds to the promoters of a number of genes whose collective function describes two major aspects of muscle wasting. By means of bioinformatics analysis of ChIP-sequencing data we found Bcl-3 to be directing transcription networks of proteolysis and energy metabolism. The proteolytic arm of the Bcl-3 networks includes many E3 ligases associated with proteasomal protein degradation, including that of the N-end rule pathway. The metabolic arm appears to be involved in organizing the change from oxidative phosphorylation to glycolysis in atrophying muscle. For one gene, MuRF1, ChIP-sequencing data identified the location of Bcl-3 and p50 binding in the promoter region which directed the creation of deletant and base-substitution mutations of MuRF1 promoter constructs to determine the effect on gene transcription. The results provide the first direct confirmation that the NF-kB binding site is involved in the muscle unloading regulation of MuRF1. Finally, we have combined the ChIP-sequencing results with gene expression microarray data from unloaded muscle to map several direct targets of Bcl-3 that are transcription factors whose own targets describe a set of indirect targets for NF-kB in atrophy. ChIP-sequencing provides the first molecular explanation for the finding that Bcl3 knockout mice are resistant to disuse muscle atrophy. Mapping the transcriptional regulation of muscle atrophy requires an unbiased analysis of the whole genome, which we show is now possible with ChIP-sequencing.	[Jackman, Robert W.; Wu, Chia-Ling; Kandarian, Susan C.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Jackman, RW (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	rjackman@bu.edu			National Institutes of Health (NIH) [AR041705, AR060217]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060217, R01AR041705, R29AR041705] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) awards AR041705 and AR060217. (http://grants.nih.gov/grants/oer.htm.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeva V, 2012, BIOINFORMATICS; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cholette J, 2009, CRIT CARE MED, V37, pA434, DOI 10.1097/CCM.0b013e3181b6e760; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Larichaudy J, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-2; Delano Matthew J, 2006, Nutr Clin Pract, V21, P68, DOI 10.1177/011542650602100168; Frenette J, 2000, AM J PATHOL, V156, P2103, DOI 10.1016/S0002-9440(10)65081-X; Fu YT, 2004, NUCLEIC ACIDS RES, V32, pW420, DOI 10.1093/nar/gkh426; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Peterson JM, 2011, CURR TOP DEV BIOL, V96, P85, DOI 10.1016/B978-0-12-385940-2.00004-8; Qin J, 2011, NUCLEIC ACIDS RES, V39, pW430, DOI 10.1093/nar/gkr332; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schefold JC, 2010, J CACHEXIA SARCOPENI, V1, P147, DOI 10.1007/s13539-010-0010-6; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Solomon V, 1998, P NATL ACAD SCI USA, V95, P12602, DOI 10.1073/pnas.95.21.12602; Solomon V, 1998, J BIOL CHEM, V273, P25216, DOI 10.1074/jbc.273.39.25216; Stein TP, 2002, J NUTR BIOCHEM, V13, P471, DOI 10.1016/S0955-2863(02)00195-X; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]	35	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51478	10.1371/journal.pone.0051478	http://dx.doi.org/10.1371/journal.pone.0051478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251550	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900094
J	Balam, S; Romero, JF; Bongfen, SE; Guillaume, P; Corradin, G				Balam, Saidou; Romero, Jackeline F.; Bongfen, Silayuv E.; Guillaume, Philippe; Corradin, Giampietro			CSP-A Model for In Vivo Presentation of Plasmodium berghei Sporozoite Antigens by Hepatocytes	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN; INFECTED HEPATOCYTES; T-CELLS; KUPFFER CELLS; LIVER STAGES; MALARIA; INTERFERON; PROTECTION; DEFICIENT; RESPONSES	One target of protective immunity against the Plasmodium liver stage in BALB/c mice is represented by the circumsporozoite protein (CSP), and mainly involves its recognition by IFN-gamma producing specific CD8+T-cells. In a previous in vitro study we showed that primary hepatocytes from BALB/c mice process Plasmodium berghei (Pb) CSP (PbCSP) and present CSP-derived peptides to specific H-2k(d) restricted CD8+T-cells with subsequent killing of the presenting cells. We now extend these observations to an in vivo infection model in which infected hepatocytes and antigen specific T-cell clones are transferred into recipient mice inducing protection from sporozoite (SPZ) challenge. In addition, using a similar protocol, we suggest the capacity of hepatocytes in priming of naive T-cells to provide protection, as further confirmed by induction of protection after depletion of cross-presenting dendritic cells (DCs) by cytochrome c (cyt c) treatment or using traversal deficient parasites. Our results clearly show that hepatocytes present Plasmodium CSP to specific-primed CD8+T-cells, and could also prime naive T-cells, leading to protection from infection. These results could contribute to a better understanding of liver stage immune response and design of malaria vaccines.	[Balam, Saidou; Romero, Jackeline F.; Bongfen, Silayuv E.; Corradin, Giampietro] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Guillaume, Philippe] Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland	University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne	Corradin, G (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	giampietro.corradin@unil.ch		BALAM, Dr Saidou/0000-0002-7178-7758				Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; Bongfen SE, 2008, PARASITE IMMUNOL, V30, P375, DOI 10.1111/j.1365-3024.2008.01032.x; Bongfen SE, 2007, J IMMUNOL, V178, P7054, DOI 10.4049/jimmunol.178.11.7054; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chattopadhyay R, 2011, J BIOL CHEM, V286, P26396, DOI 10.1074/jbc.M111.240879; Chefalo PJ, 2003, J IMMUNOL, V170, P5825, DOI 10.4049/jimmunol.170.12.5825; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; Douradinha Bruno, 2011, J Immune Based Ther Vaccines, V9, P6, DOI 10.1186/1476-8518-9-6; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; Mehal WZ, 2001, J IMMUNOL, V167, P667, DOI 10.4049/jimmunol.167.2.667; MEIS JFGM, 1983, PARASITOLOGY, V86, P231, DOI 10.1017/S003118200005040X; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Renia L, 2006, J INFECT DIS, V193, P163, DOI 10.1086/498536; RENIA L, 1994, IMMUNOLOGY, V82, P164; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SEGUIN MC, 1989, J IMMUNOL, V143, P1716; Torgler R, 2008, J IMMUNOL, V180, P3990, DOI 10.4049/jimmunol.180.6.3990; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Voza T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-362	30	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51875	10.1371/journal.pone.0051875	http://dx.doi.org/10.1371/journal.pone.0051875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272182	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300037
J	Daducci, A; Gerhard, S; Griffa, A; Lemkaddem, A; Cammoun, L; Gigandet, X; Meuli, R; Hagmann, P; Thiran, JP				Daducci, Alessandro; Gerhard, Stephan; Griffa, Alessandra; Lemkaddem, Alia; Cammoun, Leila; Gigandet, Xavier; Meuli, Reto; Hagmann, Patric; Thiran, Jean-Philippe			The Connectome Mapper: An Open-Source Processing Pipeline to Map Connectomes with MRI	PLOS ONE			English	Article							DIFFUSION; TRACTOGRAPHY; DISTORTION; NETWORK	Researchers working in the field of global connectivity analysis using diffusion magnetic resonance imaging (MRI) can count on a wide selection of software packages for processing their data, with methods ranging from the reconstruction of the local intra-voxel axonal structure to the estimation of the trajectories of the underlying fibre tracts. However, each package is generally task-specific and uses its own conventions and file formats. In this article we present the Connectome Mapper, a software pipeline aimed at helping researchers through the tedious process of organising, processing and analysing diffusion MRI data to perform global brain connectivity analyses. Our pipeline is written in Python and is freely available as open-source at www.cmtk.org.	[Daducci, Alessandro; Gerhard, Stephan; Griffa, Alessandra; Lemkaddem, Alia; Cammoun, Leila; Gigandet, Xavier; Hagmann, Patric; Thiran, Jean-Philippe] Ecole Polytech Fed Lausanne, Signal Proc Lab, Lausanne, Switzerland; [Griffa, Alessandra; Meuli, Reto; Hagmann, Patric; Thiran, Jean-Philippe] Univ Lausanne, Lausanne, Switzerland; [Griffa, Alessandra; Meuli, Reto; Hagmann, Patric; Thiran, Jean-Philippe] Univ Lausanne Hosp, Dept Radiol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Daducci, A (corresponding author), Ecole Polytech Fed Lausanne, Signal Proc Lab, Lausanne, Switzerland.	alessandro.daducci@epfl.ch	; Daducci, Alessandro/N-5308-2014	Thiran, Jean-Philippe/0000-0003-2938-9657; Hess, Christopher/0000-0002-5132-5302; Griffa, Alessandra/0000-0003-1923-1653; Daducci, Alessandro/0000-0002-4677-6678	Swiss National Science Foundation [320030-130090]; SPUM [33CM30-124089, 320030-141165]; Centre d'Imagerie BioMedicale (CIBM) of the Geneva-Lausanne universities; Swiss Federal Institute of Technology Lausanne (EPFL); Leenaards foundation; Louis-Jeantet foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SPUM; Centre d'Imagerie BioMedicale (CIBM) of the Geneva-Lausanne universities; Swiss Federal Institute of Technology Lausanne (EPFL); Leenaards foundation; Louis-Jeantet foundation	This project was partially supported by Swiss National Science Foundation (grant No320030-130090) and SPUM (grants No33CM30-124089 and 320030-141165), as well as the Centre d'Imagerie BioMedicale (CIBM) of the Geneva-Lausanne universities and the Swiss Federal Institute of Technology Lausanne (EPFL), the Leenaards and Louis-Jeantet foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Assemlal HE, 2011, MED IMAGE ANAL, V15, P369, DOI 10.1016/j.media.2011.02.002; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cote MA, 2012, LECT NOTES COMPUT SC, V7510, P699, DOI 10.1007/978-3-642-33415-3_86; Dinov I. D., 2009, FRONTIERS NEUROINFOR, V3; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; Gerhard S, 2011, FRONTIERS NEUROINFOR, P5; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Granziera C, 2012, NEUROLOGY, V79, P39, DOI 10.1212/WNL.0b013e31825f25e7; Gray WR, 2012, IEEE PULSE, V3, P42, DOI 10.1109/MPUL.2011.2181023; Hagmann P., 2005, DIFFUSION MRI BRAIN; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Meskaldji DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023009; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39; Wu YC, 2008, IEEE T MED IMAGING, V27, P858, DOI 10.1109/TMI.2008.922696; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	31	162	166	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e48121	10.1371/journal.pone.0048121	http://dx.doi.org/10.1371/journal.pone.0048121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272041	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000312483300004
J	Shang, K; Bai, YP; Wang, C; Wang, Z; Gu, HY; Du, X; Zhou, XY; Zheng, CL; Chi, YY; Mukaida, N; Li, YY				Shang, Kun; Bai, Yu-Pan; Wang, Chen; Wang, Zhen; Gu, Hong-Yu; Du, Xiang; Zhou, Xiao-Yan; Zheng, Chun-Lei; Chi, Ya-Yun; Mukaida, Naofumi; Li, Ying-Yi			Crucial Involvement of Tumor-Associated Neutrophils in the Regulation of Chronic Colitis-Associated Carcinogenesis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INFILTRATING NEUTROPHILS; COLORECTAL NEOPLASIA; PROGNOSTIC-FACTORS; ANGIOGENIC SWITCH; CELL CARCINOMA; CXC CHEMOKINES; COLON-CANCER; MOUSE MODEL	Ulcerative colitis (UC) is a major form of chronic inflammation that can frequently progress to colon cancer. Several studies have demonstrated massive infiltration of neutrophils and macrophages into the lamina propria and submucosa in the progression of UC-associated colon carcinogenesis. Macrophages contribute to the development of colitis-associated colon cancer (CAC). However, the role of neutrophils is not well understood. To better understand the involvement of tumor-associated neutrophils (TANs) in the regulation of CAC, we used a mouse CAC model produced by administering azoxymethane (AOM), followed by repeated dextran sulfate sodium (DSS) ingestion. This causes severe colonic inflammation and subsequent development of multiple tumors in mice colon. We observed that colorectal mucosal inflammation became increasingly severe with AOM and DSS treatment. Macrophages infiltrated the lamina propria and submucosa, together with a marked increase in neutrophil infiltration. The chemokine CXCL2 increased in the lamina propria and submucosal regions of the colons of the treated mice, together with the infiltration of neutrophils expressing CXCR2, a specific receptor for CXCL2. This process was followed by neoplastic transformation. After AOM and DSS treatment, the mice showed enhanced production of metalloproteinase (MMP)-9 and neutrophil elastase (NE), accompanied by excessive vessel generation and cell proliferation. Moreover, CXCL2 promoted neutrophil recruitment and induced neutrophils to express MMP-9 and NE in vitro. Furthermore, administration of neutrophil-neutralizing antibodies after the last DSS cycle markedly reduced the number and size of tumors and decreased the expression of CXCR2, CXCL2, MMP-9, and NE. These observations indicate a crucial role for TANs in the initiation and progression of CAC and suggest that the CXCL2-CXCR2 axis might be useful in reducing the risk of UC-associated colon cancer.	[Shang, Kun; Bai, Yu-Pan; Wang, Chen; Wang, Zhen; Gu, Hong-Yu; Du, Xiang; Zhou, Xiao-Yan; Zheng, Chun-Lei; Chi, Ya-Yun; Li, Ying-Yi] Fudan Univ, Canc Res Lab, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Mukaida, Naofumi; Li, Ying-Yi] Kanazawa Univ, Canc Res Inst, Canc Microenvironm Res Program, Div Mol Bioregulat, Kanazawa, Ishikawa 920, Japan	Fudan University; Kanazawa University	Li, YY (corresponding author), Fudan Univ, Canc Res Lab, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China.	liyingyi@fudan.edu.cn	Mukaida, Naofumi/D-7623-2011	Mukaida, Naofumi/0000-0002-4193-1851	National Science Foundation of China (NSFC) [30973476]; Shanghai Pujiang Program [10PJ1402100]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This study supported by funding from The National Science Foundation of China (NSFC) (30973476) and Shanghai Pujiang Program (10PJ1402100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bellocq A, 1998, AM J PATHOL, V152, P83; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; DOBBINS WO, 1984, ANNU REV MED, V35, P33, DOI 10.1146/annurev.me.35.020184.000341; Donskov F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594; Fossati G, 1999, ACTA NEUROPATHOL, V98, P349, DOI 10.1007/s004010051093; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Hannelien V, 2012, BBA-REV CANCER, V1825, P117, DOI 10.1016/j.bbcan.2011.10.008; Houghton AM, 2010, CELL CYCLE, V9, P1732, DOI 10.4161/cc.9.9.11297; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Kostadinova FI, 2010, J LEUKOCYTE BIOL, V88, P133, DOI 10.1189/jlb.1109768; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Lu PR, 2008, J IMMUNOL, V180, P4283, DOI 10.4049/jimmunol.180.6.4283; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Michael M, 2006, CLIN COLORECTAL CANC, V6, P297, DOI 10.3816/CCC.2006.n.048; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mukaida N, 2012, EXP CELL RES, V318, P95, DOI 10.1016/j.yexcr.2011.10.012; Nickkho-Amiry M, 2012, MOL CANCER RES, V10, P441, DOI 10.1158/1541-7786.MCR-11-0233; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Okayasu I, 2002, J GASTROEN HEPATOL, V17, P1078, DOI 10.1046/j.1440-1746.2002.02853.x; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; OWEN CA, 1994, AM J PHYSIOL-LUNG C, V267, pL775, DOI 10.1152/ajplung.1994.267.6.L775; Paesmans M, 2000, CANCER, V89, P523, DOI 10.1002/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Reid MD, 2011, MODERN PATHOL, V24, P1612, DOI 10.1038/modpathol.2011.113; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Schmidt H, 2007, J CLIN ONCOL, V25, P1562, DOI 10.1200/JCO.2006.09.0274; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stolfi C, 2011, J EXP MED, V208, P2279, DOI 10.1084/jem.20111106; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Terkeltaub R, 1998, ARTHRITIS RHEUM, V41, P900, DOI 10.1002/1529-0131(199805)41:5<900::AID-ART18>3.0.CO;2-K; Trellakis S, 2011, INT J IMMUNOPATH PH, V24, P683, DOI 10.1177/039463201102400314; Ullman T, 2003, GASTROENTEROLOGY, V125, P1311, DOI 10.1016/j.gastro.2003.08.023; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wislez M, 2003, CANCER RES, V63, P1405; Wu YN, 2012, J BIOL CHEM, V287, P5744, DOI 10.1074/jbc.M111.315762	57	100	105	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51848	10.1371/journal.pone.0051848	http://dx.doi.org/10.1371/journal.pone.0051848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272179	Green Submitted, gold, Green Published			2022-12-27	WOS:000312483300035
J	Alex, A; Vasconcelos, V; Tamagnini, P; Santos, A; Antunes, A				Alex, Anoop; Vasconcelos, Vitor; Tamagnini, Paula; Santos, Arlete; Antunes, Agostinho			Unusual Symbiotic Cyanobacteria Association in the Genetically Diverse Intertidal Marine Sponge Hymeniacidon perlevis (Demospongiae, Halichondrida)	PLOS ONE			English	Article							OSCILLATORIA-SPONGELIAE; NITROGEN-FIXATION; PHYLOGENETIC DIVERSITY; MOLECULAR EVIDENCE; MTDNA SEQUENCES; REEF; ACTINOBACTERIA; COMMUNITIES; EVOLUTION; ECOLOGY	Cyanobacteria represent one of the most common members of the sponge-associated bacterial community and are abundant symbionts of coral reef ecosystems. In this study we used Transmission Electron Microscopy (TEM) and molecular techniques (16S rRNA gene marker) to characterize the spatial distribution of cyanobionts in the widely dispersed marine intertidal sponge Hymeniacidon perlevis along the coast of Portugal (Atlantic Ocean). We described new sponge associated cyanobacterial morphotypes (Xenococcus-like) and we further observed Acaryochloris sp. as a sponge symbiont, previously only reported in association with ascidians. Besides these two unique cyanobacteria, H. perlevis predominantly harbored Synechococcus sp. and uncultured marine cyanobacteria. Our study supports the hypothesis that the community of sponge cyanobionts varies irrespective of the geographical location and is likely influenced by seasonal fluctuations. The observed multiple cyanobacterial association among sponges of the same host species over a large distance may be attributed to horizontal transfer of symbionts. This may explain the absence of a co-evolutionary pattern between the sponge host and its symbionts. Finally, in spite of the short geographic sampling distance covered, we observed an unexpected high intra-specific genetic diversity in H. perlevis using the mitochondrial genes ATP6 (pi = 0.00177), COI (pi = 0.00241) and intergenic spacer SP1 (pi = 0.00277) relative to the levels of genetic variation of marine sponges elsewhere. Our study suggests that genotypic variation among the sponge host H. perlevis and the associated symbiotic cyanobacteria diversity may be larger than previously recognized. Citation: Alex A, Vasconcelos V, Tamagnini P, Santos A, Antunes A (2012) Unusual Symbiotic Cyanobacteria Association in the Genetically Diverse Intertidal Marine Sponge Hymeniacidon perlevis (Demospongiae, Halichondrida). PLoS ONE 7(12): e51834. doi:10.1371/journal.pone.0051834	[Alex, Anoop; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, P-4100 Oporto, Portugal; [Alex, Anoop; Vasconcelos, Vitor; Tamagnini, Paula; Santos, Arlete; Antunes, Agostinho] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Tamagnini, Paula; Santos, Arlete] Univ Porto, IBMC Inst Biol Mol & Celular, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Tamagnini, Paula/AGF-3206-2022; Tamagnini, Paula/A-6613-2010; Vasconcelos, Vitor/A-8933-2008	Tamagnini, Paula/0000-0003-4396-2122; Tamagnini, Paula/0000-0003-4396-2122; Vasconcelos, Vitor/0000-0003-3585-2417; Alex, Anoop/0000-0001-5788-1089; Antunes, Agostinho/0000-0002-1328-1732; Santos Pinto, Arlete/0000-0001-5235-9160	FCT (Fundacao para a Ciencia e a Tecnologia) [SFRH/BD/62356/2009, PTDC/MAR/099642/2008, PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029)]	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology)	This research was supported by FCT (Fundacao para a Ciencia e a Tecnologia) grant SFRH/BD/62356/2009 conferred to Anoop Alex and in part by the FCT project PTDC/MAR/099642/2008 and PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers R.G., 1992, SPONGES BRIT ISLES S; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BERTHOLD RJ, 1982, PHYCOLOGIA, V21, P327, DOI 10.2216/i0031-8884-21-3-327.1; Brooks DR, 1991, PHYLOGENY ECOLOGY BE; Cabioch L, 1968, CAHIERS BIOL MARINE; Carballo JL, 2004, MAR ECOL PROG SER, V279, P93, DOI 10.3354/meps279093; Cassens I, 2005, SYST BIOL, V54, P363, DOI 10.1080/10635150590945377; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheshire AC, 1997, MAR FRESHWATER RES, V48, P589, DOI 10.1071/MF96070; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; DeBiasse MB, 2010, CORAL REEFS, V29, P47, DOI 10.1007/s00338-009-0554-0; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; Diaz Maria Cristina, 1997, P1399; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Erwin PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026806; Feldmann J, 1935, ARCH ZOOLOGIE EXPT G, V75, P381; FOULDS LR, 1979, J MOL EVOL, V13, P127, DOI 10.1007/BF01732868; Fromont J., 1999, Memoirs of the Queensland Museum, V44, P185; Gaino Elda, 2010, Open Marine Biology Journal, V4, P47, DOI 10.2174/1874450801004010047; Ganot P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002187; GOLDMORGAN M, 1994, ARCH PROTISTENKD, V144, P383, DOI 10.1016/S0003-9365(11)80241-1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hoshino S, 2008, HYDROBIOLOGIA, V603, P313, DOI 10.1007/s10750-008-9295-2; Jin Yan, 2006, Weishengwu Xuebao, V46, P875; Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Lambert G, 1996, INVERTEBR BIOL, V115, P67, DOI 10.2307/3226942; LARKUM AWD, 1988, MAR BIOL, V98, P143, DOI 10.1007/BF00392669; Larkum L, 1999, B I OCEANOGRAPH MONA, P149; Lee YK, 2001, J MICROBIOL, V39, P254; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Legentil S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023938; Maldonado M, 1996, MAR ECOL PROG SER, V138, P169, DOI 10.3354/meps138169; Maldonado M, 1998, LIMITS BATHYMETRIC D; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; O'Brien HE, 2005, EUR J PHYCOL, V40, P363, DOI 10.1080/09670260500342647; Ohkubo S, 2006, APPL ENVIRON MICROB, V72, P7912, DOI 10.1128/AEM.01148-06; Parks DH, 2009, GENOME RES, V19, P1896, DOI 10.1101/gr.095612.109; PROTEAU PJ, 1993, EXPERIENTIA, V49, P825, DOI 10.1007/BF01923559; Read DJ, 2000, PHILOS T R SOC B, V355, P815, DOI 10.1098/rstb.2000.0617; Redmond NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024344; Ridley CP, 2005, APPL ENVIRON MICROB, V71, P7366, DOI 10.1128/AEM.71.11.7366-7375.2005; Rua CPJ, 2011, J MAR BIOL ASSOC UK, V91, P1015, DOI 10.1017/S0025315410002122; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sara M, 1998, SYMBIOSIS, V25, P57; Schwarz JA, 1999, BIOL BULL-US, V196, P70, DOI 10.2307/1543169; Seabra R, 2009, FEMS MICROBIOL LETT, V292, P57, DOI 10.1111/j.1574-6968.2008.01471.x; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005; Stone AR, 2009, J ZOOL, V161, P443, DOI [10.1111/j.1469-7998.1970.tb02048.x, DOI 10.1111/J.1469-7998.1970.TB02048.X]; TAJIMA F, 1983, GENETICS, V105, P437; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Usher KM, 2008, MAR ECOL-EVOL PERSP, V29, P178, DOI 10.1111/j.1439-0485.2008.00245.x; Usher KM, 2007, ANNU REV ECOL EVOL S, V38, P255, DOI 10.1146/annurev.ecolsys.38.091206.095641; Usher KM, 2004, MICROB ECOL, V48, P167, DOI 10.1007/s00248-003-1062-3; Wang XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002723; WILKINSON CR, 1987, SYMBIOSIS, V4, P135; WILKINSON CR, 1984, PROC R SOC SER B-BIO, V220, P509, DOI 10.1098/rspb.1984.0017; WILKINSON CR, 1978, MAR BIOL, V49, P161, DOI 10.1007/BF00387115; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Wilmotte A, 2004, MOL BIOL CYANOBACTER, V1, P1, DOI DOI 10.1007/0-306-48205-3_1; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xin YJ, 2008, ANTON LEEUW INT J G, V94, P533, DOI 10.1007/s10482-008-9270-y; Yokobori S, 2006, MOL PHYLOGENET EVOL, V40, P8, DOI 10.1016/j.ympev.2005.11.025; Zhang HT, 2006, ANTON LEEUW INT J G, V90, P159, DOI 10.1007/s10482-006-9070-1	79	28	29	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51834	10.1371/journal.pone.0051834	http://dx.doi.org/10.1371/journal.pone.0051834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251637	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800094
J	Cui, AX; Zhang, ZK; Tang, M; Hui, PM; Fu, Y				Cui, Ai-Xiang; Zhang, Zi-Ke; Tang, Ming; Hui, Pak Ming; Fu, Yan			Emergence of Scale-Free Close-Knit Friendship Structure in Online Social Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; EVOLUTION; DISTRIBUTIONS; MOTIFS; TIME	Although the structural properties of online social networks have attracted much attention, the properties of the close-knit friendship structures remain an important question. Here, we mainly focus on how these mesoscale structures are affected by the local and global structural properties. Analyzing the data of four large-scale online social networks reveals several common structural properties. It is found that not only the local structures given by the indegree, outdegree, and reciprocal degree distributions follow a similar scaling behavior, the mesoscale structures represented by the distributions of close-knit friendship structures also exhibit a similar scaling law. The degree correlation is very weak over a wide range of the degrees. We propose a simple directed network model that captures the observed properties. The model incorporates two mechanisms: reciprocation and preferential attachment. Through rate equation analysis of our model, the local-scale and mesoscale structural properties are derived. In the local-scale, the same scaling behavior of indegree and outdegree distributions stems from indegree and outdegree of nodes both growing as the same function of the introduction time, and the reciprocal degree distribution also shows the same power-law due to the linear relationship between the reciprocal degree and in/outdegree of nodes. In the mesoscale, the distributions of four closed triples representing close-knit friendship structures are found to exhibit identical power-laws, a behavior attributed to the negligible degree correlations. Intriguingly, all the power-law exponents of the distributions in the local-scale and mesoscale depend only on one global parameter, the mean in/outdegree, while both the mean in/outdegree and the reciprocity together determine the ratio of the reciprocal degree of a node to its in/outdegree. Structural properties of numerical simulated networks are analyzed and compared with each of the four real networks. This work helps understand the interplay between structures on different scales in online social networks. Citation: Cui A-X, Zhang Z-K, Tang M, Hui PM, Fu Y (2012) Emergence of Scale-Free Close-Knit Friendship Structure in Online Social Networks. PLoS ONE 7(12): e50702. doi:10.1371/journal.pone.0050702	[Cui, Ai-Xiang; Zhang, Zi-Ke; Tang, Ming; Fu, Yan] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Zhang, Zi-Ke] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Hui, Pak Ming] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China	University of Electronic Science & Technology of China; Hangzhou Normal University; Chinese University of Hong Kong	Tang, M (corresponding author), Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China.	tangminghuang521@hotmail.com	Hui, Pak Ming/S-2586-2017	Hui, Pak Ming/0000-0002-5201-8689	National Natural Science Foundation of China [11105024, 11105025, 61103109]; China Postdoctoral Science Foundation [20110491705]; Specialized Research Fund for the Doctoral Program of Higher Education [20110185120021]; Research Grants Council of the Hong Kong SAR Government [CUHK-401109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Grants Council of the Hong Kong SAR Government(Hong Kong Research Grants Council)	This work was partially supported by the National Natural Science Foundation of China (Grant Nos. 11105024, 11105025, and 61103109), China Postdoctoral Science Foundation (Grant No. 20110491705), the Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20110185120021). P.M. Hui acknowledges the support of the Research Grants Council of the Hong Kong SAR Government under Grant No. CUHK-401109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2007, P 16 INT C WORLD WID, DOI [DOI 10.1145/1242572.1242685, 10.1145/1242572.1242685]; Ahnert SE, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036112; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Almendral JA, 2011, CHAOS, V21, DOI 10.1063/1.3570920; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Benevenuto F, 2008, P 16 ACM INT C MULT, P761; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Capocci A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036116; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corten R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034760; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Dorogovtsev SN, 2000, PHYS REV LETT, V85, P4633, DOI 10.1103/PhysRevLett.85.4633; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Farkas IJ, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/180; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Gallos LK, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031014; Garlaschelli D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268701; Ghoneim A, 2008, IEEE T SYST MAN CY B, V38, P682, DOI 10.1109/TSMCB.2008.918570; Gjoka M, 2010, IEEE INFOCOM SER, DOI 10.1109/infcom.2010.5462078; Gomez V., 2008, P 17 INT C WORLD WID, P645, DOI [10.1145/1367497.1367585, DOI 10.1145/1367497.1367585]; Hales D, 2008, NETW HETEROG MEDIA, V3, P239, DOI 10.3934/nhm.2008.3.239; Hu HB, 2009, PHYS LETT A, V373, P1105, DOI 10.1016/j.physleta.2009.02.004; Huang CY, 2007, PHYSICA A, V377, P340, DOI 10.1016/j.physa.2006.11.014; Kim Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016103; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Krapivsky PL, 2000, PHYS REV LETT, V85, P4629, DOI 10.1103/PhysRevLett.85.4629; Krapivsky PL, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066123; Krapivsky PL, 2001, PHYS REV LETT, V86, P5401, DOI 10.1103/PhysRevLett.86.5401; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Leicht EA, 2007, EUR PHYS J B, V59, P75, DOI 10.1140/epjb/e2007-00271-7; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mislove A, 2008, P 1 WORKSHOP ONLINE, P25, DOI [10.1145/1397735.1397742, DOI 10.1145/1397735.1397742]; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Mossa S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.138701; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Reichardt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021282; Rodgers GJ, 2001, EUR PHYS J B, V23, P267, DOI 10.1007/s100510170076; SCOTT J, 1988, SOCIOLOGY, V22, P109, DOI 10.1177/0038038588022001007; SCOTT J., 1991, SOCIAL NETWORK ANAL; Sousa AO, 2005, PHYSICA A, V348, P701, DOI 10.1016/j.physa.2004.09.027; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648	63	12	13	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50702	10.1371/journal.pone.0050702	http://dx.doi.org/10.1371/journal.pone.0050702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272067	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800014
J	Kazma, R; Mefford, JA; Cheng, I; Plummer, SJ; Levin, AM; Rybicki, BA; Casey, G; Witte, JS				Kazma, Remi; Mefford, Joel A.; Cheng, Iona; Plummer, Sarah J.; Levin, Albert M.; Rybicki, Benjamin A.; Casey, Graham; Witte, John S.			Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk	PLOS ONE			English	Article							SCAVENGER RECEPTOR-1 GENE; COMMON SEQUENCE VARIANTS; RNASEL GENE; COX-2 GENE; ALPHA GENE; CYCLOOXYGENASE-2; EXPRESSION; SUSCEPTIBILITY; POLYMORPHISM; MUTATIONS	Prostate cancer is the most frequent and second most lethal cancer in men in the United States. Innate immunity and inflammation may increase the risk of prostate cancer. To determine the role of innate immunity and inflammation in advanced prostate cancer, we investigated the association of 320 single nucleotide polymorphisms, located in 46 genes involved in this pathway, with disease risk using 494 cases with advanced disease and 536 controls from Cleveland, Ohio. Taken together, the whole pathway was associated with advanced prostate cancer risk (P = 0.02). Two sub-pathways (intracellular antiviral molecules and extracellular pattern recognition) and four genes in these sub-pathways (TLR1, TLR6, OAS1, and OAS2) were nominally associated with advanced prostate cancer risk and harbor several SNPs nominally associated with advanced prostate cancer risk. Our results suggest that the innate immunity and inflammation pathway may play a modest role in the etiology of advanced prostate cancer through multiple small effects. Citation: Kazma R, Mefford JA, Cheng I, Plummer SJ, Levin AM, et al. (2012) Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk. PLoS ONE 7(12): e51680. doi: 10.1371/journal.pone.0051680	[Kazma, Remi; Mefford, Joel A.; Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kazma, Remi; Mefford, Joel A.; Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Cheng, Iona] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Plummer, Sarah J.; Casey, Graham] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Levin, Albert M.; Rybicki, Benjamin A.] Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cancer Research Center of Hawaii; University of Hawaii System; University of Southern California; Henry Ford Health System; Henry Ford Hospital	Witte, JS (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	wittej@humgen.ucsf.edu	Rybicki, Benjamin/L-4614-2019	Rybicki, Benjamin/0000-0003-3190-3467	National Institutes of Health [R01CA88164, U01CA127298, R25CA112355]; NATIONAL CANCER INSTITUTE [R25CA112355, U01CA127298, R01CA088164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [Grant numbers: R01CA88164, U01CA127298, and R25CA112355 to R.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER LH, 1981, J UROLOGY, V125, P370, DOI 10.1016/S0022-5347(17)55039-9; Casey Graham, 2002, Nature Genetics, V32, P581, DOI 10.1038/ng1021; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Cheng I, 2007, BRIT J CANCER, V97, P557, DOI 10.1038/sj.bjc.6603874; Cheng I, 2010, CANCER EPIDEM BIOMAR, V19, P2124, DOI 10.1158/1055-9965.EPI-10-0268; Cohen BL, 2006, INT J CANCER, V119, P1082, DOI 10.1002/ijc.21749; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Visser KE, 2005, CANCER IMMUNOL IMMUN, V54, P1143, DOI 10.1007/s00262-005-0702-5; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Grinstein S, 2002, CANCER RES, V62, P4876; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardin J, 2011, NUTR CANCER, V63, P860, DOI 10.1080/01635581.2011.582224; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; Hedelin M, 2007, INT J CANCER, V120, P398, DOI 10.1002/ijc.22319; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman LJ, 2004, J INFECT DIS, V189, P15, DOI 10.1086/380568; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaushal N, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P443, DOI 10.1007/978-1-4614-1025-6_35; Kirschenbaum A, 2000, UROLOGY, V56, P671, DOI 10.1016/S0090-4295(00)00674-9; Lee JC, 2003, J UROLOGY, V169, P584, DOI 10.1016/S0022-5347(05)63958-4; Lee LM, 2001, ANTICANCER RES, V21, P1291; Lindmark F, 2004, JNCI-J NATL CANCER I, V96, P1248, DOI 10.1093/jnci/djh227; Lindmark F, 2005, BRIT J CANCER, V93, P493, DOI 10.1038/sj.bjc.6602729; Lindmark F, 2004, PROSTATE, V59, P132, DOI 10.1002/pros.10367; Liu X, 2006, AM J EPIDEMIOL, V164, P984, DOI 10.1093/aje/kwj294; Loza MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001035; Mandal S, 2011, CANCER-AM CANCER SOC, V117, P5509, DOI 10.1002/cncr.26219; McCarron SL, 2002, CANCER RES, V62, P3369; Miller DC, 2003, CANCER RES, V63, P3486; Molinaro RJ, 2006, NUCLEIC ACIDS RES, V34, P6684, DOI 10.1093/nar/gkl968; Nakazato H, 2003, BRIT J CANCER, V89, P691, DOI 10.1038/sj.bjc.6601075; Noonan-Wheeler FC, 2006, PROSTATE, V66, P49, DOI 10.1002/pros.20320; Oh BR, 2000, J UROLOGY, V163, P1584, DOI 10.1016/S0022-5347(05)67683-5; Panguluri RCK, 2004, CARCINOGENESIS, V25, P961, DOI 10.1093/carcin/bgh100; Platz Elizabeth A., 2004, Journal of Urology, V171, pS36, DOI 10.1097/01.ju.0000108131.43160.77; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Core Team, 2021, R LANGUAGE ENV STAT; Reese AC, 2009, J NUTRIGENET NUTRIGE, V2, P149, DOI 10.1159/000235565; Rennert H, 2005, CANCER EPIDEM BIOMAR, V14, P949, DOI 10.1158/1055-9965.EPI-04-0637; Rennert H, 2002, AM J HUM GENET, V71, P981, DOI 10.1086/342775; Rossi PG, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-71, 10.1186/1471-2407-9-69]; Rybicki BA, 2006, CANCER DETECT PREV, V30, P412, DOI 10.1016/j.cdp.2006.09.004; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Seppala EH, 2003, CLIN CANCER RES, V9, P5252; Shahedi K, 2006, INT J CANCER, V119, P668, DOI 10.1002/ijc.21864; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Sun JL, 2005, JNCI-J NATL CANCER I, V97, P525, DOI 10.1093/jnci/dji070; Sun JL, 2006, PROSTATE, V66, P728, DOI 10.1002/pros.20396; Taylor ML, 2005, FAM MED, V37, P506; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281; Wang WZ, 2005, CLIN CANCER RES, V11, P3250, DOI 10.1158/1078-0432.CCR-04-2405; Wu HC, 2004, UROL INT, V73, P41, DOI 10.1159/000078803; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Xu JF, 2005, CANCER EPIDEM BIOMAR, V14, P2563, DOI 10.1158/1055-9965.EPI-05-0356; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu JF, 2003, AM J HUM GENET, V72, P208, DOI 10.1086/345802; Zha S, 2001, CANCER RES, V61, P8617; Zheng SL, 2006, PROSTATE, V66, P1556, DOI 10.1002/pros.20496; Zheng SL, 2004, CANCER RES, V64, P2918, DOI 10.1158/0008-5472.CAN-03-3280	63	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51680	10.1371/journal.pone.0051680	http://dx.doi.org/10.1371/journal.pone.0051680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272139	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800063
J	Luna, C; Li, GR; Huang, JY; Qiu, JM; Wu, J; Yuan, F; Epstein, DL; Gonzalez, P				Luna, Coralia; Li, Guorong; Huang, Jianyong; Qiu, Jianming; Wu, Jing; Yuan, Fan; Epstein, David L.; Gonzalez, Pedro			Regulation of Trabecular Meshwork Cell Contraction and Intraocular Pressure by miR-200c	PLOS ONE			English	Article							MUSCLE-ACTIN EXPRESSION; HUMOR OUTFLOW FACILITY; GROWTH-FACTOR-BETA; SMALL NONCODING RNAS; OPEN-ANGLE GLAUCOMA; AQUEOUS-HUMOR; CILIARY MUSCLE; TRACTION FORCE; INHIBITOR Y-27632; CORNEAL INJURY	Lowering intraocular pressure (IOP) delays or prevents the loss of vision in primary open-angle glaucoma (POAG) patients with high IOP and in those with normal tension glaucoma showing progression. Abundant evidence demonstrates that inhibition of contractile machinery of the trabecular meshwork cells is an effective method to lower IOP. However, the mechanisms involved in the regulation of trabecular contraction are not well understood. Although microRNAs have been shown to play important roles in the regulation of multiple cellular functions, little is known about their potential involvement in the regulation of IOP. Here, we showed that miR-200c is a direct postranscriptional inhibitor of genes relevant to the physiologic regulation of TM cell contraction including the validated targets Zinc finger E-box binding homeobox 1 and 2 (ZEB1 and ZEB2), and formin homology 2 domain containing 1 (FHOD1), as well as three novel targets: lysophosphatidic acid receptor 1 (LPAR1/EDG2), endothelin A receptor (ETAR), and RhoA kinase (RHOA). Consistently, transfection of TM cells with miR-200c resulted in strong inhibition of contraction in collagen populated gels as well as decreased cell traction forces exerted by individual TM cells. Finally, delivery of miR-200c to the anterior chamber of living rat eyes resulted in a significant decrease in IOP, while inhibition of miR-200c using an adenoviral vector expressing a molecular sponge led to a significant increase in IOP. These results demonstrate for the first time the ability of a miRNA to regulate trabecular contraction and modulate IOP in vivo, making miR-200c a worthy candidate for exploring ways to alter trabecular contractility with therapeutic purposes in glaucoma.	[Luna, Coralia; Li, Guorong; Qiu, Jianming; Wu, Jing; Epstein, David L.; Gonzalez, Pedro] Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA; [Huang, Jianyong; Yuan, Fan] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University; Duke University	Gonzalez, P (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.	gonza012@mc.duke.edu	Yuan, Fan/A-1287-2011		NEI [EY01894, EY016228, EY05722]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY016228, P30EY005722, R01EY001894] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI EY01894, NEI EY016228, NEI EY05722, and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arend KO, 2005, KLIN MONATSBL AUGENH, V222, P807, DOI 10.1055/s-2005-858210; Bollinger KE, 2011, INVEST OPHTH VIS SCI, V52, P8287, DOI 10.1167/iovs.11-8218; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; COUSINS SW, 1991, INVEST OPHTH VIS SCI, V32, P2201; Dai ZK, 2010, PEDIATR PULM, V45, P1076, DOI 10.1002/ppul.21290; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Epstein DL, 1999, INVEST OPHTH VIS SCI, V40, P74; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Gautreau Z., 2006, CHARACTERIZING VISCO; Ghanem AA, 2011, OPHTHALMIC RES, V46, P98, DOI 10.1159/000323584; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grise F, 2012, HEPATOLOGY; Guzey M, 2001, EYE, V15, P781, DOI 10.1038/eye.2001.249; Hayasaka K, 1998, LIFE SCI, V63, P1089, DOI 10.1016/S0024-3205(98)00205-7; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Holley CL, 2011, CARDIOVASC DRUG THER, V25, P151, DOI 10.1007/s10557-011-6290-z; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Huang JY, 2012, CELL MOL BIOENG, V5, P205, DOI 10.1007/s12195-012-0224-0; Huang JY, 2009, J THEOR BIOL, V259, P811, DOI 10.1016/j.jtbi.2009.05.005; Huang JY, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/3/035101; Huang JY, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118767; HUNT RC, 1994, INVEST OPHTH VIS SCI, V35, P955; Iwabe S, 2010, CURR EYE RES, V35, P287, DOI 10.3109/02713680903545315; Iyer P, 2011, ARVO M APR 22 2011 F, V52, P2070; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kallberg ME, 2002, J GLAUCOMA, V11, P105; Krauss AHP, 1997, EXP EYE RES, V64, P447, DOI 10.1006/exer.1996.0224; Kumar J, 2011, J CELL BIOCHEM, V112, P600, DOI 10.1002/jcb.22950; Last JA, 2011, INVEST OPHTH VIS SCI, V52, P2147, DOI 10.1167/iovs.10-6342; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Liliom K, 1998, AM J PHYSIOL-CELL PH, V274, pC1065, DOI 10.1152/ajpcell.1998.274.4.C1065; Loser P, 1998, J VIROL, V72, P180; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Mansouri K, 2012, SWISS MED WKLY, V142, DOI DOI 10.4414/smw.2012.13545; Mettu PS, 2004, INVEST OPHTH VIS SCI, V45, P2263, DOI 10.1167/iovs.03-0960; MOSES RA, 1977, SURV OPHTHALMOL, V22, P88, DOI 10.1016/0039-6257(77)90088-1; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Nobe H, 2003, AM J PHYSIOL-CELL PH, V284, pC599, DOI 10.1152/ajpcell.00188.2002; Noske W, 1997, GRAEF ARCH CLIN EXP, V235, P551, DOI 10.1007/BF00947082; O'Reilly S, 2011, INVEST OPHTH VIS SCI, V52, P7316, DOI 10.1167/iovs.10-6692; Pattabiraman PP, 2010, AM J PHYSIOL-CELL PH, V298, pC749, DOI 10.1152/ajpcell.00317.2009; Rao PV, 2005, EXP EYE RES, V80, P197, DOI 10.1016/j.exer.2004.08.029; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Rao VP, 2007, BIODRUGS, V21, P167, DOI 10.2165/00063030-200721030-00004; Rosenthal R, 2011, BRIT J PHARMACOL, V162, P806, DOI 10.1111/j.1476-5381.2010.01103.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5240, DOI 10.1167/iovs.11-7287; Shahar I, 1999, INT J IMMUNOPHARMACO, V21, P759, DOI 10.1016/S0192-0561(99)00056-9; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Shoshani YZ, 2012, CURR EYE RES, V37, P1, DOI 10.3109/02713683.2011.622849; STAMER WD, 1995, CURR EYE RES, V14, P611, DOI 10.3109/02713689508998409; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Syriani E, 2009, INVEST OPHTH VIS SCI, V50, P3833, DOI 10.1167/iovs.08-2924; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Tamm ER, 1996, EXP EYE RES, V62, P389, DOI 10.1006/exer.1996.0044; Tamm ER, 2007, SURV OPHTHALMOL, V52, pS101, DOI 10.1016/j.survophthal.2007.08.002; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tanihara H, 2008, ARCH OPHTHALMOL-CHIC, V126, P309, DOI 10.1001/archophthalmol.2007.76; Thieme H, 2000, INVEST OPHTH VIS SCI, V41, P4240; Tian B, 2009, EXP EYE RES, V88, P713, DOI 10.1016/j.exer.2008.08.008; Tian BH, 2005, EXP EYE RES, V80, P215, DOI 10.1016/j.exer.2004.09.002; Tokumura A, 2012, PROSTAG OTH LIPID M, V97, P83, DOI 10.1016/j.prostaglandins.2012.01.003; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Trivedi RH, 2011, J OCUL PHARMACOL TH, V27, P477, DOI 10.1089/jop.2010.0100; Von Zee CL, 2012, INVEST OPHTHALMOL VI; Watsky MA, 2000, ANN NY ACAD SCI, V905, P142; Wiederholt M, 1996, GER J OPHTHALMOL, V5, P146; WIEDERHOLT M, 1994, INVEST OPHTH VIS SCI, V35, P2515; Wiederholt M, 1998, INVEST OPHTH VIS SCI, V39, P1012; Wierzbowska J, 2010, MED SCI MONITOR, V16, pRA252; Yao J, 2002, J AM SOC NEPHROL, V13, P2018, DOI 10.1097/01.ASN.0000023436.71816.56; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016; Yu M, 2008, J OCUL PHARMACOL TH, V24, P373, DOI 10.1089/jop.2008.0029; Zhang M, 2005, INVEST OPHTH VIS SCI, V46, P4130, DOI 10.1167/iovs.05-0164	78	63	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51688	10.1371/journal.pone.0051688	http://dx.doi.org/10.1371/journal.pone.0051688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272142	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800066
J	Schrago, CG; Menezes, AN; Moreira, MAM; Pissinatti, A; Seuanez, HN				Schrago, Carlos G.; Menezes, Albert N.; Moreira, Miguel A. M.; Pissinatti, Alcides; Seuanez, Hector N.			Chronology of Deep Nodes in the Neotropical Primate Phylogeny: Insights from Mitochondrial Genomes	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; DIVERGENCE TIMES; MOLECULAR CLOCK; DIVERSIFICATION; BIOGEOGRAPHY; ACCURATE; RODENTS; MIOCENE	The evolution of Neotropical Primates (NP) is permeated by factors associated with the pattern of diversification and the biogeography of the major lineages. These questions can be better understood by providing a robust estimate of the chronological scenario of NP evolution, a reason why molecular dating methods have been widely applied. One aspect of especial interest is the timing of diversification of the major NP lineages (pitheciids, atelids and cebids), which may have resulted from rapid episodes of adaptive radiation, a question that requires NP divergence time estimates with accurate statistical certainty. In this study, we evaluated the primate timescale focused on the age of nodes of NP radiation. We investigated the performance of complete primate mitochondrial genomes as traditional molecular markers of primate evolution and further including original mitochondrial data from the endangered muriqui, Brachyteles arachnoides (Accession No. JX262672). Comparisons of the age estimates at NP nodes based on mitochondrial genomes with those obtained from a nuclear supermatrix showed similar degrees of uncertainty. Further molecular data and more informative calibration priors are required for a more precise understanding of the early NP diversification.	[Schrago, Carlos G.; Seuanez, Hector N.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Menezes, Albert N.; Moreira, Miguel A. M.; Seuanez, Hector N.] Inst Nacl Canc, Genet Program, Rio De Janeiro, Brazil; [Pissinatti, Alcides] Ctr Primatol Rio de Janeiro, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Seuanez, HN (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	genetics@inca.gov.br	Moreira, Miguel/AAN-7405-2020; Schrago, Carlos/E-4612-2012; Ferreira, Miguel/HHZ-6251-2022	Schrago, Carlos/0000-0001-6257-8906; 	Brazilian Research Council-CNPq grant [308147/2009-0]; Rio de Janeiro State Science Foundation-FAPERJ grants [110.028/2011, 111.831/2011]; CNPq [303306/2010-6]; FAPERJ [E-26/103.012/2011]	Brazilian Research Council-CNPq grant; Rio de Janeiro State Science Foundation-FAPERJ grants; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	CGS was funded by the Brazilian Research Council-CNPq grant 308147/2009-0 and the Rio de Janeiro State Science Foundation-FAPERJ grants 110.028/2011 and 111.831/2011. HNS was funded by CNPq grant 303306/2010-6 and FAPERJ grant E-26/103.012/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests	Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Chaimanee Y, 2003, NATURE, V422, P61, DOI 10.1038/nature01449; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; de Oliveira FB, 2008, S AM PRIMATES DEV PR; Gebo DL, 1997, SCIENCE, V276, P401, DOI 10.1126/science.276.5311.401; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Hodgson JA, 2009, P NATL ACAD SCI USA, V106, P5534, DOI 10.1073/pnas.0810346106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Loss-Oliveira L, 2012, EVOL BIOINFORM, V8, P127, DOI 10.4137/EBO.S9008; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Ruff C, 2010, J HUM EVOL, V58, P166, DOI 10.1016/j.jhevol.2009.10.003; Schneider H, 2012, ZOOL SCR, V41, P1, DOI 10.1111/j.1463-6409.2011.00502.x; Schrago CG, 2007, AM J PHYS ANTHROPOL, V132, P344, DOI 10.1002/ajpa.20459; Seiffert ER, 2007, AM J PRIMATOL, V69, P27, DOI 10.1002/ajp.20324; Simons EL, 1996, AM J PHYS ANTHROPOL, V100, P261, DOI 10.1002/(SICI)1096-8644(199606)100:2<261::AID-AJPA7>3.0.CO;2-#; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Tabuce R, 2004, J HUM EVOL, V47, P305, DOI 10.1016/j.jhevol.2004.08.005; van Roosmalen Marc G.M., 2002, Neotropical Primates, V10, P1; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	26	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51699	10.1371/journal.pone.0051699	http://dx.doi.org/10.1371/journal.pone.0051699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272145	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800067
J	Prota, LFM; Cebotaru, L; Cheng, J; Wright, J; Vij, N; Morales, MM; Guggino, WB				Prota, Luiz Felipe M.; Cebotaru, Liudmila; Cheng, Jie; Wright, Jerry; Vij, Neeraj; Morales, Marcelo M.; Guggino, William B.			Dexamethasone Regulates CFTR Expression in Calu-3 Cells with the Involvement of Chaperones HSP70 and HSP90	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; FLUID TRANSPORT; DEGRADATION; LUNG; TRAFFICKING; SECRETION; PROTEIN; ENAC; DELTA-F508-CFTR	Background: Dexamethasone is widely used for pulmonary exacerbation in patients with cystic fibrosis, however, not much is known about the effects of glucocorticoids on the wild-type cystic fibrosis channel transmembrane regulator (CFTR). Our aim was to determine the effects of dexamethasone treatment on wild-type CFTR expression. Methods and Results: Dose-response (1 nM to 10 mM) and time course (3 to 48 h) curves were generated for dexamethasone for mRNA expression in Calu-3 cells using a real-time PCR. Within 24 h, dexamethasone (10 nM) showed a 0.3-fold decrease in CFTR mRNA expression, and a 3.2-fold increase in alpha ENaC mRNA expression compared with control groups. Dexamethasone (10 nM) induced a 1.97-fold increase in the total protein of wild-type CFTR, confirmed by inhibition by mifepristone. To access surface protein expression, biotinylation followed by Western blotting showed that dexamethasone treatment led to a 2.35-fold increase in the amount of CFTR in the cell surface compared with the untreated control groups. Once protein translation was inhibited with cycloheximide, dexamethasone could not increase the amount of CFTR protein. Protein stability was assessed by inhibition of protein synthesis with cycloheximide (50 mu g/ml) at different times in cells treated with dexamethasone and in untreated cells. Dexamethasone did not alter the degradation of wild-type CFTR. Assessment of the B band of CFTR within 15 min of metabolic pulse labeling showed a 1.5-fold increase in CFTR protein after treatment with dexamethasone for 24 h. Chaperone 90 (HSP90) binding to CFTR increased 1.55-fold after treatment with dexamethasone for 24 h, whereas chaperone 70 (HSP70) binding decreased 0.30 fold in an immunoprecipitation assay. Conclusion: Mature wild-type CFTR protein is regulated by dexamethasone post transcription, involving cotranslational mechanisms with HSP90 and HSP70, which enhances maturation and expression of wild-type CFTR. Citation: Prota LFM, Cebotaru L, Cheng J, Wright J, Vij N, et al. (2012) Dexamethasone Regulates CFTR Expression in Calu-3 Cells with the Involvement of Chaperones HSP70 and HSP90. PLoS ONE 7(12): e47405. doi: 10.1371/journal.pone.0047405	[Prota, Luiz Felipe M.; Morales, Marcelo M.] Univ Fed Rio de Janeiro, Lab Cellular & Mol Physiol, Rio De Janeiro, Brazil; [Prota, Luiz Felipe M.; Cebotaru, Liudmila; Cheng, Jie; Wright, Jerry; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Vij, Neeraj] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Morales, Marcelo M.] Johns Hopkins Univ, Sch Med, Inst Nanobiotechnol, Baltimore, MD USA	Universidade Federal do Rio de Janeiro; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Morales, MM (corresponding author), Univ Fed Rio de Janeiro, Lab Cellular & Mol Physiol, Rio De Janeiro, Brazil.	mmorales@biof.ufrj.br			Cystic Fibrosis Foundation; National Institutes of Health [CFFT GUGGINO5X0, NIH P01:DK72084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funding that has supported this work is from the Cystic Fibrosis Foundation and the National Institutes of Health, respectively, CFFT GUGGINO5X0 and NIH P01:DK72084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Blouquit S, 2006, AM J RESP CRIT CARE, V174, P299, DOI 10.1164/rccm.200506-987OC; Bradbury Neil A., 1999, Physiological Reviews, V79, pS175; Broackes-Carter FC, 2002, HUM MOL GENET, V11, P125, DOI 10.1093/hmg/11.2.125; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; CYR DM, 1992, J BIOL CHEM, V267, P20927; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; Foster KA, 2000, INT J PHARMACEUT, V208, P1, DOI 10.1016/S0378-5173(00)00452-X; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Husted RF, 2007, AM J PHYSIOL-RENAL, V293, pF813, DOI 10.1152/ajprenal.00225.2007; Itani OA, 2002, AM J PHYSIOL-LUNG C, V282, pL631, DOI 10.1152/ajplung.00085.2001; Konstas AA, 2002, J BIOL CHEM, V277, P25377, DOI 10.1074/jbc.M201925200; Kulaksiz H, 2001, HISTOCHEM CELL BIOL, V115, P131, DOI 10.1007/s004180000244; Lindert J, 2007, AM J RESP CELL MOL, V36, P688, DOI 10.1165/rcmb.2006-0347OC; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; McCarthy VA, 2005, PEDIATR PULM, V40, P1, DOI 10.1002/ppul.20199; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Pawliczak R, 2005, PHYSIOL GENOMICS, V23, P28, DOI 10.1152/physiolgenomics.00011.2005; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Rossi L, 2004, BLOOD CELL MOL DIS, V33, P57, DOI 10.1016/j.bcmd.2004.04.004; Rubenstein RC, 2011, AM J PHYSIOL-LUNG C, V300, pL88, DOI 10.1152/ajplung.00142.2010; Sayegh R, 1999, J BIOL CHEM, V274, P12431, DOI 10.1074/jbc.274.18.12431; Sloane PA, 2010, CURR OPIN PULM MED, V16, P591, DOI 10.1097/MCP.0b013e32833f1d00; TOMASHEFSKI JF, 1989, AM J CLIN PATHOL, V91, P522, DOI 10.1093/ajcp/91.5.522; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vankeerberghen Anne, 2002, J Cyst Fibros, V1, P13, DOI 10.1016/S1569-1993(01)00003-0; WARD CL, 1994, J BIOL CHEM, V269, P25710; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918; Yang CL, 2007, BIOCHEM BIOPH RES CO, V353, P535, DOI 10.1016/j.bbrc.2006.11.151; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	35	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e47405	10.1371/journal.pone.0047405	http://dx.doi.org/10.1371/journal.pone.0047405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272037	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600001
J	Bagnaresi, P; Biselli, C; Orru, L; Urso, S; Crispino, L; Abbruscato, P; Piffanelli, P; Lupotto, E; Cattivelli, L; Vale, G				Bagnaresi, Paolo; Biselli, Chiara; Orru, Luigi; Urso, Simona; Crispino, Laura; Abbruscato, Pamela; Piffanelli, Pietro; Lupotto, Elisabetta; Cattivelli, Luigi; Vale, Giampiero			Comparative Transcriptome Profiling of the Early Response to Magnaporthe oryzae in Durable Resistant vs Susceptible Rice (Oryza sativa L.) Genotypes	PLOS ONE			English	Article							GENE-EXPRESSION; BLAST-RESISTANCE; DISEASE RESISTANCE; RNA-SEQ; DEFENSE RESPONSES; PLANT CHITINASES; BROAD-SPECTRUM; PHYTOALEXIN; RECEPTOR; PROTEIN	Durable resistance to blast, the most significant fungal disease of rice, represents an agronomically relevant character. Gigante Vercelli (GV) and Vialone Nano (VN) are two old temperate japonica Italian rice cultivars with contrasting response to blast infection: GV displays durable and broad resistance while VN is highly susceptible. RNA-seq was used to dissect the early molecular processes deployed during the resistance response of GV at 24 h after blast inoculation. Differential gene expression analysis identified 1,070 and 1,484 modulated genes, of which 726 and 699 were up regulated in response to infection in GV and VN, respectively. Gene ontology (GO) enrichment analyses revealed a set of GO terms enriched in both varieties but, despite this commonality, the gene sets contributing to common GO enriched terms were dissimilar. The expression patterns of genes grouped in GV-specific enriched GO terms were examined in detail including at the transcript isoform level. GV exhibited a dramatic up-regulation of genes encoding diterpene phytoalexin biosynthetic enzymes, flavin-containing monooxygenase, class I chitinase and glycosyl hydrolase 17. The sensitivity and high dynamic range of RNA-seq allowed the identification of genes critically involved in conferring GV resistance during the early steps of defence perception-signalling. These included chitin oligosaccharides sensing factors, wall associated kinases, MAPK cascades and WRKY transcription factors. Candidate genes with expression patterns consistent with a potential role as GV-specific functional resistance (R) gene(s) were also identified. This first application of RNA-seq to dissect durable blast resistance supports a crucial role of the prompt induction of a battery of responses including defence-related genes as well as members of gene families involved in signalling and pathogen-related gene expression regulation.	[Bagnaresi, Paolo; Orru, Luigi; Urso, Simona; Cattivelli, Luigi; Vale, Giampiero] Consiglio Ric & Sperimentaz Agr, Genom Res Ctr, Fiorenzuola Darda, Piacenza, Italy; [Biselli, Chiara; Vale, Giampiero] Consiglio Ric & Sperimentaz Agr, Rice Res Unit, Vercelli, Italy; [Crispino, Laura; Abbruscato, Pamela; Piffanelli, Pietro] Parco Tecnol Padano, Lodi, Italy; [Lupotto, Elisabetta] Consiglio Ric & Sperimentaz Agr, Dept Plant Biol & Crop Prod, Rome, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Vale, G (corresponding author), Consiglio Ric & Sperimentaz Agr, Genom Res Ctr, Fiorenzuola Darda, Piacenza, Italy.	giampiero.vale@entecra.it	Valè, Giampiero/ABF-1492-2020; cattivelli, luigi/AAE-7046-2020	Valè, Giampiero/0000-0003-2158-9726; cattivelli, luigi/0000-0002-6067-4600; Bagnaresi, Paolo/0000-0001-8466-4805; Orru, Luigi/0000-0003-3496-218X	AGER Foundation, (RISINNOVA project) [2010-2369]	AGER Foundation, (RISINNOVA project)	This study was funded by grants from AGER Foundation, (RISINNOVA project grant no 2010-2369) to GV and L. Cattivelli. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruscato P, 2012, MOL PLANT PATHOL, V13, P828, DOI 10.1111/j.1364-3703.2012.00795.x; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Akimoto-Tomiyama C, 2003, PLANT MOL BIOL, V52, P537, DOI 10.1023/A:1024890601888; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Damasceno CMB, 2008, MOL PLANT MICROBE IN, V21, P820, DOI 10.1094/MPMI-21-6-0820; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Deng YW, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P161, DOI 10.1007/978-1-4020-9500-9_16; Dillon VM, 1997, PHYTOCHEMISTRY, V44, P599, DOI 10.1016/S0031-9422(96)00619-X; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Faivre-Rampant O, 2011, MOL BREEDING, V27, P233, DOI 10.1007/s11032-010-9426-0; Fritz-Laylin LK, 2005, PLANT PHYSIOL, V138, P611, DOI 10.1104/pp.104.054452; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hasegawa M, 2010, MOL PLANT MICROBE IN, V23, P1000, DOI 10.1094/MPMI-23-8-1000; Hayashi N, 2010, PLANT J, V64, P498, DOI 10.1111/j.1365-313X.2010.04348.x; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; HEATH MC, 1990, CAN J BOT, V68, P1627, DOI 10.1139/b90-209; Houterman PM, 2007, MOL PLANT PATHOL, V8, P215, DOI 10.1111/J.1364-3703.2007.00384.X; Houterman PM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000061; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jantasuriyarat C, 2005, PLANT PHYSIOL, V138, P105, DOI 10.1104/pp.104.055624; Jeung JU, 2007, THEOR APPL GENET, V115, P1163, DOI 10.1007/s00122-007-0642-x; Jung KH, 2010, TRENDS PLANT SCI, V15, P595, DOI 10.1016/j.tplants.2010.08.004; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; LEE FN, 1994, RICE BLAST DISEASE, P489; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li H, 2009, PLANT MOL BIOL, V69, P337, DOI 10.1007/s11103-008-9430-5; Li Q, 2006, PHYSIOL MOL PLANT P, V68, P51, DOI 10.1016/j.pmpp.2006.06.002; Li Y, 2011, J INTEGR PLANT BIOL, V53, P814, DOI 10.1111/j.1744-7909.2011.01070.x; Libault M, 2010, PLANT PHYSIOL, V152, P541, DOI 10.1104/pp.109.148379; Liu JL, 2010, MOL PLANT PATHOL, V11, P419, DOI [10.1111/J.1364-3703.2009.00607.X, 10.1111/j.1364-3703.2009.00607.x]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Marcel S, 2010, PLANT CELL, V22, P3177, DOI 10.1105/tpc.110.078048; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Menges M, 2008, NEW PHYTOL, V179, P643, DOI 10.1111/j.1469-8137.2008.02552.x; Mizuno H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-683; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nemoto T, 2007, BBA-GENE STRUCT EXPR, V1769, P678, DOI 10.1016/j.bbaexp.2007.08.007; Okada A, 2009, J BIOL CHEM, V284, P26510, DOI 10.1074/jbc.M109.036871; Okada K, 2011, BIOSCI BIOTECH BIOCH, V75, P1219, DOI 10.1271/bbb.110228; Park CJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1932; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Peng Y, 2010, RICE, V3, P36, DOI 10.1007/s12284-010-9039-6; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Roumen E, 1997, EUR J PLANT PATHOL, V103, P363, DOI 10.1023/A:1008697728788; Shen QXJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-3; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Shimono M, 2012, MOL PLANT PATHOL, V13, P83, DOI 10.1111/j.1364-3703.2011.00732.x; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Umemura K, 2003, BIOSCI BIOTECH BIOCH, V67, P899, DOI 10.1271/bbb.67.899; Vergne E, 2007, NEW PHYTOL, V174, P159, DOI 10.1111/j.1469-8137.2007.01971.x; Vergne E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-206; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu JL, 2005, THEOR APPL GENET, V111, P50, DOI 10.1007/s00122-005-1971-2; Xu YH, 2004, PLANT PHYSIOL, V135, P507, DOI 10.1104/pp.104.038612; Yang QinZhong, 2009, Scientia Agricultura Sinica, V42, P1601; Yang Xin, 2012, [Frontiers in Biology, 生物学前沿], V7, P155; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216	88	119	124	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51609	10.1371/journal.pone.0051609	http://dx.doi.org/10.1371/journal.pone.0051609			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251593	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200145
J	Ramsey, JM; Schwarz, E; Guest, PC; van Beveren, NJM; Leweke, FM; Rothermundt, M; Bogerts, B; Steiner, J; Ruta, L; Baron-Cohen, S; Bahn, S				Ramsey, Jordan M.; Schwarz, Emanuel; Guest, Paul C.; van Beveren, Nico J. M.; Leweke, F. Markus; Rothermundt, Matthias; Bogerts, Bernhard; Steiner, Johann; Ruta, Liliana; Baron-Cohen, Simon; Bahn, Sabine			Molecular Sex Differences in Human Serum	PLOS ONE			English	Article							GENDER-DIFFERENCES; DIMORPHISM; INFLAMMATION; TESTOSTERONE; ADIPONECTIN; SENSITIVITY; MECHANISMS; BIOMARKERS; STRESS; RISK	Background: Sex is an important factor in the prevalence, incidence, progression, and response to treatment of many medical conditions, including autoimmune and cardiovascular diseases and psychiatric conditions. Identification of molecular differences between typical males and females can provide a valuable basis for exploring conditions differentially affected by sex. Methodology/Principal Findings: Using multiplexed immunoassays, we analyzed 174 serum molecules in 9 independent cohorts of typical individuals, comprising 196 males and 196 females. Sex differences in analyte levels were quantified using a meta-analysis approach and put into biological context using k-means to generate clusters of analytes with distinct biological functions. Natural sex differences were established in these analyte groups and these were applied to illustrate sexually dimorphic analyte expression in a cohort of 22 males and 22 females with Asperger syndrome. Reproducible sex differences were found in the levels of 77 analytes in serum of typical controls, and these comprised clusters of molecules enriched with distinct biological functions. Analytes involved in fatty acid oxidation/hormone regulation, immune cell growth and activation, and cell death were found at higher levels in females, and analytes involved in immune cell chemotaxis and other indistinct functions were higher in males. Comparison of these naturally occurring sex differences against a cohort of people with Asperger syndrome indicated that a cluster of analytes that had functions related to fatty acid oxidation/hormone regulation was associated with sex and the occurrence of this condition. Conclusions/Significance: Sex-specific molecular differences were detected in serum of typical controls and these were reproducible across independent cohorts. This study extends current knowledge of sex differences in biological functions involved in metabolism and immune function. Deviations from typical sex differences were found in a cluster of molecules in Asperger syndrome. These findings illustrate the importance of investigating the influence of sex on medical conditions.	[Ramsey, Jordan M.; Schwarz, Emanuel; Guest, Paul C.; Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [van Beveren, Nico J. M.] Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands; [Leweke, F. Markus] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Leweke, F. Markus] Heidelberg Univ, Cent Inst Mental Hlth, Mannheim, Germany; [Rothermundt, Matthias] Univ Munster, Dept Psychiat, Munster, Germany; [Bogerts, Bernhard; Steiner, Johann] Univ Magdeburg, Dept Psychiat, D-39106 Magdeburg, Germany; [Ruta, Liliana; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Bahn, Sabine] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; University of Cologne; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Munster; Otto von Guericke University; University of Cambridge; Erasmus University Rotterdam; Erasmus MC	Bahn, S (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	sb209@cam.ac.uk	Leweke, F. Markus/D-5435-2009; Ruta, Liliana/B-2440-2012; Ruta, Liliana/AGF-5918-2022; Leweke, Markus/GVS-7897-2022	Leweke, F. Markus/0000-0002-8163-195X; Ruta, Liliana/0000-0003-4615-7495; guest, paul/0000-0002-5030-7137; Steiner, Johann/0000-0002-2611-2268; Baron-Cohen, Simon/0000-0001-9217-2544	Psynova Neurotech Inc; European Union FP7 SchizDX research programme [223427]; Dutch Fund for Economic Structure Reinforcement (FES) [0908]; AutismSpeaks grant [6009]; MRC; Wellcome Trust; Edmonton Churchill Scholarship (Canada); Natural Sciences and Engineering Research Council of Canada (NSERC); Cambridge Commonwealth Trust; MRC [G0600977] Funding Source: UKRI; Medical Research Council [G0600977] Funding Source: researchfish	Psynova Neurotech Inc; European Union FP7 SchizDX research programme; Dutch Fund for Economic Structure Reinforcement (FES); AutismSpeaks grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Edmonton Churchill Scholarship (Canada); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cambridge Commonwealth Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Psynova Neurotech Inc; the European Union FP7 SchizDX research programme (grant reference 223427); the Dutch Fund for Economic Structure Reinforcement (FES) under grant agreement number 0908 (the "NeuroBasic PharmaPhenomics project"); and the AutismSpeaks grant (#6009). SBC, BA, and LR were supported by the MRC and the Wellcome Trust during the period of this work. JMR was supported by the Edmonton Churchill Scholarship (Canada), the Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship, and the Cambridge Commonwealth Trust for the duration of the study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertenshaw GP, 2008, CANCER EPIDEM BIOMAR, V17, P2872, DOI 10.1158/1055-9965.EPI-08-0464; Cannon JG, 1997, J PSYCHIAT RES, V31, P99, DOI 10.1016/S0022-3956(96)00055-6; Casimir GJA, 2011, J CLIN MICROBIOL, V49, P478, DOI 10.1128/JCM.02096-10; Chen DC, 2011, NANOELECTRONIC CIRCUIT DESIGN, P1, DOI 10.1007/978-1-4419-7609-3_1; Cliff N., 2004, J MODERN APPL STAT M, V3, P322, DOI [10.22237/jmasm/1099267560, DOI 10.22237/JMASM/1099267560, DOI 10.22237/jmasm/1099267560]; Cliff N, 1996, ORDINAL METHODS BEHA, P123; Czlonkowska A, 2006, ENDOCRINE, V29, P243, DOI 10.1385/ENDO:29:2:243; DASILVA JAP, 1994, J RHEUMATOL, V21, P330; Delaleu N, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2375; Denton K, 2007, AM J PHYSIOL-REG I, V292, pR697, DOI 10.1152/ajpregu.00766.2006; Devaraj S, 2008, ARTERIOSCL THROM VAS, V28, P1368, DOI 10.1161/ATVBAHA.108.163303; Fabricatore AN, 2011, INT J OBESITY, V35, P1363, DOI 10.1038/ijo.2011.2; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Ghobrial IM, 2011, AM J HEMATOL, V86, P573, DOI 10.1002/ajh.22048; GROSSMAN C, 1989, J STEROID BIOCHEM, V34, P241, DOI 10.1016/0022-4731(89)90088-5; Hess MR, 2004, ANN M AM ED RES ASS; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kang K, 2012, FASEB J, V26, P259, DOI 10.1096/fj.11-191460; KROMREY JD, 2005, JOINT STAT M MINN MN; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Luster A.D., 2001, ENCY LIFE SCI, P1; Mahr S, 2003, ANN RHEUM DIS, V62, P1234, DOI 10.1136/ard.2002.005041; McCullough AJ, 2002, J CLIN GASTROENTEROL, V34, P255, DOI 10.1097/00004836-200203000-00013; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Miller VM, 2012, LANCET, V379, P873, DOI 10.1016/S0140-6736(12)60200-1; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Nalbandian Greg, 2005, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V5, P85, DOI 10.2174/1568013053005418; Pelfrey CM, 2001, CLIN APPL IMMUNOLOGY, V1, P331; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Saad F, 2011, J OBES, V2011, DOI 10.1155/2011/471584; Saltevo J, 2009, GENDER MED, V6, P463, DOI 10.1016/j.genm.2009.09.006; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Spitzer JA, 1999, LUPUS, V8, P380, DOI 10.1177/096120339900800510; STAPRANS I, 1990, ARTERIOSCLEROSIS, V10, P591, DOI 10.1161/01.ATV.10.4.591; Sutton AJAK, 2000, METHODS METAANALYSIS; Thangavel C, 2007, ENDOCRINOLOGY, V148, P2894, DOI 10.1210/en.2006-1333; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Tingen CM, 2010, WOMENS HEALTH, V6, P511, DOI 10.2217/WHE.10.45; Umstead TM, 2012, ARTIF ORGANS, V36, pE1, DOI 10.1111/j.1525-1594.2011.01412.x; VAMVAKOPOULOS NV, 1995, MEDIAT INFLAMM, V4, P163, DOI 10.1155/S0962935195000275; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; vonEckardstein A, 1997, J CLIN ENDOCR METAB, V82, P3367, DOI 10.1210/jc.82.10.3367; Wang M, 2007, AM J PHYSIOL-ENDOC M, V293, pE872, DOI 10.1152/ajpendo.00251.2007; Wolin KY, 2011, BRIT J CANCER, V104, P882, DOI 10.1038/sj.bjc.6606045	50	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51504	10.1371/journal.pone.0051504	http://dx.doi.org/10.1371/journal.pone.0051504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251558	Green Published, gold			2022-12-27	WOS:000313236200125
J	Rattinger, GB; Mullins, CD; Zuckerman, IH; Onukwugha, E; Walker, LD; Gundlapalli, A; Samore, M; DeLisle, S				Rattinger, Gail B.; Mullins, C. Daniel; Zuckerman, Ilene H.; Onukwugha, Eberechukwu; Walker, Loreen D.; Gundlapalli, Adi; Samore, Matthew; DeLisle, Sylvain			Sustainable Strategy to Prevent Misuse of Antibiotics for Acute Respiratory Infections	PLOS ONE			English	Article							CLINICAL DECISION-SUPPORT; TRACT INFECTIONS; PRINCIPLES; SYSTEMS; PRESCRIPTIONS; IMPROVE; ADULTS; TRIAL	Backgrounds: Over 50% of antibiotics prescriptions are for outpatients with acute respiratory infections (ARI). Many of them are not needed and thus contribute both avoidable adverse events and pressures toward the development of bacterial resistance. Could a clinical decision support system (CDSS), interposed at the time of electronic prescription, adjust antibiotics utilization toward consensus treatment guidelines for ARI? Methods: This is a retrospective comparison of pre- (2002) and post-intervention (2003-2006) periods at two comprehensive health care systems (intervention and control). The intervention was a CDSS that targeted fluoroquinolone and azithromycin; other antibiotics remained unrestricted. 7000 outpatients visits flagged by an ARI case-finding algorithm were reviewed for congruence with the guidelines (antibiotic prescribed-when-warranted or not-prescribed-when-unwarranted). Results: 3831 patients satisfied the case definitions for one or more ARI: pneumonia (537), bronchitis (2931), sinusitis (717) and non-specific ARI (145). All patients with pneumonia received antibiotics. The relative risk (RR) of congruent prescribing was 2.57 (95% CI = (1.865 to 3.540) in favor of the intervention site for the antibiotics targeted by the CDSS; congruence did not change for other antibiotics (adjusted RR = 1.18 (95% CI = (0.691 to 2.011)). The proportion of unwarranted prescriptions of the targeted antibiotics decreased from 22% to 3%, pre vs. post-intervention (p<0.0001). Conclusions: A CDSS interposed at the time of e-prescription nearly extinguished unwarranted use targeted antibiotics for ARI for four years. This intervention highlights a path toward sustainable antibiotics stewardship for outpatients with ARI.	[Rattinger, Gail B.; DeLisle, Sylvain] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA; [Rattinger, Gail B.; Mullins, C. Daniel; Zuckerman, Ilene H.; Onukwugha, Eberechukwu; Walker, Loreen D.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Rattinger, Gail B.] Fairleigh Dickinson Univ, Sch Pharm, Florham Pk, NJ USA; [Gundlapalli, Adi; Samore, Matthew] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Gundlapalli, Adi; Samore, Matthew] Univ Utah, Sch Med, Salt Lake City, UT USA; [Zuckerman, Ilene H.; DeLisle, Sylvain] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Fairleigh Dickinson University; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University System of Maryland; University of Maryland Baltimore	DeLisle, S (corresponding author), Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA.	sdelisle@umaryland.edu		Mullins, C. Daniel/0000-0003-4322-2490	Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs [SHP-08-162, IIR 06-119-1]; Centers for Disease Control and Prevention [R01 CI000098, RFA HK000013, 1 P01HK000069-01]; Elan Pharmaceuticals; American Foundation for Pharmaceutical Education Faculty Fellowship; National Institutes of Health [K12HD043489]; Department of Veterans Affairs; Centers for Disease Control and Prevention; American Foundation for Pharmaceutical Education; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043489] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000098] Funding Source: NIH RePORTER	Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Elan Pharmaceuticals; American Foundation for Pharmaceutical Education Faculty Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Foundation for Pharmaceutical Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This material is the result of work supported with resources and the use of facilities at the VA Maryland Health Care System and the Salt Lake City VA Health System. This work was also supported in part by grants SHP-08-162 and IIR 06-119-1 from the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs. Development and validation of the ARI case-detection algorithm was supported by grants R01 CI000098, RFA HK000013 and 1 P01HK000069-01 from the Centers for Disease Control and Prevention. GR was supported by a postdoctoral fellowship grant from Elan Pharmaceuticals (2007-2009), an American Foundation for Pharmaceutical Education Faculty Fellowship (2009) and by a National Institutes of Health K12HD043489 training grant (2010-2011). The funding agencies and the commercial sponsor played no role in the study design; in the collection, analysis, and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare financial support from the Department of Veterans Affairs (SD), the Centers for Disease Control and Prevention (SD and MS), Elan Pharmaceuticals (GBR), the American Foundation for Pharmaceutical Education (GBR) and by the National Institutes of Health (GBR). There were no financial relationships with any organizations that might have an interest in the submitted work in the previous 5 years, and no other relationships or activities that could appear to have influenced the submitted work. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Aspinall SL, 2009, AM J EMERG MED, V27, P544, DOI 10.1016/j.ajem.2008.04.015; Atkins D, 2010, AM J MED, V123, pE38, DOI 10.1016/j.amjmed.2010.10.007; Besser RE, 2003, ANN INTERN MED, V138, P605, DOI 10.7326/0003-4819-138-7-200304010-00020; Christakis DA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.2.e15; DeLisle S, 2001, CRIT CARE MED, V29, pN121, DOI 10.1097/00003246-200104001-00012; DeLisle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013377; Durieux P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002894.pub2; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Harris AD, 2006, J AM MED INFORM ASSN, V13, P16, DOI 10.1197/jamia.M1749; Huttner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036649; Huttner B, 2012, J ANTIMICROB CHEMOTH, V67, P1537, DOI 10.1093/jac/dks074; Jones M, 2012, INFECT CONT HOSP EP, V33, P362, DOI 10.1086/664767; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kuyvenhoven MM, 2003, J ANTIMICROB CHEMOTH, V52, P675, DOI 10.1093/jac/dkg412; Metlay JP, 2007, ANN EMERG MED, V50, P221, DOI 10.1016/j.annemergmed.2007.03.022; Paul M, 2006, J ANTIMICROB CHEMOTH, V58, P1238, DOI 10.1093/jac/dkl372; Pearson SA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-154; Pestotnik SL, 1996, ANN INTERN MED, V124, P884, DOI 10.7326/0003-4819-124-10-199605150-00004; Ranji SR, 2008, MED CARE, V46, P847, DOI 10.1097/MLR.0b013e318178eabd; Samore MH, 2005, JAMA-J AM MED ASSOC, V294, P2305, DOI 10.1001/jama.294.18.2305; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Snow V, 2001, ANN INTERN MED, V134, P495, DOI 10.7326/0003-4819-134-6-200103200-00016; Snow V, 2001, ANN INTERN MED, V134, P487, DOI 10.7326/0003-4819-134-6-200103200-00014; Steinman MA, 2003, ANN INTERN MED, V138, P525, DOI 10.7326/0003-4819-138-7-200304010-00008; Vanderweil SG, 2007, ACAD EMERG MED, V14, P366, DOI 10.1197/j.aem.2006.10.096; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51147	10.1371/journal.pone.0051147	http://dx.doi.org/10.1371/journal.pone.0051147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251440	gold, Green Published			2022-12-27	WOS:000313236200063
J	Wang, DY; Han, XJ; Li, SF; Liu, DQ; Yan, CG; Zuo, XN; Zhu, CZ; He, Y; Kiviniemi, V; Zang, YF				Wang, De-Yi; Han, Xiu-Jie; Li, Su-Fang; Liu, Dong-Qiang; Yan, Chao-Gan; Zuo, Xi-Nian; Zhu, Chao-Zhe; He, Yong; Kiviniemi, Vesa; Zang, Yu-Feng			Effects of Apolipoprotein E Genotype on the Off-Line Memory Consolidation	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; REGIONAL HOMOGENEITY; FUNCTIONAL MRI; BRAIN ACTIVITY; STATE; SYNCHRONIZATION; HIPPOCAMPUS; EXPERIENCES; CELLS	Spontaneous brain activity or off-line activity after memory encoding is associated with memory consolidation. A few recent resting-state functional magnetic resonance imaging (RS-fMRI) studies indicate that the RS-fMRI could map off-line memory consolidation effects. However, the gene effects on memory consolidation process remain largely unknown. Here we collected two RS-fMRI sessions, one before and another after an episodic memory encoding task, from two groups of healthy young adults, one with apolipoprotein E (APOE) epsilon 2/epsilon 3 and the other with APOE epsilon 3/epsilon 4. The ratio of regional homogeneity (ReHo), a measure of local synchronization of spontaneous RS-fMRI signal, of the two sessions was used as an index of memory-consolidation. APOE epsilon 3/epsilon 4 group showed greater ReHo ratio within the medial temporal lobe (MTL). The ReHo ratio in MTL was significantly correlated with the recognition memory performance in the APOE epsilon 3/epsilon 4 group but not in epsilon 2/epsilon 3 group. Additionally, APOE epsilon 3/epsilon 4 group showed lower ReHo ratio in the occipital and parietal picture-encoding areas. Our results indicate that APOE epsilon 3/epsilon 4 group may have a different off-line memory consolidation process compared to epsilon 2/epsilon 3 group. These results may help generate future hypotheses that the off-line memory consolidation might be impaired in Alzheimer's disease.	[Wang, De-Yi; Han, Xiu-Jie; Li, Su-Fang; Yan, Chao-Gan; Zuo, Xi-Nian; Zhu, Chao-Zhe; He, Yong; Zang, Yu-Feng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Han, Xiu-Jie] Anshan Changda Hosp, Dept Neurol, Anshan, Liaoning, Peoples R China; [Liu, Dong-Qiang; Zang, Yu-Feng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liu, Dong-Qiang; Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Yan, Chao-Gan] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Lab Funct Connectome & Dev, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Kiviniemi, Vesa] Univ Hosp Oulu, Dept Diagnost Radiol, Oulu, Finland	Beijing Normal University; Hangzhou Normal University; Hangzhou Normal University; Nathan Kline Institute for Psychiatric Research; Chinese Academy of Sciences; Institute of Psychology, CAS	Zang, YF (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zangyf@gmail.com	ZANG, Yu-Feng/J-1558-2012; Li, Sufang/N-5697-2016; He, Yong/C-2161-2009; He, Yong/Q-5756-2018; Zuo, Xi-Nian/A-7273-2009; Yan, Chao-Gan/D-1713-2015	ZANG, Yu-Feng/0000-0003-1833-8010; Li, Sufang/0000-0002-4716-4761; Zuo, Xi-Nian/0000-0001-9110-585X; Yan, Chao-Gan/0000-0003-3413-5977; He, Yong/0000-0002-7039-2850	NSFC [81020108022, 30770594]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); Ministry of Education of China [B07008]	NSFC(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ministry of Education of China(Ministry of Education, China)	This study was supported by NSFC (81020108022, 30770594), the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT), and the 111 Project from the Ministry of Education of China (B07008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Clement F, 2010, CORTEX, V46, P1005, DOI 10.1016/j.cortex.2009.07.003; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Daselaar SM, 2010, NEUROBIOL LEARN MEM, V93, P422, DOI 10.1016/j.nlm.2009.12.009; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Green DM, 1966, SIGNAL DETECTION THE, pxi; Groen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019985; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Lang P.J., 2008, A8 U FLOR; Lechner HA, 1999, LEARN MEMORY, V6, P77; Lopez-Aranda MF, 2009, SCIENCE, V325, P87, DOI 10.1126/science.1170869; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Pihlajamaki M, 2009, CURR ALZHEIMER RES, V6, P179, DOI 10.2174/156720509787602898; Schwindt GC, 2009, NEUROIMAGE, V45, P181, DOI 10.1016/j.neuroimage.2008.11.024; Smith JF, 2010, NEUROIMAGE, V50, P826, DOI 10.1016/j.neuroimage.2009.11.053; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Souchay C, 2009, CURR ALZHEIMER RES, V6, P186, DOI 10.2174/156720509788486545; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Teipel SJ, 2010, PSYCHIAT RES-NEUROIM, V182, P244, DOI 10.1016/j.pscychresns.2010.03.003; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Trivedi MA, 2008, NEUROPSYCHOLOGIA, V46, P1667, DOI 10.1016/j.neuropsychologia.2007.11.035; TSAI MS, 1994, AM J HUM GENET, V54, P643; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wang DY, 2012, NEUROREPORT, V23, P873, DOI 10.1097/WNR.0b013e3283587c96; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007	39	4	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51617	10.1371/journal.pone.0051617	http://dx.doi.org/10.1371/journal.pone.0051617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251595	Green Submitted, gold, Green Published			2022-12-27	WOS:000313236200147
J	Yanagihara, AA; Shohet, RV				Yanagihara, Angel A.; Shohet, Ralph V.			Cubozoan Venom-Induced Cardiovascular Collapse Is Caused by Hyperkalemia and Prevented by Zinc Gluconate in Mice	PLOS ONE			English	Article							JELLYFISH CHIRONEX-FLECKERI; BOX JELLYFISH; PARTIAL-PURIFICATION; HYDRA NEMATOCYSTS; IN-VIVO; TOXINS; ENVENOMATION; ANTIVENOM; HEMOLYSIS; VERAPAMIL	Chironex fleckeri (Australian box jellyfish) stings can cause acute cardiovascular collapse and death. We developed methods to recover venom with high specific activity, and evaluated the effects of both total venom and constituent porins at doses equivalent to lethal envenomation. Marked potassium release occurred within 5 min and hemolysis within 20 min in human red blood cells (RBC) exposed to venom or purified venom porin. Electron microscopy revealed abundant, similar to 12-nm transmembrane pores in RBC exposed to purified venom porins. C57BL/6 mice injected with venom showed rapid decline in ejection fraction with progression to electromechanical dissociation and electrocardiographic findings consistent with acute hyperkalemia. Recognizing that porin assembly can be inhibited by zinc, we found that zinc gluconate inhibited potassium efflux from RBC exposed to total venom or purified porin, and prolonged survival time in mice following venom injection. These findings suggest that hyperkalemia is the critical event following Chironex fleckeri envenomation and that rapid administration of zinc could be life saving in human sting victims.	[Yanagihara, Angel A.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Yanagihara, Angel A.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Bekesy Lab Neurobiol, Honolulu, HI 96822 USA; [Shohet, Ralph V.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Yanagihara, AA (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	angel@pbrc.hawaii.edu	Yanagihara, Angel/O-5664-2016	Yanagihara, Angel/0000-0001-6908-8176	Hawaii Community Foundation [958935, 991879, 20001741, 20011908, 20061497, 20071368, 47031]; Institute of Neurological Disorders and Stroke [U54NS039406]; National Heart Lung and Blood Institute [UH1HL073449]; National Center for Research Resources [P20RR016453, G12RR003061]; National Institute on Drug Abuse, National Institutes of Health [R21DA024444]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL073449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS039406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024444] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	Hawaii Community Foundation; Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by grants 958935, 991879, 20001741, 20011908, 20061497, 20071368, and 47031 from the Hawaii Community Foundation, as well as grants U54NS039406 from the Institute of Neurological Disorders and Stroke, UH1HL073449 from the National Heart Lung and Blood Institute, P20RR016453 and G12RR003061 from the National Center for Research Resources, and grant R21DA024444 from the National Institute on Drug Abuse, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVIGAD LS, 1976, INFECT IMMUN, V13, P1378, DOI 10.1128/IAI.13.5.1378-1381.1976; Bailey PM, 2005, TOXICON, V45, P233, DOI 10.1016/j.toxicon.2004.10.013; BARNES J. H., 1960, MED JOUR AUSTRALIA II, V47, P993; BASHFORD CL, 1986, J BIOL CHEM, V261, P9300; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; BERNHEIMER AW, 1979, TOXICON, V17, P69, DOI 10.1016/0041-0101(79)90257-5; Bloom DA, 1998, TOXICON, V36, P1075, DOI 10.1016/S0041-0101(98)00096-8; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; Carrette T, 2004, TOXICON, V44, P135, DOI 10.1016/j.toxicon.2004.04.008; Chung JJ, 2001, TOXICON, V39, P981, DOI 10.1016/S0041-0101(00)00237-3; Cuypers E, 2006, FEBS LETT, V580, P5728, DOI 10.1016/j.febslet.2006.09.030; Deutzmann R, 2000, DEVELOPMENT, V127, P4669; FLECKER H, 1952, Med J Aust, V1, P35; Flecker H., 1945, MED J AUSTRALIA, V20, P128; FREEMAN SE, 1969, BRIT J PHARMACOL, V35, P510, DOI 10.1111/j.1476-5381.1969.tb08292.x; HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402; Koch AW, 1998, J CELL SCI, V111, P1545; LUMLEY J, 1988, MED J AUSTRALIA, V148, P527, DOI 10.5694/j.1326-5377.1988.tb99466.x; MUSTAFA MR, 1995, TOXICOL APPL PHARM, V133, P196, DOI 10.1006/taap.1995.1142; Ramasamy S, 2004, TOXICON, V43, P685, DOI 10.1016/j.toxicon.2004.02.024; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Ruediger GF, 1903, J AMER MED ASSOC, V41, P962; Sonthichai C, 2009, OUTBREAK SURVEILLANC, V2, P9; Tibballs J, 1998, ANAESTH INTENS CARE, V26, P40, DOI 10.1177/0310057X9802600105; Tibballs J, 2006, TOXICON, V48, P830, DOI 10.1016/j.toxicon.2006.07.020; WINKEL K, 2003, J TOXICOL-TOXIN REV, V22, P13; Winkel KD, 2005, CLIN EXP PHARMACOL P, V32, P777, DOI 10.1111/j.1440-1681.2005.04258.x	27	37	40	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51368	10.1371/journal.pone.0051368	http://dx.doi.org/10.1371/journal.pone.0051368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251508	Green Submitted, gold, Green Published			2022-12-27	WOS:000313236200096
J	Bydlon, TM; Barry, WT; Kennedy, SA; Brown, JQ; Gallagher, JE; Wilke, LG; Geradts, J; Ramanujam, N				Bydlon, Torre M.; Barry, William T.; Kennedy, Stephanie A.; Brown, J. Quincy; Gallagher, Jennifer E.; Wilke, Lee G.; Geradts, Joseph; Ramanujam, Nimmi			Advancing Optical Imaging for Breast Margin Assessment: An Analysis of Excisional Time, Cautery, and Patent Blue Dye on Underlying Sources of Contrast	PLOS ONE			English	Article							FROZEN-SECTION ANALYSIS; DIFFUSE-REFLECTANCE SPECTROSCOPY; TOUCH PREPARATION CYTOLOGY; LUMPECTOMY MARGINS; SURGICAL MARGINS; RE-EXCISION; MONTE-CARLO; INTRAOPERATIVE EVALUATION; PARTIAL MASTECTOMY; POSITIVE MARGINS	Breast conserving surgery (BCS) is a recommended treatment for breast cancer patients where the goal is to remove the tumor and a surrounding rim of normal tissue. Unfortunately, a high percentage of patients return for additional surgeries to remove all of the cancer. Post-operative pathology is the gold standard for evaluating BCS margins but is limited due to the amount of tissue that can be sampled. Frozen section analysis and touch-preparation cytology have been proposed to address the surgical needs but also have sampling limitations. These issues represent an unmet clinical need for guidance in resecting malignant tissue intra-operatively and for pathological sampling. We have developed a quantitative spectral imaging device to examine margins intra-operatively. The context in which this technology is applied (intra-operative or post-operative setting) is influenced by time after excision and surgical factors including cautery and the presence of patent blue dye (specifically Lymphazurin(TM), used for sentinel lymph node mapping). Optical endpoints of hemoglobin ([THb]), fat ([beta-carotene]), and fibroglandular content via light scattering (<mu s'>) measurements were quantified from diffuse reflectance spectra of lumpectomy and mastectomy specimens using a Monte Carlo model. A linear longitudinal mixed-effects model was used to fit the optical endpoints for the cautery and kinetics studies. Monte Carlo simulations and tissue mimicking phantoms were used for the patent blue dye experiments. [THb], [beta-carotene], and <mu s'> were affected by < 3.3% error with < 80 mu M of patent blue dye. The percent change in [beta-carotene], <mu s'>, and [beta-carotene]/<mu s'>. was < 14% in 30 minutes, while percent change in [THb] was > 40%. [beta-carotene] and [beta-carotene]/<mu s'>. were the only parameters not affected by cautery. This work demonstrates the importance of understanding the post-excision kinetics of ex-vivo tissue and the presence of cautery and patent blue dye for breast tumor margin assessment, to accurately interpret data and exploit underling sources of contrast.	[Bydlon, Torre M.; Kennedy, Stephanie A.; Brown, J. Quincy; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Barry, William T.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Brown, J. Quincy; Ramanujam, Nimmi] Zenalux, Res Triangle Pk, NC USA; [Gallagher, Jennifer E.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Wilke, Lee G.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Geradts, Joseph] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27706 USA	Duke University; Harvard University; Dana-Farber Cancer Institute; Duke University; University of Wisconsin System; University of Wisconsin Madison; Duke University	Ramanujam, N (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	nimmi@duke.edu	Ramanujam, Nimmi/AAA-7575-2021; Brown, J. Quincy/F-6090-2012	Ramanujam, Nimmi/0000-0001-7319-8415; 	Department of Defense Breast Cancer Predoctoral Traineeship [W81XWH-04-1-0340]; Department of Defense [W81XWH-05-1-036]; National Institute of Health [1R41CA128160-01]; Duke University's CTSA from NCRR/NIH [1 UL1 RR024128-01]; NATIONAL CANCER INSTITUTE [R41CA128160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011574] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Predoctoral Traineeship; Department of Defense(United States Department of Defense); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University's CTSA from NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the following grants: the Department of Defense Breast Cancer Predoctoral Traineeship W81XWH-04-1-0340, the Department of Defense award W81XWH-05-1-036, National Institute of Health award 1R41CA128160-01, and was supported in part by Duke University's CTSA grant 1 UL1 RR024128-01 from NCRR/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Balch GC, 2005, AM SURGEON, V71, P22; Bender JE, 2009, IEEE T BIO-MED ENG, V56, P960, DOI 10.1109/TBME.2008.2005994; Bigio IJ, 2000, J BIOMED OPT, V5, P221, DOI 10.1117/1.429990; Breslin TM, 2004, ANN SURG ONCOL, V11, P65, DOI 10.1007/BF02524348; Brown J, 2010, IEEE J SELE IN PRESS; Brown JQ, 2010, IEEE J SEL TOP QUANT, V16, P530, DOI 10.1109/JSTQE.2009.2033257; Brown JQ, 2009, CANCER RES, V69, P2919, DOI 10.1158/0008-5472.CAN-08-3370; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Cabioglu N, 2007, ANN SURG ONCOL, V14, P1458, DOI 10.1245/s10434-006-9236-0; Cendan JC, 2005, J AM COLL SURGEONS, V201, P194, DOI 10.1016/j.jamcollsurg.2005.03.014; Cerussi AE, 2001, ACAD RADIOL, V8, P211, DOI 10.1016/S1076-6332(03)80529-9; Chagpar A, 2003, AM J SURG, V186, P371, DOI 10.1016/S0002-9610(03)00264-2; COX CE, 1991, ARCH SURG-CHICAGO, V126, P490; Creager AJ, 2002, ARCH PATHOL LAB MED, V126, P846; Demos SG, 2006, J MAMMARY GLAND BIOL, V11, P165, DOI 10.1007/s10911-006-9022-4; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Ghosh N, 2001, APPL OPTICS, V40, P176, DOI 10.1364/AO.40.000176; Guidi AJ, 1997, CANCER, V79, P1568, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1568::AID-CNCR19>3.0.CO;2-W; Haka AS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247154; Haka AS, 2006, CANCER RES, V66, P3317, DOI 10.1158/0008-5472.CAn-05-2815; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; Hsiung PL, 2007, RADIOLOGY, V244, P865, DOI 10.1148/radiol.2443061536; Huston TL, 2006, AM J SURG, V192, P509, DOI 10.1016/j.amjsurg.2006.06.021; Jacobs L, 2008, ANN SURG ONCOL, V15, P1271, DOI 10.1245/s10434-007-9766-0; Johnson A T, 2001, Breast Dis, V12, P35; Keller MD, 2010, LASER SURG MED, V42, P15, DOI 10.1002/lsm.20865; Keller MD, 2009, OPT LETT, V34, P926, DOI 10.1364/OL.34.000926; Keller MD, 2012, LASER SURG MED, V42, P15; Kennedy S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2770; Klimberg VS, 1998, ANN SURG ONCOL, V5, P220, DOI 10.1007/BF02303776; Kobbermann A, 2010, ANN SURG ONCOL; Kunos C, 2006, BREAST J, V12, P28, DOI 10.1111/j.1075-122X.2006.00181.x; Laughney AM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3516594; Lee MC, 2009, BREAST J, V15, P34, DOI 10.1111/j.1524-4741.2008.00668.x; Majumder SK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2975962; Mann RM, 2010, BREAST CANCER RES TR, V119, P415, DOI 10.1007/s10549-009-0616-6; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; Mendez JE, 2006, AM J SURG, V192, P538, DOI 10.1016/j.amjsurg.2006.06.009; Nachabe R, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3611010; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Noguchi, 1995, Breast Cancer, V2, P27, DOI 10.1007/BF02966893; Olson TP, 2007, ANN SURG ONCOL, V14, P2953, DOI 10.1245/s10434-007-9437-1; Palmer GM, 2006, APPL OPTICS, V45, P1072, DOI 10.1364/AO.45.001072; Palmer GM, 2006, APPL OPTICS, V45, P1062, DOI 10.1364/AO.45.001062; Palmer GM, 2003, IEEE T BIO-MED ENG, V50, P1233, DOI 10.1109/TBME.2003.818488; Pleijhuis RG, 2009, ANN SURG ONCOL, V16, P2717, DOI 10.1245/s10434-009-0609-z; Pogue BW, 2004, J BIOMED OPT, V9, P541, DOI 10.1117/1.1691028; Pogue BW, 2001, RADIOLOGY, V218, P261, DOI 10.1148/radiology.218.1.r01ja51261; Ruidiaz ME, 2011, J SURG ONCOL, V104, P746, DOI 10.1002/jso.22012; Saarela AO, 1997, J SURG ONCOL, V66, P248, DOI 10.1002/(SICI)1096-9098(199712)66:4<248::AID-JSO5>3.0.CO;2-B; Sanchez C, 2010, AM SURGEON, V76, P331; SAUTER ER, 1994, CANCER-AM CANCER SOC, V73, P2607, DOI 10.1002/1097-0142(19940515)73:10<2607::AID-CNCR2820731023>3.0.CO;2-1; Shah N, 2001, P NATL ACAD SCI USA, V98, P4420, DOI 10.1073/pnas.071511098; Singletary SE, 2002, AM J SURG, V184, P383, DOI 10.1016/S0002-9610(02)01012-7; Spinelli L, 2004, J BIOMED OPT, V9, P1137, DOI 10.1117/1.1803546; Valdes EK, 2007, ANN SURG ONCOL, V14, P1045, DOI 10.1245/s10434-006-9263-x; Volynskaya Z, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2909672; Weber S, 1997, CANCER J SCI AM, V3, P273; Wilke LG, 2009, AM J SURG, V198, P566, DOI 10.1016/j.amjsurg.2009.06.018; Zhu CF, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1897398; Zhu CF, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2931078; Zhu CF, 2008, OPT EXPRESS, V16, P14961, DOI 10.1364/OE.16.014961; Zhu CF, 2006, LASER SURG MED, V38, P714, DOI 10.1002/lsm.20356; Zysk AM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2358964	65	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51418	10.1371/journal.pone.0051418	http://dx.doi.org/10.1371/journal.pone.0051418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251526	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900084
J	Crouzet, SM; Joubert, OR; Thorpe, SJ; Fabre-Thorpe, M				Crouzet, Sebastien M.; Joubert, Olivier R.; Thorpe, Simon J.; Fabre-Thorpe, Michele			Animal Detection Precedes Access to Scene Category	PLOS ONE			English	Article							TIME-COURSE; OBJECT RECOGNITION; NATURAL SCENES; VISUAL-SEARCH; CATEGORIZATION; ATTENTION; PERCEPTION; CONTEXT; STATISTICS; DEPLOYMENT	The processes underlying object recognition are fundamental for the understanding of visual perception. Humans can recognize many objects rapidly even in complex scenes, a task that still presents major challenges for computer vision systems. A common experimental demonstration of this ability is the rapid animal detection protocol, where human participants earliest responses to report the presence/absence of animals in natural scenes are observed at 250-270 ms latencies. One of the hypotheses to account for such speed is that people would not actually recognize an animal per se, but rather base their decision on global scene statistics. These global statistics (also referred to as spatial envelope or gist) have been shown to be computationally easy to process and could thus be used as a proxy for coarse object recognition. Here, using a saccadic choice task, which allows us to investigate a previously inaccessible temporal window of visual processing, we showed that animal - but not vehicle - detection clearly precedes scene categorization. This asynchrony is in addition validated by a late contextual modulation of animal detection, starting simultaneously with the availability of scene category. Interestingly, the advantage for animal over scene categorization is in opposition to the results of simulations using standard computational models. Taken together, these results challenge the idea that rapid animal detection might be based on early access of global scene statistics, and rather suggests a process based on the extraction of specific local complex features that might be hardwired in the visual system.	[Crouzet, Sebastien M.; Joubert, Olivier R.; Thorpe, Simon J.; Fabre-Thorpe, Michele] Univ Toulouse, UPS, CerCo, Toulouse, France; [Crouzet, Sebastien M.; Joubert, Olivier R.; Thorpe, Simon J.; Fabre-Thorpe, Michele] CNRS, UMR 5549, Toulouse, France; [Crouzet, Sebastien M.] Brown Univ, Providence, RI 02912 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Brown University	Fabre-Thorpe, M (corresponding author), Univ Toulouse, UPS, CerCo, Toulouse, France.	michele.fabre-thorpe@cerco.ups-tlse.fr	THORPE, Simon J/A-5661-2008; Fabre-Thorpe, Michèle/B-2698-2008; Crouzet, Sébastien M./B-6429-2013	THORPE, Simon J/0000-0003-4997-3367; Crouzet, Sébastien M./0000-0003-0898-9557	CNRS (Centre National de la Recherche Scientifique); French Government (Ministere de la Recherche et de l'Enseignement Superieur) [ANR ADVISE ANR-08-MNPS-001-01]; Fondation pour la Recherche Medicale	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); French Government (Ministere de la Recherche et de l'Enseignement Superieur); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the CNRS (Centre National de la Recherche Scientifique), by the French Government (Ministere de la Recherche et de l'Enseignement Superieur - ANR ADVISE ANR-08-MNPS-001-01, Direction Generale pour l'Armement) and by the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Crouzet SM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00326; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Delorme A, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00021; Drewes J, 2011, J VISION, V11, DOI 10.1167/11.2.20; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Evans KK, 2005, J EXP PSYCHOL HUMAN, V31, P1476, DOI 10.1037/0096-1523.31.6.1476; Fabre-Thorpe M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00243; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fize D, 2011, P NATL ACAD SCI USA, V108, P7635, DOI 10.1073/pnas.1016213108; Ghebreab S, 2009, ADV NEURAL INF PROCE, P1; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hollingworth A, 1998, J EXP PSYCHOL GEN, V127, P398, DOI 10.1037/0096-3445.127.4.398; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Joubert OR, 2008, J VISION, V8, DOI 10.1167/8.13.11; Joubert OR, 2009, J VISION, V9, DOI 10.1167/9.1.2; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Lock TM, 2003, EXP BRAIN RES, V151, P455, DOI 10.1007/s00221-003-1500-y; Loschky LC, 2010, VIS COGN, V18, P513, DOI 10.1080/13506280902937606; Mace MJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005927; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; Rousselet GA, 2005, VIS COGN, V12, P852, DOI 10.1080/13506280444000553; Rousselet GA, 2007, J COGNITIVE NEUROSCI, V19, P1241, DOI 10.1162/jocn.2007.19.8.1241; Scholte HS, 2009, J VISION, V9, DOI 10.1167/9.4.29; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Treisman A, 2006, VIS COGN, V14, P411, DOI 10.1080/13506280500195250; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029; VanRullen R, 2004, J COGNITIVE NEUROSCI, V16, P4, DOI 10.1162/089892904322755502; VanRullen R, 2009, VIS COGN, V17, P103, DOI 10.1080/13506280802196451; Vo MLH, 2010, J VISION, V10, DOI 10.1167/10.3.14; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; WEBSTER MJ, 1993, J COMP NEUROL, V335, P73, DOI 10.1002/cne.903350106; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411	55	35	35	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51471	10.1371/journal.pone.0051471	http://dx.doi.org/10.1371/journal.pone.0051471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	052ML	23251545	gold, Green Published			2022-12-27	WOS:000312201900091
J	Dahdul, WM; Balhoff, JP; Blackburn, DC; Diehl, AD; Haendel, MA; Hall, BK; Lapp, H; Lundberg, JG; Mungall, CJ; Ringwald, M; Segerdell, E; Van Slyke, CE; Vickaryous, MK; Westerfield, M; Mabee, PM				Dahdul, Wasila M.; Balhoff, James P.; Blackburn, David C.; Diehl, Alexander D.; Haendel, Melissa A.; Hall, Brian K.; Lapp, Hilmar; Lundberg, John G.; Mungall, Christopher J.; Ringwald, Martin; Segerdell, Erik; Van Slyke, Ceri E.; Vickaryous, Matthew K.; Westerfield, Monte; Mabee, Paula M.			A Unified Anatomy Ontology of the Vertebrate Skeletal System	PLOS ONE			English	Article							PHENOTYPE ONTOLOGIES; GENOMICS; MODEL; INFORMATICS; MORPHOLOGY; EVOLUTION; DATABASE	The skeleton is of fundamental importance in research in comparative vertebrate morphology, paleontology, biomechanics, developmental biology, and systematics. Motivated by research questions that require computational access to and comparative reasoning across the diverse skeletal phenotypes of vertebrates, we developed a module of anatomical concepts for the skeletal system, the Vertebrate Skeletal Anatomy Ontology (VSAO), to accommodate and unify the existing skeletal terminologies for the species-specific (mouse, the frog Xenopus, zebrafish) and multispecies (teleost, amphibian) vertebrate anatomy ontologies. Previous differences between these terminologies prevented even simple queries across databases pertaining to vertebrate morphology. This module of upper-level and specific skeletal terms currently includes 223 defined terms and 179 synonyms that integrate skeletal cells, tissues, biological processes, organs (skeletal elements such as bones and cartilages), and subdivisions of the skeletal system. The VSAO is designed to integrate with other ontologies, including the Common Anatomy Reference Ontology (CARO), Gene Ontology (GO), Uberon, and Cell Ontology (CL), and it is freely available to the community to be updated with additional terms required for research. Its structure accommodates anatomical variation among vertebrate species in development, structure, and composition. Annotation of diverse vertebrate phenotypes with this ontology will enable novel inquiries across the full spectrum of phenotypic diversity.	[Dahdul, Wasila M.; Mabee, Paula M.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Dahdul, Wasila M.; Balhoff, James P.; Lapp, Hilmar] Natl Evolutionary Synth Ctr, Durham, NC USA; [Balhoff, James P.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Blackburn, David C.] Calif Acad Sci, Dept Vertebrate Zool & Anthropol, San Francisco, CA 94118 USA; [Diehl, Alexander D.] SUNY Buffalo, Jacobs Neurol Inst, Buffalo, NY 14260 USA; [Haendel, Melissa A.; Segerdell, Erik] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Hall, Brian K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Lundberg, John G.] Acad Nat Sci Philadelphia, Dept Ichthyol, Philadelphia, PA 19103 USA; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Ringwald, Martin] Jackson Lab, Bar Harbor, ME 04609 USA; [Van Slyke, Ceri E.; Westerfield, Monte] Univ Oregon, Zebrafish Informat Network, Eugene, OR 97403 USA; [Vickaryous, Matthew K.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of South Dakota; The National Evolutionary Synthesis Center; University of North Carolina; University of North Carolina Chapel Hill; California Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Oregon Health & Science University; Dalhousie University; Drexel University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Jackson Laboratory; University of Oregon; University of Guelph; University of Oregon	Dahdul, WM (corresponding author), Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA.	wasila.dahdul@usd.edu	Blackburn, David/L-3812-2019; Diehl, Alexander/G-9883-2016; Mungall, Chris/I-6006-2019; Lapp, Hilmar/A-8275-2009	Blackburn, David/0000-0002-1810-9886; Diehl, Alexander/0000-0001-9990-8331; Mungall, Chris/0000-0002-6601-2165; Balhoff, James/0000-0002-8688-6599; Haendel, Melissa/0000-0001-9114-8737; Lapp, Hilmar/0000-0001-9107-0714; Van Slyke, Ceri/0000-0002-2244-7917; Segerdell, Erik/0000-0002-9611-1279; Dahdul, Wasila/0000-0003-3162-7490; Mabee, Paula/0000-0002-8455-3213	National Science Foundation [DBI-0641025, DBI-1062404, DBI-1062542]; National Institutes of Health [HG002659]; National Evolutionary Synthesis Center [NSF EF-0423641, EF-0905606]; Direct For Biological Sciences [1062542] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1062404] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by grants from the National Science Foundation (www.nsf.gov) (DBI-0641025, DBI-1062404, DBI-1062542), National Institutes of Health (www.nih.gov) (HG002659), and the National Evolutionary Synthesis Center (www.nescent.org) (NSF EF-0423641, NSF #EF-0905606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arratia G, 2001, J MORPHOL, V250, P101, DOI 10.1002/jmor.1062; Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Blake J. A., 2008, CURR PROTOC BIOINFOR, V23, P721; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Burger A., 2008, ANATOMY ONTOLOGIES B; Burke AC, 1991, DEV PATTERNING VERTE; Courtot M, 2011, APPL ONTOL, V6, P23, DOI 10.3233/AO-2011-0087; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; Dahdul WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010708; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; Dettai A, 2004, SYST BIOL, V53, P822, DOI 10.1080/10635150490522313; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; Hall BK, 2005, ZOOLOGY, V108, P269, DOI 10.1016/j.zool.2005.09.005; Hall BK, 2005, J EXP ZOOL PART B, V304B, P548, DOI 10.1002/jez.b.21057; Hall Brian K., 2007, P13; Hayamizu TF, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r29; Janvier P, 2011, CURR BIOL, V21, pR661, DOI 10.1016/j.cub.2011.07.014; Mabee PM, 2007, J EXP ZOOL PART B, V308B, P655, DOI 10.1002/jez.b.21181; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Maglia AM, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P367; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Mungall CJ, 2011, J BIOMED INFORM, V44, P80, DOI 10.1016/j.jbi.2010.02.002; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Niknejad A, 2012, BIOINFORMATICS, V28, P1017, DOI 10.1093/bioinformatics/bts048; Parr CS, 2012, TRENDS ECOL EVOL, V27, P94, DOI 10.1016/j.tree.2011.11.001; Patterson C, 1977, PROBLEMS VERTEBRATE, P121; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; SCOTTSAVAGE P, 1979, J MORPHOL, V162, P453, DOI 10.1002/jmor.1051620310; Segerdell E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-92; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; SMITH MM, 1990, BIOL REV, V65, P277, DOI 10.1111/j.1469-185X.1990.tb01427.x; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Vickaryous Matthew K., 2007, P323; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	40	30	30	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51070	10.1371/journal.pone.0051070	http://dx.doi.org/10.1371/journal.pone.0051070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251424	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900038
J	Espinoza, JL; Takami, A; Trung, LQ; Kato, S; Nakao, S				Espinoza, J. Luis; Takami, Akiyoshi; Ly Quoc Trung; Kato, Shunichi; Nakao, Shinji			Resveratrol Prevents EBV Transformation and Inhibits the Outgrowth of EBV-Immortalized Human B Cells	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NF-KAPPA-B; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS; LATENT MEMBRANE-PROTEIN-1; MIR-155; PROLIFERATION; EXPRESSION; APOPTOSIS; LYMPHOMA; STAT3	Background: Epstein Barr virus-associated lymphoproliferative disease is an increasing complication in patients with immunosuppressive conditions. Although the current therapies for this disorder are effective, they are also associated with significant toxicity. In an attempt to identify newer therapeutic agents, this study investigated the effects of Resveratrol, a naturally occurring polyphenolic compound, on the EBV transformation of human B cells. Methodology/Principal Findings: This study demonstrates that resveratrol prevents EBV transformation in human B cells. These effects are mediated by specific cytotoxic activities of resveratrol against EBV-infected B cells that are associated with the downregulation of the anti-apoptotic proteins Mcl-1 and survivin. This occurs as a consequence of the inhibition of EBV-induced NFkB and STAT-3 signaling pathways and a resveratrol-induced decrease in the expression of the oncogenic viral product LMP1 in EBV-infected B cells. In addition, resveratrol decreased the expression of miR-155 and miR-34a in EBV-infected B cells, blocked the expression of the anti-apoptotic viral gene BHRF1, and thus interrupted events that are critical for EBV transformation and the survival of EBV-transformed cells. Conclusions/Significance: These results suggest that resveratrol may therefore be a potentially effective therapeutic alternative for preventing EBV-associated lymphoproliferative diseases in immune compromised patients.	[Takami, Akiyoshi] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan; [Espinoza, J. Luis; Ly Quoc Trung; Nakao, Shinji] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Kato, Shunichi] Tokai Univ, Sch Med, Dept Cell Transplantat, Isehara, Kanagawa 25911, Japan	Kanazawa University; Kanazawa University; Tokai University	Takami, A (corresponding author), Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan.	takami@staff.kanazawa-u.ac.jp	Takami, Akiyoshi/O-5677-2019; Espinoza, Luis/L-1586-2013	Takami, Akiyoshi/0000-0002-1822-9976; Espinoza, Luis/0000-0002-1794-6666	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports and Technology of Japan; Hokkoku Gan Kikin Fund (Kanazawa, Japan); Research on Allergic Disease and Immunology in Hearth and Labor Science Grant from the Ministry of Hearth, Labor and Welfare of Japan [H23-010]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokkoku Gan Kikin Fund (Kanazawa, Japan); Research on Allergic Disease and Immunology in Hearth and Labor Science Grant from the Ministry of Hearth, Labor and Welfare of Japan	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan, and the Ministry of Education, Culture, Sports and Technology of Japan, and a fund by Hokkoku Gan Kikin Fund (Kanazawa, Japan). This work was supported in part by the Research on Allergic Disease and Immunology (H23-010) in Hearth and Labor Science Grant from the Ministry of Hearth, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Blaes AH, 2010, EXPERT REV HEMATOL, V3, P35, DOI [10.1586/ehm.09.76, 10.1586/EHM.09.76]; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Campagna M, 2010, BIOCHEM SOC T, V38, P50, DOI 10.1042/BST0380050; De Leo A, 2011, MOL CANCER RES, V9, P1346, DOI 10.1158/1541-7786.MCR-11-0145; de Oliveira DE, 2010, TRENDS MICROBIOL, V18, P248, DOI 10.1016/j.tim.2010.04.001; Delmas D, 2011, ANN NY ACAD SCI, V1215, P48, DOI 10.1111/j.1749-6632.2010.05871.x; Dirmeier U, 2003, CANCER RES, V63, P2982; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Espinoza JL, 2012, HAEMATOLOGICA; Forte E, 2012, J VIROL, V86, P6889, DOI 10.1128/JVI.07056-11; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Goormachtigh G, 2006, J VIROL, V80, P7382, DOI 10.1128/JVI.02052-05; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Halder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007214; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Knowles DM, 1999, MODERN PATHOL, V12, P200; Kondo S, 2011, J VIROL, V85, P11255, DOI 10.1128/JVI.00188-11; Kundu JK, 2004, MUTAT RES-FUND MOL M, V555, P65, DOI 10.1016/j.mrfmmm.2004.05.019; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Lay MLJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-252; Levin LI, 2003, JAMA-J AM MED ASSOC, V289, P1533, DOI 10.1001/jama.289.12.1533; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; MAZZEI GJ, 1995, J BIOL CHEM, V270, P7025, DOI 10.1074/jbc.270.13.7025; Merlo A, 2011, INT J HEMATOL, V93, P281, DOI 10.1007/s12185-011-0782-2; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Reddy N, 2011, BIOL BLOOD MARROW TR, V17, P591, DOI 10.1016/j.bbmt.2010.08.007; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Thornburg NJ, 2006, ONCOGENE, V25, P288, DOI 10.1038/sj.onc.1209023; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Tsai SC, 2009, BLOOD, V114, P109, DOI 10.1182/blood-2008-12-193375; Tsutsui M, 2010, INT J LAB HEMATOL, V32, P419, DOI 10.1111/j.1751-553X.2009.01204.x; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464; Yiu CY, 2010, MOLECULES, V15, P7115, DOI 10.3390/molecules15107115; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	44	66	68	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51306	10.1371/journal.pone.0051306	http://dx.doi.org/10.1371/journal.pone.0051306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251493	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900066
J	Hassouna, R; Zizzari, P; Viltart, O; Yang, SK; Gardette, R; Videau, C; Badoer, E; Epelbaum, J; Tolle, V				Hassouna, Rim; Zizzari, Philippe; Viltart, Odile; Yang, Seung-Kwon; Gardette, Robert; Videau, Catherine; Badoer, Emilio; Epelbaum, Jacques; Tolle, Virginie			A Natural Variant of Obestatin, Q90L, Inhibits Ghrelin's Action on Food Intake and GH Secretion and Targets NPY and GHRH Neurons in Mice	PLOS ONE			English	Article							GROWTH-HORMONE SECRETAGOGUE; HYPOTHALAMIC ARCUATE NUCLEUS; GREEN FLUORESCENT PROTEIN; NEUROPEPTIDE-Y NEURONS; FAMILY TRIOS ANALYSIS; MESSENGER-RNA; PREPROGHRELIN GENE; PERIPHERAL GHRELIN; PEPTIDE; RECEPTOR	Background: Ghrelin and obestatin are two gut-derived peptides originating from the same ghrelin/obestatin prepropeptide gene (GHRL). While ghrelin stimulates growth hormone (GH) secretion and food intake and inhibits gamma-aminobutyric-acid synaptic transmission onto GHRH (Growth Hormone Releasing Hormone) neurons, obestatin blocks these effects. In Humans, GHRL gene polymorphisms have been associated with pathologies linked to an unbalanced energy homeostasis. We hypothesized that one polymorphism located in the obestatin sequence (Q to L substitution in position 90 of the ghrelin/obestatin prepropeptide, rs4684677) may impact on the function of obestatin. In the present study, we tested the activity of native and Q90L obestatin to modulate ghrelin-induced food intake, GH secretion, cFos activity in GHRH and Neuropeptide Y (NPY) neurons and gamma-aminobutyric-acid activity onto GHRH neurons. Methodology/Principal findings: Food intake, GH secretion and electrophysiological recordings were assessed in C57BL/6 mice. cFos activity was measured in NPY-Renilla-GFP and GHRH-eGFP mice. Mice received saline, ghrelin or ghrelin combined to native or Q90L obestatin (30 nmol each) in the early light phase. Ghrelin stimulation of food intake and GH secretion varied considerably among individual mice with 59-77% eliciting a robust response. In these high-responders, ghrelin-induced food intake and GH secretion were reduced equally by native and Q90L obestatin. In contrast to in vivo observations, Q90L was slightly more efficient than native obestatin in inhibiting ghrelin-induced cFos activation within the hypothalamic arcuate nucleus and the nucleus tractus solitarius of the brainstem. After ghrelin injection, 26% of NPY neurons in the arcuate nucleus expressed cFos protein and this number was significantly reduced by co-administration of Q90L obestatin. Q90L was also more potent that native obestatin in reducing ghrelin-induced inhibition of gamma-aminobutyric-acid synaptic transmission onto GHRH neurons. Conclusions/Significance: These data support the hypothesis that Q90L obestatin partially blocks ghrelin-induced food intake and GH secretion by acting through NPY and GHRH neurons.	[Hassouna, Rim; Zizzari, Philippe; Gardette, Robert; Videau, Catherine; Epelbaum, Jacques; Tolle, Virginie] Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S 894, Paris, France; [Viltart, Odile] INSERM, Lab Dev & Plasticite Cerveau Postnatal, Ctr Rech JPARC, UMR 837, F-59045 Lille, France; [Viltart, Odile] Univ Lille Nord France USTL Lille 1, Lille, France; [Yang, Seung-Kwon] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Badoer, Emilio] RMIT Univ, Sch Med Sci, Melbourne, Australia; [Badoer, Emilio] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Queensland; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Tolle, V (corresponding author), Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S 894, Paris, France.	virginie.tolle@inserm.fr	Hassouna, Rim/AAS-5664-2021; Epelbaum, Jacques/B-2263-2013; Tolle, Virginie S/H-5264-2015	Tolle, Virginie S/0000-0003-4456-0002; Zizzari, Philippe/0000-0001-8838-0762	INSERM Programme National de Recherche en Reproduction et Endocrinology (PNRRE)	INSERM Programme National de Recherche en Reproduction et Endocrinology (PNRRE)	This work was supported by an INSERM Programme National de Recherche en Reproduction et Endocrinology (PNRRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2006, AM J MED GENET B, V141B, P929, DOI 10.1002/ajmg.b.30387; Annemie V, 2009, REGUL PEPTIDES, V156, P77, DOI 10.1016/j.regpep.2009.04.014; Balthasar N, 2003, ENDOCRINOLOGY, V144, P2728, DOI 10.1210/en.2003-0006; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; Cellini E, 2006, PSYCHIAT GENET, V16, P51, DOI 10.1097/01.ypg.0000194444.89436.e9; Chartrel N, 2007, SCIENCE, p766c; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Dardennes RM, 2007, PSYCHONEUROENDOCRINO, V32, P106, DOI 10.1016/j.psyneuen.2006.11.003; Dickson SL, 1997, ENDOCRINOLOGY, V138, P771, DOI 10.1210/en.138.2.771; DICKSON SL, 1993, NEUROSCIENCE, V53, P303, DOI 10.1016/0306-4522(93)90197-N; Feng DD, 2011, EUR J NEUROSCI, V34, P732, DOI 10.1111/j.1460-9568.2011.07787.x; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hassouna R, 2010, J NEUROENDOCRINOL, P794; Hewson AK, 2000, J NEUROENDOCRINOL, V12, P1047, DOI 10.1046/j.1365-2826.2000.00584.x; Hinney A, 2002, J CLIN ENDOCR METAB, V87, P2716, DOI 10.1210/jc.87.6.2716; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Kamegai J, 1996, ENDOCRINOLOGY, V137, P2109, DOI 10.1210/en.137.5.2109; Katayama M, 2000, NEUROENDOCRINOLOGY, V72, P333, DOI 10.1159/000054602; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Larsen LH, 2005, CLIN BIOCHEM, V38, P420, DOI 10.1016/j.clinbiochem.2005.01.008; Lauwers E, 2006, BIOCHEM BIOPH RES CO, V351, P21, DOI 10.1016/j.bbrc.2006.09.141; Li YF, 2006, J CLIN INVEST, V116, P506, DOI 10.1172/JCI26564; Mejias R, 2011, P NATL ACAD SCI USA, V108, P4920, DOI 10.1073/pnas.1102233108; Nogueiras R, 2007, ENDOCRINOLOGY, V148, P21, DOI 10.1210/en.2006-0915; Seoane LM, 2006, J ENDOCRINOL INVEST, V29, pRC13, DOI 10.1007/BF03344174; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Steinle NI, 2005, J CLIN ENDOCR METAB, V90, P6672, DOI 10.1210/jc.2005-0549; Stengel A, 2010, PHYSIOL BEHAV, V101, P614, DOI 10.1016/j.physbeh.2010.09.009; Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253; Tannenbaum GS, 2003, ENDOCRINOLOGY, V144, P967, DOI 10.1210/en.2002-220852; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P4420, DOI 10.1210/en.139.10.4420; Tolle V, 2001, NEUROENDOCRINOLOGY, V73, P54, DOI 10.1159/000054620; Tomasetto C, 2000, GASTROENTEROLOGY, V119, P395, DOI 10.1053/gast.2000.9371; Toshinai K, 2003, ENDOCRINOLOGY, V144, P1506, DOI 10.1210/en.2002-220788; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Wang LX, 2011, PEPTIDES, V32, P51, DOI 10.1016/j.peptides.2010.10.017; Wang LX, 2002, NEUROSCI LETT, V325, P47; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yu YH, 2009, APPETITE, V52, P372, DOI 10.1016/j.appet.2008.11.011; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zizzari P, 2007, ENDOCRINOLOGY, V148, P1648, DOI 10.1210/en.2006-1231	45	33	37	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51135	10.1371/journal.pone.0051135	http://dx.doi.org/10.1371/journal.pone.0051135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251435	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900044
J	Langkilde, A; Petersen, J; Klausen, HH; Henriksen, JH; Eugen-Olsen, J; Andersen, O				Langkilde, Anne; Petersen, Janne; Klausen, Henrik Hedegaard; Henriksen, Jens Henrik; Eugen-Olsen, Jesper; Andersen, Ove			Inflammation in HIV-Infected Patients: Impact of HIV, Lifestyle, Body Composition, and Demography - A Cross Sectional Cohort Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; UROKINASE RECEPTOR; METABOLIC SYNDROME; MORTALITY; PLASMA; SURVIVAL; DISEASE; MARKER; CANCER; ADULTS	Objectives: To examine mechanisms underlying the increased inflammatory state of HIV-infected patients, by investigating the association of HIV-related factors, demography, lifestyle, and body composition with the inflammatory marker soluble urokinase plasminogen activator receptor (suPAR). Methods: suPAR was measured in EDTA-plasma and associated with HIV-related factors (HIV-duration, combination antiretroviral treatment (cART), nadir CD4+ cell count, CD4+ cell count, and HIV RNA); demography; lifestyle; and body composition determined by Dual energy X-ray Absorptiometry (DXA) scan, in multiple linear regression analyses adjusted for biological relevant covariates, in a cross-sectional study of 1142 HIV-infected patients. Results: Increased suPAR levels were significantly associated with age, female sex, daily smoking, metabolic syndrome and waist circumference. cART was associated with 17% lower suPAR levels. In cART-treated patients 10-fold higher HIV RNA was associated with 21% higher suPAR, whereas there was no association in untreated patients. Patients with CD4+ cell count<350 cells/mu L had 7% higher suPAR, but we found no association with nadir CD4+ cell count or with duration of HIV-infection. Finally, suPAR was not associated with adipose tissue distribution, but strongly associated with low muscle mass. In patients infected through intravenous drug use (IDU), CD4+ cell counts<350 cells/mu L were associated with 27% lower suPAR (p = 0.03), and suPAR was 4% lower pr.year during treatment (p = 0.05); however, there was no association with HIV RNA, duration of HIV-infection, nor cART. Conclusion: We found elevated suPAR levels in untreated patients compared to patients on cART. Moreover, we observed a significant positive association between suPAR and HIV RNA levels in cART-treated patients. Age, HIV-transmission through IDU, metabolic syndrome, smoking, and low leg muscle mass were also significantly associated with suPAR levels. Our study therefore indicates, that also other aspects of living with HIV than virologic and immunologic markers add to the increased inflammation in HIV-infected patients.	[Langkilde, Anne; Petersen, Janne; Klausen, Henrik Hedegaard; Eugen-Olsen, Jesper; Andersen, Ove] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Henriksen, Jens Henrik] Copenhagen Univ Hosp, Dept Clin Physiol & Nucl Med, Hvidovre, Denmark; [Andersen, Ove] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Langkilde, A (corresponding author), Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark.	annelangkilde@gmail.com	Andersen, Ove/D-3091-2019	Andersen, Ove/0000-0002-2274-548X; Eugen-Olsen, Jesper/0000-0002-4630-4275; Petersen, Janne/0000-0001-7323-2548	ViroGates A/S	ViroGates A/S	ViroGates A/S donated the suPARnostic (R) kits for suPAR measurements. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Andersen ES, 2011, EUR J CLIN MICROBIOL, V30, P761, DOI 10.1007/s10096-010-1149-y; Andersen O, 2008, J INFECTION, V57, P55, DOI 10.1016/j.jinf.2008.01.014; Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bonnet E, 2005, J CLIN DENSITOM, V8, P287, DOI 10.1385/JCD:8:3:287; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Celentano DD, 2007, CLIN INFECT DIS, V45, pS318, DOI 10.1086/522557; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Galli L, 2012, EUR J EPIDEMIOL, V27, P657, DOI 10.1007/s10654-012-9707-5; Gore-Felton C, 2008, PSYCHOSOM MED, V70, P569, DOI 10.1097/PSY.0b013e318177353e; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hansen BR, 2009, HIV MED, V10, P378, DOI 10.1111/j.1468-1293.2009.00697.x; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; Langkilde A, 2011, CANCER EPIDEM BIOMAR, V20, P609, DOI 10.1158/1055-9965.EPI-10-1009; Larsen MV, 2010, ADDICTION, V105, P529, DOI 10.1111/j.1360-0443.2009.02827.x; Lee JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034218; Lifson Alan R, 2012, Curr HIV/AIDS Rep, V9, P223, DOI 10.1007/s11904-012-0121-0; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Lyngbaek S, 2012, INT J CARDIOL; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Ostrowski SR, 2010, SOLUBLE FACTORS MEDIATING INNATE IMMUNE RESPONSES TO HIV INFECTION, P81; Ostrowski SR, 2005, JAIDS-J ACQ IMM DEF, V39, P23, DOI 10.1097/01.qai.0000157950.02076.a6; Ostrowski SR, 2004, JAIDS-J ACQ IMM DEF, V35, P337, DOI 10.1097/00126334-200404010-00002; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Rodriguez-Arenas MA, 2006, AIDS RES HUM RETROV, V22, P715, DOI 10.1089/aid.2006.22.715; Scherzer R, 2011, AIDS, V25, P1405, DOI 10.1097/QAD.0b013e32834884e6; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Sidenius N, 2000, BLOOD, V96, P4091; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Toldi G, 2012, CLIN CHEM LAB MED, V0, P1, DOI DOI 10.1515/CCLM-2012-0221; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wood E, 2003, CAN MED ASSOC J, V169, P656	41	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51698	10.1371/journal.pone.0051698	http://dx.doi.org/10.1371/journal.pone.0051698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251607	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900114
J	Zhang, X; Huang, YP; Gao, HN; Yang, MF; Zhao, H; Hu, JH; Chen, XM; Ma, WH; Fan, J				Zhang, Xuan; Huang, Ya Ping; Gao, Hai Nv; Yang, Mei Fang; Zhao, Hong; Hu, Jian Hua; Chen, Xiao Ming; Ma, Wei Hang; Fan, Jun			Quantification of Cytomegalovirus Glycoprotein Bn DNA in Hematopoietic Stem Cell Transplant Recipients by Real-time PCR	PLOS ONE			English	Article							PP65 ANTIGENEMIA; GENOTYPES; OUTCOMES; THERAPY; LOAD	Based on sequence variation in the N-terminus of the UL55 gene, which encodes glycoprotein B (gB), human cytomegalovirus (CMV) can be classified into four gBn genotypes. We assessed the distribution of CMV gBn genotypes and the correlation between CMV gBn DNA (detected by real-time PCR) and CMV-positive pp65 cells (identified by immunohistochemical staining) in a cohort of hematopoietic stem cell transplant patients. The distribution of gB genotypes was as follows: gBn1, 60% of patients; gBn2, 13.3%; mixed gBn1 and gBn3 infection, 26.7%; and gBn4 and other mixed infections, 0%. CMV gBn1 was the most common genotype. The detected level of CMV gB DNA correlated well with the number of CMV-positive pp65 cells detected by immunostaining (r = 0.585).	[Zhang, Xuan; Huang, Ya Ping; Gao, Hai Nv; Yang, Mei Fang; Zhao, Hong; Hu, Jian Hua; Chen, Xiao Ming; Ma, Wei Hang; Fan, Jun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Fan, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	fanjunzju@163.com		Zhang, Xuan/0000-0001-9186-4741	National Natural Science Foundation of China [30872239]; Research of Health Department of China Province-Ministry Co-construct [WKJ2009-2-023]; Technology Team for Major Infectious Diseases Prevention Control, Warning and Treatment [2009R50041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research of Health Department of China Province-Ministry Co-construct; Technology Team for Major Infectious Diseases Prevention Control, Warning and Treatment	This study was supported by the National Natural Science Foundation of China (30872239), Research of Health Department of China Province-Ministry Co-construct (WKJ2009-2-023), and the Technology Team for Major Infectious Diseases Prevention Control, Warning and Treatment (2009R50041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeckh M, 1998, CLIN MICROBIOL REV, V11, P533, DOI 10.1128/CMR.11.3.533; CHOU SW, 1992, VIROLOGY, V188, P388, DOI 10.1016/0042-6822(92)90771-G; Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496; Fan J, 2009, J VIROL METHODS, V160, P74, DOI 10.1016/j.jviromet.2009.04.018; Fan J, 2006, HEPATOB PANCREAT DIS, V1, P34; Fan J, 2006, CHINESE MED J-PEKING, V119, P871, DOI 10.1097/00029330-200605020-00014; Kusne S, 1999, TRANSPLANTATION, V68, P1125, DOI 10.1097/00007890-199910270-00011; Lukacsi A, 2001, J MED VIROL, V65, P537, DOI 10.1002/jmv.2070; Nichols WG, 2001, BLOOD, V97, P867, DOI 10.1182/blood.V97.4.867; Sarcinella L, 2002, J CLIN VIROL, V24, P99, DOI 10.1016/S1386-6532(01)00238-4; TorokStorb B, 1997, BLOOD, V90, P2097, DOI 10.1182/blood.V90.5.2097; Yan S. S., 2001, Clinical and Applied Immunology Reviews, V2, P155, DOI 10.1016/S1529-1049(02)00045-4; Zhou L, 2007, TRANSPL INFECT DIS, V9, P73, DOI 10.1111/j.1399-3062.2006.00173.x	13	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51224	10.1371/journal.pone.0051224	http://dx.doi.org/10.1371/journal.pone.0051224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251460	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900054
J	Zyzynska-Granica, B; Koziak, K				Zyzynska-Granica, Barbara; Koziak, Katarzyna			Identification of Suitable Reference Genes for Real-Time PCR Analysis of Statin-Treated Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							ENDOGENOUS REFERENCE GENES; RT-PCR; NORMALIZATION; EXPRESSION; VALIDATION; GUIDELINES	Proper data normalization in quantitative real-time reverse-transcription polymerase chain reaction (RT-qPCR) is of critical importance for reliable mRNA expression analysis. Due to a diversity in putative reference genes expression stability in different in vitro models, a validation of an internal control gene should be made for each particular tissue or cell type and every specific experimental design. A few approaches have been proposed for reference gene selection, including pair-wise comparison approach and model-based approach. In this article we have assessed the expression stability of eight putative reference genes: ACTB, B2M, GADD45A, GAPDH, HPRT1, PES1, PSMC4, YWHAZ, in human umbilical vein endothelial cells (HUVEC) treated with different statins and with TNF-alpha. The analysis was performed with three reference gene validation programs: geNorm, NormFinder and BestKeeper. We have shown that hypoxanthine phosphoribosyltransferase 1 gene (HPRT1) and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide gene (YWHAZ) are the most stably expressed genes among the analyzed ones. Furthermore, our results show that beta-actin gene (ACTB) is downregulated by statins and thus should not be used as a normalizing gene in a discussed experimental setup. A ranking of candidate reference genes stability values is provided and might serve as a valuable guide for future gene expression studies in endothelial cells. This is the first report on reference gene selection for RT-qPCR applications in statin-treated HUVEC model.	[Zyzynska-Granica, Barbara; Koziak, Katarzyna] Med Univ Warsaw, Dept Gen & Nutrit Biochem, Warsaw, Poland	Medical University of Warsaw	Zyzynska-Granica, B (corresponding author), Med Univ Warsaw, Dept Gen & Nutrit Biochem, Warsaw, Poland.	barbara.zyzynska@wum.edu.pl	Koziak, Katarzyna/V-2323-2019	Zyzynska-Granica, Barbara/0000-0002-1641-0018	National Centre for Research and Development [N R13 0094 06]; National Science Centre [N N301 521838]	National Centre for Research and Development(National Centre for Research & Development, Poland); National Science Centre(National Science Centre, Poland)	Funding for this study was from National Centre for Research and Development (N R13 0094 06) and the National Science Centre (N N301 521838). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anstaett OL, 2010, VET IMMUNOL IMMUNOP, V137, P201, DOI 10.1016/j.vetimm.2010.05.006; Balogh A, 2008, J PHOTOCH PHOTOBIO B, V93, P133, DOI 10.1016/j.jphotobiol.2008.07.010; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; Gresner SM, 2011, ANAL BIOCHEM, V408, P163, DOI 10.1016/j.ab.2010.09.010; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Pfaffl MW, 2010, METHODS, V50, P215, DOI 10.1016/j.ymeth.2010.02.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005	20	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51547	10.1371/journal.pone.0051547	http://dx.doi.org/10.1371/journal.pone.0051547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251572	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900101
J	Liang, YL; Zhang, ZH; Liu, XJ; Liu, XQ; Tao, L; Zhang, YF; Wang, H; Zhang, C; Chen, X; Xu, DX				Liang, Ying-Li; Zhang, Zhi-Hui; Liu, Xiao-Jing; Liu, Xiao-Qian; Tao, Li; Zhang, Ye-Fa; Wang, Hua; Zhang, Cheng; Chen, Xi; Xu, De-Xiang			Melatonin Protects against Apoptosis-Inducing Factor (AIF)-Dependent Cell Death during Acetaminophen-Induced Acute Liver Failure	PLOS ONE			English	Article							MITOCHONDRIAL OXIDANT STRESS; FULMINANT HEPATIC-FAILURE; ANTIOXIDANT ENZYMES; DNA FRAGMENTATION; BAX TRANSLOCATION; OXIDATIVE STRESS; INJURY; MICE; HEPATOTOXICITY; PHOSPHORYLATION	Acetaminophen (APAP) overdose is the most frequent cause of acute liver failure and is primarily caused by cytochrome P450 (CYP) 2E1-driven conversion of APAP into hepatotoxic metabolites. Several reports showed that melatonin attenuated APAP-induced acute liver failure. Nevertheless, the exact mechanism remains obscure. In the present study, we investigated the effects of melatonin on apoptosis-inducing factor (AIF)-dependent cell death in APAP-induced acute liver failure. Mice were intraperitoneally (i.p.) injected with different doses of melatonin (1.25, 5, 20 mg/kg) 30 min before APAP (300 mg/kg, i.p.). As expected, melatonin significantly alleviated APAP-induced cell death, as determined by TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay. Further analysis showed that melatonin significantly attenuated APAP-induced activation of the serine/threonine kinase receptor interacting protein 1 (RIP1). In addition, melatonin inhibited APAP-induced hepatic c-Jun N-terminal kinase (JNK) phosphorylation and mitochondrial Bax translocation. Correspondingly, melatonin inhibited APAP-induced translocation of AIF from mitochondria to nuclei. Interestingly, no changes were induced by melatonin on hepatic CYP2E1 expression. In addition, melatonin had little effect on APAP-induced hepatic glutathione (GSH) depletion. In conclusion, melatonin protects against AIF-dependent cell death during APAP-induced acute liver failure through its direct inhibition of hepatic RIP1 and subsequent JNK phosphorylation and mitochondrial Bax translocation.	[Liu, Xiao-Jing; Tao, Li; Chen, Xi; Xu, De-Xiang] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; [Liang, Ying-Li; Zhang, Zhi-Hui; Liu, Xiao-Jing; Liu, Xiao-Qian; Zhang, Ye-Fa; Wang, Hua; Zhang, Cheng; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Chen, X (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China.	chenxi402@yahoo.com.cn; xudex@126.com	zhang, zh/GWV-4677-2022; TAO, Li/HIR-4254-2022; wang, hua/E-5028-2013		National Natural Science Foundation of China [30371667, 30572223, 30973544, 81172711, 81001480]; Natural Science Foundation of Anhui province [090413142, 1208085QH143]; University Excellence Young Talent Fund of Educational Commission of Anhui Province [2011SQRL058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui province(Natural Science Foundation of Anhui Province); University Excellence Young Talent Fund of Educational Commission of Anhui Province	This project was supported by National Natural Science Foundation of China (30371667, 30572223, 30973544, 81172711, 81001480), Natural Science Foundation of Anhui province (090413142, 1208085QH143) and the University Excellence Young Talent Fund of Educational Commission of Anhui Province (2011SQRL058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Bajt ML, 2008, J PHARMACOL EXP THER, V324, P8, DOI 10.1124/jpet.107.129445; Bajt ML, 2006, TOXICOL SCI, V94, P217, DOI 10.1093/toxsci/kfl077; Bajt ML, 2011, TOXICOL SCI, V122, P598, DOI 10.1093/toxsci/kfr116; BARLOWWALDEN LR, 1995, NEUROCHEM INT, V26, P497, DOI 10.1016/0197-0186(94)00154-M; Carbajo-Pescador S, 2011, J PINEAL RES, V51, P463, DOI 10.1111/j.1600-079X.2011.00910.x; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Crespo I, 2010, J PINEAL RES, V49, P193, DOI 10.1111/j.1600-079X.2010.00787.x; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Ghosh J, 2010, FREE RADICAL BIO MED, V48, P535, DOI 10.1016/j.freeradbiomed.2009.11.023; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Ji YL, 2012, J PINEAL RES, V52, P71, DOI 10.1111/j.1600-079X.2011.00921.x; Johnson C, 2008, BIOL REPROD, V79, P806, DOI 10.1095/biolreprod.108.068833; Kang JW, 2011, J PINEAL RES, V50, P403, DOI 10.1111/j.1600-079X.2011.00858.x; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim SH, 2008, J PINEAL RES, V44, P165, DOI 10.1111/j.1600-079X.2007.00504.x; Kitagawa A, 2012, J PINEAL RES, V52, P403, DOI 10.1111/j.1600-079X.2011.00955.x; Koh PO, 2011, J PINEAL RES, V51, P214, DOI 10.1111/j.1600-079X.2011.00879.x; Latchoumycandane C, 2007, HEPATOLOGY, V45, P412, DOI 10.1002/hep.21475; Liang R, 2009, J PINEAL RES, V46, P8, DOI 10.1111/j.1600-079X.2008.00596.x; Martin-Renedo J, 2008, J PINEAL RES, V45, P532, DOI 10.1111/j.1600-079X.2008.00641.x; Matsura T, 2006, J PINEAL RES, V41, P211, DOI 10.1111/j.1600-079X.2006.00356.x; Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x; Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687; Ramachandran A, 2011, TOXICOL APPL PHARM, V251, P226, DOI 10.1016/j.taap.2011.01.004; Ressmeyer AR, 2003, REDOX REP, V8, P205, DOI 10.1179/135100003225002709; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Sainz RM, 2003, CELL MOL LIFE SCI, V60, P1407, DOI 10.1007/s00018-003-2319-1; Saito C, 2010, TOXICOL APPL PHARM, V246, P8, DOI 10.1016/j.taap.2010.04.015; Sener G, 2003, J PINEAL RES, V35, P61, DOI 10.1034/j.1600-079X.2003.00050.x; Singhal NK, 2011, J PINEAL RES, V50, P97, DOI 10.1111/j.1600-079X.2010.00819.x; Tahan V, 2009, J PINEAL RES, V46, P401, DOI 10.1111/j.1600-079X.2009.00676.x; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Tunon MJ, 2011, J PINEAL RES, V50, P38, DOI 10.1111/j.1600-079X.2010.00807.x; Vera Y, 2004, BIOL REPROD, V70, P1534, DOI 10.1095/biolreprod.103.024661; Wang H, 2007, TOXICOLOGY, V237, P49, DOI 10.1016/j.tox.2007.04.021; Wang H, 2011, J PINEAL RES, V50, P418, DOI 10.1111/j.1600-079X.2011.00860.x; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200	45	26	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51911	10.1371/journal.pone.0051911	http://dx.doi.org/10.1371/journal.pone.0051911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272189	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300041
J	Brumm, H; Teschke, I				Brumm, Henrik; Teschke, Irmgard			Juvenile Galapagos Pelicans Increase Their Foraging Success by Copying Adult Behaviour	PLOS ONE			English	Article							BROWN-PELICAN; SOCIAL INFLUENCES; HUNTING SUCCESS; ANIMALS; EVOLUTION; AGE; FISH; TRANSMISSION; INFORMATION; MECHANISMS	Social learning is the building block of culture and traditions in humans and nonhuman animals, and its study has a long history. Most investigations have addressed either the causation or the function of social learning. Though much is known about the underlying mechanisms of social learning, demonstrations of its adaptive value in a natural setting are lacking. Here we show that juvenile brown pelicans (Pelecanus occidentalis) can increase their foraging efficiency by copying adult diving behaviour, suggesting that social learning helps juveniles to find profitable food patches. Our findings demonstrate the potential fitness consequences of behavioural copying and thus highlight the possible adaptive importance of social learning. Citation: Brumm H, Teschke I (2012) Juvenile Galapagos Pelicans Increase Their Foraging Success by Copying Adult Behaviour. PLoS ONE 7(12): e51881. doi:10.1371/journal.pone.0051881	[Brumm, Henrik] Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany; [Teschke, Irmgard] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany	Max Planck Society; Max Planck Society	Brumm, H (corresponding author), Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany.	brumm@orn.mpg.de			German Research Foundation [Br2309/6-1]; Association for the Study of Animal Behaviour	German Research Foundation(German Research Foundation (DFG)); Association for the Study of Animal Behaviour	Financial support was provided by the German Research Foundation (award Br2309/6-1), and the Association for the Study of Animal Behaviour (Christopher Barnard Award for Outstanding Contributions by a New Investigator to HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISNER R, 1992, ANIM BEHAV, V44, P327, DOI 10.1016/0003-3472(92)90038-B; ARNQVIST G, 1992, CONDOR, V94, P521, DOI 10.2307/1369223; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Borenstein E, 2008, EVOLUTION, V62, P586, DOI 10.1111/j.1558-5646.2007.00313.x; Bouchard J, 2007, ANIM COGN, V10, P259, DOI 10.1007/s10071-006-0064-1; Boyd R., 1985, CULTURE EVOLUTIONARY; BRANDT CA, 1984, OECOLOGIA, V62, P132, DOI 10.1007/BF00377386; Brown C, 2001, J FISH BIOL, V59, P471, DOI [10.1006/jfbi.2001.1689, 10.1111/j.1095-8649.2001.tb02354.x]; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; CARL RA, 1987, CONDOR, V89, P525, DOI 10.2307/1368642; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Coblentz BE, 1986, J FIELD ORNITHOL, V57, P62; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Enquist M, 2007, AM ANTHROPOL, V109, P727, DOI 10.1525/AA.2007.109.4.727; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Galef B.G. Jr, 1988, P3; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Holzhaider JC, 2010, LEARN BEHAV, V38, P206, DOI 10.3758/LB.38.3.206; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Hoppitt WJE, 2008, TRENDS ECOL EVOL, V23, P486, DOI 10.1016/j.tree.2008.05.008; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hultsch H, 2008, NEUROSCIENCE BIRDSON, P204; Jackson MH, 1993, GALAPAGOS NATURAL HI; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Kendal J, 2009, J THEOR BIOL, V260, P210, DOI 10.1016/j.jtbi.2009.05.029; Kitowski I, 2009, J ETHOL, V27, P327, DOI 10.1007/s10164-008-0123-y; KREBS JR, 1972, IBIS, V114, P507, DOI 10.1111/j.1474-919X.1972.tb00852.x; Laland KN, 2011, PHILOS T R SOC B, V366, P958, DOI 10.1098/rstb.2010.0328; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; Langen TA, 1996, ETHOLOGY, V102, P157; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; LEFEBVRE L, 1986, ETHOLOGY, V71, P295; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; Midford PE, 2000, ANIM BEHAV, V59, P1199, DOI 10.1006/anbe.1999.1419; Muller CA, 2010, CURR BIOL, V20, P1171, DOI 10.1016/j.cub.2010.04.037; ORIANS GH, 1969, ANIM BEHAV, V17, P316, DOI 10.1016/0003-3472(69)90016-5; Page RA, 2006, CURR BIOL, V16, P1201, DOI 10.1016/j.cub.2006.04.038; Pike TW, 2012, BIOL LETT, V6, P466; Rapaport LG, 2008, EVOL ANTHROPOL, V17, P189, DOI 10.1002/evan.20180; Reader SM, 2010, LEARN BEHAV, V38, P265, DOI 10.3758/LB.38.3.265; SCHREIBER RW, 1975, AUK, V92, P649, DOI 10.2307/4084778; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Tebbich S, 2001, P ROY SOC B-BIOL SCI, V268, P2189, DOI 10.1098/rspb.2001.1738; Thornton A, 2006, SCIENCE, V313, P227, DOI 10.1126/science.1128727; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Thorpe, 1963, LEARNING INSTINCT AN; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Weigl PD, 1980, ECOLOGY, V61, P214; Zentall TR, 2012, J COMP PSYCHOL, V126, P114, DOI 10.1037/a0025381	54	7	7	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51881	10.1371/journal.pone.0051881	http://dx.doi.org/10.1371/journal.pone.0051881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251646	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800102
J	Buren, S; Ortega-Villasante, C; Otvos, K; Samuelsson, G; Bako, L; Villarejo, A				Buren, Stefan; Ortega-Villasante, Cristina; Otvos, Krisztina; Samuelsson, Goran; Bako, Laszlo; Villarejo, Arsenio			Use of the Foot-and-Mouth Disease Virus 2A Peptide Co-Expression System to Study Intracellular Protein Trafficking in Arabidopsis	PLOS ONE			English	Article							FLUORESCENT FUSION PROTEINS; ADP-RIBOSYLATION FACTOR-1; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; COORDINATE EXPRESSION; TRANSIENT EXPRESSION; SECRETORY PATHWAY; MULTIPLE PROTEINS; EXPORT SITES; TRANSPORT	Background: A tool for stoichiometric co-expression of effector and target proteins to study intracellular protein trafficking processes has been provided by the so called 2A peptide technology. In this system, the 16-20 amino acid 2A peptide from RNA viruses allows synthesis of multiple gene products from single transcripts. However, so far the use of the 2A technology in plant systems has been limited. Methodology/Principal Findings: The aim of this work was to assess the suitability of the 2A peptide technology to study the effects exerted by dominant mutant forms of three small GTPase proteins, RABD2a, SAR1, and ARF1 on intracellular protein trafficking in plant cells. Special emphasis was given to CAH1 protein from Arabidopsis, which is trafficking to the chloroplast via a poorly characterized endoplasmic reticulum-to-Golgi pathway. Dominant negative mutants for these GTPases were co-expressed with fluorescent marker proteins as polyproteins separated by a 20 residue self-cleaving 2A peptide. Cleavage efficiency analysis of the generated polyproteins showed that functionality of the 2A peptide was influenced by several factors. This enabled us to design constructs with greatly increased cleavage efficiency compared to previous studies. The dominant negative GTPase variants resulting from cleavage of these 2A peptide constructs were found to be stable and active, and were successfully used to study the inhibitory effect on trafficking of the N-glycosylated CAH1 protein through the endomembrane system. Conclusions/Significance: We demonstrate that the 2A peptide is a suitable tool when studying plant intracellular protein trafficking and that transient protoplast and in planta expression of mutant forms of SAR1 and RABD2a disrupts CAH1 trafficking. Similarly, expression of dominant ARF1 mutants also caused inhibition of CAH1 trafficking to a different extent. These results indicate that early trafficking of the plastid glycoprotein CAH1 depends on canonical vesicular transport mechanisms operating between the endoplasmic reticulum and Golgi apparatus.	[Buren, Stefan; Otvos, Krisztina; Samuelsson, Goran; Bako, Laszlo] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Ortega-Villasante, Cristina; Villarejo, Arsenio] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Otvos, Krisztina] Hungarian Acad Sci, Biol Res Ctr, H-6701 Szeged, Hungary	Umea University; Autonomous University of Madrid; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Buren, S (corresponding author), Spanish Natl Canc Res Ctr CNIO, Madrid, Spain.	stefan.buren@gmail.com	Burén, Stefan/L-6705-2014; Otvos, Krisztina/AAL-5796-2021; Samuelsson, Goran/E-1824-2015; Ortega-Villasante, Cristina/F-6719-2012	Burén, Stefan/0000-0002-8487-2732; Otvos, Krisztina/0000-0002-5503-4983; Ortega-Villasante, Cristina/0000-0003-1224-6676	Spanish Ministerio de Ciencia e Innovacion [BIO2006-08946]; Swedish National Research Council, FORMAS; Swedish Foundation for Strategic Research	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Swedish National Research Council, FORMAS(Swedish Research Council Formas); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by Spanish Ministerio de Ciencia e Innovacion (grant BIO2006-08946) to AV and Swedish National Research Council, FORMAS, and the Swedish Foundation for Strategic Research to GS and LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andreeva AV, 2000, BIOCHEM SOC T, V28, P505, DOI 10.1042/0300-5127:0280505; Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buren S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021021; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DaSilva LLP, 2004, PLANT CELL, V16, P1753, DOI 10.1105/tpc.022673; Davidson PJ, 2006, GLYCOBIOLOGY, V16, P602, DOI 10.1093/glycob/cwj088; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; El Amrani A, 2004, PLANT PHYSIOL, V135, P16, DOI 10.1104/pp.103.032649; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; Hancock KR, 1997, BIOTECHNIQUES, V22, P861, DOI 10.2144/97225bm16; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kitajima A, 2009, PLANT CELL, V21, P2844, DOI 10.1105/tpc.109.068288; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Matheson LA, 2006, CURR OPIN PLANT BIOL, V9, P601, DOI 10.1016/j.pbi.2006.09.016; Memon AR, 2004, BBA-BIOMEMBRANES, V1664, P9, DOI 10.1016/j.bbamem.2004.04.005; Min MK, 2007, PLANT PHYSIOL, V143, P1601, DOI 10.1104/pp.106.095091; Nanjo Y, 2006, PLANT CELL, V18, P2582, DOI 10.1105/tpc.105.039891; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Pimpl P, 2003, PLANT CELL, V15, P1242, DOI 10.1105/tpc.010140; Pinheiro H, 2009, J CELL SCI, V122, P3749, DOI 10.1242/jcs.050625; Radhamony RN, 2006, TRENDS CELL BIOL, V16, P385, DOI 10.1016/j.tcb.2006.06.003; Randall J, 2004, PLANT SCI, V167, P367, DOI 10.1016/j.plantsci.2004.04.005; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Samalova M, 2006, TRAFFIC, V7, P1701, DOI 10.1111/j.1600-0854.2006.00502.x; Sparkes IA, 2005, PLANT PHYSIOL, V139, P690, DOI 10.1104/pp.105.065094; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stefano G, 2006, PLANT J, V46, P95, DOI 10.1111/j.1365-313X.2006.02675.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takeuchi M, 2002, PLANT J, V31, P499, DOI 10.1046/j.1365-313X.2002.01372.x; Takeuchi M, 2000, PLANT J, V23, P517, DOI 10.1046/j.1365-313x.2000.00823.x; Tamura K, 2003, PLANT J, V35, P545, DOI 10.1046/j.1365-313X.2003.01822.x; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Villarejo A, 2005, NAT CELL BIOL, V7, P1224, DOI 10.1038/ncb1330; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	47	19	21	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51973	10.1371/journal.pone.0051973	http://dx.doi.org/10.1371/journal.pone.0051973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251667	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800122
J	Carl, C; Poole, AJ; Williams, MR; de Nys, R				Carl, Christina; Poole, Andrew J.; Williams, Mike R.; de Nys, Rocky			Where to Settle-Settlement Preferences of Mytilus galloprovincialis and Choice of Habitat at a Micro Spatial Scale	PLOS ONE			English	Article							NORTHERN NEW-ZEALAND; SECONDARY SETTLEMENT; LARVAL SETTLEMENT; PERNA-CANALICULUS; EDULIS-L; MUSSEL; BEHAVIOR; MICROTOPOGRAPHY; TOMOGRAPHY; MORPHOLOGY	The global mussel aquaculture industry uses specialised spat catching and nursery culture ropes made of multi-filament synthetic and natural fibres to optimise settlement and retention of mussels for on-growing. However, the settlement ecology and preferences of mussels are poorly understood and only sparse information exists in a commercial context. This study quantified the settlement preferences of pediveligers and plantigrades of Mytilus galloprovincialis on increasingly complex surfaces and settlement locations at a micro spatial scale on and within ropes under commercial hatchery operating conditions using optical microscopy and X-ray micro-computed tomography (mu CT). M. galloprovincialis has clear settlement preferences for more complex materials and high selectivity for settlement sites from the pediveliger through to the plantigrade stage. Pediveligers of M. galloprovincialis initially settle inside specialised culture ropes. Larger pediveligers were located close to the exterior of ropes as they increased in size over time. In contrast, smaller individuals were located deeper inside of the ropes over time. This study demonstrates that X-ray mu CT is an excellent non-destructive technique for mapping settlement and attachment sites of individuals as early as one day post settlement, and quantifies the number and location of settled individuals on and within ropes as a tool to understand and optimise settlement in complex multi-dimensional materials and environments.	[Carl, Christina; de Nys, Rocky] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Poole, Andrew J.] CSIRO Mat Sci Engn, Belmont, MA USA; [Williams, Mike R.] Fisheries Victoria, Fisheries Res Branch, Queenscliff, Australia; [Williams, Mike R.] Victorian Shellfish Hatcheries Pty Ltd, Queenscliff, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Carl, C (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	tine.carl@my.jcu.edu.au	de Nys, Rocky/D-6741-2012; Praeger, Christina/A-7224-2013	de Nys, Rocky/0000-0003-3869-4928; Praeger, Christina/0000-0002-1947-122X; Poole, Andrew/0000-0001-9584-6452	James Cook University; CSIRO Flagship Collaboration Fund Postgraduate Top Up Scholarship; James Cook University Postgraduate Research Scholarship; CSIRO's Wealth from Oceans Flagship	James Cook University; CSIRO Flagship Collaboration Fund Postgraduate Top Up Scholarship; James Cook University Postgraduate Research Scholarship; CSIRO's Wealth from Oceans Flagship	Financial support was provided by CSIRO's Wealth from Oceans Flagship and James Cook University. CC was further supported by a CSIRO Flagship Collaboration Fund Postgraduate Top Up Scholarship and a James Cook University Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro AC, 2004, AQUACULTURE, V241, P269, DOI 10.1016/j.aquaculture.2004.07.029; Alfaro AC, 2002, MALACOLOGIA, V44, P1; BAYNE B. L., 1965, OPHELIA, V2, P1; BAYNE BL, 1964, J ANIM ECOL, V33, P513, DOI 10.2307/2569; BAYNE BL, 1976, MARINE MUSSELS THEIR, P81; Brenner M, 2010, AQUACULT ENG, V42, P128, DOI 10.1016/j.aquaeng.2010.02.001; Buchanan S, 1997, J SHELLFISH RES, V16, P71; CACERESMARTINEZ J, 1994, MAR ECOL PROG SER, V112, P107, DOI 10.3354/meps112107; Carl C, 2012, BIOFOULING, V28, P175, DOI 10.1080/08927014.2012.662676; FAO, 2022, BLUE TRANSFORMATION, DOI [DOI 10.4060/CC0461EN, 10.4060/cc0461en]; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Filgueira R, 2007, AQUACULT ENG, V37, P195, DOI 10.1016/j.aquaeng.2007.06.001; Gorley C.K., 2006, GETTING STARTED PRIM; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Gribben PE, 2011, AQUACULTURE, V319, P240, DOI 10.1016/j.aquaculture.2011.06.026; Hayden BJ, 2011, AQUACULT INT, V19, P957, DOI 10.1007/s10499-010-9413-9; Helm M. M., 2004, 471 FAO; HICKMAN RW, 1992, MUSSEL MYTILUS ECOLO, P465; Hodson SL, 2000, AQUACULTURE, V184, P277, DOI 10.1016/S0044-8486(99)00328-2; Koehl MAR, 2007, BIOFOULING, V23, P357, DOI 10.1080/08927010701492250; Kohler J, 1999, BIOFOULING, V14, P237; LUTZ RA, 1992, MUSSEL MYTILUS ECOLO, P53; Marshall DJ, 2003, MAR ECOL PROG SER, V246, P153, DOI 10.3354/meps246153; Marshall DJ, 2003, MAR ECOL PROG SER, V255, P145, DOI 10.3354/meps255145; Pernet F, 2003, MAR ECOL PROG SER, V260, P125, DOI 10.3354/meps260125; PETERSEN JH, 1984, J EXP MAR BIOL ECOL, V82, P147, DOI 10.1016/0022-0981(84)90100-X; Pettersen AK, 2010, AQUACULTURE, V309, P115, DOI 10.1016/j.aquaculture.2010.09.024; Ribi W, 2008, J NEUROSCI METH, V171, P93, DOI 10.1016/j.jneumeth.2008.02.010; Sakellariou A, 2004, PHYSICA A, V339, P152, DOI 10.1016/j.physa.2004.03.055; Seed R., 1976, MARINE MUSSELS THEIR, P13; Silverman HG, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P273, DOI 10.1007/978-3-7091-0286-2_18; Stevens C, 2008, AQUACULT ENG, V38, P145, DOI 10.1016/j.aquaeng.2008.01.006; WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0; Walter U, 2003, BIOMOL ENG, V20, P407, DOI 10.1016/S1389-0344(03)00064-9; Walters LJ, 1996, MAR ECOL PROG SER, V137, P161, DOI 10.3354/meps137161	35	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52358	10.1371/journal.pone.0052358	http://dx.doi.org/10.1371/journal.pone.0052358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251710	Green Published, Green Accepted, gold			2022-12-27	WOS:000312386800162
J	Cheng, D; Guo, YJ; Li, ZZ; Liu, YJ; Gao, X; Gao, Y; Cheng, X; Hu, JH; Wang, HY				Cheng, De; Guo, Yanjie; Li, Zhenzhen; Liu, Yajun; Gao, Xing; Gao, Yi; Cheng, Xiang; Hu, Junhe; Wang, Huayan			Porcine Induced Pluripotent Stem Cells Require LIF and Maintain Their Developmental Potential in Early Stage of Embryos	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; GENERATION; FIBROBLASTS; FETAL; LINES; DERIVATION; MICE	Porcine induced pluripotent stem (piPS) cell lines have been generated recently by using a cocktail of defined transcription factors, however, the features of authentic piPS cells have not been agreed upon and most of published iPS clones did not meet the stringent requirements of pluripotency. Here, we report the generation of piPS cells from fibroblasts using retrovirus carrying four mouse transcription factors (mOct4, mSox2, mKlf4 and mc-Myc, 4F). Multiple LIF-dependent piPS cell lines were generated and these cells showed the morphology similar to mouse embryonic stem cells and other pluripotent stem cells. In addition to the routine characterization, piPS cells were injected into porcine pre-compacted embryos to generate chimera embryos and nuclear transfer (NT) embryos. The results showed that piPS cells retain the ability to integrate into inner and outer layers of the blastocysts, and support the NT embryos development to blastocysts. The generations of chimera embryos and NT embryos derived from piPS clones are a practical means to determine the quality of iPS cells ex vivo. Citation: Cheng D, Guo Y, Li Z, Liu Y, Gao X, et al. (2012) Porcine Induced Pluripotent Stem Cells Require LIF and Maintain Their Developmental Potential in Early Stage of Embryos. PLoS ONE 7(12): e51778. doi:10.1371/journal.pone.0051778	[Cheng, De; Guo, Yanjie; Li, Zhenzhen; Liu, Yajun; Gao, Xing; Gao, Yi; Cheng, Xiang; Hu, Junhe; Wang, Huayan] NW A&F Univ, Coll Vet Med, Dept Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wang, HY (corresponding author), NW A&F Univ, Coll Vet Med, Dept Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	hhwang101@163.com	Yajun, Liu/F-2581-2015; cheng, xiang/C-9987-2016; Yajun, Liu/R-2758-2016; Liu, Yajun/ABE-5076-2020	Yajun, Liu/0000-0002-8203-5762; Yajun, Liu/0000-0002-8203-5762; Liu, Yajun/0000-0002-8203-5762; cheng, xiang/0000-0001-5315-9830	National Basic Research Program of China [2009CB941002]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by The National Basic Research Program of China (2009CB941002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Bao L, 2011, CELL RES, V21, P600, DOI 10.1038/cr.2011.6; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cheng D, 2012, CELL REPROGRAM, V14, P312, DOI 10.1089/cell.2012.0025; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Han XP, 2011, CELL RES, V21, P1509, DOI 10.1038/cr.2011.125; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Hu J, 2012, REPROD DOMEST ANIM, V47, P873, DOI 10.1111/j.1439-0531.2011.01982.x; Hu JH, 2011, ZYGOTE, V19, P191, DOI 10.1017/S0967199410000663; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ishizuka T, 2011, EUR J PHARMACOL, V668, P42, DOI 10.1016/j.ejphar.2011.06.026; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kou ZH, 2010, BIOL REPROD, V83, P238, DOI 10.1095/biolreprod.110.084731; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Luo JS, 2011, STEM CELLS DEV, V20, P1669, DOI 10.1089/scd.2011.0127; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Ren JT, 2011, CELL RES, V21, P849, DOI 10.1038/cr.2011.37; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson AJ, 2012, CELL REPROGRAM, V14, P112, DOI 10.1089/cell.2011.0078; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; West FD, 2011, STEM CELLS, V29, P1640, DOI 10.1002/stem.713; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	43	61	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51778	10.1371/journal.pone.0051778	http://dx.doi.org/10.1371/journal.pone.0051778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251622	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800085
J	Liu, WM; Zhang, F; Moshiach, S; Zhou, B; Huang, C; Srinivasan, K; Khurana, S; Zheng, Y; Lahti, JM; Zhang, XA				Liu, Wei M.; Zhang, Feng; Moshiach, Simon; Zhou, Bin; Huang, Chao; Srinivasan, Kamalakkannan; Khurana, Seema; Zheng, Yi; Lahti, Jill M.; Zhang, Xin A.			Tetraspanin CD82 Inhibits Protrusion and Retraction in Cell Movement by Attenuating the Plasma Membrane-Dependent Actin Organization	PLOS ONE			English	Article							METASTASIS SUPPRESSOR KAI1/CD82; TRANSMEMBRANE PROTEIN FAMILY; STRESS FIBER FORMATION; PROSTATE-CANCER CELLS; HUMAN T-CELLS; ARP2/3 COMPLEX; GROWTH-FACTOR; RHO-GTPASES; LEADING-EDGE; MORPHOLOGICAL-CHANGES	To determine how tetraspanin KAI1/CD82, a tumor metastasis suppressor, inhibits cell migration, we assessed which cellular events critical for motility are altered by KAI1/CD82 and how KAI1/CD82 regulates these events. We found that KAI1/CD82-expressing cells typically exhibited elongated cellular tails and diminished lamellipodia. Live imaging demonstrated that the polarized protrusion and retraction of the plasma membrane became deficient upon KAI1/CD82 expression. The deficiency in developing these motility-related cellular events was caused by poor formations of actin cortical network and stress fiber and by aberrant dynamics in actin organization. Rac1 activity was reduced by KAI1/CD82, consistent with the diminution of lamellipodia and actin cortical network; while the growth factor-stimulated RhoA activity was blocked by KAI1/CD82, consistent with the loss of stress fiber and attenuation in cellular retraction. Upon KAI1/CD82 expression, Rac effector cofilin was not enriched at the cell periphery to facilitate lamellipodia formation while Rho kinase exhibited a significantly lower activity leading to less retraction. Phosphatidylinositol 4, 5-biphosphate, which initiates actin polymerization from the plasma membrane, became less detectable at the cell periphery in KAI1/CD82-expressing cells. Moreover, KAI1/CD82-induced phenotypes likely resulted from the suppression of multiple signaling pathways such as integrin and growth factor signaling. In summary, at the cellular level KAI1/CD82 inhibited polarized protrusion and retraction events by disrupting actin reorganization; at the molecular level, KAI1/CD82 deregulated Rac1, RhoA, and their effectors cofilin and Rho kinase by perturbing the plasma membrane lipids. Citation: Liu WM, Zhang F, Moshiach S, Zhou B, Huang C, et al. (2012) Tetraspanin CD82 Inhibits Protrusion and Retraction in Cell Movement by Attenuating the Plasma Membrane-Dependent Actin Organization. PLoS ONE 7(12): e51797. doi:10.1371/journal.pone.0051797	[Liu, Wei M.; Zhang, Feng; Zhou, Bin; Huang, Chao; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr, Memphis, TN 38163 USA; [Liu, Wei M.; Zhang, Feng; Zhou, Bin; Huang, Chao; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Ctr Canc, Memphis, TN USA; [Liu, Wei M.; Zhang, Feng; Zhou, Bin; Huang, Chao; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN USA; [Liu, Wei M.; Zhang, Feng; Zhou, Bin; Huang, Chao; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA; [Moshiach, Simon; Lahti, Jill M.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Srinivasan, Kamalakkannan; Khurana, Seema] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN USA; [Zheng, Yi] Cincinnati Childrens Hosp, Div Expt Hematol, Cincinnati, OH USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zhang, XA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr, Memphis, TN 38163 USA.	xin-zhang-1@ouhsc.edu	Zheng, Yi/J-7235-2015; Huang, Chao/O-6170-2017	Zheng, Yi/0000-0001-7089-6074; Huang, Chao/0000-0002-5747-4560; Liu, Wei/0000-0003-2846-9233; Zhang, Feng/0000-0002-6103-1498	National Institutes of Health [CA096991, W81XWH-04-1-0156]; Department of Defense Prostate Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA096991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Prostate Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health and Department of Defense Prostate Cancer Research Program. This work was supported by research grants CA096991 and W81XWH-04-1-0156 (to XAZ) from National Institutes of Health and Department of Defense Prostate Cancer Research Program, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, CANCER LETT, V266, P163, DOI 10.1016/j.canlet.2008.02.058; Aizawa H, 1996, J CELL BIOL, V132, P335, DOI 10.1083/jcb.132.3.335; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Bari R, 2009, AM J PATHOL, V174, P647, DOI 10.2353/ajpath.2009.080685; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Berditchevski F, 2001, J CELL SCI, V114, P4143; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Delaguillaumie A, 2004, J CELL SCI, V117, P5269, DOI 10.1242/jcs.01380; Delaguillaumie A, 2002, J CELL SCI, V115, P433; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; DUGINA VB, 1995, J CELL SCI, V108, P1659; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Guo QS, 2008, EUR J CELL BIOL, V87, P251, DOI 10.1016/j.ejcb.2007.11.004; Guo XZ, 1996, CANCER RES, V56, P4876; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; HEMLER ME, 1984, J IMMUNOL, V132, P3011; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Higashiyama M, 1998, CANCER, V83, P466, DOI 10.1002/(SICI)1097-0142(19980801)83:3<466::AID-CNCR15>3.0.CO;2-U; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Iwata S, 2002, EUR J IMMUNOL, V32, P1328, DOI 10.1002/1521-4141(200205)32:5<1328::AID-IMMU1328>3.0.CO;2-6; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jee B, 2003, EXP MOL MED, V35, P30, DOI 10.1038/emm.2003.5; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kroczynska B, 2006, P NATL ACAD SCI USA, V103, P14128, DOI 10.1073/pnas.0604544103; Lagaudriere-Gesbert C, 1997, CELL IMMUNOL, V182, P105, DOI 10.1006/cimm.1997.1223; Lagaudriere-Gesbert C, 1998, EUR J IMMUNOL, V28, P4332, DOI 10.1002/(SICI)1521-4141(199812)28:12<4332::AID-IMMU4332>3.0.CO;2-8; Lapidot T, 2001, ANN NY ACAD SCI, V938, P83, DOI 10.1111/j.1749-6632.2001.tb03577.x; LEBELBINAY S, 1995, J IMMUNOL, V155, P101; Lee JH, 2003, CANCER RES, V63, P7247; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Liu WM, 2006, CANCER LETT, V240, P183, DOI 10.1016/j.canlet.2005.08.018; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Marcoux N, 2005, CELL SIGNAL, V17, P1449, DOI 10.1016/j.cellsig.2005.03.001; MATSUMOTO K, 1994, J BIOL CHEM, V269, P31807; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Miyake K, 2001, J CELL SCI, V114, P3487; Miyake M, 1999, ONCOGENE, V18, P2397, DOI 10.1038/sj.onc.1202556; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nagaishi K, 1999, J BIOCHEM-TOKYO, V125, P891, DOI 10.1093/oxfordjournals.jbchem.a022365; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nebl T, 2000, CURR BIOL, V10, pR351, DOI 10.1016/S0960-9822(00)00465-6; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOJIMA Y, 1993, CELL IMMUNOL, V152, P249, DOI 10.1006/cimm.1993.1285; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Odintsova E, 2006, BIOCHEM J, V400, P315, DOI 10.1042/BJ20060259; Ono M, 1999, CANCER RES, V59, P2335; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Pujades C, 1996, BIOCHEM J, V313, P899, DOI 10.1042/bj3130899; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Sauer G, 2003, CLIN CANCER RES, V9, P6426; SCHLOSSMAN SF, 1994, BLOOD, V83, P879; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Shibagaki N, 1998, EUR J IMMUNOL, V28, P1125, DOI 10.1002/(SICI)1521-4141(199804)28:04<1125::AID-IMMU1125>3.0.CO;2-C; Shibagaki N, 1999, EUR J IMMUNOL, V29, P4081, DOI 10.1002/(SICI)1521-4141(199912)29:12<4081::AID-IMMU4081>3.3.CO;2-9; SMALL JV, 1993, SYM SOC EXP BIOL, V47, P57; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; SUZUKI K, 1995, J BIOL CHEM, V270, P19551, DOI 10.1074/jbc.270.33.19551; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Takaoka A, 1998, ONCOGENE, V16, P1443, DOI 10.1038/sj.onc.1201648; Takaoka A, 1998, JPN J CANCER RES, V89, P397, DOI 10.1111/j.1349-7006.1998.tb00577.x; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Uchida S, 1999, BRIT J CANCER, V79, P1168, DOI 10.1038/sj.bjc.6690186; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Verdijk P, 2004, EUR J IMMUNOL, V34, P156, DOI 10.1002/eji.200324241; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Xu CF, 2009, FASEB J, V23, P3273, DOI 10.1096/fj.08-123414; Yang XH, 2001, CANCER RES, V61, P5284; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zhang XA, 2003, CANCER RES, V63, P2665; Zhang XA, 2003, J BIOL CHEM, V278, P27319, DOI 10.1074/jbc.M303039200; Zhou B, 2004, CANCER RES, V64, P7455, DOI 10.1158/0008-5472.CAN-04-1574	108	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51797	10.1371/journal.pone.0051797	http://dx.doi.org/10.1371/journal.pone.0051797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251627	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800086
J	Montenegro, MF; Saez-Ayala, M; Pinero-Madrona, A; Cabezas-Herrera, J; Rodriguez-Lopez, JN				Montenegro, Maria F.; Saez-Ayala, Magali; Pinero-Madrona, Antonio; Cabezas-Herrera, Juan; Neptuno Rodriguez-Lopez, Jose			Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; PHOSPHATASE 2A; MST2 PATHWAY; CELL-DEATH; PROTEIN; DAMAGE; RAS; 3-O-(3,4,5-TRIMETHOXYBENZOYL)-(-)-EPICATECHIN; METHOTREXATE; ACETYLATION	Background: Tumour suppressor genes are often transcriptionally silenced by promoter hypermethylation, and recent research has implicated alterations in chromatin structure as the mechanistic basis for this repression. In addition to DNA methylation, other epigenetic post-translational modifications that modulate the stability and binding of specific transcription factors to gene promoters have emerged as important mechanisms for controlling gene expression. The aim of this study was to analyse the implications of these mechanisms and their molecular connections in the reactivation of RASSF1A in breast cancer. Methods: Compounds that modulate the intracellular concentration of adenosine, such as dipyridamole (DIPY), greatly increase the antiproliferative effects of 3-O-(3,4,5-trimethoxybenzoyl)-(-)-catechin (TMCG), a synthetic antifolate derived from the structure of tea catechins. Quantitative real-time PCR arrays and MALDI-TOF mass spectrometry indicated that this combination (TMCG/DIPY) induced apoptosis in breast cancer cells by modulating the methylation levels of DNA and proteins (such as E2F1), respectively. Chromatin immunoprecipitation (ChIP) assays were employed to confirm that this combination induced chromatin remodelling of the RASSF1A promoter and increased the occupancy of E2F1 at the promoter of this tumour suppressor gene. Results: The TMCG/DIPY combination acted as an epigenetic treatment that reactivated RASSF1A expression and induced apoptosis in breast cancer cells. In addition to modulating DNA methylation and chromatin remodelling, this combination also induced demethylation of the E2F1 transcription factor. The ChIP assay showed enhancement of E2F1 occupancy at the unmethylated RASSF1A promoter after TMCG/DIPY treatment. Interestingly, inhibition of E2F1 demethylation using an irreversible inhibitor of lysine-specific demethylase 1 reduced both TMCG/DIPY-mediated RASSF1A expression and apoptosis in MDA-MB-231 cells, suggesting that DNA and protein demethylation may act together to control these molecular and cellular processes. Conclusions/Significance: This study demonstrates that simultaneous targeting of DNA and E2F1 methylation is an effective epigenetic treatment that reactivates RASSF1A expression and induces apoptosis in breast cancer cells. Citation: Montenegro MF, Saez-Ayala M, Pinero-Madrona A, Cabezas-Herrera J, Rodriguez-Lopez JN (2012) Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation. PLoS ONE 7(12): e52231. doi: 10.1371/journal.pone.0052231	[Montenegro, Maria F.; Saez-Ayala, Magali; Neptuno Rodriguez-Lopez, Jose] Univ Murcia, Dept Biochem & Mol Biol A, Sch Biol, Murcia, Spain; [Pinero-Madrona, Antonio] Univ Hosp Virgen Arrixaca, Inst Murciano Invest Biomed, Dept Surg, Murcia, Spain; [Cabezas-Herrera, Juan] Univ Hosp Virgen Arrixaca, Inst Murciano Invest Biomed, Translat Canc Res Grp, Murcia, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca	Rodriguez-Lopez, JN (corresponding author), Univ Murcia, Dept Biochem & Mol Biol A, Sch Biol, Reg Campus Int Excellence,Campus Mare Nostrum, Murcia, Spain.	neptuno@um.es	CABEZAS-HERRERA, JUAN/J-9434-2015; Piñero-Madrona, Antonio/AAB-5138-2022; Saez Ayala, Magali/T-9810-2017; Montenegro, Maria Fernanda/AAF-2695-2021; Neptuno, Jose/F-5012-2016; Cabezas-Herrera, Juan/F-3850-2016	CABEZAS-HERRERA, JUAN/0000-0001-9053-5380; Saez Ayala, Magali/0000-0002-8726-0053; Rodriguez-Lopez, Jose Neptuno/0000-0001-6863-1173; Cabezas-Herrera, Juan/0000-0002-6833-4977; Montenegro, Maria Fernanda/0000-0002-0064-0484; Pinero-Madrona, Antonio/0000-0002-7718-8318	Ministerio de Ciencia e Innovacion (MICINN) [SAF2009-12043-C02-01]; Fundacion Seneca, Region de Murcia (FS-RM) [15230/PI/10]; EU [ERA293514]; Fundacion para la Formacion e Investigacion Sanitaria de la region de Murcia (FFIS); Fundacion Cientifica de la Asociacion Espanola contra el Cancer (FCAECC)	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca, Region de Murcia (FS-RM)(Fundacion Seneca); EU(European Commission); Fundacion para la Formacion e Investigacion Sanitaria de la region de Murcia (FFIS); Fundacion Cientifica de la Asociacion Espanola contra el Cancer (FCAECC)	This work was supported by grants from Ministerio de Ciencia e Innovacion (MICINN) (SAF2009-12043-C02-01), Fundacion Seneca, Region de Murcia (FS-RM) (15230/PI/10), and EU ERA293514. J.C-H is contracted by the Fundacion para la Formacion e Investigacion Sanitaria de la region de Murcia (FFIS). M.F.M is contracted by Fundacion Cientifica de la Asociacion Espanola contra el Cancer (FCAECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Cellarier E, 2003, CANCER TREAT REV, V29, P489, DOI 10.1016/S0305-7372(03)00118-X; Chang JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012847; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Dorssers LCJ, 2001, DRUGS, V61, P1721, DOI 10.2165/00003495-200161120-00004; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jenal M, 2009, MOL CANCER RES, V7, P916, DOI 10.1158/1541-7786.MCR-08-0359; Jiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036780; Kawamoto K, 2007, CLIN CANCER RES, V13, P2541, DOI 10.1158/1078-0432.CCR-06-2225; Kontaki H, 2010, CELL CYCLE, V9, P3836, DOI 10.4161/cc.9.19.13384; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Lin WC, 2001, GENE DEV, V15, P1833; Liu L, 2008, ONCOGENE, V27, P6175, DOI 10.1038/onc.2008.220; Louie MC, 2010, MOL CANCER RES, V8, P343, DOI 10.1158/1541-7786.MCR-09-0395; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Saez-Ayala M, 2012, EXP CELL RES, V318, P1146, DOI 10.1016/j.yexcr.2012.03.022; Saez-Ayala M, 2011, CHEMMEDCHEM, V6, P440, DOI 10.1002/cmdc.201000482; Sanchez-del-Campo L, 2008, INT J CANCER, V123, P2446, DOI 10.1002/ijc.23813; Sanchez-del-Campo L, 2009, MOL PHARMACEUT, V6, P883, DOI 10.1021/mp800259k; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tian YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017017; Tommasi S, 2005, CANCER RES, V65, P92; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Winter-Vann AM, 2003, P NATL ACAD SCI USA, V100, P6529, DOI 10.1073/pnas.1135239100; Xie Q, 2011, J RECEPT SIG TRANSD, V31, P139, DOI 10.3109/10799893.2011.552914; Yan PS, 2003, CANCER RES, V63, P6178; Yang X, 2001, ENDOCR-RELAT CANCER, V8, P115, DOI 10.1677/erc.0.0080115	41	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52231	10.1371/journal.pone.0052231	http://dx.doi.org/10.1371/journal.pone.0052231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251702	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800153
J	Diguisto, C; Le Ray, C; Maillard, F; Khoshnood, B; Verspyck, E; Perrotin, F; Goffinet, F				Diguisto, Caroline; Le Ray, Camille; Maillard, Francoise; Khoshnood, Babak; Verspyck, Eric; Perrotin, Franck; Goffinet, Francois		EVAPRIMA Grp	Individual and Organisational Determinants Associated with Maintenance Tocolysis in the Management of Preterm Labour: A Multilevel Analysis	PLOS ONE			English	Article							ORAL TERBUTALINE; CONTROLLED-TRIAL; CLINICAL-TRIAL; NIFEDIPINE; EFFICACY; DELIVERY; PLACEBO; BIRTH	Background: Clinical guidelines do not recommend maintenance tocolysis for the management of preterm labour. The French national survey EVAPRIMA revealed it was administered to more than 50% of women hospitalised for preterm labour. Our aim was to identify the individual and organisational determinants associated with maintenance tocolysis. Methods: The study was a secondary analysis of the prospective population-based EVAPRIMA study database. Population study included every women hospitalised for preterm labour and at risk of receiving maintenance tocolysis, over a one month period, in 99 randomly selected French maternity units. Main outcome was the prescription of maintenance tocolysis. The association between maintenance tocolysis and individual (maternal or obstetrical) and organisational determinants were evaluated with multilevel analysis. Results: Of the 531 women included, 68.9% (95% CI 0.65-0.73) received maintenance tocolysis. The only individual factor associated with maintenance tocolysis was gestational age at admission; the rate of maintenance tocolysis was higher among women hospitalised before 32 weeks of gestation. The significantly different rates between maternity units demonstrated the existence of a maternity unit effect. Maintenance tocolysis was also associated with organisational determinants and was more frequent in level 1 (ORa = 6.54[2.21-19.40]) and level 2 maternity units (ORa = 3.68[1.28-10.59]), in units with less than 1500 deliveries/year (ORa = 5.27[4.43-19.44]), and in specific areas of France. Conclusion: A maternity unit effect, explained partly by the organisational characteristics of the units, plays a major role in the practice of maintenance tocolysis. Widespread dissemination of these results might improve adherence to clinical guidelines.	[Diguisto, Caroline; Le Ray, Camille; Maillard, Francoise; Khoshnood, Babak; Goffinet, Francois] Univ Paris 06, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, INSERM, UMR S953, Paris, France; [Le Ray, Camille; Goffinet, Francois] Univ Paris 05, Assistance Publ Hop Paris, Cochin St Vincent de Paul Hosp, Dept Obstet & Gynaecol, Paris, France; [Verspyck, Eric] Univ Hosp Rouen, Dept Obstet & Gynaecol, Rouen, France; [Diguisto, Caroline; Perrotin, Franck] Univ Tours, Univ Hosp Tours, Dept Obstet & Gynaecol, Tours, France; [Le Ray, Camille; Goffinet, Francois] Premup Fdn, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU de Rouen; CHU Tours; Universite de Tours; UDICE-French Research Universities; Universite Paris Cite	Diguisto, C (corresponding author), Univ Paris 06, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, INSERM, UMR S953, Paris, France.	carolinediguisto@gmail.com	Khoshnood, Babak/N-9096-2017; Perrotin, Franck/AAL-8833-2021	Perrotin, Franck/0000-0001-9694-6658; GOFFINET, Francois/0000-0001-9643-0299; Le Ray, Camille/0000-0003-0891-1063; Khoshnood, Babak/0000-0002-4031-4915	Ferring Company	Ferring Company(Ferring Pharmaceuticals)	The EVAPRIMA survey was supported by the Ferring Company. The funders had no role in the study design, data collection, data interpretation or the writing of the report.	Blondel B, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P373; Carr DB, 1999, AM J OBSTET GYNECOL, V181, P822, DOI 10.1016/S0002-9378(99)70308-X; D'Ercole C, 2002, J GYNECOL OBST BIO R, V31, pS84; Dodd JM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003927.pub2; Gaunekar NN, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004071; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gyetvai K, 1999, OBSTET GYNECOL, V94, P869, DOI 10.1016/S0029-7844(99)00329-4; HOW HY, 1995, AM J OBSTET GYNECOL, V173, P1518, DOI 10.1016/0002-9378(95)90642-8; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Lewis R, 1996, AM J OBSTET GYNECOL, V175, P834, DOI 10.1016/S0002-9378(96)80008-1; Lyell DJ, 2008, OBSTET GYNECOL, V112, P1221, DOI 10.1097/AOG.0b013e31818d8386; Nanda K, 2002, COCHRANE DB SYST REV; Papatsonis D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005938.pub2; Parant O, 2008, BJOG-INT J OBSTET GY, V115, P1538, DOI 10.1111/j.1471-0528.2008.01929.x; PARILLA BV, 1993, AM J OBSTET GYNECOL, V169, P965, DOI 10.1016/0002-9378(93)90036-I; RCOG, 2002, CLIN GUID B; RICCI JM, 1991, AM J OBSTET GYNECOL, V165, P603, DOI 10.1016/0002-9378(91)90293-Z; Roos C, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-42; Saillour-Glenisson F, 2008, REV EPIDEMIOL SANTE, V56, pS207, DOI 10.1016/j.respe.2008.04.006; Sanchez-Ramos L, 1999, AM J OBSTET GYNECOL, V181, P484, DOI 10.1016/S0002-9378(99)70582-X; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Valenzuela GJ, 2000, AM J OBSTET GYNECOL, V182, P1184, DOI 10.1067/mob.2000.105816; Veatch RM, 2000, JAMA-J AM MED ASSOC, V283, P1685, DOI 10.1001/jama.283.13.1685	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50788	10.1371/journal.pone.0050788	http://dx.doi.org/10.1371/journal.pone.0050788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272071	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386600014
J	Sheth, S; Jajoo, S; Kaur, T; Mukherjea, D; Sheehan, K; Rybak, LP; Ramkumar, V				Sheth, Sandeep; Jajoo, Sarvesh; Kaur, Tejbeer; Mukherjea, Debashree; Sheehan, Kelly; Rybak, Leonard P.; Ramkumar, Vickram			Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway	PLOS ONE			English	Article							NEGATIVE FEEDBACK; SUPPRESSOR PDCD4; TGF-BETA; FACTOR I; MICRORNA-21; EXPRESSION; MIR-21; APOPTOSIS; INVASION; GENE	The consumption of foods containing resveratrol produces significant health benefits. Resveratrol inhibits cancer by reducing cell proliferation and metastasis and by inducing apoptosis. These actions could be explained by its ability to inhibit (ERK-1/2), Akt and suppressing the levels of estrogen and insulin growth factor -1 (IGF-1) receptor. How these processes are manifested into the antitumor actions of resveratrol is not clear. Using microarray studies, we show that resveratrol reduced the expression of various prostate-tumor associated microRNAs (miRs) including miR-21 in androgen-receptor negative and highly aggressive human prostate cancer cells, PC-3M-MM2. This effect of resveratrol was associated with reduced cell viability, migration and invasiveness. Additionally, resveratrol increased the expression of tumor suppressors, PDCD4 and maspin, which are negatively regulated by miR-21. Short interfering (si) RNA against PDCD4 attenuated resveratrol's effect on prostate cancer cells, and similar effects were observed following over expression of miR-21 with pre-miR-21 oligonucleotides. PC-3M-MM2 cells also exhibited high levels of phospho-Akt (pAkt), which were reduced by both resveratrol and LY294002 (a PI3-kinase inhibitor). MiR-21 expression in these cells appeared to be dependent on Akt, as LY294002 reduced the levels of miR-21 along with a concurrent increase in PDCD4 expression. These in vitro findings were further corroborated in a severe combined immunodeficient (SCID) mouse xenograft model of prostate cancer. Oral administration of resveratrol not only inhibited the tumor growth but also decreased the incidence and number of metastatic lung lesions. These tumor- and metastatic-suppressive effects of resveratrol were associated with reduced miR-21 and pAkt, and elevated PDCD4 levels. Similar anti-tumor effects of resveratrol were observed in DU145 and LNCaP prostate cancer cells which were associated with suppression of Akt and PDCD4, but independent of miR-21. These data suggest that resveratrol's anti-tumor actions in prostate cancer could be explained, in part, through inhibition of Akt/miR-21 signaling pathway. Citation: Sheth S, Jajoo S, Kaur T, Mukherjea D, Sheehan K, et al. (2012) Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway. PLoS ONE 7(12): e51655. doi:10.1371/journal.pone.0051655	[Sheth, Sandeep; Jajoo, Sarvesh; Kaur, Tejbeer; Ramkumar, Vickram] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Mukherjea, Debashree; Sheehan, Kelly; Rybak, Leonard P.] So Illinois Univ, Sch Med, Dept Surg, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Ramkumar, V (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	vramkumar@siumed.edu	Mukherjea, Debashree/AAR-5651-2020; Kaur, Tejbeer/AAG-1992-2019; Sheth, Sandeep/B-7839-2015	Kaur, Tejbeer/0000-0003-3626-2670; Sheth, Sandeep/0000-0001-6570-8120	NIH Grant [R15CA135494]; SIU School of Medicine Cancer Center Grant; SIU School of Medicine Excellence in Academic Medicine Award; US Department of Defense Grant [PC100127]; NATIONAL CANCER INSTITUTE [R15CA135494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002396, R03DC011621] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SIU School of Medicine Cancer Center Grant; SIU School of Medicine Excellence in Academic Medicine Award; US Department of Defense Grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIH Grant (R15CA135494), SIU School of Medicine Cancer Center Grant and SIU School of Medicine Excellence in Academic Medicine Award to VR. SJ was supported by the US Department of Defense Grant (PC100127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2000, MOL CARCINOGEN, V28, P129, DOI 10.1002/1098-2744(200007)28:3&lt;129::AID-MC1&gt;3.0.CO;2-0; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Barrack ER, 1997, PROSTATE, V31, P61; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; DELWORTH MG, 1995, INT J ONCOL, V6, P293; Dorrie J, 2001, CANCER RES, V61, P4731; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Harper CE, 2007, CARCINOGENESIS, V28, P1946, DOI 10.1093/carcin/bgm144; Himpe E, 2011, GROWTH HORM IGF RES, V21, P252, DOI 10.1016/j.ghir.2011.07.001; Jajoo S, 2006, J PHARMACOL EXP THER, V317, P1, DOI 10.1124/jpet.105.096255; Jajoo S, 2009, NEOPLASIA, V11, P1132, DOI 10.1593/neo.09744; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Levi F, 2005, EUR J CANCER PREV, V14, P139, DOI 10.1097/00008469-200504000-00009; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Li YW, 2010, PHARM RES-DORDR, V27, P1027, DOI 10.1007/s11095-010-0105-y; Liu J, 2011, INT J ORAL SCI, V3, P165, DOI 10.4248/IJOS11063; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; MAXWELL S, 1994, LANCET, V344, P193, DOI 10.1016/S0140-6736(94)92795-2; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Qin WM, 2009, ACTA BIOCH BIOPH SIN, V41, P618, DOI 10.1093/abbs/gmp049; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Ruan WF, 1999, ENDOCRINOLOGY, V140, P1984, DOI 10.1210/en.140.5.1984; Sayed D, 2010, J BIOL CHEM, V285, P20281, DOI 10.1074/jbc.M110.109207; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sgambato A, 2001, MUTAT RES-GEN TOX EN, V496, P171, DOI 10.1016/S1383-5718(01)00232-7; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Tili E, 2010, BIOCHEM PHARMACOL, V80, P2057, DOI 10.1016/j.bcp.2010.07.003; Torring N, 1997, J UROLOGY, V158, P222, DOI 10.1097/00005392-199707000-00075; van der Fits L, 2011, J INVEST DERMATOL, V131, P762, DOI 10.1038/jid.2010.349; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wei N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030311; Wolk A, 1998, J NATL CANCER I, V90, P911, DOI 10.1093/jnci/90.12.911; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	57	149	159	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51655	10.1371/journal.pone.0051655	http://dx.doi.org/10.1371/journal.pone.0051655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272133	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386600034
J	Suhs, KW; Hein, K; Pehlke, JR; Kasmann-Kellner, B; Diem, R				Suehs, Kurt-Wolfram; Hein, Katharina; Pehlke, Jens R.; Kaesmann-Kellner, Barbara; Diem, Ricarda			Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; COHERENCE TOMOGRAPHY; BRAIN ATROPHY; AXONAL LOSS; MRI; NEURODEGENERATION; INFLAMMATION; PROGRESSION; MECHANISMS; THICKNESS	Background: Optic neuritis is associated with neurodegeneration leading to chronic impairment of visual functions. Objective: This study investigated whether early treatment with interferon beta (IFN-beta) slows retinal nerve fibre layer (RNFL) thinning in clinically isolated optic neuritis. Methods: Twenty patients with optic neuritis and visual acuity decreased to <= 0.5 (decimal system) were included into this prospective, open-label, parallel group 4-month observation. After methylprednisolone pulse therapy, 10 patients received IFN-beta from week 2 onwards. This group was compared to 10 patients free of any disease modifying treatment (DMT). The parameter of interest was change in RNFL thickness assessed at baseline and at weeks 4, 8, and 16. Changes in visual acuity, visual field, and visual evoked potentials (VEPs) served as additional outcome parameters. Results: RNFL thinning did not differ between the groups with a mean reduction of 9.80 +/- 2.80 mu m in IFN-beta-treated patients (+/- SD) vs. 12.44 +/- 5.79 mu m in patients who did not receive DMT (baseline non-affected eye minus affected eye at week 16; p = 0.67, t-test, 95% confidence interval: -15.77 to 10.48). Parameters of visual function did not show any differences between the groups either. Conclusions: In isolated optic neuritis, early IFN-beta treatment did not influence RNFL thinning nor had it any effect on recovery of visual functions. Citation: Suhs K-W, Hein K, Pehlke JR, Kasmann-Kellner B, Diem R (2012) Retinal Nerve Fibre Layer Thinning in Patients with Clinically Isolated Optic Neuritis and Early Treatment with Interferon-Beta. PLoS ONE 7(12): e51645. doi:10.1371/journal.pone.0051645	[Suehs, Kurt-Wolfram; Pehlke, Jens R.; Diem, Ricarda] Univ Saarland, Dept Neurol, D-6650 Homburg, Germany; [Suehs, Kurt-Wolfram] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, D-3000 Hannover, Germany; [Hein, Katharina] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Pehlke, Jens R.] LWL Clin Munster, Dept Addict Disorders, Munster, Germany; [Kaesmann-Kellner, Barbara] Univ Saarland, Dept Ophthalmol, D-6650 Homburg, Germany; [Diem, Ricarda] Univ Clin Heidelberg, Dept Neuro Oncol, Heidelberg, Germany	Saarland University; Hannover Medical School; University of Gottingen; Saarland University; Ruprecht Karls University Heidelberg	Diem, R (corresponding author), Univ Saarland, Dept Neurol, D-6650 Homburg, Germany.	ricarda.diem@med.uni-heidelberg.de	Kasmann-Kellner, Barbara/K-3624-2012	Kasmann-Kellner, Barbara/0000-0002-5137-8658	Bayer Healthcare, Leverkusen, Germany; Merck Serono GmbH, Darmstadt	Bayer Healthcare, Leverkusen, Germany(Bayer AGBayer Healthcare Pharmaceuticals); Merck Serono GmbH, Darmstadt	This study was supported by research grants from Bayer Healthcare, Leverkusen, Germany, and Merck Serono GmbH, Darmstadt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2011, NEUROLOGY, V76, pS14, DOI 10.1212/WNL.0b013e3182050388; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Biernacki K, 2005, ARCH NEUROL-CHICAGO, V62, P563, DOI 10.1001/archneur.62.4.563; Bock M, 2010, MULT SCLER J, V16, P893, DOI 10.1177/1352458510365156; Boutros T, 1997, J NEUROCHEM, V69, P939; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Diem R, 2003, J CLIN NEUROSCI, V10, P67, DOI 10.1016/S0967-5868(02)00172-8; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Fairless R, 2012, J NEUROSCI, V32, P5585, DOI 10.1523/JNEUROSCI.5705-11.2012; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Frohman E, 2006, LANCET NEUROL, V5, P853, DOI 10.1016/S1474-4422(06)70573-7; Frohman EM, 2009, J NEUROL SCI, V282, P96, DOI 10.1016/j.jns.2009.04.010; Frohman EM, 2005, ARCH NEUROL-CHICAGO, V62, P1345, DOI 10.1001/archneur.62.9.1345; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Henderson APD, 2011, ANN NEUROL, V70, P955, DOI 10.1002/ana.22554; Henderson APD, 2010, BRAIN, V133, P2592, DOI 10.1093/brain/awq146; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jin S, 2007, BRAIN RES, V1179, P140, DOI 10.1016/j.brainres.2007.08.055; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Naismith RT, 2009, NEUROLOGY, V73, P46, DOI 10.1212/WNL.0b013e3181aaea32; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; Polman CH, 2008, J NEUROL, V255, P480, DOI 10.1007/s00415-007-0733-2; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Serbecic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019843; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Skov AG, 2011, MULT SCLER J, V17, P404, DOI 10.1177/1352458510391340; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Syc SB, 2010, MULT SCLER J, V16, P829, DOI 10.1177/1352458510371640; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Warner CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022947; Zimmermann H, 2012, MULT SCLER; Zivadinov R, 2008, NEUROLOGY, V71, P136, DOI 10.1212/01.wnl.0000316810.01120.05; Zivadinov R, 2007, MULT SCLER J, V13, P490, DOI 10.1177/1352458506070446	40	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51645	10.1371/journal.pone.0051645	http://dx.doi.org/10.1371/journal.pone.0051645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272128	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386600032
J	Douglas-Escobar, M; Rossignol, C; Steindler, D; Zheng, T; Weiss, MD				Douglas-Escobar, Martha; Rossignol, Candace; Steindler, Dennis; Zheng, Tong; Weiss, Michael D.			Neurotrophin-Induced Migration and Neuronal Differentiation of Multipotent Astrocytic Stem Cells In Vitro	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; NEURAL PROGENITOR CELLS; BRAIN-INJURY; OLIGODENDROCYTE PROGENITORS; NEONATAL ENCEPHALOPATHY; SUBVENTRICULAR ZONE; CEREBRAL-ISCHEMIA; MAGNESIUM-SULFATE; MOTOR-NEURONS; SECRETE GDNF	Hypoxic ischemic encephalopathy (HIE) affects 2-3 per 1000 full-term neonates. Up to 75% of newborns with severe HIE die or have severe neurological handicaps. Stem cell therapy offers the potential to replace HIE-damaged cells and enhances the autoregeneration process. Our laboratory implanted Multipotent Astrocytic Stem Cells (MASCs) into a neonatal rat model of hypoxia-ischemia (HI) and demonstrated that MASCs move to areas of injury in the cortex and hippocampus. However, only a small proportion of the implanted MASCs differentiated into neurons. MASCs injected into control pups did not move into the cortex or differentiate into neurons. We do not know the mechanism by which the MASCs moved from the site of injection to the injured cortex. We found neurotrophins present after the hypoxic-ischemic milieu and hypothesized that neurotrophins could enhance the migration and differentiation of MASCs. Using a Boyden chamber device, we demonstrated that neurotrophins potentiate the in vitro migration of stem cells. NGF, GDNF, BDNF and NT-3 increased stem cell migration when compared to a chemokinesis control. Also, MASCs had increased differentiation toward neuronal phenotypes when these neurotrophins were added to MASC culture tissue. Due to this finding, we believed neurotrophins could guide migration and differentiation of stem cell transplants after brain injury.	[Douglas-Escobar, Martha; Weiss, Michael D.] Univ Florida, Dept Pediat, Gainesville, FL 32611 USA; [Rossignol, Candace; Steindler, Dennis; Zheng, Tong] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Steindler, Dennis; Zheng, Tong; Weiss, Michael D.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Douglas-Escobar, M (corresponding author), Univ Florida, Dept Pediat, Gainesville, FL 32611 USA.	marthave@ufl.edu	Steindler, Dennis/AAJ-5811-2020		AAP Klaus Research Award;  [AHA 0825454E]	AAP Klaus Research Award; 	This work was supported by grants AHA 0825454E grant and AAP Klaus Research Award (MDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasios F, 2012, ARCH GYNECOL OBSTET, V285, P1001, DOI 10.1007/s00404-011-2082-8; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Barrett Robert D., 2007, Birth Defects Research, V81, P163, DOI 10.1002/bdrc.20095; BEILHARZ EJ, 1993, MOL BRAIN RES, V18, P209, DOI 10.1016/0169-328X(93)90191-Q; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Bennet L, ANN NEUROLOGY; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blits B, 2005, RESTOR NEUROL NEUROS, V23, P313; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Castellanos DA, 2002, CELL TRANSPLANT, V11, P297; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cornejo M, 2010, NEUROCHEM RES, V35, P1643, DOI 10.1007/s11064-010-0225-0; Crowther CA, 2003, JAMA-J AM MED ASSOC, V290, P2669, DOI 10.1001/jama.290.20.2669; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Daadi Marcel M., 2008, V438, P205, DOI 10.1007/978-1-59745-133-8_17; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Glaser T, 2007, STEM CELLS, V25, P3016, DOI 10.1634/stemcells.2007-0218; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LEVENE MI, 1990, DEV MED CHILD NEUROL, V32, P567; Levison SW, 2001, DEV NEUROSCI-BASEL, V23, P234, DOI 10.1159/000046149; Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038243; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Low JA, 1996, AM J OBSTET GYNECOL, V175, P1383, DOI 10.1016/S0002-9378(96)70063-7; Ma J, 2007, NEUROCHEM INT, V51, P57, DOI 10.1016/j.neuint.2007.04.012; Mittendorf R, 2006, J PERINATOL, V26, P57, DOI 10.1038/sj.jp.7211419; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Park KI, 2002, GENE THER, V9, P613, DOI 10.1038/sj.gt.3301721; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Petridis AK, 2011, J CLIN NEUROSCI, V18, P265, DOI 10.1016/j.jocn.2010.06.021; Pierrat V, 2005, ARCH DIS CHILD-FETAL, V90, P257, DOI 10.1136/adc.2003.047985; Pineda JR, 2007, GENE THER, V14, P118, DOI 10.1038/sj.gt.3302847; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Romanko MJ, 2004, J CEREBR BLOOD F MET, V24, P814, DOI 10.1097/01.WCB.0000123906.17746.00; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Sato Y, 2008, REPROD SCI, V15, P613, DOI 10.1177/1933719108317299; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2002, CLIN PERINATOL, V29, P675, DOI 10.1016/S0095-5108(02)00056-8; Shi H, 2008, AM J PHYSIOL-RENAL, V294, pF229, DOI 10.1152/ajprenal.00386.2007; Sizonenko SV, 2007, SEMIN FETAL NEONAT M, V12, P241, DOI 10.1016/j.siny.2007.01.007; Stone BS, 2008, ANN NEUROL, V64, P535, DOI 10.1002/ana.21517; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Teng YD, 2011, CURR NEUROPHARMACOL, V9, P574, DOI 10.2174/157015911798376299; THORNBERG E, 1995, ACTA PAEDIATR, V84, P927, DOI 10.1111/j.1651-2227.1995.tb13794.x; Wolfberg AJ, 2007, SEMIN FETAL NEONAT M, V12, P296, DOI 10.1016/j.siny.2007.01.021; Yang ZY, 2010, BIOMATERIALS, V31, P4846, DOI 10.1016/j.biomaterials.2010.02.015; Zhang L, 2012, INT J DEV NEUROSCI; Zheng T, 2006, BRAIN RES, V1112, P99, DOI 10.1016/j.brainres.2006.07.014; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553	64	19	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51706	10.1371/journal.pone.0051706	http://dx.doi.org/10.1371/journal.pone.0051706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251608	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200155
J	King, GM; Judd, C; Kuske, CR; Smith, C				King, Gary M.; Judd, Craig; Kuske, Cheryl R.; Smith, Conor			Analysis of Stomach and Gut Microbiomes of the Eastern Oyster (Crassostrea virginica) from Coastal Louisiana, USA	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; SP-NOV.; PHYLOGENETIC ANALYSIS; COMPLETE GENOME; DIVERSITY; MYCOPLASMA; CULTURE; IDENTIFICATION; HYBRIDIZATION; MICROFLORA	We used high throughput pyrosequencing to characterize stomach and gut content microbiomes of Crassostrea virginica, the Easter oyster, obtained from two sites, one in Barataria Bay (Hackberry Bay) and the other in Terrebonne Bay (Lake Caillou), Louisiana, USA. Stomach microbiomes in oysters from Hackberry Bay were overwhelmingly dominated by Mollicutes most closely related to Mycoplasma; a more rich community dominated by Planctomyctes occurred in Lake Caillou oyster stomachs. Gut communities for oysters from both sites differed from stomach communities, and harbored a relatively diverse assemblage of phylotypes. Phylotypes most closely related to Shewanella and a Chloroflexi strain dominated the Lake Caillou and Hackberry Bay gut microbiota, respectively. While many members of the stomach and gut microbiomes appeared to be transients or opportunists, a putative core microbiome was identified based on phylotypes that occurred in all stomach or gut samples only. The putative core stomach microbiome comprised 5 OTUs in 3 phyla, while the putative core gut microbiome contained 44 OTUs in 12 phyla. These results collectively revealed novel microbial communities within the oyster digestive system, the functions of the oyster microbiome are largely unknown. A comparison of microbiomes from Louisiana oysters with bacterial communities reported for other marine invertebrates and fish indicated that molluscan microbiomes were more similar to each other than to microbiomes of polychaetes, decapods and fish.	[King, Gary M.; Judd, Craig; Smith, Conor] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Kuske, Cheryl R.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Los Alamos National Laboratory	King, GM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	gkingme@gmail.com			NSF [OCE-1043126]; GoMRI-LSU; Los Alamos National Laboratory Laboratory Directed Research and Development Grant (LDRD) [20080464ER]	NSF(National Science Foundation (NSF)); GoMRI-LSU; Los Alamos National Laboratory Laboratory Directed Research and Development Grant (LDRD)(United States Department of Energy (DOE)Los Alamos National Laboratory)	The authors acknowledge NSF award OCE-1043126 and GoMRI-LSU funding to GK for support of GK, CS and CJ. The 454 Titanium sequencing was provided by a Los Alamos National Laboratory Laboratory Directed Research and Development Grant (LDRD) to CRK (20080464ER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; AZEVEDO C, 1993, DIS AQUAT ORGAN, V16, P55, DOI 10.3354/dao016055; Bano N, 2007, ENVIRON MICROBIOL, V9, P2636, DOI 10.1111/j.1462-2920.2007.01381.x; Bevins CL, 2011, CELL MOL LIFE SCI, V68, P3675, DOI 10.1007/s00018-011-0830-3; Bianchi TS, 2011, MAR ENVIRON RES, V72, P248, DOI 10.1016/j.marenvres.2011.09.007; Boettcher KJ, 2000, APPL ENVIRON MICROB, V66, P3924, DOI 10.1128/AEM.66.9.3924-3930.2000; Boettcher KJ, 2005, INT J SYST EVOL MICR, V55, P1531, DOI 10.1099/ijs.0.63620-0; BOYLE PJ, 1987, CURR MICROBIOL, V15, P85, DOI 10.1007/BF01589367; Cardoso AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033440; Chen JG, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/209406; Clements KD, 2007, MAR BIOL, V150, P1431, DOI 10.1007/s00227-006-0443-9; Sobrinho PDC, 2010, APPL ENVIRON MICROB, V76, P1290, DOI 10.1128/AEM.00861-09; CROSBY MP, 1990, LIMNOL OCEANOGR, V35, P625, DOI 10.4319/lo.1990.35.3.0625; DAME RF, 1985, NETH J SEA RES, V19, P265, DOI 10.1016/0077-7579(85)90032-8; DAME RF, 1992, J EXP MAR BIOL ECOL, V164, P147, DOI 10.1016/0022-0981(92)90171-6; DEPAOLA A, 1990, APPL ENVIRON MICROB, V56, P2299, DOI 10.1128/AEM.56.8.2299-2302.1990; DOUILLET P, 1993, BIOL BULL-US, V184, P36, DOI 10.2307/1542378; Fall S, 2007, APPL ENVIRON MICROB, V73, P5199, DOI 10.1128/AEM.02616-06; Faury N, 2004, INT J SYST EVOL MICR, V54, P2137, DOI 10.1099/ijs.0.63232-0; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Galtsoff P.S, 1964, AM OYSTER CRASSOSTRE, V64; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Godoy-Vitorino F, 2008, APPL ENVIRON MICROB, V74, P5905, DOI 10.1128/AEM.00574-08; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Green TJ, 2010, J APPL MICROBIOL, V109, P613, DOI 10.1111/j.1365-2672.2010.04687.x; Gruenthal, 2007, CONSERVATION GENETIC; Han SF, 2010, AQUAC RES, V42, P47, DOI 10.1111/j.1365-2109.2010.02543.x; HARSHBARGER JC, 1977, SCIENCE, V196, P666, DOI 10.1126/science.193184; Harwood VJ, 2004, J MICROBIOL METH, V59, P301, DOI 10.1016/j.mimet.2004.08.001; Hernandez-Zarate G, 2006, J APPL MICROBIOL, V100, P664, DOI 10.1111/j.1365-2672.2005.02800.x; Holben WE, 2002, MICROB ECOL, V44, P175, DOI 10.1007/s00248-002-1011-6; Huang ZB, 2010, AQUAC RES, V41, pe760, DOI 10.1111/j.1365-2109.2010.02577.x; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Johnson CN, 2010, APPL ENVIRON MICROB, V76, P7076, DOI 10.1128/AEM.00697-10; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kassaify ZG, 2009, J COASTAL RES, V25, P469, DOI 10.2112/07-0962.1; Kellogg CA, 2009, APPL ENVIRON MICROB, V75, P2294, DOI 10.1128/AEM.02357-08; KIRCHHOFF H, 1987, INT J SYST BACTERIOL, V37, P192, DOI 10.1099/00207713-37-3-192; Kostanjsek R, 2007, APPL ENVIRON MICROB, V73, P5566, DOI 10.1128/AEM.02468-06; KROL RM, 1991, J INVERTEBR PATHOL, V57, P362, DOI 10.1016/0022-2011(91)90140-L; KUEH CSW, 1985, J APPL BACTERIOL, V59, P41, DOI 10.1111/j.1365-2672.1985.tb01773.x; La Valley KJ, 2009, J SHELLFISH RES, V28, P827, DOI 10.2983/035.028.0412; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li K, 2007, J APPL MICROBIOL, V103, P675, DOI 10.1111/j.1365-2672.2007.03295.x; Li M, 2009, MICROB ECOL, V58, P892, DOI 10.1007/s00248-009-9550-8; MAYASICH SA, 1987, MICROBIAL ECOL, V14, P157, DOI 10.1007/BF02013020; Meziti A, 2010, FEMS MICROBIOL ECOL, V74, P472, DOI 10.1111/j.1574-6941.2010.00964.x; Moran D, 2005, MICROB ECOL, V49, P590, DOI 10.1007/s00248-004-0097-4; Mouchet MA, 2012, FEMS MICROBIOL ECOL, V79, P568, DOI 10.1111/j.1574-6941.2011.01241.x; Nechitaylo TY, 2009, ENVIRON MICROBIOL, V11, P1016, DOI 10.1111/j.1462-2920.2008.01837.x; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; OLAFSEN JA, 1993, APPL ENVIRON MICROB, V59, P1848, DOI 10.1128/AEM.59.6.1848-1854.1993; Pujalte M J, 1999, Int Microbiol, V2, P259; Roeselers G, 2011, ISME J, DOI [10.1038/ismeJ2011.38, DOI 10.1038/ISMEJ2011.38]; Romero J, 2002, MICROBIAL ECOL, V44, P365, DOI 10.1007/s00248-002-1063-7; Schauer C, 2012, APPL ENVIRON MICROB, V78, P2758, DOI 10.1128/AEM.07788-11; Schlesner H, 2004, INT J SYST EVOL MICR, V54, P1567, DOI 10.1099/ijs.0.63113-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smriga S, 2010, FEMS MICROBIOL ECOL, V73, P31, DOI 10.1111/j.1574-6941.2010.00879.x; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Tanaka R, 2004, AQUACULTURE, V241, P453, DOI 10.1016/j.aquaculture.2004.08.032; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; WARD N, 1995, APPL ENVIRON MICROB, V61, P2270, DOI 10.1128/AEM.61.6.2270-2275.1995; Ward N., 2006, PROKARYOTES HDB BIOL, V7, P757, DOI DOI 10.1007/0-387-30747-8_; Wetz MS, 2002, AQUAT MICROB ECOL, V28, P87, DOI 10.3354/ame028087; WISEMAN WJ, 1990, ESTUARIES, V13, P265, DOI 10.2307/1351917; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]	70	160	162	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51475	10.1371/journal.pone.0051475	http://dx.doi.org/10.1371/journal.pone.0051475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251548	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200117
J	Aubert, D; Naas, T; Nordmann, P				Aubert, Daniel; Naas, Thierry; Nordmann, Patrice			Integrase-Mediated Recombination of the veb1 Gene Cassette Encoding an Extended-Spectrum beta-Lactamase	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; 59-BASE ELEMENT; DNA; SITE; EXPRESSION; INSERTION; IS1999; BINDS	The veb1 gene cassette encodes the extended spectrum beta-lactamase, VEB-1 that is increasingly isolated from worldwide Gram-negative rods. Veb1 is commonly inserted into the variable region of different class 1 integrons in which it is always associated with a downstream-located aadB gene cassette encoding an aminoglycoside adenylyltransferase. In Pseudomonas aeruginosa, the majority of veb1-containing integrons also carry an insertion sequence, IS1999 that is inserted upstream of the veb1 gene cassette and disrupts the integron specific recombination site, attI1. Investigation of the recombination properties of the sites surrounding veb1 revealed that insertion of IS1999 reduces significantly the recombination frequency of attI1 and that veb1 attC is not efficient for recombination in contrast to aadB attC. Subsequent sequence optimisation of veb1 attC by mutagenesis, into a more consensual attC site resembling aadB attC, successfully improved recombination efficiency. Overall, this work gives some insights into the organisation of veb1-containing integrons. We propose that IS1999 and the nature of veb1 attC stabilize the veb1 gene cassette environment likely by impairing recombination events upstream or downstream of veb1, respectively.	[Aubert, Daniel; Naas, Thierry; Nordmann, Patrice] Univ Paris 11, Hop Bicetre, AP HP,LabEx LERMIT,Serv Bacteriol Virol, INSERM,Emerging Resistance Antibiot U914,Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Naas, T (corresponding author), Univ Paris 11, Hop Bicetre, AP HP,LabEx LERMIT,Serv Bacteriol Virol, INSERM,Emerging Resistance Antibiot U914,Fac Med, Paris, France.	thierry.naas@bct.aphp.fr	Naas, Thierry/O-3999-2018	Naas, Thierry/0000-0001-9937-9572	INSERM; Ministere de l'Education Nationale et de la Recherche [UPRES-EA3539]; European Community [241742]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale et de la Recherche; European Community(European Commission)	The research leading to these results has received funding from INSERM, from the Ministere de l'Education Nationale et de la Recherche (UPRES-EA3539), and from the European Community's Seventh Framework Programme FP7/2010-2013 under grant agreement no. 241742 (TEMPOtest-QC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert D, 2003, J BACTERIOL, V185, P5314, DOI 10.1128/JB.185.17.5314-5319.2003; Aubert D, 2006, J BACTERIOL, V188, P6506, DOI 10.1128/JB.00375-06; AVILA P, 1988, J BACTERIOL, V170, P1350, DOI 10.1128/jb.170.3.1350-1353.1988; Bikard D, 2010, MICROBIOL MOL BIOL R, V74, P570, DOI 10.1128/MMBR.00026-10; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Bouvier M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000632; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Collis CM, 1998, MOL MICROBIOL, V29, P477, DOI 10.1046/j.1365-2958.1998.00936.x; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; COLLIS CM, 1992, MOL MICROBIOL, V6, P2875, DOI 10.1111/j.1365-2958.1992.tb01467.x; COLLIS CM, 1992, J BACTERIOL, V174, P1574, DOI 10.1128/jb.174.5.1574-1585.1992; Collis CM, 2001, J BACTERIOL, V183, P2535, DOI 10.1128/JB.183.8.2535-2542.2001; Demarre G, 2007, NUCLEIC ACIDS RES, V35, P6475, DOI 10.1093/nar/gkm709; Francia MV, 1999, J BACTERIOL, V181, P6844, DOI 10.1128/JB.181.21.6844-6849.1999; Girlich D, 2002, CLIN INFECT DIS, V34, P603, DOI 10.1086/338786; Hall RM, 1999, ANN NY ACAD SCI, V870, P68, DOI 10.1111/j.1749-6632.1999.tb08866.x; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; Hansson K, 1997, MOL MICROBIOL, V26, P441, DOI 10.1046/j.1365-2958.1997.5401964.x; Johansson C, 2004, NUCLEIC ACIDS RES, V32, P4033, DOI 10.1093/nar/gkh730; Jove T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000793; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Larouche A, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-3; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; MARTINEZ E, 1990, EMBO J, V9, P1275, DOI 10.1002/j.1460-2075.1990.tb08236.x; Naas T, 2008, CLIN MICROBIOL INFEC, V14, P42, DOI 10.1111/j.1469-0691.2007.01861.x; Naas T, 1999, FEMS MICROBIOL LETT, V176, P411, DOI 10.1016/S0378-1097(99)00266-9; Naas T, 2006, EMERG INFECT DIS, V12, P1214, DOI 10.3201/eid1708.051547; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Partridge SR, 2000, MICROBIOL-UK, V146, P2855, DOI 10.1099/00221287-146-11-2855; Philippon LN, 1997, ANTIMICROB AGENTS CH, V41, P2188, DOI 10.1128/AAC.41.10.2188; Poirel L, 1999, ANTIMICROB AGENTS CH, V43, P573, DOI 10.1128/AAC.43.3.573; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; RECCHIA GD, 1994, NUCLEIC ACIDS RES, V22, P2071, DOI 10.1093/nar/22.11.2071; Recchia GD, 1995, MICROBIOL-UK, V141, P3015, DOI 10.1099/13500872-141-12-3015; Rowe-Magnus DA, 2002, MOL MICROBIOL, V43, P1657, DOI 10.1046/j.1365-2958.2002.02861.x; Sambrook J., 2001, MOL CLONING LAB MANU; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x	38	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51602	10.1371/journal.pone.0051602	http://dx.doi.org/10.1371/journal.pone.0051602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251590	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900109
J	Lin, MH; Sivakumaran, H; Apolloni, A; Wei, T; Jans, DA; Harrich, D				Lin, Min-Hsuan; Sivakumaran, Haran; Apolloni, Ann; Wei, Ting; Jans, David A.; Harrich, David			Nullbasic, a Potent Anti-HIV Tat Mutant, Induces CRM1-Dependent Disruption of HIV Rev Trafficking	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR EXPORT FACTOR; TRANSDOMINANT TAT; INTRACELLULAR TRAFFICKING; NUCLEOLAR-LOCALIZATION; BASIC DOMAIN; PROTEIN B23; MATRIN 3; IN-VIVO; REPLICATION	Nullbasic, a mutant of the HIV-1 Tat protein, has anti-HIV-1 activity through mechanisms that include inhibition of Rev function and redistribution of the HIV-1 Rev protein from the nucleolus to the nucleoplasm and cytoplasm. Here we investigate the mechanism of this effect for the first time, establishing that redistribution of Rev by Nullbasic is not due to direct interaction between the two proteins. Rather, Nullbasic affects subcellular localization of cellular proteins that regulate Rev trafficking. In particular, Nullbasic induced redistribution of exportin 1 (CRM1), nucleophosmin (B23) and nucleolin (C23) from the nucleolus to the nucleus when Rev was coexpressed, but never in its absence. Inhibition of the Rev: CRM1 interaction by leptomycin B or a non-interacting RevM10 mutant completely blocked redistribution of Rev by Nullbasic. Finally, Nullbasic did not inhibit importin beta- or transportin 1-mediated nuclear import, suggesting that cytoplasmic accumulation of Rev was due to increased export by CRM1. Overall, our data support the conclusion that CRM1-dependent subcellular redistribution of Rev from the nucleolus by Nullbasic is not through general perturbation of either nuclear import or export. Rather, Nullbasic appears to interact with and disrupt specific components of a Rev trafficking complex required for its nucleocytoplasmic shuttling and, in particular, its nucleolar accumulation.	[Lin, Min-Hsuan; Sivakumaran, Haran; Apolloni, Ann; Wei, Ting; Harrich, David] Queensland Inst Med Res, Mol Virol Lab, Brisbane, Qld 4006, Australia; [Lin, Min-Hsuan] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Monash University	Harrich, D (corresponding author), Queensland Inst Med Res, Mol Virol Lab, Brisbane, Qld 4006, Australia.	david.harrich@qimr.edu.au	Lin, Min-Hsuan/ABA-3334-2020; Harrich, David/H-6668-2016	Jans, David/0000-0001-5115-4745; Sivakumaran, Haran/0000-0002-4691-4989; Lin, Min-Hsuan/0000-0001-7074-6041; Harrich, David/0000-0003-3690-0150	National Health and Medical Research Council (NHMRC); Australian Centre for HIV and Hepatitis Research Centre (ACH2); Australian Research Council; University of Queensland Research Scholarship; University of Queensland International Research Tuition Award	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Research Centre (ACH2); Australian Research Council(Australian Research Council); University of Queensland Research Scholarship(University of Queensland); University of Queensland International Research Tuition Award	This work in the DH Laboratory was sponsored by the National Health and Medical Research Council (NHMRC) Project grant and the Australian Centre for HIV and Hepatitis Research Centre (ACH2). DH is funded by the Australian Research Council Future Fellowship. MHL is sponsored by a University of Queensland Research Scholarship and a University of Queensland International Research Tuition Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; Daelemans D, 2004, J BIOL CHEM, V279, P50167, DOI 10.1074/jbc.M407713200; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; DUNDR M, 1995, J CELL SCI, V108, P2811; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Freed Eric O., 2001, Somatic Cell and Molecular Genetics, V26, P13, DOI 10.1023/A:1021070512287; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; HAUBER J, 1989, J VIROL, V63, P1181, DOI 10.1128/JVI.63.3.1181-1187.1989; He JJ, 2009, RNA BIOL, V6, P384, DOI 10.4161/rna.6.4.8920; Henderson BR, 1997, J MOL BIOL, V274, P693, DOI 10.1006/jmbi.1997.1420; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kula A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-60; Li YP, 1996, EUR J BIOCHEM, V237, P153, DOI 10.1111/j.1432-1033.1996.0153n.x; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MARASCO WA, 1994, ARCH VIROL, V139, P133, DOI 10.1007/BF01309460; Matthews DA, 2001, J VIROL, V75, P1031, DOI 10.1128/JVI.75.2.1031-1038.2001; Meredith LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007769; Miyazaki Y, 1996, BIOCHIMIE, V78, P1081, DOI 10.1016/S0300-9084(97)86733-8; MIYAZAKI Y, 1995, EXP CELL RES, V219, P93, DOI 10.1006/excr.1995.1209; MODESTI N, 1991, NEW BIOL, V3, P759; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Orsini MJ, 1996, J VIROL, V70, P8055, DOI 10.1128/JVI.70.11.8055-8063.1996; PEARSON L, 1990, P NATL ACAD SCI USA, V87, P5079, DOI 10.1073/pnas.87.13.5079; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Stauber RH, 1998, VIROLOGY, V252, P126, DOI 10.1006/viro.1998.9400; Stauber RH, 1998, VIROLOGY, V251, P38, DOI 10.1006/viro.1998.9295; Strebel Klaus, 2003, AIDS, V17 Suppl 4, pS25, DOI 10.1097/00002030-200317004-00003; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Taliansky ME, 2010, ADV VIRUS RES, V77, P119, DOI 10.1016/S0065-3527(10)77005-6; Truant R, 1999, MOL CELL BIOL, V19, P1210; Ulich C, 1996, J VIROL, V70, P4871, DOI 10.1128/JVI.70.7.4871-4876.1996; Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589; Yedavalli VSRK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-61; Yedavalli VSRK, 2011, RNA BIOL, V8, P195, DOI 10.4161/rna.8.2.14803; Yi R, 2002, J VIROL, V76, P2036, DOI 10.1128/JVI.76.5.2036-2042.2002; Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999	49	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51466	10.1371/journal.pone.0051466	http://dx.doi.org/10.1371/journal.pone.0051466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251541	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900089
J	Moreno, AM; de Souza, DD; Reinhard, J				Moreno, Antonio Mauricio; de Souza, Deisy das Gracas; Reinhard, Judith			A Comparative Study of Relational Learning Capacity in Honeybees (Apis mellifera) and Stingless Bees (Melipona rufiventris)	PLOS ONE			English	Article							ATLANTIC RAIN-FOREST; PROBOSCIS EXTENSION; BUMBLE-BEES; AFRICANIZED HONEYBEES; COLOR DISCRIMINATION; BOMBUS-TERRESTRIS; MEMORY; QUADRIFASCIATA; COMMUNICATION; PREFERENCES	Background: Learning of arbitrary relations is the capacity to acquire knowledge about associations between events or stimuli that do not share any similarities, and use this knowledge to make behavioural choices. This capacity is well documented in humans and vertebrates, and there is some evidence it exists in the honeybee (Apis mellifera). However, little is known about whether the ability for relational learning extends to other invertebrates, although many insects have been shown to possess excellent learning capacities in spite of their small brains. Methodology/Principal Findings: Using a symbolic matching-to-sample procedure, we show that the honeybee Apis mellifera rapidly learns arbitrary relations between colours and patterns, reaching 68.2% correct choice for pattern-colour relations and 73.3% for colour-pattern relations. However, Apis mellifera does not transfer this knowledge to the symmetrical relations when the stimulus order is reversed. A second bee species, the stingless bee Melipona rufiventris from Brazil, seems unable to learn the same arbitrary relations between colours and patterns, although it exhibits excellent discrimination learning. Conclusions/Significance: Our results confirm that the capacity for learning arbitrary relations is not limited to vertebrates, but even insects with small brains can perform this learning task. Interestingly, it seems to be a species-specific ability. The disparity in relational learning performance between the two bee species we tested may be linked to their specific foraging and recruitment strategies, which evolved in adaptation to different environments.	[Moreno, Antonio Mauricio; Reinhard, Judith] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Moreno, Antonio Mauricio; de Souza, Deisy das Gracas] Univ Fed Sao Carlos, Dept Psicol, Sao Paulo, Brazil; [Moreno, Antonio Mauricio; de Souza, Deisy das Gracas] Univ Fed Sao Carlos, Natl Inst Sci & Technol Behav Cognit & Teaching, Sao Paulo, Brazil	University of Queensland; Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos	Reinhard, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	j.reinhard@uq.edu.au	de Souza, Deisy das Graças/AAE-9056-2019; de Souza, Deisy G./B-8778-2012	de Souza, Deisy das Graças/0000-0001-6164-174X; de Souza, Deisy G./0000-0001-6164-174X	Foundation for Research Support in the State of Sao Paulo (FAPESP) [08/50576-8, 08/57705-8]; National Council for Scientific and Technological Development of Brazil (CNPq) [573972/2008-7]	Foundation for Research Support in the State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AMM was supported by the Foundation for Research Support in the State of Sao Paulo (FAPESP grants no. 08/50576-8 and no. 08/57705-8) and by the National Council for Scientific and Technological Development of Brazil (CNPq grant no. 573972/2008-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avargues-Weber A, 2011, ANNU REV ENTOMOL, V56, P423, DOI 10.1146/annurev-ento-120709-144855; Benard J, 2004, LEARN MEMORY, V11, P328, DOI 10.1101/lm.72204; Biesmeijer JC, 2006, APIDOLOGIE, V37, P240, DOI 10.1051/apido:2006014; Brown MF, 1998, ANIM LEARN BEHAV, V26, P264, DOI 10.3758/BF03199220; Chittka L, 2004, POPUL ECOL, V46, P243, DOI 10.1007/s10144-004-0180-1; Cooke MHY, 2007, J COMP PSYCHOL, V121, P106, DOI 10.1037/0735-7036.121.1.106; Cumming WW, 1965, STIMULUS GENERALIZAT, P284; DUKAS R, 1991, ANIM BEHAV, V42, P269, DOI 10.1016/S0003-3472(05)80558-5; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; Hertz M, 1938, SOURCEBOOK GESTALT P, P253; Hoedjes KM, 2011, P ROY SOC B-BIOL SCI, V278, P889, DOI 10.1098/rspb.2010.2199; Hrncir M, 2009, CONTEMP TOP ENTOMOL, P199; Ings TC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1207, DOI 10.1007/s00265-009-0731-8; IVERSEN IH, 1986, J EXP ANAL BEHAV, V45, P297, DOI 10.1901/jeab.1986.45-297; Jarau S, 2009, CONTEMP TOP ENTOMOL, P223; Kandori I, 2009, J EXP BIOL, V212, P3810, DOI 10.1242/jeb.032870; Laloi D, 1999, ENTOMOL EXP APPL, V90, P123, DOI 10.1023/A:1003598301272; Mc Cabe SI, 2007, J COMP PHYSIOL A, V193, P1089, DOI 10.1007/s00359-007-0260-8; Mc Cabe SI, 2009, J COMP PHYSIOL A, V195, P113, DOI 10.1007/s00359-008-0391-6; MENZEL R, 1989, J COMP PHYSIOL A, V166, P151; MENZEL R, 1973, Apidologie, V4, P1, DOI 10.1051/apido:19730101; MENZEL R, 1985, FORTS ZOOL, V31, P55; Nieh JC, 2004, APIDOLOGIE, V35, P159, DOI 10.1051/apido:2004007; PESSOTTI I, 1981, Revista Brasileira de Biologia, V41, P681; Pessotti I., 1972, Journal apic Res, V11, P89; Pessotti I, 1967, REV PSICOL NORMAL PA, V3-4, P171; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2006, ADV STUD BEHAV, V36, P305, DOI 10.1016/S0065-3454(06)36007-X; RAMALHO M, 1989, APIDOLOGIE, V20, P185, DOI 10.1051/apido:19890301; RAMALHO M, 1990, APIDOLOGIE, V21, P469, DOI 10.1051/apido:19900508; Reinhard J, 2004, J EXP BIOL, V207, P4371, DOI 10.1242/jeb.01306; Reinhard J, 2006, J COMP PHYSIOL A, V192, P409, DOI 10.1007/s00359-005-0079-0; Riveros AJ, 2009, NATURWISSENSCHAFTEN, V96, P851, DOI 10.1007/s00114-009-0532-y; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; Srinivasan MV, 1998, NATURE, V396, P637, DOI 10.1038/25272; Toda NRT, 2009, NATURWISSENSCHAFTEN, V96, P1185, DOI 10.1007/s00114-009-0582-1; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Vorel CA, 2010, J KANSAS ENTOMOL SOC, V83, P80, DOI 10.2317/0022-8567-83.1.80; Wilms W, 1996, STUD NEOTROP FAUNA E, V31, P137, DOI 10.1076/snfe.31.3.137.13336; Wilms W, 1997, APIDOLOGIE, V28, P339, DOI 10.1051/apido:19970602; Zhang SW, 1999, NEUROBIOL LEARN MEM, V72, P180, DOI 10.1006/nlme.1998.3901	46	26	29	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51467	10.1371/journal.pone.0051467	http://dx.doi.org/10.1371/journal.pone.0051467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251542	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900090
J	Bekkers, MBM; Brunekreef, B; Koppelman, GH; Kerkhof, M; de Jongste, JC; Smit, HA; Wijga, AH				Bekkers, Marga B. M.; Brunekreef, Bert; Koppelman, Gerard H.; Kerkhof, Marjan; de Jongste, Johan C.; Smit, Henriette A.; Wijga, Alet H.			BMI and Waist Circumference; Cross-Sectional and Prospective Associations with Blood Pressure and Cholesterol in 12-Year-Olds	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; CAUSE-SPECIFIC MORTALITY; CORONARY-HEART-DISEASE; METABOLIC SYNDROME; CHILDHOOD OBESITY; BIRTH COHORT; CHILDREN; ADOLESCENTS; PREVENTION	Objective: Childhood and adolescent overweight, defined by body mass index (BMI) are associated with an increased risk of cardiovascular disease in later life. Abdominal adiposity may be more important in associations with cardiovascular diseases but waist circumference (WC) has been rarely studied in children. We studied associations between BMI and WC and blood pressure (BP) and cholesterol in 12-year-old children and prospectively changes in BMI or WC status between age 8 and 12 years and BP and cholesterol at age 12. Study Design: Weight, height, WC, BP and cholesterol concentrations were measured in 1432 children at age 12 years. Linear regression was used to study the associations between high BMI and large WC (>90th percentile) and BP and cholesterol. Results: Systolic BP was 4.9 mmHg higher (95% (CI 2.5, 7.2) in girls and 4.2 mmHg (95% CI 1.9, 6.5) in boys with a high BMI. Large WC was also associated with higher systolic BP in girls (3.7 mmHg (95% CI 1.3, 6.1)) and boys (3.5 mmHg (95% CI 1.2, 5.8)). Diastolic BP and cholesterol concentrations were significantly positively (HDL cholesterol negatively) associated with high BMI and large WC, too. Normal weight children with a history of overweight did not have higher blood pressure levels or adverse cholesterol concentrations than children that were normal weight at both ages. Conclusion: A high BMI and large WC were associated with higher BP levels and adverse cholesterol concentrations. WC should be taken into account when examining cardiovascular risk factors in children. Citation: Bekkers MBM, Brunekreef B, Koppelman GH, Kerkhof M, de Jongste JC, et al. (2012) BMI and Waist Circumference; Cross-Sectional and Prospective Associations with Blood Pressure and Cholesterol in 12-Year-Olds. PLoS ONE 7(12): e51801. doi:10.1371/journal.pone.0051801	[Bekkers, Marga B. M.; Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Bekkers, Marga B. M.; Wijga, Alet H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Kerkhof, Marjan] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol & Bioinformat, Groningen, Netherlands; [de Jongste, Johan C.] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Bekkers, MBM (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.	marga.bekkers@rivm.nl	Koppelman, Gerard/AAG-9187-2020	brunekreef, bert/0000-0001-9908-0060; Koppelman, Gerard/0000-0001-8567-3252	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing and the Environment; Netherlands Ministry of Health, Welfare and Sport	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing and the Environment; Netherlands Ministry of Health, Welfare and Sport	Research relating to this manuscript was funded by The Netherlands Organization for Health Research and Development; The Netherlands Organization for Scientific Research; The Netherlands Asthma Fund, The Netherlands Ministry of Spatial Planning Housing and the Environment; and The Netherlands Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; Ashwell M, 2011, OBES REV; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; Davies AA, 2004, CIRCULATION, V110, P1258, DOI 10.1161/01.CIR.0000140980.61294.4D; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Gopinath B, 2011, ANN EPIDEMIOL, V21, P351, DOI 10.1016/j.annepidem.2011.02.002; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Larsson C, 2011, ACTA PAEDIATR, V100, P102, DOI 10.1111/j.1651-2227.2010.01969.x; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Mamun AA, 2005, HYPERTENSION, V45, P1083, DOI 10.1161/01.HYP.0000166720.18319.51; Maximova K, 2011, J HYPERTENS, V29, P2075, DOI 10.1097/HJH.0b013e32834be614; Maximova K, 2010, EPIDEMIOLOGY, V21, P324, DOI 10.1097/EDE.0b013e3181d61d10; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; Nadeau KJ, 2011, NAT REV CARDIOL, V8, P513, DOI 10.1038/nrcardio.2011.86; Owen CG, 2009, INT J OBESITY, V33, P866, DOI 10.1038/ijo.2009.102; Tybor DJ, 2011, AM J CLIN NUTR, V93, P392, DOI 10.3945/ajcn.110.001719; Watts K, 2008, J PAEDIATR CHILD H, V44, P709, DOI 10.1111/j.1440-1754.2008.01411.x; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	28	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51801	10.1371/journal.pone.0051801	http://dx.doi.org/10.1371/journal.pone.0051801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251628	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800087
J	Carra, S; Foglia, E; Cermenati, S; Bresciani, E; Giampietro, C; Lamia, CL; Dejana, E; Beltrame, M; Cotelli, F				Carra, Silvia; Foglia, Efrem; Cermenati, Solei; Bresciani, Erica; Giampietro, Costanza; Lamia, Carla Lora; Dejana, Elisabetta; Beltrame, Monica; Cotelli, Franco			Ve-ptp Modulates Vascular Integrity by Promoting Adherens Junction Maturation	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; BLOOD-VESSEL DEVELOPMENT; CELL-CELL ADHESION; MOLECULAR-ORGANIZATION; PARACELLULAR PATHWAY; ENDOTHELIAL-CELLS; IN-VIVO; PHOSPHORYLATION; ZEBRAFISH; CADHERIN	Background: Endothelial cell junctions control blood vessel permeability. Altered permeability can be associated with vascular fragility that leads to vessel weakness and haemorrhage formation. In vivo studies on the function of genes involved in the maintenance of vascular integrity are essential to better understand the molecular basis of diseases linked to permeability defects. Ve-ptp (Vascular Endothelial-Protein Tyrosine Phosphatase) is a transmembrane protein present at endothelial adherens junctions (AJs). Methodology/Principal Findings: We investigated the role of Ve-ptp in AJ maturation/stability and in the modulation of endothelial permeability using zebrafish (Danio rerio). Whole-mount in situ hybridizations revealed zve-ptp expression exclusively in the developing vascular system. Generation of altered zve-ptp transcripts, induced separately by two different splicing morpholinos, resulted in permeability defects closely linked to vascular wall fragility. The ultrastructural analysis revealed a statistically significant reduction of junction complexes and the presence of immature AJs in zve-ptp morphants but not in control embryos. Conclusions/Significance: Here we show the first in vivo evidence of a potentially critical role played by Ve-ptp in AJ maturation, an important event for permeability modulation and for the development of a functional vascular system. Citation: Carra S, Foglia E, Cermenati S, Bresciani E, Giampietro C, et al. (2012) Ve-ptp Modulates Vascular Integrity by Promoting Adherens Junction Maturation. PLoS ONE 7(12): e51245. doi:10.1371/journal.pone.0051245	[Carra, Silvia; Foglia, Efrem; Bresciani, Erica; Lamia, Carla Lora; Cotelli, Franco] Univ Milan, Dipartimento Biol, Milan, Italy; [Carra, Silvia; Foglia, Efrem; Cermenati, Solei; Lamia, Carla Lora; Dejana, Elisabetta; Beltrame, Monica; Cotelli, Franco] Univ Milan, Dipartimento Biosci, Milan, Italy; [Cermenati, Solei; Dejana, Elisabetta; Beltrame, Monica] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy; [Giampietro, Costanza; Dejana, Elisabetta] FIRC Inst Mol Oncol, Milan, Italy	University of Milan; University of Milan; University of Milan; IFOM - FIRC Institute of Molecular Oncology	Cotelli, F (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	franco.cotelli@unimi.it	Beltrame, Monica/D-8093-2017; Foglia, Efrem Alessandro/AAF-1840-2020; Dejana, Elisabetta/A-6274-2016; Foglia, Efrem Alessandro/AGW-8220-2022; Carra, Silvia/P-2627-2019; Carra, Silvia/K-4643-2016; Giampietro, Costanza/D-4643-2016	Foglia, Efrem Alessandro/0000-0002-7446-8365; Carra, Silvia/0000-0002-9321-9508; Carra, Silvia/0000-0002-9321-9508; Giampietro, Costanza/0000-0001-5229-3835; Beltrame, Monica/0000-0001-5094-3494; DEJANA, ELISABETTA/0000-0002-0007-0426	Cassa di Risparmio delle Provincie Lombarde (CARIPLO); Biological and molecular characterization of Cancer Stem Cells; Fondazione CARIPLO [2006.0807]; Associazione Italiana per la Ricerca sul Cancro; Leducq Foundation Transatlantic Network of Excellence; Adriano Buzzati-Traverso foundation	Cassa di Risparmio delle Provincie Lombarde (CARIPLO)(Fondazione Cariplo); Biological and molecular characterization of Cancer Stem Cells; Fondazione CARIPLO(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Leducq Foundation Transatlantic Network of Excellence(Leducq Foundation); Adriano Buzzati-Traverso foundation	Financial support from Cassa di Risparmio delle Provincie Lombarde (CARIPLO) N.O.B.E.L. Biological and molecular characterization of Cancer Stem Cells to F.C., Fondazione CARIPLO (2006.0807) to M.B., Associazione Italiana per la Ricerca sul Cancro and the Leducq Foundation Transatlantic Network of Excellence to E.D. Dr Foglia was funded by a fellowship in memory of Arturo Falaschi from Adriano Buzzati-Traverso foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenton F, 2004, MECH DEVELOP, V121, P131, DOI 10.1016/j.mod.2004.01.001; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bogatcheva NV, 2002, VASC PHARMACOL, V39, P201, DOI 10.1016/S1537-1891(03)00009-0; Brevier J, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016005; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Dejana E, 2000, INT J DEV BIOL, V44, P743; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Esser S, 1998, J CELL SCI, V111, P1853; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Nwariaku FE, 2002, SURGERY, V132, P180, DOI 10.1067/msy.2002.125305; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shi S, 1998, ENDOTHELIUM-J ENDOTH, V6, P153, DOI 10.3109/10623329809072202; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; THISSE C, 1993, DEVELOPMENT, V119, P1203; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vestweber D, 2000, J PATHOL, V190, P281; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Weis SM, 2008, CURR OPIN HEMATOL, V15, P243, DOI 10.1097/MOH.0b013e3282f97d86; Westerfield M, 1993, ZEBRAFISH BOOK; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Young BA, 2003, AM J PHYSIOL-LUNG C, V285, pL63, DOI 10.1152/ajplung.00423.2002	42	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51245	10.1371/journal.pone.0051245	http://dx.doi.org/10.1371/journal.pone.0051245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251467	Green Published, gold			2022-12-27	WOS:000312386800033
J	Rodriguez, MC; Viadas, C; Seoane, A; Sangari, FJ; Lopez-Goni, I; Garcia-Lobo, JM				Cruz Rodriguez, Maria; Viadas, Cristina; Seoane, Asuncion; Javier Sangari, Felix; Lopez-Goni, Ignacio; Maria Garcia-Lobo, Juan			Evaluation of the Effects of Erythritol on Gene Expression in Brucella abortus	PLOS ONE			English	Article							B19 VACCINE STRAIN; 2,3-DIHYDROXYBENZOIC ACID; RNA-SEQ; METABOLISM; VIRULENCE; CATABOLISM; OPERON; IDENTIFICATION; SIDEROPHORE; ADAPTATION	Bacteria of the genus Brucella have the unusual capability to catabolize erythritol and this property has been associated with their virulence mainly because of the presence of erythritol in bovine foetal tissues and because the attenuated S19 vaccine strain is the only Brucella strain unable to oxydize erythritol. In this work we have analyzed the transcriptional changes produced in Brucella by erythritol by means of two high throughput approaches: RNA hybridization against a microarray containing most of Brucella ORF's constructed from the Brucella ORFeome and next generation sequencing of Brucella mRNA in an Illumina GAIIx platform. The results obtained showed the overexpression of a group of genes, many of them in a single cluster around the ery operon, able to co-ordinately mediate the transport and degradation of erythritol into three carbon atoms intermediates that will be then converted into fructose-6P (F6P) by gluconeogenesis. Other induced genes participating in the nonoxidative branch of the pentose phosphate shunt and the TCA may collaborate with the ery genes to conform an efficient degradation of sugars by this route. On the other hand, several routes of amino acid and nucleotide biosynthesis are up-regulated whilst amino acid transport and catabolism genes are down-regulated. These results corroborate previous descriptions indicating that in the presence of erythritol, this sugar was used preferentially over other compounds and provides a neat explanation of the the reported stimulation of growth induced by erythritol. Citation: Rodriguez MC, Viadas C, Seoane A, Sangari FJ, Lopez-Goni I, et al. (2012) Evaluation of the Effects of Erythritol on Gene Expression in Brucella abortus. PLoS ONE 7(12): e50876. doi:10.1371/journal.pone.0050876	[Cruz Rodriguez, Maria; Seoane, Asuncion; Javier Sangari, Felix; Maria Garcia-Lobo, Juan] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Dept Biol Mol,SODERCAN, E-39005 Santander, Cantabria, Spain; [Viadas, Cristina; Lopez-Goni, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Navarra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of Navarra	Sangari, FJ (corresponding author), Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Dept Biol Mol,SODERCAN, E-39005 Santander, Cantabria, Spain.	sangarif@unican.es; jmglobo@unican.es	Lobo, Juan M Garcia/K-2727-2014; Sangari, Félix J/K-9104-2014; Rodriguez, Maria-Cruz/K-6533-2014; López-Goñi, Ignacio/K-2572-2017	Lobo, Juan M Garcia/0000-0002-9187-0671; Sangari, Félix J/0000-0002-3298-6076; Rodriguez, Maria-Cruz/0000-0001-6778-1663; López-Goñi, Ignacio/0000-0002-3873-8743	Ministerio de Ciencia y Tecnologia of Spain [BIO2005-04985, AGL2008-04514, BIO2007-63656, BFU2011-25658]; Instituto de Salud Carlos III [PI050894]; Gobierno Vasco; Fundacion Marques de Valdecilla-IFIMAV	Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Gobierno Vasco(Basque Government); Fundacion Marques de Valdecilla-IFIMAV	This work was supported by the Ministerio de Ciencia y Tecnologia of Spain (BIO2005-04985 and AGL2008-04514 to ILG, and BIO2007-63656 and BFU2011-25658 to FJS) and Instituto de Salud Carlos III (PI050894 to JMG-L). Fellowships support to CV from the Gobierno Vasco and to MCR from Fundacion Marques de Valdecilla-IFIMAV are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; ANDERSON JD, 1965, J GEN MICROBIOL, V38, P109, DOI 10.1099/00221287-38-1-109; Barbier T, 2011, FEBS LETT, V585, P2929, DOI 10.1016/j.febslet.2011.08.011; Bellaire BH, 2003, INFECT IMMUN, V71, P1794, DOI 10.1128/IAI.71.4.1794-1803.2003; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Burkhardt S, 2005, INFECT IMMUN, V73, P6782, DOI 10.1128/IAI.73.10.6782-6790.2005; Carrero MIG, 2002, MICROBIOL-SGM, V148, P353, DOI 10.1099/00221287-148-2-353; Crasta OR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002193; Delrue RM, 2004, FEMS MICROBIOL LETT, V231, P1, DOI 10.1016/S0378-1097(03)00963-7; Dozot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012679; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Eskra L, 2001, INFECT IMMUN, V69, P7736, DOI 10.1128/IAI.69.12.7736-7742.2001; Eskra L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031747; Essenberg RC, 2002, VET MICROBIOL, V90, P249, DOI 10.1016/S0378-1135(02)00212-2; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Hernandez-Castro R, 2003, MICROBIOL-SGM, V149, P3185, DOI 10.1099/mic.0.26678-0; Jain N, 2011, FEMS MICROBIOL LETT, V316, P1, DOI 10.1111/j.1574-6968.2010.02186.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lillo AM, 2003, BIOORG MED CHEM LETT, V13, P737, DOI 10.1016/S0960-894X(02)01032-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPEZGONI I, 1992, INFECT IMMUN, V60, P4496; MEYER ME, 1966, J BACTERIOL, V92, P584, DOI 10.1128/JB.92.3.584-588.1966; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Poysti NJ, 2007, J BACTERIOL, V189, P3445, DOI 10.1128/JB.01707-06; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANGARI FJ, 1994, FEMS MICROBIOL LETT, V121, P337, DOI 10.1111/j.1574-6968.1994.tb07123.x; Sangari FJ, 1998, VACCINE, V16, P1640, DOI 10.1016/S0264-410X(98)00063-2; SANGARI FJ, 1994, VACCINE, V12, P435, DOI 10.1016/0264-410X(94)90121-X; Sangari FJ, 2000, MICROBIOL-UK, V146, P487, DOI 10.1099/00221287-146-2-487; Simon R, 2007, CANCER INFORM, V3, P11; SMITH H, 1962, NATURE, V193, P47, DOI 10.1038/193047a0; SPERRY JF, 1975, J BACTERIOL, V121, P619, DOI 10.1128/JB.121.2.619-630.1975; Sun YH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00047; Trant CGMC, 2010, INFECT IMMUN, V78, P2283, DOI 10.1128/IAI.01433-09; Viadas C, 2009, MICROB PATHOGENESIS, V47, P189, DOI 10.1016/j.micpath.2009.06.002; Viadas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010216; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yost CK, 2006, MICROBIOL-SGM, V152, P2061, DOI 10.1099/mic.0.28938-0	41	14	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50876	10.1371/journal.pone.0050876	http://dx.doi.org/10.1371/journal.pone.0050876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272076	Green Published, gold			2022-12-27	WOS:000312386800019
J	Farrelly, MC; Kamyab, K; Nonnemaker, J; Crankshaw, E; Allen, JA				Farrelly, Matthew C.; Kamyab, Kian; Nonnemaker, James; Crankshaw, Erik; Allen, Jane A.			Movie Smoking and Youth Initiation: Parsing Smoking Imagery and Other Adult Content	PLOS ONE			English	Article							6 EUROPEAN COUNTRIES; ADOLESCENT SMOKING; ESTABLISHED SMOKING; ENTERTAINMENT MEDIA; SENSATION SEEKING; VIEWING SMOKING; YOUNG-ADULTS; EXPOSURE; TOBACCO; RISK	Objectives: To isolate the independent influence of exposure to smoking and other adult content in the movies on youth smoking uptake. Methods: We used discrete time survival analysis to quantify the influence of exposure to smoking and other adult content in the movies on transitioning from (1) closed to open to smoking; (2) never to ever trying smoking; and (3) never to ever hitting, slapping, or shoving someone on two or more occasions in the past 30 days. The latter is a comparative outcome, hypothesized to have no correlation with exposure to smoking in the movies. Results: Assessed separately, both exposure to smoking imagery and exposure to adult content were associated with increased likelihood of youth becoming open to smoking (OR = 1.09, 95% CI: 1.04-1.15 and OR = 1.10, 95% CI: 1.04-1.17) and having tried smoking (OR = 1.06, 95% CI: 1.00-1.12 and OR = 1.06, 95% CI: 1.00-1.13). Both measures were also separately associated with aggressive behavior (OR = 1.09, 95% CI: 1.04-1.14 and OR = 1.09, 95% CI: 1.04-1.15). A very high correlation between the two measures (0.995, p<0.000) prevented an assessment of their independent effects on smoking initiation. Conclusion: Although exposure to smoking in the movies is correlated with smoking susceptibility and initiation, the high correlation between exposure to smoking in the movies and other adult content suggests that more research is needed to disentangle their independent influence on smoking.	[Farrelly, Matthew C.; Kamyab, Kian; Nonnemaker, James; Allen, Jane A.] RTI Int, Publ Hlth Policy Res Program, Res Triangle Pk, NC USA; [Crankshaw, Erik] RTI Int, Community Hlth Promot Res Program, Res Triangle Pk, NC USA	Research Triangle Institute; Research Triangle Institute	Farrelly, MC (corresponding author), RTI Int, Publ Hlth Policy Res Program, Res Triangle Pk, NC USA.	mcf@rti.org		Appleyard Allen, Jane/0000-0001-7914-1866; Farrelly, Matthew/0000-0002-6035-1596; nonnemaker, james/0000-0003-1044-7482; Crankshaw, Erik/0000-0002-2919-5273	New York State Department of Health	New York State Department of Health	This study was supported by the New York State Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Mejia AM, 2009, ARCH PEDIAT ADOL MED, V163, P638, DOI 10.1001/archpediatrics.2009.59; Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Bandura A., 1986, SOCIAL FDN THOUGHT A; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P910; Chapman S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001078; Choi K, 2011, AM J PREV MED, V41, P167, DOI 10.1016/j.amepre.2011.04.010; Currivan DB, 2004, PUBLIC OPIN QUART, V68, P542, DOI 10.1093/poq/nfh039; Dal Cin S, 2007, PSYCHOL SCI, V18, P559, DOI 10.1111/j.1467-9280.2007.01939.x; Dal Cin S, 2012, J HEALTH COMMUN, V17, P76, DOI 10.1080/10810730.2011.585697; Dalton MA, 2003, LANCET, V362, P281, DOI 10.1016/S0140-6736(03)13970-0; Dalton MA, 2006, PEDIATRICS, V118, P1932, DOI 10.1542/peds.2005-3082; Dalton MA, 2009, PEDIATRICS, V123, pE551, DOI 10.1542/peds.2008-2102; DONOVAN JE, 1988, J CONSULT CLIN PSYCH, V56, P762, DOI 10.1037/0022-006X.56.5.762; Green MC, 2012, ADDICTION; Hanewinkel R, 2008, ADDICTION, V103, P1722, DOI 10.1111/j.1360-0443.2008.02308.x; Hanewinkel R, 2007, AM J PREV MED, V32, P466, DOI 10.1016/j.amepre.2007.02.025; Hanewinkel R, 2012, PEDIATRICS, V129, P709, DOI 10.1542/peds.2011-2809; Heatherton TF, 2009, CURR DIR PSYCHOL SCI, V18, P63, DOI 10.1111/j.1467-8721.2009.01610.x; Jackson C, 2007, ARCH PEDIAT ADOL MED, V161, P260, DOI 10.1001/archpedi.161.3.260; JESSOR R, 1992, ADOLESCENTS AT RISK, P19; Morgenstern M, 2011, THORAX, V66, P875, DOI 10.1136/thoraxjnl-2011-200489; Mowery PD, 2004, AM J PUBLIC HEALTH, V94, P331, DOI 10.2105/AJPH.94.2.331; Primack BA, 2012, JNCI-J NATL CANCER I, V104, P549, DOI 10.1093/jnci/djs138; Reynolds EK, 2011, J CLIN CHILD ADOLESC, V40, P67, DOI 10.1080/15374416.2011.533406; Sargent JD, 2009, TOB CONTROL, V18, P47, DOI 10.1136/tc.2008.026153; Sargent JD, 2007, ARCH PEDIAT ADOL MED, V161, P849, DOI 10.1001/archpedi.161.9.849; Sargent JD, 2009, ADDICTION, V104, P815, DOI 10.1111/j.1360-0443.2009.02542.x; Sargent JD, 2005, PEDIATRICS, V116, P1183, DOI 10.1542/peds.2005-0714; Sargent JD, 2004, PEDIATRICS, V114, P149, DOI 10.1542/peds.114.1.149; Shadel WG, 2012, DRUG ALCOHOL DEPEN, V123, P66, DOI 10.1016/j.drugalcdep.2011.10.019; Shadel WG, 2010, NICOTINE TOB RES, V12, P850, DOI 10.1093/ntr/ntq099; Shmueli D, 2010, AM J PREV MED, V38, P351, DOI 10.1016/j.amepre.2009.12.025; SINGER JD, 1993, J EDUC STAT, V18, P155, DOI 10.2307/1165085; Song AV, 2007, AM J PREV MED, V33, P396, DOI 10.1016/j.amepre.2007.07.026; Stephenson MT, 2003, DRUG ALCOHOL DEPEN, V72, P279, DOI 10.1016/j.drugalcdep.2003.08.003; Tanski SE, 2012, PREV SCI, V13, P55, DOI 10.1007/s11121-011-0244-3; Thrasher JF, 2008, AM J PREV MED, V35, P95, DOI 10.1016/j.amepre.2008.03.036; Thrasher JF, 2009, CANCER EPIDEM BIOMAR, V18, P3444, DOI 10.1158/1055-9965.EPI-09-0883; Tickle JJ, 2009, J HEALTH COMMUN, V14, P756, DOI 10.1080/10810730903295567; Titus K., 2009, SMOKING PRESENTATION; Titus-Ernstoff L, 2008, PEDIATRICS, V121, P15, DOI 10.1542/peds.2007-0051; Vallone D, 2007, ADDICTION, V102, P71, DOI 10.1111/j.1360-0443.2007.01957.x; Wellman RJ, 2006, ARCH PEDIAT ADOL MED, V160, P1285, DOI 10.1001/archpedi.160.12.1285; Wilkinson AV, 2009, CANCER EPIDEM BIOMAR, V18, P3435, DOI 10.1158/1055-9965.EPI-09-0766	44	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51935	10.1371/journal.pone.0051935	http://dx.doi.org/10.1371/journal.pone.0051935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251654	gold, Green Published			2022-12-27	WOS:000312386800110
J	Leclercq, S; Cordaux, R				Leclercq, Sebastien; Cordaux, Richard			Selection-Driven Extinction Dynamics for Group II Introns in Enterobacteriales	PLOS ONE			English	Article							HOMING ENDONUCLEASE GENES; TRANSPOSABLE ELEMENTS; INSERTION SEQUENCES; YERSINIA-PESTIS; GENOME; EVOLUTION; RETROTRANSPOSITION; TRANSPOSITION; POPULATION; INSIGHTS	Transposable elements (TEs) are one of the major driving forces of genome evolution, raising the question of the long-term dynamics underlying their evolutionary success. Some TEs were proposed to evolve under a pattern of periodic extinctions-recolonizations, in which elements recurrently invade and quickly proliferate within their host genomes, then start to disappear until total extinction. Depending on the model, TE extinction is assumed to be driven by purifying selection against colonized host genomes (Sel-DE model) or by saturation of host genomes (Sat-DE model). Bacterial group II introns are suspected to follow an extinction-recolonization model of evolution, but whether they follow Sel-DE or Sat-DE dynamics is not known. Our analysis of almost 200 group II intron copies from 90 sequenced Enterobacteriales genomes confirms their extinction-recolonization dynamics: patchy element distributions among genera and even among strains within genera, acquisition of new group II introns through plasmids or other mobile genetic elements, and evidence for recent proliferations in some genomes. Distributions of recent and past proliferations and of their respective homing sites further provide strong support for the Sel-DE model, suggesting that group II introns are deleterious to their hosts. Overall, our observations emphasize the critical impact of host properties on TE dynamics.	[Leclercq, Sebastien; Cordaux, Richard] Univ Poitiers, CNRS UMR Ecol & Biol Interact 7267, Poitiers, France	Universite de Poitiers	Cordaux, R (corresponding author), Univ Poitiers, CNRS UMR Ecol & Biol Interact 7267, Poitiers, France.	richard.cordaux@univ-poitiers.fr		Leclercq, Sebastien/0000-0002-3601-2316	Centre National de la Recherche Scientifique (CNRS); European Research Council Starting Grant; CNRS	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Research Council Starting Grant(European Research Council (ERC)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This research was funded by a Young Investigator ATIP Award from the Centre National de la Recherche Scientifique (CNRS) and a European Research Council Starting Grant to RC. SL was supported by a postdoctoral fellowship from the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Belfort Marlene, 2002, P761; Bichsel M, 2010, THEOR POPUL BIOL, V78, P278, DOI 10.1016/j.tpb.2010.08.003; Biondi Emanuele G, 2011, Mob Genet Elements, V1, P2; Boutin TS, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-5; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Candales MA, 2012, NUCLEIC ACIDS RES, V40, pD187, DOI 10.1093/nar/gkr1043; Castoe TA, 2011, GENOME BIOL EVOL, V3, P641, DOI 10.1093/gbe/evr043; Cerveau N, 2011, GENOME BIOL EVOL, V3, P1175, DOI 10.1093/gbe/evr096; Cerveau N, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P291, DOI 10.1007/978-3-642-20763-1_17; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chee GJ, 2005, GENE, V363, P211, DOI 10.1016/j.gene.2005.08.017; Chen YQ, 2005, APPL ENVIRON MICROB, V71, P2576, DOI 10.1128/AEM.71.5.2576-2586.2005; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Chillon I, 2011, NUCLEIC ACIDS RES, V39, P1095, DOI 10.1093/nar/gkq847; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cordaux R, 2009, MOL BIOL EVOL, V26, P1679, DOI 10.1093/molbev/msp093; Cousineau B, 2000, NATURE, V404, P1018, DOI 10.1038/35010029; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai LX, 2002, RNA, V8, P1294, DOI 10.1017/S1355838202023014; Dai LX, 2002, NUCLEIC ACIDS RES, V30, P1091, DOI 10.1093/nar/30.5.1091; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Escobar-Paramo P, 2005, MOL BIOL EVOL, V22, P2297, DOI 10.1093/molbev/msi227; Fernandez-Lopez M, 2005, MOL BIOL EVOL, V22, P1518, DOI 10.1093/molbev/msi144; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Garcia-Rodriguez FM, 2011, APPL ENVIRON MICROB, V77, P854, DOI 10.1128/AEM.02319-10; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Han CG, 2004, J MICROBIOL, V42, P56; Hua-Van A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-19; Ichiyanagi K, 2003, P NATL ACAD SCI USA, V100, P15742, DOI 10.1073/pnas.2536659100; Ichiyanagi K, 2002, MOL MICROBIOL, V46, P1259, DOI 10.1046/j.1365-2958.2002.03226.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Klein JR, 2002, FRONT BIOSCI-LANDMRK, V7, pD1843, DOI 10.2741/klein1; Koonin EV, 2009, J HERED, V100, P618, DOI 10.1093/jhered/esp056; Kube M, 2008, ENVIRON MICROBIOL, V10, P2211, DOI 10.1111/j.1462-2920.2008.01639.x; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laukkanen-Ninios R, 2011, ENVIRON MICROBIOL, V13, P3114, DOI 10.1111/j.1462-2920.2011.02588.x; LAWRENCE JG, 1992, GENETICS, V131, P9; Le Rouzic A, 2005, GENET RES, V85, P171, DOI 10.1017/S0016672305007585; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Leclercq S, 2011, EVOLUTION, V65, P3327, DOI 10.1111/j.1558-5646.2011.01395.x; Leclercq S, 2011, MOL BIOL EVOL, V28, P685, DOI 10.1093/molbev/msq238; Luchetti A, 2011, MOL GENET GENOMICS, V285, P175, DOI 10.1007/s00438-010-0595-7; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martinez-Abarca F, 2000, NUCLEIC ACIDS RES, V28, P4397, DOI 10.1093/nar/28.21.4397; Matic I, 1996, TRENDS MICROBIOL, V4, P69, DOI 10.1016/0966-842X(96)81514-9; Mira A, 2006, TRENDS MICROBIOL, V14, P200, DOI 10.1016/j.tim.2006.03.001; Mohr G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000391; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Nisa-Martinez R, 2007, NUCLEIC ACIDS RES, V35, P214, DOI 10.1093/nar/gkl1072; PETES TD, 1988, ANNU REV GENET, V22, P147, DOI 10.1146/annurev.ge.22.120188.001051; Raghavan R, 2009, J BACTERIOL, V191, P6193, DOI 10.1128/JB.00675-09; Robart AR, 2007, P NATL ACAD SCI USA, V104, P6620, DOI 10.1073/pnas.0700561104; Robart AR, 2005, CYTOGENET GENOME RES, V110, P589, DOI 10.1159/000084992; Robertson Hugh M., 2002, P1093; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Simon DM, 2009, MOL BIOL EVOL, V26, P2795, DOI 10.1093/molbev/msp193; Singh NN, 2001, J MOL BIOL, V309, P361, DOI 10.1006/jmbi.2001.4658; Staddon JH, 2004, J BACTERIOL, V186, P2393, DOI 10.1128/JB.186.8.2393-2401.2004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; Touchon M, 2007, MOL BIOL EVOL, V24, P969, DOI 10.1093/molbev/msm014; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tourasse NJ, 2008, NUCLEIC ACIDS RES, V36, P4529, DOI 10.1093/nar/gkn372; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Wagner A, 2006, MOL BIOL EVOL, V23, P723, DOI 10.1093/molbev/msj085; Wagner A, 2007, NUCLEIC ACIDS RES, V35, P5284, DOI 10.1093/nar/gkm597; Yahara K, 2009, P NATL ACAD SCI USA, V106, P18861, DOI 10.1073/pnas.0908404106; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700; Zhuang FL, 2009, RNA, V15, P432, DOI 10.1261/rna.1378909	82	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52268	10.1371/journal.pone.0052268	http://dx.doi.org/10.1371/journal.pone.0052268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251705	gold, Green Published			2022-12-27	WOS:000312386800156
J	Foutz, TJ; Ackermann, DM; Kilgore, KL; McIntyre, CC				Foutz, Thomas J.; Ackermann, D. Michael, Jr.; Kilgore, Kevin L.; McIntyre, Cameron C.			Energy Efficient Neural Stimulation: Coupling Circuit Design and Membrane Biophysics	PLOS ONE			English	Article							SPINAL-CORD STIMULATION; DEEP-BRAIN-STIMULATION; ELECTRICAL-STIMULATION; NERVE; ELECTRODES; FIBERS; MODEL	The delivery of therapeutic levels of electrical current to neural tissue is a well-established treatment for numerous indications such as Parkinson's disease and chronic pain. While the neuromodulation medical device industry has experienced steady clinical growth over the last two decades, much of the core technology underlying implanted pulse generators remain unchanged. In this study we propose some new methods for achieving increased energy-efficiency during neural stimulation. The first method exploits the biophysical features of excitable tissue through the use of a centered-triangular stimulation waveform. Neural activation with this waveform is achieved with a statistically significant reduction in energy compared to traditional rectangular waveforms. The second method demonstrates energy savings that could be achieved by advanced circuitry design. We show that the traditional practice of using a fixed compliance voltage for constant-current stimulation results in substantial energy loss. A portion of this energy can be recuperated by adjusting the compliance voltage to real-time requirements. Lastly, we demonstrate the potential impact of axon fiber diameter on defining the energy-optimal pulse-width for stimulation. When designing implantable pulse generators for energy efficiency, we propose that the future combination of a variable compliance system, a centered-triangular stimulus waveform, and an axon diameter specific stimulation pulse-width has great potential to reduce energy consumption and prolong battery life in neuromodulation devices. Citation: Foutz TJ, Ackermann DM Jr, Kilgore KL, McIntyre CC (2012) Energy Efficient Neural Stimulation: Coupling Circuit Design and Membrane Biophysics. PLoS ONE 7(12): e51901. doi:10.1371/journal.pone.0051901	[Foutz, Thomas J.; Ackermann, D. Michael, Jr.; Kilgore, Kevin L.; McIntyre, Cameron C.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Foutz, Thomas J.; McIntyre, Cameron C.] Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA; [Ackermann, D. Michael, Jr.; Kilgore, Kevin L.] MetroHlth Med Ctr, Cleveland, OH USA; [Ackermann, D. Michael, Jr.] Stanford Univ, Palo Alto, CA 94304 USA; [Kilgore, Kevin L.; McIntyre, Cameron C.] Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH USA	Case Western Reserve University; Cleveland Clinic Foundation; MetroHealth System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	McIntyre, CC (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	mcintyc@ccf.org	Foutz, Tom/AHE-3189-2022	Foutz, Tom/0000-0002-0114-0019; Kilgore, Kevin/0000-0002-2642-9855	National Institutes of Health [R01 NS047388, R01 EB002091]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health R01 NS047388, R01 EB002091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann DM, 2009, IEEE T NEUR SYS REH, V17, P469, DOI 10.1109/TNSRE.2009.2034069; Carnevale N.T., 2009, NEURON BOOK, V1st; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Foldes EL, 2011, J NEUROSCI METH, V196, P31, DOI 10.1016/j.jneumeth.2010.12.020; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Haefner PA, 2011, US Patent, Patent No. [8,014,866, 8014866]; HARRISON LM, 1975, EXP NEUROL, V47, P364, DOI 10.1016/0014-4886(75)90266-6; Holsheimer J, 2002, NEUROMODULATION, V5, P25, DOI 10.1046/j.1525-1403.2002._2005.x; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Mogyoros I, 1996, BRAIN, V119, P439, DOI 10.1093/brain/119.2.439; MORTIMER JT, 1970, J NEUROSURG, V32, P553, DOI 10.3171/jns.1970.32.5.0553; NORTH RB, 1993, NEUROSURGERY, V32, P384, DOI 10.1227/00006123-199303000-00008; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Peckham PH, 2009, IMPLANTABLE NEURAL S; Sahin M, 2007, J NEURAL ENG, V4, P227, DOI 10.1088/1741-2560/4/3/008; SHANNON RV, 1992, IEEE T BIO-MED ENG, V39, P424, DOI 10.1109/10.126616; Shepherd Robert K, 2006, Adv Otorhinolaryngol, V64, P186, DOI 10.1159/000094652; Shi JW, 2012, US Patent, Patent No. [8,175,719, 8175719]; Wongsarnpigoon A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046009	21	23	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51901	10.1371/journal.pone.0051901	http://dx.doi.org/10.1371/journal.pone.0051901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272188	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600048
J	Drechsler, S; Weixelbaumer, K; Raeven, P; Jafarmadar, M; Khadem, A; van Griensven, M; Bahrami, S; Osuchowski, MF				Drechsler, Susanne; Weixelbaumer, Katrin; Raeven, Pierre; Jafarmadar, Mohammad; Khadem, Anna; van Griensven, Martijn; Bahrami, Soheyl; Osuchowski, Marcin Filip			Relationship between Age/Gender-Induced Survival Changes and the Magnitude of Inflammatory Activation and Organ Dysfunction in Post-Traumatic Sepsis	PLOS ONE			English	Article							BLUNT TRAUMA PATIENTS; INTENSIVE-CARE UNITS; HEMORRHAGIC-SHOCK; GENDER-DIFFERENCES; IMMUNE FUNCTION; ANIMAL-MODELS; SEPTIC SHOCK; MURINE MODEL; MORTALITY; COMPLICATIONS	Age/gender may likely influence the course of septic complications after trauma. We aimed to characterize the influence of age/gender on the response of circulating cytokines, cells and organ function in post-traumatic sepsis. We additionally tested whether post-traumatic responses alone can accurately predict outcomes in subsequent post-traumatic sepsis. A mouse 2-hit model of trauma/hemorrhage (TH, 1st hit) and cecal ligation and puncture (CLP, 2nd hit) was employed. 3, 15 and 20 month (m) old female (female) and male (male) CD-1 mice underwent sublethal TH followed by CLP 2 days later. Blood was sampled daily until day 6 post-TH and survival was followed for 16 days. To compare general response patterns among groups, we calculated two scores: the inflammatory response (including KC, MIP-1 alpha, TNF alpha, MCP-1, IFN gamma, IL-1 beta,-5,-6,-10) and the organ dysfunction score (Urea, ALT, AST and LDH). Moreover, mice were retrospectively divided into survivors (SUR) and dying (DIE) based on post-CLP outcome. In general, females survived better than males and their survival did not correspond to any specific estrus cycle phase. Pre-CLP phase: the post-TH inflammatory score was weakest in 3 m male but there were no changes among remaining groups (similar lack of differences in the organ dysfunction score). TH induced a 40% increase of IFN gamma, MIP-1 alpha and IL-5 in 15 m male SUR (vs. DIE) but predictive accuracy for post-CLP outcomes was moderate. Post-CLP phase: while stable in males, inflammatory response score in 15 m and 20 m females decreased with age at day 1 and 2 post-CLP. SUR vs. DIE differences in inflammatory and organ dysfunction score were evident but their magnitude was comparable across age/gender. Nearly identical activation of the humoral inflammatory and organ function compartments, both across groups and according to sepsis severity, suggests that they are not directly responsible for the age/gender-dependent disparity in TH-CLP survival in the studied young-to-mature population.	[Drechsler, Susanne; Weixelbaumer, Katrin; Raeven, Pierre; Jafarmadar, Mohammad; Khadem, Anna; van Griensven, Martijn; Bahrami, Soheyl; Osuchowski, Marcin Filip] Trauma Res Ctr Allgemeine, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria	Ludwig Boltzmann Institute	Osuchowski, MF (corresponding author), Trauma Res Ctr Allgemeine, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.	Marcin.Osuchowski@trauma.lbg.ac.at	van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881; Bahrami, Soheyl/0000-0002-4563-6251; Drechsler, Susanne/0000-0002-0758-303X; Osuchowski, Marcin/0000-0002-1321-9883	Vienna Science and Technology Fund (WWTF) [LS07-065]	Vienna Science and Technology Fund (WWTF)	The study was funded by the Vienna Science and Technology Fund (WWTF) Grant LS07-065. http://www.wwtf.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele Martin K., 2006, Clinics, V61, P479, DOI 10.1590/S1807-59322006000500017; Angele MK, 1997, ARCH SURG-CHICAGO, V132, P1207; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bahrami S, 2010, CRIT CARE MED, V38, P161, DOI 10.1097/CCM.0b013e3181b78a06; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Castelli GP, 2009, CRIT CARE MED, V37, P1845, DOI 10.1097/CCM.0b013e31819ffd5b; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Drechsler S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/357926; EATON GJ, 1980, LAB ANIM, V14, P17, DOI 10.1258/002367780780943141; Foex BA, 1999, BRIT MED BULL, V55, P726, DOI 10.1258/0007142991902745; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Giannoudis PV, 2003, INJURY, V34, P397, DOI 10.1016/S0020-1383(02)00416-3; Guyette F, 2011, J TRAUMA, V70, P782, DOI 10.1097/TA.0b013e318210f5c9; Kahlke V, 2000, AM J PHYSIOL-CELL PH, V278, pC509, DOI 10.1152/ajpcell.2000.278.3.C509; Kahlke V, 2000, CYTOKINE, V12, P69, DOI 10.1006/cyto.1999.0511; Knoferl MW, 2002, ANN SURG, V235, P105, DOI 10.1097/00000658-200201000-00014; Koch A, 2012, CLIN BIOCHEM, V45, P429, DOI 10.1016/j.clinbiochem.2012.01.009; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Majetschak M, 2000, J TRAUMA, V48, P832, DOI 10.1097/00005373-200005000-00006; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; Mees ST, 2007, LANGENBECK ARCH SURG, V392, P629, DOI 10.1007/s00423-007-0152-y; Nachtigall I, 2011, CRIT CARE, V15, DOI 10.1186/cc10277; Nast-Kolb D, 2001, J TRAUMA, V51, P835, DOI 10.1097/00005373-200111000-00003; NastKolb D, 1997, J TRAUMA, V42, P446, DOI 10.1097/00005373-199703000-00012; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Osuchowski MF, 2010, SHOCK, V34, P369, DOI 10.1097/SHK.0b013e3181dc40a8; Osuchowski MF, 2012, J IMMUNOL; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Pape HC, 2001, J TRAUMA, V50, P989, DOI 10.1097/00005373-200106000-00004; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Povoa P, 2005, CLIN MICROBIOL INFEC, V11, P101, DOI 10.1111/j.1469-0691.2004.01044.x; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Tsukamoto T, 2009, SHOCK, V31, P3, DOI 10.1097/SHK.0b013e31817fdabf; Turnbull IR, 2004, SHOCK, V21, P121, DOI 10.1097/01.shk.0000108399.56565.e7; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Uusitalo-Seppala R, 2012, SCAND J INFECT DIS; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Weixelbaumer KM, 2010, SHOCK, V34, P420, DOI 10.1097/SHK.0b013e3181dc0918; Wichmann MW, 1996, ARCH SURG-CHICAGO, V131, P995; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zanotti-Cavazzoni SL, 2009, INTENS CARE MED, V35, P748, DOI 10.1007/s00134-008-1360-9	52	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51457	10.1371/journal.pone.0051457	http://dx.doi.org/10.1371/journal.pone.0051457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251540	Green Submitted, gold, Green Published			2022-12-27	WOS:000313236200113
J	Lauterbach, T; Manna, M; Ruhnow, M; Wisantoso, Y; Wang, YF; Matysik, A; Oglecka, K; Mu, YG; Geifman-Shochat, S; Wohland, T; Kraut, R				Lauterbach, Tim; Manna, Manoj; Ruhnow, Maria; Wisantoso, Yudi; Wang, Yaofeng; Matysik, Artur; Oglecka, Kamila; Mu, Yuguang; Geifman-Shochat, Susana; Wohland, Thorsten; Kraut, Rachel			Weak Glycolipid Binding of a Microdomain-Tracer Peptide Correlates with Aggregation and Slow Diffusion on Cell Membranes	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; SURFACE-PLASMON RESONANCE; A-BETA; CORRELATION SPECTROSCOPY; ALZHEIMERS-DISEASE; MODEL MEMBRANES; GM1 GANGLIOSIDE; LIPID-BILAYERS; MOLECULAR SIMULATION; FIBRIL FORMATION	Organized assembly or aggregation of sphingolipid-binding ligands, such as certain toxins and pathogens, has been suggested to increase binding affinity of the ligand to the cell membrane and cause membrane reorganization or distortion. Here we show that the diffusion behavior of the fluorescently tagged sphingolipid-interacting peptide probe SBD (Sphingolipid Binding Domain) is altered by modifications in the construction of the peptide sequence that both result in a reduction in binding to ganglioside-containing supported lipid membranes, and at the same time increase aggregation on the cell plasma membrane, but that do not change relative amounts of secondary structural features. We tested the effects of modifying the overall charge and construction of the SBD probe on its binding and diffusion behavior, by Surface Plasmon Resonance (SPR; Biacore) analysis on lipid surfaces, and by Fluorescence Correlation Spectroscopy (FCS) on live cells, respectively. SBD binds preferentially to membranes containing the highly sialylated gangliosides GT1b and GD1a. However, simple charge interactions of the peptide with the negative ganglioside do not appear to be a critical determinant of binding. Rather, an aggregation-suppressing amino acid composition and linker between the fluorophore and the peptide are required for optimum binding of the SBD to ganglioside-containing supported lipid bilayer surfaces, as well as for interaction with the membrane. Interestingly, the strength of interactions with ganglioside-containing artificial membranes is mirrored in the diffusion behavior by FCS on cell membranes, with stronger binders displaying similar characteristic diffusion profiles. Our findings indicate that for aggregation-prone peptides, aggregation occurs upon contact with the cell membrane, and rather than giving a stronger interaction with the membrane, aggregation is accompanied by weaker binding and complex diffusion profiles indicative of heterogeneous diffusion behavior in the probe population.	[Lauterbach, Tim; Manna, Manoj; Ruhnow, Maria; Wisantoso, Yudi; Wang, Yaofeng; Matysik, Artur; Oglecka, Kamila; Mu, Yuguang; Geifman-Shochat, Susana; Kraut, Rachel] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Lauterbach, Tim; Ruhnow, Maria] Tech Univ Dresden, Inst Lebensmittel & Bioverfahrenstech, D-01062 Dresden, Germany; [Wohland, Thorsten] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Wohland, Thorsten] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wohland, Thorsten] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Technische Universitat Dresden; National University of Singapore; National University of Singapore; National University of Singapore	Kraut, R (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	rskraut@ntu.edu.sg	WOHLAND, THORSTEN/R-6404-2019; w, y w/HGD-6995-2022; W, Yudi/AAF-8649-2019; Wohland, Thorsten/H-8285-2012	Wohland, Thorsten/0000-0002-0148-4321; Matysik, Artur/0000-0003-3702-9491	Nanyang Technological University; Singapore Ministry of Education Academic Research Fund [MOE2009-T2-2-019]; Life Science Institute - Baden Wurttemberg initiative [BE2010-02: R-143-000-422-646]	Nanyang Technological University(Nanyang Technological University); Singapore Ministry of Education Academic Research Fund(Ministry of Education, Singapore); Life Science Institute - Baden Wurttemberg initiative	RK was supported by a start-up grant from Nanyang Technological University and Tier II grant from the Singapore Ministry of Education Academic Research Fund (MOE2009-T2-2-019). TW gratefully acknowledges funding from the Life Science Institute - Baden Wurttemberg initiative (BE2010-02: R-143-000-422-646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTES P, 1992, CHEM PHYS LIPIDS, V62, P269, DOI 10.1016/0009-3084(92)90064-V; Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Baldwin MR, 2007, NAT STRUCT MOL BIOL, V14, P9, DOI 10.1038/nsmb0107-9; Bateman DA, 2010, INT J ALZHEIMERS DIS, V2011; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; Dertinger T, 2006, LANGMUIR, V22, P9339, DOI 10.1021/la061389s; Dowhan W, 2008, FUNCTIONAL ROLES LIP; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Fantini J, 2007, CURR MED CHEM, V14, P2911, DOI 10.2174/092986707782360033; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ikeda K, 2008, BIOCHEM BIOPH RES CO, V370, P525, DOI 10.1016/j.bbrc.2008.03.130; Inaba S, 2005, J PEPT RES, V65, P485, DOI 10.1111/j.1399-3011.2005.00250.X; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Johnson RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023970; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kakio A, 2003, BIOCHEM BIOPH RES CO, V303, P514, DOI 10.1016/S0006-291X(03)00386-3; Kremer JJ, 2003, J BIOCHEM BIOPH METH, V57, P159, DOI 10.1016/S0165-022X(03)00103-9; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001; Levy M, 2006, FEBS J, V273, P5724, DOI 10.1111/j.1742-4658.2006.05562.x; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; Nag S, 2010, BIOPHYS J, V99, P1969, DOI 10.1016/j.bpj.2010.07.020; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pellizzari R, 1999, PHILOS T R SOC B, V354, P259, DOI 10.1098/rstb.1999.0377; Petrasek Z, 2010, METHOD ENZYMOL, V472, P317, DOI 10.1016/S0076-6879(10)72005-X; Poulsen SA, 2000, J STRUCT BIOL, V130, P142, DOI 10.1006/jsbi.2000.4267; Rocheleau JV, 2000, BIOSCIENCE REP, V20, P139, DOI 10.1023/A:1005559317975; Rocheleau JV, 2001, EUR J BIOCHEM, V268, P2924, DOI 10.1046/j.1432-1327.2001.02181.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Roy R, 1996, CURR OPIN STRUC BIOL, V6, P692, DOI 10.1016/S0959-440X(96)80037-6; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Sankaran J, 2009, BIOPHYS J, V97, P2630, DOI 10.1016/j.bpj.2009.08.025; Stefl M, 2012, BIOPHYS J, V102, P2104, DOI 10.1016/j.bpj.2012.03.054; Steinert S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002933; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; Valdes-Gonzalez T, 2003, SPECTROSC-INT J, V17, P241, DOI 10.1155/2003/185737; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Zanten TS, 2010, P NATL ACAD SCI USA, V107, P15437, DOI 10.1073/pnas.1003876107; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Waschuk SA, 2001, J BIOL CHEM, V276, P33561, DOI 10.1074/jbc.M103598200; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Widenbrant MJO, 2006, BIOPHYS J, V91, P4071, DOI 10.1529/biophysj.106.085944; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Yamamoto N, 2004, FEBS LETT, V569, P135, DOI 10.1016/j.febslet.2004.05.037; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 1997, FEBS LETT, V420, P43, DOI 10.1016/S0014-5793(97)01484-1; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200; Zhang DW, 2009, J CELL SCI, V122, P3715, DOI 10.1242/jcs.051557	75	6	6	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51222	10.1371/journal.pone.0051222	http://dx.doi.org/10.1371/journal.pone.0051222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251459	Green Published, gold			2022-12-27	WOS:000313236200074
J	Lipp, I; Benedek, M; Fink, A; Koschutnig, K; Reishofer, G; Bergner, S; Ischebeck, A; Ebner, F; Neubauer, A				Lipp, Ilona; Benedek, Mathias; Fink, Andreas; Koschutnig, Karl; Reishofer, Gernot; Bergner, Sabine; Ischebeck, Anja; Ebner, Franz; Neubauer, Aljoscha			Investigating Neural Efficiency in the Visuo-Spatial Domain: An fmri Study	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; EEG-ALPHA SYNCHRONIZATION; MENTAL ROTATION TASKS; SEX-DIFFERENCES; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; BRAIN ACTIVATION; SPATIAL ABILITIES; BASIC PRINCIPLES; IQ RELATIONSHIP	The neural efficiency hypothesis postulates an inverse relationship between intelligence and brain activation. Previous research suggests that gender and task modality represent two important moderators of the neural efficiency phenomenon. Since most of the existing studies on neural efficiency have used ERD in the EEG as a measure of brain activation, the central aim of this study was a more detailed analysis of this phenomenon by means of functional MRI. A sample of 20 males and 20 females, who had been screened for their visuo-spatial intelligence, was confronted with a mental rotation task employing an event-related approach. Results suggest that less intelligent individuals show a stronger deactivation of parts of the default mode network, as compared to more intelligent people. Furthermore, we found evidence of an interaction between task difficulty, intelligence and gender, indicating that more intelligent females show an increase in brain activation with an increase in task difficulty. These findings may contribute to a better understanding of the neural efficiency hypothesis, and possibly also of gender differences in the visuo-spatial domain.	[Lipp, Ilona; Benedek, Mathias; Fink, Andreas; Koschutnig, Karl; Bergner, Sabine; Ischebeck, Anja; Neubauer, Aljoscha] Graz Univ, Inst Psychol, Graz, Austria; [Lipp, Ilona] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff CF10 3AX, S Glam, Wales; [Reishofer, Gernot; Ebner, Franz] Med Univ Graz, Dept Radiol, Graz, Austria	University of Graz; Cardiff University; Medical University of Graz	Lipp, I (corresponding author), Graz Univ, Inst Psychol, Graz, Austria.	LippI@cardiff.ac.uk	Benedek, Mathias/B-6110-2012; Reishofer, Gernot/E-9215-2011; Koschutnig, Karl/W-3106-2019; Lipp, Ilona/M-7113-2017	Benedek, Mathias/0000-0001-6258-4476; Reishofer, Gernot/0000-0002-3068-6475; Koschutnig, Karl/0000-0001-6234-0498; Lipp, Ilona/0000-0002-5644-2057; Fink, Andreas/0000-0001-7316-3140; Bergner, Sabine/0000-0003-0027-2949; Ischebeck, Anja/0000-0002-3493-2848	Austrian Science Fund (FWF) [P19842, P23914]; Austrian Science Fund (FWF) [P 23914] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Austrian Science Fund (FWF): P19842 and P23914. http://www.fwf.ac.at/en/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Amthauer R, 2001, INTELLIGENZ STRUKTUR; Benedek M, 2011, NEUROPSYCHOLOGIA, V49, P3505, DOI 10.1016/j.neuropsychologia.2011.09.004; Borkenau P., 1993, NEO FUNF FAKTOREN IN; Bors DA, 2011, LEARN INDIVID DIFFER, V21, P129, DOI 10.1016/j.lindif.2010.09.014; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Clements-Stephens AM, 2009, NEUROSCI LETT, V449, P155, DOI 10.1016/j.neulet.2008.10.094; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Doppelmayr M, 2005, BRAIN RES BULL, V66, P171, DOI 10.1016/j.brainresbull.2005.04.007; Fay E., 2001, INTELLIGENZ STRUKTUR; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Geake JG, 2005, NEUROIMAGE, V26, P555, DOI 10.1016/j.neuroimage.2005.01.035; Glabus MF, 2003, CEREB CORTEX, V13, P1352, DOI 10.1093/cercor/bhg082; Gogos A, 2010, NEUROPSYCHOLOGIA, V48, P529, DOI 10.1016/j.neuropsychologia.2009.10.013; Gould RL, 2006, NEUROIMAGE, V31, P818, DOI 10.1016/j.neuroimage.2005.12.045; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haier RJ, 1995, DEV NEUROPSYCHOL, V11, P405, DOI 10.1080/87565649509540629; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; HAIER RJ, 1992, INTELLIGENCE, V16, P415, DOI 10.1016/0160-2896(92)90018-M; Halpern DF, 2000, EDUC PSYCHOL REV, V12, P229, DOI 10.1023/A:1009027516424; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Jordan K, 2010, J INDIVID DIFFER, V31, P83, DOI 10.1027/1614-0001/a000015; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kelly AMC, 2006, NEUROIMAGE, V31, P866, DOI 10.1016/j.neuroimage.2006.01.008; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Larson GE, 1995, INTELLIGENCE, V21, P267, DOI 10.1016/0160-2896(95)90017-9; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Laux L., 1981, STATE TRAIT ANGSTINV; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; NEUBAUER A, 1995, INTELLIGENCE, V20, P249, DOI 10.1016/0160-2896(95)90010-1; Neubauer AC, 2005, COGNITIVE BRAIN RES, V25, P217, DOI 10.1016/j.cogbrainres.2005.05.011; Neubauer AC, 2002, INTELLIGENCE, V30, P515, DOI 10.1016/S0160-2896(02)00091-0; Neubauer AC, 2010, INTELLIGENCE, V38, P529, DOI 10.1016/j.intell.2010.06.001; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; POSNER MI, 1967, PSYCHOL REV, V74, P392, DOI 10.1037/h0024913; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Preusse F, 2011, FRONT HUM NEUROSCI, V5, P1; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ED, 2000, COGNITIVE PSYCHOL, V40, P261, DOI 10.1006/cogp.2000.0733; Ruff CC, 2003, NEUROPSYCHOLOGIA, V41, P1241, DOI 10.1016/S0028-3932(03)00016-2; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Song M, 2009, IEEE T AUTON MENT DE, V1, P101, DOI 10.1109/TAMD.2009.2029312; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Tagaris GA, 1996, NEUROREPORT, V7, P773, DOI 10.1097/00001756-199602290-00022; Tang CY, 2010, INTELLIGENCE, V38, P293, DOI 10.1016/j.intell.2010.03.003; Unterrainer J, 2000, NEUROPSYCHOBIOLOGY, V41, P95, DOI 10.1159/000026639; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Vogel JJ, 2003, BRAIN COGNITION, V52, P197, DOI 10.1016/S0278-2626(03)00056-3; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	67	23	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51316	10.1371/journal.pone.0051316	http://dx.doi.org/10.1371/journal.pone.0051316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251496	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000313236200088
J	Wang, YL; Lu, SL; Li, XD; Du, N; Sun, YB; Xing, JY; Pan, XT; Chen, BS; Miao, ZM				Wang, Yunlong; Lu, Shulai; Li, Xinde; Du, Na; Sun, Yunbo; Xing, Jinyan; Pan, Xinting; Chen, Baosheng; Miao, Zhimin			The Lipid-Bound Apolipoprotein A-I Cysteine Mutant (N74C) Inhibits the Activation of NF-kappa B, JNK and p38 in Endotoxemic Mice and RAW264.7 Cells	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; MIMETIC PEPTIDE; SEVERE SEPSIS; LUNG INJURY; APOA-I; PLASMA; MILANO; ANTAGONIST; BACTERIAL	Our previous studies showed that recombinant high-density lipoprotein (rHDL) rHDL74 exhibited higher anti-inflammatory capabilities compared to wild-type rHDL (rHDLwt), while rHDL228 showed hyper-proinflammation. In this paper, we further investigated the potential mechanisms involved in their different inflammatory functions using two models: endotoxemic mice and the RAW264.7 inflammation model. Our results showed that 24 h after the injection of lipopolysaccharide (LPS), mice treated with rHDL74 had a significant decrease in plasma CRP (P < 0.01 vs. rHDLwt; P < 0.01 vs. LPS), MCP-1 (P < 0.05 vs. rHDLwt; P < 0.01 vs. LPS) and CD14 (P < 0.01 vs. LPS) compared with the mice treated with rHDLwt or the controls that received LPS only. Similar to our previous study, rHDL228 increased the plasma level of CRP (P < 0.05 vs. LPS) and MCP-1 (P, 0.01 vs. LPS). Our immunohistochemistry and western blot analysis showed that rHDL74 inhibited the activation of NF-kappa B in endotoxemic mice and JNK and p38 in the RAW264.7 inflammation model, while rHDL228 exacerbated the activation of NF-kappa B and ERK. In summary, our data suggest that rHDL74 exhibits higher anti-inflammatory activity by decreasing inflammatory factors and inhibiting the activation of NF-kappa B, JNK and p38, while rHDL228 appears to be hyper-proinflammation by increasing these inflammatory factors and aggravating the activation of NF-kappa B and ERK.	[Wang, Yunlong; Li, Xinde; Miao, Zhimin] Qingdao Univ, Gout Lab, Affiliated Hosp, Coll Med,Shandong Prov Key Lab Metab Dis, Qingdao 266071, Peoples R China; [Lu, Shulai] Qingdao Municipal Hosp, Dept Stomatol, Qingdao, Peoples R China; [Du, Na] Ocean Univ China, Sch Pharm, Minist Educ China, Key Lab Marine Drugs, Qingdao, Peoples R China; [Sun, Yunbo; Xing, Jinyan; Pan, Xinting] Qingdao Univ, Affiliated Hosp, Coll Med, ICU, Qingdao 266071, Peoples R China; [Chen, Baosheng] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Dept Biochem & Mol Biol, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Chen, Baosheng] Peking Union Med Coll, Beijing 100021, Peoples R China	Qingdao University; Qingdao Municipal Hospital; Ministry of Education, China; Ocean University of China; Qingdao University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, YL (corresponding author), Qingdao Univ, Gout Lab, Affiliated Hosp, Coll Med,Shandong Prov Key Lab Metab Dis, Qingdao 266071, Peoples R China.	wylapollo@163.com; miaozhm@qdumh.qd.sd.cn			fund of the National Nature Science [30900238]	fund of the National Nature Science	This work was supported by a fund of the National Nature Science (30900238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2009, ADV EXP MED BIOL, V667, P39, DOI 10.1007/978-1-4419-1603-7_4; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baker JV, 2011, AIDS, V25, P2133, DOI 10.1097/QAD.0b013e32834be088; Barlage S, 2009, INTENS CARE MED, V35, P1877, DOI 10.1007/s00134-009-1609-y; Buttenschoen K, 2010, LANGENBECK ARCH SURG, V395, P597, DOI 10.1007/s00423-010-0658-6; Calabresi L, 1997, BIOCHEM BIOPH RES CO, V238, P61, DOI 10.1006/bbrc.1997.7236; Dai LJ, 2010, J LIPID RES, V51, P2695, DOI 10.1194/jlr.M008086; Gupta H, 2005, CIRC RES, V97, P236, DOI 10.1161/01.RES.0000176530.66400.48; Haas MJ, 2011, CURR OPIN INFECT DIS, V24, P265, DOI 10.1097/QCO.0b013e328344b724; HUBSCH AP, 1995, J LAB CLIN MED, V126, P548; KOTANI S, 1985, INFECT IMMUN, V49, P225, DOI 10.1128/IAI.49.1.225-237.1985; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rose JR, 2000, ANTIMICROB AGENTS CH, V44, P504, DOI 10.1128/AAC.44.3.504-510.2000; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; Shah PK, 1998, CIRCULATION, V97, P780, DOI 10.1161/01.CIR.97.8.780; Shah PK, 2001, CIRCULATION, V103, P3047, DOI 10.1161/hc2501.092494; Sirtori CR, 2001, CIRCULATION, V103, P1949; Tsai MH, 2009, J HEPATOL, V50, P906, DOI 10.1016/j.jhep.2008.12.024; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Vesy CJ, 2000, INFECT IMMUN, V68, P2410, DOI 10.1128/IAI.68.5.2410-2417.2000; Wang YL, 2008, J LIPID RES, V49, P1640, DOI 10.1194/jlr.M700446-JLR200; Wasan KM, 1999, ANTIMICROB AGENTS CH, V43, P2562, DOI 10.1128/AAC.43.10.2562; Yan YJ, 2006, LIFE SCI, V79, P210, DOI 10.1016/j.lfs.2006.02.011; Zhu XW, 2005, J LIPID RES, V46, P1303, DOI 10.1194/jlr.M400401-JLR200	29	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51327	10.1371/journal.pone.0051327	http://dx.doi.org/10.1371/journal.pone.0051327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251501	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200091
J	Li, Z; Zhao, ZJ; Zhu, XQ; Ren, QS; Nie, FF; Gao, JM; Gao, XJ; Yang, TB; Zhou, WL; Shen, JL; Wang, Y; Lu, FL; Chen, XG; Hide, G; Ayala, FJ; Lun, ZR				Li, Zhi; Zhao, Zhi-Jun; Zhu, Xing-Quan; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Shen, Ji-Long; Wang, Yong; Lu, Fang-Li; Chen, Xiao-Guang; Hide, Geoff; Ayala, Francisco J.; Lun, Zhao-Rong			Differences in iNOS and Arginase Expression and Activity in the Macrophages of Rats Are Responsible for the Resistance against T. gondii Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATED MURINE MACROPHAGES; L-ARGININE METABOLISM; TOXOPLASMA-GONDII; PERITONEAL-MACROPHAGES; POLYAMINE LEVELS; RH STRAIN; CELLS; MECHANISMS; IMMUNITY	Toxoplasma gondii infects humans and warm blooded animals causing devastating disease worldwide. It has long been a mystery as to why the peritoneal macrophages of rats are naturally resistant to T. gondii infection while those of mice are not. Here, we report that high expression levels and activity of inducible nitric oxide synthase (iNOS) and low levels of arginase-1 (Arg 1) activity in the peritoneal macrophages of rats are responsible for their resistance against T. gondii infection, due to high nitric oxide and low polyamines within these cells. The opposite situation was observed in the peritoneal macrophages of mice. This discovery of the opposing functions of iNOS and Arg 1 in rodent peritoneal macrophages may lead to a better understanding of the resistance mechanisms of mammals, particularly humans and livestock, against T. gondii and other intracellular pathogens.	[Li, Zhi; Zhao, Zhi-Jun; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Lu, Fang-Li; Lun, Zhao-Rong] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Zhi; Zhao, Zhi-Jun; Ren, Qing-Shi; Nie, Fang-Fang; Gao, Jiang-Mei; Gao, Xiao-Jie; Yang, Ting-Bao; Zhou, Wen-Liang; Lu, Fang-Li; Lun, Zhao-Rong] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Xing-Quan; Lun, Zhao-Rong] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China; [Shen, Ji-Long] Anhui Med Univ, Dept Pathogen Biol, Hefei, Anhui, Peoples R China; [Wang, Yong] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Chen, Xiao-Guang] So Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Hide, Geoff; Lun, Zhao-Rong] Univ Salford, Sch Environm & Life Sci, Ctr Parasitol & Dis, Salford M5 4WT, Lancs, England; [Ayala, Francisco J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Zhao, Zhi-Jun] Ningxia Med Univ, Affiliated Hosp, Yinchuan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Anhui Medical University; Nanjing Medical University; Southern Medical University - China; University of Salford; University of California System; University of California Irvine; Ningxia Medical University	Li, Z (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsslzr@mail.sysu.edu.cn		Hide, Geoff/0000-0002-3608-0175	National Basic Research Program of China (973 Program) [2010CB530000]; National Special Research Programs for Non-Profit Trades (Agriculture) [200803017]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Special Research Programs for Non-Profit Trades (Agriculture)	The work was supported by National Basic Research Program of China (973 Program) (No. 2010CB530000) and the National Special Research Programs for Non-Profit Trades (Agriculture) (No. 200803017), http://www.973.gov.cn/English/Index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallahi OMS, 2001, CELL MOL LIFE SCI, V58, P1350, DOI 10.1007/PL00000947; ADAMS LB, 1990, J IMMUNOL, V144, P2725; Blachier F, 1997, NITRIC OXIDE-BIOL CH, V1, P268, DOI 10.1006/niox.1997.0127; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cavailles P, 2006, P NATL ACAD SCI USA, V103, P744, DOI 10.1073/pnas.0506643103; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; CHINCHILLA M, 1982, J PARASITOL, V68, P952, DOI 10.2307/3281014; CHINCHILLA M, 1978, INFECT IMMUN, V19, P999, DOI 10.1128/IAI.19.3.999-1012.1978; COOK HT, 1994, AM J PHYSIOL-RENAL, V267, pF646, DOI 10.1152/ajprenal.1994.267.4.F646; Cook T, 2007, MICROBIOL-SGM, V153, P1123, DOI 10.1099/mic.0.2006/001768-0; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Da Gama LM, 2004, MICROBES INFECT, V6, P1287, DOI 10.1016/j.micinf.2004.07.008; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; De Champs C, 1998, PARASITE, V5, P215, DOI 10.1051/parasite/1998053215; DING AH, 1988, J IMMUNOL, V141, P2407; Dubey JP, 1998, VET PARASITOL, V77, P1, DOI 10.1016/S0304-4017(97)00227-6; Dubey JP, 1999, J PARASITOL, V85, P657, DOI 10.2307/3285739; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gobert AP, 2002, J IMMUNOL, V168, P6002, DOI 10.4049/jimmunol.168.12.6002; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Hayashi S, 1996, J IMMUNOL, V156, P1476; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; JAMES SL, 1995, MICROBIOL REV, V59, P533, DOI 10.1128/MMBR.59.4.533-547.1995; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kempf MC, 1999, MED MICROBIOL IMMUN, V187, P137, DOI 10.1007/s004300050085; Kmonickova E, 2007, NITRIC OXIDE-BIOL CH, V17, P160, DOI 10.1016/j.niox.2007.06.006; KRAHENBUHL JL, 1975, EXP PARASITOL, V37, P83, DOI 10.1016/0014-4894(75)90055-7; LANGERMANS JAM, 1992, J IMMUNOL, V148, P568; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; MCCABE RE, 1986, INFECT IMMUN, V52, P151, DOI 10.1128/IAI.52.1.151-155.1986; Mullner N, 2002, INT J BIOCHEM CELL B, V34, P1080, DOI 10.1016/S1357-2725(02)00028-6; Munder M, 1998, J IMMUNOL, V160, P5347; Nishikawa Y, 2003, INT J PARASITOL, V33, P1525, DOI 10.1016/S0020-7519(03)00204-2; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Seabra SH, 2004, J PARASITOL, V90, P455, DOI 10.1645/GE-179R; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Sergent W, 2005, INFECT IMMUN, V73, P6990, DOI 10.1128/IAI.73.10.6990-6997.2005; Stempin CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/683485; von Bargen K, 2011, INFECT IMMUN, V79, P2098, DOI 10.1128/IAI.00983-10; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zenner L, 1998, EXP PARASITOL, V90, P86, DOI 10.1006/expr.1998.4301	49	79	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35834	10.1371/journal.pone.0035834	http://dx.doi.org/10.1371/journal.pone.0035834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558235	Green Accepted, Green Published, gold			2022-12-27	WOS:000305345200084
J	McCann, FJ; Chapman, SJ; Yu, WC; Maskell, NA; Davies, RJO; Lee, YCG				McCann, Fiona J.; Chapman, Stephen J.; Yu, Wai Cho; Maskell, Nick A.; Davies, Robert J. O.; Lee, Y. C. Gary			Ability of Procalcitonin to Discriminate Infection from Non-Infective Inflammation Using Two Pleural Disease Settings	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; FLUID PROCALCITONIN; SEPSIS; DIAGNOSIS; PLEURODESIS; BIOMARKERS; ADULTS; SERUM	Procalcitonin has been shown to be useful in separating infection from non-infective disorders. However, infection is often paralleled by tissue inflammation. Most studies supporting the use of procalcitonin were confounded by more significant inflammation in the infection group. Few studies have examined the usefulness of procalcitonin when adjusted for inflammation. Pleural inflammation underlies the development of most exudative effusions including pleural infection and malignancy. Pleurodesis, often used to treat effusions, involves provocation of intense aseptic pleural inflammation. We conducted a two-part proof-of-concept study to test the specificity of procalcitonin in differentiating infection using cohorts of patients with pleural effusions of infective and non-infective etiologies, as well as subjects undergoing pleurodesis. Methods: We measured the blood procalcitonin level (i) in 248 patients with pleural infection or with non-infective pleural inflammation, matched for severity of systemic inflammation by C-reactive protein (CRP), age and gender; and (ii) in patients before and 24-48 hours after induction of non-infective pleural inflammation (from talc pleurodesis). Results: 1) Procalcitonin was significantly higher in patients with pleural infection compared with controls with noninfective effusions (n = 32 each group) that were case-matched for systemic inflammation as measured by CRP [median (25-75% IQR): 0.58 (0.35-1.50) vs 0.34 (0.31-0.42) mu g/L respectively, p = 0.003]. 2) Talc pleurodesis provoked intense systemic inflammation, and raised serum CRP by 360% over baseline. However procalcitonin remained relatively unaffected (21% rise). 3) Procalcitonin and CRP levels did not correlate. In 214 patients with pleural infection, procalcitonin levels did not predict the survival or need for surgical intervention. Conclusion: Using a pleural model, this proof-of-principle study confirmed that procalcitonin is a biomarker specific for infection and is not affected by non-infective inflammation. Procalcitonin is superior to CRP in distinguishing infection from non-infective pleural diseases, even when controlled for the level of systemic inflammation.	[McCann, Fiona J.; Chapman, Stephen J.; Davies, Robert J. O.; Lee, Y. C. Gary] Oxford Ctr Resp Med, Oxford, England; [McCann, Fiona J.; Chapman, Stephen J.; Davies, Robert J. O.; Lee, Y. C. Gary] Univ Oxford, Oxford, England; [Lee, Y. C. Gary] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Yu, Wai Cho] Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Maskell, Nick A.] Southmead Hosp, N Bristol Lung Ctr, Bristol, Avon, England	University of Oxford; University of Western Australia; Southmead Hospital	Lee, YCG (corresponding author), Oxford Ctr Resp Med, Oxford, England.	gary.lee@uwa.edu.au	Lee, Y C Gary/H-5264-2014	Ming, Zhangyin/0000-0002-8773-3930; Lee, Yun Chor Gary/0000-0002-0036-511X; maskell, nick/0000-0002-1276-6500	Oxford Health and Research Committee; NIHR Oxford Biomedical Research Centre, Medical Research Council Project Grant; United Kingdom and National Health & Medical Research Council (Australia) Project Grant; Western Australia; Higher Education Funding Council for England Clinical Senior Lecturer Awards, United Kingdom; MRC [G1001712] Funding Source: UKRI; Medical Research Council [G1001712] Funding Source: researchfish; National Institute for Health Research [CL-2006-13-003] Funding Source: researchfish	Oxford Health and Research Committee; NIHR Oxford Biomedical Research Centre, Medical Research Council Project Grant; United Kingdom and National Health & Medical Research Council (Australia) Project Grant; Western Australia; Higher Education Funding Council for England Clinical Senior Lecturer Awards, United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the Oxford Health and Research Committee research grant (FJMcC, SJC, RJOD & YCGL). NIHR Oxford Biomedical Research Centre (RJOD), Medical Research Council Project Grant, United Kingdom and National Health & Medical Research Council (Australia) Project Grant, Westcare Grant of Western Australia (YCGL) & Higher Education Funding Council for England Clinical Senior Lecturer Awards, United Kingdom (NAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, CLIN INFECT DIS, V53, P379, DOI 10.1093/cid/cir408; Albert SS, 2008, CLIN RESP MED, P853; Becker KL, 2008, CRIT CARE MED, V36, P941, DOI 10.1097/CCM.0B013E318165BABB; Brims FJH, 2010, EUR RESPIR REV, V19, P220, DOI 10.1183/09059180.00005610; Brunkhorst FM, 1999, CRIT CARE MED, V27, P2172, DOI 10.1097/00003246-199910000-00016; Cuquemelle E, 2011, INTENS CARE MED, V37, P796, DOI 10.1007/s00134-011-2189-1; de Kruif MD, 2008, INTENS CARE MED, V34, P518, DOI 10.1007/s00134-007-0955-x; San Jose ME, 2010, J INVEST MED, V58, P971, DOI 10.231/JIM.0b013e3181f88648; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Jereb M, 2001, INFECTION, V29, P209, DOI 10.1007/s15010-001-1165-z; Ko YC, 2009, J KOREAN MED SCI, V24, P398, DOI 10.3346/jkms.2009.24.3.398; Lee YCG, 2004, RESPIROLOGY, V9, P148, DOI 10.1111/j.1440-1843.2004.00566.x; Lin MC, 2009, CHEST, V136, P205, DOI 10.1378/chest.08-1134; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2004, CHEST, V126, P2022, DOI 10.1378/chest.126.6.2022; Maskell NA, 2004, AM J RESP CRIT CARE, V170, P377, DOI 10.1164/rccm.200311-1579OC; Muller F, 2010, CHEST, V138, P121, DOI 10.1378/chest.09-2920; Muller B, 2002, J LEUKOCYTE BIOL, V72, P643; Olah A, 2005, HEPATO-GASTROENTEROL, V52, P243; Papassotiriou I, 2008, EUR J CLIN INVEST, V38, P276, DOI 10.1111/j.1365-2362.2008.01935.x; Porcel JM, 2009, EUR RESP J IN PRESS; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; RAHMAN NM, 2008, TXB PLEURAL DIS, P341; Reinhart K, 2011, CRIT CARE CLIN, V27, P253, DOI 10.1016/j.ccc.2011.01.002; Russwurm S, 1999, CLIN CHEM LAB MED, V37, P789, DOI 10.1515/CCLM.1999.119; Sahn SA, 2008, TXB PLEURAL DIS, P209; Schuetz P, 2012, CHEST, V141, P1063, DOI 10.1378/chest.11-2430; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Tobin CL, 2012, CURR OPIN PULM MED, V18, P321, DOI 10.1097/MCP.0b013e328352c673; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Wang CY, 2011, EUR J CLIN MICROBIOL, V30, P313, DOI 10.1007/s10096-010-1082-0; West SD, 2004, CURR OPIN PULM MED, V10, P305, DOI 10.1097/01.mcp.0000129756.87090.55	32	137	142	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49894	10.1371/journal.pone.0049894	http://dx.doi.org/10.1371/journal.pone.0049894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251674	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200021
J	Chen, RL; Song, YQ; Hu, Z; Brunner, EJ				Chen, Ruoling; Song, Yiqing; Hu, Zhi; Brunner, Eric John			Predictors of Diabetes in Older People in Urban China	PLOS ONE			English	Article							GMS-AGECAT PREVALENCE; RISK-FACTORS; MRC-ALPHA; DEPRESSION; HEALTH; COMMUNITY; MELLITUS; WOMEN; MEN; POPULATION	Background: China has the largest number of people with diabetes in the world. Over the last 30 years China has experienced rapid economic growth and a growing income gap between rich and poor. The population is ageing, however diabetes in older people has not been well studied to date. In this study we determined incidence and predictors of diabetes in older Chinese people. Methods: During 2001, using a standard interview method, we examined 1,317 adults aged >= 65 years who did not have diabetes in the city of Hefei, and characterized baseline risk factors. Over 7.5 years of follow up, we documented incident diabetes using self-reported doctor diagnosis and the cause of death in the whole cohort, and HbA(1C) >= 48 mmol/mol in a nested case-control sample. A multivariate Cox regression model was employed to investigate risk of diabetes in relation to baseline risk factors. Results: During follow up, 119 persons had newly diagnosed diabetes. World age-standardised incidence of diabetes was 24.5 (95% CI 19.5-29.5) per 1,000 person-years. Risk of diabetes was significantly and positively associated with income, waist circumference and body mass index, smoking and uncontrolled hypertension, but negatively associated with having a hobby of walking and frequency of visiting children/other relatives and contacting neighbours/friends. Higher income was significantly associated with increased diabetes risk regardless of cardiovascular and psychosocial risk factors. Compared to those with middle income and no psychosocial risk factors, the hazard ratio for incident diabetes among participants with high income and psychosocial risk was 2.13 (95% CI 1.02-4.45). Conclusions: Increasing incidence of diabetes in relation to high income has become an important public health issue in China. Maintaining social networks and gentle physical activities and reducing psychosocial factors may be integrated into current multi-faceted preventive strategies for curbing the epidemic of diabetes in the older population.	[Chen, Ruoling; Hu, Zhi] Anhui Med Univ, Sch Hlth Adm, Hefei, Anhui, Peoples R China; [Song, Yiqing] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China; [Brunner, Eric John] UCL, Sch Med, Dept Epidemiol & Publ Hlth, London W1N 8AA, England; [Chen, Ruoling] Kings Coll London, Sch Med, Dept Primary Care & Publ Hlth Sci, London, England	Anhui Medical University; Peking University; University of London; University College London; UCL Medical School; University of London; King's College London	Chen, RL (corresponding author), Anhui Med Univ, Sch Hlth Adm, Hefei, Anhui, Peoples R China.	ruoling.chen@ucl.ac.uk	Brunner, Eric/H-2114-2011	Brunner, Eric/0000-0002-0595-4474; Chen, Ruoling/0000-0002-3033-8753	BUPA Foundation, UK [45NOV06, TBF-M09-50]; British Heart Foundation	BUPA Foundation, UK; British Heart Foundation(British Heart Foundation)	The cohort follow-up data collection work was funded by two research grants from the BUPA Foundation, UK (number of grants: 45NOV06 and TBF-M09-50). Eric Brunner is supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard JF, 1996, DIABETES CARE, V19, P807, DOI 10.2337/diacare.19.8.807; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Chen R, 2009, PSYCHOL MED, V39, P425, DOI 10.1017/S0033291708003735; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Chen RL, 2004, INT J GERIATR PSYCH, V19, P407, DOI 10.1002/gps.1103; Chen RL, 2005, EUR J EPIDEMIOL, V20, P141, DOI 10.1007/s10654-004-4498-y; Chen RL, 2008, BRIT J PSYCHIAT, V193, P373, DOI 10.1192/bjp.bp.107.044974; Chen RL, 2012, INT J GERIATR PSYCH, V27, P692, DOI 10.1002/gps.2767; Chen RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024817; COPELAND JRM, 1988, PSYCHOL MED, V18, P219, DOI 10.1017/S003329170000204X; Copeland JRM, 1999, BRIT J PSYCHIAT, V175, P340, DOI 10.1192/bjp.175.4.340; Cugati S, 2007, MED J AUSTRALIA, V186, P131, DOI 10.5694/j.1326-5377.2007.tb00836.x; de JP, 2006, DIABETOLOGIA, V49, P2797; Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Guize L, 2008, B ACAD NAT MED PARIS, V192, P1707, DOI 10.1016/S0001-4079(19)32638-X; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Liu Meina, 2007, Prim Care Diabetes, V1, P123, DOI 10.1016/j.pcd.2007.05.001; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Peng LN, 2010, AGE AGEING, V39, P125, DOI 10.1093/ageing/afp193; Rockwood K, 2000, CAN MED ASSOC J, V162, P769; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Woo J, 2002, INT J EPIDEMIOL, V31, P772, DOI 10.1093/ije/31.4.772; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	31	91	99	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50957	10.1371/journal.pone.0050957	http://dx.doi.org/10.1371/journal.pone.0050957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23226432	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100243
J	Li, ZR; Carlow, CKS				Li, Zhiru; Carlow, Clotilde K. S.			Characterization of Transcription Factors That Regulate the Type IV Secretion System and Riboflavin Biosynthesis in Wolbachia of Brugia malayi	PLOS ONE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM; MACROFILARICIDAL ACTIVITY; INTRACELLULAR BACTERIA; LEGIONELLA-PNEUMOPHILA; ENDOSYMBIOTIC BACTERIA; DOXYCYCLINE TREATMENT; GENE CLUSTERS; EXPRESSION; PROTEIN; ENDOBACTERIA	The human filarial parasite Brugia malayi harbors an endosymbiotic bacterium Wolbachia (wBm) that is required for parasite survival. Consequently, targeting wBm is a promising approach for anti-filarial drug development. The Type IV secretion system (T4SS) plays an important role in bacteria-host interactions and is under stringent regulation by transcription factors. In wBm, most T4SS genes are contained in two operons. We show the wBm is active since the essential assembly factor virB8-1, is transcribed in adult worms and larval stages, and VirB8-1 is present in parasite lysates. We also identify two transcription factors (wBmxR1 and wBmxR2) that bind to the promoter region of several genes of the T4SS. Gel shift assays show binding of wBmxR1 to regions upstream of the virB9-2 and wBmxR2 genes, whereas wBmxR2 binds to virB4-2 and wBmxR1 promoter regions. Interestingly, both transcription factors bind to the promoter of the ribA gene that precedes virB8-1, the first gene in operon 1 of the wBm T4SS. RT-PCR reveals ribA and virB8-1 genes are co-transcribed as one operon, indicating the ribA gene and T4SS operon 1 are co-regulated by both wBmxR1 and wBmxR2. RibA encodes a bi-functional enzyme that catalyzes two essential steps in riboflavin (Vitamin B2) biosynthesis. Importantly, the riboflavin pathway is absent in B. malayi. We demonstrate the pathway is functional in wBm, and observe vitamin B2 supplementation partially rescues filarial parasites treated with doxycycline, indicating Wolbachia may supply the essential vitamin to its worm host. This is the first characterization of a transcription factor(s) from wBm and first report of co-regulation of genes of the T4SS and riboflavin biosynthesis pathway. In addition, our results demonstrate a requirement of vitamin B2 for worm health and fertility, and imply a nutritional role of the symbiont for the filarial parasite host.	[Li, Zhiru; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Parasitol, Ipswich, MA USA	New England Biolabs	Carlow, CKS (corresponding author), New England Biolabs Inc, Div Parasitol, Ipswich, MA USA.	carlow@neb.com		Hide, Geoff/0000-0002-3608-0175	New England Biolabs	New England Biolabs	This work was funded by New England Biolabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Bennett GM, 2012, FLY, V6; Bennuru S, 2011, P NATL ACAD SCI USA, V108, P9649, DOI 10.1073/pnas.1011481108; Bermingham J, 2009, APPL ENVIRON MICROB, V75, P7294, DOI 10.1128/AEM.01472-09; Cheng ZH, 2008, J BACTERIOL, V190, P2096, DOI 10.1128/JB.01813-07; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Debrah AY, 2007, TROP MED INT HEALTH, V12, P1433, DOI 10.1111/j.1365-3156.2007.01949.x; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; Debrah Alexander Yaw, 2006, Filaria J, V5, P1, DOI 10.1186/1475-2883-5-1; Debrah Alexander Yaw, 2011, J Parasitol Res, V2011, P201617, DOI 10.1155/2011/201617; Felix C, 2008, RES MICROBIOL, V159, P481, DOI 10.1016/j.resmic.2008.05.007; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hilleringmann M, 2006, MICROBIOL-SGM, V152, P2919, DOI 10.1099/mic.0.28984-0; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf A, 2009, PARASITOL RES, V104, P437, DOI 10.1007/s00436-008-1217-8; Hoerauf A, 2008, PARASITOL RES, V103, P279, DOI 10.1007/s00436-008-0964-x; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOZEK WJ, 1977, J PARASITOL, V63, P992, DOI 10.2307/3279832; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; Mand S, 2009, AM J TROP MED HYG, V81, P702, DOI 10.4269/ajtmh.2009.09-0155; Martinez-Nunez C, 2010, J BACTERIOL, V192, P5603, DOI 10.1128/JB.00567-10; Masui S, 2000, J BACTERIOL, V182, P6529, DOI 10.1128/JB.182.22.6529-6531.2000; Mathews SA, 1999, FEBS LETT, V458, P354, DOI 10.1016/S0014-5793(99)01182-5; McGarry HF, 2004, MOL BIOCHEM PARASIT, V135, P57, DOI 10.1016/j.molbiopara.2004.01.006; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; Miller MA, 1972, EXPT MOL GENETICS; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Narita S, 2007, APPL ENVIRON MICROB, V73, P4332, DOI 10.1128/AEM.00145-07; Ohashi N, 2002, INFECT IMMUN, V70, P2128, DOI 10.1128/IAI.70.4.2128-2138.2002; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; Rao RU, 2002, EXP PARASITOL, V101, P77, DOI 10.1016/S0014-4894(02)00019-X; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Rikihisa Y, 2009, ANN NY ACAD SCI, V1166, P106, DOI 10.1111/j.1749-6632.2009.04527.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sunish IP, 2011, TROP BIOMED, V28, P569; Taylor MJ, 2005, LANCET, V365, P2116, DOI 10.1016/S0140-6736(05)66591-9; Taylor MJ, 1999, EXP PARASITOL, V91, P356, DOI 10.1006/expr.1998.4383; Wang XQ, 2007, J BACTERIOL, V189, P4880, DOI 10.1128/JB.00318-07; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544; Zusman T, 2007, MOL MICROBIOL, V63, P1508, DOI 10.1111/j.1365-2958.2007.05604.x	62	79	87	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51597	10.1371/journal.pone.0051597	http://dx.doi.org/10.1371/journal.pone.0051597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	22558235	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900107
J	Long, LE; Chesworth, R; Huang, XF; Wong, A; Spiro, A; McGregor, IS; Arnold, JC; Karl, T				Long, Leonora E.; Chesworth, Rose; Huang, Xu-Feng; Wong, Alexander; Spiro, Adena; McGregor, Iain S.; Arnold, Jonathon C.; Karl, Tim			Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; PREPULSE INHIBITION; SOCIAL-INTERACTION; BASE-LINE; RECEPTORS; DELTA(9)-TETRAHYDROCANNABINOL; DELTA-9-TETRAHYDROCANNABINOL; GENE; RAT; BEHAVIOR	The cannabis constituent cannabidiol (CBD) possesses anxiolytic and antipsychotic properties. We have previously shown that transmembrane domain neuregulin 1 mutant (Nrg1 TM HET) mice display altered neurobehavioural responses to the main psychoactive constituent of cannabis, Delta(9)-tetrahydrocannabinol. Here we investigated whether Nrg1 TM HET mice respond differently to CBD and whether CBD reverses schizophrenia-related phenotypes expressed by these mice. Adult male Nrg1 TM HET and wild type-like littermates (WT) received vehicle or CBD (1, 50 or 100 mg/kg i.p.) for 21 days. During treatment and 48 h after withdrawal we measured behaviour, whole blood CBD concentrations and autoradiographic receptor binding. Nrg1 HET mice displayed locomotor hyperactivity, PPI deficits and reduced 5-HT2A receptor binding density in the substantia nigra, but these phenotypes were not reversed by CBD. However, long-term CBD (50 and 100 mg/kg) selectively enhanced social interaction in Nrg1 TM HET mice. Furthermore, acute CBD (100 mg/kg) selectively increased PPI in Nrg1 TM HET mice, although tolerance to this effect was manifest upon repeated CBD administration. Long-term CBD (50 mg/kg) also selectively increased GABA(A) receptor binding in the granular retrosplenial cortex in Nrg1 TM HET mice and reduced 5-HT2A binding in the substantia nigra in WT mice. Nrg1 appears necessary for CBD-induced anxiolysis since only WT mice developed decreased anxiety-related behaviour with repeated CBD treatment. Altered pharmacokinetics in mutant mice could not explain our findings since no genotype differences existed in CBD blood concentrations. Here we demonstrate that Nrg1 modulates acute and long-term neurobehavioural effects of CBD, which does not reverse the schizophrenia-relevant phenotypes.	[Long, Leonora E.; Chesworth, Rose; Huang, Xu-Feng; Arnold, Jonathon C.; Karl, Tim] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Long, Leonora E.; Chesworth, Rose; Karl, Tim] Neurosci Res Australia, Randwick, NSW, Australia; [Long, Leonora E.; Karl, Tim] Univ New S Wales, Sydney, NSW, Australia; [Huang, Xu-Feng] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW, Australia; [Wong, Alexander; Spiro, Adena; Arnold, Jonathon C.] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; [McGregor, Iain S.; Arnold, Jonathon C.] Brain & Mind Res Inst, Sydney, NSW, Australia; [McGregor, Iain S.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Wollongong; University of Sydney; University of Sydney; University of Sydney	Long, LE (corresponding author), Schizophrenia Res Inst, Darlinghurst, NSW, Australia.	jonathon.arnold@sydney.edu.au; t.karl@neura.edu.au	Wong, Alexander/GZM-2929-2022; Huang, Xu-Feng/H-7408-2015; Huang, Xu-Feng/D-6053-2013; Karl, Tim/E-2088-2011; Arnold, Jonathon C/ACF-5231-2022; Long, Leonora/D-2576-2010	Wong, Alexander/0000-0002-5295-2797; Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; Karl, Tim/0000-0001-9904-8482; Long, Leonora/0000-0002-1759-4138; Chesworth, Rose/0000-0002-3758-9598; Arnold, Jonathon/0000-0002-0159-9997; mcgregor, iain/0000-0002-9307-7159	National Health and Medical Research Council (NHMRC) [493301, 568752]; Schizophrenia Research Institute; NSW Health; Baxter Charitable Foundation; Alma Hazel Eddy Trust; National Alliance for Research on Schizophrenia and Depression	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute; NSW Health; Baxter Charitable Foundation; Alma Hazel Eddy Trust; National Alliance for Research on Schizophrenia and Depression(NARSAD)	This work was supported by the National Health and Medical Research Council (NHMRC, project grant 493301) and by the Schizophrenia Research Institute, utilising infrastructure funding from NSW Health, the Baxter Charitable Foundation and the Alma Hazel Eddy Trust. TK is funded by a NHMRC career development award (568752). TK and JCA are also supported by the National Alliance for Research on Schizophrenia and Depression (Young Investigator Awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert L, 2006, GENES BRAIN BEHAV, V5, P423, DOI 10.1111/j.1601-183X.2005.00178.x; Bergamaschi MM, 2011, NEUROPSYCHOPHARMACOL, V36, P1219, DOI 10.1038/npp.2011.6; Bhattacharyya S, 2010, NEUROPSYCHOPHARMACOL, V35, P764, DOI 10.1038/npp.2009.184; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Boucher AA, 2007, NEUROSCIENCE, V149, P861, DOI 10.1016/j.neuroscience.2007.08.020; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Boucher AA, 2011, INT J NEUROPSYCHOPH, V14, P631, DOI 10.1017/S146114571000091X; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Campos AC, 2008, PSYCHOPHARMACOLOGY, V199, P223, DOI 10.1007/s00213-008-1168-x; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Cato MA, 2004, J COGNITIVE NEUROSCI, V16, P167, DOI 10.1162/089892904322984481; CORBETT R, 1991, PSYCHOPHARMACOLOGY, V104, P312, DOI 10.1007/BF02246029; Crippa JAD, 2004, NEUROPSYCHOPHARMACOL, V29, P417, DOI 10.1038/sj.npp.1300340; Dean B, 2008, SCHIZOPHR RES, V99, P341, DOI 10.1016/j.schres.2007.10.013; Deiana S, 2012, PSYCHOPHARMACOLOGY, V219, P859, DOI 10.1007/s00213-011-2415-0; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Deng C, 2006, EXP BRAIN RES, V168, P587, DOI 10.1007/s00221-005-0290-9; Deng Chao, 2007, Neurosci Bull, V23, P341, DOI 10.1007/s12264-007-0051-9; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; El-Alfy AT, 2010, PHARMACOL BIOCHEM BE, V95, P434, DOI 10.1016/j.pbb.2010.03.004; Ellenbroek BA, 2000, BEHAV PHARMACOL, V11, P223, DOI 10.1097/00008877-200006000-00006; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Frisher M, 2005, J EPIDEMIOL COMMUN H, V59, P847, DOI 10.1136/jech.2004.030833; Fusar-Poli P, 2009, ARCH GEN PSYCHIAT, V66, P95, DOI 10.1001/archgenpsychiatry.2008.519; Geyer MA, 2003, CURR PROTOC NEUROSCI; Gomes FV, 2011, PSYCHOPHARMACOLOGY, V213, P465, DOI 10.1007/s00213-010-2036-z; Gunasekaran N, 2009, BRIT J PHARMACOL, V158, P1330, DOI 10.1111/j.1476-5381.2009.00399.x; Gururajan A, 2011, BEHAV BRAIN RES, V222, P299, DOI 10.1016/j.bbr.2011.03.053; Han M, 2009, NEUROSCIENCE, V164, P1754, DOI 10.1016/j.neuroscience.2009.09.041; Kang K, 2009, PROG NEURO-PSYCHOPH, V33, P867, DOI 10.1016/j.pnpbp.2009.04.010; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2011, BEHAV BRAIN RES, V223, P336, DOI 10.1016/j.bbr.2011.04.051; Karschner EL, 2010, ANAL BIOANAL CHEM, V397, P603, DOI 10.1007/s00216-010-3599-6; Keene CS, 2008, BEHAV NEUROSCI, V122, P1070, DOI 10.1037/a0012895; Klein C, 2011, PSYCHOPHARM IN PRESS; Koethe D, 2009, PSYCHOPHARMACOLOGY, V206, P551, DOI 10.1007/s00213-009-1591-7; Koethe D, 2009, BRIT J PSYCHIAT, V194, P371, DOI 10.1192/bjp.bp.108.053843; KREUZ DS, 1973, SCIENCE, V179, P391, DOI 10.1126/science.179.4071.391; Long LE, 2006, NEUROPSYCHOPHARMACOL, V31, P795, DOI 10.1038/sj.npp.1300838; Long LE, 2010, INT J NEUROPSYCHOPH, V13, P861, DOI 10.1017/S1461145709990605; Long LE, 2010, PSYCHOPHARMACOLOGY, V211, P277, DOI 10.1007/s00213-010-1896-6; Malone DT, 2009, PHARMACOL BIOCHEM BE, V93, P91, DOI 10.1016/j.pbb.2009.04.010; MARTIN WR, 1963, PSYCHOPHARMACOLOGIA, V4, P247, DOI 10.1007/BF00408180; McLaren J, 2008, ADDICTION, V103, P1100, DOI 10.1111/j.1360-0443.2008.02230.x; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Moreira FA, 2005, EUR J PHARMACOL, V512, P199, DOI 10.1016/j.ejphar.2005.02.040; Moreira FA, 2006, PROG NEURO-PSYCHOPH, V30, P1466, DOI 10.1016/j.pnpbp.2006.06.004; Nadulski T, 2005, J ANAL TOXICOL, V29, P782, DOI 10.1093/jat/29.8.782; Newell KA, 2007, J NEURAL TRANSM, V114, P995, DOI 10.1007/s00702-007-0668-x; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; O'Tuathaigh CMP, 2008, PROG NEURO-PSYCHOPH, V32, P462, DOI 10.1016/j.pnpbp.2007.09.018; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Petitet F, 1998, LIFE SCI, V63, pPL1, DOI 10.1016/S0024-3205(98)00238-0; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Porras G, 2002, NEUROPSYCHOPHARMACOL, V26, P311, DOI 10.1016/S0893-133X(01)00333-5; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; SCHMIDT CJ, 1992, EUR J PHARMACOL, V223, P65, DOI 10.1016/0014-2999(92)90819-P; Schwarcz G, 2009, J CLIN PSYCHOPHARM, V29, P255, DOI 10.1097/JCP.0b013e3181a6bc3b; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V12, P1383, DOI 10.1017/S1461145709000388; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P1865, DOI 10.1038/sj.npp.1300480; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x; Zuardi AW, 2006, J PSYCHOPHARMACOL, V20, P683, DOI 10.1177/0269881106060967; ZUARDI AW, 1982, PSYCHOPHARMACOLOGY, V76, P245, DOI 10.1007/BF00432554	68	73	74	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34129	10.1371/journal.pone.0034129	http://dx.doi.org/10.1371/journal.pone.0034129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	23272167	gold, Green Submitted, Green Published			2022-12-27	WOS:000304805900013
J	Park, JI; Steen, EJ; Burd, H; Evans, SS; Redding-Johnson, AM; Batth, T; Benke, PI; D'haeseleer, P; Sun, N; Sale, KL; Keasling, JD; Lee, TS; Petzold, CJ; Mukhopadhyay, A; Singer, SW; Simmons, BA; Gladden, JM				Park, Joshua I.; Steen, Eric J.; Burd, Helcio; Evans, Sophia S.; Redding-Johnson, Alyssa M.; Batth, Tanveer; Benke, Peter I.; D'haeseleer, Patrik; Sun, Ning; Sale, Kenneth L.; Keasling, Jay D.; Lee, Taek Soon; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Singer, Steven W.; Simmons, Blake A.; Gladden, John M.			A Thermophilic Ionic Liquid-Tolerant Cellulase Cocktail for the Production of Cellulosic Biofuels	PLOS ONE			English	Article							GLYCOSIDE HYDROLASE ACTIVITIES; ESCHERICHIA-COLI; CLOSTRIDIUM-THERMOCELLUM; BACTERIAL CONSORTIA; SP-NOV.; BIOMASS; PRETREATMENT; ETHANOL; GROWTH; SWITCHGRASS	Generation of biofuels from sugars in lignocellulosic biomass is a promising alternative to liquid fossil fuels, but efficient and inexpensive bioprocessing configurations must be developed to make this technology commercially viable. One of the major barriers to commercialization is the recalcitrance of plant cell wall polysaccharides to enzymatic hydrolysis. Biomass pretreatment with ionic liquids (ILs) enables efficient saccharification of biomass, but residual ILs inhibit both saccharification and microbial fuel production, requiring extensive washing after IL pretreatment. Pretreatment itself can also produce biomass-derived inhibitory compounds that reduce microbial fuel production. Therefore, there are multiple points in the process from biomass to biofuel production that must be interrogated and optimized to maximize fuel production. Here, we report the development of an IL-tolerant cellulase cocktail by combining thermophilic bacterial glycoside hydrolases produced by a mixed consortia with recombinant glycoside hydrolases. This enzymatic cocktail saccharifies IL-pretreated biomass at higher temperatures and in the presence of much higher IL concentrations than commercial fungal cocktails. Sugars obtained from saccharification of IL-pretreated switchgrass using this cocktail can be converted into biodiesel (fatty acid ethyl-esters or FAEEs) by a metabolically engineered strain of E. coli. During these studies, we found that this biodiesel-producing E. coli strain was sensitive to ILs and inhibitors released by saccharification. This cocktail will enable the development of novel biomass to biofuel bioprocessing configurations that may overcome some of the barriers to production of inexpensive cellulosic biofuels.	[Park, Joshua I.; Steen, Eric J.; Burd, Helcio; Evans, Sophia S.; Redding-Johnson, Alyssa M.; Batth, Tanveer; Benke, Peter I.; D'haeseleer, Patrik; Sun, Ning; Sale, Kenneth L.; Keasling, Jay D.; Lee, Taek Soon; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Singer, Steven W.; Simmons, Blake A.; Gladden, John M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst JBEI, Biosci Div, Berkeley, CA 94720 USA; [Park, Joshua I.; Sale, Kenneth L.; Simmons, Blake A.; Gladden, John M.] Sandia Natl Labs, Bioengn & Biomass Sci & Convers Technol Dept, Livermore, CA USA; [D'haeseleer, Patrik] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Geochem, Berkeley, CA 94720 USA; [Singer, Steven W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Ecol, Div Earth Sci, Berkeley, CA 94720 USA; [Evans, Sophia S.] Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Park, JI (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	JMGladden@lbl.gov; JMGladden@lbl.gov	Simmons, Blake/N-6022-2016; Mukhopadhyay, Aindrila/AAW-7257-2021; Keasling, Jay D/J-9162-2012; Sun, Ning/D-6709-2012; Sun, Ning/E-4815-2011; Singer, STeven W/I-1851-2014	Simmons, Blake/0000-0002-1332-1810; Keasling, Jay D/0000-0003-4170-6088; Sun, Ning/0000-0002-9689-9430; D'haeseleer, Patrik/0000-0003-0007-8150; Petzold, Christopher/0000-0002-8270-5228; Batth, Tanveer Singh/0000-0001-5346-4544	US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; US Department of Energy	US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) and the Joint Genome Institute supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlei T, 2004, BIOCHEM ENG J, V17, P187, DOI 10.1016/S1369-703X(03)00181-5; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; Bjornsdottir SH, 2006, EXTREMOPHILES, V10, P1, DOI 10.1007/s00792-005-0466-z; Brennan TCR, 2010, BIOENERG RES, V3, P123, DOI 10.1007/s12155-010-9091-5; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chhabra SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021470; Datta S, 2010, GREEN CHEM, V12, P338, DOI 10.1039/b916564a; DECKER J, 2009, RENEWABLE ENERGY WOR, P11; DOE US, 2010, US FEM CAT MAK FUELS; Fu DB, 2011, BIORESOURCE TECHNOL, V102, P7008, DOI 10.1016/j.biortech.2011.04.049; Ganske F, 2006, BIOTECHNOL LETT, V28, P465, DOI 10.1007/s10529-006-0006-7; Gladden JM, 2012, BIOTECHNOL BIOENG, V109, P1140, DOI 10.1002/bit.24388; Gladden JM, 2011, APPL ENVIRON MICROB, V77, P5804, DOI 10.1128/AEM.00032-11; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; KUNDU S, 1983, BIOTECHNOL BIOENG, V25, P1109, DOI 10.1002/bit.260250418; Laboratory ORN, 2011, US BILL TON UPD BIOM; Lee SM, 2005, KOREAN J CHEM ENG, V22, P687, DOI 10.1007/BF02705783; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8; Lyon PF, 2000, CAN J MICROBIOL, V46, P1029, DOI 10.1139/cjm-46-11-1029; Meyer AS, 2009, J CEREAL SCI, V50, P337, DOI 10.1016/j.jcs.2009.01.010; Nakayama S, 2011, APPL ENVIRON MICROB, V77, P6470, DOI 10.1128/AEM.00706-11; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Ouellet M, 2011, GREEN CHEM; Park JI, 2011, BIORESOURCE TECHNOL, V102, P5988, DOI 10.1016/j.biortech.2011.02.036; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pimentel D, 2003, NAT RESOUR RES, V12, P127, DOI DOI 10.1023/A:1024214812527; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sluiter B., 2011, NRELTP51042618; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Tadesse H., 2011, ENERGY ENV SCI; Touzel JP, 2000, INT J SYST EVOL MICR, V50, P315, DOI 10.1099/00207713-50-1-315; Turner MB, 2003, GREEN CHEM, V5, P443, DOI 10.1039/b302570e; Wald M.L., 2011, NY TIMES; Wang Y, 2011, BIOTECHNOL BIOENG, V108, P1042, DOI 10.1002/bit.23045; Watanabe K, 2007, INT J SYST EVOL MICR, V57, P1473, DOI 10.1099/ijs.0.64672-0; Zaldivar J, 1999, BIOTECHNOL BIOENG, V65, P24, DOI 10.1002/(SICI)1097-0290(19991005)65:1<24::AID-BIT4>3.0.CO;2-2; Zhang T, 2011, GREEN CHEM, V13, P2083, DOI 10.1039/c1gc15193b; Zhao H, 2009, J BIOTECHNOL, V139, P47, DOI 10.1016/j.jbiotec.2008.08.009	43	143	149	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37010	10.1371/journal.pone.0037010	http://dx.doi.org/10.1371/journal.pone.0037010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	23251512	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335800023
J	Yu, HL; Zhang, ZL; Chen, J; Pei, AJ; Hua, F; Qian, XC; He, JJ; Liu, CF; Xu, XS				Yu, Hailong; Zhang, Zeng-Li; Chen, Jing; Pei, Aijie; Hua, Fang; Qian, Xuanchen; He, Jinjiang; Liu, Chun-Feng; Xu, Xingshun			Carvacrol, a Food-Additive, Provides Neuroprotection on Focal Cerebral Ischemia/Reperfusion Injury in Mice	PLOS ONE			English	Article							ESSENTIAL OILS; HUMANIN; 5-ISOPROPYL-2-METHYLPHENOL; ACETYLCHOLINESTERASE; INFLAMMATION; INVOLVEMENT; MECHANISMS; ISCHEMIA; THYMOL; ACETYL	Carvacrol (CAR), a naturally occurring monoterpenic phenol and food additive, has been shown to have antimicrobials, antitumor, and antidepressant-like activities. A previous study demonstrated that CAR has the ability to protect liver against ischemia/reperfusion injury in rats. In this study, we investigated the protective effects of CAR on cerebral ischemia/reperfusion injury in a middle cerebral artery occlusion mouse model. We found that CAR (50 mg/kg) significantly reduced infarct volume and improved neurological deficits after 75 min of ischemia and 24 h of reperfusion. This neuroprotection was in a dose-dependent manner. Post-treatment with CAR still provided protection on infarct volume when it was administered intraperitoneally at 2 h after reperfusion; however, intracerebroventricular post-treatment reduced infarct volume even when the mice were treated with CAR at 6 h after reperfusion. These findings indicated that CAR has an extended therapeutic window, but delivery strategies may affect the protective effects of CAR. Further, we found that CAR significantly decreased the level of cleaved caspase-3, a marker of apoptosis, suggesting the anti-apoptotic activity of CAR. Finally, our data indicated that CAR treatment increased the level of phosphorylated Akt and the neuroprotection of CAR was reversed by a PI3K inhibitor LY-294002, demonstrating the involvement of the PI3K/Akt pathway in the anti-apoptotic mechanisms of CAR. Due to its safety and wide use in the food industry, CAR is a promising agent to be translated into clinical trials.	[Yu, Hailong; Chen, Jing; Qian, Xuanchen; Liu, Chun-Feng; Xu, Xingshun] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China; [Yu, Hailong; Chen, Jing; Pei, Aijie; Qian, Xuanchen; Liu, Chun-Feng; Xu, Xingshun] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Zhang, Zeng-Li; He, Jinjiang] Soochow Univ, Dept Toxicol, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China; [Hua, Fang] Emory Univ, Sch Med, Dept Emergency Med, Brain Res Lab, Atlanta, GA USA	Soochow University - China; Soochow University - China; Soochow University - China; Emory University	Yu, HL (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China.	liucf@suda.edu.cn; Xingshunxu@suda.edu.cn	Xu, Xingshun/AAF-8183-2020	Lee, Peter P./0000-0002-2660-4377; Holmes, Susan/0000-0002-2208-8168; Xu, Xingshun/0000-0003-0205-6342	National Natural Science Foundation of China [81071095, 81120108011]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions of China	This study was supported by grants 81071095 and 81120108011 from the National Natural Science Foundation of China (to XX) and the Priority Academic Program Development of Jiangsu Higher Education Institutions of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, EUR J CLIN MICROBIOL, V30, P41, DOI 10.1007/s10096-010-1050-8; Amiri H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/728065; [Anonymous], 2006, INT J TOXICOL, V25, P29, DOI 10.1080/10915810600716653; Arunasree KM, 2010, PHYTOMEDICINE, V17, P581, DOI 10.1016/j.phymed.2009.12.008; Auriel E, 2010, J CELL MOL MED, V14, P2200, DOI 10.1111/j.1582-4934.2010.01135.x; Boskabady MH, 2011, PHYTOTHER RES, V25, P530, DOI 10.1002/ptr.3290; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Canbek M, 2008, PHYTOMEDICINE, V15, P447, DOI 10.1016/j.phymed.2007.11.022; Melo FHC, 2011, FUND CLIN PHARMACOL, V25, P362, DOI 10.1111/j.1472-8206.2010.00850.x; Melo FHC, 2010, FUND CLIN PHARMACOL, V24, P437, DOI 10.1111/j.1472-8206.2009.00788.x; Cho S, 2012, J NUTR BIOCHEM, V23, P192, DOI 10.1016/j.jnutbio.2010.11.016; Coimbra M, 2011, J CONTROL RELEASE; Dambolena JS, 2011, INT J FOOD MICROBIOL, V145, P140, DOI 10.1016/j.ijfoodmicro.2010.12.001; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Garcia-Garcia R, 2011, J FOOD SCI, V76, pM95, DOI 10.1111/j.1750-3841.2010.02005.x; Guimaraes A. G., 2011, NAUNYN SCHMIEDEBERGS; Guimaraes AG, 2010, BASIC CLIN PHARMACOL, V107, P949, DOI 10.1111/j.1742-7843.2010.00609.x; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Jayakumar S, 2012, MOL CELL BIOCHEM, V360, P51, DOI 10.1007/s11010-011-1043-7; Jukic M, 2007, PHYTOTHER RES, V21, P259, DOI 10.1002/ptr.2063; Kaufmann D, 2011, J PHARM PHARMACOL, V63, P1368, DOI 10.1111/j.2042-7158.2011.01344.x; Lee J, 2008, J DERMATOL SCI, V52, P160, DOI 10.1016/j.jdermsci.2008.06.007; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nostro A., 2011, RECENT PAT ANTIINFEC; Orhan I, 2008, Z NATURFORSCH C, V63, P547; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Savelev SU, 2004, PHYTOTHER RES, V18, P315, DOI 10.1002/ptr.1451; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tang XR, 2011, NAT PROD RES, V25, P320, DOI 10.1080/14786419.2010.532796; Trabace L, 2011, TOXICOL APPL PHARM, V255, P169, DOI 10.1016/j.taap.2011.06.011; Ultee A, 1999, APPL ENVIRON MICROB, V65, P4606; Virmani Renu, 2006, Neurosurgery, V59, pS219; Wieten L, 2010, ARTHRITIS RHEUM-US, V62, P1026, DOI 10.1002/art.27344; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Yin QH, 2012, CYTOTECHNOLOGY, V64, P43, DOI 10.1007/s10616-011-9389-y; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	40	84	88	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33584	10.1371/journal.pone.0033584	http://dx.doi.org/10.1371/journal.pone.0033584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	23251464	Green Submitted, Green Published, gold			2022-12-27	WOS:000303309100062
J	Yin, X; Yin, Y; Cao, FL; Chen, YF; Peng, Y; Hou, WG; Sun, SK; Luo, ZJ				Yin, Xin; Yin, Yue; Cao, Fa-Le; Chen, Yu-Fei; Peng, Ye; Hou, Wu-Gang; Sun, Shu-Kai; Luo, Zhuo-Jing			Tanshinone IIA Attenuates the Inflammatory Response and Apoptosis after Traumatic Injury of the Spinal Cord in Adult Rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; GLIAL APOPTOSIS; FACTOR-ALPHA; CELL-DEATH; EXPRESSION; CYTOKINES; INHIBITION; ASTROCYTES	Background: Spinal cord injury (SCI), including immediate mechanical injury and secondary injury, is associated with the inflammatory response, apoptosis and oxidative stress in response to traumatic injury. Tanshinone IIA (TIIA) is one of the major extracts obtained from Salvia miltiorrhiza BUNGE, which has anti-inflammatory and anti-apoptotic effects on many diseases. However, little is known about the effects of TIIA treatment on SCI. Therefore, the aim of the present study is to evaluate the pharmacological action of TIIA on secondary damage and the underlying mechanisms of experimental SCI in rats. Methodology/Principal Findings: SCI was generated using a weight drop device on the dorsal spinal cord via a two-level T9-T11 laminectomy. SCI in rats resulted in severe trauma, characterized by locomotor disturbance, edema, neutrophil infiltration, the production of astrocytes and inflammatory mediators, apoptosis and oxidative stress. TIIA treatment (20 mg/kg, i.p.) after SCI induced significant effects: (1) improved motor function (Basso, Beattie and Bresnahan scores), (2) reduced the degree of tissue injury (histological score), neutrophil infiltration (myeloperoxidase activity) and the expression of astrocytes, (3) inhibited the activation of SCI-related pathways, such as NF-kappa B and MAPK signaling pathways, (4) decreased the production of pro-inflammatory cytokines (TNF-alpha, IL-1 beta, and IL-6) and iNOS, (5) reduced apoptosis (TUNEL staining, and Bcl-2 and caspase-3 expression) and (6) reversed the redox state imbalance. Conclusions/Significance: The results clearly show that TIIA has a prominent protective effect against SCI through inhibiting the inflammatory response and apoptosis in the spinal cord tissue after SCI.	[Yin, Xin; Chen, Yu-Fei; Peng, Ye; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Inst Orhopaed Surg, Xian 710032, Shaanxi, Peoples R China; [Yin, Yue] Fourth Mil Med Univ, Xijing Hosp, Dept Plast Surg, Xian 710032, Shaanxi, Peoples R China; [Cao, Fa-Le] 222th Hosp CPLA, Dept Neurol & Respirat, Jilin, Peoples R China; [Hou, Wu-Gang] Xijing Hosp, Dept Anesthesia, Xian, Shaanxi, Peoples R China; [Sun, Shu-Kai] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yin, X (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orhopaed Surg, Xian 710032, Shaanxi, Peoples R China.	zjluo@fmmu.edu.cn	peng, ye/GXZ-9245-2022	, Chen/0000-0003-3224-5662	Istitute of Orthopaedics, Fourth Military Medical University	Istitute of Orthopaedics, Fourth Military Medical University	This study was supported by a grant from the Istitute of Orthopaedics, Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen F, 1999, CLIN CHEM, V45, P7; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Esposito E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012170; Fang ZY, 2008, J ETHNOPHARMACOL, V115, P217, DOI 10.1016/j.jep.2007.09.025; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao M, 2008, TRANSL RES, V151, P79, DOI [10.1016/j.trs1.2007.11.005, 10.1016/j.trsl.2007.11.005]; Genovese T, 2007, SHOCK, V27, P258, DOI 10.1097/01.shk.0000239775.41022.54; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Lam BYH, 2003, PHYTOMEDICINE, V10, P286, DOI 10.1078/094471103322004776; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; Li JH, 2011, RESP PHYSIOL NEUROBI, V176, P39, DOI 10.1016/j.resp.2011.01.005; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu XZ, 1997, J NEUROSCI, V17, P5395; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Uto T, 2005, BIOCHEM PHARMACOL, V70, P1211, DOI 10.1016/j.bcp.2005.07.011; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Yang RF, 2008, J CARDIOVASC PHARM, V51, P396, DOI 10.1097/FJC.0b013e3181671439; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zhao BL, 1996, BIOCHEM MOL BIOL INT, V38, P1171; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	40	146	172	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2012	7	6							e38381	10.1371/journal.pone.0038381	http://dx.doi.org/10.1371/journal.pone.0038381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UI	23251642	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339900026
J	Wang, JA; Gao, F; Liu, ZZ; Qiao, M; Niu, XM; Zhang, KQ; Huang, XW				Wang, Ji'ai; Gao, Feng; Liu, Zhongzhong; Qiao, Min; Niu, Xuemei; Zhang, Ke-Qin; Huang, Xiaowei			Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp MG2	PLOS ONE			English	Article							CRYSTAL VIOLET; TRIPHENYLMETHANE; DECOLORIZATION; DYES; DEGRADATION; AZO	Malachite green (MG), N-methylated diaminotriphenylmethane, is one of the most common dyes in textile industry and has also been used as an effective antifungal agent. However, due to its negative impact on the environment and carcinogenic effects to mammalian cells, there is a significant interest in developing microbial agents to degrade this type of recalcitrant molecules. Here, an Exiguobacterium sp. MG2 was isolated from a river in Yunnan Province of China as one of the best malachite green degraders. This strain had a high decolorization capability even at the concentration of 2500 mg/l and maintained its stable activity within the pH range from 5.0 to 9.0. High-pressure liquid chromatography, liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry were employed to detect the catabolic pathway of MG. Six intermediate products were identified and a potential biodegradation pathway was proposed. This pathway involves a series of reactions of N-demethylation, reduction, benzene ring-removal, and oxidation, which eventually converted N-methylated diaminotriphenylmethane into N, N-dimethylaniline that is the key precursor to MG. Furthermore, our molecular biology experiments suggested that both triphenylmethane reductase gene tmr and cytochrome P450 participated in MG degradation, consistent with their roles in the proposed pathway. Collectively, our investigation is the first report on a biodegradation pathway of triphenylmethane dye MG in bacteria. Citation: Wang J, Gao F, Liu Z, Qiao M, Niu X, et al. (2012) Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp. MG2. PLoS ONE 7(12): e51808. doi:10.1371/journal.pone.0051808	[Huang, Xiaowei] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Huang, XW (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.	xwhuang@ynu.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	National Basic Research Program of China (Program 973) [2010CB134503]; Department of Science and Technology of Yunnan Province, China [2010GA012]	National Basic Research Program of China (Program 973)(National Basic Research Program of China); Department of Science and Technology of Yunnan Province, China	This work was supported by the National Basic Research Program of China (Program 973, grant No. 2010CB134503), and the Department of Science and Technology of Yunnan Province, China (grant No 2010GA012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; BUMPUS JA, 1988, APPL ENVIRON MICROB, V54, P1143, DOI 10.1128/AEM.54.5.1143-1150.1988; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; COOPER P, 1993, J SOC DYERS COLOUR, V109, P97; Deng DY, 2008, INT BIODETER BIODEGR, V62, P263, DOI 10.1016/j.ibiod.2008.01.017; Doerge DR, 1998, RAPID COMMUN MASS SP, V12, P1625, DOI 10.1002/(SICI)1097-0231(19981115)12:21<1625::AID-RCM373>3.0.CO;2-I; Gao GD, 2008, CHINESE J CATAL, V29, P426, DOI 10.1016/S1872-2067(08)60043-1; GEORGE KL, 1989, CAN J MICROBIOL, V35, P529, DOI 10.1139/m89-084; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; Jones JJ, 2003, ANTIMICROB AGENTS CH, V47, P2323, DOI 10.1128/AAC.47.7.2323-2326.2003; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Ortega-Calvo JJ, 2010, APPL ENVIRON MICROB, V76, P4430, DOI 10.1128/AEM.00461-10; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8; Wang JA, 2011, J MOL MICROB BIOTECH, V20, P220, DOI 10.1159/000330669; Wu J, 2009, J ENVIRON SCI-CHINA, V21, P960, DOI 10.1016/S1001-0742(08)62368-2; YATOME C, 1993, APPL MICROBIOL BIOT, V38, P565; YATOME C, 1991, J ENVIRON SCI HEAL A, V26, P75, DOI 10.1080/10934529109375621; Yoon JH, 1998, INT J SYST BACTERIOL, V48, P187, DOI 10.1099/00207713-48-1-187	21	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51808	10.1371/journal.pone.0051808	http://dx.doi.org/10.1371/journal.pone.0051808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	22629437	gold, Green Submitted, Green Published			2022-12-27	WOS:000312386800088
J	Wang, J; Hopkins, CJ; Hou, JN; Zou, XX; Wang, CN; Long, Y; Kurup, S; King, GJ; Meng, JL				Wang, Jing; Hopkins, Clare J.; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Kurup, Smita; King, Graham J.; Meng, Jinling			Promoter Variation and Transcript Divergence in Brassicaceae Lineages of FLOWERING LOCUS T	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENTS; FUNCTIONAL DIVERGENCE; COMPARATIVE GENOMICS; FLORAL INDUCTION; GENE-EXPRESSION; EVOLUTION; NAPUS; MECHANISMS; OLERACEA	Brassica napus (AACC, 2n = 38), an oil crop of world-wide importance, originated from interspecific hybridization of B. rapa (AA, 2n = 20) and B. oleracea (CC, 2n = 18), and has six FLOWERING LOCUS T (FT) paralogues. Two located on the homeologous chromosomes A2 and C2 arose from a lineage distinct from four located on A7 and C6. A set of three conserved blocks A, B and C, which were found to be essential for FT activation by CONSTANS (CO) in Arabidopsis, was identified within the FT upstream region in B. napus and its progenitor diploids. However, on chromosome C2, insertion of a DNA transposable element (TE) and a retro-element in FT upstream blocks A and B contributed to significant structural divergence between the A and C genome orthologues. Phylogenetic analysis of upstream block A indicated the conserved evolutionary relationships of distinct FT genes within Brassicaceae. We conclude that the ancient At-a whole genome duplication contributed to distinct ancestral lineages for this key adaptive gene, which co-exist within the same genus. FT-A2 was found to be transcribed in all leaf samples from different developmental stages in both B. rapa and B. napus, whereas FT-C2 was not transcribed in either B. napus or B. oleracea. Silencing of FT-C2 appeared to result from TE insertion and consequent high levels of cytosine methylation in TE sequences within upstream block A. Interestingly, FT-A7/C6 paralogues were specifically silenced in winter type B. napus but abundantly expressed in spring type cultivars under vernalization-free conditions. Motif prediction indicated the presence of two CO protein binding sites within all Brassica block A and additional sites for FT activation in block C. We propose that the ancestral whole genome duplications have contributed to more complex mechanisms of floral regulation and niche adaptation in Brassica compared to Arabidopsis.	[King, Graham J.] So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia; [Wang, Jing; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hopkins, Clare J.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Kurup, Smita] Rothamsted Res, Harpenden, Herts, England	Southern Cross University; Huazhong Agricultural University; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	King, GJ (corresponding author), So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia.	graham.king@scu.edu.au; jmeng@mail.hzau.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Postdoctoral Science Foundation [20100480915]; 111 Project in China [B07041]; UK Biotechnology and Biological Sciences Research Council	Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project in China(Ministry of Education, China - 111 Project); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Postdoctoral Science Foundation (20100480915) and 111 Project (B07041) in China. Rothamsted Research receives grant-aided funds from the UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cardenas PD, 2012, THEOR APPL GENET, V124, P1215, DOI 10.1007/s00122-011-1781-7; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Chopra S, 1999, P NATL ACAD SCI USA, V96, P15330, DOI 10.1073/pnas.96.26.15330; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Henry Y, 2006, TRENDS PLANT SCI, V11, P267, DOI 10.1016/j.tplants.2006.04.002; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Howell EC, 2005, GENOME, V48, P1093, DOI 10.1139/G05-069; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lagercrantz U, 1998, GENETICS, V150, P1217; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lukens L, 2003, GENETICS, V164, P359; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martynov VV, 2005, RUSS J PLANT PHYSL+, V52, P242, DOI 10.1007/s11183-005-0037-2; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; PEREIRA A, 1986, EMBO J, V5, P835, DOI 10.1002/j.1460-2075.1986.tb04292.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Qiu D, 2009, PLANT CELL REP, V28, P649, DOI 10.1007/s00299-008-0661-3; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; UN, 1953, JPN J BOT, V7, P389; Wang J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-39; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Whittle CA, 2009, PLANT CELL, V21, P2203, DOI 10.1105/tpc.109.068411; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101	73	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47127	10.1371/journal.pone.0047127	http://dx.doi.org/10.1371/journal.pone.0047127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	22629437	Green Published, gold, Green Submitted			2022-12-27	WOS:000309807700058
J	Wang, JK; Xu, MY; Zhu, K; Li, L; Liu, XQ				Wang, Juke; Xu, Mengyuan; Zhu, Kai; Li, Lei; Liu, Xinqi			The N-terminus of FILIA Forms an Atypical KH Domain with a Unique Extension Involved in Interaction with RNA	PLOS ONE			English	Article							MATERNAL EFFECT GENE; BINDING PROTEIN; STRUCTURAL BASIS; CELLS; EXPRESSION; SEQUENCE; COMPLEX; ANTIGEN; NOVA; RECOGNITION	FILIA is a member of the recently identified oocyte/embryo expressed gene family in eutherian mammals, which is characterized by containing an N-terminal atypical KH domain. Here we report the structure of the N-terminal fragment of FILIA (FILIA-N), which represents the first reported three-dimensional structure of a KH domain in the oocyte/embryo expressed gene family of proteins. The structure of FILIA-N revealed a unique N-terminal extension beyond the canonical KH region, which plays important roles in interaction with RNA. By co-incubation with the lysates of mice ovaries, FILIA and FILIA-N could sequester specific RNA components, supporting the critical roles of FILIA in regulation of RNA transcripts during mouse oogenesis and early embryogenesis.	[Wang, Juke; Xu, Mengyuan; Liu, Xinqi] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhu, Kai; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, JK (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	lil@ioz.ac.cn; liu2008@nankai.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Ministry of Science and Technology, China [2010CB911800]; National Basic Research Program of China [2011CB944501]; Chinese Academy of Sciences [XDA01010103]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Liu X is supported by National Basic Research Program of China (973 program) (2010CB911800) from Ministry of Science and Technology, China. Li L is funded by National Basic Research Program of China (2011CB944501) and the Chinese Academy of Sciences (XDA01010103 and the Hundred Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Amarasinghe AK, 2001, RNA, V7, P1239, DOI 10.1017/S1355838201010603; ASTIGIANO S, 1991, DIFFERENTIATION, V46, P61, DOI 10.1111/j.1432-0436.1991.tb00866.x; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cai CL, 2010, MOL BIOL CELL, V21, P3137, DOI 10.1091/mbc.E10-03-0255; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Herr JC, 2008, DEV BIOL, V314, P300, DOI 10.1016/j.ydbio.2007.11.027; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JANIN J, 1990, J BIOL CHEM, V265, P16027; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NEUYILIK G, 1993, EUR J BIOCHEM, V213, P727, DOI 10.1111/j.1432-1033.1993.tb17813.x; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierre A, 2007, GENOMICS, V90, P583, DOI 10.1016/j.ygeno.2007.06.003; Pozdnyakova I, 2005, FEBS J, V272, P872, DOI 10.1111/j.1742-4658.2004.04527.x; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ramos A, 2002, BIOCHEMISTRY-US, V41, P4193, DOI 10.1021/bi011994o; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHMIDT C, 1992, EUR J BIOCHEM, V206, P625, DOI 10.1111/j.1432-1033.1992.tb16967.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	60	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30209	10.1371/journal.pone.0030209	http://dx.doi.org/10.1371/journal.pone.0030209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22629437	Green Published, gold, Green Submitted			2022-12-27	WOS:000301457200043
J	Wang, LH; Lv, XJ; Zhai, YG; Fu, SH; Wang, D; Rayner, S; Tang, Q; Liang, GD				Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Wang, David; Rayner, Simon; Tang, Qing; Liang, Guodong			Genomic Characterization of a Novel Virus of the Family Tymoviridae Isolated from Mosquitoes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-MOSAIC-VIRUS; MINUS-STRAND SYNTHESIS; RNA; GENUS; ORGANIZATION; INITIATION; MEMBER; LINE	Background: The family Tymoviridae comprises three plant virus genera, including Tymovirus, Marafivirus, and Maculavirus, which are found in most parts of the world and cause severe agricultural losses. We describe a putatively novel member of the family Tymoviridae, which is isolated from mosquitoes (Culex spp.), referred to as CuTLV. Methods and Results: The CuTLV was isolated by cell culture, which replicates and causes cytopathic effects in Aedes albopictus C6/36 cells, but not in mammalian BHK-21 or Vero cells. The complete 6471 nucleotide sequence of CuTLV was determined. The genome of CuTLV is predicted to contain three open reading frames (ORFs). The largest ORF1 is 5307 nucleotides (nt) in length and encodes a putative polypeptide of 1769 amino acids (aa), which contains the conserved motifs for the methyltransferase (MTR), Tymovirus endopeptidase (PRO), helicase (HEL), and RNA-dependent RNA polymerase (RdRp) of the replication-associated proteins (RPs) of positive-stranded RNA viruses. In contrast, the ORF1 sequence does not contain the so-called "tymobox'' or "marafibox'', the conserved subgenomic RNA promoter present in all tymoviruses or marafiviruses, respectively. ORF2 and ORF3 putatively encode a 248-aa coat protein (CP) and a proline-rich 149-aa polypeptide. The whole genomic nucleotide identity of CuTLV with other members of family Tymoviridae ranged from 46.2% (ChiYMV) to 52.4% (GFkV). Phylogenetic analysis based on the putative RP and CP genes of CuTLV demonstrated that the virus is most closely related to viruses in the genus Maculavirus. Conclusions: The CuTLV is a novel virus related to members of the family Tymoviridae, with molecular characters that are distinct from those of tymoviruses, marafiviruses, and other maculaviruses or macula-like viruses. This is the first report of the isolation of a Tymoviridae-like virus from mosquitoes. Further investigations are required to clarify the origin, replication strategy, and the public health or agricultural importance of the CuTLV.	[Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, David] Washington Univ, St Louis, MO USA; [Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Beijing 100864, Hubei, Peoples R China	Chinese Center for Disease Control & Prevention; Washington University (WUSTL); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, LH (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	Ministry of Science and Technology, People's Republic of China [2003BA712A08-01, 2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	Funding was provided by the Ministry of Science and Technology, People's Republic of China (no. 2003BA712A08-01 and 2011CB504702); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabdullah A, 2010, VIRUS RES, V152, P10, DOI 10.1016/j.virusres.2010.05.010; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; DING S, 1990, NUCLEIC ACIDS RES, V18, P1181, DOI 10.1093/nar/18.5.1181; Dreher TW, 2004, MOL PLANT PATHOL, V5, P367, DOI 10.1111/j.1364-3703.2004.00236.X; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Hammond RW, 2001, VIROLOGY, V282, P338, DOI 10.1006/viro.2001.0859; Hellendoorn K, 1996, NUCLEIC ACIDS RES, V24, P4910, DOI 10.1093/nar/24.24.4910; Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7; Iwanaga M, 2012, J VIROL METHODS, V179, P316, DOI 10.1016/j.jviromet.2011.11.016; Izadpanah K, 2002, VIRUS GENES, V24, P131, DOI 10.1023/A:1014516515454; Jakubiec A, 2007, J VIROL, V81, P11402, DOI 10.1128/JVI.01428-07; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; King AMQ, 2011, 9 INT COMM TAX VIR, P944; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Martelli GP, 2002, ARCH VIROL, V147, P1847, DOI 10.1007/s007050200046; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Sabanadzovic S, 2001, J GEN VIROL, V82, P2009, DOI 10.1099/0022-1317-82-8-2009; Sabanadzovic S, 2009, ARCH VIROL, V154, P1729, DOI 10.1007/s00705-009-0510-x; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Stephan D, 2008, VIRUS GENES, V36, P231, DOI 10.1007/s11262-007-0181-1; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39845	10.1371/journal.pone.0039845	http://dx.doi.org/10.1371/journal.pone.0039845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	23272162	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200014
J	Wang, L; Si, WN; Yao, YF; Tian, DC; Araki, H; Yang, SH				Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai			Genome-Wide Survey of Pseudogenes in 80 Fully Resequenced Arabidopsis thaliana Accessions	PLOS ONE			English	Article							PROCESSED PSEUDOGENES; GENETIC DIVERSITY; DNA; ASSOCIATION; POLYMORPHISMS; EVOLUTIONARY; ANNOTATION; MECHANISMS; RESISTANCE; PATTERNS	Pseudogenes (Psi s), including processed and non-processed Psi s, are ubiquitous genetic elements derived from originally functional genes in all studied genomes within the three kingdoms of life. However, systematic surveys of non-processed Psi s utilizing genomic information from multiple samples within a species are still rare. Here a systematic comparative analysis was conducted of Psi s within 80 fully re-sequenced Arabidopsis thaliana accessions, and 7546 genes, representing similar to 28% of the genomic annotated open reading frames (ORFs), were found with disruptive mutations in at least one accession. The distribution of these Psi s on chromosomes showed a significantly negative correlation between Psi s/ORFs and their local gene densities, suggesting a higher proportion of Psi s in gene desert regions, e. g. near centromeres. On the other hand, compared with the non-Psi loci, even the intact coding sequences (CDSs) in the Psi loci were found to have shorter CDS length, fewer exon number and lower GC content. In addition, a significant functional bias against the null hypothesis was detected in the Psi s mainly involved in responses to environmental stimuli and biotic stress as reported, suggesting that they are likely important for adaptive evolution to rapidly changing environments by pseudogenization to accumulate successive mutations.	[Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Araki, Hitoshi] Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Switzerland	Nanjing University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Araki, H (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	Hitoshi.Araki@eawag.ch; sihaiyang@nju.edu.cn	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	National Natural Science Foundation of China [30970198, J1103512]; NSFC of Jiangsu province [BK2011015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC of Jiangsu province	This work was supported by National Natural Science Foundation of China (30970198 and J1103512) and NSFC of Jiangsu province (BK2011015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benovoy D, 2006, J MOL EVOL, V62, P511, DOI 10.1007/s00239-005-0045-z; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Du JC, 2008, GENE, V426, P1, DOI 10.1016/j.gene.2008.09.003; Freeling M, 2012, CURR OPIN PLANT BIOL, V15, P131, DOI 10.1016/j.pbi.2012.01.015; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Khachane AN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-38; Lafontaine I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-260; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Sen K, 2010, FEBS LETT, V584, P4015, DOI 10.1016/j.febslet.2010.08.012; TAJIMA F, 1989, GENETICS, V123, P585; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Yang S, 2012, P NATL ACAD SCI USA; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Zhang YL, 2009, J MOL EVOL, V68, P393, DOI 10.1007/s00239-009-9217-6; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	43	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51769	10.1371/journal.pone.0051769	http://dx.doi.org/10.1371/journal.pone.0051769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272162	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600039
